Citrus Sinensis ID: 003140
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 845 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGD7 | 953 | Probable LRR receptor-lik | yes | no | 0.959 | 0.850 | 0.736 | 0.0 | |
| Q9LFG1 | 937 | Putative leucine-rich rep | no | no | 0.933 | 0.842 | 0.560 | 0.0 | |
| C0LGU1 | 959 | Probable LRR receptor-lik | no | no | 0.947 | 0.835 | 0.545 | 0.0 | |
| Q9LT96 | 946 | Probable leucine-rich rep | no | no | 0.912 | 0.815 | 0.353 | 1e-113 | |
| Q9ZWC8 | 1166 | Serine/threonine-protein | no | no | 0.854 | 0.619 | 0.304 | 8e-79 | |
| C0LGN2 | 1020 | Probable leucine-rich rep | no | no | 0.894 | 0.741 | 0.293 | 9e-75 | |
| Q1PEM5 | 513 | Proline-rich receptor-lik | no | no | 0.253 | 0.417 | 0.545 | 6e-63 | |
| Q9LK35 | 855 | Receptor-like protein kin | no | no | 0.248 | 0.245 | 0.553 | 9e-63 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.253 | 0.328 | 0.531 | 9e-62 | |
| Q9LX66 | 830 | Receptor-like protein kin | no | no | 0.257 | 0.262 | 0.542 | 1e-61 |
| >sp|C0LGD7|Y1684_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g06840 OS=Arabidopsis thaliana GN=At1g06840 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 1231 bits (3186), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 600/815 (73%), Positives = 702/815 (86%), Gaps = 4/815 (0%)
Query: 29 DSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQ 88
D IT+P+EV ALR IK+SL D +L NW GDPC SNWTGV+CFN+T+DDGYLH+ ELQ
Sbjct: 30 DDITNPVEVRALRVIKESLNDPVHRLRNWKHGDPCNSNWTGVVCFNSTLDDGYLHVSELQ 89
Query: 89 LLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPE 148
L ++NLSGNLSPE+GRLS LTIL FMWNKI+GSIPKEIGNIKSLELLLLNGN L G+LPE
Sbjct: 90 LFSMNLSGNLSPELGRLSRLTILSFMWNKITGSIPKEIGNIKSLELLLLNGNLLNGNLPE 149
Query: 149 ELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHML 208
ELG+LP LDRIQID+N ISG LPKSFANLNKT+HFHMNNNSISGQIPPEL LPS+VH+L
Sbjct: 150 ELGFLPNLDRIQIDENRISGPLPKSFANLNKTKHFHMNNNSISGQIPPELGSLPSIVHIL 209
Query: 209 LDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP 268
LDNNNL+GYLPPELS +P+LLILQLDNN+F+GTTIP SY NMSKLLK+SLRNCSLQGP+P
Sbjct: 210 LDNNNLSGYLPPELSNMPRLLILQLDNNHFDGTTIPQSYGNMSKLLKMSLRNCSLQGPVP 269
Query: 269 DLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 328
DLS IPNLGYLDLS NQLNGSIP G+LS +ITTI LSNN LTGTIP+NFSGLPRLQ+L +
Sbjct: 270 DLSSIPNLGYLDLSQNQLNGSIPAGKLSDSITTIDLSNNSLTGTIPTNFSGLPRLQKLSL 329
Query: 329 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNT 388
ANN+LSGSIPS IWQ R LN+TE+ I+D +NN +NISG ++ PNVTV L+GNP C +
Sbjct: 330 ANNALSGSIPSRIWQERELNSTESIIVDLRNNGFSNISGRSDLRPNVTVWLQGNPLCSDG 389
Query: 389 NAEQFCGSHSDDD-NEIDRSTNSTLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKS 447
N + CG +++D N+ ++N+T+ CP YE+SP RCFCAAPLLVGYRLKS
Sbjct: 390 NLLRLCGPITEEDINQGSTNSNTTI---CSDCPPPYEFSPEPLRRCFCAAPLLVGYRLKS 446
Query: 448 PGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYV 507
PG S F Y++ FE+Y+TSGL LNLYQL +DSF+W+KGPRL+MYLK FPV+ +++ NS++
Sbjct: 447 PGFSDFVPYRSEFEQYITSGLSLNLYQLRLDSFQWQKGPRLRMYLKFFPVFGSNANNSFI 506
Query: 508 FNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFPPSRNSGISKAALAGIIL 567
FN SEV RIR MFTGWNI D D+FGPYEL+NFTL YRDVFP + SG+S A+AGI+L
Sbjct: 507 FNRSEVRRIRGMFTGWNIRDEDLFGPYELMNFTLLDVYRDVFPSASPSGLSNGAVAGIVL 566
Query: 568 GAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFN 627
G++A AVT++AI++L+I+R M+ Y A++RR+ SSK S+KI+GV+SFTY E+ALAT+NFN
Sbjct: 567 GSVAAAVTLTAIIALIIMRKRMRGYSAVARRKRSSKASLKIEGVKSFTYAELALATDNFN 626
Query: 628 SSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
SSTQIGQGGYGKVYKG L GTVVA+KRAQEGSLQGEKEFLTEI+ LSRLHHRNLVSL+G
Sbjct: 627 SSTQIGQGGYGKVYKGTLGSGTVVAIKRAQEGSLQGEKEFLTEIELLSRLHHRNLVSLLG 686
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+CDEEGEQMLVYE+M NGTLRD +S K KEPL FAMRL IALGS++GILYLHTEA+PP+F
Sbjct: 687 FCDEEGEQMLVYEYMENGTLRDNISVKLKEPLDFAMRLRIALGSAKGILYLHTEANPPIF 746
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
HRDIKASNILLD +FTAKVADFGLSRLAPVPD+EGI P HVSTVVKGTPGYLDPEYFLTH
Sbjct: 747 HRDIKASNILLDSRFTAKVADFGLSRLAPVPDMEGISPQHVSTVVKGTPGYLDPEYFLTH 806
Query: 808 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 842
+LTDKSDVYSLGVV LEL TGMQPI+HGKNIVRE+
Sbjct: 807 QLTDKSDVYSLGVVLLELFTGMQPITHGKNIVREI 841
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LFG1|Y3359_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At3g53590 OS=Arabidopsis thaliana GN=At3g53590 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 877 bits (2267), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 456/814 (56%), Positives = 568/814 (69%), Gaps = 25/814 (3%)
Query: 37 VSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSG 96
V+ALR IK+SL+D LSNW +GDPC SNWTG++CF + +DG+ H+RELQL+ LNLSG
Sbjct: 34 VNALREIKRSLIDPMRNLSNWAKGDPCNSNWTGIICFGRSHNDGHFHVRELQLMRLNLSG 93
Query: 97 NLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKL 156
L+PE+G+L YL ILD MWN ++G IP EIG I SL+LLLLNGN+ TGSLP ELG L L
Sbjct: 94 ELAPEVGQLLYLEILDVMWNNLTGRIPLEIGRISSLKLLLLNGNKFTGSLPPELGNLQNL 153
Query: 157 DRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTG 216
+R+Q+D+N I+GS+P SF NL +H H+NNN+ISG+IP ELS+LP LVHM+LDNNNLTG
Sbjct: 154 NRLQVDENNITGSVPFSFGNLRSIKHLHLNNNTISGEIPVELSKLPKLVHMILDNNNLTG 213
Query: 217 YLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNL 276
LP EL++LP L ILQLDNNNFEG+TIP +Y + S+L+KLSLRNC LQG +PDLSRI NL
Sbjct: 214 TLPLELAQLPSLTILQLDNNNFEGSTIPEAYGHFSRLVKLSLRNCGLQGSIPDLSRIENL 273
Query: 277 GYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGS 336
YLDLS N L G+IP +LS N+TTI+LS N LTG+IP +FS L LQ L + NNSLSGS
Sbjct: 274 SYLDLSWNHLTGTIPESKLSDNMTTIELSYNHLTGSIPQSFSDLNSLQLLSLENNSLSGS 333
Query: 337 IPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNA------ 390
+P+ IWQ ++ + + D NNN ++ +G+ P NVT+ LRGNP C +T+
Sbjct: 334 VPTEIWQDKSFENNKLQVYDL-NNNFSDATGNLRTPDNVTLYLRGNPICKSTSIPMVTQF 392
Query: 391 -EQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPG 449
E CG STNS C SCP +E SP C C APL + YRLKSP
Sbjct: 393 FEYICGEKKQT------STNSNTPCSNVSCP--FENVKVSPGICLCTAPLSIDYRLKSPS 444
Query: 450 LSYFPAY-KNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYVF 508
+F Y + F EY+TS L+L +QL ID E R +MYLKL P F
Sbjct: 445 FFFFTPYIERQFREYITSSLQLETHQLAIDRLVDENRLRPRMYLKLVP------KGRITF 498
Query: 509 NASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFPPSRNSGISKAALAGIILG 568
N SEV RIR F W+ +D FGPYEL++F LQGPY D+ ++ SGI I+ G
Sbjct: 499 NKSEVIRIRDRFMSWSFNKTDFFGPYELLDFPLQGPYADLL--AQTSGIRTIVWMMIVAG 556
Query: 569 AIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNS 628
++ A +S +LL VR +N H ++++R S +I GV+ F++ E++ ATN F+S
Sbjct: 557 SVVAATVLSVTATLLYVRKRRENSHTLTKKRVFRTISREIKGVKKFSFVELSDATNGFDS 616
Query: 629 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 688
ST IG+G YGKVYKGIL + T VA+KR +E SLQ EKEFL EI LSRLHHRNLVSL+GY
Sbjct: 617 STLIGRGSYGKVYKGILSNKTEVAIKRGEETSLQSEKEFLNEIDLLSRLHHRNLVSLIGY 676
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 748
+ GEQMLVYE+M NG +RD LSA + + L F+MR +ALGS++GILYLHTEA+PPV H
Sbjct: 677 SSDIGEQMLVYEYMPNGNVRDWLSANAADTLSFSMRSHVALGSAKGILYLHTEANPPVIH 736
Query: 749 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 808
RDIK SNILLD + AKVADFGLSRLAP PAHVSTVV+GTPGYLDPEYF+T +
Sbjct: 737 RDIKTSNILLDCQLHAKVADFGLSRLAPAFGEGDGEPAHVSTVVRGTPGYLDPEYFMTQQ 796
Query: 809 LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 842
LT +SDVYS GVV LELLTGM P G +I+REV
Sbjct: 797 LTVRSDVYSFGVVLLELLTGMHPFFEGTHIIREV 830
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGU1|Y5374_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g37450 OS=Arabidopsis thaliana GN=At5g37450 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 877 bits (2266), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 458/839 (54%), Positives = 593/839 (70%), Gaps = 38/839 (4%)
Query: 27 DDDSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRE 86
D IT P +VSAL+ + + L D + L +W + DPC SNWTGV+C DG+LH++E
Sbjct: 23 DAQEITHPTDVSALQYVHRKLKDPLNHLQDWKKTDPCASNWTGVICIPDP-SDGFLHVKE 81
Query: 87 LQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSL 146
L+LLN+NL+G L+PE+G LS LTIL+FMWN ++G IP E+GN+ L LLL+GN+LTGSL
Sbjct: 82 LRLLNMNLTGQLAPELGLLSNLTILNFMWNDLTGQIPPELGNLTHLIFLLLSGNQLTGSL 141
Query: 147 PEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVH 206
P+ELG L L +QID N ISG LP S ANL K +HFHMNNNSI+GQIPPE S L +++H
Sbjct: 142 PQELGSLSNLLILQIDYNEISGKLPTSLANLKKLKHFHMNNNSITGQIPPEYSTLTNVLH 201
Query: 207 MLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGP 266
L+DNN LTG LPPEL+++P L ILQLD +NF+GT IP+SY ++ L+KLSLRNC+L+GP
Sbjct: 202 FLMDNNKLTGNLPPELAQMPSLRILQLDGSNFDGTEIPSSYGSIPNLVKLSLRNCNLEGP 261
Query: 267 MPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRL 326
+PDLS+ L YLD+SSN+L G IP + S NITTI L NN L+G+IPSNFSGLPRLQRL
Sbjct: 262 IPDLSKSLVLYYLDISSNKLTGEIPKNKFSANITTINLYNNLLSGSIPSNFSGLPRLQRL 321
Query: 327 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-FNIPPNVTVRLRGNPFC 385
+ NN+LSG IP IW++R L A E ILD +NN +N+S N P NVTV+L GNP C
Sbjct: 322 QVQNNNLSGEIP-VIWENRILKAEEKLILDLRNNMFSNVSSVLLNPPSNVTVKLYGNPVC 380
Query: 386 LNTNAEQ---FCG--SHSDDDNEIDRSTNSTLDCRAQSCPT--DYEYSPTSPIRCFCAAP 438
N NA + CG + + T ST DC+ QSCP +Y+Y SP+ CFCAAP
Sbjct: 381 ANVNAGKLADLCGISTLEVESPATSSETISTGDCKRQSCPVSENYDYVIGSPVACFCAAP 440
Query: 439 LLVGYRLKSPGLSYFPAYK--NLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFP 496
L + RL+SP S F YK + + L +N YQ+ ID+F W+ GPRL M +K+FP
Sbjct: 441 LGIDLRLRSPSFSDFRPYKVSYMLDVASPKNLGINPYQISIDTFAWQSGPRLFMNMKIFP 500
Query: 497 VYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDV---FPPSR 553
Y S NS FN++EV RI F + + D GPYE+I+ G Y+DV FP +
Sbjct: 501 EY--SELNSK-FNSTEVQRIVDFFATFTLNTDDSLGPYEIISIN-TGAYKDVTIIFP--K 554
Query: 554 NSGISKAALAGIILGAIAGAVTISAIVSLLIV----------RAHMKNYHAISRRRHSSK 603
SG+S GII+GAIA + +S++ + + M+ H + K
Sbjct: 555 KSGMSIGVSVGIIIGAIAFFLVLSSLALVFFIKRSKRKRKTREVDMEQEHPL------PK 608
Query: 604 TSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG 663
+ ++ V+ + + E+ AT++F+ +QIG+GGYGKVYKG LP G VVAVKRA++GSLQG
Sbjct: 609 PPMNMESVKGYNFTELDSATSSFSDLSQIGRGGYGKVYKGHLPGGLVVAVKRAEQGSLQG 668
Query: 664 EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAM 723
+KEF TEI+ LSRLHHRNLVSL+GYCD++GEQMLVYE+M NG+L+D LSA+ ++PL A+
Sbjct: 669 QKEFFTEIELLSRLHHRNLVSLLGYCDQKGEQMLVYEYMPNGSLQDALSARFRQPLSLAL 728
Query: 724 RLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783
RL IALGS+RGILYLHTEADPP+ HRDIK SNILLD K KVADFG+S+L + D G+
Sbjct: 729 RLRIALGSARGILYLHTEADPPIIHRDIKPSNILLDSKMNPKVADFGISKLIAL-DGGGV 787
Query: 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 842
HV+T+VKGTPGY+DPEY+L+H+LT+KSDVYSLG+VFLE+LTGM+PISHG+NIVREV
Sbjct: 788 QRDHVTTIVKGTPGYVDPEYYLSHRLTEKSDVYSLGIVFLEILTGMRPISHGRNIVREV 846
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LT96|Y5977_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g49770 OS=Arabidopsis thaliana GN=At5g49770 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 410 bits (1053), Expect = e-113, Method: Compositional matrix adjust.
Identities = 305/863 (35%), Positives = 455/863 (52%), Gaps = 92/863 (10%)
Query: 30 SITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQL 89
+ TD + +AL+++K D SK +W DPC + W G+ C N + + L
Sbjct: 25 AFTDGSDFTALQALKNEW-DTLSK--SWKSSDPCGTEWVGITCNNDN------RVVSISL 75
Query: 90 LNLNLSGNLSPEIGRLSYLTILDFMWN-KISGSIPKEIGNIKSLELLLLNGNELTGSLPE 148
N NL G L EI LS L LD N ++SG +P IGN++ L L L G G +P+
Sbjct: 76 TNRNLKGKLPTEISTLSELQTLDLTGNPELSGPLPANIGNLRKLTFLSLMGCAFNGPIPD 135
Query: 149 ELGYLPKLDRIQIDQNYISGSLPKSFANLNK----------------------------- 179
+G L +L R+ ++ N SG++P S L+K
Sbjct: 136 SIGNLEQLTRLSLNLNKFSGTIPASMGRLSKLYWFDIADNQLEGKLPVSDGASLPGLDML 195
Query: 180 --TRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNN 236
T HFH NN +SG+IP +L S +L+H+L D N TG +P L + L +L+LD N
Sbjct: 196 LQTGHFHFGNNKLSGEIPEKLFSSEMTLLHVLFDGNQFTGSIPESLGLVQNLTVLRLDRN 255
Query: 237 NFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS 296
G IP+S +N++ L +L L + G +P+L+ + +L LD+S+N L S P +
Sbjct: 256 RLSGD-IPSSLNNLTNLQELHLSDNKFTGSLPNLTSLTSLYTLDVSNNPLALSPVPSWIP 314
Query: 297 L--NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 354
+++T++L + +L G +P++ +LQ + + +N ++ ++ S+ L+
Sbjct: 315 FLNSLSTLRLEDIQLDGPVPTSLFSPLQLQTVSLKHNLINTTLDLGTNYSKQLD-----F 369
Query: 355 LDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEID-RSTNSTLD 413
+D ++N +T N P V V L N C + A Q G N + ST STL
Sbjct: 370 VDLRDNFITGYKSPANNP--VNVMLADNQVCQDP-ANQLSGYC----NAVQPNSTFSTLT 422
Query: 414 CRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNL--FEEYMTSGLKLN 471
C E + C C PL + L+SP S F N F E + + K
Sbjct: 423 KCGNHCGKGKEPNQG----CHCVYPLTGVFTLRSPSFSGFSNNSNFLKFGESLMTFFKNG 478
Query: 472 LYQLDIDSFR-WEKGP---RLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPD 527
Y +D + R + P L + L +FP SG FN +E+ I S FT +
Sbjct: 479 KYPVDSVAMRNISENPTDYHLLINLLIFP-----SGRDR-FNQTEMDSINSAFTIQDYKP 532
Query: 528 SDIFGPYELINFTLQGPYRDVFPPSRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRA 587
FGPY + Y+ F +S + ++ + + + A+ + +R
Sbjct: 533 PPRFGPYIFV----ADQYK-TFSDLEDSKTVSMKVIIGVVVGVVVLLLLLALAGIYALRQ 587
Query: 588 HMKNYHAISRRRHSSK--------TSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGK 639
+ A + +K + ++ G ++FT+ E++ TNNF+ + +G GGYG+
Sbjct: 588 KKRAQRATDQMNPFAKWDAGKNEMDAPQLMGTKAFTFEELSKCTNNFSDANDVGGGGYGQ 647
Query: 640 VYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699
VYKG LP+G V+A+KRAQ+GS+QG EF TEI+ LSR+HH+N+V L+G+C ++ EQMLVY
Sbjct: 648 VYKGTLPNGQVIAIKRAQQGSMQGAFEFKTEIELLSRVHHKNVVKLLGFCFDQKEQMLVY 707
Query: 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD 759
E++ NG+LRD LS K+ L + RL IALGS +G+ YLH ADPP+ HRD+K++NILLD
Sbjct: 708 EYIPNGSLRDGLSGKNGVKLDWTRRLKIALGSGKGLAYLHELADPPIIHRDVKSNNILLD 767
Query: 760 HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLG 819
TAKVADFGLS+L P+ AHV+T VKGT GYLDPEY++T++LT+KSDVY G
Sbjct: 768 EHLTAKVADFGLSKLVGDPE-----KAHVTTQVKGTMGYLDPEYYMTNQLTEKSDVYGFG 822
Query: 820 VVFLELLTGMQPISHGKNIVREV 842
VV LELLTG PI G +V+EV
Sbjct: 823 VVMLELLTGKSPIDRGSYVVKEV 845
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 295 bits (756), Expect = 8e-79, Method: Compositional matrix adjust.
Identities = 252/827 (30%), Positives = 389/827 (47%), Gaps = 105/827 (12%)
Query: 81 YLHLRELQLLNLNLSGNLSPEIGRL-SYLTILDFMWNKISGSIPKEIGNIKSLELLLLNG 139
+ +L++L L + LSG + PE+ L L ILD N SG +P + L+ L L
Sbjct: 276 FQNLKQLSLAHNRLSGEIPPELSLLCKTLVILDLSGNTFSGELPSQFTACVWLQNLNLGN 335
Query: 140 NELTGS-LPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL 198
N L+G L + + + + + N ISGS+P S N + R +++N +G +P
Sbjct: 336 NYLSGDFLNTVVSKITGITYLYVAYNNISGSVPISLTNCSNLRVLDLSSNGFTGNVPSGF 395
Query: 199 SRL---PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLK 255
L P L +L+ NN L+G +P EL + L + L N G IP + L
Sbjct: 396 CSLQSSPVLEKILIANNYLSGTVPMELGKCKSLKTIDLSFNELTGP-IPKEIWMLPNLSD 454
Query: 256 LSLRNCSLQGPMPD--LSRIPNLGYLDLSSNQLNGSIPPG-RLSLNITTIKLSNNKLTGT 312
L + +L G +P+ + NL L L++N L GSIP N+ I LS+N+LTG
Sbjct: 455 LVMWANNLTGTIPEGVCVKGGNLETLILNNNLLTGSIPESISRCTNMIWISLSSNRLTGK 514
Query: 313 IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT-NISGSFNI 371
IPS L +L L + NNSLSG++P + ++L LD +NNLT ++ G
Sbjct: 515 IPSGIGNLSKLAILQLGNNSLSGNVPRQLGNCKSL-----IWLDLNSNNLTGDLPGELAS 569
Query: 372 PPNV----TVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYEYSP 427
+ +V + F N G+ + E R+ SCP YS
Sbjct: 570 QAGLVMPGSVSGKQFAFVRNEGGTDCRGAGGLVEFEGIRAERLERLPMVHSCPATRIYSG 629
Query: 428 TSPIRCFCAAPLLVGYRLKSPGLSYF--PAYKNLFEEYMTSGLKLNLYQLDI-----DSF 480
+ + F A ++ + + +S F P Y N+ Y+ LNL I DSF
Sbjct: 630 MT-MYTFSANGSMIYFDISYNAVSGFIPPGYGNM--GYLQV---LNLGHNRITGTIPDSF 683
Query: 481 RWEKGPRLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFT 540
LK V D S N + +G + S + ++ ++++ GP
Sbjct: 684 GG---------LKAIGVLDLSHNNLQGYLPGSLGSL-SFLSDLDVSNNNLTGPIPF---- 729
Query: 541 LQGPYRDVFPPSR---NSGI----------------------SKAALAGIILGAIAGAVT 575
G FP SR NSG+ K +A ++ IA +
Sbjct: 730 --GGQLTTFPVSRYANNSGLCGVPLRPCGSAPRRPITSRIHAKKQTVATAVIAGIAFSFM 787
Query: 576 ISAIVSLLIVRAHMKNYHAISRRRH------SSKTSIKIDGV---------------RSF 614
++ + + R R ++ S S K+ V R
Sbjct: 788 CFVMLVMALYRVRKVQKKEQKREKYIESLPTSGSCSWKLSSVPEPLSINVATFEKPLRKL 847
Query: 615 TYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFL 674
T+ + ATN F++ T +G GG+G+VYK L DG+VVA+K+ + QG++EF+ E++ +
Sbjct: 848 TFAHLLEATNGFSAETMVGSGGFGEVYKAQLRDGSVVAIKKLIRITGQGDREFMAEMETI 907
Query: 675 SRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEP----LGFAMRLSIALG 730
++ HRNLV L+GYC E++LVYE+M G+L L KS + L +A R IA+G
Sbjct: 908 GKIKHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVLHEKSSKKGGIYLNWAARKKIAIG 967
Query: 731 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS- 789
++RG+ +LH P + HRD+K+SN+LLD F A+V+DFG++RL D H+S
Sbjct: 968 AARGLAFLHHSCIPHIIHRDMKSSNVLLDEDFEARVSDFGMARLVSALD------THLSV 1021
Query: 790 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836
+ + GTPGY+ PEY+ + + T K DVYS GV+ LELL+G +PI G+
Sbjct: 1022 STLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPGE 1068
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGN2|Y3148_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840 OS=Arabidopsis thaliana GN=LRR-RLK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 282 bits (721), Expect = 9e-75, Method: Compositional matrix adjust.
Identities = 257/875 (29%), Positives = 396/875 (45%), Gaps = 119/875 (13%)
Query: 36 EVSALRSIKKSLVDDYSKLSNWNRG-DPC----------------------TSNWTGVLC 72
EV AL+S+ +L K SNWN DPC T N + V+C
Sbjct: 33 EVDALQSVATAL-----KKSNWNFSVDPCDETLSEGGWRNPNAAKGFEDAVTCNCSSVIC 87
Query: 73 FNTTMD--------------DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKI 118
T + G L+EL L L+G++ PE G S L I + N+I
Sbjct: 88 HVTNIVLKAQDLQGSLPTDLSGLPFLQELDLTRNYLNGSIPPEWGASSLLNI-SLLGNRI 146
Query: 119 SGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLN 178
SGSIPKE+GN+ +L L+L N+L+G +P ELG LP L R+ + N +SG +P +FA L
Sbjct: 147 SGSIPKELGNLTTLSGLVLEYNQLSGKIPPELGNLPNLKRLLLSSNNLSGEIPSTFAKLT 206
Query: 179 KTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNF 238
+++N +G IP + L +++ + L G +P + L L L++ + +
Sbjct: 207 TLTDLRISDNQFTGAIPDFIQNWKGLEKLVIQASGLVGPIPSAIGLLGTLTDLRITDLSG 266
Query: 239 EGTTIPASYSNMSKLLKLSLRNCSLQGPMP------------DLS-------------RI 273
+ P NM+ + L LRNC+L G +P DLS +
Sbjct: 267 PESPFPP-LRNMTSMKYLILRNCNLTGDLPAYLGQNRKLKNLDLSFNKLSGPIPATYSGL 325
Query: 274 PNLGYLDLSSNQLNGSIPPGRL----SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 329
++ ++ +SN LNG +P + +++IT S +K + + L +A
Sbjct: 326 SDVDFIYFTSNMLNGQVPSWMVDQGDTIDITYNNFSKDKTEECQQKSVNTFSSTSPL-VA 384
Query: 330 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTN 389
NNS + S S +T ++ N +T+ ++ T G N
Sbjct: 385 NNSSNVSCLSKYTCPKTFYGLH---INCGGNEITSNETKYDAD---TWDTPGYYDSKNGW 438
Query: 390 AEQFCGSHSDDDNEID-----------RSTNSTLDCRAQSCPTDYEYSPTSPIRCFCAAP 438
G+ DDD + + TNS++D R + S T C
Sbjct: 439 VSSNTGNFLDDDRTNNGKSKWSNSSELKITNSSIDFRLYTQARLSAISLTYQALCLGKGN 498
Query: 439 LLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFPVY 498
V + Y NL Y ++ D + KG K +K FPV
Sbjct: 499 YTVNLHFAEIMFNEKNMYSNLGRRYFDIYVQGKREVKDFNIVDEAKGVG-KAVVKKFPVM 557
Query: 499 DNSSGNSYVFNASEVGRIRSMFTGWN-IPDSDIFGPYELINFTLQGPYRDVFPPSRNSGI 557
V N R++ G IP ++GP LI+ P D PP
Sbjct: 558 --------VTNGKLEIRLQWAGKGTQAIPVRGVYGP--LISAVSVDP--DFIPPKE---- 601
Query: 558 SKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIK-ID-GVRSFT 615
G I++ V L+++ + + R + + K +D + SF+
Sbjct: 602 PGTGTGGGSSVGTVVGSVIASTVFLVLLIGGILWWRGCLRPKSQMEKDFKNLDFQISSFS 661
Query: 616 YGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLS 675
++ +AT+NF+ + +IG+GG+G V+KGI+ DGTV+AVK+ S QG +EFL EI +S
Sbjct: 662 LRQIKVATDNFDPANKIGEGGFGPVHKGIMTDGTVIAVKQLSAKSKQGNREFLNEIAMIS 721
Query: 676 RLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--SAKSKEPLGFAMRLSIALGSSR 733
L H +LV L G C E + +LVYE++ N +L L +++ PL + MR I +G +R
Sbjct: 722 ALQHPHLVKLYGCCVEGDQLLLVYEYLENNSLARALFGPQETQIPLNWPMRQKICVGIAR 781
Query: 734 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 793
G+ YLH E+ + HRDIKA+N+LLD + K++DFGL++L + H+ST V
Sbjct: 782 GLAYLHEESRLKIVHRDIKATNVLLDKELNPKISDFGLAKLDEEEN------THISTRVA 835
Query: 794 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG 828
GT GY+ PEY + LTDK+DVYS GVV LE++ G
Sbjct: 836 GTYGYMAPEYAMRGHLTDKADVYSFGVVALEIVHG 870
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 243 bits (619), Expect = 6e-63, Method: Compositional matrix adjust.
Identities = 120/220 (54%), Positives = 159/220 (72%), Gaps = 6/220 (2%)
Query: 613 SFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQ 672
+FTYGE+A ATN F+ + +G+GG+G VYKGIL +G VAVK+ + GS QGEKEF E+
Sbjct: 170 TFTYGELARATNKFSEANLLGEGGFGFVYKGILNNGNEVAVKQLKVGSAQGEKEFQAEVN 229
Query: 673 FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS 732
+S++HHRNLVSLVGYC +++LVYEF+ N TL L K + + +++RL IA+ SS
Sbjct: 230 IISQIHHRNLVSLVGYCIAGAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSLRLKIAVSSS 289
Query: 733 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 792
+G+ YLH +P + HRDIKA+NIL+D KF AKVADFGL+++A + HVST V
Sbjct: 290 KGLSYLHENCNPKIIHRDIKAANILIDFKFEAKVADFGLAKIALDTN------THVSTRV 343
Query: 793 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 832
GT GYL PEY + KLT+KSDVYS GVV LEL+TG +P+
Sbjct: 344 MGTFGYLAPEYAASGKLTEKSDVYSFGVVLLELITGRRPV 383
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK35|THE1_ARATH Receptor-like protein kinase THESEUS 1 OS=Arabidopsis thaliana GN=THE1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 242 bits (617), Expect = 9e-63, Method: Compositional matrix adjust.
Identities = 119/215 (55%), Positives = 147/215 (68%), Gaps = 5/215 (2%)
Query: 612 RSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEI 671
R F + E+ ATN F+ S+ +G GG+G+VYKG L DGT VAVKR S QG EF TEI
Sbjct: 496 RCFMFQEIMDATNKFDESSLLGVGGFGRVYKGTLEDGTKVAVKRGNPRSEQGMAEFRTEI 555
Query: 672 QFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGS 731
+ LS+L HR+LVSL+GYCDE E +LVYE+M+NG LR L PL + RL I +G+
Sbjct: 556 EMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGADLPPLSWKQRLEICIGA 615
Query: 732 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 791
+RG+ YLHT A + HRD+K +NILLD AKVADFGLS+ P D HVST
Sbjct: 616 ARGLHYLHTGASQSIIHRDVKTTNILLDENLVAKVADFGLSKTGPSLD-----QTHVSTA 670
Query: 792 VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELL 826
VKG+ GYLDPEYF +LT+KSDVYS GVV +E+L
Sbjct: 671 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVL 705
|
Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Mediates the response of growing plant cells to the perturbation of cellulose synthesis and may act as a cell-wall-integrity sensor. Controls ectopic-lignin accumulation in cellulose-deficient mutant backgrounds. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 239 bits (609), Expect = 9e-62, Method: Compositional matrix adjust.
Identities = 117/220 (53%), Positives = 159/220 (72%), Gaps = 6/220 (2%)
Query: 613 SFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQ 672
+FTY E++ ATN F+ + +GQGG+G V+KGILP G VAVK+ + GS QGE+EF E++
Sbjct: 267 TFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVE 326
Query: 673 FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS 732
+SR+HHR+LVSL+GYC +++LVYEF+ N L L K + + ++ RL IALGS+
Sbjct: 327 IISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIALGSA 386
Query: 733 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 792
+G+ YLH + +P + HRDIKASNIL+D KF AKVADFGL+++A + HVST V
Sbjct: 387 KGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTN------THVSTRV 440
Query: 793 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 832
GT GYL PEY + KLT+KSDV+S GVV LEL+TG +P+
Sbjct: 441 MGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPV 480
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LX66|HERK_ARATH Receptor-like protein kinase HERK 1 OS=Arabidopsis thaliana GN=HERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 238 bits (608), Expect = 1e-61, Method: Compositional matrix adjust.
Identities = 121/223 (54%), Positives = 147/223 (65%), Gaps = 5/223 (2%)
Query: 604 TSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG 663
TSI + + + ATNNF+ S IG GG+GKVYKG L DGT VAVKR S QG
Sbjct: 463 TSITTNANYRIPFAAVKDATNNFDESRNIGVGGFGKVYKGELNDGTKVAVKRGNPKSQQG 522
Query: 664 EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAM 723
EF TEI+ LS+ HR+LVSL+GYCDE E +L+YE+M NGT++ L L +
Sbjct: 523 LAEFRTEIEMLSQFRHRHLVSLIGYCDENNEMILIYEYMENGTVKSHLYGSGLPSLTWKQ 582
Query: 724 RLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783
RL I +G++RG+ YLHT PV HRD+K++NILLD F AKVADFGLS+ P D
Sbjct: 583 RLEICIGAARGLHYLHTGDSKPVIHRDVKSANILLDENFMAKVADFGLSKTGPELD---- 638
Query: 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELL 826
HVST VKG+ GYLDPEYF +LTDKSDVYS GVV E+L
Sbjct: 639 -QTHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVL 680
|
Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 845 | ||||||
| 225434309 | 959 | PREDICTED: probable LRR receptor-like se | 0.976 | 0.860 | 0.763 | 0.0 | |
| 297745743 | 960 | unnamed protein product [Vitis vinifera] | 0.977 | 0.860 | 0.751 | 0.0 | |
| 334182352 | 953 | putative leucine-rich repeat transmembra | 0.959 | 0.850 | 0.736 | 0.0 | |
| 357460549 | 955 | hypothetical protein MTR_3g062590 [Medic | 0.981 | 0.868 | 0.705 | 0.0 | |
| 297848960 | 941 | predicted protein [Arabidopsis lyrata su | 0.968 | 0.869 | 0.732 | 0.0 | |
| 356569432 | 953 | PREDICTED: probable LRR receptor-like se | 0.977 | 0.866 | 0.696 | 0.0 | |
| 224124832 | 926 | predicted protein [Populus trichocarpa] | 0.951 | 0.868 | 0.721 | 0.0 | |
| 356537716 | 954 | PREDICTED: probable LRR receptor-like se | 0.977 | 0.865 | 0.691 | 0.0 | |
| 449439195 | 952 | PREDICTED: probable LRR receptor-like se | 0.965 | 0.857 | 0.703 | 0.0 | |
| 356551958 | 977 | PREDICTED: probable LRR receptor-like se | 0.969 | 0.838 | 0.674 | 0.0 |
| >gi|225434309|ref|XP_002276020.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g06840-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1285 bits (3324), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 636/833 (76%), Positives = 713/833 (85%), Gaps = 8/833 (0%)
Query: 11 LFLCLCWSSSKIVVAADDDSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGV 70
L + LCWSSS I A ++TDP+EV+ALR+IK+SL D + L+NWNRGDPCTS WTGV
Sbjct: 21 LLVWLCWSSSFIGAKA---TVTDPVEVTALRAIKESLEDPMNNLTNWNRGDPCTSEWTGV 77
Query: 71 LCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIK 130
LCFNTTM+D YLH++ELQLLN++LSG LSPE+GRLSY+ ILDFMWN I+GSIPKEIGNI
Sbjct: 78 LCFNTTMNDSYLHVKELQLLNMHLSGTLSPELGRLSYMQILDFMWNNITGSIPKEIGNIT 137
Query: 131 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSI 190
+LELLLLNGN+LTGSLPEELG LP LDRIQIDQN ISGS+P+SFANLNKT+HFHMNNNSI
Sbjct: 138 TLELLLLNGNKLTGSLPEELGNLPNLDRIQIDQNQISGSIPRSFANLNKTKHFHMNNNSI 197
Query: 191 SGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNM 250
SGQIP ELSRLP LVH LLDNNNL+GYLPPE SE+PKLLI+QLDNN+F G+ IPASYSNM
Sbjct: 198 SGQIPSELSRLPELVHFLLDNNNLSGYLPPEFSEMPKLLIVQLDNNHFNGS-IPASYSNM 256
Query: 251 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLT 310
SKLLKLSLRNCSLQG +P+LS+IP LGYLDLSSNQLNG+IPPGR S NITTI LSNN LT
Sbjct: 257 SKLLKLSLRNCSLQGEIPNLSKIPYLGYLDLSSNQLNGTIPPGRFSENITTIDLSNNNLT 316
Query: 311 GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFN 370
GTIP+NFSGLP LQ+L + NNSLSG++ SSIWQ+RT N ET+++DFQNN+L+NISG+ +
Sbjct: 317 GTIPANFSGLPHLQKLSLENNSLSGTVSSSIWQNRTSNGNETYVVDFQNNDLSNISGTLD 376
Query: 371 IPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYEYSPTSP 430
+P NVTVRL GNP C N + QFCGS S+++N+ NST+DC A CP YE SP S
Sbjct: 377 LPLNVTVRLYGNPLCTNESLVQFCGSQSEEENDTLNPVNSTVDCTAVRCPLYYEISPASL 436
Query: 431 IRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKM 490
C CAAPLLVGYRLKSPG S F AY+N+FE Y+TSGL LNL QL IDS WEKGPRLKM
Sbjct: 437 EICLCAAPLLVGYRLKSPGFSNFLAYQNMFEYYLTSGLSLNLDQLKIDSVEWEKGPRLKM 496
Query: 491 YLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFP 550
Y KLFP + NS FN+SEV RIR MFTGWNIPDSD+FGPYELINFTL Y+DV
Sbjct: 497 YFKLFP---DDVNNSSEFNSSEVLRIRGMFTGWNIPDSDVFGPYELINFTLTDIYKDVIG 553
Query: 551 PSRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDG 610
S +SGIS AL GIILG IA AVT+SAIV LLI++ +K YH ISRRR S++ SIKIDG
Sbjct: 554 SSSSSGISTGALVGIILGTIAVAVTLSAIVFLLILKNRLKKYHTISRRRKSTRISIKIDG 613
Query: 611 VRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTE 670
V+ FTYGEMALATNNFN S ++GQGGYGKVYKGIL DGTVVA+KRAQEGSLQG+KEF TE
Sbjct: 614 VKDFTYGEMALATNNFNDSAEVGQGGYGKVYKGILADGTVVAIKRAQEGSLQGQKEFFTE 673
Query: 671 IQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS-AKSKEPLGFAMRLSIAL 729
I+ LSR+HHRNLVSL+GYCDEEGEQMLVYEFM NGTLRD LS AKSKEPL FAMRLSIAL
Sbjct: 674 IELLSRVHHRNLVSLIGYCDEEGEQMLVYEFMPNGTLRDHLSAAKSKEPLSFAMRLSIAL 733
Query: 730 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 789
GSS+GILYLHTEA+PP+FHRD+KASNILLD KF AKVADFGLSRLAPVPDIEG PAHVS
Sbjct: 734 GSSKGILYLHTEANPPIFHRDVKASNILLDSKFIAKVADFGLSRLAPVPDIEGSTPAHVS 793
Query: 790 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 842
TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGM PISHGKNIVREV
Sbjct: 794 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMHPISHGKNIVREV 846
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297745743|emb|CBI15799.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1266 bits (3276), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 626/833 (75%), Positives = 704/833 (84%), Gaps = 7/833 (0%)
Query: 11 LFLCLCWSSSKIVVAADDDSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGV 70
L + LCWSSS I A ++TDP+EV+ALR+IK+SL D + L+NWNRGDPCTS WTGV
Sbjct: 21 LLVWLCWSSSFIGAKA---TVTDPVEVTALRAIKESLEDPMNNLTNWNRGDPCTSEWTGV 77
Query: 71 LCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIK 130
LCFNTTM+D YLH++ELQLLN++LSG LSPE+GRLSY+ ILDFMWN I+GSIPKEIGNI
Sbjct: 78 LCFNTTMNDSYLHVKELQLLNMHLSGTLSPELGRLSYMQILDFMWNNITGSIPKEIGNIT 137
Query: 131 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSI 190
+LELLLLNGN+LTGSLPEELG LP LDRIQIDQN ISGS+P+SFANLNKT+HFHMNNNSI
Sbjct: 138 TLELLLLNGNKLTGSLPEELGNLPNLDRIQIDQNQISGSIPRSFANLNKTKHFHMNNNSI 197
Query: 191 SGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNM 250
SGQIP ELSRLP LVH LLDNNNL+GYLPPE SE+PKLLI+QLDNN+F GT +
Sbjct: 198 SGQIPSELSRLPELVHFLLDNNNLSGYLPPEFSEMPKLLIVQLDNNHFNGTFFLPKLQSR 257
Query: 251 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLT 310
S L+ LSLRNCSLQG +P+LS+IP LGYLDLSSNQLNG+IPPGR S NITTI LSNN LT
Sbjct: 258 SMLMNLSLRNCSLQGEIPNLSKIPYLGYLDLSSNQLNGTIPPGRFSENITTIDLSNNNLT 317
Query: 311 GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFN 370
GTIP+NFSGLP LQ+L + NNSLSG++ SSIWQ+RT N ET+++DFQNN+L+NISG+ +
Sbjct: 318 GTIPANFSGLPHLQKLSLENNSLSGTVSSSIWQNRTSNGNETYVVDFQNNDLSNISGTLD 377
Query: 371 IPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYEYSPTSP 430
+P NVTVRL GNP C N + QFCGS S+++N+ NST+DC A CP YE SP S
Sbjct: 378 LPLNVTVRLYGNPLCTNESLVQFCGSQSEEENDTLNPVNSTVDCTAVRCPLYYEISPASL 437
Query: 431 IRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKM 490
C CAAPLLVGYRLKSPG S F AY+N+FE Y+TSGL LNL QL IDS WEKGPRLKM
Sbjct: 438 EICLCAAPLLVGYRLKSPGFSNFLAYQNMFEYYLTSGLSLNLDQLKIDSVEWEKGPRLKM 497
Query: 491 YLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFP 550
Y KLFP + NS FN+SEV RIR MFTGWNIPDSD+FGPYELINFTL Y+DV
Sbjct: 498 YFKLFP---DDVNNSSEFNSSEVLRIRGMFTGWNIPDSDVFGPYELINFTLTDIYKDVIG 554
Query: 551 PSRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDG 610
S +SGIS AL GIILG IA AVT+SAIV LLI++ +K YH ISRRR S++ SIKIDG
Sbjct: 555 SSSSSGISTGALVGIILGTIAVAVTLSAIVFLLILKNRLKKYHTISRRRKSTRISIKIDG 614
Query: 611 VRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTE 670
V+ FTYGEMALATNNFN S ++GQGGYGKVYKGIL DGTVVA+KRAQEGSLQG+KEF TE
Sbjct: 615 VKDFTYGEMALATNNFNDSAEVGQGGYGKVYKGILADGTVVAIKRAQEGSLQGQKEFFTE 674
Query: 671 IQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS-AKSKEPLGFAMRLSIAL 729
I+ LSR+HHRNLVSL+GYCDEEGEQMLVYEFM NGTLRD LS AKSKEPL FAMRLSIAL
Sbjct: 675 IELLSRVHHRNLVSLIGYCDEEGEQMLVYEFMPNGTLRDHLSAAKSKEPLSFAMRLSIAL 734
Query: 730 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 789
GSS+GILYLHTEA+PP+FHRD+KASNILLD KF AKVADFGLSRLAPVPDIEG PAHVS
Sbjct: 735 GSSKGILYLHTEANPPIFHRDVKASNILLDSKFIAKVADFGLSRLAPVPDIEGSTPAHVS 794
Query: 790 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 842
TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGM PISHGKNIVREV
Sbjct: 795 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMHPISHGKNIVREV 847
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|334182352|ref|NP_172169.2| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] gi|264664524|sp|C0LGD7.2|Y1684_ARATH RecName: Full=Probable LRR receptor-like serine/threonine-protein kinase At1g06840; Flags: Precursor gi|332189923|gb|AEE28044.1| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1231 bits (3186), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 600/815 (73%), Positives = 702/815 (86%), Gaps = 4/815 (0%)
Query: 29 DSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQ 88
D IT+P+EV ALR IK+SL D +L NW GDPC SNWTGV+CFN+T+DDGYLH+ ELQ
Sbjct: 30 DDITNPVEVRALRVIKESLNDPVHRLRNWKHGDPCNSNWTGVVCFNSTLDDGYLHVSELQ 89
Query: 89 LLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPE 148
L ++NLSGNLSPE+GRLS LTIL FMWNKI+GSIPKEIGNIKSLELLLLNGN L G+LPE
Sbjct: 90 LFSMNLSGNLSPELGRLSRLTILSFMWNKITGSIPKEIGNIKSLELLLLNGNLLNGNLPE 149
Query: 149 ELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHML 208
ELG+LP LDRIQID+N ISG LPKSFANLNKT+HFHMNNNSISGQIPPEL LPS+VH+L
Sbjct: 150 ELGFLPNLDRIQIDENRISGPLPKSFANLNKTKHFHMNNNSISGQIPPELGSLPSIVHIL 209
Query: 209 LDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP 268
LDNNNL+GYLPPELS +P+LLILQLDNN+F+GTTIP SY NMSKLLK+SLRNCSLQGP+P
Sbjct: 210 LDNNNLSGYLPPELSNMPRLLILQLDNNHFDGTTIPQSYGNMSKLLKMSLRNCSLQGPVP 269
Query: 269 DLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 328
DLS IPNLGYLDLS NQLNGSIP G+LS +ITTI LSNN LTGTIP+NFSGLPRLQ+L +
Sbjct: 270 DLSSIPNLGYLDLSQNQLNGSIPAGKLSDSITTIDLSNNSLTGTIPTNFSGLPRLQKLSL 329
Query: 329 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNT 388
ANN+LSGSIPS IWQ R LN+TE+ I+D +NN +NISG ++ PNVTV L+GNP C +
Sbjct: 330 ANNALSGSIPSRIWQERELNSTESIIVDLRNNGFSNISGRSDLRPNVTVWLQGNPLCSDG 389
Query: 389 NAEQFCGSHSDDD-NEIDRSTNSTLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKS 447
N + CG +++D N+ ++N+T+ CP YE+SP RCFCAAPLLVGYRLKS
Sbjct: 390 NLLRLCGPITEEDINQGSTNSNTTI---CSDCPPPYEFSPEPLRRCFCAAPLLVGYRLKS 446
Query: 448 PGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYV 507
PG S F Y++ FE+Y+TSGL LNLYQL +DSF+W+KGPRL+MYLK FPV+ +++ NS++
Sbjct: 447 PGFSDFVPYRSEFEQYITSGLSLNLYQLRLDSFQWQKGPRLRMYLKFFPVFGSNANNSFI 506
Query: 508 FNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFPPSRNSGISKAALAGIIL 567
FN SEV RIR MFTGWNI D D+FGPYEL+NFTL YRDVFP + SG+S A+AGI+L
Sbjct: 507 FNRSEVRRIRGMFTGWNIRDEDLFGPYELMNFTLLDVYRDVFPSASPSGLSNGAVAGIVL 566
Query: 568 GAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFN 627
G++A AVT++AI++L+I+R M+ Y A++RR+ SSK S+KI+GV+SFTY E+ALAT+NFN
Sbjct: 567 GSVAAAVTLTAIIALIIMRKRMRGYSAVARRKRSSKASLKIEGVKSFTYAELALATDNFN 626
Query: 628 SSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
SSTQIGQGGYGKVYKG L GTVVA+KRAQEGSLQGEKEFLTEI+ LSRLHHRNLVSL+G
Sbjct: 627 SSTQIGQGGYGKVYKGTLGSGTVVAIKRAQEGSLQGEKEFLTEIELLSRLHHRNLVSLLG 686
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+CDEEGEQMLVYE+M NGTLRD +S K KEPL FAMRL IALGS++GILYLHTEA+PP+F
Sbjct: 687 FCDEEGEQMLVYEYMENGTLRDNISVKLKEPLDFAMRLRIALGSAKGILYLHTEANPPIF 746
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
HRDIKASNILLD +FTAKVADFGLSRLAPVPD+EGI P HVSTVVKGTPGYLDPEYFLTH
Sbjct: 747 HRDIKASNILLDSRFTAKVADFGLSRLAPVPDMEGISPQHVSTVVKGTPGYLDPEYFLTH 806
Query: 808 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 842
+LTDKSDVYSLGVV LEL TGMQPI+HGKNIVRE+
Sbjct: 807 QLTDKSDVYSLGVVLLELFTGMQPITHGKNIVREI 841
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357460549|ref|XP_003600556.1| hypothetical protein MTR_3g062590 [Medicago truncatula] gi|355489604|gb|AES70807.1| hypothetical protein MTR_3g062590 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1219 bits (3154), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 597/846 (70%), Positives = 704/846 (83%), Gaps = 17/846 (2%)
Query: 1 MFSSRG---AVLFLFLCLCWSSSKIVVAADDDSITDPIEVSALRSIKKSLVDDYSKLSNW 57
MF S+G V+F+ C+ +++ A ++IT+P EV AL++IKK L+D LSNW
Sbjct: 6 MFFSKGYKHEVVFILWFCCY----VLLVAAQENITNPTEVEALKAIKKRLIDPNRNLSNW 61
Query: 58 NRGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNK 117
NRGDPCTS+WTGVLCFN T+ DGYLH++ELQL+NL+LSGNL+PEIG L Y+ L+FMWNK
Sbjct: 62 NRGDPCTSHWTGVLCFNETLVDGYLHVQELQLMNLSLSGNLAPEIGSLVYMERLNFMWNK 121
Query: 118 ISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANL 177
I+GSIPKEIGNIKSL LLLLNGN+LTGSLPEELG+LPKLDRIQIDQN ISG LPKSFANL
Sbjct: 122 ITGSIPKEIGNIKSLFLLLLNGNQLTGSLPEELGFLPKLDRIQIDQNNISGPLPKSFANL 181
Query: 178 NKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNN 237
NKT+HFHMNNNSISGQIPPEL+RLPSLVH LLDNNNL+GYLPP+LS+LP LLILQLDNNN
Sbjct: 182 NKTKHFHMNNNSISGQIPPELARLPSLVHFLLDNNNLSGYLPPQLSQLPNLLILQLDNNN 241
Query: 238 FEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL 297
FEG +IP +YS+MSKLLKLSL+NC+LQGP+PDLSRIP+L YLDLSSNQLN S+P +L+
Sbjct: 242 FEGNSIPDTYSDMSKLLKLSLKNCNLQGPIPDLSRIPHLLYLDLSSNQLNESLP-SKLAE 300
Query: 298 NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDF 357
NITTI LSNN+LTG IPS+FS L +LQRL +ANNSL+GS+PS+IWQ + LN +E FIL+
Sbjct: 301 NITTIDLSNNQLTGNIPSSFSSLSKLQRLSLANNSLNGSVPSTIWQDKKLNGSERFILEL 360
Query: 358 QNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQ 417
+NN T +SGS ++P VTV LRGNP C N Q C S ++ ++ TN+ C Q
Sbjct: 361 ENNQFTTVSGSTDLPSKVTVLLRGNPLCSNNTLSQLCSSEGVNNTDVLVPTNNNGSCLVQ 420
Query: 418 SCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDI 477
SCP YE+S + CFCAAPLLVGYRLKSPG S F +KN FEEY+T+GL +N+ QL+
Sbjct: 421 SCPPPYEFS----LDCFCAAPLLVGYRLKSPGFSDFLPFKNEFEEYLTTGLSINISQLNF 476
Query: 478 DSFRWEKGPRLKMYLKLFPVY-DNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYEL 536
+FRW GPRL+M LK FP+Y D++S S+ FN +EV RIRSMFTGWNIPDSD+FGPYEL
Sbjct: 477 -TFRWVAGPRLRMDLKFFPLYVDHNS--SHTFNETEVQRIRSMFTGWNIPDSDLFGPYEL 533
Query: 537 INFTLQGPYRDVFPPSRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAIS 596
INF + G Y++ S SGIS A+ GI+LGAIA AVT+SAIV+LLI+R +K+YHA+S
Sbjct: 534 INFNM-GLYQNATSTSSKSGISTGAIVGIVLGAIACAVTLSAIVTLLILRTKLKDYHAVS 592
Query: 597 RRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRA 656
+RRH SK IK+DGVRSFTY E++ ATNNF+SS Q+GQGGYGKVYKG++ GT VA+KRA
Sbjct: 593 KRRHVSKIKIKMDGVRSFTYEELSSATNNFSSSAQVGQGGYGKVYKGVISGGTAVAIKRA 652
Query: 657 QEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK 716
QEGSLQGEKEFLTEI LSRLHHRNLVSL+GYCDEEGEQMLVYE+M NGTLRD LS +K
Sbjct: 653 QEGSLQGEKEFLTEISLLSRLHHRNLVSLIGYCDEEGEQMLVYEYMPNGTLRDHLSVSAK 712
Query: 717 EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776
EPL F MRL IALGS++G++YLH EADPP+FHRD+KASNILLD K +AKVADFGLSRLAP
Sbjct: 713 EPLTFIMRLKIALGSAKGLMYLHNEADPPIFHRDVKASNILLDSKLSAKVADFGLSRLAP 772
Query: 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836
VPD+EGIVP HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLE+LTGM PISHGK
Sbjct: 773 VPDMEGIVPGHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLEILTGMHPISHGK 832
Query: 837 NIVREV 842
NIVREV
Sbjct: 833 NIVREV 838
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297848960|ref|XP_002892361.1| predicted protein [Arabidopsis lyrata subsp. lyrata] gi|297338203|gb|EFH68620.1| predicted protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1214 bits (3141), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 602/822 (73%), Positives = 703/822 (85%), Gaps = 4/822 (0%)
Query: 23 VVAADDDSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYL 82
V+AA + + ALR IK+SL D +L NW GDPC SNWTGV+CFN+T+DDGYL
Sbjct: 10 VMAAAKRKLLLTFLLRALRVIKESLNDPVHRLRNWKHGDPCNSNWTGVVCFNSTLDDGYL 69
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
H+ ELQL ++NLSGNLSP++GRL+ LTIL FMWNKI+GSIPKEIGNIKSLELLLLNGN L
Sbjct: 70 HVSELQLFSMNLSGNLSPDLGRLTRLTILSFMWNKITGSIPKEIGNIKSLELLLLNGNLL 129
Query: 143 TGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLP 202
G+LPEELG+LP LDRIQID+N ISG LPKSFANLNKT+HFHMNNNSISGQIPPE+ LP
Sbjct: 130 IGNLPEELGFLPNLDRIQIDENRISGPLPKSFANLNKTKHFHMNNNSISGQIPPEIGSLP 189
Query: 203 SLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCS 262
S+VH+LLDNNNL+GYLPPELS +P LLILQLDNN+F+GTTIP SY NMSKLLK+SLRNCS
Sbjct: 190 SIVHILLDNNNLSGYLPPELSNMPHLLILQLDNNHFDGTTIPQSYGNMSKLLKMSLRNCS 249
Query: 263 LQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPR 322
LQGP+PDLS IPNLGYLDLS NQLNGSIP G+LS NITTI LS+N LTGTIP+NFSGLPR
Sbjct: 250 LQGPVPDLSSIPNLGYLDLSQNQLNGSIPTGKLSDNITTIDLSSNSLTGTIPTNFSGLPR 309
Query: 323 LQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGN 382
LQ+L +ANN+LSGSIPS IWQ R LN+TE+ I+D +NN +NISG ++ PNVTV L+GN
Sbjct: 310 LQKLSLANNALSGSIPSRIWQERELNSTESIIVDLRNNRFSNISGRSDLRPNVTVWLQGN 369
Query: 383 PFCLNTNAEQFCGSHSDDD-NEIDRSTNS-TLDCRAQSCPTDYEYSPTSPIRCFCAAPLL 440
P C + N + CG +++D N+ STNS T C CP YE+SP RCFCAAPLL
Sbjct: 370 PLCSDGNLLRLCGPITEEDINQGQGSTNSYTTTC--SDCPPPYEFSPEPLRRCFCAAPLL 427
Query: 441 VGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFPVYDN 500
VGYRLKSPG S F Y++ FEEY+TSGL LNLYQL +DSF+W+KGPRL+MYLK FPV+ +
Sbjct: 428 VGYRLKSPGFSDFVPYRSEFEEYITSGLSLNLYQLRLDSFQWQKGPRLRMYLKFFPVFGS 487
Query: 501 SSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFPPSRNSGISKA 560
++ NS++FN SEV RIR MFTGWNI D D+FGPYEL+NFTL YRDVFP + SG+SK
Sbjct: 488 NANNSFIFNRSEVRRIRGMFTGWNIRDEDLFGPYELMNFTLLDVYRDVFPSASPSGLSKG 547
Query: 561 ALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMA 620
A+AGI+LG++A AVT++AI++L+I+R M+ Y+A++RR+ SSK S+KI+GV+SFTY E+A
Sbjct: 548 AVAGIVLGSVAAAVTLTAIIALIIMRKRMRGYNAVARRKRSSKASLKIEGVKSFTYAELA 607
Query: 621 LATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHR 680
LAT+NFNSSTQIGQGGYGKVYKG L GTVVA+KRAQEGSLQGEKEFLTEI+ LSRLHHR
Sbjct: 608 LATDNFNSSTQIGQGGYGKVYKGTLGSGTVVAIKRAQEGSLQGEKEFLTEIELLSRLHHR 667
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 740
NLVSL+G+CDEEGEQMLVYE+M NGTLRD +S K KEPL FAMRL IALGS++GILYLHT
Sbjct: 668 NLVSLLGFCDEEGEQMLVYEYMENGTLRDNISVKLKEPLDFAMRLRIALGSAKGILYLHT 727
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
EA+PP+FHRDIKASNILLD +FTAKVADFGLSRLAPVPD+EGI P HVSTVVKGTPGYLD
Sbjct: 728 EANPPIFHRDIKASNILLDSRFTAKVADFGLSRLAPVPDMEGISPHHVSTVVKGTPGYLD 787
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 842
PEYFLTH+LTDKSDVYSLGVVFLELLTGMQPI+HGKNIVRE+
Sbjct: 788 PEYFLTHQLTDKSDVYSLGVVFLELLTGMQPITHGKNIVREI 829
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356569432|ref|XP_003552905.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g06840-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1179 bits (3051), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 584/839 (69%), Positives = 694/839 (82%), Gaps = 13/839 (1%)
Query: 5 RGAVLFLFLCLCWSSSKIVVAADDDSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCT 64
+ V+F+ C+ ++ AA ++ITDP+EV ALR+IK L+D LSNWN GDPCT
Sbjct: 8 KHEVVFILWFCCY----LLHAAGQNNITDPVEVDALRAIKSRLIDPNGNLSNWNDGDPCT 63
Query: 65 SNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPK 124
S W GVLCFN T +DG+LH+ ELQLL LNL G L+P++G+L+Y+ L+FMWN ISGSIP
Sbjct: 64 SRWKGVLCFNETKEDGHLHVEELQLLRLNLLGTLAPDLGKLTYMKRLNFMWNNISGSIPN 123
Query: 125 EIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFH 184
E+GNI SLELLLLNGN+LTGSLPEE+GYLP LDRIQIDQN ISG +P SFANLNKT+HFH
Sbjct: 124 EVGNITSLELLLLNGNKLTGSLPEEIGYLPNLDRIQIDQNQISGPIPTSFANLNKTKHFH 183
Query: 185 MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP 244
MNNNS+SGQIPPELSRLP+LVH+LLDNNNL+GYLP EL+++P LLI+QLDNNNFEG +IP
Sbjct: 184 MNNNSLSGQIPPELSRLPNLVHLLLDNNNLSGYLPRELADMPSLLIIQLDNNNFEGNSIP 243
Query: 245 ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKL 304
+Y+NMSKLLK+SLRNCSLQGP+PDLSRIP+L YLDLS NQLN SIPP +LS +ITTI L
Sbjct: 244 DTYANMSKLLKMSLRNCSLQGPIPDLSRIPHLLYLDLSLNQLNESIPPNKLSEHITTIDL 303
Query: 305 SNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 364
S+N+LTG IPS F+ LPRLQ+L +ANNSL G++ SSIWQ++T N T+TF+L+ +NNNLT
Sbjct: 304 SSNRLTGNIPSYFADLPRLQKLSLANNSLDGTVSSSIWQNKTSNGTKTFLLELENNNLTT 363
Query: 365 ISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYE 424
ISGS ++PPNVTV L GNP C N QFCGS + + +TNS+ C Q+CP YE
Sbjct: 364 ISGSIDLPPNVTVGLNGNPLCSNVTLTQFCGSEGANVTDGSFTTNSS-SCPPQACPPPYE 422
Query: 425 YSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEK 484
YS + CFC PL+V YRLKSPG S F Y N FE YM SG+K++ QL D F W+
Sbjct: 423 YS----VNCFCGLPLIVDYRLKSPGFSNFLPYLNDFEVYMASGVKISTNQLQYD-FYWQV 477
Query: 485 GPRLKMYLKLFPVY-DNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQG 543
GPRL+M LK FP Y DNSS S+ FN SE+ R+ SMFTGW IPDSD+FGPYEL+ F L G
Sbjct: 478 GPRLRMNLKFFPAYVDNSS--SHTFNRSELLRLTSMFTGWLIPDSDLFGPYELMGFNLLG 535
Query: 544 PYRDVFPPSRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSK 603
PY+D S SGIS AL GI++GAIA AVT+SAIV++LI+R +++YHA+SRRRH+SK
Sbjct: 536 PYQDEIGRSSKSGISTGALVGIVIGAIAFAVTLSAIVTILILRIRLRDYHAVSRRRHASK 595
Query: 604 TSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG 663
SIKIDGVR+F+YGE++ ATNNF++S Q+GQGGYGKVYKG+L DGT+VA+KRAQEGSLQG
Sbjct: 596 ISIKIDGVRAFSYGELSSATNNFSTSAQVGQGGYGKVYKGVLSDGTIVAIKRAQEGSLQG 655
Query: 664 EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAM 723
EKEFLTEI LSRLHHRNLVSL+GYCDEEGEQMLVYEFMSNGTLRD LS +K+PL FAM
Sbjct: 656 EKEFLTEISLLSRLHHRNLVSLIGYCDEEGEQMLVYEFMSNGTLRDHLSVTAKDPLTFAM 715
Query: 724 RLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783
RL +ALG+++G+LYLH+EADPP+FHRD+KASNILLD KF+AKVADFGLSRLAPVPD+EG+
Sbjct: 716 RLKMALGAAKGLLYLHSEADPPIFHRDVKASNILLDSKFSAKVADFGLSRLAPVPDMEGV 775
Query: 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 842
VP HVSTVVKGTPGYLDPEYFLT KLTDKSDVYSLGVVFLELLTGM PISHGKNIVREV
Sbjct: 776 VPGHVSTVVKGTPGYLDPEYFLTRKLTDKSDVYSLGVVFLELLTGMHPISHGKNIVREV 834
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224124832|ref|XP_002319433.1| predicted protein [Populus trichocarpa] gi|222857809|gb|EEE95356.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1179 bits (3049), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 582/807 (72%), Positives = 668/807 (82%), Gaps = 3/807 (0%)
Query: 37 VSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSG 96
V AL+ I+ SL+D LSNW RGDPCTSNWTGVLCFNTT +D YLH+RELQLLN+NLSG
Sbjct: 9 VKALQDIRNSLIDINKNLSNWRRGDPCTSNWTGVLCFNTTKEDAYLHVRELQLLNMNLSG 68
Query: 97 NLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKL 156
LSP +G LSY+ ILDFMWN I+GSIP EIGNIKSLELLLLNGN+LTG LPEELG LPKL
Sbjct: 69 TLSPSLGLLSYMEILDFMWNSITGSIPPEIGNIKSLELLLLNGNQLTGPLPEELGNLPKL 128
Query: 157 DRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTG 216
DRIQIDQN+ISG +PKSFA LN T+HFHMNNNSISGQIP ELSRLP+LVH LLDNNNL+G
Sbjct: 129 DRIQIDQNHISGPIPKSFAYLNSTKHFHMNNNSISGQIPAELSRLPNLVHFLLDNNNLSG 188
Query: 217 YLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNL 276
LPP+L +LPKLLILQLDNN F+G+TIP SY NM++LLKLSLRNCSL+G MPDLS IPNL
Sbjct: 189 TLPPDLYKLPKLLILQLDNNQFDGSTIPPSYGNMTQLLKLSLRNCSLRGLMPDLSGIPNL 248
Query: 277 GYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGS 336
GYLDLS NQL G IPP +L NITTI LSNN L GTIP+ FS LPRLQ L IANNSLSGS
Sbjct: 249 GYLDLSFNQLAGPIPPNKLFENITTINLSNNTLNGTIPAYFSDLPRLQLLSIANNSLSGS 308
Query: 337 IPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGS 396
+PS+IWQ+RT N E L F+NN L+NISGS ++P NVT+ L+GNP C N+N +FCGS
Sbjct: 309 VPSTIWQTRT-NGNEGLDLHFENNRLSNISGSTSLPQNVTLWLQGNPACSNSNIVKFCGS 367
Query: 397 HSDDDNEIDRSTNSTLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAY 456
+ D N+ + ++ C QSCP YEY T I C CAAPL+ YRLKSPG S F Y
Sbjct: 368 QNGDMNDQSTTESNVTTCSVQSCPPPYEYFQTPTISCVCAAPLIFEYRLKSPGFSKFIPY 427
Query: 457 KNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYVFNASEVGRI 516
+ F++Y+TSGL+L+LYQLD+ S WEKGPRLKM LKLFPVY N + +S+ FN SEV RI
Sbjct: 428 RVAFQDYLTSGLELHLYQLDLSSAIWEKGPRLKMQLKLFPVYVNEN-SSHKFNDSEVRRI 486
Query: 517 RSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFPPS-RNSGISKAALAGIILGAIAGAVT 575
SMFTGWNIPDS +FGPYEL+ L GPY +V + + S +S AL GI+LGAIAGAV
Sbjct: 487 ISMFTGWNIPDSQLFGPYELLYINLLGPYINVLSVTPQKSKLSTGALVGIVLGAIAGAVA 546
Query: 576 ISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQG 635
+SA+VSLLI+R +N+ AIS+RR SK S+KI+GV+ F+Y EMALATNNFNSS+Q+GQG
Sbjct: 547 LSAVVSLLILRKRSRNHGAISKRRRVSKASLKIEGVKYFSYAEMALATNNFNSSSQVGQG 606
Query: 636 GYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695
GYGKVYKG L DG VA+KRA+E S QGE+EFLTEI+ LSR+HHRNLVSL+G+CDE GEQ
Sbjct: 607 GYGKVYKGYLADGRTVAIKRAEEASFQGEREFLTEIELLSRVHHRNLVSLIGFCDEGGEQ 666
Query: 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 755
MLVYEFMSNGTLRD LSAK+KEPL FA RL IAL S++GILYLHTEADPP+FHRD+KASN
Sbjct: 667 MLVYEFMSNGTLRDHLSAKAKEPLSFATRLGIALASAKGILYLHTEADPPIFHRDVKASN 726
Query: 756 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDV 815
ILLD ++ AKVADFGLS+LAPVPDIEG VP H+STVVKGTPGYLDPEYFLTHKLTDKSDV
Sbjct: 727 ILLDSRYNAKVADFGLSKLAPVPDIEGDVPGHISTVVKGTPGYLDPEYFLTHKLTDKSDV 786
Query: 816 YSLGVVFLELLTGMQPISHGKNIVREV 842
YSLGVVFLELLTGMQPISHGKNIVREV
Sbjct: 787 YSLGVVFLELLTGMQPISHGKNIVREV 813
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356537716|ref|XP_003537371.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g06840-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1165 bits (3013), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 580/839 (69%), Positives = 686/839 (81%), Gaps = 13/839 (1%)
Query: 5 RGAVLFLFLCLCWSSSKIVVAADDDSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCT 64
G V L+ C C+ ++ AA ++ITDP+EV ALR+IK+ L+D LSNW DPCT
Sbjct: 9 HGVVFLLWFC-CY----LLHAAGQNNITDPVEVDALRAIKRRLIDPNGNLSNWEDRDPCT 63
Query: 65 SNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPK 124
S W GVLCFN T +DGYLH+ ELQLL LNL G L+P++G+L+Y+ L+FMWN ISGSIPK
Sbjct: 64 SRWKGVLCFNETKEDGYLHVEELQLLRLNLFGTLAPDLGKLTYMKRLNFMWNNISGSIPK 123
Query: 125 EIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFH 184
E+GNI SLELLLLNGN LTGSLPEE+GYLP LDRIQIDQN ISG +P SFANLNKT+HFH
Sbjct: 124 EVGNITSLELLLLNGNNLTGSLPEEIGYLPNLDRIQIDQNQISGPIPTSFANLNKTKHFH 183
Query: 185 MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP 244
MNNNS+SGQIPPELSRLP LVH+LLDNNNL+GYLP EL+++P LLI+QLDNNNFEG +IP
Sbjct: 184 MNNNSLSGQIPPELSRLPKLVHLLLDNNNLSGYLPRELADMPSLLIIQLDNNNFEGNSIP 243
Query: 245 ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKL 304
+Y+NMSKLLK+SLRNC+L+GP+PDL RIP+L YLDLS NQLNGSIPP +LS NITTI L
Sbjct: 244 DTYANMSKLLKMSLRNCNLRGPLPDLRRIPHLLYLDLSFNQLNGSIPPNKLSENITTIDL 303
Query: 305 SNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 364
SNN LTG IPS F+ LPRLQ+L +ANNSL G++ SSIWQ++TLN TE F L+ +NNNLT
Sbjct: 304 SNNLLTGNIPSYFADLPRLQKLSLANNSLDGTVSSSIWQNKTLNGTEKFFLELENNNLTT 363
Query: 365 ISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYE 424
ISGS ++PPNVTV L GNP C N QFCGS + +TN + C Q CP +E
Sbjct: 364 ISGSIDLPPNVTVGLNGNPLCSNITLIQFCGSEAATVTNGSLTTNFS-SCPPQGCPPPFE 422
Query: 425 YSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEK 484
Y+ + CFCA PL+V YRLKSPG + F Y N F++YMT GL+++ QL+ D F W+
Sbjct: 423 YT----VDCFCALPLIVFYRLKSPGFTNFLPYLNGFKDYMTHGLEISFDQLEYD-FYWQV 477
Query: 485 GPRLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGP 544
GPRLKM LK FP Y N++ N + FN SE+ RI+S FTGW IPD+D FGPYELI F L G
Sbjct: 478 GPRLKMDLKFFPPYLNNTSN-HTFNESELLRIKSKFTGWLIPDNDTFGPYELIGFNLLGS 536
Query: 545 YRDVFPP-SRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSK 603
Y+DV P S + I L GI++GAIA AVT+SAIV++LI+R +++YHA+S++RH+SK
Sbjct: 537 YQDVIPTRSESQNIRTGVLVGIVIGAIACAVTLSAIVTILILRIKLRDYHAVSKQRHASK 596
Query: 604 TSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG 663
SIKIDGVR+FTYGE++ ATNNF+ S Q+GQGGYGKVYKG+L DGTVVA+KRAQEGSLQG
Sbjct: 597 ISIKIDGVRAFTYGELSFATNNFSISAQVGQGGYGKVYKGVLSDGTVVAIKRAQEGSLQG 656
Query: 664 EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAM 723
EKEFLTEI LSRLHHRNLVSL+GYCDEEGEQMLVYEFMSNGTLRD LS +K+PL FAM
Sbjct: 657 EKEFLTEISLLSRLHHRNLVSLIGYCDEEGEQMLVYEFMSNGTLRDHLSVTAKDPLTFAM 716
Query: 724 RLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783
RL IALG+++G++YLHTEADPP+FHRD+KASNILLD KF+AKVADFGLSRLAPVPD+EG+
Sbjct: 717 RLKIALGAAKGLMYLHTEADPPIFHRDVKASNILLDSKFSAKVADFGLSRLAPVPDMEGV 776
Query: 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 842
VP HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGM PISHGKNIVREV
Sbjct: 777 VPGHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMHPISHGKNIVREV 835
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439195|ref|XP_004137372.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g06840-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1145 bits (2963), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 579/823 (70%), Positives = 668/823 (81%), Gaps = 7/823 (0%)
Query: 22 IVVAADDDSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGY 81
+VVAA+ T P EV AL IK SL D LSNWN+GDPC SNWTGVLC+NTT DD Y
Sbjct: 24 VVVAAEMG--THPSEVDALLLIKSSLFDPNGNLSNWNKGDPCNSNWTGVLCYNTTFDDNY 81
Query: 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNE 141
LH+ ELQLLN++LSG LSP +GRLSYL +LDFMWNKISG IP+EIGN+ SLELLLLNGN+
Sbjct: 82 LHVAELQLLNMSLSGKLSPALGRLSYLRVLDFMWNKISGEIPREIGNLTSLELLLLNGNQ 141
Query: 142 LTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRL 201
L+GSLPE+LG L LDRIQIDQN+ISG +PKSFANL T+HFHMNNNSISG+IP ELS L
Sbjct: 142 LSGSLPEDLGNLLHLDRIQIDQNHISGLIPKSFANLKATKHFHMNNNSISGEIPSELSGL 201
Query: 202 PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261
P+LVH LLDNNNL+G LPPEL +LP L ILQLDNNNF G TIP SY M+KLLKLSLRNC
Sbjct: 202 PNLVHFLLDNNNLSGKLPPELFQLPNLEILQLDNNNFSGATIPDSYGKMTKLLKLSLRNC 261
Query: 262 SLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLP 321
+LQG +PDLSRI NLGYLDLSSNQL+G IP G+LS NITTI LS+N+LTGTIPS+ GLP
Sbjct: 262 TLQGSIPDLSRIKNLGYLDLSSNQLSGLIPRGKLSENITTIILSDNRLTGTIPSSLLGLP 321
Query: 322 RLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRG 381
LQ+L +ANNSL+GS+PS+IWQSR LN+ ++ ++ QNNN ++I GS ++P NV+VRL+G
Sbjct: 322 HLQKLSVANNSLNGSVPSTIWQSRMLNSLDSLTVELQNNNFSDILGSIHLPLNVSVRLQG 381
Query: 382 NPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYE-YSPTSPIRCFCAAPLL 440
NP C N + FCGS S+D ID TN+ L C CP YE YS P C C+APLL
Sbjct: 382 NPACANNSLLDFCGSESEDI--IDIPTNNPLGCSGPICPPSYECYSAKCPSSCLCSAPLL 439
Query: 441 VGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFPVYDN 500
+GYRLKSPG S F Y+++FEEY+TSGLK++L QLDI S WEKGPRL+M LK+FP+Y
Sbjct: 440 IGYRLKSPGFSRFSPYQHMFEEYLTSGLKVHLEQLDIGSAVWEKGPRLRMSLKVFPLYVA 499
Query: 501 SSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDV-FPPSRNSGISK 559
S +S++FN SEV RI FT W I DSDIFGPYEL++ T+ Y+ V F PS +S +SK
Sbjct: 500 DSNSSHMFNDSEVLRIVYKFTNWKIQDSDIFGPYELLSLTISDVYKKVFFTPSSDSTMSK 559
Query: 560 AALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGVRSFTYGEM 619
ALAGIILGAIAG +SAIV + I+R+ ++ +H ISRRRH SKTSIKI GV+ F Y EM
Sbjct: 560 GALAGIILGAIAGGAMLSAIVFIFIIRSRVRGHH-ISRRRHLSKTSIKIKGVKEFGYREM 618
Query: 620 ALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH 679
ALATNNF+ S +GQGGYGKVYKGIL D VA+KRAQEGSLQGEKEFLTEIQ LSRLHH
Sbjct: 619 ALATNNFHCSMVVGQGGYGKVYKGILADSMAVAIKRAQEGSLQGEKEFLTEIQLLSRLHH 678
Query: 680 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
RNLV+L+GYCDEEGEQML YEFMSNGTLRD LS S EPL FA RL ALG+++GILYLH
Sbjct: 679 RNLVALIGYCDEEGEQMLAYEFMSNGTLRDHLSVNSAEPLSFATRLKAALGAAKGILYLH 738
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
TEADPP+FHRDIK+SNILLD K+ AKVADFGLSRLAP+P+ EG VPAHVSTVVKGTPGYL
Sbjct: 739 TEADPPIFHRDIKSSNILLDSKYVAKVADFGLSRLAPLPNAEGDVPAHVSTVVKGTPGYL 798
Query: 800 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 842
DPEYFLTHKLTDKSDVYSLGVVFLELLTG PISHGKNIVREV
Sbjct: 799 DPEYFLTHKLTDKSDVYSLGVVFLELLTGRHPISHGKNIVREV 841
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356551958|ref|XP_003544339.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g06840-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1119 bits (2895), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 566/839 (67%), Positives = 674/839 (80%), Gaps = 20/839 (2%)
Query: 7 AVLFLFLCLCWSSSKIVVAADDDSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSN 66
VLFL+ C C+ +++ A IT+P EV ALR+IK+SL+D LS+W+ GDPC S
Sbjct: 42 VVLFLWFC-CY----LLLTAGQ--ITEPTEVDALRAIKRSLIDINGSLSSWDHGDPCASQ 94
Query: 67 --WTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPK 124
W G+ C NTT+ D YLH+R+L L+ LNLSG L PEIGRLSYL ILDFMWN ISGSIPK
Sbjct: 95 SEWKGITCSNTTLVDDYLHVRQLHLMKLNLSGTLVPEIGRLSYLEILDFMWNNISGSIPK 154
Query: 125 EIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFH 184
EIGNIK+L LLLLNGN+LTG LPEELG L L+RIQID+N I+GS+P SFANLN+T H H
Sbjct: 155 EIGNIKTLRLLLLNGNKLTGDLPEELGQLSVLNRIQIDENNITGSIPLSFANLNRTEHIH 214
Query: 185 MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP 244
MNNNS+SGQI PEL +L SLVH+LLDNNN TGYLPPE SE+P L ILQLDNN+F G +IP
Sbjct: 215 MNNNSLSGQILPELFQLGSLVHLLLDNNNFTGYLPPEFSEMPSLRILQLDNNDFGGNSIP 274
Query: 245 ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKL 304
SY N+SKL KLSLRNC+LQGP+PD SRIP+L YLDLS NQLN SIP +LS NITTI L
Sbjct: 275 ESYGNISKLSKLSLRNCNLQGPIPDFSRIPHLAYLDLSFNQLNESIPTNKLSDNITTIDL 334
Query: 305 SNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 364
SNNKLTGTIPS+FSGLPRLQ+L ANNSLSG +PS+IWQ R+LN TE ILD QNN LT
Sbjct: 335 SNNKLTGTIPSSFSGLPRLQKLSFANNSLSGYVPSTIWQDRSLNGTERLILDMQNNQLTI 394
Query: 365 ISGSFNIPPNVTVRLRGNPFCLNTNA-EQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDY 423
ISG+ N+PPNVT+ L GNP C N N QFCG D+ + N +++C +Q CP+ Y
Sbjct: 395 ISGTTNLPPNVTLLLEGNPVCTNNNTLVQFCGPEIDN----GLNGNYSVNCPSQECPSPY 450
Query: 424 EYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWE 483
EY+ + CFC APL+V YRLKSPG S F Y+ FE ++T GL +++ QL I SF WE
Sbjct: 451 EYT----VECFCVAPLVVHYRLKSPGFSDFRTYERTFESFLTDGLNVDINQLFIKSFAWE 506
Query: 484 KGPRLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQG 543
+GPRL+M LKLFP N+ + F+ SEV RIR++F W I SD+FGPYEL++F + G
Sbjct: 507 EGPRLRMNLKLFPECINNKSYCF-FSTSEVIRIRNLFRDWGILSSDLFGPYELLDFIV-G 564
Query: 544 PYRDVFPPSRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSK 603
PYRDV PS +S ISK AL GI+LGAIA A+T+SAIVS+LI+R +++Y A+SR+R++S+
Sbjct: 565 PYRDVISPSPSSWISKGALVGIVLGAIACAITLSAIVSILILRIRLRDYGALSRQRNASR 624
Query: 604 TSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG 663
S+KIDGVRSF Y EMALA+NNF+ S QIG+GGYGKVYKG LPDGTVVA+KRAQEGSLQG
Sbjct: 625 ISVKIDGVRSFDYNEMALASNNFSESAQIGEGGYGKVYKGHLPDGTVVAIKRAQEGSLQG 684
Query: 664 EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAM 723
E+EFLTEI+ LSRLHHRNL+SL+GYCD+ GEQMLVYE+M NG LR+ LSA SKEPL F+M
Sbjct: 685 EREFLTEIELLSRLHHRNLLSLIGYCDQGGEQMLVYEYMPNGALRNHLSANSKEPLSFSM 744
Query: 724 RLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783
RL IALGS++G+LYLHTEA+PP+FHRD+KASNILLD ++TAKVADFGLSRLAPVPDIEG
Sbjct: 745 RLKIALGSAKGLLYLHTEANPPIFHRDVKASNILLDSRYTAKVADFGLSRLAPVPDIEGN 804
Query: 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 842
VP HVSTVVKGTPGYLDPEYFLT+KLTDKSDVYSLGVVFLEL+TG PI HG+NI+R V
Sbjct: 805 VPGHVSTVVKGTPGYLDPEYFLTYKLTDKSDVYSLGVVFLELVTGRPPIFHGENIIRHV 863
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 845 | ||||||
| TAIR|locus:2181017 | 951 | AT5G01950 [Arabidopsis thalian | 0.968 | 0.860 | 0.581 | 3.8e-252 | |
| TAIR|locus:2084016 | 937 | AT3G53590 [Arabidopsis thalian | 0.937 | 0.845 | 0.515 | 8.3e-209 | |
| TAIR|locus:2019863 | 971 | AT1G79620 [Arabidopsis thalian | 0.918 | 0.799 | 0.366 | 4.4e-116 | |
| TAIR|locus:2157042 | 953 | AT5G49760 [Arabidopsis thalian | 0.918 | 0.814 | 0.355 | 1.1e-112 | |
| TAIR|locus:2156992 | 946 | AT5G49770 [Arabidopsis thalian | 0.918 | 0.820 | 0.347 | 8.1e-108 | |
| TAIR|locus:2157002 | 857 | AT5G49780 [Arabidopsis thalian | 0.269 | 0.266 | 0.587 | 6.6e-102 | |
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.279 | 0.197 | 0.443 | 3.7e-72 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.340 | 0.261 | 0.370 | 2.9e-71 | |
| TAIR|locus:2005507 | 976 | ER "ERECTA" [Arabidopsis thali | 0.256 | 0.222 | 0.410 | 2.8e-70 | |
| TAIR|locus:2146102 | 638 | NIK1 "NSP-interacting kinase 1 | 0.282 | 0.374 | 0.434 | 7.8e-70 |
| TAIR|locus:2181017 AT5G01950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2428 (859.8 bits), Expect = 3.8e-252, P = 3.8e-252
Identities = 480/826 (58%), Positives = 576/826 (69%)
Query: 23 VVAADDDSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYX 82
V+ D T P EV+ALRS+K+SL+D L NWNRGDPC SNWTGV+CFN D Y
Sbjct: 19 VLLLADAQRTHPSEVTALRSVKRSLLDPKDYLRNWNRGDPCRSNWTGVICFNEIGTDDYL 78
Query: 83 XXXXXXXXXXXXXXXXSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKXXXXXXXXXXXX 142
SPE+ +L++L ILDFMWN ISGSIP EIG I
Sbjct: 79 HVRELLLMNMNLSGTLSPELQKLAHLEILDFMWNNISGSIPNEIGQISSLVLLLLNGNKL 138
Query: 143 XXXXPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLP 202
P ELGYL L+R QID+N I+G +PKSF+NL K +H H NNNS++GQIP ELS L
Sbjct: 139 SGTLPSELGYLSNLNRFQIDENNITGPIPKSFSNLKKVKHLHFNNNSLTGQIPVELSNLT 198
Query: 203 SLVHMLLDNNNLTGYXXXXXXXXXXXXXXXXDNNNFEGTTIPASYSNMSKLLKLSLRNCS 262
++ H+LLDNN L+G DNNNF G+ IPASY N S +LKLSLRNCS
Sbjct: 199 NIFHVLLDNNKLSGNLPPQLSALPNLQILQLDNNNFSGSDIPASYGNFSNILKLSLRNCS 258
Query: 263 LQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPR 322
L+G +PD S+I +L YLDLS N+L G IP S ++TTI LSNN L G+IP +FS LP
Sbjct: 259 LKGALPDFSKIRHLKYLDLSWNELTGPIPSSNFSKDVTTINLSNNILNGSIPQSFSDLPL 318
Query: 323 LQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGN 382
LQ L + NN LSGS+P S+W++ + +LD +NN+L+ + G P NVT+RL GN
Sbjct: 319 LQMLLLKNNMLSGSVPDSLWKNISFPKKARLLLDLRNNSLSRVQGDLTPPQNVTLRLDGN 378
Query: 383 PFCLN---TNAEQFCGSHSDDDNEI-DRSTNSTLDCRAQSCPTD--YEYSPTSPIRCFCA 436
C N +NA FC S + + + STNS LDC +CPT YEYSP SP+RCFCA
Sbjct: 379 LICTNGSISNANLFCESKGKEWISLPNNSTNSALDCPPLACPTPDFYEYSPASPLRCFCA 438
Query: 437 APLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFP 496
APL +GYRLKSP SYFP Y + F EY+T L++ YQL IDS++WEKGPRL+MYLKLFP
Sbjct: 439 APLRIGYRLKSPSFSYFPPYIDQFGEYVTDFLQMEPYQLWIDSYQWEKGPRLRMYLKLFP 498
Query: 497 VYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFPPSRNSG 556
+ + + FN SEV RIR +F W P SD+FGPYEL+NFTLQGPY V S G
Sbjct: 499 KVNETYTRT--FNESEVLRIRGIFASWRFPGSDLFGPYELLNFTLQGPYSYVNFNSERKG 556
Query: 557 ISKXXXXXXXXXXXXXXVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGVRSFTY 616
+S V ISA+V+ L++R + K+ ISRRR SSK S+ G+R F++
Sbjct: 557 VSWRRLAAITAGAVVTAVAISAVVAALLLRRYSKHEREISRRRSSSKASLLNSGIRGFSF 616
Query: 617 GEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSR 676
E+A AT++F+SST +G+GGYGKVY+G+L D TV A+KRA EGSLQGEKEFL EI+ LSR
Sbjct: 617 KELAEATDDFSSSTLVGRGGYGKVYRGVLSDNTVAAIKRADEGSLQGEKEFLNEIELLSR 676
Query: 677 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 736
LHHRNLVSL+GYCDEE EQMLVYEFMSNGTLRD LSAK KE L F MR+ +ALG+++GIL
Sbjct: 677 LHHRNLVSLIGYCDEESEQMLVYEFMSNGTLRDWLSAKGKESLSFGMRIRVALGAAKGIL 736
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
YLHTEA+PPVFHRDIKASNILLD F AKVADFGLSRLAPV + E VP HVSTVV+GTP
Sbjct: 737 YLHTEANPPVFHRDIKASNILLDPNFNAKVADFGLSRLAPVLEDEEDVPKHVSTVVRGTP 796
Query: 797 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 842
GYLDPEYFLTHKLTDKSDVYS+GVVFLELLTGM ISHGKNIVREV
Sbjct: 797 GYLDPEYFLTHKLTDKSDVYSIGVVFLELLTGMHAISHGKNIVREV 842
|
|
| TAIR|locus:2084016 AT3G53590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2019 (715.8 bits), Expect = 8.3e-209, P = 8.3e-209
Identities = 418/811 (51%), Positives = 525/811 (64%)
Query: 37 VSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYXXXXXXXXXXXXXXX 96
V+ALR IK+SL+D LSNW +GDPC SNWTG++CF + +DG+
Sbjct: 34 VNALREIKRSLIDPMRNLSNWAKGDPCNSNWTGIICFGRSHNDGHFHVRELQLMRLNLSG 93
Query: 97 XXSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKXXXXXXXXXXXXXXXXPEELGYLPKL 156
+PE+G+L YL ILD MWN ++G IP EIG I P ELG L L
Sbjct: 94 ELAPEVGQLLYLEILDVMWNNLTGRIPLEIGRISSLKLLLLNGNKFTGSLPPELGNLQNL 153
Query: 157 DRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTG 216
+R+Q+D+N I+GS+P SF NL +H H+NNN+ISG+IP ELS+LP LVHM+LDNNNLTG
Sbjct: 154 NRLQVDENNITGSVPFSFGNLRSIKHLHLNNNTISGEIPVELSKLPKLVHMILDNNNLTG 213
Query: 217 YXXXXXXXXXXXXXXXXDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNL 276
DNNNFEG+TIP +Y + S+L+KLSLRNC LQG +PDLSRI NL
Sbjct: 214 TLPLELAQLPSLTILQLDNNNFEGSTIPEAYGHFSRLVKLSLRNCGLQGSIPDLSRIENL 273
Query: 277 GYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGS 336
YLDLS N L G+IP +LS N+TTI+LS N LTG+IP +FS L LQ L + NNSLSGS
Sbjct: 274 SYLDLSWNHLTGTIPESKLSDNMTTIELSYNHLTGSIPQSFSDLNSLQLLSLENNSLSGS 333
Query: 337 IPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTN---AEQF 393
+P+ IWQ ++ + + D NNN ++ +G+ P NVT+ LRGNP C +T+ QF
Sbjct: 334 VPTEIWQDKSFENNKLQVYDL-NNNFSDATGNLRTPDNVTLYLRGNPICKSTSIPMVTQF 392
Query: 394 CGSHSDDDNEIDRSTNSTLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYF 453
+ + STNS C SCP +E SP C C APL + YRLKSP +F
Sbjct: 393 FEYICGEKKQT--STNSNTPCSNVSCP--FENVKVSPGICLCTAPLSIDYRLKSPSFFFF 448
Query: 454 PAY-KNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYVFNASE 512
Y + F EY+TS L+L +QL ID E R +MYLKL P G FN SE
Sbjct: 449 TPYIERQFREYITSSLQLETHQLAIDRLVDENRLRPRMYLKLVP-----KGR-ITFNKSE 502
Query: 513 VGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFPPSRNSGISKXXXXXXXXXXXXX 572
V RIR F W+ +D FGPYEL++F LQGPY D+ ++ SGI
Sbjct: 503 VIRIRDRFMSWSFNKTDFFGPYELLDFPLQGPYADLL--AQTSGIRTIVWMMIVAGSVVA 560
Query: 573 XVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQI 632
+S +LL VR +N H ++++R S +I GV+ F++ E++ ATN F+SST I
Sbjct: 561 ATVLSVTATLLYVRKRRENSHTLTKKRVFRTISREIKGVKKFSFVELSDATNGFDSSTLI 620
Query: 633 GQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 692
G+G YGKVYKGIL + T VA+KR +E SLQ EKEFL EI LSRLHHRNLVSL+GY +
Sbjct: 621 GRGSYGKVYKGILSNKTEVAIKRGEETSLQSEKEFLNEIDLLSRLHHRNLVSLIGYSSDI 680
Query: 693 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIK 752
GEQMLVYE+M NG +RD LSA + + L F+MR +ALGS++GILYLHTEA+PPV HRDIK
Sbjct: 681 GEQMLVYEYMPNGNVRDWLSANAADTLSFSMRSHVALGSAKGILYLHTEANPPVIHRDIK 740
Query: 753 ASNILLDHKFTAKVADFGLSRLAPV-PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD 811
SNILLD + AKVADFGLSRLAP + +G PAHVSTVV+GTPGYLDPEYF+T +LT
Sbjct: 741 TSNILLDCQLHAKVADFGLSRLAPAFGEGDG-EPAHVSTVVRGTPGYLDPEYFMTQQLTV 799
Query: 812 KSDVYSLGVVFLELLTGMQPISHGKNIVREV 842
+SDVYS GVV LELLTGM P G +I+REV
Sbjct: 800 RSDVYSFGVVLLELLTGMHPFFEGTHIIREV 830
|
|
| TAIR|locus:2019863 AT1G79620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1144 (407.8 bits), Expect = 4.4e-116, P = 4.4e-116
Identities = 314/857 (36%), Positives = 441/857 (51%)
Query: 30 SITDPIEVSALRSIKKSLVDDYSKLS-NWNRGD-PCTSNWTGVLCFNT--------TM-- 77
S+TDP + +ALRS L+D + +W D PC + W GV C N+ TM
Sbjct: 30 SVTDPRDAAALRS----LMDQWDNTPPSWGGSDDPCGTPWEGVSCNNSRITALGLSTMGL 85
Query: 78 ------DDGYXXXXXXXXXXXXXXXXXS--PEIGRLSYLTILDFMWNKISGSIPKEIGNI 129
D G S +G L L IL +G+IP E+G +
Sbjct: 86 KGRLSGDIGELAELRSLDLSFNRGLTGSLTSRLGDLQKLNILILAGCGFTGTIPNELGYL 145
Query: 130 KXXXXXXXXXXXXXXXXPEELGYLPKLDRIQIDQNYISGSLPKSFAN------LNKTRHF 183
K P LG L K+ + + N ++G +P S + L K +HF
Sbjct: 146 KDLSFLALNSNNFTGKIPASLGNLTKVYWLDLADNQLTGPIPISSGSSPGLDLLLKAKHF 205
Query: 184 HMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYXXXXXXXXXXXXXXXXDNNNFEGTT 242
H N N +SG IPP+L S L+H+L D N TG D N G
Sbjct: 206 HFNKNQLSGTIPPKLFSSEMILIHVLFDGNRFTGSIPSTLGLIQTLEVLRLDRNTLTGK- 264
Query: 243 IPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NIT 300
+P + SN++ +++L+L + L G +PDLS + ++ Y+DLS+N + S P S ++T
Sbjct: 265 VPENLSNLTNIIELNLAHNKLVGSLPDLSDMKSMNYVDLSNNSFDPSESPLWFSTLPSLT 324
Query: 301 TIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNN 360
T+ + L G +P+ G P+LQ++ + N+ +G++ S+ T+ E ++D Q+N
Sbjct: 325 TLVMEYGSLQGPLPNKLFGFPQLQQVRLKKNAFNGTL--SLGD--TVGP-ELQLVDLQDN 379
Query: 361 NLTNISGSFNIPPNVTVRLRGNPFCLNTNAE-QFCGSHSDDDNEIDRSTNSTLDCRAQSC 419
++++++ S N T+ L GNP C + +C I ST S +C +SC
Sbjct: 380 DISSVTLSSGYT-N-TLILEGNPVCTTALSNTNYCQIQQQQVKRI-YST-SLANCGGKSC 435
Query: 420 PTDYEYSPTSPIRCFCAAPLLVGYRLKSP---GLSYFPAYKNLFEEYMTSGLKLNLYQLD 476
P D + SP S C CA P + P LS Y +L E + L L +
Sbjct: 436 PLDQKVSPQS---CECAYPYEGTLYFRGPMFRDLSNVNTYHSL-EMSLWVKLGLTPGSVS 491
Query: 477 IDSFRWEKGPRLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYEL 536
+ + + L++ L LFP Y FN +EV RI + +FGPY
Sbjct: 492 LQNPFFNNDDYLQIQLALFPPM-----GKY-FNRTEVQRIGFDLSNQTYKPPPLFGPY-- 543
Query: 537 INFTLQGPYRDVFPPSRNSGISKXXXXXXXXXXXXXXVTISAIVSLLIVRAHMKNY--HA 594
+ + PY FP N G S + + +V+L I K A
Sbjct: 544 --YFIASPY--TFPADGN-GHSLSSRMVTGIITGCSALVL-CLVALGIYAMWQKRRAEQA 597
Query: 595 ISRRR------HSSKTS---IKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGIL 645
I R S K S ++ G R F+Y E+ TNNF+ S+++G GGYGKVYKG+L
Sbjct: 598 IGLSRPFVSWASSGKDSGGAPQLKGARWFSYEELKKITNNFSVSSELGYGGYGKVYKGML 657
Query: 646 PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 705
DG +VA+KRAQ+GS QG EF TEI+ LSR+HH+NLV LVG+C E+GEQ+LVYE+MSNG
Sbjct: 658 QDGHMVAIKRAQQGSTQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQILVYEYMSNG 717
Query: 706 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAK 765
+L+D L+ +S L + RL +ALGS+RG+ YLH ADPP+ HRD+K++NILLD TAK
Sbjct: 718 SLKDSLTGRSGITLDWKRRLRVALGSARGLAYLHELADPPIIHRDVKSTNILLDENLTAK 777
Query: 766 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLEL 825
VADFGLS+L V D HVST VKGT GYLDPEY+ T KLT+KSDVYS GVV +EL
Sbjct: 778 VADFGLSKL--VSDC---TKGHVSTQVKGTLGYLDPEYYTTQKLTEKSDVYSFGVVMMEL 832
Query: 826 LTGMQPISHGKNIVREV 842
+T QPI GK IVRE+
Sbjct: 833 ITAKQPIEKGKYIVREI 849
|
|
| TAIR|locus:2157042 AT5G49760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1112 (396.5 bits), Expect = 1.1e-112, P = 1.1e-112
Identities = 305/857 (35%), Positives = 431/857 (50%)
Query: 30 SITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNT--------TMD-DG 80
++T+ ++ SAL ++K + W DPC +NW G+ C N +D +G
Sbjct: 23 ALTNGLDASALNALKSEWT---TPPDGWEGSDPCGTNWVGITCQNDRVVSISLGNLDLEG 79
Query: 81 YXXXXXXXXXXXXXXXXX---------SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKX 131
P IG L L L + SG IP+ IG +K
Sbjct: 80 KLPADISFLSELRILDLSYNPKLSGPLPPNIGNLGKLRNLILVGCSFSGQIPESIGTLKE 139
Query: 132 XXXXXXXXXXXXXXXPEELGYLPKLDRIQIDQNYISGSLPKSFAN-------LNKTRHFH 184
P +G L KL I N I G LP S L +T+HFH
Sbjct: 140 LIYLSLNLNKFSGTIPPSIGLLSKLYWFDIADNQIEGELPVSNGTSAPGLDMLLQTKHFH 199
Query: 185 MNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYXXXXXXXXXXXXXXXXDNNNFEGTTI 243
N +SG IP EL S SL+H+L D N TG D N G I
Sbjct: 200 FGKNKLSGNIPKELFSSNMSLIHVLFDGNQFTGEIPETLSLVKTLTVLRLDRNKLIGD-I 258
Query: 244 PASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGS-IPPGRLSL-NITT 301
P+ +N++ L +L L N G +P+L+ + +L LD+S+N L+ S IP SL +++T
Sbjct: 259 PSYLNNLTNLNELYLANNRFTGTLPNLTSLTSLYTLDVSNNTLDFSPIPSWISSLPSLST 318
Query: 302 IKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNN 361
+++ +L G IP +F P+LQ + + NS+ S+ S L F+ D Q N
Sbjct: 319 LRMEGIQLNGPIPISFFSPPQLQTVILKRNSIVESLDFGTDVSSQLE----FV-DLQYNE 373
Query: 362 LTNISGSFNIPPNVTVRLRGNPFCLNT-NAEQFCGSHSDDDNEIDRSTN-STLDCRAQSC 419
+T+ S N + V L NP CL N +C + I +T+ STL C
Sbjct: 374 ITDYKPSAN--KVLQVILANNPVCLEAGNGPSYCSA-------IQHNTSFSTLPTNCSPC 424
Query: 420 PTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLS-YFPAYK-NLFEEYMTSGLKLNLYQLDI 477
E SPT C CA P + +SP S F + ++ ++ + K Y +D
Sbjct: 425 EPGMEASPT----CRCAYPFMGTLYFRSPSFSGLFNSTNFSILQKAIADFFKKFNYPVDS 480
Query: 478 DSFR-WEKGP---RLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGP 533
R + P +L + L +FP+ S FN + + + F+ IFGP
Sbjct: 481 VGVRNIRENPTDHQLLIDLLVFPLGRES------FNQTGMSLVGFAFSNQTYKPPPIFGP 534
Query: 534 YELINFTLQGPYRDVFPPSRNSGISKXXXXXXXXXXXXXXVTISAIVSLLIVRAHMKNYH 593
Y + L + DV S++S S +TI+ I +L R +
Sbjct: 535 Y-IFKADLYKQFSDVEVSSKSSNKSILIGAVVGVVVLLLLLTIAGIYAL---RQKKRAER 590
Query: 594 AISRRR-----HSSKTSI---KIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGIL 645
A + +SK+SI ++ G ++FT+ E+ T+NF+ + +G GGYGKVY+GIL
Sbjct: 591 ATGQNNPFAKWDTSKSSIDAPQLMGAKAFTFEELKKCTDNFSEANDVGGGGYGKVYRGIL 650
Query: 646 PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 705
P+G ++A+KRAQ+GSLQG EF TEI+ LSR+HH+N+V L+G+C + EQMLVYE++SNG
Sbjct: 651 PNGQLIAIKRAQQGSLQGGLEFKTEIELLSRVHHKNVVRLLGFCFDRNEQMLVYEYISNG 710
Query: 706 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAK 765
+L+D LS KS L + RL IALGS +G+ YLH ADPP+ HRDIK++NILLD TAK
Sbjct: 711 SLKDSLSGKSGIRLDWTRRLKIALGSGKGLAYLHELADPPIIHRDIKSNNILLDENLTAK 770
Query: 766 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLEL 825
VADFGLS+L P+ HV+T VKGT GYLDPEY++T++LT+KSDVY GVV LEL
Sbjct: 771 VADFGLSKLVGDPE-----KTHVTTQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVVLLEL 825
Query: 826 LTGMQPISHGKNIVREV 842
LTG PI GK +VREV
Sbjct: 826 LTGRSPIERGKYVVREV 842
|
|
| TAIR|locus:2156992 AT5G49770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1066 (380.3 bits), Expect = 8.1e-108, P = 8.1e-108
Identities = 298/858 (34%), Positives = 429/858 (50%)
Query: 30 SITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLC-----------FNTTMD 78
+ TD + +AL+++K D SK +W DPC + W G+ C N +
Sbjct: 25 AFTDGSDFTALQALKNEW-DTLSK--SWKSSDPCGTEWVGITCNNDNRVVSISLTNRNLK 81
Query: 79 DGYXXXXXXXXXXXXXXXXXSPE--------IGRLSYLTILDFMWNKISGSIPKEIGNIK 130
+PE IG L LT L M +G IP IGN++
Sbjct: 82 GKLPTEISTLSELQTLDLTGNPELSGPLPANIGNLRKLTFLSLMGCAFNGPIPDSIGNLE 141
Query: 131 XXXXXXXXXXXXXXXXPEELGYLPKLDRIQIDQNYISGSLP----KSFANLN---KTRHF 183
P +G L KL I N + G LP S L+ +T HF
Sbjct: 142 QLTRLSLNLNKFSGTIPASMGRLSKLYWFDIADNQLEGKLPVSDGASLPGLDMLLQTGHF 201
Query: 184 HMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYXXXXXXXXXXXXXXXXDNNNFEGTT 242
H NN +SG+IP +L S +L+H+L D N TG D N G
Sbjct: 202 HFGNNKLSGEIPEKLFSSEMTLLHVLFDGNQFTGSIPESLGLVQNLTVLRLDRNRLSGD- 260
Query: 243 IPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS-LN-IT 300
IP+S +N++ L +L L + G +P+L+ + +L LD+S+N L S P + LN ++
Sbjct: 261 IPSSLNNLTNLQELHLSDNKFTGSLPNLTSLTSLYTLDVSNNPLALSPVPSWIPFLNSLS 320
Query: 301 TIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQN 359
T++L + +L G +P++ FS L +LQ + + +N ++ ++ S+ L+ F+ D ++
Sbjct: 321 TLRLEDIQLDGPVPTSLFSPL-QLQTVSLKHNLINTTLDLGTNYSKQLD----FV-DLRD 374
Query: 360 NNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEID-RSTNSTLDCRAQS 418
N +T N P NV L N C + A Q G N + ST STL
Sbjct: 375 NFITGYKSPANNPVNVM--LADNQVCQDP-ANQLSGYC----NAVQPNSTFSTLTKCGNH 427
Query: 419 CPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNL--FEEYMTSGLKLNLYQLD 476
C E P C C PL + L+SP S F N F E + + K Y +D
Sbjct: 428 CGKGKE--PNQG--CHCVYPLTGVFTLRSPSFSGFSNNSNFLKFGESLMTFFKNGKYPVD 483
Query: 477 IDSFR-WEKGP---RLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFG 532
+ R + P L + L +FP SG FN +E+ I S FT + FG
Sbjct: 484 SVAMRNISENPTDYHLLINLLIFP-----SGRDR-FNQTEMDSINSAFTIQDYKPPPRFG 537
Query: 533 PYELINFTLQGPYRDVFPPSRNSGISKXXXXXXXXXXXXXXVTISAIVSLLIVRAHMKNY 592
PY + Y+ F +S + + A+ + +R +
Sbjct: 538 PYIFV----ADQYK-TFSDLEDSKTVSMKVIIGVVVGVVVLLLLLALAGIYALRQKKRAQ 592
Query: 593 HAISRRRHSSKTSI---KID-----GVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGI 644
A + +K ++D G ++FT+ E++ TNNF+ + +G GGYG+VYKG
Sbjct: 593 RATDQMNPFAKWDAGKNEMDAPQLMGTKAFTFEELSKCTNNFSDANDVGGGGYGQVYKGT 652
Query: 645 LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 704
LP+G V+A+KRAQ+GS+QG EF TEI+ LSR+HH+N+V L+G+C ++ EQMLVYE++ N
Sbjct: 653 LPNGQVIAIKRAQQGSMQGAFEFKTEIELLSRVHHKNVVKLLGFCFDQKEQMLVYEYIPN 712
Query: 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 764
G+LRD LS K+ L + RL IALGS +G+ YLH ADPP+ HRD+K++NILLD TA
Sbjct: 713 GSLRDGLSGKNGVKLDWTRRLKIALGSGKGLAYLHELADPPIIHRDVKSNNILLDEHLTA 772
Query: 765 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLE 824
KVADFGLS+L P+ AHV+T VKGT GYLDPEY++T++LT+KSDVY GVV LE
Sbjct: 773 KVADFGLSKLVGDPE-----KAHVTTQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVVMLE 827
Query: 825 LLTGMQPISHGKNIVREV 842
LLTG PI G +V+EV
Sbjct: 828 LLTGKSPIDRGSYVVKEV 845
|
|
| TAIR|locus:2157002 AT5G49780 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 712 (255.7 bits), Expect = 6.6e-102, Sum P(2) = 6.6e-102
Identities = 137/233 (58%), Positives = 177/233 (75%)
Query: 610 GVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLT 669
G ++FT+ EM NNF+ + +G GGYG+VYKGILP G ++A+KRAQ GSLQG EF T
Sbjct: 518 GTKAFTFEEMRKCANNFSVANDVGGGGYGQVYKGILPSGQLIAIKRAQPGSLQGALEFKT 577
Query: 670 EIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIAL 729
EI+ LSR+HH+N+V L+G+C + GEQMLVYE++ NG+LRD LS KS L + RL IAL
Sbjct: 578 EIELLSRVHHKNVVKLLGFCFDRGEQMLVYEYIPNGSLRDSLSGKSGIRLDWTRRLRIAL 637
Query: 730 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 789
GS +G+ YLH ADPP+ HRD+K+SN+LLD TAKVADFGLS+L V D E A+V+
Sbjct: 638 GSGKGLAYLHELADPPIIHRDVKSSNVLLDESLTAKVADFGLSQL--VEDAE---KANVT 692
Query: 790 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 842
VKGT GYLDPEY++T++LT+KSDVY GV+ LELLTG PI +GK +V+E+
Sbjct: 693 AQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVMMLELLTGKIPIENGKYVVKEM 745
|
|
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 498 (180.4 bits), Expect = 3.7e-72, Sum P(2) = 3.7e-72
Identities = 110/248 (44%), Positives = 152/248 (61%)
Query: 590 KNYHAISRRRHSSKTSIKI----DGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGIL 645
+N + +S R SI I + G++ AT++F+ IG GG+G VYK L
Sbjct: 877 QNLYFLSGSRSREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACL 936
Query: 646 PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 705
P VAVK+ E QG +EF+ E++ L ++ H NLVSL+GYC E++LVYE+M NG
Sbjct: 937 PGEKTVAVKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNG 996
Query: 706 TLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 763
+L L ++ E L ++ RL IA+G++RG+ +LH P + HRDIKASNILLD F
Sbjct: 997 SLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFE 1056
Query: 764 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFL 823
KVADFGL+RL + +HVSTV+ GT GY+ PEY + + T K DVYS GV+ L
Sbjct: 1057 PKVADFGLARLISACE------SHVSTVIAGTFGYIPPEYGQSARATTKGDVYSFGVILL 1110
Query: 824 ELLTGMQP 831
EL+TG +P
Sbjct: 1111 ELVTGKEP 1118
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 482 (174.7 bits), Expect = 2.9e-71, Sum P(2) = 2.9e-71
Identities = 116/313 (37%), Positives = 176/313 (56%)
Query: 549 FPPSRNSG------ISKXXXXXXXXXXXXXXVTISAIVSLLIVRAHMKNYHAISRRRHSS 602
F PS+++G SK + I+ IV L+ R ++ + ++ S
Sbjct: 721 FAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLM--RRPVRTVASSAQDGQPS 778
Query: 603 KTSIKI--DGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRA---Q 657
+ S+ I FT+ ++ AT+NF+ S +G+G G VYK +LP G +AVK+
Sbjct: 779 EMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNH 838
Query: 658 EGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS 715
EG + F EI L + HRN+V L G+C+ +G +L+YE+M G+L + L S
Sbjct: 839 EGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDPS 898
Query: 716 KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775
L ++ R IALG+++G+ YLH + P +FHRDIK++NILLD KF A V DFGL+++
Sbjct: 899 CN-LDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 957
Query: 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG---MQPI 832
+P + + + + G+ GY+ PEY T K+T+KSD+YS GVV LELLTG +QPI
Sbjct: 958 DMPHSKSM------SAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPI 1011
Query: 833 SHGKNIVREVLPY 845
G ++V V Y
Sbjct: 1012 DQGGDVVNWVRSY 1024
|
|
| TAIR|locus:2005507 ER "ERECTA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 423 (154.0 bits), Expect = 2.8e-70, Sum P(2) = 2.8e-70
Identities = 92/224 (41%), Positives = 132/224 (58%)
Query: 616 YGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLS 675
Y ++ T N + IG G VYK +L + VA+KR + Q K+F TE++ LS
Sbjct: 638 YEDIMRMTENLSEKYIIGHGASSTVYKCVLKNCKPVAIKRLYSHNPQSMKQFETELEMLS 697
Query: 676 RLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEP-LGFAMRLSIALGSSRG 734
+ HRNLVSL Y +L Y+++ NG+L D L +K+ L + RL IA G+++G
Sbjct: 698 SIKHRNLVSLQAYSLSHLGSLLFYDYLENGSLWDLLHGPTKKKTLDWDTRLKIAYGAAQG 757
Query: 735 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 794
+ YLH + P + HRD+K+SNILLD A++ DFG+++ V +H ST V G
Sbjct: 758 LAYLHHDCSPRIIHRDVKSSNILLDKDLEARLTDFGIAKSLCVSK------SHTSTYVMG 811
Query: 795 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 838
T GY+DPEY T +LT+KSDVYS G+V LELLT + + N+
Sbjct: 812 TIGYIDPEYARTSRLTEKSDVYSYGIVLLELLTRRKAVDDESNL 855
|
|
| TAIR|locus:2146102 NIK1 "NSP-interacting kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 539 (194.8 bits), Expect = 7.8e-70, Sum P(2) = 7.8e-70
Identities = 109/251 (43%), Positives = 167/251 (66%)
Query: 588 HMKN-YHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILP 646
H +N + + H + S+ +R F + E+ +ATNNF+S +G+GGYG VYKGIL
Sbjct: 275 HNQNTFFDVKDGNHHEEVSL--GNLRRFGFRELQIATNNFSSKNLLGKGGYGNVYKGILG 332
Query: 647 DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 705
D TVVAVKR ++G +L GE +F TE++ +S HRNL+ L G+C + E++LVY +MSNG
Sbjct: 333 DSTVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYPYMSNG 392
Query: 706 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAK 765
++ ++ K+K L +++R IA+G++RG++YLH + DP + HRD+KA+NILLD A
Sbjct: 393 SVASRM--KAKPVLDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLDDYCEAV 450
Query: 766 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLEL 825
V DFGL++L D +HV+T V+GT G++ PEY T + ++K+DV+ G++ LEL
Sbjct: 451 VGDFGLAKLLDHQD------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL 504
Query: 826 LTGMQPISHGK 836
+TG + GK
Sbjct: 505 VTGQRAFEFGK 515
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGD7 | Y1684_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7361 | 0.9597 | 0.8509 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 845 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-47 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-47 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-46 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-45 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-44 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-40 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-39 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-38 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-33 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-28 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-27 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-27 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-27 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-26 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-26 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-26 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-25 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-24 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-23 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-23 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-23 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-23 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-23 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-23 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-22 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-22 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-20 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-20 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-19 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-19 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-19 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-19 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-19 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-19 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-18 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-18 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-16 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-15 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-14 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-12 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 9e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 9e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-06 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 2e-06 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 2e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.002 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.002 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 0.003 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 4e-47
Identities = 75/211 (35%), Positives = 107/211 (50%), Gaps = 23/211 (10%)
Query: 631 QIGQGGYGKVYKGIL--PDGTV---VAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVS 684
++G+G +G+VYKG L G VAVK +E S Q +EFL E + + +L H N+V
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 744
L+G C EE +V E+M G L L K++ L + LS AL +RG+ YL ++
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLR-KNRPKLSLSDLLSFALQIARGMEYLESK--- 121
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG---YLDP 801
HRD+ A N L+ K++DFGLSR + +G ++ P
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRD---------LYDDDYYRKRGGKLPIRWMAP 172
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
E K T KSDV+S GV+ E+ T G QP
Sbjct: 173 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 8e-47
Identities = 76/212 (35%), Positives = 109/212 (51%), Gaps = 24/212 (11%)
Query: 631 QIGQGGYGKVYKGIL-----PDGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVS 684
++G+G +G+VYKG L VAVK +E S Q +EFL E + + +L H N+V
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 744
L+G C EE M+V E+M G L D L + L + LS AL +RG+ YL ++
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK--- 122
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI----EGIVPAHVSTVVKGTPGYLD 800
HRD+ A N L+ K++DFGLSR D G +P ++ ++
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLP------IR----WMA 172
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
PE K T KSDV+S GV+ E+ T G +P
Sbjct: 173 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 2e-46
Identities = 74/219 (33%), Positives = 102/219 (46%), Gaps = 31/219 (14%)
Query: 631 QIGQGGYGKVYKGILPDG----TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSL 685
++G+G +G+VYKG L T VAVK +E S + K+FL E + + +L H N+V L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAK-------SKEPLGFAMRLSIALGSSRGILYL 738
+G C EE LV E+M G L D L K L LS A+ ++G+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----EGIVPAHVSTVVK 793
HRD+ A N L+ K++DFGLSR D G +P ++
Sbjct: 122 A---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLP------IR 172
Query: 794 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
PE T KSDV+S GV+ E+ T G P
Sbjct: 173 WMA----PESLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 176 bits (447), Expect = 2e-45
Identities = 120/354 (33%), Positives = 172/354 (48%), Gaps = 40/354 (11%)
Query: 36 EVSALRSIKKSLVDDYSKLSNWN-RGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNL 94
E+ L S K S+ D LSNWN D C W G+ C N++ + + L N+
Sbjct: 30 ELELLLSFKSSINDPLKYLSNWNSSADVC--LWQGITCNNSS------RVVSIDLSGKNI 81
Query: 95 SGNLSPEIGRLSYLTILDFMWNKISGSIPKEI-----------------------GNIKS 131
SG +S I RL Y+ ++ N++SG IP +I G+I +
Sbjct: 82 SGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPN 141
Query: 132 LELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSIS 191
LE L L+ N L+G +P ++G L + + N + G +P S NL + +N +
Sbjct: 142 LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLV 201
Query: 192 GQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMS 251
GQIP EL ++ SL + L NNL+G +P E+ L L L L NN G IP+S N+
Sbjct: 202 GQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTG-PIPSSLGNLK 260
Query: 252 KLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKL 309
L L L L GP+P + + L LDLS N L+G IP + L N+ + L +N
Sbjct: 261 NLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNF 320
Query: 310 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 363
TG IP + LPRLQ L + +N SG IP ++ + L +LD NNLT
Sbjct: 321 TGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLT-----VLDLSTNNLT 369
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 2e-44
Identities = 70/198 (35%), Positives = 98/198 (49%), Gaps = 15/198 (7%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVGYC 689
+G+GG+G VY G VA+K ++ E L EI+ L +L+H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
++E LV E+ G+L+D L L L I L G+ YLH+ + HR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG-KLSEDEILRILLQILEGLEYLHSN---GIIHR 116
Query: 750 DIKASNILLDHK-FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-TH 807
D+K NILLD K+ADFGLS+L + GTP Y+ PE L
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSL-------LKTIVGTPAYMAPEVLLGKG 169
Query: 808 KLTDKSDVYSLGVVFLEL 825
++KSD++SLGV+ EL
Sbjct: 170 YYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 3e-44
Identities = 68/212 (32%), Positives = 103/212 (48%), Gaps = 15/212 (7%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVGY 688
++G+G +GKVY G +VA+K ++ ++ ++E L EI+ L +L H N+V L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 748
++E + LV E+ G L D L + + A + YLH + H
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEA--RFYLRQILSALEYLH---SKGIVH 120
Query: 749 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 808
RD+K NILLD K+ADFGL+R + ++T V GTP Y+ PE L
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGE-------KLTTFV-GTPEYMAPEVLLGKG 172
Query: 809 LTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 840
D++SLGV+ ELLTG P ++
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPPFPGDDQLLE 204
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 5e-43
Identities = 75/213 (35%), Positives = 104/213 (48%), Gaps = 26/213 (12%)
Query: 631 QIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVS 684
++G+G +G+VYKG L T VAVK +EG+ + E+ EFL E + +L H N+V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 744
L+G C + +V E+M G L D L E L L +AL ++G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKH-GEKLTLKDLLQMALQIAKGMEYLE---SK 121
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----EGIVPAHVSTVVKGTPGYL 799
HRD+ A N L+ K++DFGLSR D G +P +K
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLP------IKWMA--- 172
Query: 800 DPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
PE K T KSDV+S GV+ E+ T G QP
Sbjct: 173 -PESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 5e-40
Identities = 75/212 (35%), Positives = 104/212 (49%), Gaps = 16/212 (7%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
++G G +G VYK G +VAVK + + + ++ EI+ L RL H N+V L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+++ LV E+ G L D LS PL IAL RG+ YLH+ +
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGG--PLSEDEAKKIALQILRGLEYLHSNG---II 120
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
HRD+K NILLD K+ADFGL++ + + T GTP Y+ PE L
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKK-------LLKSSSSLTTFVGTPWYMAPEVLLGG 173
Query: 808 KL-TDKSDVYSLGVVFLELLTGMQPISHGKNI 838
K DV+SLGV+ ELLTG P S +
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENIL 205
|
Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 6e-39
Identities = 106/318 (33%), Positives = 154/318 (48%), Gaps = 33/318 (10%)
Query: 73 FNTTMDDGYLHLRE-LQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKS 131
F ++ G + E L L N LSG + +IG S L +LD N + G IP + N+ S
Sbjct: 130 FTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTS 189
Query: 132 LELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSIS 191
LE L L N+L G +P ELG + L I + N +SG +P L H + N+++
Sbjct: 190 LEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLT 249
Query: 192 GQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKL----------------LILQLDN 235
G IP L L +L ++ L N L+G +PP + L KL L++QL N
Sbjct: 250 GPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQN 309
Query: 236 --------NNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQL 286
NNF G IP + +++ +L L L + G +P +L + NL LDLS+N L
Sbjct: 310 LEILHLFSNNFTG-KIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNL 368
Query: 287 NGSIPPGRL-SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSR 345
G IP G S N+ + L +N L G IP + L+R+ + +NS SG +PS +
Sbjct: 369 TGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLP 428
Query: 346 TLNATETFILDFQNNNLT 363
+ LD NNNL
Sbjct: 429 LVY-----FLDISNNNLQ 441
|
Length = 968 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 9e-39
Identities = 68/217 (31%), Positives = 105/217 (48%), Gaps = 25/217 (11%)
Query: 631 QIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVG 687
+G+G +G VY + D G ++AVK + E + EI+ LS L H N+V G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 688 -YCDEEGEQMLVY-EFMSNGTLRDQLSAKSK--EPLGFAMRL---SIALGSSRGILYLHT 740
DEE + ++ E++S G+L L K EP+ +R I G+ YLH+
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV---IRKYTRQIL----EGLAYLHS 119
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
+ HRDIK +NIL+D K+ADFG ++ + I + V+GTP ++
Sbjct: 120 NG---IVHRDIKGANILVDSDGVVKLADFGCAKR-----LGDIETGEGTGSVRGTPYWMA 171
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
PE + +D++SLG +E+ TG P S N
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 2e-38
Identities = 106/320 (33%), Positives = 154/320 (48%), Gaps = 39/320 (12%)
Query: 84 LRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140
L+ LQ L L LSG + P I L L LD N +SG IP+ + +++LE+L L N
Sbjct: 259 LKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSN 318
Query: 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG-------- 192
TG +P L LP+L +Q+ N SG +PK+ N ++ N+++G
Sbjct: 319 NFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCS 378
Query: 193 ----------------QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNN 236
+IP L SL + L +N+ +G LP E ++LP + L + NN
Sbjct: 379 SGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNN 438
Query: 237 NFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS 296
N +G I + +M L LSL G +PD L LDLS NQ +G++P S
Sbjct: 439 NLQG-RINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGS 497
Query: 297 LN-ITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 355
L+ + +KLS NKL+G IP S +L L +++N LSG IP+S + L+ L
Sbjct: 498 LSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQ-----L 552
Query: 356 DFQNNNLTNISGSFNIPPNV 375
D N L S IP N+
Sbjct: 553 DLSQNQL-----SGEIPKNL 567
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 2e-33
Identities = 90/265 (33%), Positives = 144/265 (54%), Gaps = 7/265 (2%)
Query: 82 LHLRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLN 138
+ L+ L++L+L N +G + + L L +L NK SG IPK +G +L +L L+
Sbjct: 305 IQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLS 364
Query: 139 GNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL 198
N LTG +PE L L ++ + N + G +PKS R + +NS SG++P E
Sbjct: 365 TNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEF 424
Query: 199 SRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSL 258
++LP + + + NNNL G + ++P L +L L N F G +P S+ + +L L L
Sbjct: 425 TKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGG-LPDSFGS-KRLENLDL 482
Query: 259 RNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSN 316
G +P L + L L LS N+L+G IP S + ++ LS+N+L+G IP++
Sbjct: 483 SRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPAS 542
Query: 317 FSGLPRLQRLFIANNSLSGSIPSSI 341
FS +P L +L ++ N LSG IP ++
Sbjct: 543 FSEMPVLSQLDLSQNQLSGEIPKNL 567
|
Length = 968 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 68/205 (33%), Positives = 106/205 (51%), Gaps = 15/205 (7%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
+IG+GG+G+VYK G VA+K + S + +++ + EIQ L + H N+V G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
++ E +V EF S G+L+D L + + L + + +G+ YLH+ + HR
Sbjct: 67 LKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHR 122
Query: 750 DIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 808
DIKA+NILL K+ DFGLS +L+ +V GTP ++ PE
Sbjct: 123 DIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---------GTPYWMAPEVINGKP 173
Query: 809 LTDKSDVYSLGVVFLELLTGMQPIS 833
K+D++SLG+ +EL G P S
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYS 198
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 71/213 (33%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 625 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRN 681
N+ IG+G +G VYKG+ L G VA+K+ ++ E K + EI L L H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLH 739
+V +G + ++ E+ NG+LR + E L A+ + L +G+ YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL-VAVYVYQVL---QGLAYLH 116
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGY 798
+ V HRDIKA+NIL K+ADFG++ +L V + V GTP +
Sbjct: 117 EQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV--------SKDDASVVGTPYW 165
Query: 799 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
+ PE + SD++SLG +ELLTG P
Sbjct: 166 MAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 66/206 (32%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 620 ALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH 679
A+ + IG+G +G V G G VAVK ++ S + FL E ++ L H
Sbjct: 2 AINSKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQA-FLAEASVMTTLRH 59
Query: 680 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
NLV L+G + +V E+M+ G+L D L ++ + + A +L AL G+ YL
Sbjct: 60 PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE 119
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
+ HRD+ A N+L+ AKV+DFGL++ A G +P VK T
Sbjct: 120 EKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP------VKWTA--- 167
Query: 800 DPEYFLTHKLTDKSDVYSLGVVFLEL 825
PE K + KSDV+S G++ E+
Sbjct: 168 -PEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 63/199 (31%), Positives = 101/199 (50%), Gaps = 14/199 (7%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
++G G +G+V++G+ + T VAVK + G++ K+FL E Q + +L H L+ L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
E +V E M G+L + L + L + +A + G+ YL + HRD
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRD 128
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV--VKGTPGYLDPEYFLTHK 808
+ A N+L+ KVADFGL+R+ E I A +K T PE L ++
Sbjct: 129 LAARNVLVGENNICKVADFGLARVI----KEDIYEAREGAKFPIKWTA----PEAALYNR 180
Query: 809 LTDKSDVYSLGVVFLELLT 827
+ KSDV+S G++ E++T
Sbjct: 181 FSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 631 QIGQGGYGKVYKG---ILPDGT--VVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVS 684
Q+G+G +GKV L D T VAVK G Q +F EI+ L L H N+V
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 685 LVGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 742
G C++ G + L+ E++ +G+LRD L + ++ + L + +G+ YL ++
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ-RHRDQINLKRLLLFSSQICKGMDYLGSQR 129
Query: 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG-YLDP 801
HRD+ A NIL++ + K++DFGL+++ P + +P + P
Sbjct: 130 ---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDK-----DYYYVKEPGESPIFWYAP 181
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834
E T K + SDV+S GV EL T P
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 13/210 (6%)
Query: 630 TQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVG 687
+GQG G VYK P G + A+K+ + K+ L E++ L +V G
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+EGE +V E+M G+L D L K P ++ + +G+ YLHT+ +
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQI--LKGLDYLHTKRH--II 122
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
HRDIK SN+L++ K K+ADFG+S+ +E + + V GT Y+ PE
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISK-----VLENTLDQCNTFV--GTVTYMSPERIQGE 175
Query: 808 KLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
+ +D++SLG+ LE G P
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQ 205
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 70/210 (33%), Positives = 102/210 (48%), Gaps = 18/210 (8%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 688
IG G +GKVY + L G ++AVK R Q+ + KE E++ L L H NLV G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG- 66
Query: 689 CDEEGEQMLVY-EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+ E++ ++ E+ S GTL + L ++ L G+ YLH+ +
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLHSHG---IV 121
Query: 748 HRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 806
HRDIK +NI LDH K+ DFG + +L G ++ GTP Y+ PE
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA----GTPAYMAPEVITG 177
Query: 807 HKLTDK---SDVYSLGVVFLELLTGMQPIS 833
K +D++SLG V LE+ TG +P S
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWS 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 78/220 (35%), Positives = 106/220 (48%), Gaps = 27/220 (12%)
Query: 632 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 691
+G G +G+V+ G T VAVK + G++ E FL E Q + +L H LV L C E
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 692 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS----IALGSSRGILYLHTEADPPVF 747
E +V E+MS G+L D L K G +RL +A + G+ YL +
Sbjct: 73 EEPIYIVTEYMSKGSLLDFL----KSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YI 125
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG-IVPAHVSTV--VKGTPGYLDPEYF 804
HRD+ A NIL+ K+ADFGL+RL IE A +K T PE
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARL-----IEDDEYTAREGAKFPIKWTA----PEAA 176
Query: 805 LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVL 843
+ T KSDV+S G++ E++T G P N REVL
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--REVL 214
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 63/198 (31%), Positives = 97/198 (48%), Gaps = 11/198 (5%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
++G G +G V+ G VA+K +EG++ E +F+ E + + +L H NLV L G C
Sbjct: 11 ELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS-EDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
++ +V E+M+NG L + L + K LG L + + YL + HRD
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRER-KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 810
+ A N L+ KV+DFGL+R V D + VK P PE F + +
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSSQGTKFPVKWAP----PEVFDYSRFS 179
Query: 811 DKSDVYSLGVVFLELLTG 828
KSDV+S GV+ E+ +
Sbjct: 180 SKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 67/224 (29%), Positives = 104/224 (46%), Gaps = 34/224 (15%)
Query: 631 QIGQGGYGKVYKG----ILPDG--TVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLV 683
++G+G +GKV+ G + P+ +VAVK +E + K+F E + L+ H N+V
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS------------KEPLGFAMRLSIALGS 731
G C E ++V+E+M +G L L + L + L IA+
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 732 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD---IEGIVPAHV 788
+ G++YL A HRD+ N L+ + K+ DFG+SR D + G H
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGG----HT 184
Query: 789 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
++ P PE + K T +SDV+S GVV E+ T G QP
Sbjct: 185 MLPIRWMP----PESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 70/203 (34%), Positives = 103/203 (50%), Gaps = 12/203 (5%)
Query: 631 QIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
++G G YG+VY+G+ VAVK +E +++ E EFL E + + H NLV L+G C
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
E ++ EFM+ G L D L +++ + + L +A S + YL + HR
Sbjct: 72 TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 128
Query: 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 809
D+ A N L+ KVADFGLSRL + A +K T PE +K
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTA----PESLAYNKF 182
Query: 810 TDKSDVYSLGVVFLELLT-GMQP 831
+ KSDV++ GV+ E+ T GM P
Sbjct: 183 SIKSDVWAFGVLLWEIATYGMSP 205
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 74/214 (34%), Positives = 107/214 (50%), Gaps = 20/214 (9%)
Query: 629 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 688
+IG G +G V+ G + VA+K +EG++ E++F+ E Q + +L H LV L G
Sbjct: 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAK----SKEPLGFAMRLSIALGSSRGILYLHTEADP 744
C E LV+EFM +G L D L A+ S+E L L + L G+ YL +
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETL-----LGMCLDVCEGMAYLESSN-- 120
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 804
V HRD+ A N L+ KV+DFG++R V D + ST K + PE F
Sbjct: 121 -VIHRDLAARNCLVGENQVVKVSDFGMTRF--VLDDQ----YTSSTGTKFPVKWSSPEVF 173
Query: 805 LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKN 837
K + KSDV+S GV+ E+ + G P + N
Sbjct: 174 SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN 207
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 29/218 (13%)
Query: 623 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN 681
+ + +IG+G G+VYK G VA+K+ + Q ++ + EI + H N
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRD---QLSAKSKEP-LGFAMRLSIALGSSRGILY 737
+V E +V E+M G+L D Q + EP + + R + +G+ Y
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVL-----QGLEY 131
Query: 738 LHTEADPPVFHRDIKASNILLDHKFTAKVADFG----LSRLAPVPDIEGIVPAHVSTVVK 793
LH++ V HRDIK+ NILL + K+ADFG L++ ++VV
Sbjct: 132 LHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS----------KRNSVV- 177
Query: 794 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
GTP ++ PE K D++SLG++ +E+ G P
Sbjct: 178 GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 6e-26
Identities = 80/216 (37%), Positives = 113/216 (52%), Gaps = 15/216 (6%)
Query: 625 NFNSSTQIGQGGYGKVYKGILPDGTVVAVKR---AQEGSLQGEKEFLTEIQFLSRL-HHR 680
++ ++G+G +G+VY D +VA+K E + + FL EIQ L+ L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA-KSKEPLGFAMRLSIALGSSRGILYLH 739
N+V L + +EG LV E++ G+L D L K PL + L I + YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 740 TEADPPVFHRDIKASNILLDHK-FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
++ + HRDIK NILLD K+ DFGL++L P P +PA ST V GTPGY
Sbjct: 119 SK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV-GTPGY 174
Query: 799 LDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQP 831
+ PE L + SD++SLG+ ELLTG+ P
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210
|
Length = 384 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 74/215 (34%), Positives = 108/215 (50%), Gaps = 24/215 (11%)
Query: 632 IGQGGYGKVYKGILPDG----TVVAVKRAQE-GSLQGEKEFLTEIQFLSRLHHRNLVSLV 686
IG+G +G VY G L D AVK L+ ++FL E + H N++SL+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 687 GYC-DEEGEQMLVYEFMSNGTLRDQLSAKSKEP-----LGFAMRLSIALGSSRGILYLHT 740
G C EG ++V +M +G LR+ + +++ P +GF ++++ +G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVA------KGMEYL-- 114
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
A HRD+ A N +LD FT KVADFGL+R + D E H T K ++
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLAR--DIYDKEYYSV-HNHTGAKLPVKWMA 170
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 834
E T K T KSDV+S GV+ EL+T G P
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 205
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 68/211 (32%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 631 QIGQGGYGKVYKG-ILPDGTVVAVKRAQ-EGSLQGEKEF-LTEIQFLSRLHHRNLVSLVG 687
QIG+G +GKVY DG + +K + E+E L E++ L +L+H N++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK--- 63
Query: 688 YCD---EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLHT 740
Y + E+G+ +V E+ G L ++ + KE F + + L + YLH+
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL--ALKYLHS 121
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
+ HRDIK NI L K+ DFG+S++ + V TVV GTP YL
Sbjct: 122 RK---ILHRDIKPQNIFLTSNGLVKLGDFGISKV-----LSSTVD-LAKTVV-GTPYYLS 171
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
PE KSD++SLG V EL T P
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 69/215 (32%), Positives = 105/215 (48%), Gaps = 27/215 (12%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-----EIQFLSRLHHRNLVSL 685
+G+G YG VYK G +VA+K+ + L E+E + EI L L H N+V L
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIR---LDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGSSRGILYLHTEAD 743
+ E + LV+E+ L+ L K P + L SI RG+ Y H+
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYLD---KRPGPLSPNLIKSIMYQLLRGLAYCHSHR- 118
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
+ HRD+K NIL++ K+ADFGL+R +P + + VV T Y PE
Sbjct: 119 --ILHRDLKPQNILINRDGVLKLADFGLARAFGIP-----LRTYTHEVV--TLWYRAPEI 169
Query: 804 FLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 837
L K + D++S+G +F E++TG +P+ G +
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITG-KPLFPGDS 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 67/227 (29%), Positives = 103/227 (45%), Gaps = 46/227 (20%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNLVS 684
QIG+G YG+VYK G +VA+K+ ++ EKE + EI+ L +L H N+V
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKI---RMENEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 685 LVGYCDEE--GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS---------- 732
L + G +V+E+M + D L+ G + S
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH----D-LT-------GLLDSPEVKFTESQIKCYMKQLL 110
Query: 733 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTV 791
G+ YLH+ + HRDIK SNIL+++ K+ADFGL+R + + V
Sbjct: 111 EGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-----ADYTNRV 162
Query: 792 VKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
+ T Y PE L + + D++S+G + EL G +PI G
Sbjct: 163 I--TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG-KPIFQGST 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 67/205 (32%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
+G+G YG VYK I G VVA+K E LQ E + EI L + +V G
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ---EIIKEISILKQCDSPYIVKYYGSY 67
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
+ + +V E+ G++ D + +K L +I + +G+ YLH HR
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLH---SNKKIHR 123
Query: 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 809
DIKA NILL+ + AK+ADFG+S A +TV+ GTP ++ PE
Sbjct: 124 DIKAGNILLNEEGQAKLADFGVS------GQLTDTMAKRNTVI-GTPFWMAPEVIQEIGY 176
Query: 810 TDKSDVYSLGVVFLELLTGMQPISH 834
+K+D++SLG+ +E+ G P S
Sbjct: 177 NNKADIWSLGITAIEMAEGKPPYSD 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-24
Identities = 85/294 (28%), Positives = 132/294 (44%), Gaps = 56/294 (19%)
Query: 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISG----------------------- 120
L+ LQL + SG + +G+ + LT+LD N ++G
Sbjct: 334 LQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLE 393
Query: 121 -SIPKEIGNIKSLELLLLNGNELTGSLPEELGYL------------------------PK 155
IPK +G +SL + L N +G LP E L P
Sbjct: 394 GEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPS 453
Query: 156 LDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT 215
L + + +N G LP SF + + + ++ N SG +P +L L L+ + L N L+
Sbjct: 454 LQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLS 512
Query: 216 GYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIP 274
G +P ELS KL+ L L +N G IPAS+S M L +L L L G +P +L +
Sbjct: 513 GEIPDELSSCKKLVSLDLSHNQLSGQ-IPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVE 571
Query: 275 NLGYLDLSSNQLNGSIPP--GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRL 326
+L +++S N L+GS+P L++N + + N L G + SGLP +R+
Sbjct: 572 SLVQVNISHNHLHGSLPSTGAFLAINASAVA-GNIDLCGGDTT--SGLPPCKRV 622
|
Length = 968 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 72/210 (34%), Positives = 97/210 (46%), Gaps = 14/210 (6%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHHRNLVSLVGY 688
IG G VY I LP+ VA+KR Q E E+Q +S+ +H N+V
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIAL---GSSRGILYLHTEADPP 745
E LV ++S G+L D + KS P G IA +G+ YLH+
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIM--KSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
HRDIKA NILL + K+ADFG+S A + D G V GTP ++ PE
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVS--ASLAD-GGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 806 THK-LTDKSDVYSLGVVFLELLTGMQPISH 834
K+D++S G+ +EL TG P S
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPYSK 209
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
++G G +G+V++G+ + VA+K + L +++F E+Q L RL H++L+SL C
Sbjct: 13 KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
++ E M G+L L + + L A + +A + G+ YL + HRD
Sbjct: 73 VGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRD 129
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-VKGTPGYLDPEYFLTHKL 809
+ A NIL+ KVADFGL+RL E + + + K T PE
Sbjct: 130 LAARNILVGEDLVCKVADFGLARLIK----EDVYLSSDKKIPYKWTA----PEAASHGTF 181
Query: 810 TDKSDVYSLGVVFLELLT 827
+ KSDV+S G++ E+ T
Sbjct: 182 STKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 70/226 (30%), Positives = 112/226 (49%), Gaps = 36/226 (15%)
Query: 631 QIGQGGYGKVYKGIL--PDG----TVVAVKRAQE-GSLQGEKEFLTEIQFLSRLHHRNLV 683
++G+G +GKVYKG L P+ T VA+K +E + ++EF E + +S L H N+V
Sbjct: 12 ELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIV 71
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQL-----------------SAKSKEPLGFAMRLS 726
L+G C +E +++E++++G L + L S + F L
Sbjct: 72 CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF---LH 128
Query: 727 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 786
IA+ + G+ YL + HRD+ A N L+ T K++DFGLSR D +
Sbjct: 129 IAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 787 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
+ V ++ PE L K T +SD++S GVV E+ + G+QP
Sbjct: 186 SLLPV-----RWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 70/207 (33%), Positives = 104/207 (50%), Gaps = 22/207 (10%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
++G G +G V G VA+K +EGS+ E EF+ E + + +L H LV L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
++ +V E+MSNG L + L K + L + G+ YL ++ HRD
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRF-QPSQLLEMCKDVCEGMAYLESKQ---FIHRD 125
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-----VKGTPGYLDPEYFL 805
+ A N L+D + KV+DFGLSR V D E + S+V V+ +P PE L
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRY--VLDDE-----YTSSVGSKFPVRWSP----PEVLL 174
Query: 806 THKLTDKSDVYSLGVVFLELLT-GMQP 831
K + KSDV++ GV+ E+ + G P
Sbjct: 175 YSKFSSKSDVWAFGVLMWEVYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 65/200 (32%), Positives = 101/200 (50%), Gaps = 12/200 (6%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVGYC 689
+IG+G +G VYKG+L T VAVK + K FL E + L + H N+V L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
++ +V E + G+L L K K L L ++L ++ G+ YL ++ HR
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLR-KKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHR 117
Query: 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP-GYLDPEYFLTHK 808
D+ A N L+ K++DFG+SR + EG + VS +K P + PE +
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR-----EEEGGIYT-VSDGLKQIPIKWTAPEALNYGR 171
Query: 809 LTDKSDVYSLGVVFLELLTG 828
T +SDV+S G++ E +
Sbjct: 172 YTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 68/225 (30%), Positives = 96/225 (42%), Gaps = 37/225 (16%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSL-QGEKEFLT-EIQFLSRLHHRNLVSLVGY 688
IG+G +G V K DG ++ K G++ + EK+ L E+ L L H N+V Y
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV---RY 64
Query: 689 CDEE--GEQMLVY---EFMSNGTLRDQLSAKSKEP---------LGFAMRLSIALGSSRG 734
D +Y E+ G L QL K K+ +L +AL
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLA-QLIQKCKKERKYIEEEFIWRILTQLLLALY---- 119
Query: 735 ILYLHTEADPP--VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 792
H +DP V HRD+K +NI LD K+ DFGL+++ A T V
Sbjct: 120 --ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG----HDSSFAK--TYV 171
Query: 793 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
GTP Y+ PE +KSD++SLG + EL P +N
Sbjct: 172 -GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPF-TARN 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 70/242 (28%), Positives = 110/242 (45%), Gaps = 48/242 (19%)
Query: 624 NNFNSSTQIGQGGYGKVYK----GILP--DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSR 676
NN IGQG +G+V++ G+LP T+VAVK +E S + +F E ++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 677 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS--------------------K 716
H N+V L+G C L++E+M+ G L + L +S
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 717 EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776
PL +L IA + G+ YL ++ HRD+ N L+ K+ADFGLSR
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR--- 178
Query: 777 VPDIEGIVPAHVSTVVKGTPG------YLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GM 829
+I + + K + ++ PE ++ T +SDV++ GVV E+ + GM
Sbjct: 179 --NI------YSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGM 230
Query: 830 QP 831
QP
Sbjct: 231 QP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 28/212 (13%)
Query: 631 QIGQGGYGKVYKG-ILPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 688
++G G G V K P G ++AVK + E + +K+ L E+ L + + +V G
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSK----EPLGFAMRLSIALGSSRGILYLHTEADP 744
G+ + E+M G+L L LG IA+ +G+ YLH
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK-----IAVAVLKGLTYLHE--KH 120
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK---GTPGYLDP 801
+ HRD+K SNIL++ + K+ DFG+S V+++ K GT Y+ P
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQL------------VNSLAKTFVGTSSYMAP 168
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833
E + + KSD++SLG+ +EL TG P
Sbjct: 169 ERIQGNDYSVKSDIWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 67/221 (30%), Positives = 103/221 (46%), Gaps = 28/221 (12%)
Query: 631 QIGQGGYGKVY----KGILP--DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 684
++G+G +GKV+ +LP D +VAVK +E S ++F E + L+ L H+++V
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE-------------PLGFAMRLSIALGS 731
G C E ++V+E+M +G L L + + L L+IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 732 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 791
+ G++YL A HRD+ N L+ K+ DFG+SR DI V
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-----DIYSTDYYRVGGR 183
Query: 792 VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
++ PE L K T +SD++S GVV E+ T G QP
Sbjct: 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 75/214 (35%), Positives = 107/214 (50%), Gaps = 14/214 (6%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
++GQG +G+V+ G T VA+K + G++ E FL E Q + +L H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
EE +V E+MS G+L D L + + L + +A + G+ Y+ HRD
Sbjct: 72 EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 127
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 810
++A+NIL+ KVADFGL+RL + D E +K T PE L + T
Sbjct: 128 LRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTA----PEAALYGRFT 181
Query: 811 DKSDVYSLGVVFLELLT-GMQPISHGKNIVREVL 843
KSDV+S G++ EL T G P N REVL
Sbjct: 182 IKSDVWSFGILLTELTTKGRVPYPGMVN--REVL 213
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 3e-23
Identities = 81/243 (33%), Positives = 112/243 (46%), Gaps = 49/243 (20%)
Query: 632 IGQGGYGKVYKG----ILPDGT---VVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLV 683
+G G +G+VY+G IL G+ VAVK ++G+ EK EFL E +S +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 684 SLVGYCDEEGEQMLVYEFMSNGT----LRDQLSAKSKEP-LGFAMRLSIALGSSRGILYL 738
L+G C Q ++ E M G LRD + P L L I L ++G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 739 HTEADPPVFHRDIKASNILLDHK-----FTAKVADFGLSRLAPVPDI----------EGI 783
HRD+ A N L+ K K+ DFGL+R DI EG+
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-----DIYKSDYYRKEGEGL 174
Query: 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREV 842
+P ++ PE L K T +SDV+S GV+ E+LT G QP N EV
Sbjct: 175 LPVR----------WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EV 222
Query: 843 LPY 845
L +
Sbjct: 223 LQH 225
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 70/213 (32%), Positives = 102/213 (47%), Gaps = 28/213 (13%)
Query: 631 QIGQGGYGKVYKGI--LPDGTV--VAVKR-AQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 685
++G G +G V KG+ + G VAVK QE G+KEFL E +++L H +V L
Sbjct: 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
+G C E MLV E G L L + + P+ + +A + G+ YL E+
Sbjct: 62 IGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPV--SDLKELAHQVAMGMAYL--ESKHF 116
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG------YL 799
V HRD+ A N+LL ++ AK++DFG+SR A S + T +
Sbjct: 117 V-HRDLAARNVLLVNRHQAKISDFGMSR-ALGAG---------SDYYRATTAGRWPLKWY 165
Query: 800 DPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
PE K + KSDV+S GV E + G +P
Sbjct: 166 APECINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 4e-23
Identities = 73/214 (34%), Positives = 105/214 (49%), Gaps = 14/214 (6%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
++G G +G+V+ G T VAVK + G++ E FL E Q + +L H LV L
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
EE +V E+MS G+L D L L + +A + G+ Y+ HRD
Sbjct: 72 EE-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRD 127
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 810
++++NIL+ K+ADFGL+RL + D E +K T PE L + T
Sbjct: 128 LRSANILVGDGLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTA----PEAALYGRFT 181
Query: 811 DKSDVYSLGVVFLELLT-GMQPISHGKNIVREVL 843
KSDV+S G++ EL+T G P N REVL
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMNN--REVL 213
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 8e-23
Identities = 67/237 (28%), Positives = 106/237 (44%), Gaps = 47/237 (19%)
Query: 625 NFNSSTQIGQGGYGKVYKGI------LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRL 677
N +G+G +GKV K T VAVK +E + E ++ L+E L ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 678 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--------------------- 716
+H +++ L G C ++G +L+ E+ G+LR L K
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 717 -EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-- 773
L +S A SRG+ YL A+ + HRD+ A N+L+ K++DFGLSR
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 774 ---LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 827
+ V +G +P VK ++ E H T +SDV+S GV+ E++T
Sbjct: 178 YEEDSYVKRSKGRIP------VK----WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 70/215 (32%), Positives = 105/215 (48%), Gaps = 14/215 (6%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
++G G +G V+ G VA+K EG++ E++F+ E + + +L H LV L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS-EEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
++ +V EFM NG L + L + + L M LS+ G+ YL + HRD
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRD 125
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 810
+ A N L+ KV+DFG++R V D E + VK +P PE F K +
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRY--VLDDEYTSSSGAKFPVKWSP----PEVFNFSKYS 179
Query: 811 DKSDVYSLGVVFLELLT-GMQPISHGKN--IVREV 842
KSDV+S GV+ E+ T G P N +V +
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 70/216 (32%), Positives = 97/216 (44%), Gaps = 34/216 (15%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKR---AQEGSLQGE--KEFLTEIQFLSRLHHRNLVSL 685
+G G +G VY+G+ L DG AVK A +G E K+ EI LS+L H N+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLS--AKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
+G EE + E + G+L L EP+ I LG + YLH D
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYLH---D 120
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-----VKGTPGY 798
HRDIK +NIL+D K+ADFG+++ V KG+P +
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAK-------------QVVEFSFAKSFKGSPYW 167
Query: 799 LDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPIS 833
+ PE +D++SLG LE+ TG P S
Sbjct: 168 MAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWS 203
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 68/221 (30%), Positives = 101/221 (45%), Gaps = 29/221 (13%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGE-----KEFLTEIQFLSRL 677
N+ +GQG +G+VY D G +AVK+ E EIQ L L
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 678 HHRNLVSLVGYCDEEGEQMLVY-EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR--- 733
H +V G C + E + ++ E+M G+++DQL A A+ ++ +R
Sbjct: 62 QHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG------ALTETVTRKYTRQIL 114
Query: 734 -GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS-RLAPV-PDIEGIVPAHVST 790
G+ YLH+ + HRDIK +NIL D K+ DFG S RL + G+
Sbjct: 115 EGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS----- 166
Query: 791 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
V GTP ++ PE K+DV+S+G +E+LT P
Sbjct: 167 -VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 27/209 (12%)
Query: 632 IGQGGYGKVYKGILPD-GTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL-V 686
IG+G +GKV D + A+K + + + L E + L L+H LV+L
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFA---MRLSIA-LGSSRGILYLHTEA 742
+ DEE ++V + + G LR LS K K F+ ++ I + + YLH++
Sbjct: 68 SFQDEENMYLVV-DLLLGGDLRYHLSQKVK----FSEEQVKFWICEIVL--ALEYLHSKG 120
Query: 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
+ HRDIK NILLD + + DF ++ P ++T GTPGY+ PE
Sbjct: 121 ---IIHRDIKPDNILLDEQGHVHITDFNIATKVT--------PDTLTTSTSGTPGYMAPE 169
Query: 803 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
+ D +SLGV E L G +P
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 3e-22
Identities = 70/207 (33%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 632 IGQGGYGKVYKGIL------PDGT--VVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNL 682
+G+G +GKV L DGT +VAVK + Q + EI L L+H N+
Sbjct: 12 LGEGHFGKV---SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 683 VSLVGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 740
V G C E+G + L+ E++ G+LRD L K L A L A G+ YLH+
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLP---KHKLNLAQLLLFAQQICEGMAYLHS 125
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
+ HRD+ A N+LLD+ K+ DFGL++ P EG V +
Sbjct: 126 QH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP----EGHEYYRVREDGDSPVFWYA 178
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLT 827
E +K + SDV+S GV ELLT
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 3e-22
Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 14/214 (6%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
++GQG +G+V+ G T VA+K + G++ E FL E Q + +L H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
EE +V EFM G+L D L + L + +A + G+ Y+ HRD
Sbjct: 72 EE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRD 127
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 810
++A+NIL+ K+ADFGL+RL + D E +K T PE L + T
Sbjct: 128 LRAANILVGDNLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTA----PEAALYGRFT 181
Query: 811 DKSDVYSLGVVFLELLT-GMQPISHGKNIVREVL 843
KSDV+S G++ EL+T G P N REVL
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMVN--REVL 213
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 5e-22
Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 25/211 (11%)
Query: 632 IGQGGYGKVYKGIL--PDGTV--VAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 686
IG G +G+V +G L P VA+K + GS ++ +FLTE + + H N++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
G + M++ E+M NG+L D+ ++ + + G + G+ YL ++
Sbjct: 72 GVVTKSRPVMIITEYMENGSL-DKFLRENDGKFTVGQLVGMLRGIASGMKYL---SEMNY 127
Query: 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVSTVVKGTPGYLDP 801
HRD+ A NIL++ KV+DFGLSR + G +P + P
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR----------WTAP 177
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
E K T SDV+S G+V E+++ G +P
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 6e-22
Identities = 68/222 (30%), Positives = 106/222 (47%), Gaps = 29/222 (13%)
Query: 631 QIGQGGYGKVY----KGILP--DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 684
++G+G +GKV+ + P D +VAVK ++ +L K+F E + L+ L H ++V
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSA--------------KSKEPLGFAMRLSIALG 730
G C + ++V+E+M +G L L A ++K LG + L IA
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 731 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 790
+ G++YL A HRD+ N L+ K+ DFG+SR D V H
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR-VGGHTML 187
Query: 791 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
++ P PE + K T +SDV+S GV+ E+ T G QP
Sbjct: 188 PIRWMP----PESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 63/228 (27%), Positives = 99/228 (43%), Gaps = 44/228 (19%)
Query: 630 TQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNL 682
++GQG +G VY+G+ T VA+K E + E+ EFL E + + ++
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV 71
Query: 683 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE--------PLGFAMRLSIALGSSRG 734
V L+G ++V E M+ G L+ L ++ E P + +A + G
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 735 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI----------EGIV 784
+ YL A HRD+ A N ++ T K+ DFG++R DI +G++
Sbjct: 132 MAYL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR-----DIYETDYYRKGGKGLL 183
Query: 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
P ++ PE T KSDV+S GVV E+ T QP
Sbjct: 184 PVR----------WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 71/209 (33%), Positives = 101/209 (48%), Gaps = 25/209 (11%)
Query: 631 QIGQGGYGKVYK---GILPDGT--VVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 685
Q+G+G +G V L D T VVAVK+ Q + + ++F EI+ L L H N+V
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 686 VGYCDEEG--EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
G C G LV E++ G+LRD L K +E L L A +G+ YL ++
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQ-KHRERLDHRKLLLYASQICKGMEYLGSKR- 128
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG-----Y 798
HRD+ NIL++ + K+ DFGL+++ P D E V+ PG +
Sbjct: 129 --YVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKE-------YYKVR-EPGESPIFW 177
Query: 799 LDPEYFLTHKLTDKSDVYSLGVVFLELLT 827
PE K + SDV+S GVV EL T
Sbjct: 178 YAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 71/214 (33%), Positives = 108/214 (50%), Gaps = 22/214 (10%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
IG+G +G V +G G VAVK + + + Q FL E +++LHH+NLV L+G
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
G +V E MS G L + L + + + L +L + G+ YL ++ + HR
Sbjct: 69 LHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHR 124
Query: 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 809
D+ A NIL+ AKV+DFGL+R+ + +P VK T PE K
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP------VKWTA----PEALKHKKF 174
Query: 810 TDKSDVYSLGVVFLELLT-GMQPISHGKNIVREV 842
+ KSDV+S GV+ E+ + G P + K ++EV
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAP--YPKMSLKEV 206
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 3e-21
Identities = 69/219 (31%), Positives = 103/219 (47%), Gaps = 26/219 (11%)
Query: 631 QIGQGGYGKVY----KGILP--DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 684
++G+G +GKV+ + P D +VAVK ++ S K+F E + L+ L H ++V
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFA-----------MRLSIALGSSR 733
G C E ++V+E+M +G L L A + + A L IA +
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 734 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 793
G++YL A HRD+ N L+ K+ DFG+SR D V H ++
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYR-VGGHTMLPIR 187
Query: 794 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
P PE + K T +SDV+SLGVV E+ T G QP
Sbjct: 188 WMP----PESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 5e-21
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 13/210 (6%)
Query: 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRA--QEGSLQGEKEFLTEIQFLSRLHHRN 681
+F +IG+G +G V+K + D V A+K+ + + + +E + E + L++L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
++ ++G+ +V E+ NG L L + PL + G+ +LH++
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
+ HRDIK+ N+ LD K+ D G+++L +T+V GTP YL P
Sbjct: 121 K---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLL------SDNTNFANTIV-GTPYYLSP 170
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
E +KSDV++LGVV E TG P
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 5e-21
Identities = 61/197 (30%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
++G G +G+V+ G T VA+K ++GS+ E FL E + +L H LV L
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA-FLAEANLMKQLQHPRLVRLYAVVT 71
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
+E ++ E+M NG+L D L L + +A + G+ ++ + HRD
Sbjct: 72 QE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRD 127
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 810
++A+NIL+ K+ADFGL+RL + D E +K T PE T
Sbjct: 128 LRAANILVSETLCCKIADFGLARL--IEDNEYTAREGAKFPIKWTA----PEAINYGTFT 181
Query: 811 DKSDVYSLGVVFLELLT 827
KSDV+S G++ E++T
Sbjct: 182 IKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 5e-21
Identities = 65/203 (32%), Positives = 106/203 (52%), Gaps = 14/203 (6%)
Query: 632 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLVGYCD 690
+G+G +G+V+KG L D T VAVK +E Q K +FL+E + L + H N+V L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
+ +V E + G L K K+ L + AL ++ G+ YL ++ HRD
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLR-KKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRD 118
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP-GYLDPEYFLTHKL 809
+ A N L+ K++DFG+SR + +GI + S+ +K P + PE +
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR----QEDDGI---YSSSGLKQIPIKWTAPEALNYGRY 171
Query: 810 TDKSDVYSLGVVFLELLT-GMQP 831
+ +SDV+S G++ E + G+ P
Sbjct: 172 SSESDVWSYGILLWETFSLGVCP 194
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 8e-21
Identities = 65/211 (30%), Positives = 104/211 (49%), Gaps = 17/211 (8%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVG 687
+IG+G YG VYK G +VA+K+ + K L EI+ L L+H N++ L+
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+G+ LV+EFM +L + L ++ S +G+ + H+ +
Sbjct: 66 VFRHKGDLYLVFEFMDTDLY--KLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---IL 120
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
HRD+K N+L++ + K+ADFGL+R P V + VV T Y PE L
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSP-----VRPYTHYVV--TRWYRAPELLLGD 173
Query: 808 KLTDKS-DVYSLGVVFLELLTGMQPISHGKN 837
K D++S+G +F ELL+ +P+ GK+
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSR-RPLFPGKS 203
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 64/206 (31%), Positives = 105/206 (50%), Gaps = 14/206 (6%)
Query: 632 IGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 686
IG G +G+V++GIL VA+K + G + ++ +FL+E + + H N++ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
G + M++ E+M NG L L E + + + + G + G+ YL +D
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-VGMLRGIAAGMKYL---SDMNY 128
Query: 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 806
HRD+ A NIL++ KV+DFGLSR+ D EG + ++ K + PE
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLE-DDPEG---TYTTSGGKIPIRWTAPEAIAY 184
Query: 807 HKLTDKSDVYSLGVVFLELLT-GMQP 831
K T SDV+S G+V E+++ G +P
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 72/215 (33%), Positives = 112/215 (52%), Gaps = 20/215 (9%)
Query: 632 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY-CD 690
IG+G +G V G G VAVK + + + FL E +++L H NLV L+G +
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
E+G +V E+M+ G+L D L ++ + LG L +L + YL EA+ V HRD
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EANNFV-HRD 127
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 810
+ A N+L+ AKV+DFGL++ A G +P VK T PE K +
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP------VKWTA----PEALREKKFS 177
Query: 811 DKSDVYSLGVVFLELLT-GMQPISHGKNIVREVLP 844
KSDV+S G++ E+ + G P + + +++V+P
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVP--YPRIPLKDVVP 210
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 74/237 (31%), Positives = 111/237 (46%), Gaps = 34/237 (14%)
Query: 622 ATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEF-----LTEIQFLS 675
++ ++G+G +G+VYK + G VVA+K+ + EK+ L EI+ L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI---LMHNEKDGFPITALREIKILK 62
Query: 676 RLHHRNLVSL----VGYCDEEGEQM----LVYEFMS---NGTLRDQLSAKSKEPLGFAMR 724
+L H N+V L V D+ + +V +M +G L + S K E
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP-SVKLTESQIKCYM 121
Query: 725 LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL----APVPDI 780
L + GI YLH + + HRDIKA+NIL+D++ K+ADFGL+R P P
Sbjct: 122 LQLL----EGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG 174
Query: 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGK 836
G T + T Y PE L + T D++ +G VF E+ T +PI GK
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR-RPILQGK 230
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 67/212 (31%), Positives = 106/212 (50%), Gaps = 22/212 (10%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNLVS 684
+IG+G YG VYK G +VA+K+ + L+ E E + EI L L+H N+V
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIR---LETEDEGVPSTAIREISLLKELNHPNIVR 62
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 744
L+ E + LV+EF+ + L+ + + L + S +GI Y H+
Sbjct: 63 LLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR-- 119
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 804
V HRD+K N+L+D + K+ADFGL+R VP V + VV T Y PE
Sbjct: 120 -VLHRDLKPQNLLIDREGALKLADFGLARAFGVP-----VRTYTHEVV--TLWYRAPEIL 171
Query: 805 L-THKLTDKSDVYSLGVVFLELLTGMQPISHG 835
L + + + D++S+G +F E++ +P+ G
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNR-RPLFPG 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 69/212 (32%), Positives = 108/212 (50%), Gaps = 21/212 (9%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNLVS 684
+IG+G YG VYKG G +VA+K+ + L+ E+E + EI L L H N+V
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIR---LESEEEGVPSTAIREISLLKELQHPNIVC 63
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 744
L +E L++EF+S + S + + + S +GIL+ H+
Sbjct: 64 LQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR-- 121
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 804
V HRD+K N+L+D+K K+ADFGL+R +P V + VV T Y PE
Sbjct: 122 -VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP-----VRVYTHEVV--TLWYRAPEVL 173
Query: 805 L-THKLTDKSDVYSLGVVFLELLTGMQPISHG 835
L + + + D++S+G +F E+ T +P+ HG
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMAT-KKPLFHG 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 68/214 (31%), Positives = 102/214 (47%), Gaps = 33/214 (15%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLVGYC 689
IG+G +G+VYK I VVA+K + E E + EIQFLS+ + G
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG-S 67
Query: 690 DEEGEQM-LVYEFMSNGTLRDQL-SAKSKEP-LGFAMRLSIALGSSRGILYLHTEADPPV 746
+G ++ ++ E+ G+ D L K E + F +R + G+ YLH E
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVL-----LGLEYLHEEG---K 119
Query: 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS-TVVK-----GTPGYLD 800
HRDIKA+NILL + K+ADFG V ++ T+ K GTP ++
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFG-------------VSGQLTSTMSKRNTFVGTPFWMA 166
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834
PE +K+D++SLG+ +EL G P+S
Sbjct: 167 PEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 1e-19
Identities = 64/202 (31%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNLVSL 685
+G+G Y VYK G +VA+K+ + G + K+ L EI+ L L H N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
+ + LV+EFM L + KS L A S L + RG+ YLH
Sbjct: 68 LDVFGHKSNINLVFEFME-TDLEKVIKDKSI-VLTPADIKSYMLMTLRGLEYLH---SNW 122
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
+ HRD+K +N+L+ K+ADFGL+R P+ + VV T Y PE
Sbjct: 123 ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK-----MTHQVV--TRWYRAPELLF 175
Query: 806 THKL-TDKSDVYSLGVVFLELL 826
+ D++S+G +F ELL
Sbjct: 176 GARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 67/213 (31%), Positives = 107/213 (50%), Gaps = 29/213 (13%)
Query: 632 IGQGGYGKVYKGI-LPDG----TVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSL 685
+G G +G VYKG+ +P+G VA+K +E + + KE L E ++ + H ++V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 686 VGYCDEEGEQ-MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 744
+G C Q L+ + M G L D + K+ +G L+ + ++G+ YL +
Sbjct: 75 LGIC--LSSQVQLITQLMPLGCLLDYVR-NHKDNIGSQYLLNWCVQIAKGMSYLE---EK 128
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVSTVVKGTPGYL 799
+ HRD+ A N+L+ K+ DFGL++L V + E G VP +K ++
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP------IK----WM 178
Query: 800 DPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
E L T KSDV+S GV EL+T G +P
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 66/228 (28%), Positives = 99/228 (43%), Gaps = 48/228 (21%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVG-- 687
IG+G YGKVYK G +VA+K + E+E E L + +H N+ + G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 688 ----YCDEEGEQMLVYEFMSNGT-------LRDQLSAKSKEPLGFAMRLSIALGSSRGIL 736
+ + LV E G+ LR + +E + + +R ++ RG+
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETL-----RGLA 127
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV-STVVK-- 793
YLH + V HRDIK NILL K+ DFG+S A + ST+ +
Sbjct: 128 YLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVS-------------AQLDSTLGRRN 171
Query: 794 ---GTPGYLDPE-----YFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833
GTP ++ PE +SDV+SLG+ +EL G P+
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 3e-19
Identities = 68/212 (32%), Positives = 105/212 (49%), Gaps = 32/212 (15%)
Query: 648 GTVVAVKRAQEGSLQGEKE---FLTEIQFLSRLHHRNLVSLV--GYCDEEGEQMLVYEFM 702
G VA+K + + + E + F E +RL+H N+V+L+ G G V+E++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 703 SNGTLRDQLSAKSKEPLGFAMRL------SIALGSSRGILYLHTEADPPVFHRDIKASNI 756
TLR+ L+A P G RL ++A ++GI+ HRD+K NI
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIV-----------HRDLKPQNI 110
Query: 757 LL---DHKFTAKVADFGLSRLAPVPDIEGIVPAHVS--TVVKGTPGYLDPEYFLTHKLTD 811
++ + AKV DFG+ L +P + A ++ T V GTP Y PE +T
Sbjct: 111 MVSQTGVRPHAKVLDFGIGTL--LPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTP 168
Query: 812 KSDVYSLGVVFLELLTGMQPISHGKNIVREVL 843
SD+Y+ G++FLE LTG Q + G + V E+L
Sbjct: 169 NSDLYAWGLIFLECLTG-QRVVQGAS-VAEIL 198
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 74/238 (31%), Positives = 110/238 (46%), Gaps = 46/238 (19%)
Query: 632 IGQGGYGKVYKGI---LPDGTV---VAVK-RAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 684
+G G +G+VY+G+ V VAVK + S Q E +FL E +S+ +H+N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLS---AKSKEPLGFAMR--LSIALGSSRGILYLH 739
L+G E + ++ E M+ G L+ L + + P M+ L A ++G YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 740 TEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEG----------IVPA 786
HRDI A N LL K AK+ADFG++R DI ++P
Sbjct: 134 ENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMAR-----DIYRASYYRKGGRAMLP- 184
Query: 787 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVL 843
+K P PE FL T K+DV+S GV+ E+ + G P N +EV+
Sbjct: 185 -----IKWMP----PEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--QEVM 231
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 632 IGQGGYGK--VYKGILPDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVG 687
+G+G +G+ +Y+ D ++V K L + ++ L EI LS L H N+++
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+ ++ ++ E+ + GTL D++ + + M L + Y+H +
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---IL 123
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
HRDIK NI L K+ DFG+S+ I G + TVV GTP Y+ PE
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISK------ILGSEYSMAETVV-GTPYYMSPELCQGV 176
Query: 808 KLTDKSDVYSLGVVFLELLT 827
K KSD+++LG V ELLT
Sbjct: 177 KYNFKSDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 6e-19
Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 42/225 (18%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNLVS 684
+IG+G YG V+K +VA+KR + L + E L EI L L H+N+V
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVR---LDDDDEGVPSSALREICLLKELKHKNIVR 63
Query: 685 LVGYCDEEGEQMLVYEFMS----------NGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 734
L + + LV+E+ NG + D KS F +L +G
Sbjct: 64 LYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDI-DPEIVKS-----FMFQLL------KG 111
Query: 735 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 794
+ + H+ V HRD+K N+L++ K+ADFGL+R +P V + + VV
Sbjct: 112 LAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIP-----VRCYSAEVV-- 161
Query: 795 TPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNI 838
T Y P+ KL S D++S G +F EL +P+ G ++
Sbjct: 162 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 8e-19
Identities = 65/208 (31%), Positives = 95/208 (45%), Gaps = 24/208 (11%)
Query: 632 IGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVSLVG 687
+G+G +GKV G + A+K ++ + KE LTE LSR++H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLG----FAMRLSIALGSSRGILYLHTEAD 743
E + LV E+ G L LS + + +A + +AL YLH+
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALE------YLHSLG- 113
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
+ +RD+K NILLD K+ DFGL++ + +T GTP YL PE
Sbjct: 114 --IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG------SRTNTFC-GTPEYLAPEV 164
Query: 804 FLTHKLTDKSDVYSLGVVFLELLTGMQP 831
L D +SLGV+ E+LTG P
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 8e-19
Identities = 71/219 (32%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 625 NFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQ--EGSLQGEKE---FLTEIQFLSRLH 678
N+ +GQG +G+VY D G +A K+ Q S + KE EIQ L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 679 HRNLVSLVGYCDEEGEQMLV--YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 736
H +V G + E+ L E+M G+++DQL A A+ S+ +R IL
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG------ALTESVTRKYTRQIL 116
Query: 737 ----YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 792
YLH+ + HRDIK +NIL D K+ DFG S+ + G V+
Sbjct: 117 EGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT--- 170
Query: 793 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
GTP ++ PE K+DV+SLG +E+LT P
Sbjct: 171 -GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 8e-19
Identities = 68/210 (32%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 625 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLH 678
NF +IG+G YG VYK G VVA+K+ + L E E + EI L L+
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELN 57
Query: 679 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 738
H N+V L+ E + LV+EF+ + L+ + A + + S +G+ +
Sbjct: 58 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC 116
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
H+ V HRD+K N+L++ + K+ADFGL+R VP V + VV T Y
Sbjct: 117 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-----VRTYTHEVV--TLWY 166
Query: 799 LDPEYFLTHKL-TDKSDVYSLGVVFLELLT 827
PE L K + D++SLG +F E++T
Sbjct: 167 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 9e-19
Identities = 60/201 (29%), Positives = 92/201 (45%), Gaps = 26/201 (12%)
Query: 649 TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 707
+VAVK + + + +FL E++ LSRL N+ L+G C + ++ E+M NG L
Sbjct: 47 VLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106
Query: 708 ---------RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 758
A + + L F+ L +A + G+ YL HRD+ N L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLV 163
Query: 759 DHKFTAKVADFGLSRLAPVPD---IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDV 815
+T K+ADFG+SR D ++G P + ++ E L K T KSDV
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIR--------WMAWESVLLGKFTTKSDV 215
Query: 816 YSLGVVFLELLT--GMQPISH 834
++ GV E+LT QP H
Sbjct: 216 WAFGVTLWEILTLCREQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-18
Identities = 71/232 (30%), Positives = 105/232 (45%), Gaps = 40/232 (17%)
Query: 620 ALATNNFNSSTQIGQGGYGKVYKG-ILPDGTVV--AVKRAQE-GSLQGEKEFLTEIQFLS 675
L N+ IG+G +G+V K I DG + A+KR +E S ++F E++ L
Sbjct: 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 62
Query: 676 RL-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLG 720
+L HH N+++L+G C+ G L E+ +G L D L + + L
Sbjct: 63 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 122
Query: 721 FAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780
L A +RG+ YL + HRD+ A NIL+ + AK+ADFGLSR V
Sbjct: 123 SQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--- 176
Query: 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKL-----TDKSDVYSLGVVFLELLT 827
VK T G L + L T SDV+S GV+ E+++
Sbjct: 177 ----------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 66/223 (29%), Positives = 109/223 (48%), Gaps = 40/223 (17%)
Query: 632 IGQGGYGKVYKGIL-----PDGTV-VAVKRAQEGSLQGE-KEFLTEIQFLSRL-HHRNLV 683
+G+G +G+V K P+ T VAVK ++ + + + + ++E++ + + H+N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSIAL 729
+L+G C +EG +V E+ ++G LRD L A+ +E L +S A
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 730 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 789
+RG+ +L A HRD+ A N+L+ K+ADFGL+R DI H+
Sbjct: 140 QVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR-----DIH-----HID 186
Query: 790 TVVKGTPGYLD-----PEYFLTHKLTDKSDVYSLGVVFLELLT 827
K T G L PE T +SDV+S GV+ E+ T
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 69/236 (29%), Positives = 105/236 (44%), Gaps = 41/236 (17%)
Query: 626 FNSSTQIGQGGYGKVYKGIL---PDGTVVAVKRAQEGSLQGEKEFLT--------EIQFL 674
+ IG+G YG+VYK DG A+K+ +G+KE T EI L
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKK-----FKGDKEQYTGISQSACREIALL 56
Query: 675 SRLHHRNLVSLVGYC--DEEGEQMLVYEFMSN---GTLRDQLSAKSKEPLGFAMRLSIAL 729
L H N+VSLV + L++++ + ++ AK + +M S+
Sbjct: 57 RELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRV-SIPPSMVKSLLW 115
Query: 730 GSSRGILYLHTEADPPVFHRDIKASNILL----DHKFTAKVADFGLSRL---APVPDIEG 782
G+ YLH+ V HRD+K +NIL+ + K+ D GL+RL P
Sbjct: 116 QILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP---- 168
Query: 783 IVPAHVSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
A + VV T Y PE L T D++++G +F ELLT ++PI G+
Sbjct: 169 --LADLDPVVV-TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPIFKGRE 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 2e-18
Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 20/200 (10%)
Query: 34 PIEVSALRSIKK----------SLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLH 83
P + A RS+++ L +++KL D +N G ++
Sbjct: 397 PKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQG------RINSRKWD 450
Query: 84 LRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140
+ LQ+L+L G L P+ L LD N+ SG++P+++G++ L L L+ N
Sbjct: 451 MPSLQMLSLARNKFFGGL-PDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSEN 509
Query: 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR 200
+L+G +P+EL KL + + N +SG +P SF+ + ++ N +SG+IP L
Sbjct: 510 KLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGN 569
Query: 201 LPSLVHMLLDNNNLTGYLPP 220
+ SLV + + +N+L G LP
Sbjct: 570 VESLVQVNISHNHLHGSLPS 589
|
Length = 968 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 10/197 (5%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
++G G +G+V+ G + T VAVK + G++ + FL E + L H LV L
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVT 71
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
+E ++ E+M+ G+L D L + + + + + G+ Y+ + HRD
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRD 128
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 810
++A+N+L+ K+ADFGL+R+ + D E +K T PE T
Sbjct: 129 LRAANVLVSESLMCKIADFGLARV--IEDNEYTAREGAKFPIKWTA----PEAINFGSFT 182
Query: 811 DKSDVYSLGVVFLELLT 827
KSDV+S G++ E++T
Sbjct: 183 IKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 12/208 (5%)
Query: 632 IGQGGYGKVYKGILPDGTVVAVKRAQ---EGSLQGEKEFLT---EIQFLSRLHHRNLVSL 685
+G+G YG VY G+ G ++AVK+ + L EKE+ E+ L L H N+V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
+G C ++ + EF+ G++ L+ P + + + G+ YLH +
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI--LDGVAYLH---NNC 122
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
V HRDIK +N++L K+ DFG +R + G +++ + GTP ++ PE
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG-THSNMLKSMHGTPYWMAPEVIN 181
Query: 806 THKLTDKSDVYSLGVVFLELLTGMQPIS 833
KSD++S+G E+ TG P++
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPPLA 209
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 66/205 (32%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGY 688
+G G G V K +P GTV+A K G+ K+ L E+Q + +VS G
Sbjct: 12 DLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 748
E + EFM G+L D++ K P+ + IA+ G+ YL+ + H
Sbjct: 72 FLNENNICMCMEFMDCGSL-DRIYKKGG-PIPVEILGKIAVAVVEGLTYLYNVHR--IMH 127
Query: 749 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 808
RDIK SNIL++ + K+ DFG+S G + ++ GT Y+ PE K
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVS---------GELINSIADTFVGTSTYMSPERIQGGK 178
Query: 809 LTDKSDVYSLGVVFLELLTGMQPIS 833
T KSDV+SLG+ +EL G P +
Sbjct: 179 YTVKSDVWSLGISIIELALGKFPFA 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 68/219 (31%), Positives = 109/219 (49%), Gaps = 33/219 (15%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE---F----LTEIQFLSRLHHRNLV 683
I +G YG VY+ G +VA+K+ L+ EKE F L EI L +L H N+V
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKK-----LKMEKEKEGFPITSLREINILLKLQHPNIV 67
Query: 684 SL----VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
++ VG + +V E++ + L+ + K+P + + L G+ +LH
Sbjct: 68 TVKEVVVG--SNLDKIYMVMEYVEH-DLKSLMETM-KQPFLQSEVKCLMLQLLSGVAHLH 123
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
D + HRD+K SN+LL+++ K+ DFGL+R P + + VV T Y
Sbjct: 124 ---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-----LKPYTQLVV--TLWYR 173
Query: 800 DPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
PE L + + D++S+G +F ELLT +P+ GK+
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLT-KKPLFPGKS 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 63/223 (28%), Positives = 108/223 (48%), Gaps = 30/223 (13%)
Query: 631 QIGQGGYGKVYKG--ILP---DGTVVAVKRAQE-GSLQGEKEFLTEIQFLSRLHHRNLVS 684
++G+ +GK+YKG LP +VA+K ++ + Q EF E ++ LHH N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS---------------KEPLGFAMRLSIAL 729
L+G +E +++E+++ G L + L +S K L L IA+
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 730 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 789
+ G+ YL + H+D+ A NIL+ + K++D GLSR D + P +
Sbjct: 132 QIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 790 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
+ ++ PE + K + SD++S GVV E+ + G+QP
Sbjct: 189 PI-----RWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 63/221 (28%), Positives = 95/221 (42%), Gaps = 18/221 (8%)
Query: 631 QIGQGGYGKVYKG--ILPDGTV--VAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSL 685
++G G +G V +G G V VAVK + L +FL E + L H NL+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
G M+V E G+L D+L + + A+ + G+ YL ++
Sbjct: 62 YGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--- 117
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP-GYLDPEYF 804
HRD+ A NILL K+ DFGL R P + +V P + PE
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNE-----DHYVMEEHLKVPFAWCAPESL 172
Query: 805 LTHKLTDKSDVYSLGVVFLELLT-GMQPISH--GKNIVREV 842
T + SDV+ GV E+ T G +P + G I++++
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 4e-18
Identities = 72/207 (34%), Positives = 101/207 (48%), Gaps = 23/207 (11%)
Query: 626 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR-AQEGSLQGEK--EFLTEIQFLSRLHHRN 681
F +IG G +G VY + VVA+K+ + G EK + + E++FL +L H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+ G E LV E+ G+ D L K+PL +I G+ +G+ YLH+
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
HRDIKA NILL T K+ADFG + L PA+ S V GTP ++ P
Sbjct: 135 E---RIHRDIKAGNILLTEPGTVKLADFGSASLVS--------PAN-SFV--GTPYWMAP 180
Query: 802 EYFLTH---KLTDKSDVYSLGVVFLEL 825
E L + K DV+SLG+ +EL
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-18
Identities = 67/219 (30%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 625 NFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQ--EGSLQGEKE---FLTEIQFLSRLH 678
N+ +GQG +G+VY D G +AVK+ Q S + KE EIQ L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 679 HRNLVSLVGYCDEEGEQML--VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR--- 733
H +V G + E+ L E M G+++DQL + A+ ++ +R
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG------ALTENVTRKYTRQIL 116
Query: 734 -GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 792
G+ YLH+ + HRDIK +NIL D K+ DFG S+ + G V+
Sbjct: 117 EGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT--- 170
Query: 793 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
GTP ++ PE K+D++S+G +E+LT P
Sbjct: 171 -GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 6e-18
Identities = 66/213 (30%), Positives = 97/213 (45%), Gaps = 22/213 (10%)
Query: 632 IGQGGYGKVYKGILPD-GTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 688
+G+G YG V K G +VA+K + E +K L E++ L +L H N+V+L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF---AMRLSIALGSSRGILYLHTEADPP 745
+G LV+E++ TL + L A P G A+R I + I Y H+
Sbjct: 69 FRRKGRLYLVFEYVER-TLLELLEAS---PGGLPPDAVRSYI-WQLLQAIAYCHSHN--- 120
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
+ HRDIK NIL+ K+ DFG +R PA T T Y PE +
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRAR------PASPLTDYVATRWYRAPELLV 174
Query: 806 THKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 837
K DV+++G + ELL G +P+ G +
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDG-EPLFPGDS 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 7e-18
Identities = 59/234 (25%), Positives = 90/234 (38%), Gaps = 28/234 (11%)
Query: 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEK---EFLTEIQFLSRL-H 678
++F IG+G + V A+K + L EK E + L+RL
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 679 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 738
H ++ L +E V E+ NG L + L A + YL
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILLALEYL 118
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP------------- 785
H++ + HRD+K NILLD K+ DFG +++
Sbjct: 119 HSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 786 -AHVSTVVKGTPGYLDPEYFLTHKLTDK-SDVYSLGVVFLELLTGMQPISHGKN 837
++ V GT Y+ PE L K K SD+++LG + ++LTG P G N
Sbjct: 176 RRRFASFV-GTAEYVSPE-LLNEKPAGKSSDLWALGCIIYQMLTGKPPF-RGSN 226
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 8e-18
Identities = 61/217 (28%), Positives = 109/217 (50%), Gaps = 27/217 (12%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRA--------QEGSLQGE--KEFLTEIQFLSRLHHR 680
IG+G YG+VY + + G ++AVK+ + S Q + K +EI+ L L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS--AKSKEPLGFAMRLSIALGSSRGILYL 738
N+V +G+ E + E++ G++ L + +E L +R G+ YL
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL---VR-FFTEQVLEGLAYL 124
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
H++ + HRD+KA N+L+D K++DFG+S+ + + I + ++G+ +
Sbjct: 125 HSKG---ILHRDLKADNLLVDADGICKISDFGISKKS-----DDIYDNDQNMSMQGSVFW 176
Query: 799 LDPEYFLTHK--LTDKSDVYSLGVVFLELLTGMQPIS 833
+ PE ++ + K D++SLG V LE+ G +P S
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 8e-18
Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 16/210 (7%)
Query: 632 IGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGY 688
IG+G +G V+K G VA+K+ L+G + L EI+ L H +V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 748
+LV E+M L + L + PL A S +G+ Y+H + H
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLR-DEERPLPEAQVKSYMRMLLKGVAYMHANG---IMH 122
Query: 749 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-TH 807
RD+K +N+L+ K+ADFGL+RL E + V T Y PE
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFS----EEEPRLYSHQV--ATRWYRAPELLYGAR 176
Query: 808 KLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
K D++++G +F ELL G P+ G+N
Sbjct: 177 KYDPGVDLWAVGCIFAELLNG-SPLFPGEN 205
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 74/232 (31%), Positives = 115/232 (49%), Gaps = 39/232 (16%)
Query: 616 YGEMALATNNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKE-----FLT 669
+G+ + + F+ QIG+G YG+VYK D G +VA+K+ + L EKE +
Sbjct: 1 WGKRCV--DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVR---LDNEKEGFPITAIR 55
Query: 670 EIQFLSRLHHRNLVSL----------VGYCDEEGEQMLVYEFMSN---GTLRDQLSAKSK 716
EI+ L +L+HRN+V+L + + ++G LV+E+M + G L L S+
Sbjct: 56 EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE 115
Query: 717 EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776
+ + M+ + G+ Y H HRDIK SNILL++K K+ADFGL+RL
Sbjct: 116 DHIKSFMKQLL-----EGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN 167
Query: 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLT 827
+ + + V+ T Y PE L + DV+S G + EL T
Sbjct: 168 SEESR----PYTNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-17
Identities = 54/146 (36%), Positives = 80/146 (54%), Gaps = 9/146 (6%)
Query: 32 TDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSN---WTGVLC-FNTTMDDGYLHLREL 87
T EVSAL+++K SL + WN GDPC W+G C F++T G + L
Sbjct: 369 TLLEEVSALQTLKSSL-GLPLRFG-WN-GDPCVPQQHPWSGADCQFDSTK--GKWFIDGL 423
Query: 88 QLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLP 147
L N L G + +I +L +L ++ N I G+IP +G+I SLE+L L+ N GS+P
Sbjct: 424 GLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP 483
Query: 148 EELGYLPKLDRIQIDQNYISGSLPKS 173
E LG L L + ++ N +SG +P +
Sbjct: 484 ESLGQLTSLRILNLNGNSLSGRVPAA 509
|
Length = 623 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 68/223 (30%), Positives = 101/223 (45%), Gaps = 26/223 (11%)
Query: 631 QIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
++G G +GKVYK + G A K Q S + ++F+ EI LS H N+V L
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY 71
Query: 690 DEEGEQMLVYEFMSNGTLR---DQLSAKSKEP-LGFAMRLSIALGSSRGILYLHTEADPP 745
E + ++ EF G L +L EP + + R + + +LH+
Sbjct: 72 FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQML-----EALNFLHSHK--- 123
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
V HRD+KA NILL K+ADFG+S T + GTP ++ PE
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL------QKRDTFI-GTPYWMAPEVVA 176
Query: 806 THKLTD-----KSDVYSLGVVFLELLTGMQPISHGKNIVREVL 843
D K+D++SLG+ +E L M+P H N +R +L
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIE-LAQMEPPHHELNPMRVLL 218
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 14/207 (6%)
Query: 632 IGQGGYGKVYKGIL-PDG---TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLV 686
IG G +G+V +G L G VA+K + G + + ++FL+E + + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
G + M++ EFM NG L D ++ + + G + G+ YL ++
Sbjct: 72 GVVTKSRPVMIITEFMENGAL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEMNY 127
Query: 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP-GYLDPEYFL 805
HRD+ A NIL++ KV+DFGLSR + + P + S++ P + PE
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFL---EDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 806 THKLTDKSDVYSLGVVFLELLT-GMQP 831
K T SDV+S G+V E+++ G +P
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-17
Identities = 69/222 (31%), Positives = 109/222 (49%), Gaps = 27/222 (12%)
Query: 624 NNFNSSTQIGQGGYGKVYK----GILPDGTV--VAVKRAQEGSLQGEKEFL-TEIQFLSR 676
NN + +G G +GKV + G+ V VAVK + + E+E L +E++ +S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 677 L-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 735
L +H N+V+L+G C G +++ E+ G L + L K + L LS + ++G+
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154
Query: 736 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST-VVKG 794
+L A HRD+ A N+LL H K+ DFGL+R DI + S VVKG
Sbjct: 155 AFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR-----DI-----MNDSNYVVKG 201
Query: 795 TP----GYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
++ PE T +SDV+S G++ E+ + G P
Sbjct: 202 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNP 243
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 67/212 (31%), Positives = 105/212 (49%), Gaps = 27/212 (12%)
Query: 632 IGQGGYGKVYKGI-LPDG----TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSL 685
+G G +G VYKGI +PDG VA+K +E S + KE L E ++ + + L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
+G C Q LV + M G L D + ++K+ +G L+ + ++G+ YL +
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVR-ENKDRIGSQDLLNWCVQIAKGMSYLE---EVR 129
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVSTVVKGTPGYLD 800
+ HRD+ A N+L+ K+ DFGL+RL + + E G VP ++
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK----------WMA 179
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
E L + T +SDV+S GV EL+T G +P
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 68/235 (28%), Positives = 101/235 (42%), Gaps = 53/235 (22%)
Query: 625 NFNSSTQIGQGGYGKVYKG-ILPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLH 678
F +IG+G YG VY+ G +VA+K+ + + E++ L EI L L
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVR---MDNERDGIPISSLREITLLLNLR 64
Query: 679 HRNLVSL---------------VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAM 723
H N+V L + YC EQ L +L D + P +
Sbjct: 65 HPNIVELKEVVVGKHLDSIFLVMEYC----EQDL-------ASLLDNMPT----PFSESQ 109
Query: 724 RLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783
+ L RG+ YLH + HRD+K SN+LL K K+ADFGL+R G+
Sbjct: 110 VKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY------GL 160
Query: 784 VPAHVS-TVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGK 836
++ VV T Y PE L + D++++G + ELL +P+ GK
Sbjct: 161 PAKPMTPKVV--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH-KPLLPGK 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 65/211 (30%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHHRNLVSLVGY- 688
IG+G YG VY+G +P G VVA+K + + + E+ LS+L ++ Y
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 689 -CDEEGEQM-LVYEFMSNGTLRDQLSA-KSKEP-LGFAMR-LSIALGSSRGILYLHTEAD 743
+G ++ ++ E+ G++R + A E + +R + +AL Y+H
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALK------YIHKV-- 120
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
V HRDIKA+NIL+ + K+ DFG++ L + ST V GTP ++ PE
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALL------NQNSSKRSTFV-GTPYWMAPEV 172
Query: 804 FLTHKLTD-KSDVYSLGVVFLELLTGMQPIS 833
K D K+D++SLG+ E+ TG P S
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATGNPPYS 203
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 4e-17
Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 632 IGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 686
IG G +G+V G L VA+K + G + ++ +FL+E + + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
G + M+V E+M NG+L D K + + G + G+ YL +D
Sbjct: 72 GVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDMGY 127
Query: 747 FHRDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
HRD+ A NIL++ KV+DFGLSR L P+ A+ + K + PE
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE-----AAYTTRGGKIPIRWTAPEAIA 182
Query: 806 THKLTDKSDVYSLGVVFLELLT-GMQP 831
K T SDV+S G+V E+++ G +P
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 4e-17
Identities = 67/227 (29%), Positives = 114/227 (50%), Gaps = 46/227 (20%)
Query: 632 IGQGGYGKVYK----GI---LPDGTV-VAVKRAQE-GSLQGEKEFLTEIQFLSRL-HHRN 681
+G+G +G+V + GI PD TV VAVK ++ + + + ++E++ + + H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSI 727
+++L+G C +EG ++ E+ + G LR+ L A+ +E L F +S
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 728 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE------ 781
A +RG+ YL + HRD+ A N+L+ K+ADFGL+R V DI+
Sbjct: 140 AYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLAR--GVHDIDYYKKTS 194
Query: 782 -GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 827
G +P VK ++ PE T +SDV+S G++ E+ T
Sbjct: 195 NGRLP------VK----WMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 4e-17
Identities = 60/220 (27%), Positives = 106/220 (48%), Gaps = 32/220 (14%)
Query: 632 IGQGGYGKVYK----GILPD----GTVVAVKRAQEGSLQGE-KEFLTEIQFLSRL-HHRN 681
+G+G +G+V GI D VAVK ++ + + + + ++E++ + + H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSI 727
+++L+G C ++G ++ E+ S G LR+ L A+ E + F +S
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 728 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 787
+RG+ YL A HRD+ A N+L+ K+ADFGL+R D+ I
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DVNNIDYYK 194
Query: 788 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 827
+T + ++ PE T +SDV+S GV+ E+ T
Sbjct: 195 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 62/217 (28%), Positives = 94/217 (43%), Gaps = 27/217 (12%)
Query: 632 IGQGGYGKVYKGIL----PDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLV 686
IG+G +G VY+G+ + VAVK + + +E FL E + + H ++V L+
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
G E +V E G LR L +K L A + + S + YL ++
Sbjct: 74 GVI-TENPVWIVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTALAYLESKR---F 128
Query: 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG-----YLDP 801
HRDI A N+L+ K+ DFGLSR + K + G ++ P
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSRY-----------LEDESYYKASKGKLPIKWMAP 177
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKN 837
E + T SDV+ GV E+L G++P KN
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 5e-17
Identities = 65/215 (30%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 623 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEK---EFLTEIQFLSRLH 678
NF +IG+G + VYK I L DG VVA+K+ Q + K + L EI L +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 679 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS--AKSKEPL------GFAMRLSIALG 730
H N++ + E E +V E G L + K K + + ++L AL
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 731 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 790
++H++ + HRDIK +N+ + K+ D GL R AH S
Sbjct: 121 ------HMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA----AH-SL 166
Query: 791 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLEL 825
V GTP Y+ PE + KSD++SLG + E+
Sbjct: 167 V--GTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 7e-17
Identities = 63/215 (29%), Positives = 108/215 (50%), Gaps = 23/215 (10%)
Query: 625 NFNSSTQIGQGGYGKVYK-GILPDGTVVAVKRAQEGSL-QGEKE-FLTEIQFLSRLHHRN 681
+F ++G+G YG VYK L D A+K GS+ Q E+E + EI+ L+ ++H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 682 LVSLVGYCDE--EGEQM-LVYEFMSNGTLRDQLS--AKSKEPLGFAMRLSIALGSSRGIL 736
++S Y + +G ++ +V E+ G L +S K ++ + I + RG+
Sbjct: 61 IIS---YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
LH + + HRD+K++NILL K+ D G+S++ +++ GTP
Sbjct: 118 ALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLK---------KNMAKTQIGTP 165
Query: 797 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
Y+ PE + + KSD++SLG + E+ T P
Sbjct: 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 7e-17
Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 35/220 (15%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEF--------LTEIQFLSRL-HHR 680
Q+G G +G VY G +VA+K+ + K+F L E++ L +L H
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHP 58
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 740
N+V L E E V+E+M G L + + +P ++ SI +G+ ++H
Sbjct: 59 NIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP--AHVSTVVKGTPGY 798
FHRD+K N+L+ K+ADFGL+R +I P +VS T Y
Sbjct: 118 HG---FFHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTDYVS-----TRWY 164
Query: 799 LDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 837
PE L D+++LG + EL T ++P+ G +
Sbjct: 165 RAPEILLRSTSYSSPVDIWALGCIMAELYT-LRPLFPGSS 203
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 9e-17
Identities = 63/202 (31%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 632 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVGY 688
+G+G YG V K + G +VA+K+ E K + EI+ L +L H NLV+L+
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 748
+ LV+EF+ + T+ D L K L + RGI + H+ + H
Sbjct: 69 FRRKKRLYLVFEFVDH-TVLDDLE-KYPNGLDESRVRKYLFQILRGIEFCHSHN---IIH 123
Query: 749 RDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
RDIK NIL+ K+ DFG +R LA P V T T Y PE +
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLA--------APGEVYTDYVATRWYRAPELLVGD 175
Query: 808 -KLTDKSDVYSLGVVFLELLTG 828
K D++++G + E+LTG
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQ--EGSLQGEKE-------FLTEIQFLSRLHHRN 681
IG G +G VY G+ G ++AVK+ + S + EI L L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNG---TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 738
+V +G + + E++ G L + A +E L I +G+ YL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA-FEETLVRNFVRQIL----KGLNYL 122
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
H + HRDIK +NIL+D+K K++DFG+S+ + + ++G+ +
Sbjct: 123 HNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS-LQGSVFW 178
Query: 799 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
+ PE T K+D++SLG + +E+LTG P
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 2e-16
Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 17/207 (8%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRA-----QEGSLQGEKEFLTEIQFLSRLHHRNLVSL 685
+G G +G VYKGI +P+G V + A + + EF+ E ++ + H +LV L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
+G C Q LV + M +G L D + + K+ +G + L+ + ++G++YL
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVH-EHKDNIGSQLLLNWCVQIAKGMMYLEERR--- 129
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
+ HRD+ A N+L+ K+ DFGL+RL +EG + + K ++ E
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARL-----LEGDEKEYNADGGKMPIKWMALECIH 184
Query: 806 THKLTDKSDVYSLGVVFLELLT-GMQP 831
K T +SDV+S GV EL+T G +P
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 71/209 (33%), Positives = 102/209 (48%), Gaps = 23/209 (11%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKR-AQEGSLQGEK--EFLTEIQFLSRLHHRNLVSLV 686
+IG G +G VY VVAVK+ + G EK + + E++FL +L H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
G +E LV E+ G+ D L K+PL +I G+ +G+ YLH+ +
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---M 142
Query: 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 806
HRDIKA NILL K+ADFG + + PA+ S V GTP ++ PE L
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASKSS--------PAN-SFV--GTPYWMAPEVILA 191
Query: 807 H---KLTDKSDVYSLGVVFLELLTGMQPI 832
+ K DV+SLG+ +EL P+
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 66/216 (30%), Positives = 102/216 (47%), Gaps = 19/216 (8%)
Query: 625 NFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRA--QEGSLQGEKE---FLTEIQFLSRLH 678
N+ +G+G +G+VY D G +AVK+ S + KE EIQ L L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 679 HRNLVSLVGYC--DEEGEQMLVY-EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 735
H +V G C D E +++ ++ E+M G+++DQL A R + + +G+
Sbjct: 63 HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI--LQGV 119
Query: 736 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 795
YLH+ + HRDIK +NIL D K+ DFG S+ + G V+ GT
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT----GT 172
Query: 796 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
P ++ PE K+DV+S+ +E+LT P
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 70/214 (32%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 626 FNSSTQIGQGGYGKVY-KGILPDGTVVAVKR-AQEGSLQGEK--EFLTEIQFLSRLHHRN 681
F +IG G +G VY + VVA+K+ + G EK + + E++FL R+ H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+ G E LV E+ G+ D L K+PL +I G+ +G+ YLH+
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
+ HRDIKA NILL K+ADFG + +A PA+ GTP ++ P
Sbjct: 145 N---MIHRDIKAGNILLTEPGQVKLADFGSASIAS--------PANSFV---GTPYWMAP 190
Query: 802 EYFLTH---KLTDKSDVYSLGVVFLELLTGMQPI 832
E L + K DV+SLG+ +EL P+
Sbjct: 191 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 63/215 (29%), Positives = 90/215 (41%), Gaps = 34/215 (15%)
Query: 632 IGQGGYGKVYKGILPD-GTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
+G+G G V K L + G + A+K LQ K+ L E++ +V G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ--KQILRELEINKSCKSPYIVKYYG 66
Query: 688 YCDEEGEQML--VYEFMSNGTLRDQLSAKSKE--------PLGFAMRLSIALGSSRGILY 737
+E + E+ G+L D + K K+ LG IA +G+ Y
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLG-----KIAESVLKGLSY 120
Query: 738 LHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG 797
LH+ + HRDIK SNILL K K+ DFG+S V + T GT
Sbjct: 121 LHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGEL--------VNSLAGTFT-GTSF 168
Query: 798 YLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 832
Y+ PE + SDV+SLG+ LE+ P
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 42/221 (19%)
Query: 632 IGQGGYGKVY---KGILPDGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHRNLVSL 685
I +G YG+V+ K G + A+K ++ + + + LTE LS+ +V L
Sbjct: 1 ISKGAYGRVFLAKKKST--GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 686 VGYCDEEGEQML--VYEFMSNGTLR---------DQLSAK--SKEPLGFAMRLSIALGSS 732
Y +G++ L V E++ G L D+ A+ E I L
Sbjct: 59 --YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAE---------IVLA-- 105
Query: 733 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI--EGIVPAHVST 790
+ YLH+ + HRD+K NIL+D K+ DFGLS++ V
Sbjct: 106 --LEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160
Query: 791 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
+V GTP Y+ PE L + D +SLG + E L G+ P
Sbjct: 161 IV-GTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 63/199 (31%), Positives = 99/199 (49%), Gaps = 15/199 (7%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
++G G +G+V+ T VAVK + GS+ E FL E + L H LV L
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAVVT 71
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 748
+E ++ EFM+ G+L D L + SK+PL + S + + G+ ++ H
Sbjct: 72 KE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMAFIEQRN---YIH 125
Query: 749 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 808
RD++A+NIL+ K+ADFGL+R+ + D E +K T PE
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTA----PEAINFGS 179
Query: 809 LTDKSDVYSLGVVFLELLT 827
T KSDV+S G++ +E++T
Sbjct: 180 FTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 66/219 (30%), Positives = 104/219 (47%), Gaps = 20/219 (9%)
Query: 625 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR----AQEGSLQGEKEFLTEIQFLSRLHH 679
NF ++G+G Y VYKG G +VA+K A+EG+ + EI + L H
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGT---PSTAIREISLMKELKH 57
Query: 680 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
N+V L E + MLV+E+M + + + L S +GI + H
Sbjct: 58 ENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
+ V HRD+K N+L++ + K+ADFGL+R +P V + VV T Y
Sbjct: 118 ---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP-----VNTFSNEVV--TLWYR 167
Query: 800 DPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 837
P+ L + S D++S+G + E++TG +P+ G N
Sbjct: 168 APDVLLGSRTYSTSIDIWSVGCIMAEMITG-RPLFPGTN 205
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 4e-16
Identities = 67/210 (31%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQ--EGSLQGEKEFLTEIQFLSRLHHRNLVSLV- 686
IG G YG V + G VA+K+ L K L EI+ L L H N++ L+
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLD 66
Query: 687 ----GYCDEEGEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHT 740
++ + +V E M D L KS +PL RG+ YLH+
Sbjct: 67 ILRPPSPEDFNDVYIVTELMET----D-LHKVIKSPQPLTDDHIQYFLYQILRGLKYLHS 121
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST-VVKGTPGYL 799
A+ V HRD+K SNIL++ K+ DFGL+R D + ++ VV T Y
Sbjct: 122 -AN--VIHRDLKPSNILVNSNCDLKICDFGLARGV---DPDEDEKGFLTEYVV--TRWYR 173
Query: 800 DPEYFLT-HKLTDKSDVYSLGVVFLELLTG 828
PE L+ + T D++S+G +F ELLT
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 632 IGQGGYGKVY--KGILPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVGY 688
+G+G +G V+ + V+ + E + E+ E Q L L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAK------SKEPLGFAMRLSIALGSSRGILYLHTEA 742
E+ M+V E+ GTL + + + L F +++ +AL ++HT+
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH------HVHTKL 121
Query: 743 DPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
+ HRD+K NILLD HK K+ DFG+S++ + TVV GTP Y+ P
Sbjct: 122 ---ILHRDLKTQNILLDKHKMVVKIGDFGISKIL-------SSKSKAYTVV-GTPCYISP 170
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLT 827
E KSD+++LG V EL +
Sbjct: 171 ELCEGKPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 67/218 (30%), Positives = 96/218 (44%), Gaps = 27/218 (12%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKE---FLTEIQFLSRLHH 679
+F TQ+GQGGYG+V+ D G +VA+KR ++ L E LTE L+
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 680 RNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAK---SKEPLGFAMRLSIALGSSRGI 735
LV L+ Y ++ E + L E++ G R L+ S++ F M +
Sbjct: 61 EWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDA--- 116
Query: 736 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 795
LH HRD+K N L+D K+ DFGLS+ + A+ S V G+
Sbjct: 117 --LHELG---YIHRDLKPENFLIDASGHIKLTDFGLSK-------GIVTYAN-SVV--GS 161
Query: 796 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833
P Y+ PE D +SLG + E L G P S
Sbjct: 162 PDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-16
Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 40/220 (18%)
Query: 632 IGQGGYGKVYKGILP-DGTVV--AVKRAQE-GSLQGEKEFLTEIQFLSRL-HHRNLVSLV 686
IG+G +G+V + ++ DG + A+K +E S ++F E++ L +L HH N+++L+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLS---------AKSKE-----PLGFAMRLSIALGSS 732
G C+ G + E+ G L D L A +KE L L A +
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 733 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 792
G+ YL ++ HRD+ A N+L+ +K+ADFGLSR V V
Sbjct: 130 TGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEV-------------YV 173
Query: 793 KGTPGYLDPEYFLTHKL-----TDKSDVYSLGVVFLELLT 827
K T G L + L T KSDV+S GV+ E+++
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-16
Identities = 64/225 (28%), Positives = 109/225 (48%), Gaps = 42/225 (18%)
Query: 632 IGQGGYGKVYK----GILPDG----TVVAVKRAQEGSLQGE-KEFLTEIQFLSRL-HHRN 681
+G+G +G+V G+ + T VAVK + + + + + ++E++ + + H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSI 727
+++L+G C ++G ++ E+ S G LR+ L A+ +E L F +S
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 728 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 787
A +RG+ YL A HRD+ A N+L+ K+ADFGL+R DI H
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIH-----H 192
Query: 788 VSTVVKGTPG-----YLDPEYFLTHKLTDKSDVYSLGVVFLELLT 827
+ K T G ++ PE T +SDV+S GV+ E+ T
Sbjct: 193 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 18/208 (8%)
Query: 631 QIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 684
++G G +G V KG+ D + +K E S++ E + E + + +L + +V
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVR--DEMMREAEIMHQLDNPYIVR 59
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 744
++G C+ E MLV E S G L LS K K+ + + + + S G+ YL +
Sbjct: 60 MIGVCEAEA-LMLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKN-- 115
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 804
HRD+ A N+LL ++ AK++DFGLS+ D + K + PE
Sbjct: 116 -FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY----YKARSAGKWPLKWYAPECI 170
Query: 805 LTHKLTDKSDVYSLGVVFLELLT-GMQP 831
K + +SDV+S G+ E + G +P
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 33/227 (14%)
Query: 621 LATNNFNSSTQIGQGGYGKVY----KGILPDG--TVVAVKRAQEGSLQGEK-EFLTEIQF 673
+A S ++GQG +G VY KG++ D T VA+K E + E+ EFL E
Sbjct: 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 62
Query: 674 LSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------SAKSKEPLGFAMRL 725
+ + ++V L+G + +++ E M+ G L+ L + + P +
Sbjct: 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 726 SIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI----- 780
+A + G+ YL+ HRD+ A N ++ FT K+ DFG++R D
Sbjct: 123 QMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 827
+G++P ++ PE T SDV+S GVV E+ T
Sbjct: 180 KGLLPVR----------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 64/223 (28%), Positives = 100/223 (44%), Gaps = 15/223 (6%)
Query: 625 NFNSSTQIGQGGYGKVY--KGILPDGTVVAVKRAQEGSLQGEKEF-LTEIQFLSRLHHRN 681
+ +IG+G +GK+Y K V + EKE E+ L+++ H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+V+ E G +V E+ G L +++ + LS + S G+ ++H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH-- 118
Query: 742 ADPPVFHRDIKASNILLDHK-FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
D + HRDIK+ NI L AK+ DFG++R + D ++ GTP YL
Sbjct: 119 -DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LND-----SMELAYTCVGTPYYLS 170
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVL 843
PE +K+D++SLG V EL T P G N+ + VL
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCTLKHPF-EGNNLHQLVL 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 20/203 (9%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 688
+G G G VYK L ++AVK + +++ +K+ ++E++ L + ++ G
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 748
E + EFM G+L D + LG IA+ +G+ YL + + H
Sbjct: 68 FFVENRISICTEFMDGGSL-DVYRKIPEHVLG-----RIAVAVVKGLTYLWSLK---ILH 118
Query: 749 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 808
RD+K SN+L++ + K+ DFG+S +V + T V GT Y+ PE +
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVST--------QLVNSIAKTYV-GTNAYMAPERISGEQ 169
Query: 809 LTDKSDVYSLGVVFLELLTGMQP 831
SDV+SLG+ F+EL G P
Sbjct: 170 YGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 66/226 (29%), Positives = 98/226 (43%), Gaps = 39/226 (17%)
Query: 623 TNNFNSSTQIGQGGYGKVYKGILPDGTV-VAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN 681
+ +G+G YG VY V +A+K E + + EI S L HRN
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK-----SKEP-LGFAMRLSIALGSSRGI 735
+V +G E G + E + G+L L +K E + F + + G+
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-----EGL 121
Query: 736 LYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVK 793
YLH D + HRDIK N+L++ + K++DFG S RLA GI P +
Sbjct: 122 KYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA------GINP--CTETFT 170
Query: 794 GTPGYLDPEYFLTHKLTDK--------SDVYSLGVVFLELLTGMQP 831
GT Y+ PE + DK +D++SLG +E+ TG P
Sbjct: 171 GTLQYMAPE------VIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 66/212 (31%), Positives = 102/212 (48%), Gaps = 19/212 (8%)
Query: 626 FNSSTQIGQGGYGKVYKGILPDG---TVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRN 681
F +IG+G +G+V+KGI D VVA+K + E E + EI LS+
Sbjct: 6 FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+ G + + ++ E++ G+ D L A + A L L +G+ YLH+E
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHSE 120
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
HRDIKA+N+LL + K+ADFG++ I+ +T V GTP ++ P
Sbjct: 121 KK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR------NTFV-GTPFWMAP 170
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833
E K+D++SLG+ +EL G P S
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-15
Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 32/220 (14%)
Query: 632 IGQGGYGKVYK----GILPD----GTVVAVKRAQE-GSLQGEKEFLTEIQFLSRL-HHRN 681
+G+G +G+V GI D VAVK ++ + + + ++E++ + + H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSI 727
+++L+G C ++G ++ E+ S G LR+ L A+ +E L F +S
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 728 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 787
A +RG+ YL A HRD+ A N+L+ K+ADFGL+R D+ I
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DVHNIDYYK 191
Query: 788 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 827
+T + ++ PE T +SDV+S GV+ E+ T
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 64/216 (29%), Positives = 100/216 (46%), Gaps = 21/216 (9%)
Query: 624 NNFNSSTQIGQGGYGKVYKG-ILPDGTVVAVKR-AQEGSLQGEKEFLTEIQFLSRLHH-R 680
N+ + +IG G G+VYK G V+AVK+ + G+ + K L ++ + + H
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCP 74
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 740
+V GY + + + E MS T D+L + + P+ + + + + + YL
Sbjct: 75 YIVKCYGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE 132
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGYL 799
+ V HRD+K SNILLD K+ DFG+S RL V + T G Y+
Sbjct: 133 KHG--VIHRDVKPSNILLDASGNVKLCDFGISGRL---------VDSKAKTRSAGCAAYM 181
Query: 800 DPEYFLTHKLTDK----SDVYSLGVVFLELLTGMQP 831
PE K +DV+SLG+ +EL TG P
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 23/214 (10%)
Query: 626 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR-AQEGSLQGEK--EFLTEIQFLSRLHHRN 681
F+ +IG G +G VY + + VVA+K+ + G EK + + E++FL +L H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+ G E LV E+ G+ D L K+PL ++ G+ +G+ YLH+
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
+ HRD+KA NILL K+ DFG + + + PA+ GTP ++ P
Sbjct: 135 N---MIHRDVKAGNILLSEPGLVKLGDFGSASI--------MAPANXFV---GTPYWMAP 180
Query: 802 EYFLTH---KLTDKSDVYSLGVVFLELLTGMQPI 832
E L + K DV+SLG+ +EL P+
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 65/220 (29%), Positives = 96/220 (43%), Gaps = 31/220 (14%)
Query: 632 IGQGGYGKVYKGIL--PDGTV--VAVKRAQ-EGSLQGE-KEFLTEIQFLSRLHHRNLVSL 685
+G+G +G V +G L DG+ VAVK + + E +EFL+E + H N++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 686 VGYCDEEGEQ------MLVYEFMSNGTLRDQL----SAKSKEPLGFAMRLSIALGSSRGI 735
+G C E M++ FM +G L L E L L + + G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 736 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI--EGIVPAHVSTV-V 792
YL HRD+ A N +L T VADFGLS+ D +G ++ + V
Sbjct: 127 EYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQG----RIAKMPV 179
Query: 793 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
K ++ E T KSDV++ GV E+ T G P
Sbjct: 180 K----WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 57/198 (28%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 631 QIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVG 687
+IG+G +G+V+ G L D T VAVK +E +L + +FL E + L + H N+V L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRE-TLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
C ++ +V E + G L + L + + ++ G+ YL ++
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPR-LKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP-GYLDPEYFLT 806
HRD+ A N L+ K K++DFG+SR + +G+ + + +K P + PE
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYAS--TGGMKQIPVKWTAPEALNY 170
Query: 807 HKLTDKSDVYSLGVVFLE 824
+ + +SDV+S G++ E
Sbjct: 171 GRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 632 IGQGGYGKV----YKGILPDG----TVVAVKRAQEGSLQGEKEFL-TEIQFLSRLHHRNL 682
+G+G +GKV Y P+G VAVK + S L EI+ L L+H N+
Sbjct: 12 LGEGHFGKVELCRYD---PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 683 VSLVGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 740
V G C E+G L+ EF+ +G+L++ L ++K + +L A+ +G+ YL +
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP-RNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
HRD+ A N+L++ + K+ DFGL++ V + + V +
Sbjct: 128 RQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF----WYA 180
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLT 827
PE + K SDV+S GV ELLT
Sbjct: 181 PECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 63/232 (27%), Positives = 110/232 (47%), Gaps = 44/232 (18%)
Query: 631 QIGQGGYGKVYK------GILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 684
++G G +GKVYK G L V+ K +E ++++ EI+ L+ +H +V
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE-----LEDYMVEIEILATCNHPYIVK 73
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRD---QLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
L+G +G+ ++ EF G + +L EP +++ I + YLH+
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP---QIQV-ICRQMLEALQYLHSM 129
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK-----GTP 796
+ HRD+KA N+LL K+ADFG+S +V T+ + GTP
Sbjct: 130 K---IIHRDLKAGNVLLTLDGDIKLADFGVS------------AKNVKTLQRRDSFIGTP 174
Query: 797 GYLDPEYFLTHKLTD-----KSDVYSLGVVFLELLTGMQPISHGKNIVREVL 843
++ PE + + D K+D++SLG+ +E + ++P H N +R +L
Sbjct: 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIE-MAQIEPPHHELNPMRVLL 225
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 61/240 (25%), Positives = 99/240 (41%), Gaps = 50/240 (20%)
Query: 620 ALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQG-EKEFLTEIQ 672
A +N T +G+G +G+V+ T+V VK Q+ + + EF E+
Sbjct: 1 AFPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELD 60
Query: 673 FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA-KSKE------PLGFAMRL 725
+L H+N+V L+G C E ++ E+ G L+ L A KSK+ PL ++
Sbjct: 61 MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKV 120
Query: 726 SIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR------------ 773
++ + G+ +L HRD+ A N L+ + KV+ LS+
Sbjct: 121 ALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRN 177
Query: 774 -LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
L P+ +L PE + KSDV+S GV+ E+ T G P
Sbjct: 178 ALIPLR-------------------WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP 218
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 17/209 (8%)
Query: 632 IGQGGYGKVYKGI-LPDGTV----VAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSL 685
+G G +G V+KGI +P+G VA+K Q+ S Q +E + + L H +V L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
+G C Q LV + G+L D + + ++ L L+ + ++G+ YL
Sbjct: 75 LGICPGASLQ-LVTQLSPLGSLLDHVR-QHRDSLDPQRLLNWCVQIAKGMYYLEEHR--- 129
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
+ HR++ A NILL ++ADFG++ L PD + + T +K ++ E L
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLY-PDDKKYFYSEHKTPIK----WMALESIL 184
Query: 806 THKLTDKSDVYSLGVVFLELLT-GMQPIS 833
+ T +SDV+S GV E+++ G +P +
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMSYGAEPYA 213
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 34/222 (15%)
Query: 631 QIGQGGYGKVYKGILPD------GTVVAVKRAQE-GSLQGEKEFLTEIQFLSRLHHRNLV 683
++GQG +G VY+G D T VAVK E SL+ EFL E + ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSA---KSKEPLG-----FAMRLSIALGSSRGI 735
L+G + ++V E M++G L+ L + +++ G + +A + G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 736 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----EGIVPAHVST 790
YL+ + HRD+ A N ++ H FT K+ DFG++R D +G++P
Sbjct: 133 AYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186
Query: 791 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
++ PE T SD++S GVV E+ + QP
Sbjct: 187 -------WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 5e-15
Identities = 74/217 (34%), Positives = 102/217 (47%), Gaps = 31/217 (14%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLV 686
+IG G G VYK I P G + A+K E +++ ++ EI+ L ++H N+V
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR--RQICREIEILRDVNHPNVVKCH 138
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR-LSIALGSSRGILYLHTEADPP 745
D GE ++ EFM G+L A + A + LS GI YLH
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQILS-------GIAYLHRRH--- 188
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 804
+ HRDIK SN+L++ K+ADFG+SR LA D P + S GT Y+ PE
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-----PCNSSV---GTIAYMSPERI 240
Query: 805 ---LTHKLTD--KSDVYSLGVVFLELLTGMQPISHGK 836
L H D D++SLGV LE G P G+
Sbjct: 241 NTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 6e-15
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 631 QIGQGGYGKVYKGILPD---GTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNL 682
+IG+G YG VYK D +A+K+ + L+ E E + EI L + H N+
Sbjct: 9 KIGEGTYGVVYKA--RDRVTNETIALKKIR---LEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 683 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK---SKEPLGFAMRLSIALGSSRGILYLH 739
V L E LV+E++ + L+ + + +K P L L RGI Y H
Sbjct: 64 VRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQIL---RGIAYCH 119
Query: 740 TEADPPVFHRDIKASNILLDHKFTA-KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
+ V HRD+K N+L+D + A K+ADFGL+R +P V VV T Y
Sbjct: 120 SHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-----VRTFTHEVV--TLWY 169
Query: 799 LDPEYFL-THKLTDKSDVYSLGVVFLELLT 827
PE L + + D++S+G +F E++
Sbjct: 170 RAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 7e-15
Identities = 68/220 (30%), Positives = 101/220 (45%), Gaps = 40/220 (18%)
Query: 632 IGQGGYGKVYKGILP-DGTVV--AVKRAQE-GSLQGEKEFLTEIQFLSRL-HHRNLVSLV 686
IG+G +G+V K + DG + A+KR +E S ++F E++ L +L HH N+++L+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSIALGSS 732
G C+ G L E+ +G L D L + L L A +
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 733 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 792
RG+ YL + HRD+ A NIL+ + AK+ADFGLSR V V
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV-------------YV 166
Query: 793 KGTPGYLDPEYFLTHKL-----TDKSDVYSLGVVFLELLT 827
K T G L + L T SDV+S GV+ E+++
Sbjct: 167 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 61/224 (27%), Positives = 104/224 (46%), Gaps = 28/224 (12%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVGYC 689
++G G +GKVYK + V+A + + + E E ++ EI L+ H N+V L+
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
E ++ EF + G + D + + + PL + + + YLH + + HR
Sbjct: 72 YYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHR 127
Query: 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK-----GTPGYLDPEYF 804
D+KA NIL K+ADFG+S + T+ + GTP ++ PE
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVS------------AKNTRTIQRRDSFIGTPYWMAPEVV 175
Query: 805 LTHKLTD-----KSDVYSLGVVFLELLTGMQPISHGKNIVREVL 843
+ D K+DV+SLG+ +E + ++P H N +R +L
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIE-MAQIEPPHHELNPMRVLL 218
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 7e-15
Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 625 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEK---EFLTEIQFLSRLHHR 680
NF +IG+G + +VY+ L DG VA+K+ Q L K + + EI L +L+H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE----PLGFAMRLSIALGSSRGIL 736
N++ E+ E +V E G L + K+ P + + L S+ +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA--LE 120
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
++H+ V HRDIK +N+ + K+ D GL R AH + GTP
Sbjct: 121 HMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS----SKTTAAHS---LVGTP 170
Query: 797 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
Y+ PE + KSD++SLG + E+ P
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 9e-15
Identities = 70/218 (32%), Positives = 103/218 (47%), Gaps = 36/218 (16%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKR--AQEGSLQGEKEFLTEIQFLSR-LHHRNLVSLV 686
++G+G YG V K +P GT++AVKR A S Q +K L ++ R + V+
Sbjct: 8 ELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEP--------LGFAMRLSIALGSSRGILYL 738
G EG+ + E M T D+ K + LG IA+ + + YL
Sbjct: 67 GALFREGDVWICMEVMD--TSLDKFYKKVYDKGLTIPEDILG-----KIAVSIVKALEYL 119
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG-IVPAHVSTVVKGTPG 797
H++ V HRD+K SN+L++ K+ DFG+S G +V + T+ G
Sbjct: 120 HSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS---------GYLVDSVAKTIDAGCKP 168
Query: 798 YLDPEYF---LTHKLTD-KSDVYSLGVVFLELLTGMQP 831
Y+ PE L K D KSDV+SLG+ +EL TG P
Sbjct: 169 YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 27/200 (13%)
Query: 650 VVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 708
+VAVK + + + +FL EI+ +SRL + N++ L+G C + ++ E+M NG L
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 709 DQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE--------ADPPVFHRDIKASNILLDH 760
LS + E F +I S +LY+ + A HRD+ N L+ +
Sbjct: 106 QFLSQREIES-TFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN 164
Query: 761 KFTAKVADFGLSRLAPVPD---IEG--IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDV 815
+T K+ADFG+SR D I+G ++P ++ E L K T SDV
Sbjct: 165 HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR----------WMAWESILLGKFTTASDV 214
Query: 816 YSLGVVFLEL--LTGMQPIS 833
++ GV E+ L QP S
Sbjct: 215 WAFGVTLWEMFTLCKEQPYS 234
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 626 FNSSTQIGQGGYGKVYKGILPDGT-VVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLV 683
F +IG+G +G+VYKGI VVA+K + E E + EI LS+ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
G + + ++ E++ G+ D L E A L L +G+ YLH+E
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL---KGLDYLHSERK 122
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
HRDIKA+N+LL + K+ADFG++ I+ GTP ++ PE
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK-------RNTFVGTPFWMAPEV 172
Query: 804 FLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833
K+D++SLG+ +EL G P S
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 18/218 (8%)
Query: 632 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVG 687
+G+GG+G+V + G + A K+ + L +GE+ L E + L ++ R +VSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 688 YCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
Y E + + LV M+ G L+ + + A + A G+ +LH +
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---I 116
Query: 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 806
+RD+K N+LLD +++D GL+ +++G GTPGY+ PE
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLA-----VELKGGKKIKGRA---GTPGYMAPEVLQG 168
Query: 807 HKLTDKSDVYSLGVVFLELLTGMQPI-SHGKNIVREVL 843
D ++LG E++ G P + + +E L
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-14
Identities = 65/223 (29%), Positives = 106/223 (47%), Gaps = 27/223 (12%)
Query: 621 LATNNFNSSTQIGQGGYGKVYKGI-LPDG----TVVAVKRAQEG-SLQGEKEFLTEIQFL 674
L F +G G +G VYKG+ +P+G VA+K +E S + KE L E +
Sbjct: 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 63
Query: 675 SRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 734
+ + + ++ L+G C Q L+ + M G L D + + K+ +G L+ + ++G
Sbjct: 64 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKG 121
Query: 735 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVS 789
+ YL + + HRD+ A N+L+ K+ DFGL++L + E G VP
Sbjct: 122 MNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK-- 176
Query: 790 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
++ E L T +SDV+S GV EL+T G +P
Sbjct: 177 --------WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 65/222 (29%), Positives = 99/222 (44%), Gaps = 45/222 (20%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVK--RAQEG----SLQGEKEFLTEIQFLSRLHHRNLV 683
+IG G YG VYK + G +VA+K + + G +Q E I L H N+V
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQE------ISMLKECRHPNIV 63
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIAL---GSSRGILYLHT 740
+ G + +V E+ G+L+D ++ PL L IA + +G+ YLH
Sbjct: 64 AYFGSYLRRDKLWIVMEYCGGGSLQDIYQ-VTRGPLS---ELQIAYVCRETLKGLAYLHE 119
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS-TVVK-----G 794
HRDIK +NILL K+ADFG+S A ++ T+ K G
Sbjct: 120 TG---KIHRDIKGANILLTEDGDVKLADFGVS-------------AQLTATIAKRKSFIG 163
Query: 795 TPGYLDPEYFLTHKLTD---KSDVYSLGVVFLELLTGMQPIS 833
TP ++ PE + K D+++LG+ +EL P+
Sbjct: 164 TPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMF 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-14
Identities = 79/225 (35%), Positives = 111/225 (49%), Gaps = 10/225 (4%)
Query: 89 LLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKS-LELLLLNGNELTGSLP 147
LNLN + E+ L+ LT LD N I+ IP IG +KS L+ L L+ N++ SLP
Sbjct: 99 DLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLP 156
Query: 148 EELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHM 207
L LP L + + N +S LPK +NL+ + ++ N IS +PPE+ L +L +
Sbjct: 157 SPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEEL 214
Query: 208 LLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPM 267
L NN++ L LS L L L+L NN + +P S N+S L L L N +
Sbjct: 215 DLSNNSIIE-LLSSLSNLKNLSGLELSNN--KLEDLPESIGNLSNLETLDLSNNQISSIS 271
Query: 268 PDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGT 312
L + NL LDLS N L+ + P L + L N LT
Sbjct: 272 S-LGSLTNLRELDLSGNSLS-NALPLIALLLLLLELLLNLLLTLK 314
|
Length = 394 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 67/241 (27%), Positives = 105/241 (43%), Gaps = 46/241 (19%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQ--EGSLQGEKEF------------LTEIQFLSR 676
+G+G YGKV K G +VA+K+ + E S K+ L E++ ++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 677 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS------IALG 730
+ H N++ LV E LV + M+ L+ + K +RL+ I L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK--------IRLTESQVKCILLQ 127
Query: 731 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH--- 787
G+ LH HRD+ +NI ++ K K+ADFGL+R P +
Sbjct: 128 ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 788 ------VSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 840
S VV T Y PE + K D++S+G +F ELLTG +P+ G+N +
Sbjct: 185 QRREEMTSKVV--TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPLFPGENEID 241
Query: 841 E 841
+
Sbjct: 242 Q 242
|
Length = 335 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 57/216 (26%), Positives = 103/216 (47%), Gaps = 18/216 (8%)
Query: 625 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRA---QEGSLQGEK---EFLTEIQFLSRL 677
+ Q+G G + Y+ + GT++AVK+ + S + E+ EI+ ++RL
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 678 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILY 737
+H +++ ++G E+ L E+M+ G++ LS A+ ++ RG+ Y
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSY 118
Query: 738 LHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGT 795
LH + + HRD+K +N+L+D ++ADFG + RLA G + GT
Sbjct: 119 LH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA--AKGTG--AGEFQGQLLGT 171
Query: 796 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
++ PE + DV+S+G V +E+ T P
Sbjct: 172 IAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 3e-14
Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 24/214 (11%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYC 689
+G G YG+VYKG + G + A+K + + E+E EI L + HHRN+ + G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 690 DEEG-----EQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
++ +Q+ LV EF G++ D + L I RG+ +LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK- 131
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
V HRDIK N+LL K+ DFG+S ++ V + + GTP ++ PE
Sbjct: 132 --VIHRDIKGQNVLLTENAEVKLVDFGVS-----AQLDRTVGRRNTFI--GTPYWMAPEV 182
Query: 804 FLTHKLTD-----KSDVYSLGVVFLELLTGMQPI 832
+ D KSD++SLG+ +E+ G P+
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 74/235 (31%), Positives = 101/235 (42%), Gaps = 35/235 (14%)
Query: 631 QIGQGGYGKVYKGILPDG---TVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLV 686
+IG G +GKV G + G V VK + S+Q + +FL E Q L H NL+ +
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSK------EPLGFA-MRLSIALGSSRGILYLH 739
G C E +LV EF G L+ L + K +P M IAL G+L+LH
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL----GLLHLH 117
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP-GY 798
H D+ N LL T K+ D+GLS D +V+ P +
Sbjct: 118 KNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY------YVTPDQLWVPLRW 168
Query: 799 LDPEY-------FLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVLPY 845
+ PE L T +S+V+SLGV EL G QP H + +VL Y
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD--EQVLTY 221
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 5e-14
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 626 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLV 683
F +IG+G +G+V+KGI VVA+K + E E + EI LS+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
G ++ + ++ E++ G+ D L + A L L +G+ YLH+E
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSEKK 122
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
HRDIKA+N+LL K+ADFG++ I+ GTP ++ PE
Sbjct: 123 ---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-------RNTFVGTPFWMAPEV 172
Query: 804 FLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833
K+D++SLG+ +EL G P S
Sbjct: 173 IKQSAYDSKADIWSLGITAIELAKGEPPHS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 6e-14
Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 32/219 (14%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQ--EGSLQGEKEFLTEIQFLSRLHHRNLVSL--- 685
IG+G YG V P G VA+K+ E ++ L EI+ L R H N++ +
Sbjct: 13 IGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT-LREIKILRRFKHENIIGILDI 71
Query: 686 --VGYCDEEGEQMLVYEFMSNG---TLRDQ-LSAKSKEPLGFAMRLSIALGSSRGILYLH 739
+ + +V E M ++ Q LS + + + RG+ Y+H
Sbjct: 72 IRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQIL--------RGLKYIH 123
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA-PVPDIEGIVPAHVSTVVKGTPGY 798
+ A+ V HRD+K SN+LL+ K+ DFGL+R+A P D G + +V+ T Y
Sbjct: 124 S-AN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA-----TRWY 175
Query: 799 LDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGK 836
PE L K K+ D++S+G + E+L+ +P+ GK
Sbjct: 176 RAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPLFPGK 213
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 34/218 (15%)
Query: 634 QGGYGKVYKGILPDGTV-----VAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVG 687
+G +G+++ GIL D V VK ++ + + + L E L L H+N++ ++
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 688 YCDEEGEQ-MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS------IALGSSRGILYLHT 740
C E+GE ++Y +M+ G L+ L LS +A+ + G+ YLH
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSR-LAP-----VPDIEGIVPAHVSTVVKG 794
V H+DI A N ++D + K+ D LSR L P + D E + VK
Sbjct: 136 RG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE-------NRPVK- 184
Query: 795 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
++ E + + + SDV+S GV+ EL+T G P
Sbjct: 185 ---WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 8e-14
Identities = 57/220 (25%), Positives = 89/220 (40%), Gaps = 45/220 (20%)
Query: 632 IGQGGYGKVYKGIL-PDGTVVAVKR---------AQEGSLQGEKEFLTEI--QFLSRLHH 679
+G GG+G+V + A+K Q+ + EKE L E F+ +L+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 680 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK---SKEPLGF---AMRLSIALGSSR 733
+ D++ ML+ E+ G L L + + F + L+ +R
Sbjct: 61 T-------FKDKKYIYMLM-EYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNR 112
Query: 734 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 793
GI+Y RD+K N+LLD K+ DFG ++ ++ T
Sbjct: 113 GIIY-----------RDLKPENLLLDSNGYVKLVDFGFAK-----KLKSGQKTW--TFC- 153
Query: 794 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833
GTP Y+ PE L D +SLG++ ELLTG P
Sbjct: 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFG 193
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 24/214 (11%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGY- 688
+G G YG+VYKG + G + A+K + + E+E EI L + HHRN+ + G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 689 -----CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
+ + LV EF G++ D + L I RG+ +LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK- 141
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
V HRDIK N+LL K+ DFG+S ++ V + + GTP ++ PE
Sbjct: 142 --VIHRDIKGQNVLLTENAEVKLVDFGVS-----AQLDRTVGRRNTFI--GTPYWMAPEV 192
Query: 804 FLTHKLTD-----KSDVYSLGVVFLELLTGMQPI 832
+ D +SD++SLG+ +E+ G P+
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 51/175 (29%), Positives = 82/175 (46%), Gaps = 12/175 (6%)
Query: 670 EIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIAL 729
E L+++ H N+V+ + +G +V E+ G L ++ + + L +
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107
Query: 730 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 789
G+ ++H + V HRDIK+ NI L K+ DFG +RL P A+
Sbjct: 108 QMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP------GAYAC 158
Query: 790 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG--KNIVREV 842
T V GTP Y+ PE + +KSD++SLG + EL T P KN++ +V
Sbjct: 159 TYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKV 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 27/216 (12%)
Query: 630 TQIGQGGYGKVYKGILPD-GTVVAVKR--AQEGSLQGEKEFLTEIQFLSRLHHRNLVSLV 686
++IG+G YG V+K + G +VA+K+ E +K L EI+ L +L H NLV+L+
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA---- 742
+ + LV+E+ + T+ ++L K P G + + I++ +A
Sbjct: 67 EVFRRKRKLHLVFEYCDH-TVLNELE---KNPRG------VPEHLIKKIIWQTLQAVNFC 116
Query: 743 -DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
HRD+K NIL+ + K+ DFG +R+ P + T T Y P
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD-------YTDYVATRWYRAP 169
Query: 802 EYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGK 836
E + + DV+++G VF ELLTG QP+ GK
Sbjct: 170 ELLVGDTQYGPPVDVWAIGCVFAELLTG-QPLWPGK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 36/200 (18%)
Query: 650 VVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 708
+VAVK + + + +FL E++ LSRL N++ L+G C +E ++ E+M NG L
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 709 DQLSAKSKE-----------------PLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI 751
LS+ + + ++ L +AL + G+ YL + HRD+
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDL 164
Query: 752 KASNILLDHKFTAKVADFGLSRLAPVPD---IEG--IVPAHVSTVVKGTPGYLDPEYFLT 806
N L+ T K+ADFG+SR D I+G ++P ++ E L
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIR----------WMAWECILM 214
Query: 807 HKLTDKSDVYSLGVVFLELL 826
K T SDV++ GV E+L
Sbjct: 215 GKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 58/209 (27%), Positives = 101/209 (48%), Gaps = 25/209 (11%)
Query: 632 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVSLVG 687
+G+G +GKV L G + AVK ++ + + + +TE + LS + ++ +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 688 YCDEEGEQML-VYEFMSNGTL--RDQLSAKSKEPLG--FAMRLSIALGSSRGILYLHTEA 742
C + +++ V EF++ G L Q S + E +A ++ AL ++LH
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSAL------MFLH--- 113
Query: 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
D + +RD+K N+LLDH+ K+ADFG+ + EGI ++ GTP Y+ PE
Sbjct: 114 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-------EGIFNGKTTSTFCGTPDYIAPE 166
Query: 803 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
D +++GV+ E+L G P
Sbjct: 167 ILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 30/202 (14%)
Query: 650 VVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 708
+VAVK +E + + + +FL EI+ +SRL N++ L+ C ++ E+M NG L
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 709 DQLSA-KSKEPLGFAMRLSIALGS--------SRGILYLHTEADPPVFHRDIKASNILLD 759
LS + +E A ++I+ + + G+ YL + HRD+ N L+
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVG 164
Query: 760 HKFTAKVADFGLSRLAPVPD---IEG--IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSD 814
+T K+ADFG+SR D I+G ++P ++ E L K T SD
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR----------WMSWESILLGKFTTASD 214
Query: 815 VYSLGVVFLELLT--GMQPISH 834
V++ GV E+LT QP S
Sbjct: 215 VWAFGVTLWEILTLCKEQPYSQ 236
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 64/238 (26%), Positives = 107/238 (44%), Gaps = 36/238 (15%)
Query: 618 EMALATNNFNSSTQIGQGGYGKVYKGIL-------PDGTVV--AVKRAQEGSLQGEKEFL 668
E+ L+T F ++G+ +GKVYKG L V +K EG L+ +EF
Sbjct: 1 EINLSTVRFME--ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLR--EEFK 56
Query: 669 TEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS------------- 715
E SRL H N+V L+G +E +++ + S+ L + L +S
Sbjct: 57 HEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKT 116
Query: 716 -KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774
K L A + I + G+ +L + V H+D+ N+L+ K K++D GL R
Sbjct: 117 VKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFRE 173
Query: 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
D ++ + + ++ PE + K + SD++S GVV E+ + G+QP
Sbjct: 174 VYAADYYKLMGNSLLPI-----RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 63/225 (28%), Positives = 97/225 (43%), Gaps = 15/225 (6%)
Query: 631 QIGQGGYGKVYKGILPDGTVVA---VKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 686
+IG G +GKV G G A VK + + E+ FL E+Q L+H N++ +
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFA---MRLSIALGSSRGILYLHTEAD 743
G C E +LV EF G L++ L + A + +A + G+L+LH +AD
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH-QAD 120
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP-- 801
H D+ N L + K+ D+GL+ D H + P ++
Sbjct: 121 --FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVLPY 845
+ L T KS+++SLGV EL T QP + +VL
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD--EQVLKQ 221
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 30/216 (13%)
Query: 625 NFNSSTQIGQGGYGKVYKGILPD---GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN 681
++ +IG+G G V I D G VAVK+ Q + E+ + H N
Sbjct: 20 YLDNFVKIGEGSTGIVC--IATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN 77
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS------IALGSSRGI 735
+V + E +V EF+ G L D ++ R++ + L + +
Sbjct: 78 IVEMYSSYLVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIATVCLAVLKAL 128
Query: 736 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 795
+LH + V HRDIK+ +ILL K++DFG + VP S V GT
Sbjct: 129 SFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGF-----CAQVSKEVPRRKSLV--GT 178
Query: 796 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
P ++ PE + D++SLG++ +E++ G P
Sbjct: 179 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 66/224 (29%), Positives = 101/224 (45%), Gaps = 23/224 (10%)
Query: 623 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHH 679
TN + +G G +G V G VA+K+ + + K E++ L L H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 680 RNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 738
N++SL E + V E + L L+++ E L L RG+ Y+
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQIL---RGLKYV 124
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
H+ V HRD+K SNIL++ K+ DFGL+R+ P + G V T Y
Sbjct: 125 HSAG---VVHRDLKPSNILINENCDLKICDFGLARIQD-PQMTGYV---------STRYY 171
Query: 799 LDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVRE 841
PE LT K + D++S G +F E+L G +P+ GK+ V +
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPLFPGKDHVNQ 214
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 69/218 (31%), Positives = 106/218 (48%), Gaps = 31/218 (14%)
Query: 632 IGQGGYGKVY---KGILPD-GTVVAVKRAQEGSLQGEKEFLT--EIQFLSRLHHRNLVSL 685
+GQG +GKV+ K PD G + A+K ++ +L+ T E L+ ++H +V L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAK---SKEPLGFAM-RLSIALGS--SRGILYLH 739
EG+ L+ +F+ G L +LS + ++E + F + L++AL S GI+Y
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY-- 121
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
RD+K NILLD + K+ DFGLS+ E I + GT Y+
Sbjct: 122 ---------RDLKPENILLDEEGHIKLTDFGLSK-------ESIDHEKKAYSFCGTVEYM 165
Query: 800 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
PE T +D +S GV+ E+LTG P GK+
Sbjct: 166 APEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF-QGKD 202
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 64/208 (30%), Positives = 88/208 (42%), Gaps = 25/208 (12%)
Query: 631 QIGQGGYGKVYKGILPD-GTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLH---HRNLVS 684
+IG G YG VYK P G VA+K R Q + E+ L RL H N+V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 685 LVGYC-----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
L+ C D E + LV+E + LR L L + RG+ +LH
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS-TVVKGTPGY 798
+ HRD+K NIL+ K+ADFGL+R I ++ T V T Y
Sbjct: 126 ANC---IVHRDLKPENILVTSGGQVKLADFGLAR---------IYSCQMALTPVVVTLWY 173
Query: 799 LDPEYFLTHKLTDKSDVYSLGVVFLELL 826
PE L D++S+G +F E+
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 66/230 (28%), Positives = 107/230 (46%), Gaps = 32/230 (13%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRN--- 681
+IG+G YGKVYK G +VA+K+ + L+ ++E L EI L L
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTR---LEMDEEGIPPTALREISLLQMLSESIYIV 64
Query: 682 -LVSLVGYCDEEGEQM--LVYEFMSNGTLR--DQLSAKSKEPLGFAMRLSIALGSSRGIL 736
L+ + ++ G+ LV+E++ + + D PL S +G+
Sbjct: 65 RLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124
Query: 737 YLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 795
+ H V HRD+K N+L+D K K+AD GL R +P V ++ +V T
Sbjct: 125 HCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIP-----VKSYTHEIV--T 174
Query: 796 PGYLDPEYFL--THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVL 843
Y PE L TH T D++S+G +F E+ QP+ G + ++++L
Sbjct: 175 LWYRAPEVLLGSTHYST-PVDIWSVGCIFAEMSR-KQPLFPGDSELQQLL 222
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 14/202 (6%)
Query: 631 QIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
+IG+G G V G VAVK+ Q + E+ + HH N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
E +V EF+ G L D ++ A ++ L R + YLH + V HR
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA---TVCLSVLRALSYLHNQG---VIHR 142
Query: 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 809
DIK+ +ILL K++DFG + VP S V GTP ++ PE
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGF-----CAQVSKEVPKRKSLV--GTPYWMAPEVISRLPY 195
Query: 810 TDKSDVYSLGVVFLELLTGMQP 831
+ D++SLG++ +E++ G P
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 15/214 (7%)
Query: 621 LATNNFNSSTQIGQGGYGKVYK-GILPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLH 678
L ++F +++G G G V K P G ++A K E + + E+Q L +
Sbjct: 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61
Query: 679 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 738
+V G +GE + E M G+L L + P ++SIA+ RG+ YL
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV--LRGLAYL 119
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
+ + HRD+K SNIL++ + K+ DFG+S G + ++ GT Y
Sbjct: 120 REKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS---------GQLIDSMANSFVGTRSY 168
Query: 799 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 832
+ PE + +SD++S+G+ +EL G PI
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-13
Identities = 69/236 (29%), Positives = 103/236 (43%), Gaps = 39/236 (16%)
Query: 629 STQIGQGGYGKV-YKGILPDGTVVAVK--------RAQEGSLQGEKEFLTEIQFLSRLH- 678
S +G G G V + DG AVK A + Q E L F S +
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96
Query: 679 HRNLVSLVGYCDEEGEQM-----LVYEFMSNGTLRDQLSAKSKEPLGF----AMRLSIAL 729
H + D + LV ++ + G LR ++ +++K F A L I +
Sbjct: 97 HEDFA----KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQV 152
Query: 730 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL--APVPDIEGIVPAH 787
+L +H + HRDIK++NILL K+ DFG S++ A V D
Sbjct: 153 -----LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSD-------D 200
Query: 788 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVL 843
V GTP Y+ PE + + K+D++SLGV+ ELLT +P G+N+ EV+
Sbjct: 201 VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD-GENM-EEVM 254
|
Length = 496 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 62/227 (27%), Positives = 106/227 (46%), Gaps = 33/227 (14%)
Query: 631 QIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSLQGEK--EFLTEIQFLSRLHHRNLVS 684
+IG+G +GK IL DG +K + ++ E E+ LS + H N+V
Sbjct: 7 KIGEGSFGK---AILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAK------SKEPLGFAMRLSIALGSSRGILYL 738
+E G +V ++ G L +++A+ + L + +++ +AL ++
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK------HV 117
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
H D + HRDIK+ NI L T K+ DFG++R+ + V ++ GTP Y
Sbjct: 118 H---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARV-----LNSTV--ELARTCIGTPYY 167
Query: 799 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG--KNIVREVL 843
L PE +KSD+++LG V E+ T G KN+V +++
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-13
Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 38/214 (17%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFL-TEIQFLSRLHHRNLVSLVGY 688
+IGQG G VY I + G VA+K+ Q +KE + EI + H N+V+ +
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 689 CDEEGEQMLVYEFMSNGTLRD----------QLSAKSKEPLGFAMRLSIALGSSRGILYL 738
E +V E+++ G+L D Q++A +E L + + +L
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-------------QALEFL 131
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGL-SRLAPVPDIEGIVPAHVSTVVKGTPG 797
H+ V HRDIK+ NILL + K+ DFG +++ P + ST+V GTP
Sbjct: 132 HSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-------EQSKRSTMV-GTPY 180
Query: 798 YLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
++ PE K D++SLG++ +E++ G P
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 15/214 (7%)
Query: 621 LATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLH 678
L ++F +++G G G V+K P G ++A K E + + E+Q L +
Sbjct: 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61
Query: 679 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 738
+V G +GE + E M G+L L + P ++SIA+ +G+ YL
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYL 119
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
+ + HRD+K SNIL++ + K+ DFG+S G + ++ GT Y
Sbjct: 120 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS---------GQLIDSMANSFVGTRSY 168
Query: 799 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 832
+ PE + +SD++S+G+ +E+ G PI
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 68/215 (31%), Positives = 95/215 (44%), Gaps = 37/215 (17%)
Query: 629 STQIGQGGYGKVYKGI-LPDGTVVAVKR-----AQEGSLQGEKEFLTEIQFLSRL---HH 679
+IG+G YG VYK L G VA+K+ ++EG L EI L +L H
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLST---LREIALLKQLESFEH 60
Query: 680 RNLVSLVGYC-----DEEGEQMLVYEFMSN--GTLRDQLSAK--SKEPLGFAMRLSIALG 730
N+V L+ C D E + LV+E + T + E + MR +
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLL--- 117
Query: 731 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 790
RG+ +LH+ + HRD+K NIL+ K+ADFGL+R I A S
Sbjct: 118 --RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR------IYSFEMALTSV 166
Query: 791 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLEL 825
VV T Y PE L D++S+G +F EL
Sbjct: 167 VV--TLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-13
Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 14/202 (6%)
Query: 631 QIGQGGYGKV-YKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
+IG+G G V + G +VAVK+ Q + E+ + H N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
E +V EF+ G L D ++ A ++ L + + LH + V HR
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA---AVCLAVLKALSVLHAQG---VIHR 140
Query: 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 809
DIK+ +ILL H K++DFG + VP S V GTP ++ PE
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGF-----CAQVSKEVPRRKSLV--GTPYWMAPELISRLPY 193
Query: 810 TDKSDVYSLGVVFLELLTGMQP 831
+ D++SLG++ +E++ G P
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 7e-13
Identities = 68/238 (28%), Positives = 104/238 (43%), Gaps = 45/238 (18%)
Query: 624 NNFNSSTQIGQGGYGKVYKG--ILPDGTVVAVKRAQEGSLQGEKE-F----LTEIQFLSR 676
+ + +IGQG +G+V+K +VA+K+ ++ EKE F L EI+ L
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKT-KQIVALKKVL---MENEKEGFPITALREIKILQL 67
Query: 677 LHHRNLVSLVGYCDEEGEQ--------MLVYEF--------MSNGTLRDQLSAKSKEPLG 720
L H N+V+L+ C + LV+EF +SN ++ LS K
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKV--- 124
Query: 721 FAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780
M L+ G+ Y+H + HRD+KA+NIL+ K+ADFGL+R A
Sbjct: 125 MKMLLN-------GLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLAR-AFSLSK 173
Query: 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGKN 837
+ + VV T Y PE L + D++ G + E+ T PI G
Sbjct: 174 NSKPNRYTNRVV--TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNT 228
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 20/215 (9%)
Query: 625 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHR 680
NF +IG+G + +VY+ L D VA+K+ Q + + ++ + EI L +L+H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE----PLGFAMRLSIALGSSRGIL 736
N++ + E+ E +V E G L + K+ P + + L S+ +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA--VE 120
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
++H+ V HRDIK +N+ + K+ D GL R AH S V GTP
Sbjct: 121 HMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS----SKTTAAH-SLV--GTP 170
Query: 797 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
Y+ PE + KSD++SLG + E+ P
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 22/224 (9%)
Query: 626 FNSSTQIGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRN 681
F +G+GG+G+V + G + A K+ ++ ++ GE L E Q L +++ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+VSL + + LV M+ G L+ + + + A G+ LH E
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD---IEGIVPAHVSTVVKGTPGY 798
+ +RD+K NILLD +++D GL+ VP+ I+G V GT GY
Sbjct: 122 R---IVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRV---------GTVGY 167
Query: 799 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH-GKNIVRE 841
+ PE + T D ++LG + E++ G P K I RE
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE 211
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 632 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKE---FLTEIQ-FLSRLHHRNLVSLV 686
IG+G +GKV DG AVK Q+ ++ +KE + E L + H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 687 GYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FAMRLSIALGSSRGILYLHTE 741
Y + +++ V ++++ G L L + EP +A ++ ALG YLH+
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALG------YLHSL 115
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
+ +RD+K NILLD + + DFGL + EGI + ++ GTP YL P
Sbjct: 116 N---IIYRDLKPENILLDSQGHVVLTDFGLCK-------EGIEHSKTTSTFCGTPEYLAP 165
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
E D + LG V E+L G+ P
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 62/234 (26%), Positives = 96/234 (41%), Gaps = 61/234 (26%)
Query: 625 NFNSSTQIGQGGYGKVY----KG--------------ILPDGTVVAV---KRAQEGSLQG 663
+FN +G+G +GKV KG I+ D V KR +L G
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVL--ALPG 58
Query: 664 EKEFLTEI----QFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL--RDQLSAKSKE 717
+ FLT++ Q + RL+ V E+++ G L Q K KE
Sbjct: 59 KPPFLTQLHSCFQTMDRLY------------------FVMEYVNGGDLMYHIQQVGKFKE 100
Query: 718 PLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777
P IA+G + +LH++ + +RD+K N++LD + K+ADFG+ +
Sbjct: 101 PHAVFYAAEIAIG----LFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK---- 149
Query: 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
E I + GTP Y+ PE D ++ GV+ E+L G P
Sbjct: 150 ---ENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 27/210 (12%)
Query: 632 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKE---FLTEIQ-FLSRLHHRNLVSLV 686
IG+G +GKV DG+ AVK Q+ ++ +KE + E L L H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 687 GYCDEEGEQM-LVYEFMSNGTLRDQLSAKS--KEPLG--FAMRLSIALGSSRGILYLHTE 741
Y + E++ V ++++ G L L + EP +A ++ A+G YLH+
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIG------YLHSL 115
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
+ +RD+K NILLD + + DFGL + EG+ P ++ GTP YL P
Sbjct: 116 N---IIYRDLKPENILLDSQGHVVLTDFGLCK-------EGVEPEETTSTFCGTPEYLAP 165
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
E D + LG V E+L G+ P
Sbjct: 166 EVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-12
Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
+IGQG G V+ I + G VA+K+ ++ + EI + L + N+V+ +
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
E +V E+++ G+L D ++ + A ++ + + +LH V HR
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIA---AVCRECLQALEFLHANQ---VIHR 139
Query: 750 DIKASNILLDHKFTAKVADFGL-SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 808
DIK+ N+LL + K+ DFG +++ P + ST+V GTP ++ PE
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITP-------EQSKRSTMV-GTPYWMAPEVVTRKA 191
Query: 809 LTDKSDVYSLGVVFLELLTGMQP 831
K D++SLG++ +E++ G P
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 61/221 (27%), Positives = 93/221 (42%), Gaps = 49/221 (22%)
Query: 632 IGQGGYGKV----YKGILPDGTVVAVKRAQEG---------SLQGEKEFLTEIQFLSRLH 678
+G+G +GKV KG + AVK ++ EK L L+
Sbjct: 3 LGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLA----LAG-K 54
Query: 679 HRNLVSLVGYCDEEGEQML--VYEFMSNGTL--RDQLSAKSKEPLG--FAMRLSIALG-- 730
H L L + + + L V E+++ G L Q S + EP +A + + L
Sbjct: 55 HPFLTQL--HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFL 112
Query: 731 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 790
RGI+Y RD+K N+LLD + K+ADFG+ + EGI+ ++
Sbjct: 113 HERGIIY-----------RDLKLDNVLLDSEGHIKIADFGMCK-------EGILGGVTTS 154
Query: 791 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
GTP Y+ PE D ++LGV+ E+L G P
Sbjct: 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 39/116 (33%), Positives = 48/116 (41%), Gaps = 20/116 (17%)
Query: 734 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 793
G+ LH + HRDIK N+L+D K+ DFGLSR G+
Sbjct: 109 GVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRN-------GLENKKFV---- 154
Query: 794 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG------KNIVREVL 843
GTP YL PE L SD +SLG V E L G P NI+ +
Sbjct: 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRI 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 632 IGQGGYGKV----YKGILPDGTVVAVKRA--QEGSLQGEKEFLTEIQFLSRLHHRNLVSL 685
+G+G YG+V ++ DG +K+ + S + K E Q LS+L H N+V+
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 686 V-GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 744
+ E+G +V F G L +L + + L + + + + YLH +
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH-- 122
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
+ HRD+K N+ L KV D G++R L D+ ST++ GTP Y+ PE
Sbjct: 123 -ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM-------ASTLI-GTPYYMSPEL 173
Query: 804 FLTHKLTDKSDVYSLGVVFLELLT 827
F KSDV++LG E+ T
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 5e-12
Identities = 66/224 (29%), Positives = 99/224 (44%), Gaps = 54/224 (24%)
Query: 631 QIGQGGYGKVYKGILPD---GTVVAVKR---AQEGSLQGEKEFLTEIQFLSRL-HHRNLV 683
++G+G YG V+K I D VVA+K+ A + ++ F EI FL L H N+V
Sbjct: 14 KLGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTF-REIMFLQELGDHPNIV 70
Query: 684 SLVGYCDEEGEQ--MLVYEFMSN--------GTLRD--------QLSAKSKEPLGFAMRL 725
L+ E ++ LV+E+M L D QL
Sbjct: 71 KLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQLL------------- 117
Query: 726 SIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP 785
+ + Y+H+ V HRD+K SNILL+ K+ADFGL+R + ++E
Sbjct: 118 -------KALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS--LSELEENPE 165
Query: 786 AHVSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTG 828
V T T Y PE L + + T D++S+G + E+L G
Sbjct: 166 NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 8e-12
Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 27/210 (12%)
Query: 632 IGQGGYGKVYKGILPDGT--VVAVKRAQEGSLQGEKEF---LTEIQFLS-RLHHRNLVSL 685
+G+G +GKV L GT V A+K ++ + + + +TE + L+ H L +L
Sbjct: 3 LGKGSFGKVMLAEL-KGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQL--SAKSKEPLG--FAMRLSIALGSSRGILYLHTE 741
+ V E+++ G L Q+ S K EP +A +++AL ++LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLAL------MFLHRH 115
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
V +RD+K NILLD + K+ADFG+ + EGI+ +T GTP Y+ P
Sbjct: 116 G---VIYRDLKLDNILLDAEGHCKLADFGMCK-------EGILNGVTTTTFCGTPDYIAP 165
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
E + D ++LGV+ E++ G P
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 8e-12
Identities = 52/177 (29%), Positives = 86/177 (48%), Gaps = 8/177 (4%)
Query: 669 TEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIA 728
+E+ L+ H +V + + +L+ E+ S G L Q+ + KE L F +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPF-QEYEVG 172
Query: 729 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 788
L + +L L + HRD+K++NI L K+ DFG S+ V V
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK-----QYSDSVSLDV 227
Query: 789 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS--HGKNIVREVL 843
++ GTP YL PE + + + K+D++SLGV+ ELLT +P + I+++VL
Sbjct: 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVL 284
|
Length = 478 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 9e-12
Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
+IGQG G VY I + G VA+K+ ++ + EI + + N+V+ +
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
E +V E+++ G+L D ++ + A ++ + + +LH+ V HR
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA---AVCRECLQALDFLHSNQ---VIHR 139
Query: 750 DIKASNILLDHKFTAKVADFGL-SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 808
DIK+ NILL + K+ DFG +++ P + ST+V GTP ++ PE
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITP-------EQSKRSTMV-GTPYWMAPEVVTRKA 191
Query: 809 LTDKSDVYSLGVVFLELLTGMQP 831
K D++SLG++ +E++ G P
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 17/220 (7%)
Query: 626 FNSSTQIGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRN 681
F +G+GG+G+V + G + A KR ++ ++ GE L E Q L +++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+V+L + + LV M+ G L+ + L A G+ LH E
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD-IEGIVPAHVSTVVKGTPGYLD 800
+RD+K NILLD +++D GL+ P + I G V GT GY+
Sbjct: 122 N---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV---------GTVGYMA 169
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 840
PE + T D + LG + E++ G P K V+
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 1e-11
Identities = 63/246 (25%), Positives = 94/246 (38%), Gaps = 51/246 (20%)
Query: 624 NNFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRA---------QEGSLQGEKEFLTE 670
++F IG+G +G+V+ L G V A+K Q ++ E++ L +
Sbjct: 1 DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD 57
Query: 671 IQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 730
+V L +E LV E+M G L + L K P A R IA
Sbjct: 58 A------DSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETA-RFYIA-- 108
Query: 731 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS--------------RLAP 776
+L L + HRDIK NIL+D K+ADFGL
Sbjct: 109 --ELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHN 166
Query: 777 VPDIEGIVPA---------HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 827
+ + ++ ++ V GTP Y+ PE + D +SLGV+ E+L
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTV-GTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY 225
Query: 828 GMQPIS 833
G P
Sbjct: 226 GFPPFY 231
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 65/206 (31%), Positives = 94/206 (45%), Gaps = 19/206 (9%)
Query: 632 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKE---FLTEIQ-FLSRLHHRNLVSLV 686
IG+G +GKV DG AVK Q+ + KE + E L + H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 687 GYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
Y + E++ V +F++ G L L + P A + + S+ G YLH+
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALG--YLHSIN--- 116
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
+ +RD+K NILLD + + DFGL + EGI + +T GTP YL PE
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK-------EGIAQSDTTTTFCGTPEYLAPEVIR 169
Query: 806 THKLTDKSDVYSLGVVFLELLTGMQP 831
+ D + LG V E+L G+ P
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 17/205 (8%)
Query: 632 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQ-----FLSRLHHRNLVSLV 686
IG+G Y KV L + + + L + E + +Q F +H LV L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
E V E+++ G L + + K P A S + S + YLH +
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI--SLALNYLHERG---I 117
Query: 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 806
+RD+K N+LLD + K+ D+G+ + EG+ P ++ GTP Y+ PE
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCK-------EGLRPGDTTSTFCGTPNYIAPEILRG 170
Query: 807 HKLTDKSDVYSLGVVFLELLTGMQP 831
D ++LGV+ E++ G P
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 16/206 (7%)
Query: 632 IGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVSLVG 687
+G+GG+G+V + G + A K+ + L+ K + + E + L+++H R +VSL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS--RGILYLHTEADPP 745
+ + LV M+ G LR + +E GF + + G+ +LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--- 117
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
+ +RD+K N+LLD+ +++D GL+ +E + GTPG++ PE
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLA-------VELKDGQSKTKGYAGTPGFMAPELLQ 170
Query: 806 THKLTDKSDVYSLGVVFLELLTGMQP 831
+ D ++LGV E++ P
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 67/227 (29%), Positives = 102/227 (44%), Gaps = 33/227 (14%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVS---- 684
IG+G YG V I G VA+K+ + + L EI+ L L H ++V
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 685 -LVGYCDEEGEQMLVYEFMSNG-----TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 738
L E + +V+E M + D L+ + + + + R + Y+
Sbjct: 68 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLL--------RALKYI 119
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
HT VFHRD+K NIL + K+ DFGL+R+A A T T Y
Sbjct: 120 HTAN---VFHRDLKPKNILANADCKLKICDFGLARVA----FNDTPTAIFWTDYVATRWY 172
Query: 799 LDPEY---FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 842
PE F + K T D++S+G +F E+LTG +P+ GKN+V ++
Sbjct: 173 RAPELCGSFFS-KYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQL 217
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (161), Expect = 1e-11
Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 31/218 (14%)
Query: 624 NNFNSSTQIGQGGYGKV----YKGILPDGTVVAVKR---AQEGSLQGEKEFLTEIQFLSR 676
++F +G G +G+V +K G A+K A+ L+ + L E + L
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHK---GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57
Query: 677 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS--IALGSSRG 734
+ H LV+L G ++ LV E++ G L L + P A + + L
Sbjct: 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLA---- 113
Query: 735 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 794
+ YLH+ + +RD+K N+LLD K+ DFG ++ V T+ G
Sbjct: 114 LEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAK---------RVKGRTYTLC-G 160
Query: 795 TPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 831
TP YL PE L K K+ D ++LG++ E+L G P
Sbjct: 161 TPEYLAPEIIL-SKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 64/227 (28%), Positives = 99/227 (43%), Gaps = 31/227 (13%)
Query: 631 QIGQGGYGKVYKG--ILPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLH---HR 680
+IG+G YGKV+K + G VA+KR + +Q +E + E+ L L H
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVR---VQTGEEGMPLSTIREVAVLRHLETFEHP 64
Query: 681 NLVSLVGYC-----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 735
N+V L C D E + LV+E + L L + + + RG+
Sbjct: 65 NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGL 123
Query: 736 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 795
+LH+ V HRD+K NIL+ K+ADFGL+R+ T V T
Sbjct: 124 DFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF--------QMALTSVVVT 172
Query: 796 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 842
Y PE L D++S+G +F E+ +P+ G + V ++
Sbjct: 173 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQL 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 69/224 (30%), Positives = 104/224 (46%), Gaps = 32/224 (14%)
Query: 631 QIGQGGYGKVYKGILP-DGTVVAVK----RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 685
++G+G Y VYKGI +G +VA+K + +EG + E L L H N+V L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGV---PFTAIREASLLKGLKHANIVLL 68
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLG---FAMRLSIALGSSRGILYLHTEA 742
+ V+E+M D + P G + +RL RG+ Y+H +
Sbjct: 69 HDIIHTKETLTFVFEYMHT----DLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHGQH 123
Query: 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
+ HRD+K N+L+ + K+ADFGL+R +P + S VV T Y P+
Sbjct: 124 ---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-----QTYSSEVV--TLWYRPPD 173
Query: 803 YFLTHKLTDKS---DVYSLGVVFLELLTGMQPISHGKNIVREVL 843
L TD S D++ G +F+E+L G QP G + V E L
Sbjct: 174 VLLGA--TDYSSALDIWGAGCIFIEMLQG-QPAFPGVSDVFEQL 214
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-11
Identities = 61/227 (26%), Positives = 97/227 (42%), Gaps = 41/227 (18%)
Query: 632 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHRNLVSLVG 687
IG+GG G+VY P VA+K+ +E + K FL E + + L H +V +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 688 YCDEEGEQMLVY---EFMSNGTLR---------DQLSAKSKEPLGFAMRLSIALGSSRGI 735
C + G+ VY ++ TL+ + LS + E LSI I
Sbjct: 70 ICSD-GD--PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 736 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL------------APVPDI--- 780
Y+H++ V HRD+K NILL + D+G + +I
Sbjct: 127 EYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 827
+P + GTP Y+ PE L ++ +D+Y+LGV+ ++LT
Sbjct: 184 SMTIPGKIV----GTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 68/228 (29%), Positives = 105/228 (46%), Gaps = 33/228 (14%)
Query: 623 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVK-----RAQEGSLQGEKEFLTEIQFLSR 676
T+ + IG+G YGKVYK DG++ AVK + ++ E L Q L
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNIL---QSLP- 76
Query: 677 LHHRNLVSLVG--YCDEE---GEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIAL 729
+H N+V G Y ++ G+ LV E + G++ + + + L AM I
Sbjct: 77 -NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135
Query: 730 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 789
G+ G+ +LH + HRD+K +NILL + K+ DFG+S + +
Sbjct: 136 GALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR------N 186
Query: 790 TVVKGTPGYLDPEYFLTHKLTDKS-----DVYSLGVVFLELLTGMQPI 832
T V GTP ++ PE + D S DV+SLG+ +EL G P+
Sbjct: 187 TSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 51/165 (30%), Positives = 80/165 (48%), Gaps = 16/165 (9%)
Query: 671 IQFLSRLHHRNLVSLVGYCD---EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSI 727
I+ L LH N +VG+ +GE + E M G+L L + P ++SI
Sbjct: 47 IRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISI 106
Query: 728 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 787
A+ RG+ YL + + HRD+K SNIL++ + K+ DFG+S G +
Sbjct: 107 AV--LRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS---------GQLIDS 153
Query: 788 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 832
++ GT Y+ PE T +SD++SLG+ +E+ G PI
Sbjct: 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 60/221 (27%), Positives = 92/221 (41%), Gaps = 44/221 (19%)
Query: 632 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHH-RNLVSLVGY 688
IG+G +G V K + GT++AVKR + + E K L ++ + R +V G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 689 CDEEGEQMLVYEFMS--------------NGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 734
EG+ + E M + +++ K IA+ + +
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGK------------IAVATVKA 119
Query: 735 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG-IVPAHVSTVVK 793
+ YL E + HRD+K SNILLD K+ DFG+S G +V + T
Sbjct: 120 LNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS---------GQLVDSIAKTRDA 168
Query: 794 GTPGYLDPEYFLTHKLTD---KSDVYSLGVVFLELLTGMQP 831
G Y+ PE +SDV+SLG+ E+ TG P
Sbjct: 169 GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 72/274 (26%), Positives = 107/274 (39%), Gaps = 87/274 (31%)
Query: 632 IGQGGYGKVYK----GI--LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRL-HHRNLV 683
+G+G +GKV + GI VAVK +EG+ E K +TE++ L + HH N+V
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74
Query: 684 SLVGYCDE-EGEQMLVYEFMSNGTLRDQLSAK----------------SKEPLGFAMRL- 725
+L+G C + G M++ E+ G L + L +K K+ G RL
Sbjct: 75 NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134
Query: 726 ------------------------------------------SIALGSSRGILYLHTEAD 743
S + +RG+ +L A
Sbjct: 135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---AS 191
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTP----GY 798
HRD+ A NILL K+ DFGL+R + PD V KG +
Sbjct: 192 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY----------VRKGDARLPLKW 241
Query: 799 LDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
+ PE T +SDV+S GV+ E+ + G P
Sbjct: 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 4e-11
Identities = 66/225 (29%), Positives = 94/225 (41%), Gaps = 44/225 (19%)
Query: 626 FNSSTQIGQGGYGKV----YKGILPDGTVVAVKRAQEG---------SLQGEKE-FLTEI 671
F +G+G +GKV YK G + A+K ++G SL EK F T
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFET-- 55
Query: 672 QFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL-----RDQLSAKSKEPLGFAMRLS 726
+ H LV+L E V E+ + G L D S EP
Sbjct: 56 --ANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS----EPRAVFYAAC 109
Query: 727 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 786
+ LG + YLH + + +RD+K N+LLD + K+ADFGL + EG+
Sbjct: 110 VVLG----LQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK-------EGMGFG 155
Query: 787 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
++ GTP +L PE T D + LGV+ E+L G P
Sbjct: 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 28/214 (13%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRN---LVSL 685
++G+G YG VYK + P G +A+K E L+ E +F I L LH +V
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMK---EIRLELDESKFNQIIMELDILHKAVSPYIVDF 64
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF--AMRLSIALGSSRGILYLHTEAD 743
G EG + E+M G+L D+L A G + I +G+ +L E +
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
+ HRD+K +N+L++ K+ DFG+S G + A ++ G Y+ PE
Sbjct: 124 --IIHRDVKPTNVLVNGNGQVKLCDFGVS---------GNLVASLAKTNIGCQSYMAPER 172
Query: 804 FLTHKLTD------KSDVYSLGVVFLELLTGMQP 831
+ +SDV+SLG+ LE+ G P
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 23/217 (10%)
Query: 632 IGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVG 687
+G+GG+G+V + G + A K+ ++ ++ GE L E + L +++ R +VSL
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 688 YCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR--GILYLHTEADP 744
Y E + + LV M+ G L+ + GF + +I + G+ L E
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNP--GFDEQRAIFYAAELCCGLEDLQRER-- 122
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD-IEGIVPAHVSTVVKGTPGYLDPEY 803
+ +RD+K NILLD + +++D GL+ P + + G V GT GY+ PE
Sbjct: 123 -IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV---------GTVGYMAPEV 172
Query: 804 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 840
K T D + LG + E++ G P K V+
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 7e-11
Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
+IGQG G VY + + G VA+++ ++ + EI + + N+V+ +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
E +V E+++ G+L D ++ + A ++ + + +LH+ V HR
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA---AVCRECLQALEFLHSNQ---VIHR 140
Query: 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS-TVVKGTPGYLDPEYFLTHK 808
DIK+ NILL + K+ DFG I P + + GTP ++ PE
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFC--------AQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 809 LTDKSDVYSLGVVFLELLTGMQP 831
K D++SLG++ +E++ G P
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 24/212 (11%)
Query: 630 TQIGQGGYGKVYKGIL---PDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 684
++G G +G V KG+ VAVK + + E L E + +L + +V
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLS----AKSKEPLGFAMRLSIALGSSRGILYLHT 740
++G C+ E MLV E G L L K ++S+ G+ YL
Sbjct: 61 MIGICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM------GMKYLE- 112
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
+ HRD+ A N+LL + AK++DFGLS+ + H VK +
Sbjct: 113 --ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK----WYA 166
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
PE +K + KSDV+S GV+ E + G +P
Sbjct: 167 PECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 50/203 (24%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 640 VYKGILPDGTVV--AVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY----CDEEG 693
+YKGI + V+ K+ +G EI+ L R+ N++ + G+ D+
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKA 753
L+ E+ + G LR+ L K K+ L F +L +A+ +G+ L+ + P ++++ +
Sbjct: 96 RLSLILEYCTRGYLREVLD-KEKD-LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTS 151
Query: 754 SNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTD 811
+ L+ + K+ GL ++ P + +V+ +V Y + + T
Sbjct: 152 VSFLVTENYKLKIICHGLEKILSSPPFK-----NVNFMV-----YFSYKMLNDIFSEYTI 201
Query: 812 KSDVYSLGVVFLELLTGMQPISH 834
K D+YSLGVV E+ TG P +
Sbjct: 202 KDDIYSLGVVLWEIFTGKIPFEN 224
|
Length = 283 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 16/204 (7%)
Query: 632 IGQGGYGKVYKGILPDGT-VVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVSLVG 687
IG+G +GKV + D + A+K ++ + E L E L++++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+ LV F++ G L L + + L A + L + L V
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAEL-----LCALENLHKFNVI 115
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
+RD+K NILLD++ + DFGL +L + + GTP YL PE L H
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKL-------NMKDDDKTNTFCGTPEYLAPELLLGH 168
Query: 808 KLTDKSDVYSLGVVFLELLTGMQP 831
T D ++LGV+ E+LTG+ P
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 67/214 (31%), Positives = 96/214 (44%), Gaps = 23/214 (10%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKR--AQEGSLQGEKEFLTEIQFLSRL-HHRNLVSL- 685
+IG+G + +V K G A+K SL+ + L EIQ L RL H N++ L
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLI 64
Query: 686 -VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 744
V + + G LV+E M + L + L K PL S + + ++H
Sbjct: 65 EVLFDRKTGRLALVFELM-DMNLYE-LIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG-- 120
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 804
+FHRDIK NIL+ K+ADFG R GI T T Y PE
Sbjct: 121 -IFHRDIKPENILIK-DDILKLADFGSCR--------GIYSKPPYTEYISTRWYRAPECL 170
Query: 805 LTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKN 837
LT K D++++G VF E+L+ + P+ G N
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILS-LFPLFPGTN 203
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 23/214 (10%)
Query: 625 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT---EIQFLSRLHHR 680
+F +IG G YG VYK + G + A+K + L+ ++F EI + H
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKHS 66
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 740
N+V+ G + + EF G+L+D PL + ++ + +G+ YLH+
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHS 124
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
+ HRDIK +NILL K+ADFG+S I + S + GTP ++
Sbjct: 125 KGK---MHRDIKGANILLTDNGHVKLADFGVS-----AQITATIAKRKSFI--GTPYWMA 174
Query: 801 PEYFLTHK---LTDKSDVYSLGVVFLELLTGMQP 831
PE + D++++G+ +E L +QP
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIE-LAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 29/211 (13%)
Query: 632 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQ-----FLSRLHHRNLVSLV 686
IG+G Y KV L + + + L + E + +Q F + +H LV L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLG----FAMRLSIALG--SSRGILYLHT 740
E V EF+S G L + + K P ++ +S+AL RGI+Y
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIY--- 119
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
RD+K N+LLD + K+ D+G+ + EGI P ++ GTP Y+
Sbjct: 120 --------RDLKLDNVLLDAEGHIKLTDYGMCK-------EGIRPGDTTSTFCGTPNYIA 164
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
PE D ++LGV+ E++ G P
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 27/219 (12%)
Query: 632 IGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVG 687
+G+GG+G+V + G + A K+ ++ ++ GE L E Q L +++ R +VSL
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66
Query: 688 YCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSI--ALGSSRGILYLHTEADP 744
Y E + + LV M+ G L+ + + GF ++ A + G+ LH E
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIY--NMGNPGFDEERAVFYAAEITCGLEDLHRER-- 122
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD---IEGIVPAHVSTVVKGTPGYLDP 801
+ +RD+K NILLD +++D GL+ +P+ I G V GT GY+ P
Sbjct: 123 -IVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRV---------GTVGYMAP 170
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 840
E + T D + LG + E++ G P K V+
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 632 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEK----EFLTEIQFLSRLHHRNLVSLV 686
+G+G Y VYKG G +VA+K E L+ E+ + E L L H N+V+L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALK---EIRLEHEEGAPFTAIREASLLKDLKHANIVTLH 69
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR-----LSIALGSSRGILYLHTE 741
+ LV+E++ D G +M L L RG+ Y H
Sbjct: 70 DIIHTKKTLTLVFEYLD----TDLKQYMDDCGGGLSMHNVRLFLFQLL---RGLAYCH-- 120
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
V HRD+K N+L+ + K+ADFGL+R VP + + VV T Y P
Sbjct: 121 -QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP-----SKTYSNEVV--TLWYRPP 172
Query: 802 EYFLTHKLTDKS---DVYSLGVVFLELLTGM 829
+ L T+ S D++ +G +F E+ TG
Sbjct: 173 DVLLGS--TEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 34/224 (15%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGY 688
IG G YG V I G VA+K+ K L E++ L H N++++
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 689 CDEEGEQM----LVYEFMSNGTLRDQLSAKSKEPLG------FAMRLSIALGSSRGILYL 738
G +V + M + S +PL F +L RG+ Y+
Sbjct: 73 LRPPGADFKDVYVVMDLMESDLHH---IIHSDQPLTEEHIRYFLYQLL------RGLKYI 123
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE--GIVPAHVSTVVKGTP 796
H+ A+ V HRD+K SN+L++ ++ DFG++R E + +V+T
Sbjct: 124 HS-AN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR----- 175
Query: 797 GYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 839
Y PE L+ + T D++S+G +F E+L G + + GKN V
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGKNYV 218
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 25/209 (11%)
Query: 632 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQ-----FLSRLHHRNLVSLV 686
IG+G Y KV L + + + L + E + +Q F + LV L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLG----FAMRLSIALGSSRGILYLHTEA 742
LV E+++ G L + + K P +A + IAL +LH
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALN------FLHERG 116
Query: 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
+ +RD+K N+LLD K+ D+G+ + EG+ P ++ GTP Y+ PE
Sbjct: 117 ---IIYRDLKLDNVLLDADGHIKLTDYGMCK-------EGLGPGDTTSTFCGTPNYIAPE 166
Query: 803 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
+ D ++LGV+ E++ G P
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 60/216 (27%), Positives = 104/216 (48%), Gaps = 18/216 (8%)
Query: 631 QIGQGGYGKVYKG--ILPDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLVG 687
++G+G Y VYKG L D +VA+K + +G + E+ L L H N+V+L
Sbjct: 13 KLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
E LV+E++ + L+ L ++L + RG+ Y H V
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFL-FQLLRGLNYCHRRK---VL 126
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-T 806
HRD+K N+L++ + K+ADFGL+R +P + + VV T Y P+ L +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIP-----TKTYSNEVV--TLWYRPPDILLGS 179
Query: 807 HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 842
+ + D++ +G +F E+ TG +P+ G + ++
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTG-RPLFPGSTVEEQL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 11/104 (10%)
Query: 734 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 793
G+ +LH++ + +RD+K NILLD K+ADFG+ + E ++ +
Sbjct: 108 GLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCK-------ENMLGDAKTCTFC 157
Query: 794 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
GTP Y+ PE L K D +S GV+ E+L G P HG +
Sbjct: 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPF-HGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 3e-10
Identities = 73/254 (28%), Positives = 104/254 (40%), Gaps = 58/254 (22%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEG------SLQGEKE-----FLTEIQ 672
N + +IG G +G+V+ +V KR QE S +G KE + E+
Sbjct: 13 NEYEVIKKIGNGRFGEVF--------LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVN 64
Query: 673 FLSRLHHRNLVSLVGYCDEEGEQML--VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 730
+ L H+N+V + + Q L + EF G L + K + G +I +
Sbjct: 65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQ-KCYKMFGKIEEHAI-VD 122
Query: 731 SSRGIL----YLHTEADPP----VFHRDIKASNILLDH------KFTA-----------K 765
+R +L Y H D P V HRD+K NI L K TA K
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182
Query: 766 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL--THKLTDKSDVYSLGVVFL 823
+ DFGLS+ + + AH GTP Y PE L T DKSD+++LG +
Sbjct: 183 IGDFGLSKNIGIESM-----AHSCV---GTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234
Query: 824 ELLTGMQPISHGKN 837
EL +G P N
Sbjct: 235 ELCSGKTPFHKANN 248
|
Length = 1021 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 15/212 (7%)
Query: 632 IGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVG 687
+G+GG+G+V + G + A K+ + L+ GEK L E + L +++ +V+L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+ + LV M+ G L+ + + L + + + GIL+LH+ +
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IV 117
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
+RD+K N+LLD + +++D GL+ + D + I T GT GY+ PE
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTI------TQRAGTNGYMAPEILKEE 169
Query: 808 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 839
+ D +++G E++ G P K V
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 38/221 (17%)
Query: 632 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---------QGEKEFLT---EIQFLSRLH 678
+G+G +GKV L G AVK ++ + EK L E FL+ L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL- 61
Query: 679 HRNLVSLVGYCDEEGEQML--VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 736
YC + ++ L V EF++ G L + K + L A + + G+
Sbjct: 62 ---------YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC--GLQ 110
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
+LH++ + +RD+K N++LD K+ADFG+ + E + + ++ GTP
Sbjct: 111 FLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCK-------ENVFGDNRASTFCGTP 160
Query: 797 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
Y+ PE K T D +S GV+ E+L G P HG +
Sbjct: 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPF-HGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 60/234 (25%), Positives = 97/234 (41%), Gaps = 61/234 (26%)
Query: 625 NFNSSTQIGQGGYGKVY----KG--------ILPDGTVV---------AVKRAQEGSLQG 663
+FN +G+G +GKV KG IL V+ KR +L G
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVL--ALSG 58
Query: 664 EKEFLTEI----QFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS--AKSKE 717
+ FLT++ Q + RL+ V E+++ G L Q+ + KE
Sbjct: 59 KPPFLTQLHSCFQTMDRLY------------------FVMEYVNGGDLMYQIQQVGRFKE 100
Query: 718 PLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777
P IA+G + +LH++ + +RD+K N++LD + K+ADFG+ +
Sbjct: 101 PHAVFYAAEIAIG----LFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---- 149
Query: 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
E + + GTP Y+ PE D ++ GV+ E+L G P
Sbjct: 150 ---ENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 52/184 (28%), Positives = 80/184 (43%), Gaps = 13/184 (7%)
Query: 648 GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 707
G VAVK Q + E+ + H+N+V + E ++ EF+ G L
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 708 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVA 767
D +S A L + + YLH++ V HRDIK+ +ILL K++
Sbjct: 106 TDIVSQTRLNEEQIATVCESVL---QALCYLHSQG---VIHRDIKSDSILLTLDGRVKLS 159
Query: 768 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 827
DFG I VP S V GTP ++ PE + D++SLG++ +E++
Sbjct: 160 DFGF-----CAQISKDVPKRKSLV--GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVD 212
Query: 828 GMQP 831
G P
Sbjct: 213 GEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 5e-10
Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 20/208 (9%)
Query: 632 IGQGGYGKVYKGILP----DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLV 686
+G G +G++ +G L VA+ + G S + + FL E L + H N+V L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
G M+V E+MSNG L D K + L + + G + G+ YL ++
Sbjct: 73 GVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLASGMKYL---SEMGY 128
Query: 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL--DPEYF 804
H+ + A +L++ K++ F RL E I T + G L PE
Sbjct: 129 VHKGLAAHKVLVNSDLVCKISGFR--RL-QEDKSEAIY-----TTMSGKSPVLWAAPEAI 180
Query: 805 LTHKLTDKSDVYSLGVVFLELLT-GMQP 831
H + SDV+S G+V E+++ G +P
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 64/223 (28%), Positives = 97/223 (43%), Gaps = 29/223 (13%)
Query: 632 IGQGGYGKV----YKGILPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLH-HRNLVS 684
+GQG YG V + VA+K+ K L E++ L H+N+
Sbjct: 8 LGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 685 LVG----YCDEEGEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYL 738
L + E L E M L +S +PL A S G+ Y+
Sbjct: 67 LYDMDIVFPGNFNELYLYEELMEA-----DLHQIIRSGQPLTDAHFQSFIYQILCGLKYI 121
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTPG 797
H+ A+ V HRD+K N+L++ K+ DFGL+R + P G ++ V T
Sbjct: 122 HS-AN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENP---GENAGFMTEYV-ATRW 174
Query: 798 YLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIV 839
Y PE L+ + K+ DV+S+G + ELL G +P+ GK+ V
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYV 216
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 5e-10
Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 25/217 (11%)
Query: 632 IGQGGYGKVYKGILP--DGTV--VAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 685
+G+G +G V + L DG+ VAVK +A S +EFL E + H N++ L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 686 VGYCDEEGEQ------MLVYEFMSNGTLRDQL--SAKSKEPLGFAMR--LSIALGSSRGI 735
+G + M++ FM +G L L S +EP ++ + + + G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 736 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 795
YL ++ HRD+ A N +L+ T VADFGLS+ D K
Sbjct: 127 EYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDY-----YRQGCASKLP 178
Query: 796 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
+L E + T SDV++ GV E++T G P
Sbjct: 179 VKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 6e-10
Identities = 62/211 (29%), Positives = 89/211 (42%), Gaps = 30/211 (14%)
Query: 632 IGQGGYGKVYKGIL----PDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVS 684
+G+G +GKV IL G A+K ++ + + E LTE + L H L +
Sbjct: 3 LGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAK---SKEPLGF-AMRLSIALGSSRGILYLHT 740
L V E+ + G L LS + S++ F + ALG YLH+
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALG------YLHS 113
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
V +RD+K N++LD K+ DFGL + EGI GTP YL
Sbjct: 114 CD---VVYRDLKLENLMLDKDGHIKITDFGLCK-------EGISDGATMKTFCGTPEYLA 163
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
PE + D + LGVV E++ G P
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 66/225 (29%), Positives = 107/225 (47%), Gaps = 36/225 (16%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSL-QGEKEFLT-----EIQFLSRLHHRNLVS 684
++G+G YG VYK DG K +E +L Q E ++ EI L L H N+++
Sbjct: 8 KVGRGTYGHVYKAKRKDG-----KDEKEYALKQIEGTGISMSACREIALLRELKHPNVIA 62
Query: 685 L--VGYCDEEGEQMLVYEFMSNGTLR----DQLSAKSKEPLGF--AMRLSIALGSSRGIL 736
L V + + L++++ + + S +K+P+ +M S+ GI
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 737 YLHTEADPPVFHRDIKASNILL----DHKFTAKVADFGLSRL--APVPDIEGIVPAHVST 790
YLH V HRD+K +NIL+ + K+AD G +RL +P+ + + P V
Sbjct: 123 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-- 177
Query: 791 VVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISH 834
T Y PE L + K+ D++++G +F ELLT +PI H
Sbjct: 178 ----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFH 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 23/215 (10%)
Query: 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHH 679
+++ ++G G YG VYK L G + AVK + L+ +F EI + H
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMVKECKH 65
Query: 680 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
N+V+ G + + E+ G+L+D PL + + +G+ YLH
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLH 123
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
++ HRDIK +NILL K+ADFG++ I + S + GTP ++
Sbjct: 124 SKGK---MHRDIKGANILLTDNGDVKLADFGVA-----AKITATIAKRKSFI--GTPYWM 173
Query: 800 DPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQP 831
PE K D++++G+ +E L +QP
Sbjct: 174 APEVAAVEKNGGYNQLCDIWAVGITAIE-LAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 30/222 (13%)
Query: 631 QIGQGGYGKVYKGILPDG---TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL-- 685
++G+G YG VYK DG A+K+ + + EI L L H N++SL
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQK 65
Query: 686 VGYCDEEGEQMLVYEFMSNGTLR----DQLSAKSKEPLGF--AMRLSIALGSSRGILYLH 739
V + + L++++ + + S +K+P+ M S+ GI YLH
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 740 TEADPPVFHRDIKASNILL----DHKFTAKVADFGLSRL--APVPDIEGIVPAHVSTVVK 793
V HRD+K +NIL+ + K+AD G +RL +P+ + + P V
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV----- 177
Query: 794 GTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISH 834
T Y PE L + K+ D++++G +F ELLT +PI H
Sbjct: 178 -TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFH 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 7e-10
Identities = 59/216 (27%), Positives = 90/216 (41%), Gaps = 45/216 (20%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEG-SLQGEKEFLT-------------EIQFLSR 676
++G+G +G VY +V K+A L+ KE E Q LS+
Sbjct: 7 RLGKGSFGTVY--------LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSK 58
Query: 677 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK------EPLGFAMRLSIALG 730
L H +V E ++ E+ L +L E + + LG
Sbjct: 59 LDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118
Query: 731 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 790
+ Y+H + HRD+KA NI L + K+ DFG+SRL + ++T
Sbjct: 119 ----VHYMHQRR---ILHRDLKAKNIFLKNNLL-KIGDFGVSRLL-------MGSCDLAT 163
Query: 791 VVKGTPGYLDPEYFLTHKLTD-KSDVYSLGVVFLEL 825
GTP Y+ PE L H+ D KSD++SLG + E+
Sbjct: 164 TFTGTPYYMSPEA-LKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 8e-10
Identities = 48/166 (28%), Positives = 78/166 (46%), Gaps = 21/166 (12%)
Query: 668 LTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSI 727
+EI + +L H N+V L+G C E L++E++ L + L S E R I
Sbjct: 731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWE-----RRRKI 785
Query: 728 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 787
A+G ++ + +LH P V ++ I++D K + RL+ P
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSL--------PGL 831
Query: 788 VSTVVKG--TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
+ T K + Y+ PE T +T+KSD+Y G++ +ELLTG P
Sbjct: 832 LCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 58/220 (26%), Positives = 104/220 (47%), Gaps = 26/220 (11%)
Query: 631 QIGQGGYGKVYKG--ILPDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLVG 687
++G+G Y V+KG L + +VA+K + +G + E+ L L H N+V+L
Sbjct: 13 KLGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS----IALGSSRGILYLHTEAD 743
+ LV+E++ D+ + + G M + RG+ Y H
Sbjct: 72 IVHTDKSLTLVFEYL------DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK- 124
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
V HRD+K N+L++ + K+ADFGL+R VP + + VV T Y P+
Sbjct: 125 --VLHRDLKPQNLLINERGELKLADFGLARAKSVP-----TKTYSNEVV--TLWYRPPDV 175
Query: 804 FL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 842
L + + + + D++ +G +F E+ +G +P+ G + E+
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASG-RPLFPGSTVEDEL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 21/221 (9%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRN 681
+++ ++G+G Y VYKG +G +VA+K + +G + E L L H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF---AMRLSIALGSSRGILYL 738
+V L + LV+E++ D K P G ++L + RG+ Y+
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHT----DLCQYMDKHPGGLHPENVKLFL-FQLLRGLSYI 119
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
H + HRD+K N+L+ K+ADFGL+R VP+H + T Y
Sbjct: 120 HQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS-------VPSHTYSNEVVTLWY 169
Query: 799 LDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 838
P+ L + + + D++ +G +F+E++ G+ K+I
Sbjct: 170 RPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI 210
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 53/212 (25%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 625 NFNSSTQIGQGGYGKVYKGILPDGTV--VAVKRAQEGSLQGEKEF---LTEIQFLSRLHH 679
+FN +G G +G+V + VA+KR ++ + +K+ +E + L+ ++H
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90
Query: 680 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
V+L G +E LV EF+ G L + P +++ +L
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVG-----CFYAAQIVLIFE 145
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
+ +RD+K N+LLD K+ DFG ++ +V T+ GTP Y+
Sbjct: 146 YLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK---------VVDTRTYTLC-GTPEYI 195
Query: 800 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
PE L +D ++LG+ E+L G P
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 60/218 (27%), Positives = 92/218 (42%), Gaps = 37/218 (16%)
Query: 626 FNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNL 682
+ + + +G G YG+V G VA+K+ S K E++ L + H N+
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENV 76
Query: 683 VSL--VGYCDEEGEQM----LVYEFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSS 732
+ L V E LV M N ++ Q LS + L + +
Sbjct: 77 IGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQIL-------- 128
Query: 733 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 792
RG+ Y+H+ A + HRD+K SNI ++ K+ DFGL+R ++ G V
Sbjct: 129 RGLKYIHS-AG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDD-EMTGYV-------- 176
Query: 793 KGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTG 828
T Y PE L H D++S+G + ELLTG
Sbjct: 177 -ATRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 38/219 (17%)
Query: 632 IGQGGYGKVYKGILPDGT----VVAVKRAQEGSL-QGEKEFL---TEIQFLSRLHHRNLV 683
+G+GGYGKV++ G + A+K ++ ++ + +K+ E L + H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR---------LSIALGSSRG 734
L+ G+ L+ E++S G L L E G M +S+AL
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHL-----EREGIFMEDTACFYLSEISLALE---- 114
Query: 735 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 794
+LH + + +RD+K NILLD + K+ DFGL + E I V+ G
Sbjct: 115 --HLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCK-------ESIHEGTVTHTFCG 162
Query: 795 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833
T Y+ PE + D +SLG + ++LTG P +
Sbjct: 163 TIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT 201
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 68/224 (30%), Positives = 104/224 (46%), Gaps = 37/224 (16%)
Query: 632 IGQGGYGKVYKGILPD-GTVVAVKR---AQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
IG+G YG V + VA+K+ A + + K L EI+ L L H N++++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDA-KRTLREIKLLRHLDHENVIAIKD 71
Query: 688 YCDEEGEQM-----LVYEFMSNGTLRDQLSAKSKEPLG------FAMRLSIALGSSRGIL 736
+ +VYE M T Q+ +S + L F +L RG+
Sbjct: 72 IMPPPHREAFNDVYIVYELMD--TDLHQI-IRSSQTLSDDHCQYFLYQLL------RGLK 122
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
Y+H+ A+ V HRD+K SN+LL+ K+ DFGL+R + + +V T
Sbjct: 123 YIHS-AN--VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVV-----TR 172
Query: 797 GYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 839
Y PE L + T DV+S+G +F ELL G +P+ GK+ V
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFPGKDYV 215
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 11/104 (10%)
Query: 734 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 793
G+ +LH + + +RD+K N+LLD K+ADFG+ + E + ++
Sbjct: 108 GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCK-------ENMNGEGKASTFC 157
Query: 794 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
GTP Y+ PE K + D +S GV+ E+L G P HG++
Sbjct: 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPF-HGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 25/209 (11%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSL---QGEKEFLTEIQ-FLSRLHHRNLVSLV 686
IG+G +GKV + AVK Q+ ++ + EK ++E L + H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKS--KEPLG--FAMRLSIALGSSRGILYLHTEA 742
+ V ++++ G L L + EP +A ++ ALG YLH+
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG------YLHSLN 116
Query: 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
+ +RD+K NILLD + + DFGL + E I ++ GTP YL PE
Sbjct: 117 ---IVYRDLKPENILLDSQGHIVLTDFGLCK-------ENIEHNGTTSTFCGTPEYLAPE 166
Query: 803 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
D + LG V E+L G+ P
Sbjct: 167 VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 34/224 (15%)
Query: 631 QIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLVGY 688
++G+G Y V+KG +VA+K + +G + E+ L L H N+V+L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 689 CDEEGEQMLVYEFMSN---------GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
E LV+E++ + G L + K F +L RG+ Y H
Sbjct: 72 IHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKI-----FMFQL------LRGLSYCH 120
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
+ HRD+K N+L++ K K+ADFGL+R VP + + VV T Y
Sbjct: 121 KRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVP-----TKTYSNEVV--TLWYR 170
Query: 800 DPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 842
P+ L + + + D++ +G + E+ TG +P+ G + E+
Sbjct: 171 PPDVLLGSTEYSTPIDMWGVGCILYEMATG-RPMFPGSTVKEEL 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 24/216 (11%)
Query: 632 IGQGGYGKVYKGIL-PDGTV--VAVKRAQEG-SLQGEKE-FLTEIQFLSRLHHRNLVSLV 686
+G+G +G V +G L D ++ VAVK + + E E FL+E + H N++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 687 GYCDEEGEQ------MLVYEFMSNGTLRDQL--SAKSKEPLGFAMRLSIALGS--SRGIL 736
G C + E +++ FM +G L L S P ++ + + + G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
YL +++ HRD+ A N +L+ VADFGLS+ D + K
Sbjct: 127 YLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDY-----YRQGRIAKMPV 178
Query: 797 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
++ E T KSDV+S GV E+ T G P
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 44/162 (27%), Positives = 73/162 (45%), Gaps = 26/162 (16%)
Query: 673 FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTL--RDQLSAKSKEPLGFAMRLSIAL 729
FL++LH C + +++ V E+++ G L Q K KEP I++
Sbjct: 62 FLTQLHS---------CFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISV 112
Query: 730 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 789
G + +LH + +RD+K N++LD + K+ADFG+ + E +V +
Sbjct: 113 G----LFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-------EHMVDGVTT 158
Query: 790 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
GTP Y+ PE D ++ GV+ E+L G P
Sbjct: 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 6e-09
Identities = 60/209 (28%), Positives = 90/209 (43%), Gaps = 26/209 (12%)
Query: 632 IGQGGYGKVYKGIL----PDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVS 684
+G+G +GKV IL G A+K ++ + + E LTE + L H L S
Sbjct: 3 LGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS--RGILYLHTEA 742
L + V E+++ G L LS + F+ + G+ + YLH+
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGELFFHLSRERV----FSEDRTRFYGAEIVSALDYLHSGK 115
Query: 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
+ +RD+K N++LD K+ DFGL + EGI A GTP YL PE
Sbjct: 116 ---IVYRDLKLENLMLDKDGHIKITDFGLCK-------EGITDAATMKTFCGTPEYLAPE 165
Query: 803 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
+ D + LGVV E++ G P
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 8e-09
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 632 IGQGGYGKV----YKGILPDGTVVAVK--RAQEG-SLQGEKEFLTEIQFLSRLHHRNLVS 684
+G G +G+V +KG G A+K + +E ++ + E L L H +V+
Sbjct: 26 LGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVN 82
Query: 685 LV-GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL---YLHT 740
++ + DE + EF+ G L L + P A L +L YLH+
Sbjct: 83 MMCSFQDEN-RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAEL-----VLAFEYLHS 136
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
+ + +RD+K N+LLD+K KV DFG ++ VP T+ GTP YL
Sbjct: 137 KD---IIYRDLKPENLLLDNKGHVKVTDFGFAKK---------VPDRTFTLC-GTPEYLA 183
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
PE + D +++GV+ E + G P
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 31/212 (14%)
Query: 632 IGQGGYGKVYKGIL----PDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVS 684
+G+G +GKV IL G A+K ++ + + E LTE + L H L +
Sbjct: 3 LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 685 LVGYCDEEGEQMLVYEFMSNGTL-----RDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
L V E+ + G L R+++ ++ + + + AL YLH
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALD------YLH 112
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
+E + V +RD+K N++LD K+ DFGL + EGI GTP YL
Sbjct: 113 SEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-------EGIKDGATMKTFCGTPEYL 163
Query: 800 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
PE + D + LGVV E++ G P
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 33/220 (15%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVG-Y 688
IG+G YGKV+K + +G+ AVK + ++E E L L H N+V G Y
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 689 CDEE---GEQM-LVYEFMSNGTLRDQLSA------KSKEPLGFAMRLSIALGSSRGILYL 738
++ G+Q+ LV E + G++ D + + +EP+ A L AL G+ +L
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI-IAYILHEAL---MGLQHL 140
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
H HRD+K +NILL + K+ DFG+S A + GTP +
Sbjct: 141 HVNK---TIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTR-----LRRNTSVGTPFW 190
Query: 799 LDPEYFLTHKLTDKS-----DVYSLGVVFLELLTGMQPIS 833
+ PE + D + DV+SLG+ +EL G P++
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 65/245 (26%), Positives = 100/245 (40%), Gaps = 52/245 (21%)
Query: 625 NFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGS-LQGEK---EFLTEIQFLSR 676
NF +G G YGKV+ G G + A+K ++ + +Q K TE Q L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 677 LHHRN-LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK----EPLGFAMRLSIALGS 731
+ LV+L + + L+ ++++ G L L + E + + +AL
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120
Query: 732 --SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR--LAPVPD-------- 779
GI+Y RDIK NILLD + + DFGLS+ LA +
Sbjct: 121 LHQLGIIY-----------RDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGT 169
Query: 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP--ISHGKN 837
IE + P + G+ G+ D +SLGV+ ELLTG P + +N
Sbjct: 170 IEYMAPEVIRG---GSGGH-----------DKAVDWWSLGVLTFELLTGASPFTVDGEQN 215
Query: 838 IVREV 842
E+
Sbjct: 216 SQSEI 220
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-08
Identities = 38/116 (32%), Positives = 53/116 (45%), Gaps = 29/116 (25%)
Query: 209 LDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP 268
LDN L G++P ++S+L L + L N+ G IP S +
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGN-IPPSLGS------------------- 464
Query: 269 DLSRIPNLGYLDLSSNQLNGSIPP--GRL-SLNITTIKLSNNKLTGTIPSNFSGLP 321
I +L LDLS N NGSIP G+L SL I + L+ N L+G +P+ G
Sbjct: 465 ----ITSLEVLDLSYNSFNGSIPESLGQLTSLRI--LNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 21/207 (10%)
Query: 631 QIGQGGYGKVYKGILP-DGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSLV- 686
IG G +G V+ P DG VA+K+ +L K E++ L H N++S +
Sbjct: 7 PIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALD 66
Query: 687 ----GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 742
+ D E +V E M + + +S + + L L RG+ YLH+
Sbjct: 67 ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQIL---RGLKYLHSAG 123
Query: 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
+ HRDIK N+L++ K+ DFGL+R+ PD + V T Y PE
Sbjct: 124 ---ILHRDIKPGNLLVNSNCVLKICDFGLARVEE-PDESKHMTQEVVTQY-----YRAPE 174
Query: 803 YFL-THKLTDKSDVYSLGVVFLELLTG 828
+ + T D++S+G +F ELL
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 58/217 (26%), Positives = 84/217 (38%), Gaps = 32/217 (14%)
Query: 633 GQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVGYCD 690
+ K P T+VAVK+ S E K EI +L H N++ V
Sbjct: 11 EDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI 69
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIAL---GSSRGILYLHTEADPPVF 747
+ E +V M+ G+ D L K+ P G L+IA + Y+H++
Sbjct: 70 VDSELYVVSPLMAYGSCEDLL--KTHFPEGLP-ELAIAFILKDVLNALDYIHSKG---FI 123
Query: 748 HRDIKASNILLDHKFTAKVADFGLS--------RLAPVPDIEGIVPAHVSTVVKGTPGYL 799
HR +KAS+ILL ++ S R V D P + +L
Sbjct: 124 HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF----PKSSVKNLP----WL 175
Query: 800 DPEYFLTHKL---TDKSDVYSLGVVFLELLTGMQPIS 833
PE L L +KSD+YS+G+ EL G P
Sbjct: 176 SPE-VLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 34/232 (14%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQE----GSLQGEKEFLTEIQFLSRLHHRNLVSLV 686
+IG G +GKV + T VA +E S + + EFL + L H N++ +
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKS-KEPLGFAMRLS-IALGSSRGILYLHTEADP 744
G C E +LV+E+ G L+ LS + + L +A + G+ ++H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN-- 119
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGL--SRLAP---VPDIEGIVPAHVSTVVKGTPGYL 799
H D+ N L T KV D+G+ SR + + VP +L
Sbjct: 120 -FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR----------WL 168
Query: 800 DPEY-------FLTHKLTDKSDVYSLGVVFLELL-TGMQPISHGKNIVREVL 843
PE +T + T S+V++LGV EL QP SH + REVL
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--REVL 218
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 3e-08
Identities = 66/257 (25%), Positives = 105/257 (40%), Gaps = 68/257 (26%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVK---------RAQEGSLQGEKEFLTEIQF 673
++F S IG+G +G+V D G + A+K + Q ++ E++ L E
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-- 58
Query: 674 LSRLHHRNLVSLVGYCDEEGEQ--MLVYEFMSNGTLRDQLSAK---SKEPLGFAMRLSI- 727
+ +V L Y + E L+ E++ G + L K ++E F + +I
Sbjct: 59 ----DNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETIL 112
Query: 728 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS---RLAPVPDIEGIV 784
A+ S + Y+H RDIK N+LLD K K++DFGL + + + I+
Sbjct: 113 AIDSIHKLGYIH---------RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRIL 163
Query: 785 PAHV------------------------------STVVKGTPGYLDPEYFLTHKLTDKSD 814
+ STV GTP Y+ PE FL + D
Sbjct: 164 SHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTV--GTPDYIAPEVFLQTGYNKECD 221
Query: 815 VYSLGVVFLELLTGMQP 831
+SLGV+ E+L G P
Sbjct: 222 WWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 30/217 (13%)
Query: 632 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRN--LVSL 685
IG+GG+G+VY D G + A+K + + QGE L E LS + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 686 VGYCDEEGEQM-LVYEFMSNGTLRDQLSA----KSKEPLGFAMRLSIALGSSRGILYLHT 740
+ Y +++ + + M+ G L LS KE +A + + G+ ++H
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL------GLEHMHN 115
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
V +RD+K +NILLD +++D GL+ D P H S GT GY+
Sbjct: 116 RF---VVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKP-HASV---GTHGYMA 163
Query: 801 PEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGK 836
PE D S D +SLG + +LL G P K
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 34/95 (35%), Positives = 44/95 (46%), Gaps = 10/95 (10%)
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
YLH+ V +RDIK N++LD K+ DFGL + EGI GTP
Sbjct: 110 YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK-------EGISDGATMKTFCGTP 159
Query: 797 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
YL PE + D + LGVV E++ G P
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 38/222 (17%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHRNLVSLV 686
Q+G G YG V + G VA+K+ Q E K E++ L + H N++ L+
Sbjct: 22 QVGSGAYGTVCSALDRRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 687 GY------CDEEGEQMLVYEFMSN--GTL--RDQLSAKSKEPLGFAMRLSIALGSSRGIL 736
D + LV FM G L ++LS + L + M +G+
Sbjct: 81 DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQML--------KGLK 132
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
Y+H + HRD+K N+ ++ K+ DFGL+R ++ G V T
Sbjct: 133 YIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTD-SEMTGYVV---------TR 179
Query: 797 GYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
Y PE L T D++S+G + E+LTG +P+ G +
Sbjct: 180 WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG-KPLFKGHD 220
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 59/227 (25%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPD---GTVVAVKRAQEGSLQGEKE---FLTEIQFLSRL 677
+F+ + +G+G +G+V ++ + G + A+K ++ L ++ F E LS
Sbjct: 1 KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58
Query: 678 HHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAM-RLSIALGSSRGI 735
+ + L Y ++ + + LV E+ G L L+ + ++ M + +A +
Sbjct: 59 NSPWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLN-RYEDQFDEDMAQFYLA----ELV 112
Query: 736 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKG 794
L +H+ HRDIK N+L+D K+ADFG + RL +V S + G
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL----TANKMV---NSKLPVG 165
Query: 795 TPGYLDPEYFLTHKLTDKS------DVYSLGVVFLELLTGMQPISHG 835
TP Y+ PE T K D +SLGV+ E++ G P G
Sbjct: 166 TPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG 212
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 49/202 (24%), Positives = 82/202 (40%), Gaps = 38/202 (18%)
Query: 635 GGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 693
G G+V+ P V +K Q+G+ L E L ++H +++ +
Sbjct: 77 GSEGRVFVATKPGQPDPVVLKIGQKGTT------LIEAMLLQNVNHPSVIRM-------- 122
Query: 694 EQMLVYEFMS-------NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
+ LV ++ + L L+ +S+ PL L I G+ YLH + +
Sbjct: 123 KDTLVSGAITCMVLPHYSSDLYTYLTKRSR-PLPIDQALIIEKQILEGLRYLHAQR---I 178
Query: 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPV--PDIEGIVPAHVSTVVKGTPGYLDPEYF 804
HRD+K NI ++ + D G ++ PV P G + GT PE
Sbjct: 179 IHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLG---------LAGTVETNAPEVL 228
Query: 805 LTHKLTDKSDVYSLGVVFLELL 826
K K+D++S G+V E+L
Sbjct: 229 ARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 64/250 (25%), Positives = 100/250 (40%), Gaps = 59/250 (23%)
Query: 625 NFNSSTQIGQGGYGKVYKGILPD-GTVVAVK---------RAQEGSLQGEKEFLTEIQFL 674
+F S IG+G +G+V D G V A+K + Q G ++ E++ L E L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 675 SRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK---SKEPLGFAMRLSIALGS 731
+V + ++ L+ EF+ G + L K ++E F +
Sbjct: 62 W------VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYI-------- 107
Query: 732 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS-------RLAPVPDIEGIV 784
+ +L + + HRDIK N+LLD K K++DFGL R ++ +
Sbjct: 108 AETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSL 167
Query: 785 PAH-----------------------VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVV 821
P+ STV GTP Y+ PE F+ D +SLGV+
Sbjct: 168 PSDFTFQNMNSKRKAETWKRNRRQLAFSTV--GTPDYIAPEVFMQTGYNKLCDWWSLGVI 225
Query: 822 FLELLTGMQP 831
E+L G P
Sbjct: 226 MYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-07
Identities = 39/125 (31%), Positives = 63/125 (50%), Gaps = 9/125 (7%)
Query: 73 FNTTMDDGYLHLRELQLLNLN---LSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNI 129
F+ + L EL L L+ LSG + E+ L LD N++SG IP +
Sbjct: 487 FSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEM 546
Query: 130 KSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNS 189
L L L+ N+L+G +P+ LG + L ++ I N++ GSLP + A L +N ++
Sbjct: 547 PVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLA------INASA 600
Query: 190 ISGQI 194
++G I
Sbjct: 601 VAGNI 605
|
Length = 968 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 15/223 (6%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQ--EGSLQGEKEFLTEIQFLSRLHHR 680
N F +G+G YG V K + +VA+K+ + E + + ++ L E++ L L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 740
N+V L G+ LV+E++ ++ L + P G + + I +H
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVE----KNMLELLEEMPNG-VPPEKVRSYIYQLIKAIHW 115
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
+ HRDIK N+L+ H K+ DFG +R EG + V T Y
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS----EGSNANYTEYV--ATRWYRS 169
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVL 843
PE L D++S+G + EL G QP+ G++ + ++
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDG-QPLFPGESEIDQLF 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 32/89 (35%), Positives = 44/89 (49%), Gaps = 12/89 (13%)
Query: 748 HRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 806
HRD+K N+LLD K+ADFG ++ D G+V T V GTP Y+ PE +
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKM----DANGMV--RCDTAV-GTPDYISPEVLKS 217
Query: 807 HKLTD----KSDVYSLGVVFLELLTGMQP 831
+ D +S+GV E+L G P
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-07
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 1/91 (1%)
Query: 156 LDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT 215
+D + +D + G +P + L + +++ NSI G IPP L + SL + L N+
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 216 GYLPPELSELPKLLILQLDNNNFEGTTIPAS 246
G +P L +L L IL L+ N+ G +PA+
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSG-RVPAA 509
|
Length = 623 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 58/187 (31%), Positives = 83/187 (44%), Gaps = 27/187 (14%)
Query: 653 VKRAQEGSLQGEKEFLT--EIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQ 710
+KRA+ + E+ L + Q+++ LH+ +E LV ++ G L
Sbjct: 40 LKRAETACFREERNVLVNGDCQWITTLHYA--------FQDENYLYLVMDYYVGGDLLTL 91
Query: 711 LSA-KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 769
LS + + P A R IA +L +H+ HRDIK N+LLD ++ADF
Sbjct: 92 LSKFEDRLPEDMA-RFYIA----EMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADF 146
Query: 770 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-----KLTDKSDVYSLGVVFLE 824
G S L D G V S+V GTP Y+ PE K + D +SLGV E
Sbjct: 147 G-SCLKMNQD--GTVQ---SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYE 200
Query: 825 LLTGMQP 831
+L G P
Sbjct: 201 MLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 54/224 (24%), Positives = 97/224 (43%), Gaps = 45/224 (20%)
Query: 625 NFNSSTQIGQGGYGKVYKG------------ILPDGTVVAVKRAQEGSLQGEKEFLTEIQ 672
+ +G G +G+V+ ++ V+ +K QE + EK L E+
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLK--QEQHVHNEKRVLKEVS 59
Query: 673 FLSRLHHRNLVSLVGYCDEEGEQML--VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 730
H ++ L + E ++ L + E++ G L L + F+ +
Sbjct: 60 ------HPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGR----FSNSTGLFYA 107
Query: 731 SS--RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 788
S + YLH++ + +RD+K NILLD + K+ DFG ++ + D
Sbjct: 108 SEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK--KLRD--------R 154
Query: 789 STVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 831
+ + GTP YL PE + K +K+ D ++LG++ E+L G P
Sbjct: 155 TWTLCGTPEYLAPE-VIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 5e-07
Identities = 59/230 (25%), Positives = 88/230 (38%), Gaps = 60/230 (26%)
Query: 632 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
+G G G V+ + D VAVK+ Q K L EI+ + RL H N+V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK------ 66
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKS----------KEPLGFAMRLSIALGSS-------- 732
VYE + S +E + + + G
Sbjct: 67 -------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLF 119
Query: 733 -----RGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPA 786
RG+ Y+H+ V HRD+K +N+ ++ K+ DFGL+R IV
Sbjct: 120 MYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLAR---------IVDP 167
Query: 787 HVSTVVKG-------TPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTG 828
H S KG T Y P L+ + T D+++ G +F E+LTG
Sbjct: 168 HYSH--KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 60/208 (28%), Positives = 92/208 (44%), Gaps = 22/208 (10%)
Query: 632 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRN--LVSL 685
IG+GG+G+VY D G + A+K + + QGE L E LS + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 686 VGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 744
+ Y +++ + + M+ G L LS G + ++ IL L +
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMHNR 116
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 804
V +RD+K +NILLD +++D GL+ D P H S GT GY+ PE
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKP-HASV---GTHGYMAPEVL 167
Query: 805 LTHKLTDKS-DVYSLGVVFLELLTGMQP 831
D S D +SLG + +LL G P
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 20/208 (9%)
Query: 632 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVSLVG 687
IG+G +G+VY+ D + A+K + + +KE + E L R +VG
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 688 Y---CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 744
+ + LV ++MS G L L + + A + IA +L L
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRA-KFYIA----ELVLALEHLHKY 115
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 804
+ +RD+K NILLD + DFGLS+ ++ + GT YL PE
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSK----ANLTD---NKTTNTFCGTTEYLAPEVL 168
Query: 805 LTHK-LTDKSDVYSLGVVFLELLTGMQP 831
L K T D +SLGV+ E+ G P
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 7e-07
Identities = 67/266 (25%), Positives = 96/266 (36%), Gaps = 89/266 (33%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVK---------RAQEGSLQGEKEFLTEIQ- 672
++F S IG+G +G+V D G + A+K + Q ++ E++ L E
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 673 ------FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK---SKEPLGFAM 723
F S RNL L+ EF+ G + L K S+E F +
Sbjct: 61 AWVVKMFYSFQDKRNL-------------YLIMEFLPGGDMMTLLMKKDTLSEEATQFYI 107
Query: 724 RLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783
+ +L + HRDIK N+LLD K K++DFGL G+
Sbjct: 108 --------AETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLC--------TGL 151
Query: 784 VPAH--------------------------------------VSTVVKGTPGYLDPEYFL 805
AH STV GTP Y+ PE F+
Sbjct: 152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTV--GTPDYIAPEVFM 209
Query: 806 THKLTDKSDVYSLGVVFLELLTGMQP 831
D +SLGV+ E+L G P
Sbjct: 210 QTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 7e-07
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 30/214 (14%)
Query: 626 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHRN 681
+ S Q+G G YG V I G VA+K+ Q E K E+ L + H N
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSR-PFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 682 LVSLVGY------CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 735
++ L+ DE + LV +M + S++ + + + + G+
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQML-----CGL 130
Query: 736 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 795
Y+H+ + HRD+K N+ ++ K+ DFGL+R A ++ G V T
Sbjct: 131 KYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADA-EMTGYVV---------T 177
Query: 796 PGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTG 828
Y PE L +++ D++S+G + E+LTG
Sbjct: 178 RWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 9e-07
Identities = 35/89 (39%), Positives = 44/89 (49%), Gaps = 11/89 (12%)
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-- 805
HRDIK N+LLD ++ADFG S L + D G V S V GTP Y+ PE
Sbjct: 125 HRDIKPDNVLLDKNGHIRLADFG-SCLRLLAD--GTV---QSNVAVGTPDYISPEILQAM 178
Query: 806 ---THKLTDKSDVYSLGVVFLELLTGMQP 831
+ + D +SLGV E+L G P
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 32/95 (33%), Positives = 47/95 (49%), Gaps = 11/95 (11%)
Query: 734 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 793
GI +LH+ + HRD+K SNI++ T K+ DFGL+R A G VV
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA------GTSFMMTPYVV- 179
Query: 794 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG 828
T Y PE L + D++S+G + E++ G
Sbjct: 180 -TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 59/216 (27%), Positives = 87/216 (40%), Gaps = 16/216 (7%)
Query: 169 SLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKL 228
S +L+ +++ S E + L N N EL EL L
Sbjct: 64 SSLSRLLSLDLLSPSGISSLDGS-----ENLLNLLPLPSLDLNLNRLRSNISELLELTNL 118
Query: 229 LILQLDNNNFEGTTIPASYSNMSKLLK-LSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLN 287
L LDNNN T IP + LK L L + ++ L +PNL LDLS N L+
Sbjct: 119 TSLDLDNNNI--TDIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS 176
Query: 288 GSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 347
N+ + LS NK++ +P L L+ L ++NNS+ + SS+
Sbjct: 177 DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSL-----S 229
Query: 348 NATETFILDFQNNNLTNISGSFNIPPNV-TVRLRGN 382
N L+ NN L ++ S N+ T+ L N
Sbjct: 230 NLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNN 265
|
Length = 394 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 2e-06
Identities = 19/40 (47%), Positives = 23/40 (57%), Gaps = 5/40 (12%)
Query: 36 EVSALRSIKKSLVDDYS-KLSNWNR--GDPCTSNWTGVLC 72
+ AL + K SL D S LS+WN DPC +WTGV C
Sbjct: 4 DRDALLAFKSSLNGDPSGALSSWNPSSSDPC--SWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 52/228 (22%), Positives = 96/228 (42%), Gaps = 34/228 (14%)
Query: 631 QIGQGGYGKVYKGILPDG--TVVAVKRA-----QEGSLQGEKE-----FLTEIQFL-SRL 677
+G G +G VYK + ++A+K G + E++ ++E+ + +L
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 678 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA-KSK-----EPLGFAMRLSIALGS 731
H N+V E +V + + L + ++ K K E + + + + L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA- 125
Query: 732 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 791
+ YLH E + HRD+ +NI+L + DFGL++ P T
Sbjct: 126 ---LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ--------PESKLTS 172
Query: 792 VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 839
V GT Y PE +K+DV++ G + ++ T +QP + N++
Sbjct: 173 VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT-LQPPFYSTNML 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 31/209 (14%)
Query: 632 IGQGGYGKV---YKGILPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 685
IG G G V + +L G VAVK R + ++ + E+ L ++H+N++SL
Sbjct: 29 IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISL 85
Query: 686 VGY------CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
+ +E + LV E M + E + + + + GI +LH
Sbjct: 86 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLC-----GIKHLH 140
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
+ + HRD+K SNI++ T K+ DFGL+R A + + P V T Y
Sbjct: 141 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM--MTPYVV------TRYYR 189
Query: 800 DPEYFLTHKLTDKSDVYSLGVVFLELLTG 828
PE L + D++S+G + EL+ G
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 62/243 (25%), Positives = 99/243 (40%), Gaps = 37/243 (15%)
Query: 88 QLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
L L+LS N L + L L LD +N +S +PK + N+ +L L L+GN+++
Sbjct: 141 NLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS 199
Query: 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPS 203
LP L+ ++NNSI ++ LS L +
Sbjct: 200 -------------------------DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKN 233
Query: 204 LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263
L + L NN L LP + L L L L NN + +S +++ L +L L SL
Sbjct: 234 LSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQ---ISSISSLGSLTNLRELDLSGNSL 289
Query: 264 QGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRL 323
+P ++ + L L L+ ++ S+ + LSN + + P S L L
Sbjct: 290 SNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGET--SSPEALSILESL 347
Query: 324 QRL 326
L
Sbjct: 348 NNL 350
|
Length = 394 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 45/222 (20%)
Query: 632 IGQGGYGKVYKGILPDGTVV----------AVKRAQEGSLQGEKEFLT--EIQFLSRLHH 679
IG+G +G+V L + V +KRA+ + E++ L + Q+++ LH+
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 680 RNLVSLVGYCDEEGEQMLVYEFMSNG---TLRDQLSAKSKEPLG--FAMRLSIALGSSRG 734
+E LV ++ G TL + + E + + + IA+ S
Sbjct: 69 A--------FQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 735 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 794
+ Y+H RDIK NIL+D ++ADFG S L + D G V S+V G
Sbjct: 121 LHYVH---------RDIKPDNILMDMNGHIRLADFG-SCLKLMED--GTVQ---SSVAVG 165
Query: 795 TPGYLDPEYFLTH-----KLTDKSDVYSLGVVFLELLTGMQP 831
TP Y+ PE K + D +SLGV E+L G P
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 29/103 (28%), Positives = 46/103 (44%), Gaps = 11/103 (10%)
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK--- 793
YLH + HRD+K N+L+ K+ DFGLS++ + + H+ +
Sbjct: 116 YLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172
Query: 794 -----GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
GTP Y+ PE L D +++G++ E L G P
Sbjct: 173 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 59/229 (25%), Positives = 97/229 (42%), Gaps = 40/229 (17%)
Query: 625 NFNSSTQIGQGGYGKVY---------------KGILPDGTVVAVKRAQEGSLQGEKEFLT 669
NF +G G YGKV+ +L T+V + E + + E++ L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHT-RTERQVLE 59
Query: 670 EIQ---FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS 726
I+ FL LH+ + + L+ ++++ G L LS + + F +
Sbjct: 60 HIRQSPFLVTLHYA--------FQTDTKLHLILDYINGGELFTHLSQRER----FKEQ-E 106
Query: 727 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 786
+ + S +L L + +RDIK NILLD + DFGLS+ ++E
Sbjct: 107 VQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVER---- 162
Query: 787 HVSTVVKGTPGYLDPEYFLTHKLT-DKS-DVYSLGVVFLELLTGMQPIS 833
+ GT Y+ P+ DK+ D +S+GV+ ELLTG P +
Sbjct: 163 --AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 6e-06
Identities = 37/119 (31%), Positives = 55/119 (46%), Gaps = 17/119 (14%)
Query: 718 PLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777
PL L + ++G+ +L A HRD+ A N+LL AK+ DFGL+R
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR---- 260
Query: 778 PDIEGIVPAHVSTVVKGTP----GYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
DI + VVKG ++ PE T +SDV+S G++ E+ + G P
Sbjct: 261 -DIMN----DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 7e-06
Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 41/220 (18%)
Query: 626 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNL 682
+ + + +G G YG V G VAVK+ S+ K E++ L + H N+
Sbjct: 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 78
Query: 683 VSLVGY------CDEEGEQMLVYEFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSS 732
+ L+ +E + LV M N ++ Q L+ + L + +
Sbjct: 79 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL-------- 130
Query: 733 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 792
RG+ Y+H+ AD + HRD+K SN+ ++ K+ DFGL+R H +
Sbjct: 131 RGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEM 174
Query: 793 KG---TPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTG 828
G T Y PE L +++ D++S+G + ELLTG
Sbjct: 175 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-06
Identities = 65/225 (28%), Positives = 94/225 (41%), Gaps = 33/225 (14%)
Query: 625 NFNSSTQIGQGGYGKVY---KGILPD-GTVVAVKRAQEGSL-QGEK---EFLTEIQFLSR 676
NF +G G YGKV+ K D G + A+K Q+ +L Q K TE L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 677 LHHRN-LVSLVGYCDEEGEQMLVYEFMSNGTL------RDQLSAKSKEPLGFAMRLSIAL 729
+ LV+L E + L+ +++S G + RD S + L++
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 730 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 789
GI+Y RDIK NILLD + + DFGLS+ + E +
Sbjct: 121 LHKLGIVY-----------RDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER------T 163
Query: 790 TVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPIS 833
GT Y+ PE K+ D +SLG++ ELLTG P +
Sbjct: 164 YSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFT 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 9e-06
Identities = 39/143 (27%), Positives = 66/143 (46%), Gaps = 26/143 (18%)
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 748
+Q + E + D+L+ +++ L F+ +++ +G+ +L A H
Sbjct: 191 SGSYIDQDVTSEILEE----DELALDTEDLLSFSYQVA------KGMSFL---ASKNCIH 237
Query: 749 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP----GYLDPEYF 804
RD+ A NILL H K+ DFGL+R DI + VVKG ++ PE
Sbjct: 238 RDLAARNILLTHGRITKICDFGLAR-----DIRN----DSNYVVKGNARLPVKWMAPESI 288
Query: 805 LTHKLTDKSDVYSLGVVFLELLT 827
T +SDV+S G++ E+ +
Sbjct: 289 FNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 32/124 (25%), Positives = 46/124 (37%), Gaps = 40/124 (32%)
Query: 748 HRDIKASNILLDHKFTAKVADFGLS-------------RL-------APVPDIEGIVPAH 787
HRDIK NIL+D K++DFGLS +L + + +
Sbjct: 124 HRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDS 183
Query: 788 VSTVVK--------------------GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 827
++ + GTP Y+ PE FL + D +SLG + E L
Sbjct: 184 INLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLI 243
Query: 828 GMQP 831
G P
Sbjct: 244 GWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 37/126 (29%), Positives = 62/126 (49%), Gaps = 8/126 (6%)
Query: 624 NNFNSSTQIGQGGYGKVYK----GILPDGTV--VAVKRAQEGSLQGEKEFL-TEIQFLSR 676
+N +G G +GKV + G+ + V VAVK + + E+E L +E++ LS
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 677 L-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 735
L H+N+V+L+G C G +++ E+ G L + L K++ L F M L +S
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDY 157
Query: 736 LYLHTE 741
+ E
Sbjct: 158 KNITLE 163
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 37/214 (17%)
Query: 630 TQIGQGGYGKVYKGILPDGTV---VAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVS 684
T +G G YG V D + VAVK+ SL + E++ L + H N++
Sbjct: 21 TPVGSGAYGSVCSAY--DTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIG 78
Query: 685 LVGY------CDEEGEQMLVYEFMS---NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 735
L+ + E LV M N ++ Q S E + F + + RG+
Sbjct: 79 LLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQ--KLSDEHVQFLIYQLL-----RGL 131
Query: 736 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 795
Y+H+ + HRD+K SN+ ++ ++ DFGL+R A ++ G V T
Sbjct: 132 KYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQAD-DEMTGYV---------AT 178
Query: 796 PGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTG 828
Y PE L +++ D++S+G + ELL G
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-05
Identities = 38/119 (31%), Positives = 55/119 (46%), Gaps = 13/119 (10%)
Query: 279 LDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI 337
L L + L G IP L ++ +I LS N + G IP + + L+ L ++ NS +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 338 PSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVR-LRGNPFCLNTNAEQFCG 395
P S+ Q +L IL+ N+L S +P + R L F NA CG
Sbjct: 483 PESLGQLTSLR-----ILNLNGNSL-----SGRVPAALGGRLLHRASFNFTDNA-GLCG 530
|
Length = 623 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 40/134 (29%), Positives = 62/134 (46%), Gaps = 18/134 (13%)
Query: 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 758
Y+ ++ +++ LS E L LS +RG+ +L A HRD+ A N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLL 270
Query: 759 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV-KGTP----GYLDPEYFLTHKLTDKS 813
K+ DFGL+R DI H S V KG+ ++ PE + T S
Sbjct: 271 AQGKIVKICDFGLAR-----DI-----MHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLS 320
Query: 814 DVYSLGVVFLELLT 827
DV+S G++ E+ +
Sbjct: 321 DVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 44/153 (28%), Positives = 68/153 (44%), Gaps = 24/153 (15%)
Query: 688 YCDEEGEQML--VYEFMSNGTLRDQLS---AKSKEPLGFAMRLSIALGSSRGILYLHTEA 742
+C + ++ L V E+M G L + +S K + + +AL + +H+
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDA------IHSMG 162
Query: 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
+ HRD+K N+LLD K+ADFG D G+V T V GTP Y+ PE
Sbjct: 163 ---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM---DETGMV--RCDTAV-GTPDYISPE 213
Query: 803 YFLTHK----LTDKSDVYSLGVVFLELLTGMQP 831
+ + D +S+GV E+L G P
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 36/122 (29%), Positives = 54/122 (44%), Gaps = 19/122 (15%)
Query: 716 KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-L 774
K+ L + + ++G+ +L A HRD+ A NILL K+ DFGL+R +
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDI 229
Query: 775 APVPDIEGIVPAHVSTVVKGTP----GYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GM 829
PD V KG ++ PE T +SDV+S GV+ E+ + G
Sbjct: 230 YKDPDY----------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 279
Query: 830 QP 831
P
Sbjct: 280 SP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 38/122 (31%), Positives = 55/122 (45%), Gaps = 19/122 (15%)
Query: 716 KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-L 774
K PL + + +RG+ +L A HRD+ A NILL K+ DFGL+R +
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDI 224
Query: 775 APVPDIEGIVPAHVSTVVKGTP----GYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GM 829
PD V KG+ ++ PE T +SDV+S GV+ E+ + G
Sbjct: 225 YKDPDY----------VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGA 274
Query: 830 QP 831
P
Sbjct: 275 SP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 48/205 (23%), Positives = 87/205 (42%), Gaps = 27/205 (13%)
Query: 632 IGQGGYGKV---YKGILPDGTVVA-VKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
IG G G V Y +L + + R + ++ + E+ + ++H+N++SL+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISLLN 83
Query: 688 Y------CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+E + LV E M + E + + + + GI +LH+
Sbjct: 84 VFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSA 138
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
+ HRD+K SNI++ T K+ DFGL+R A + + T T Y P
Sbjct: 139 G---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--------SFMMTPYVVTRYYRAP 187
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELL 826
E L + D++S+G + E++
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 5e-05
Identities = 33/120 (27%), Positives = 46/120 (38%), Gaps = 36/120 (30%)
Query: 748 HRDIKASNILLDHKFTAKVADFGL---------SR------------LAPVPDIEGIVPA 786
HRDIK NIL+D K+ DFGL S+ + P + I
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRC 183
Query: 787 HVSTVVK---------------GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
+ + + GTP Y+ PE L T D +S+GV+ E+L G P
Sbjct: 184 RLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 36/135 (26%), Positives = 65/135 (48%), Gaps = 12/135 (8%)
Query: 632 IGQGGYGKVYKGI---LPDG-----TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 683
+GQG + K++KGI + D T V +K + + F +S+L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
G C E ++V E++ G+L D K+K + + +L +A + + +L D
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSL-DTYLKKNKNLINISWKLEVAKQLAWALHFLE---D 118
Query: 744 PPVFHRDIKASNILL 758
+ H ++ A N+LL
Sbjct: 119 KGLTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 6e-05
Identities = 22/65 (33%), Positives = 33/65 (50%), Gaps = 5/65 (7%)
Query: 298 NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDF 357
N+ ++ LSNN+LT F GLP L+ L ++ N+L+ P + +L LD
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSL-----RSLDL 55
Query: 358 QNNNL 362
NNL
Sbjct: 56 SGNNL 60
|
Length = 60 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-05
Identities = 32/95 (33%), Positives = 47/95 (49%), Gaps = 11/95 (11%)
Query: 734 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 793
GI +LH+ + HRD+K SNI++ T K+ DFGL+R A G VV
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA------GTSFMMTPYVV- 187
Query: 794 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG 828
T Y PE L + D++S+G + E++ G
Sbjct: 188 -TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 9/95 (9%)
Query: 632 IGQGGYGKVYK----GILPDGT--VVAVKRAQEGSLQGE-KEFLTEIQFLSRL-HHRNLV 683
+G+G +G+V + GI T VAVK +EG+ E + ++E++ L + HH N+V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 684 SLVGYCDEE-GEQMLVYEFMSNGTLRDQLSAKSKE 717
+L+G C + G M++ EF G L + L +K E
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGE 109
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 1e-04
Identities = 28/63 (44%), Positives = 37/63 (58%), Gaps = 7/63 (11%)
Query: 275 NLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIAN 330
NL LDLS+N+L IP G L N+ + LS N LT +I FSGLP L+ L ++
Sbjct: 1 NLKSLDLSNNRL-TVIPDGAFKGLP-NLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSG 57
Query: 331 NSL 333
N+L
Sbjct: 58 NNL 60
|
Length = 60 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 59/226 (26%), Positives = 106/226 (46%), Gaps = 32/226 (14%)
Query: 632 IGQGGYGKVYKGILPDGT-VVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY-- 688
IG G +G VY+ I D + VA+K+ LQ + E+ + L+H N++ L Y
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKV----LQDPQYKNRELLIMKNLNHINIIFLKDYYY 129
Query: 689 --CDEEGEQML----VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGS---SRGILYLH 739
C ++ E+ + V EF+ T+ + ++ + L + L S R + Y+H
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFL-VKLYSYQLCRALAYIH 187
Query: 740 TEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
++ + HRD+K N+L+D + T K+ DFG ++ ++ S + Y
Sbjct: 188 SKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAK--------NLLAGQRSVSYICSRFY 236
Query: 799 LDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVL 843
PE L T D++SLG + E++ G PI G++ V +++
Sbjct: 237 RAPELMLGATNYTTHIDLWSLGCIIAEMILGY-PIFSGQSSVDQLV 281
|
Length = 440 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 41/154 (26%), Positives = 60/154 (38%), Gaps = 25/154 (16%)
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLG----FAMRLSIALGSSRGIL 736
N+V L Y E LV + G L +S P +A + +AL +
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFG-LSRLAPVPDIEGIVPAHVSTVVKGT 795
LH E + RD+ +NILLD + ++ F S + D E +
Sbjct: 101 -LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAV-----------E 145
Query: 796 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGM 829
Y PE + T+ D +SLG + ELLTG
Sbjct: 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 40/191 (20%), Positives = 65/191 (34%), Gaps = 34/191 (17%)
Query: 193 QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSK 252
+ L PSL + L N E +P+ L L +
Sbjct: 42 ALASALRPQPSLKELCLSLN--------ETGRIPRGLQSLLQG-----------LTKGCG 82
Query: 253 LLKLSLRNCSLQ----GPMPDLSRIPNLGYLDLSSNQLNGSIPP------GRLSLNITTI 302
L +L L + +L G + L R +L L L++N L L + +
Sbjct: 83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKL 142
Query: 303 KLSNNKLTGT----IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQ 358
L N+L G + L+ L +ANN + + ++ + N +LD
Sbjct: 143 VLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKAN-CNLEVLDLN 201
Query: 359 NNNLTNISGSF 369
NN LT+ S
Sbjct: 202 NNGLTDEGASA 212
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 52/198 (26%), Positives = 82/198 (41%), Gaps = 23/198 (11%)
Query: 646 PDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703
P GT+V V+ + E K E+ H N+++ ++ FM+
Sbjct: 23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82
Query: 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 763
G+ L E + A+ +I G+ RG+ YLH HR+IKAS+IL
Sbjct: 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHIL------ 133
Query: 764 AKVADFGLSRLAPVPDIEGIVP-AHVSTVVKGTPGY-------LDPEYFLT--HKLTDKS 813
++ GL L+ + + +V + VV P + L PE + KS
Sbjct: 134 --ISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKS 191
Query: 814 DVYSLGVVFLELLTGMQP 831
D+YS+G+ EL TG P
Sbjct: 192 DIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 55/212 (25%), Positives = 85/212 (40%), Gaps = 33/212 (15%)
Query: 632 IGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ---------GEKEFLTEIQFLSRLHHRN 681
+GQG + +YKG+L + V QE S+ F +S+L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
LV L G C + M V E++ G L D + K + +L +A + + YL
Sbjct: 63 LVKLYGVCVRDENIM-VEEYVKFGPL-DVFLHREKNNVSLHWKLDVAKQLASALHYLE-- 118
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGT 795
D + H ++ NIL VA +GL VP I+ I V+
Sbjct: 119 -DKKLVHGNVCGKNIL--------VARYGL-NEGYVPFIKLSDPGIPITVLSREERVERI 168
Query: 796 PGYLDPEYF--LTHKLTDKSDVYSLGVVFLEL 825
P ++ PE LT +D +S G LE+
Sbjct: 169 P-WIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 3e-04
Identities = 58/248 (23%), Positives = 93/248 (37%), Gaps = 48/248 (19%)
Query: 626 FNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLH 678
F +G+G G+V+ KG G + A+K + + + LTE + L+ L
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD 59
Query: 679 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLG------FAMRLSIALGSS 732
H L +L E LV ++ G L L + + L +A + +AL
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALE-- 117
Query: 733 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD--IEGIVPAHVS- 789
YLH + +RD+K NILL ++DF LS+ + V + +
Sbjct: 118 ----YLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170
Query: 790 ---------TVVK----------GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQ 830
T + GT Y+ PE D ++LG++ E+L G
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTT 230
Query: 831 PISHGKNI 838
P G N
Sbjct: 231 PFK-GSNR 237
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 30/88 (34%), Positives = 42/88 (47%), Gaps = 10/88 (11%)
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
HRD+K N+LLD K+ADFG + EG+V + GTP Y+ PE +
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKM---NKEGMVRCDTAV---GTPDYISPEVLKSQ 218
Query: 808 K----LTDKSDVYSLGVVFLELLTGMQP 831
+ D +S+GV E+L G P
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 4e-04
Identities = 15/60 (25%), Positives = 27/60 (45%)
Query: 155 KLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNL 214
L + + N ++ +F L + ++ N+++ P S LPSL + L NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 49/178 (27%), Positives = 69/178 (38%), Gaps = 18/178 (10%)
Query: 651 VAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQ 710
V +K Q G TE L ++H +++ L G L+ L
Sbjct: 120 VVIKAGQRGGT------ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCY 172
Query: 711 LSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 770
L+AK + L+I R I YLH + HRDIKA NI ++H + DFG
Sbjct: 173 LAAKRNIAI--CDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFG 227
Query: 771 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG 828
+ PV DI A+ GT PE D++S G+V E+ T
Sbjct: 228 -AACFPV-DIN----ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 7e-04
Identities = 28/89 (31%), Positives = 43/89 (48%), Gaps = 4/89 (4%)
Query: 296 SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 355
S + +I LS ++G I S LP +Q + ++NN LSG IP I+ + ++ L
Sbjct: 68 SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTT----SSSLRYL 123
Query: 356 DFQNNNLTNISGSFNIPPNVTVRLRGNPF 384
+ NNN T +IP T+ L N
Sbjct: 124 NLSNNNFTGSIPRGSIPNLETLDLSNNML 152
|
Length = 968 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 0.001
Identities = 46/163 (28%), Positives = 69/163 (42%), Gaps = 26/163 (15%)
Query: 670 EIQFLSRLHHRNLVSLVGYCDEEGEQMLVY-EFMSNGTLRDQLSAKSKEPLGFAMRLSIA 728
E + L RL H +++L+ G LV ++ S+ L L A+ + PLG A ++A
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSD--LYTYLGARLR-PLGLAQVTAVA 266
Query: 729 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL------SRLAPVP-DIE 781
I Y+H E + HRDIK N+L++ + DFG S P I
Sbjct: 267 RQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA 323
Query: 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLE 824
G V + V+ G P T D++S G+V E
Sbjct: 324 GTVDTNAPEVLAGDP------------YTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.002
Identities = 16/61 (26%), Positives = 32/61 (52%), Gaps = 2/61 (3%)
Query: 131 SLELLLLNGNELTGSLPEE-LGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNS 189
+L+ L L+ N LT +P+ LP L + + N ++ P++F+ L R ++ N+
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 190 I 190
+
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.002
Identities = 47/186 (25%), Positives = 71/186 (38%), Gaps = 32/186 (17%)
Query: 131 SLELLLLNGNELTGS----LPEELGYL-PKLDRIQIDQNYISG----SLPKSFANLNKTR 181
SL+ L LN N L L + L L P L+++ + +N + G +L K+ +
Sbjct: 109 SLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLK 168
Query: 182 HFHMNNNSISGQ----IPPELSRLPSLVHMLLDNNNLT----GYLPPELSELPKLLILQL 233
++ NN I + L +L + L+NN LT L L+ L L +L L
Sbjct: 169 ELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNL 228
Query: 234 DNNNFEGTTI----PASYSNMSKLLKLSLRNC--------SLQGPMPDLSRIPNLGYLDL 281
+NN A S LL LSL L + + +L LDL
Sbjct: 229 GDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEK---ESLLELDL 285
Query: 282 SSNQLN 287
N+
Sbjct: 286 RGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 54/201 (26%), Positives = 79/201 (39%), Gaps = 29/201 (14%)
Query: 646 PDGTVVAVKRAQEGSLQGEK-EFL-TEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703
P G V V+R + E FL E+ +H N+V + E +V FM+
Sbjct: 23 PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82
Query: 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 763
G+ +D + + + I G + + Y+H HR +KAS+IL+
Sbjct: 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILI--SVD 137
Query: 764 AKVADFGL----------SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT--- 810
KV GL RL V D P + V+ +L PE L L
Sbjct: 138 GKVYLSGLRSNLSMINHGQRLRVVHDF----PKYSVKVLP----WLSPE-VLQQNLQGYD 188
Query: 811 DKSDVYSLGVVFLELLTGMQP 831
KSD+YS+G+ EL G P
Sbjct: 189 AKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 0.003
Identities = 26/85 (30%), Positives = 35/85 (41%), Gaps = 12/85 (14%)
Query: 748 HRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 806
H DIK N+L D K + D+GL + + GT Y PE
Sbjct: 132 HNDIKLENVLYDRAKDRIYLCDYGLCK-----------IIGTPSCYDGTLDYFSPEKIKG 180
Query: 807 HKLTDKSDVYSLGVVFLELLTGMQP 831
H D +++GV+ ELLTG P
Sbjct: 181 HNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 845 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.98 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.98 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.98 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.98 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.98 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.98 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.98 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.98 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.98 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.98 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.98 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.98 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.98 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.96 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.96 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.95 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.95 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.94 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.94 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.93 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.91 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.91 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.91 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.88 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.84 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.83 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.8 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.79 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.78 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.76 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.76 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.72 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.71 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.71 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.66 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.65 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.59 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.56 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.45 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.42 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.41 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.39 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.38 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.34 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.27 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.26 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.22 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.2 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.17 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.17 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.15 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.15 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.15 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.14 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.14 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.13 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.13 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.12 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.1 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.08 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.04 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.03 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.02 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.98 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.97 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.95 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.91 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.86 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.79 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.74 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.73 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.7 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.68 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.65 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.63 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.57 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.53 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.5 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.47 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.46 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.44 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.36 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.36 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-72 Score=701.84 Aligned_cols=190 Identities=28% Similarity=0.493 Sum_probs=163.9
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcC
Q 003140 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 702 (845)
..|...+.||+|+||.||+|.. .+|..||||+++..... ..+|++.+++++|||||+++|+|.+.+..++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4577888999999999999996 57899999998753322 234688999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCC
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 782 (845)
++|+|.++++. ++|..+.+|+.|+|+||+|||..++++|+||||||+||+++.++.+++. ||.+.....
T Consensus 766 ~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----- 834 (968)
T PLN00113 766 EGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----- 834 (968)
T ss_pred CCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence 99999999953 7899999999999999999997766779999999999999999988876 665543211
Q ss_pred ccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
.....+|.+|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 835 ------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 835 ------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred ------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 1123578999999999999999999999999999999999999853
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=410.51 Aligned_cols=220 Identities=59% Similarity=0.980 Sum_probs=196.3
Q ss_pred CccccchHHHHHHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEE
Q 003140 610 GVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689 (845)
Q Consensus 610 ~~~~~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~ 689 (845)
....|++.++..+|++|...+.||+|+||.||+|.+++|+.||||++.....+..++|.+|++++++++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999988765433156799999999999999999999999
Q ss_pred eeCC-eEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEe
Q 003140 690 DEEG-EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 768 (845)
Q Consensus 690 ~~~~-~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~D 768 (845)
.+.+ +.+||||||++|+|.++|+.....+++|.+|++||.++|+||+|||+.++|+||||||||+|||+|+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9998 599999999999999999886543899999999999999999999999999999999999999999999999999
Q ss_pred cCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 769 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 769 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
||+|+..+... ....+...||.+|+|||++..+..+.|+|||||||+++|++||+.|.+..
T Consensus 221 FGLa~~~~~~~------~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 221 FGLAKLGPEGD------TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred ccCcccCCccc------cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 99997654210 11111117999999999999999999999999999999999999988743
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=364.04 Aligned_cols=198 Identities=30% Similarity=0.530 Sum_probs=180.1
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
.++|...+.||+|+||+||+|++. ++..||||.+... ..+..+-...|+++|+.++|||||.+++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 357888888999999999999975 6899999998765 4555667899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC------CcEEEEecCCcc
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK------FTAKVADFGLSR 773 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~------~~~kl~DFGla~ 773 (845)
|||.+|+|.+|++..+ .+++...+.++.|+|.||++||+++ ||||||||.|||++.. -.+||+|||+||
T Consensus 89 EyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999998764 6899999999999999999999999 9999999999999765 468999999999
Q ss_pred cCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003140 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833 (845)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~ 833 (845)
.+.. .....+.+|++-|||||+++..+|+.|+|+||.|+++|||++|+.||.
T Consensus 164 ~L~~--------~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~ 215 (429)
T KOG0595|consen 164 FLQP--------GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD 215 (429)
T ss_pred hCCc--------hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence 8863 334456789999999999999999999999999999999999999997
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=365.22 Aligned_cols=204 Identities=41% Similarity=0.618 Sum_probs=178.1
Q ss_pred CCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhh--HHHHHHHHHHHHhcCCCceeeEEEEEeeCC-eEEEEEEc
Q 003140 625 NFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGYCDEEG-EQMLVYEF 701 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~--~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~LV~E~ 701 (845)
.+...+.||+|+||+||+|.+.....||||++....... .++|.+|+.+|++++|||||+|+|+|.+.. ..++||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 344455699999999999999655559999998644332 568999999999999999999999999887 79999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEEecCCcccCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~-~~kl~DFGla~~~~~~~~ 780 (845)
|++|+|.++++......+++..++.++.|||+||+|||+++. ||||||||+|||++.++ ++||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 999999999988656789999999999999999999999874 99999999999999997 99999999998754211
Q ss_pred CCccccceeecccCCCCccchhhhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFL--THKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
...+...||+.|||||++. ...|+.|+|||||||++|||+||+.||.....
T Consensus 199 ------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 199 ------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred ------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 2233468999999999999 66999999999999999999999999987664
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=340.70 Aligned_cols=196 Identities=31% Similarity=0.455 Sum_probs=175.5
Q ss_pred CCCCccccccCceEEEEEEeC-CCcEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-eEEEEEEcC
Q 003140 626 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG-EQMLVYEFM 702 (845)
Q Consensus 626 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~LV~E~~ 702 (845)
.+..+.||+|..|+|||+.++ +++.+|+|.+... .....+++.+|++++++.+||+||++||.|.... +..++||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 344678999999999999976 6899999998543 3445689999999999999999999999999988 599999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
++|||++++... +++++...-+|+.++++||.|||+ .+ ||||||||+|||++..|++||+|||.++.+.+.
T Consensus 161 DgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 161 DGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred CCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 999999999764 568999999999999999999996 55 999999999999999999999999999876422
Q ss_pred CccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
...+.+||..|||||.+.+..|+.++||||||++++|+.+|+.||...
T Consensus 233 ------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 233 ------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred ------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 345678999999999999999999999999999999999999999764
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=338.38 Aligned_cols=203 Identities=27% Similarity=0.430 Sum_probs=180.7
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
..++|++.++||+|+||+||.++.. +++.+|+|++++... ...+....|..+|.+++||.||+++..|++.+..||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3578999999999999999999965 689999999876432 234667899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
|+||+.||.|..+|+++ ..+++....-++..|+.||.|||+.+ ||||||||+|||+|++|+++|+|||+++....
T Consensus 103 Vld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999999765 35888888889999999999999999 99999999999999999999999999985432
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
. +....+.+||+.|||||++.+..|+.++|+||+|+++|||++|..||...+
T Consensus 178 ~-------~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~ 229 (357)
T KOG0598|consen 178 D-------GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED 229 (357)
T ss_pred C-------CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence 2 233455899999999999999999999999999999999999999997654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=353.84 Aligned_cols=200 Identities=27% Similarity=0.493 Sum_probs=181.9
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
.+|...+.||+|||+.||+++. ..|+.||+|++.... ....+...+|+++.++|+|||||+|+++|++.+.+|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688889999999999999997 789999999987632 233457889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
|+|++|+|..+++ ..+++++..++.+..||+.||.|||+.+ |||||||-.|+|+++++++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~- 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD- 171 (592)
T ss_pred EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc-
Confidence 9999999999996 4567999999999999999999999999 999999999999999999999999999887543
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.....+..||+.|+|||++.....+..+||||+|||||.|+.|+.||+..
T Consensus 172 ------~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk 221 (592)
T KOG0575|consen 172 ------GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK 221 (592)
T ss_pred ------ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc
Confidence 24456789999999999999999999999999999999999999999753
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=355.38 Aligned_cols=209 Identities=33% Similarity=0.533 Sum_probs=183.0
Q ss_pred hHHHHHHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeE
Q 003140 616 YGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (845)
Q Consensus 616 ~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 695 (845)
.+.+++....+...+.||+|.||.||.|.+.....||||.++.... ..++|.+|+++|++++|++||+++|+|..++..
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 4445555555666789999999999999998778999999988643 456899999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
+||||||+.|+|.+||+...+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||+||..
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEccccccccc
Confidence 99999999999999999877788999999999999999999999999 999999999999999999999999999955
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 834 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~ 834 (845)
.+..+. ......-.+.|.|||.+..+.++.|||||||||+||||+| |+.|+..
T Consensus 354 ~d~~Y~------~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ 407 (468)
T KOG0197|consen 354 GDDEYT------ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG 407 (468)
T ss_pred CCCcee------ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC
Confidence 433221 1222334578999999999999999999999999999999 9999864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=328.59 Aligned_cols=204 Identities=30% Similarity=0.483 Sum_probs=177.4
Q ss_pred cCCCCCccccccCceEEEEEE-eCCCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEE-EEeeCCe-EEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVG-YCDEEGE-QMLV 698 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g-~~~~~~~-~~LV 698 (845)
.+|.+.++||+|.||+|||+. ..+|..||.|.++-. ..+..++...|+.+|++++|||||++++ -+.++.+ .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 457778899999999999998 568999999988743 3344567899999999999999999998 4444444 8999
Q ss_pred EEcCCCCCHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003140 699 YEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPP--VFHRDIKASNILLDHKFTAKVADFGLSRL 774 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--iiHrDLk~~NILl~~~~~~kl~DFGla~~ 774 (845)
|||+.+|+|..+++. ...+.+++...+++..|+++||..+|.+- ++ |+||||||.||+++.+|.+|++|||++++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999999976 45567999999999999999999999843 33 88999999999999999999999999998
Q ss_pred CCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
+... .......+||+.||+||.+....|+.||||||+||++|||..-+.||.+.
T Consensus 178 l~s~-------~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~ 231 (375)
T KOG0591|consen 178 LSSK-------TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD 231 (375)
T ss_pred hcch-------hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence 7532 23345678999999999999999999999999999999999999999764
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=338.22 Aligned_cols=202 Identities=28% Similarity=0.476 Sum_probs=173.4
Q ss_pred HhcCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCChh-------hHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ-------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 693 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~-------~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~ 693 (845)
..+.|-+.+.||+|+||.|-+|.. .+|+.||||+++..... ......+|+++|++++|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 346678889999999999999985 47999999998753211 2334679999999999999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CcEEEEecC
Q 003140 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK---FTAKVADFG 770 (845)
Q Consensus 694 ~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~---~~~kl~DFG 770 (845)
..|||||||+||+|.+.+-.+. .+.+..-..++.|++.|+.|||++| |+||||||+|||++.+ ..+||+|||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 9999999999999999886543 4666777889999999999999999 9999999999999766 789999999
Q ss_pred CcccCCCCCCCCccccceeecccCCCCccchhhhcCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 771 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 771 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
+|+.... .....+.+||+.|.|||++.+.. +..+.|+||+||++|-+++|..||...-
T Consensus 325 lAK~~g~--------~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~ 385 (475)
T KOG0615|consen 325 LAKVSGE--------GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY 385 (475)
T ss_pred hhhcccc--------ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc
Confidence 9998652 45567889999999999997653 3448899999999999999999997543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=358.58 Aligned_cols=209 Identities=32% Similarity=0.521 Sum_probs=181.6
Q ss_pred HHHHHhcCCCCCccccccCceEEEEEEeC------CCcEEEEEEccCCChh-hHHHHHHHHHHHHhcCCCceeeEEEEEe
Q 003140 618 EMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCD 690 (845)
Q Consensus 618 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~ 690 (845)
..+....+....+.||+|+||+||+|... +...||||.+++.... ..++|.+|+++++.++|||||+|+|.|.
T Consensus 480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR 559 (774)
T ss_pred eeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence 33445556667889999999999999843 3568999999986555 6789999999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCCHHHHHhccC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 003140 691 EEGEQMLVYEFMSNGTLRDQLSAKS------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 758 (845)
Q Consensus 691 ~~~~~~LV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl 758 (845)
+++.++||+|||.+|||.+||+... ..+++..+.+.||.|||.||+||-++. +|||||..+|+||
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLV 636 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLV 636 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhcee
Confidence 9999999999999999999996531 223889999999999999999999998 9999999999999
Q ss_pred cCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 003140 759 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 834 (845)
Q Consensus 759 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~ 834 (845)
.++..|||+|||++|.....|+..... ...-.++||+||.++.++|+.+||||||||+|||+++ |+.||.+
T Consensus 637 ge~l~VKIsDfGLsRdiYssDYYk~~~-----~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~g 708 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDYYKVRG-----NTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYG 708 (774)
T ss_pred ccceEEEecccccchhhhhhhhhcccC-----CceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccc
Confidence 999999999999999887666553221 1123479999999999999999999999999999999 9999975
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=335.55 Aligned_cols=205 Identities=30% Similarity=0.446 Sum_probs=175.7
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CeEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQML 697 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~L 697 (845)
.+.|+..+.||+|.||.||||+. .+|+.||+|++.... .....-..+||.+|++++||||++|.+...+. ...||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 35577788999999999999994 579999999987543 33345678999999999999999999998776 68999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
|+|||++ ||.-++.. ..-.++..++..++.|++.||+|+|+++ |+|||||.+|||||.+|.+||+|||||+++..
T Consensus 196 VFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 9999975 77777754 3456999999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCc
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 838 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~ 838 (845)
.. ....+..+-|.+|+|||++.+ ..|+.++|+||.||||.||++|+..|.+..++
T Consensus 271 ~~------~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv 326 (560)
T KOG0600|consen 271 SG------SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV 326 (560)
T ss_pred CC------CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH
Confidence 32 223566678999999999987 47999999999999999999999888766553
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=309.82 Aligned_cols=199 Identities=25% Similarity=0.389 Sum_probs=179.5
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhh---HHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~---~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|+..+.||.|+||+|..++.+ +|..+|+|+++....-. .+...+|-.+|+.+.||+++++++.+.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 56778899999999999999965 68999999998654333 345678999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||++||.|.+++++. .++++...+-+|.+|+.||+|||+.+ |++|||||+|||+|.+|.+||+|||.|+....
T Consensus 124 eyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-- 196 (355)
T ss_pred eccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC--
Confidence 999999999999764 46899999999999999999999999 99999999999999999999999999987632
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
...+.+||+.|+|||.+.+..|..++|.|||||++|||+.|..||.....
T Consensus 197 --------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 197 --------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred --------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 25678999999999999999999999999999999999999999976543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=314.46 Aligned_cols=201 Identities=28% Similarity=0.428 Sum_probs=171.8
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
+.|+...++|+|+||.|||++.+ +|+.||||++.+... .-.+-.++|+++|++++|+|+|.++++|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 45777889999999999999976 599999999986443 224567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
||+.--|++ |.+. ...++.....+++.|+++|+.|+|+++ ||||||||+|||++.++.+|++|||.||.+..+
T Consensus 82 ~~dhTvL~e-Le~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-- 154 (396)
T KOG0593|consen 82 YCDHTVLHE-LERY-PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP-- 154 (396)
T ss_pred ecchHHHHH-HHhc-cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC--
Confidence 998654444 3332 234788999999999999999999999 999999999999999999999999999987532
Q ss_pred CCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
+...+..+.|.+|+|||.+.+ ..|+..+||||.||++.||++|..-|-+..
T Consensus 155 -----gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S 206 (396)
T KOG0593|consen 155 -----GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS 206 (396)
T ss_pred -----cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc
Confidence 334566778999999999987 789999999999999999999986554433
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=331.70 Aligned_cols=210 Identities=25% Similarity=0.377 Sum_probs=180.1
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCChhh---HHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~---~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~L 697 (845)
..+|...+.||+|+|++|++|+. ..++.+|||++.+.-.-. .+-...|-.+|.+| .||.|++|+-.|.++...|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 35677788999999999999995 468999999986543222 23456788899999 89999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
|+||+++|+|.++|++. ..+++...+.++.+|+.||+|||++| ||||||||+|||+|+||++||+|||.|+.+..
T Consensus 152 vLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 99999999999999876 46899999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCC-----cc-ccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 778 PDIEG-----IV-PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 778 ~~~~~-----~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
..... .. ........+||..|++||++.+...++.+|+|+|||++|+|+.|+.||....+
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne 292 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE 292 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH
Confidence 32220 00 01112568999999999999999999999999999999999999999987654
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=304.41 Aligned_cols=206 Identities=30% Similarity=0.497 Sum_probs=178.7
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCChhh--HHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~--~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
++|...+.+|+|.||.||+|++ .+|+.||||+++.....+ .....+|++.|+.++|+||+.++++|...+..-||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4677788999999999999995 579999999998654332 3467899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
||+ -+|+..+++. ...+.......++.++++|++|+|++. |+||||||.|+|++++|.+||+|||+|+....++
T Consensus 82 fm~-tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~- 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN- 155 (318)
T ss_pred ecc-ccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC-
Confidence 996 6999999764 457899999999999999999999999 9999999999999999999999999999887554
Q ss_pred CCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCceecc
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 842 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~ 842 (845)
...+..+-|.+|+|||.+.+ ..|+...||||.||++.||+-| .||..|+.+++++
T Consensus 156 ------~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr-~P~fpG~sDidQL 211 (318)
T KOG0659|consen 156 ------RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLR-VPFFPGDSDIDQL 211 (318)
T ss_pred ------cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHcc-CCCCCCCchHHHH
Confidence 22333467899999999876 5799999999999999999987 4777777666543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=339.22 Aligned_cols=207 Identities=27% Similarity=0.474 Sum_probs=180.1
Q ss_pred chHHHHHHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC
Q 003140 615 TYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 692 (845)
Q Consensus 615 ~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~ 692 (845)
+..+|++..+.+.+.+.||+|.||+||+|.|. -.||||+++... .+..+.|..|+.++++-+|.||+-|+|||...
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 34677788888888999999999999999985 469999988654 44567899999999999999999999999988
Q ss_pred CeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 003140 693 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 772 (845)
Q Consensus 693 ~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla 772 (845)
.. +||+.+|+|.+|+.++|... ..++..+.+.||.|||+||.|||.++ |||||||+.||++.++++|||+|||++
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred ce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccce
Confidence 77 99999999999999998754 46899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCCCccccceeecccCCCCccchhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003140 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPIS 833 (845)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltG~~Pf~ 833 (845)
....... .........|...|||||+++. ..|++.+||||||||+|||+||..||.
T Consensus 536 tvk~~w~-----g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys 594 (678)
T KOG0193|consen 536 TVKTRWS-----GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS 594 (678)
T ss_pred eeeeeec-----cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence 6543221 1222334468899999999864 478999999999999999999999997
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=331.16 Aligned_cols=198 Identities=31% Similarity=0.495 Sum_probs=178.8
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
++|.+.+.||+|.||.||||+-+ +.+.||+|.+.+.. .+..+.+.+|++++++++|||||.+++.|+...+.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46888899999999999999965 68999999886532 3345678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
|+.+ +|..++... ..++++....|+.+++.||.|||+.. |+|||+||.|||++..+.+|++|||+|+-+..
T Consensus 82 ~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST--- 152 (808)
T ss_pred hhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc---
Confidence 9975 999999654 45899999999999999999999998 99999999999999999999999999997643
Q ss_pred CCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
...+.+.+.||+.|||||...+..|+..+|+||+||++||+++|+.||..
T Consensus 153 ----~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a 202 (808)
T KOG0597|consen 153 ----NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA 202 (808)
T ss_pred ----CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH
Confidence 24567788999999999999999999999999999999999999999953
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=318.78 Aligned_cols=210 Identities=30% Similarity=0.468 Sum_probs=173.3
Q ss_pred hcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHh--cCCCceeeEEEEEeeCC----eEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSR--LHHRNLVSLVGYCDEEG----EQM 696 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~--l~H~nIv~l~g~~~~~~----~~~ 696 (845)
....+..++||+|.||.||||.+. ++.||||++.. +..+.|+.|-++.+. ++|+||++|+++-.... +++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 345566788999999999999995 49999999965 345678888877776 48999999999876554 899
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 003140 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE------ADPPVFHRDIKASNILLDHKFTAKVADFG 770 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~iiHrDLk~~NILl~~~~~~kl~DFG 770 (845)
||+||.+.|+|.+||..+ .++|....+|+.-+++||+|||+. .+|+|+|||||++||||..|+++.|+|||
T Consensus 285 LVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 999999999999999765 589999999999999999999975 47899999999999999999999999999
Q ss_pred CcccCCCCCCCCccccceeecccCCCCccchhhhcCCC-CC-----chhhHHHHHHHHHHHHhCCCCCCCCCCceecccC
Q 003140 771 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK-LT-----DKSDVYSLGVVFLELLTGMQPISHGKNIVREVLP 844 (845)
Q Consensus 771 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~ 844 (845)
+|..+...... ......+||.+|||||++.+.. +. .+.||||+|.|+|||+++..-+.. +.++..-+|
T Consensus 362 LAl~~~p~~~~-----~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~-~~vp~Yqlp 435 (534)
T KOG3653|consen 362 LALRLEPGKPQ-----GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP-GPVPEYQLP 435 (534)
T ss_pred eeEEecCCCCC-----cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC-CCCCcccCc
Confidence 99887633211 1123378999999999998643 22 368999999999999998876654 566666666
Q ss_pred C
Q 003140 845 Y 845 (845)
Q Consensus 845 ~ 845 (845)
|
T Consensus 436 f 436 (534)
T KOG3653|consen 436 F 436 (534)
T ss_pred h
Confidence 5
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=324.26 Aligned_cols=211 Identities=25% Similarity=0.358 Sum_probs=178.2
Q ss_pred HHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhh---HHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEE
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~---~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 696 (845)
...++|+..+.||+|+||.||.|+-+ +|..+|+|++++..... .+....|-.+|...++|.||+++..|.+.+..|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 35578999999999999999999955 69999999998765433 345788999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCC
Q 003140 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~ 776 (845)
|||||++||++..+|.+. ..|++.....++.+++-|++-+|+.| ||||||||+|+|||..|++||+||||+.-+.
T Consensus 218 LiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999999664 46888888889999999999999999 9999999999999999999999999985322
Q ss_pred CCCCC--------------C----cccc---ce-------------------eecccCCCCccchhhhcCCCCCchhhHH
Q 003140 777 VPDIE--------------G----IVPA---HV-------------------STVVKGTPGYLDPEYFLTHKLTDKSDVY 816 (845)
Q Consensus 777 ~~~~~--------------~----~~~~---~~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dvw 816 (845)
..... . ..+. .. ....+||+.|||||++.+..|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 10000 0 0000 00 0123799999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCC
Q 003140 817 SLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 817 S~Gvvl~elltG~~Pf~~~~ 836 (845)
|+|||||||+.|..||....
T Consensus 373 SLG~ImyEmLvGyPPF~s~t 392 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSET 392 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999997643
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=342.90 Aligned_cols=214 Identities=30% Similarity=0.489 Sum_probs=183.1
Q ss_pred ccchHHHHHHhcCC---------CCCccccccCceEEEEEEeC----CCcEEEEEEccCCChh-hHHHHHHHHHHHHhcC
Q 003140 613 SFTYGEMALATNNF---------NSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLH 678 (845)
Q Consensus 613 ~~~~~~~~~~~~~f---------~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~~~~~~~~-~~~~~~~Ei~~l~~l~ 678 (845)
.++|++...+...| .+.++||.|.||.||+|.++ ....||||.++....+ ...+|+.|+.||.+++
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 45666655554444 46789999999999999975 3467999999976544 4578999999999999
Q ss_pred CCceeeEEEEEeeCCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 003140 679 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 758 (845)
Q Consensus 679 H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl 758 (845)
||||++|-|+....+..+||+|||+||+|++||+.+.++ +.+.+...+..+||.||+||-+++ +|||||.++|||+
T Consensus 689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILV 764 (996)
T KOG0196|consen 689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILV 764 (996)
T ss_pred CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheee
Confidence 999999999999999999999999999999999887654 999999999999999999999998 9999999999999
Q ss_pred cCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 003140 759 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 834 (845)
Q Consensus 759 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~ 834 (845)
+.+-.+||+|||++|.+.+.. + ..+....-+-.++|.|||.+..++++.+||||||||||||+++ |.+||.+
T Consensus 765 NsnLvCKVsDFGLSRvledd~-~---~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd 837 (996)
T KOG0196|consen 765 NSNLVCKVSDFGLSRVLEDDP-E---AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 837 (996)
T ss_pred ccceEEEeccccceeecccCC-C---ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc
Confidence 999999999999999875432 1 1111222223478999999999999999999999999999998 9999974
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=325.24 Aligned_cols=202 Identities=25% Similarity=0.388 Sum_probs=176.0
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCChhhHH-HHHHHHHHHHhcC-CCceeeEEEEEeeCC-eEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLH-HRNLVSLVGYCDEEG-EQMLV 698 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~-~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~-~~~LV 698 (845)
-++|...+.||.|.||.||+|+- .+|..||||+++......++ .-++|++.|+++. |||||++.+++.+.+ ..++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 46788899999999999999994 57999999999876544332 3478999999998 999999999998888 99999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
||||+ .+|++++++. ++.+++..++.|+.||++||+|+|.+| +.|||+||+|||+.....+||+|||+||....
T Consensus 89 fE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S- 162 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS- 162 (538)
T ss_pred HHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc-
Confidence 99995 7999999876 778999999999999999999999999 99999999999999999999999999997643
Q ss_pred CCCCccccceeecccCCCCccchhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
....+..+.|.+|+|||++. ++.|+.+.||||+|||++|+.+-+.-|-+..+
T Consensus 163 -------kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE 215 (538)
T KOG0661|consen 163 -------KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE 215 (538)
T ss_pred -------CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH
Confidence 22345667889999999975 67899999999999999999998766644443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=328.75 Aligned_cols=199 Identities=28% Similarity=0.461 Sum_probs=180.1
Q ss_pred cCCCCCccccccCceEEEEEE-eCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcC
Q 003140 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 702 (845)
..|.....||+|+.|.||.+. ..+++.||||++........+-..+|+.+|+..+|+|||++++.|...++.|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 456777899999999999998 4578999999998777667777899999999999999999999998889999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCC
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 782 (845)
++|+|.+.+.. ..+++.++..|+.++++||+|||.++ |+|||||++|||++.+|.+||+|||++..+...
T Consensus 353 ~ggsLTDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~---- 422 (550)
T KOG0578|consen 353 EGGSLTDVVTK---TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE---- 422 (550)
T ss_pred CCCchhhhhhc---ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccc----
Confidence 99999998854 34899999999999999999999999 999999999999999999999999998766432
Q ss_pred ccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.....+.+||++|||||+.....|++|.||||||++++||+-|..||..+
T Consensus 423 ---~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE 472 (550)
T KOG0578|consen 423 ---QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE 472 (550)
T ss_pred ---cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC
Confidence 22456788999999999999999999999999999999999999999763
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.17 Aligned_cols=203 Identities=31% Similarity=0.498 Sum_probs=173.8
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC--eEEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG--EQMLVYE 700 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~LV~E 700 (845)
.++...+.||+|+||.||++... +|...|||..........+.+.+|+++|++++|||||+.+|...... ...+.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45666789999999999999975 49999999887653333667899999999999999999999854444 6899999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEEecCCcccCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~-~~~~kl~DFGla~~~~~~~ 779 (845)
|+++|+|.+++.+.+. .+++...+.++.||++||+|||+++ ||||||||+|||++. ++.+||+|||+++......
T Consensus 97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999988776 7999999999999999999999999 999999999999999 7999999999998764200
Q ss_pred CCCccccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
..........||+.|||||++..+ ....++||||+||++.||+||+.||..
T Consensus 173 ----~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 173 ----TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred ----ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 012234457899999999999864 334599999999999999999999976
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=304.78 Aligned_cols=201 Identities=30% Similarity=0.425 Sum_probs=171.8
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChh-h-HHHHHHHHHHHHhcCCCceeeEEEEEe--eCCeEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-G-EKEFLTEIQFLSRLHHRNLVSLVGYCD--EEGEQMLV 698 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~-~-~~~~~~Ei~~l~~l~H~nIv~l~g~~~--~~~~~~LV 698 (845)
+.|+..+.|++|.||.||+|++. +++.||+|+++-.... + .-..++|+.+|.+++|||||.+-.+.. +-+..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45777889999999999999975 6899999998753311 1 234689999999999999999988874 44679999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
||||+ -+|.+.++... +++...+...++.|+++|++|||.+. |+|||||++|+|+++.|.+||+|||+||.+..+
T Consensus 156 Me~~E-hDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 156 MEYVE-HDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHHH-hhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 99997 58999987644 67899999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
-...+..+-|.+|+|||.+.+ ..|+...||||+|||+.||++++.-|.+..
T Consensus 231 -------~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s 282 (419)
T KOG0663|consen 231 -------LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS 282 (419)
T ss_pred -------cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc
Confidence 233566778999999999886 579999999999999999999987775443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.45 Aligned_cols=208 Identities=29% Similarity=0.383 Sum_probs=182.4
Q ss_pred hcCCCCCccccccCceEEEEEE-eCCCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
.+.|+..+.||.|.-++||+|+ .+.++.||||++.-.. ....+.+.+|+..|+.++||||++.+..|..+...|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4678889999999999999999 4678999999987533 3345789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
||.+||+.+.++..-...+++..+..|..++++||.|||.++ .||||||+.||||+.+|.|||+|||.+-.+....
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G- 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG- 180 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC-
Confidence 999999999998876667999999999999999999999999 9999999999999999999999999876665422
Q ss_pred CCccccceeecccCCCCccchhhhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFL--THKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.+.........||++|||||+++ ...|+.|+||||||++..||.+|+.||....
T Consensus 181 --~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p 236 (516)
T KOG0582|consen 181 --DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP 236 (516)
T ss_pred --ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC
Confidence 11122226678999999999965 3589999999999999999999999998654
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=323.86 Aligned_cols=198 Identities=29% Similarity=0.496 Sum_probs=173.6
Q ss_pred HHHHHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 618 EMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 618 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
.|++..+.....+-||.|+.|.||.|+++ ++.||||+++.- -..+++-|++|+|+||+.|.|+|...-.++|
T Consensus 118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCI 189 (904)
T KOG4721|consen 118 LWEIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCI 189 (904)
T ss_pred hccCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEE
Confidence 44444555556778999999999999995 589999987642 2346888999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
|||||..|-|+..|+. ..++.......+..+||.||.|||.+. |||||||+-||||+.+..+||+|||.++....
T Consensus 190 iMEfCa~GqL~~VLka--~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 190 IMEFCAQGQLYEVLKA--GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSD 264 (904)
T ss_pred eeeccccccHHHHHhc--cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhh
Confidence 9999999999999965 456788888999999999999999988 99999999999999999999999999987542
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
....+.+.||+.|||||++.....++|+||||||||||||+||..||.+-+
T Consensus 265 --------~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd 315 (904)
T KOG4721|consen 265 --------KSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD 315 (904)
T ss_pred --------hhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc
Confidence 233567899999999999999999999999999999999999999997544
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=316.20 Aligned_cols=206 Identities=33% Similarity=0.468 Sum_probs=181.2
Q ss_pred HHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhH-HHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~-~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
.+.+...+.++||+|.||.|..+....+..||||+++....... ++|.+|+++|.+++|||||.++|+|..++..++|+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 34455667899999999999999998889999999998766654 89999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
|||++|+|.+|+..+......-.....|+.|||.||+||.+.+ +|||||.++|+|+|.++++||+|||++|-+...+
T Consensus 615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence 9999999999998875544566677789999999999999998 9999999999999999999999999999765554
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh--CCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT--GMQPISH 834 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt--G~~Pf~~ 834 (845)
+. +.....+-.++|||+|.+.-++++.++|||+||+++||+++ ...||..
T Consensus 692 yy-----~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~ 743 (807)
T KOG1094|consen 692 YY-----RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQ 743 (807)
T ss_pred ce-----eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhh
Confidence 33 22333445689999999999999999999999999999977 8889974
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=322.41 Aligned_cols=204 Identities=29% Similarity=0.444 Sum_probs=178.2
Q ss_pred HHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC----Ch-hhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCC
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG----SL-QGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEG 693 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~----~~-~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~ 693 (845)
...++|...+.||+|+||+||.|... ++..||||++... .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34568889999999999999999854 7899999976653 11 23456678999999998 999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEEecCCc
Q 003140 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLS 772 (845)
Q Consensus 694 ~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~-~~~kl~DFGla 772 (845)
..++||||+.+|+|.+++.. ..++.+.....++.|++.|++|+|+.+ |+||||||+|||++.+ +++||+|||++
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred eEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 99999999999999999977 456888999999999999999999999 9999999999999999 99999999999
Q ss_pred ccCCCCCCCCccccceeecccCCCCccchhhhcCCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK-LT-DKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
..... .........||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||.+.+
T Consensus 169 ~~~~~-------~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~ 227 (370)
T KOG0583|consen 169 AISPG-------EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN 227 (370)
T ss_pred cccCC-------CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence 87631 123456678999999999999877 75 78999999999999999999998733
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=326.73 Aligned_cols=205 Identities=25% Similarity=0.430 Sum_probs=178.9
Q ss_pred HHHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCe
Q 003140 620 ALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGE 694 (845)
Q Consensus 620 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 694 (845)
....++|...++||+|.||+|+.+..+ +++.+|||.+++.. .+..+..+.|-+++... +||.+++++..|...++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 344578889999999999999999975 68899999998753 34456778898888877 59999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003140 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (845)
Q Consensus 695 ~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~ 774 (845)
.++||||+.||++..+. ....+++..+.-+|..|+.||+|||+++ ||+||||-+|||+|.+|++||+|||+++.
T Consensus 444 l~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 99999999999943333 3456999999999999999999999999 99999999999999999999999999985
Q ss_pred CCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
.- .......+..||+.|||||++.+..|+.++|.|||||+||||+.|+.||.+.++
T Consensus 518 ~m-------~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE 573 (694)
T KOG0694|consen 518 GM-------GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE 573 (694)
T ss_pred cC-------CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 42 223456778999999999999999999999999999999999999999975443
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=329.53 Aligned_cols=212 Identities=33% Similarity=0.503 Sum_probs=180.1
Q ss_pred cchHHHHHHhcCCCCCccccccCceEEEEEEeCC--C--cE-EEEEEccC---CChhhHHHHHHHHHHHHhcCCCceeeE
Q 003140 614 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILPD--G--TV-VAVKRAQE---GSLQGEKEFLTEIQFLSRLHHRNLVSL 685 (845)
Q Consensus 614 ~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~--g--~~-vAVK~~~~---~~~~~~~~~~~Ei~~l~~l~H~nIv~l 685 (845)
+..+.|+..-++....+.||+|+||.||+|.+.. + .. ||||..+. ......++|++|+++|++++|||||++
T Consensus 147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~ 226 (474)
T KOG0194|consen 147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRF 226 (474)
T ss_pred ccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 3344566666666777999999999999999653 2 23 89999885 335567899999999999999999999
Q ss_pred EEEEeeCCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEE
Q 003140 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAK 765 (845)
Q Consensus 686 ~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~k 765 (845)
||++..+...++|||+|+||+|.++|++... .++..++..++.++|+||+|||+++ +|||||.++|+|++.++.+|
T Consensus 227 yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 227 YGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred EEEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEE
Confidence 9999999999999999999999999987654 6999999999999999999999999 99999999999999999999
Q ss_pred EEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 766 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 766 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
|+|||+++.-.. + ........-...|+|||.+..+.|++++|||||||++||+++ |..||.+-.
T Consensus 303 ISDFGLs~~~~~--~-----~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~ 367 (474)
T KOG0194|consen 303 ISDFGLSRAGSQ--Y-----VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK 367 (474)
T ss_pred eCccccccCCcc--e-----eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC
Confidence 999999875421 0 000111234579999999999999999999999999999999 899997654
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=312.88 Aligned_cols=200 Identities=27% Similarity=0.410 Sum_probs=175.2
Q ss_pred CCCCccccccCceEEEEEEe-CCCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 626 FNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 626 f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
|...+.||+|+||.||+|.. .+|+.||||.+.... ......+.+|++++++++|++|+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 66788999999999999996 479999999886432 22345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~--- 155 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--- 155 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC---
Confidence 99999999887655557899999999999999999999998 999999999999999999999999999765321
Q ss_pred CccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......||..|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 156 -----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 205 (285)
T cd05631 156 -----ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205 (285)
T ss_pred -----CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCC
Confidence 11233468999999999999999999999999999999999999997644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=289.10 Aligned_cols=202 Identities=30% Similarity=0.462 Sum_probs=182.8
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
-++|++.+.||+|.||.||.|+.+ ++..||+|++..... .-++++.+|+++-+.++||||+++|+++.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 467889999999999999999954 788999999876432 2357899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
+||.+.|++...|+.....++++.....++.|+|.|+.|+|..+ ||||||||+|+|++.++..||+|||.+...+
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 99999999999999777778899999999999999999999988 9999999999999999999999999986542
Q ss_pred CCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.....+..||..|.+||...+..++.++|+|++|++.||++.|..||.+..
T Consensus 176 -------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~ 226 (281)
T KOG0580|consen 176 -------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS 226 (281)
T ss_pred -------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence 334567889999999999999999999999999999999999999997643
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=322.15 Aligned_cols=208 Identities=26% Similarity=0.361 Sum_probs=175.7
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|+..+.||+|+||+||++... +++.||||++.... ......+.+|++++.+++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999865 68999999986532 222356788999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999999999754 46899999999999999999999998 9999999999999999999999999997643211
Q ss_pred CCCc----------------------------cccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003140 780 IEGI----------------------------VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831 (845)
Q Consensus 780 ~~~~----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~P 831 (845)
.... ..........||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0000 000011235799999999999999999999999999999999999999
Q ss_pred CCCCC
Q 003140 832 ISHGK 836 (845)
Q Consensus 832 f~~~~ 836 (845)
|.+..
T Consensus 236 f~~~~ 240 (363)
T cd05628 236 FCSET 240 (363)
T ss_pred CCCCC
Confidence 97543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=305.72 Aligned_cols=208 Identities=31% Similarity=0.444 Sum_probs=171.3
Q ss_pred HHHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChh--------------hHHHHHHHHHHHHhcCCCceee
Q 003140 620 ALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--------------GEKEFLTEIQFLSRLHHRNLVS 684 (845)
Q Consensus 620 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~--------------~~~~~~~Ei~~l~~l~H~nIv~ 684 (845)
....++|.+.+.||+|.||.|-+|... +++.||||++.+.... ..+...+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 345578999999999999999999964 7999999998653211 1247889999999999999999
Q ss_pred EEEEEeeC--CeEEEEEEcCCCCCHHHHHhccCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC
Q 003140 685 LVGYCDEE--GEQMLVYEFMSNGTLRDQLSAKSKEP-LGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK 761 (845)
Q Consensus 685 l~g~~~~~--~~~~LV~E~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~ 761 (845)
|+++..+. +..|||+|||..|.+... ....+ +++.+.+++..+++.||+|||.++ ||||||||+|+||+++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 99998664 578999999998877432 33444 899999999999999999999999 9999999999999999
Q ss_pred CcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 762 FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK----LTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 762 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
|++||+|||.+......+.++. ........||+.|+|||...++. .+.+.||||+||+||-|+.|+.||.+.
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~--d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~ 322 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGS--DDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD 322 (576)
T ss_pred CcEEeeccceeeecccCCcccc--HHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence 9999999999986643322211 11123368999999999987632 466899999999999999999999764
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=320.17 Aligned_cols=208 Identities=29% Similarity=0.497 Sum_probs=172.9
Q ss_pred HHHhcCCCCCccccccCceEEEEEEe------CCCcEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEEee
Q 003140 620 ALATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE 691 (845)
Q Consensus 620 ~~~~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~ 691 (845)
.+..++|.+.+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|+++++++ +||||++++++|..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 34567899999999999999999974 235789999987543 23346789999999999 89999999999876
Q ss_pred C-CeEEEEEEcCCCCCHHHHHhccC-------------------------------------------------------
Q 003140 692 E-GEQMLVYEFMSNGTLRDQLSAKS------------------------------------------------------- 715 (845)
Q Consensus 692 ~-~~~~LV~E~~~~gsL~~~l~~~~------------------------------------------------------- 715 (845)
. +..++||||+++|+|.++++...
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 4 45899999999999999997532
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCccccceee
Q 003140 716 -----KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 790 (845)
Q Consensus 716 -----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~ 790 (845)
..++++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .....
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~-----~~~~~ 234 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-----YVRKG 234 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcc-----hhccc
Confidence 134788899999999999999999998 99999999999999999999999999986532110 11112
Q ss_pred cccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 791 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 791 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
...++..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 235 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~ 280 (338)
T cd05102 235 SARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 280 (338)
T ss_pred CCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCC
Confidence 3346688999999999999999999999999999997 99999754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=343.31 Aligned_cols=207 Identities=33% Similarity=0.524 Sum_probs=177.9
Q ss_pred hcCCCCCccccccCceEEEEEEeC--CCc----EEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP--DGT----VVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~--~g~----~vAVK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 695 (845)
.++.+..+.||+|+||.||+|... +|. .||||.+++. +.+...+|.+|..+|++++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 455566789999999999999964 343 4999998865 455678999999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 003140 696 MLVYEFMSNGTLRDQLSAKS-----KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 770 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFG 770 (845)
++++|||++|+|.+||++.. ...+.....+.++.|||+|+.||++++ +|||||.++|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999998752 346889999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 003140 771 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKN 837 (845)
Q Consensus 771 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~ 837 (845)
+|+.+...++.... ....-...|||||.+.++.++.|+|||||||++||++| |..||.+..+
T Consensus 848 lArDiy~~~yyr~~-----~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n 910 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKH-----GEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN 910 (1025)
T ss_pred hhHhhhhchheecc-----CccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch
Confidence 99966544433211 11123468999999999999999999999999999999 9999976544
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=299.51 Aligned_cols=212 Identities=26% Similarity=0.322 Sum_probs=182.6
Q ss_pred hcCCCCCccccccCceEEEEEEeCC-CcEEEEEEccCCChh---hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~~~~~~~~---~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
-+.|...+.||+|.-|+||.+.+.+ +..+|+|++.+.... ...+.+.|-+||+.++||.++.||+.++.++..++|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 3456677899999999999999764 689999999875443 345678899999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
||||+||+|+..++++..+.+++..++-++..++-||+|||..| ||.|||||+||||.++|++.|+||.++......
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999999999999999999999999999999999999999 999999999999999999999999997432110
Q ss_pred -------C------------------------C-CC-----------------ccccceeecccCCCCccchhhhcCCCC
Q 003140 779 -------D------------------------I-EG-----------------IVPAHVSTVVKGTPGYLDPEYFLTHKL 809 (845)
Q Consensus 779 -------~------------------------~-~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~~~ 809 (845)
+ . .. ...+..+...+||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 00 000123345689999999999999999
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 810 TDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 810 ~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
+.++|+|+|||++|||+.|+.||.+.++
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~ 340 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNN 340 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCc
Confidence 9999999999999999999999976554
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=311.58 Aligned_cols=198 Identities=24% Similarity=0.360 Sum_probs=174.4
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|+..+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999975 68999999986432 223456889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++|+|.++++.. ..+++.....++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 999999999999654 35889999999999999999999998 999999999999999999999999999765321
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~ 202 (291)
T cd05612 155 ---------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN 202 (291)
T ss_pred ---------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 123468999999999999899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=301.11 Aligned_cols=201 Identities=28% Similarity=0.461 Sum_probs=180.0
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCChhhHH---HHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEK---EFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~---~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
.+|++.+.||+|.||+|-+|.. ..|+.||||.++.....+++ .+.+|+++|+.++||||+.++++|+..+...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4677788999999999999985 57999999998876555444 4678999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||..+|.|++|+.+. ..+++...+.++.||..|+.|+|.+. ++|||||-+|||+|.++++||+|||++.++..
T Consensus 133 EYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~-- 205 (668)
T KOG0611|consen 133 EYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD-- 205 (668)
T ss_pred EecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc--
Confidence 999999999999664 46899999999999999999999998 99999999999999999999999999987642
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
.....+++|++-|.+||++.+..| ++..|-||+||++|.|+.|..||++.+.
T Consensus 206 ------~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh 258 (668)
T KOG0611|consen 206 ------KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH 258 (668)
T ss_pred ------ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH
Confidence 344567899999999999999887 5789999999999999999999987654
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=321.78 Aligned_cols=208 Identities=26% Similarity=0.381 Sum_probs=175.4
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|+..+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999975 68999999987532 223456788999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999999999754 35899999999999999999999998 9999999999999999999999999987543211
Q ss_pred CCCccc-------------------------------cceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhC
Q 003140 780 IEGIVP-------------------------------AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG 828 (845)
Q Consensus 780 ~~~~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG 828 (845)
...... ........||+.|+|||++....++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 000000 0011124699999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 003140 829 MQPISHGK 836 (845)
Q Consensus 829 ~~Pf~~~~ 836 (845)
+.||....
T Consensus 236 ~~Pf~~~~ 243 (364)
T cd05599 236 YPPFCSDN 243 (364)
T ss_pred CCCCCCCC
Confidence 99997543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=316.91 Aligned_cols=199 Identities=26% Similarity=0.399 Sum_probs=174.3
Q ss_pred hcCCCCCccccccCceEEEEEEeCC--CcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILPD--GTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~~--g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
.++|...+.||+|+||.||+|...+ +..||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3568889999999999999998643 3689999886422 2234578899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 109 v~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999999754 35889999999999999999999998 99999999999999999999999999976532
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 184 ~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 232 (340)
T PTZ00426 184 R----------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE 232 (340)
T ss_pred C----------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC
Confidence 1 123468999999999999889999999999999999999999997654
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=322.07 Aligned_cols=207 Identities=26% Similarity=0.340 Sum_probs=173.3
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999999864 78999999886432 223456889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++|+|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999999999653 45888899999999999999999998 9999999999999999999999999996432110
Q ss_pred CCC---------ccc-------------------------------cceeecccCCCCccchhhhcCCCCCchhhHHHHH
Q 003140 780 IEG---------IVP-------------------------------AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLG 819 (845)
Q Consensus 780 ~~~---------~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G 819 (845)
... ... ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 000 000 0000124699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCC
Q 003140 820 VVFLELLTGMQPISHG 835 (845)
Q Consensus 820 vvl~elltG~~Pf~~~ 835 (845)
|++|||++|+.||...
T Consensus 236 vil~elltG~~Pf~~~ 251 (377)
T cd05629 236 AIMFECLIGWPPFCSE 251 (377)
T ss_pred hhhhhhhcCCCCCCCC
Confidence 9999999999999654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=315.88 Aligned_cols=198 Identities=25% Similarity=0.422 Sum_probs=174.8
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|.+.+.||+|+||.||+|... +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888899999999999999975 68999999986532 223457889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++|+|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred cCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence 999999999999754 35788889999999999999999998 999999999999999999999999999865321
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 172 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 219 (329)
T PTZ00263 172 ---------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT 219 (329)
T ss_pred ---------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC
Confidence 123468999999999999999999999999999999999999997543
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=320.80 Aligned_cols=207 Identities=23% Similarity=0.316 Sum_probs=173.5
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
.|...+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778899999999999999864 68999999986532 2334578999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
|+++|+|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+|||++.++++||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99999999999654 35788888999999999999999998 99999999999999999999999999864321000
Q ss_pred CCc----------------------------------------cccceeecccCCCCccchhhhcCCCCCchhhHHHHHH
Q 003140 781 EGI----------------------------------------VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGV 820 (845)
Q Consensus 781 ~~~----------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gv 820 (845)
... ..........||..|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 000 0000012356999999999999889999999999999
Q ss_pred HHHHHHhCCCCCCCCC
Q 003140 821 VFLELLTGMQPISHGK 836 (845)
Q Consensus 821 vl~elltG~~Pf~~~~ 836 (845)
++|||++|+.||....
T Consensus 237 il~elltG~~Pf~~~~ 252 (381)
T cd05626 237 ILFEMLVGQPPFLAPT 252 (381)
T ss_pred HHHHHHhCCCCCcCCC
Confidence 9999999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=314.15 Aligned_cols=195 Identities=26% Similarity=0.334 Sum_probs=169.8
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCCC
Q 003140 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 705 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g 705 (845)
+.||+|+||.||++... +|+.||+|+++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 78999999987532 223456789999999999999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCccc
Q 003140 706 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP 785 (845)
Q Consensus 706 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 785 (845)
+|.+++... ..+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~------- 148 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD------- 148 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-------
Confidence 999998654 46889999999999999999999998 999999999999999999999999998753211
Q ss_pred cceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 786 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 786 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
........||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 199 (323)
T cd05571 149 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC
Confidence 112234569999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=297.46 Aligned_cols=205 Identities=28% Similarity=0.424 Sum_probs=174.3
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccC--CChhhHHHHHHHHHHHHhcCCCceeeEEEEEee-----CC
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-----EG 693 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~--~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-----~~ 693 (845)
....|...+.||+|+||.|+++... +|+.||||++.. ......++-.+|+++++.++|+||+.+.+.+.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3445666789999999999999964 789999999873 345567889999999999999999999998855 35
Q ss_pred eEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003140 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (845)
Q Consensus 694 ~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~ 773 (845)
..|+|+|+| .-+|++.++.. ..++......++.|+++||+|+|+.+ |+||||||+|+|++.+..+||+|||+||
T Consensus 100 DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence 789999999 57999999654 34889999999999999999999999 9999999999999999999999999999
Q ss_pred cCCCCCCCCccccceeecccCCCCccchhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
..... ......+..+.|.+|+|||++. ...|+.+.||||.||++.||++|+.-|-+.+.
T Consensus 174 ~~~~~-----~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~ 233 (359)
T KOG0660|consen 174 YLDKF-----FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY 233 (359)
T ss_pred ecccc-----CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch
Confidence 87532 1233446677899999999976 56899999999999999999999877755443
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=295.86 Aligned_cols=202 Identities=29% Similarity=0.458 Sum_probs=172.0
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChh--hHHHHHHHHHHHHhcCCCc-eeeEEEEEeeCC------
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRN-LVSLVGYCDEEG------ 693 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~--~~~~~~~Ei~~l~~l~H~n-Iv~l~g~~~~~~------ 693 (845)
..|...++||+|+||+||+|+.. +|+.||+|++.-...+ ......+|+.++++++|+| ||++++++....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 45666778999999999999954 7899999998754332 2345689999999999999 999999998776
Q ss_pred eEEEEEEcCCCCCHHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 003140 694 EQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 771 (845)
Q Consensus 694 ~~~LV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGl 771 (845)
..++|+||++ -+|.+++..... ..++......++.||++||+|||+++ |+||||||.|||++++|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 7889999995 799999987543 35777889999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCCCccccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
|+....+ ....+...+|.+|+|||++.+. .|+...||||+||+++||++++.-|.+..
T Consensus 167 Ara~~ip-------~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s 225 (323)
T KOG0594|consen 167 ARAFSIP-------MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS 225 (323)
T ss_pred HHHhcCC-------cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc
Confidence 9865432 3335667789999999999876 78999999999999999999887775543
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=319.85 Aligned_cols=205 Identities=22% Similarity=0.315 Sum_probs=174.9
Q ss_pred HHHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeE
Q 003140 620 ALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG---SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (845)
Q Consensus 620 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 695 (845)
....++|+..+.||+|+||.||++... +++.||+|.+... .....+.+.+|+++++.++||||+++++++.+++..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 344578999999999999999999975 5889999988642 222345688999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+..
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 9999999999999999643 4788889999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH----KLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus 193 ~~~~------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~ 251 (370)
T cd05621 193 DETG------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251 (370)
T ss_pred ccCC------ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence 3221 1112345799999999998754 37889999999999999999999997543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=300.68 Aligned_cols=194 Identities=27% Similarity=0.408 Sum_probs=160.0
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-----eEEEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG-----EQMLV 698 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~LV 698 (845)
.|...+++|.|+||.||+|... +++.||||+.-..... --+|+++|++++|||||++.-+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4566789999999999999964 5799999987653321 236899999999999999998885432 34689
Q ss_pred EEcCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEEecCCcccC
Q 003140 699 YEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLSRLA 775 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~-~~~kl~DFGla~~~ 775 (845)
||||+ .+|+++++.. .+..++...+.-+..||.+||.|||+.+ |+||||||.|+|+|.+ |.+||+|||.|+.+
T Consensus 101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 99997 6999998752 3456777788889999999999999988 9999999999999977 89999999999987
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
.... .......|..|+|||.+.+ ..|+.+.||||.|||+.||+-|+.-|.+
T Consensus 177 ~~~e--------pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG 228 (364)
T KOG0658|consen 177 VKGE--------PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG 228 (364)
T ss_pred ccCC--------CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC
Confidence 5332 1233446789999999886 5799999999999999999999876654
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=311.09 Aligned_cols=195 Identities=26% Similarity=0.338 Sum_probs=169.4
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCCC
Q 003140 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 705 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g 705 (845)
+.||+|+||.||++... +|+.||+|+++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999964 68999999987532 233456788999999999999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCccc
Q 003140 706 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP 785 (845)
Q Consensus 706 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 785 (845)
+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~------- 148 (323)
T cd05595 81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD------- 148 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC-------
Confidence 999988654 36889999999999999999999998 999999999999999999999999998753211
Q ss_pred cceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 786 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 786 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 199 (323)
T cd05595 149 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC
Confidence 111233568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=297.79 Aligned_cols=197 Identities=25% Similarity=0.441 Sum_probs=162.8
Q ss_pred hcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhc--CCCceeeEEEEEeeC----CeEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL--HHRNLVSLVGYCDEE----GEQM 696 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l--~H~nIv~l~g~~~~~----~~~~ 696 (845)
..+....+.||+|.||.||+|.+ .|+.||||++.. .+++.+.+|.++.+.+ +|+||+.|++.-..+ .+.+
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hheeEEEEEecCccccceeeccc-cCCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 35667789999999999999999 589999999965 3456788888888864 999999999886433 2679
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 003140 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-----EADPPVFHRDIKASNILLDHKFTAKVADFGL 771 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~iiHrDLk~~NILl~~~~~~kl~DFGl 771 (845)
||++|.++|||++||.+ ..++....++++..+|.||++||. +++|.|.|||||+.||||.+++.+.|+|+|+
T Consensus 286 LvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 99999999999999976 468899999999999999999994 5899999999999999999999999999999
Q ss_pred cccCCCCCCCCccccceeecccCCCCccchhhhcCC------CCCchhhHHHHHHHHHHHHhCC
Q 003140 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH------KLTDKSDVYSLGVVFLELLTGM 829 (845)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwS~Gvvl~elltG~ 829 (845)
|....... +. -.......+||.+|||||++... ..-..+||||||.|+||+..+.
T Consensus 363 Av~h~~~t-~~--idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc 423 (513)
T KOG2052|consen 363 AVRHDSDT-DT--IDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRC 423 (513)
T ss_pred eEEecccC-Cc--ccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHh
Confidence 97654321 11 12223456899999999998543 2234689999999999998743
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=320.87 Aligned_cols=207 Identities=22% Similarity=0.301 Sum_probs=173.2
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
+|...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999964 68899999986532 2234578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
|+++|+|.+++.+. ..+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99999999999654 35788888999999999999999998 99999999999999999999999999853211000
Q ss_pred CC----------------------------------------ccccceeecccCCCCccchhhhcCCCCCchhhHHHHHH
Q 003140 781 EG----------------------------------------IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGV 820 (845)
Q Consensus 781 ~~----------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gv 820 (845)
.. ...........||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00 00000112346999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCC
Q 003140 821 VFLELLTGMQPISHGK 836 (845)
Q Consensus 821 vl~elltG~~Pf~~~~ 836 (845)
++|||++|+.||...+
T Consensus 237 il~elltG~~Pf~~~~ 252 (382)
T cd05625 237 ILYEMLVGQPPFLAQT 252 (382)
T ss_pred HHHHHHhCCCCCCCCC
Confidence 9999999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=314.28 Aligned_cols=197 Identities=30% Similarity=0.441 Sum_probs=174.7
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|++.+.||+|+||.||+|... +++.||||+++... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999976 58999999987532 223457889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999999999653 35889999999999999999999998 99999999999999999999999999975432
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 --------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 201 (333)
T cd05600 154 --------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS 201 (333)
T ss_pred --------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCC
Confidence 123456899999999999999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=308.89 Aligned_cols=192 Identities=29% Similarity=0.410 Sum_probs=168.3
Q ss_pred ccccCceEEEEEEeC-CCcEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCCCCH
Q 003140 632 IGQGGYGKVYKGILP-DGTVVAVKRAQEG---SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 707 (845)
Q Consensus 632 LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL 707 (845)
||+|+||.||+|... +++.||+|+++.. .....+.+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999975 5889999998643 223346788999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCccccc
Q 003140 708 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 787 (845)
Q Consensus 708 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 787 (845)
.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-------~ 148 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-------D 148 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-------C
Confidence 9999754 35889999999999999999999998 9999999999999999999999999997542211 1
Q ss_pred eeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 788 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~ 196 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE 196 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC
Confidence 123456899999999999999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=310.14 Aligned_cols=195 Identities=27% Similarity=0.351 Sum_probs=169.6
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCCC
Q 003140 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 705 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g 705 (845)
+.||+|+||.||++... +|+.||||++.... .....++.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999964 68999999987532 233467889999999999999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCccc
Q 003140 706 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP 785 (845)
Q Consensus 706 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 785 (845)
+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~------- 148 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD------- 148 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc-------
Confidence 999988654 45889999999999999999999998 999999999999999999999999998753211
Q ss_pred cceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 786 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 786 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~ 199 (328)
T cd05593 149 AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (328)
T ss_pred ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC
Confidence 111233568999999999999999999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=316.39 Aligned_cols=209 Identities=22% Similarity=0.301 Sum_probs=177.5
Q ss_pred hHHHHHHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEee
Q 003140 616 YGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 691 (845)
Q Consensus 616 ~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~ 691 (845)
..+.....++|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3445566689999999999999999999975 68899999986421 2234567889999999999999999999999
Q ss_pred CCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 003140 692 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 771 (845)
Q Consensus 692 ~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGl 771 (845)
.+..++||||+++|+|.+++... .++...+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 99999999999999999998653 4788888899999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCCCccccceeecccCCCCccchhhhcCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH----KLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
++...... ........||+.|+|||++... .++.++|||||||++|||++|+.||....
T Consensus 189 a~~~~~~~------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 251 (371)
T cd05622 189 CMKMNKEG------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (371)
T ss_pred eeEcCcCC------cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence 98653221 1112345699999999998653 37889999999999999999999997543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=319.48 Aligned_cols=207 Identities=23% Similarity=0.318 Sum_probs=173.2
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
+|.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|++++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999999999999964 68999999986432 1234568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
|+++|+|.+++... ..+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|........
T Consensus 82 ~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 82 YIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 99999999999664 35788888899999999999999998 99999999999999999999999999853210000
Q ss_pred CC---------------------c---------------cccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHH
Q 003140 781 EG---------------------I---------------VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLE 824 (845)
Q Consensus 781 ~~---------------------~---------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~e 824 (845)
.. . ..........||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 00 0 00001123469999999999999999999999999999999
Q ss_pred HHhCCCCCCCCC
Q 003140 825 LLTGMQPISHGK 836 (845)
Q Consensus 825 lltG~~Pf~~~~ 836 (845)
|++|+.||....
T Consensus 237 ll~G~~Pf~~~~ 248 (376)
T cd05598 237 MLVGQPPFLADT 248 (376)
T ss_pred hhhCCCCCCCCC
Confidence 999999997654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=316.60 Aligned_cols=204 Identities=23% Similarity=0.318 Sum_probs=173.5
Q ss_pred HHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEE
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG---SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 696 (845)
...++|+..+.||+|+||.||++... +++.||+|++... .....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34568889999999999999999965 6899999998642 1223455788999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCC
Q 003140 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~ 776 (845)
+||||+++|+|.+++... .++......++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 120 lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 999999999999998653 4778888889999999999999998 9999999999999999999999999997653
Q ss_pred CCCCCCccccceeecccCCCCccchhhhcCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH----KLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 194 ~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 251 (370)
T cd05596 194 ANG------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (370)
T ss_pred CCC------cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC
Confidence 221 1112345699999999998653 47899999999999999999999997643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=348.57 Aligned_cols=299 Identities=30% Similarity=0.515 Sum_probs=273.1
Q ss_pred ceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeec
Q 003140 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (845)
Q Consensus 82 ~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (845)
.+++.|++++|.+++.+|..+..+++|++|+|++|.+++.+|..+.++++|++|+|++|.+++.+|..+..+++|+.|+|
T Consensus 260 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L 339 (968)
T PLN00113 260 KNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQL 339 (968)
T ss_pred CCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEEC
Confidence 46889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCC
Q 003140 162 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT 241 (845)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 241 (845)
++|.+++.+|..+..+++|+.|+|++|++++.+|..+..+++|+.|++++|++.+.+|..+..+++|+.|+|++|++++
T Consensus 340 ~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~- 418 (968)
T PLN00113 340 WSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSG- 418 (968)
T ss_pred cCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeee-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred CCccccccCCCccEEEcccCCCCCCCCC-CCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccCCC
Q 003140 242 TIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGL 320 (845)
Q Consensus 242 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l 320 (845)
..|..+.++++|+.|++++|++++..+. +..+++|+.|++++|.+.+.+|..+...+|+.|+|++|++++.+|..|.++
T Consensus 419 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l 498 (968)
T PLN00113 419 ELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSL 498 (968)
T ss_pred ECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhh
Confidence 6888999999999999999999987764 778899999999999999888887777789999999999999999999999
Q ss_pred CCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCC-CCCCC-CCCCCcEEEecCCcccc
Q 003140 321 PRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN-ISGSF-NIPPNVTVRLRGNPFCL 386 (845)
Q Consensus 321 ~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~-i~~~~-~~~~l~~l~l~~Np~~c 386 (845)
++|+.|+|++|++++.+|..+..+.. |+.|+|++|++++ +|..+ .++.++.|+|++|.+.-
T Consensus 499 ~~L~~L~Ls~N~l~~~~p~~~~~l~~-----L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 561 (968)
T PLN00113 499 SELMQLKLSENKLSGEIPDELSSCKK-----LVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSG 561 (968)
T ss_pred hccCEEECcCCcceeeCChHHcCccC-----CCEEECCCCcccccCChhHhCcccCCEEECCCCcccc
Confidence 99999999999999999988876544 4589999999985 44444 58888999999988753
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=300.85 Aligned_cols=201 Identities=27% Similarity=0.420 Sum_probs=175.4
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
+|+..+.||+|+||.||++... +++.||||++..... .....+.+|++++++++|+||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4777899999999999999964 689999999865322 223567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
|+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 999999999887655567899999999999999999999998 9999999999999999999999999987653211
Q ss_pred CCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
......|+..|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~ 205 (285)
T cd05605 157 -------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205 (285)
T ss_pred -------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc
Confidence 1123468899999999998899999999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=308.46 Aligned_cols=202 Identities=28% Similarity=0.344 Sum_probs=172.5
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG---SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999965 6899999998642 1223456889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++|+|.+++.+. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999999653 345889999999999999999999998 9999999999999999999999999987643221
Q ss_pred CCCccccceeecccCCCCccchhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
........||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 157 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 157 ------TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred ------CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 111223468999999999863 45788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=309.81 Aligned_cols=202 Identities=27% Similarity=0.320 Sum_probs=173.0
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|.+.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|..++..++|++|+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47888999999999999999965 68899999986421 222345788999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999997632 36889999999999999999999998 9999999999999999999999999997653221
Q ss_pred CCCccccceeecccCCCCccchhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 157 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 157 ------TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred ------ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 111223568999999999875 46788999999999999999999999754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=304.99 Aligned_cols=199 Identities=26% Similarity=0.423 Sum_probs=174.8
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
.++|+..+.||+|+||.||++... +|..||+|.+.... ....+++.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468899999999999999999975 68899999887542 2335679999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.+ .|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 84 HMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 99999999999654 35889999999999999999999853 2999999999999999999999999998755321
Q ss_pred CCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 -------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 158 -------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred -------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 12234689999999999998999999999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=314.51 Aligned_cols=208 Identities=25% Similarity=0.373 Sum_probs=175.1
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|+..+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++.+++|++|+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999999999999965 68999999986432 223456788999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++|+|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999999999654 35889999999999999999999998 9999999999999999999999999987543211
Q ss_pred CCCc----------------------------cccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003140 780 IEGI----------------------------VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831 (845)
Q Consensus 780 ~~~~----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~P 831 (845)
.... ..........||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0000 000011235699999999999999999999999999999999999999
Q ss_pred CCCCC
Q 003140 832 ISHGK 836 (845)
Q Consensus 832 f~~~~ 836 (845)
|....
T Consensus 236 f~~~~ 240 (360)
T cd05627 236 FCSET 240 (360)
T ss_pred CCCCC
Confidence 97543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=306.63 Aligned_cols=195 Identities=27% Similarity=0.405 Sum_probs=168.0
Q ss_pred ccccccCceEEEEEEe----CCCcEEEEEEccCCC----hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 630 TQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGS----LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~----~~g~~vAVK~~~~~~----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
+.||+|+||.||++.. .+++.||||.++... ......+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 357899999987532 22335678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+++|+|.+++... ..+.+..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 153 (323)
T cd05584 82 LSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE--- 153 (323)
T ss_pred CCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC---
Confidence 9999999999654 35778888899999999999999998 999999999999999999999999998753221
Q ss_pred CccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 154 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~ 204 (323)
T cd05584 154 ----GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204 (323)
T ss_pred ----CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence 111233568999999999998889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=301.40 Aligned_cols=204 Identities=29% Similarity=0.475 Sum_probs=171.0
Q ss_pred hcCCCCCccccccCceEEEEEEeCC-----------------CcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceee
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILPD-----------------GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVS 684 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~~-----------------g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~ 684 (845)
.++|.+.+.||+|+||.||++.+++ +..||+|.+.... ....++|.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578888999999999999997532 3479999987643 334567999999999999999999
Q ss_pred EEEEEeeCCeEEEEEEcCCCCCHHHHHhccC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 003140 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS-----------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747 (845)
Q Consensus 685 l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ii 747 (845)
+++++.+.+..++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999986431 124688899999999999999999998 99
Q ss_pred ecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh
Q 003140 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 827 (845)
Q Consensus 748 HrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt 827 (845)
||||||+|||+++++.+||+|||+++.....+. ........++..|+|||++....++.++|||||||++|||++
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 235 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDY-----YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCce-----eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHH
Confidence 999999999999999999999999986532221 111223345788999999988899999999999999999987
Q ss_pred --CCCCCCC
Q 003140 828 --GMQPISH 834 (845)
Q Consensus 828 --G~~Pf~~ 834 (845)
|..||..
T Consensus 236 ~~~~~p~~~ 244 (304)
T cd05096 236 LCKEQPYGE 244 (304)
T ss_pred ccCCCCCCc
Confidence 5677764
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=305.45 Aligned_cols=200 Identities=23% Similarity=0.362 Sum_probs=171.3
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeEEEEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
+|...+.||+|+||.||+|... +++.||||++.... ....+.+..|.+++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999965 57899999987532 22234567788888877 5899999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~- 154 (323)
T cd05616 81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD- 154 (323)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC-
Confidence 999999999998654 35889999999999999999999998 999999999999999999999999998753211
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
........||+.|+|||++.+..++.++|||||||++|||+||+.||...+
T Consensus 155 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~ 205 (323)
T cd05616 155 ------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205 (323)
T ss_pred ------CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC
Confidence 112234568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=319.42 Aligned_cols=203 Identities=24% Similarity=0.318 Sum_probs=175.8
Q ss_pred CCCCCccccccCceEEEEEEeC-C-CcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcC
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-D-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~-g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 702 (845)
.|...+.||+|+||.||+|... + +..||+|............+.+|+++++.++||||+++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3788899999999999999854 3 6788889876555555567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 703 SNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 703 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
++|+|.++++.. ...++++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~- 223 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV- 223 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc-
Confidence 999999988652 3456889999999999999999999988 9999999999999999999999999998654221
Q ss_pred CCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.........||++|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 224 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~ 274 (478)
T PTZ00267 224 ----SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP 274 (478)
T ss_pred ----ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 111233456999999999999999999999999999999999999999754
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=308.58 Aligned_cols=197 Identities=29% Similarity=0.435 Sum_probs=174.4
Q ss_pred CCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
-|...+.||+|+-|.|-.|+. .+|+.+|||++.... ......+.+|+.+|+-+.|||++++|+++++..+.|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 466678999999999999995 579999999987542 2224567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
|+++|-|.+++-++ +++.+....+++.||+.|+.|+|..+ |+||||||+|+|+|+.+++||+|||+|..-.
T Consensus 93 yv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~---- 163 (786)
T KOG0588|consen 93 YVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV---- 163 (786)
T ss_pred ecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc----
Confidence 99999999999665 45888899999999999999999999 9999999999999999999999999997643
Q ss_pred CCccccceeecccCCCCccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
++....+.+|++.|.|||++++..| +.++||||.|||+|.|+||+.||++
T Consensus 164 ----~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD 214 (786)
T KOG0588|consen 164 ----PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD 214 (786)
T ss_pred ----CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC
Confidence 2334456789999999999999887 5689999999999999999999983
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=313.93 Aligned_cols=208 Identities=26% Similarity=0.334 Sum_probs=177.8
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|.+.+.||+|+||.||+|... +|+.||||+++... ....+.+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999975 68999999987532 233467889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999999765 56889999999999999999999988 9999999999999999999999999997654321
Q ss_pred CC----------------------CccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IE----------------------GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~----------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.. ............||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 00 0000011234568999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=298.18 Aligned_cols=192 Identities=23% Similarity=0.370 Sum_probs=166.2
Q ss_pred CccccccCceEEEEEEeCCCcEEEEEEccCCChhh---HHHHHHHHHHHHhcCCCceeeEEEEEee----CCeEEEEEEc
Q 003140 629 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRLHHRNLVSLVGYCDE----EGEQMLVYEF 701 (845)
Q Consensus 629 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~---~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~LV~E~ 701 (845)
...||+|++|.||+|.+ +|+.||||+++...... .+.|.+|+++|++++||||++++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999998 68999999987643322 4678899999999999999999999876 3468999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
+++|+|.++++.. ..+++.....++.+++.||.|||+. + ++||||||+|||+++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 104 CTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 9999999999764 4688999999999999999999984 5 7899999999999999999999999998653221
Q ss_pred CCccccceeecccCCCCccchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 178 ---------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~ 226 (283)
T PHA02988 178 ---------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT 226 (283)
T ss_pred ---------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC
Confidence 12357889999999976 689999999999999999999999997653
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=304.64 Aligned_cols=200 Identities=23% Similarity=0.365 Sum_probs=171.1
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCC-CceeeEEEEEeeCCeEEEEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHH-RNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~LV~ 699 (845)
+|.+.+.||+|+||.||+|... +++.||||++.... ....+.+..|.++++.++| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999965 57899999987532 2334568889999999966 56888999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~- 154 (324)
T cd05587 81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG- 154 (324)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC-
Confidence 999999999998654 35789999999999999999999998 999999999999999999999999998743211
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
........||..|+|||++.+..++.++||||+||++|||+||+.||...+
T Consensus 155 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (324)
T cd05587 155 ------GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205 (324)
T ss_pred ------CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 112234568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=299.86 Aligned_cols=208 Identities=26% Similarity=0.388 Sum_probs=185.2
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
..+.|..-++||+|+||.||-+... +|+.+|.|++.... ..++...+.|-.++.+++.+.||.+-..|+..+..++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 3456778899999999999999865 69999999886532 3445667899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
|+..|.||+|.-+|...+...+++...+-++.+|+.||++||+.. ||.||+||+|||+|+.|+++|+|.|+|..++.
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999998887778999999999999999999999998 99999999999999999999999999987753
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCcee
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 840 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~ 840 (845)
. ......+||.||||||++....|+...|.||+||++|||+.|+.||...+..++
T Consensus 340 g--------~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk 394 (591)
T KOG0986|consen 340 G--------KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK 394 (591)
T ss_pred C--------CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh
Confidence 2 223445899999999999999999999999999999999999999987766554
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=308.28 Aligned_cols=195 Identities=26% Similarity=0.337 Sum_probs=168.4
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCCC
Q 003140 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 705 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g 705 (845)
+.||+|+||.||++... +|+.||+|+++... .....++.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 78999999987532 223456788999999999999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCcc
Q 003140 706 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (845)
Q Consensus 706 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 784 (845)
+|..++... ..+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~----- 150 (325)
T cd05594 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG----- 150 (325)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-----
Confidence 999988654 358899999999999999999997 57 9999999999999999999999999987532111
Q ss_pred ccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......||..|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~ 200 (325)
T cd05594 151 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 200 (325)
T ss_pred --cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC
Confidence 11233568999999999999999999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=299.49 Aligned_cols=200 Identities=26% Similarity=0.420 Sum_probs=171.0
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
++|...+.||+|+||.||+|... +++.||+|+++... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888999999999999999965 68999999986433 22345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
++ |+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-- 157 (288)
T cd07871 85 LD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-- 157 (288)
T ss_pred CC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC--
Confidence 97 5999988654 335788999999999999999999998 9999999999999999999999999997643221
Q ss_pred CccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.......++..|+|||.+.+ ..++.++||||+||++|||+||+.||...
T Consensus 158 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~ 207 (288)
T cd07871 158 -----KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS 207 (288)
T ss_pred -----ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11223457899999999865 56899999999999999999999999654
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=301.67 Aligned_cols=203 Identities=26% Similarity=0.431 Sum_probs=172.5
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
.++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999975 689999999875332 234467889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
|++ ++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 84 YVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred CCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 995 7888888654 345888899999999999999999998 9999999999999999999999999987543211
Q ss_pred CCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
.......+|..|+|||++.+ ..++.++||||+||++|||++|+.||....+
T Consensus 158 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 209 (303)
T cd07869 158 ------HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD 209 (303)
T ss_pred ------ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 11233457899999999865 4688999999999999999999999976543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=310.68 Aligned_cols=203 Identities=25% Similarity=0.340 Sum_probs=175.1
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|.+.+.||+|+||.||++... +|+.||+|+++... ....+.+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999965 68999999987532 223456889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++|+|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 999999999999764 246899999999999999999999998 9999999999999999999999999998654221
Q ss_pred CCCccccceeecccCCCCccchhhhc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFL------THKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
........||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 157 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 213 (330)
T cd05601 157 ------MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213 (330)
T ss_pred ------ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence 11223456899999999986 4567899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=306.83 Aligned_cols=202 Identities=28% Similarity=0.324 Sum_probs=171.8
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++..++|++|+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999975 57889999986422 122345788999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++|+|.+++++. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 999999999999763 235889999999999999999999998 9999999999999999999999999987543211
Q ss_pred CCCccccceeecccCCCCccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
........||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 157 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 157 ------TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred ------cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 11123356899999999986 346889999999999999999999999754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=296.98 Aligned_cols=194 Identities=25% Similarity=0.404 Sum_probs=168.1
Q ss_pred ccccCceEEEEEEeC-CCcEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCCCCH
Q 003140 632 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 707 (845)
Q Consensus 632 LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL 707 (845)
||+|+||+||++... +|+.||+|++..... ...+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999865 789999999865322 2235678899999999999999999999999999999999999999
Q ss_pred HHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCccc
Q 003140 708 RDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP 785 (845)
Q Consensus 708 ~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 785 (845)
..++... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~------ 151 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ------ 151 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC------
Confidence 9888542 3356899999999999999999999998 9999999999999999999999999997653221
Q ss_pred cceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 786 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 786 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 152 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 152 -SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred -ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 1122346899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=299.65 Aligned_cols=202 Identities=25% Similarity=0.356 Sum_probs=172.9
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
++|++.+.||+|+||.||+|... +++.||||+++... ....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888999999999999999975 68899999987532 2234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
|++++.+..+... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 154 (287)
T cd07848 81 YVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS- 154 (287)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc-
Confidence 9998877655432 345889999999999999999999988 9999999999999999999999999998653221
Q ss_pred CCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
........||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~ 205 (287)
T cd07848 155 -----NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES 205 (287)
T ss_pred -----cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence 111223468899999999998899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=303.25 Aligned_cols=195 Identities=25% Similarity=0.394 Sum_probs=166.0
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeEEEEEEcCCC
Q 003140 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~~ 704 (845)
+.||+|+||.||+|... +++.||||.++... ....+.+..|.+++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 58899999987532 22334566777777654 899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCcc
Q 003140 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (845)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 784 (845)
|+|..++... ..+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~----- 150 (316)
T cd05592 81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE----- 150 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-----
Confidence 9999998654 35888999999999999999999998 9999999999999999999999999997543211
Q ss_pred ccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......||..|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~ 200 (316)
T cd05592 151 --GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200 (316)
T ss_pred --CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Confidence 12234568999999999999899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=311.69 Aligned_cols=210 Identities=27% Similarity=0.454 Sum_probs=175.0
Q ss_pred HHHHHhcCCCCCccccccCceEEEEEEeC------CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEE
Q 003140 618 EMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYC 689 (845)
Q Consensus 618 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~ 689 (845)
.+....++|++.+.||+|+||.||+|... ++..||||+++... ....+.+.+|+++++.+ +|+||++++++|
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 34455678999999999999999998742 34589999997543 33345788999999999 899999999999
Q ss_pred eeCCeEEEEEEcCCCCCHHHHHhccC------------------------------------------------------
Q 003140 690 DEEGEQMLVYEFMSNGTLRDQLSAKS------------------------------------------------------ 715 (845)
Q Consensus 690 ~~~~~~~LV~E~~~~gsL~~~l~~~~------------------------------------------------------ 715 (845)
...+..++||||+++|+|.++++...
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 99999999999999999999986421
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 716 --------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 716 --------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
..++++...++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~-- 266 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS-- 266 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCc--
Confidence 124788899999999999999999988 9999999999999999999999999997653221
Q ss_pred CccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
.........++..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 267 ---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~ 318 (374)
T cd05106 267 ---NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGI 318 (374)
T ss_pred ---ceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccc
Confidence 0111222335678999999999999999999999999999997 99999653
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=305.90 Aligned_cols=202 Identities=27% Similarity=0.444 Sum_probs=180.5
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCe-EEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE-QMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~-~~LV~ 699 (845)
++|...+.+|+|+||.++..+.+ ++..+++|++.-... ...+...+|+.++++++|||||.+.+.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999988865 678999998765432 223467899999999999999999999999888 99999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
+|++||++.+.+.+..+..+++.+...++.|++.|+.|||++. |+|||||+.|||++.+..+||+|||+|+.+..++
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999998887788999999999999999999999888 9999999999999999999999999999876443
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.......||+.||.||.+.+..|..|+||||+||++|||.+-+.+|...
T Consensus 161 -------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~ 209 (426)
T KOG0589|consen 161 -------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS 209 (426)
T ss_pred -------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc
Confidence 1234578999999999999999999999999999999999999999643
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=298.31 Aligned_cols=201 Identities=29% Similarity=0.435 Sum_probs=169.1
Q ss_pred cCCCCCccccccCceEEEEEEeC--CCcEEEEEEccCCCh--hhHHHHHHHHHHHHhc---CCCceeeEEEEEe-----e
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP--DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRL---HHRNLVSLVGYCD-----E 691 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vAVK~~~~~~~--~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~-----~ 691 (845)
++|.+.+.||+|+||.||+|... +|+.||||+++.... .....+.+|+++++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999863 468899998864322 2234566777777765 6999999999885 2
Q ss_pred CCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 003140 692 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 771 (845)
Q Consensus 692 ~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGl 771 (845)
....++||||++ ++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999996 79999998766667899999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
++..... .......||..|+|||.+....++.++|||||||++|||++|+.||....
T Consensus 157 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 213 (290)
T cd07862 157 ARIYSFQ--------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213 (290)
T ss_pred eEeccCC--------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence 9765321 11234568999999999988899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=304.69 Aligned_cols=198 Identities=27% Similarity=0.429 Sum_probs=168.2
Q ss_pred CCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHH---HhcCCCceeeEEEEEeeCCeEEEE
Q 003140 626 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFL---SRLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 626 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l---~~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
|.+.+.||+|+||.||+|... +|+.||||+++... ....+.+.+|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999965 68999999987532 22234566666554 567899999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
|||+++|+|..+++. ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999988854 35899999999999999999999998 999999999999999999999999998753211
Q ss_pred CCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
........|++.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 155 -------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~ 205 (324)
T cd05589 155 -------GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205 (324)
T ss_pred -------CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Confidence 111234568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=310.48 Aligned_cols=199 Identities=27% Similarity=0.406 Sum_probs=173.4
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcC-C-----CceeeEEEEEeeCCeEEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-H-----RNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~-H-----~nIv~l~g~~~~~~~~~L 697 (845)
+|.+.+.||+|+||.|.||.+. +++.||||+++.. .....+-+.|+++|..++ | -|+|+++++|...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7899999999999999999965 6999999999873 344567788999999996 4 399999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC--CcEEEEecCCcccC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK--FTAKVADFGLSRLA 775 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~--~~~kl~DFGla~~~ 775 (845)
|+|.+ .-+|+++++.+....++....+.|+.||+.||..||+.+ |||+||||+||||.+- ..+||+|||.|...
T Consensus 266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99988 579999999988888999999999999999999999998 9999999999999654 48999999999875
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCce
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 839 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~ 839 (845)
... ......+..|+|||++.+..|+.+.||||||||++||++| .|+..|++..
T Consensus 342 ~q~----------vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG-~PLfpG~ne~ 394 (586)
T KOG0667|consen 342 SQR----------VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTG-EPLFPGDNEY 394 (586)
T ss_pred CCc----------ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcC-ccccCCCCHH
Confidence 321 1144567899999999999999999999999999999999 5655555543
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=303.37 Aligned_cols=195 Identities=27% Similarity=0.421 Sum_probs=168.0
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeEEEEEEcCCC
Q 003140 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~~ 704 (845)
+.||+|+||.||+|... +++.||||+++... ....+.+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 68999999987532 22345678888888877 699999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCcc
Q 003140 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (845)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 784 (845)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~------ 149 (320)
T cd05590 81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN------ 149 (320)
T ss_pred chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC------
Confidence 9999998654 35889999999999999999999998 999999999999999999999999998753211
Q ss_pred ccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 200 (320)
T cd05590 150 -GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN 200 (320)
T ss_pred -CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 112234568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=305.76 Aligned_cols=199 Identities=27% Similarity=0.346 Sum_probs=169.8
Q ss_pred CCCCCccccccCceEEEEEEe----CCCcEEEEEEccCCC----hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeE
Q 003140 625 NFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGS----LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQ 695 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~----~~g~~vAVK~~~~~~----~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 695 (845)
+|++.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+++++++ +|++|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999875 358899999986432 22345678899999999 599999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++||||+++|+|.+++... ..+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 9999999999999998653 35889999999999999999999998 999999999999999999999999999764
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
.... ........||..|+|||++.+. .++.++|||||||++|||+||+.||..
T Consensus 156 ~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 156 LSEE------KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred cccC------CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 3221 1112245689999999998765 478899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=310.36 Aligned_cols=209 Identities=28% Similarity=0.455 Sum_probs=174.4
Q ss_pred HHHHhcCCCCCccccccCceEEEEEEe------CCCcEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEEe
Q 003140 619 MALATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCD 690 (845)
Q Consensus 619 ~~~~~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~ 690 (845)
+....++|...+.||+|+||.||+|.+ .++..||||+++... ....+.+.+|+++++.+ +||||++++++|.
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 344456788899999999999999973 246689999987543 33456789999999999 8999999999999
Q ss_pred eCCeEEEEEEcCCCCCHHHHHhccC-------------------------------------------------------
Q 003140 691 EEGEQMLVYEFMSNGTLRDQLSAKS------------------------------------------------------- 715 (845)
Q Consensus 691 ~~~~~~LV~E~~~~gsL~~~l~~~~------------------------------------------------------- 715 (845)
+.+..++||||+++|+|.++++...
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 9999999999999999999986432
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 716 ------------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 716 ------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 124788999999999999999999988 99999999999999999999999999986542
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
... ........++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 267 ~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~ 320 (375)
T cd05104 267 DSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320 (375)
T ss_pred ccc-----ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence 210 111122335678999999999999999999999999999998 89998653
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=303.91 Aligned_cols=195 Identities=26% Similarity=0.401 Sum_probs=168.0
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeEEEEEEcCCC
Q 003140 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~~ 704 (845)
+.||+|+||.||+|... +++.||||+++... ....+.+..|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999975 57899999987532 22345678899999876 799999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCcc
Q 003140 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (845)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 784 (845)
|+|..++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~----- 150 (321)
T cd05591 81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG----- 150 (321)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC-----
Confidence 9999988654 35889999999999999999999998 9999999999999999999999999987532211
Q ss_pred ccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 200 (321)
T cd05591 151 --VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200 (321)
T ss_pred --ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC
Confidence 11234568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=302.72 Aligned_cols=200 Identities=25% Similarity=0.422 Sum_probs=174.8
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
..++|++.+.||+|+||.||++... ++..+|+|.+.... ....+++.+|++++++++|+||+++++++.+.+..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3478999999999999999999976 68899999877542 233467899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
||+++|+|.+++... ..+++.....++.|+++||.|||+. + |+||||||+|||+++++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 83 EHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999999654 3578899999999999999999975 5 999999999999999999999999998754321
Q ss_pred CCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 ---------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ---------ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 112346889999999999889999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=304.55 Aligned_cols=192 Identities=26% Similarity=0.395 Sum_probs=166.8
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEccCC---ChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeEEEEEEcCCC
Q 003140 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEG---SLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~~ 704 (845)
+.||+|+||.||+|... +++.||+|+++.. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 6889999998753 223345678899988877 899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCcc
Q 003140 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (845)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 784 (845)
|+|..++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~------ 149 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP------ 149 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC------
Confidence 9999988654 45889999999999999999999998 999999999999999999999999998753211
Q ss_pred ccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003140 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833 (845)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~ 833 (845)
........||..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 150 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred -CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 111234568999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=293.75 Aligned_cols=203 Identities=27% Similarity=0.468 Sum_probs=177.7
Q ss_pred HhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
..++|+..+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 456788899999999999999998888899999987543 3356899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+++|+|.++++......+++..++.++.|+++||+|||+.+ ++||||||+||++++++.++|+|||+++......
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-- 157 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNE-- 157 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCc--
Confidence 99999999998766667899999999999999999999988 9999999999999999999999999998654221
Q ss_pred CccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 834 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~ 834 (845)
........++..|+|||++....++.++|||||||++|||+| |+.||..
T Consensus 158 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~ 207 (261)
T cd05072 158 ----YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG 207 (261)
T ss_pred ----eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC
Confidence 111122345678999999988889999999999999999998 9999964
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=292.98 Aligned_cols=193 Identities=26% Similarity=0.423 Sum_probs=168.7
Q ss_pred ccccCceEEEEEEeC-CCcEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCCCCH
Q 003140 632 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 707 (845)
Q Consensus 632 LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL 707 (845)
||+|+||.||++... +|+.||+|.+..... ...+.+..|++++++++||||+++++++.+....++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999865 689999998864222 2234567799999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCccccc
Q 003140 708 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 787 (845)
Q Consensus 708 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 787 (845)
.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++...... .
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--------~ 149 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--------K 149 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC--------c
Confidence 99987766667899999999999999999999988 999999999999999999999999998765321 1
Q ss_pred eeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 788 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
......|+..|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 123356899999999999888999999999999999999999999653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=304.17 Aligned_cols=192 Identities=26% Similarity=0.384 Sum_probs=167.5
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeEEEEEEcCCC
Q 003140 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~~ 704 (845)
+.||+|+||.||++... +++.||||+++... ....+.+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999965 68999999987532 22345688899999998 799999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCcc
Q 003140 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (845)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 784 (845)
|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~------ 149 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP------ 149 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC------
Confidence 9999988654 46899999999999999999999998 999999999999999999999999998743211
Q ss_pred ccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003140 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833 (845)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~ 833 (845)
........||..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 197 (329)
T cd05588 150 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred -CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcc
Confidence 112234578999999999999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=302.63 Aligned_cols=200 Identities=24% Similarity=0.365 Sum_probs=170.8
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCeEEEEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~ 699 (845)
+|+..+.||+|+||.||+|... +|+.||+|++.... ....+.+..|.++++.+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677889999999999999965 68999999987532 223456788999998885 577888999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999999998654 35889999999999999999999998 9999999999999999999999999987532211
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......||..|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 156 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (323)
T cd05615 156 -------VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205 (323)
T ss_pred -------ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Confidence 11233468999999999998899999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=293.65 Aligned_cols=203 Identities=24% Similarity=0.401 Sum_probs=172.3
Q ss_pred hcCCCCCccccccCceEEEEEEeC----CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
.++|++.+.||+|+||.||+|.+. .+..||+|.++... ....+.|.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 456888899999999999999853 36789999988643 2334679999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ ++||||||+|||++.++.++++|||.+.....
T Consensus 84 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999997643 46899999999999999999999998 99999999999999999999999998765321
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
.. ........++..|+|||.+.+..++.++|||||||++||+++ |+.||...
T Consensus 160 ~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~ 212 (266)
T cd05064 160 EA------IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred cc------hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 11 011112335678999999999999999999999999999875 99999754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=299.91 Aligned_cols=195 Identities=27% Similarity=0.425 Sum_probs=166.8
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeEEEEEEcCCC
Q 003140 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~~ 704 (845)
+.||+|+||.||+|... +++.||||+++... ....+.+..|..+++.. +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 57899999987532 22345567788888765 899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCcc
Q 003140 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (845)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 784 (845)
|+|.+++... ..+++.....++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....+
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~----- 150 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD----- 150 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-----
Confidence 9999999653 45788999999999999999999998 9999999999999999999999999987532111
Q ss_pred ccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......||..|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (316)
T cd05619 151 --AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200 (316)
T ss_pred --CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Confidence 11234568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=308.34 Aligned_cols=195 Identities=25% Similarity=0.301 Sum_probs=169.7
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
..+|.+.+.||+|+||.||++... +++.||+|.... +.+.+|++++++++||||+++++++...+..++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 357999999999999999999964 689999997542 3578899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+. ++|..++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 165 ~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-- 236 (391)
T PHA03212 165 YK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-- 236 (391)
T ss_pred CC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc--
Confidence 95 7898888654 35889999999999999999999998 9999999999999999999999999997532211
Q ss_pred CccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 237 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~ 286 (391)
T PHA03212 237 ----ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK 286 (391)
T ss_pred ----ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCc
Confidence 11223457999999999999999999999999999999999999998654
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=323.54 Aligned_cols=208 Identities=27% Similarity=0.432 Sum_probs=174.6
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|++.+.||+|+||.||+|... +|+.||+|++.... ....++|.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47888999999999999999975 58999999987532 223467999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcc---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 003140 700 EFMSNGTLRDQLSAK---------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 770 (845)
Q Consensus 700 E~~~~gsL~~~l~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFG 770 (845)
||+++|+|.+++... ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998642 1234567888999999999999999998 9999999999999999999999999
Q ss_pred CcccCCCCCCCCc-----------cccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 771 LSRLAPVPDIEGI-----------VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 771 la~~~~~~~~~~~-----------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
+++.....+.... ..........||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9986521110000 000111234699999999999999999999999999999999999999965
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=303.99 Aligned_cols=195 Identities=29% Similarity=0.413 Sum_probs=165.9
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHH-HHHhcCCCceeeEEEEEeeCCeEEEEEEcCCC
Q 003140 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQ-FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 704 (845)
+.||+|+||.||+|... +|+.||+|++.... ....+++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999964 68999999986432 223345666655 56778999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCcc
Q 003140 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (845)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 784 (845)
|+|..++... ..+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~------ 149 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ------ 149 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC------
Confidence 9999988653 46889999999999999999999998 999999999999999999999999998753211
Q ss_pred ccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
........||..|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (325)
T cd05604 150 -SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD 200 (325)
T ss_pred -CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC
Confidence 112234568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=300.21 Aligned_cols=195 Identities=26% Similarity=0.398 Sum_probs=167.0
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeEEEEEEcCCC
Q 003140 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~~ 704 (845)
+.||+|+||.||+|... +|+.||+|.++... ....+.+..|.+++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999975 68999999987532 12344567788888765 899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCcc
Q 003140 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (845)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 784 (845)
|+|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~------ 149 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG------ 149 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC------
Confidence 9999998654 45788999999999999999999998 999999999999999999999999998743211
Q ss_pred ccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
........||..|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~ 200 (316)
T cd05620 150 -DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200 (316)
T ss_pred -CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 112334568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=303.04 Aligned_cols=202 Identities=30% Similarity=0.431 Sum_probs=168.8
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----CeEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GEQM 696 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~ 696 (845)
+|++.+.||+|+||.||+|... +|+.||||++... ......++.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999964 6899999998743 223445789999999999999999999988543 2479
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCC
Q 003140 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~ 776 (845)
+||||++ ++|.+++... ..+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 7999988654 35889999999999999999999998 9999999999999999999999999997543
Q ss_pred CCCCCCccccceeecccCCCCccchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
..... ........||..|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus 155 ~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 155 NDTPT----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred cccCc----cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 22110 111234568999999999875 678999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=289.64 Aligned_cols=202 Identities=32% Similarity=0.501 Sum_probs=174.3
Q ss_pred cCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCC
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 703 (845)
++|+..+.||+|+||.||++.+.++..+|+|.+.... ...++|.+|++++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4577888999999999999999888899999886533 335689999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCc
Q 003140 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (845)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 783 (845)
+|+|.++++... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~--- 155 (256)
T cd05114 83 NGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY--- 155 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce---
Confidence 999999997543 35889999999999999999999998 99999999999999999999999999876532211
Q ss_pred cccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
.......++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~ 206 (256)
T cd05114 156 ---TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS 206 (256)
T ss_pred ---eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 11122335568999999988889999999999999999999 999997543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=275.56 Aligned_cols=213 Identities=27% Similarity=0.387 Sum_probs=179.6
Q ss_pred HHhcCCCCCccccccCceEEEEEE-eCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----Ce
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GE 694 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~ 694 (845)
+..++|.+.+.||+|||+.||.++ ..++..+|+|++...+.++.+..++|++..++++|||+++++++...+ .+
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 345789999999999999999998 568999999999988888888999999999999999999999887433 35
Q ss_pred EEEEEEcCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 003140 695 QMLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 772 (845)
Q Consensus 695 ~~LV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla 772 (845)
.||+++|...|+|.+.+... .+..+++.+.++|+.++++||++||+.. ||+.||||||.|||+.+.+.+++.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 89999999999999999763 4457999999999999999999999975 78999999999999999999999999998
Q ss_pred ccCCCCCC--CCccccceeecccCCCCccchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 773 RLAPVPDI--EGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 773 ~~~~~~~~--~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
...+..-. .....-+.......|..|+|||.+. +...++++|||||||++|+|+.|..||+.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 76542210 0001111223345789999999985 45678999999999999999999999973
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=279.13 Aligned_cols=205 Identities=28% Similarity=0.450 Sum_probs=177.5
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh----hh----HHHHHHHHHHHHhc-CCCceeeEEEEEee
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL----QG----EKEFLTEIQFLSRL-HHRNLVSLVGYCDE 691 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~----~~----~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~ 691 (845)
.-.+|...+.+|+|..+.|.++..+ .|..+|+|++..... +. .+.-.+|+.+|+++ .||+|+++.++|+.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3456788899999999999988865 688999998764221 11 23456799999998 79999999999999
Q ss_pred CCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 003140 692 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 771 (845)
Q Consensus 692 ~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGl 771 (845)
+...++|+|.|+.|.|.++|.. .-.++++....|+.|+..|++|||..+ ||||||||+|||+|++.++||+|||.
T Consensus 95 ~sF~FlVFdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred cchhhhhhhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccce
Confidence 9999999999999999999954 346899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCCCccccceeecccCCCCccchhhhcC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCce
Q 003140 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT------HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 839 (845)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~ 839 (845)
|..++ ++......+||++|+|||.+.. ..|+...|+||.||+||.|+.|..||.|.+.+.
T Consensus 170 a~~l~--------~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml 235 (411)
T KOG0599|consen 170 ACQLE--------PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML 235 (411)
T ss_pred eeccC--------CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH
Confidence 98765 3445677899999999998853 468889999999999999999999999987654
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=298.05 Aligned_cols=202 Identities=29% Similarity=0.395 Sum_probs=177.1
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
..|...+.||+|.||.||||.+. .++.||+|++.-.. ....++.++|+.++.+++++||.+.||.+..+...+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 45677789999999999999964 68999999987543 34457899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
|.+|++.+.++.. ..+++.....|..++..|+.|||.++ .+|||||+.|||+..+|.+|++|||.+-.+....
T Consensus 93 ~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~-- 165 (467)
T KOG0201|consen 93 CGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV-- 165 (467)
T ss_pred hcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh--
Confidence 9999999999543 34477777788999999999999999 9999999999999999999999999987654322
Q ss_pred CccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
....+.+||+.|||||++....|+.|+||||||++.+||.+|..|+....-
T Consensus 166 -----~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP 216 (467)
T KOG0201|consen 166 -----KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP 216 (467)
T ss_pred -----hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc
Confidence 223568899999999999988999999999999999999999999976554
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=293.06 Aligned_cols=200 Identities=41% Similarity=0.611 Sum_probs=169.1
Q ss_pred CCccccccCceEEEEEEeC-----CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 628 SSTQIGQGGYGKVYKGILP-----DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 628 ~~~~LG~G~fG~Vy~~~~~-----~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
..+.||.|.||.||+|.+. .+..|+||.++... ....++|.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999976 35789999997643 33478899999999999999999999999988889999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+++|+|.++++......+++..+..|+.||++||.|||+.+ ++||||+++||++++++.+||+|||+++......
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~-- 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS-- 157 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS--
T ss_pred ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--
Confidence 99999999998876678999999999999999999999998 9999999999999999999999999998752211
Q ss_pred CccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
.............|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 158 ---~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~ 209 (259)
T PF07714_consen 158 ---KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY 209 (259)
T ss_dssp ---SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred ---cccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 1122233446688999999999899999999999999999999 78998654
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=293.71 Aligned_cols=200 Identities=28% Similarity=0.432 Sum_probs=174.4
Q ss_pred CCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 626 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 626 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
|+..+.||+|+||.||++... +++.||||.+..... ...+.+.+|+.++++++|++++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667788999999999999965 689999998865322 2235678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+++|+|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 99999999997665567899999999999999999999988 9999999999999999999999999987543211
Q ss_pred CccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 157 ------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 157 ------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred ------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 1123468999999999999999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=308.93 Aligned_cols=199 Identities=31% Similarity=0.469 Sum_probs=171.8
Q ss_pred CCCCccccccCceEEEEEEe-CCCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC------CeEEE
Q 003140 626 FNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------GEQML 697 (845)
Q Consensus 626 f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~~L 697 (845)
+...+.||+|+||.||+|+. ..|+.||||.++... ....+...+|+++|++++|+|||++++.-++. +...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 34467899999999999995 579999999988643 34456778999999999999999999986543 46799
Q ss_pred EEEcCCCCCHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc--CCC--cEEEEecCCc
Q 003140 698 VYEFMSNGTLRDQLSAK-SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD--HKF--TAKVADFGLS 772 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~--~~~--~~kl~DFGla 772 (845)
|||||.+|||...+.+. ....+++...+.+..+++.||.|||+++ |+||||||.||++- ++| .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999999999999874 3456999999999999999999999998 99999999999983 334 5699999999
Q ss_pred ccCCCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
|.++. +.......||..|.+||+... +.|+..+|.|||||++||++||..||.+-
T Consensus 172 rel~d--------~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 172 RELDD--------NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred ccCCC--------CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 98753 235677899999999999994 88999999999999999999999999753
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=301.97 Aligned_cols=194 Identities=28% Similarity=0.413 Sum_probs=165.3
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHH-HHHhcCCCceeeEEEEEeeCCeEEEEEEcCCC
Q 003140 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQ-FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 704 (845)
+.||+|+||+||+|... +|+.||+|++.... ....+++.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999975 68999999986432 122345555654 56789999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCcc
Q 003140 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (845)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 784 (845)
|+|..++... ..+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~------ 149 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH------ 149 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC------
Confidence 9999998653 46889999999999999999999998 999999999999999999999999998753211
Q ss_pred ccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 199 (323)
T cd05575 150 -SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (323)
T ss_pred -CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC
Confidence 11223456899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=301.94 Aligned_cols=195 Identities=29% Similarity=0.426 Sum_probs=164.9
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEccCCCh---hhHHHHHHHHH-HHHhcCCCceeeEEEEEeeCCeEEEEEEcCCC
Q 003140 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQ-FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 704 (845)
+.||+|+||.||+|... +|+.||+|++..... ...+++.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 689999999864322 22345556654 67889999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCcc
Q 003140 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (845)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 784 (845)
|+|..++... ..+++.....++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~------ 149 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP------ 149 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC------
Confidence 9999888653 45788888899999999999999988 999999999999999999999999998753211
Q ss_pred ccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (321)
T cd05603 150 -EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (321)
T ss_pred -CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence 111234568999999999998899999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=300.31 Aligned_cols=193 Identities=24% Similarity=0.377 Sum_probs=167.7
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEccCCCh---hhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeEEEEEEcCCC
Q 003140 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~~ 704 (845)
+.||+|+||+||+|... +++.||+|+++.... ...+.+.+|+.++.++ +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 678999999875322 2345688999999888 699999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCcc
Q 003140 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (845)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 784 (845)
|+|..++... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~------ 149 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP------ 149 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC------
Confidence 9999988654 35899999999999999999999998 999999999999999999999999998753211
Q ss_pred ccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 150 -GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred -CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 1122345689999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=306.41 Aligned_cols=209 Identities=26% Similarity=0.406 Sum_probs=175.1
Q ss_pred HHHHHhcCCCCCccccccCceEEEEEEeC------CCcEEEEEEccCCCh-hhHHHHHHHHHHHHhcC-CCceeeEEEEE
Q 003140 618 EMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLH-HRNLVSLVGYC 689 (845)
Q Consensus 618 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~~-~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~ 689 (845)
.+....++|.+.+.||+|+||.||+|... .+..||||+++.... ...+.+.+|+++++++. ||||+++++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 45556788999999999999999999852 234799999975433 33467999999999996 99999999999
Q ss_pred eeCCeEEEEEEcCCCCCHHHHHhccC------------------------------------------------------
Q 003140 690 DEEGEQMLVYEFMSNGTLRDQLSAKS------------------------------------------------------ 715 (845)
Q Consensus 690 ~~~~~~~LV~E~~~~gsL~~~l~~~~------------------------------------------------------ 715 (845)
.+.+..++||||+++|+|.++++...
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 99999999999999999999886521
Q ss_pred ----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 003140 716 ----------------------------------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 755 (845)
Q Consensus 716 ----------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~N 755 (845)
...+++..+..++.|+++||+|||+.+ |+||||||+|
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~N 267 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHh
Confidence 124788889999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 003140 756 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 834 (845)
Q Consensus 756 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~ 834 (845)
||++.++.+||+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~ 342 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDSN-----YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342 (400)
T ss_pred EEEeCCCEEEEEeCCcceecccccc-----ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence 9999999999999999986532211 111122346788999999999999999999999999999997 9999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=293.36 Aligned_cols=200 Identities=28% Similarity=0.411 Sum_probs=174.4
Q ss_pred CCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 626 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 626 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
|...+.||+|+||+||+|... +++.||+|.+..... ...+.+.+|++++++++|+||+++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999964 689999999865322 2234678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+++|+|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 99999999987665567999999999999999999999998 9999999999999999999999999987643211
Q ss_pred CccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
......|+..|+|||++.+..++.++|+|||||++|||++|+.||....
T Consensus 157 ------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~ 205 (285)
T cd05632 157 ------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205 (285)
T ss_pred ------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 1123468999999999998899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=316.72 Aligned_cols=216 Identities=23% Similarity=0.358 Sum_probs=177.8
Q ss_pred HHhcCCCCCccccccCceEEEEEEeCCC-cEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCceeeEEEE-Eee------
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGILPDG-TVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGY-CDE------ 691 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~g-~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~-~~~------ 691 (845)
++..++++.+.|.+|||+.||.|.+..+ ..||+|++-..+....+...+|+++|++|+ |+|||.+++. ...
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 3445667788999999999999998765 999999988777777888999999999996 9999999993 211
Q ss_pred CCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 003140 692 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 771 (845)
Q Consensus 692 ~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGl 771 (845)
.-+++|.||||++|.|-+++.......|++..+++|+.|+++|+.+||.. +|||||||||-+||||+.++..||||||-
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 23689999999999999999876556699999999999999999999986 58999999999999999999999999999
Q ss_pred cccCCCC--CCCCccccceeecccCCCCccchhhh---cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 772 SRLAPVP--DIEGIVPAHVSTVVKGTPGYLDPEYF---LTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 772 a~~~~~~--~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
|.-.... ...+...-........|+.|+|||++ .+..+++|+|||++||+||-|+..+.||+....
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~ 263 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK 263 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc
Confidence 8632211 10000000111223578999999987 466899999999999999999999999987643
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=308.63 Aligned_cols=198 Identities=32% Similarity=0.493 Sum_probs=170.0
Q ss_pred CCCccccccCceEEEEEEe-CCCc----EEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 627 NSSTQIGQGGYGKVYKGIL-PDGT----VVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 627 ~~~~~LG~G~fG~Vy~~~~-~~g~----~vAVK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
...++||+|+||+||||.+ ++|+ +||+|++... ..+..+++++|+-+|.+++|||+++++|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3467899999999999995 4443 6899987653 4555789999999999999999999999998765 889999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
||+.|+|.+|++.+. ..+.-...+.|..|||+||.|||++. +|||||.++||||.+-..+||+|||+|+.+...+.
T Consensus 778 ~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred hcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999998754 46888899999999999999999888 99999999999999999999999999998764432
Q ss_pred CCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 834 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~ 834 (845)
+ ......+-.+.|||-|.+....|+.++|||||||++||++| |..|+++
T Consensus 854 e-----y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g 903 (1177)
T KOG1025|consen 854 E-----YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG 903 (1177)
T ss_pred c-----ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC
Confidence 2 11122233478999999999999999999999999999999 9999975
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=290.33 Aligned_cols=205 Identities=30% Similarity=0.498 Sum_probs=177.6
Q ss_pred HHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
+..++|+..+.||+|++|.||+|...+++.||+|.++... ...+++.+|++++++++|+||+++++++...+..++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 3456788899999999999999998888899999987643 345679999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
|+++++|.+++.......+++..+..++.|++.|+.|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 999999999997765567899999999999999999999998 99999999999999999999999999987642211
Q ss_pred CCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
. .......+..|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 159 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 208 (261)
T cd05068 159 E------AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM 208 (261)
T ss_pred c------ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 0 0111223457999999998899999999999999999999 99999653
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=300.41 Aligned_cols=194 Identities=27% Similarity=0.388 Sum_probs=163.8
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEccCCCh---hhHHHHHHHH-HHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCC
Q 003140 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEI-QFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei-~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 704 (845)
+.||+|+||.||+|... +++.||+|++..... ...+++.+|. .+++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999975 678899999865321 2233455554 456788999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCcc
Q 003140 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (845)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 784 (845)
|+|.+++... ..+.+.....++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~------ 149 (325)
T cd05602 81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH------ 149 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC------
Confidence 9999999653 34778888889999999999999998 999999999999999999999999998753221
Q ss_pred ccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
........||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (325)
T cd05602 150 -NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (325)
T ss_pred -CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC
Confidence 11223456899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=302.94 Aligned_cols=195 Identities=28% Similarity=0.376 Sum_probs=169.2
Q ss_pred ccccccCceEEEEEEe----CCCcEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCC
Q 003140 630 TQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~----~~g~~vAVK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 703 (845)
+.||+|+||.||++.. .+|+.||+|+++.... .....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 3689999999875322 234567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCc
Q 003140 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (845)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 783 (845)
+|+|.+++.+. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~---- 152 (318)
T cd05582 82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE---- 152 (318)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC----
Confidence 99999999653 45899999999999999999999998 9999999999999999999999999987643211
Q ss_pred cccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......||..|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 202 (318)
T cd05582 153 ---KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD 202 (318)
T ss_pred ---CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC
Confidence 11234568999999999998889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=314.88 Aligned_cols=207 Identities=25% Similarity=0.352 Sum_probs=175.4
Q ss_pred HHhcCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC----
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG---- 693 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~---- 693 (845)
...++|.+.+.||+|+||.||+|.. .+|+.||||++... .......+.+|+.++..++|+|++++.+.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3457899999999999999999985 47999999998653 2334567889999999999999999988764332
Q ss_pred ----eEEEEEEcCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 003140 694 ----EQMLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVA 767 (845)
Q Consensus 694 ----~~~LV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~ 767 (845)
..++||||+++|+|.++++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEE
Confidence 368999999999999999653 3456899999999999999999999988 9999999999999999999999
Q ss_pred ecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 768 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 768 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
|||+++...... .........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 186 DFGls~~~~~~~-----~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~ 248 (496)
T PTZ00283 186 DFGFSKMYAATV-----SDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE 248 (496)
T ss_pred ecccCeeccccc-----cccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 999998654221 111223457999999999999999999999999999999999999999653
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=304.76 Aligned_cols=195 Identities=27% Similarity=0.505 Sum_probs=166.2
Q ss_pred CccccccCceEEEEEEeC-CCcEEEEEEcc--C--CChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC--eEEEEEEc
Q 003140 629 STQIGQGGYGKVYKGILP-DGTVVAVKRAQ--E--GSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG--EQMLVYEF 701 (845)
Q Consensus 629 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~--~--~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~LV~E~ 701 (845)
..+||+|+|-+||||.+. +|..||--.++ + .+....++|..|+++|+.|+|+||++++.++.+.. ...+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 567999999999999975 57788743222 1 23334578999999999999999999999997665 47899999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEEecCCcccCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~-~~~~kl~DFGla~~~~~~~~ 780 (845)
|..|+|..|+++.. ..+......|+.||++||.|||++ .|||||||||.+||+|+. .|.|||+|.|+|......
T Consensus 125 ~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s-- 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS-- 199 (632)
T ss_pred ccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc--
Confidence 99999999998764 477889999999999999999997 599999999999999975 589999999999876432
Q ss_pred CCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
......||+.|||||+.. ..|.+.+||||||++|+||+|+.+||..-.
T Consensus 200 -------~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~ 247 (632)
T KOG0584|consen 200 -------HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT 247 (632)
T ss_pred -------ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC
Confidence 123478999999999987 789999999999999999999999997433
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=303.48 Aligned_cols=194 Identities=31% Similarity=0.453 Sum_probs=163.3
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcC
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 702 (845)
+|+..+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4455788999999999999965 689999999865432 33567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCC
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 782 (845)
++|+|.+.. ...+.....++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 155 ~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--- 222 (353)
T PLN00034 155 DGGSLEGTH------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--- 222 (353)
T ss_pred CCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc---
Confidence 999986532 3456778889999999999999998 9999999999999999999999999998653211
Q ss_pred ccccceeecccCCCCccchhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 783 IVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||..
T Consensus 223 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 223 ----DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred ----ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 11233468999999998743 2345689999999999999999999973
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=297.13 Aligned_cols=194 Identities=25% Similarity=0.390 Sum_probs=167.5
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeEEEEEEcCCC
Q 003140 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~~ 704 (845)
+.||+|+||.||+|... +++.||||+++... ....+.+..|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 57899999987532 23345678899999888 799999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCcc
Q 003140 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (845)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 784 (845)
|+|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~----- 150 (318)
T cd05570 81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG----- 150 (318)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC-----
Confidence 9999988654 35899999999999999999999998 9999999999999999999999999987532111
Q ss_pred ccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 151 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~ 199 (318)
T cd05570 151 --VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199 (318)
T ss_pred --CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC
Confidence 1122346899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=291.51 Aligned_cols=205 Identities=31% Similarity=0.525 Sum_probs=174.9
Q ss_pred hcCCCCCccccccCceEEEEEEeCC------CcEEEEEEccCCChh-hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 695 (845)
.++|.+.+.||+|+||.||+|...+ ++.||||.++..... ..+.|.+|++++++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3567888999999999999998633 478999998765443 457899999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 003140 696 MLVYEFMSNGTLRDQLSAKS------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 763 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~ 763 (845)
++||||+++|+|.++++... ...+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999997542 245789999999999999999999998 999999999999999999
Q ss_pred EEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 764 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 764 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
+||+|||+++.....+. ........++..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 161 ~kl~d~g~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~ 228 (280)
T cd05049 161 VKIGDFGMSRDVYTTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL 228 (280)
T ss_pred EEECCcccceecccCcc-----eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999976432211 111122345688999999999999999999999999999998 99999653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=296.46 Aligned_cols=203 Identities=28% Similarity=0.472 Sum_probs=170.4
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCc----EEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 696 (845)
..+|+..+.||+|+||.||+|.+. +|. .||+|.++... ....+++.+|+.+++.++||||++++|+|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 356888999999999999999864 343 38999987543 34467899999999999999999999999764 567
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCC
Q 003140 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~ 776 (845)
+|+||+++|+|.++++... ..+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 85 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 9999999999999997643 35889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
.... ........++..|+|||++....++.++|||||||++|||++ |+.||.+.
T Consensus 161 ~~~~-----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~ 215 (316)
T cd05108 161 ADEK-----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 215 (316)
T ss_pred CCCc-----ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 3211 111112234678999999999999999999999999999998 99999653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=289.58 Aligned_cols=205 Identities=30% Similarity=0.490 Sum_probs=181.3
Q ss_pred HHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
....+|+..+.||+|+||.||+|...+++.+|+|.+.........++.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34567888999999999999999988899999999987666566789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
|+++|+|.++++......+++..+..++.|+++|++|||+.+ |+||||||+||++++++.+||+|||.+.......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~- 158 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV- 158 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc-
Confidence 999999999998766677999999999999999999999988 9999999999999999999999999997653221
Q ss_pred CCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
.......++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 159 ------~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~ 208 (261)
T cd05148 159 ------YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM 208 (261)
T ss_pred ------ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcC
Confidence 11123345678999999988899999999999999999998 89999654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=290.88 Aligned_cols=207 Identities=29% Similarity=0.471 Sum_probs=173.7
Q ss_pred HHhcCCCCCccccccCceEEEEEEeC------CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 693 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~ 693 (845)
+.+++|+..+.||+|+||.||+|.+. .+..||||++.... .....+|.+|+.+++.++|+||+++++++.+..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678999999999999999998753 35679999986533 334567999999999999999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEE
Q 003140 694 EQMLVYEFMSNGTLRDQLSAKS--------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAK 765 (845)
Q Consensus 694 ~~~LV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~k 765 (845)
..++||||+++|+|.++++... ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence 9999999999999999996532 234678899999999999999999988 99999999999999999999
Q ss_pred EEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 766 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 766 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
|+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 160 l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~ 225 (277)
T cd05062 160 IGDFGMTRDIYETDY-----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM 225 (277)
T ss_pred ECCCCCccccCCcce-----eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999876543221 111122345678999999998899999999999999999999 78888643
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=286.60 Aligned_cols=201 Identities=32% Similarity=0.490 Sum_probs=173.7
Q ss_pred cCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCC
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 703 (845)
++|...+.||+|+||.||+|...++..+|+|.+.... ...++|.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4577788999999999999998777789999887543 335679999999999999999999999999899999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCc
Q 003140 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (845)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 783 (845)
+|+|.+++..... .+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~---- 154 (256)
T cd05113 83 NGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE---- 154 (256)
T ss_pred CCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCc----
Confidence 9999999976433 6899999999999999999999998 9999999999999999999999999987653221
Q ss_pred cccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
........++..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 155 --~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 205 (256)
T cd05113 155 --YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF 205 (256)
T ss_pred --eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 111122345678999999988889999999999999999999 99999653
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=288.48 Aligned_cols=201 Identities=33% Similarity=0.517 Sum_probs=174.5
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcC
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 702 (845)
.+|...+.||+|+||.||+|... .++.||+|.+... ....+++.+|++++++++|+||+++++++...+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45777889999999999999965 5889999998754 334568999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCC
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 782 (845)
++++|.+++.......+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++.......
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-- 159 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-- 159 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee--
Confidence 9999999997766667899999999999999999999988 99999999999999999999999999986543211
Q ss_pred ccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 003140 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 834 (845)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~ 834 (845)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||.+
T Consensus 160 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~ 208 (263)
T cd05052 160 ----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208 (263)
T ss_pred ----eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 11112234568999999998999999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=299.35 Aligned_cols=210 Identities=32% Similarity=0.504 Sum_probs=185.9
Q ss_pred hHHHHHHhcCCCCCccccccCceEEEEEEeCC-CcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCe
Q 003140 616 YGEMALATNNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 694 (845)
Q Consensus 616 ~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 694 (845)
+++|+....+....++||.|.||.||.|.|+. .-.||||.+++... ..++|+.|..+|+.++|||+|+++|+|..+..
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 47788888888889999999999999999975 56899999998554 35699999999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003140 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (845)
Q Consensus 695 ~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~ 774 (845)
.|||+|||.+|+|.+||++-.+..++-...+.+|.||+.||+||..++ +|||||.++|+|+.++..+||+|||++++
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence 999999999999999999887777888889999999999999999998 99999999999999999999999999999
Q ss_pred CCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
+....+.. + ....-.+.|.|||.+....++.|+|||+|||+|||+.| |..||-+-
T Consensus 415 MtgDTYTA----H--AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi 470 (1157)
T KOG4278|consen 415 MTGDTYTA----H--AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI 470 (1157)
T ss_pred hcCCceec----c--cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc
Confidence 86443221 1 11123468999999999999999999999999999998 99998654
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-32 Score=289.67 Aligned_cols=203 Identities=34% Similarity=0.568 Sum_probs=172.9
Q ss_pred cCCCCCccccccCceEEEEEEeCC------CcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 696 (845)
++|+..+.||+|+||.||+|.... ...||+|.++... .....+|.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467888999999999999998642 2579999987543 333567899999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC
Q 003140 697 LVYEFMSNGTLRDQLSAKSK--------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF 762 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~ 762 (845)
++|||+++|+|.+++..... ..+++...+.++.|++.||+|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999975421 45888999999999999999999998 99999999999999999
Q ss_pred cEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 003140 763 TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 834 (845)
Q Consensus 763 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~ 834 (845)
.+||+|||+++.....+. ........++..|+|||.+.+..++.++|||||||++|||++ |..||.+
T Consensus 162 ~~~L~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~ 229 (283)
T cd05048 162 TVKISDFGLSRDIYSADY-----YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG 229 (283)
T ss_pred cEEECCCcceeecccccc-----ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999976532221 111223346788999999998899999999999999999998 9999964
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-32 Score=289.89 Aligned_cols=205 Identities=32% Similarity=0.522 Sum_probs=175.3
Q ss_pred hcCCCCCccccccCceEEEEEEe------CCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 696 (845)
.++|.+.+.||+|+||+||++.. .++..+|+|.+........+.+.+|++++++++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 46788899999999999999984 235679999988766566678999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEE
Q 003140 697 LVYEFMSNGTLRDQLSAKS-----------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAK 765 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~k 765 (845)
+||||+++|+|.+++.... ...+++..++.++.|++.||+|||+++ ++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999997532 235899999999999999999999998 99999999999999999999
Q ss_pred EEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 766 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 766 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
|+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 161 l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~ 226 (288)
T cd05093 161 IGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226 (288)
T ss_pred eccCCccccccCCce-----eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999976532210 111122335678999999998999999999999999999998 99998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=289.70 Aligned_cols=204 Identities=30% Similarity=0.508 Sum_probs=172.5
Q ss_pred cCCCCCccccccCceEEEEEEe-----CCCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
++|+..+.||+|+||.||+|.. .++..||+|.+.... ....++|.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577789999999999999984 246789999987533 3345678999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC
Q 003140 698 VYEFMSNGTLRDQLSAKS---------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF 762 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~ 762 (845)
||||+++|+|.+++.... ...+++...+.++.|++.||+|||+++ |+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999985321 235788999999999999999999998 99999999999999999
Q ss_pred cEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 763 TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 763 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
.+||+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 162 ~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05090 162 HVKISDLGLSREIYSADY-----YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF 230 (283)
T ss_pred cEEeccccccccccCCcc-----eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999986532221 111223345678999999988889999999999999999999 99999653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-32 Score=283.94 Aligned_cols=202 Identities=29% Similarity=0.478 Sum_probs=177.4
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
+|...+.||+|++|.||+|... +++.|++|.+... .....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999975 6899999987643 344567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+++++|.++++......+++..++.++.|++.||.|||+.+ |+||||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-- 155 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-- 155 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc--
Confidence 99999999998765667999999999999999999999988 9999999999999999999999999988654221
Q ss_pred CccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......|+..|+|||+..+..++.++|||||||++|||++|+.||....
T Consensus 156 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 156 -----NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred -----chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 11223457889999999999999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-32 Score=290.48 Aligned_cols=204 Identities=31% Similarity=0.544 Sum_probs=175.3
Q ss_pred cCCCCCccccccCceEEEEEEeC------CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
.+|...+.||+|+||.||+|... ++..+++|.++.......+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45777889999999999999742 356799999887666667789999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 003140 698 VYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 763 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~ 763 (845)
||||+++++|.+++.... ...+++..++.++.|++.|++|||+++ |+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999997532 234899999999999999999999998 999999999999999999
Q ss_pred EEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 764 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 764 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
++|+|||+++....... ........++..|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 162 ~~l~dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 229 (291)
T cd05094 162 VKIGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 229 (291)
T ss_pred EEECCCCcccccCCCce-----eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999976532211 111223446788999999999999999999999999999999 99998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=284.68 Aligned_cols=201 Identities=30% Similarity=0.492 Sum_probs=172.2
Q ss_pred cCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCC
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 703 (845)
.+|++.+.||+|+||.||+|.+.++..+|+|.+..... ...+|.+|++++++++|+||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 35778899999999999999987778899999865332 34578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCc
Q 003140 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (845)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 783 (845)
+++|.++++.... .+++..++.++.|+++|++|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~---- 154 (256)
T cd05059 83 NGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---- 154 (256)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccc----
Confidence 9999999976433 6899999999999999999999998 9999999999999999999999999987653211
Q ss_pred cccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 155 --~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 205 (256)
T cd05059 155 --YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF 205 (256)
T ss_pred --ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC
Confidence 011111223467999999998899999999999999999999 89998643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=301.93 Aligned_cols=200 Identities=28% Similarity=0.442 Sum_probs=169.8
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-----eEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG-----EQM 696 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~ 696 (845)
+|+..+.||+|+||.||++... +|+.||||++... .....+++.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999964 7899999998653 2234567899999999999999999999998776 789
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCC
Q 003140 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~ 776 (845)
+||||+. ++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999996 6888887543 46899999999999999999999998 9999999999999999999999999998653
Q ss_pred CCCCCCccccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
... ........+|..|+|||++.+. .++.++||||+||++|||++|+.||...+
T Consensus 155 ~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 209 (372)
T cd07853 155 PDE------SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS 209 (372)
T ss_pred cCc------cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence 221 1112334578999999998764 57999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=299.07 Aligned_cols=207 Identities=30% Similarity=0.506 Sum_probs=172.2
Q ss_pred HHHhcCCCCCccccccCceEEEEEEeC------CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEEee
Q 003140 620 ALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE 691 (845)
Q Consensus 620 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~ 691 (845)
....++|.+.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|+++++++ +|+||++++++|..
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~ 82 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK 82 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence 344568999999999999999999632 35789999987543 23346788999999999 89999999998865
Q ss_pred C-CeEEEEEEcCCCCCHHHHHhccC-------------------------------------------------------
Q 003140 692 E-GEQMLVYEFMSNGTLRDQLSAKS------------------------------------------------------- 715 (845)
Q Consensus 692 ~-~~~~LV~E~~~~gsL~~~l~~~~------------------------------------------------------- 715 (845)
. ...++||||+++|+|.+++....
T Consensus 83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 4 56889999999999999986432
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCccccceeec
Q 003140 716 ----KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 791 (845)
Q Consensus 716 ----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~ 791 (845)
..++++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..... ......
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~-----~~~~~~ 234 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-----YVRKGD 234 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcc-----hhhccC
Confidence 136899999999999999999999988 99999999999999999999999999987532210 111223
Q ss_pred ccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 003140 792 VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 834 (845)
Q Consensus 792 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~ 834 (845)
..++..|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 235 ~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~ 278 (337)
T cd05054 235 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 278 (337)
T ss_pred CCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCC
Confidence 455678999999999999999999999999999998 9999964
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=296.10 Aligned_cols=200 Identities=29% Similarity=0.459 Sum_probs=178.7
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChh---hHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCeEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~---~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~L 697 (845)
.+.|...+.||+|.||.||+++.. +|+.+|+|.+...... ..+.+.+|+++|+++. |||||.+++.+++....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 456788899999999999999976 4999999998765443 3458899999999998 9999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC----CcEEEEecCCcc
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK----FTAKVADFGLSR 773 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~----~~~kl~DFGla~ 773 (845)
|||++.||.|.+.+... .+++.....++.|++.+++|||+.+ |+||||||+|+|+... +.+|++|||+|.
T Consensus 114 vmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999998766 3899999999999999999999998 9999999999999543 579999999998
Q ss_pred cCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.... ........||++|+|||++....|+..+||||+||++|.|++|..||.+..
T Consensus 188 ~~~~--------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~ 242 (382)
T KOG0032|consen 188 FIKP--------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET 242 (382)
T ss_pred EccC--------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence 7642 234566789999999999999999999999999999999999999998765
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=285.75 Aligned_cols=204 Identities=28% Similarity=0.475 Sum_probs=176.3
Q ss_pred HHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
+..++|++.+.||+|+||.||+|...+++.||+|.+..... ..+++.+|+.++++++|+||+++++++. .+..++|||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 34567888999999999999999988899999999875433 3568999999999999999999999874 457899999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
|+++|+|.+++.......+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 156 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE- 156 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC-
Confidence 999999999998766667899999999999999999999988 9999999999999999999999999997654221
Q ss_pred CCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
........++..|+|||++....++.++||||||+++|||++ |+.||...
T Consensus 157 -----~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 207 (260)
T cd05067 157 -----YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM 207 (260)
T ss_pred -----cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 111122345678999999998899999999999999999999 99999644
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=286.82 Aligned_cols=202 Identities=32% Similarity=0.487 Sum_probs=173.0
Q ss_pred hcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcC
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 702 (845)
.++|.+.+.||+|+||.||+|.+.++..||+|+++... ...++|.+|++++++++|+||+++++++.+ +..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 45688899999999999999998777789999987533 234679999999999999999999998754 5679999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCC
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 782 (845)
++|+|.++++......+++..+..++.|+++||+|||+.+ |+||||||+||++++++.++|+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-- 157 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-- 157 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc--
Confidence 9999999998765566899999999999999999999988 99999999999999999999999999976543221
Q ss_pred ccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
.......++..|+|||+..+..++.++|||||||++|||+| |+.||...
T Consensus 158 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~ 207 (262)
T cd05071 158 ----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 207 (262)
T ss_pred ----ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 11122345678999999988899999999999999999999 88888643
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=285.50 Aligned_cols=203 Identities=31% Similarity=0.494 Sum_probs=174.1
Q ss_pred HhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
..++|++.+.||+|+||.||+|...++..||+|.+..... ..++|.+|+.++++++|+|++++++++. .+..++||||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 3457888999999999999999988888999999876433 3567999999999999999999999885 4568899999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+++++|.++++......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY- 157 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc-
Confidence 99999999998765567899999999999999999999998 99999999999999999999999999976542211
Q ss_pred CccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 158 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 207 (260)
T cd05070 158 -----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207 (260)
T ss_pred -----ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 11112235568999999988899999999999999999999 88998653
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-33 Score=277.98 Aligned_cols=215 Identities=30% Similarity=0.420 Sum_probs=176.2
Q ss_pred hcCCCCCccccccCceEEEEEEeC---C--CcEEEEEEccCCChh-h-HHHHHHHHHHHHhcCCCceeeEEEEEee-CCe
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP---D--GTVVAVKRAQEGSLQ-G-EKEFLTEIQFLSRLHHRNLVSLVGYCDE-EGE 694 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~---~--g~~vAVK~~~~~~~~-~-~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~ 694 (845)
...|+....||+|.||.||||.-. + ...+|+|+++..... + .....+|+.+++.++|||++.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 356888899999999999999633 2 237999999864221 1 2457899999999999999999998866 778
Q ss_pred EEEEEEcCCCCCHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC----CcEEEE
Q 003140 695 QMLVYEFMSNGTLRDQLSAK---SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK----FTAKVA 767 (845)
Q Consensus 695 ~~LV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~----~~~kl~ 767 (845)
.+|++||.++ +|.+.++-+ ....++..+...|..||+.|+.|||++. |+||||||.|||+..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 9999999975 888888653 2356899999999999999999999999 9999999999999877 899999
Q ss_pred ecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCceecccCC
Q 003140 768 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVLPY 845 (845)
Q Consensus 768 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~ 845 (845)
|||+||.+..+-. +-.....++-|.+|+|||.+.+. .|+++.||||.||++.||+|-..-|.+.+..++.--||
T Consensus 179 DlGlaR~~~~plk----pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pf 253 (438)
T KOG0666|consen 179 DLGLARLFNNPLK----PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPF 253 (438)
T ss_pred cccHHHHhhcccc----ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCc
Confidence 9999998765421 22233456678999999999874 68999999999999999999988887776666554444
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=306.92 Aligned_cols=198 Identities=25% Similarity=0.395 Sum_probs=163.4
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC--------C
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--------G 693 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--------~ 693 (845)
..+|...+.||+|+||.||+|... +++.||||++.... ....+|+.++++++|+||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 457889999999999999999964 68999999875432 2345799999999999999999886432 2
Q ss_pred eEEEEEEcCCCCCHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEEecC
Q 003140 694 EQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFG 770 (845)
Q Consensus 694 ~~~LV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~-~~kl~DFG 770 (845)
..++||||++ ++|.+++.. .....+++...+.++.||++||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 4679999997 578777754 23456899999999999999999999998 99999999999999665 79999999
Q ss_pred CcccCCCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 771 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 771 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
+|+...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..
T Consensus 217 la~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 275 (440)
T PTZ00036 217 SAKNLLAGQ--------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS 275 (440)
T ss_pred cchhccCCC--------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 998653211 1223467899999999875 468999999999999999999999997643
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=284.38 Aligned_cols=205 Identities=32% Similarity=0.506 Sum_probs=178.6
Q ss_pred HHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
+..++|.+.+.||+|+||.||+|..++++.||||.+.... ...+++.+|++++++++|+||+++++++......++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 4567889999999999999999998888899999987543 345689999999999999999999999999899999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
|+++++|.+++.......+++..+..++.+++.|++|||+++ ++||||||+||++++++.+|++|||+++......
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE- 157 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh-
Confidence 999999999998766667999999999999999999999998 9999999999999999999999999987654211
Q ss_pred CCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
........++..|+|||.+.+..++.++||||+|+++|||++ |+.||...
T Consensus 158 -----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 208 (261)
T cd05034 158 -----YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM 208 (261)
T ss_pred -----hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 011112234568999999998899999999999999999999 99999653
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-32 Score=298.98 Aligned_cols=199 Identities=27% Similarity=0.370 Sum_probs=169.0
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-----
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----- 693 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----- 693 (845)
..++|...+.||+|+||.||++... +|+.||||++... .....+++.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3478999999999999999999964 6899999998643 2334567889999999999999999999986443
Q ss_pred -eEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 003140 694 -EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 772 (845)
Q Consensus 694 -~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla 772 (845)
..++||||++ ++|.+.++. .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCc
Confidence 4799999996 567666643 3788888999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
+..... .......||..|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 171 ~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 171 RTACTN--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred cccccC--------ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 754321 11233468899999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=283.37 Aligned_cols=203 Identities=30% Similarity=0.466 Sum_probs=173.9
Q ss_pred hcCCCCCccccccCceEEEEEEeCC----CcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
.++|+..+.||+|+||.||+|.+.. ...||||.++... ....++|.+|+.++++++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3578889999999999999999742 4579999987543 3345679999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
||||+++|+|.+++.... ..+++..++.++.|++.|++|||+.+ |+||||||+||++++++.++|+|||+++....
T Consensus 83 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 83 ITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999999997644 36899999999999999999999988 99999999999999999999999999987642
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 834 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~ 834 (845)
.+. ........++..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 159 ~~~-----~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~ 211 (266)
T cd05033 159 SEA-----TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred ccc-----ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCC
Confidence 111 111122345678999999998899999999999999999998 9999964
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=298.91 Aligned_cols=210 Identities=24% Similarity=0.419 Sum_probs=175.7
Q ss_pred HHHHHHhcCCCCCccccccCceEEEEEEeC------CCcEEEEEEccCCChh-hHHHHHHHHHHHHhcC-CCceeeEEEE
Q 003140 617 GEMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLH-HRNLVSLVGY 688 (845)
Q Consensus 617 ~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~~~-~~~~~~~Ei~~l~~l~-H~nIv~l~g~ 688 (845)
.++....++|.+.+.||+|+||.||+|++. .++.||||+++..... ..+.+.+|++++.++. ||||++++++
T Consensus 30 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 30 SAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred CcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 356677778889999999999999999853 3468999999764332 2457899999999997 9999999999
Q ss_pred EeeCCeEEEEEEcCCCCCHHHHHhccCC----------------------------------------------------
Q 003140 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSK---------------------------------------------------- 716 (845)
Q Consensus 689 ~~~~~~~~LV~E~~~~gsL~~~l~~~~~---------------------------------------------------- 716 (845)
+...+..++||||+++|+|.++++....
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 9999999999999999999999975321
Q ss_pred --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 003140 717 --------------------------------------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIK 752 (845)
Q Consensus 717 --------------------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk 752 (845)
..+++...+.++.|++.||+|||+.+ |+|||||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlk 266 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLA 266 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCC
Confidence 23677888999999999999999888 9999999
Q ss_pred CCCEEEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 003140 753 ASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831 (845)
Q Consensus 753 ~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~P 831 (845)
|+|||+++++.+||+|||+++....... ........++..|+|||.+....++.++|||||||++|||++ |..|
T Consensus 267 p~NiLl~~~~~~kL~DfGla~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P 341 (401)
T cd05107 267 ARNVLICEGKLVKICDFGLARDIMRDSN-----YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTP 341 (401)
T ss_pred cceEEEeCCCEEEEEecCcceecccccc-----cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999986532210 011122346788999999998889999999999999999998 8999
Q ss_pred CCC
Q 003140 832 ISH 834 (845)
Q Consensus 832 f~~ 834 (845)
|..
T Consensus 342 ~~~ 344 (401)
T cd05107 342 YPE 344 (401)
T ss_pred CCC
Confidence 864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=290.90 Aligned_cols=201 Identities=24% Similarity=0.427 Sum_probs=170.4
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
++|...+.||+|+||.||+|... +++.||+|.++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999965 68899999987433 22345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
++ ++|.+++... ...+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 158 (309)
T cd07872 86 LD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT-- 158 (309)
T ss_pred CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc--
Confidence 97 5888888654 345788999999999999999999998 9999999999999999999999999987543221
Q ss_pred CccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......+|..|+|||.+.+ ..++.++|||||||++|||+||+.||...+
T Consensus 159 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 209 (309)
T cd07872 159 -----KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST 209 (309)
T ss_pred -----cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 11223457899999998865 568999999999999999999999996543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=288.85 Aligned_cols=197 Identities=27% Similarity=0.428 Sum_probs=172.3
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
++|++.+.||+|+||.||++... ++..+|+|.++... .....++.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46888999999999999999965 68889999887542 23346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
+++++|.++++.. ..+++..+..++.|+++||.|||+. + ++||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 153 (308)
T cd06615 81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 153 (308)
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence 9999999999764 4588999999999999999999974 5 999999999999999999999999998754321
Q ss_pred CCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
......++..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 154 -------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 154 -------MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred -------ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 12234688999999999888899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=284.78 Aligned_cols=193 Identities=27% Similarity=0.430 Sum_probs=169.4
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
++|+..+.||+|+||.||+|.. .+++.||+|.+... .....+++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3577889999999999999986 47899999988643 334456799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+++|+|..+. .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--- 148 (279)
T cd06619 81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--- 148 (279)
T ss_pred CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence 9999997653 3678888899999999999999998 999999999999999999999999998754321
Q ss_pred CccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 149 ------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 149 ------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred ------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 12234688999999999988999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=291.48 Aligned_cols=204 Identities=22% Similarity=0.242 Sum_probs=167.4
Q ss_pred CCcccccc--CceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcC
Q 003140 628 SSTQIGQG--GYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (845)
Q Consensus 628 ~~~~LG~G--~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 702 (845)
+.++||+| +||+||++... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 78999999864 78999999987542 223456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCC
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 782 (845)
++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+..........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 9999999997655556899999999999999999999998 9999999999999999999999998754332111000
Q ss_pred ccccceeecccCCCCccchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 783 IVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
...........++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 000011122346778999999876 4689999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=302.99 Aligned_cols=198 Identities=26% Similarity=0.312 Sum_probs=170.1
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
...+|.+.+.||+|+||.||+|... .++.||||.... ..+.+|++++++++|+|||++++++...+..++|||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 3457889999999999999999976 578999996432 246789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
++. ++|.+++... ...+++..++.++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 241 ~~~-~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~- 314 (461)
T PHA03211 241 KYR-SDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW- 314 (461)
T ss_pred ccC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc-
Confidence 994 7999988653 236899999999999999999999998 9999999999999999999999999998653221
Q ss_pred CCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.........||..|+|||++.+..++.++|||||||++|||++|..|+...
T Consensus 315 ----~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~ 365 (461)
T PHA03211 315 ----STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSA 365 (461)
T ss_pred ----ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccC
Confidence 111223456999999999999999999999999999999999998877543
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=299.29 Aligned_cols=196 Identities=28% Similarity=0.409 Sum_probs=170.9
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCCCCHH
Q 003140 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 708 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~ 708 (845)
-+||+|.||+||.|++. +...+|||.+.+...+..+.+.+|+.+.++++|+|||+++|.+.+.++.-+.||-++||||.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 36999999999999965 46679999998776666778899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcEEEEecCCcccCCCCCCCCccc
Q 003140 709 DQLSAKSKEPL--GFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVP 785 (845)
Q Consensus 709 ~~l~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~ 785 (845)
++|+..- .++ .+.+.-.+..||++||.|||++. |||||||-+|||++ -.|.+||+|||.++.+..-
T Consensus 661 sLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi------- 729 (1226)
T KOG4279|consen 661 SLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI------- 729 (1226)
T ss_pred HHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC-------
Confidence 9997653 244 67777788999999999999998 99999999999996 5789999999999876432
Q ss_pred cceeecccCCCCccchhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 786 AHVSTVVKGTPGYLDPEYFLTH--KLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 786 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.....+..||..|||||++..+ .|+.++|||||||++.||.||+.||-...
T Consensus 730 nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elg 782 (1226)
T KOG4279|consen 730 NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELG 782 (1226)
T ss_pred CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecC
Confidence 2234567899999999999754 69999999999999999999999996443
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=290.21 Aligned_cols=199 Identities=29% Similarity=0.401 Sum_probs=162.3
Q ss_pred CccccccCceEEEEEEeC---CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEee--CCeEEEEEEcCC
Q 003140 629 STQIGQGGYGKVYKGILP---DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQMLVYEFMS 703 (845)
Q Consensus 629 ~~~LG~G~fG~Vy~~~~~---~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~LV~E~~~ 703 (845)
.+.||+|+||.||+|... +++.||+|.+.... ....+.+|++++++++||||+++++++.. ....++||||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 467999999999999864 46789999986532 23457889999999999999999998854 456899999985
Q ss_pred CCCHHHHHhcc-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----cCCCcEEEEecCCc
Q 003140 704 NGTLRDQLSAK-------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL----DHKFTAKVADFGLS 772 (845)
Q Consensus 704 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl----~~~~~~kl~DFGla 772 (845)
++|.+++... ....+++..+..++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 6888887532 1235889999999999999999999998 9999999999999 45679999999999
Q ss_pred ccCCCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
+....... .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||....+
T Consensus 160 ~~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~ 221 (317)
T cd07868 160 RLFNSPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221 (317)
T ss_pred eccCCCCc----cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcc
Confidence 87543211 1112234568999999999876 4589999999999999999999999975544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=286.95 Aligned_cols=207 Identities=28% Similarity=0.464 Sum_probs=172.7
Q ss_pred HHHhcCCCCCccccccCceEEEEEEeC------CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC
Q 003140 620 ALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 692 (845)
Q Consensus 620 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~ 692 (845)
.+..++|++.+.||+|+||.||+|... .+..||+|.+.... .....++.+|+.++++++|+||+++++++.+.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 345678999999999999999999753 24589999876543 23345688999999999999999999999999
Q ss_pred CeEEEEEEcCCCCCHHHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 003140 693 GEQMLVYEFMSNGTLRDQLSAKS--------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 764 (845)
Q Consensus 693 ~~~~LV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~ 764 (845)
+..++||||+++|+|.++++... ....++..+..++.|++.||.|||+++ |+||||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcE
Confidence 99999999999999999997532 234567788899999999999999988 9999999999999999999
Q ss_pred EEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 003140 765 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 834 (845)
Q Consensus 765 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~ 834 (845)
+|+|||+++.....+. ........++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 159 ~L~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~ 224 (288)
T cd05061 159 KIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG 224 (288)
T ss_pred EECcCCcccccccccc-----ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999986543221 111122335678999999998899999999999999999999 7888864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=282.39 Aligned_cols=201 Identities=25% Similarity=0.385 Sum_probs=173.6
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
.++|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35788899999999999999996 47899999998765545556788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+++++|.++++.. ..+++..+..++.|+++|++|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 88 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06646 88 CGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI-- 160 (267)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc--
Confidence 9999999998653 35889999999999999999999988 9999999999999999999999999997653211
Q ss_pred CccccceeecccCCCCccchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.......|+..|+|||.+. ...++.++|||||||++|||++|+.||...
T Consensus 161 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~ 212 (267)
T cd06646 161 -----AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred -----cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 1112345788999999874 345788999999999999999999999644
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=285.28 Aligned_cols=204 Identities=31% Similarity=0.508 Sum_probs=174.3
Q ss_pred cCCCCCccccccCceEEEEEEeC------CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
.+|...+.||+|+||.||++... ++..+|+|.+........+.|.+|++++++++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46777889999999999999632 466899999887666667789999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 003140 698 VYEFMSNGTLRDQLSAKSK-------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 764 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~ 764 (845)
||||+++|+|.++++.... ..+++..++.++.|++.|++|||+.+ |+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999976432 35889999999999999999999988 9999999999999999999
Q ss_pred EEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 765 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 765 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
||+|||+++....... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 162 kL~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 228 (280)
T cd05092 162 KIGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228 (280)
T ss_pred EECCCCceeEcCCCce-----eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC
Confidence 9999999875532210 111122335678999999999999999999999999999998 99999543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=284.79 Aligned_cols=206 Identities=31% Similarity=0.477 Sum_probs=172.2
Q ss_pred HhcCCCCCccccccCceEEEEEEeCC------CcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCe
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 694 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 694 (845)
.+++|.+.+.||+|+||.||+|.+.+ +..||+|...... ......|.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 35678889999999999999999753 5789999886543 3345679999999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhccCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC---cEEE
Q 003140 695 QMLVYEFMSNGTLRDQLSAKSK-----EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TAKV 766 (845)
Q Consensus 695 ~~LV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~---~~kl 766 (845)
.++||||+++|+|.++++.... ..+++..++.++.||++||+|||+.+ ++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999976432 35899999999999999999999998 99999999999998754 6999
Q ss_pred EecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 767 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 767 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
+|||+++........ ........+..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 161 ~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~ 225 (277)
T cd05036 161 ADFGMARDIYRASYY-----RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR 225 (277)
T ss_pred ccCccccccCCccce-----ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999865322110 01112223468999999999999999999999999999997 99999754
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-33 Score=297.72 Aligned_cols=197 Identities=33% Similarity=0.507 Sum_probs=172.2
Q ss_pred CCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
.|...+.||.|+||.||-|.+ .+.++||||++.-.. .+...+++.|++.|++++|||+|.+-|+|..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 355578899999999999995 478899999987543 3345689999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
|| -||-.+++.-+ .+++.+..+..|+.|.++||+|||+.+ .||||||+.|||+++.|.||++|||.|.....
T Consensus 107 YC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--- 178 (948)
T KOG0577|consen 107 YC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP--- 178 (948)
T ss_pred HH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence 99 47888887543 457888899999999999999999999 99999999999999999999999999977542
Q ss_pred CCccccceeecccCCCCccchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
...++||++|||||++. .+.|+.|+||||+|++..||..++.|++.-+.
T Consensus 179 --------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA 230 (948)
T KOG0577|consen 179 --------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 230 (948)
T ss_pred --------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH
Confidence 23578999999999985 47899999999999999999999999986543
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=283.61 Aligned_cols=203 Identities=31% Similarity=0.465 Sum_probs=173.4
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeC------C
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE------G 693 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~------~ 693 (845)
+++.|+..+.||+|+||.||+|... +++.||+|++.... ....++.+|+.+++++ +|+||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 5677888999999999999999965 68899999986533 3456788999999998 799999999998653 4
Q ss_pred eEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003140 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (845)
Q Consensus 694 ~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~ 773 (845)
..++||||+++|+|.+++.......+++..+..++.|++.|++|||+.+ |+||||||+||++++++.++|+|||+++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCce
Confidence 6899999999999999998765667899999999999999999999998 9999999999999999999999999987
Q ss_pred cCCCCCCCCccccceeecccCCCCccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
...... .......|+..|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~ 219 (272)
T cd06637 160 QLDRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219 (272)
T ss_pred eccccc-------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 643211 1123456889999999986 346888999999999999999999999643
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=282.04 Aligned_cols=201 Identities=32% Similarity=0.491 Sum_probs=172.3
Q ss_pred cCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCC
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 703 (845)
++|.+.+.||+|+||.||+|...++..+|+|.+.... ...+.+.+|++++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5678889999999999999998777789999876533 33567899999999999999999999875 456889999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCc
Q 003140 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (845)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 783 (845)
+|+|.++++......+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++.......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~--- 157 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY--- 157 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc---
Confidence 999999998765566899999999999999999999988 99999999999999999999999999976532211
Q ss_pred cccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
.......++..|+|||...+..++.++|||||||++|||+| |+.||...
T Consensus 158 ---~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 207 (260)
T cd05069 158 ---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207 (260)
T ss_pred ---cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 11112345678999999988899999999999999999999 99999654
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=300.90 Aligned_cols=199 Identities=23% Similarity=0.298 Sum_probs=171.1
Q ss_pred HhcCCCCCccccccCceEEEEEEeC---CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEE
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILP---DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~---~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
...+|.+.+.||+|+||.||++... .++.||||.+... +.+.+|++++++++||||+++++++......++|
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 3457999999999999999999753 3578999987643 2456899999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
||++. ++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 165 ~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 165 MPKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred ehhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 99995 789998843 356899999999999999999999998 999999999999999999999999999765432
Q ss_pred CCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
. .........||..|+|||++....++.++|||||||++|||++|+.||....
T Consensus 239 ~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 239 P-----DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred c-----ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 1 1112234578999999999999999999999999999999999999997643
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=284.10 Aligned_cols=202 Identities=28% Similarity=0.435 Sum_probs=168.5
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCc----EEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
++|...+.||+|+||.||+|.+. ++. .|++|...... ....+++..|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46778899999999999999964 444 47888875432 2334678889999999999999999998854 45788
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
++||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++....
T Consensus 86 i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 999999999999997543 46899999999999999999999988 99999999999999999999999999986532
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
.+ .........++..|+|||.+.+..++.++|||||||++|||++ |+.||.+.
T Consensus 162 ~~-----~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 215 (279)
T cd05111 162 DD-----KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM 215 (279)
T ss_pred CC-----cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 21 1111233457789999999998899999999999999999998 99999754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=286.94 Aligned_cols=200 Identities=25% Similarity=0.425 Sum_probs=175.7
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcC
Q 003140 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 702 (845)
.+|+..+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4788889999999999999986 468999999987655555678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCC
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 782 (845)
++++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 100 ~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--- 170 (296)
T cd06654 100 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 170 (296)
T ss_pred CCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc---
Confidence 99999999854 24789999999999999999999998 9999999999999999999999999987543211
Q ss_pred ccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......++..|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 171 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~ 220 (296)
T cd06654 171 ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (296)
T ss_pred ----cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 11223468899999999998889999999999999999999999996543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-33 Score=279.36 Aligned_cols=199 Identities=30% Similarity=0.477 Sum_probs=176.9
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCC
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 703 (845)
-|++.++||+|+||.|||+.++ .|..||||+.... .+.+++.+|+.+|++.+.|++|++||.|......++|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 3667789999999999999975 6999999987643 456789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCc
Q 003140 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (845)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 783 (845)
.|+..+.++- ..+++.+..+..+....++||+|||... =||||||+.|||++-+|.+|++|||.|-.+...
T Consensus 112 AGSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT----- 182 (502)
T KOG0574|consen 112 AGSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT----- 182 (502)
T ss_pred CCcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh-----
Confidence 9999998865 4568999999999999999999999887 799999999999999999999999998654321
Q ss_pred cccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.....++.||+.|||||++..-.|..++||||+|++..||..|+.||.+-.
T Consensus 183 --MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH 233 (502)
T KOG0574|consen 183 --MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIH 233 (502)
T ss_pred --HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccc
Confidence 233456789999999999999999999999999999999999999997544
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-33 Score=297.72 Aligned_cols=316 Identities=23% Similarity=0.247 Sum_probs=220.3
Q ss_pred ceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeec
Q 003140 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (845)
Q Consensus 82 ~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (845)
..++.|++++|.|+..-+..|.+|++|++++|.+|.++ .||...+...+|+.|+|.+|.|+..-.+.+..++.|+.|||
T Consensus 78 ~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDL 156 (873)
T KOG4194|consen 78 SQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDL 156 (873)
T ss_pred cceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhh
Confidence 46778889988888877777888888888888888887 67755455556777777777777666666777777777777
Q ss_pred ccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCC
Q 003140 162 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT 241 (845)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 241 (845)
|.|.|+......|..-.++++|+|++|+|+..-...|..+.+|.+|.|++|+++...+..|.++++|+.|+|..|+|+-.
T Consensus 157 SrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~iriv 236 (873)
T KOG4194|consen 157 SRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIV 236 (873)
T ss_pred hhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeee
Confidence 77777755555666666777777777777766666677777777777777777755555666677777777777766521
Q ss_pred -----------------------CCccccccCCCccEEEcccCCCCCCCC-CCCCCCCccEEEcccccCCcCCCCCC-Cc
Q 003140 242 -----------------------TIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGR-LS 296 (845)
Q Consensus 242 -----------------------~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~ip~~~-~~ 296 (845)
.....|-.+.++++|+|+.|+++..-. .+.+++.|+.|+||+|.|...-++.| +.
T Consensus 237 e~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsft 316 (873)
T KOG4194|consen 237 EGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFT 316 (873)
T ss_pred hhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhc
Confidence 112234444555556666666555443 25667777788888887775545444 34
Q ss_pred cccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCChhhhhhccC----------------------CCCcceE
Q 003140 297 LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTL----------------------NATETFI 354 (845)
Q Consensus 297 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l----------------------~~~~l~~ 354 (845)
.+|++|+|++|+|+...+..|..|.+|++|+|++|.++..--..|..+.+| .+++|+.
T Consensus 317 qkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~Lrk 396 (873)
T KOG4194|consen 317 QKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRK 396 (873)
T ss_pred ccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhh
Confidence 478888888888887777777777777766666666664333333333322 2366788
Q ss_pred EEccCCCCCCCCCC-C-CCCCCcEEEecCCc-----------------------ccccCCCccccCCCC
Q 003140 355 LDFQNNNLTNISGS-F-NIPPNVTVRLRGNP-----------------------FCLNTNAEQFCGSHS 398 (845)
Q Consensus 355 L~ls~N~l~~i~~~-~-~~~~l~~l~l~~Np-----------------------~~c~~~~~~~~~~~~ 398 (845)
|+|.+|+|+.|+.. + .++.+..|+|.+|+ |-|||++.|+.+|..
T Consensus 397 L~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCql~Wl~qWl~ 465 (873)
T KOG4194|consen 397 LRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQLKWLAQWLY 465 (873)
T ss_pred eeecCceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEeccHHHHHHHHH
Confidence 99999999999875 3 58899999998886 469999999999984
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-33 Score=276.51 Aligned_cols=203 Identities=26% Similarity=0.372 Sum_probs=177.9
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~---~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
-++|+..++||+|.||+|..++-+ .|+.+|+|++++...-.. ..-..|-++|+..+||.+..+-..|...+..++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 367888999999999999999854 799999999987543332 3456799999999999999998889999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
|||..||.|.-+|.+. ..+++...+-+-..|+.||.|||+++ ||.||||-+|.|+|.+|++||+|||+++.-
T Consensus 247 MeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~--- 318 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE--- 318 (516)
T ss_pred EEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc---
Confidence 9999999998888653 45778888888999999999999998 999999999999999999999999999742
Q ss_pred CCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
+..+....+.+||+.|+|||++....|+.+.|.|.+||+||||++|+.||...+.
T Consensus 319 ----I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh 373 (516)
T KOG0690|consen 319 ----IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH 373 (516)
T ss_pred ----ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch
Confidence 3345566788999999999999999999999999999999999999999975543
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=286.10 Aligned_cols=199 Identities=30% Similarity=0.451 Sum_probs=166.8
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh--hhHHHHHHHHHHHHhc---CCCceeeEEEEEee-----CC
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRL---HHRNLVSLVGYCDE-----EG 693 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~~-----~~ 693 (845)
+|++.+.||+|+||.||+|... +++.||+|.++.... .....+.+|+++++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999965 689999998865322 1234566777777665 69999999998854 34
Q ss_pred eEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003140 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (845)
Q Consensus 694 ~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~ 773 (845)
..++||||++ ++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccc
Confidence 5799999997 58999997765566899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
...... ......||..|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 157 ~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 157 IYSCQM--------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred cccCcc--------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 653221 122346789999999999889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=287.76 Aligned_cols=208 Identities=27% Similarity=0.444 Sum_probs=175.9
Q ss_pred HHHhcCCCCCccccccCceEEEEEEeC------CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEEee
Q 003140 620 ALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE 691 (845)
Q Consensus 620 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~ 691 (845)
....++|...+.||+|+||.||++... .+..||||+++... ....+.+.+|+++++++ +|+||+++++++..
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 344567889999999999999999741 35689999987543 23346789999999999 79999999999999
Q ss_pred CCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 003140 692 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 771 (845)
Q Consensus 692 ~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGl 771 (845)
.+..++||||+++|+|.++++......+++.++..++.|++.||+|||+++ |+||||||+|||++.++.++++|||+
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999999997655555899999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
++....... ........++..|+|||.+....++.++|||||||++|||++ |+.||...
T Consensus 188 ~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~ 247 (302)
T cd05055 188 ARDIMNDSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM 247 (302)
T ss_pred cccccCCCc-----eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCC
Confidence 976542210 111122345678999999998899999999999999999998 99998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=296.22 Aligned_cols=199 Identities=24% Similarity=0.352 Sum_probs=169.4
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC------
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------ 692 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------ 692 (845)
..++|...+.||+|+||.||++... .++.||||++... .....+++.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999964 6889999998753 233456788999999999999999999987543
Q ss_pred CeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 003140 693 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 772 (845)
Q Consensus 693 ~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla 772 (845)
...++||||++ ++|.+++.. .+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 35799999996 578777743 3788899999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
+..... .......||..|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 174 ~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 174 RTAGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred cccCCC--------CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 764321 11233468999999999999999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=281.74 Aligned_cols=204 Identities=27% Similarity=0.451 Sum_probs=175.7
Q ss_pred HHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
+..++|...+.||+|+||.||++...++..+|+|.+.... ...+.|.+|++++++++|+||+++++++.+ ...++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 4457888999999999999999998788889999887543 335678999999999999999999999887 77899999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
|+++|+|.+++.......+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||.++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 999999999998766667899999999999999999999988 99999999999999999999999999876532211
Q ss_pred CCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
.......++..|+|||++....++.++|||||||++||++| |+.||...
T Consensus 158 ------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 207 (260)
T cd05073 158 ------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 207 (260)
T ss_pred ------ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC
Confidence 11112335678999999998889999999999999999999 99999653
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-32 Score=291.21 Aligned_cols=209 Identities=30% Similarity=0.488 Sum_probs=178.8
Q ss_pred HHHHHhcCCCCCccccccCceEEEEEEeCC---C--cEEEEEEccC-CChhhHHHHHHHHHHHHhcCCCceeeEEEEEee
Q 003140 618 EMALATNNFNSSTQIGQGGYGKVYKGILPD---G--TVVAVKRAQE-GSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 691 (845)
Q Consensus 618 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~---g--~~vAVK~~~~-~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~ 691 (845)
+.++..+.....++||+|-||.||+|.+.+ | -.||||.-+. ...++.+.|++|..+|++++|||||+++|+|.+
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 344455556667899999999999999632 3 3588998776 345567789999999999999999999999986
Q ss_pred CCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 003140 692 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 771 (845)
Q Consensus 692 ~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGl 771 (845)
. ..++|||.++-|.|..||+.+. ..++......++.||+.+|.|||+.. +|||||..+|||+....-+|++|||+
T Consensus 463 ~-P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 463 Q-PMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred c-ceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccch
Confidence 4 7899999999999999998754 56899999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 003140 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKN 837 (845)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~ 837 (845)
+|.+...++... +...-.+.|||||.+.-.+++.++|||-|||+|||+++ |..||++-++
T Consensus 538 SR~~ed~~yYka------S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN 598 (974)
T KOG4257|consen 538 SRYLEDDAYYKA------SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN 598 (974)
T ss_pred hhhccccchhhc------cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc
Confidence 999876654322 22334578999999999999999999999999999988 9999986443
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=295.78 Aligned_cols=200 Identities=25% Similarity=0.343 Sum_probs=169.8
Q ss_pred HHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE----- 692 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~----- 692 (845)
...++|...+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999864 6899999998753 233456788999999999999999999988543
Q ss_pred -CeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 003140 693 -GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 771 (845)
Q Consensus 693 -~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGl 771 (845)
...++||||++ +++.+++.. .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 94 FQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred cceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 35799999996 567776643 4788899999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus 166 ~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 166 ARTAGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred cccCCCc--------cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9764321 11233568999999999999999999999999999999999999997644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=279.51 Aligned_cols=202 Identities=26% Similarity=0.417 Sum_probs=176.6
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcC
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 702 (845)
+|++.+.||+|+||.||++... +++.+|+|.++.. .....+++.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4777899999999999999965 6899999988642 3344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCC
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 782 (845)
++|+|.+++.......+++...+.++.|+++||.|||+.+ |+|+||||+||++++++.++++|||+++......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--- 154 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--- 154 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc---
Confidence 9999999987665667899999999999999999999998 9999999999999999999999999987653221
Q ss_pred ccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......|+..|+|||++.+..++.++||||||+++|+|++|+.||...+
T Consensus 155 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 204 (255)
T cd08219 155 ----AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204 (255)
T ss_pred ----cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence 11233568889999999998899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=280.93 Aligned_cols=202 Identities=26% Similarity=0.410 Sum_probs=174.4
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG---SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|.+.+.||+|+||.||+|... +++.||||.+... .....+++.+|+++++.++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57888999999999999999964 7899999987542 2333467899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 700 EFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 700 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
||+++|+|.+++... ....+++.....++.|+++||+|||+++ ++||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999988642 2345788999999999999999999988 99999999999999999999999999886542
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.. .......++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 159 ~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 159 KT-------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred hh-------HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 21 1112345788999999998888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=280.90 Aligned_cols=198 Identities=31% Similarity=0.413 Sum_probs=163.5
Q ss_pred ccccccCceEEEEEEeCC---CcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCCC
Q 003140 630 TQIGQGGYGKVYKGILPD---GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 705 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~~---g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g 705 (845)
+.||+|+||.||+|...+ +..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999998643 4679999887543 334567899999999999999999999999999999999999999
Q ss_pred CHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCC
Q 003140 706 TLRDQLSAKS---KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (845)
Q Consensus 706 sL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 782 (845)
+|.++++... ....++..+..++.|+++|++|||+.+ ++||||||+||+++.++++||+|||+++.....+.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~-- 155 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY-- 155 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcce--
Confidence 9999997532 234677888899999999999999998 99999999999999999999999999875432211
Q ss_pred ccccceeecccCCCCccchhhhcCC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 783 IVPAHVSTVVKGTPGYLDPEYFLTH-------KLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
........++..|+|||++... .++.++|||||||++|||++ |+.||...
T Consensus 156 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 213 (269)
T cd05087 156 ---YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL 213 (269)
T ss_pred ---eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence 1112234567889999998542 35789999999999999996 99999643
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-32 Score=296.42 Aligned_cols=192 Identities=27% Similarity=0.360 Sum_probs=161.6
Q ss_pred ccccCceEEEEEEeC-CCcEEEEEEccCCCh---hhHHHHHHHHHHHHhc---CCCceeeEEEEEeeCCeEEEEEEcCCC
Q 003140 632 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL---HHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (845)
Q Consensus 632 LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~~~~~~~LV~E~~~~ 704 (845)
||+|+||+||+|... +++.||||++..... .....+..|..++.+. +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999965 689999999864322 1223456677777665 699999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCcc
Q 003140 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (845)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 784 (845)
|+|.+++... ..+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~----- 150 (330)
T cd05586 81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN----- 150 (330)
T ss_pred ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-----
Confidence 9999998653 45889999999999999999999998 9999999999999999999999999987532211
Q ss_pred ccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 785 PAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.......||..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~ 200 (330)
T cd05586 151 --KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE 200 (330)
T ss_pred --CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC
Confidence 112345689999999998754 4899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=307.03 Aligned_cols=203 Identities=25% Similarity=0.378 Sum_probs=166.7
Q ss_pred HHHHHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCC------CceeeEEEEEe
Q 003140 618 EMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH------RNLVSLVGYCD 690 (845)
Q Consensus 618 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H------~nIv~l~g~~~ 690 (845)
++....++|.+.+.||+|+||+||+|... .++.||||+++... ...+++..|++++++++| .+++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34456788999999999999999999964 68899999986432 233456667777777654 45889999886
Q ss_pred eC-CeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCC------
Q 003140 691 EE-GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKF------ 762 (845)
Q Consensus 691 ~~-~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDLk~~NILl~~~~------ 762 (845)
.. +..++|||++ +++|.+++.+. ..+++..+..|+.||+.||+|||++ + ||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence 54 5789999988 78899988654 4689999999999999999999974 7 99999999999998765
Q ss_pred ----------cEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 003140 763 ----------TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 832 (845)
Q Consensus 763 ----------~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf 832 (845)
.+||+|||.+.... .......||..|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~----------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf 345 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDER----------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY 345 (467)
T ss_pred cccccCCCCceEEECCCCccccCc----------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 49999999875421 1223467899999999999999999999999999999999999999
Q ss_pred CCCCC
Q 003140 833 SHGKN 837 (845)
Q Consensus 833 ~~~~~ 837 (845)
...++
T Consensus 346 ~~~~~ 350 (467)
T PTZ00284 346 DTHDN 350 (467)
T ss_pred CCCCh
Confidence 76543
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=284.35 Aligned_cols=206 Identities=28% Similarity=0.466 Sum_probs=174.5
Q ss_pred HHhcCCCCCccccccCceEEEEEEeCC------CcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 693 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~ 693 (845)
+..++|.+.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.+++.++|+||+++++++...+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 345678889999999999999998642 3689999987543 334567899999999999999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEE
Q 003140 694 EQMLVYEFMSNGTLRDQLSAKS--------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAK 765 (845)
Q Consensus 694 ~~~LV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~k 765 (845)
..++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEE
Confidence 9999999999999999996532 234788999999999999999999988 99999999999999999999
Q ss_pred EEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 003140 766 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 834 (845)
Q Consensus 766 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~ 834 (845)
|+|||+++.....+. ........++..|+|||.+....++.++|||||||++||+++ |+.||..
T Consensus 160 l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 224 (277)
T cd05032 160 IGDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG 224 (277)
T ss_pred ECCcccchhhccCcc-----cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc
Confidence 999999976543221 111223346789999999988889999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-32 Score=269.47 Aligned_cols=209 Identities=22% Similarity=0.397 Sum_probs=174.4
Q ss_pred chHHHHHHhcCCCCCccccccCceEEEEEE-eCCCcEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeC
Q 003140 615 TYGEMALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE 692 (845)
Q Consensus 615 ~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~ 692 (845)
.++++...+ .+.||+|+|++|--++ +.+|.++|||++.+.......+..+|++++.+. .|+||++++++|+++
T Consensus 74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 356666666 4569999999999887 678999999999876556678899999999999 599999999999999
Q ss_pred CeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC---cEEEEec
Q 003140 693 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TAKVADF 769 (845)
Q Consensus 693 ~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~---~~kl~DF 769 (845)
...|||||.|.||+|.+++++. ..+++....++..+||.||.+||.++ |.|||+||+|||-.+.. -+||+||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred ceEEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecc
Confidence 9999999999999999999764 45889999999999999999999999 99999999999996543 5899999
Q ss_pred CCcccCCC-CCCCCccccceeecccCCCCccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 770 GLSRLAPV-PDIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 770 Gla~~~~~-~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
.++.-... .+.. ........+..|+..|||||+.. ...|+.++|.||+|||+|-|++|..||.+
T Consensus 224 DLgSg~k~~~~~s-pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG 293 (463)
T KOG0607|consen 224 DLGSGIKLNNDCS-PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG 293 (463)
T ss_pred ccccccccCCCCC-CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence 88753321 1111 11122334567999999999874 34688999999999999999999999964
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=314.73 Aligned_cols=212 Identities=25% Similarity=0.413 Sum_probs=174.1
Q ss_pred HHHHHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEee--C
Q 003140 618 EMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--E 692 (845)
Q Consensus 618 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~ 692 (845)
+.....++|.+.+.||+|+||.||++... .+..||+|.+... .......|..|+.++++++|||||++++++.+ .
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 34455678999999999999999999965 5788999987643 23345678999999999999999999998854 3
Q ss_pred CeEEEEEEcCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEecCCCCCCEEEcCC-----
Q 003140 693 GEQMLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEAD----PPVFHRDIKASNILLDHK----- 761 (845)
Q Consensus 693 ~~~~LV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~iiHrDLk~~NILl~~~----- 761 (845)
...+|||||+++|+|.++|... ....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.+
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 5689999999999999999753 23569999999999999999999998542 349999999999999642
Q ss_pred ------------CcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcC--CCCCchhhHHHHHHHHHHHHh
Q 003140 762 ------------FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLT 827 (845)
Q Consensus 762 ------------~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~ellt 827 (845)
..+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||+|
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLT 238 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIES--------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccc--------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHH
Confidence 358999999997653221 1234568999999999854 458899999999999999999
Q ss_pred CCCCCCCCCC
Q 003140 828 GMQPISHGKN 837 (845)
Q Consensus 828 G~~Pf~~~~~ 837 (845)
|+.||...+.
T Consensus 239 Gk~PF~~~~~ 248 (1021)
T PTZ00266 239 GKTPFHKANN 248 (1021)
T ss_pred CCCCCCcCCc
Confidence 9999976543
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-33 Score=269.37 Aligned_cols=200 Identities=27% Similarity=0.431 Sum_probs=172.5
Q ss_pred HhcCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEE
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
.++.|++.+.||+|.|+.||++.. ++|+.+|+|++... +..+.+++.+|+++-+.++||||+++.+.+.+....+||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 356788889999999999999885 57999999987542 233567889999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEEecCCcccC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLSRLA 775 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~---~~~~kl~DFGla~~~ 775 (845)
+|+|+||+|..-+-.. ...++...-..+.||+++|.|.|.++ |||||+||+|+|+.. .--+|++|||+|..+
T Consensus 89 Fe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred EecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999997644322 34667778889999999999999999 999999999999943 346999999999877
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
.. ........||++|||||++...+|+..+|||+-||++|-|+.|+.||.+
T Consensus 164 ~~--------g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~ 214 (355)
T KOG0033|consen 164 ND--------GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 214 (355)
T ss_pred CC--------ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence 52 2334567899999999999999999999999999999999999999987
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=275.79 Aligned_cols=196 Identities=30% Similarity=0.484 Sum_probs=168.1
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCCCCHH
Q 003140 630 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 708 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~ 708 (845)
+.||+|+||.||+|...+++.||+|.+..... .....+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36999999999999988899999999876443 33457899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCccccce
Q 003140 709 DQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 788 (845)
Q Consensus 709 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 788 (845)
+++.... ..+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~------~~~ 150 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI------YSS 150 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccc------ccc
Confidence 9986543 35789999999999999999999988 9999999999999999999999999987543211 011
Q ss_pred eecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 789 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 789 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
.....++..|+|||++.+..++.++||||||+++||+++ |..||...
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~ 198 (250)
T cd05085 151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM 198 (250)
T ss_pred CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 112234578999999998899999999999999999998 99999643
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=278.88 Aligned_cols=204 Identities=29% Similarity=0.437 Sum_probs=174.0
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh-----hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-----QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-----~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
++|...+.||+|++|.||++... +++.||+|.+..... ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57888999999999999999864 689999998764321 123578899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 99999999999998654 35788999999999999999999998 99999999999999999999999999876532
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.... ........++..|+|||++.+..++.++||||+|+++|||++|+.||...+
T Consensus 157 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 211 (263)
T cd06625 157 ICSS----GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE 211 (263)
T ss_pred cccc----cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc
Confidence 1100 111123457789999999999889999999999999999999999997543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=285.67 Aligned_cols=201 Identities=30% Similarity=0.493 Sum_probs=168.8
Q ss_pred cCCCCCccccccCceEEEEEEeCC-C--cEEEEEEccCC-ChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILPD-G--TVVAVKRAQEG-SLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~~-g--~~vAVK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV 698 (845)
++|++.+.||+|+||.||+|...+ + ..+++|.++.. .....+.|.+|+++++++ +||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999998753 3 34788888743 334456799999999999 799999999999999999999
Q ss_pred EEcCCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 003140 699 YEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 764 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~ 764 (845)
|||+++|+|.++++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999996532 135889999999999999999999988 9999999999999999999
Q ss_pred EEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 765 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 765 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |+.||.+.
T Consensus 159 kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~ 222 (297)
T cd05089 159 KIADFGLSRGEEVY--------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM 222 (297)
T ss_pred EECCcCCCccccce--------eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999998643210 00111223467999999998899999999999999999998 99999653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=287.03 Aligned_cols=210 Identities=30% Similarity=0.515 Sum_probs=176.3
Q ss_pred HHHHHhcCCCCCccccccCceEEEEEEeC------CCcEEEEEEccCC-ChhhHHHHHHHHHHHHhc-CCCceeeEEEEE
Q 003140 618 EMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRL-HHRNLVSLVGYC 689 (845)
Q Consensus 618 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~ 689 (845)
++....++|+..+.||+|+||.||++... ....+|+|.+... ......++.+|+++++++ +|+||+++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34556678888999999999999999864 2368999998753 233446789999999999 899999999999
Q ss_pred eeCCeEEEEEEcCCCCCHHHHHhcc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 003140 690 DEEGEQMLVYEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 755 (845)
Q Consensus 690 ~~~~~~~LV~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~N 755 (845)
...+..++||||+++|+|.++++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~N 162 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARN 162 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceee
Confidence 9999999999999999999999652 2356899999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 003140 756 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 834 (845)
Q Consensus 756 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~ 834 (845)
|++++++.+||+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 237 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDY-----YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 237 (293)
T ss_pred EEEcCCCeEEeCccccccccccccc-----eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC
Confidence 9999999999999999987543221 111122235678999999988999999999999999999998 9999865
Q ss_pred C
Q 003140 835 G 835 (845)
Q Consensus 835 ~ 835 (845)
.
T Consensus 238 ~ 238 (293)
T cd05053 238 I 238 (293)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=282.14 Aligned_cols=199 Identities=27% Similarity=0.427 Sum_probs=172.0
Q ss_pred CCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCC
Q 003140 626 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (845)
Q Consensus 626 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 704 (845)
|++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|+||+++++++...+..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567788999999999999976 5788999998766666667899999999999999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCcc
Q 003140 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (845)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 784 (845)
|+|..++... ..++++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 87 ~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~------ 156 (282)
T cd06643 87 GAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT------ 156 (282)
T ss_pred CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc------
Confidence 9999988653 346899999999999999999999998 999999999999999999999999998754321
Q ss_pred ccceeecccCCCCccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 785 PAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
........++..|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 157 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 211 (282)
T cd06643 157 -IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211 (282)
T ss_pred -ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc
Confidence 11123346889999999974 345788999999999999999999999653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=284.79 Aligned_cols=200 Identities=26% Similarity=0.425 Sum_probs=176.3
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcC
Q 003140 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 702 (845)
.+|...+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 6788899999999999999996 479999999987655555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCC
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 782 (845)
++++|.+++.+ ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 99 ~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~--- 169 (297)
T cd06656 99 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 169 (297)
T ss_pred CCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc---
Confidence 99999999864 34788999999999999999999988 9999999999999999999999999987643221
Q ss_pred ccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......++..|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 170 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~ 219 (297)
T cd06656 170 ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (297)
T ss_pred ----cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 11223457889999999999899999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=280.30 Aligned_cols=198 Identities=28% Similarity=0.394 Sum_probs=161.4
Q ss_pred ccccccCceEEEEEEeCC---CcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCCC
Q 003140 630 TQIGQGGYGKVYKGILPD---GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 705 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~~---g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g 705 (845)
+.||+|+||.||+|...+ ...+|+|.+.... ......|.+|+++++.++|+||+++++++.+.+..++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 359999999999997543 3578888876433 333567899999999999999999999999999999999999999
Q ss_pred CHHHHHhccCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCC
Q 003140 706 TLRDQLSAKSK---EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (845)
Q Consensus 706 sL~~~l~~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 782 (845)
+|.+++..... ...++.....++.|+++|++|||+.+ |+||||||+|||++.++.+||+|||+++.....+..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~- 156 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY- 156 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhe-
Confidence 99999976432 33567888899999999999999998 999999999999999999999999998754322110
Q ss_pred ccccceeecccCCCCccchhhhcC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 783 IVPAHVSTVVKGTPGYLDPEYFLT-------HKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
.......++..|+|||++.. ..++.++|||||||++|||++ |..||...
T Consensus 157 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 157 ----ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred ----eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 11122345678999998743 356889999999999999999 78888654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=278.37 Aligned_cols=197 Identities=30% Similarity=0.455 Sum_probs=170.1
Q ss_pred ccccccCceEEEEEEeCC--C--cEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCC
Q 003140 630 TQIGQGGYGKVYKGILPD--G--TVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~~--g--~~vAVK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 704 (845)
+.||+|++|.||+|.+.+ + ..||||.+..... ...+++.+|++++++++|+||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 3699999987665 556789999999999999999999999988 889999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCcc
Q 003140 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (845)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 784 (845)
|+|.+++.......+++...+.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--- 153 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH--- 153 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccc---
Confidence 99999997754357899999999999999999999998 999999999999999999999999999876432210
Q ss_pred ccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 003140 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 834 (845)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~ 834 (845)
........++..|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 154 -~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 203 (257)
T cd05040 154 -YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAG 203 (257)
T ss_pred -eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 111123457789999999999999999999999999999999 9999964
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=287.30 Aligned_cols=199 Identities=29% Similarity=0.394 Sum_probs=161.8
Q ss_pred ccccccCceEEEEEEeC---CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEee--CCeEEEEEEcCCC
Q 003140 630 TQIGQGGYGKVYKGILP---DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQMLVYEFMSN 704 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~---~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~LV~E~~~~ 704 (845)
..||+|+||.||+|... ++..||+|.+.... ....+.+|++++++++||||+++++++.. ....++||||++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 57999999999999964 45789999887543 23467899999999999999999998853 457899999986
Q ss_pred CCHHHHHhcc-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----cCCCcEEEEecCCcc
Q 003140 705 GTLRDQLSAK-------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL----DHKFTAKVADFGLSR 773 (845)
Q Consensus 705 gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl----~~~~~~kl~DFGla~ 773 (845)
++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 5888877532 2235889999999999999999999998 9999999999999 566799999999998
Q ss_pred cCCCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCc
Q 003140 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 838 (845)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~ 838 (845)
....... .........||..|+|||++.+ ..++.++|||||||++|||+||+.||....+.
T Consensus 161 ~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~ 222 (317)
T cd07867 161 LFNSPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 222 (317)
T ss_pred ccCCCcc----cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccccc
Confidence 7543221 1111234568899999999876 45899999999999999999999999765543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=280.32 Aligned_cols=203 Identities=30% Similarity=0.448 Sum_probs=168.4
Q ss_pred CCCCccccccCceEEEEEEeCC----CcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCe-----
Q 003140 626 FNSSTQIGQGGYGKVYKGILPD----GTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE----- 694 (845)
Q Consensus 626 f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~----- 694 (845)
|.+.+.||+|+||.||+|.... +..||+|+++... ......+.+|++.++.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5667899999999999998642 3679999987532 3335679999999999999999999999866554
Q ss_pred -EEEEEEcCCCCCHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEec
Q 003140 695 -QMLVYEFMSNGTLRDQLSAK----SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 769 (845)
Q Consensus 695 -~~LV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DF 769 (845)
.++||||+++|+|..++... ....+++.....++.|++.||+|||+++ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 79999999999999998543 2346899999999999999999999988 999999999999999999999999
Q ss_pred CCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 770 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 770 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
|+++.....+.. .......++..|+|||.+....++.++|||||||++|||++ |..||.+.+
T Consensus 158 g~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~ 220 (273)
T cd05035 158 GLSKKIYSGDYY-----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE 220 (273)
T ss_pred cceeeccccccc-----cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 999865432211 11112234678999999988899999999999999999999 889986543
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=279.02 Aligned_cols=206 Identities=27% Similarity=0.391 Sum_probs=175.3
Q ss_pred HHHHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 619 MALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 619 ~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
++.+++++.....||+|+||.||+|... ++..||+|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 4456677777889999999999999964 678899999887666667789999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEEecCCccc
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPL--GFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGLSRL 774 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~-~~~~kl~DFGla~~ 774 (845)
|+||+++++|.++++... ..+ ++..+..++.|+++||+|||+.+ |+||||||+||+++. ++.++|+|||++..
T Consensus 83 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 999999999999997642 234 78888899999999999999988 999999999999986 67999999999876
Q ss_pred CCCCCCCCccccceeecccCCCCccchhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH--KLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
....+ .......++..|+|||++... .++.++||||||+++|||++|+.||...
T Consensus 159 ~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~ 214 (268)
T cd06624 159 LAGIN-------PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214 (268)
T ss_pred cccCC-------CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccc
Confidence 53211 111223578999999998654 3788999999999999999999999643
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=277.26 Aligned_cols=198 Identities=32% Similarity=0.529 Sum_probs=175.3
Q ss_pred hcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcC
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 702 (845)
.++|+..+.||+|+||.||+|... |+.||+|.++.... ..+++.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 457888999999999999999874 78999999986544 5678999999999999999999999999899999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCC
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 782 (845)
++++|.++++......+++..+..++.|++.|+.|||+.+ |+||||||+||+++.++.+||+|||.++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--- 156 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence 9999999998766567999999999999999999999998 9999999999999999999999999998653211
Q ss_pred ccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
.....+..|+|||++....++.++||||||+++|||++ |+.||...
T Consensus 157 -------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 203 (256)
T cd05039 157 -------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred -------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence 12234568999999988899999999999999999997 99998644
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=277.20 Aligned_cols=196 Identities=29% Similarity=0.482 Sum_probs=166.3
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCCCCH
Q 003140 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 707 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL 707 (845)
+.||+|+||.||+|... +++.||+|...... .+....|.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999975 78999999876533 33456799999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCccccc
Q 003140 708 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 787 (845)
Q Consensus 708 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 787 (845)
.++++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-----~~ 151 (252)
T cd05084 81 LTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY-----AS 151 (252)
T ss_pred HHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccc-----cc
Confidence 9999654 345889999999999999999999988 99999999999999999999999999875432110 00
Q ss_pred eeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 003140 788 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 834 (845)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~ 834 (845)
.......+..|+|||.+.++.++.++|||||||++|||++ |..||..
T Consensus 152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~ 199 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN 199 (252)
T ss_pred cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 0111223467999999998899999999999999999998 8888864
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=286.61 Aligned_cols=210 Identities=26% Similarity=0.354 Sum_probs=177.8
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChh---hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~---~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|+..+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|+++++.++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36788899999999999999975 5899999998754322 4567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++++|.+++.......+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 9999999999998765667999999999999999999999998 9999999999999999999999999987543211
Q ss_pred CCCcc----------------------ccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IEGIV----------------------PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~~~~----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
..... .........||..|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 00000 0011123468899999999998899999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=281.17 Aligned_cols=200 Identities=27% Similarity=0.409 Sum_probs=173.1
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcC
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 702 (845)
++|...+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777889999999999999864 68999999987655455567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCC
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 782 (845)
++++|.+++... ..+++.....++.|++.|+.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 89 ~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--- 160 (267)
T cd06645 89 GGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI--- 160 (267)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc---
Confidence 999999998654 35889999999999999999999998 9999999999999999999999999987543211
Q ss_pred ccccceeecccCCCCccchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 783 IVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.......|+..|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 161 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~ 212 (267)
T cd06645 161 ----AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred ----cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccc
Confidence 1123346889999999874 456889999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=287.48 Aligned_cols=206 Identities=29% Similarity=0.502 Sum_probs=172.0
Q ss_pred HHhcCCCCCccccccCceEEEEEEeC--------CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEEe
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCD 690 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~ 690 (845)
...++|.+.+.||+|+||.||++... ++..+|+|.++... .....++.+|+++++++ +|+||+++++++.
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 34467889999999999999999752 23579999987542 33456788999999999 7999999999999
Q ss_pred eCCeEEEEEEcCCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 003140 691 EEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 756 (845)
Q Consensus 691 ~~~~~~LV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NI 756 (845)
..+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni 171 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 171 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHhe
Confidence 9999999999999999999997642 235889999999999999999999988 99999999999
Q ss_pred EEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 003140 757 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 834 (845)
Q Consensus 757 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~ 834 (845)
+++.++.+||+|||+++.....+.. .......++..|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~ 245 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 245 (307)
T ss_pred EEcCCCcEEECCCcccccccccchh-----hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc
Confidence 9999999999999998765322110 11112234568999999998899999999999999999998 8888854
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=287.27 Aligned_cols=202 Identities=27% Similarity=0.441 Sum_probs=178.8
Q ss_pred CccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCCC
Q 003140 629 STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 705 (845)
Q Consensus 629 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g 705 (845)
.++||.|.||+||-|+.+ +|+.||||++.+.. ...+.++.+|+.+|++++||.||.+---|+..+..++|||.+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 578999999999999965 79999999986532 334567899999999999999999999999999999999999 57
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CcEEEEecCCcccCCCCCCCC
Q 003140 706 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEG 782 (845)
Q Consensus 706 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~---~~~kl~DFGla~~~~~~~~~~ 782 (845)
+..+++-.....++++....-++.||+.||.|||.++ |+|+||||+|||+.+. -.+||+|||.||+++.
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE----- 719 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE----- 719 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecch-----
Confidence 7777666666778999888889999999999999999 9999999999999643 4899999999999763
Q ss_pred ccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCceecc
Q 003140 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 842 (845)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~ 842 (845)
.......+||+.|+|||++....|...-||||.||++|--++|..||..++++.+++
T Consensus 720 ---ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQI 776 (888)
T KOG4236|consen 720 ---KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQI 776 (888)
T ss_pred ---hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHh
Confidence 345567899999999999999999999999999999999999999999888877654
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=282.45 Aligned_cols=202 Identities=31% Similarity=0.481 Sum_probs=169.8
Q ss_pred CCCCCccccccCceEEEEEEeC------CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
+|.+.+.||+|+||.||+|... ....+|+|.+.... ....+++.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677889999999999999853 23578999887543 3345679999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcc----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 003140 698 VYEFMSNGTLRDQLSAK----------------------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 755 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~----------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~N 755 (845)
||||+++|+|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 99999999999998642 1235889999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 003140 756 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 834 (845)
Q Consensus 756 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~ 834 (845)
||+++++.+||+|||+++....... ........++..|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDS-----YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred EEEcCCCcEEeccccccccccCccc-----hhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 9999999999999999976532211 011122345678999999988899999999999999999999 9999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=278.38 Aligned_cols=203 Identities=29% Similarity=0.431 Sum_probs=170.3
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-----hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CeE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-----LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQ 695 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~ 695 (845)
.+|...+.||+|+||.||+|... +|+.||+|.+.... ....+.+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999965 58999999875321 12245788899999999999999999988663 467
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++||||+++|+|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 8999999999999998654 34788888999999999999999998 999999999999999999999999998765
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
...... ........++..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 157 QTICLS----GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred cccccc----ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 321110 11122345889999999998888999999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=278.09 Aligned_cols=206 Identities=28% Similarity=0.502 Sum_probs=174.5
Q ss_pred CCCCCccccccCceEEEEEEeCCCcEEEEEEccCCC------hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS------LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~------~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
+|...+.||+|+||.||+|...+|+.+|||.++... ....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 467788999999999999998889999999876432 12235688999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
|||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||+++.....
T Consensus 81 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 9999999999999654 35789999999999999999999988 999999999999999999999999998765321
Q ss_pred CCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
..... .........|+..|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 156 ~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 212 (265)
T cd06631 156 GLHGT-HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212 (265)
T ss_pred ccccc-ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC
Confidence 11100 1112233568899999999998889999999999999999999999997543
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=313.06 Aligned_cols=207 Identities=28% Similarity=0.314 Sum_probs=180.3
Q ss_pred hHHHHHHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEee
Q 003140 616 YGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 691 (845)
Q Consensus 616 ~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~ 691 (845)
..++....++|.+.++||+|+||.|..++.. .++++|+|++.... +....-|..|-.+|..-+.+-|+++.-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3456667789999999999999999999975 68999999987622 2233468888999999999999999999999
Q ss_pred CCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 003140 692 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 771 (845)
Q Consensus 692 ~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGl 771 (845)
+.+.|+|||||+||+|-.++.+.. ++++..++.++..|+-||.-||+.| +|||||||+|||+|..|++|++|||.
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence 999999999999999999997765 6888888899999999999999999 99999999999999999999999998
Q ss_pred cccCCCCCCCCccccceeecccCCCCccchhhhc----C-CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003140 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL----T-HKLTDKSDVYSLGVVFLELLTGMQPIS 833 (845)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwS~Gvvl~elltG~~Pf~ 833 (845)
+-.+.... .-.+...+|||.|++||++. + +.|++.+|.||+||++|||+.|..||-
T Consensus 222 Clkm~~dG------~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 222 CLKMDADG------TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred HHhcCCCC------cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 86664321 23345678999999999985 2 579999999999999999999999995
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=282.44 Aligned_cols=206 Identities=26% Similarity=0.410 Sum_probs=174.5
Q ss_pred HhcCCCCCccccccCceEEEEEEeCC-----CcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEee-CCe
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILPD-----GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-EGE 694 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-----g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~ 694 (845)
..++|...+.||+|+||.||+|...+ +..|++|++.... ....+.+.+|+.++++++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45788889999999999999999765 7889999887542 3345678999999999999999999998866 567
Q ss_pred EEEEEEcCCCCCHHHHHhccCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEe
Q 003140 695 QMLVYEFMSNGTLRDQLSAKSK------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 768 (845)
Q Consensus 695 ~~LV~E~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~D 768 (845)
.++++||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 8999999999999999976422 46899999999999999999999988 99999999999999999999999
Q ss_pred cCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 769 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 769 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
||+++.+...+. ........++..|+|||++....++.++|||||||++||+++ |+.||...
T Consensus 161 ~g~~~~~~~~~~-----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 223 (280)
T cd05043 161 NALSRDLFPMDY-----HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI 223 (280)
T ss_pred CCCcccccCCce-----EEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC
Confidence 999986532221 011122345678999999998899999999999999999999 99999653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=279.97 Aligned_cols=205 Identities=29% Similarity=0.493 Sum_probs=172.3
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CC---cEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DG---TVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g---~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
.++|+..+.||+|+||.||+|... ++ ..+|+|.++... ....+++.+|++++++++|+|++++++++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 456788899999999999999975 33 379999987542 3345679999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
||||+++++|.+++.... ..+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 84 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 84 ITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999997643 46899999999999999999999998 99999999999999999999999999876542
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
.... .........+..|+|||++....++.++|||||||++|||++ |+.||...
T Consensus 160 ~~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~ 214 (268)
T cd05063 160 DPEG----TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM 214 (268)
T ss_pred cccc----ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 2110 111111223457999999998899999999999999999998 99999643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=277.56 Aligned_cols=202 Identities=28% Similarity=0.435 Sum_probs=175.7
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG---SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|+..+.||+|+||.||+|... +|+.||+|.++.. .....+++.+|++++++++|+|++++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999976 7999999987632 2233567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 700 EFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 700 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
||+++|+|.+++... ....+++..+..++.++++||.|||+.+ |+||||||+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998652 3456899999999999999999999998 99999999999999999999999999876532
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.. .......++..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 159 ~~-------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 159 KT-------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CC-------cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 21 1112345788999999998888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=278.22 Aligned_cols=196 Identities=32% Similarity=0.526 Sum_probs=169.6
Q ss_pred hcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEe-eCCeEEEEEEc
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD-EEGEQMLVYEF 701 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~-~~~~~~LV~E~ 701 (845)
.++|...+.||+|+||.||++... |..||+|..+... ..+.|.+|+.++++++|+|++++++++. +.+..++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 357888899999999999999864 7889999886532 3467899999999999999999999764 45678999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+++|+|.++++......+++..++.++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--- 155 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 155 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecccc---
Confidence 99999999998766666899999999999999999999988 999999999999999999999999998754321
Q ss_pred CccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 834 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~ 834 (845)
.....++..|+|||++....++.++|||||||++|||++ |+.||..
T Consensus 156 -------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~ 202 (256)
T cd05082 156 -------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202 (256)
T ss_pred -------CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 112234568999999998899999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=276.15 Aligned_cols=196 Identities=29% Similarity=0.473 Sum_probs=163.4
Q ss_pred cccccCceEEEEEEeC---CCcEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCCCC
Q 003140 631 QIGQGGYGKVYKGILP---DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGT 706 (845)
Q Consensus 631 ~LG~G~fG~Vy~~~~~---~g~~vAVK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gs 706 (845)
.||+|+||.||+|.+. .+..||+|++..... ...++|.+|++++++++|+||+++++++. .+..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999864 356799999876533 33467999999999999999999999885 457899999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCcccc
Q 003140 707 LRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 786 (845)
Q Consensus 707 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 786 (845)
|.+++... ...+++..++.++.|+++||+|||+++ ++||||||+||+++.++.+||+|||+++........ .
T Consensus 81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~----~ 152 (257)
T cd05115 81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY----Y 152 (257)
T ss_pred HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccc----e
Confidence 99998653 346899999999999999999999998 999999999999999999999999999765322110 0
Q ss_pred ceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 787 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 787 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
.......++..|+|||++....++.++|||||||++||+++ |+.||...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 202 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM 202 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC
Confidence 11122234578999999988889999999999999999996 99999754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=283.54 Aligned_cols=203 Identities=28% Similarity=0.431 Sum_probs=170.2
Q ss_pred CCCCCccccccCceEEEEEEeC------CCcEEEEEEccCCChh-hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
+|.+.+.||+|+||.||+|... ++..||+|+++..... ..+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4666789999999999999853 2578999998754332 34578899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 003140 698 VYEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 763 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~ 763 (845)
++||+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 99999999999998532 1235788999999999999999999998 999999999999999999
Q ss_pred EEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 764 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 764 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
+||+|||+++.....+. ........+++.|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 163 ~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 230 (283)
T cd05091 163 VKISDLGLFREVYAADY-----YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230 (283)
T ss_pred eEecccccccccccchh-----eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999886532221 111223345789999999988899999999999999999998 88888653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=286.24 Aligned_cols=206 Identities=28% Similarity=0.519 Sum_probs=173.2
Q ss_pred HHhcCCCCCccccccCceEEEEEEe--------CCCcEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEEe
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGIL--------PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCD 690 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~--------~~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~ 690 (845)
...++|.+.+.||+|+||.||+|.. .++..||+|.+.... ....+++.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 4567788899999999999999974 134579999987532 34456899999999999 8999999999999
Q ss_pred eCCeEEEEEEcCCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 003140 691 EEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 756 (845)
Q Consensus 691 ~~~~~~LV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NI 756 (845)
..+..++||||+++|+|.+++.... ...+++..+..++.||++||+|||+++ |+||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 9999999999999999999997632 235788999999999999999999998 99999999999
Q ss_pred EEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 003140 757 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 834 (845)
Q Consensus 757 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~ 834 (845)
+++.++.+||+|||+++....... ........++..|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 242 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 242 (304)
T ss_pred EEcCCCcEEECCCccceecccccc-----cccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999986543221 111122345678999999988899999999999999999998 7888854
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-32 Score=254.89 Aligned_cols=210 Identities=27% Similarity=0.383 Sum_probs=175.1
Q ss_pred hHHHHHHhcCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCC-ChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeC
Q 003140 616 YGEMALATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE 692 (845)
Q Consensus 616 ~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~ 692 (845)
.+.+++..+.......||+|++|.|-+.++ .+|...|||++... ..+..++.++|+.+..+. .+|.+|.|+|...++
T Consensus 38 ~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re 117 (282)
T KOG0984|consen 38 DRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE 117 (282)
T ss_pred cCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc
Confidence 334566667777788999999999988885 58999999998753 344566788898876554 799999999999999
Q ss_pred CeEEEEEEcCCCCCHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 003140 693 GEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 770 (845)
Q Consensus 693 ~~~~LV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFG 770 (845)
...++.||.|+ -||..+-++ ..+..+++...-+||..+.+||.|||++-+ +||||+||+|||++.+|++||+|||
T Consensus 118 gdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFG 194 (282)
T KOG0984|consen 118 GDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFG 194 (282)
T ss_pred ccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccc
Confidence 99999999995 688877654 355678999999999999999999999764 9999999999999999999999999
Q ss_pred CcccCCCCCCCCccccceeecccCCCCccchhhhcC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 771 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT----HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 771 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
++-.+.+ +...+...|...|||||.+.. ..|+-|+||||+|+.+.||.+++.||....
T Consensus 195 IsG~L~d--------SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 195 ISGYLVD--------SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred cceeehh--------hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 9866532 233345678999999999853 478999999999999999999999997543
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=286.69 Aligned_cols=202 Identities=33% Similarity=0.516 Sum_probs=169.2
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCc--EEEEEEccCC-ChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGT--VVAVKRAQEG-SLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~--~vAVK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~L 697 (845)
.++|++.+.||+|+||.||+|.+. ++. .+|+|.++.. .....+++.+|++++.++ +|+||+++++++.+.+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357888899999999999999964 454 4678877643 233456789999999999 89999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 003140 698 VYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 763 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~ 763 (845)
||||+++|+|.++++... ...+++..++.++.|+++|++|||+.+ |+||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999997532 235789999999999999999999988 999999999999999999
Q ss_pred EEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 764 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 764 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
+||+|||+++..... .......++..|+|||++.+..++.++|||||||++|||+| |..||...
T Consensus 163 ~kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 227 (303)
T cd05088 163 AKIADFGLSRGQEVY--------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 227 (303)
T ss_pred EEeCccccCcccchh--------hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC
Confidence 999999998642110 01111234568999999988889999999999999999998 99999643
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=281.93 Aligned_cols=202 Identities=26% Similarity=0.409 Sum_probs=174.6
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
.+.|++.+.||+|+||.||+|... +++.||+|.+........+++.+|++++++++|+||+++++++..++..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 367888999999999999999975 5899999999876666677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+++++|..++.... ..+++..+..++.|+++|++|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 91 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--- 163 (292)
T cd06644 91 CPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--- 163 (292)
T ss_pred CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc---
Confidence 99999998876543 45899999999999999999999988 999999999999999999999999998653211
Q ss_pred CccccceeecccCCCCccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
........++..|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 164 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 218 (292)
T cd06644 164 ----LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218 (292)
T ss_pred ----ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence 11123345788999999884 345788999999999999999999999653
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=280.88 Aligned_cols=202 Identities=31% Similarity=0.465 Sum_probs=170.0
Q ss_pred cCCCCCccccccCceEEEEEEe-----CCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEee--CCeEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQM 696 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~ 696 (845)
.+|.+.+.||+|+||.||++.. .++..||+|++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4678889999999999999974 2578999999887666667789999999999999999999998754 34689
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCC
Q 003140 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~ 776 (845)
+||||+++|+|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999999996542 35899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003140 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833 (845)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~ 833 (845)
..... ........++..|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 160 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 160 QDKEY----YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred CCCcc----eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 32100 001111223456999999998899999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=282.63 Aligned_cols=198 Identities=27% Similarity=0.440 Sum_probs=174.7
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|+..+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888899999999999999965 68999999886432 233467889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++++|.++++.. ..+++..+..++.|++.||+|||+.+ |+||||+|+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999999999764 46889999999999999999999988 999999999999999999999999998765322
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.....+++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 155 ---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 155 ---------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred ---------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 223458899999999988889999999999999999999999997554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=281.90 Aligned_cols=202 Identities=29% Similarity=0.392 Sum_probs=175.7
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
.++|++.+.||+|+||.||+|... ++..||+|.+........+.|.+|++++++++|+||+++++++...+..++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 456888999999999999999975 6899999998876666667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-- 157 (280)
T cd06611 84 CDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-- 157 (280)
T ss_pred cCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc--
Confidence 99999999986543 46899999999999999999999998 9999999999999999999999999986543211
Q ss_pred CccccceeecccCCCCccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.......++..|+|||.+. ...++.++|||||||++|||++|+.||...
T Consensus 158 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~ 211 (280)
T cd06611 158 -----QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211 (280)
T ss_pred -----cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence 1123345889999999974 345778999999999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=278.85 Aligned_cols=204 Identities=29% Similarity=0.459 Sum_probs=172.0
Q ss_pred cCCCCCccccccCceEEEEEEeC----CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
.+|.+.+.||+|+||.||+|... .+..+|+|.++... ....+.|.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 56788899999999999999863 23479999987543 23356889999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
|||+++|+|.+++.... ..+++..++.++.|++.|+.|||+.+ ++||||||+|||++.++.++++|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999997653 45899999999999999999999998 999999999999999999999999999876432
Q ss_pred CCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
... ........++..|+|||++.+..++.++|||||||++||+++ |+.||...
T Consensus 160 ~~~----~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~ 213 (267)
T cd05066 160 PEA----AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM 213 (267)
T ss_pred cce----eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC
Confidence 110 111112233568999999998899999999999999999887 99999654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=281.34 Aligned_cols=199 Identities=32% Similarity=0.458 Sum_probs=167.1
Q ss_pred CCCccccccCceEEEEEEe-----CCCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CeEEEE
Q 003140 627 NSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQMLV 698 (845)
Q Consensus 627 ~~~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~LV 698 (845)
...+.||+|+||+||++.. .++..||+|.++... ....+.|.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7789999999999988653 357899999987543 23456789999999999999999999988653 458899
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
|||+++|+|.+++... .+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 87 ~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 87 MEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred ecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 9999999999999653 4899999999999999999999998 999999999999999999999999999865432
Q ss_pred CCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
... ........++..|+|||.+....++.++||||||+++|||+||+.||...
T Consensus 161 ~~~----~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 161 HEY----YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred chh----hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 110 01112223566799999998888999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=275.77 Aligned_cols=201 Identities=27% Similarity=0.412 Sum_probs=176.1
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
+|+..+.||+|+||.||.+... +++.+++|.+... .....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4778899999999999998854 6899999987643 334456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+++|+|.+++.......+++..+..++.|+++|+.|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 99999999998765567899999999999999999999988 99999999999999999999999999976543221
Q ss_pred CccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
......++..|+|||...+..++.++||||||+++|||++|+.||...
T Consensus 157 ------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08221 157 ------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT 204 (256)
T ss_pred ------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC
Confidence 123345889999999998888999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=278.28 Aligned_cols=202 Identities=28% Similarity=0.443 Sum_probs=165.9
Q ss_pred CCCCccccccCceEEEEEEeCC-Cc--EEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC------Ce
Q 003140 626 FNSSTQIGQGGYGKVYKGILPD-GT--VVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------GE 694 (845)
Q Consensus 626 f~~~~~LG~G~fG~Vy~~~~~~-g~--~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------~~ 694 (845)
|.+.+.||+|+||.||+|.+.+ +. .||+|.++.. .....+.+.+|++++++++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3457889999999999999754 33 6899988653 334456889999999999999999999987432 24
Q ss_pred EEEEEEcCCCCCHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 003140 695 QMLVYEFMSNGTLRDQLSAK----SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 770 (845)
Q Consensus 695 ~~LV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFG 770 (845)
.++||||+++|+|.+++... ....+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 68999999999999987432 2345899999999999999999999988 9999999999999999999999999
Q ss_pred CcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 771 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 771 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
+++....... ........++..|+|||+.....++.++|||||||++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 218 (272)
T cd05075 158 LSKKIYNGDY-----YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV 218 (272)
T ss_pred cccccCcccc-----eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9987543221 111122345678999999999999999999999999999999 88898643
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=279.43 Aligned_cols=202 Identities=26% Similarity=0.416 Sum_probs=174.7
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEG---SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|+..+.||+|+||.||+|.. .+++.+|||.+... .....+++.+|+++++.++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4677889999999999999995 47899999987642 2233467899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 700 EFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 700 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
||+++++|.+++... ....+++..++.++.|+++|+.|||+.+ ++|+||||+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999998642 3456899999999999999999999998 99999999999999999999999999876532
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.. .......++..|+|||++.+..++.++||||||+++|||++|..||...
T Consensus 159 ~~-------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08229 159 KT-------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CC-------cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 21 1112345788999999999888999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=283.51 Aligned_cols=200 Identities=26% Similarity=0.444 Sum_probs=176.0
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcC
Q 003140 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 702 (845)
.+|+..+.||.|+||.||+|.. .+++.||+|.+........+.+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688889999999999999985 478999999987655555678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCC
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 782 (845)
++++|..++... .+++..+..++.|+++|++|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~--- 169 (296)
T cd06655 99 AGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--- 169 (296)
T ss_pred CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc---
Confidence 999999998643 5899999999999999999999998 9999999999999999999999999987543221
Q ss_pred ccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......++..|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 170 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~ 219 (296)
T cd06655 170 ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (296)
T ss_pred ----ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 11223457889999999998889999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=279.94 Aligned_cols=203 Identities=30% Similarity=0.477 Sum_probs=169.7
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCc----EEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 696 (845)
.++|+..+.||+|+||.||+|.+. +|+ .||+|.++.. .....+++.+|+.+++.++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 457888899999999999999853 454 4899998754 33446688999999999999999999999875 4577
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCC
Q 003140 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~ 776 (845)
++|||+++|+|.++++... ..+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 85 l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 9999999999999997543 46899999999999999999999998 9999999999999999999999999998664
Q ss_pred CCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
.... ........++..|+|||...+..++.++|||||||++|||++ |..||...
T Consensus 161 ~~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 215 (279)
T cd05109 161 IDET-----EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215 (279)
T ss_pred cccc-----eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 2211 011112234678999999998899999999999999999998 99998653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=275.30 Aligned_cols=202 Identities=26% Similarity=0.403 Sum_probs=173.9
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEee-CCeEEEEEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-EGEQMLVYE 700 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~LV~E 700 (845)
+|++.+.||+|++|.||++... +++.||+|++.... ....+.+.+|++++++++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999965 57899999986432 3345678899999999999999999998764 446789999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
|+++++|.+++.......+++..++.++.+++.|++|||+.+ |+||||||+||+++.++.++|+|||+++......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 999999999998765667899999999999999999999998 9999999999999999999999999997653221
Q ss_pred CCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......+++.|+|||++.+..++.++||||||++++||++|+.||...+
T Consensus 157 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 206 (257)
T cd08223 157 ------DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD 206 (257)
T ss_pred ------CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 11233457899999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=274.92 Aligned_cols=200 Identities=31% Similarity=0.475 Sum_probs=176.3
Q ss_pred hcCCCCCccccccCceEEEEEEeCC-CcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
.++|+..+.||+|+||.||+|...+ ++.+++|.+..... .+++.+|++++++++|+||+++++++.+.+..++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3678889999999999999999764 88999999875432 67899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+++++|.+++... ...+++..+..++.|+++|+.|||+.+ ++||||+|+||+++.++.+||+|||++.......
T Consensus 80 ~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~-- 153 (256)
T cd06612 80 CGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM-- 153 (256)
T ss_pred CCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc--
Confidence 9999999998653 346899999999999999999999998 9999999999999999999999999988654321
Q ss_pred CccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.......++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 154 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~ 202 (256)
T cd06612 154 -----AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202 (256)
T ss_pred -----cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 1122345788999999999889999999999999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=280.08 Aligned_cols=200 Identities=32% Similarity=0.480 Sum_probs=170.3
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
+|...+.||+|++|.||+|... ++..||+|+++... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777889999999999999975 68999999886432 22346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 702 MSNGTLRDQLSAKS-KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 702 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
++ ++|.+++.... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 78999886643 357899999999999999999999998 9999999999999999999999999987543211
Q ss_pred CCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.......++..|+|||.+.+ ..++.++|||||||++|||+||+.||...
T Consensus 156 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 156 ------RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred ------ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 11223356789999998865 45789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=285.30 Aligned_cols=207 Identities=28% Similarity=0.509 Sum_probs=172.4
Q ss_pred HHHhcCCCCCccccccCceEEEEEEeC--------CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEE
Q 003140 620 ALATNNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYC 689 (845)
Q Consensus 620 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~ 689 (845)
....++|.+.+.||+|+||.||++... ....||+|.++... .....++.+|+++++++ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 344567888999999999999999742 24579999987532 33456789999999999 699999999999
Q ss_pred eeCCeEEEEEEcCCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 003140 690 DEEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 755 (845)
Q Consensus 690 ~~~~~~~LV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~N 755 (845)
.+.+..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecccccee
Confidence 99999999999999999999996532 235889999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 003140 756 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 834 (845)
Q Consensus 756 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~ 834 (845)
||+++++.+||+|||+++.....+.. .......++..|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 239 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYY-----KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239 (314)
T ss_pred EEEcCCCcEEEccccccccccccccc-----cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999865422211 01111234467999999998899999999999999999999 8999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=280.31 Aligned_cols=202 Identities=25% Similarity=0.384 Sum_probs=177.3
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCChhh--HHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~--~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
.-|+..+.||+|.|+.|-.|++ -.|..||||++.+...+. ...+.+|++.|+-++|||||++|++.......|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4577788999999999999884 489999999997654333 4578999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE-cCCCcEEEEecCCcccCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL-DHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl-~~~~~~kl~DFGla~~~~~~~ 779 (845)
.=++|+|++|+-++.. .+.+....+++.||+.|+.|.|+.+ +|||||||+||.+ .+-|-+|++|||.+..+.
T Consensus 98 LGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~--- 170 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ--- 170 (864)
T ss_pred ecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC---
Confidence 9999999999977543 4888999999999999999999999 9999999999866 667899999999986543
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT-DKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
++...++..|+..|-|||++.+..|+ ++.||||+||++|-|++|+.||+..++
T Consensus 171 -----PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND 224 (864)
T KOG4717|consen 171 -----PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND 224 (864)
T ss_pred -----CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc
Confidence 45556778999999999999998875 589999999999999999999987655
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=276.79 Aligned_cols=205 Identities=27% Similarity=0.481 Sum_probs=172.8
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChh---------hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCe
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 694 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~---------~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 694 (845)
+|...+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|++++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667889999999999999864 6889999987643221 12568899999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003140 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (845)
Q Consensus 695 ~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~ 774 (845)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||.++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 99999999999999999654 45788899999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
......... .........|+..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~~~~~~-~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 215 (267)
T cd06628 156 LEANSLSTK-TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215 (267)
T ss_pred cccccccCC-ccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence 642211100 111122345788999999999888999999999999999999999999754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=275.85 Aligned_cols=203 Identities=31% Similarity=0.448 Sum_probs=170.9
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-----hhhHHHHHHHHHHHHhcCCCceeeEEEEEee--CCeE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-----LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQ 695 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~ 695 (845)
.+|...+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999864 68999999875322 1234568899999999999999999998865 3567
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
+++|||+++++|.+++... ..+++...+.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 8999999999999999654 34788999999999999999999988 999999999999999999999999998765
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
...... ........++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 157 QTICMS----GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred cccccc----CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 321100 11112345789999999999888999999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=278.82 Aligned_cols=199 Identities=31% Similarity=0.429 Sum_probs=175.3
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
++|+..+.||.|+||.||+|... +++.||+|.+.... ......+.+|++++++++|+||+++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36788899999999999999965 68999999987543 33456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+++++|.+++... ++++..+..++.|++.|+.|||+.+ ++||||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 152 (274)
T cd06609 81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-- 152 (274)
T ss_pred eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc--
Confidence 9999999999654 7899999999999999999999988 9999999999999999999999999998764321
Q ss_pred CccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.......++..|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 153 -----~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~ 201 (274)
T cd06609 153 -----SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201 (274)
T ss_pred -----cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 1123345788999999999888999999999999999999999999653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=281.78 Aligned_cols=205 Identities=31% Similarity=0.473 Sum_probs=173.8
Q ss_pred hcCCCCCccccccCceEEEEEEeCC-----------------CcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceee
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILPD-----------------GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVS 684 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~~-----------------g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~ 684 (845)
..+|.+.+.||+|+||.||+|...+ +..||+|.+.... ....+++.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578889999999999999988642 2468999987543 344678999999999999999999
Q ss_pred EEEEEeeCCeEEEEEEcCCCCCHHHHHhccC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 003140 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS---------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 755 (845)
Q Consensus 685 l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~N 755 (845)
+++++...+..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999997643 236899999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh--CCCCCC
Q 003140 756 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT--GMQPIS 833 (845)
Q Consensus 756 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt--G~~Pf~ 833 (845)
|+++.++.++|+|||+++.....+. ........++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDY-----YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred eeecCCCceEEccccceeecccCcc-----eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 9999999999999999876533221 111223456788999999988899999999999999999998 778886
Q ss_pred CC
Q 003140 834 HG 835 (845)
Q Consensus 834 ~~ 835 (845)
..
T Consensus 236 ~~ 237 (296)
T cd05051 236 HL 237 (296)
T ss_pred Cc
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=289.79 Aligned_cols=207 Identities=28% Similarity=0.478 Sum_probs=170.4
Q ss_pred HHhcCCCCCccccccCceEEEEEEe------CCCcEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeC
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE 692 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~ 692 (845)
...++|.+.+.||+|+||.||+|.+ .+++.||||+++... ....+.+.+|++++.++ +|+||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 3456899999999999999999973 357899999987543 23346788999999999 689999999988654
Q ss_pred -CeEEEEEEcCCCCCHHHHHhccC--------------------------------------------------------
Q 003140 693 -GEQMLVYEFMSNGTLRDQLSAKS-------------------------------------------------------- 715 (845)
Q Consensus 693 -~~~~LV~E~~~~gsL~~~l~~~~-------------------------------------------------------- 715 (845)
...++||||+++|+|.++++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 46789999999999999986431
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCcccc
Q 003140 716 ---------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 786 (845)
Q Consensus 716 ---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 786 (845)
...+++..+..++.|+++||+|||+++ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-----~~ 235 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDP-----DY 235 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCc-----ch
Confidence 124688889999999999999999998 9999999999999999999999999997653211 01
Q ss_pred ceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 787 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 787 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
.......++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 236 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 285 (343)
T cd05103 236 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 285 (343)
T ss_pred hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 11122345678999999998899999999999999999997 99998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=276.24 Aligned_cols=190 Identities=23% Similarity=0.368 Sum_probs=160.9
Q ss_pred ccccccCceEEEEEEeCC-------------CcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEE
Q 003140 630 TQIGQGGYGKVYKGILPD-------------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~~-------------g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 696 (845)
+.||+|+||.||+|...+ ...||+|.+..........|.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358999887655555668899999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc-------EEEEec
Q 003140 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT-------AKVADF 769 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~-------~kl~DF 769 (845)
+||||+++|+|..+++... ..+++..++.++.||++||+|||+.+ |+||||||+|||++.++. ++++||
T Consensus 81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999886543 45899999999999999999999988 999999999999987664 899999
Q ss_pred CCcccCCCCCCCCccccceeecccCCCCccchhhhc-CCCCCchhhHHHHHHHHHHHH-hCCCCCCC
Q 003140 770 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELL-TGMQPISH 834 (845)
Q Consensus 770 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~ell-tG~~Pf~~ 834 (845)
|++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|+.||..
T Consensus 157 g~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 212 (262)
T cd05077 157 GIPITVLSR-----------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD 212 (262)
T ss_pred CCCccccCc-----------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 998654211 1234778899999886 467899999999999999998 58888864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=283.16 Aligned_cols=200 Identities=26% Similarity=0.437 Sum_probs=169.9
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
++|...+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++|+||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888999999999999999875 68899999886432 22345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
++ ++|.+++... ...+++.....++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 86 ~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 158 (301)
T cd07873 86 LD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-- 158 (301)
T ss_pred cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--
Confidence 97 6999988654 335789999999999999999999998 9999999999999999999999999987543221
Q ss_pred CccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 159 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~ 208 (301)
T cd07873 159 -----KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS 208 (301)
T ss_pred -----CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11122356889999999865 45788999999999999999999999654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=282.43 Aligned_cols=204 Identities=29% Similarity=0.458 Sum_probs=170.2
Q ss_pred hcCCCCCccccccCceEEEEEEeCC---------------CcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILPD---------------GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLV 686 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~~---------------g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~ 686 (845)
.++|.+.+.||+|+||.||++...+ ...||+|.++... .....+|.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4678889999999999999987532 2358999987543 33456799999999999999999999
Q ss_pred EEEeeCCeEEEEEEcCCCCCHHHHHhccC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 003140 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKS----------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 756 (845)
Q Consensus 687 g~~~~~~~~~LV~E~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NI 756 (845)
+++...+..++||||+++++|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999986532 124688999999999999999999998 99999999999
Q ss_pred EEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh--CCCCCCC
Q 003140 757 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT--GMQPISH 834 (845)
Q Consensus 757 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt--G~~Pf~~ 834 (845)
++++++.+||+|||+++....... ........++..|+|||++....++.++|||||||++|||++ |..||..
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred EEcCCCcEEecccccccccccCcc-----eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 999999999999999976532210 111122345678999999998899999999999999999998 6678864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=290.50 Aligned_cols=198 Identities=26% Similarity=0.410 Sum_probs=168.6
Q ss_pred HHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE----- 692 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~----- 692 (845)
...++|...+.||+|+||.||+|... +++.||||++.... ....+++.+|++++++++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34578999999999999999999864 68899999987532 22345688999999999999999999887533
Q ss_pred -CeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 003140 693 -GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 771 (845)
Q Consensus 693 -~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGl 771 (845)
...++++|++ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 4578999988 7899888753 35899999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
++..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 165 ~~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 219 (343)
T cd07878 165 ARQADDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219 (343)
T ss_pred ceecCCC----------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 9864321 223468899999999876 57899999999999999999999999654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=274.16 Aligned_cols=195 Identities=29% Similarity=0.436 Sum_probs=163.7
Q ss_pred cccccCceEEEEEEeC---CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCCC
Q 003140 631 QIGQGGYGKVYKGILP---DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 705 (845)
Q Consensus 631 ~LG~G~fG~Vy~~~~~---~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g 705 (845)
.||+|+||.||+|.++ ++..+|+|+++... ....+++.+|+.++++++|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 57899999986433 234568999999999999999999999885 45678999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCccc
Q 003140 706 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP 785 (845)
Q Consensus 706 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 785 (845)
+|.+++... ..+++..+..++.|++.|++|||+++ |+||||||+||++++++.+||+|||+++........
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~---- 151 (257)
T cd05116 81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY---- 151 (257)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCe----
Confidence 999999653 35889999999999999999999998 999999999999999999999999999865432210
Q ss_pred cceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 786 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 786 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
........++..|+|||.+....++.++|||||||++|||++ |+.||...
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 202 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM 202 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 011122234578999999988889999999999999999998 99999754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=277.79 Aligned_cols=198 Identities=36% Similarity=0.588 Sum_probs=172.7
Q ss_pred CCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHH--HHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcC
Q 003140 626 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEK--EFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (845)
Q Consensus 626 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~--~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 702 (845)
|+..+.||+|+||+||++... +++.||+|++......... ...+|++++++++||||+++++++.+.+..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999976 5678999999876544332 3466999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCC
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 782 (845)
++++|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.++|+|||.+.....
T Consensus 81 ~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~----- 150 (260)
T PF00069_consen 81 PGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE----- 150 (260)
T ss_dssp TTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS-----
T ss_pred ccccccccccc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-----
Confidence 99999999973 345899999999999999999999998 99999999999999999999999999875411
Q ss_pred ccccceeecccCCCCccchhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 783 IVPAHVSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.........++..|+|||++. +..++.++||||+|+++|+|++|..||...
T Consensus 151 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 151 --NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp --TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred --cccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 122334566889999999998 888999999999999999999999999865
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=279.29 Aligned_cols=190 Identities=25% Similarity=0.369 Sum_probs=159.6
Q ss_pred cccccCceEEEEEEeCC-------------------------CcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeE
Q 003140 631 QIGQGGYGKVYKGILPD-------------------------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 685 (845)
Q Consensus 631 ~LG~G~fG~Vy~~~~~~-------------------------g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l 685 (845)
.||+|+||.||+|.+.. ...||+|++........++|.+|++++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997421 23589999876555555688999999999999999999
Q ss_pred EEEEeeCCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC---
Q 003140 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF--- 762 (845)
Q Consensus 686 ~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~--- 762 (845)
++++.+....++||||+++|+|..++... ...+++..+..++.|+++||+|||+++ |+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999998653 346889999999999999999999988 99999999999997653
Q ss_pred ----cEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHH-HhCCCCCCCC
Q 003140 763 ----TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLEL-LTGMQPISHG 835 (845)
Q Consensus 763 ----~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~el-ltG~~Pf~~~ 835 (845)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++||| ++|+.||...
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 225 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER 225 (274)
T ss_pred CccceeeecCCccccccccc-----------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 4899999987643211 12346788999998865 5689999999999999999 4799999653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=275.03 Aligned_cols=203 Identities=28% Similarity=0.424 Sum_probs=177.2
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
.++|+..+.||+|+||.||+|... +++.+|+|.+........+.+.+|++++++++||||+++++++.+.+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367888999999999999999975 5788999998865555667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++......
T Consensus 82 ~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--- 154 (262)
T cd06613 82 CGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTAT--- 154 (262)
T ss_pred CCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhh---
Confidence 9999999998654 246889999999999999999999988 999999999999999999999999998764321
Q ss_pred CccccceeecccCCCCccchhhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTH---KLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
........++..|+|||.+... .++.++|||||||++|||++|+.||....
T Consensus 155 ----~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~ 208 (262)
T cd06613 155 ----IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH 208 (262)
T ss_pred ----hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 1112334678899999998776 88999999999999999999999997543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=283.49 Aligned_cols=198 Identities=27% Similarity=0.432 Sum_probs=172.0
Q ss_pred CCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCC
Q 003140 626 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (845)
Q Consensus 626 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 704 (845)
|.....||+|+||.||++... ++..||||.+........+.+.+|+.++++++|+||+++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 333467999999999999864 6899999998765555667799999999999999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCcc
Q 003140 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (845)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 784 (845)
++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 104 ~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~----- 172 (292)
T cd06658 104 GALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV----- 172 (292)
T ss_pred CcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc-----
Confidence 999998854 35889999999999999999999998 9999999999999999999999999987543211
Q ss_pred ccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......|+..|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 173 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 222 (292)
T cd06658 173 --PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP 222 (292)
T ss_pred --ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 11123457899999999988899999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=274.12 Aligned_cols=201 Identities=34% Similarity=0.558 Sum_probs=172.9
Q ss_pred cCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCC
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 703 (845)
.+|+..+.||+|+||.||+|.+.++..+|+|.+.... ....+|.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4677789999999999999998778899999987533 335679999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCc
Q 003140 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (845)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 783 (845)
+|+|.++++... ..+++..++.++.+++.|++|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~---- 154 (256)
T cd05112 83 HGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ---- 154 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCc----
Confidence 999999987543 35789999999999999999999998 9999999999999999999999999987653221
Q ss_pred cccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
........++.+|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 155 --~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 205 (256)
T cd05112 155 --YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR 205 (256)
T ss_pred --ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 111122234578999999998899999999999999999998 99999644
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=274.12 Aligned_cols=198 Identities=37% Similarity=0.564 Sum_probs=172.5
Q ss_pred ccccccCceEEEEEEeCC----CcEEEEEEccCCChhh-HHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCC
Q 003140 630 TQIGQGGYGKVYKGILPD----GTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~~----g~~vAVK~~~~~~~~~-~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 704 (845)
+.||+|+||.||+|.... +..||+|.+....... .+++.+|+++++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999753 7899999988654433 67899999999999999999999999999999999999999
Q ss_pred CCHHHHHhccC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 705 GTLRDQLSAKS-------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 705 gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
++|.++++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999997642 357899999999999999999999988 99999999999999999999999999987653
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
... ........++..|+|||.+....++.++||||+||++|||++ |+.||...
T Consensus 158 ~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 211 (262)
T cd00192 158 DDY-----YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL 211 (262)
T ss_pred ccc-----cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence 221 112234457889999999988899999999999999999999 69999754
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=280.95 Aligned_cols=200 Identities=26% Similarity=0.429 Sum_probs=171.1
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
++|++.+.||+|+||.||++... +|..||+|.++.. .....+++.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999976 7899999988653 233346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 702 MSNGTLRDQLSAKS-KEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 702 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
+++++|.++++... ...+++..+..++.|+++||.|||+. + |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999999987532 34689999999999999999999974 5 999999999999999999999999998754321
Q ss_pred CCCccccceeecccCCCCccchhhhcCC------CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTH------KLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 157 --------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 210 (286)
T cd06622 157 --------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE 210 (286)
T ss_pred --------ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence 12233578899999998554 3588999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=280.85 Aligned_cols=207 Identities=24% Similarity=0.387 Sum_probs=173.2
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|+..+.||+|+||.||++... .++.||+|.+..... ...+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999965 578999998875432 23457889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++++|.+++... ..+++..+..++.|+++|++|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999999999654 35889999999999999999999988 9999999999999999999999999987421110
Q ss_pred CCCc--------cccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 780 IEGI--------VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 780 ~~~~--------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.... ..........++..|+|||++....++.++|+|||||++|||++|+.||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~ 219 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 219 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 0000 0011112345788999999998889999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=276.87 Aligned_cols=203 Identities=29% Similarity=0.497 Sum_probs=170.3
Q ss_pred CCCCCccccccCceEEEEEEeC-CC---cEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DG---TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g---~~vAVK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
.|...+.||+|+||.||+|... ++ ..||||.++.. .....++|..|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4677889999999999999964 33 36999998754 3334568999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++|+|.+++.... ..+++..++.++.|++.|+.|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 85 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 85 EFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred ecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999997643 45899999999999999999999988 9999999999999999999999999987654322
Q ss_pred CCCccccceeeccc--CCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 780 IEGIVPAHVSTVVK--GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 780 ~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
.. ........ .+..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 161 ~~----~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~ 215 (269)
T cd05065 161 SD----PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 215 (269)
T ss_pred cc----cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC
Confidence 11 00011111 2457999999999999999999999999999986 99999654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=289.89 Aligned_cols=195 Identities=24% Similarity=0.378 Sum_probs=167.0
Q ss_pred HHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
....+|.+.+.||+|+||.||+|... +++.||+|..... ....|+.++++++|+||+++++++...+..++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34457999999999999999999975 5788999975432 2356899999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+. |+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 210 (357)
T PHA03209 137 PHYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA- 210 (357)
T ss_pred EccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence 9994 7899988653 346899999999999999999999998 999999999999999999999999999753211
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
.......||..|+|||++.+..++.++|||||||++|||+++..|+..
T Consensus 211 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~ 258 (357)
T PHA03209 211 -------PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFE 258 (357)
T ss_pred -------cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcccc
Confidence 112335689999999999999999999999999999999997666643
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=275.63 Aligned_cols=195 Identities=33% Similarity=0.525 Sum_probs=163.4
Q ss_pred ccccccCceEEEEEEeCC-Cc--EEEEEEccCC-ChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeEEEEEEcCCC
Q 003140 630 TQIGQGGYGKVYKGILPD-GT--VVAVKRAQEG-SLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~~-g~--~vAVK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~~ 704 (845)
+.||+|+||.||+|.+.+ +. .+|+|.++.. .....+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 369999999999999753 43 4788888753 334456889999999999 899999999999999999999999999
Q ss_pred CCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 003140 705 GTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 770 (845)
Q Consensus 705 gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFG 770 (845)
|+|.++++... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999997532 134789999999999999999999988 9999999999999999999999999
Q ss_pred CcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 771 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 771 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
+++..... ........+..|+|||++....++.++|||||||++|||++ |+.||...
T Consensus 158 l~~~~~~~--------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~ 215 (270)
T cd05047 158 LSRGQEVY--------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 215 (270)
T ss_pred Cccccchh--------hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 98632110 01111233567999999988899999999999999999997 99999643
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=280.64 Aligned_cols=205 Identities=29% Similarity=0.447 Sum_probs=171.1
Q ss_pred hcCCCCCccccccCceEEEEEEeC-----------------CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceee
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-----------------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVS 684 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-----------------~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~ 684 (845)
.++|++.+.||+|+||.||++... ++..||+|.+.... ....++|.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 457889999999999999998532 24579999987543 334568999999999999999999
Q ss_pred EEEEEeeCCeEEEEEEcCCCCCHHHHHhccCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 003140 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK---------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 755 (845)
Q Consensus 685 l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~N 755 (845)
+++++...+..++||||+++|+|.+++..... ..+++.....++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999999976421 24778899999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh--CCCCCC
Q 003140 756 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT--GMQPIS 833 (845)
Q Consensus 756 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt--G~~Pf~ 833 (845)
||++.++.++|+|||+++....... ........++..|+|||....+.++.++|||||||++|||++ |..||.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcc-----eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence 9999999999999999976532211 011122234678999999888899999999999999999998 778886
Q ss_pred CC
Q 003140 834 HG 835 (845)
Q Consensus 834 ~~ 835 (845)
..
T Consensus 236 ~~ 237 (296)
T cd05095 236 QL 237 (296)
T ss_pred cc
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=283.04 Aligned_cols=195 Identities=26% Similarity=0.394 Sum_probs=170.6
Q ss_pred CccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCCCCH
Q 003140 629 STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 707 (845)
Q Consensus 629 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL 707 (845)
...||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 457999999999999864 6899999998765555567789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCccccc
Q 003140 708 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 787 (845)
Q Consensus 708 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 787 (845)
.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... .
T Consensus 106 ~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-------~ 172 (297)
T cd06659 106 TDIVSQ---TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-------P 172 (297)
T ss_pred HHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc-------c
Confidence 998754 35889999999999999999999998 9999999999999999999999999987543211 1
Q ss_pred eeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 788 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 221 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS 221 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1223468899999999998899999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=277.98 Aligned_cols=201 Identities=28% Similarity=0.421 Sum_probs=172.0
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
++|+..+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++|+|++++++++...+..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999976 68999999886432 2234578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
|+++++|..++... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 99999888877543 35899999999999999999999988 99999999999999999999999999986543221
Q ss_pred CCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 156 -------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~ 205 (286)
T cd07847 156 -------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS 205 (286)
T ss_pred -------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 1223357789999999876 567899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=273.58 Aligned_cols=201 Identities=27% Similarity=0.423 Sum_probs=175.5
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
+|+..+.||+|+||.||++... +|+.||+|.+... .....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999964 6899999988643 233456889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+++++|.+++.......+++..++.++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 155 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-- 155 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch--
Confidence 99999999997765556889999999999999999999988 9999999999999999999999999997653221
Q ss_pred CccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.......|+..|+|||+..+..++.++|||||||+++||++|+.||...
T Consensus 156 -----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08218 156 -----ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG 204 (256)
T ss_pred -----hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC
Confidence 1122345788999999999889999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=277.45 Aligned_cols=203 Identities=29% Similarity=0.447 Sum_probs=170.5
Q ss_pred hcCCCCCccccccCceEEEEEEeCC----CcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
.++|...+.||+|+||.||+|...+ ...||||...... ....+.+.+|+.++++++|+||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4567888999999999999998643 3468999887654 4456689999999999999999999999875 45789
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
||||+++|+|.+++.... ..+++..++.++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 84 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 84 VMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999997643 35899999999999999999999988 99999999999999999999999999986543
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
... .......++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 160 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 213 (270)
T cd05056 160 ESY------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK 213 (270)
T ss_pred ccc------eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 211 11112234568999999988889999999999999999996 999997543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=280.00 Aligned_cols=205 Identities=33% Similarity=0.533 Sum_probs=172.4
Q ss_pred HhcCCCCCccccccCceEEEEEEeC------CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCe
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 694 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 694 (845)
..++|+..+.||+|+||.||+|... ++..||+|.+.... ....+++.+|++++++++||||+++++++.+.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3467888999999999999999853 46789999987543 3345679999999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhccC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 003140 695 QMLVYEFMSNGTLRDQLSAKS--------------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKAS 754 (845)
Q Consensus 695 ~~LV~E~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~ 754 (845)
.++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence 999999999999999996432 124788899999999999999999998 999999999
Q ss_pred CEEEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 003140 755 NILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPIS 833 (845)
Q Consensus 755 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~ 833 (845)
||+++.++.++|+|||+++....... .........+..|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADY-----YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred heEecCCCceEECccccceecccCcc-----ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999875432211 011112234567999999998899999999999999999998 888986
Q ss_pred C
Q 003140 834 H 834 (845)
Q Consensus 834 ~ 834 (845)
+
T Consensus 235 ~ 235 (288)
T cd05050 235 G 235 (288)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=272.33 Aligned_cols=196 Identities=31% Similarity=0.498 Sum_probs=164.5
Q ss_pred ccccccCceEEEEEEeC--C--CcEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCC
Q 003140 630 TQIGQGGYGKVYKGILP--D--GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~--~--g~~vAVK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 704 (845)
+.||+|+||.||+|.+. + +..+|+|.+..... ...+++.+|+++++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999853 2 36899999876543 34678999999999999999999999876 4568999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCcc
Q 003140 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (845)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 784 (845)
|+|.+++.... .+++..+..++.|++.|++|||+.+ ++||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~---- 150 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD---- 150 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCc----
Confidence 99999997654 6899999999999999999999988 99999999999999999999999999986532210
Q ss_pred ccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
.........++..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~ 202 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202 (257)
T ss_pred ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC
Confidence 0111112234568999999998899999999999999999998 99999654
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=290.75 Aligned_cols=201 Identities=30% Similarity=0.442 Sum_probs=174.3
Q ss_pred CCCCCccccccCceEEEEEEeC--CC--cEEEEEEccCCChh-hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP--DG--TVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~--~g--~~vAVK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
+....++||+|.||.|++|.|. +| ..||||.++..... ...+|++|+.+|-+|+|+|+++|||+..+ ....|||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 3445678999999999999985 34 46899999876544 56789999999999999999999999987 6788999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
|.++.|||.+.|++.....+-......++.|||.||.||.+++ +|||||.++|+|+-....+||+|||+.|-+...+
T Consensus 190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999999999866677889999999999999999999998 9999999999999999999999999999876433
Q ss_pred CCCcccccee-ecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 003140 780 IEGIVPAHVS-TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 834 (845)
Q Consensus 780 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~ 834 (845)
. .++. ....-.+.|.|||.+....++.++|||+|||++|||+| |..||-+
T Consensus 267 d-----~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G 318 (1039)
T KOG0199|consen 267 D-----MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG 318 (1039)
T ss_pred c-----ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCC
Confidence 1 1122 22344578999999999999999999999999999999 8889864
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=276.39 Aligned_cols=202 Identities=30% Similarity=0.487 Sum_probs=170.3
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCc----EEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
.+|+..+.||+|+||.||+|... +|. .||+|...... .....++.+|++++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 56778899999999999999864 333 58999887543 3345688999999999999999999999987 78899
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
||||+++|+|.++++.... .+++..+..++.|+++|++|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 86 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 9999999999999976433 4899999999999999999999988 99999999999999999999999999987542
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
... ........++..|+|||.+....++.++|||||||++||+++ |+.||...
T Consensus 162 ~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 215 (279)
T cd05057 162 DEK-----EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI 215 (279)
T ss_pred ccc-----ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 211 011111223568999999988899999999999999999999 99999753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=277.96 Aligned_cols=202 Identities=29% Similarity=0.451 Sum_probs=170.0
Q ss_pred cCCCCCccccccCceEEEEEEe-----CCCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CeE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQ 695 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~ 695 (845)
..|.+.+.||+|+||.||.+.. .++..||+|.++... ....+.+.+|++++++++|+||+++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467889999999999999974 357899999987543 33456799999999999999999999998775 568
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++||||+++++|.+++.+.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence 99999999999999996543 35899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~ 833 (845)
...... ........++..|+|||.+.+..++.++|||||||++|||+|++.|+.
T Consensus 160 ~~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~ 213 (284)
T cd05079 160 ETDKEY----YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES 213 (284)
T ss_pred ccCccc----eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCc
Confidence 432210 111223456778999999988889999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=285.60 Aligned_cols=210 Identities=29% Similarity=0.494 Sum_probs=173.7
Q ss_pred HHHHHhcCCCCCccccccCceEEEEEEeC--------CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEE
Q 003140 618 EMALATNNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVG 687 (845)
Q Consensus 618 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g 687 (845)
+++....+|.+.+.||+|+||.||++... .+..||+|.++... ....+++.+|+++++++ +|+||+++++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 34455567889999999999999999742 12478999887532 33456899999999999 7999999999
Q ss_pred EEeeCCeEEEEEEcCCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 003140 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKA 753 (845)
Q Consensus 688 ~~~~~~~~~LV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~ 753 (845)
++...+..++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp 162 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAA 162 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eecccccc
Confidence 9999999999999999999999997532 235889999999999999999999998 99999999
Q ss_pred CCEEEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 003140 754 SNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPI 832 (845)
Q Consensus 754 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf 832 (845)
+|||++.++.+||+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~ 237 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccc-----cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCC
Confidence 999999999999999999976532211 011122234567999999999999999999999999999998 88888
Q ss_pred CCC
Q 003140 833 SHG 835 (845)
Q Consensus 833 ~~~ 835 (845)
...
T Consensus 238 ~~~ 240 (334)
T cd05100 238 PGI 240 (334)
T ss_pred CCC
Confidence 653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=272.30 Aligned_cols=199 Identities=30% Similarity=0.478 Sum_probs=173.0
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-----hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-----LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
+|...+.||+|+||.||+|... +++.|++|.+.... .+..+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4667789999999999999976 78999999876432 23456789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
|||+++++|.+++... ..+++..+..++.|+++|++|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 9999999999999764 35889999999999999999999998 999999999999999999999999998765322
Q ss_pred CCCCccccceeecccCCCCccchhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
. ......++..|+|||.+.... ++.++|+|||||++|||++|+.||....
T Consensus 156 ~--------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 156 S--------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred c--------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 1 123345788999999987766 8999999999999999999999996543
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=278.84 Aligned_cols=201 Identities=26% Similarity=0.438 Sum_probs=170.4
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
++|+..+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999975 689999999865332 2234577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
++ ++|.+++.... ..+++.....++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 85 ~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-- 157 (291)
T cd07844 85 LD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS-- 157 (291)
T ss_pred CC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC--
Confidence 97 59999987643 36889999999999999999999998 9999999999999999999999999987542211
Q ss_pred CccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......++..|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 158 -----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 158 -----KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred -----ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 11122346789999999875 458899999999999999999999996544
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=270.43 Aligned_cols=197 Identities=30% Similarity=0.484 Sum_probs=168.3
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEccCCChh-hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCCCCHH
Q 003140 630 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 708 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~ 708 (845)
+.||+|+||.||++...+++.||+|.+...... ..+.+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999998764433 4568999999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCccccce
Q 003140 709 DQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 788 (845)
Q Consensus 709 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 788 (845)
+++.... ..+++..+..++.+++.|++|||+++ ++||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-----~~~ 151 (251)
T cd05041 81 TFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY-----TVS 151 (251)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcc-----eec
Confidence 9996643 35789999999999999999999998 99999999999999999999999999875431110 001
Q ss_pred eecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 789 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 789 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
......+..|+|||.+.+..++.++|||||||++|||+| |..||...
T Consensus 152 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~ 199 (251)
T cd05041 152 DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM 199 (251)
T ss_pred cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC
Confidence 111223567999999988899999999999999999999 88888653
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=278.85 Aligned_cols=203 Identities=26% Similarity=0.419 Sum_probs=170.3
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChh-hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++++|...+.||+|+||.||+|... +|+.||+|++...... ....+.+|+++++.++|+||+++++++...+..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3467889999999999999999864 6899999998654322 2346788999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||++ +++.+++.... ..+.+..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred eccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9995 78887775433 45778888899999999999999998 9999999999999999999999999987543221
Q ss_pred CCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus 158 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 158 -------QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred -------CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 11223346889999999875 457889999999999999999999997544
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=276.08 Aligned_cols=194 Identities=26% Similarity=0.410 Sum_probs=168.8
Q ss_pred ccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCCCCH
Q 003140 632 IGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 707 (845)
Q Consensus 632 LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL 707 (845)
||+|+||+||++... +|+.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999864 68999999886432 22345678899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCccccc
Q 003140 708 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 787 (845)
Q Consensus 708 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 787 (845)
.+++.......+++..+..++.|+++|+.|||+.+ ++||||+|+||++++++.++|+|||.++..... .
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--------~ 149 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--------K 149 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC--------C
Confidence 99998766567899999999999999999999998 999999999999999999999999998765321 1
Q ss_pred eeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 788 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
......++..|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 198 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198 (277)
T ss_pred ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCc
Confidence 1123457789999999988889999999999999999999999997644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=278.90 Aligned_cols=212 Identities=27% Similarity=0.402 Sum_probs=176.3
Q ss_pred cchHHHHHHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEe-
Q 003140 614 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCD- 690 (845)
Q Consensus 614 ~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~- 690 (845)
+.++.+..+.++|++.+.||+|+||.||++... +++.+|+|++.... ....++.+|+.+++++ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445566678899999999999999999999864 68899999876532 2345688899999999 6999999999874
Q ss_pred ----eCCeEEEEEEcCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 003140 691 ----EEGEQMLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 764 (845)
Q Consensus 691 ----~~~~~~LV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~ 764 (845)
..+..++||||+++|+|.++++.. ....+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 345689999999999999988642 3356889999999999999999999988 9999999999999999999
Q ss_pred EEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 765 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 765 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
||+|||+++...... .......|+..|+|||++. +..++.++||||+||++|||++|+.||...+
T Consensus 164 kl~dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~ 233 (286)
T cd06638 164 KLVDFGVSAQLTSTR-------LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233 (286)
T ss_pred EEccCCceeecccCC-------CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence 999999987653221 1122346889999999875 3457889999999999999999999997543
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=277.99 Aligned_cols=213 Identities=28% Similarity=0.428 Sum_probs=176.2
Q ss_pred HHhcCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCCh--hh-----HHHHHHHHHHHHhcCCCceeeEEEEEe-e
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL--QG-----EKEFLTEIQFLSRLHHRNLVSLVGYCD-E 691 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~--~~-----~~~~~~Ei~~l~~l~H~nIv~l~g~~~-~ 691 (845)
...++|-..++||+|||+.||||.+ ...+.||||+-..... +. .+...+|.++.+.++||.||++|+|+. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 3446777889999999999999984 5678899998543211 11 234678999999999999999999985 5
Q ss_pred CCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCcEEEEe
Q 003140 692 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD---HKFTAKVAD 768 (845)
Q Consensus 692 ~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~---~~~~~kl~D 768 (845)
.+..+-|+|||+|.+|+-||+.+ +.+++..++.|+.||+.||.||.+. +|||||-||||.|||+- ..|.+||+|
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred cccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 66789999999999999999765 3588999999999999999999986 58999999999999995 457999999
Q ss_pred cCCcccCCCCCCCCccccceeecccCCCCccchhhhcCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 769 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH----KLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 769 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
||+++.+....+.....-.......||.+|++||.+.-+ .++.|+||||.||++|+.+.|+.||.+..
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq 688 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ 688 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence 999999876654433333344557899999999998543 57889999999999999999999998653
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=276.05 Aligned_cols=202 Identities=27% Similarity=0.425 Sum_probs=172.1
Q ss_pred cCCCCCccccccCceEEEEEEeC------CCcEEEEEEccCCChh-hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 696 (845)
++|...+.||+|+||.||+|... +.+.||+|.+...... ..+++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888899999999999999863 3467999988754433 3567999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEec
Q 003140 697 LVYEFMSNGTLRDQLSAKSK-------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 769 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DF 769 (845)
+||||+++|+|.++++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999976442 26899999999999999999999998 999999999999999999999999
Q ss_pred CCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 003140 770 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 834 (845)
Q Consensus 770 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~ 834 (845)
|+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 162 ~~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~ 221 (275)
T cd05046 162 SLSKDVYNSEY------YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG 221 (275)
T ss_pred ccccccCcccc------cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 99875432211 11122345678999999988889999999999999999999 8889864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=278.30 Aligned_cols=200 Identities=31% Similarity=0.453 Sum_probs=173.7
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
.++|++.+.||+|+||+||++... +|+.||+|++.... ....+++.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 356778899999999999999965 68999999876543 3345789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
|+++|+|.++++.. ..+++.....++.+++.||.|||+ .+ ++||||||+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 84 FMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred cCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 99999999998653 358899999999999999999997 45 999999999999999999999999998654211
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 158 --------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~ 206 (284)
T cd06620 158 --------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN 206 (284)
T ss_pred --------ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 1123468899999999988899999999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=278.26 Aligned_cols=197 Identities=30% Similarity=0.446 Sum_probs=171.1
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcC
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 702 (845)
.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3556778999999999999865 57899999887433 334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCC
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 782 (845)
++++|.+++.. ..+++..+..++.|+++|+.|||+++ ++|+||+|+||++++++.++++|||+++......
T Consensus 85 ~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--- 155 (277)
T cd06642 85 GGGSALDLLKP---GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--- 155 (277)
T ss_pred CCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc---
Confidence 99999999854 35889999999999999999999988 9999999999999999999999999987654221
Q ss_pred ccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
.......++..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 156 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06642 156 ----IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred ----hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcc
Confidence 112234578899999999988999999999999999999999999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=279.36 Aligned_cols=201 Identities=26% Similarity=0.437 Sum_probs=169.6
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
+|+..+.||+|+||.||+|... +|+.||+|+++.... ...+.+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777889999999999999975 689999998864322 2235678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
++ ++|.+++.... ..+++...+.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-- 153 (284)
T cd07839 81 CD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-- 153 (284)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC--
Confidence 96 68888876543 45899999999999999999999998 9999999999999999999999999997643211
Q ss_pred CccccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
.......++..|+|||++.+. .++.++|||||||++|||+||..||..+.+
T Consensus 154 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~ 205 (284)
T cd07839 154 -----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 205 (284)
T ss_pred -----CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC
Confidence 112234568899999998764 478999999999999999999999865443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=274.16 Aligned_cols=199 Identities=29% Similarity=0.434 Sum_probs=173.1
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
..|+..+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++|+||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35677889999999999999975 58899999887533 34456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+++|+|.+++.. .++++.....++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06640 84 LGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc--
Confidence 999999999864 35788999999999999999999988 9999999999999999999999999997653221
Q ss_pred CccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.......++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 -----~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 204 (277)
T cd06640 156 -----IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204 (277)
T ss_pred -----cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 1122345788999999998888999999999999999999999999643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=272.75 Aligned_cols=189 Identities=25% Similarity=0.409 Sum_probs=161.4
Q ss_pred ccccccCceEEEEEEeCCCc-----------EEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEE
Q 003140 630 TQIGQGGYGKVYKGILPDGT-----------VVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~~g~-----------~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
+.||+|+||.||+|...+.. .|++|.+...... ...|.+|+.++++++|+||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999976432 5788877654433 6789999999999999999999999988 788999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-------cEEEEecCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-------TAKVADFGL 771 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~-------~~kl~DFGl 771 (845)
|||+++|+|.+++..... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999976543 6889999999999999999999988 99999999999999888 799999999
Q ss_pred cccCCCCCCCCccccceeecccCCCCccchhhhcCC--CCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH--KLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
++.... .....++..|+|||++... .++.++|||||||++|||++ |..||...
T Consensus 155 a~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~ 210 (259)
T cd05037 155 PITVLS-----------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL 210 (259)
T ss_pred cccccc-----------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence 876432 1123456789999998876 78999999999999999999 57777654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=276.67 Aligned_cols=200 Identities=29% Similarity=0.426 Sum_probs=167.1
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-hhhHHHHHHHHHH-HHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQF-LSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~~-l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
++|++.+.||+|+||.||+|... +|+.||+|+++... .....++..|+.. ++..+||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999975 69999999987542 2334566667665 566789999999999999999999999
Q ss_pred cCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 701 FMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 701 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
|++ |+|.++++.. ....+++..++.++.|++.||+|||++ + ++||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 7898888652 335689999999999999999999986 6 99999999999999999999999999876532
Q ss_pred CCCCCccccceeecccCCCCccchhhhcC----CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT----HKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
. .......++..|+|||.+.+ ..++.++|+|||||++|||++|+.||...
T Consensus 157 ~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (283)
T cd06617 157 S--------VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW 210 (283)
T ss_pred c--------cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcc
Confidence 1 11223457889999998864 45688999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=274.51 Aligned_cols=199 Identities=27% Similarity=0.393 Sum_probs=159.7
Q ss_pred ccccccCceEEEEEEeCCC---cEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCCC
Q 003140 630 TQIGQGGYGKVYKGILPDG---TVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 705 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~~g---~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g 705 (845)
+.||+|+||.||+|...++ ..+++|.+.... ....+.|.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3599999999999985433 346677665433 344678999999999999999999999999999999999999999
Q ss_pred CHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCc
Q 003140 706 TLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (845)
Q Consensus 706 sL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 783 (845)
+|.++++... ....++.....++.|+++||+|||+.+ ++||||||+|||++.++.+||+|||++......+.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~--- 154 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY--- 154 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchh---
Confidence 9999997642 234667778899999999999999988 99999999999999999999999999864321110
Q ss_pred cccceeecccCCCCccchhhhcC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 784 VPAHVSTVVKGTPGYLDPEYFLT-------HKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
........++..|+|||++.. ..++.++|||||||++|||++ |..||....
T Consensus 155 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 213 (268)
T cd05086 155 --IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS 213 (268)
T ss_pred --hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 011123457889999998753 245789999999999999997 567886433
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=276.24 Aligned_cols=198 Identities=35% Similarity=0.524 Sum_probs=166.4
Q ss_pred ccccccCceEEEEEEeCC-------CcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 630 TQIGQGGYGKVYKGILPD-------GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~~-------g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
+.||+|+||.||+|...+ ++.+|+|.+.... .....++.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998642 2579999876543 23456899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-----cEEEEecCC
Q 003140 702 MSNGTLRDQLSAKS-----KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-----TAKVADFGL 771 (845)
Q Consensus 702 ~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~-----~~kl~DFGl 771 (845)
+++|+|.++++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997532 234789999999999999999999988 99999999999999877 899999999
Q ss_pred cccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
++.....+.. .......++..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~ 217 (269)
T cd05044 158 ARDIYKSDYY-----RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL 217 (269)
T ss_pred cccccccccc-----ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc
Confidence 9765432211 11122345688999999999999999999999999999998 99998643
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=271.41 Aligned_cols=200 Identities=27% Similarity=0.413 Sum_probs=174.0
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
+|+..+.||+|+||.||++... +++.+|||.+.... ....+.+.+|++++++++|+|++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999864 68899999886542 23456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEEecCCcccCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~-~~~kl~DFGla~~~~~~~~ 780 (845)
+++++|.+++.......+++..+..++.++++|++|||+++ |+||||||+||+++++ +.+||+|||.++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 99999999998766667899999999999999999999998 9999999999999855 468999999998654221
Q ss_pred CCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
......++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 204 (256)
T cd08220 157 -------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA 204 (256)
T ss_pred -------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC
Confidence 112345788999999999888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-33 Score=271.36 Aligned_cols=203 Identities=29% Similarity=0.427 Sum_probs=169.1
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh-hhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeEEEEEEc
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
+.+....||.|+||+|+|-.++ .|+..|||++..... ...+++..|.+...+- +.||||+++|.+..++..|+.||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 3344568999999999999865 799999999986554 5567899998876555 799999999999999999999999
Q ss_pred CCCCCHHHHH---hccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 702 MSNGTLRDQL---SAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 702 ~~~gsL~~~l---~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
|+ -|+..+- .......+++...-.|....++||.||.++.+ |||||+||+|||++..|.+|++|||++-.+.
T Consensus 145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv-- 219 (361)
T KOG1006|consen 145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLV-- 219 (361)
T ss_pred Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHH--
Confidence 95 6766543 33445678888888999999999999987653 9999999999999999999999999985442
Q ss_pred CCCCccccceeecccCCCCccchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCc
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 838 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~ 838 (845)
.+...+..+|...|||||.+.. ..|+.+|||||+|++|||+.||+.|+..=+.+
T Consensus 220 ------~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv 275 (361)
T KOG1006|consen 220 ------DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV 275 (361)
T ss_pred ------HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH
Confidence 2344566789999999999863 45899999999999999999999999765443
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=271.80 Aligned_cols=206 Identities=30% Similarity=0.412 Sum_probs=177.1
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
++|++.+.||.|+||.||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+...+..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999964 68899999986432 33567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 702 MSNGTLRDQLSAKSK-EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
+++++|.++++.... ..+++.....++.|++.|++|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999976433 56899999999999999999999988 99999999999999999999999999876643321
Q ss_pred CCccccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
. .........|+..|+|||++... .++.++|||||||++|||++|+.||...
T Consensus 158 ~---~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 210 (267)
T cd06610 158 R---TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY 210 (267)
T ss_pred c---cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc
Confidence 1 01122344688999999998776 7899999999999999999999999654
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=285.12 Aligned_cols=199 Identities=30% Similarity=0.456 Sum_probs=176.0
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
...|.+.+.||+|.|++|..|+.. .|..||+|.+.+... ...+.+.+|+++|+.++|||||+++.+.+.+...++||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 457888999999999999999965 699999999887543 33355899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||..+|.+.+|+.+++. ........+..|+.++++|+|+++ |||||||++||||+.++++||+|||++.++..
T Consensus 135 eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-- 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY-- 207 (596)
T ss_pred EeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc--
Confidence 99999999999987654 444777788999999999999999 99999999999999999999999999987652
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
.....+..|++.|.|||++.+..| ++.+|+||+|+++|-|+.|..||++
T Consensus 208 ------~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG 257 (596)
T KOG0586|consen 208 ------GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG 257 (596)
T ss_pred ------cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC
Confidence 334556789999999999998765 6799999999999999999999984
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=273.68 Aligned_cols=202 Identities=27% Similarity=0.455 Sum_probs=170.5
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChh----------hHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ----------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 693 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~----------~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~ 693 (845)
+|...+.||+|+||.||+|... +|+.||+|.++..... ..+.+.+|++++++++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667889999999999999864 6899999987532110 1246788999999999999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003140 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (845)
Q Consensus 694 ~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~ 773 (845)
..++||||+++|+|.++++.. ..+++..+..++.|++.||.|||+++ ++||||+|+||+++.++.++++|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccc
Confidence 999999999999999999765 46889999999999999999999988 9999999999999999999999999987
Q ss_pred cCCCCCCCCccccceeecccCCCCccchhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK--LTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
...... .........|+..|+|||.+.... ++.++||||||+++||+++|..||...+
T Consensus 157 ~~~~~~-----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 216 (272)
T cd06629 157 KSDDIY-----DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE 216 (272)
T ss_pred cccccc-----cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc
Confidence 643211 111123456889999999987654 8899999999999999999999996543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=278.47 Aligned_cols=200 Identities=31% Similarity=0.456 Sum_probs=170.0
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChh-----hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-----GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~-----~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
+|+..+.||+|+||.||+|... +|+.||||++...... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999965 6899999998754332 235677899999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
|||+ +|+|.+++.... ..+++..++.++.|+++||.|||+++ |+||||||+||+++.++.++|+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 899999997644 46899999999999999999999998 999999999999999999999999999865432
Q ss_pred CCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
. .......++..|+|||.+.+ ..++.++|||||||++|||++|..||....
T Consensus 156 ~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~ 207 (298)
T cd07841 156 N-------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS 207 (298)
T ss_pred C-------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc
Confidence 1 11122346788999998864 467899999999999999999977775433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=272.07 Aligned_cols=195 Identities=32% Similarity=0.528 Sum_probs=168.3
Q ss_pred cCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCC
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 703 (845)
++|.+.+.||+|+||.||++.. +++.||+|.++... ..+.+.+|+.++++++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4678889999999999999975 67889999986532 345789999999999999999999998654 5799999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCc
Q 003140 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (845)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 783 (845)
+|+|.+++.......+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----- 153 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----- 153 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence 999999998766667899999999999999999999988 999999999999999999999999998754211
Q ss_pred cccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
......+..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 154 -----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 201 (254)
T cd05083 154 -----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201 (254)
T ss_pred -----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC
Confidence 111223467999999988899999999999999999998 99998644
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=271.56 Aligned_cols=203 Identities=29% Similarity=0.429 Sum_probs=170.7
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC-----ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CeE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG-----SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQ 695 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~ 695 (845)
.+|.+.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999964 6899999986422 123346788999999999999999999998654 457
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++|+||+++++|.+++... ..+++.....++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 8999999999999998654 34788889999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
...... ........++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 157 QTICMS----GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred cccccc----CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 321100 11122345889999999999888999999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=277.42 Aligned_cols=201 Identities=31% Similarity=0.478 Sum_probs=171.9
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
+|+..+.||+|++|.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999975 68999999886432 22345789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+. ++|.+++.......+++..+..++.|+++||+|||+.+ ++||||+|+||++++++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-- 154 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-- 154 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc--
Confidence 95 78999997766677899999999999999999999988 9999999999999999999999999987653211
Q ss_pred CccccceeecccCCCCccchhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......++..|+|||++.+.. ++.++|||||||++|||+||+.||...+
T Consensus 155 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 205 (284)
T cd07860 155 -----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205 (284)
T ss_pred -----cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 1122334678999999887644 6889999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=271.18 Aligned_cols=197 Identities=34% Similarity=0.525 Sum_probs=160.2
Q ss_pred ccccccCceEEEEEEeC----CCcEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEe-eCCeEEEEEEcCC
Q 003140 630 TQIGQGGYGKVYKGILP----DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD-EEGEQMLVYEFMS 703 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~----~g~~vAVK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~-~~~~~~LV~E~~~ 703 (845)
+.||+|+||.||+|.+. ++..||+|++... .....+.+.+|+.+++.++||||+++++++. .++..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2457999988643 3344568899999999999999999999875 4556899999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCc
Q 003140 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (845)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 783 (845)
+|+|.+++.... ....+..+..++.|+++||.|||+.+ ++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~-- 154 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY-- 154 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce--
Confidence 999999997643 34677888899999999999999988 999999999999999999999999999754322110
Q ss_pred cccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCC
Q 003140 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG-MQPIS 833 (845)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG-~~Pf~ 833 (845)
.........++..|+|||++....++.++|||||||++|||++| ..||.
T Consensus 155 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 204 (262)
T cd05058 155 -SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204 (262)
T ss_pred -eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCC
Confidence 00111233456789999999888999999999999999999995 44554
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=278.78 Aligned_cols=204 Identities=25% Similarity=0.366 Sum_probs=173.7
Q ss_pred hcCCCCCccccccCceEEEEEEeCCCcEEEEEEccC--CChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeEEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~--~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
...|++.+.||+||.++||++...+.+.+|+|+... ...+....|..|++.|.++ .|.+||++++|-..++..||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 346788899999999999999988889999997654 3445567899999999999 5999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||= ..+|.++|+.......+| .++.++.|++.++.++|+++ |||.||||.|+|+-. |.+||+|||+|.-+....
T Consensus 440 E~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT 513 (677)
T ss_pred ecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence 965 579999998877666667 66779999999999999999 999999999998864 689999999998765432
Q ss_pred CCCccccceeecccCCCCccchhhhcCCC-----------CCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHK-----------LTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
.+......+||+.||+||.+.... .+.++||||+||++|+|+.|+.||.+-.+
T Consensus 514 -----TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n 577 (677)
T KOG0596|consen 514 -----TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN 577 (677)
T ss_pred -----cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH
Confidence 234456678999999999985432 56789999999999999999999986543
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=275.81 Aligned_cols=200 Identities=28% Similarity=0.401 Sum_probs=171.9
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
+|.+.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999964 68999999987543 23356899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+ +++|.+++.... ..+++..++.++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||+++.......
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9 999999987543 56899999999999999999999998 99999999999999999999999999986643221
Q ss_pred CccccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.......++..|+|||.+.+. .++.++||||+||++|||++|+.||...
T Consensus 155 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 204 (286)
T cd07832 155 -----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE 204 (286)
T ss_pred -----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence 112234688999999998654 4689999999999999999997777543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=277.37 Aligned_cols=212 Identities=30% Similarity=0.443 Sum_probs=175.8
Q ss_pred cchHHHHHHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEee
Q 003140 614 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE 691 (845)
Q Consensus 614 ~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~ 691 (845)
+...++..+.++|...+.||+|+||.||++... +++.+|+|.+.... ....++.+|+.+++++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 334455556789999999999999999999974 68899999986532 2345678899999999 89999999999865
Q ss_pred C-----CeEEEEEEcCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 003140 692 E-----GEQMLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 764 (845)
Q Consensus 692 ~-----~~~~LV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~ 764 (845)
. +..++||||+++|+|.++++.. ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 4 3589999999999999988642 3456899999999999999999999988 9999999999999999999
Q ss_pred EEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 765 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-----KLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 765 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
||+|||+++...... .......|+..|+|||.+... .++.++|||||||++|||++|+.||...+
T Consensus 168 kl~dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~ 237 (291)
T cd06639 168 KLVDFGVSAQLTSTR-------LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237 (291)
T ss_pred EEeecccchhccccc-------ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc
Confidence 999999987654221 112234578899999987543 36889999999999999999999997543
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=275.65 Aligned_cols=210 Identities=29% Similarity=0.452 Sum_probs=176.2
Q ss_pred chHHHHHHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEee-
Q 003140 615 TYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE- 691 (845)
Q Consensus 615 ~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~- 691 (845)
+..++..+.+.|+..+.||+|+||.||+|... +++.||+|.+.... ....++..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 44455566788999999999999999999974 68899999876533 3345788899999998 79999999999853
Q ss_pred -----CCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 003140 692 -----EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV 766 (845)
Q Consensus 692 -----~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl 766 (845)
.+..++||||+++|+|.+++.......+++..+..++.|++.|+.|||+.+ |+||||||+||++++++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 457899999999999999998766667889999999999999999999998 999999999999999999999
Q ss_pred EecCCcccCCCCCCCCccccceeecccCCCCccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 767 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 767 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
+|||+++...... .......|+..|+|||.+. ...++.++|||||||++|||++|+.||...
T Consensus 163 ~dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 163 VDFGVSAQLDRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred eeCcchhhhhccc-------cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence 9999987543211 1122346889999999875 346788999999999999999999999654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=278.80 Aligned_cols=201 Identities=29% Similarity=0.439 Sum_probs=171.4
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
++|+..+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46788899999999999999976 589999998765322 235678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
|+++++|..+.... ..+++..+..++.|+++||.|||+.+ |+||||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 81 FVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred cCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 99999998877543 34899999999999999999999988 9999999999999999999999999987653221
Q ss_pred CCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 155 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~ 205 (286)
T cd07846 155 ------EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205 (286)
T ss_pred ------cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc
Confidence 11223457889999999875 457889999999999999999999886443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-30 Score=269.18 Aligned_cols=200 Identities=37% Similarity=0.573 Sum_probs=172.5
Q ss_pred CCCCccccccCceEEEEEEeCC-----CcEEEEEEccCCChh-hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 626 FNSSTQIGQGGYGKVYKGILPD-----GTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 626 f~~~~~LG~G~fG~Vy~~~~~~-----g~~vAVK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
|++.+.||+|+||.||++...+ +..||+|.++..... ..+.+.+|+++++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567889999999999999753 488999999765443 5678999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++++|.+++.......+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+++......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999997654444899999999999999999999998 9999999999999999999999999998764332
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 834 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~ 834 (845)
.. ......++..|+|||.+....++.++||||+|++++||++ |+.||..
T Consensus 158 ~~------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~ 207 (258)
T smart00219 158 YY------KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG 207 (258)
T ss_pred cc------ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 11 1112236789999999988889999999999999999998 7888864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=272.46 Aligned_cols=203 Identities=25% Similarity=0.432 Sum_probs=172.4
Q ss_pred CCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCC------hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS------LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~------~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
+|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+++.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999985 578999999886432 1134678999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEEecCCcccCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAP 776 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~-~~kl~DFGla~~~~ 776 (845)
||||+++++|.+++.+. .++++..+..++.|++.||.|||+.+ ++||||||+||+++.++ .+||+|||.+....
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 99999999999999754 35889999999999999999999998 99999999999998776 69999999987664
Q ss_pred CCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
..... .........++..|+|||.+.+..++.++||||+|+++|||++|+.||...
T Consensus 156 ~~~~~---~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 211 (268)
T cd06630 156 AKGTG---AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAE 211 (268)
T ss_pred ccccc---CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 32110 011122345788999999998888999999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=276.90 Aligned_cols=200 Identities=26% Similarity=0.432 Sum_probs=175.2
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcC
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 702 (845)
++|...+.||+|+||.||++... ++..||+|.+........+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 67888999999999999999854 68899999987554455677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCC
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 782 (845)
++++|.+++.+. .+++..+..++.|+++|+.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~--- 169 (293)
T cd06647 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 169 (293)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc---
Confidence 999999998653 4788999999999999999999998 9999999999999999999999999987543221
Q ss_pred ccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......++..|+|||.+....++.++|||||||++||+++|+.||...+
T Consensus 170 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~ 219 (293)
T cd06647 170 ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (293)
T ss_pred ----cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 11223458889999999988889999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=278.31 Aligned_cols=202 Identities=30% Similarity=0.504 Sum_probs=167.9
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCc----EEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 696 (845)
.++|...+.||+|+||.||+|.+. +|. .||+|.+..... ....++.+|+.++++++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 456778899999999999999863 444 578998875432 3345789999999999999999999998754 467
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCC
Q 003140 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~ 776 (845)
+|+||+++|+|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 9999999999999987543 35889999999999999999999988 9999999999999999999999999998654
Q ss_pred CCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 003140 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 834 (845)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~ 834 (845)
.... ........++..|+|||++.+..++.++|||||||++|||++ |+.||.+
T Consensus 161 ~~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~ 214 (303)
T cd05110 161 GDEK-----EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214 (303)
T ss_pred Cccc-----ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2210 111122345678999999998899999999999999999997 9999965
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=274.40 Aligned_cols=199 Identities=29% Similarity=0.407 Sum_probs=175.6
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
+|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999976 58999999886532 2345789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
|+++++|.+++... .++++.....++.|+++||.|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999999664 46889999999999999999999988 9999999999999999999999999987654221
Q ss_pred CCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 155 -------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 155 -------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred -------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence 1233457889999999988889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-30 Score=270.05 Aligned_cols=201 Identities=30% Similarity=0.429 Sum_probs=177.4
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
++|+..+.||+|++|.||+|... +++.|+||++..... ...+++.+|++++++++|+|++++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999976 599999999876543 4467899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
+++++|.+++... ..+++..+..++.|+++|++|||+ .+ ++||||+|+||+++.++.++|+|||.++.......
T Consensus 81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 9999999999754 568999999999999999999999 88 99999999999999999999999999876542221
Q ss_pred CCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
......++..|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 156 -------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 156 -------QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred -------cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 1123457889999999999899999999999999999999999997664
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-30 Score=270.25 Aligned_cols=203 Identities=32% Similarity=0.469 Sum_probs=174.6
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
+|+..+.||+|+||.||+|... +++.||+|.++.... ...+++.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999864 789999999875443 3567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+++++|.++++.. ..+++..+..++.++++|+.|||+.+ |+||||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999999999754 34788999999999999999999998 999999999999999999999999999876433211
Q ss_pred CccccceeecccCCCCccchhhhcCCC---CCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
. ........++..|+|||++.+.. ++.++||||||+++|||++|+.||...
T Consensus 156 ~---~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 156 M---GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred c---cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 0 11012345788999999998766 889999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=273.07 Aligned_cols=198 Identities=25% Similarity=0.412 Sum_probs=172.7
Q ss_pred CCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCC
Q 003140 625 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 703 (845)
.|...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++|+||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 344567899999999999996 4789999999876555556778999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCc
Q 003140 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (845)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 783 (845)
+++|.+++.. .++++..+..++.|++.|++|||+.+ |+||||+|+||+++.++.++|+|||.+.......
T Consensus 100 ~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~---- 169 (285)
T cd06648 100 GGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV---- 169 (285)
T ss_pred CCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC----
Confidence 9999999865 35889999999999999999999998 9999999999999999999999999887543211
Q ss_pred cccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.......|+..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 170 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~ 218 (285)
T cd06648 170 ---PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE 218 (285)
T ss_pred ---cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC
Confidence 1122345889999999998888999999999999999999999999653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=273.67 Aligned_cols=190 Identities=24% Similarity=0.414 Sum_probs=160.4
Q ss_pred ccccccCceEEEEEEeCC--------CcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 630 TQIGQGGYGKVYKGILPD--------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~~--------g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
+.||+|+||.||+|.... ...||+|.+........+++.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998632 234888887665555567889999999999999999999999998999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc--------EEEEecCCcc
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT--------AKVADFGLSR 773 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~--------~kl~DFGla~ 773 (845)
+++|+|.++++.... .+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||++.
T Consensus 81 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999976433 6889999999999999999999998 999999999999987765 6999999886
Q ss_pred cCCCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCC-CCCCC
Q 003140 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGM-QPISH 834 (845)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~-~Pf~~ 834 (845)
.... .....++..|+|||++.+ ..++.++|||||||++|||++|. .||..
T Consensus 157 ~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~ 208 (258)
T cd05078 157 TVLP-----------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA 208 (258)
T ss_pred ccCC-----------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh
Confidence 5431 122457789999999876 45799999999999999999995 55543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=271.91 Aligned_cols=191 Identities=27% Similarity=0.384 Sum_probs=158.8
Q ss_pred cccccCceEEEEEEeC-CCcEEEEEEccCCCh---hhHHHHHHHHHHHHh---cCCCceeeEEEEEeeCCeEEEEEEcCC
Q 003140 631 QIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSR---LHHRNLVSLVGYCDEEGEQMLVYEFMS 703 (845)
Q Consensus 631 ~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~~l~~---l~H~nIv~l~g~~~~~~~~~LV~E~~~ 703 (845)
.||+|+||.||++... +++.+|+|.+..... ...+.+.+|..+++. .+|+||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999974 689999998865322 222344555544443 479999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCc
Q 003140 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (845)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 783 (845)
+|+|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---- 151 (279)
T cd05633 81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (279)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence 99999998654 35899999999999999999999998 9999999999999999999999999987543211
Q ss_pred cccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 784 VPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.....|+..|+|||.+.. ..++.++||||+||++|||++|+.||...
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 199 (279)
T cd05633 152 -----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (279)
T ss_pred -----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence 123458899999999864 56899999999999999999999999643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=272.89 Aligned_cols=203 Identities=28% Similarity=0.437 Sum_probs=177.6
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
.++.|+..+.||+|+||.||+|... ++..|++|.+..... ..+.+.+|++++++++|+|++++++++...+..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4566788889999999999999976 689999999876544 56688999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
|+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~- 170 (286)
T cd06614 96 YMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK- 170 (286)
T ss_pred ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch-
Confidence 999999999997654 47899999999999999999999988 9999999999999999999999999986543211
Q ss_pred CCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......++..|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 171 ------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~ 220 (286)
T cd06614 171 ------SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP 220 (286)
T ss_pred ------hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 11223457889999999988889999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=271.26 Aligned_cols=198 Identities=29% Similarity=0.465 Sum_probs=171.1
Q ss_pred CCCCCccccccCceEEEEEEe-CCCcEEEEEEccCC-ChhhHHHHHHHHHHHHhcC---CCceeeEEEEEeeCCeEEEEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLH---HRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~-~~~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~LV~ 699 (845)
.|+..+.||+|+||.||+|.. .+++.||+|.+... .....+++.+|++++++++ |||++++++++.+....++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467788999999999999996 47899999998654 2334567889999999996 999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++++|.++++.. .+++...+.++.|++.|+.|||+.+ |+||||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999998653 6889999999999999999999998 9999999999999999999999999998764322
Q ss_pred CCCccccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.......|+..|+|||.+.++ .++.++|||||||++|||++|+.||...
T Consensus 156 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 205 (277)
T cd06917 156 -------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV 205 (277)
T ss_pred -------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCC
Confidence 112234588899999998654 5688999999999999999999999643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=242.02 Aligned_cols=205 Identities=28% Similarity=0.450 Sum_probs=174.1
Q ss_pred CCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 625 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
+|+..++||+|.||+||||+. +.++.||+|+.+-.. ..-.....+|+-+++.++|+|||++++....++..-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 466678999999999999995 468999999876432 22245789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
| ..+|.+|...-. ..++......++.|+++|+.+.|+++ +.|||+||.|.|++.+|+.|++|||+|+-...+
T Consensus 83 c-dqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgip--- 154 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIP--- 154 (292)
T ss_pred h-hHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCc---
Confidence 9 478888886543 45889999999999999999999999 999999999999999999999999999876533
Q ss_pred CccccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCceec
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVRE 841 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~ 841 (845)
-.-....+-|.+|++|.++.+. -|+...|+||.||++.|+.....|...+.++.++
T Consensus 155 ----vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq 211 (292)
T KOG0662|consen 155 ----VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211 (292)
T ss_pred ----eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH
Confidence 2223445678999999998875 5788999999999999999977888877776554
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=272.22 Aligned_cols=199 Identities=28% Similarity=0.443 Sum_probs=174.8
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
++|+..+.||+|+||.||++... +++.||+|.+.... ....+++.+|++++++++||||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999976 68999999887643 34457899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
+++++|.+++.... ..+++.....++.|+++|++|||+ .+ ++||||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~- 155 (265)
T cd06605 81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL- 155 (265)
T ss_pred cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH-
Confidence 99999999997643 568899999999999999999999 77 9999999999999999999999999986543111
Q ss_pred CCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 156 --------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 156 --------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred --------hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 11156788999999999999999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=272.49 Aligned_cols=200 Identities=28% Similarity=0.385 Sum_probs=171.8
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~LV~ 699 (845)
++|...+.||.|++|.||++... +++.+|+|.+.... .....++.+|++++++++||||+++++++.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46778899999999999999975 68899999887532 34467799999999999999999999998553 4689999
Q ss_pred EcCCCCCHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 700 EFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 700 E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
||+++++|.+++.. .....+++.....++.|+++||.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999998764 23456889999999999999999999998 99999999999999999999999999875432
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.. .....++..|+|||.+.+..++.++||||+||++|||++|+.||...
T Consensus 158 ~~---------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 158 SL---------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred cc---------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 11 12345678999999999899999999999999999999999999755
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=270.06 Aligned_cols=197 Identities=30% Similarity=0.455 Sum_probs=171.7
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcC
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 702 (845)
-|+..+.||+|+||.||+|... +++.||+|...... ....+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4667889999999999999864 68999999876433 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCC
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 782 (845)
++++|.+++.. ..+++.....++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||+++.....+
T Consensus 85 ~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--- 155 (277)
T cd06641 85 GGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--- 155 (277)
T ss_pred CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch---
Confidence 99999999864 35889999999999999999999988 9999999999999999999999999987654221
Q ss_pred ccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
.......++..|+|||.+.+..++.++|||||||++|||++|..||..
T Consensus 156 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 203 (277)
T cd06641 156 ----IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE 203 (277)
T ss_pred ----hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 112234578899999999888899999999999999999999999964
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=286.90 Aligned_cols=200 Identities=25% Similarity=0.410 Sum_probs=173.0
Q ss_pred cCCCCCccccccCceEEEEEEeCC-CcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcC
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 702 (845)
+.|.+...||.|+||+||||..++ +-..|.|.+...+....++|+-|+++|+.++||+||++++.|+.++..++..|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 445667789999999999999764 4556778887777777889999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCC
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 782 (845)
.||-++..+-.. +..+.+.++..+++|++.||.|||++. |||||||+.|||++-+|.++++|||.+....
T Consensus 112 ~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~------ 181 (1187)
T KOG0579|consen 112 GGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK------ 181 (1187)
T ss_pred CCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch------
Confidence 999999877654 346899999999999999999999998 9999999999999999999999999875321
Q ss_pred ccccceeecccCCCCccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 783 IVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
..-.....+.||++|||||+.+ +..|+.++||||||++|.||..+..|-..
T Consensus 182 -~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe 237 (1187)
T KOG0579|consen 182 -STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE 237 (1187)
T ss_pred -hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc
Confidence 1223345678999999999875 45799999999999999999999888643
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-30 Score=271.44 Aligned_cols=203 Identities=32% Similarity=0.452 Sum_probs=172.8
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCC------
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEG------ 693 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~------ 693 (845)
++++|++.+.||+|+||.||+|... +++.+++|++..... ..+++.+|+++++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4678999999999999999999975 678999999876433 346799999999999 7999999999996644
Q ss_pred eEEEEEEcCCCCCHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 003140 694 EQMLVYEFMSNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 771 (845)
Q Consensus 694 ~~~LV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGl 771 (845)
..++||||+++++|.++++... ...+++..+..++.|+++||.|||+.+ ++||||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999987643 567899999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCCCccccceeecccCCCCccchhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
+....... .......|+..|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 221 (275)
T cd06608 160 SAQLDSTL-------GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221 (275)
T ss_pred ceecccch-------hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence 87643211 11233458899999998753 34678999999999999999999999743
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=272.69 Aligned_cols=201 Identities=27% Similarity=0.428 Sum_probs=168.9
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
++|+..+.||+|++|.||+|... +|+.||+|++..... ...+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999975 689999998865332 234578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEEecCCcccCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~-~~~~kl~DFGla~~~~~~~ 779 (845)
|++ ++|.+++.......+++.....++.||+.||+|||+.+ ++||||||+||+++. ++.+||+|||+++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 68888886655555788888899999999999999988 999999999999985 5679999999997643211
Q ss_pred CCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.......++..|+|||++.+ ..++.++||||+||++|||+||+.||...
T Consensus 158 -------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~ 207 (294)
T PLN00009 158 -------RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207 (294)
T ss_pred -------cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11123356789999998865 45789999999999999999999999654
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=276.54 Aligned_cols=205 Identities=29% Similarity=0.404 Sum_probs=169.6
Q ss_pred CCCCCccccccCceEEEEEEeC---CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CeEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP---DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQM 696 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~---~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~ 696 (845)
+|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4777889999999999999974 47899999987632 23346778899999999999999999999888 7899
Q ss_pred EEEEcCCCCCHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC----CCcEEEEec
Q 003140 697 LVYEFMSNGTLRDQLSAK---SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH----KFTAKVADF 769 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~----~~~~kl~DF 769 (845)
+||||++ +++.+++... ....+++.....++.|++.||+|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999997 5777776542 2236889999999999999999999998 999999999999999 899999999
Q ss_pred CCcccCCCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 770 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 770 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
|+++........ ........++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.
T Consensus 157 g~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 157 GLARLFNAPLKP----LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred ccccccCCCccc----ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 999865432210 111223457889999998866 4588999999999999999999999975444
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=271.81 Aligned_cols=206 Identities=23% Similarity=0.394 Sum_probs=175.9
Q ss_pred HHHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh---hhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCe
Q 003140 620 ALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGE 694 (845)
Q Consensus 620 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 694 (845)
.+...+|....+||+|+||+|..|.-+ ..+.+|||+++.... ++.+--+.|-++|+-. +-|.++++..++..-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 444567888999999999999999855 468899999886432 1222235566777766 67899999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003140 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (845)
Q Consensus 695 ~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~ 774 (845)
.|+||||+.+|+|--.++..+ .+.+..+.-+|..||-||-+||+++ ||.||||-+|||+|.+|++||+|||+++.
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred eeeEEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccc
Confidence 999999999999998887644 4677788889999999999999999 99999999999999999999999999975
Q ss_pred CCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
. +.......+..||+.|+|||++....|+..+|.|||||+||||+.|+.||++.++
T Consensus 500 n-------i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE 555 (683)
T KOG0696|consen 500 N-------IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 555 (683)
T ss_pred c-------ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 3 3334556778999999999999999999999999999999999999999987665
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=273.81 Aligned_cols=201 Identities=28% Similarity=0.394 Sum_probs=172.0
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
++|+..+.||+|+||.||+|... +++.||||+++... ....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999976 58899999887532 2335678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
|++++.+..+.... ..+++..+..++.|+++|+.|||+.+ ++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99987776665432 45889999999999999999999998 99999999999999999999999999887543221
Q ss_pred CCccccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.......++..|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 156 ------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 156 ------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred ------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 122334578899999999887 8899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-30 Score=269.06 Aligned_cols=201 Identities=27% Similarity=0.464 Sum_probs=173.9
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
+|+..+.||+|+||.||+|... +|..||+|.+.... ....+.+.+|++++++++|+||+++++.+.+.+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4777899999999999999975 58899999886432 23345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEEecCCcccCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~-~~kl~DFGla~~~~~~~~ 780 (845)
+++++|.+++.......+++..+..++.|+++||.|||+.+ ++||||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM- 156 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc-
Confidence 99999999997766567899999999999999999999998 99999999999999885 56999999987653211
Q ss_pred CCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.......|+..|+|||+..+..++.++||||||+++|||++|+.||...
T Consensus 157 ------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 205 (257)
T cd08225 157 ------ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205 (257)
T ss_pred ------ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 1122345889999999998888999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-30 Score=272.89 Aligned_cols=204 Identities=29% Similarity=0.462 Sum_probs=172.4
Q ss_pred cCCCCCccccccCceEEEEEEeC-----CCcEEEEEEccCCChh-hHHHHHHHHHHHHhcCCCceeeEEEEEee--CCeE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-----DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQ 695 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-----~g~~vAVK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~ 695 (845)
..|...+.||+|+||.||+|.+. ++..||||.++..... ..++|.+|++++++++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45677889999999999999853 3689999998865443 46789999999999999999999999877 5578
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 99999999999999997643 35899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
...... ........++..|+|||......++.++||||||+++|||++|+.|+...
T Consensus 160 ~~~~~~----~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 160 PEDKDY----YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred ccCCcc----eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 422100 11111234556799999998889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=268.35 Aligned_cols=200 Identities=22% Similarity=0.374 Sum_probs=170.3
Q ss_pred CCCCCccccccCceEEEEEEeCC--CcEEEEEEccCCC----------hhhHHHHHHHHHHHHh-cCCCceeeEEEEEee
Q 003140 625 NFNSSTQIGQGGYGKVYKGILPD--GTVVAVKRAQEGS----------LQGEKEFLTEIQFLSR-LHHRNLVSLVGYCDE 691 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~~--g~~vAVK~~~~~~----------~~~~~~~~~Ei~~l~~-l~H~nIv~l~g~~~~ 691 (845)
+|++.+.||+|+||.||+|.... ++.+|+|.+.... .....++.+|++++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788899999999999999764 7889999875321 2233567889988875 699999999999999
Q ss_pred CCeEEEEEEcCCCCCHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEEe
Q 003140 692 EGEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVAD 768 (845)
Q Consensus 692 ~~~~~LV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDLk~~NILl~~~~~~kl~D 768 (845)
.+..++||||+++++|.+++.. .....+++..++.++.|++.||.|||+ .+ ++||||||+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999998854 234568999999999999999999996 55 99999999999999999999999
Q ss_pred cCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 769 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 769 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
||++....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 158 fg~~~~~~~~~--------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~ 216 (269)
T cd08528 158 FGLAKQKQPES--------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST 216 (269)
T ss_pred ccceeeccccc--------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc
Confidence 99997654221 223456889999999999888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=270.56 Aligned_cols=201 Identities=28% Similarity=0.474 Sum_probs=171.1
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcC
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 702 (845)
+|+..+.||+|++|.||+|... +|+.||||+++.... ...+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999975 689999999875433 23456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 703 SNGTLRDQLSAKS-KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 703 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+ |+|.+++.... ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.++++|||+++......
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-- 154 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-- 154 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--
Confidence 8 58999886543 346899999999999999999999998 9999999999999999999999999997543211
Q ss_pred CccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......++..|++||++.+ ..++.++|||||||++|||++|+.||.+..
T Consensus 155 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 205 (284)
T cd07836 155 -----NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205 (284)
T ss_pred -----cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 11223456789999998865 457889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=267.03 Aligned_cols=204 Identities=25% Similarity=0.420 Sum_probs=171.7
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEee--CCeEEEEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQMLVY 699 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~LV~ 699 (845)
+|+..+.||.|+||.||++... ++..||+|.+... .....+++.+|++++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4777899999999999999864 6889999988643 33345678899999999999999999998754 45679999
Q ss_pred EcCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 700 EFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEA--DPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 700 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
||+++++|.+++... ...++++..++.++.|+++||.|||..+ +.+|+||||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999653 3457899999999999999999999332 233999999999999999999999999999876
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.... .......++..|+|||.+....++.++||||||+++|+|++|+.||...
T Consensus 161 ~~~~-------~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 213 (265)
T cd08217 161 GHDS-------SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR 213 (265)
T ss_pred cCCc-------ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc
Confidence 4321 1122345889999999999888999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-29 Score=266.27 Aligned_cols=195 Identities=23% Similarity=0.325 Sum_probs=163.3
Q ss_pred HHHhcCCCCCccc--cccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeE
Q 003140 620 ALATNNFNSSTQI--GQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQ 695 (845)
Q Consensus 620 ~~~~~~f~~~~~L--G~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 695 (845)
....++|.+.+.+ |+|+||.||++... ++..+|+|.+........ |+.....+ +|+||+++++++...+..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3344677777776 99999999999964 688999999865322111 22222222 799999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEEecCCccc
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRL 774 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~-~~kl~DFGla~~ 774 (845)
++||||+++|+|.+++.... .+++..+..++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||+++.
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 99999999999999997643 7899999999999999999999998 99999999999999998 999999999876
Q ss_pred CCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.... ....++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 209 (267)
T PHA03390 160 IGTP-----------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED 209 (267)
T ss_pred cCCC-----------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 5321 1235789999999999989999999999999999999999999743
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=273.62 Aligned_cols=197 Identities=33% Similarity=0.506 Sum_probs=168.7
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
..|...+.||+|+||.||+|... +++.||+|.+.... ....+++.+|+++++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999965 68999999886432 233467899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||++ |++.+++.... ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 95 EYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 9996 67877775432 45899999999999999999999998 999999999999999999999999998754311
Q ss_pred CCCccccceeecccCCCCccchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
....++..|+|||++. ...++.++||||||+++|||+||+.||...+
T Consensus 169 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~ 218 (307)
T cd06607 169 ----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (307)
T ss_pred ----------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc
Confidence 1235778999999874 4568899999999999999999999997543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=272.41 Aligned_cols=202 Identities=28% Similarity=0.405 Sum_probs=167.6
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh--hhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCe-----
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGE----- 694 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~----- 694 (845)
++|+..+.||+|+||.||+|... +++.||+|+.+.... ...+.+.+|++++++++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999965 689999998765322 23457889999999994 6999999999877665
Q ss_pred EEEEEEcCCCCCHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEEecC
Q 003140 695 QMLVYEFMSNGTLRDQLSAKS---KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFG 770 (845)
Q Consensus 695 ~~LV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~-~~~~kl~DFG 770 (845)
.++||||+++ +|.+++.... ...+++..++.++.||++||+|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999984 8999886532 346899999999999999999999998 999999999999998 8899999999
Q ss_pred CcccCCCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 771 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 771 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
+++...... .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 157 ~~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~ 216 (295)
T cd07837 157 LGRAFSIPV-------KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS 216 (295)
T ss_pred cceecCCCc-------cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 987653221 11122346788999998865 457899999999999999999999996543
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=295.34 Aligned_cols=201 Identities=20% Similarity=0.265 Sum_probs=160.0
Q ss_pred HhcCCCCCccccccCceEEEEEEeCC--CcEEEEE------------------EccCCChhhHHHHHHHHHHHHhcCCCc
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILPD--GTVVAVK------------------RAQEGSLQGEKEFLTEIQFLSRLHHRN 681 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~~--g~~vAVK------------------~~~~~~~~~~~~~~~Ei~~l~~l~H~n 681 (845)
..++|.+.+.||+|+||+||++..+. +..+++| ... ........+.+|++++++++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 35789999999999999999987532 2222222 111 11223456889999999999999
Q ss_pred eeeEEEEEeeCCeEEEEEEcCCCCCHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 003140 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS---KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 758 (845)
Q Consensus 682 Iv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl 758 (845)
|+++++++...+..++|+|++. ++|.+++.... ...........++.|++.||+|||+++ ||||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999985 67888775432 122345667789999999999999998 9999999999999
Q ss_pred cCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003140 759 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833 (845)
Q Consensus 759 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~ 833 (845)
+.++.+||+|||+++...... ........||..|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~ 369 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKER------EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPI 369 (501)
T ss_pred CCCCCEEEEeCCCceecCccc------ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCc
Confidence 999999999999998654321 111233568999999999999999999999999999999999886543
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=276.09 Aligned_cols=204 Identities=24% Similarity=0.223 Sum_probs=166.5
Q ss_pred CccccccCceEEEEEEeCCCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCCCC
Q 003140 629 STQIGQGGYGKVYKGILPDGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGT 706 (845)
Q Consensus 629 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gs 706 (845)
.+.+|.|+++.||++.. +++.||||++... .....+.+.+|++++++++|+||+++++++.+.+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34455556666666555 7899999998754 34455789999999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCcccc
Q 003140 707 LRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 786 (845)
Q Consensus 707 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 786 (845)
|.+++.......+++.....++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.+......+.......
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 999998765567889999999999999999999998 99999999999999999999999999875532221111111
Q ss_pred ceeecccCCCCccchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 787 HVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 787 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||....
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~ 214 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP 214 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 11233457789999999875 458899999999999999999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=268.97 Aligned_cols=202 Identities=28% Similarity=0.415 Sum_probs=165.4
Q ss_pred CCCCccccccCceEEEEEEeC----CCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC------
Q 003140 626 FNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG------ 693 (845)
Q Consensus 626 f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 693 (845)
|.+.+.||+|+||.||+|.+. +++.||||++... .....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556788999999999999853 3688999988753 2334567899999999999999999999886532
Q ss_pred eEEEEEEcCCCCCHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEec
Q 003140 694 EQMLVYEFMSNGTLRDQLSAK----SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 769 (845)
Q Consensus 694 ~~~LV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DF 769 (845)
..++++||+++|+|.+++... ....+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 247899999999999887532 2235788999999999999999999998 999999999999999999999999
Q ss_pred CCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 770 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 770 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
|+++....... ........++..|++||.+....++.++|||||||++|||++ |+.||...
T Consensus 158 g~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~ 219 (273)
T cd05074 158 GLSKKIYSGDY-----YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV 219 (273)
T ss_pred cccccccCCcc-----eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC
Confidence 99986532210 011122345678999999998889999999999999999999 88888644
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-29 Score=262.31 Aligned_cols=199 Identities=34% Similarity=0.515 Sum_probs=176.9
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCC
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 703 (845)
.|+..+.||+|++|.||++... +++.+++|++........+++.+|++++++++|+|++++++++...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677889999999999999976 689999999987655566789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCc
Q 003140 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (845)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 783 (845)
+++|.+++.... ..+++..+..++.|+++|++|||+.+ ++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 999999987643 46899999999999999999999988 99999999999999999999999999876543210
Q ss_pred cccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.....++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 154 -----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 154 -----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred -----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 23346788999999998888999999999999999999999999765
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=271.52 Aligned_cols=200 Identities=30% Similarity=0.461 Sum_probs=170.5
Q ss_pred CCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcC
Q 003140 626 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (845)
Q Consensus 626 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 702 (845)
|+..+.||+|++|.||+|... +|+.||+|++.... ....+.+.+|++++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999965 79999999886433 223457889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCC
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 782 (845)
+ ++|.+++.......+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++.++|+|||+++......
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--- 153 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--- 153 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc---
Confidence 5 79999997765567899999999999999999999988 9999999999999999999999999997653221
Q ss_pred ccccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 783 IVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......++..|+|||++.+. .++.++||||||+++|||++|+.||...+
T Consensus 154 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 204 (283)
T cd07835 154 ----RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDS 204 (283)
T ss_pred ----cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 111223467899999987654 57889999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=272.31 Aligned_cols=207 Identities=16% Similarity=0.183 Sum_probs=156.7
Q ss_pred hcCCCCCccccccCceEEEEEEeCC----CcEEEEEEccCCChhh--H---------HHHHHHHHHHHhcCCCceeeEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKRAQEGSLQG--E---------KEFLTEIQFLSRLHHRNLVSLVG 687 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~~~~~~~~~--~---------~~~~~Ei~~l~~l~H~nIv~l~g 687 (845)
.++|.+.+.||+|+||.||+|...+ +..+|+|+........ + .....+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3678899999999999999999654 4566777543222111 1 11233445566778999999999
Q ss_pred EEeeCC----eEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 003140 688 YCDEEG----EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 763 (845)
Q Consensus 688 ~~~~~~----~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~ 763 (845)
++.... ..++++|++. .++.+.+... ...++..+..++.|+++||+|||+.+ |+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCc
Confidence 875543 4578888774 4676666543 23567888999999999999999988 999999999999999999
Q ss_pred EEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 764 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 764 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
++|+|||+|+....................||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999865422111100111123346999999999999999999999999999999999999999755
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=272.34 Aligned_cols=200 Identities=28% Similarity=0.401 Sum_probs=169.7
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CeEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQMLV 698 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~LV 698 (845)
++|+..+.||+|+||.||+|... +++.+|+|.++.... .....+.+|++++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999976 588999999875332 2234678899999999999999999998777 889999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
|||++ ++|.+++.... ..+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 85 ~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 99997 59999886643 36899999999999999999999998 999999999999999999999999999865432
Q ss_pred CCCCccccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
. .......++..|+|||.+.+. .++.++|+||||+++|||++|+.||...
T Consensus 160 ~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 160 L-------KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred c-------cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1 112234567899999998754 4689999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=272.21 Aligned_cols=194 Identities=26% Similarity=0.429 Sum_probs=169.9
Q ss_pred CccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCCCCH
Q 003140 629 STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 707 (845)
Q Consensus 629 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL 707 (845)
...||+|+||.||++... +++.||||++........+.+.+|+.++++++|+||+++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 357999999999999874 7899999998765555567799999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCccccc
Q 003140 708 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 787 (845)
Q Consensus 708 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 787 (845)
.+++.. ..+++.....++.|++.|++|||+.+ ++||||||+||++++++.++|+|||++....... .
T Consensus 105 ~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-------~ 171 (292)
T cd06657 105 TDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-------P 171 (292)
T ss_pred HHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc-------c
Confidence 998753 25789999999999999999999998 9999999999999999999999999987543211 1
Q ss_pred eeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 788 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
......|+..|+|||++.+..++.++||||+|+++|||++|+.||...
T Consensus 172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~ 219 (292)
T cd06657 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 219 (292)
T ss_pred cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 123345789999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=271.32 Aligned_cols=199 Identities=27% Similarity=0.365 Sum_probs=168.8
Q ss_pred CCCCCccccccCceEEEEEEe----CCCcEEEEEEccCCCh----hhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeE
Q 003140 625 NFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSL----QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQ 695 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~----~~g~~vAVK~~~~~~~----~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 695 (845)
+|++.+.||+|+||.||++.. .+|..||+|++..... ...+.+.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999985 3689999999875322 2346788899999999 599999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++||||+++++|.+++... ..+++.....++.|+++||.|||+.+ ++||||||+|||++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 9999999999999999654 35788889999999999999999988 999999999999999999999999999765
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
...+. .......|+..|+|||.+.. ..++.++||||||+++|||++|+.||..
T Consensus 156 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 156 HEDEV------ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred ccccc------cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 32211 11223458899999999875 3468899999999999999999999963
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=310.42 Aligned_cols=208 Identities=30% Similarity=0.424 Sum_probs=174.5
Q ss_pred HhcCCCCCccccccCceEEEEEE-eCCCcEEEEEEccC--CChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEE
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~~~~--~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
.+-+++....||.|.||.||.|. .++|...|||.++. ......+...+|+.++..++|||+|+.+|+-.+.+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 34567778899999999999998 45799999997653 3334456778999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
||||++|+|.+.+... ...++.....+..|++.|+.|||+.+ ||||||||.||+++.+|.+|.+|||.|..+...
T Consensus 1313 MEyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 9999999999999643 34677777789999999999999999 999999999999999999999999999877543
Q ss_pred CCCCccccceeecccCCCCccchhhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTH---KLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
- .. .+ .......||+.|||||.+.+. ....+.||||+|||+.||+||++||..-++
T Consensus 1388 ~-~~-~~-~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn 1446 (1509)
T KOG4645|consen 1388 A-QT-MP-GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN 1446 (1509)
T ss_pred h-hc-CC-HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc
Confidence 1 11 11 122356799999999999753 456789999999999999999999975443
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-29 Score=266.30 Aligned_cols=192 Identities=24% Similarity=0.375 Sum_probs=168.6
Q ss_pred ccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCCCCH
Q 003140 632 IGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 707 (845)
Q Consensus 632 LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL 707 (845)
||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+....++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 48999999986532 23456799999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCccccc
Q 003140 708 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 787 (845)
Q Consensus 708 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 787 (845)
.+++.+. ..+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||+++......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-------- 147 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-------- 147 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--------
Confidence 9999764 34889999999999999999999988 9999999999999999999999999998654321
Q ss_pred eeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 788 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
......++..|+|||.+....++.++|+||+|+++|||++|+.||...+
T Consensus 148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 1223457889999999988889999999999999999999999997655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-29 Score=268.51 Aligned_cols=191 Identities=27% Similarity=0.385 Sum_probs=159.2
Q ss_pred cccccCceEEEEEEeC-CCcEEEEEEccCCCh---hhHHHHHHHHH---HHHhcCCCceeeEEEEEeeCCeEEEEEEcCC
Q 003140 631 QIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQ---FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703 (845)
Q Consensus 631 ~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~---~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 703 (845)
.||+|+||.||++... +++.||+|.+..... .....+..|.. .++...||+|+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 689999998865322 22223444443 4444579999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCc
Q 003140 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (845)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 783 (845)
+|+|.+++... ..+++..+..++.|+++|++|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---- 151 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence 99999988653 46899999999999999999999988 9999999999999999999999999987543211
Q ss_pred cccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 784 VPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.....|+..|+|||.+.++ .++.++||||+||++|||++|+.||...
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 152 -----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred -----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 1234688999999998754 6899999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=279.51 Aligned_cols=199 Identities=25% Similarity=0.378 Sum_probs=169.7
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC------
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------ 692 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------ 692 (845)
..++|+..+.||+|+||.||+|... +|+.||+|.+... .....+++.+|++++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999964 7899999998642 233446788899999999999999999988543
Q ss_pred CeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 003140 693 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 772 (845)
Q Consensus 693 ~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla 772 (845)
...++||||++ ++|.+.+... ++...+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccc
Confidence 35799999995 6888887542 788899999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
+...... ......++..|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 166 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 166 RTAGTSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred eeCCCCC--------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 8653211 1223457889999999999999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=271.92 Aligned_cols=199 Identities=29% Similarity=0.412 Sum_probs=165.9
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCeEEEEEEc
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
+|...+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556678999999999999965 68999999986533 334567899999999996 99999999999999999999999
Q ss_pred CCCCCHHHHH---hccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 702 MSNGTLRDQL---SAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 702 ~~~gsL~~~l---~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
++ +++.++. .......+++.....++.++++||+|||+. + |+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 86 5665543 333446789999999999999999999975 6 99999999999999999999999999976532
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTH---KLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.. ......|+..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 161 ~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 213 (288)
T cd06616 161 SI--------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213 (288)
T ss_pred CC--------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence 21 11233578899999998765 6899999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=274.88 Aligned_cols=204 Identities=24% Similarity=0.298 Sum_probs=165.2
Q ss_pred cccccc--CceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCC
Q 003140 630 TQIGQG--GYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (845)
Q Consensus 630 ~~LG~G--~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 704 (845)
..||+| +||+||++... +|+.||+|+..... ....+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456776 99999999964 79999999986432 23346788999999999999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCcc
Q 003140 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (845)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 784 (845)
|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+............
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99999998765556899999999999999999999988 999999999999999999999999865433211100000
Q ss_pred ccceeecccCCCCccchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 785 PAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.........++..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 214 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence 0000111234567999999876 357899999999999999999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=262.28 Aligned_cols=202 Identities=29% Similarity=0.449 Sum_probs=176.7
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CeEEEEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQMLVY 699 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~LV~ 699 (845)
+|...+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++|+||+++++.+.+. +..++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999976 689999999875442 4467899999999999999999999999888 8899999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++++|.+++.... .+++..+..++.|+++|++|||+.+ ++||||+|+||+++.++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999997654 7899999999999999999999988 9999999999999999999999999988764332
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.. .......++..|+|||......++.++||||||+++|||++|+.||...+
T Consensus 156 ~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 156 TG-----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred cc-----ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 10 01234567889999999988889999999999999999999999997655
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-30 Score=253.38 Aligned_cols=200 Identities=28% Similarity=0.454 Sum_probs=167.9
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC-ChhhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCeEEEEEEc
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~-~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
+.+....||.|.-|.|+++... .|..+|||.+... +.+..++++..+.++.+-+ +|.||+.+|||..+...++.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 3445678999999999999976 5899999998754 4555678888888877764 89999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
|. -.++.++++ ...++++...-++...+++||.||.++++ |||||+||+|||+|+.|++|++|||++-++-.
T Consensus 173 Ms-~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlvd---- 244 (391)
T KOG0983|consen 173 MS-TCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVD---- 244 (391)
T ss_pred HH-HHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceeec----
Confidence 83 455666654 34568888888999999999999998764 99999999999999999999999999866532
Q ss_pred CccccceeecccCCCCccchhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
+...+...|.+.|||||.+.- ..|+.++||||||+.++||.||+.||...+
T Consensus 245 ----SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~ 298 (391)
T KOG0983|consen 245 ----SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK 298 (391)
T ss_pred ----ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC
Confidence 334556689999999999864 468889999999999999999999998644
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=260.93 Aligned_cols=200 Identities=32% Similarity=0.521 Sum_probs=175.8
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
+|+..+.||+|++|.||++... +++.||+|.+..... ...+++.+|++++++++|+|++++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4777899999999999999865 678999999876543 4456899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+++++|.+++... ..+++..+..++.|++.|+.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK- 154 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc-
Confidence 9999999999654 46899999999999999999999998 99999999999999999999999999987643221
Q ss_pred CccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
......++..|+|||...+..++.++||||+|+++|||++|+.||...+
T Consensus 155 ------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~ 203 (254)
T cd06627 155 ------DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN 203 (254)
T ss_pred ------cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc
Confidence 1233467889999999988888999999999999999999999997543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=276.74 Aligned_cols=202 Identities=27% Similarity=0.411 Sum_probs=167.9
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----CeE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GEQ 695 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~ 695 (845)
+++|.+.+.||+|+||.||+|... +|+.||+|++.... .....++.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999864 68999999986432 23346788999999999999999999987544 357
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++|+||++ ++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeec
Confidence 99999996 588887743 35899999999999999999999998 999999999999999999999999999765
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
...... ........|+..|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus 157 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 157 DPEHDH----TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred cccccc----cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 322110 111233467899999998754 56899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=265.12 Aligned_cols=200 Identities=28% Similarity=0.437 Sum_probs=169.4
Q ss_pred ccccCceEEEEEEeC-CCcEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCCCCH
Q 003140 632 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 707 (845)
Q Consensus 632 LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL 707 (845)
||+|+||.||++... +|+.+|+|.+..... ...+.+.+|++++++++|+||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999986 499999999875433 3456789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCC-cccc
Q 003140 708 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG-IVPA 786 (845)
Q Consensus 708 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~ 786 (845)
.+++++.. .+++..+..++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||++.......... ....
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99997643 6899999999999999999999998 9999999999999999999999999987643221100 0001
Q ss_pred ceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 787 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 787 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......++..|+|||......++.++||||||+++||+++|+.||....
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 205 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET 205 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 12233457889999999988889999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=272.15 Aligned_cols=202 Identities=31% Similarity=0.440 Sum_probs=168.7
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChh--hHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CeEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQML 697 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~L 697 (845)
.++|++.+.||+|+||.||+|... +|+.||+|+++..... ....+.+|++++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467889999999999999999975 6899999998643222 234567899999999999999999998654 56899
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
||||++ ++|.+++.... ..+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 86 v~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 999996 58988886543 56899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.. .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||...+
T Consensus 161 ~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~ 213 (309)
T cd07845 161 PA-------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS 213 (309)
T ss_pred cc-------CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 11122345788999999865 567899999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=270.06 Aligned_cols=194 Identities=34% Similarity=0.529 Sum_probs=166.5
Q ss_pred CCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 626 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 626 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
|...+.||+|+||.||+|... ++..||+|++.... ....+++.+|++++++++|+|++++++++.+.+..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 566788999999999999964 68999999886432 23345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
++ |++.+++... ..++++..+..++.|++.|+.|||+.+ |+||||+|+||+++.++.+||+|||++.....
T Consensus 107 ~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---- 177 (317)
T cd06635 107 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP---- 177 (317)
T ss_pred CC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence 96 6888877543 346899999999999999999999998 99999999999999999999999999875432
Q ss_pred CccccceeecccCCCCccchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.....|+..|+|||++. .+.++.++|||||||++|||++|+.||...
T Consensus 178 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 227 (317)
T cd06635 178 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 227 (317)
T ss_pred -------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 12235788999999974 457889999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=267.68 Aligned_cols=200 Identities=30% Similarity=0.429 Sum_probs=169.5
Q ss_pred CCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CeEEEEEE
Q 003140 626 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQMLVYE 700 (845)
Q Consensus 626 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~LV~E 700 (845)
|++.+.||+|+||.||+|... +++.+|+|++.... ....+.+.+|++++++++|+|++++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999976 58999999988653 23346788999999999999999999999887 88999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
|++ ++|.+++.... ..+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 997 58998886542 46899999999999999999999988 99999999999999999999999999986643221
Q ss_pred CCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 156 ------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~ 206 (287)
T cd07840 156 ------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST 206 (287)
T ss_pred ------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 11223356788999998764 467899999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=269.77 Aligned_cols=206 Identities=32% Similarity=0.409 Sum_probs=170.5
Q ss_pred HHHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC---
Q 003140 620 ALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG--- 693 (845)
Q Consensus 620 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~--- 693 (845)
+...++|++.+.||+|+||.||+|... +|+.||+|+++... ......+.+|++++++++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 345678999999999999999999975 58999999986532 223456788999999999999999999987654
Q ss_pred -------eEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 003140 694 -------EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV 766 (845)
Q Consensus 694 -------~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl 766 (845)
..++|+||+++ ++.+.+... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999975 777777554 346899999999999999999999998 999999999999999999999
Q ss_pred EecCCcccCCCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 767 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 767 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
+|||+++....... .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+
T Consensus 158 ~dfg~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~ 222 (302)
T cd07864 158 ADFGLARLYNSEES------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ 222 (302)
T ss_pred CcccccccccCCcc------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999986543221 11122345778999998864 457899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=265.62 Aligned_cols=196 Identities=29% Similarity=0.376 Sum_probs=163.6
Q ss_pred CCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh-hhHHHHHHHHHHHHhcC-CCceeeEEEEEeeC--CeEEEEEE
Q 003140 626 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEE--GEQMLVYE 700 (845)
Q Consensus 626 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~--~~~~LV~E 700 (845)
|...+.||+|+||.||+|... +++.||+|+++.... .......+|+.++.++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 566788999999999999964 689999999875322 22334567899999985 99999999999887 88999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
|++ |++.+++.... ..+++..+..++.|+++||+|||+.+ ++||||||+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~- 153 (282)
T cd07831 81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP- 153 (282)
T ss_pred cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC-
Confidence 996 68888886533 46899999999999999999999998 999999999999999 999999999997653221
Q ss_pred CCccccceeecccCCCCccchhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
......++..|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 154 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~ 202 (282)
T cd07831 154 -------PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGT 202 (282)
T ss_pred -------CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCC
Confidence 112235788999999765 456788999999999999999999999654
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=261.67 Aligned_cols=190 Identities=27% Similarity=0.369 Sum_probs=161.1
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEccCCCh---hhHHHHHHHHHHH-HhcCCCceeeEEEEEeeCCeEEEEEEcCCC
Q 003140 630 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFL-SRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~~l-~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 704 (845)
+.||+|+||.||+|... +|+.||||.+..... .....+..|..++ ...+|+|++++++++...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999864 689999999865432 2223445555544 445899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCcc
Q 003140 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (845)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 784 (845)
++|.++++.. ..+++..+..++.|+++||.|||+.+ ++||||+|+||++++++.++|+|||+++....
T Consensus 82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------- 149 (260)
T cd05611 82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------- 149 (260)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-------
Confidence 9999999654 35788889999999999999999988 99999999999999999999999999875421
Q ss_pred ccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.....++..|+|||.+.+..++.++||||||+++|||++|..||...
T Consensus 150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 196 (260)
T cd05611 150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE 196 (260)
T ss_pred ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC
Confidence 12345788999999998888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=260.81 Aligned_cols=201 Identities=30% Similarity=0.514 Sum_probs=176.7
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
+|...+.||+|+||.||++... +++.||+|++..... ...+++.+|++++++++|+|++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777889999999999999975 689999999876433 4566789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 702 MSNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 702 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
+++++|.+++.... ...+++..+..++.++++||.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999997643 467999999999999999999999998 9999999999999999999999999987654321
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.......|+..|+|||...+..++.++||||+|+++++|++|+.||...
T Consensus 158 -------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 206 (258)
T cd08215 158 -------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE 206 (258)
T ss_pred -------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence 1223346788999999998888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=274.82 Aligned_cols=205 Identities=30% Similarity=0.448 Sum_probs=169.4
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC--ChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeC--CeE
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE--GEQ 695 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~--~~~ 695 (845)
..++|+..+.||+|+||.||+|... +|+.+|||++... .......+.+|+.+++++ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467888999999999999999975 6889999987542 233445678899999999 999999999998654 368
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++||||++ ++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 99999997 6999988653 6789999999999999999999988 999999999999999999999999999866
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
....... .........|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 158 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~ 216 (337)
T cd07852 158 SELEENP--ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216 (337)
T ss_pred ccccccc--cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence 4322110 0112233468899999998754 56788999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-29 Score=269.30 Aligned_cols=205 Identities=27% Similarity=0.398 Sum_probs=167.7
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-------
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG------- 693 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------- 693 (845)
++|+..+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 57888999999999999999965 68999999876432 222345678999999999999999999986654
Q ss_pred -eEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 003140 694 -EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 772 (845)
Q Consensus 694 -~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla 772 (845)
..++||||+. ++|.+++.... ..+++...+.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCc
Confidence 3599999996 58888886532 35899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCCCccccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||...+
T Consensus 167 ~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~ 228 (310)
T cd07865 167 RAFSLSKNSK---PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT 228 (310)
T ss_pred ccccCCcccC---CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 8664322110 1112234577899999988664 47889999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=264.93 Aligned_cols=198 Identities=31% Similarity=0.434 Sum_probs=167.0
Q ss_pred CCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChh--hHHHHHHHHHHHHhc---CCCceeeEEEEEeeCCe-----
Q 003140 626 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRL---HHRNLVSLVGYCDEEGE----- 694 (845)
Q Consensus 626 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~--~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~~~~~----- 694 (845)
|++.+.||+|+||.||+|... +++.||+|+++..... ....+.+|+++++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566789999999999999986 4899999998743221 234566788777666 59999999999988776
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003140 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (845)
Q Consensus 695 ~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~ 774 (845)
.+++|||++ ++|.+++.......+++..++.++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence 899999996 58999987755557899999999999999999999998 99999999999999999999999999876
Q ss_pred CCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
..... ......++..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~ 209 (287)
T cd07838 157 YSFEM--------ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGT 209 (287)
T ss_pred ccCCc--------ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCC
Confidence 53221 112234678999999999889999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=272.99 Aligned_cols=203 Identities=25% Similarity=0.398 Sum_probs=170.8
Q ss_pred hHHHHHHhcCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC
Q 003140 616 YGEMALATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 692 (845)
Q Consensus 616 ~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~ 692 (845)
..++...+++|...+.||+|+||.||+|.. .+++.||+|+++... ....+.+.+|++++++++|+||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 345566779999999999999999999985 478999999987532 22346788999999999999999999988543
Q ss_pred ------CeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 003140 693 ------GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV 766 (845)
Q Consensus 693 ------~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl 766 (845)
...+++++++ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence 3467888877 7899888854 35889999999999999999999998 999999999999999999999
Q ss_pred EecCCcccCCCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 767 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 767 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
+|||+++.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 162 ~dfg~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 221 (345)
T cd07877 162 LDFGLARHTDD----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221 (345)
T ss_pred ecccccccccc----------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999875421 1123457889999998866 56889999999999999999999999643
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-29 Score=261.26 Aligned_cols=200 Identities=28% Similarity=0.460 Sum_probs=174.2
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
+|++.+.||+|+||.||++... +++.+|+|.+.... .....++.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999854 68899999987532 33356788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 702 MSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 702 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
+++++|.+++.+. ....+++..++.++.|+++||+|||+.+ ++||||+|+||++++++.+|++|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999998662 2356899999999999999999999998 999999999999999999999999999876432
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
......++..|+|||.+.+..++.++|+||+|+++|||++|+.||...+
T Consensus 157 --------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 205 (256)
T cd08530 157 --------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS 205 (256)
T ss_pred --------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1122357889999999999899999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=265.64 Aligned_cols=208 Identities=25% Similarity=0.371 Sum_probs=176.7
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC---ChhhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCeEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG---SLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV 698 (845)
++|...+.||+|+||.||+|... +|+.||+|++... .....+.+.+|++++++++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999975 7899999988653 2233467889999999998 99999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++++|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999997643 6899999999999999999999998 999999999999999999999999999865432
Q ss_pred CCCCcc-------------ccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 779 DIEGIV-------------PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 779 ~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
...... .........++..|+|||......++.++||||||++++|+++|+.||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 211000 0112234467899999999988889999999999999999999999997554
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=267.10 Aligned_cols=201 Identities=29% Similarity=0.454 Sum_probs=167.5
Q ss_pred HhcCCCCCccccccCceEEEEEEeCC-CcEEEEEEccCCC-hhhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCeEEEE
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV 698 (845)
..++|+..+.||+|+||.||+|...+ ++.||||.++... ....+++.+|++++.+.. |+||+++++++.+....++|
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34678889999999999999999864 8999999987543 233456777888777774 99999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
|||++ +++.+++.... ..+++..+..++.|+++||+|||+. + |+||||+|+||++++++.+||+|||++.....
T Consensus 93 ~e~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 93 MELMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eeccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 99985 57877765533 3789999999999999999999974 6 99999999999999999999999999876532
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK----LTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.. ......++..|+|||++.+.. ++.++||||||+++|||++|+.||...
T Consensus 168 ~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 221 (296)
T cd06618 168 SK--------AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC 221 (296)
T ss_pred CC--------cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcc
Confidence 11 112234778999999987554 788999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=273.94 Aligned_cols=204 Identities=26% Similarity=0.411 Sum_probs=169.9
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEee----CCeE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE----EGEQ 695 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~ 695 (845)
.++|+..+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368888999999999999999965 69999999987532 2345678889999999999999999988753 3468
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++||||+. |+|.+++... ..+++.....++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 7899988643 34899999999999999999999988 999999999999999999999999999765
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
...... .........++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~~---~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 215 (334)
T cd07855 158 SSSPTE---HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215 (334)
T ss_pred cccCcC---CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence 432211 1122234568899999999865 56889999999999999999999999653
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=272.23 Aligned_cols=196 Identities=27% Similarity=0.425 Sum_probs=164.6
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC------C
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------G 693 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------~ 693 (845)
.++|...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++|+||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 368888999999999999999964 68999999886432 22245688999999999999999999998654 3
Q ss_pred eEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003140 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (845)
Q Consensus 694 ~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~ 773 (845)
..++|+||+. ++|.++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 4699999996 47777652 35889999999999999999999998 9999999999999999999999999987
Q ss_pred cCCCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+
T Consensus 166 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 166 HADAE----------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred CCCCC----------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 54211 122356788999999876 468899999999999999999999997543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=264.99 Aligned_cols=199 Identities=28% Similarity=0.344 Sum_probs=168.3
Q ss_pred CCCCCccccccCceEEEEEEe----CCCcEEEEEEccCCC----hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeE
Q 003140 625 NFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGS----LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQ 695 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~----~~g~~vAVK~~~~~~----~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 695 (845)
+|++.+.||+|+||.||++.. .+++.||||.++... ....+.+.+|+++++++ +|+||+++++.+...+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367788999999999999884 357889999887432 22345688999999999 599999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++||||+++|+|.+++... ..+++.....++.|+++||.|||+.+ ++||||||+||+++.++.++|+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 9999999999999998653 45889999999999999999999988 999999999999999999999999998765
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK--LTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
.... ........|+..|+|||...+.. .+.++||||||+++|||++|+.||..
T Consensus 156 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 156 LAEE------EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred cccc------ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 3221 11112345789999999987655 78899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=269.01 Aligned_cols=207 Identities=23% Similarity=0.341 Sum_probs=169.9
Q ss_pred hcCCCCCccccccCceEEEEEE-eCCCcEEEEEEccCCChhh---HHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~~~~~~~~~---~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
...|..++.||-|+||+|..+. .++...+|.|.+.+...-. ......|-.||...+.+-||+||-.|.+.+..|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 3457778999999999999987 4457789999887654332 23467899999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc-----
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR----- 773 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~----- 773 (845)
|||++||++-++|-+.+ .+.+...+.++..+..|+++.|..| +|||||||+|||||.+|++||+||||+.
T Consensus 708 MdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred EeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence 99999999999886543 4777777888889999999999999 9999999999999999999999999983
Q ss_pred ----cCCCCCCCC---ccc-----------------------cceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHH
Q 003140 774 ----LAPVPDIEG---IVP-----------------------AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFL 823 (845)
Q Consensus 774 ----~~~~~~~~~---~~~-----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ 823 (845)
++...+-.. ..+ .......+||..|+|||++....|+.-+|.||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 221110000 000 00012347999999999999999999999999999999
Q ss_pred HHHhCCCCCCC
Q 003140 824 ELLTGMQPISH 834 (845)
Q Consensus 824 elltG~~Pf~~ 834 (845)
||+.|+.||..
T Consensus 863 em~~g~~pf~~ 873 (1034)
T KOG0608|consen 863 EMLVGQPPFLA 873 (1034)
T ss_pred HHhhCCCCccC
Confidence 99999999964
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-28 Score=264.21 Aligned_cols=195 Identities=33% Similarity=0.520 Sum_probs=166.2
Q ss_pred CCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 626 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 626 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
|...+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++|+|++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999964 68999999986432 23345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+. |++.+++... ..++++..+..++.|++.|+.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 95 6888877543 346899999999999999999999998 99999999999999999999999999864321
Q ss_pred CccccceeecccCCCCccchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.....|+..|+|||++. ...++.++|||||||++|||++|+.||...+
T Consensus 174 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~ 224 (313)
T cd06633 174 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 224 (313)
T ss_pred -------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 12345788999999984 4568889999999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=270.39 Aligned_cols=198 Identities=26% Similarity=0.407 Sum_probs=168.2
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-----
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----- 693 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----- 693 (845)
..++|+..+.||+|+||.||+|... +|..||||++.... ....+.+.+|++++++++|+||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4678999999999999999999854 78999999986432 223457889999999999999999999886543
Q ss_pred -eEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 003140 694 -EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 772 (845)
Q Consensus 694 -~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla 772 (845)
..++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccc
Confidence 458999999 7899888853 35899999999999999999999998 999999999999999999999999998
Q ss_pred ccCCCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
+..... .....++..|+|||.+.+ ..++.++||||+||++|+|++|+.||...+
T Consensus 166 ~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 220 (343)
T cd07880 166 RQTDSE----------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220 (343)
T ss_pred cccccC----------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 764321 122356889999999876 468899999999999999999999997554
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=252.12 Aligned_cols=197 Identities=24% Similarity=0.365 Sum_probs=168.0
Q ss_pred hcCCCCC-ccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEee----CCeE
Q 003140 623 TNNFNSS-TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE----EGEQ 695 (845)
Q Consensus 623 ~~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~----~~~~ 695 (845)
+++|.+. ++||-|-.|+|-.+..+ +|+.+|+|++.+.. ...+|++..-.. .|||||.++++|.. .+..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-----KARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-----HHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 3445443 67999999999998865 68999999987632 445788887666 69999999998754 4577
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEEecCCc
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLS 772 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~---~~~~kl~DFGla 772 (845)
++|||.|+||.|.+.++.++...+++.++-+|+.||+.|+.|||+.+ |.||||||+|+|... +..+|++|||.|
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccc
Confidence 89999999999999999999999999999999999999999999999 999999999999964 457999999999
Q ss_pred ccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
+....+ ....+..-|+.|.|||++...+|+..+|+||+||+||-|+.|..||-+.
T Consensus 212 K~t~~~--------~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~ 266 (400)
T KOG0604|consen 212 KETQEP--------GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_pred cccCCC--------ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccccc
Confidence 875421 2234456789999999999999999999999999999999999999643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=289.29 Aligned_cols=206 Identities=29% Similarity=0.400 Sum_probs=163.4
Q ss_pred HHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEee-------
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE------- 691 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~------- 691 (845)
.-..+|+..+.||+||||.|||++.+ ||+.+|||++.-.. ........+|++++++++|||||+++..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 44567888899999999999999976 89999999987543 3334568899999999999999998722110
Q ss_pred --------------------------------------------------------------------------------
Q 003140 692 -------------------------------------------------------------------------------- 691 (845)
Q Consensus 692 -------------------------------------------------------------------------------- 691 (845)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------C--------CeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH
Q 003140 692 ------------------------E--------GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739 (845)
Q Consensus 692 ------------------------~--------~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH 739 (845)
+ -..||-||||+.-.++++++++.... .....++++.+|+.||.|+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHH
Confidence 0 13478899999988888887653321 46677889999999999999
Q ss_pred hCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCC----CC-------CCCCccccceeecccCCCCccchhhhcCC-
Q 003140 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP----VP-------DIEGIVPAHVSTVVKGTPGYLDPEYFLTH- 807 (845)
Q Consensus 740 ~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~----~~-------~~~~~~~~~~~~~~~gt~~y~aPE~~~~~- 807 (845)
+++ ||||||||.||++|++..|||+|||+|.... .. +..........+..+||.-|+|||++.+.
T Consensus 715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 999 9999999999999999999999999998721 00 00011112245678899999999999764
Q ss_pred --CCCchhhHHHHHHHHHHHHhCCCCCC
Q 003140 808 --KLTDKSDVYSLGVVFLELLTGMQPIS 833 (845)
Q Consensus 808 --~~~~~~DvwS~Gvvl~elltG~~Pf~ 833 (845)
.|+.|+||||+|||++||+. ||.
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~ 816 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFG 816 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCC
Confidence 49999999999999999995 664
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=264.47 Aligned_cols=198 Identities=29% Similarity=0.442 Sum_probs=168.9
Q ss_pred CCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh-hhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCeEEEEEEcC
Q 003140 626 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEFM 702 (845)
Q Consensus 626 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~E~~ 702 (845)
|.+.+.||+|+||.||+|... +++.||||++..... .......+|+..+++++ |+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566789999999999999976 578999999865432 23334567999999998 999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCC
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 782 (845)
+|+|.+++.......+++..+..++.|++++|.|||+++ ++|+||+|+||++++++.++|+|||+++......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--- 153 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--- 153 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC---
Confidence 899999997765567899999999999999999999998 9999999999999999999999999987653211
Q ss_pred ccccceeecccCCCCccchhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 783 IVPAHVSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
......++..|+|||.+. ...++.++||||||++++||++|+.||...
T Consensus 154 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~ 202 (283)
T cd07830 154 -----PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202 (283)
T ss_pred -----CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence 112345788999999875 456789999999999999999999998543
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=268.85 Aligned_cols=207 Identities=28% Similarity=0.384 Sum_probs=167.5
Q ss_pred cCCCC-CccccccCceEEEEEEeC-CCcEEEEEEccCCChhh--------------HHHHHHHHHHHHhcCCCceeeEEE
Q 003140 624 NNFNS-STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG--------------EKEFLTEIQFLSRLHHRNLVSLVG 687 (845)
Q Consensus 624 ~~f~~-~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~--------------~~~~~~Ei~~l~~l~H~nIv~l~g 687 (845)
++|.. .+.||+|+||.||+|... +++.||||+++...... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45543 467999999999999965 68999999886532221 125789999999999999999999
Q ss_pred EEeeCCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 003140 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVA 767 (845)
Q Consensus 688 ~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~ 767 (845)
++...+..++||||++ |+|.+++... ..+++.....++.|+++||+|||+.+ |+||||||+||+++.++.++|+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEEC
Confidence 9999999999999996 7999998643 35889999999999999999999988 9999999999999999999999
Q ss_pred ecCCcccCCCCCCCCc-------cccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 768 DFGLSRLAPVPDIEGI-------VPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 768 DFGla~~~~~~~~~~~-------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
|||+++.......... ..........++..|+|||.+.+. .++.++|||||||++|||++|+.||...+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999976542111100 001111233467899999998764 47899999999999999999999997544
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=290.00 Aligned_cols=208 Identities=30% Similarity=0.503 Sum_probs=176.7
Q ss_pred HHHHHhcCCCCCccccccCceEEEEEEeC----C----CcEEEEEEccCCCh-hhHHHHHHHHHHHHhc-CCCceeeEEE
Q 003140 618 EMALATNNFNSSTQIGQGGYGKVYKGILP----D----GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVG 687 (845)
Q Consensus 618 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~----~----g~~vAVK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~g 687 (845)
.++...++..+.+.||+|+||.|++|... . ...||||.++.... ...+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 56667777777789999999999999843 1 45799999986543 4567899999999999 6999999999
Q ss_pred EEeeCCeEEEEEEcCCCCCHHHHHhccC------------C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 003140 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKS------------K--EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKA 753 (845)
Q Consensus 688 ~~~~~~~~~LV~E~~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~ 753 (845)
+|...+..++|+||+++|+|.++++... . ..+.....+.++.|||+|++||++.. +|||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999999999999999999999998754 0 23889999999999999999999988 99999999
Q ss_pred CCEEEcCCCcEEEEecCCcccCCCCCCCCccccceeeccc--CCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCC
Q 003140 754 SNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK--GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQ 830 (845)
Q Consensus 754 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~ 830 (845)
+|||+.++..+||+|||+|+.....+... ..... -...|||||.+....|+.|+|||||||+|||++| |..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~------~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~ 520 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYR------TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGT 520 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceE------ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCC
Confidence 99999999999999999999765443221 11111 2356999999999999999999999999999999 889
Q ss_pred CCCC
Q 003140 831 PISH 834 (845)
Q Consensus 831 Pf~~ 834 (845)
||.+
T Consensus 521 PYp~ 524 (609)
T KOG0200|consen 521 PYPG 524 (609)
T ss_pred CCCC
Confidence 9865
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=267.60 Aligned_cols=208 Identities=31% Similarity=0.419 Sum_probs=167.6
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChh--hHHHHHHHHHHHHhcCCCceeeEEEEEeeC-------
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------- 692 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------- 692 (845)
.++|.+.+.||+|+||.||+|... +++.||||++...... ....+.+|++++++++|+||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999965 6899999988643322 234678899999999999999999987443
Q ss_pred -CeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 003140 693 -GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 771 (845)
Q Consensus 693 -~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGl 771 (845)
...++||||++ +++...+... ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.++|+|||+
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCcc
Confidence 34699999996 5777777543 346899999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCCCcc----ccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 772 SRLAPVPDIEGIV----PAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 772 a~~~~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
++........... .....+...++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~ 230 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK 230 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCC
Confidence 9765432211100 1111233467889999998765 45889999999999999999999998643
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=255.11 Aligned_cols=197 Identities=30% Similarity=0.439 Sum_probs=165.1
Q ss_pred CCCccccccCceEEEEEEeC-CCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----CeEEEE
Q 003140 627 NSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GEQMLV 698 (845)
Q Consensus 627 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~LV 698 (845)
+..+.||-|+||.||...++ +|+.||.|++... +...-+++.+|++++.-++|.|++..++..... .+.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 44678999999999999975 7999999987643 233457899999999999999999998876543 356888
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
+|.|. .+|++.+- ..+.++-....-+..||++||+|||+.+ |.||||||.|.|++.+..+||+|||+|+.....
T Consensus 136 TELmQ-SDLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 136 TELMQ-SDLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHH-hhhhheec--cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchh
Confidence 99884 67777763 4567888888889999999999999999 999999999999999999999999999975433
Q ss_pred CCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
+ ....+..+-|.+|+|||++++ ..|+.+.||||.||++.|++.++..|+..
T Consensus 210 ~------~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq 261 (449)
T KOG0664|consen 210 D------RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA 261 (449)
T ss_pred h------hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc
Confidence 2 333455567889999999987 46899999999999999999998888654
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=262.39 Aligned_cols=199 Identities=30% Similarity=0.456 Sum_probs=170.7
Q ss_pred CCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChh--hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcC
Q 003140 626 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (845)
Q Consensus 626 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 702 (845)
|...+.||+|++|.||+|... +++.+++|++...... ....+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566788999999999999975 6899999998754332 4567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCC
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 782 (845)
+ +++.+++.... ..+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.++|+|||.+.......
T Consensus 81 ~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--- 152 (283)
T cd05118 81 D-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--- 152 (283)
T ss_pred C-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc---
Confidence 7 58888886643 56899999999999999999999998 9999999999999999999999999987654321
Q ss_pred ccccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 783 IVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......++..|+|||.+.+. .++.++||||+|+++|+|+||+.||...+
T Consensus 153 ----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 203 (283)
T cd05118 153 ----RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203 (283)
T ss_pred ----ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 112234577899999998776 78999999999999999999999996544
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=272.31 Aligned_cols=204 Identities=22% Similarity=0.332 Sum_probs=179.0
Q ss_pred hcCCCCCccccccCceEEEEEEeCCC-cEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILPDG-TVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~~g-~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
..++.....||-|+||.|-.+..... ..+|+|++++.. ...++....|-.+|...+.|.||++|..|.+.++.|+.
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 34556677899999999998887543 348888877543 33455688899999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
||-|-||.|+..+++. ..++..+..-++..+.+|++|||+++ ||.|||||+|.++|.+|-+||.|||.|+.+..
T Consensus 499 mEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~- 572 (732)
T KOG0614|consen 499 MEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS- 572 (732)
T ss_pred HHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc-
Confidence 9999999999999764 45788888889999999999999999 99999999999999999999999999998753
Q ss_pred CCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCce
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 839 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~ 839 (845)
+....+.+||+.|.|||++.....+.++|.||+|+++|||++|..||++.+.+.
T Consensus 573 -------g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk 626 (732)
T KOG0614|consen 573 -------GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK 626 (732)
T ss_pred -------CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH
Confidence 445678899999999999999999999999999999999999999999877654
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=264.92 Aligned_cols=195 Identities=32% Similarity=0.516 Sum_probs=166.2
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG---SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
.|+..+.||+|+||.||+|... ++..||+|.+... .....+++.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666788999999999999965 6889999987632 23345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
|+. |++.+++... ...+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 96 YCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred ccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 996 6888877543 345889999999999999999999988 999999999999999999999999998754321
Q ss_pred CCccccceeecccCCCCccchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
....++..|+|||.+. ...++.++|||||||++|||++|+.||...
T Consensus 169 ---------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 217 (308)
T cd06634 169 ---------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (308)
T ss_pred ---------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc
Confidence 2235788999999974 356788999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=267.75 Aligned_cols=202 Identities=29% Similarity=0.423 Sum_probs=169.9
Q ss_pred HHHHHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEee-CC
Q 003140 618 EMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-EG 693 (845)
Q Consensus 618 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~ 693 (845)
++...+++|+..+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++++++.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 34456788999999999999999999865 7899999987542 22335678899999999999999999998865 56
Q ss_pred eEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003140 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (845)
Q Consensus 694 ~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~ 773 (845)
..++|+||+ +++|.++++. .++++.....++.|+++||+|||+.+ |+||||||+||++++++.++|+|||+++
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred cEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccc
Confidence 789999998 5789988854 34788888899999999999999998 9999999999999999999999999987
Q ss_pred cCCCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus 157 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~ 210 (328)
T cd07856 157 IQDPQ----------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD 210 (328)
T ss_pred ccCCC----------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 54211 122356788999998765 578999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=270.51 Aligned_cols=202 Identities=31% Similarity=0.451 Sum_probs=172.1
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-----eEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG-----EQM 696 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~ 696 (845)
+|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999975 58999999987643 344578999999999999999999999987765 789
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCC
Q 003140 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~ 776 (845)
+||||++ ++|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999997 58999886543 7899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCCCccccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
..... ........++..|+|||.+.+. .++.++||||||+++|+|++|+.||....
T Consensus 155 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 155 PDEDE----KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred ccccc----cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence 32210 0112334578899999999877 88999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=269.15 Aligned_cols=200 Identities=29% Similarity=0.437 Sum_probs=168.2
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----Ce
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GE 694 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~ 694 (845)
.++|.+.+.||+|+||.||+|... +++.||||.+... .....+++.+|+++++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 357888999999999999999964 6899999988653 233345778899999999999999999987644 35
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003140 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (845)
Q Consensus 695 ~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~ 774 (845)
.++||||+. ++|.+++... ..+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 799999996 7899988653 46899999999999999999999998 99999999999999999999999999986
Q ss_pred CCCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
..... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 158 TSEKG-------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred cCCCc-------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 53221 11223457889999998865 56899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-28 Score=265.69 Aligned_cols=203 Identities=28% Similarity=0.364 Sum_probs=165.5
Q ss_pred CCCCCccccccCceEEEEEEeC-C--CcEEEEEEccCC--ChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeC----Ce
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-D--GTVVAVKRAQEG--SLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE----GE 694 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~--g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~----~~ 694 (845)
+|...+.||+|+||.||++... . +..||+|++... .....+.+.+|+++++++ +|+||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677889999999999999965 3 789999987643 222356788999999999 599999999875432 45
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003140 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (845)
Q Consensus 695 ~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~ 774 (845)
.++++||++ ++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 788999985 789998854 346889999999999999999999998 99999999999999999999999999986
Q ss_pred CCCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
....... .........||..|+|||++.+ ..++.++||||+||++|||++|+.||...+
T Consensus 155 ~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 155 FSENPGE---NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred ccccccc---ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 5422111 1111233468899999998765 468999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=260.78 Aligned_cols=199 Identities=31% Similarity=0.488 Sum_probs=170.3
Q ss_pred CCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcC
Q 003140 626 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (845)
Q Consensus 626 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 702 (845)
|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+..|++++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456788999999999999976 58999999987643 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCC
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 782 (845)
+ ++|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||+|+||++++++.++|+|||+++......
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~--- 152 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPL--- 152 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCc---
Confidence 7 69999997643 46899999999999999999999998 9999999999999999999999999987654221
Q ss_pred ccccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 783 IVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......++..|+|||.+.+. .++.++|||||||++|||++|+.||....
T Consensus 153 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 203 (282)
T cd07829 153 ----RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS 203 (282)
T ss_pred ----cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 111223456789999998766 88999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=269.47 Aligned_cols=201 Identities=26% Similarity=0.406 Sum_probs=166.3
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC----------
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE---------- 692 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~---------- 692 (845)
.+|...+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 67888999999999999999964 6899999998766556667889999999999999999999776543
Q ss_pred ----CeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEE
Q 003140 693 ----GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVA 767 (845)
Q Consensus 693 ----~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~-~~~~kl~ 767 (845)
...++||||++ ++|.+++.. ..+++...+.++.||++||+|||+.+ |+||||||+||+++. ++.+|++
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEEC
Confidence 35789999997 699888853 35889999999999999999999998 999999999999974 5678999
Q ss_pred ecCCcccCCCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 768 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 768 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
|||+++........ ........++..|+|||.+.. ..++.++|||||||++|||++|+.||...
T Consensus 158 dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 222 (342)
T cd07854 158 DFGLARIVDPHYSH----KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA 222 (342)
T ss_pred CcccceecCCcccc----ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999765321100 111122357889999998754 56888999999999999999999999654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=249.41 Aligned_cols=203 Identities=24% Similarity=0.383 Sum_probs=178.3
Q ss_pred HHHHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC---ChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCC
Q 003140 619 MALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG---SLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEG 693 (845)
Q Consensus 619 ~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 693 (845)
+.....+|...++||+|+|++|..+.+. +.+.+|+|++++. ..++....+.|-.+..+. +||.+|-+..++..+.
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes 324 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES 324 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence 3455678999999999999999999865 6789999998753 234456778888888777 7999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003140 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (845)
Q Consensus 694 ~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~ 773 (845)
..++|.||+++|+|--+++++ ..+++..++-+...|.-||.|||+.+ ||.||||-+|||+|..|++|++|+|+++
T Consensus 325 rlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred eEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhh
Confidence 999999999999997776554 45888888889999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003140 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833 (845)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~ 833 (845)
.- ..+.....+..||+.|+|||++.+..|+...|.|++||+|+||+.|+.||.
T Consensus 400 e~-------l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 400 EG-------LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred cC-------CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 53 334555677899999999999999999999999999999999999999996
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-28 Score=253.51 Aligned_cols=193 Identities=31% Similarity=0.434 Sum_probs=168.8
Q ss_pred ccccCceEEEEEEeC-CCcEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCCCCH
Q 003140 632 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 707 (845)
Q Consensus 632 LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL 707 (845)
||+|+||.||++... +++.+|+|.+..... ...+.+..|++++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999975 589999998875432 2356789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCccccc
Q 003140 708 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 787 (845)
Q Consensus 708 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 787 (845)
.+++.... .+++.....++.|+++|+.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-------~ 148 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-------S 148 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-------C
Confidence 99996543 5899999999999999999999988 9999999999999999999999999987653221 1
Q ss_pred eeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 788 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
......++..|+|||...+...+.++|+||||+++|||++|+.||...+
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 1234567889999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-28 Score=285.71 Aligned_cols=146 Identities=25% Similarity=0.367 Sum_probs=131.1
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|.+.+.||+|+||.||+|... +++.||||+++... ....+.+.+|+.+++.++|+||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999976 68999999987533 223467889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~ 774 (845)
||+++++|.++++.. ..+++...+.++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+++.
T Consensus 84 Ey~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 84 EYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 999999999999654 35788899999999999999999988 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-28 Score=256.04 Aligned_cols=199 Identities=26% Similarity=0.367 Sum_probs=165.8
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC-----ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG-----SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
+|.+.+.||+|+||.||++... .+..+++|..+.. ......++..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4778899999999999999864 3455666655432 122344677899999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCC
Q 003140 699 YEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~ 776 (845)
|||+++++|.++++. .....+++..++.++.|+++|+.|||+.+ ++|+||||+||+++. +.++|+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999875 23457899999999999999999999988 999999999999975 569999999987653
Q ss_pred CCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
... .......|+..|+|||...+..++.++||||||+++|+|++|+.||..
T Consensus 157 ~~~-------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~ 207 (260)
T cd08222 157 GSC-------DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG 207 (260)
T ss_pred CCc-------ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 221 112234578899999999888899999999999999999999999964
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-28 Score=272.06 Aligned_cols=203 Identities=23% Similarity=0.379 Sum_probs=155.1
Q ss_pred HhcCCCCCccccccCceEEEEEEe-----------------CCCcEEEEEEccCCChhhHHH--------------HHHH
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGIL-----------------PDGTVVAVKRAQEGSLQGEKE--------------FLTE 670 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~-----------------~~g~~vAVK~~~~~~~~~~~~--------------~~~E 670 (845)
..++|.+.++||+|+||.||+|.. .+++.||||+++.......++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 245789999987543332233 3457
Q ss_pred HHHHHhcCCCce-----eeEEEEEee--------CCeEEEEEEcCCCCCHHHHHhccC----------------------
Q 003140 671 IQFLSRLHHRNL-----VSLVGYCDE--------EGEQMLVYEFMSNGTLRDQLSAKS---------------------- 715 (845)
Q Consensus 671 i~~l~~l~H~nI-----v~l~g~~~~--------~~~~~LV~E~~~~gsL~~~l~~~~---------------------- 715 (845)
+.++.+++|.++ ++++++|.. .+..+|||||+++|+|.++++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888876654 677887753 356899999999999999987421
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCC
Q 003140 716 KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 795 (845)
Q Consensus 716 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt 795 (845)
...+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ........+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~------~~~~~~g~~t 373 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI------NFNPLYGMLD 373 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCC------ccCccccCCC
Confidence 123567888999999999999999988 9999999999999999999999999997543211 0111122347
Q ss_pred CCccchhhhcCCC--------------------C--CchhhHHHHHHHHHHHHhCCC-CCC
Q 003140 796 PGYLDPEYFLTHK--------------------L--TDKSDVYSLGVVFLELLTGMQ-PIS 833 (845)
Q Consensus 796 ~~y~aPE~~~~~~--------------------~--~~~~DvwS~Gvvl~elltG~~-Pf~ 833 (845)
+.|+|||.+.... + ..+.||||+||++|||++|.. ||.
T Consensus 374 p~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 374 PRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred cceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 8999999875432 1 124799999999999999886 765
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=273.31 Aligned_cols=211 Identities=29% Similarity=0.442 Sum_probs=181.0
Q ss_pred chHHHHHHhcCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEee-
Q 003140 615 TYGEMALATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE- 691 (845)
Q Consensus 615 ~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~- 691 (845)
.++.+...++.|.+.+.||+|.+|.||+++. ++|+.+|||+..... +..++...|.++++.. .|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 3445556678899999999999999999994 579999999987643 3445778889999988 79999999999853
Q ss_pred ----CCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 003140 692 ----EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVA 767 (845)
Q Consensus 692 ----~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~ 767 (845)
+++.|||||||.+||.-++++.-.+.++.|..+..|+..+++|+.+||... +||||||-.|||++.++.||+.
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEe
Confidence 578999999999999999998877889999999999999999999999988 9999999999999999999999
Q ss_pred ecCCcccCCCCCCCCccccceeecccCCCCccchhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 768 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 768 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
|||++..+... -....+..||+.|||||++.. ..|+.++|+||+|++..||--|..|+.+-.
T Consensus 166 DFGvSaQldsT-------~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH 232 (953)
T KOG0587|consen 166 DFGVSAQLDST-------VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH 232 (953)
T ss_pred eeeeeeeeecc-------cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc
Confidence 99998755321 223456789999999999853 357779999999999999999999997644
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-28 Score=266.96 Aligned_cols=197 Identities=26% Similarity=0.439 Sum_probs=168.0
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCe-----
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE----- 694 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~----- 694 (845)
.++|...+.||+|+||.||+|... +++.||||++... .....+++.+|++++++++|+|++++.+++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 567889999999999999999975 6889999988643 22334668889999999999999999988766554
Q ss_pred -EEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003140 695 -QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (845)
Q Consensus 695 -~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~ 773 (845)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccccc
Confidence 89999999 6799998864 35899999999999999999999998 9999999999999999999999999997
Q ss_pred cCCCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+
T Consensus 167 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~ 220 (343)
T cd07851 167 HTDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD 220 (343)
T ss_pred ccccc----------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 64321 123357788999999865 467899999999999999999999996543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-29 Score=254.95 Aligned_cols=205 Identities=24% Similarity=0.347 Sum_probs=174.2
Q ss_pred HHHHHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcC-CC-----ceeeEEEEEe
Q 003140 618 EMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HR-----NLVSLVGYCD 690 (845)
Q Consensus 618 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~-H~-----nIv~l~g~~~ 690 (845)
.....+.+|.+...+|+|.||.|.++.+. .+..||||+++..... .+..+-|+++++++. +. -+|++.+++.
T Consensus 83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 33344789999999999999999999865 4789999998864333 335677999999994 32 4678889999
Q ss_pred eCCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC----------
Q 003140 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---------- 760 (845)
Q Consensus 691 ~~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~---------- 760 (845)
-.++.++|+|.| |-|+.+++..+.-.+++...++.|+.|++++++|||+.. ++|.||||+|||+.+
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccC
Confidence 999999999988 569999999988889999999999999999999999998 999999999999831
Q ss_pred ----------CCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Q 003140 761 ----------KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQ 830 (845)
Q Consensus 761 ----------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~ 830 (845)
+..+||+|||-|++.. ......+.|..|+|||++.+-.++..+||||+||||.|+.||..
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~----------e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~ 307 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDH----------EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGET 307 (415)
T ss_pred CccceeccCCCcceEEEecCCcceec----------cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccce
Confidence 3468999999998642 12355678899999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 003140 831 PISHGKN 837 (845)
Q Consensus 831 Pf~~~~~ 837 (845)
.|...++
T Consensus 308 LFqtHen 314 (415)
T KOG0671|consen 308 LFQTHEN 314 (415)
T ss_pred ecccCCc
Confidence 9975553
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=249.19 Aligned_cols=180 Identities=23% Similarity=0.209 Sum_probs=153.9
Q ss_pred cCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCCCCHHHHHhc
Q 003140 635 GGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA 713 (845)
Q Consensus 635 G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~ 713 (845)
|.||+||++... +++.||+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999975 68999999987542 234455555566799999999999999999999999999999999865
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCccccceeeccc
Q 003140 714 KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 793 (845)
Q Consensus 714 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~ 793 (845)
. ..+++.....++.|+++||+|||+.+ |+||||||+||+++.++.++++|||.+...... .....
T Consensus 79 ~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----------~~~~~ 143 (237)
T cd05576 79 F--LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----------CDGEA 143 (237)
T ss_pred h--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----------cccCC
Confidence 4 34899999999999999999999988 999999999999999999999999987654321 11223
Q ss_pred CCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 794 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 794 gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
++..|+|||......++.++||||+|+++|||++|+.|+..
T Consensus 144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 56789999999888899999999999999999999988764
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=235.82 Aligned_cols=201 Identities=20% Similarity=0.406 Sum_probs=170.1
Q ss_pred hcCCCCCccccccCceEEEEEE-eCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCceeeEEEEEeeC--CeEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEE--GEQMLV 698 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~--~~~~LV 698 (845)
.++|++.+++|+|.|+.|+.|. ..+.+.++||++++. ..+...+|++++..++ ||||+++++...+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4678899999999999999998 457889999999874 3457889999999996 99999999998665 456899
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEEecCCcccCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLSRLAPV 777 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~-~~~kl~DFGla~~~~~ 777 (845)
+||+++.+....-. .++...+..++.++++||.|+|++| |+|||+||.|+++|+. ..++++|+|+|.++-.
T Consensus 114 FE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 99999988877653 3566677889999999999999999 9999999999999976 5799999999988642
Q ss_pred CCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCceecc
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 842 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~ 842 (845)
+......+.+..|..||.+.. ..|+..-|+|||||++.+|+..+.||+++.+-.+++
T Consensus 186 --------~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQL 243 (338)
T KOG0668|consen 186 --------GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 243 (338)
T ss_pred --------CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHH
Confidence 333344556788999999876 467888999999999999999999999988765544
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-30 Score=278.45 Aligned_cols=290 Identities=26% Similarity=0.388 Sum_probs=224.7
Q ss_pred ceEeEEEecCCCCcc-cCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCc-cCCCCcccee
Q 003140 82 LHLRELQLLNLNLSG-NLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEE-LGYLPKLDRI 159 (845)
Q Consensus 82 ~~v~~L~L~~~~l~~-~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L 159 (845)
++++.+.++.|+|.. -+|+.+.+|..|+.||||+|+++ ..|..+..-+++-+|+||+|+|. .||.. |.+|+.|-.|
T Consensus 78 p~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfL 155 (1255)
T KOG0444|consen 78 PRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFL 155 (1255)
T ss_pred hhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhh
Confidence 356677777777764 37778888888888888888887 67777777788888888888887 55544 5677888888
Q ss_pred ecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccc-cCCCcccCCCCCCcEEEccCCcC
Q 003140 160 QIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT-GYLPPELSELPKLLILQLDNNNF 238 (845)
Q Consensus 160 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l 238 (845)
|||+|++. .+|..+..|..|++|.|++|.+....-..+..+++|++|.+++.+-+ ..+|.++..+.+|..+|||.|.+
T Consensus 156 DLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~L 234 (1255)
T KOG0444|consen 156 DLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNL 234 (1255)
T ss_pred ccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCC
Confidence 88888887 67777778888888888888776443344556777778888776654 45777788888888888888888
Q ss_pred CCCCCccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCCcCCCCCCCc-cccCEEEccCCcCC-CCcccc
Q 003140 239 EGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLT-GTIPSN 316 (845)
Q Consensus 239 ~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~-~~L~~L~Ls~N~l~-~~~p~~ 316 (845)
. .+|+.+-++.+|+.|+||+|+|+..........+|+.|+||.|+++ .+|+..+. ..|+.|.+.+|+++ .-+|..
T Consensus 235 p--~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSG 311 (1255)
T KOG0444|consen 235 P--IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSG 311 (1255)
T ss_pred C--cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccc
Confidence 6 6788888888888888888888876666667778888888888888 67766554 37888888888775 346788
Q ss_pred cCCCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCCCC-CCCCcEEEecCCc
Q 003140 317 FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFN-IPPNVTVRLRGNP 383 (845)
Q Consensus 317 ~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~~-~~~l~~l~l~~Np 383 (845)
+++|.+|+++..++|+|. .+|+++..+.. |+.|.|++|+|-++|.... ++.+..|+++.||
T Consensus 312 IGKL~~Levf~aanN~LE-lVPEglcRC~k-----L~kL~L~~NrLiTLPeaIHlL~~l~vLDlreNp 373 (1255)
T KOG0444|consen 312 IGKLIQLEVFHAANNKLE-LVPEGLCRCVK-----LQKLKLDHNRLITLPEAIHLLPDLKVLDLRENP 373 (1255)
T ss_pred hhhhhhhHHHHhhccccc-cCchhhhhhHH-----HHHhcccccceeechhhhhhcCCcceeeccCCc
Confidence 888888888888888887 78888876554 4589999999999999985 8999999999998
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-29 Score=245.00 Aligned_cols=206 Identities=27% Similarity=0.412 Sum_probs=165.6
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccC-CCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEee--------C
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQE-GSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--------E 692 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~-~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--------~ 692 (845)
..|....+||+|.||.||+|+.. .|+.||+|+..- ... .......+|++++..++|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34555678999999999999965 578889986532 211 223467899999999999999999988743 2
Q ss_pred CeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 003140 693 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 772 (845)
Q Consensus 693 ~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla 772 (845)
...++||++|++ +|.-.|.. ...+++...+.+++.++..||.|+|... |+|||+|+.|+|++.++.+||+|||+|
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence 357999999974 77777744 3456889999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
+.+...+.. .....+..+-|.+|++||.+.+ ..|+++.|||..||+|.||.||.+-+++..+
T Consensus 172 r~fs~~~n~---~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte 234 (376)
T KOG0669|consen 172 RAFSTSKNV---VKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE 234 (376)
T ss_pred cceeccccc---CCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH
Confidence 876543321 1122455567899999999876 5799999999999999999999877765543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=239.02 Aligned_cols=199 Identities=36% Similarity=0.527 Sum_probs=173.0
Q ss_pred CCCCccccccCceEEEEEEeCC-CcEEEEEEccCCChh-hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCC
Q 003140 626 FNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703 (845)
Q Consensus 626 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 703 (845)
|...+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++...+..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999865 899999999876554 56789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCc
Q 003140 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (845)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 783 (845)
+++|.+++...... +++.....++.++++++.|||+.+ ++|+|++|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~---- 152 (225)
T smart00221 81 GGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDL---- 152 (225)
T ss_pred CCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc----
Confidence 99999999764322 789999999999999999999998 9999999999999999999999999988764321
Q ss_pred cccceeecccCCCCccchhhh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 784 VPAHVSTVVKGTPGYLDPEYF-LTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
........++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 153 --~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 --AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred --cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 0012334577889999998 667788899999999999999999999966
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-27 Score=259.98 Aligned_cols=195 Identities=25% Similarity=0.336 Sum_probs=163.7
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeEEEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
++.|.....+|.|+|+.|-.+.. .+++..+||++.... .+-.+|+.++... +||||+++.+.+.+..+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 45666777899999999988885 468999999987652 2345677776666 79999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE-cCCCcEEEEecCCcccCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL-DHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl-~~~~~~kl~DFGla~~~~~~~ 779 (845)
++.+|-+.+.+..... ....+..|+.+|+.++.|||+++ +|||||||+|||+ +..++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~~---~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE---FCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hccccHHHHHHHhcch---hHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9999888777755432 22667789999999999999999 9999999999999 68999999999999876422
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
....+-|..|.|||+.....|++++|+||||++||||++|+.||....+
T Consensus 470 ---------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~ 518 (612)
T KOG0603|consen 470 ---------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA 518 (612)
T ss_pred ---------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc
Confidence 2233457899999999999999999999999999999999999976544
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-27 Score=253.12 Aligned_cols=197 Identities=25% Similarity=0.358 Sum_probs=167.6
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChh---h-----HHHHHHHHHHHHhcC---CCceeeEEEEEe
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---G-----EKEFLTEIQFLSRLH---HRNLVSLVGYCD 690 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~---~-----~~~~~~Ei~~l~~l~---H~nIv~l~g~~~ 690 (845)
..+|...+.+|+|+||.|+.|.++ +...|+||.+.+...- + .-..-.|+.+|..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 346888999999999999999976 5678999987653211 1 112457999999997 999999999999
Q ss_pred eCCeEEEEEEcC-CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEec
Q 003140 691 EEGEQMLVYEFM-SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 769 (845)
Q Consensus 691 ~~~~~~LV~E~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DF 769 (845)
+++.+||+||-. ++-+|.+++..+. .+++.....|..||+-|+++||+++ |||||||-+||.++.+|-+||+||
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 999999999975 5568999996653 5889999999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCC
Q 003140 770 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPIS 833 (845)
Q Consensus 770 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltG~~Pf~ 833 (845)
|.|...... .....+||.+|.|||++.+..| +..-|||++|+++|.++....||-
T Consensus 715 gsaa~~ksg---------pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSG---------PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCC---------CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 998765422 2346789999999999998877 556799999999999999999984
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-29 Score=272.91 Aligned_cols=292 Identities=26% Similarity=0.362 Sum_probs=185.9
Q ss_pred eEEEecCCCCcccCCCCccCCCCccEEEecCCCCCC-CCcccccccccchhhhccCCCCCCCCCCccCCCCccceeeccc
Q 003140 85 RELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISG-SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQ 163 (845)
Q Consensus 85 ~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 163 (845)
+.|.+.+|+|. .+-.++..|+.|+.+++..|++.. -||..+.++..|.+||||+|+++ +.|..+..-+++-.|+||+
T Consensus 58 EHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~ 135 (1255)
T KOG0444|consen 58 EHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSY 135 (1255)
T ss_pred hhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEccc
Confidence 33334444443 222344444444444444444421 24444444444444455555444 4444444444444445555
Q ss_pred ccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCC
Q 003140 164 NYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTI 243 (845)
Q Consensus 164 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~ 243 (845)
|+|..+....|.+|+.|-.||||+|++. .+|+.+..+..|++|+|++|.+.-.--..+..+++|+.|++++.+-+-..+
T Consensus 136 N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~ 214 (1255)
T KOG0444|consen 136 NNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNI 214 (1255)
T ss_pred CccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcC
Confidence 5544222233444444445555555544 344444444455555555554432222233344445555555544433357
Q ss_pred ccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccCCCCCC
Q 003140 244 PASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRL 323 (845)
Q Consensus 244 p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L 323 (845)
|.++..+.+|..+|+|.|++...|..+..+++|+.|+||+|+|+..-.......+|++|+||.|+++ .+|..+++|++|
T Consensus 215 Ptsld~l~NL~dvDlS~N~Lp~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL 293 (1255)
T KOG0444|consen 215 PTSLDDLHNLRDVDLSENNLPIVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKL 293 (1255)
T ss_pred CCchhhhhhhhhccccccCCCcchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHHhhhHHH
Confidence 8888889999999999999998888899999999999999999832222223348999999999999 789999999999
Q ss_pred CeEecccccCc-ccCChhhhhhccCCCCcceEEEccCCCCCCCCCCC-CCCCCcEEEecCCccc
Q 003140 324 QRLFIANNSLS-GSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFC 385 (845)
Q Consensus 324 ~~L~L~~N~l~-~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~-~~~~l~~l~l~~Np~~ 385 (845)
+.|++.+|+|+ .-||+.|+++.+|. ++..++|.|.-+|..+ +.+.+..|.|..|.+.
T Consensus 294 ~kLy~n~NkL~FeGiPSGIGKL~~Le-----vf~aanN~LElVPEglcRC~kL~kL~L~~NrLi 352 (1255)
T KOG0444|consen 294 TKLYANNNKLTFEGIPSGIGKLIQLE-----VFHAANNKLELVPEGLCRCVKLQKLKLDHNRLI 352 (1255)
T ss_pred HHHHhccCcccccCCccchhhhhhhH-----HHHhhccccccCchhhhhhHHHHHhccccccee
Confidence 99999999987 45899998877654 8999999999999987 6888899999888754
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=236.56 Aligned_cols=212 Identities=25% Similarity=0.337 Sum_probs=178.7
Q ss_pred hHHHHHHhcCCCCCccccccCceEEEEEEeCC------CcEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEE
Q 003140 616 YGEMALATNNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGY 688 (845)
Q Consensus 616 ~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~ 688 (845)
.+++.+..++++....+.+|.||.||.|.|.+ .+.|.||.++.. +.-....+.+|.-.+..+.|||+.++.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 45777788889999999999999999997643 456778877653 33345678999999999999999999999
Q ss_pred Eee-CCeEEEEEEcCCCCCHHHHHh-----c-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC
Q 003140 689 CDE-EGEQMLVYEFMSNGTLRDQLS-----A-KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK 761 (845)
Q Consensus 689 ~~~-~~~~~LV~E~~~~gsL~~~l~-----~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~ 761 (845)
+.+ .+..+..|.++.-|+|+.++. + ...+.++..+...++.|++.|++|||+.+ |||.||.++|+++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 855 466799999999999999997 2 34456788889999999999999999999 9999999999999999
Q ss_pred CcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 762 FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 762 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
-.+||+|=.++|.+...|+.-.- ........||+||.+....|+.++|||||||+||||+| |+.|+..-
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLG-----DnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI 502 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLG-----DNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI 502 (563)
T ss_pred eeEEeccchhccccCcccccccC-----CCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc
Confidence 99999999999987766654322 12234578999999999999999999999999999999 99998643
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-27 Score=255.06 Aligned_cols=292 Identities=22% Similarity=0.256 Sum_probs=209.3
Q ss_pred EeEEEecCCCCcccCCCCccC-C-CCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeec
Q 003140 84 LRELQLLNLNLSGNLSPEIGR-L-SYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (845)
Q Consensus 84 v~~L~L~~~~l~~~~~~~l~~-L-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (845)
...|+++++.|...--..+.. + +.-+.|||++|.++..-+..|.++++|+.++|..|.++ .||.......+|+.|+|
T Consensus 54 ~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L 132 (873)
T KOG4194|consen 54 TRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDL 132 (873)
T ss_pred ceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEee
Confidence 345666666555321112211 1 35678999999999988999999999999999999999 89988888888999999
Q ss_pred ccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCC
Q 003140 162 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT 241 (845)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 241 (845)
.+|.|+..-.+.+..++.|+.|||+.|.|+...-..|..-.++++|+|++|+|+..-...|..+.+|..|.|+.|+++.
T Consensus 133 ~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNritt- 211 (873)
T KOG4194|consen 133 RHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITT- 211 (873)
T ss_pred eccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccc-
Confidence 9999998888999999999999999999996555678888899999999999998888889999999999999999985
Q ss_pred CCccccccCCCccEEEcccCCCCCCC-CCCCCCCCccEEEcccccCCcCCCCCCC--ccccCEEEccCCcCCCCcccccC
Q 003140 242 TIPASYSNMSKLLKLSLRNCSLQGPM-PDLSRIPNLGYLDLSSNQLNGSIPPGRL--SLNITTIKLSNNKLTGTIPSNFS 318 (845)
Q Consensus 242 ~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~l~~l~~L~~L~Ls~N~l~~~ip~~~~--~~~L~~L~Ls~N~l~~~~p~~~~ 318 (845)
..+..|.++++|+.|+|..|++.-.. -.|..+++|+.|.|..|.+. .+.++.+ ..++++|+|..|++...-..++-
T Consensus 212 Lp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~-kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lf 290 (873)
T KOG4194|consen 212 LPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDIS-KLDDGAFYGLEKMEHLNLETNRLQAVNEGWLF 290 (873)
T ss_pred cCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcc-cccCcceeeecccceeecccchhhhhhccccc
Confidence 45668899999999999999987542 23556666666666666655 3333322 12555555555555555555555
Q ss_pred CCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCCC--CCCCCcEEEecCCc
Q 003140 319 GLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNP 383 (845)
Q Consensus 319 ~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~--~~~~l~~l~l~~Np 383 (845)
+|+.|+.|+|++|.|...-++++...++| ..|+|++|+|+.+++.. .+..+++|.|+.|.
T Consensus 291 gLt~L~~L~lS~NaI~rih~d~WsftqkL-----~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Ns 352 (873)
T KOG4194|consen 291 GLTSLEQLDLSYNAIQRIHIDSWSFTQKL-----KELDLSSNRITRLDEGSFRVLSQLEELNLSHNS 352 (873)
T ss_pred ccchhhhhccchhhhheeecchhhhcccc-----eeEeccccccccCChhHHHHHHHhhhhcccccc
Confidence 55555555555555555445544443333 25555555555554432 14444444444444
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.6e-26 Score=235.00 Aligned_cols=186 Identities=35% Similarity=0.550 Sum_probs=165.4
Q ss_pred CceEEEEEEeC-CCcEEEEEEccCCChhh-HHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCCCCHHHHHhc
Q 003140 636 GYGKVYKGILP-DGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA 713 (845)
Q Consensus 636 ~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~-~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~ 713 (845)
+||.||+|... +|+.+|+|++....... .+.+.+|++.+++++|+|++++++++......++||||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999986 58999999988655444 67899999999999999999999999999999999999999999999976
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCccccceeeccc
Q 003140 714 KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 793 (845)
Q Consensus 714 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~ 793 (845)
... +++..+..++.++++++.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 81 ~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--------~~~~~~ 147 (244)
T smart00220 81 RGR--LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--------LLTTFV 147 (244)
T ss_pred ccC--CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--------cccccc
Confidence 433 889999999999999999999998 9999999999999999999999999998764321 223456
Q ss_pred CCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 794 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 794 gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
++..|++||.+....++.++||||||++++||++|..||..
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 78899999999888899999999999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=266.48 Aligned_cols=199 Identities=24% Similarity=0.333 Sum_probs=142.0
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-C----CcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEE------Ee
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILP-D----GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY------CD 690 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~----g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~------~~ 690 (845)
..++|...+.||+|+||.||+|.+. + +..||||++...... +.+..| .+....+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5678999999999999999999975 4 689999987643211 111111 1222222233222211 24
Q ss_pred eCCeEEEEEEcCCCCCHHHHHhccCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 003140 691 EEGEQMLVYEFMSNGTLRDQLSAKSKE------------------PLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIK 752 (845)
Q Consensus 691 ~~~~~~LV~E~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk 752 (845)
.....++||||+++++|.++++..... ......+..++.|+++||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 567899999999999999998653210 1112345679999999999999988 9999999
Q ss_pred CCCEEEcC-CCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCC----------------------CC
Q 003140 753 ASNILLDH-KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH----------------------KL 809 (845)
Q Consensus 753 ~~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~ 809 (845)
|+|||++. ++.+||+|||+|+...... ........+++.|+|||.+... .+
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~------~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~ 356 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 356 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc------ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence 99999986 5799999999998653221 1223445788999999965322 23
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCC
Q 003140 810 TDKSDVYSLGVVFLELLTGMQPIS 833 (845)
Q Consensus 810 ~~~~DvwS~Gvvl~elltG~~Pf~ 833 (845)
+.++|||||||++|||+++..|+.
T Consensus 357 ~~k~DVwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 357 PDRFDIYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred CCCcccHHHHHHHHHHHhCcCCCc
Confidence 456799999999999999876654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-26 Score=234.19 Aligned_cols=199 Identities=27% Similarity=0.373 Sum_probs=167.0
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC------Ce
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------GE 694 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------~~ 694 (845)
.+|.....+|.|+- .|..+.+. .++.||+|+.... .....++..+|..++..+.|+||++++.++... .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46667788999997 66666543 6899999987543 334467889999999999999999999998654 35
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003140 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (845)
Q Consensus 695 ~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~ 774 (845)
.|+||||| .++|...++. .++-.+...|..|++.|++|||+.+ |+||||||+||++..+..+||.|||+|+.
T Consensus 96 ~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcc
Confidence 79999999 4799888863 3667788899999999999999999 99999999999999999999999999985
Q ss_pred CCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCce
Q 003140 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 839 (845)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~ 839 (845)
.. .....+....|..|+|||++.+..+.+.+||||.||++.||++|+.-|.+.+.+.
T Consensus 168 e~--------~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~id 224 (369)
T KOG0665|consen 168 ED--------TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHID 224 (369)
T ss_pred cC--------cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHH
Confidence 43 1234556778899999999999889999999999999999999999998655543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-26 Score=258.16 Aligned_cols=198 Identities=29% Similarity=0.411 Sum_probs=161.9
Q ss_pred CCCCCccccccCceE-EEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeEEEEEEcC
Q 003140 625 NFNSSTQIGQGGYGK-VYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFM 702 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~-Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~ 702 (845)
-|...+.+|.|+-|+ ||+|.. +|+.||||++-... .+-..+|+..++.- +|||||++++.-.++...||..|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 345567899999987 699998 57999999986533 33567899999988 6999999999999999999999999
Q ss_pred CCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---C--CcEEEEecCCcccC
Q 003140 703 SNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---K--FTAKVADFGLSRLA 775 (845)
Q Consensus 703 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~---~--~~~kl~DFGla~~~ 775 (845)
..+|.+++... ......-...+.+..|+++|+++||+.+ ||||||||.||||+. + ..++|+|||+++.+
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 58999999763 1111222445678899999999999988 999999999999975 3 47999999999987
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG-MQPISH 834 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG-~~Pf~~ 834 (845)
+..... -.......||-||+|||++....-+.++||||+||++|..++| .+||.+
T Consensus 662 ~~~~sS----~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd 717 (903)
T KOG1027|consen 662 AGGKSS----FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD 717 (903)
T ss_pred CCCcch----hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc
Confidence 643211 1113456799999999999998888899999999999999996 999975
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-27 Score=245.41 Aligned_cols=287 Identities=31% Similarity=0.467 Sum_probs=199.7
Q ss_pred EeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeeccc
Q 003140 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQ 163 (845)
Q Consensus 84 v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 163 (845)
+..+++.+|.+....|..+. ++.|++||...|-++ .+|+.++.+.+|.-|||.+|++. .+| .|..++.|++|++..
T Consensus 162 l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~ 237 (565)
T KOG0472|consen 162 LSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGE 237 (565)
T ss_pred HHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcc
Confidence 33444455555533333333 666677777666666 67777888888888888888877 666 677778888888888
Q ss_pred ccccCCCCcc-ccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCC-
Q 003140 164 NYISGSLPKS-FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT- 241 (845)
Q Consensus 164 N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~- 241 (845)
|+|+ .+|.. ..++++|..|||.+|+++ ..|+.+..+.+|++||+++|.++ .+|..++++ .|+.|.+.+|.+...
T Consensus 238 N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiR 313 (565)
T KOG0472|consen 238 NQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIR 313 (565)
T ss_pred cHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHH
Confidence 8887 55544 458888888888888888 78888888888888888888888 577788888 888888888876421
Q ss_pred --------------------------------------------------------------CCccccccCCC---ccEE
Q 003140 242 --------------------------------------------------------------TIPASYSNMSK---LLKL 256 (845)
Q Consensus 242 --------------------------------------------------------------~~p~~~~~l~~---L~~L 256 (845)
.+|+......+ ....
T Consensus 314 r~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~V 393 (565)
T KOG0472|consen 314 REIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSV 393 (565)
T ss_pred HHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEE
Confidence 00100000000 2234
Q ss_pred EcccCCCCCC------------------------CCCCCCCCCccEEEcccccCCcCCCCCCCcc-ccCEEEccCCcCCC
Q 003140 257 SLRNCSLQGP------------------------MPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTG 311 (845)
Q Consensus 257 ~Ls~N~l~~~------------------------~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~-~L~~L~Ls~N~l~~ 311 (845)
+++.|++... +..++.+++|..|+|++|.+. .+|..++.. .|+.||+|.|++.
T Consensus 394 nfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr- 471 (565)
T KOG0472|consen 394 NFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR- 471 (565)
T ss_pred ecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-
Confidence 4444444332 223455677777777777777 566554443 6777777777777
Q ss_pred CcccccCCCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCCC-CCCCCcEEEecCCccc
Q 003140 312 TIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFC 385 (845)
Q Consensus 312 ~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~-~~~~l~~l~l~~Np~~ 385 (845)
.+|+.+..+..|+.+-.++|++....|+.+..+++| ..|||.+|.|..||+.+ .+.++++|.+.||||.
T Consensus 472 ~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL-----~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 472 MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNL-----TTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred cchHHHhhHHHHHHHHhccccccccChHHhhhhhhc-----ceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence 667777777777777777777775555557666655 49999999999999988 5999999999999986
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-25 Score=229.58 Aligned_cols=215 Identities=25% Similarity=0.387 Sum_probs=174.5
Q ss_pred HHHHHhcCCCCCccccccCceEEEEEEeC----CCcEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeC
Q 003140 618 EMALATNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE 692 (845)
Q Consensus 618 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~ 692 (845)
.+....+.|...++||+|.|++||++.+. ..+.||+|.+...+. ..+...|+++|..+ .+.||+++.+++...
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 34445567888999999999999999853 467899999876433 34689999999999 599999999999999
Q ss_pred CeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEEecCC
Q 003140 693 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGL 771 (845)
Q Consensus 693 ~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~-~~~~kl~DFGl 771 (845)
+...+|+||+++..-.++... ++......+...+.+||+++|.++ ||||||||+|+|.+. .+.-.|.|||+
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred CeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 999999999999999998854 567888889999999999999999 999999999999985 46889999999
Q ss_pred cccCCCCC------C----------C---------C------------ccccceeecccCCCCccchhhhcC-CCCCchh
Q 003140 772 SRLAPVPD------I----------E---------G------------IVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKS 813 (845)
Q Consensus 772 a~~~~~~~------~----------~---------~------------~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~ 813 (845)
|....... . . . ...........||+||+|||++.. ..-+.++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 97211000 0 0 0 000111233579999999999864 5678899
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCCceecc
Q 003140 814 DVYSLGVVFLELLTGMQPISHGKNIVREV 842 (845)
Q Consensus 814 DvwS~Gvvl~elltG~~Pf~~~~~~~~~~ 842 (845)
||||.||+++.++++++||....+.+.++
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al 288 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADAL 288 (418)
T ss_pred ceeeccceeehhhccccccccCccccchH
Confidence 99999999999999999999888776553
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-25 Score=217.49 Aligned_cols=195 Identities=25% Similarity=0.434 Sum_probs=158.2
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEE-EeeCCeEEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGY-CDEEGEQMLVY 699 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~-~~~~~~~~LV~ 699 (845)
.+.|++.+.+|+|.||.+-.+.++ ..+.+++|.+.. .....++|.+|..---.+ .|.||+.-|+. |...+..++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 467889999999999999999976 567788887654 345577999998765555 58999987764 67778899999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE-cC-CCcEEEEecCCcccCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL-DH-KFTAKVADFGLSRLAPV 777 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl-~~-~~~~kl~DFGla~~~~~ 777 (845)
||++.|+|.+-+.. ..+.+....+++.|+++||.|+|+++ +||||||.+|||| +. ..++|++|||+.+..+.
T Consensus 102 E~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred ccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 99999999887744 34778888899999999999999999 9999999999999 33 45899999999875431
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-----KLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
......-+..|-+||..... ...+.+|||.||++++.++||+.||+.
T Consensus 176 ----------tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk 227 (378)
T KOG1345|consen 176 ----------TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK 227 (378)
T ss_pred ----------eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence 11223345679999987532 356789999999999999999999983
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-26 Score=235.67 Aligned_cols=311 Identities=23% Similarity=0.257 Sum_probs=190.8
Q ss_pred CCCCCCC-cc--eEecCCCCC----CCcceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccch
Q 003140 61 DPCTSNW-TG--VLCFNTTMD----DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLE 133 (845)
Q Consensus 61 ~~c~~~w-~G--v~C~~~~~~----~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 133 (845)
.+|.|+- .| |.|...... +-....++|+|..|.|+..-+.+|+.+++|+.||||+|+|+.+-|.+|..+.+|.
T Consensus 39 ~pC~Cs~~~g~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~ 118 (498)
T KOG4237|consen 39 APCTCSDVEGGIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLL 118 (498)
T ss_pred CCcccCCCCCceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhh
Confidence 4565543 23 778654322 2345678888888888877777888888888888888888888888888888877
Q ss_pred hhhccC-CCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCcc-ccCCCCCcceeeccc
Q 003140 134 LLLLNG-NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPP-ELSRLPSLVHMLLDN 211 (845)
Q Consensus 134 ~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~L~~ 211 (845)
.|-+.+ |+|+...-+.|++|..|+.|.+.-|++.-...+.|..|++|..|.+.+|.+. .++. .|..+.+++.+.+..
T Consensus 119 ~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~ 197 (498)
T KOG4237|consen 119 SLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQ 197 (498)
T ss_pred HHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhc
Confidence 776666 8888555567888888888888888888777788888888888888888887 4444 777888888888888
Q ss_pred ccccc------------CCCcccCCCCCCcEEEccCCcCCCCCCcccc-ccCCCccEEEcccCCCCCCCCC--CCCCCCc
Q 003140 212 NNLTG------------YLPPELSELPKLLILQLDNNNFEGTTIPASY-SNMSKLLKLSLRNCSLQGPMPD--LSRIPNL 276 (845)
Q Consensus 212 N~l~~------------~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~~~--l~~l~~L 276 (845)
|.+.. ..|.+++...-..-..|.++++... .+..| ..+.++..--.+.+...+.-|. |.++++|
T Consensus 198 np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~-~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L 276 (498)
T KOG4237|consen 198 NPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQE-DARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNL 276 (498)
T ss_pred CccccccccchhhhHHhhchhhcccceecchHHHHHHHhccc-chhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccc
Confidence 87431 1222233333333333333333321 11111 1111111111111112222221 4445555
Q ss_pred cEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCChhhhhhccCCCCcceEEE
Q 003140 277 GYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILD 356 (845)
Q Consensus 277 ~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ 356 (845)
+.|+| ++|+|+.+-+.+|.++..|++|.|..|+|...--..|.. +..|..|+
T Consensus 277 ~~lnl-----------------------snN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~-----ls~L~tL~ 328 (498)
T KOG4237|consen 277 RKLNL-----------------------SNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQG-----LSGLKTLS 328 (498)
T ss_pred eEecc-----------------------CCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhc-----cccceeee
Confidence 55554 445555555555555556666666666555222222222 23334566
Q ss_pred ccCCCCCCCCCC-C-CCCCCcEEEecCCcccccCCCccccCCCCCCC
Q 003140 357 FQNNNLTNISGS-F-NIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDD 401 (845)
Q Consensus 357 ls~N~l~~i~~~-~-~~~~l~~l~l~~Np~~c~~~~~~~~~~~~~~~ 401 (845)
|.+|+|+.+... | ..-.+.+|.|-+|||+|||.+.|+-+|.....
T Consensus 329 L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~ 375 (498)
T KOG4237|consen 329 LYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKS 375 (498)
T ss_pred ecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCC
Confidence 666666554433 3 35567889999999999999999988875443
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-27 Score=243.55 Aligned_cols=264 Identities=28% Similarity=0.426 Sum_probs=195.8
Q ss_pred eEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecc
Q 003140 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162 (845)
Q Consensus 83 ~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 162 (845)
.+..+.+++|.+. .+.+.+.+|..|++|++.+|+++ ..|++++.+..++.|+.++|+++ .+|..++.+.+|..|+++
T Consensus 46 ~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s 122 (565)
T KOG0472|consen 46 DLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCS 122 (565)
T ss_pred chhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcc
Confidence 3567788888887 45567888888899999999888 67888888888999999999888 888888888888888888
Q ss_pred cccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCC
Q 003140 163 QNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTT 242 (845)
Q Consensus 163 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 242 (845)
+|.+. .+|+.++.+-.|+.|+..+|+++ ..|..+..+.+|..+++.+|++....|+.+. ++.|++||...|-++ .
T Consensus 123 ~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~--t 197 (565)
T KOG0472|consen 123 SNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE--T 197 (565)
T ss_pred cccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh--c
Confidence 88887 66777777777777777777777 5666666667777777777777643333333 666666666666664 4
Q ss_pred CccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccC-CCC
Q 003140 243 IPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFS-GLP 321 (845)
Q Consensus 243 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~-~l~ 321 (845)
+|..++.+.+|..|+|.+|++...| +|..+..|++|+++.|+| + .+|.+.. +++
T Consensus 198 lP~~lg~l~~L~~LyL~~Nki~~lP-ef~gcs~L~Elh~g~N~i-----------------------~-~lpae~~~~L~ 252 (565)
T KOG0472|consen 198 LPPELGGLESLELLYLRRNKIRFLP-EFPGCSLLKELHVGENQI-----------------------E-MLPAEHLKHLN 252 (565)
T ss_pred CChhhcchhhhHHHHhhhcccccCC-CCCccHHHHHHHhcccHH-----------------------H-hhHHHHhcccc
Confidence 5666666666666666666655443 455555555555555554 4 4454444 899
Q ss_pred CCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCCCCCCCCcEEEecCCccc
Q 003140 322 RLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 385 (845)
Q Consensus 322 ~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~~~~~l~~l~l~~Np~~ 385 (845)
+|..|||.+|+++ ++|+++..+++|+ .||+|+|.|+++|.++..-.++.+.+.|||+.
T Consensus 253 ~l~vLDLRdNklk-e~Pde~clLrsL~-----rLDlSNN~is~Lp~sLgnlhL~~L~leGNPlr 310 (565)
T KOG0472|consen 253 SLLVLDLRDNKLK-EVPDEICLLRSLE-----RLDLSNNDISSLPYSLGNLHLKFLALEGNPLR 310 (565)
T ss_pred cceeeeccccccc-cCchHHHHhhhhh-----hhcccCCccccCCcccccceeeehhhcCCchH
Confidence 9999999999998 8999998887765 89999999999999985338999999999974
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.9e-23 Score=209.09 Aligned_cols=183 Identities=38% Similarity=0.630 Sum_probs=159.2
Q ss_pred ccccCceEEEEEEeCC-CcEEEEEEccCCChh-hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCCCCHHH
Q 003140 632 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRD 709 (845)
Q Consensus 632 LG~G~fG~Vy~~~~~~-g~~vAVK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~ 709 (845)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999764 899999998865433 35689999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEEecCCcccCCCCCCCCccccce
Q 003140 710 QLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGLSRLAPVPDIEGIVPAHV 788 (845)
Q Consensus 710 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~ 788 (845)
++.... ..+++..+..++.+++++++|||+.+ ++|+||+|+||+++. ++.++|+|||.+........ .
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-------~ 149 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-------L 149 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-------h
Confidence 997542 45889999999999999999999998 999999999999999 89999999999976543210 1
Q ss_pred eecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHH
Q 003140 789 STVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLEL 825 (845)
Q Consensus 789 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~el 825 (845)
.....+...|++||..... .++.+.|+|++|+++++|
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 2234567899999999877 888999999999999987
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-25 Score=234.49 Aligned_cols=213 Identities=23% Similarity=0.258 Sum_probs=178.3
Q ss_pred CccccchHHHHHHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcC------CCce
Q 003140 610 GVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH------HRNL 682 (845)
Q Consensus 610 ~~~~~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~------H~nI 682 (845)
....|.+.-.++...+|.+....|+|-|++|.+|.+. .|..||||++..... -.+.=+.|+++|++|+ --++
T Consensus 418 aEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 418 AEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred ccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHH
Confidence 3455667777778889999999999999999999975 588999999986432 2344578999999995 2478
Q ss_pred eeEEEEEeeCCeEEEEEEcCCCCCHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC
Q 003140 683 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK-EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK 761 (845)
Q Consensus 683 v~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~ 761 (845)
++++-.|...++.|||+|-+ .-+|.+.|++.+. ..|.......++.|+.-||..|...+ |+|.||||+|||+++.
T Consensus 497 lrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNES 572 (752)
T ss_pred HHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccC
Confidence 89999999999999999977 5799999987543 35778889999999999999999988 9999999999999876
Q ss_pred C-cEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 762 F-TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 762 ~-~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
. .+||||||.|......+ .+...-+..|+|||++.+..|+...|+||.||+||||.||+.-|.+..
T Consensus 573 k~iLKLCDfGSA~~~~ene---------itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENE---------ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred cceeeeccCcccccccccc---------ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 4 78999999998765333 223334568999999999999999999999999999999999997643
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=219.69 Aligned_cols=131 Identities=21% Similarity=0.355 Sum_probs=113.8
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCChhhHHHHHHHHHHHHhcC-----C---CceeeEEEEEee---
Q 003140 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-----H---RNLVSLVGYCDE--- 691 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~-----H---~nIv~l~g~~~~--- 691 (845)
.+|.+.++||=|.|++||.+.+ ++.+.||+|+.+..... .+..+.|+++|++++ | ..||+|+++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY-tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY-TEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH-HHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 6888999999999999999985 46789999998864333 346788999999984 2 479999999965
Q ss_pred -CCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 003140 692 -EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 758 (845)
Q Consensus 692 -~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl 758 (845)
..+++||+|++ |-+|..+|....-+-++...+.+|+.||+.||.|||+++ +|||.||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 45789999999 789999998877778999999999999999999999988 49999999999999
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.5e-25 Score=238.98 Aligned_cols=200 Identities=27% Similarity=0.413 Sum_probs=173.6
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
.++|.....+|.|.||.|||+++. .++..|||+++-......+-.++|+-+++..+|+|||.++|.+...+..+++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 467888899999999999999964 7899999999876666677788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
|.+|+|++.-+. ..++++.+....+....+|++|||+++ =+|||||-.|||+++.|.+|++|||.+-.+..
T Consensus 94 cgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita---- 164 (829)
T KOG0576|consen 94 CGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA---- 164 (829)
T ss_pred cCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh----
Confidence 999999987643 457889999999999999999999999 79999999999999999999999998754321
Q ss_pred CccccceeecccCCCCccchhhh---cCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYF---LTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
.-.......||+.|||||+. ..+.|..++|||+.|+...|+-.-+.|.++
T Consensus 165 ---ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfd 217 (829)
T KOG0576|consen 165 ---TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFD 217 (829)
T ss_pred ---hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccc
Confidence 11234567899999999986 357899999999999999999877777654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.2e-23 Score=224.31 Aligned_cols=171 Identities=19% Similarity=0.205 Sum_probs=131.0
Q ss_pred HHHhcCCCCCccccccCceEEEEEEeC--CCcEEEEEEccCC-----ChhhHHHHHHHHHHHHhcCCCceee-EEEEEee
Q 003140 620 ALATNNFNSSTQIGQGGYGKVYKGILP--DGTVVAVKRAQEG-----SLQGEKEFLTEIQFLSRLHHRNLVS-LVGYCDE 691 (845)
Q Consensus 620 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vAVK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~nIv~-l~g~~~~ 691 (845)
....++|...+.||+|+||+||+|... +++.||||++... .....+.|.+|++++++++|+|+++ +++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---- 89 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---- 89 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----
Confidence 344578999999999999999999864 5788899986532 1223456899999999999999985 443
Q ss_pred CCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCEEEcCCCcEEEEecC
Q 003140 692 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI-KASNILLDHKFTAKVADFG 770 (845)
Q Consensus 692 ~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDL-k~~NILl~~~~~~kl~DFG 770 (845)
.+..++||||+++++|.. .... . ...++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+|||
T Consensus 90 ~~~~~LVmE~~~G~~L~~-~~~~-----~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 90 TGKDGLVRGWTEGVPLHL-ARPH-----G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred cCCcEEEEEccCCCCHHH-hCcc-----c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 246799999999999963 2111 1 1457889999999999998 999999 9999999999999999999
Q ss_pred CcccCCCCCCCCccccce-eecccCCCCccchhhhcC
Q 003140 771 LSRLAPVPDIEGIVPAHV-STVVKGTPGYLDPEYFLT 806 (845)
Q Consensus 771 la~~~~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~ 806 (845)
+|+.............+. .+...+++.|+|||++..
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 999765432111111111 145678899999998854
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=235.37 Aligned_cols=257 Identities=27% Similarity=0.336 Sum_probs=207.6
Q ss_pred EeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeeccc
Q 003140 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQ 163 (845)
Q Consensus 84 v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 163 (845)
-..|+|++++|+ .+|+.+. ++|+.|+|++|+|+ .+|.. +++|++|+|++|+|+ .+|.. .++|+.|+|++
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~ 271 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIFS 271 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeeccC
Confidence 346899999998 6888776 48999999999999 57742 578999999999999 56753 46899999999
Q ss_pred ccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCC
Q 003140 164 NYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTI 243 (845)
Q Consensus 164 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~ 243 (845)
|.|+ .+|..+ .+|+.|+|++|+|+ .+|.. +++|+.|+|++|+|++ +|.. ..+|+.|++++|++++ +
T Consensus 272 N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~--L 337 (788)
T PRK15387 272 NPLT-HLPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTS--L 337 (788)
T ss_pred Cchh-hhhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCC---cccccccccccCcccc--c
Confidence 9998 455433 57889999999998 45643 4789999999999995 4542 2468899999999974 5
Q ss_pred ccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccCCCCCC
Q 003140 244 PASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRL 323 (845)
Q Consensus 244 p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L 323 (845)
|.. ..+|+.|+|++|+|++.++. ..+|+.|++++|+|+ .+|... .+|+.|+|++|+|++ +|.. .++|
T Consensus 338 P~l---p~~Lq~LdLS~N~Ls~LP~l---p~~L~~L~Ls~N~L~-~LP~l~--~~L~~LdLs~N~Lt~-LP~l---~s~L 404 (788)
T PRK15387 338 PTL---PSGLQELSVSDNQLASLPTL---PSELYKLWAYNNRLT-SLPALP--SGLKELIVSGNRLTS-LPVL---PSEL 404 (788)
T ss_pred ccc---ccccceEecCCCccCCCCCC---Ccccceehhhccccc-cCcccc--cccceEEecCCcccC-CCCc---ccCC
Confidence 542 25899999999999986653 357889999999999 577643 479999999999995 5543 3679
Q ss_pred CeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCCC-CCCCCcEEEecCCccccc
Q 003140 324 QRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFCLN 387 (845)
Q Consensus 324 ~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~-~~~~l~~l~l~~Np~~c~ 387 (845)
+.|++++|+|+ .+|... ..|+.|++++|+|+.+|..+ .++.+..|+|++|||+..
T Consensus 405 ~~LdLS~N~Ls-sIP~l~--------~~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~Ls~~ 460 (788)
T PRK15387 405 KELMVSGNRLT-SLPMLP--------SGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSER 460 (788)
T ss_pred CEEEccCCcCC-CCCcch--------hhhhhhhhccCcccccChHHhhccCCCeEECCCCCCCch
Confidence 99999999998 477643 24568999999999999876 589999999999999753
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.9e-22 Score=216.76 Aligned_cols=209 Identities=24% Similarity=0.300 Sum_probs=170.8
Q ss_pred CCCCCccccccCceEEEEEEeCCC--cEEEEEEccCCChhhHHHHHHHHHHHHhcCC----CceeeEEEEE-eeCCeEEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGILPDG--TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH----RNLVSLVGYC-DEEGEQML 697 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~~g--~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H----~nIv~l~g~~-~~~~~~~L 697 (845)
+|.+.+.||+|+||.||++..... ..+|+|............+..|+.++..+.. +++..+++.. ...+..++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 788999999999999999997553 5788887665433322367888888888863 6888999888 57888999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-----CcEEEEecCCc
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-----FTAKVADFGLS 772 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~-----~~~kl~DFGla 772 (845)
||+.+ |.+|.++........++..+...|+.|++.+|++||+.+ ++||||||.|+++... ..++|.|||+|
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99977 899999886666678999999999999999999999999 9999999999999754 46999999999
Q ss_pred c--cCCCCCCCCccccce-eecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 773 R--LAPVPDIEGIVPAHV-STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 773 ~--~~~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
+ .....+.....+... .....||..|.+++.+.+...+.+.|+||++.++.|++.|..||...+.
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 8 332222111111111 2456799999999999999999999999999999999999999976554
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.8e-22 Score=232.96 Aligned_cols=247 Identities=25% Similarity=0.441 Sum_probs=203.0
Q ss_pred CCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEc
Q 003140 106 SYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHM 185 (845)
Q Consensus 106 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 185 (845)
.+...|+|++++++ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|++|+|++|+|+ .+|..+. .+|+.|+|
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L 248 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMEL 248 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence 56789999999999 5787664 58999999999999 6777664 58999999999998 5676554 47999999
Q ss_pred cCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCC
Q 003140 186 NNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG 265 (845)
Q Consensus 186 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~ 265 (845)
++|++. .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|++++ +|..+. ++|+.|++++|+++.
T Consensus 249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~--LP~~lp--~sL~~L~Ls~N~Lt~ 318 (754)
T PRK15370 249 SINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT--LPAHLP--SGITHLNVQSNSLTA 318 (754)
T ss_pred cCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc--Ccccch--hhHHHHHhcCCcccc
Confidence 999998 6777664 58999999999999 5677664 589999999999984 565543 579999999999998
Q ss_pred CCCCCCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCChhhhhhc
Q 003140 266 PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSR 345 (845)
Q Consensus 266 ~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~ 345 (845)
.+..+. ++|+.|++++|.+++ +|.... .+|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+..
T Consensus 319 LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~-~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~~-- 388 (754)
T PRK15370 319 LPETLP--PGLKTLEAGENALTS-LPASLP-PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLPA-- 388 (754)
T ss_pred CCcccc--ccceeccccCCcccc-CChhhc-CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHHH--
Confidence 765443 689999999999994 665443 58999999999998 4676553 68999999999999 67876642
Q ss_pred cCCCCcceEEEccCCCCCCCCCCC-----CCCCCcEEEecCCcccc
Q 003140 346 TLNATETFILDFQNNNLTNISGSF-----NIPPNVTVRLRGNPFCL 386 (845)
Q Consensus 346 ~l~~~~l~~L~ls~N~l~~i~~~~-----~~~~l~~l~l~~Np~~c 386 (845)
.|+.|++++|+|+.+|..+ ..+.+..+++.+||+..
T Consensus 389 -----sL~~LdLs~N~L~~LP~sl~~~~~~~~~l~~L~L~~Npls~ 429 (754)
T PRK15370 389 -----ALQIMQASRNNLVRLPESLPHFRGEGPQPTRIIVEYNPFSE 429 (754)
T ss_pred -----HHHHHhhccCCcccCchhHHHHhhcCCCccEEEeeCCCccH
Confidence 4678999999999998764 25788999999999874
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-24 Score=243.69 Aligned_cols=180 Identities=24% Similarity=0.326 Sum_probs=122.5
Q ss_pred CcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCC---------------------CCccccccCCCccEEEcccC
Q 003140 203 SLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT---------------------TIPASYSNMSKLLKLSLRNC 261 (845)
Q Consensus 203 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~---------------------~~p~~~~~l~~L~~L~Ls~N 261 (845)
+|+++++++|+++ .+|+.++.+.+|+.|+..+|++... .+|.....++.|++|+|..|
T Consensus 242 nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N 320 (1081)
T KOG0618|consen 242 NLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLVALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSN 320 (1081)
T ss_pred cceeeecchhhhh-cchHHHHhcccceEecccchhHHhhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehhc
Confidence 4556666666666 3445566666666666666655310 34555566667777777777
Q ss_pred CCCCCCCCC--------------------------CCCCCccEEEcccccCCcC-CCCCCCccccCEEEccCCcCCCCcc
Q 003140 262 SLQGPMPDL--------------------------SRIPNLGYLDLSSNQLNGS-IPPGRLSLNITTIKLSNNKLTGTIP 314 (845)
Q Consensus 262 ~l~~~~~~l--------------------------~~l~~L~~L~Ls~N~l~~~-ip~~~~~~~L~~L~Ls~N~l~~~~p 314 (845)
+|...++.+ ..++.|+.|++.+|.++.. +|......+|+.|+|++|+|.....
T Consensus 321 ~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpa 400 (1081)
T KOG0618|consen 321 NLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPA 400 (1081)
T ss_pred cccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCH
Confidence 766544421 0123456666666666643 3334445589999999999986666
Q ss_pred cccCCCCCCCeEecccccCcccCChhhhhhccC-----------------CCCcceEEEccCCCCCCCC--CCCCCCCCc
Q 003140 315 SNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTL-----------------NATETFILDFQNNNLTNIS--GSFNIPPNV 375 (845)
Q Consensus 315 ~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l-----------------~~~~l~~L~ls~N~l~~i~--~~~~~~~l~ 375 (845)
..+.+|+.|++|+||||+|+ .+|+.+..+..| +.+.|+++|+|.|+|+.+- .....|.|+
T Consensus 401 s~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~fPe~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~Lk 479 (1081)
T KOG0618|consen 401 SKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSFPELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLK 479 (1081)
T ss_pred HHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeechhhhhcCcceEEecccchhhhhhhhhhCCCcccc
Confidence 77888999999999999998 788877766544 3477899999999998644 445668999
Q ss_pred EEEecCCcc
Q 003140 376 TVRLRGNPF 384 (845)
Q Consensus 376 ~l~l~~Np~ 384 (845)
.|+++||++
T Consensus 480 yLdlSGN~~ 488 (1081)
T KOG0618|consen 480 YLDLSGNTR 488 (1081)
T ss_pred eeeccCCcc
Confidence 999999995
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=201.46 Aligned_cols=207 Identities=22% Similarity=0.351 Sum_probs=179.0
Q ss_pred cCCCCCccccccCceEEEEEE-eCCCcEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeEEEEEEc
Q 003140 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
-+|.+.++||+|.||..+.|+ +-+++.||||.-...+ ..-++..|.+..+.| ..++|...+-|-.+..+-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 468889999999999999998 5588999999754322 234677788888888 579999999888888899999998
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-----CcEEEEecCCcccCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-----FTAKVADFGLSRLAP 776 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~-----~~~kl~DFGla~~~~ 776 (845)
+ |-||+++.. -.+..++.++...+|.|++.-++|+|++. +|.|||||+|+||..- ..+.|+|||+|+.+.
T Consensus 106 L-GPSLEDLFD-~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 106 L-GPSLEDLFD-LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred h-CcCHHHHHH-HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 8 789998764 45667999999999999999999999999 9999999999999643 468999999999988
Q ss_pred CCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
+++-..-.+-.......||.+||+-..+.+.+-+.+.|+-|+|-|+...+.|..||++.+.
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 7766666667777888999999999999999999999999999999999999999997654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-22 Score=196.29 Aligned_cols=210 Identities=23% Similarity=0.352 Sum_probs=175.5
Q ss_pred HHhcCCCCCccccccCceEEEEEE-eCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCC-CceeeEEEEEeeCCeEEEE
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH-RNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~LV 698 (845)
+...+|...+.||.|+||.+|.|. ..+|..||||.-..... ..++..|.++.+.++| ..|..+.-|..+...-.+|
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 345688999999999999999999 57899999998654322 3367789999999975 6788888888899999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCcEEEEecCCcccC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD---HKFTAKVADFGLSRLA 775 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~---~~~~~kl~DFGla~~~ 775 (845)
||.+ |-||.++..- ....++.++.+-.+-|++.-++|+|.++ +|||||||+|+|.. ....+.++|||+|+.+
T Consensus 90 MdLL-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eecc-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 9988 7899997744 3456889999999999999999999999 99999999999996 3457999999999876
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
-+.....-.+........||.+|.+-....+...+.+.|+-|+|.++...-.|..||++...
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 54433333344555677899999999888888889999999999999999999999987654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-21 Score=237.90 Aligned_cols=154 Identities=19% Similarity=0.191 Sum_probs=114.6
Q ss_pred hcCC-CceeeEEEEE-------eeCCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 003140 676 RLHH-RNLVSLVGYC-------DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747 (845)
Q Consensus 676 ~l~H-~nIv~l~g~~-------~~~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ii 747 (845)
.++| +||.++++++ .+.+..+.++||+ +++|.++++.. ...+++..++.++.||++||+|||+++ |+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQG---IV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 3455 5888888877 2334567888987 57999999753 356899999999999999999999998 99
Q ss_pred ecCCCCCCEEEcCCCc-------------------EEEEecCCcccCCCCC---CC------CccccceeecccCCCCcc
Q 003140 748 HRDIKASNILLDHKFT-------------------AKVADFGLSRLAPVPD---IE------GIVPAHVSTVVKGTPGYL 799 (845)
Q Consensus 748 HrDLk~~NILl~~~~~-------------------~kl~DFGla~~~~~~~---~~------~~~~~~~~~~~~gt~~y~ 799 (845)
||||||+||||+..+. +|++|||+++...... .. ............||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999965444 5555555554321000 00 000000112245889999
Q ss_pred chhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 800 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 800 aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
|||++.+..++.++|||||||++|||++|..|+..
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 99999999999999999999999999999988764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-19 Score=197.59 Aligned_cols=205 Identities=36% Similarity=0.605 Sum_probs=170.5
Q ss_pred CCCCccccccCceEEEEEEeCCCcEEEEEEccCCChh---hHHHHHHHHHHHHhcCCC-ceeeEEEEEeeCCeEEEEEEc
Q 003140 626 FNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHR-NLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 626 f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~---~~~~~~~Ei~~l~~l~H~-nIv~l~g~~~~~~~~~LV~E~ 701 (845)
|...+.||.|+||.||++... ..+++|.+...... ....|.+|+.+++.+.|+ +++++.+++......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999986 88999988754332 367899999999999988 799999999777778999999
Q ss_pred CCCCCHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEEecCCcccCCCCC
Q 003140 702 MSNGTLRDQLSAKSK-EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVPD 779 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~-~~kl~DFGla~~~~~~~ 779 (845)
+.++++.+++..... ..+.......++.|++.+++|+|+.+ ++|||+||+||+++... .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977755432 26888999999999999999999999 99999999999999998 79999999998554322
Q ss_pred CCCccccceeecccCCCCccchhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
..... ........||..|+|||.+.. ..+....|+||+|++++++++|..||....
T Consensus 157 ~~~~~-~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 157 STSSI-PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred ccccc-cccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 11000 013456789999999999987 678899999999999999999999976544
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.9e-21 Score=223.17 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=203.7
Q ss_pred eEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecc
Q 003140 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162 (845)
Q Consensus 83 ~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 162 (845)
..+.|++.+++++. +|..+. ++|+.|+|++|+|+ .+|..+. ++|++|+|++|+|+ .+|..+. ++|+.|+|+
T Consensus 179 ~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLTT-IPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 46789999999984 676664 58999999999999 6776664 58999999999999 6777654 579999999
Q ss_pred cccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCC
Q 003140 163 QNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTT 242 (845)
Q Consensus 163 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 242 (845)
+|+++ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|++ +|..+. ++|+.|+|++|+++.
T Consensus 250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-- 318 (754)
T PRK15370 250 INRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-- 318 (754)
T ss_pred CCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc--
Confidence 99999 6777664 58999999999999 5777664 589999999999994 565543 479999999999984
Q ss_pred CccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccCCCCC
Q 003140 243 IPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPR 322 (845)
Q Consensus 243 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~ 322 (845)
+|..+. ++|+.|++++|.+++.+..+. ++|+.|++++|+|+ .+|... ..+|+.|+|++|+|+. +|..+. ..
T Consensus 319 LP~~l~--~sL~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~L~-~LP~~l-p~~L~~LdLs~N~Lt~-LP~~l~--~s 389 (754)
T PRK15370 319 LPETLP--PGLKTLEAGENALTSLPASLP--PELQVLDVSKNQIT-VLPETL-PPTITTLDVSRNALTN-LPENLP--AA 389 (754)
T ss_pred CCcccc--ccceeccccCCccccCChhhc--CcccEEECCCCCCC-cCChhh-cCCcCEEECCCCcCCC-CCHhHH--HH
Confidence 555443 689999999999998766554 69999999999998 577644 3589999999999994 565554 36
Q ss_pred CCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCC
Q 003140 323 LQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 363 (845)
Q Consensus 323 L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~ 363 (845)
|+.|++++|+|+ .+|..+..+.. ..+.+..|+|.+|.|+
T Consensus 390 L~~LdLs~N~L~-~LP~sl~~~~~-~~~~l~~L~L~~Npls 428 (754)
T PRK15370 390 LQIMQASRNNLV-RLPESLPHFRG-EGPQPTRIIVEYNPFS 428 (754)
T ss_pred HHHHhhccCCcc-cCchhHHHHhh-cCCCccEEEeeCCCcc
Confidence 999999999998 78887765543 2356779999999987
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-20 Score=217.04 Aligned_cols=239 Identities=26% Similarity=0.311 Sum_probs=188.1
Q ss_pred ceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeec
Q 003140 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (845)
Q Consensus 82 ~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (845)
.+++.|++.+|+|+. +|. .+++|++|+|++|+|+ .+|.. .++|+.|+|++|.++ .+|..+ ++|+.|+|
T Consensus 222 ~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~L~-~Lp~lp---~~L~~L~L 289 (788)
T PRK15387 222 AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNPLT-HLPALP---SGLCKLWI 289 (788)
T ss_pred cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-cccCc---ccccceeeccCCchh-hhhhch---hhcCEEEC
Confidence 378999999999995 554 2589999999999999 56643 468999999999998 566533 57889999
Q ss_pred ccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCC
Q 003140 162 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT 241 (845)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 241 (845)
++|+|+ .+|.. +++|+.|+|++|+|++ +|.. ..+|+.|++++|+|++ +|.. ..+|+.|+|++|+|++
T Consensus 290 s~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~- 356 (788)
T PRK15387 290 FGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS- 356 (788)
T ss_pred cCCccc-ccccc---ccccceeECCCCcccc-CCCC---cccccccccccCcccc-cccc---ccccceEecCCCccCC-
Confidence 999998 45543 4789999999999995 4543 2468889999999984 5532 2479999999999984
Q ss_pred CCccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccCCCC
Q 003140 242 TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLP 321 (845)
Q Consensus 242 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~ 321 (845)
+|.. ..+|+.|++++|+|+..+.. ..+|+.|++++|+|+ .+|... .+|+.|++++|+|+. +|.. ..
T Consensus 357 -LP~l---p~~L~~L~Ls~N~L~~LP~l---~~~L~~LdLs~N~Lt-~LP~l~--s~L~~LdLS~N~Lss-IP~l---~~ 422 (788)
T PRK15387 357 -LPTL---PSELYKLWAYNNRLTSLPAL---PSGLKELIVSGNRLT-SLPVLP--SELKELMVSGNRLTS-LPML---PS 422 (788)
T ss_pred -CCCC---CcccceehhhccccccCccc---ccccceEEecCCccc-CCCCcc--cCCCEEEccCCcCCC-CCcc---hh
Confidence 5543 35788899999999975542 357999999999998 466532 479999999999985 5653 34
Q ss_pred CCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCC
Q 003140 322 RLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 365 (845)
Q Consensus 322 ~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i 365 (845)
+|+.|++++|+|+ .+|..+..+.. |..|+|++|+|+..
T Consensus 423 ~L~~L~Ls~NqLt-~LP~sl~~L~~-----L~~LdLs~N~Ls~~ 460 (788)
T PRK15387 423 GLLSLSVYRNQLT-RLPESLIHLSS-----ETTVNLEGNPLSER 460 (788)
T ss_pred hhhhhhhccCccc-ccChHHhhccC-----CCeEECCCCCCCch
Confidence 6888999999998 78998876654 45899999999853
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.4e-19 Score=225.77 Aligned_cols=266 Identities=17% Similarity=0.215 Sum_probs=130.9
Q ss_pred CCCCccCCC-CccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccC
Q 003140 98 LSPEIGRLS-YLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFAN 176 (845)
Q Consensus 98 ~~~~l~~L~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 176 (845)
+|+.+..++ +|+.|++.+|.+. .+|..| ...+|+.|+|++|++. .++..+..+++|+.|+|++|.....+|. +..
T Consensus 580 lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~ 655 (1153)
T PLN03210 580 LPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSM 655 (1153)
T ss_pred cCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-ccc
Confidence 344444432 3445555444443 344333 2344444444444444 3444444444444444444432223332 444
Q ss_pred ccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEE
Q 003140 177 LNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKL 256 (845)
Q Consensus 177 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L 256 (845)
+++|+.|+|++|.....+|..+..+++|+.|++++|.....+|..+ ++++|+.|+|++|...+ .+|.. ..+|+.|
T Consensus 656 l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~-~~p~~---~~nL~~L 730 (1153)
T PLN03210 656 ATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLK-SFPDI---STNISWL 730 (1153)
T ss_pred CCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCcc-ccccc---cCCcCee
Confidence 4444444444444333444444444444444444433222333332 34444444444443221 12211 1233344
Q ss_pred EcccCCCCCCCCC------------------------------CCCCCCccEEEcccccCCcCCCCCCCc-cccCEEEcc
Q 003140 257 SLRNCSLQGPMPD------------------------------LSRIPNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLS 305 (845)
Q Consensus 257 ~Ls~N~l~~~~~~------------------------------l~~l~~L~~L~Ls~N~l~~~ip~~~~~-~~L~~L~Ls 305 (845)
+|++|.++..+.. ....++|+.|+|++|...+.+|..+.. .+|+.|+|+
T Consensus 731 ~L~~n~i~~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls 810 (1153)
T PLN03210 731 DLDETAIEEFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIE 810 (1153)
T ss_pred ecCCCccccccccccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECC
Confidence 4444433322211 112246777777777666666665443 367777777
Q ss_pred CCcCCCCcccccCCCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCCC-CCCCCcEEEecC
Q 003140 306 NNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRG 381 (845)
Q Consensus 306 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~-~~~~l~~l~l~~ 381 (845)
+|...+.+|..+ ++++|+.|+|++|.....+|.. ..+|+.|+|++|.|+.+|..+ .++.+..|++.+
T Consensus 811 ~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~--------~~nL~~L~Ls~n~i~~iP~si~~l~~L~~L~L~~ 878 (1153)
T PLN03210 811 NCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI--------STNISDLNLSRTGIEEVPWWIEKFSNLSFLDMNG 878 (1153)
T ss_pred CCCCcCeeCCCC-CccccCEEECCCCCcccccccc--------ccccCEeECCCCCCccChHHHhcCCCCCEEECCC
Confidence 765444566554 6777777777776555455432 134557777777777777655 467777777766
|
syringae 6; Provisional |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.5e-20 Score=185.45 Aligned_cols=140 Identities=19% Similarity=0.160 Sum_probs=108.9
Q ss_pred CccccccCceEEEEEEeCCCcEEEEEEccCCChh--h-------H-----------------HHHHHHHHHHHhcCCCce
Q 003140 629 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--G-------E-----------------KEFLTEIQFLSRLHHRNL 682 (845)
Q Consensus 629 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~--~-------~-----------------~~~~~Ei~~l~~l~H~nI 682 (845)
...||+|+||.||+|...+|+.||||+++..... . . .....|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999889999999998753211 1 1 122459999999988776
Q ss_pred eeEEEEEeeCCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCCCCCCEEEcCC
Q 003140 683 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL-HTEADPPVFHRDIKASNILLDHK 761 (845)
Q Consensus 683 v~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiHrDLk~~NILl~~~ 761 (845)
.....+.. ...+|||||++++++...... ...++......++.|++.+|.|+ |+.+ |+||||||+|||++ +
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-C
Confidence 44333322 233899999998877654322 24688899999999999999999 6888 99999999999998 4
Q ss_pred CcEEEEecCCcccCC
Q 003140 762 FTAKVADFGLSRLAP 776 (845)
Q Consensus 762 ~~~kl~DFGla~~~~ 776 (845)
+.++|+|||+|....
T Consensus 154 ~~v~LiDFG~a~~~~ 168 (190)
T cd05147 154 GKLYIIDVSQSVEHD 168 (190)
T ss_pred CcEEEEEccccccCC
Confidence 789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.4e-20 Score=188.47 Aligned_cols=172 Identities=15% Similarity=0.107 Sum_probs=134.0
Q ss_pred HHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHH---------HHHHHHHHHhcCCCceeeEEEEEee
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKE---------FLTEIQFLSRLHHRNLVSLVGYCDE 691 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~---------~~~Ei~~l~~l~H~nIv~l~g~~~~ 691 (845)
...++|...+.+|.|+||.||.... ++..+|||.+.+.....++. +.+|++.+.+++|++|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3468899999999999999999665 57789999997654333322 6789999999999999999988654
Q ss_pred C--------CeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 003140 692 E--------GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 763 (845)
Q Consensus 692 ~--------~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~ 763 (845)
. +..+|||||++|.+|.++.. ++. ....+++.++..+|+.+ ++|||+||+||++++++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 3 35789999999999988742 222 24558899999999999 99999999999999998
Q ss_pred EEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHH
Q 003140 764 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELL 826 (845)
Q Consensus 764 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ell 826 (845)
++|+|||..+...... . ...+.....+..++|+||||+.+.-..
T Consensus 173 i~liDfg~~~~~~e~~-------a------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRK-------A------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchh-------h------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 9999999876542111 0 011334455667999999999877654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=178.91 Aligned_cols=192 Identities=13% Similarity=0.047 Sum_probs=141.7
Q ss_pred CCCccccccCceEEEEEEeCCCcEEEEEEccCCChhh----HHHHHHHHHHHHhcC-CCceeeEEEEEeeCCeEEEEEEc
Q 003140 627 NSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG----EKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 627 ~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~----~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
.....|++|+||+||.+.. .+..++.+.+....... ...|.+|+++|+++. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467899999999997665 67888877776543311 225889999999995 5889999886 457999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI-KASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDL-k~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
++|.+|.+.+.. ....+..|++++++|+|+.+ |+|||| ||+|||+++++.++|+|||+|........
T Consensus 80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999999764421 11346788999999999999 999999 79999999999999999999985432210
Q ss_pred C------CccccceeecccCCCCccchhhhcCC-CCC-chhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 781 E------GIVPAHVSTVVKGTPGYLDPEYFLTH-KLT-DKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 781 ~------~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
. .....-...-...++.|++|+...-. ..+ .+.+.++-|..+|+++||..|+...
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 00000001112368889999865422 333 5779999999999999999998643
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=4e-19 Score=178.43 Aligned_cols=139 Identities=20% Similarity=0.155 Sum_probs=111.1
Q ss_pred CccccccCceEEEEEEeCCCcEEEEEEccCCChh---------------------h-----HHHHHHHHHHHHhcCCCce
Q 003140 629 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ---------------------G-----EKEFLTEIQFLSRLHHRNL 682 (845)
Q Consensus 629 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~---------------------~-----~~~~~~Ei~~l~~l~H~nI 682 (845)
.+.||+|+||.||+|...+|+.||||+++..... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999878999999998754211 0 1224678999999999987
Q ss_pred eeEEEEEeeCCeEEEEEEcCCCCCHHHH-HhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcC
Q 003140 683 VSLVGYCDEEGEQMLVYEFMSNGTLRDQ-LSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDH 760 (845)
Q Consensus 683 v~l~g~~~~~~~~~LV~E~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDLk~~NILl~~ 760 (845)
.....+... ..+|||||++++++... +.. ..++......++.+++.++.|+|+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 554444333 24899999998865443 322 346778889999999999999999 88 99999999999999
Q ss_pred CCcEEEEecCCcccCC
Q 003140 761 KFTAKVADFGLSRLAP 776 (845)
Q Consensus 761 ~~~~kl~DFGla~~~~ 776 (845)
++.++|+|||+|+...
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 8899999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.80 E-value=1e-18 Score=220.18 Aligned_cols=268 Identities=22% Similarity=0.310 Sum_probs=138.2
Q ss_pred CCccCCCCccEEEecCCC------CCCCCcccccccc-cchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCc
Q 003140 100 PEIGRLSYLTILDFMWNK------ISGSIPKEIGNIK-SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPK 172 (845)
Q Consensus 100 ~~l~~L~~L~~L~L~~N~------l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 172 (845)
.+|..+++|+.|.+..+. +...+|..|..++ +|+.|++.+|.+. .+|..| .+.+|+.|+|++|++. .++.
T Consensus 552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~ 628 (1153)
T PLN03210 552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD 628 (1153)
T ss_pred HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence 345556666666654432 2223454554443 4666666666555 555555 3456666666666655 4555
Q ss_pred cccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCC
Q 003140 173 SFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSK 252 (845)
Q Consensus 173 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~ 252 (845)
.+..+++|+.|+|++|...+.+|. ++.+++|++|+|++|.....+|..+..+++|+.|++++|...+ .+|..+ ++++
T Consensus 629 ~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~-~Lp~~i-~l~s 705 (1153)
T PLN03210 629 GVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLE-ILPTGI-NLKS 705 (1153)
T ss_pred ccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcC-ccCCcC-CCCC
Confidence 555566666666665543334442 5555666666666655444555566666666666666543222 344433 4556
Q ss_pred ccEEEcccCCCCCCCCCCCCCCCccEEEcccccCCcCCCCCCC-------------------------------ccccCE
Q 003140 253 LLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRL-------------------------------SLNITT 301 (845)
Q Consensus 253 L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~-------------------------------~~~L~~ 301 (845)
|+.|++++|......|.+ ..+|+.|++++|.++ .+|.... ..+|+.
T Consensus 706 L~~L~Lsgc~~L~~~p~~--~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~ 782 (1153)
T PLN03210 706 LYRLNLSGCSRLKSFPDI--STNISWLDLDETAIE-EFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTR 782 (1153)
T ss_pred CCEEeCCCCCCccccccc--cCCcCeeecCCCccc-cccccccccccccccccccchhhccccccccchhhhhccccchh
Confidence 666666665433333322 235555666665554 3332110 124555
Q ss_pred EEccCCcCCCCcccccCCCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCC-CCCCCCCCCCCCCCcEEEec
Q 003140 302 IKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNN-NLTNISGSFNIPPNVTVRLR 380 (845)
Q Consensus 302 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N-~l~~i~~~~~~~~l~~l~l~ 380 (845)
|+|++|...+.+|..++++++|+.|+|++|...+.+|..+ ..++|+.|+|++| ++..+|.. ..++..|+|.
T Consensus 783 L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~------~L~sL~~L~Ls~c~~L~~~p~~--~~nL~~L~Ls 854 (1153)
T PLN03210 783 LFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI------NLESLESLDLSGCSRLRTFPDI--STNISDLNLS 854 (1153)
T ss_pred eeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC------CccccCEEECCCCCcccccccc--ccccCEeECC
Confidence 5555555555556666666666666666654444555443 2334456666654 33333322 2345555665
Q ss_pred CCcc
Q 003140 381 GNPF 384 (845)
Q Consensus 381 ~Np~ 384 (845)
+|.+
T Consensus 855 ~n~i 858 (1153)
T PLN03210 855 RTGI 858 (1153)
T ss_pred CCCC
Confidence 5544
|
syringae 6; Provisional |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.9e-21 Score=179.01 Aligned_cols=166 Identities=29% Similarity=0.501 Sum_probs=114.9
Q ss_pred cccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcce
Q 003140 127 GNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVH 206 (845)
Q Consensus 127 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 206 (845)
.++.+.+.|-||+|+++ .+|..++.|.+|+.|++++|+|+ .+|..++.++.|+.
T Consensus 30 f~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-------------------------~lp~~issl~klr~ 83 (264)
T KOG0617|consen 30 FNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-------------------------ELPTSISSLPKLRI 83 (264)
T ss_pred cchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-------------------------hcChhhhhchhhhh
Confidence 34455555666666665 45555555555555555555555 44445555555555
Q ss_pred eeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccC
Q 003140 207 MLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQL 286 (845)
Q Consensus 207 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l 286 (845)
|+++-|++. .+|..|+.++.|+.|||.+|++....+|..|..++.|+.|+|++|.+.-.+++++++++|+.|.+.+|.+
T Consensus 84 lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndl 162 (264)
T KOG0617|consen 84 LNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDL 162 (264)
T ss_pred eecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCch
Confidence 555555555 5566666666666666666666655677777777888888888888887888888888888888888777
Q ss_pred CcCCCCCCCccccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCChhhhhh
Q 003140 287 NGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS 344 (845)
Q Consensus 287 ~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l 344 (845)
- ..|..++.|++|++|++.+|+++ .+|.+++.+
T Consensus 163 l------------------------~lpkeig~lt~lrelhiqgnrl~-vlppel~~l 195 (264)
T KOG0617|consen 163 L------------------------SLPKEIGDLTRLRELHIQGNRLT-VLPPELANL 195 (264)
T ss_pred h------------------------hCcHHHHHHHHHHHHhcccceee-ecChhhhhh
Confidence 6 67888899999999999999998 788877654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.8e-19 Score=175.14 Aligned_cols=108 Identities=28% Similarity=0.376 Sum_probs=94.7
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCcc
Q 003140 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (845)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 784 (845)
|+|.++++.. ...+++..++.++.|+++||+|||+++ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc------
Confidence 7899999754 346999999999999999999999875 999999999999999 9998765321
Q ss_pred ccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
...||+.|||||++.+..++.++|||||||++|||+||+.||....
T Consensus 63 ------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~ 108 (176)
T smart00750 63 ------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEER 108 (176)
T ss_pred ------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence 1258899999999999999999999999999999999999996543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-19 Score=177.79 Aligned_cols=195 Identities=17% Similarity=0.353 Sum_probs=154.6
Q ss_pred CCccccccCceEEEEEEeCCCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCCC
Q 003140 628 SSTQIGQGGYGKVYKGILPDGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 705 (845)
Q Consensus 628 ~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g 705 (845)
...+|.+...|..|+|+++. ..+++|+++.. ...-.++|.+|.-.++.+.||||++++|.|.......++..||+.|
T Consensus 194 l~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 35578899999999999964 45556766532 2333468999999999999999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCccc
Q 003140 706 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP 785 (845)
Q Consensus 706 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 785 (845)
+|+..+++...-..+-.+..+++.++|+|++|||+.. |-|-.--|.+..|++|++.+++|+- +=+++-
T Consensus 273 slynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kfs---------- 340 (448)
T KOG0195|consen 273 SLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKFS---------- 340 (448)
T ss_pred HHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-ccceee----------
Confidence 9999999988777888999999999999999999875 3233457899999999999988752 111110
Q ss_pred cceeecccCCCCccchhhhcCCCC---CchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 786 AHVSTVVKGTPGYLDPEYFLTHKL---TDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 786 ~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......-.+.||+||.+....- -.++|+|||++++||+.|+..||..-.
T Consensus 341 -fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadls 393 (448)
T KOG0195|consen 341 -FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLS 393 (448)
T ss_pred -eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCC
Confidence 00111223478999999976543 347899999999999999999997543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.6e-18 Score=171.63 Aligned_cols=139 Identities=18% Similarity=0.270 Sum_probs=107.9
Q ss_pred CCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhc-----CCCceeeEEEEEeeCC---eE-E
Q 003140 626 FNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-----HHRNLVSLVGYCDEEG---EQ-M 696 (845)
Q Consensus 626 f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l-----~H~nIv~l~g~~~~~~---~~-~ 696 (845)
+...+.||+|+||.||. .++....+||+.........+++.+|+++++.+ .||||++++|+++++. .. .
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34567899999999996 443333479988765445567899999999999 5799999999998763 43 3
Q ss_pred EEEEc--CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEecCCCCCCEEEcC----CCcEEEEe-
Q 003140 697 LVYEF--MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI-LYLHTEADPPVFHRDIKASNILLDH----KFTAKVAD- 768 (845)
Q Consensus 697 LV~E~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~iiHrDLk~~NILl~~----~~~~kl~D- 768 (845)
+|+|| +++|+|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 78999 5579999999653 25544 34577888777 9999999 999999999999974 34899999
Q ss_pred cCCccc
Q 003140 769 FGLSRL 774 (845)
Q Consensus 769 FGla~~ 774 (845)
||....
T Consensus 154 ~G~~~~ 159 (210)
T PRK10345 154 IGESTF 159 (210)
T ss_pred CCCcce
Confidence 454433
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.3e-21 Score=207.49 Aligned_cols=251 Identities=22% Similarity=0.267 Sum_probs=159.0
Q ss_pred EEEecCCCCcc-cCCCCccCCCCccEEEecCCCCCC----CCcccccccccchhhhccCCCCCC------CCCCccCCCC
Q 003140 86 ELQLLNLNLSG-NLSPEIGRLSYLTILDFMWNKISG----SIPKEIGNIKSLELLLLNGNELTG------SLPEELGYLP 154 (845)
Q Consensus 86 ~L~L~~~~l~~-~~~~~l~~L~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~------~~p~~~~~l~ 154 (845)
.|+|.++.+++ .....+..+.+|+.|+|+++.++. .++..+...++|++|+++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 36677777773 344556677778888888888754 245556677778888888887762 2234566677
Q ss_pred ccceeecccccccCCCCccccCccC---CCEEEccCCCCCC----CCccccCCC-CCcceeeccccccccC----CCccc
Q 003140 155 KLDRIQIDQNYISGSLPKSFANLNK---TRHFHMNNNSISG----QIPPELSRL-PSLVHMLLDNNNLTGY----LPPEL 222 (845)
Q Consensus 155 ~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~p~~l~~l-~~L~~L~L~~N~l~~~----~p~~l 222 (845)
+|+.|+|++|.+.+..+..+..+.+ |+.|++++|++++ .+...+..+ ++|+.|++++|.+++. ++..+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 8888888888887655655555555 8888888888763 222344555 7788888888887732 23345
Q ss_pred CCCCCCcEEEccCCcCCCCC---CccccccCCCccEEEcccCCCCCCCC-----CCCCCCCccEEEcccccCCcCCCCC-
Q 003140 223 SELPKLLILQLDNNNFEGTT---IPASYSNMSKLLKLSLRNCSLQGPMP-----DLSRIPNLGYLDLSSNQLNGSIPPG- 293 (845)
Q Consensus 223 ~~l~~L~~L~Ls~N~l~~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~~-----~l~~l~~L~~L~Ls~N~l~~~ip~~- 293 (845)
..+++|++|+|++|.+++.. ++..+..+++|+.|+|++|.+++... .+..+++|+.|++++|.+++.....
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l 241 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAAL 241 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHH
Confidence 56677888888888776422 22334455678888888887764322 2556677777777777776421111
Q ss_pred ---C--CccccCEEEccCCcCC----CCcccccCCCCCCCeEecccccCccc
Q 003140 294 ---R--LSLNITTIKLSNNKLT----GTIPSNFSGLPRLQRLFIANNSLSGS 336 (845)
Q Consensus 294 ---~--~~~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~L~~N~l~~~ 336 (845)
. ....|+.|++++|.++ ..+...+..+++|++|++++|+++..
T Consensus 242 ~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~ 293 (319)
T cd00116 242 ASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEE 293 (319)
T ss_pred HHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHH
Confidence 1 1135666666666665 12334444556666666666666644
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3e-20 Score=210.48 Aligned_cols=265 Identities=25% Similarity=0.298 Sum_probs=169.2
Q ss_pred ceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeec
Q 003140 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (845)
Q Consensus 82 ~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (845)
..++.|+..+|.+....+ -..-.+|+++|+++|+++ .+|..++.+.+|+.|+..+|+|+ .+|..+..+++|+.|++
T Consensus 219 ~~l~~L~a~~n~l~~~~~--~p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~ 294 (1081)
T KOG0618|consen 219 PSLTALYADHNPLTTLDV--HPVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSA 294 (1081)
T ss_pred cchheeeeccCcceeecc--ccccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHh
Confidence 356666666666662221 122356788888888888 56677788888888888888886 77888888888888888
Q ss_pred ccccccCCCCccccCccCCCEEEccCCCCCCCCcc-ccCCCCC-cceeeccccccccCCCcccCCCCCCcEEEccCCcCC
Q 003140 162 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPP-ELSRLPS-LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFE 239 (845)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~l~~l~~-L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 239 (845)
.+|.++ .+|.....++.|++|+|..|+|. .+|+ .+..+.. |..|..+.|++....-..=..++.|+.|.+.+|.++
T Consensus 295 ~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Lt 372 (1081)
T KOG0618|consen 295 AYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLT 372 (1081)
T ss_pred hhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCccc
Confidence 888887 67777777888888888888887 3443 3333332 566666666666322111122455667777777776
Q ss_pred CCCCccccccCCCccEEEcccCCCCCCCCC-CCCCCCccEEEcccccCCcCCCCCCC-ccccCEEEccCCcCCCCccccc
Q 003140 240 GTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRL-SLNITTIKLSNNKLTGTIPSNF 317 (845)
Q Consensus 240 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~ip~~~~-~~~L~~L~Ls~N~l~~~~p~~~ 317 (845)
. ..-..+.++++|+.|+|++|+|...+.. +.+++.|+.|+||+|+|+ .+|.... ...|++|...+|+|. ..| .+
T Consensus 373 d-~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~ 448 (1081)
T KOG0618|consen 373 D-SCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-EL 448 (1081)
T ss_pred c-cchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hh
Confidence 5 3444566666777777777777665553 666677777777777776 5554332 335667777777766 445 66
Q ss_pred CCCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCC
Q 003140 318 SGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNN 361 (845)
Q Consensus 318 ~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~ 361 (845)
..+++|+.+|++.|+|+...-.. .+..++|++|||++|.
T Consensus 449 ~~l~qL~~lDlS~N~L~~~~l~~-----~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 449 AQLPQLKVLDLSCNNLSEVTLPE-----ALPSPNLKYLDLSGNT 487 (1081)
T ss_pred hhcCcceEEecccchhhhhhhhh-----hCCCcccceeeccCCc
Confidence 67777777777777766322211 1122556677777775
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.4e-20 Score=170.88 Aligned_cols=166 Identities=26% Similarity=0.524 Sum_probs=145.0
Q ss_pred CccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCC
Q 003140 101 EIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180 (845)
Q Consensus 101 ~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 180 (845)
.+.++.+++.|.||+|+++ .+|..+..+.+|+.|++++|++. .+|..++.|++|+.|++.-|++. ..|..|+.++.|
T Consensus 28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l 104 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL 104 (264)
T ss_pred cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence 4556778888999999999 67778999999999999999998 88999999999999999999988 889999999999
Q ss_pred CEEEccCCCCC-CCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcc
Q 003140 181 RHFHMNNNSIS-GQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLR 259 (845)
Q Consensus 181 ~~L~L~~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls 259 (845)
+.|||+.|+++ ..+|..|..++.|+-|+|++|.+. .+|..++++++|+.|.+.+|.+- .+|..++.++.|++|.+.
T Consensus 105 evldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll--~lpkeig~lt~lrelhiq 181 (264)
T KOG0617|consen 105 EVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL--SLPKEIGDLTRLRELHIQ 181 (264)
T ss_pred hhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh--hCcHHHHHHHHHHHHhcc
Confidence 99999999986 356888888899999999999998 78888999999999999999885 688899999999999999
Q ss_pred cCCCCCCCCCCCC
Q 003140 260 NCSLQGPMPDLSR 272 (845)
Q Consensus 260 ~N~l~~~~~~l~~ 272 (845)
+|+++-.+|+++.
T Consensus 182 gnrl~vlppel~~ 194 (264)
T KOG0617|consen 182 GNRLTVLPPELAN 194 (264)
T ss_pred cceeeecChhhhh
Confidence 9988888776544
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.4e-18 Score=202.58 Aligned_cols=200 Identities=24% Similarity=0.264 Sum_probs=161.9
Q ss_pred HHHHHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcC---CCceeeEEEEEeeCCe
Q 003140 618 EMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH---HRNLVSLVGYCDEEGE 694 (845)
Q Consensus 618 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~~~~ 694 (845)
+.++..+.|.+.+.||+|+||+||+|...+|+.||+|+-++.+... |.-=.+++.+|+ -+.|..+...+.-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 5556678899999999999999999998889999999988766552 222234444444 2344445555566778
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-------CCCcEEEE
Q 003140 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-------HKFTAKVA 767 (845)
Q Consensus 695 ~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~-------~~~~~kl~ 767 (845)
-+||+||.+.|+|.+++. ..+.++|...+.++.|+++.++.||..+ |||+||||+|.||. ...-++|+
T Consensus 769 S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred ceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence 899999999999999996 5567899999999999999999999999 99999999999993 23469999
Q ss_pred ecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Q 003140 768 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQ 830 (845)
Q Consensus 768 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~ 830 (845)
|||.+-.+.-- ..........+|-++-.+|+..+..++..+|.|.++-+++-|+.|++
T Consensus 844 DfG~siDm~lf-----p~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 844 DFGRSIDMKLF-----PDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ecccceeeeEc-----CCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99998654211 12334556678899999999999999999999999999999999974
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.2e-17 Score=166.31 Aligned_cols=135 Identities=20% Similarity=0.330 Sum_probs=114.8
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEccCCChh--------hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 630 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~--------~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
+.||+|++|.||+|.. +|..|+||+....... ...++.+|++++..++|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6778999986543211 124678899999999999998877777777888999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
+++++|.+++.... + .+..++.+++.++.++|+.+ ++|||++|+|||++ ++.++|+|||.++..
T Consensus 81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 99999999985432 2 78889999999999999998 99999999999999 789999999998753
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=7.6e-20 Score=189.23 Aligned_cols=281 Identities=18% Similarity=0.183 Sum_probs=209.0
Q ss_pred EEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeeccc-c
Q 003140 86 ELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQ-N 164 (845)
Q Consensus 86 ~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N 164 (845)
.++.++-+|+ .+|..+. +.-.+++|..|+|+.+.|.+|+.+++|+.||||+|+|+.+-|++|.+|.+|.+|-+.+ |
T Consensus 50 ~VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~N 126 (498)
T KOG4237|consen 50 IVDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNN 126 (498)
T ss_pred eEEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCC
Confidence 4566777776 4554443 3567899999999988889999999999999999999999999999999998887766 9
Q ss_pred cccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCc
Q 003140 165 YISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP 244 (845)
Q Consensus 165 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p 244 (845)
+|+......|.+|..|+.|.+.-|++.-.....|..+++|..|.+.+|.+...-...|..+..++.+++..|.+..
T Consensus 127 kI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~ic---- 202 (498)
T KOG4237|consen 127 KITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFIC---- 202 (498)
T ss_pred chhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccc----
Confidence 9997777889999999999999999997778899999999999999999995444488999999999999998642
Q ss_pred cccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCCcCCCCCCCccccCE----EEccCCcCCCCcccccCCC
Q 003140 245 ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITT----IKLSNNKLTGTIPSNFSGL 320 (845)
Q Consensus 245 ~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~----L~Ls~N~l~~~~p~~~~~l 320 (845)
..+++.|... +..|.+ .++...-..-..+.++++. .+++..+.-.++. +....+.........|.+|
T Consensus 203 --dCnL~wla~~-~a~~~i-----etsgarc~~p~rl~~~Ri~-q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L 273 (498)
T KOG4237|consen 203 --DCNLPWLADD-LAMNPI-----ETSGARCVSPYRLYYKRIN-QEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKL 273 (498)
T ss_pred --ccccchhhhH-Hhhchh-----hcccceecchHHHHHHHhc-ccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhc
Confidence 2333333321 111111 1222223333344445544 3333222212222 2222233333334669999
Q ss_pred CCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCCC--CCCCCcEEEecCCccccc
Q 003140 321 PRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLN 387 (845)
Q Consensus 321 ~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~--~~~~l~~l~l~~Np~~c~ 387 (845)
++|+.|+|++|+|++.-+.+|..+.. ++.|.|..|+|..+...+ .+..+++|+|.||.+.|-
T Consensus 274 ~~L~~lnlsnN~i~~i~~~aFe~~a~-----l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~ 337 (498)
T KOG4237|consen 274 PNLRKLNLSNNKITRIEDGAFEGAAE-----LQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTV 337 (498)
T ss_pred ccceEeccCCCccchhhhhhhcchhh-----hhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEE
Confidence 99999999999999888888887655 458999999999998875 589999999999999874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.5e-18 Score=199.32 Aligned_cols=199 Identities=23% Similarity=0.304 Sum_probs=157.3
Q ss_pred CCccccccCceEEEEEEeC-CCcEEEEEEcc----CCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 628 SSTQIGQGGYGKVYKGILP-DGTVVAVKRAQ----EGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 628 ~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~----~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
..+.+|.|++|.|+..... ..+..+.|.+. ... ......+..|+.+-..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4678999999988777643 34444444332 111 1112236678888888999999888877777766666699
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
|+++ +|...+... ..+....+-.+..|+.+|++|+|+.+ |.|||+|++|++++.++.+||+|||.+.....+..
T Consensus 402 ~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred cccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 9999 999988654 35778888899999999999999999 99999999999999999999999999976654321
Q ss_pred CCccccceeecccCCCCccchhhhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD-KSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
. .........|+..|+|||.+....|.+ ..||||.|++++.|++|+.||...
T Consensus 476 ~---~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a 528 (601)
T KOG0590|consen 476 K---NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVA 528 (601)
T ss_pred h---hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccc
Confidence 1 124456678999999999999998877 579999999999999999999643
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.8e-18 Score=197.38 Aligned_cols=202 Identities=21% Similarity=0.251 Sum_probs=154.0
Q ss_pred CCCCCccccccCceEEEEEEeCCCcEEEEEEccCCC-hhhHHHHHHHHHH--HHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 625 NFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS-LQGEKEFLTEIQF--LSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~-~~~~~~~~~Ei~~--l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
++...+.||.+.|=+|.+|++++|. |+||++-... .-..+.|.++++- ...++|||.+++...-...+..|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5666889999999999999998888 8888875433 3334455444333 4455899999998887777788899999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+. -+|++.+.. +..+...+.+.|+.|++.|+.-.|..+ |+|||||.+|||++.-.-+.|+||---+...-+...
T Consensus 103 vk-hnLyDRlST--RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 103 VK-HNLYDRLST--RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred Hh-hhhhhhhcc--chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 85 588888743 334677788889999999999999999 999999999999999999999999876543322211
Q ss_pred CccccceeecccCCCCccchhhhcCC-----------CCCchhhHHHHHHHHHHHHh-CCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTH-----------KLTDKSDVYSLGVVFLELLT-GMQPIS 833 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwS~Gvvl~ellt-G~~Pf~ 833 (845)
.........+.....+|+|||.+... ..+++.||||+||++.||++ |+.||.
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 11122333344455789999988542 15778999999999999999 677775
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.2e-18 Score=191.88 Aligned_cols=186 Identities=29% Similarity=0.341 Sum_probs=153.2
Q ss_pred cccccCceEEEEEE----eCCCcEEEEEEccCCChhh--HHHHHHHHHHHHhcC-CCceeeEEEEEeeCCeEEEEEEcCC
Q 003140 631 QIGQGGYGKVYKGI----LPDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEFMS 703 (845)
Q Consensus 631 ~LG~G~fG~Vy~~~----~~~g~~vAVK~~~~~~~~~--~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~E~~~ 703 (845)
.+|+|+||.|+.+. .+.|..+|.|.++...... ......|..++..++ ||.+|++...+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999998654 2357788888876543221 124566788888886 9999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCc
Q 003140 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (845)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 783 (845)
+|+|...+... ..+++.....+...++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++..-...
T Consensus 81 gg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 81 GGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred cchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence 99998877543 34566666667778889999999999 9999999999999999999999999998653211
Q ss_pred cccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
...||..|||||++. ....+.|.||||++++||+||..||..
T Consensus 152 -------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 152 -------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred -------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 117899999999997 567789999999999999999999987
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=1e-16 Score=162.59 Aligned_cols=131 Identities=22% Similarity=0.337 Sum_probs=107.8
Q ss_pred cccccCceEEEEEEeCCCcEEEEEEccCCChh--------hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcC
Q 003140 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (845)
Q Consensus 631 ~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~--------~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 702 (845)
.||+|+||.||+|.+ +|..|++|........ ..+++.+|+++++.++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 6788999986542211 1256788999999999887665555666667778999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++++|.+++..... .++.+++++|.+||+.+ ++|||++|+||+++ ++.++++|||+++..
T Consensus 80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGND---------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcHH---------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999998754211 78999999999999998 99999999999999 889999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.8e-19 Score=196.92 Aligned_cols=273 Identities=20% Similarity=0.250 Sum_probs=201.4
Q ss_pred EEEecCCCCC-CCCcccccccccchhhhccCCCCCCC----CCCccCCCCccceeecccccccC------CCCccccCcc
Q 003140 110 ILDFMWNKIS-GSIPKEIGNIKSLELLLLNGNELTGS----LPEELGYLPKLDRIQIDQNYISG------SLPKSFANLN 178 (845)
Q Consensus 110 ~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~------~~p~~~~~l~ 178 (845)
.|+|..+.++ ......+..+.+|+.|+|+++.++.. ++..+...++|++|+++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 5788888887 45566678888999999999998632 55667788889999999998873 2345677889
Q ss_pred CCCEEEccCCCCCCCCccccCCCCC---cceeecccccccc----CCCcccCCC-CCCcEEEccCCcCCCC---CCcccc
Q 003140 179 KTRHFHMNNNSISGQIPPELSRLPS---LVHMLLDNNNLTG----YLPPELSEL-PKLLILQLDNNNFEGT---TIPASY 247 (845)
Q Consensus 179 ~L~~L~L~~N~l~~~~p~~l~~l~~---L~~L~L~~N~l~~----~~p~~l~~l-~~L~~L~Ls~N~l~~~---~~p~~~ 247 (845)
+|+.|++++|.+.+..+..+..+.. |++|++++|++++ .+...+..+ ++|+.|+|++|.+++. .++..+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 9999999999998766666665555 9999999999883 333456667 8999999999999842 234456
Q ss_pred ccCCCccEEEcccCCCCCCC-----CCCCCCCCccEEEcccccCCcCCCCC-----CCccccCEEEccCCcCCCCccccc
Q 003140 248 SNMSKLLKLSLRNCSLQGPM-----PDLSRIPNLGYLDLSSNQLNGSIPPG-----RLSLNITTIKLSNNKLTGTIPSNF 317 (845)
Q Consensus 248 ~~l~~L~~L~Ls~N~l~~~~-----~~l~~l~~L~~L~Ls~N~l~~~ip~~-----~~~~~L~~L~Ls~N~l~~~~p~~~ 317 (845)
..+++|+.|+|++|.+++.. ..+..+++|+.|++++|.+++..... ....+|+.|++++|.+++.....+
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l 241 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAAL 241 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHH
Confidence 77789999999999998521 12556679999999999987433221 123479999999999986433333
Q ss_pred C-----CCCCCCeEecccccCcccCChhhhh-hccCCCCcceEEEccCCCCCCCCCC-----C-CC-CCCcEEEecCCcc
Q 003140 318 S-----GLPRLQRLFIANNSLSGSIPSSIWQ-SRTLNATETFILDFQNNNLTNISGS-----F-NI-PPNVTVRLRGNPF 384 (845)
Q Consensus 318 ~-----~l~~L~~L~L~~N~l~~~ip~~l~~-l~~l~~~~l~~L~ls~N~l~~i~~~-----~-~~-~~l~~l~l~~Np~ 384 (845)
. ..+.|+.|++++|.++......+.. +.. .+.|+.+++++|.++.-+.. . .. +.+..+++.+|||
T Consensus 242 ~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~--~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 242 ASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAE--KESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhc--CCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 2 2478999999999997332222221 222 25678999999999854321 1 23 6888899999886
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-16 Score=161.27 Aligned_cols=141 Identities=19% Similarity=0.162 Sum_probs=110.4
Q ss_pred HHHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChh----------------------hHHHHHHHHHHHHhc
Q 003140 620 ALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ----------------------GEKEFLTEIQFLSRL 677 (845)
Q Consensus 620 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~----------------------~~~~~~~Ei~~l~~l 677 (845)
......|...+.||+|+||.||++...+|+.||||++...... ....+..|..++.++
T Consensus 11 ~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 90 (198)
T cd05144 11 VKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL 90 (198)
T ss_pred HHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH
Confidence 3333347778999999999999999888999999986542200 112367789999999
Q ss_pred CCCc--eeeEEEEEeeCCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 003140 678 HHRN--LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 755 (845)
Q Consensus 678 ~H~n--Iv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~N 755 (845)
.|++ +++.++ ....++||||+++++|...... .....++.++++++.++|+.+ |+||||||+|
T Consensus 91 ~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~N 155 (198)
T cd05144 91 YEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFN 155 (198)
T ss_pred HHcCCCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCccc
Confidence 8774 444444 2456899999999999775421 234568889999999999988 9999999999
Q ss_pred EEEcCCCcEEEEecCCcccC
Q 003140 756 ILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 756 ILl~~~~~~kl~DFGla~~~ 775 (845)
|++++++.++|+|||++...
T Consensus 156 ill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 156 ILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred EEEcCCCcEEEEECCccccC
Confidence 99999999999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-16 Score=164.87 Aligned_cols=143 Identities=20% Similarity=0.149 Sum_probs=111.2
Q ss_pred CCCCCccccccCceEEEEEE--eCCCcEEEEEEccCCChh------------------------hHHHHHHHHHHHHhcC
Q 003140 625 NFNSSTQIGQGGYGKVYKGI--LPDGTVVAVKRAQEGSLQ------------------------GEKEFLTEIQFLSRLH 678 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~--~~~g~~vAVK~~~~~~~~------------------------~~~~~~~Ei~~l~~l~ 678 (845)
-|.+.+.||+|+||.||+|. ..+|+.||||+++..... ....+..|++.++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 568999999988643210 0123568999999997
Q ss_pred CC--ceeeEEEEEeeCCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 003140 679 HR--NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 756 (845)
Q Consensus 679 H~--nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NI 756 (845)
+. .+.+.+++ ...++||||+++++|..+.... ..+.......++.|++.+++|||+.+ .|+||||||+||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NI 180 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNI 180 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhE
Confidence 53 34455543 2358999999998887654222 23555667789999999999999876 399999999999
Q ss_pred EEcCCCcEEEEecCCcccCC
Q 003140 757 LLDHKFTAKVADFGLSRLAP 776 (845)
Q Consensus 757 Ll~~~~~~kl~DFGla~~~~ 776 (845)
+++ ++.++|+|||.|....
T Consensus 181 li~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEE-CCCEEEEEChhhhccC
Confidence 999 8899999999988654
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-16 Score=185.72 Aligned_cols=139 Identities=20% Similarity=0.293 Sum_probs=113.4
Q ss_pred HhcCCCCCccccccCceEEEEEEeCCCcEEEEEE-ccCC-C------hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKR-AQEG-S------LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 693 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~-~~~~-~------~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~ 693 (845)
....|...+.||+|+||.||+|.+.+.. +++|+ .... . ....+++.+|++++++++|++++....++....
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 3445567889999999999999875543 33333 2211 1 112356889999999999999998888887777
Q ss_pred eEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003140 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (845)
Q Consensus 694 ~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~ 773 (845)
..++||||+++++|.+++. .+..++.+++++|.|||+.+ |+||||||+|||+ .++.++|+|||+++
T Consensus 410 ~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 8899999999999999885 35678999999999999998 9999999999999 67899999999998
Q ss_pred cC
Q 003140 774 LA 775 (845)
Q Consensus 774 ~~ 775 (845)
..
T Consensus 476 ~~ 477 (535)
T PRK09605 476 YS 477 (535)
T ss_pred cC
Confidence 64
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.1e-16 Score=184.75 Aligned_cols=157 Identities=35% Similarity=0.566 Sum_probs=114.6
Q ss_pred CCCCCHHHHHHHHHHHHhccCCCCCCCCCCCCCCCC---CCCcceEecCCCCCCCcceEeEEEecCCCCcccCCCCccCC
Q 003140 29 DSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCT---SNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRL 105 (845)
Q Consensus 29 ~~~~~~~~~~al~~~k~~~~~~~~~l~~W~~~~~c~---~~w~Gv~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~l~~L 105 (845)
...+++.|.+||+++|+++.++. ..+|. +++|+ +.|.||.|..... .....++.|+|.+++++|.+|+.++.|
T Consensus 366 ~~~t~~~~~~aL~~~k~~~~~~~--~~~W~-g~~C~p~~~~w~Gv~C~~~~~-~~~~~v~~L~L~~n~L~g~ip~~i~~L 441 (623)
T PLN03150 366 ESKTLLEEVSALQTLKSSLGLPL--RFGWN-GDPCVPQQHPWSGADCQFDST-KGKWFIDGLGLDNQGLRGFIPNDISKL 441 (623)
T ss_pred ccccCchHHHHHHHHHHhcCCcc--cCCCC-CCCCCCcccccccceeeccCC-CCceEEEEEECCCCCccccCCHHHhCC
Confidence 44678889999999999987542 24896 46774 3699999953211 112357888888888888888888888
Q ss_pred CCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCc-cCCCEEE
Q 003140 106 SYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANL-NKTRHFH 184 (845)
Q Consensus 106 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~ 184 (845)
++|+.|+|++|+++|.+|..++++++|+.|+|++|+++|.+|..+++|++|+.|+|++|+++|.+|..+..+ .++..++
T Consensus 442 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~ 521 (623)
T PLN03150 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFN 521 (623)
T ss_pred CCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEE
Confidence 888888888888888888778888888888888888887777777777777777777777777777666543 2344444
Q ss_pred ccCCC
Q 003140 185 MNNNS 189 (845)
Q Consensus 185 L~~N~ 189 (845)
+.+|.
T Consensus 522 ~~~N~ 526 (623)
T PLN03150 522 FTDNA 526 (623)
T ss_pred ecCCc
Confidence 44443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.5e-16 Score=160.18 Aligned_cols=194 Identities=24% Similarity=0.302 Sum_probs=129.8
Q ss_pred CCccccccCceEEEEEEeC-CCcEEEEEEccCC---ChhhHHHHHHHHHHHHhcCC----------CceeeEEEE-----
Q 003140 628 SSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG---SLQGEKEFLTEIQFLSRLHH----------RNLVSLVGY----- 688 (845)
Q Consensus 628 ~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~~l~~l~H----------~nIv~l~g~----- 688 (845)
..+.||.|+++.||.+++. +|+.+|||++... .....+++.+|.-....+.+ -.++.-++.
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 3567999999999999986 5899999986532 22335667777655555322 122211111
Q ss_pred ----EeeC---C-----eEEEEEEcCCCCCHHHHHhc---cC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 003140 689 ----CDEE---G-----EQMLVYEFMSNGTLRDQLSA---KS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI 751 (845)
Q Consensus 689 ----~~~~---~-----~~~LV~E~~~~gsL~~~l~~---~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDL 751 (845)
.... . ..+++|+-+ .+||.+++.- .. ...+....++.+..|+++.+++||+.+ ++|+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEeccc
Confidence 1111 1 236778877 5889887542 22 223556778888899999999999999 999999
Q ss_pred CCCCEEEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcC--------CCCCchhhHHHHHHHHH
Q 003140 752 KASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--------HKLTDKSDVYSLGVVFL 823 (845)
Q Consensus 752 k~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwS~Gvvl~ 823 (845)
||+|++++.+|.++|+||+...... ........+..|.+||.... ..++.+.|.|++|+++|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g----------~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly 241 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAG----------TRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY 241 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETT----------EEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred ceeeEEEcCCCCEEEcChHHHeecC----------ceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence 9999999999999999999776532 11111345588999997744 25788999999999999
Q ss_pred HHHhCCCCCCCC
Q 003140 824 ELLTGMQPISHG 835 (845)
Q Consensus 824 elltG~~Pf~~~ 835 (845)
.|.+|+.||...
T Consensus 242 ~lWC~~lPf~~~ 253 (288)
T PF14531_consen 242 SLWCGRLPFGLS 253 (288)
T ss_dssp HHHHSS-STCCC
T ss_pred HHHHccCCCCCC
Confidence 999999999743
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.6e-16 Score=163.02 Aligned_cols=150 Identities=24% Similarity=0.294 Sum_probs=111.9
Q ss_pred CCCceeeEEEEEee---------------------------CCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHH
Q 003140 678 HHRNLVSLVGYCDE---------------------------EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 730 (845)
Q Consensus 678 ~H~nIv~l~g~~~~---------------------------~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ 730 (845)
+|||||++.++|.+ ....|+||.-++ .+|..|+..+. .+...+.-|..|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC---CchHHHHHHHHH
Confidence 59999999886643 335689998774 69999996543 456667778899
Q ss_pred HHHHHHHHHhCCCCCeEecCCCCCCEEE--cCCC--cEEEEecCCcccCCCCCCCCccc--cceeecccCCCCccchhhh
Q 003140 731 SSRGILYLHTEADPPVFHRDIKASNILL--DHKF--TAKVADFGLSRLAPVPDIEGIVP--AHVSTVVKGTPGYLDPEYF 804 (845)
Q Consensus 731 ia~gL~yLH~~~~~~iiHrDLk~~NILl--~~~~--~~kl~DFGla~~~~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~ 804 (845)
+++|+.|||.++ |.|||+|++|||+ |+|+ .+.|+|||++---.. .+..- .......-|...-||||+.
T Consensus 350 lLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~---hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 350 LLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDN---HGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccc---cccccccccccccCCCcceecchhhh
Confidence 999999999999 9999999999999 3444 578999998732111 11101 1112334578889999988
Q ss_pred cCCC------CCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 805 LTHK------LTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 805 ~~~~------~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
.... -..|+|.|+.|.+.||+++...||-...+
T Consensus 424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe 462 (598)
T KOG4158|consen 424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE 462 (598)
T ss_pred hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch
Confidence 5431 24589999999999999999999976444
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.9e-15 Score=141.34 Aligned_cols=135 Identities=19% Similarity=0.163 Sum_probs=115.4
Q ss_pred CCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCC--CceeeEEEEEeeCCeEEEEEEcCCCC
Q 003140 628 SSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH--RNLVSLVGYCDEEGEQMLVYEFMSNG 705 (845)
Q Consensus 628 ~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~LV~E~~~~g 705 (845)
+.+.||+|.++.||++...+ ..+++|....... ..++.+|+.+++.++| ..+++++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35779999999999999855 7899999866433 5678999999999976 58999999988888999999999887
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003140 706 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (845)
Q Consensus 706 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~ 774 (845)
.+..+ +......++.+++++++++|.....+++|||++|+||++++.+.++++|||.++.
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 5566778899999999999986555699999999999999999999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.59 E-value=6.7e-16 Score=178.13 Aligned_cols=170 Identities=28% Similarity=0.443 Sum_probs=122.0
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcC
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 702 (845)
.+|+.++.|..|+||.||..+++ ..+.+|.|+-+..- +.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l------ilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL------ILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccch------hhhc--cccccCCccee-------------------
Confidence 57888999999999999999876 35678885433211 1110 22222333333
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC----C
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV----P 778 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~----~ 778 (845)
|+-...++..+..+. .. +.+++|||+.+ |+|||+||+|.+|+.-|++|++|||+.+..-. .
T Consensus 136 --gDc~tllk~~g~lPv--dm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 --GDCATLLKNIGPLPV--DM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred --chhhhhcccCCCCcc--hh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 666666654333332 22 67899999998 99999999999999999999999999864211 1
Q ss_pred CCCCcc----ccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 779 DIEGIV----PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 779 ~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.+++.. ..-......||+.|+|||++....|+..+|+|++|+++||.+-|+.||++.
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd 261 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 261 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence 111110 011123457999999999999999999999999999999999999999875
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=7.3e-15 Score=147.31 Aligned_cols=136 Identities=23% Similarity=0.218 Sum_probs=98.4
Q ss_pred CccccccCceEEEEEEeCCCcEEEEEEccCCChh--hHHH----------------------HHHHHHHHHhcCCC--ce
Q 003140 629 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--GEKE----------------------FLTEIQFLSRLHHR--NL 682 (845)
Q Consensus 629 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~--~~~~----------------------~~~Ei~~l~~l~H~--nI 682 (845)
.+.||+|+||.||+|...+|+.||||++...... .... ...|.+.+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999987653211 1111 13566666666443 34
Q ss_pred eeEEEEEeeCCeEEEEEEcCCCCCHHH-HHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcC
Q 003140 683 VSLVGYCDEEGEQMLVYEFMSNGTLRD-QLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDH 760 (845)
Q Consensus 683 v~l~g~~~~~~~~~LV~E~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDLk~~NILl~~ 760 (845)
.+.+++ ...++||||++++.+.. .+.... .. .....++.+++.++.++|. .+ |+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 455543 24589999999854321 111110 01 5567889999999999998 77 99999999999999
Q ss_pred CCcEEEEecCCcccCC
Q 003140 761 KFTAKVADFGLSRLAP 776 (845)
Q Consensus 761 ~~~~kl~DFGla~~~~ 776 (845)
++.++++|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.4e-14 Score=147.51 Aligned_cols=136 Identities=21% Similarity=0.243 Sum_probs=106.1
Q ss_pred Ccccc-ccCceEEEEEEeCCCcEEEEEEccCCC-------------hhhHHHHHHHHHHHHhcCCCce--eeEEEEEeeC
Q 003140 629 STQIG-QGGYGKVYKGILPDGTVVAVKRAQEGS-------------LQGEKEFLTEIQFLSRLHHRNL--VSLVGYCDEE 692 (845)
Q Consensus 629 ~~~LG-~G~fG~Vy~~~~~~g~~vAVK~~~~~~-------------~~~~~~~~~Ei~~l~~l~H~nI--v~l~g~~~~~ 692 (845)
...|| .|+.|+||++... +..++||++.... ......+.+|++++.+++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 8999999998874 6788999875321 1223568899999999998775 6777765432
Q ss_pred C-e---EEEEEEcCCC-CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 003140 693 G-E---QMLVYEFMSN-GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVA 767 (845)
Q Consensus 693 ~-~---~~LV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~ 767 (845)
. . .++||||+++ .+|.+++... +++.. .+.+++.++.+||+.+ |+||||||+|||++.++.++|+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 2 3599999997 6999988542 34433 3568899999999999 9999999999999999999999
Q ss_pred ecCCcccC
Q 003140 768 DFGLSRLA 775 (845)
Q Consensus 768 DFGla~~~ 775 (845)
|||.++..
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99998764
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=7.1e-15 Score=162.79 Aligned_cols=155 Identities=30% Similarity=0.518 Sum_probs=127.7
Q ss_pred HHhcCCCceeeEEEEEeeCCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe-EecCCC
Q 003140 674 LSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV-FHRDIK 752 (845)
Q Consensus 674 l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i-iHrDLk 752 (845)
|+.+.|.|+.+|+|.+.++...+.|.+|+..|+|.+.+.. ....++|.-...++.+|+.||+|||.-. | .|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeeec
Confidence 4578999999999999999999999999999999999976 4556899999999999999999999754 5 899999
Q ss_pred CCCEEEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCC---C----CCchhhHHHHHHHHHHH
Q 003140 753 ASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH---K----LTDKSDVYSLGVVFLEL 825 (845)
Q Consensus 753 ~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~----~~~~~DvwS~Gvvl~el 825 (845)
++|+++|....+|++|||+........ .........-..-|.|||.+... . .+.+.||||||++++|+
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~-----~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei 151 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETA-----EPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI 151 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccc-----cccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence 999999999999999999987764210 00111112234679999998763 1 46789999999999999
Q ss_pred HhCCCCCCCCCC
Q 003140 826 LTGMQPISHGKN 837 (845)
Q Consensus 826 ltG~~Pf~~~~~ 837 (845)
++.+.||.....
T Consensus 152 ~~r~~~~~~~~~ 163 (484)
T KOG1023|consen 152 LFRSGPFDLRNL 163 (484)
T ss_pred HhccCccccccc
Confidence 999999976433
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.54 E-value=2e-15 Score=163.70 Aligned_cols=128 Identities=27% Similarity=0.401 Sum_probs=110.0
Q ss_pred CeEEEEEEcCCCCCHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 003140 693 GEQMLVYEFMSNGTLRDQLSA-KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 771 (845)
Q Consensus 693 ~~~~LV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGl 771 (845)
...++.|++|+-.+|.+|+.+ ......++.....++.|++.|++| ++ .+|||+||.||+...+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 357899999999999999974 445667888999999999999999 66 89999999999999999999999999
Q ss_pred cccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh
Q 003140 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 827 (845)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt 827 (845)
........ .........+...||..||+||.+.+..|+.|+||||+|++++|+++
T Consensus 403 ~ts~~~~~-~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDE-TVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCC-cccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 87654332 22223445677889999999999999999999999999999999997
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.9e-13 Score=152.61 Aligned_cols=141 Identities=23% Similarity=0.247 Sum_probs=102.5
Q ss_pred CccccccCceEEEEEEeCCCcEEEEEEccCCChhh----------------------------------------HHHHH
Q 003140 629 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG----------------------------------------EKEFL 668 (845)
Q Consensus 629 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~----------------------------------------~~~~~ 668 (845)
.+.||.|++|.||+|++.+|+.||||+.++..... +-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 46899999999999999999999999987642111 01355
Q ss_pred HHHHHHHhcC----CCceeeEEEEE-eeCCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 003140 669 TEIQFLSRLH----HRNLVSLVGYC-DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR-GILYLHTEA 742 (845)
Q Consensus 669 ~Ei~~l~~l~----H~nIv~l~g~~-~~~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~~ 742 (845)
+|.+.+.+++ |.+-+.+-..+ ......+|||||++|++|.++...... .. .+.+++..+++ .+..+|..+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHhCC
Confidence 6766666652 33323332333 334567999999999999887653211 12 23456666666 478889888
Q ss_pred CCCeEecCCCCCCEEEcCCCcEEEEecCCcccCC
Q 003140 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (845)
Q Consensus 743 ~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~ 776 (845)
++|+|+||.||++++++.++++|||++..+.
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999997764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.1e-14 Score=157.79 Aligned_cols=195 Identities=25% Similarity=0.411 Sum_probs=161.0
Q ss_pred cCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCE
Q 003140 103 GRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRH 182 (845)
Q Consensus 103 ~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 182 (845)
-.|..-...||+.|++. .+|..+..+..|+.|.|.+|.+. .+|..+.+|..|++|||+.|+++ .+|..+..|+ |+.
T Consensus 72 ~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkv 147 (722)
T KOG0532|consen 72 YDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKV 147 (722)
T ss_pred ccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-cee
Confidence 44666678889999988 78888888889999999999998 88889999999999999999988 7777777775 788
Q ss_pred EEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCC
Q 003140 183 FHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCS 262 (845)
Q Consensus 183 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~ 262 (845)
|-+++|+++ .+|..++.++.|..||.+.|++. .+|..++.+.+|+.|.+..|++. .+|..+..| .|..||+++|+
T Consensus 148 li~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~--~lp~El~~L-pLi~lDfScNk 222 (722)
T KOG0532|consen 148 LIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE--DLPEELCSL-PLIRLDFSCNK 222 (722)
T ss_pred EEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh--hCCHHHhCC-ceeeeecccCc
Confidence 889999998 78888888889999999999988 67888888899999999999886 578877743 58889999999
Q ss_pred CCCCCCCCCCCCCccEEEcccccCCcCCCCCCCcc---c-cCEEEccCC
Q 003140 263 LQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL---N-ITTIKLSNN 307 (845)
Q Consensus 263 l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~---~-L~~L~Ls~N 307 (845)
+..++-.|.+|..|++|-|.+|.|. ..|+..+.+ + .++|+..-+
T Consensus 223 is~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~ 270 (722)
T KOG0532|consen 223 ISYLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQAC 270 (722)
T ss_pred eeecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhc
Confidence 9888888999999999999999998 666655443 1 355665555
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.41 E-value=8.9e-15 Score=158.37 Aligned_cols=183 Identities=29% Similarity=0.502 Sum_probs=131.2
Q ss_pred cccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcce
Q 003140 127 GNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVH 206 (845)
Q Consensus 127 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 206 (845)
..++--...||+.|++. ++|..+..+-.|+.|.|..|.+. .+|..+.++..|++|+|+.|+++ .+|..+..++ |+.
T Consensus 72 ~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkv 147 (722)
T KOG0532|consen 72 YDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKV 147 (722)
T ss_pred ccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-cee
Confidence 34556678888888888 88888888888888888888888 77888888888888888888887 6666666554 677
Q ss_pred eeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccC
Q 003140 207 MLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQL 286 (845)
Q Consensus 207 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l 286 (845)
|-+++|+++ .+|+.++.+.+|..||.+.|.+. .+|..++++.+|+.|.+..|++...++++.
T Consensus 148 li~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~--slpsql~~l~slr~l~vrRn~l~~lp~El~--------------- 209 (722)
T KOG0532|consen 148 LIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ--SLPSQLGYLTSLRDLNVRRNHLEDLPEELC--------------- 209 (722)
T ss_pred EEEecCccc-cCCcccccchhHHHhhhhhhhhh--hchHHhhhHHHHHHHHHhhhhhhhCCHHHh---------------
Confidence 777777777 66777776677777777777775 466667777777777766666665555544
Q ss_pred CcCCCCCCCccccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCChhhh
Q 003140 287 NGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIW 342 (845)
Q Consensus 287 ~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~ 342 (845)
...|..||+|.|+++ .+|-.|.+|..|++|-|.+|.|+ .-|..+.
T Consensus 210 ---------~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC 254 (722)
T KOG0532|consen 210 ---------SLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQIC 254 (722)
T ss_pred ---------CCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHH
Confidence 334445555555555 66777777778888888888777 4455443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.5e-13 Score=151.88 Aligned_cols=198 Identities=37% Similarity=0.526 Sum_probs=118.5
Q ss_pred EEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccc-cchhhhccCCCCCCCCCCccCCCCccceeeccccc
Q 003140 87 LQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIK-SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNY 165 (845)
Q Consensus 87 L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 165 (845)
+++..+.+...+ ..+..++.++.|++.+|+++ .+|.....++ +|+.|++++|++. .+|..+..+++|+.|++++|+
T Consensus 98 l~~~~~~~~~~~-~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~ 174 (394)
T COG4886 98 LDLNLNRLRSNI-SELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND 174 (394)
T ss_pred eeccccccccCc-hhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCch
Confidence 445444443222 23444466677777777766 4555555553 6777777777766 555566666777777777777
Q ss_pred ccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCcc
Q 003140 166 ISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPA 245 (845)
Q Consensus 166 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~ 245 (845)
++ .+|.....+++|+.|++++|++. .+|........|++|.+++|++. ..+..+..+.++..|.+.+|++.. .+.
T Consensus 175 l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~--~~~ 249 (394)
T COG4886 175 LS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED--LPE 249 (394)
T ss_pred hh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee--ccc
Confidence 66 45555556666666777777666 55555444555666666666433 344456666666666666666642 355
Q ss_pred ccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCCcCCCCC
Q 003140 246 SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG 293 (845)
Q Consensus 246 ~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~ 293 (845)
.+.++++|+.|++++|+++.... +..+.+|+.|++++|.+....|..
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~i~~-~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISSISS-LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred hhccccccceecccccccccccc-ccccCccCEEeccCccccccchhh
Confidence 56666666666666666665554 556666666666666666444443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=5.1e-14 Score=163.58 Aligned_cols=205 Identities=25% Similarity=0.324 Sum_probs=160.8
Q ss_pred cCCCCCccccccCceEEEEEEeC--CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCeEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP--DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV 698 (845)
..|...+.||+|+|+.|-..... ....+|+|.+.... ....+....|..+-+.+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 45667778999999999877653 34567777665433 223344555777777775 99999999999999999999
Q ss_pred EEcCCCCCHHHHH-hccCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCCCCCCEEEcCCC-cEEEEecCCcccC
Q 003140 699 YEFMSNGTLRDQL-SAKSKEPLGFAMRLSIALGSSRGILYLH-TEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLA 775 (845)
Q Consensus 699 ~E~~~~gsL~~~l-~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~iiHrDLk~~NILl~~~~-~~kl~DFGla~~~ 775 (845)
+||.++|++.+-+ +... ...+....-.+..|+..++.|+| +.+ +.|||+||+|.+++..+ ..+++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~~~~-~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDS-TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccCCc-cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 9999999998888 3332 13444455568899999999999 877 99999999999999999 9999999999876
Q ss_pred CC-CCCCCccccceeecccC-CCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 776 PV-PDIEGIVPAHVSTVVKG-TPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 776 ~~-~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
.. .. .........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+.....
T Consensus 176 ~~~~g-----~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~ 235 (601)
T KOG0590|consen 176 RNKNG-----AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR 235 (601)
T ss_pred cccCC-----cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc
Confidence 54 22 1233344567 9999999998874 557789999999999999999999975433
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.34 E-value=7.1e-13 Score=149.33 Aligned_cols=198 Identities=32% Similarity=0.503 Sum_probs=112.1
Q ss_pred EEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCC-ccceeecccccccCCCCccccCccCCCEEEccCC
Q 003140 110 ILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLP-KLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN 188 (845)
Q Consensus 110 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 188 (845)
.|++..|.+...+ ..+..++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..+.++++|+.|++++|
T Consensus 97 ~l~~~~~~~~~~~-~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRSNI-SELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccccCc-hhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 4666666654222 23445566666777776666 5566565553 6666666666666 44455666666666666666
Q ss_pred CCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCC
Q 003140 189 SISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP 268 (845)
Q Consensus 189 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 268 (845)
+++ .+|...+.+++|+.|++++|+++ .+|........|++|.+++|++. ..+..+.+++++..|.+.+|++...+.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~--~~~~~~~~~~~l~~l~l~~n~~~~~~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII--ELLSSLSNLKNLSGLELSNNKLEDLPE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce--ecchhhhhcccccccccCCceeeeccc
Confidence 666 44444445566666666666666 44444444445666666666432 344455555555555555555554444
Q ss_pred CCCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCCh
Q 003140 269 DLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPS 339 (845)
Q Consensus 269 ~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~ 339 (845)
.+..+++|++|++++|.++ ...+ ++.+.+|+.|++++|.+....|.
T Consensus 250 ~~~~l~~l~~L~~s~n~i~-----------------------~i~~--~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 250 SIGNLSNLETLDLSNNQIS-----------------------SISS--LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred hhccccccceecccccccc-----------------------cccc--ccccCccCEEeccCccccccchh
Confidence 4444555555555555554 2222 55666666666666666644444
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.4e-11 Score=121.24 Aligned_cols=131 Identities=16% Similarity=0.104 Sum_probs=97.5
Q ss_pred CccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcee-eEEEEEeeCCeEEEEEEcCCCCCH
Q 003140 629 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV-SLVGYCDEEGEQMLVYEFMSNGTL 707 (845)
Q Consensus 629 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~LV~E~~~~gsL 707 (845)
.+.++.|.++.||++... +..|++|....... ....+..|+++++.+.+.+++ +++++.. +..++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 457899999999999874 77899999765432 223567899999988655544 4554433 345799999999887
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003140 708 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA--DPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (845)
Q Consensus 708 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~ 774 (845)
.+.- .....++.+++++++.||+.. ...++|||++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5430 011235678999999999876 23369999999999999 66899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.2e-11 Score=138.82 Aligned_cols=146 Identities=18% Similarity=0.209 Sum_probs=96.9
Q ss_pred hcCCCCCccccccCceEEEEEEeCC-CcEEEEEEccCCChh---------------------------------------
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQ--------------------------------------- 662 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~~~~~~~~--------------------------------------- 662 (845)
...|+. +.||+|++|.||+|++++ |+.||||+.++.-.+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345666 789999999999999987 999999998754210
Q ss_pred -hHHHHHHHHHHHHhcC----CCceeeEEEEEe-eCCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHH-HH
Q 003140 663 -GEKEFLTEIQFLSRLH----HRNLVSLVGYCD-EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR-GI 735 (845)
Q Consensus 663 -~~~~~~~Ei~~l~~l~----H~nIv~l~g~~~-~~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-gL 735 (845)
.+-+|.+|+..+.+++ +...+.+-.++. -....+|||||++|+.+.++-.-.. ...+.. .++...++ -+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~-~g~d~~---~la~~~v~~~~ 273 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA-AGTDMK---LLAERGVEVFF 273 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh-cCCCHH---HHHHHHHHHHH
Confidence 0113556666555553 444444444443 3567899999999999987432111 111111 12221111 12
Q ss_pred HHHHhCCCCCeEecCCCCCCEEEcCCC----cEEEEecCCcccCC
Q 003140 736 LYLHTEADPPVFHRDIKASNILLDHKF----TAKVADFGLSRLAP 776 (845)
Q Consensus 736 ~yLH~~~~~~iiHrDLk~~NILl~~~~----~~kl~DFGla~~~~ 776 (845)
.-+...+ ++|+|+||.||+++.++ .+++.|||++..+.
T Consensus 274 ~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 274 TQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 3344567 99999999999999988 99999999987664
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.4e-10 Score=115.06 Aligned_cols=137 Identities=17% Similarity=0.092 Sum_probs=99.4
Q ss_pred CccccccCceEEEEEEeCC-------CcEEEEEEccCCCh---------------------hh-HHHH----HHHHHHHH
Q 003140 629 STQIGQGGYGKVYKGILPD-------GTVVAVKRAQEGSL---------------------QG-EKEF----LTEIQFLS 675 (845)
Q Consensus 629 ~~~LG~G~fG~Vy~~~~~~-------g~~vAVK~~~~~~~---------------------~~-~~~~----~~Ei~~l~ 675 (845)
...||.|.-+.||.|...+ +..+|||+++.... .+ .+.+ .+|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999998653 47999997653210 00 1122 38999999
Q ss_pred hcCC--CceeeEEEEEeeCCeEEEEEEcCCCCCHHH-HHhccCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCC
Q 003140 676 RLHH--RNLVSLVGYCDEEGEQMLVYEFMSNGTLRD-QLSAKSKEPLGFAMRLSIALGSSRGILYL-HTEADPPVFHRDI 751 (845)
Q Consensus 676 ~l~H--~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiHrDL 751 (845)
++.. -++.+.+++ ...+|||||+.++.+.. .+++ ..++......+..+++.+|.+| |+.+ ||||||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 9853 566677765 56789999997654422 2322 1244455667788999999999 7887 999999
Q ss_pred CCCCEEEcCCCcEEEEecCCcccCC
Q 003140 752 KASNILLDHKFTAKVADFGLSRLAP 776 (845)
Q Consensus 752 k~~NILl~~~~~~kl~DFGla~~~~ 776 (845)
++.||+++ ++.++|+|||.|....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4689999999886554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.9e-10 Score=107.73 Aligned_cols=144 Identities=22% Similarity=0.234 Sum_probs=109.3
Q ss_pred CCccccccCceEEEEEEeCCCcEEEEEEccCCCh--------hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 628 SSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL--------QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 628 ~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~--------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
....+-+|+-+.|+++.+ .|+...||.-..... -..++..+|++.+.+++--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 467899999999999998 577777775332211 12356789999999987666665555666667777999
Q ss_pred EcCCC-CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC---cEEEEecCCcccC
Q 003140 700 EFMSN-GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TAKVADFGLSRLA 775 (845)
Q Consensus 700 E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~---~~kl~DFGla~~~ 775 (845)
||+++ .++.+++................+..|-+.+.-||.++ |||+||..+||++..++ .+.++|||++..-
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhcc
Confidence 99975 48888887754433333334678888889999999999 99999999999997655 4689999998653
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.4e-11 Score=122.90 Aligned_cols=156 Identities=24% Similarity=0.379 Sum_probs=117.0
Q ss_pred HHHHhcCCCceeeEEEEEeeCC-----eEEEEEEcCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 003140 672 QFLSRLHHRNLVSLVGYCDEEG-----EQMLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADP 744 (845)
Q Consensus 672 ~~l~~l~H~nIv~l~g~~~~~~-----~~~LV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 744 (845)
.-+-++.|-|||++..|+.+.+ ...++.|||..|++.++|++. ....+....-.+++-||..||.|||+. .|
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 3444567999999999986543 478999999999999999873 345677777788999999999999985 69
Q ss_pred CeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHH
Q 003140 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLE 824 (845)
Q Consensus 745 ~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~e 824 (845)
+|+|+++..+-|++.+++-+||.----... ..... ...........+-++|.|||+-.....+.++|||+||+...|
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~--h~s~~-~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDST--HPSVN-STREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCcccc--chhhh-hhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 999999999999999999988752111000 00000 001111223346689999998877778889999999999999
Q ss_pred HHhCCCC
Q 003140 825 LLTGMQP 831 (845)
Q Consensus 825 lltG~~P 831 (845)
|.-|..-
T Consensus 275 mailEiq 281 (458)
T KOG1266|consen 275 MAILEIQ 281 (458)
T ss_pred HHHheec
Confidence 9877543
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.3e-12 Score=136.17 Aligned_cols=184 Identities=21% Similarity=0.251 Sum_probs=80.3
Q ss_pred CCCCccceeecccccccCCC--CccccCccCCCEEEccCCCCCCCCccc-cCCCCCcceeeccccccccC-CCcccCCCC
Q 003140 151 GYLPKLDRIQIDQNYISGSL--PKSFANLNKTRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGY-LPPELSELP 226 (845)
Q Consensus 151 ~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~L~~N~l~~~-~p~~l~~l~ 226 (845)
..+++++.|||++|-+.... -.....|++|+.|+|+.|++.....+. -..++.|+.|.|+.|.|+.. +...+..++
T Consensus 143 k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fP 222 (505)
T KOG3207|consen 143 KILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFP 222 (505)
T ss_pred hhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCC
Confidence 33444444444444443221 122333444444444444443221111 11234444555555544411 111123344
Q ss_pred CCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCC--CCCCCCCCccEEEcccccCCcC-CCCC------CCcc
Q 003140 227 KLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPM--PDLSRIPNLGYLDLSSNQLNGS-IPPG------RLSL 297 (845)
Q Consensus 227 ~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--~~l~~l~~L~~L~Ls~N~l~~~-ip~~------~~~~ 297 (845)
+|+.|+|..|...+ ........+..|+.|||++|++-... +..+.++.|..|+++.+.+... +|+. ....
T Consensus 223 sl~~L~L~~N~~~~-~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~ 301 (505)
T KOG3207|consen 223 SLEVLYLEANEIIL-IKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFP 301 (505)
T ss_pred cHHHhhhhcccccc-eecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccc
Confidence 55555555553211 12222333444555555555554433 2344555555555555555421 1221 1112
Q ss_pred ccCEEEccCCcCCCC-cccccCCCCCCCeEecccccCcc
Q 003140 298 NITTIKLSNNKLTGT-IPSNFSGLPRLQRLFIANNSLSG 335 (845)
Q Consensus 298 ~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~ 335 (845)
+|+.|+++.|++... .-..+..+++|+.|.+..|.|..
T Consensus 302 kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 302 KLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred cceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 566666666655321 11334556777778888888763
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.3e-11 Score=142.30 Aligned_cols=110 Identities=26% Similarity=0.426 Sum_probs=99.8
Q ss_pred cchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeecc
Q 003140 131 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLD 210 (845)
Q Consensus 131 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 210 (845)
.++.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..+..+++|+.|+|++|+++|.+|..++++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCcccCCC-CCCcEEEccCCcCCC
Q 003140 211 NNNLTGYLPPELSEL-PKLLILQLDNNNFEG 240 (845)
Q Consensus 211 ~N~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~ 240 (845)
+|+++|.+|..+..+ .++..+++.+|...+
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc 529 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLC 529 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCcccc
Confidence 999999999988764 467889999987654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.5e-10 Score=126.61 Aligned_cols=166 Identities=20% Similarity=0.218 Sum_probs=126.5
Q ss_pred eCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHH
Q 003140 645 LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR 724 (845)
Q Consensus 645 ~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~ 724 (845)
..++..|.|..++...........+-++.|+.+|||||++++..++.++..|||+|-+. -|..++.+.+ ....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-----~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-----KEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-----HHHH
Confidence 34788899998876555444556777899999999999999999999999999999984 5777776543 4455
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhh
Q 003140 725 LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 804 (845)
Q Consensus 725 ~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 804 (845)
...+.||+.||.+||+.++ ++|++|.-+-|++++.|+.||++|.++.....-+. +. ....--..|..|+.+
T Consensus 107 ~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~----~~---~~~~~~~s~~~P~~~ 177 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA----PA---KSLYLIESFDDPEEI 177 (690)
T ss_pred HHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc----cc---ccchhhhcccChhhc
Confidence 5678899999999997764 99999999999999999999999998764322110 00 011112356777755
Q ss_pred cCCCCCchhhHHHHHHHHHHHHhC
Q 003140 805 LTHKLTDKSDVYSLGVVFLELLTG 828 (845)
Q Consensus 805 ~~~~~~~~~DvwS~Gvvl~elltG 828 (845)
.... -..|.|-|||+++|++.|
T Consensus 178 ~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 178 DPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred Cccc--cchhhhhHHHHHHHHhCc
Confidence 3333 236999999999999999
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=5e-10 Score=106.96 Aligned_cols=132 Identities=22% Similarity=0.305 Sum_probs=101.5
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEccCCChh--------hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 630 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~--------~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
..+++|+-+.+|.+.+. |..+.+|.-.++... ...+-.+|++++.+++--.|...+-|..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 45899999999999774 444666643332211 124567899999999766666666677777888899999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
+++-.|.+.+... +..++..+-+-+.-||..+ |+|+||.++||.+..+. +.++|||++.+-
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999999888654 2345666667778899999 99999999999998776 999999999754
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.14 E-value=6.1e-12 Score=126.38 Aligned_cols=135 Identities=21% Similarity=0.290 Sum_probs=89.8
Q ss_pred cccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCCCCCCCCC
Q 003140 196 PELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPN 275 (845)
Q Consensus 196 ~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~ 275 (845)
..+.....|++|||++|.|+ .+.++..-+++++.|++++|+++. + ..+..+++|+.|||++|.++.....-.++-+
T Consensus 278 ~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~--v-~nLa~L~~L~~LDLS~N~Ls~~~Gwh~KLGN 353 (490)
T KOG1259|consen 278 VSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT--V-QNLAELPQLQLLDLSGNLLAECVGWHLKLGN 353 (490)
T ss_pred EecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceee--e-hhhhhcccceEeecccchhHhhhhhHhhhcC
Confidence 33445567777788888777 566667777788888888888763 2 3477777788888888777665544445567
Q ss_pred ccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCc-ccccCCCCCCCeEecccccCcc
Q 003140 276 LGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTI-PSNFSGLPRLQRLFIANNSLSG 335 (845)
Q Consensus 276 L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~ 335 (845)
++.|.|+.|.|. .+.-.....+|..||+++|+|.... -..+++||-|+.|.|.+|.+.+
T Consensus 354 IKtL~La~N~iE-~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 354 IKTLKLAQNKIE-TLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred EeeeehhhhhHh-hhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 777777777775 2222222236777777777776432 2456778888888888888773
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.8e-11 Score=131.93 Aligned_cols=204 Identities=24% Similarity=0.268 Sum_probs=158.7
Q ss_pred cCCCCCccccc--cCceEEEEEEe---CCCcEEEEEEccCC--ChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeE
Q 003140 624 NNFNSSTQIGQ--GGYGKVYKGIL---PDGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQ 695 (845)
Q Consensus 624 ~~f~~~~~LG~--G~fG~Vy~~~~---~~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 695 (845)
..|...+.+|. |.+|.||++.. .++..+|+|+-+.. .......=.+|+....++ .|+|.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34566788999 99999999986 36888999984432 223333446677777777 499999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEEecC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR----GILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFG 770 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~iiHrDLk~~NILl~~~-~~~kl~DFG 770 (845)
++-+|++ +.+|.++.+... ..++....+.+..+..+ |+.++|+.. ++|-|+||.||+...+ ...+++|||
T Consensus 194 fiqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 9999988 478888776532 23556666677777777 999999988 9999999999999999 899999999
Q ss_pred CcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 771 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 771 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
+...+...+.... ........|...|++||... +.++.++|+||+|.++.|...|..++..+
T Consensus 269 ~v~~i~~~~~~~~--~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 269 LVSKISDGNFSSV--FKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred eeEEccCCccccc--eeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCC
Confidence 9987765543321 12223336788999999764 46789999999999999999998887655
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.1e-12 Score=126.39 Aligned_cols=182 Identities=21% Similarity=0.253 Sum_probs=125.8
Q ss_pred CCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCC-----------------------CCCCCccCCCC
Q 003140 98 LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT-----------------------GSLPEELGYLP 154 (845)
Q Consensus 98 ~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-----------------------~~~p~~~~~l~ 154 (845)
+|-.+.-+.+|..+.++.+.-.. |-.-...-+.|+++...+..+. |..-..+....
T Consensus 206 l~f~l~~f~~l~~~~~s~~~~~~-i~~~~~~kptl~t~~v~~s~~~~~~~l~pe~~~~D~~~~E~~t~~G~~~~~~dTWq 284 (490)
T KOG1259|consen 206 LSFNLNAFRNLKTLKFSALSTEN-IVDIELLKPTLQTICVHNTTIQDVPSLLPETILADPSGSEPSTSNGSALVSADTWQ 284 (490)
T ss_pred cccchHHhhhhheeeeeccchhh-eeceeecCchhheeeeecccccccccccchhhhcCccCCCCCccCCceEEecchHh
Confidence 44455666777777777764331 1111111234555555444333 11122233345
Q ss_pred ccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEcc
Q 003140 155 KLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 234 (845)
Q Consensus 155 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 234 (845)
.|++||||+|.|+ .+.++..-+++++.|++++|.|. .+. .+..+++|+.|||++|.++. +...-.++.+.++|.|+
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLAE-CVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhHh-hhhhHhhhcCEeeeehh
Confidence 7889999999988 77888888899999999999987 333 37888899999999998883 33444567888999999
Q ss_pred CCcCCCCCCccccccCCCccEEEcccCCCCCCCC--CCCCCCCccEEEcccccCC
Q 003140 235 NNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP--DLSRIPNLGYLDLSSNQLN 287 (845)
Q Consensus 235 ~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~--~l~~l~~L~~L~Ls~N~l~ 287 (845)
+|.+.. -..++.+-+|..||+++|++..... .++++|-|+.|.|.+|.+.
T Consensus 361 ~N~iE~---LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~ 412 (490)
T KOG1259|consen 361 QNKIET---LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA 412 (490)
T ss_pred hhhHhh---hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence 998853 2567777888889999998876443 5888888888888888887
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.7e-10 Score=116.32 Aligned_cols=143 Identities=22% Similarity=0.326 Sum_probs=111.2
Q ss_pred CccccccCceEEEEEEeCCCcEEEEEEccCCCh-hhHHHHHHHHHHHHhcCC--CceeeEEEEEeeCC---eEEEEEEcC
Q 003140 629 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHH--RNLVSLVGYCDEEG---EQMLVYEFM 702 (845)
Q Consensus 629 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~-~~~~~~~~Ei~~l~~l~H--~nIv~l~g~~~~~~---~~~LV~E~~ 702 (845)
.+.|+.|..+.||++...+|+.+++|....... ....++..|+++++.+++ ..+.+++.+....+ ..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 356899999999999987778999998765332 234578899999999975 44677888776543 568999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA---------------------------------------- 742 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------- 742 (845)
+++++.+.+.. ..++...+..++.+++++|.+||+..
T Consensus 83 ~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 83 DGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 99888765421 24677778888888888888888521
Q ss_pred -------------CCCeEecCCCCCCEEEcC--CCcEEEEecCCccc
Q 003140 743 -------------DPPVFHRDIKASNILLDH--KFTAKVADFGLSRL 774 (845)
Q Consensus 743 -------------~~~iiHrDLk~~NILl~~--~~~~kl~DFGla~~ 774 (845)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 67789999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.12 E-value=9.9e-12 Score=131.42 Aligned_cols=209 Identities=20% Similarity=0.242 Sum_probs=148.3
Q ss_pred cCCCCccEEEecCCCCCCCCc--ccccccccchhhhccCCCCCCCC--CCccCCCCccceeecccccccCCCCcc-ccCc
Q 003140 103 GRLSYLTILDFMWNKISGSIP--KEIGNIKSLELLLLNGNELTGSL--PEELGYLPKLDRIQIDQNYISGSLPKS-FANL 177 (845)
Q Consensus 103 ~~L~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l 177 (845)
.++.+|+.+.|.+..+.. .+ .....|++++.|||++|-|.... -.....|++|+.|+|+.|++....... -..+
T Consensus 118 sn~kkL~~IsLdn~~V~~-~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVED-AGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCccccc-cchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 467888888888887762 23 35667888899999988887332 233567888999999999887433322 2356
Q ss_pred cCCCEEEccCCCCCC-CCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEE
Q 003140 178 NKTRHFHMNNNSISG-QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKL 256 (845)
Q Consensus 178 ~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L 256 (845)
+.|+.|.|+.|.|+- .+...+..+|+|+.|+|..|.....-......+..|++|||++|++-....-...+.++.|..|
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence 788999999998872 2233455678999999999964333334455577899999999988654444567888899999
Q ss_pred EcccCCCCCCC-CC------CCCCCCccEEEcccccCCc--CCCCCCCccccCEEEccCCcCCCC
Q 003140 257 SLRNCSLQGPM-PD------LSRIPNLGYLDLSSNQLNG--SIPPGRLSLNITTIKLSNNKLTGT 312 (845)
Q Consensus 257 ~Ls~N~l~~~~-~~------l~~l~~L~~L~Ls~N~l~~--~ip~~~~~~~L~~L~Ls~N~l~~~ 312 (845)
+++.+.++..- ++ ...+++|++|+++.|++.. .+.......+|+.|.+..|.|+..
T Consensus 277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~e 341 (505)
T KOG3207|consen 277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNKE 341 (505)
T ss_pred hccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccccc
Confidence 99999887632 22 3567899999999999852 222334455888888888888743
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.5e-11 Score=118.01 Aligned_cols=108 Identities=33% Similarity=0.536 Sum_probs=24.6
Q ss_pred ccccccchhhhccCCCCCCCCCCccC-CCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCcccc-CCCCC
Q 003140 126 IGNIKSLELLLLNGNELTGSLPEELG-YLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL-SRLPS 203 (845)
Q Consensus 126 ~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l-~~l~~ 203 (845)
+.+..++++|+|.+|+|+ .+ +.++ .+.+|+.|+|++|.|+.. +.+..+++|+.|++++|+|+. +...+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT
T ss_pred cccccccccccccccccc-cc-cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc-cccchHHhCCc
Confidence 445556777777777776 33 2344 466667777777766632 235555666666666666652 22222 23555
Q ss_pred cceeeccccccccCCC-cccCCCCCCcEEEccCCcC
Q 003140 204 LVHMLLDNNNLTGYLP-PELSELPKLLILQLDNNNF 238 (845)
Q Consensus 204 L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l 238 (845)
|++|+|++|+|...-. ..+..+++|+.|+|.+|.+
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv 125 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPV 125 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GG
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcc
Confidence 5555555555542110 1233344444444444444
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.9e-12 Score=133.40 Aligned_cols=135 Identities=19% Similarity=0.274 Sum_probs=68.5
Q ss_pred CCccceeecccccccCCCCc----cccCccCCCEEEccCCCCCCCC-------------ccccCCCCCcceeeccccccc
Q 003140 153 LPKLDRIQIDQNYISGSLPK----SFANLNKTRHFHMNNNSISGQI-------------PPELSRLPSLVHMLLDNNNLT 215 (845)
Q Consensus 153 l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~L~~N~l~~~~-------------p~~l~~l~~L~~L~L~~N~l~ 215 (845)
.++|++||||+|-|...-+. .+..+..|+.|+|.+|.+.-.- ....+.-+.|+++...+|++.
T Consensus 91 ~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrle 170 (382)
T KOG1909|consen 91 CPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLE 170 (382)
T ss_pred CCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccc
Confidence 34555555555555432222 2334455556666665554110 111233356666666666665
Q ss_pred cC----CCcccCCCCCCcEEEccCCcCCCC---CCccccccCCCccEEEcccCCCCCCCC-----CCCCCCCccEEEccc
Q 003140 216 GY----LPPELSELPKLLILQLDNNNFEGT---TIPASYSNMSKLLKLSLRNCSLQGPMP-----DLSRIPNLGYLDLSS 283 (845)
Q Consensus 216 ~~----~p~~l~~l~~L~~L~Ls~N~l~~~---~~p~~~~~l~~L~~L~Ls~N~l~~~~~-----~l~~l~~L~~L~Ls~ 283 (845)
.- +...|...+.|+.+.++.|.|... .+...|..+++|+.|||.+|-++.... .++.+++|+.|++++
T Consensus 171 n~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~d 250 (382)
T KOG1909|consen 171 NGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGD 250 (382)
T ss_pred cccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccc
Confidence 22 112344456666666666666421 123345566666666666666653221 255556666666666
Q ss_pred ccCC
Q 003140 284 NQLN 287 (845)
Q Consensus 284 N~l~ 287 (845)
|.+.
T Consensus 251 cll~ 254 (382)
T KOG1909|consen 251 CLLE 254 (382)
T ss_pred cccc
Confidence 6665
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.8e-11 Score=136.74 Aligned_cols=176 Identities=28% Similarity=0.348 Sum_probs=79.1
Q ss_pred CccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCC
Q 003140 101 EIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180 (845)
Q Consensus 101 ~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 180 (845)
.+..+++|+.|+|.+|+|.. +...+..+.+|++|+|++|+|+.. ..+..++.|+.|++++|.|+.. ..+..+++|
T Consensus 90 ~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L 164 (414)
T KOG0531|consen 90 HLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELNLSGNLISDI--SGLESLKSL 164 (414)
T ss_pred ccccccceeeeeccccchhh-cccchhhhhcchheeccccccccc--cchhhccchhhheeccCcchhc--cCCccchhh
Confidence 34555555555555555552 221244455555555555555532 2234444455555555555421 223335555
Q ss_pred CEEEccCCCCCCCCc-cccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCC--ccEEE
Q 003140 181 RHFHMNNNSISGQIP-PELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSK--LLKLS 257 (845)
Q Consensus 181 ~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~--L~~L~ 257 (845)
+.+++++|++...-+ . ...+.+|+.+++.+|.+... ..+..+..+..+++..|.++.. ..+..+.. |+.++
T Consensus 165 ~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~---~~l~~~~~~~L~~l~ 238 (414)
T KOG0531|consen 165 KLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKISKL---EGLNELVMLHLRELY 238 (414)
T ss_pred hcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccceec---cCcccchhHHHHHHh
Confidence 555555555552222 1 34445555555555555421 2233333344445555554321 11111121 44555
Q ss_pred cccCCCCCCCCCCCCCCCccEEEcccccCC
Q 003140 258 LRNCSLQGPMPDLSRIPNLGYLDLSSNQLN 287 (845)
Q Consensus 258 Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~ 287 (845)
+++|.+......+..+..+..|++++|++.
T Consensus 239 l~~n~i~~~~~~~~~~~~l~~l~~~~n~~~ 268 (414)
T KOG0531|consen 239 LSGNRISRSPEGLENLKNLPVLDLSSNRIS 268 (414)
T ss_pred cccCccccccccccccccccccchhhcccc
Confidence 555555443333444444455555555444
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.03 E-value=1e-10 Score=113.70 Aligned_cols=106 Identities=32% Similarity=0.448 Sum_probs=26.6
Q ss_pred CCCccEEEecCCCCCCCCccccc-ccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccc-cCccCCCE
Q 003140 105 LSYLTILDFMWNKISGSIPKEIG-NIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSF-ANLNKTRH 182 (845)
Q Consensus 105 L~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~ 182 (845)
..++++|+|++|.|+. |. .++ .+.+|+.|||++|.|+ .++ .+..+++|++|+|++|+|+. +...+ ..+++|+.
T Consensus 18 ~~~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~ 92 (175)
T PF14580_consen 18 PVKLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQE 92 (175)
T ss_dssp --------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT--E
T ss_pred cccccccccccccccc-cc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCc-cccchHHhCCcCCE
Confidence 3345556666666552 22 343 3455566666666655 222 35555566666666666653 22222 24555666
Q ss_pred EEccCCCCCCCC-ccccCCCCCcceeeccccccc
Q 003140 183 FHMNNNSISGQI-PPELSRLPSLVHMLLDNNNLT 215 (845)
Q Consensus 183 L~L~~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~ 215 (845)
|+|++|+|...- -..+..+++|+.|+|.+|.++
T Consensus 93 L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 93 LYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp EE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred EECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 666666554211 123445555666666666555
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.9e-11 Score=138.08 Aligned_cols=217 Identities=22% Similarity=0.273 Sum_probs=131.9
Q ss_pred CCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEc
Q 003140 106 SYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHM 185 (845)
Q Consensus 106 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 185 (845)
+.++.++...+.+.+.--. ...+..++.+++..|.+. .+-..+..+++|+.|++.+|+|. .+...+..+++|++|+|
T Consensus 49 ~~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~l 125 (414)
T KOG0531|consen 49 SDLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDL 125 (414)
T ss_pred chhhhhcchhccccchhhh-HHHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheec
Confidence 3445555555544321111 145677888888888887 44555778888888888888887 33434677788888888
Q ss_pred cCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccc-cccCCCccEEEcccCCCC
Q 003140 186 NNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPAS-YSNMSKLLKLSLRNCSLQ 264 (845)
Q Consensus 186 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~-~~~l~~L~~L~Ls~N~l~ 264 (845)
++|.|+... .+..++.|+.|++++|.++.. ..+..++.|+.+++++|++... ... ...+.+|+.+++..|.+.
T Consensus 126 s~N~I~~i~--~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~i--e~~~~~~~~~l~~l~l~~n~i~ 199 (414)
T KOG0531|consen 126 SFNKITKLE--GLSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDI--ENDELSELISLEELDLGGNSIR 199 (414)
T ss_pred ccccccccc--chhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhh--hhhhhhhccchHHHhccCCchh
Confidence 888887443 345666678888888887743 3455577777788888877642 221 466677777777777765
Q ss_pred CCCCCCCCCCCccEEEcccccCCcCCCCCCCcc--ccCEEEccCCcCCCCcccccCCCCCCCeEecccccCc
Q 003140 265 GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 334 (845)
Q Consensus 265 ~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 334 (845)
.... +..+..+..+++..|.++..- ...... .|+.+++++|++. .++..+..+..+..|++.+|++.
T Consensus 200 ~i~~-~~~~~~l~~~~l~~n~i~~~~-~l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~ 268 (414)
T KOG0531|consen 200 EIEG-LDLLKKLVLLSLLDNKISKLE-GLNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRIS 268 (414)
T ss_pred cccc-hHHHHHHHHhhcccccceecc-CcccchhHHHHHHhcccCccc-cccccccccccccccchhhcccc
Confidence 3322 233334444466666665222 111111 2566666666665 22244555556666666666655
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.3e-11 Score=125.59 Aligned_cols=257 Identities=21% Similarity=0.239 Sum_probs=148.6
Q ss_pred CCccCCCCccEEEecCCCCCC----CCcccccccccchhhhccCC---CCCCCCCCccCCCCccceeecccccccCCCCc
Q 003140 100 PEIGRLSYLTILDFMWNKISG----SIPKEIGNIKSLELLLLNGN---ELTGSLPEELGYLPKLDRIQIDQNYISGSLPK 172 (845)
Q Consensus 100 ~~l~~L~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N---~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 172 (845)
+.+..+..++.|+|++|.|.. .+-..+.+.++|+..++++= ++...+|+.+. .+..
T Consensus 24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~-----------------~l~~ 86 (382)
T KOG1909|consen 24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALK-----------------MLSK 86 (382)
T ss_pred HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHH-----------------HHHH
Confidence 345567778888888887753 23344556666766666642 12222332221 1224
Q ss_pred cccCccCCCEEEccCCCCCCCCccc----cCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccc
Q 003140 173 SFANLNKTRHFHMNNNSISGQIPPE----LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYS 248 (845)
Q Consensus 173 ~~~~l~~L~~L~L~~N~l~~~~p~~----l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~ 248 (845)
.+...++|++|+||+|-|.-..+.. +.+..+|+.|+|.+|.+.-.--..++. .|..|. .|+. ..
T Consensus 87 aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~kk--------~~ 154 (382)
T KOG1909|consen 87 ALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNKK--------AA 154 (382)
T ss_pred HHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHhc--------cC
Confidence 5666779999999999997544433 456788999999999876221111111 111111 1111 11
Q ss_pred cCCCccEEEcccCCCCCCCCC-----CCCCCCccEEEcccccCCcCCCC-----CCCccccCEEEccCCcCCC----Ccc
Q 003140 249 NMSKLLKLSLRNCSLQGPMPD-----LSRIPNLGYLDLSSNQLNGSIPP-----GRLSLNITTIKLSNNKLTG----TIP 314 (845)
Q Consensus 249 ~l~~L~~L~Ls~N~l~~~~~~-----l~~l~~L~~L~Ls~N~l~~~ip~-----~~~~~~L~~L~Ls~N~l~~----~~p 314 (845)
+-++|+.+...+|++...... |...+.|+.+.+++|.|...--. .....+|+.|||++|-++. .+.
T Consensus 155 ~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~La 234 (382)
T KOG1909|consen 155 SKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALA 234 (382)
T ss_pred CCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHH
Confidence 224555555555555443321 44445566666666655411110 0122356666666665542 245
Q ss_pred cccCCCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCC-----CCCCC-CCCCCcEEEecCCccc
Q 003140 315 SNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN-----ISGSF-NIPPNVTVRLRGNPFC 385 (845)
Q Consensus 315 ~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~-----i~~~~-~~~~l~~l~l~~Np~~ 385 (845)
+.+..+++|++|+++++.++..--..+.....=..+.|++|+|.+|.++. +...+ ..|.+..|.|++|-+.
T Consensus 235 kaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 235 KALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred HHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 66777888888888888888776666655433346788888888888873 11112 3788888999998873
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.97 E-value=2.7e-10 Score=126.63 Aligned_cols=198 Identities=21% Similarity=0.249 Sum_probs=152.8
Q ss_pred HHHHhcCCCCCccccccCceEEEEEEeC--CCcEEEEEEccCCChhhHHH--HHHHHHHHHhc-CCCceeeEEEEEeeCC
Q 003140 619 MALATNNFNSSTQIGQGGYGKVYKGILP--DGTVVAVKRAQEGSLQGEKE--FLTEIQFLSRL-HHRNLVSLVGYCDEEG 693 (845)
Q Consensus 619 ~~~~~~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vAVK~~~~~~~~~~~~--~~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 693 (845)
......+|..+..||.|.|+.|++...+ ++..+++|...........+ -..|+-+...+ .|.+++..+..+...+
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 3445678889999999999999988743 67899999887654433322 24566666666 5899998888888888
Q ss_pred eEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEEecCCc
Q 003140 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLS 772 (845)
Q Consensus 694 ~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~-~~~kl~DFGla 772 (845)
..++--||++++++...+ .....++...++.+..|++.++.++|+.. ++|+|+||+||++..+ +..+++|||++
T Consensus 340 ~~~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred cccCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccc
Confidence 888999999999987766 23345677788899999999999999888 9999999999999886 78899999998
Q ss_pred ccCCCCCCCCccccceeecccCCCCcc--chhhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003140 773 RLAPVPDIEGIVPAHVSTVVKGTPGYL--DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831 (845)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~P 831 (845)
..+.. .........++. +++......+..+.|++|||.-+.|.++|..-
T Consensus 415 t~~~~----------~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 415 TRLAF----------SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred cccce----------ecccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 64321 111222233344 56666778889999999999999999988643
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=2.3e-10 Score=137.98 Aligned_cols=104 Identities=26% Similarity=0.335 Sum_probs=54.0
Q ss_pred EeEEEecCCC--CcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeec
Q 003140 84 LRELQLLNLN--LSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (845)
Q Consensus 84 v~~L~L~~~~--l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (845)
+++|-+.++. +.....+.|..++.|++|||++|.=-+.+|..+++|-+||+|+|+++.++ .+|..+.+|..|.+|++
T Consensus 547 L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl 625 (889)
T KOG4658|consen 547 LRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNL 625 (889)
T ss_pred cceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheecc
Confidence 4444444443 22222233455555555555555444455555555555555555555555 55555555555555555
Q ss_pred ccccccCCCCccccCccCCCEEEccCC
Q 003140 162 DQNYISGSLPKSFANLNKTRHFHMNNN 188 (845)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N 188 (845)
..+.-...+|.....|.+|++|.+..-
T Consensus 626 ~~~~~l~~~~~i~~~L~~Lr~L~l~~s 652 (889)
T KOG4658|consen 626 EVTGRLESIPGILLELQSLRVLRLPRS 652 (889)
T ss_pred ccccccccccchhhhcccccEEEeecc
Confidence 555444344444445555555555443
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.91 E-value=3.2e-08 Score=104.01 Aligned_cols=140 Identities=14% Similarity=0.136 Sum_probs=101.9
Q ss_pred cccccCceEEEEEEeCCCcEEEEEEccCCChhh-H----------HHHHHHHHHHHhcCCCc--eeeEEEEEee-----C
Q 003140 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG-E----------KEFLTEIQFLSRLHHRN--LVSLVGYCDE-----E 692 (845)
Q Consensus 631 ~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~-~----------~~~~~Ei~~l~~l~H~n--Iv~l~g~~~~-----~ 692 (845)
.+-+-....|++..+ +|+.+.||+........ . ..+.+|.+.+.++...+ .++.+++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 344444455777666 67889999775433111 1 14789999888885333 3355556543 2
Q ss_pred CeEEEEEEcCCCC-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-------CCcE
Q 003140 693 GEQMLVYEFMSNG-TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-------KFTA 764 (845)
Q Consensus 693 ~~~~LV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~-------~~~~ 764 (845)
...+||||++++- +|.+++......+.+...+..++.+++..+.-||..+ |+|+|++++|||++. +..+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceE
Confidence 3578999999875 8999885432334566777889999999999999999 999999999999975 4689
Q ss_pred EEEecCCccc
Q 003140 765 KVADFGLSRL 774 (845)
Q Consensus 765 kl~DFGla~~ 774 (845)
.++||+.++.
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.5e-08 Score=100.27 Aligned_cols=125 Identities=26% Similarity=0.309 Sum_probs=81.5
Q ss_pred EEEEEEeCCCcEEEEEEccCCChh--------------------------hHHHHHHHHHHHHhcCCC--ceeeEEEEEe
Q 003140 639 KVYKGILPDGTVVAVKRAQEGSLQ--------------------------GEKEFLTEIQFLSRLHHR--NLVSLVGYCD 690 (845)
Q Consensus 639 ~Vy~~~~~~g~~vAVK~~~~~~~~--------------------------~~~~~~~Ei~~l~~l~H~--nIv~l~g~~~ 690 (845)
.||.|...+|..+|||+.+..... ......+|.+.|.++... ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489999999999999986542110 013467899999999765 566776553
Q ss_pred eCCeEEEEEEcCC--CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 003140 691 EEGEQMLVYEFMS--NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILY-LHTEADPPVFHRDIKASNILLDHKFTAKVA 767 (845)
Q Consensus 691 ~~~~~~LV~E~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~iiHrDLk~~NILl~~~~~~kl~ 767 (845)
..+|||||++ +..+..+.... ++......+..++++.+.. +|..+ |+|+||.+.||+++++ .+.|+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEE
Confidence 3469999998 55554433221 1122344566677775555 57877 9999999999999988 99999
Q ss_pred ecCCcccC
Q 003140 768 DFGLSRLA 775 (845)
Q Consensus 768 DFGla~~~ 775 (845)
|||.+...
T Consensus 149 Df~qav~~ 156 (188)
T PF01163_consen 149 DFGQAVDS 156 (188)
T ss_dssp -GTTEEET
T ss_pred ecCcceec
Confidence 99988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.4e-09 Score=126.79 Aligned_cols=209 Identities=21% Similarity=0.270 Sum_probs=141.8
Q ss_pred HHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEE
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 696 (845)
...+.+.+.+.+.+|.++.+.-+.-. .|...+.|....... ...+....+-.+.-..+||-++...--+.......
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34566777788899999999876532 343334443222110 01111112222222234566665554455567789
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCC
Q 003140 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~ 776 (845)
||++|..+++|...++... ..+..........+....+|||... ++|||++|.|++...++..+++|||......
T Consensus 881 L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 9999999999999998754 2343444455566778899999877 8999999999999999999999998543221
Q ss_pred CC----CCC--------------------CccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 003140 777 VP----DIE--------------------GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 832 (845)
Q Consensus 777 ~~----~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf 832 (845)
.. +.. ............||+.|.|||...+......+|+|++|++++|.++|..||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 000 000012234457899999999999999999999999999999999999999
Q ss_pred CC
Q 003140 833 SH 834 (845)
Q Consensus 833 ~~ 834 (845)
..
T Consensus 1036 na 1037 (1205)
T KOG0606|consen 1036 NA 1037 (1205)
T ss_pred CC
Confidence 74
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=7.6e-11 Score=131.25 Aligned_cols=130 Identities=26% Similarity=0.364 Sum_probs=78.7
Q ss_pred CCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCCcCCCCC-CCccccCEEEcc
Q 003140 227 KLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG-RLSLNITTIKLS 305 (845)
Q Consensus 227 ~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~~~~L~~L~Ls 305 (845)
+|...+.+.|++. ....++.-++.|+.|+|++|+++... .+..+++|++|||++|.+. .+|.. ...-.|..|.|+
T Consensus 165 ~L~~a~fsyN~L~--~mD~SLqll~ale~LnLshNk~~~v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLV--LMDESLQLLPALESLNLSHNKFTKVD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHH--hHHHHHHHHHHhhhhccchhhhhhhH-HHHhcccccccccccchhc-cccccchhhhhheeeeec
Confidence 5666666777775 34556666777777777777776554 5667777777777777777 44432 222246666666
Q ss_pred CCcCCCCcccccCCCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCCCCCCCCcEEEecCCccc
Q 003140 306 NNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 385 (845)
Q Consensus 306 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~~~~~l~~l~l~~Np~~ 385 (845)
+|.++.. ..+.+|.+|+.||+++|-|.+-- ++...+.+..++.|+|.|||+|
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hs--------------------------eL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHS--------------------------ELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcch--------------------------hhhHHHHHHHHHHHhhcCCccc
Confidence 6666532 23455666666666666655211 1111123445667788888888
Q ss_pred ccC
Q 003140 386 LNT 388 (845)
Q Consensus 386 c~~ 388 (845)
|.-
T Consensus 293 c~p 295 (1096)
T KOG1859|consen 293 CAP 295 (1096)
T ss_pred cCH
Confidence 853
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=9.8e-09 Score=124.02 Aligned_cols=271 Identities=22% Similarity=0.241 Sum_probs=171.8
Q ss_pred eEeEEEecCCCCcccCCCCccCCCCccEEEecCCC--CCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceee
Q 003140 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNK--ISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (845)
Q Consensus 83 ~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~--l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (845)
.++...+-++.+.- ++.... .+.|++|-+..|. +....++.|..++.|++|||++|.=-+.+|..++.|-+|++|+
T Consensus 524 ~~rr~s~~~~~~~~-~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~ 601 (889)
T KOG4658|consen 524 SVRRMSLMNNKIEH-IAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLD 601 (889)
T ss_pred heeEEEEeccchhh-ccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhccc
Confidence 45666666665542 222222 2379999999996 5534445588899999999999987779999999999999999
Q ss_pred cccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccc--cccCCCcccCCCCCCcEEEccCCcC
Q 003140 161 IDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNN--LTGYLPPELSELPKLLILQLDNNNF 238 (845)
Q Consensus 161 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~--l~~~~p~~l~~l~~L~~L~Ls~N~l 238 (845)
|++..++ .+|..+.+|++|.+|++..+.-...+|.....|++|++|.+..-. .+...-..+..+.+|+.|.......
T Consensus 602 L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~ 680 (889)
T KOG4658|consen 602 LSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV 680 (889)
T ss_pred ccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh
Confidence 9999999 899999999999999999988766667777889999999987654 2233333445555555555533322
Q ss_pred CCCCCccccccCCCcc----EEEcccCCCCCCCCCCCCCCCccEEEcccccCCcCCCCCCCcc-------ccCEEEccCC
Q 003140 239 EGTTIPASYSNMSKLL----KLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-------NITTIKLSNN 307 (845)
Q Consensus 239 ~~~~~p~~~~~l~~L~----~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~-------~L~~L~Ls~N 307 (845)
.+-..+..+..|. .+.+..+........+..+.+|+.|.+.++.+........... ++..+...++
T Consensus 681 ---~~~e~l~~~~~L~~~~~~l~~~~~~~~~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~ 757 (889)
T KOG4658|consen 681 ---LLLEDLLGMTRLRSLLQSLSIEGCSKRTLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNC 757 (889)
T ss_pred ---HhHhhhhhhHHHHHHhHhhhhcccccceeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhcc
Confidence 1112233333333 3444445555555667888899999998888863322211110 1111111111
Q ss_pred cCCCCcccccCCCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCC
Q 003140 308 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 365 (845)
Q Consensus 308 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i 365 (845)
..- ..+.+.--.++|+.|++..+.....+.+....+..+. .+-+..+.+..+
T Consensus 758 ~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~-----~~i~~f~~~~~l 809 (889)
T KOG4658|consen 758 HML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELK-----ELILPFNKLEGL 809 (889)
T ss_pred ccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcc-----cEEecccccccc
Confidence 110 1223334567889999988887766666555554433 244445555444
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=1e-07 Score=96.73 Aligned_cols=136 Identities=22% Similarity=0.216 Sum_probs=97.3
Q ss_pred CCCccccccCceEEEEEEeCCCcEEEEEEccCCChh----------------------hHHHHHHHHHHHHhcCCC--ce
Q 003140 627 NSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ----------------------GEKEFLTEIQFLSRLHHR--NL 682 (845)
Q Consensus 627 ~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~----------------------~~~~~~~Ei~~l~~l~H~--nI 682 (845)
.+.+.||.|.-+.||.|..++|.++|||.-+..... ......+|.++|.++... .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 456789999999999999999999999953321100 112357899999999654 67
Q ss_pred eeEEEEEeeCCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC
Q 003140 683 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF 762 (845)
Q Consensus 683 v~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~ 762 (845)
.+.+++ +..++||||+++--|...- ++....-.+...|++-+.-+-..| |||+|+.+-||+++++|
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg 239 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCC
Confidence 776655 5678999999886554321 112223334444555555455677 99999999999999999
Q ss_pred cEEEEecCCcccCC
Q 003140 763 TAKVADFGLSRLAP 776 (845)
Q Consensus 763 ~~kl~DFGla~~~~ 776 (845)
.+.++||--+....
T Consensus 240 ~~~vIDwPQ~v~~~ 253 (304)
T COG0478 240 DIVVIDWPQAVPIS 253 (304)
T ss_pred CEEEEeCcccccCC
Confidence 99999997665443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.68 E-value=2.2e-07 Score=101.25 Aligned_cols=167 Identities=19% Similarity=0.255 Sum_probs=125.9
Q ss_pred ceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEe----eCCeEEEEEEcCCC-CCHHHH
Q 003140 637 YGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD----EEGEQMLVYEFMSN-GTLRDQ 710 (845)
Q Consensus 637 fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~----~~~~~~LV~E~~~~-gsL~~~ 710 (845)
-.+.||+... ||..|+.|+++.........-..-+++++++.|.|+|+|.+++. .+...++||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3567898854 89999999995433332223345688999999999999999875 34468999999986 688776
Q ss_pred Hhcc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 711 LSAK-------------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 711 l~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
-... .+...++...|.++.|+..||.++|+.| +.-+-|.+++|+++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 5332 1224678899999999999999999999 88899999999999999999988877655432
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQ 830 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~ 830 (845)
++ . |-+ .--.+-|.-.||.++.-|.||+.
T Consensus 446 d~-------------------~--~~l---e~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DP-------------------T--EPL---ESQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CC-------------------C--cch---hHHhhhhHHHHHHHHHHHhhccc
Confidence 21 0 111 11345788899999999999954
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.65 E-value=9.8e-09 Score=82.12 Aligned_cols=38 Identities=29% Similarity=0.601 Sum_probs=13.7
Q ss_pred CCCCccceeecccccccCCCCccccCccCCCEEEccCC
Q 003140 151 GYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN 188 (845)
Q Consensus 151 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 188 (845)
.++++|++|++++|+++...+..|.++++|++|++++|
T Consensus 22 ~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N 59 (61)
T PF13855_consen 22 SNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNN 59 (61)
T ss_dssp TTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSS
T ss_pred cCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCC
Confidence 33333333333333333333333333333333333333
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.8e-08 Score=80.62 Aligned_cols=61 Identities=33% Similarity=0.579 Sum_probs=37.0
Q ss_pred CccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeecccccc
Q 003140 154 PKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNL 214 (845)
Q Consensus 154 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l 214 (845)
++|++|+|++|+|+...+..|.++++|++|++++|.++...+..|..+++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3566666666666655555666666666666666666655455566666666666666553
|
... |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.3e-06 Score=86.99 Aligned_cols=138 Identities=19% Similarity=0.171 Sum_probs=104.9
Q ss_pred ccccCceEEEEEEeCCCcEEEEEEccCC---C---hhhHHHHHHHHHHHHhcCC--CceeeEEEEEe-e----CCeEEEE
Q 003140 632 IGQGGYGKVYKGILPDGTVVAVKRAQEG---S---LQGEKEFLTEIQFLSRLHH--RNLVSLVGYCD-E----EGEQMLV 698 (845)
Q Consensus 632 LG~G~fG~Vy~~~~~~g~~vAVK~~~~~---~---~~~~~~~~~Ei~~l~~l~H--~nIv~l~g~~~-~----~~~~~LV 698 (845)
-|+||-+.|++...+ |..+-+|+-... + +-....|.+|...+.++.. -.+.+.+ ++. . .-..+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 467888899987764 457888975421 1 2356789999999999853 2344554 332 1 1236899
Q ss_pred EEcCCC-CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc--EEEEecCCccc
Q 003140 699 YEFMSN-GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT--AKVADFGLSRL 774 (845)
Q Consensus 699 ~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~--~kl~DFGla~~ 774 (845)
+|-+++ -+|.+++......+.+...+..+..++++.+.-||..+ +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997753 69999987655556778888899999999999999999 999999999999986666 99999987764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.53 E-value=9.1e-07 Score=89.91 Aligned_cols=107 Identities=25% Similarity=0.294 Sum_probs=84.9
Q ss_pred HHHHHHHHHHHHhcCC--CceeeEEEEEeeCC----eEEEEEEcCCC-CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHH
Q 003140 664 EKEFLTEIQFLSRLHH--RNLVSLVGYCDEEG----EQMLVYEFMSN-GTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 736 (845)
Q Consensus 664 ~~~~~~Ei~~l~~l~H--~nIv~l~g~~~~~~----~~~LV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~ 736 (845)
.....+|.+.+..+.. -..++.+++..... ..++|+|++++ -+|.+++..... .+...+..++.++++.+.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 3467888888888753 33456666665532 45899999987 489999876332 556677889999999999
Q ss_pred HHHhCCCCCeEecCCCCCCEEEcCCC---cEEEEecCCcccC
Q 003140 737 YLHTEADPPVFHRDIKASNILLDHKF---TAKVADFGLSRLA 775 (845)
Q Consensus 737 yLH~~~~~~iiHrDLk~~NILl~~~~---~~kl~DFGla~~~ 775 (845)
-||+.+ |+|+|+++.|||++.+. .+.++||+-++..
T Consensus 133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999 99999999999999887 8999999987754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=3.5e-09 Score=118.28 Aligned_cols=127 Identities=24% Similarity=0.312 Sum_probs=69.5
Q ss_pred cchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCcc-ccCCCCCcceeec
Q 003140 131 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPP-ELSRLPSLVHMLL 209 (845)
Q Consensus 131 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~L 209 (845)
.|.+.+.+.|++. .+..++.-++.|+.|||++|+++... .+..|++|+.|||+.|.+. .+|. ....+ .|..|.+
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhh-hheeeee
Confidence 3555556666655 45555555666666666666665322 5556666666666666665 3332 11122 2666666
Q ss_pred cccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCC
Q 003140 210 DNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264 (845)
Q Consensus 210 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~ 264 (845)
++|.++.. ..+.++.+|+.|||++|-|.+..--..+..|..|+.|+|.+|.+-
T Consensus 240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 66666532 245556666666666666654333334455556666666666654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=7.2e-07 Score=101.46 Aligned_cols=140 Identities=22% Similarity=0.282 Sum_probs=97.5
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEccCCChhh----------------------------------------HHHHHH
Q 003140 630 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG----------------------------------------EKEFLT 669 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~----------------------------------------~~~~~~ 669 (845)
+.|+.++-|.||+|++++|+.||||+.++.-.+. +-+|.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 7899999999999999999999999877642211 012456
Q ss_pred HHHHHHhcC-----CCceeeEEEEEeeCCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHH-HHHHHhCCC
Q 003140 670 EIQFLSRLH-----HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRG-ILYLHTEAD 743 (845)
Q Consensus 670 Ei~~l~~l~-----H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~g-L~yLH~~~~ 743 (845)
|..-+.+++ .+++.----|++-.....|+|||++|-.+.+...-.. ...+ +..++..++++ +..+=..+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d---~k~ia~~~~~~f~~q~~~dg- 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGID---RKELAELLVRAFLRQLLRDG- 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCC---HHHHHHHHHHHHHHHHHhcC-
Confidence 666666652 3444333334455678899999999988888742222 2244 23334433332 33333456
Q ss_pred CCeEecCCCCCCEEEcCCCcEEEEecCCcccCC
Q 003140 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (845)
Q Consensus 744 ~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~ 776 (845)
++|.|.+|.||+++.++++.+.|||+...+.
T Consensus 286 --ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 286 --FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred --ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 9999999999999999999999999987654
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.5e-08 Score=100.86 Aligned_cols=205 Identities=18% Similarity=0.133 Sum_probs=128.4
Q ss_pred EeEEEecCCCCcccCC-CCcc-CCCCccEEEecCCCCCC--CCcccccccccchhhhccCCCCCCCCCCccCCCCcccee
Q 003140 84 LRELQLLNLNLSGNLS-PEIG-RLSYLTILDFMWNKISG--SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRI 159 (845)
Q Consensus 84 v~~L~L~~~~l~~~~~-~~l~-~L~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 159 (845)
+..|.+.++.|-..-. ..|+ ..+.+++|||.+|.|+. .|-.-+.+|+.|++|+|+.|.+...|-..-..+.+|+.|
T Consensus 47 ~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~l 126 (418)
T KOG2982|consen 47 LELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVL 126 (418)
T ss_pred hhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEE
Confidence 4455566666653211 2333 34778889999998875 344456778889999999998885443333566788888
Q ss_pred ecccccccC-CCCccccCccCCCEEEccCCCCCCCC--ccccC-CCCCcceeecccccccc--CCCcccCCCCCCcEEEc
Q 003140 160 QIDQNYISG-SLPKSFANLNKTRHFHMNNNSISGQI--PPELS-RLPSLVHMLLDNNNLTG--YLPPELSELPKLLILQL 233 (845)
Q Consensus 160 ~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~--p~~l~-~l~~L~~L~L~~N~l~~--~~p~~l~~l~~L~~L~L 233 (845)
-|.+..+.- .....+..++.++.|+++.|++.... ..... .-+.+.+|++..|...- .+..--..++++..+.+
T Consensus 127 VLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpnv~sv~v 206 (418)
T KOG2982|consen 127 VLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPNVNSVFV 206 (418)
T ss_pred EEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcccchheee
Confidence 888877663 23455677888888888888543110 11111 11234444443333220 00001122467788888
Q ss_pred cCCcCCCCCCccccccCCCccEEEcccCCCCC--CCCCCCCCCCccEEEcccccCCc
Q 003140 234 DNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG--PMPDLSRIPNLGYLDLSSNQLNG 288 (845)
Q Consensus 234 s~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~~~l~~l~~L~~L~Ls~N~l~~ 288 (845)
..|.+......+.+..++.+-.|+|+.|++.. ...++.++++|..|.+++|.+..
T Consensus 207 ~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d 263 (418)
T KOG2982|consen 207 CEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSD 263 (418)
T ss_pred ecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccc
Confidence 88888765556667777888888888888875 33357788888888888888763
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.44 E-value=2.5e-08 Score=100.92 Aligned_cols=194 Identities=21% Similarity=0.317 Sum_probs=137.9
Q ss_pred ceEeEEEecCCCCcc--cCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCC-CCCCCccCCCCccce
Q 003140 82 LHLRELQLLNLNLSG--NLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT-GSLPEELGYLPKLDR 158 (845)
Q Consensus 82 ~~v~~L~L~~~~l~~--~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~ 158 (845)
.+|+++||.+|.|+. .+-.-+.+|++|++|+|+.|.+...|-..-..+++|++|-|.+..+. ......+..++.++.
T Consensus 71 ~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vte 150 (418)
T KOG2982|consen 71 TDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTE 150 (418)
T ss_pred hhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhhh
Confidence 489999999999885 34445688999999999999998654321135679999999998876 234455778899999
Q ss_pred eecccccccCC--CCccccC-ccCCCEEEcc---------CCCCCCCCccccCCCCCcceeeccccccccCC-CcccCCC
Q 003140 159 IQIDQNYISGS--LPKSFAN-LNKTRHFHMN---------NNSISGQIPPELSRLPSLVHMLLDNNNLTGYL-PPELSEL 225 (845)
Q Consensus 159 L~Ls~N~l~~~--~p~~~~~-l~~L~~L~L~---------~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~l~~l 225 (845)
|++|.|.+... ..+.... -+.+++|++. -|++.. .+|++..+.+..|.+.... ...+..+
T Consensus 151 lHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r-------~Fpnv~sv~v~e~PlK~~s~ek~se~~ 223 (418)
T KOG2982|consen 151 LHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSR-------IFPNVNSVFVCEGPLKTESSEKGSEPF 223 (418)
T ss_pred hhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHh-------hcccchheeeecCcccchhhcccCCCC
Confidence 99999955421 1111111 1233444433 334432 3467888888888776432 2346667
Q ss_pred CCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCCC-------CCCCCCccEEEcc
Q 003140 226 PKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-------LSRIPNLGYLDLS 282 (845)
Q Consensus 226 ~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-------l~~l~~L~~L~Ls 282 (845)
+.+..|+|+.|+|..+..-+.+..+++|..|.+++|.+...... ++++++++.|+=+
T Consensus 224 p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l~~~err~llIaRL~~v~vLNGs 287 (418)
T KOG2982|consen 224 PSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPLRGGERRFLLIARLTKVQVLNGS 287 (418)
T ss_pred CcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccccccCCcceEEEEeeccceEEecCc
Confidence 88889999999998776677899999999999999999765442 5777888877654
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.8e-08 Score=90.76 Aligned_cols=112 Identities=25% Similarity=0.348 Sum_probs=80.4
Q ss_pred CCCCCCccEEEcccccCCcCCCCCCCcc--ccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCChhhhhhccC
Q 003140 270 LSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 347 (845)
Q Consensus 270 l~~l~~L~~L~Ls~N~l~~~ip~~~~~~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l 347 (845)
+.+...|+..+|++|.+. ..|..+... .++.|+|++|.|+ .+|..+..++.|+.|+++.|.+. ..|.-+.++.++
T Consensus 49 l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l 125 (177)
T KOG4579|consen 49 LSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKL 125 (177)
T ss_pred HhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhH
Confidence 344445555666666665 344433322 5677777777777 67888999999999999999998 788888777665
Q ss_pred CCCcceEEEccCCCCCCCCCCCCCCCC-cEEEecCCcccccCC
Q 003140 348 NATETFILDFQNNNLTNISGSFNIPPN-VTVRLRGNPFCLNTN 389 (845)
Q Consensus 348 ~~~~l~~L~ls~N~l~~i~~~~~~~~l-~~l~l~~Np~~c~~~ 389 (845)
. +||..+|.+..|+.+.-.+.+ ..+.++.|||.-.|.
T Consensus 126 ~-----~Lds~~na~~eid~dl~~s~~~al~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 126 D-----MLDSPENARAEIDVDLFYSSLPALIKLGNEPLGDETK 163 (177)
T ss_pred H-----HhcCCCCccccCcHHHhccccHHHHHhcCCcccccCc
Confidence 4 899999999999988644433 344568889886664
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=8e-06 Score=87.09 Aligned_cols=193 Identities=17% Similarity=0.184 Sum_probs=127.8
Q ss_pred CCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEE-----E-eeCC-eEEEEE
Q 003140 628 SSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGY-----C-DEEG-EQMLVY 699 (845)
Q Consensus 628 ~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~-----~-~~~~-~~~LV~ 699 (845)
..+.||+|+-+.+|-.- +-.-.+.|++.........+ .++.|... .||-+-.=+.+ + -+.+ ..-+.|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 46789999999999532 11123346665433322222 23344444 56544321111 1 1122 256778
Q ss_pred EcCCCC-CHHHHHhc----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003140 700 EFMSNG-TLRDQLSA----KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (845)
Q Consensus 700 E~~~~g-sL~~~l~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~ 774 (845)
..+++. -...+... +.-...+|...++.+..+|.+.+-||+.+ .+-+|+.++|+|+++++.+.+.|=.--..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 777654 22223221 22234789999999999999999999999 88899999999999999999988543332
Q ss_pred CCCCCCCCccccceeecccCCCCccchhhhc-----CCCCCchhhHHHHHHHHHHHHhC-CCCCCCCC
Q 003140 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTG-MQPISHGK 836 (845)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltG-~~Pf~~~~ 836 (845)
.. .+......+|...|.+||... +..-+...|-|.+|+++++++.| ++||.+-.
T Consensus 167 ~~--------ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~ 226 (637)
T COG4248 167 NA--------NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP 226 (637)
T ss_pred cc--------CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence 21 133344567889999999765 33456689999999999999987 99998643
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 845 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-51 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-49 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-46 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-46 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-36 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-36 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-35 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-33 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-30 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-29 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-22 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-22 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-22 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-21 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-21 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-21 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-21 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-21 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-21 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-21 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-21 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-21 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-21 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-21 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-21 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-21 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-21 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-21 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-21 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-21 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-21 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-21 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-21 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-21 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-21 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-21 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-20 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-20 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-20 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-20 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-20 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-17 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-17 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 9e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-13 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-13 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 4e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-13 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-13 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-13 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 6e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-13 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-13 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 6e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-13 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-13 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 7e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 8e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-12 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-12 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 9e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-05 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-05 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 6e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 7e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-05 | ||
| 1p8v_A | 279 | Crystal Structure Of The Complex Of Platelet Recept | 1e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1P8V|A Chain A, Crystal Structure Of The Complex Of Platelet Receptor Gpib-alpha And Alpha-thrombin At 2.6a Length = 279 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 401 bits (1033), Expect = e-134
Identities = 107/257 (41%), Positives = 145/257 (56%), Gaps = 16/257 (6%)
Query: 596 SRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKR 655
SS + + ++ ATNNF+ IG G +GKVYKG+L DG VA+KR
Sbjct: 12 INDALSSSYLVPFES-YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR 70
Query: 656 AQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--SA 713
S QG +EF TEI+ LS H +LVSL+G+CDE E +L+Y++M NG L+ L S
Sbjct: 71 RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD 130
Query: 714 KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773
+ + RL I +G++RG+ YLHT + HRD+K+ NILLD F K+ DFG+S+
Sbjct: 131 LPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISK 187
Query: 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833
D H+STVVKGT GY+DPEYF+ +LT+KSDVYS GVV E+L I
Sbjct: 188 KGTELD-----QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242
Query: 834 HGK-----NIVREVLPY 845
N+ +
Sbjct: 243 QSLPREMVNLAEWAVES 259
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 344 bits (885), Expect = e-112
Identities = 103/229 (44%), Positives = 152/229 (66%), Gaps = 9/229 (3%)
Query: 611 VRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG-EKEFLT 669
++ F+ E+ +A++NF++ +G+GG+GKVYKG L DGT+VAVKR +E QG E +F T
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 670 EIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--SAKSKEPLGFAMRLSI 727
E++ +S HRNL+ L G+C E++LVY +M+NG++ L +S+ PL + R I
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 728 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 787
ALGS+RG+ YLH DP + HRD+KA+NILLD +F A V DFGL++L D H
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD------TH 190
Query: 788 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836
V+T V+GT G++ PEY T K ++K+DV+ GV+ LEL+TG + +
Sbjct: 191 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 239
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 331 bits (851), Expect = e-107
Identities = 87/238 (36%), Positives = 137/238 (57%), Gaps = 21/238 (8%)
Query: 610 GVRSFTYGEMALATNNFNSSTQ------IGQGGYGKVYKGILPDGTVVAVKR----AQEG 659
SF++ E+ TNNF+ +G+GG+G VYKG + + T VAVK+
Sbjct: 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 69
Query: 660 SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL-SAKSKEP 718
+ + +++F EI+ +++ H NLV L+G+ + + LVY +M NG+L D+L P
Sbjct: 70 TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 719 LGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778
L + MR IA G++ GI +LH + HRDIK++NILLD FTAK++DFGL+R +
Sbjct: 130 LSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836
+++ + GT Y+ PE L ++T KSD+YS GVV LE++TG+ + +
Sbjct: 187 AQT-----VMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 238
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 261 bits (669), Expect = 1e-80
Identities = 88/319 (27%), Positives = 134/319 (42%), Gaps = 18/319 (5%)
Query: 31 ITDPIEVSALRSIKKSLVDDYSKLSNWNRG-DPCTSNWTGVLCFNTTMDDGYLHLRELQL 89
+ +P + AL IKK L + + LS+W D C W GVLC T + L L
Sbjct: 2 LCNPQDKQALLQIKKDLGNPTT-LSSWLPTTDCCNRTWLGVLCDTDT---QTYRVNNLDL 57
Query: 90 LNLNLSG--NLSPEIGRLSYLTILDFM-WNKISGSIPKEIGNIKSLELLLLNGNELTGSL 146
LNL + + L YL L N + G IP I + L L + ++G++
Sbjct: 58 SGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAI 117
Query: 147 PEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVH 206
P+ L + L + N +SG+LP S ++L + N ISG IP L
Sbjct: 118 PDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFT 177
Query: 207 ML-LDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG 265
+ + N LTG +PP + L L + L N EG + + K+ L SL
Sbjct: 178 SMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEG-DASVLFGSDKNTQKIHLAKNSLAF 235
Query: 266 PMPDLSRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTIKLSNNKLTGTIPS--NFSGLP 321
+ + NL LDL +N++ G++P +L + ++ +S N L G IP N
Sbjct: 236 DLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLK-FLHSLNVSFNNLCGEIPQGGNLQRFD 294
Query: 322 RLQRLFIANNSLSGSIPSS 340
+ N L GS +
Sbjct: 295 VSA--YANNKCLCGSPLPA 311
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 46/168 (27%), Positives = 77/168 (45%), Gaps = 15/168 (8%)
Query: 211 NNNLTGYLPPELSELPKLLILQLDNNNFEGT-TIPASYSNMSKLLKLSLRN-CSLQGPMP 268
N G L ++ ++ L L N IP+S +N+ L L + +L GP+P
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 269 D-LSRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQR 325
++++ L YL ++ ++G+IP ++ + T+ S N L+GT+P + S LP L
Sbjct: 95 PAIAKLTQLHYLYITHTNVSGAIPDFLSQIK-TLVTLDFSYNALSGTLPPSISSLPNLVG 153
Query: 326 LFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPP 373
+ N +SG+IP S L + N L +G IPP
Sbjct: 154 ITFDGNRISGAIPDSYGSFSKLFT----SMTISRNRL---TGK--IPP 192
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 7e-68
Identities = 87/312 (27%), Positives = 139/312 (44%), Gaps = 35/312 (11%)
Query: 80 GYLHLRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLL 136
LQ L L +G + P + S L L +N +SG+IP +G++ L L
Sbjct: 389 CQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLK 448
Query: 137 LNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPP 196
L N L G +P+EL Y+ L+ + +D N ++G +P +N ++NN ++G+IP
Sbjct: 449 LWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPK 508
Query: 197 ELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLK- 255
+ RL +L + L NN+ +G +P EL + L+ L L+ N F GT IPA+ S +
Sbjct: 509 WIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGT-IPAAMFKQSGKIAA 567
Query: 256 ---------------------LSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPP- 292
+ QG L+R+ +++S G P
Sbjct: 568 NFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPT 627
Query: 293 -GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATE 351
++ + +S N L+G IP +P L L + +N +SGSIP + R LN
Sbjct: 628 FDNNG-SMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLN--- 683
Query: 352 TFILDFQNNNLT 363
ILD +N L
Sbjct: 684 --ILDLSSNKLD 693
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 9e-66
Identities = 89/314 (28%), Positives = 132/314 (42%), Gaps = 23/314 (7%)
Query: 83 HLRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNG 139
EL+ L + +SG++ + R L LD N S IP +G+ +L+ L ++G
Sbjct: 176 GCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISG 232
Query: 140 NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELS 199
N+L+G + +L + I N G +P L ++ + N +G+IP LS
Sbjct: 233 NKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLS 290
Query: 200 -RLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASY-SNMSKLLKLS 257
+L + L N+ G +PP L L L +NNF G +P M L L
Sbjct: 291 GACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSG-ELPMDTLLKMRGLKVLD 349
Query: 258 LRNCSLQGPMPD-LSRI-PNLGYLDLSSNQLNGSIPP--GRLSL-NITTIKLSNNKLTGT 312
L G +P+ L+ + +L LDLSSN +G I P + + + L NN TG
Sbjct: 350 LSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGK 409
Query: 313 IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT-NISGSFNI 371
IP S L L ++ N LSG+IPSS+ L L N L I
Sbjct: 410 IPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLR-----DLKLWLNMLEGEIPQELMY 464
Query: 372 PPN-VTVRLRGNPF 384
T+ L N
Sbjct: 465 VKTLETLILDFNDL 478
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 2e-61
Identities = 67/287 (23%), Positives = 119/287 (41%), Gaps = 17/287 (5%)
Query: 84 LRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140
L +L+ L L L G + E+ + L L +N ++G IP + N +L + L+ N
Sbjct: 441 LSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNN 500
Query: 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR 200
LTG +P+ +G L L +++ N SG++P + +N N +G IP + +
Sbjct: 501 RLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK 560
Query: 201 LPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT-TIPASYSNMSKLLKLSLR 259
+ N + G + N E + +S ++
Sbjct: 561 QSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNIT 616
Query: 260 NCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTIKLSNNKLTGTIPSN 316
+ G ++ +LD+S N L+G IP G + + + L +N ++G+IP
Sbjct: 617 SRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMP-YLFILNLGHNDISGSIPDE 675
Query: 317 FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 363
L L L +++N L G IP ++ L +D NNNL+
Sbjct: 676 VGDLRGLNILDLSSNKLDGRIPQAMSALTMLT-----EIDLSNNNLS 717
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 3e-60
Identities = 66/337 (19%), Positives = 126/337 (37%), Gaps = 51/337 (15%)
Query: 36 EVSALRSIKKSLVDDYSKLSNWNRG-DPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNL 94
E+ L S K L D + L +W+ +PC + GV C + + + L + L
Sbjct: 13 EIHQLISFKDVLPDK-NLLPDWSSNKNPC--TFDGVTCRDD-------KVTSIDLSSKPL 62
Query: 95 SGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLP 154
+ ++ + ++ LE L L+ + + GS+
Sbjct: 63 NVGF---------------------SAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSA 100
Query: 155 KLDRIQIDQNYISGSLP--KSFANLNKTRHFHMNNNSISGQIP-PELSRLPSLVHMLLDN 211
L + + +N +SG + S + + + ++++N++ +L SL + L
Sbjct: 101 SLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSA 160
Query: 212 NNLTGYLPPEL---SELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP 268
N+++G +L L + N G + S L L + + + +P
Sbjct: 161 NSISGANVVGWVLSDGCGELKHLAISGNKISG-DVD--VSRCVNLEFLDVSSNNFSTGIP 217
Query: 269 DLSRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRL 326
L L +LD+S N+L+G + + + +S+N+ G IP L LQ L
Sbjct: 218 FLGDCSALQHLDISGNKLSGDFSRAISTCT-ELKLLNISSNQFVGPIPP--LPLKSLQYL 274
Query: 327 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 363
+A N +G IP + LD N+
Sbjct: 275 SLAENKFTGEIPDFLSG----ACDTLTGLDLSGNHFY 307
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-27
Identities = 34/158 (21%), Positives = 60/158 (37%), Gaps = 3/158 (1%)
Query: 89 LLNLNLSGNLSPEIGRLSYLTILDFMWN--KISGSIPKEIGNIKSLELLLLNGNELTGSL 146
+ ++G I N + G +++ + + + G
Sbjct: 565 IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHT 624
Query: 147 PEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVH 206
+ + + N +SG +PK ++ ++ +N ISG IP E+ L L
Sbjct: 625 SPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNI 684
Query: 207 MLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP 244
+ L +N L G +P +S L L + L NNN G IP
Sbjct: 685 LDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSG-PIP 721
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-25
Identities = 41/142 (28%), Positives = 66/142 (46%)
Query: 78 DDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLL 137
+DG L G S ++ RLS + G N S+ L +
Sbjct: 580 NDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDM 639
Query: 138 NGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE 197
+ N L+G +P+E+G +P L + + N ISGS+P +L +++N + G+IP
Sbjct: 640 SYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQA 699
Query: 198 LSRLPSLVHMLLDNNNLTGYLP 219
+S L L + L NNNL+G +P
Sbjct: 700 MSALTMLTEIDLSNNNLSGPIP 721
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 7e-68
Identities = 55/236 (23%), Positives = 89/236 (37%), Gaps = 26/236 (11%)
Query: 614 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQF 673
+ + +G +G V+K VAVK Q + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSW-QNEYEVYS 71
Query: 674 LSRLHHRNLVSLVGYCDE----EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIAL 729
L + H N++ +G + + L+ F G+L D L + + IA
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVVSWNELCHIAE 128
Query: 730 GSSRGILYLHTEAD-------PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782
+RG+ YLH + P + HRDIK+ N+LL + TA +ADFGL+ G
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188
Query: 783 IVPAHVSTVVKGTPGYLDPEYF-----LTHKLTDKSDVYSLGVVFLELLTGMQPIS 833
+ GT Y+ PE + D+Y++G+V EL +
Sbjct: 189 -----DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 2e-62
Identities = 66/253 (26%), Positives = 107/253 (42%), Gaps = 28/253 (11%)
Query: 614 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTE--I 671
E +L +N IG+G YG VYKG L D VAVK S + F+ E I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNI 58
Query: 672 QFLSRLHHRNLVSLVGYC-----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS 726
+ + H N+ + D E +LV E+ NG+L LS +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS---LHTSDWVSSCR 115
Query: 727 IALGSSRGILYLHTEAD------PPVFHRDIKASNILLDHKFTAKVADFGLSR-LAPVPD 779
+A +RG+ YLHTE P + HRD+ + N+L+ + T ++DFGLS L
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 780 IEGIVPAHVSTVVKGTPGYLDPEYF-------LTHKLTDKSDVYSLGVVFLELLTGMQPI 832
+ + + GT Y+ PE + D+Y+LG+++ E+ +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 833 SHGKNIVREVLPY 845
G+++ + +
Sbjct: 236 FPGESVPEYQMAF 248
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 3e-60
Identities = 75/204 (36%), Positives = 111/204 (54%), Gaps = 12/204 (5%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 688
+IG G +G V++ G+ VAVK Q+ + EFL E+ + RL H N+V +G
Sbjct: 44 KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 689 CDEEGEQMLVYEFMSNGTLRDQL-SAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+ +V E++S G+L L + ++E L RLS+A ++G+ YLH +PP+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIV 161
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
HR++K+ N+L+D K+T KV DFGLSRL + S GTP ++ PE
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-------SKSAAGTPEWMAPEVLRDE 214
Query: 808 KLTDKSDVYSLGVVFLELLTGMQP 831
+KSDVYS GV+ EL T QP
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQP 238
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 2e-57
Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
+G+G +G V K VA+K+ + S K F+ E++ LSR++H N+V L G C
Sbjct: 15 VVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 691 EEGEQMLVYEFMSNGTLRDQL-SAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
LV E+ G+L + L A+ A +S L S+G+ YLH+ + HR
Sbjct: 72 NP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129
Query: 750 DIKASNILLDHKFT-AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 808
D+K N+LL T K+ DFG + T KG+ ++ PE F
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTACDI----------QTHMTNNKGSAAWMAPEVFEGSN 179
Query: 809 LTDKSDVYSLGVVFLELLTGMQP 831
++K DV+S G++ E++T +P
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKP 202
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 4e-57
Identities = 69/216 (31%), Positives = 110/216 (50%), Gaps = 29/216 (13%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE-------KEFLTEIQFLSRLHHRNL 682
QIG+GG+G V+KG + D +VVA+K G +GE +EF E+ +S L+H N+
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 683 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 742
V L G +V EF+ G L +L P+ ++++L + L + GI Y+ +
Sbjct: 86 VKLYGLMHN--PPRMVMEFVPCGDLYHRLL-DKAHPIKWSVKLRLMLDIALGIEYMQNQ- 141
Query: 743 DPPVFHRDIKASNILLDHK-----FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG 797
+PP+ HRD+++ NI L AKVADFGLS+ + H + + G
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS----------VHSVSGLLGNFQ 191
Query: 798 YLDPEYFLTHKL--TDKSDVYSLGVVFLELLTGMQP 831
++ PE + T+K+D YS ++ +LTG P
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 1e-56
Identities = 69/213 (32%), Positives = 99/213 (46%), Gaps = 25/213 (11%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ----GEKEFLTEIQFLSRLHHRNLVSLV 686
IG GG+GKVY+ G VAVK A+ + + E + + L H N+++L
Sbjct: 14 IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
G C +E LV EF G L L S + + + ++ A+ +RG+ YLH EA P+
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 747 FHRDIKASNILLDHKF--------TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
HRD+K+SNIL+ K K+ DFGL+R G +
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---------EWHRTTKMSAAGAYAW 180
Query: 799 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
+ PE + SDV+S GV+ ELLTG P
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 7e-55
Identities = 44/210 (20%), Positives = 91/210 (43%), Gaps = 23/210 (10%)
Query: 630 TQIGQGGYGKVYKGILPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
T++ + G+++KG G + VK + ++ S + ++F E L H N++ ++G
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 688 YCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
C L+ +M G+L + L + + + + AL +RG+ +LHT +P
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL-EPL 133
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
+ + + ++++D TA+++ + S P ++ PE L
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFS------------FQSPGRMYAPAWVAPE-AL 180
Query: 806 THK----LTDKSDVYSLGVVFLELLTGMQP 831
K +D++S V+ EL+T P
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVP 210
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 6e-54
Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 12/209 (5%)
Query: 631 QIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
+G+G +G+ K G V+ +K + ++ FL E++ + L H N++ +G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
++ + E++ GTLR + ++ R+S A + G+ YLH+ + HR
Sbjct: 77 YKDKRLNFITEYIKGGTLRGII-KSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHR 132
Query: 750 DIKASNILLDHKFTAKVADFGLSRL-------APVPDIEGIVPAHVSTVVKGTPGYLDPE 802
D+ + N L+ VADFGL+RL V G P ++ PE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 803 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
+K DV+S G+V E++ +
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 5e-52
Identities = 50/212 (23%), Positives = 82/212 (38%), Gaps = 20/212 (9%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVGY 688
IG+G +G+VY G G V A++ + K F E+ + H N+V +G
Sbjct: 40 LIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 748
C ++ TL + +K L IA +G+ YLH + H
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVR-DAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILH 153
Query: 749 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 808
+D+K+ N+ D+ + DFGL ++ V + G +L PE
Sbjct: 154 KDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGR--REDKLRIQNGWLCHLAPEIIRQLS 210
Query: 809 L---------TDKSDVYSLGVVFLELLTGMQP 831
+ SDV++LG ++ EL P
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 3e-51
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 17/206 (8%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVGY 688
+IG G +G VYKG G V AVK + + + F E+ L + H N++ +GY
Sbjct: 31 RIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 748
+ +V ++ +L L S+ + IA ++RG+ YLH + H
Sbjct: 89 STAP-QLAIVTQWCEGSSLYHHLH-ASETKFEMKKLIDIARQTARGMDYLHA---KSIIH 143
Query: 749 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE---YFL 805
RD+K++NI L T K+ DFGL+ +H + G+ ++ PE
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATE-----KSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 806 THKLTDKSDVYSLGVVFLELLTGMQP 831
++ + +SDVY+ G+V EL+TG P
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLP 224
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 2e-50
Identities = 59/335 (17%), Positives = 109/335 (32%), Gaps = 58/335 (17%)
Query: 87 LQLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISG-------------------SIP 123
L+ + N +S + RL+ L + +
Sbjct: 183 LKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTED 242
Query: 124 KEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYI--------SGSLPKSFA 175
+ N+K L + + LP L LP++ I + N
Sbjct: 243 LKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAP 302
Query: 176 NLNKTRHFHMNNNSI-SGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 234
K + ++ N++ + + L ++ L + N L G P KL L L
Sbjct: 303 VGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLA 361
Query: 235 NNNFEGTTIPAS-YSNMSKLLKLSLRNCSLQG--PMPDLSRIPNLGYLDLSSNQLNG--- 288
N T IPA+ ++ LS + L+ + D + + +D S N++
Sbjct: 362 YNQI--TEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDG 419
Query: 289 ----SIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSG-------S 336
+ P N+++I LSNN+++ FS L + + N L+
Sbjct: 420 KNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKD 479
Query: 337 IPSSIWQSRTLNATETFILDFQNNNLTNISGSFNI 371
+ + L +D + N LT +S F
Sbjct: 480 ENENFKNTYLLT-----SIDLRFNKLTKLSDDFRA 509
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 9e-49
Identities = 47/323 (14%), Positives = 104/323 (32%), Gaps = 34/323 (10%)
Query: 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140
+ L + + + ++ T + + N I+ + K + + L + +
Sbjct: 158 FSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNS 216
Query: 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR 200
E + + + NL + N ++P L
Sbjct: 217 PFVAENICEAWENENSE-----YAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKA 271
Query: 201 LPSLVHMLLDNNNLTGY--------LPPELSELPKLLILQLDNNNFEGTTIPASYSNMSK 252
LP + + + N + K+ I+ + NN + + S M K
Sbjct: 272 LPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKK 331
Query: 253 LLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLT 310
L L L+G +P L L+L+ NQ+ IP + + ++NKL
Sbjct: 332 LGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLK 390
Query: 311 GTIPSNFS--GLPRLQRLFIANNSLSG-------SIPSSIWQSRTLNATETFILDFQNNN 361
IP+ F + + + + N + + + ++ ++ ++ NN
Sbjct: 391 -YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVS-----SINLSNNQ 444
Query: 362 LT-NISGSFNIPPNVTV-RLRGN 382
++ F+ ++ L GN
Sbjct: 445 ISKFPKELFSTGSPLSSINLMGN 467
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-44
Identities = 53/314 (16%), Positives = 116/314 (36%), Gaps = 39/314 (12%)
Query: 84 LRELQLLNLN----LSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNG 139
++Q++ + + + + ++ L +L+ ++N++ G +P G+ L L L
Sbjct: 304 GEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAY 362
Query: 140 NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA--NLNKTRHFHMNNNSISG----- 192
N++T G+ +++ + N + +P F +++ + N I
Sbjct: 363 NQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKN 421
Query: 193 --QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG------TTIP 244
+ P + ++ + L NN ++ + S L + L N
Sbjct: 422 FDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDEN 481
Query: 245 ASYSNMSKLLKLSLRNCSLQGPMPDL--SRIPNLGYLDLSSNQLNGSIPPGRLSLN---- 298
++ N L + LR L D + +P L +DLS N + P L+ +
Sbjct: 482 ENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKG 540
Query: 299 ---ITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 355
N+ P + P L +L I +N + + I + ++ +L
Sbjct: 541 FGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITPN--IS-----VL 592
Query: 356 DFQNNNLTNISGSF 369
D ++N +I S+
Sbjct: 593 DIKDNPNISIDLSY 606
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-37
Identities = 49/355 (13%), Positives = 99/355 (27%), Gaps = 58/355 (16%)
Query: 28 DDSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLREL 87
D+++TD V S + DY L L
Sbjct: 9 DNALTDDAIVPIKLSRTAEYIKDYLALKEIWDA--------------------------L 42
Query: 88 QLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLP 147
N + G + ++ LD MW G + + + L L G +G +P
Sbjct: 43 NGKNWSQQGFGTQPGANWNFNKELD-MWGAQPGV---SLNSNGRVTGLSLEGFGASGRVP 98
Query: 148 EELGYLPKLDRIQIDQNYISG----SLPKSFANLNKTRHFHMNNNSISGQIPPELSRL-- 201
+ +G L +L+ + + + PK + R
Sbjct: 99 DAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDF 158
Query: 202 PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261
L+ ++++ + K + +NN T + + ++KL + + N
Sbjct: 159 SDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI--TFVSKAVMRLTKLRQFYMGNS 216
Query: 262 SLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTIKLSNNKLTGTIPSNFSG 319
+ Q + L ++T +++ N +P+
Sbjct: 217 PFVAENI----CEAWENENSEYAQQYKTEDLKWDNLK-DLTDVEVYNCPNLTKLPTFLKA 271
Query: 320 LPRLQRLFIANNSL--------SGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 366
LP +Q + +A N + + I+ NNL
Sbjct: 272 LPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQ-----IIYIGYNNLKTFP 321
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-29
Identities = 34/264 (12%), Positives = 75/264 (28%), Gaps = 53/264 (20%)
Query: 84 LRELQLLNL----------NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLE 133
+ + ++ L P + ++ ++ N+IS + L
Sbjct: 401 VSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLS 460
Query: 134 LLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQ 193
+ L GN LT +P+ ++F N + N ++
Sbjct: 461 SINLMGNMLTE-IPKNSL----------------KDENENFKNTYLLTSIDLRFNKLTK- 502
Query: 194 IPPEL--SRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMS 251
+ + + LP LV + L N+ + P + L + N
Sbjct: 503 LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ--------------- 546
Query: 252 KLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLT 310
+ P+ ++ P+L L + SN + + NI+ + + +N
Sbjct: 547 ----RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITP-NISVLDIKDNPNI 600
Query: 311 GTIPSNFSGLPRLQRLFIANNSLS 334
S + +
Sbjct: 601 SIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-23
Identities = 35/202 (17%), Positives = 70/202 (34%), Gaps = 24/202 (11%)
Query: 75 TTMDDGYLHLRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISG-------SIPK 124
+D + +NL +S S L+ ++ M N ++ +
Sbjct: 423 DPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENE 482
Query: 125 EIGNIKSLELLLLNGNELTGSLPEELGY--LPKLDRIQIDQNYISGSLPKSFANLNKTRH 182
N L + L N+LT L ++ LP L I + N S P N + +
Sbjct: 483 NFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKG 540
Query: 183 FHMNN------NSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNN 236
F + N N + P ++ PSL + + +N++ + ++ P + +L + +N
Sbjct: 541 FGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDN 597
Query: 237 NFEGTTIPASYSNMSKLLKLSL 258
+ + L
Sbjct: 598 PNIS-IDLSYVCPYIEAGMYML 618
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-09
Identities = 14/126 (11%), Positives = 35/126 (27%), Gaps = 15/126 (11%)
Query: 270 LSRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTIKLSNNKLTG----TIPSNFSGLPRL 323
L+ + L L +G +P G+L+ + + L ++ P S
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLT-ELEVLALGSHGEKVNERLFGPKGISANMSD 135
Query: 324 QRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNP 383
++ + D + + + +I + + L+
Sbjct: 136 EQKQKMRMHYQKTFVDYD--------PREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQ 187
Query: 384 FCLNTN 389
+N
Sbjct: 188 IGQLSN 193
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 11/100 (11%), Positives = 27/100 (27%), Gaps = 4/100 (4%)
Query: 81 YLHLRELQLLNLN-LSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNG 139
+R + N I LT L N I + ++I ++ +L +
Sbjct: 540 GFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKIT--PNISVLDIKD 596
Query: 140 NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNK 179
N + + + + ++ +
Sbjct: 597 NPNISIDLSYVCPYIEAGMYMLFYDKTQDIRGCDALDIKR 636
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-49
Identities = 56/232 (24%), Positives = 92/232 (39%), Gaps = 30/232 (12%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFL--TEIQFLSRLHHRNLVSLVGY 688
+G+G YG+V++G G VAVK S + EK + TE+ L H N++ +
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 689 C----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD- 743
+ L+ + G+L D L L L I L + G+ +LH E
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 744 ----PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
P + HRD+K+ NIL+ +AD GL+ + + V + GT Y+
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG---NNPRVGTKRYM 184
Query: 800 DPE------YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVLPY 845
PE + D+++ G+V E+ M + P+
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS---NGIVEDYKPPF 233
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 4e-48
Identities = 67/317 (21%), Positives = 117/317 (36%), Gaps = 16/317 (5%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
++ L L + L + R S LT LD +N IS P+ + L++L L NEL
Sbjct: 26 NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNEL 85
Query: 143 TGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLP 202
+ + + L + + N I F +++N +S +L
Sbjct: 86 SQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLE 145
Query: 203 SLVHMLLDNNNLTGYLPPELS--ELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRN 260
+L +LL NN + EL L L+L +N + P + + +L L L N
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKE-FSPGCFHAIGRLFGLFLNN 204
Query: 261 CSLQGPMPD----LSRIPNLGYLDLSSNQLNGSIPP---GRLSLNITTIKLSNNKLTGTI 313
L + + ++ L LS++QL+ + G N+T + LS N L
Sbjct: 205 VQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVG 264
Query: 314 PSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLN----ATETFILDFQNNNLTNI-SGS 368
+F+ LP+L+ F+ N++ S+ + +L I S
Sbjct: 265 NDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFS 324
Query: 369 FNIPPNVTV-RLRGNPF 384
F + + N
Sbjct: 325 FQWLKCLEHLNMEDNDI 341
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-44
Identities = 66/325 (20%), Positives = 117/325 (36%), Gaps = 32/325 (9%)
Query: 88 QLLNLNLSGN----LSPE---IGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140
L L LS N L E I S L L+ N+I P I L L LN
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV 205
Query: 141 ELTGSLPEELGY---LPKLDRIQIDQNYISGSLPKSFANLNKT--RHFHMNNNSISGQIP 195
+L SL E+L + + + + +S + +F L T ++ N+++
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265
Query: 196 PELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTT--------IPASY 247
+ LP L + L+ NN+ L L + L L + + + S+
Sbjct: 266 DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSF 325
Query: 248 SNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRL-----SLNITT 301
+ L L++ + + G + + + NL YL LS++ + +
Sbjct: 326 QWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHI 385
Query: 302 IKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNN 361
+ L+ NK++ FS L L+ L + N + + W+ F + N
Sbjct: 386 LNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWR----GLENIFEIYLSYNK 441
Query: 362 LTNI-SGSFNIPPNVTV-RLRGNPF 384
+ SF + P++ LR
Sbjct: 442 YLQLTRNSFALVPSLQRLMLRRVAL 466
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-41
Identities = 61/321 (19%), Positives = 108/321 (33%), Gaps = 24/321 (7%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
+ + +L L L L+ N I G + +L+ L L+ +
Sbjct: 306 SFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFT 365
Query: 143 TGSLPEELG----YLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPP-E 197
+ L + + +N IS +F+ L + N I ++ E
Sbjct: 366 SLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQE 425
Query: 198 LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG-TTIPASYSNMSKLLKL 256
L ++ + L N + +P L L L + + P+ + + L L
Sbjct: 426 WRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTIL 485
Query: 257 SLRNCSLQGPMPD-LSRIPNLGYLDLSSNQL-------NGSIPPGRLS--LNITTIKLSN 306
L N ++ D L + L LDL N L N P L ++ + L +
Sbjct: 486 DLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLES 545
Query: 307 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 366
N F L L+ + + N+L+ S +L L+ Q N +T++
Sbjct: 546 NGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLK-----SLNLQKNLITSVE 600
Query: 367 GSF--NIPPNVTV-RLRGNPF 384
N+T +R NPF
Sbjct: 601 KKVFGPAFRNLTELDMRFNPF 621
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-40
Identities = 70/311 (22%), Positives = 114/311 (36%), Gaps = 30/311 (9%)
Query: 66 NWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSY--LTILDFMWNKISGSIP 123
L ++ +R L L N LS + L + LT+LD +N ++
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265
Query: 124 KEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHF 183
+ LE L N + L L + + + +++ S+
Sbjct: 266 DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSI------------- 312
Query: 184 HMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTI 243
+ S+ L L H+ +++N++ G + L L L L N+ T+
Sbjct: 313 --SLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTL 370
Query: 244 PA---SYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLS--L 297
S L L+L + D S + +L LDL N++ +
Sbjct: 371 TNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLE 430
Query: 298 NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSG--SIPSSIWQSRTLNATETFIL 355
NI I LS NK ++F+ +P LQRL + +L S PS R L IL
Sbjct: 431 NIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLT-----IL 485
Query: 356 DFQNNNLTNIS 366
D NNN+ NI+
Sbjct: 486 DLSNNNIANIN 496
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 5e-21
Identities = 31/219 (14%), Positives = 63/219 (28%), Gaps = 15/219 (6%)
Query: 83 HLRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISG--SIPKEIGNIKSLELLLL 137
L + + L + L L + S P +++L +L L
Sbjct: 428 GLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDL 487
Query: 138 NGNELTGSLPEELGYLPKLDRIQIDQNYIS--------GSLPKSFANLNKTRHFHMNNNS 189
+ N + + L L KL+ + + N ++ G L+ ++ +N
Sbjct: 488 SNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNG 547
Query: 190 ISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSN 249
L L + L NNL + L L L N
Sbjct: 548 FDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPA 607
Query: 250 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNG 288
L +L +R ++ + +++ + +
Sbjct: 608 FRNLTELDMRFNPFDCTCESIA--WFVNWINETHTNIPE 644
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 3e-47
Identities = 60/218 (27%), Positives = 90/218 (41%), Gaps = 27/218 (12%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFL--TEIQFLSRLHHRNLVSLVGY 688
QIG+G YG+V+ G G VAVK E + TEI + H N++ +
Sbjct: 44 QIGKGRYGEVWMGKW-RGEKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 689 C----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD- 743
+ L+ ++ NG+L D L L L +A S G+ +LHTE
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLK---STTLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 744 ----PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
P + HRD+K+ NIL+ T +AD GL+ E +P GT Y+
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP---PNTRVGTKRYM 213
Query: 800 DPE-----YFLTHKLTD-KSDVYSLGVVFLELLTGMQP 831
PE H + +D+YS G++ E+
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS 251
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 8e-47
Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 27/221 (12%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTE--IQFLSRLHHRNLVSLVGY 688
IG+G +G+V++G G VAVK S + E+ + E I L H N++ +
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 689 C----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD- 743
+ LV ++ +G+L D L+ + + + +AL ++ G+ +LH E
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 744 ----PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
P + HRD+K+ NIL+ T +AD GL+ D GT Y+
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV---RHDSATDTIDIAPNHRVGTKRYM 218
Query: 800 DPE-----YFLTHKLTD-KSDVYSLGVVFLELLTGMQPISH 834
PE + H + ++D+Y++G+VF E+
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 8e-46
Identities = 51/313 (16%), Positives = 110/313 (35%), Gaps = 22/313 (7%)
Query: 81 YLHLRELQLLNLNLSGNLSPEI-GRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNG 139
L + E +L L+ + ++ L+ ++ + I + L L
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVN 313
Query: 140 NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSIS--GQIPPE 197
+ +L L +L G S +L ++ N +S G
Sbjct: 314 CKFGQFPTLKLKSLKRLTF-----TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQS 368
Query: 198 LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLS 257
SL ++ L N + + L +L L ++N + + + + ++ L+ L
Sbjct: 369 DFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 427
Query: 258 LRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLTGTIP 314
+ + + + + +L L ++ N + P + N+T + LS +L P
Sbjct: 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487
Query: 315 SNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS--FNIP 372
+ F+ L LQ L +++N+ +L +LD+ N++ + P
Sbjct: 488 TAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQ-----VLDYSLNHIMTSKKQELQHFP 542
Query: 373 PN-VTVRLRGNPF 384
+ + L N F
Sbjct: 543 SSLAFLNLTQNDF 555
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-41
Identities = 45/282 (15%), Positives = 103/282 (36%), Gaps = 13/282 (4%)
Query: 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
+ L+L+N + ++ L LT G ++ SLE L L+ N L+
Sbjct: 306 WQHLELVNCKFGQFPTLKLKSLKRLTFTS-----NKGGNAFSEVDLPSLEFLDLSRNGLS 360
Query: 144 --GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE-LSR 200
G + L + + N + + +F L + H ++++
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 419
Query: 201 LPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRN 260
L +L+++ + + + + L L +L++ N+F+ +P ++ + L L L
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479
Query: 261 CSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFS 318
C L+ P + + +L L++S N L ++ + S N + +
Sbjct: 480 CQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQ 539
Query: 319 GLPR-LQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQN 359
P L L + N + + + + +++ +
Sbjct: 540 HFPSSLAFLNLTQNDFACTCE-HQSFLQWIKDQRQLLVEVER 580
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-37
Identities = 48/261 (18%), Positives = 88/261 (33%), Gaps = 10/261 (3%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
IP + S + L L+ N L P+L + + + I ++ +L+
Sbjct: 21 KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 181 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240
+ N I S L SL ++ NL + L L L + +N +
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 241 TTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGY----LDLSSNQLNGSIPPGRL 295
+P +SN++ L L L + +Q DL + + LDLS N +N P
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198
Query: 296 SLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 354
+ + + L NN + + GL L+ + + L
Sbjct: 199 EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN-- 256
Query: 355 LDFQNNNLTNISGSFNIPPNV 375
L + L + + ++
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDL 277
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-35
Identities = 47/312 (15%), Positives = 94/312 (30%), Gaps = 19/312 (6%)
Query: 86 ELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGS 145
Q + LN + + LD +N + + L++L L+ E+
Sbjct: 11 TYQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI 67
Query: 146 LPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLV 205
L L + + N I +F+ L+ + +++ + L +L
Sbjct: 68 EDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK 127
Query: 206 HMLLDNNNLTGY-LPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKL----LKLSLRN 260
+ + +N + + LP S L L L L +N + + ++ L L L
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS-IYCTDLRVLHQMPLLNLSLDLSL 186
Query: 261 CSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRL----SLNITTIKL----SNNKLTGT 312
+ P + L L L +N + ++ + L + + L + L
Sbjct: 187 NPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246
Query: 313 IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIP 372
S GL L L + I L + + + +
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSS--FSLVSVTIERVKDFSYNF 304
Query: 373 PNVTVRLRGNPF 384
+ L F
Sbjct: 305 GWQHLELVNCKF 316
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 8e-29
Identities = 38/243 (15%), Positives = 77/243 (31%), Gaps = 32/243 (13%)
Query: 88 QLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGNEL 142
L L+LS N +S L L LDF + + + ++++L L ++
Sbjct: 374 SLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 433
Query: 143 TGSLPEELGYLPKLDRIQIDQNYISGSL-PKSFANLNKTRHFHMNNNSISGQIPPELSRL 201
+ L L+ +++ N + P F L ++ + P + L
Sbjct: 434 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL 493
Query: 202 PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261
SL + + +NN L L +L N+ + +
Sbjct: 494 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT-SKKQELQHFPS--------- 543
Query: 262 SLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNI---TTIKLSNNKLTGTIPSNFS 318
+L +L+L+ N + I + + ++ PS+
Sbjct: 544 -------------SLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQ 590
Query: 319 GLP 321
G+P
Sbjct: 591 GMP 593
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-17
Identities = 26/151 (17%), Positives = 55/151 (36%), Gaps = 7/151 (4%)
Query: 83 HLRELQLLNL---NLSGNLSPEI-GRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLN 138
L L++L + + N P+I L LT LD ++ P ++ SL++L ++
Sbjct: 443 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMS 502
Query: 139 GNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT-RHFHMNNNSISGQIPPE 197
N L L + N+I S + + + ++ N + +
Sbjct: 503 HNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ 562
Query: 198 --LSRLPSLVHMLLDNNNLTGYLPPELSELP 226
L + +L++ + P + +P
Sbjct: 563 SFLQWIKDQRQLLVEVERMECATPSDKQGMP 593
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 175 bits (444), Expect = 2e-45
Identities = 67/334 (20%), Positives = 124/334 (37%), Gaps = 51/334 (15%)
Query: 82 LHLRELQLLNL-NLSGNLSPEIGRLSYLTILDFMWNKISG-------------------S 121
+ L++ Q+ NL N +S I RL+ L I+ F + + +
Sbjct: 423 ISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYEN 482
Query: 122 IPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISG---------SLPK 172
N+K L + L LP+ L LP+L + I N L
Sbjct: 483 EELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLAD 542
Query: 173 SFANLNKTRHFHMNNNSISGQIPPE--LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLI 230
K + F+M N++ P L ++ L + +N + KL
Sbjct: 543 DEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVRH--LEAFGTNVKLTD 599
Query: 231 LQLDNNNFEGTTIPASY-SNMSKLLKLSLRNCSLQG--PMPDLSRIPNLGYLDLSSNQLN 287
L+LD N IP + + ++ L + L+ + + + +G +D S N++
Sbjct: 600 LKLDYNQI--EEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKI- 656
Query: 288 GSIPPGRLS-------LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSS 340
GS +N +T+ LS N++ F+ + + ++NN ++ SIP +
Sbjct: 657 GSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPEN 715
Query: 341 IWQSRTL---NATETFILDFQNNNLTNISGSFNI 371
+ + N +D + N LT++S F
Sbjct: 716 SLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRA 749
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-35
Identities = 54/328 (16%), Positives = 110/328 (33%), Gaps = 46/328 (14%)
Query: 88 QLLNLNLSGN------LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNE 141
++ + N S + ++ L +LD + NK+ + G L L L+ N+
Sbjct: 549 KIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQ 606
Query: 142 LTGSLPEELGY-LPKLDRIQIDQNYISGSLPK--SFANLNKTRHFHMNNNSISGQIPPEL 198
+ +PE+ +++ + N + +P + ++ + N I +
Sbjct: 607 IE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGS-EGRNI 663
Query: 199 S------RLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFE------GTTIPAS 246
S + + + L N + + + + + L NN +
Sbjct: 664 SCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGN 723
Query: 247 YSNMSKLLKLSLRNCSLQGPMPDL--SRIPNLGYLDLSSNQLNGSIPPGRLSLN------ 298
Y N L + LR L D + +P L +D+S N + S P L+ +
Sbjct: 724 YKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFG 782
Query: 299 -ITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDF 357
N++ P+ + P L +L I +N + + + L ILD
Sbjct: 783 IRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLTPQ--LY-----ILDI 834
Query: 358 QNNNLTNISGSFNIP--PNVTVRLRGNP 383
+N +I + P L +
Sbjct: 835 ADNPNISIDVTSVCPYIEAGMYVLLYDK 862
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-25
Identities = 32/250 (12%), Positives = 82/250 (32%), Gaps = 29/250 (11%)
Query: 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140
+ ++ + + + S + + + + +N+I + + ++L+ N
Sbjct: 648 SVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNN 707
Query: 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL-- 198
+T S+PE ++ N + N ++ + +
Sbjct: 708 LMT-SIPEN----------------SLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRA 749
Query: 199 SRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNN-----NFEGTTIPASYSNMSKL 253
+ LP L +M + N + P + +L + + N P + L
Sbjct: 750 TTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSL 808
Query: 254 LKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQL-NGSIPPGRLSLNITTIKLSNNKLTGT 312
++L + + ++ L+ P L LD++ N + + + L +K
Sbjct: 809 IQLQIGSNDIRKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDI 866
Query: 313 IPSNFSGLPR 322
+ G+ R
Sbjct: 867 RGCDALGIER 876
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-22
Identities = 27/236 (11%), Positives = 62/236 (26%), Gaps = 34/236 (14%)
Query: 162 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE 221
+ + N + + G++P + +L L + ++ T
Sbjct: 307 ELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLF 366
Query: 222 LSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDL 281
E + + + +L L ++ P++ I + L
Sbjct: 367 GDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR-NPEMKPIKKDSRISL 425
Query: 282 SSNQLNG------SIPP--GRLSLNITTIKLSNNKLTGTI-------------------P 314
Q+ I RL+ + I +N+ T
Sbjct: 426 KDTQIGNLTNRITFISKAIQRLT-KLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEE 484
Query: 315 SNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFN 370
++S L L + + N +P ++ L L+ N + +
Sbjct: 485 LSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQ-----SLNIACNRGISAAQLKA 535
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 7e-08
Identities = 29/211 (13%), Positives = 58/211 (27%), Gaps = 32/211 (15%)
Query: 211 NNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLK--LSLRNC--SLQGP 266
+ + E + +DN + +P ++ +K +L+ +L G
Sbjct: 225 SQSGIKRSELETQSVRGESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGK 284
Query: 267 MPDLSRIPNLGYLDLSSNQLN------GSIPPGRLSLN--ITTIKLSNNKLTGTIPSNFS 318
+ + N G P L N +T + L+ G +P
Sbjct: 285 NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIG 344
Query: 319 GLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI--------------------LDFQ 358
L L+ L +S + S + T + +E D
Sbjct: 345 QLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLL 404
Query: 359 NNNLTNISGSFNIPPNVTVRLRGNPFCLNTN 389
+ + I + + L+ TN
Sbjct: 405 QDAINRNPEMKPIKKDSRISLKDTQIGNLTN 435
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-41
Identities = 64/317 (20%), Positives = 117/317 (36%), Gaps = 22/317 (6%)
Query: 83 HLRELQLLNLNLSGN----LSPEI-GRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLL 137
L E+ + ++NL + +S S L LD +S +P + + +L+ L+L
Sbjct: 250 GLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVL 308
Query: 138 NGNELTGSLPEELGYLPKLDRIQIDQNYISGSL-PKSFANLNKTRHFHMNNNSI--SGQI 194
+ N+ P L + I N L NL R ++++ I S
Sbjct: 309 SANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCC 368
Query: 195 PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLL 254
+L L L + L N E P+L +L L + + + N+ L
Sbjct: 369 NLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLK 428
Query: 255 KLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSL----NITTIKLSNNKL 309
L+L + L +P L +L+L N SL + + LS L
Sbjct: 429 VLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDL 488
Query: 310 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GS 368
+ F+ L + + +++N L+ S ++ + + L+ +N+++ I
Sbjct: 489 SSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI------YLNLASNHISIILPSL 542
Query: 369 FNIPPN-VTVRLRGNPF 384
I T+ LR NP
Sbjct: 543 LPILSQQRTINLRQNPL 559
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 8e-41
Identities = 59/324 (18%), Positives = 100/324 (30%), Gaps = 14/324 (4%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
L+ L + RL LT LD +I + L+ L+L N L
Sbjct: 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93
Query: 143 TGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLP 202
L L + Q IS N ++ +N IS P+
Sbjct: 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTE 153
Query: 203 SLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCS 262
L + NN + ++S L + L L+ N + I + + L+
Sbjct: 154 KLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQ 213
Query: 263 LQGPMP---DLSRIPNLGYLDLSSNQLNG---SIPPGRLSLNITTIKLSNNKLTGTIPSN 316
+ S I +L ++ G +++ +I L + +
Sbjct: 214 NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNT 273
Query: 317 FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNV 375
F LQ L + LS +PS + TL L N N+ S + P++
Sbjct: 274 FHCFSGLQELDLTATHLS-ELPSGLVGLSTLK-----KLVLSANKFENLCQISASNFPSL 327
Query: 376 TV-RLRGNPFCLNTNAEQFCGSHS 398
T ++GN L +
Sbjct: 328 THLSIKGNTKRLELGTGCLENLEN 351
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 6e-40
Identities = 64/322 (19%), Positives = 102/322 (31%), Gaps = 17/322 (5%)
Query: 75 TTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTI-----LDFMWNKISGSIPKEIGNI 129
++ G Q LN + NL L TI F P +
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 130 K--SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNN 187
S+E + L + L + + ++S LP L+ + ++
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSA 310
Query: 188 NSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFEGTTI-PA 245
N S PSL H+ + N L L L L L L +++ E +
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL 370
Query: 246 SYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTI 302
N+S L L+L + P L LDL+ +L + +
Sbjct: 371 QLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430
Query: 303 KLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNL 362
LS++ L + F GLP LQ L + N +TL E L +L
Sbjct: 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEI--LVLSFCDL 488
Query: 363 TNIS-GSFNIPPNVTV-RLRGN 382
++I +F + L N
Sbjct: 489 SSIDQHAFTSLKMMNHVDLSHN 510
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-39
Identities = 58/300 (19%), Positives = 107/300 (35%), Gaps = 21/300 (7%)
Query: 83 HLRELQLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEIGN--IKSLELLL 136
L++ L+LNL+GN + P + L+F + I K + N I+SL L
Sbjct: 175 SLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGT 234
Query: 137 LNGNELTGSLPEELGYLPKLDRIQID--QNYISGSLPKSFANLNKTRHFHMNNNSISGQI 194
+ P L ++ I+ ++Y +F + + + +S ++
Sbjct: 235 FEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-EL 293
Query: 195 PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLL 254
P L L +L ++L N S P L L + N N+ L
Sbjct: 294 PSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLR 353
Query: 255 KLSLRNCSLQGPMPD---LSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKL 309
+L L + ++ L + +L L+LS N+ S+ + + L+ +L
Sbjct: 354 ELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL-SLKTEAFKECPQLELLDLAFTRL 412
Query: 310 TGTIP-SNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS 368
S F L L+ L ++++ L S L L+ Q N+ +
Sbjct: 413 KVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQ-----HLNLQGNHFPKGNIQ 467
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 7e-38
Identities = 52/328 (15%), Positives = 103/328 (31%), Gaps = 23/328 (7%)
Query: 71 LCFNTTMDDGYLHLRELQLLNLNLSG--NLSPEIGRLSYLTILDFMWNKISGSIPKEIGN 128
+ F + L +++ E + ++ +
Sbjct: 217 VIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHC 276
Query: 129 IKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN 188
L+ L L L+ LP L L L ++ + N S +N H + N
Sbjct: 277 FSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGN 335
Query: 189 SISGQIPPE-LSRLPSLVHMLLDNNNLT--GYLPPELSELPKLLILQLDNNNFEGTTIPA 245
+ ++ L L +L + L ++++ +L L L L L N ++
Sbjct: 336 TKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEP--LSLKT 393
Query: 246 SY-SNMSKLLKLSLRNCSLQGPMPD--LSRIPNLGYLDLSSNQLNGSIPPGRLSL--NIT 300
+L L L L+ + L L+LS + L+ +
Sbjct: 394 EAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLD-ISSEQLFDGLPALQ 452
Query: 301 TIKLSNNKLTGTI---PSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDF 357
+ L N ++ L RL+ L ++ LS + + +N +D
Sbjct: 453 HLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMN-----HVDL 507
Query: 358 QNNNLTNIS-GSFNIPPNVTVRLRGNPF 384
+N LT+ S + + + + L N
Sbjct: 508 SHNRLTSSSIEALSHLKGIYLNLASNHI 535
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 7e-37
Identities = 56/296 (18%), Positives = 107/296 (36%), Gaps = 13/296 (4%)
Query: 75 TTMDDGYLHLRELQLLNLN---LSGNLSPEIGRLSYLTILDFMWNKISGSIPKE-IGNIK 130
+ + G + L L+ L L+ LT L N + + N++
Sbjct: 291 SELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLE 350
Query: 131 SLELLLLNGNELTGS--LPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN 188
+L L L+ +++ S +L L L + + N ++F + +
Sbjct: 351 NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFT 410
Query: 189 SISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTI--PA 245
+ + L L + L ++ L LP L L L N+F I
Sbjct: 411 RLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTN 470
Query: 246 SYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLS-LNITTIK 303
S + +L L L C L + + + ++DLS N+L S LS L +
Sbjct: 471 SLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLT-SSSIEALSHLKGIYLN 529
Query: 304 LSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQN 359
L++N ++ +PS L + + + + N L + S+I+ + D ++
Sbjct: 530 LASNHISIILPSLLPILSQQRTINLRQNPLDCT-CSNIYFLEWYKENMQKLEDTED 584
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-40
Identities = 65/247 (26%), Positives = 113/247 (45%), Gaps = 20/247 (8%)
Query: 591 NYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGIL-PDGT 649
++ +++ + K+ + + R+ + L + QIG+G +G+V+ G L D T
Sbjct: 83 DHLLSTQQPLTKKSGVVL--HRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNT 140
Query: 650 VVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 708
+VAVK +E + +FL E + L + H N+V L+G C ++ +V E + G
Sbjct: 141 LVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 200
Query: 709 DQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 768
L L L + ++ G+ YL ++ HRD+ A N L+ K K++D
Sbjct: 201 TFLR-TEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISD 256
Query: 769 FGLSRLAPVPDIEGIVPAHVSTV---VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLEL 825
FG+SR +G+ A VK T PE + + +SDV+S G++ E
Sbjct: 257 FGMSREEA----DGVYAASGGLRQVPVKWTA----PEALNYGRYSSESDVWSFGILLWET 308
Query: 826 LT-GMQP 831
+ G P
Sbjct: 309 FSLGASP 315
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-40
Identities = 67/203 (33%), Positives = 100/203 (49%), Gaps = 18/203 (8%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC- 689
IG+G +G V G G VAVK + + + FL E +++L H NLV L+G
Sbjct: 28 TIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
+E+G +V E+M+ G+L D L ++ + LG L +L + YL HR
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHR 141
Query: 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 809
D+ A N+L+ AKV+DFGL++ A G +P VK T PE K
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP------VKWTA----PEALREKKF 191
Query: 810 TDKSDVYSLGVVFLELLT-GMQP 831
+ KSDV+S G++ E+ + G P
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVP 214
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-39
Identities = 72/250 (28%), Positives = 109/250 (43%), Gaps = 19/250 (7%)
Query: 585 VRAHMKNYHAISRR-RHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKG 643
V + + + R + F AL IG+G +G V G
Sbjct: 153 VEHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLG 212
Query: 644 ILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC-DEEGEQMLVYEFM 702
G VAVK + + + FL E +++L H NLV L+G +E+G +V E+M
Sbjct: 213 DY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269
Query: 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF 762
+ G+L D L ++ + LG L +L + YL HRD+ A N+L+
Sbjct: 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDN 326
Query: 763 TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVF 822
AKV+DFGL++ A G +P VK T PE K + KSDV+S G++
Sbjct: 327 VAKVSDFGLTKEASSTQDTGKLP------VKWTA----PEALREKKFSTKSDVWSFGILL 376
Query: 823 LELLT-GMQP 831
E+ + G P
Sbjct: 377 WEIYSFGRVP 386
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
++G G +G+V+ G T VAVK ++GS+ FL E + +L H+ LV L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
+E ++ E+M NG+L D L S L L +A + G+ ++ + HRD
Sbjct: 79 QEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRD 134
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGTPGYLDPEYF 804
++A+NIL+ + K+ADFGL+RL + D E P +K T PE
Sbjct: 135 LRAANILVSDTLSCKIADFGLARL--IEDNEYTAREGAKFP------IKWTA----PEAI 182
Query: 805 LTHKLTDKSDVYSLGVVFLELLT-GMQP 831
T KSDV+S G++ E++T G P
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 67/208 (32%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
+IG G +G V+ G + VA+K +EG++ E++F+ E + + +L H LV L G C
Sbjct: 15 EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
E+ LV EFM +G L D L + L + L G+ YL + V HRD
Sbjct: 74 EQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRD 129
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGTPGYLDPEYF 804
+ A N L+ KV+DFG++R V D + P VK PE F
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFP------VKWAS----PEVF 177
Query: 805 LTHKLTDKSDVYSLGVVFLELLT-GMQP 831
+ + KSDV+S GV+ E+ + G P
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 63/227 (27%), Positives = 100/227 (44%), Gaps = 22/227 (9%)
Query: 631 QIGQGGYGKVYKGILP-----DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 685
Q+G+G +G V G VVAVK+ Q + + ++F EI+ L L H N+V
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 686 VGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
G C G + L+ E++ G+LRD L K KE + L +G+ YL T+
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTKR- 134
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV--VKGTPGYLDP 801
HRD+ NIL++++ K+ DFGL+++ +P + + P
Sbjct: 135 --YIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEFFKVKEPGESPIFWYA----P 186
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVL---PY 845
E K + SDV+S GVV EL T ++ ++
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 233
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-38
Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 18/210 (8%)
Query: 631 QIGQGGYGKVYKGILP-----DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 685
Q+G+G +G V G +VAVK+ Q +++F EIQ L LH +V
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 686 VGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
G G Q LV E++ +G LRD L + + L + L + +G+ YL +
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLGSRR- 147
Query: 744 PPVF-HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
HRD+ A NIL++ + K+ADFGL++L P+ +V + + PE
Sbjct: 148 ---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA----PE 200
Query: 803 YFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
+ + +SDV+S GVV EL T +
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-38
Identities = 78/344 (22%), Positives = 134/344 (38%), Gaps = 42/344 (12%)
Query: 63 CTSNWTGVLCFNTTMDDGYLHLREL------QLLNLNLSGNLSPEI-----GRLSYLTIL 111
C++ VLC + + L+L N + +L L
Sbjct: 9 CSAQDRAVLC-------HRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEEL 61
Query: 112 DFMWNKISGSIPKEI-GNIKSLELLLLNGNELTGSLPEE-LGYLPKLDRIQIDQNYISGS 169
+ N +S ++ N+ +L L L N L +P L L ++ I +N I
Sbjct: 62 ELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVIL 119
Query: 170 LPKSFANLNKTRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPE-LSELPK 227
L F +L + + +N + I S L SL + L+ NLT +P E LS L
Sbjct: 120 LDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHG 177
Query: 228 LLILQLDNNNFEGTTIPA-SYSNMSKLLKLSL-RNCSLQGPMPDLSRIPNLGYLDLSSNQ 285
L++L+L + N I S+ + +L L + L P+ NL L ++
Sbjct: 178 LIVLRLRHLNI--NAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCN 235
Query: 286 LNGSIPPGRLS--LNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIW 342
L ++P + + + + LS N ++ TI + L RLQ + + L+ + +
Sbjct: 236 LT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAF 292
Query: 343 QSRTLNATETFILDFQNNNLTNIS-GSFNIPPN-VTVRLRGNPF 384
+ LN +L+ N LT + F+ N T+ L NP
Sbjct: 293 RG--LNYLR--VLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-31
Identities = 50/260 (19%), Positives = 104/260 (40%), Gaps = 20/260 (7%)
Query: 88 QLLNLNLSGN----LSPEI-GRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGNE 141
L L L N + + LS LT LD NKI + + ++ +L+ L + N+
Sbjct: 81 NLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDND 139
Query: 142 LTGSLPEE-LGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE-LS 199
L + L L+++ +++ ++ ++ ++L+ + + +I+ I
Sbjct: 140 LV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFK 197
Query: 200 RLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPA-SYSNMSKLLKLSL 258
RL L + + + + P L L + + N T +P + ++ L L+L
Sbjct: 198 RLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL--TAVPYLAVRHLVYLRFLNL 255
Query: 259 RNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGTIPS 315
+ L + L + L QL + P + + +S N+LT T+
Sbjct: 256 SYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEE 313
Query: 316 N-FSGLPRLQRLFIANNSLS 334
+ F + L+ L + +N L+
Sbjct: 314 SVFHSVGNLETLILDSNPLA 333
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 144 bits (367), Expect = 4e-38
Identities = 60/299 (20%), Positives = 116/299 (38%), Gaps = 24/299 (8%)
Query: 88 QLLNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
L LNL+GN + L LT L NKI+ + N+ +L L LN + ++
Sbjct: 67 NLEYLNLNGNQITDISPLSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD 124
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
L L K+ + + N+ S +N+ + + + + ++ L L
Sbjct: 125 --ISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKD--VTPIANLTDL 179
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264
+ L+ N + L+ L L N T I +NM++L L + N +
Sbjct: 180 YSLSLNYNQIED--ISPLASLTSLHYFTAYVNQI--TDIT-PVANMTRLNSLKIGNNKIT 234
Query: 265 GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQ 324
+ L+ + L +L++ +NQ++ L+ + + + +N+++ S + L +L
Sbjct: 235 D-LSPLANLSQLTWLEIGTNQISDINAVKDLT-KLKMLNVGSNQISD--ISVLNNLSQLN 290
Query: 325 RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNP 383
LF+ NN L I L L N++T+I ++ +
Sbjct: 291 SLFLNNNQLGNEDMEVIGGLTNLT-----TLFLSQNHITDIRPLASLSKMDSADFANQV 344
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-36
Identities = 61/279 (21%), Positives = 112/279 (40%), Gaps = 24/279 (8%)
Query: 88 QLLNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
+L NL + N + L+ L L + IS P + N+ + L L N
Sbjct: 89 KLTNLYIGTNKITDISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNL- 145
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
S L + L+ + + ++ + P ANL +N N I P L+ L SL
Sbjct: 146 SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSL 201
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264
+ N +T ++ + +L L++ NN T + +N+S+L L + +
Sbjct: 202 HYFTAYVNQITD--ITPVANMTRLNSLKIGNNKI--TDLSP-LANLSQLTWLEIGTNQIS 256
Query: 265 GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQ 324
+ + L L++ SNQ++ LS + ++ L+NN+L GL L
Sbjct: 257 DI-NAVKDLTKLKMLNVGSNQISDISVLNNLS-QLNSLFLNNNQLGNEDMEVIGGLTNLT 314
Query: 325 RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 363
LF++ N ++ P + + ++ DF N +
Sbjct: 315 TLFLSQNHITDIRPLA-------SLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 5e-36
Identities = 55/284 (19%), Positives = 121/284 (42%), Gaps = 25/284 (8%)
Query: 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
L L ++ + P L+ ++ + ++S+ L++ G ++
Sbjct: 2 AATLATLPAPIN-QIFP-DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPS 203
+ + YL L+ + ++ N I+ P +NL K + ++ N I+ L L +
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 204 LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263
L + L+ +N++ L+ L K+ L L N+ + + SNM+ L L++ +
Sbjct: 112 LRELYLNEDNISD--ISPLANLTKMYSLNLGANHN--LSDLSPLSNMTGLNYLTVTESKV 167
Query: 264 QGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRL 323
+ + ++ + +L L L+ NQ+ P L+ ++ N++T P + + RL
Sbjct: 168 KD-VTPIANLTDLYSLSLNYNQIEDISPLASLT-SLHYFTAYVNQITDITP--VANMTRL 223
Query: 324 QRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 367
L I NN ++ P + N ++ L+ N +++I+
Sbjct: 224 NSLKIGNNKITDLSPLA-------NLSQLTWLEIGTNQISDINA 260
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 134 bits (341), Expect = 1e-34
Identities = 58/301 (19%), Positives = 116/301 (38%), Gaps = 28/301 (9%)
Query: 88 QLLNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
+ L ++G I L+ L L+ N+I+ P + N+ L L + N++T
Sbjct: 45 SITKLVVAGEKVASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD 102
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
L L L + ++++ IS ANL K ++ N LS + L
Sbjct: 103 --ISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGL 157
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264
++ + + + ++ L L L L+ N I ++++ L + +
Sbjct: 158 NYLTVTESKVKD--VTPIANLTDLYSLSLNYNQI--EDISPL-ASLTSLHYFTAYVNQIT 212
Query: 265 GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQ 324
+ ++ + L L + +N++ P LS +T +++ N+++ + L +L+
Sbjct: 213 D-ITPVANMTRLNSLKIGNNKITDLSPLANLS-QLTWLEIGTNQISD--INAVKDLTKLK 268
Query: 325 RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGN 382
L + +N +S S + LN L NN L N + T+ L N
Sbjct: 269 MLNVGSNQISD--ISVLNNLSQLN-----SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQN 321
Query: 383 P 383
Sbjct: 322 H 322
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 69/207 (33%), Positives = 103/207 (49%), Gaps = 20/207 (9%)
Query: 631 QIGQGGYGKVYKGILPDGTV-VAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
++G G YG+VY+G+ ++ VAVK +E +++ +EFL E + + H NLV L+G C
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
E ++ EFM+ G L D L +++ + + L +A S + YL HR
Sbjct: 79 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHR 135
Query: 750 DIKASNILLDHKFTAKVADFGLSRLAP----VPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
D+ A N L+ KVADFGLSRL P +K T PE
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTA----PESLA 185
Query: 806 THKLTDKSDVYSLGVVFLELLT-GMQP 831
+K + KSDV++ GV+ E+ T GM P
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-38
Identities = 62/226 (27%), Positives = 99/226 (43%), Gaps = 21/226 (9%)
Query: 631 QIGQGGYGKVYKGILP-----DGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHHRNLVS 684
+G+G +GKV G VAVK + S + EI+ L L+H N+V
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 685 LVGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 742
G C E+G L+ EF+ +G+L++ L K+K + +L A+ +G+ YL +
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLP-KNKNKINLKQQLKYAVQICKGMDYLGSRQ 146
Query: 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV--VKGTPGYLD 800
HRD+ A N+L++ + K+ DFGL++ + + V
Sbjct: 147 ---YVHRDLAARNVLVESEHQVKIGDFGLTKA--IETDKEYYTVKDDRDSPVFWYA---- 197
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVLPY 845
PE + K SDV+S GV ELLT S ++ + P
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT 243
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 7e-38
Identities = 55/310 (17%), Positives = 110/310 (35%), Gaps = 20/310 (6%)
Query: 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNE 141
+ + E +L N + + L+ ++ + I +++ + L + +
Sbjct: 261 VTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQ 318
Query: 142 LTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSIS--GQIPPELS 199
L +L +L L + N S S L + ++ N++S G
Sbjct: 319 LKQFPTLDLPFLKSLT---LTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDL 373
Query: 200 RLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLR 259
SL H+ L N + L +L L ++ + T +++ ++ KLL L +
Sbjct: 374 GTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDIS 432
Query: 260 NCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLTGTIPSN 316
+ + + +L L ++ N + + N+T + LS +L
Sbjct: 433 YTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGV 492
Query: 317 FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPN- 374
F L RLQ L +++N+L S Q +L+ LD N + + P +
Sbjct: 493 FDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLS-----TLDCSFNRIETSKGILQHFPKSL 547
Query: 375 VTVRLRGNPF 384
L N
Sbjct: 548 AFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-35
Identities = 49/281 (17%), Positives = 104/281 (37%), Gaps = 13/281 (4%)
Query: 87 LQLLNLNLSGNLSPEI--GRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
+ +L++ + L +L L NK S I + + SL L L+ N L+
Sbjct: 307 FKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSF 364
Query: 145 SLPE--ELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE-LSRL 201
S L + + N + +F L + +H ++++ L
Sbjct: 365 SGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSL 423
Query: 202 PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261
L+++ + N L L L++ N+F+ T+ ++N + L L L C
Sbjct: 424 EKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKC 483
Query: 262 SLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGTIPSNFS 318
L+ + L L++S N L + + +++T+ S N++ +
Sbjct: 484 QLEQISWGVFDTLHRLQLLNMSHNNLL-FLDSSHYNQLYSLSTLDCSFNRIETSKGILQH 542
Query: 319 GLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQN 359
L + NNS++ I + + + F+++ +
Sbjct: 543 FPKSLAFFNLTNNSVA-CICEHQKFLQWVKEQKQFLVNVEQ 582
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 8e-34
Identities = 65/354 (18%), Positives = 113/354 (31%), Gaps = 52/354 (14%)
Query: 88 QLLNLNLSGN----LSPE-IGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
L NL L+GN SP L+ L L + K++ IG + +L+ L + N +
Sbjct: 81 HLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFI 140
Query: 143 TG-SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHF----HMNNNSISGQIPPE 197
LP L L + + NYI L + M+ N I I +
Sbjct: 141 HSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQ 199
Query: 198 LSRLPSLVHMLLDNNNLTGYL-------------------------------PPELSELP 226
+ L + L N + + P + L
Sbjct: 200 AFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLC 259
Query: 227 KLLILQLDNNNFEGTTI-PASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQ 285
+ I + + + ++ + +SL S++ + D+ + L + Q
Sbjct: 260 DVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY-LEDVPKHFKWQSLSIIRCQ 318
Query: 286 LNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSR 345
L P L + ++ L+ NK + I LP L L ++ N+LS S S
Sbjct: 319 LK-QFPTLDLP-FLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLG 374
Query: 346 TLNATETFILDFQNNNLTNISGSFNIPPN-VTVRLRGNPFCLNTNAEQFCGSHS 398
T + LD N +S +F + + + T F
Sbjct: 375 TNSLRH---LDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEK 425
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-33
Identities = 60/336 (17%), Positives = 100/336 (29%), Gaps = 41/336 (12%)
Query: 61 DPCTSNWTGVLCFNTTMDDGYLHLREL------QLLNLNLSGN----LSPE-IGRLSYLT 109
+PC N T L ++ N++LS N L S L
Sbjct: 5 NPCIEV-----VPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQ 59
Query: 110 ILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGS 169
LD +I K + L L+L GN + P L L+ + + ++
Sbjct: 60 WLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASL 119
Query: 170 LPKSFANLNKTRHFHMNNNSISG-QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKL 228
L + ++ +N I ++P S L +LVH+ L N + +L L +
Sbjct: 120 ESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLREN 179
Query: 229 ----LILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD--LSRIPNLGYLDLS 282
L L + N I KL +L+LR + L + L L
Sbjct: 180 PQVNLSLDMSLNPI--DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLI 237
Query: 283 SNQLNG---------SIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 333
+ SI G + I +L+ F L + + +A S+
Sbjct: 238 LGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI 297
Query: 334 SGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 369
+ + L L
Sbjct: 298 K-YLEDVPKHFKWQ------SLSIIRCQLKQFPTLD 326
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-32
Identities = 57/299 (19%), Positives = 106/299 (35%), Gaps = 17/299 (5%)
Query: 96 GNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPK 155
G+L+P I + +T M K+S +P +I + S + + L+ N L +
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57
Query: 156 LDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT 215
L + + + I K++ L+ + + N I P S L SL +++ L
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 216 GYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG-PMPDLSRIP 274
+ +L L L + +N +PA +SN++ L+ + L +Q + DL +
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 275 NLG----YLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFI 328
LD+S N ++ I + + + L N + I L L +
Sbjct: 178 ENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236
Query: 329 ANNSLSGSIPSSIWQSRT---LNATETFILDFQNNNLTNIS-GSFNIPPNVTV-RLRGN 382
I++ L N + F+ NV+ L G
Sbjct: 237 ILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGV 295
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 5e-14
Identities = 24/137 (17%), Positives = 42/137 (30%), Gaps = 4/137 (2%)
Query: 83 HLRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLN 138
L +L L++ N + L+ L L N + + N +L L L+
Sbjct: 422 SLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLS 481
Query: 139 GNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL 198
+L L +L + + N + + L + N I
Sbjct: 482 KCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQ 541
Query: 199 SRLPSLVHMLLDNNNLT 215
SL L NN++
Sbjct: 542 HFPKSLAFFNLTNNSVA 558
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 7e-38
Identities = 63/227 (27%), Positives = 100/227 (44%), Gaps = 22/227 (9%)
Query: 631 QIGQGGYGKVYKGILP-----DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 685
Q+G+G +G V G VVAVK+ Q + + ++F EI+ L L H N+V
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 686 VGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
G C G + L+ E++ G+LRD L K KE + L +G+ YL T+
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTKR- 165
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV--VKGTPGYLDP 801
HRD+ NIL++++ K+ DFGL+++ +P + + P
Sbjct: 166 --YIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEYYKVKEPGESPIFWYA----P 217
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVL---PY 845
E K + SDV+S GVV EL T ++ ++
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 264
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 9e-38
Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 12/203 (5%)
Query: 631 QIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
++G G YG+VY+G+ VAVK +E +++ +EFL E + + H NLV L+G C
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
E ++ EFM+ G L D L +++ + + L +A S + YL + HR
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHR 342
Query: 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 809
++ A N L+ KVADFGLSRL + A +K T PE +K
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTA----PESLAYNKF 396
Query: 810 TDKSDVYSLGVVFLELLT-GMQP 831
+ KSDV++ GV+ E+ T GM P
Sbjct: 397 SIKSDVWAFGVLLWEIATYGMSP 419
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 1e-37
Identities = 70/201 (34%), Positives = 102/201 (50%), Gaps = 12/201 (5%)
Query: 632 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 691
+GQG +G+V+ G T VA+K + G++ E FL E Q + +L H LV L E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 692 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI 751
E +V E+MS G+L D L ++ + L + +A + G+ Y+ HRD+
Sbjct: 251 EP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 306
Query: 752 KASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD 811
+A+NIL+ KVADFGL+RL + D E +K T PE L + T
Sbjct: 307 RAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTA----PEAALYGRFTI 360
Query: 812 KSDVYSLGVVFLELLT-GMQP 831
KSDV+S G++ EL T G P
Sbjct: 361 KSDVWSFGILLTELTTKGRVP 381
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
++G G +G V G VAVK +EGS+ E EF E Q + +L H LV G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
+E +V E++SNG L + L + K L + L + G+ +L HRD
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFL---ESHQFIHRD 129
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGTPGYLDPEYF 804
+ A N L+D KV+DFG++R V D + P VK + PE F
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSSVGTKFP------VKWSA----PEVF 177
Query: 805 LTHKLTDKSDVYSLGVVFLELLT-GMQP 831
K + KSDV++ G++ E+ + G P
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 65/232 (28%), Positives = 104/232 (44%), Gaps = 49/232 (21%)
Query: 631 QIGQGGYGKVYKGILPDG------TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 684
++G+G +GKV+ + +VAVK ++ +L K+F E + L+ L H ++V
Sbjct: 22 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALG 730
G C + ++V+E+M +G L L A K LG + L IA
Sbjct: 82 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 731 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE--------- 781
+ G++YL A HRD+ N L+ K+ DFG+SR D+
Sbjct: 142 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-----DVYSTDYYRVGG 193
Query: 782 -GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
++P ++ P PE + K T +SDV+S GV+ E+ T G QP
Sbjct: 194 HTMLP------IRWMP----PESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-37
Identities = 66/226 (29%), Positives = 103/226 (45%), Gaps = 38/226 (16%)
Query: 631 QIGQGGYGKVYKGILPDG------TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 684
++G+G +GKV+ + +VAVK +E S ++F E + L+ L H+++V
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQL-------------SAKSKEPLGFAMRLSIALGS 731
G C E ++V+E+M +G L L + PLG L++A
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 732 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----EGIVPA 786
+ G++YL A HRD+ N L+ K+ DFG+SR D ++P
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP- 223
Query: 787 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
++ P PE L K T +SDV+S GVV E+ T G QP
Sbjct: 224 -----IRWMP----PESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
++G G +G V G VA+K +EGS+ E EF+ E + + L H LV L G C
Sbjct: 31 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
++ ++ E+M+NG L + L + + L + + YL HRD
Sbjct: 90 KQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRD 145
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGTPGYLDPEYF 804
+ A N L++ + KV+DFGLSR V D E P V+ +P PE
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFP------VRWSP----PEVL 193
Query: 805 LTHKLTDKSDVYSLGVVFLELLT-GMQP 831
+ K + KSD+++ GV+ E+ + G P
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-37
Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 12/201 (5%)
Query: 632 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 691
+G G +G+V+ T VAVK + GS+ + FL E + L H LV L +
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVTK 254
Query: 692 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI 751
E ++ EFM+ G+L D L + + + + G+ ++ HRD+
Sbjct: 255 EP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDL 310
Query: 752 KASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD 811
+A+NIL+ K+ADFGL+R+ + D E +K T PE T
Sbjct: 311 RAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTA----PEAINFGSFTI 364
Query: 812 KSDVYSLGVVFLELLT-GMQP 831
KSDV+S G++ +E++T G P
Sbjct: 365 KSDVWSFGILLMEIVTYGRIP 385
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 67/214 (31%), Positives = 97/214 (45%), Gaps = 28/214 (13%)
Query: 632 IGQGGYGKVYKGILPDG----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 686
IG+G +G VY G D A+K + + FL E + L+H N+++L+
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 687 GYC-DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
G EG ++ +M +G L + + +S L +RG+ YL A+
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFI-RSPQRNPTVKDLISFGLQVARGMEYL---AEQK 144
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRL-------APVPDIEGIVPAHVSTVVKGTPGY 798
HRD+ A N +LD FT KVADFGL+R + +P VK T
Sbjct: 145 FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP------VKWTA-- 196
Query: 799 LDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
E T++ T KSDV+S GV+ ELLT G P
Sbjct: 197 --LESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-37
Identities = 64/241 (26%), Positives = 103/241 (42%), Gaps = 46/241 (19%)
Query: 631 QIGQGGYGKVYKGILPDG------TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLV 683
++GQG +G VY+G+ T VA+K E + E+ EFL E + + ++V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE--------PLGFAMRLSIALGSSRGI 735
L+G + +++ E M+ G L+ L + P + + +A + G+
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 736 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI----------EGIVP 785
YL HRD+ A N ++ FT K+ DFG++R DI +G++P
Sbjct: 152 AYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETDYYRKGGKGLLP 203
Query: 786 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVLP 844
V+ PE T SDV+S GVV E+ T QP N +VL
Sbjct: 204 ------VRWMS----PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--EQVLR 251
Query: 845 Y 845
+
Sbjct: 252 F 252
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-37
Identities = 74/219 (33%), Positives = 100/219 (45%), Gaps = 38/219 (17%)
Query: 632 IGQGGYGKVYKGILPDG----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 686
IG+G +G VY G L D AVK + GE +FLTE + H N++SL+
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 687 GYC-DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
G C EG ++V +M +G LR+ + + L ++G+ YL A
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYL---ASKK 148
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE------------GIVPAHVSTVVK 793
HRD+ A N +LD KFT KVADFGL+R D+ +P VK
Sbjct: 149 FVHRDLAARNCMLDEKFTVKVADFGLAR-----DMYDKEYYSVHNKTGAKLP------VK 197
Query: 794 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
E T K T KSDV+S GV+ EL+T G P
Sbjct: 198 WMA----LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 145 bits (366), Expect = 9e-37
Identities = 70/201 (34%), Positives = 102/201 (50%), Gaps = 12/201 (5%)
Query: 632 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 691
+GQG +G+V+ G T VA+K + G++ E FL E Q + +L H LV L E
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 692 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI 751
E +V E+MS G+L D L ++ + L + +A + G+ Y+ HRD+
Sbjct: 334 EP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 389
Query: 752 KASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD 811
+A+NIL+ KVADFGL+RL + D E +K T PE L + T
Sbjct: 390 RAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTA----PEAALYGRFTI 443
Query: 812 KSDVYSLGVVFLELLT-GMQP 831
KSDV+S G++ EL T G P
Sbjct: 444 KSDVWSFGILLTELTTKGRVP 464
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 27/212 (12%)
Query: 632 IGQGGYGKVYKGIL-PDG----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSL 685
+G G +G VYKG+ P+G VA+K +E + E L E ++ + + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
+G C L+ + M G L D + + K+ +G L+ + ++G+ YL D
Sbjct: 83 LGICLTS-TVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYL---EDRR 137
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVSTVVKGTPGYLD 800
+ HRD+ A N+L+ K+ DFGL++L + E G VP +K
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP------IKWMA---- 187
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
E L T +SDV+S GV EL+T G +P
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-36
Identities = 56/213 (26%), Positives = 86/213 (40%), Gaps = 15/213 (7%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
++G+GG+ V L DG A+KR Q +E E +H N++ LV YC
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 690 DEEGEQM----LVYEFMSNGTLRDQLSAKSKEPLGFAMR--LSIALGSSRGILYLHTEAD 743
E L+ F GTL +++ + L + LG RG+ +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLA--PVPDIEGIVPAHVSTVVKGTPGYLDP 801
HRD+K +NILL + + D G A V + + T Y P
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 802 EYFLTHK---LTDKSDVYSLGVVFLELLTGMQP 831
E F + +++DV+SLG V ++ G P
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 55/309 (17%), Positives = 100/309 (32%), Gaps = 23/309 (7%)
Query: 82 LHLRELQLLNL--NLSGNLSPEIGR-LSYLTILDFMWNKISGSIPKEIGNIKSLELLLLN 138
+ ++ + + + + + LD N +S ++ LELL L+
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 139 GNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL 198
N L +L L L + ++ NY+ H NN+IS ++
Sbjct: 67 SNVLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR 118
Query: 199 SRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSL 258
++ L NN +T + ++ L L N + ++ L L+L
Sbjct: 119 --GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 259 RNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNF 317
+ + + L LDLSSN+L + P S +T I L NNKL I
Sbjct: 177 QYNFIYD-VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKAL 233
Query: 318 SGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTV 377
L+ + N + S+ + + ++G V
Sbjct: 234 RFSQNLEHFDLRGNGFH-CGTLRDFFSKNQR-----VQTVAKQTVKKLTGQNEEECTVPT 287
Query: 378 RLRGNPFCL 386
+C
Sbjct: 288 LGHYGAYCC 296
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 49/269 (18%), Positives = 98/269 (36%), Gaps = 25/269 (9%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
+I + N ++ + + L +L + + + N +S A K
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 181 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240
++++N + +L L +L + L+NN + EL P + L NNN
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-- 111
Query: 241 TTIPASYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRL---S 296
+ + S + L N + D + YLDL N+++ ++ L S
Sbjct: 112 SRVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASS 168
Query: 297 LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILD 356
+ + L N + + +L+ L +++N L+ + + + +
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQ-VVFAKLKTLDLSSNKLA-FMGPEFQSAAGVT-----WIS 220
Query: 357 FQNNNLTNISGSFNIPPNVTV-RLRGNPF 384
+NN L I + N+ LRGN F
Sbjct: 221 LRNNKLVLIEKALRFSQNLEHFDLRGNGF 249
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 40/240 (16%), Positives = 78/240 (32%), Gaps = 11/240 (4%)
Query: 88 QLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLP 147
L L+L+ N E+ + L N IS + G + + + L N++T
Sbjct: 81 TLRTLDLNNNYVQELLVGPSIETLHAANNNIS-RVSCSRG--QGKKNIYLANNKITMLRD 137
Query: 148 EELGYLPKLDRIQIDQNYISG-SLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVH 206
+ G ++ + + N I + + A+ + H ++ N I + ++ L
Sbjct: 138 LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKT 195
Query: 207 MLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGP 266
+ L +N L ++ PE + + L NN I + L LR
Sbjct: 196 LDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL--VLIEKALRFSQNLEHFDLRGNGFHCG 252
Query: 267 MPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRL 326
N ++ + + T+ +P+ F RL L
Sbjct: 253 TLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPF--ADRLIAL 310
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 35/200 (17%), Positives = 62/200 (31%), Gaps = 11/200 (5%)
Query: 89 LLNLNLSGN----LSP-EIGRLSYLTILDFMWNKISG-SIPKEIGNIKSLELLLLNGNEL 142
N+ L+ N L + G S + LD N+I + + + +LE L L N +
Sbjct: 122 KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181
Query: 143 TGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLP 202
+ ++ KL + + N ++ + F + + NN + I L
Sbjct: 182 Y-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQ 237
Query: 203 SLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCS 262
+L H L N + + + T L C
Sbjct: 238 NLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCC 296
Query: 263 LQGPMPDLSRIPNLGYLDLS 282
P P R+ LG+
Sbjct: 297 EDLPAPFADRLIALGHHHHH 316
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 25/217 (11%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVG 687
+IG+G + VYKG+ VA Q+ L + F E + L L H N+V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 688 YC-DEEGEQMLVY---EFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGSSRGILYLHTE 741
+ + E M++GTL+ L K +++ S +G+ +LHT
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHTR 148
Query: 742 ADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
PP+ HRD+K NI + + K+ D GL+ + A + V GTP ++
Sbjct: 149 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT---------LKRASFAKAVIGTPEFMA 198
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
PE + K + DVY+ G+ LE+ T P S +N
Sbjct: 199 PEMY-EEKYDESVDVYAFGMCMLEMATSEYPYSECQN 234
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-36
Identities = 69/208 (33%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 632 IGQGGYGKVYKGILPDG----TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLV 686
IG+G +G VY G L D AVK + +FLTE + H N++SL+
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 687 GYC-DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
G C EG ++V +M +G LR+ + + L ++G+ +L A
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFL---ASKK 212
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-VKGTPGYLDPEYF 804
HRD+ A N +LD KFT KVADFGL+R + + + + + VK E
Sbjct: 213 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA----LESL 268
Query: 805 LTHKLTDKSDVYSLGVVFLELLT-GMQP 831
T K T KSDV+S GV+ EL+T G P
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-36
Identities = 63/227 (27%), Positives = 91/227 (40%), Gaps = 44/227 (19%)
Query: 631 QIGQGGYGKVYKGILPDG----TVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 684
+G+G +G V +G L VAVK + S + +EFL+E + H N++
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 685 LVGYCDEEGEQ-----MLVYEFMSNGTLRDQL----SAKSKEPLGFAMRLSIALGSSRGI 735
L+G C E Q M++ FM G L L + + L + + G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 736 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE----------GIVP 785
YL ++ HRD+ A N +L T VADFGLS+ I +P
Sbjct: 161 EYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK-----KIYSGDYYRQGRIAKMP 212
Query: 786 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
VK E T KSDV++ GV E+ T GM P
Sbjct: 213 ------VKWIA----IESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-36
Identities = 64/231 (27%), Positives = 96/231 (41%), Gaps = 32/231 (13%)
Query: 631 QIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHHRNLVS 684
+G+G +GKV G +VAVK + + + EI L L+H +++
Sbjct: 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 685 LVGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 742
G C++ G LV E++ G+LRD L + +G A L A G+ YLH +
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYLP---RHSIGLAQLLLFAQQICEGMAYLHAQH 154
Query: 743 DPPVF-HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL-- 799
+ HRD+ A N+LLD+ K+ DFGL++ VP G
Sbjct: 155 ----YIHRDLAARNVLLDNDRLVKIGDFGLAKA---------VPEGHEYYRVREDGDSPV 201
Query: 800 ---DPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREV-LPY 845
PE +K SDV+S GV ELLT S + + +
Sbjct: 202 FWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ 252
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 56/233 (24%), Positives = 100/233 (42%), Gaps = 50/233 (21%)
Query: 631 QIGQGGYGKVYKGILPDG------TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLV 683
++G+ +GKVYKG L VA+K ++ +EF E +RL H N+V
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIAL 729
L+G ++ +++ + S+G L + L +S K L + +
Sbjct: 76 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 730 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-------- 781
+ G+ YL + V H+D+ N+L+ K K++D GL R ++
Sbjct: 136 QIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR-----EVYAADYYKLL 187
Query: 782 --GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
++P ++ PE + K + SD++S GVV E+ + G+QP
Sbjct: 188 GNSLLP------IRWMA----PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 630 TQIGQGGYGKVYKGIL--PDGTV-VAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSL 685
++G G +G V +G+ + VA+K ++G+ + + E + E Q + +L + +V L
Sbjct: 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
+G C E MLV E G L L +E + + + S G+ YL +
Sbjct: 76 IGVCQAE-ALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYL---EEKN 130
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
HRD+ A N+LL ++ AK++DFGLS+ D + +K PE
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA----PECIN 186
Query: 806 THKLTDKSDVYSLGVVFLELLT-GMQP 831
K + +SDV+S GV E L+ G +P
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 57/228 (25%), Positives = 86/228 (37%), Gaps = 45/228 (19%)
Query: 631 QIGQGGYGKVYKGILPDG----TVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVS 684
+G+G +G V + L VAVK + + +EFL E + H ++
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 685 LVGYCDEEGEQ------MLVYEFMSNGTLRDQL----SAKSKEPLGFAMRLSIALGSSRG 734
LVG + M++ FM +G L L ++ L + + + G
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 735 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE----------GIV 784
+ YL + HRD+ A N +L T VADFGLSR I +
Sbjct: 150 MEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR-----KIYSGDYYRQGCASKL 201
Query: 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
P VK E + T SDV++ GV E++T G P
Sbjct: 202 P------VKWLA----LESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 50/303 (16%), Positives = 99/303 (32%), Gaps = 23/303 (7%)
Query: 75 TTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLEL 134
+ + H + L S L P LS N + ++
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW-HSAWRQANSNNPQI 60
Query: 135 LLLNGNELTGSLPEELGYL--PKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG 192
G L + + L P +++ + P L+ +H ++ +
Sbjct: 61 ETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM- 117
Query: 193 QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNN--------FEGTTIP 244
++P + + L + L N L LP ++ L +L L + T
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDAS 176
Query: 245 ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTI 302
+ + L L L ++ ++ + NL L + ++ L+ ++ P L + +
Sbjct: 177 GEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLP-KLEEL 234
Query: 303 KLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNL 362
L P F G L+RL + + S ++P I + L E L NL
Sbjct: 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQL---EKLDLR-GCVNL 290
Query: 363 TNI 365
+ +
Sbjct: 291 SRL 293
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 8e-35
Identities = 53/296 (17%), Positives = 98/296 (33%), Gaps = 28/296 (9%)
Query: 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLEL--LLLNGNE 141
+ + N + + I + + + + L L
Sbjct: 35 WQRHYNADRNRWHSAW-RQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVP 92
Query: 142 LTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRL 201
L P++ L L + ID + LP + + N + +P ++ L
Sbjct: 93 LP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASL 149
Query: 202 PSLVHMLLDNNNLTGYLPPEL---------SELPKLLILQLDNNNFEGTTIPASYSNMSK 252
L + + LP L L L L+L+ ++PAS +N+
Sbjct: 150 NRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGI--RSLPASIANLQN 207
Query: 253 LLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTIKLSN-NKL 309
L L +RN L P + +P L LDL + PP G + + + L + + L
Sbjct: 208 LKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRA-PLKRLILKDCSNL 266
Query: 310 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 365
T+P + L +L++L + +PS I Q I+ + +
Sbjct: 267 L-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANC-----IILVPPHLQAQL 316
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 28/146 (19%), Positives = 52/146 (35%), Gaps = 7/146 (4%)
Query: 88 QLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
L +L L L I L L L + +S ++ I ++ LE L L G
Sbjct: 184 NLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTAL 242
Query: 144 GSLPEELGYLPKLDRIQI-DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLP 202
+ P G L R+ + D + + +LP L + + ++P +++LP
Sbjct: 243 RNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLP 301
Query: 203 SLVHMLLDNNNLTGYLPPELSELPKL 228
+ +L+ + P
Sbjct: 302 ANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 21/90 (23%), Positives = 32/90 (35%), Gaps = 2/90 (2%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMW-NKISGSIPKEIGNIKSLELLLLNGNE 141
L EL L N P G + L L + + ++P +I + LE L L G
Sbjct: 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCV 288
Query: 142 LTGSLPEELGYLPKLDRIQIDQNYISGSLP 171
LP + LP I + + +
Sbjct: 289 NLSRLPSLIAQLPANCIILVPPHLQAQLDQ 318
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 6e-08
Identities = 14/74 (18%), Positives = 26/74 (35%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
L+ L L + + L +I RL+ L LD +P I + + ++L+ +
Sbjct: 254 PLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313
Query: 143 TGSLPEELGYLPKL 156
P
Sbjct: 314 AQLDQHRPVARPAE 327
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 61/215 (28%), Positives = 95/215 (44%), Gaps = 35/215 (16%)
Query: 632 IGQGGYGKVYKGIL----PDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 686
+G+G +G+VY+G+ + VAVK ++ K +F++E + L H ++V L+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
G +EE ++ E G L L ++K L + +L + + YL E+ V
Sbjct: 80 GIIEEE-PTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYL--ESINCV 135
Query: 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE---------GIVPAHVSTVVKGTPG 797
HRDI NIL+ K+ DFGLSR IE +P +K
Sbjct: 136 -HRDIAVRNILVASPECVKLGDFGLSR-----YIEDEDYYKASVTRLP------IKWMS- 182
Query: 798 YLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
PE + T SDV+ V E+L+ G QP
Sbjct: 183 ---PESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 51/219 (23%), Positives = 88/219 (40%), Gaps = 33/219 (15%)
Query: 631 QIGQGGYGKVYKGIL--------PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL 682
+GQG + K++KG+ T V +K + + F +S+L H++L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 683 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 742
V G C E +LV EF+ G+L L K+K + +L +A + + +L
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFL---E 130
Query: 743 DPPVFHRDIKASNILLDHKFT--------AKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 794
+ + H ++ A NILL + K++D G+S +P +
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-LPKDILQER------IPW 183
Query: 795 TPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLT-GMQP 831
P PE K +D +S G E+ + G +P
Sbjct: 184 VP----PECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 631 QIGQGGYGKVYKGIL--PDGTV-VAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSL 685
++G G +G V KG VAVK + + + E L E + +L + +V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
+G C+ E MLV E G L L + + + + S G+ YL E
Sbjct: 84 IGICEAES-WMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYL--EESNF 138
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV--VKGTPGYLDPEY 803
V HRD+ A N+LL + AK++DFGLS+ + E A VK PE
Sbjct: 139 V-HRDLAARNVLLVTQHYAKISDFGLSKA--LRADENYYKAQTHGKWPVKWYA----PEC 191
Query: 804 FLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
+K + KSDV+S GV+ E + G +P
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-35
Identities = 59/305 (19%), Positives = 105/305 (34%), Gaps = 24/305 (7%)
Query: 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGN 140
++ + E L+ I+ F + + +P + + + +ELL LN
Sbjct: 21 CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDL 79
Query: 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL-S 199
++ Y + ++ + N I P F N+ + N +S +P +
Sbjct: 80 QIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFH 138
Query: 200 RLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSL 258
P L + + NNNL + + L LQL +N T + S + L ++
Sbjct: 139 NTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRL--THVDL--SLIPSLFHANV 193
Query: 259 RNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFS 318
L L+ + LD S N +N + +T +KL +N LT
Sbjct: 194 SYNLLS----TLAIPIAVEELDASHNSIN-VVRGPVNV-ELTILKLQHNNLT-DTAW-LL 245
Query: 319 GLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTV- 377
P L + ++ N L I + L NN L ++ P + V
Sbjct: 246 NYPGLVEVDLSYNELE-KIMYHPFV----KMQRLERLYISNNRLVALNLYGQPIPTLKVL 300
Query: 378 RLRGN 382
L N
Sbjct: 301 DLSHN 305
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 62/311 (19%), Positives = 116/311 (37%), Gaps = 57/311 (18%)
Query: 88 QLLNLNLSGN----LSPEI-GRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGNE 141
Q+ LNL+ + + L +N I +P + N+ L +L+L N+
Sbjct: 70 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND 128
Query: 142 LTGSLPEEL-GYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR 200
L+ SLP + PKL + + N + +F ++ +++N ++ + S
Sbjct: 129 LS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL--SL 184
Query: 201 LPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRN 260
+PSL H + N L+ L+ + L +N+ + +L L L++
Sbjct: 185 IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSI--NVVRGP--VNVELTILKLQH 235
Query: 261 CSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG---------RLSL-------------- 297
+L L P L +DLS N+L I RL +
Sbjct: 236 NNLT-DTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVALNLYGQP 293
Query: 298 --NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 355
+ + LS+N L + N RL+ L++ +NS+ ++ S + L
Sbjct: 294 IPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLK-------NL 344
Query: 356 DFQNNNLTNIS 366
+N+ S
Sbjct: 345 TLSHNDWDCNS 355
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 51/266 (19%), Positives = 101/266 (37%), Gaps = 23/266 (8%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
I + + ++ E L + + + + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 181 RHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNF 238
++N+ I +I + ++ + + N + YLPP +P L +L L+ N+
Sbjct: 72 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 129
Query: 239 EGTTIPAS-YSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS 296
+++P + N KL LS+ N +L+ +L L LSSN+L + +
Sbjct: 130 --SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIP 186
Query: 297 LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILD 356
++ +S N L+ + ++ L ++NS++ + + T IL
Sbjct: 187 -SLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVNVELT-------ILK 232
Query: 357 FQNNNLTNISGSFNIPPNVTVRLRGN 382
Q+NNLT+ + N P V V L N
Sbjct: 233 LQHNNLTDTAWLLNYPGLVEVDLSYN 258
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-35
Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 18/209 (8%)
Query: 631 QIGQGGYGKVYKGILPDG----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSL 685
IG G G+V G L VA+K + G + ++ +FL+E + + H N++ L
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
G M+V E+M NG+L L + + G G+ YL
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYLSDLG--- 171
Query: 746 VF-HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-VKGTPGYLDPEY 803
+ HRD+ A N+L+D KV+DFGLSR+ D + + ++ T PE
Sbjct: 172 -YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED-DPDAAYTTTGGKIPIRWTA----PEA 225
Query: 804 FLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
+ SDV+S GVV E+L G +P
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 60/231 (25%), Positives = 103/231 (44%), Gaps = 43/231 (18%)
Query: 631 QIGQGGYGKVYKGILPD--------GTVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHR 680
+G+G +G+V VAVK ++ + + + + ++E++ + + H+
Sbjct: 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLGFAMRLS 726
N+++L+G C ++G ++ E+ S G LR+ L + +E + F +S
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 727 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----E 781
+RG+ YL A HRD+ A N+L+ K+ADFGL+R D
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
G +P VK PE T +SDV+S GV+ E+ T G P
Sbjct: 219 GRLP------VKWMA----PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 27/212 (12%)
Query: 632 IGQGGYGKVYKGILPDG-----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSL 685
+G G +G VYKG+ VA+K +E + E L E ++ + + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
+G C L+ + M G L D + + K+ +G L+ + ++G+ YL D
Sbjct: 83 LGICLTS-TVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYL---EDRR 137
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVSTVVKGTPGYLD 800
+ HRD+ A N+L+ K+ DFGL++L + E G VP +K
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP------IKWMA---- 187
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
E L T +SDV+S GV EL+T G +P
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-34
Identities = 58/316 (18%), Positives = 101/316 (31%), Gaps = 23/316 (7%)
Query: 82 LHLRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLN 138
+ ++ + +L L+ + LD N +S ++ LELL L+
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 139 GNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL 198
N L +L L L + ++ NY+ H NN+IS ++
Sbjct: 67 SNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR 118
Query: 199 SRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSL 258
++ L NN +T + ++ L L N + ++ L L+L
Sbjct: 119 --GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 259 RNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNF 317
+ + + L LDLSSN+L + P S +T I L NNKL I
Sbjct: 177 QYNFIYD-VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKAL 233
Query: 318 SGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTV 377
L+ + N R + + + ++G V
Sbjct: 234 RFSQNLEHFDLRGNGFHCGTL------RDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 378 RLRGNPFCLNTNAEQF 393
+C F
Sbjct: 288 LGHYGAYCCEDLPAPF 303
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-32
Identities = 48/269 (17%), Positives = 98/269 (36%), Gaps = 25/269 (9%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
+I + N ++ + + L +L + + + N +S A K
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 181 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240
++++N + +L L +L + L+NN + EL P + L NNN
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-- 111
Query: 241 TTIPASYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-- 297
+ + S + L N + D + YLDL N+++ ++ L+
Sbjct: 112 SRVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASS 168
Query: 298 -NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILD 356
+ + L N + + +L+ L +++N L+ + + + +
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQ-VVFAKLKTLDLSSNKLA-FMGPEFQSAAGVT-----WIS 220
Query: 357 FQNNNLTNISGSFNIPPNVTV-RLRGNPF 384
+NN L I + N+ LRGN F
Sbjct: 221 LRNNKLVLIEKALRFSQNLEHFDLRGNGF 249
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-28
Identities = 50/301 (16%), Positives = 92/301 (30%), Gaps = 17/301 (5%)
Query: 88 QLLNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
+L LNLS N+ + ++ LS L LD N + E+ S+E L N ++
Sbjct: 59 KLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG-QIPPELSRLPS 203
+ I + N I+ ++ ++ + N I + +
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 204 LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263
L H+ L N + + ++ KL L L +N + + + + + +SLRN L
Sbjct: 171 LEHLNLQYNFIYD-VKGQVV-FAKLKTLDLSSNKL--AFMGPEFQSAAGVTWISLRNNKL 226
Query: 264 QGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRL 323
L NL + DL N + S N ++ + N
Sbjct: 227 VLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 324 QRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTVRLRGN 382
+ L E +L Q + + N +
Sbjct: 287 TLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKE 346
Query: 383 P 383
Sbjct: 347 Q 347
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-26
Identities = 48/333 (14%), Positives = 94/333 (28%), Gaps = 56/333 (16%)
Query: 88 QLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLP 147
L L+L+ N E+ + L N IS + G + + + L N++T
Sbjct: 81 TLRTLDLNNNYVQELLVGPSIETLHAANNNIS-RVSCSRG--QGKKNIYLANNKITMLRD 137
Query: 148 EELGYLPKLDRIQIDQNYISG-SLPKSFANLNKTRHFHMNNNSISG-------------- 192
+ G ++ + + N I + + A+ + H ++ N I
Sbjct: 138 LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLD 197
Query: 193 -------QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPA 245
+ PE + + L NN L + L L L N F T+
Sbjct: 198 LSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRD 256
Query: 246 SYSNMSKLLKLSLR-----------------------NCSLQGPMPDLSRIPNLGYLDLS 282
+S ++ ++ + C P P R+ L + +
Sbjct: 257 FFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHA 316
Query: 283 SNQLNGS----IPPGRLSLN-ITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI 337
GS + R + I + I L +L +
Sbjct: 317 LLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQV 376
Query: 338 PSSIWQSRTLNATETFILDFQNNNLTNISGSFN 370
+ L+ T + L + + +
Sbjct: 377 SNGRRAHAELDGTLQQAV--GQIELQHATEEQS 407
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 9e-21
Identities = 38/284 (13%), Positives = 83/284 (29%), Gaps = 14/284 (4%)
Query: 88 QLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
L +LNL N + ++ + L LD NK++ + E + + + L N+L
Sbjct: 170 TLEHLNLQYNFIYDVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 144 GSLPEELGYLPKLDRIQIDQNYIS-GSLPKSFANLNKTRHFHMN-NNSISGQIPPELSRL 201
+ + L + L+ + N G+L F+ + + ++GQ E +
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 202 PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261
+ +L L L + L E + N ++ ++
Sbjct: 287 TLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKE 346
Query: 262 SLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGL 320
+ R L+ L+ + GR + +L
Sbjct: 347 QYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAH----AELDGTLQQAVGQIELQHA 402
Query: 321 PRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 364
Q ++ + +++ D + T
Sbjct: 403 TEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQ 446
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 27/212 (12%)
Query: 632 IGQGGYGKVYKGILPDG-----TVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSL 685
+G G +G V+KG+ V +K ++ S Q + + + L H ++V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
+G C LV +++ G+L D + + + LG + L+ + ++G+ YL +
Sbjct: 81 LGLCPGS-SLQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYL---EEHG 135
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVSTVVKGTPGYLD 800
+ HR++ A N+LL +VADFG++ L P D + P +K
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP------IKWMA---- 185
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
E K T +SDV+S GV EL+T G +P
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 60/232 (25%), Positives = 97/232 (41%), Gaps = 49/232 (21%)
Query: 631 QIGQGGYGKVYKGILPD------GTVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHRNL 682
+G G +GKV + VAVK + + EK ++E++ +S L H N+
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 683 VSLVGYCDEEGEQMLVYEFMSNGTLRDQL------------SAKSKEPLGFAMRLSIALG 730
V+L+G C G +++ E+ G L + L A + L +
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 731 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI---------- 780
++G+ +L A HRD+ A N+LL + AK+ DFGL+R DI
Sbjct: 173 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIVKG 224
Query: 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
+P VK PE T +SDV+S G++ E+ + G+ P
Sbjct: 225 NARLP------VKWMA----PESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 34/222 (15%)
Query: 631 QIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLV 683
+G G +G+VY+G + P VAVK E + ++ +FL E +S+ +H+N+V
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQL-----SAKSKEPLGFAMRLSIALGSSRGILYL 738
+G + + ++ E M+ G L+ L L L +A + G YL
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 739 HTEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDI-----EGIVPAHVST 790
+ HRDI A N LL AK+ DFG++R ++P
Sbjct: 157 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP----- 208
Query: 791 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
VK P PE F+ T K+D +S GV+ E+ + G P
Sbjct: 209 -VKWMP----PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 62/212 (29%), Positives = 93/212 (43%), Gaps = 29/212 (13%)
Query: 632 IGQGGYGKVYKGILPDG----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 686
IG+G +G V++GI VA+K + + + +FL E + + H ++V L+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
G E ++ E + G LR L K L A + A S + YL E+ V
Sbjct: 83 GVITEN-PVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYL--ESKRFV 138
Query: 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGTPGYLD 800
HRDI A N+L+ K+ DFGLSR + D G +P +K
Sbjct: 139 -HRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLP------IKWMA---- 185
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
PE + T SDV+ GV E+L G++P
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 65/228 (28%), Positives = 101/228 (44%), Gaps = 45/228 (19%)
Query: 631 QIGQGGYGKVYKGILPDG---TVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHRNLVSL 685
IG+G +G+V K + A+KR +E + + + +F E++ L +L HH N+++L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLGFAMRLSIALGS 731
+G C+ G L E+ +G L D L + + L L A
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 732 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-------GIV 784
+RG+ YL + HRD+ A NIL+ + AK+ADFGLSR E G +
Sbjct: 152 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRL 203
Query: 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
P V+ E T SDV+S GV+ E+++ G P
Sbjct: 204 P------VRWMA----IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 67/241 (27%), Positives = 104/241 (43%), Gaps = 58/241 (24%)
Query: 631 QIGQGGYGKVYKGILPDG------TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLV 683
+G+G +GKV K T VAVK +E + E + L+E L +++H +++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQL----------------------SAKSKEPLGF 721
L G C ++G +L+ E+ G+LR L + L
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 722 AMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI- 780
+S A S+G+ YL A+ + HRD+ A NIL+ K++DFGLSR D+
Sbjct: 150 GDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR-----DVY 201
Query: 781 ---------EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQ 830
+G +P VK E H T +SDV+S GV+ E++T G
Sbjct: 202 EEDSYVKRSQGRIP------VKWMA----IESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 831 P 831
P
Sbjct: 252 P 252
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 17/209 (8%)
Query: 631 QIGQGGYGKVYKGIL--PDGTV---VAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVS 684
IG G +G+VYKG+L G VA+K + G + ++ +FL E + + H N++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 744
L G + M++ E+M NG L L + + + G + G+ YL A+
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYL---ANM 166
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-VKGTPGYLDPEY 803
HRD+ A NIL++ KV+DFGLSR+ D E + ++ T PE
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRV-LEDDPEATYTTSGGKIPIRWTA----PEA 221
Query: 804 FLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
K T SDV+S G+V E++T G +P
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 57/235 (24%), Positives = 95/235 (40%), Gaps = 17/235 (7%)
Query: 600 HSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQE 658
H +S G + + M + +IG+G +GK DG +K
Sbjct: 4 HHHHSSGVDLGTENLYFQSM----EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINI 59
Query: 659 GSL-QGEKEF-LTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK 716
+ E+E E+ L+ + H N+V +E G +V ++ G L +++A+
Sbjct: 60 SRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKG 119
Query: 717 EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776
L + + ++H D + HRDIK+ NI L T ++ DFG++R+
Sbjct: 120 VLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176
Query: 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
+ GTP YL PE +KSD+++LG V EL T
Sbjct: 177 STV------ELARACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-34
Identities = 60/231 (25%), Positives = 104/231 (45%), Gaps = 43/231 (18%)
Query: 631 QIGQGGYGKVYKGIL--------PDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHR 680
+G+G +G+V + VAVK ++ + + + + ++E++ + + H+
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLGFAMRLS 726
N+++L+G C ++G ++ E+ S G LR+ L + +E + F +S
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 727 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----E 781
+RG+ YL A HRD+ A N+L+ K+ADFGL+R D
Sbjct: 208 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264
Query: 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
G +P VK PE T +SDV+S GV+ E+ T G P
Sbjct: 265 GRLP------VKWMA----PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 64/244 (26%), Positives = 99/244 (40%), Gaps = 43/244 (17%)
Query: 631 QIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHRNL 682
+G+G +G+V + VAVK +EG+ E ++E++ L + HH N+
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 683 VSLVGYC-DEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLGFAMRLSI 727
V+L+G C G M++ EF G L L K+ L +
Sbjct: 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 728 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----EG 782
+ ++G+ +L A HRD+ A NILL K K+ DFGL+R +
Sbjct: 154 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210
Query: 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVRE 841
+P +K PE T +SDV+S GV+ E+ + G P G I E
Sbjct: 211 RLP------LKWMA----PETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEE 259
Query: 842 VLPY 845
Sbjct: 260 FCRR 263
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 60/209 (28%), Positives = 90/209 (43%), Gaps = 17/209 (8%)
Query: 631 QIGQGGYGKVYKGIL--PDGTV--VAVKRAQEGSLQGEK---EFLTEIQFLSRLHHRNLV 683
++G G +G V +G P G VAVK + L + +F+ E+ + L HRNL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
L G +V E G+L D+L K + A+ + G+ YL E+
Sbjct: 85 RLYGVVLTPP-MKMVTELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQVAEGMGYL--ESK 140
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
+ HRD+ A N+LL + K+ DFGL R P D ++ H PE
Sbjct: 141 RFI-HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA----PES 195
Query: 804 FLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
T + SD + GV E+ T G +P
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 7e-34
Identities = 65/227 (28%), Positives = 97/227 (42%), Gaps = 44/227 (19%)
Query: 631 QIGQGGYGKVYKGILPDG------TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLV 683
+G G +G+VY+G + VAVK E S Q E +FL E +S+ +H+N+V
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQL-----SAKSKEPLGFAMRLSIALGSSRGILYL 738
+G + + ++ E M+ G L+ L L L +A + G YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 739 HTEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDI----------EGIVP 785
+ HRDI A N LL AK+ DFG++R DI ++P
Sbjct: 198 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGYYRKGGCAMLP 249
Query: 786 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
VK P PE F+ T K+D +S GV+ E+ + G P
Sbjct: 250 ------VKWMP----PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-34
Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 24/212 (11%)
Query: 631 QIGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSL 685
+G G +G+V G L VA+K + G + ++ +FL E + + H N++ L
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
G + M+V E+M NG+L L K + + G + G+ YL +D
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-----VKGTPGYLD 800
HRD+ A NIL++ KV+DFGL R +E A +T ++ T
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLGR-----VLEDDPEAAYTTRGGKIPIRWTS---- 218
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
PE K T SDV+S G+V E+++ G +P
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 9e-34
Identities = 73/328 (22%), Positives = 116/328 (35%), Gaps = 47/328 (14%)
Query: 88 QLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
+L L +SGN L L L+I + L L + GN+LT
Sbjct: 82 ELRTLEVSGNQLTSLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLT 134
Query: 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPS 203
SLP L +L + N ++ SLP + L NN ++ +P S
Sbjct: 135 -SLPVLPPGLQELS---VSDNQLA-SLPALPSEL---CKLWAYNNQLT-SLPMLPS---G 182
Query: 204 LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263
L + + +N L LP SEL KL NN T++PA S L +L + L
Sbjct: 183 LQELSVSDNQLA-SLPTLPSELYKL---WAYNNRL--TSLPAL---PSGLKELIVSGNRL 233
Query: 264 QGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRL 323
+P L L L +S N+L S+P L ++ + N+LT +P + L
Sbjct: 234 TS-LPVL--PSELKELMVSGNRLT-SLPMLPSGL--LSLSVYRNQLT-RLPESLIHLSSE 286
Query: 324 QRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNP 383
+ + N LS + T + + + P T L
Sbjct: 287 TTVNLEGNPLS-ERTLQALREITS-------APGYSGPIIRFDMAGASAPRETRALHLAA 338
Query: 384 FCLNTNAEQFCGSHSDDDNEIDRSTNST 411
A + + +D + + N+
Sbjct: 339 ADWLVPAREGEPAPADRWHMFGQEDNAD 366
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 48/246 (19%), Positives = 85/246 (34%), Gaps = 30/246 (12%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
L+EL + + L+ +L L L + N+++ S+P ++ L + + N+L
Sbjct: 142 GLQELSVSDNQLA-SLPALPSELCKLWAYN---NQLT-SLPMLPSGLQELSV---SDNQL 193
Query: 143 TGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLP 202
SLP L KL N ++ SLP + L + ++ N ++ +P S L
Sbjct: 194 A-SLPTLPSELYKLW---AYNNRLT-SLPALPSGL---KELIVSGNRLT-SLPVLPSELK 244
Query: 203 SLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCS 262
L+ + N LT LP S L L + N T +P S ++S ++L
Sbjct: 245 ELM---VSGNRLT-SLPMLPSGLLSL---SVYRNQL--TRLPESLIHLSSETTVNLEGNP 295
Query: 263 LQGPMPDLSRIPNLGYLDLSSNQLN--GSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGL 320
L R + S + + + L +
Sbjct: 296 LSERTLQALR--EITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPA 353
Query: 321 PRLQRL 326
R
Sbjct: 354 DRWHMF 359
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 3e-12
Identities = 28/154 (18%), Positives = 53/154 (34%), Gaps = 11/154 (7%)
Query: 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
L+EL + L+ +L L L + N+++ S+P L L + N+LT
Sbjct: 223 LKELIVSGNRLT-SLPVLPSELKELMVSG---NRLT-SLPMLPSG---LLSLSVYRNQLT 274
Query: 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPS 203
LPE L +L + ++ N +S + + R
Sbjct: 275 -RLPESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSGPIIRFDMAGASAPRETR 332
Query: 204 LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNN 237
+H L + L E + + + ++N
Sbjct: 333 ALH-LAAADWLVPAREGEPAPADRWHMFGQEDNA 365
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 20/91 (21%), Positives = 41/91 (45%), Gaps = 12/91 (13%)
Query: 275 NLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 334
L++ + L ++P + +ITT+ + +N LT ++P+ P L+ L ++ N L+
Sbjct: 41 GNAVLNVGESGLT-TLPDCLPA-HITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT 94
Query: 335 GSIPSSIWQSRTLNATETFILDFQNNNLTNI 365
S+P L+ I +L +
Sbjct: 95 -SLPVLPPGLLELS-----IFSNPLTHLPAL 119
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 6e-07
Identities = 22/124 (17%), Positives = 40/124 (32%), Gaps = 28/124 (22%)
Query: 251 SKLLKLSLRNCSLQGPMPDLSRIP-----NLGYLDLSSNQLNGSIPPGRLSLNITTIKLS 305
+ L++ L + +P ++ L + N L S+P + T+++S
Sbjct: 40 NGNAVLNVGESGL-------TTLPDCLPAHITTLVIPDNNLT-SLPA-LPP-ELRTLEVS 89
Query: 306 NNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 365
N+LT ++P GL L L L N LT++
Sbjct: 90 GNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSG--LCK----------LWIFGNQLTSL 136
Query: 366 SGSF 369
Sbjct: 137 PVLP 140
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-33
Identities = 64/283 (22%), Positives = 109/283 (38%), Gaps = 28/283 (9%)
Query: 88 QLLNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
+ + L + L +T L I + + +L + + N+LT
Sbjct: 25 EKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQLTD 82
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
L L KL I ++ N I+ ANL + NN I+ L L +L
Sbjct: 83 I--TPLKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITD--IDPLKNLTNL 136
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264
+ L +N ++ LS L L L N T +N++ L +L + + +
Sbjct: 137 NRLELSSNTISD--ISALSGLTSLQQLSFGNQV----TDLKPLANLTTLERLDISSNKVS 190
Query: 265 GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQ 324
L+++ NL L ++NQ++ P G L+ N+ + L+ N+L + L L
Sbjct: 191 DI-SVLAKLTNLESLIATNNQISDITPLGILT-NLDELSLNGNQLKD--IGTLASLTNLT 246
Query: 325 RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 367
L +ANN +S P + L L N ++NIS
Sbjct: 247 DLDLANNQISNLAP--LSGLTKLT-----ELKLGANQISNISP 282
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-33
Identities = 79/300 (26%), Positives = 122/300 (40%), Gaps = 28/300 (9%)
Query: 88 QLLNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
L L L N + L+ L L+ N IS + + SL+ L N++T
Sbjct: 113 NLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTD 169
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
P L L L+R+ I N +S A L NN IS P L L +L
Sbjct: 170 LKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNL 223
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264
+ L+ N L L+ L L L L NN + + S ++KL +L L +
Sbjct: 224 DELSLNGNQLKD--IGTLASLTNLTDLDLANNQI--SNLAP-LSGLTKLTELKLGANQIS 278
Query: 265 GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQ 324
+ L+ + L L+L+ NQL P L N+T + L N ++ P S L +LQ
Sbjct: 279 N-ISPLAGLTALTNLELNENQLEDISPISNLK-NLTYLTLYFNNISDISP--VSSLTKLQ 334
Query: 325 RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPF 384
RLF NN +S SS+ +N L +N +++++ N+ + L +
Sbjct: 335 RLFFYNNKVSD--VSSLANLTNIN-----WLSAGHNQISDLTPLANLTRITQLGLNDQAW 387
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-31
Identities = 60/297 (20%), Positives = 117/297 (39%), Gaps = 24/297 (8%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
L LQ L+ + L+ L LD NK+S + + +LE L+ N++
Sbjct: 154 GLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQI 211
Query: 143 TGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLP 202
+ LG L LD + ++ N + + A+L + NN IS LS L
Sbjct: 212 SDI--TPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN--LAPLSGLT 265
Query: 203 SLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCS 262
L + L N ++ L+ L L L+L+ N I SN+ L L+L +
Sbjct: 266 KLTELKLGANQISN--ISPLAGLTALTNLELNENQL--EDISPI-SNLKNLTYLTLYFNN 320
Query: 263 LQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPR 322
+ + +S + L L +N+++ L+ NI + +N+++ P + L R
Sbjct: 321 ISD-ISPVSSLTKLQRLFFYNNKVSDVSSLANLT-NINWLSAGHNQISDLTP--LANLTR 376
Query: 323 LQRLFIANNSLSGSIPSSI------WQSRTLNATETFILDFQNN-NLTNISGSFNIP 372
+ +L + + + + + + + + + + T ++N+P
Sbjct: 377 ITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLP 433
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 7e-28
Identities = 50/250 (20%), Positives = 96/250 (38%), Gaps = 18/250 (7%)
Query: 88 QLLNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
L +L + N +G L+ L L N++ + ++ +L L L N+++
Sbjct: 200 NLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN 257
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
L L KL +++ N IS P A L + +N N + +S L +L
Sbjct: 258 L--APLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNL 311
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264
++ L NN++ +S L KL L NN + +S +N++ + LS + +
Sbjct: 312 TYLTLYFNNISD--ISPVSSLTKLQRLFFYNNKV---SDVSSLANLTNINWLSAGHNQIS 366
Query: 265 GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQ 324
+ L+ + + L L+ + + +++I + P+ S
Sbjct: 367 D-LTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL-IAPATISDGGSYT 424
Query: 325 RLFIANNSLS 334
I N S
Sbjct: 425 EPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-18
Identities = 41/195 (21%), Positives = 77/195 (39%), Gaps = 19/195 (9%)
Query: 173 SFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQ 232
+ L + + +++ + + L + + D + + L L +
Sbjct: 19 TDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQIN 74
Query: 233 LDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP 292
NN T I N++KL+ + + N + L+ + NL L L +NQ+ P
Sbjct: 75 FSNNQL--TDITP-LKNLTKLVDILMNNNQIADI-TPLANLTNLTGLTLFNNQITDIDPL 130
Query: 293 GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATET 352
L+ N+ ++LS+N ++ S SGL LQ+L N + TL
Sbjct: 131 KNLT-NLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLANLTTLE---- 180
Query: 353 FILDFQNNNLTNISG 367
LD +N +++IS
Sbjct: 181 -RLDISSNKVSDISV 194
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-12
Identities = 26/159 (16%), Positives = 54/159 (33%), Gaps = 10/159 (6%)
Query: 88 QLLNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
L L L N + L+ L L F NK+S + N+ ++ L N+++
Sbjct: 310 NLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISD 367
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
L L ++ ++ ++ + + AN++ ++ P +S S
Sbjct: 368 --LTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSY 423
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTI 243
+ N + Y + + + F GT
Sbjct: 424 TEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-33
Identities = 63/231 (27%), Positives = 103/231 (44%), Gaps = 43/231 (18%)
Query: 631 QIGQGGYGKVYKGILPD--------GTVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHR 680
+G+G +G+V T VAVK + + + + + ++E++ + + H+
Sbjct: 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLGFAMRLS 726
N+++L+G C ++G ++ E+ S G LR+ L S +E L +S
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 727 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----E 781
A +RG+ YL A HRD+ A N+L+ K+ADFGL+R D
Sbjct: 196 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252
Query: 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
G +P VK PE T +SDV+S GV+ E+ T G P
Sbjct: 253 GRLP------VKWMA----PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 57/247 (23%), Positives = 99/247 (40%), Gaps = 31/247 (12%)
Query: 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRN 681
+F +G+GG+G V++ D A+KR + + + +E + E++ L++L H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 682 LVSLVGYCDEEGEQM------------LVYEFMSNGTLRDQLSA-KSKEPLGFAMRLSIA 728
+V E+ + + L+D ++ + E ++ L I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 729 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-------LAPVPDIE 781
L + + +LH + HRD+K SNI KV DFGL V
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELL----TGMQPISHGKN 837
H V GT Y+ PE + + K D++SLG++ ELL T M+ + +
Sbjct: 182 PAYARHTGQV--GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTD 239
Query: 838 IVREVLP 844
+ P
Sbjct: 240 VRNLKFP 246
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 57/236 (24%), Positives = 93/236 (39%), Gaps = 32/236 (13%)
Query: 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL 682
+F IG GG+G+V+K DG +KR + ++ E++ L++L H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK----YNNEKAEREVKALAKLDHVNI 66
Query: 683 VSLVGYCDEEGEQM----------------LVYEFMSNGTLRDQLSAKSKEPLGFAMRLS 726
V G D + EF GTL + + E L + L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 727 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 786
+ ++G+ Y+H + +RD+K SNI L K+ DFGL +
Sbjct: 127 LFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS--------LKND 175
Query: 787 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 842
T KGT Y+ PE + + D+Y+LG++ ELL ++
Sbjct: 176 GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDL 231
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 61/231 (26%), Positives = 94/231 (40%), Gaps = 43/231 (18%)
Query: 631 QIGQGGYGKVYKGILPD------GTVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHRNL 682
+G G +GKV + VAVK + + E+ ++E++ LS L +H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 683 VSLVGYCDEEGEQMLVYEFMSNGTLRDQL----------------SAKSKEPLGFAMRLS 726
V+L+G C G +++ E+ G L + L + L LS
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 727 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----E 781
+ ++G+ +L A HRD+ A NILL H K+ DFGL+R
Sbjct: 150 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
+P VK PE T +SDV+S G+ EL + G P
Sbjct: 207 ARLP------VKWMA----PESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 65/241 (26%), Positives = 105/241 (43%), Gaps = 58/241 (24%)
Query: 631 QIGQGGYGKVYKGILPDG------TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLV 683
IG+G +G+V++ P T+VAVK +E S + +F E ++ + N+V
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE----------------------PLGF 721
L+G C L++E+M+ G L + L + S PL
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 722 AMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI- 780
A +L IA + G+ YL ++ HRD+ N L+ K+ADFGLSR +I
Sbjct: 174 AEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR-----NIY 225
Query: 781 ---------EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQ 830
+P ++ P PE ++ T +SDV++ GVV E+ + G+Q
Sbjct: 226 SADYYKADGNDAIP------IRWMP----PESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275
Query: 831 P 831
P
Sbjct: 276 P 276
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 55/245 (22%), Positives = 100/245 (40%), Gaps = 31/245 (12%)
Query: 623 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN 681
++F +GQG +G+V K D A+K+ + + L+E+ L+ L+H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 682 LVSLVG-YCDEEGEQM------------LVYEFMSNGTLRDQL-SAKSKEPLGFAMRLSI 727
+V + + + E+ NGTL D + S + RL
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 728 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-------LAPVPDI 780
+ + Y+H++ + HRD+K NI +D K+ DFGL++ + +
Sbjct: 124 QILE--ALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD--KSDVYSLGVVFLELLTGMQPISHGKNI 838
+ T GT Y+ E L K D+YSLG++F E++ NI
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNI 237
Query: 839 VREVL 843
++++
Sbjct: 238 LKKLR 242
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 55/207 (26%), Positives = 87/207 (42%), Gaps = 16/207 (7%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE---FLTEIQFLSRLHHRNLVSLV 686
+IG+G + +VY+ L DG VA+K+ Q L K + EI L +L+H N++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF--AMRLSIALGSSRGILYLHTEADP 744
E+ E +V E G L + K+ + + ++H
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SR 155
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 804
V HRDIK +N+ + K+ D GL R ++V GTP Y+ PE
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT------TAAHSLV-GTPYYMSPERI 208
Query: 805 LTHKLTDKSDVYSLGVVFLELLTGMQP 831
+ KSD++SLG + E+ P
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 64/222 (28%), Positives = 96/222 (43%), Gaps = 16/222 (7%)
Query: 619 MALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSL-QGEKEFL-TEIQFLS 675
M ++ IG G YG+ K DG ++ K GS+ + EK+ L +E+ L
Sbjct: 1 MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 676 RLHHRNLVSLVGYCDEEGEQML--VYEFMSNGTLRDQLSAKSKEPLGFAMR--LSIALGS 731
L H N+V + L V E+ G L ++ +KE L +
Sbjct: 61 ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 732 SRGILYLHTEADPP--VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 789
+ + H +D V HRD+K +N+ LD K K+ DFGL+R+ +
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT------SFAK 174
Query: 790 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
T V GTP Y+ PE +KSD++SLG + EL M P
Sbjct: 175 TFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-33
Identities = 61/241 (25%), Positives = 97/241 (40%), Gaps = 58/241 (24%)
Query: 631 QIGQGGYGKVYKGILPDG------TVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHRNL 682
+G G +GKV VAVK +E + E+ ++E++ +++L H N+
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 683 VSLVGYCDEEGEQMLVYEFMSNGTLRDQL---------------------SAKSKEPLGF 721
V+L+G C G L++E+ G L + L + L F
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 722 AMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI- 780
L A ++G+ +L HRD+ A N+L+ H K+ DFGL+R DI
Sbjct: 172 EDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR-----DIM 223
Query: 781 ---------EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQ 830
+P VK PE T KSDV+S G++ E+ + G+
Sbjct: 224 SDSNYVVRGNARLP------VKWMA----PESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273
Query: 831 P 831
P
Sbjct: 274 P 274
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-32
Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 630 TQIGQGGYGKVYKGIL--PDGTV-VAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSL 685
++G G +G V +G+ + VA+K ++G+ + + E + E Q + +L + +V L
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
+G C E MLV E G L L +E + + + S G+ YL E
Sbjct: 402 IGVCQAE-ALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYL--EEKNF 457
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
V HR++ A N+LL ++ AK++DFGLS+ D + +K PE
Sbjct: 458 V-HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA----PECIN 512
Query: 806 THKLTDKSDVYSLGVVFLELLT-GMQP 831
K + +SDV+S GV E L+ G +P
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 57/219 (26%), Positives = 90/219 (41%), Gaps = 25/219 (11%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
+G+G YG VY G L + +A+K E + + EI L H+N+V +G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG-SF 88
Query: 691 EEGEQMLVY-EFMSNGTLRDQLSAK-----SKEPLGFAMRLSIALGSSRGILYLHTEADP 744
E + ++ E + G+L L +K E + G+ YLH
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT---IG-FYTKQILEGLKYLHDNQ-- 142
Query: 745 PVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
+ HRDIK N+L++ K++DFG S+ + GI P + GT Y+ PE
Sbjct: 143 -IVHRDIKGDNVLINTYSGVLKISDFGTSK-----RLAGINPCTET--FTGTLQYMAPEI 194
Query: 804 FLTHKL--TDKSDVYSLGVVFLELLTGMQPISHGKNIVR 840
+D++SLG +E+ TG P
Sbjct: 195 IDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA 233
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-32
Identities = 62/212 (29%), Positives = 93/212 (43%), Gaps = 29/212 (13%)
Query: 632 IGQGGYGKVYKGILPDG----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 686
IG+G +G V++GI VA+K + + + +FL E + + H ++V L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
G E ++ E + G LR L K L A + A S + YL E+ V
Sbjct: 458 GVITEN-PVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYL--ESKRFV 513
Query: 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGTPGYLD 800
HRDI A N+L+ K+ DFGLSR + D G +P +K
Sbjct: 514 -HRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLP------IKWMA---- 560
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
PE + T SDV+ GV E+L G++P
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 48/224 (21%), Positives = 82/224 (36%), Gaps = 27/224 (12%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNL--VSLV 686
QIG GG KV++ + + A+K + + EI +L++L + + L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
Y + +V E N L L K + + +H +
Sbjct: 95 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE--AVHTIHQHG---I 148
Query: 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE---- 802
H D+K +N L+ K+ DFG++ ++ + V GT Y+ PE
Sbjct: 149 VHSDLKPANFLIVDG-MLKLIDFGIANQ-----MQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 803 -------YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 839
K++ KSDV+SLG + + G P N +
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 246
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 7e-32
Identities = 64/330 (19%), Positives = 117/330 (35%), Gaps = 47/330 (14%)
Query: 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGN 140
++ + E L+ I+ F + + +P + + + +ELL LN
Sbjct: 27 CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDL 85
Query: 141 ELTGSLPEE-LGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL- 198
++ + Y + ++ + N I P F N+ + N +S +P +
Sbjct: 86 QIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIF 143
Query: 199 SRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLS 257
P L + + NNNL + + L LQL +N T + S + L +
Sbjct: 144 HNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRL--THVDLS--LIPSLFHAN 198
Query: 258 LRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLT------- 310
+ L L+ + LD S N +N + +T +KL +N LT
Sbjct: 199 VSYNLLS----TLAIPIAVEELDASHNSIN-VVRGPVNV-ELTILKLQHNNLTDTAWLLN 252
Query: 311 --------------GTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 355
I + F + RL+RL+I+NN L ++ TL +L
Sbjct: 253 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLK-----VL 306
Query: 356 DFQNNNLTNI-SGSFNIPPNVTVRLRGNPF 384
D +N+L ++ + L N
Sbjct: 307 DLSHNHLLHVERNQPQFDRLENLYLDHNSI 336
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-26
Identities = 62/311 (19%), Positives = 116/311 (37%), Gaps = 57/311 (18%)
Query: 88 QLLNLNLSGN----LSPEI-GRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGNE 141
Q+ LNL+ + + L +N I +P + N+ L +L+L N+
Sbjct: 76 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND 134
Query: 142 LTGSLPEEL-GYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR 200
L+ SLP + PKL + + N + +F ++ +++N ++ + S
Sbjct: 135 LS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL--SL 190
Query: 201 LPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRN 260
+PSL H + N L+ L+ + L +N+ + +L L L++
Sbjct: 191 IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSI--NVVRGP--VNVELTILKLQH 241
Query: 261 CSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG---------RLSL-------------- 297
+L L P L +DLS N+L I RL +
Sbjct: 242 NNLT-DTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVALNLYGQP 299
Query: 298 --NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 355
+ + LS+N L + N RL+ L++ +NS+ ++ S + L
Sbjct: 300 IPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLK-------NL 350
Query: 356 DFQNNNLTNIS 366
+N+ S
Sbjct: 351 TLSHNDWDCNS 361
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 2e-15
Identities = 50/323 (15%), Positives = 109/323 (33%), Gaps = 47/323 (14%)
Query: 88 QLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEI--------------------G 127
L + N+S NL + + LD N I+ + +
Sbjct: 193 SLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPVNVELTILKLQHNNLTDTAWLL 251
Query: 128 NIKSLELLLLNGNELTGSLPEE-LGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMN 186
N L + L+ NEL + + +L+R+ I N + +L + + ++
Sbjct: 252 NYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLS 309
Query: 187 NNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPAS 246
+N + + + L ++ LD+N++ L L L L +N+++ ++ A
Sbjct: 310 HNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDWDCNSLRAL 365
Query: 247 YSNMSKL------------LKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGR 294
+ N+++ +L C + P L R+ L ++ +
Sbjct: 366 FRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCS 425
Query: 295 LSLNITTIKLSNNKLTGTIPSNFSGLPRLQ----RLFIANNSLSGSIPSSIWQSRTLNAT 350
+ I +++ ++ +T G +L+ L L+ + L+A
Sbjct: 426 ATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAE 485
Query: 351 ETFILD---FQNNNLTNISGSFN 370
L + L S + N
Sbjct: 486 IDTNLRRYRLPKDGLARSSDNLN 508
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 57/214 (26%), Positives = 90/214 (42%), Gaps = 22/214 (10%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE---FLTEIQFLSRL-HHRNLVSL 685
++G G YG+V+K DG + AVKR+ +G K+ L E+ ++ H V L
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMS-PFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 686 VGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 744
EEG + L E +L+ L A + + +LH++
Sbjct: 123 EQ-AWEEGGILYLQTEL-CGPSLQQHCE-AWGASLPEAQVWGYLRDTLLALAHLHSQG-- 177
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 804
+ H D+K +NI L + K+ DFGL + A V +G P Y+ PE
Sbjct: 178 -LVHLDVKPANIFLGPRGRCKLGDFGLLVE--------LGTAGAGEVQEGDPRYMAPE-L 227
Query: 805 LTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 838
L +DV+SLG+ LE+ M+ G+
Sbjct: 228 LQGSYGTAADVFSLGLTILEVACNMELPHGGEGW 261
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-31
Identities = 72/323 (22%), Positives = 117/323 (36%), Gaps = 55/323 (17%)
Query: 80 GYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGN----------- 128
L+E + NL+ + E + T W++ + P G
Sbjct: 9 SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67
Query: 129 --IKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMN 186
+ L LN L+ SLPE +L L N ++ LP+ +L + N
Sbjct: 68 CLDRQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLLVDNNN 122
Query: 187 NNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPAS 246
++S P L ++ + NN L PEL L I+ +DNN+ +P
Sbjct: 123 LKALSDLP-------PLLEYLGVSNNQLEKL--PELQNSSFLKIIDVDNNSL--KKLP-- 169
Query: 247 YSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSN 306
L ++ N L+ P+L +P L + +N L +P LSL +I N
Sbjct: 170 -DLPPSLEFIAAGNNQLEEL-PELQNLPFLTAIYADNNSLK-KLPDLPLSL--ESIVAGN 224
Query: 307 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI------------ 354
N L LP L ++ NN L ++P LN + ++
Sbjct: 225 NIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTDLPELPQSLTF 281
Query: 355 LDFQNNNLTNISGSFNIPPNVTV 377
LD N + +S +PPN+
Sbjct: 282 LDVSENIFSGLS---ELPPNLYY 301
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-29
Identities = 77/324 (23%), Positives = 126/324 (38%), Gaps = 42/324 (12%)
Query: 45 KSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGR 104
KS + Y+ S W R P + + + D EL+L NL LS +L
Sbjct: 34 KSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPPH 92
Query: 105 LSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164
L L N ++ +P+ ++KSL + N L+ LP L YL + N
Sbjct: 93 LESLVASC---NSLT-ELPELPQSLKSLLVDNNNLKALS-DLPPLLEYL------GVSNN 141
Query: 165 YISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSE 224
+ LP N + + ++NNS+ ++P PSL + NN L PEL
Sbjct: 142 QLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLP---PSLEFIAAGNNQLEE--LPELQN 193
Query: 225 LPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSN 284
LP L + DNN+ +P L + N L+ P+L +P L + +N
Sbjct: 194 LPFLTAIYADNNSL--KKLPDL---PLSLESIVAGNNILEEL-PELQNLPFLTTIYADNN 247
Query: 285 QLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS 344
L ++P L ++ + + +N LT +P L L + LS P+
Sbjct: 248 LLK-TLPD--LPPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPN----- 298
Query: 345 RTLNATETFILDFQNNNLTNISGS 368
L L+ +N + ++
Sbjct: 299 --LY-----YLNASSNEIRSLCDL 315
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-25
Identities = 51/266 (19%), Positives = 97/266 (36%), Gaps = 47/266 (17%)
Query: 88 QLLNLNLSGN-LS--PEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
L ++ N L PE+ L +LT + N + ++P ++++L + N LT
Sbjct: 216 SLESIVAGNNILEELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVR---DNYLT- 270
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
LPE L LD + +N S L + NL + + ++N I + L L
Sbjct: 271 DLPELPQSLTFLD---VSENIFS-GLSELPPNL---YYLNASSNEIR-SLCDLPPSLEEL 322
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264
+ NN L LP + P+L L N+ +P L +L + L+
Sbjct: 323 N---VSNNKLI-ELP---ALPPRLERLIASFNHL--AEVPEL---PQNLKQLHVEYNPLR 370
Query: 265 ------GPMPDL----------SRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNK 308
+ DL NL L + +N L P + ++ +++++ +
Sbjct: 371 EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPD--IPESVEDLRMNSER 427
Query: 309 LTGTIPSNFSGLPRLQRLFIANNSLS 334
+ +L+ ++
Sbjct: 428 VVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-25
Identities = 53/256 (20%), Positives = 87/256 (33%), Gaps = 43/256 (16%)
Query: 123 PKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANL----- 177
P+ + N L+ L + + LT +P E + + + P
Sbjct: 5 PRNVSN-TFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62
Query: 178 --------NKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLL 229
+ +NN +S +P L SLV N+LT LP L LL
Sbjct: 63 SRLRDCLDRQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLL 117
Query: 230 ILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGS 289
+ + L L + N L+ +P+L L +D+ +N L
Sbjct: 118 VDNNNLKALS--------DLPPLLEYLGVSNNQLEK-LPELQNSSFLKIIDVDNNSLK-K 167
Query: 290 IPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNA 349
+P L ++ I NN+L +P LP L ++ NNSL +P +
Sbjct: 168 LPD--LPPSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLES--- 219
Query: 350 TETFILDFQNNNLTNI 365
+ NN L +
Sbjct: 220 -----IVAGNNILEEL 230
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-13
Identities = 34/172 (19%), Positives = 57/172 (33%), Gaps = 28/172 (16%)
Query: 194 IPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKL 253
I P L L ++NLT +P E + + +E P ++
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWER-NAPPGNGEQREM 60
Query: 254 LKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTI 313
LR+C + L+L++ L+ S+P L ++ ++ S N LT +
Sbjct: 61 AVSRLRDCLDR----------QAHELELNNLGLS-SLPE--LPPHLESLVASCNSLT-EL 106
Query: 314 PSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 365
P L L +LS P + L NN L +
Sbjct: 107 PELPQSLKSLLVDNNNLKALSDLPPLLEY------------LGVSNNQLEKL 146
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 49/224 (21%), Positives = 83/224 (37%), Gaps = 27/224 (12%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRL--HHRNLVSLV 686
QIG GG KV++ + + A+K + + EI +L++L H ++ L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
Y + +V E N L L K + + +H +
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE--AVHTIHQHG---I 129
Query: 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE---- 802
H D+K +N L+ K+ DFG++ ++ + V GT Y+ PE
Sbjct: 130 VHSDLKPANFLIVDG-MLKLIDFGIANQ-----MQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 803 -------YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 839
K++ KSDV+SLG + + G P N +
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 227
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 631 QIGQGGYGKVYKG---ILPDGTVVAVK--RAQEGSLQGEKEFLT----EIQFLSRLHHRN 681
++G GG VY IL VA+K + ++E L E+ S+L H+N
Sbjct: 18 KLGGGGMSTVYLAEDTIL--NIKVAIKAIFIP---PREKEETLKRFEREVHNSSQLSHQN 72
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+VS++ +E+ LV E++ TL + + +S PL ++ GI + H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
+ HRDIK NIL+D T K+ DFG+++ + + V+ GT Y P
Sbjct: 131 R---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-----TQTNHVL-GTVQYFSP 181
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
E + +D+YS+G+V E+L G P
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 53/265 (20%), Positives = 114/265 (43%), Gaps = 21/265 (7%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
+PK++ LL L N++T + L L + + N IS P +FA L K
Sbjct: 45 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102
Query: 181 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFE 239
+++ N + ++P ++ +L + + N +T + + L ++++++L N +
Sbjct: 103 ERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLK 158
Query: 240 GTTIPA-SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS-- 296
+ I ++ M KL + + + ++ L P+L L L N++ + L
Sbjct: 159 SSGIENGAFQGMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKIT-KVDAASLKGL 215
Query: 297 LNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 355
N+ + LS N ++ + + + P L+ L + NN L +P + + + ++
Sbjct: 216 NNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQ-----VV 268
Query: 356 DFQNNNLTNISGSFNIPPNVTVRLR 380
NNN++ I + PP +
Sbjct: 269 YLHNNNISAIGSNDFCPPGYNTKKA 293
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 74/337 (21%), Positives = 128/337 (37%), Gaps = 64/337 (18%)
Query: 72 CFNTTMDDGYLHLREL------QLLNLNLSGNLSPEI-----GRLSYLTILDFMWNKISG 120
C + L L ++ L+L N EI L L L + NKIS
Sbjct: 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS- 89
Query: 121 SIPKEI-GNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNK 179
I + LE L L+ N+L LPE++ L +++ +N I+ F LN+
Sbjct: 90 KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQ 146
Query: 180 TRHFHMNNNSI-SGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNN 237
+ N + S I + L ++ + + N+T +P L P L L LD N
Sbjct: 147 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNK 203
Query: 238 FEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS- 296
T + A+ L + NL L LS N ++ ++ G L+
Sbjct: 204 I--TKVDAA----------------------SLKGLNNLAKLGLSFNSIS-AVDNGSLAN 238
Query: 297 -LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI- 354
++ + L+NNKL +P + +Q +++ NN++S +I S+ + N +
Sbjct: 239 TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYS 296
Query: 355 -LDFQNNNLTNISGSFNIPPNV--------TVRLRGN 382
+ +N + I P+ V+L
Sbjct: 297 GVSLFSNPVQYWE----IQPSTFRCVYVRAAVQLGNY 329
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 52/209 (24%), Positives = 87/209 (41%), Gaps = 25/209 (11%)
Query: 632 IGQGGYGKVYKG---ILPDGTVVAVK--RAQEGSLQGEKEFLT----EIQFLSRLHHRNL 682
+G+GG G VY+ + +VA+K L + F T E + RL ++
Sbjct: 42 VGRGGMGDVYEAEDTVR--ERIVALKLMSET---LSSDPVFRTRMQREARTAGRLQEPHV 96
Query: 683 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 742
V + + + +G+ + ++ L L + + PL ++I + H A
Sbjct: 97 VPIHDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAAH-AA 153
Query: 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
HRD+K NIL+ A + DFG++ + + V GT Y+ PE
Sbjct: 154 G--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-----TQLGNTV-GTLYYMAPE 205
Query: 803 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
F T ++D+Y+L V E LTG P
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-31
Identities = 65/275 (23%), Positives = 114/275 (41%), Gaps = 28/275 (10%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
++PKEI LL L N+++ ++ L L + + N IS K+F+ L K
Sbjct: 47 AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKL 104
Query: 181 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFE 239
+ +++ N + +IPP L SLV + + +N + +P S L + +++ N E
Sbjct: 105 QKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLE 160
Query: 240 GTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--L 297
+ + KL L + L G DL L L L N++ +I L
Sbjct: 161 NSGFEPGAFDGLKLNYLRISEAKLTGIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYS 217
Query: 298 NITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILD 356
+ + L +N++ I + S LP L+ L + NN LS +P+ + + L ++
Sbjct: 218 KLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQ-----VVY 270
Query: 357 FQNNNLTNIS-GSF-------NIPPNVTVRLRGNP 383
NN+T + F + L NP
Sbjct: 271 LHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNP 305
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-30
Identities = 66/320 (20%), Positives = 109/320 (34%), Gaps = 53/320 (16%)
Query: 72 CFNTTMDDGYLHLREL------QLLNLNLSGNLSPEI-----GRLSYLTILDFMWNKISG 120
C + L L+ + L+L N E+ L +L L + NKIS
Sbjct: 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK 92
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
K ++ L+ L ++ N L +P L L ++I N I F+ L
Sbjct: 93 IHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNM 149
Query: 181 RHFHMNNNSI-SGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFE 239
M N + + P L ++ + LT +P +L L L LD+N
Sbjct: 150 NCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKI- 205
Query: 240 GTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--L 297
I DL R L L L NQ+ I G LS
Sbjct: 206 -QAIELE----------------------DLLRYSKLYRLGLGHNQIR-MIENGSLSFLP 241
Query: 298 NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI--L 355
+ + L NNKL+ +P+ L LQ +++ N+++ + + + + +
Sbjct: 242 TLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGI 299
Query: 356 DFQNNNLTNISGSFNIPPNV 375
NN + + P
Sbjct: 300 SLFNNPVPYWE----VQPAT 315
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 41/214 (19%), Positives = 81/214 (37%), Gaps = 24/214 (11%)
Query: 89 LLNLNLSGN----LSPEI-GRLSYLTILDFMWNKI-SGSIPKEIGNIKSLELLLLNGNEL 142
L+ L + N + + L + ++ N + + + L L ++ +L
Sbjct: 125 LVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKL 184
Query: 143 TGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE-LSRL 201
T +P++L L+ + +D N I + +K + +N I I LS L
Sbjct: 185 T-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFL 240
Query: 202 PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPAS-------YSNMSKLL 254
P+L + LDNN L+ +P L +L L ++ L NN T + + +
Sbjct: 241 PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNI--TKVGVNDFCPVGFGVKRAYYN 297
Query: 255 KLSLRNCSLQGPM--PDL-SRIPNLGYLDLSSNQ 285
+SL N + P + + + + +
Sbjct: 298 GISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 7e-07
Identities = 28/111 (25%), Positives = 47/111 (42%), Gaps = 14/111 (12%)
Query: 275 NLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSL 333
+L + S L ++P +S + T + L NN ++ + + F GL L L + NN +
Sbjct: 34 HLRVVQCSDLGLK-AVPKE-ISPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKI 90
Query: 334 SGSIPSSIWQS-RTLNATETFILDFQNNNLTNISGSFNIPPNVTV-RLRGN 382
S I + R L L N+L I N+P ++ R+ N
Sbjct: 91 S-KIHEKAFSPLRKLQ-----KLYISKNHLVEIPP--NLPSSLVELRIHDN 133
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-31
Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 15/204 (7%)
Query: 632 IGQGGYGKVYKGIL-PDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
+G G G V+K P G V+A K E + + E+Q L + +V G
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
+GE + E M G+L L K + + +++ +G+ YL + + HR
Sbjct: 101 YSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHR 156
Query: 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 809
D+K SNIL++ + K+ DFG+S ++ + ++ V GT Y+ PE
Sbjct: 157 DVKPSNILVNSRGEIKLCDFGVSG--------QLIDSMANSFV-GTRSYMSPERLQGTHY 207
Query: 810 TDKSDVYSLGVVFLELLTGMQPIS 833
+ +SD++S+G+ +E+ G PI
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIP 231
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-31
Identities = 49/204 (24%), Positives = 81/204 (39%), Gaps = 18/204 (8%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
+G+G +G+V++ G AVK+ + + E E+ + L +V L G
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAVR 120
Query: 691 EEGEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 748
E + E + G+L + E L AL G+ YLHT + H
Sbjct: 121 EGPWVNIFMELLEGGSLGQLIKQMGCLPEDR-ALYYLGQAL---EGLEYLHTRR---ILH 173
Query: 749 RDIKASNILLDHK-FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
D+KA N+LL A + DFG + + + + GT ++ PE +
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY--IPGTETHMAPEVVMGK 231
Query: 808 KLTDKSDVYSLGVVFLELLTGMQP 831
K D++S + L +L G P
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-30
Identities = 47/224 (20%), Positives = 81/224 (36%), Gaps = 27/224 (12%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNL--VSLV 686
QIG GG KV++ + + A+K + + EI +L++L + + L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
Y + +V E N L L K + + +H +
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE--AVHTIHQHG---I 176
Query: 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE---- 802
H D+K +N L+ K+ DFG++ ++ + V G Y+ PE
Sbjct: 177 VHSDLKPANFLIVDG-MLKLIDFGIANQ-----MQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 803 -------YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 839
K++ KSDV+SLG + + G P N +
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 274
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 27/213 (12%)
Query: 632 IGQGGYGKVYKG---ILPDGTVVAVK--RAQEGSLQGEKEFLT----EIQFLSRLHHRNL 682
+G GG +V+ VAVK RA L + F E Q + L+H +
Sbjct: 20 LGFGGMSEVHLARDLRD--HRDVAVKVLRAD---LARDPSFYLRFRREAQNAAALNHPAI 74
Query: 683 VSL--VGYCDEEGEQM--LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 738
V++ G + + +V E++ TLRD + ++ P+ + + + + + +
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFS 132
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
H + + HRD+K +NI++ KV DFG++R + + V GT Y
Sbjct: 133 H-QNG--IIHRDVKPANIMISATNAVKVMDFGIARAIA----DSGNSVTQTAAVIGTAQY 185
Query: 799 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
L PE + +SDVYSLG V E+LTG P
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 58/261 (22%), Positives = 98/261 (37%), Gaps = 48/261 (18%)
Query: 617 GEMALATN---NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR--AQEGSLQGEKEFLTE 670
G M + + F+ +IG G +G V+K + DG + A+KR E+ L E
Sbjct: 1 GAMGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALRE 60
Query: 671 IQFLSRL-HHRNLVSLVGYCDEEGEQMLVY-EFMSNGTLRDQLSAKSKEPLGF--AMRLS 726
+ + L H ++V E + ML+ E+ + G+L D +S + F A
Sbjct: 61 VYAHAVLGQHSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 119
Query: 727 IALGSSRGILYLHTEADPPVFHRDIKASNILLDH-------------------KFTAKVA 767
+ L RG+ Y+H+ + + H DIK SNI + K K+
Sbjct: 120 LLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIG 176
Query: 768 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELL 826
D G P V +G +L E + K+D+++L + +
Sbjct: 177 DLGHVTRISSPQ-----------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAA 225
Query: 827 TGMQPISHG---KNIVREVLP 844
+G I + LP
Sbjct: 226 GAEPLPRNGDQWHEIRQGRLP 246
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 52/219 (23%), Positives = 90/219 (41%), Gaps = 19/219 (8%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGY 688
+ +GG+ VY+ + G A+KR + + + E+ F+ +L H N+V
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 689 C-------DEEGEQMLVYEFMSNGTLRDQL-SAKSKEPLGFAMRLSIALGSSRGILYLHT 740
D + L+ + G L + L +S+ PL L I + R + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-----VKGT 795
PP+ HRD+K N+LL ++ T K+ DFG + + V T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 796 PGYLDPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQP 831
P Y PE + + +K D+++LG + L P
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-30
Identities = 57/248 (22%), Positives = 110/248 (44%), Gaps = 19/248 (7%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
+P I + LL L+ N++ +L L+ +Q+ +N+I +F L
Sbjct: 57 EVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114
Query: 181 RHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNNF 238
+ +N ++ IP L L + L NN + +P + +P L L L
Sbjct: 115 NTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELK- 171
Query: 239 EGTTIPA-SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS- 296
+ I ++ +S L L+L C+L+ +P+L+ + L LDLS N L+ +I PG
Sbjct: 172 RLSYISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNHLS-AIRPGSFQG 229
Query: 297 -LNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 354
+++ + + +++ I N F L L + +A+N+L+ +P ++ L+ E
Sbjct: 230 LMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTP--LHHLER-- 283
Query: 355 LDFQNNNL 362
+ +N
Sbjct: 284 IHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 35/153 (22%), Positives = 51/153 (33%), Gaps = 49/153 (32%)
Query: 88 QLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLP 147
L LNL+ EI L+ L L+ L L+GN L+ ++
Sbjct: 186 NLRYLNLAMCNLREIPNLTPLI---------------------KLDELDLSGNHLS-AIR 223
Query: 148 EELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE-LSRLPSLVH 206
SF L + M + I I L SLV
Sbjct: 224 PG-----------------------SFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVE 259
Query: 207 MLLDNNNLTGYLPPE-LSELPKLLILQLDNNNF 238
+ L +NNLT LP + + L L + L +N +
Sbjct: 260 INLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-30
Identities = 57/248 (22%), Positives = 106/248 (42%), Gaps = 19/248 (7%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
+P+ I + L L N + + +L L+ +Q+ +N I +F L
Sbjct: 68 EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASL 125
Query: 181 RHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNF 238
+ +N ++ IP L L + L NN + +P + +P L+ L L
Sbjct: 126 NTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELK- 182
Query: 239 EGTTIPA-SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS- 296
+ I ++ + L L+L C+++ MP+L+ + L L++S N I PG
Sbjct: 183 KLEYISEGAFEGLFNLKYLNLGMCNIKD-MPNLTPLVGLEELEMSGNHFP-EIRPGSFHG 240
Query: 297 -LNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 354
++ + + N++++ I N F GL L L +A+N+LS S+P ++ L
Sbjct: 241 LSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTP--LRYLVE-- 294
Query: 355 LDFQNNNL 362
L +N
Sbjct: 295 LHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 9e-08
Identities = 24/129 (18%), Positives = 46/129 (35%), Gaps = 25/129 (19%)
Query: 88 QLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLP 147
L LNL ++ L+ L LE L ++GN +
Sbjct: 197 NLKYLNLGMCNIKDMPNLTPLV---------------------GLEELEMSGNHFP-EIR 234
Query: 148 EE-LGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE-LSRLPSLV 205
L L ++ + + +S +F L ++ +N++S +P + + L LV
Sbjct: 235 PGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLV 293
Query: 206 HMLLDNNNL 214
+ L +N
Sbjct: 294 ELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 27/114 (23%), Positives = 42/114 (36%), Gaps = 11/114 (9%)
Query: 274 PNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 333
+ + L+ +P G + N + L N + F L L+ L + NS+
Sbjct: 54 NQFSKVVCTRRGLS-EVPQG-IPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 334 SGSIPSSI-WQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGNPF 384
I +LN L+ +N LT I SG+F + LR NP
Sbjct: 112 R-QIEVGAFNGLASLN-----TLELFDNWLTVIPSGAFEYLSKLRELWLRNNPI 159
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-29
Identities = 43/210 (20%), Positives = 79/210 (37%), Gaps = 32/210 (15%)
Query: 632 IGQGGYGKVYKG---ILPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL- 685
I GG G +Y + +G V +K G + + + E QFL+ + H ++V +
Sbjct: 88 IAHGGLGWIYLALDRNV-NGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 686 -VGYCDEEGEQMLVY---EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+ + Y E++ +L+ + L A ++ L + YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPALSYLH-- 199
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
+ + D+K NI+L + K+ D G + GTPG+ P
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI----------NSFGYLY-GTPGFQAP 246
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
E + T +D+Y++G L +
Sbjct: 247 EI-VRTGPTVATDIYTVGRTLAALTLDLPT 275
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 50/205 (24%), Positives = 82/205 (40%), Gaps = 18/205 (8%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
+G+GG+ K ++ V A K ++ ++ EI L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+ ++ +V E +L + + A + G YLH V
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL--GCQYLHRNR---VI 137
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
HRD+K N+ L+ K+ DFGL+ V+ GTP Y+ PE L+
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-------ERKKVLCGTPNYIAPE-VLSK 189
Query: 808 KLTD-KSDVYSLGVVFLELLTGMQP 831
K + DV+S+G + LL G P
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 50/205 (24%), Positives = 82/205 (40%), Gaps = 18/205 (8%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
+G+GG+ K ++ V A K ++ ++ EI L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+ ++ +V E +L + + A + G YLH V
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL--GCQYLHRNR---VI 163
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
HRD+K N+ L+ K+ DFGL+ V+ GTP Y+ PE L+
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-------ERKKVLCGTPNYIAPE-VLSK 215
Query: 808 KLTD-KSDVYSLGVVFLELLTGMQP 831
K + DV+S+G + LL G P
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 53/220 (24%), Positives = 86/220 (39%), Gaps = 34/220 (15%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLVGYC 689
+GQG V++G G + A+K S + E + L +L+H+N+V L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 690 DEEGEQM--LVYEFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLHTEAD 743
+E + L+ EF G+L L S G + + + G+ +L
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAY-GLPESEFLIVLRDVVG--GMNHLRENG- 132
Query: 744 PPVFHRDIKASNILL----DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
+ HR+IK NI+ D + K+ DFG +R + + GT YL
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--------LEDDEQFVSLYGTEEYL 182
Query: 800 DPEYFLTHKLTD--------KSDVYSLGVVFLELLTGMQP 831
P+ + L D++S+GV F TG P
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 45/232 (19%), Positives = 85/232 (36%), Gaps = 37/232 (15%)
Query: 632 IGQGGYGKVYKGILPDGTVVAVK-----------------RAQEGSLQGEKEFLTEIQFL 674
+ QG + K+ D A+K + +F E+Q +
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 675 SRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS-- 732
+ + + ++ G E ++YE+M N ++ + + I +
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 733 ----RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 788
Y+H E + + HRD+K SNIL+D K++DFG S +
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV--------DKKI 207
Query: 789 STVVKGTPGYLDPEYFLTHKLTD--KSDVYSLGVVFLELLTGMQPISHGKNI 838
GT ++ PE+F + K D++SLG+ + + P S ++
Sbjct: 208 KGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-29
Identities = 58/224 (25%), Positives = 89/224 (39%), Gaps = 29/224 (12%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLV--- 686
+G GG+G V + I G VA+K+ ++ +E EIQ + +L+H N+VS
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 687 ---GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLH 739
+L E+ G LR L+ G L + S + YLH
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC-GLKEGPIRTLLSDISS--ALRYLH 138
Query: 740 TEADPPVFHRDIKASNILLD---HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
+ HRD+K NI+L + K+ D G ++ + + T GT
Sbjct: 139 ENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--------LDQGELCTEFVGTL 187
Query: 797 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 840
YL PE K T D +S G + E +TG +P V+
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ 231
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 69/213 (32%), Positives = 95/213 (44%), Gaps = 16/213 (7%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
IG G V P VA+KR E E L EIQ +S+ HH N+VS
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS---IAL---GSSRGILYLHTEAD 743
+ E LV + +S G++ D + + + L IA G+ YLH
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG- 141
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
HRD+KA NILL + ++ADFG+S LA DI T V GTP ++ PE
Sbjct: 142 --QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK--TFV-GTPCWMAPE 196
Query: 803 YFLTHKLTD-KSDVYSLGVVFLELLTGMQPISH 834
+ D K+D++S G+ +EL TG P
Sbjct: 197 VMEQVRGYDFKADIWSFGITAIELATGAAPYHK 229
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 45/265 (16%), Positives = 101/265 (38%), Gaps = 23/265 (8%)
Query: 131 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSI 190
S + N LT S+P + R++++ N + F L + +++N +
Sbjct: 8 SGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 191 SGQ--IPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPAS-- 246
S + SL ++ L N + + L +L L ++N +
Sbjct: 65 SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL--KQMSEFSV 121
Query: 247 YSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIK 303
+ ++ L+ L + + + + + +L L ++ N + P + N+T +
Sbjct: 122 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 181
Query: 304 LSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNL 362
LS +L + F+ L LQ L +++N+ S+ + ++ +LD+ N++
Sbjct: 182 LSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYK----CLNSLQVLDYSLNHI 235
Query: 363 TNISGS--FNIPPN-VTVRLRGNPF 384
+ P + + L N F
Sbjct: 236 MTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 47/252 (18%), Positives = 93/252 (36%), Gaps = 22/252 (8%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYIS--GSLPKSFANLN 178
S+P I S L L N+L L +L ++ + N +S G +S
Sbjct: 21 SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 179 KTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE--LSELPKLLILQLDNN 236
++ ++ N + + L L H+ ++NL + L L+ L + +
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHT 136
Query: 237 NFEGTTIPA-SYSNMSKLLKLSLRNCSLQGPMPD--LSRIPNLGYLDLSSNQLNGSIPPG 293
+ ++ +S L L + S Q + + NL +LDLS QL + P
Sbjct: 137 HT--RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPT 193
Query: 294 RLS--LNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNAT 350
+ ++ + +S+N ++ + + L LQ L + N + + Q +
Sbjct: 194 AFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLA 251
Query: 351 ETFILDFQNNNL 362
L+ N+
Sbjct: 252 F---LNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 41/236 (17%), Positives = 90/236 (38%), Gaps = 13/236 (5%)
Query: 108 LTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT--GSLPEELGYLPKLDRIQIDQNY 165
T L+ NK+ + L L L+ N L+ G + L + + N
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89
Query: 166 ISGSLPKSFANLNKTRHFHMNNNSISGQIPPE--LSRLPSLVHMLLDNNNLTGYLPPE-L 222
+ ++ +F L + H ++++ Q+ L +L+++ + + +
Sbjct: 90 VI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIF 146
Query: 223 SELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDL 281
+ L L +L++ N+F+ +P ++ + L L L C L+ P + + +L L++
Sbjct: 147 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM 206
Query: 282 SSNQLNGSIPPGRLS--LNITTIKLSNNKLTGTIPSNFSGLPR-LQRLFIANNSLS 334
S N S+ ++ + S N + + P L L + N +
Sbjct: 207 SHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 44/259 (16%), Positives = 90/259 (34%), Gaps = 26/259 (10%)
Query: 72 CFNTTMDDGYLHLREL------QLLNLNLSGN----LSPEI-GRLSYLTILDFMWNKIS- 119
C T + L + L L N L + +L+ LT L N +S
Sbjct: 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 120 -GSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS-FANL 177
G + SL+ L L+ N + ++ L +L+ + + + S F +L
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 125
Query: 178 NKTRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDN 235
+ +++ + L SL + + N+ P+ +EL L L L
Sbjct: 126 RNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184
Query: 236 NNFEGTTIPA-SYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPG 293
+ +++++S L L++ + + + +L LD S N + +
Sbjct: 185 CQL--EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQ 241
Query: 294 ---RLSLNITTIKLSNNKL 309
++ + L+ N
Sbjct: 242 ELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 20/112 (17%), Positives = 41/112 (36%), Gaps = 4/112 (3%)
Query: 83 HLRELQLLNLNLSGNLSPEI-GRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGN 140
L L++ + N P+I L LT LD ++ + ++ SL++L ++ N
Sbjct: 151 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHN 209
Query: 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT-RHFHMNNNSIS 191
L L + N+I S + + + ++ N +
Sbjct: 210 NFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 64/254 (25%), Positives = 101/254 (39%), Gaps = 34/254 (13%)
Query: 601 SSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQ-E 658
S +KI + + + +IG+G YG V K + P G ++AVKR +
Sbjct: 4 ESSGKLKISPEQHWD-----FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST 58
Query: 659 GSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE 717
+ +K+ L ++ + R +V G EG+ + E MS + S
Sbjct: 59 VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVL 118
Query: 718 PLGFAMRL--SIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS-RL 774
+ I L + + + +L + HRDIK SNILLD K+ DFG+S +L
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176
Query: 775 APVPDIEGIVPAHVSTVVK----GTPGYLDPEYFLTHKLTD----KSDVYSLGVVFLELL 826
V ++ K G Y+ PE +SDV+SLG+ EL
Sbjct: 177 -------------VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELA 223
Query: 827 TGMQPISHGKNIVR 840
TG P ++
Sbjct: 224 TGRFPYPKWNSVFD 237
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-28
Identities = 54/341 (15%), Positives = 109/341 (31%), Gaps = 48/341 (14%)
Query: 82 LHLRELQLLNLNLSGNLSPE-IGRLSYLTILD------FMWNKISGSIPKEIGNIKSLEL 134
+ L +L L N S N+ I L+ L + + + + +L +
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259
Query: 135 LLLNGNELTGS---LPEELGYLPKLDRIQIDQNYISGSLPKSF----------------- 174
L + + L + + I S+
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQF 319
Query: 175 --ANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT--GYLPPELSELPKLLI 230
L + +N LPSL + L N L+ G L
Sbjct: 320 PTLKLKSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKY 377
Query: 231 LQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG--PMPDLSRIPNLGYLDLSSNQLNG 288
L L N T+ +++ + +L L ++ +L+ + NL YLD+S
Sbjct: 378 LDLSFNGV--ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR- 434
Query: 289 SIPPGRLS--LNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSR 345
G + ++ +K++ N + F+ L L L ++ L + + +
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFN-- 491
Query: 346 TLNATETFILDFQNNNLTNI-SGSFNIPPN-VTVRLRGNPF 384
+ + +L+ +N L ++ G F+ + + L NP+
Sbjct: 492 --SLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 8e-27
Identities = 53/280 (18%), Positives = 108/280 (38%), Gaps = 39/280 (13%)
Query: 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
+ L+L+N P + L L L F NK + + ++ SLE L L+ N L+
Sbjct: 306 WQHLELVNCKF--GQFPTLK-LKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLS 360
Query: 144 --GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE--LS 199
G + L + + N + ++ +F L + H ++++ Q+
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFL 418
Query: 200 RLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSL 258
L +L+++ + + + + L L +L++ N+F+ +P ++ + L
Sbjct: 419 SLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT---- 473
Query: 259 RNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGTIPSN 316
+LDLS QL + P + ++ + +++N+L
Sbjct: 474 -------------------FLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLKSVPDGI 513
Query: 317 FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILD 356
F L LQ++++ N S P + SR LN
Sbjct: 514 FDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQG 553
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-26
Identities = 50/262 (19%), Positives = 90/262 (34%), Gaps = 12/262 (4%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
IP + S + L L+ N L P+L + + + I ++ +L+
Sbjct: 21 KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 181 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240
+ N I S L SL ++ NL + L L L + +N +
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 241 TTIPASYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGY----LDLSSNQLNGSIPPGRL 295
+P +SN++ L L L + +Q DL + + LDLS N +N I PG
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAF 197
Query: 296 S-LNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 353
+ + + L NN + + GL L+ + + L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN- 256
Query: 354 ILDFQNNNLTNISGSFNIPPNV 375
L + L + + ++
Sbjct: 257 -LTIEEFRLAYLDYYLDDIIDL 277
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-26
Identities = 58/315 (18%), Positives = 120/315 (38%), Gaps = 24/315 (7%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKI-SGSIPKEIGNIKSLELLLLNGNE 141
L++L + NL+ + IG L L L+ N I S +P+ N+ +LE L L+ N+
Sbjct: 101 SLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK 160
Query: 142 LTGSLPEELGYLPKLD----RIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE 197
+ +L L ++ + + N ++ P +F + + NN S +
Sbjct: 161 IQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKT 219
Query: 198 -LSRLPSL------VHMLLDNNNLTGYLPPELSELPKLLILQLDNN--NFEGTTIPASYS 248
+ L L + + NL + L L L I + ++ I ++
Sbjct: 220 CIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN 279
Query: 249 NMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNK 308
++ + SL + +++ + D S +L+L + + P +L ++ + ++NK
Sbjct: 280 CLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFG-QFPTLKLK-SLKRLTFTSNK 336
Query: 309 LTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS 368
LP L+ L ++ N LS + + LD N + +S +
Sbjct: 337 GGNAFS--EVDLPSLEFLDLSRNGLS-FKGCCSQSDFGTTSLKY--LDLSFNGVITMSSN 391
Query: 369 FNIPPNVTV-RLRGN 382
F + + +
Sbjct: 392 FLGLEQLEHLDFQHS 406
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-25
Identities = 66/381 (17%), Positives = 119/381 (31%), Gaps = 50/381 (13%)
Query: 61 DPCTSNWTGVLCFNTTMDDGYLHLREL------QLLNLNLSGNLSPEI-----GRLSYLT 109
+PC N T L+ ++ NL+LS N + L
Sbjct: 1 EPCVEV-----VPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQ 55
Query: 110 ILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGS 169
+LD +I ++ L L+L GN + L L ++ + ++
Sbjct: 56 VLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASL 115
Query: 170 LPKSFANLNKTRHFHMNNNSI-SGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKL 228
+L + ++ +N I S ++P S L +L H+ L +N + +L L ++
Sbjct: 116 ENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQM 175
Query: 229 ----LILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD--LSRIPNLGYLDLS 282
L L L N I +L KL+LRN + + + L L
Sbjct: 176 PLLNLSLDLSLNPM--NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLV 233
Query: 283 SNQLNG-----SIPPGRL----SLNITTIKLSNNKLTGT-IPSNFSGLPRLQRLFIANNS 332
+ L +L I +L+ I F+ L + + + +
Sbjct: 234 LGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVT 293
Query: 333 LSGSIPSSIWQS--------------RTLNATETFILDFQNNNLTNISGSFNIPPNVTVR 378
+ S TL L F +N N ++P +
Sbjct: 294 IERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLD 353
Query: 379 LRGNPF-CLNTNAEQFCGSHS 398
L N ++ G+ S
Sbjct: 354 LSRNGLSFKGCCSQSDFGTTS 374
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-28
Identities = 53/220 (24%), Positives = 86/220 (39%), Gaps = 34/220 (15%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLVGYC 689
+GQG V++G G + A+K S + E + L +L+H+N+V L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 690 DEEGEQM--LVYEFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLHTEAD 743
+E + L+ EF G+L L S G + + + G+ +L
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAY-GLPESEFLIVLRDVVG--GMNHLRENG- 132
Query: 744 PPVFHRDIKASNILL----DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
+ HR+IK NI+ D + K+ DFG +R + + GT YL
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--------LEDDEQFVSLYGTEEYL 182
Query: 800 DPEYF--------LTHKLTDKSDVYSLGVVFLELLTGMQP 831
P+ + K D++S+GV F TG P
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 63/206 (30%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
+G+G +G VY ++A+K +AQ E + E++ S L H N++ L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPP 745
Y + L+ E+ GT+ +L SK E +A + Y H++
Sbjct: 77 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----LSYCHSKR--- 129
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
V HRDIK N+LL K+ADFG S A P+ T + GT YL PE
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHA---------PSSRRTDLCGTLDYLPPEMIE 180
Query: 806 THKLTDKSDVYSLGVVFLELLTGMQP 831
+K D++SLGV+ E L G P
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 5e-28
Identities = 46/211 (21%), Positives = 78/211 (36%), Gaps = 12/211 (5%)
Query: 632 IGQG--GYGKVYKGI-LPDGTVVAVKRA--QEGSLQGEKEFLTEIQFLSRLHHRNLVSLV 686
IG+G V P G V V+R + S + E+ +H N+V
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
+ E +V FM+ G+ +D + + + I G + + Y+H
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---Y 149
Query: 747 FHRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
HR +KAS+IL+ ++ + + + +V V +L PE
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV-KVLPWLSPEVLQ 208
Query: 806 THKL--TDKSDVYSLGVVFLELLTGMQPISH 834
+ KSD+YS+G+ EL G P
Sbjct: 209 QNLQGYDAKSDIYSVGITACELANGHVPFKD 239
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 8e-28
Identities = 69/283 (24%), Positives = 109/283 (38%), Gaps = 37/283 (13%)
Query: 93 NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGY 152
+ + + N+ + + I L LN L+ SLP+ L
Sbjct: 24 GTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQFSELQLNRLNLS-SLPDNLP- 79
Query: 153 LPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNN 212
P++ ++I QN + SLP+ A+L + +N +S +P SL H+ +DNN
Sbjct: 80 -PQITVLEITQNALI-SLPELPASL---EYLDACDNRLS-TLPELP---ASLKHLDVDNN 130
Query: 213 NLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSR 272
LT LP + L + DNN T +P + L LS+RN L +P+L
Sbjct: 131 QLT-MLPELPA---LLEYINADNNQL--TMLPEL---PTSLEVLSVRNNQLTF-LPEL-- 178
Query: 273 IPNLGYLDLSSNQLNGSIPPG-----RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLF 327
+L LD+S+N L S+P + N++T IP N L +
Sbjct: 179 PESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTII 236
Query: 328 IANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFN 370
+ +N LS I S+ Q T + G N
Sbjct: 237 LEDNPLSSRIRESLSQQ-----TAQPDYHGPRIYFSMSDGQQN 274
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 6e-24
Identities = 71/321 (22%), Positives = 114/321 (35%), Gaps = 50/321 (15%)
Query: 38 SALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYL-HLRELQLLNLNLSG 96
S +I + D +S W + N + + + + + ELQL LNLS
Sbjct: 17 SFYNTISGTYADYFSAWDKWEKQALPGENRNEAV---SLLKECLINQFSELQLNRLNLS- 72
Query: 97 NLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKL 156
+L + +T+L+ N + S+P+ + LE L N L+ +LPE L L
Sbjct: 73 SLPDNLP--PQITVLEITQNALI-SLPELPAS---LEYLDACDNRLS-TLPELPASLKHL 125
Query: 157 DRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTG 216
D +D N ++ LP+ A L + + +NN ++ +P + L L + NN LT
Sbjct: 126 D---VDNNQLT-MLPELPALL---EYINADNNQLT-MLPELPTSLEVL---SVRNNQLT- 173
Query: 217 YLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNL 276
+LP L L + N ++PA +
Sbjct: 174 FLPELPE---SLEALDVSTNLL--ESLPAVPVRNHHSEET-------------------E 209
Query: 277 GYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSG 335
+ N++ IP LSL TI L +N L+ I + S S
Sbjct: 210 IFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSM 268
Query: 336 SIPSSIWQSRTLNATETFILD 356
S R L T
Sbjct: 269 SDGQQNTLHRPLADAVTAWFP 289
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 80.4 bits (198), Expect = 9e-16
Identities = 48/278 (17%), Positives = 97/278 (34%), Gaps = 30/278 (10%)
Query: 75 TTMDDGYLHLREL-----QLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKE 125
+D L L L +L++ N L L ++ N+++ +P+
Sbjct: 103 EYLDACDNRLSTLPELPASLKHLDVDNNQLTMLPELPALL---EYINADNNQLT-MLPEL 158
Query: 126 IGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTR---- 181
+ LE+L + N+LT LPE L LD + N + SLP + +
Sbjct: 159 PTS---LEVLSVRNNQLT-FLPELPESLEALD---VSTNLLE-SLPAVPVRNHHSEETEI 210
Query: 182 HFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT 241
F N I+ IP + L ++L++N L+ + LS+ F +
Sbjct: 211 FFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF--S 267
Query: 242 TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITT 301
+ + + L ++ + D+S+I + + +N + + +++
Sbjct: 268 MSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARN 327
Query: 302 IKLSNNKLTGTIPSNFSGLPRL-QRLFIANNSLSGSIP 338
++ S L Q+ F + S
Sbjct: 328 TSGFREQVA-AWLEKLSASAELRQQSFAVAADATESCE 364
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 23/208 (11%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
+G+G + VY+ + G VA+K + + E++ +L H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSK---EPLGFAMRLSIALGSSRGILYLHTEADP 744
Y ++ LV E NG + L + K E I G+LYLH+
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII----TGMLYLHSHG-- 132
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 804
+ HRD+ SN+LL K+ADFGL+ +P + GTP Y+ PE
Sbjct: 133 -ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH-------EKHYTLCGTPNYISPE-I 183
Query: 805 LTHKLTD-KSDVYSLGVVFLELLTGMQP 831
T +SDV+SLG +F LL G P
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 15/205 (7%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLVGYC 689
IG+G +G+V+KGI VVA+K + E E + EI LS+ + G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
++ + ++ E++ G+ D L PL +I +G+ YLH+E HR
Sbjct: 90 LKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEK---KIHR 143
Query: 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 809
DIKA+N+LL K+ADFG++ + D + +T V GTP ++ PE
Sbjct: 144 DIKAANVLLSEHGEVKLADFGVA--GQLTDTQ----IKRNTFV-GTPFWMAPEVIKQSAY 196
Query: 810 TDKSDVYSLGVVFLELLTGMQPISH 834
K+D++SLG+ +EL G P S
Sbjct: 197 DSKADIWSLGITAIELARGEPPHSE 221
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 60/222 (27%), Positives = 97/222 (43%), Gaps = 30/222 (13%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGY 688
+G G G+V+K G V+AVK+ + G+ + K L ++ + + H +V G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 748
+ + E M GT ++L + + P+ + + + + + YL + V H
Sbjct: 93 FITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIH 148
Query: 749 RDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVK----GTPGYLDPEY 803
RD+K SNILLD + K+ DFG+S RL V K G Y+ PE
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISGRL-------------VDDKAKDRSAGCAAYMAPER 195
Query: 804 FLTHKLTD-----KSDVYSLGVVFLELLTGMQPISHGKNIVR 840
T ++DV+SLG+ +EL TG P + K
Sbjct: 196 IDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE 237
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 56/223 (25%), Positives = 92/223 (41%), Gaps = 30/223 (13%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKR-AQEGSLQGEKEFLTEIQF-LSRLHHRNLVSLVGY 688
+G+G YG V K +P G ++AVKR + Q +K L ++ + + V+ G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGSSRGILYLHTEADPPV 746
EG+ + E M + +L + + IA+ + + +LH++ V
Sbjct: 75 LFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 131
Query: 747 FHRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVK----GTPGYLDP 801
HRD+K SN+L++ K+ DFG+S L V V K G Y+ P
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYL-------------VDDVAKDIDAGCKPYMAP 178
Query: 802 EYFLTHKLTD----KSDVYSLGVVFLELLTGMQPISHGKNIVR 840
E KSD++SLG+ +EL P +
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ 221
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 51/216 (23%), Positives = 96/216 (44%), Gaps = 31/216 (14%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
+G G +GKVYK G + A K + S + ++++ EI+ L+ H +V L+G
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
+G+ ++ EF G + + + L + + +LH++ + HRD
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDR-GLTEPQIQVVCRQMLEALNFLHSKR---IIHRD 142
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS-------TVVKGTPGYLDPEY 803
+KA N+L+ + ++ADFG+S A + + GTP ++ PE
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVS-------------AKNLKTLQKRDSFI-GTPYWMAPEV 188
Query: 804 FLTHKLTD-----KSDVYSLGVVFLELLTGMQPISH 834
+ + D K+D++SLG+ +E+ P
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 224
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 58/207 (28%), Positives = 87/207 (42%), Gaps = 24/207 (11%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
+G+G +G VY + ++A+K ++Q E + EI+ S L H N++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
Y + L+ EF G L +L + + L + Y H V
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELAD--ALHYCHERK---VI 136
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK---GTPGYLDPEYF 804
HRDIK N+L+ +K K+ADFG S AP S + GT YL PE
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWSVHAP------------SLRRRTMCGTLDYLPPEMI 184
Query: 805 LTHKLTDKSDVYSLGVVFLELLTGMQP 831
+K D++ GV+ E L GM P
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 53/210 (25%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 626 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 684
+ +IGQG G VY + + G VA+++ ++ + EI + + N+V+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 744
+ E +V E+++ G+L D ++ + A ++ + + +LH+
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA---AVCRECLQALEFLHSNQ-- 136
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS---TVVKGTPGYLDP 801
V HRDIK+ NILL + K+ DFG + S T+V GTP ++ P
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFC---------AQITPEQSKRSTMV-GTPYWMAP 185
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
E K D++SLG++ +E++ G P
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 64/223 (28%), Positives = 97/223 (43%), Gaps = 38/223 (17%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVS----- 684
+G G YG+VYKG + G + A+K + + E+E EI L + HHRN+ +
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIKV-MDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 685 LVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
+ +Q+ LV EF G++ D + L I RG+ +LH
Sbjct: 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK- 149
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS-------TVVKGTP 796
V HRDIK N+LL K+ DFG+S A + T + GTP
Sbjct: 150 --VIHRDIKGQNVLLTENAEVKLVDFGVS-------------AQLDRTVGRRNTFI-GTP 193
Query: 797 GYLDPEYFLTHKLTD-----KSDVYSLGVVFLELLTGMQPISH 834
++ PE + D KSD++SLG+ +E+ G P+
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-27
Identities = 62/336 (18%), Positives = 108/336 (32%), Gaps = 38/336 (11%)
Query: 88 QLLNLNLSGNLSPEIGR-------LSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140
++ + + + S + LD + + +K L++L L N
Sbjct: 241 HIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYN 300
Query: 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR 200
++ E L L + + N + +F L K + + N I+
Sbjct: 301 KINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKF 360
Query: 201 LPSLVHMLLDNNNLT--GYLPP---------ELSELPKLLI----LQLDNNNFEGTTIPA 245
L L + L +N LT ++P +L LPK+ + + L N E I
Sbjct: 361 LEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILY 420
Query: 246 SYSNMSKLLKLSLRNCSLQGPMPD--LSRIPNLGYLDLSSNQLNG----SIPPGRLSL-- 297
+ L L L D S P+L L L N L +
Sbjct: 421 FLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLS 480
Query: 298 NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDF 357
++ + L++N L P FS L L+ L + +N L+ + + + ILD
Sbjct: 481 HLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPANLE------ILDI 533
Query: 358 QNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQF 393
N L + + + N F F
Sbjct: 534 SRNQLLAPNPDV-FVSLSVLDITHNKFICECELSTF 568
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 4e-25
Identities = 46/301 (15%), Positives = 104/301 (34%), Gaps = 36/301 (11%)
Query: 110 ILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGS 169
I + + ++ +P+ + + E LLL+ N + +L +L +++ Y +
Sbjct: 8 IAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT 63
Query: 170 L-PKSFANLNKTRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPE--LSEL 225
+ ++F NL R + ++ I + P+ L L + L L+ + + L
Sbjct: 64 IDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNL 122
Query: 226 PKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG-PMPDLS--RIPNLGYLDLS 282
L L L N + S+ ++ L + + + +L + L + L+
Sbjct: 123 KALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLA 182
Query: 283 SNQLNGSIPPGRLS-------LNITTIKLSNNKLTGTIPSNFS------------GLPRL 323
+N L + + + + +S N T I NFS +
Sbjct: 183 ANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHI 242
Query: 324 QRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRG 381
+++ ++ + LD + + ++ S F ++ V L
Sbjct: 243 MGAGFGFHNIKDPDQNTFAGLARSSVRH---LDLSHGFVFSLNSRVFETLKDLKVLNLAY 299
Query: 382 N 382
N
Sbjct: 300 N 300
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-24
Identities = 67/335 (20%), Positives = 113/335 (33%), Gaps = 36/335 (10%)
Query: 80 GYLHLRELQLLNLNLSGNLSPEI-GRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLN 138
L+ L+L + + E L L ILD +KI P + L L L
Sbjct: 46 FLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLY 105
Query: 139 GNELTGSL--PEELGYLPKLDRIQIDQNYISG-SLPKSFANLNKTRHFHMNNNSISGQIP 195
L+ ++ L L R+ + +N I L SF LN + ++N I
Sbjct: 106 FCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCE 165
Query: 196 PELSRL--PSLVHMLLDNNNLTGYLPPELSELPKLL------ILQLDNNNFEGTTIPASY 247
EL L +L L N+L + + + IL + N +
Sbjct: 166 HELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFS 225
Query: 248 SNMSKLLKLSLRN----CSLQGPMPDLSRIP----------NLGYLDLSSNQLNGSIPPG 293
+ +SK SL ++ ++ +LDLS + S+
Sbjct: 226 NAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSR 284
Query: 294 RLSL--NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATE 351
++ + L+ NK+ F GL LQ L ++ N L S+ + +
Sbjct: 285 VFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVA--- 341
Query: 352 TFILDFQNNNLTNIS-GSFNIPPNVTV-RLRGNPF 384
+D Q N++ I +F + LR N
Sbjct: 342 --YIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL 374
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-23
Identities = 46/258 (17%), Positives = 93/258 (36%), Gaps = 28/258 (10%)
Query: 131 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSI 190
+ LT +P+ L +R+ + NYI SF L + + + +
Sbjct: 5 DGRIAFYRFCNLT-QVPQVL---NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYT 60
Query: 191 SGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFEGTTIPASY- 247
I E LP+L + L ++ + +L P+ L L L+L + Y
Sbjct: 61 PLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYF 119
Query: 248 SNMSKLLKLSLRNCSLQ--GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS----LNITT 301
N+ L +L L ++ P ++ +L +D SSNQ+ + L ++
Sbjct: 120 RNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGKTLSF 178
Query: 302 IKLSNNKLTGTIPSNFSGLP------RLQRLFIANNSLSGSIPSSIWQSRTLNATETFI- 354
L+ N L + ++ L+ L ++ N + I + + + + + I
Sbjct: 179 FSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLIL 238
Query: 355 ------LDFQNNNLTNIS 366
F +N+ +
Sbjct: 239 AHHIMGAGFGFHNIKDPD 256
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 2e-21
Identities = 72/291 (24%), Positives = 111/291 (38%), Gaps = 30/291 (10%)
Query: 83 HLRELQLLNLNLSGNLSPEIGR-----LSYLTILDFMWNKISGSIPKEIGNIKSLELLLL 137
L LQ+LNL S NL E+ L + +D N I+ + ++ L+ L L
Sbjct: 312 GLDNLQVLNL--SYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDL 369
Query: 138 NGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG-QIPP 196
N LT + ++P + I + N + +LPK N H++ N + I
Sbjct: 370 RDNALT-----TIHFIPSIPDIFLSGNKLV-TLPKINLTAN---LIHLSENRLENLDILY 420
Query: 197 ELSRLPSLVHMLLDNNNLTGYLPPE--LSELPKLLILQLDNNNFEGTTI----PASYSNM 250
L R+P L ++L+ N + + SE P L L L N + + +
Sbjct: 421 FLLRVPHLQILILNQNRFS-SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGL 479
Query: 251 SKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 309
S L L L + L P S + L L L+SN+L + L N+ + +S N+L
Sbjct: 480 SHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPANLEILDISRNQL 538
Query: 310 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNN 360
P F L L I +N S LN T I +
Sbjct: 539 LAPNPDVF---VSLSVLDITHNKFICECELS-TFINWLNHTNVTIAGPPAD 585
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 54/217 (24%), Positives = 88/217 (40%), Gaps = 34/217 (15%)
Query: 626 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 684
+S +IG+G G V G VAVK Q + E+ + H N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRD----------QLSAKSKEPLGFAMRLSIALGSSRG 734
+ E ++ EF+ G L D Q++ + L +
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVL-------------QA 153
Query: 735 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 794
+ YLH + V HRDIK+ +ILL K++DFG A + ++V G
Sbjct: 154 LAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFC--AQISKDV----PKRKSLV-G 203
Query: 795 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
TP ++ PE + D++SLG++ +E++ G P
Sbjct: 204 TPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 42/220 (19%), Positives = 81/220 (36%), Gaps = 14/220 (6%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
++P I + + + L+GN ++ L + + N ++ +F L
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 181 RHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNF 238
+++N+ + P L L + LD L L P L L L L +N
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL 141
Query: 239 EGTTIPA-SYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLS 296
+P ++ ++ L L L + + +L L L N++ + P
Sbjct: 142 --QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFR 198
Query: 297 --LNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSL 333
+ T+ L N L+ +P+ + L LQ L + +N
Sbjct: 199 DLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 61/214 (28%), Positives = 107/214 (50%), Gaps = 16/214 (7%)
Query: 623 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHHR 680
F+ ++G+G YG VYK I G +VA+K+ ++ + +E + EI + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV---PVESDLQEIIKEISIMQQCDSP 84
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 740
++V G + + +V E+ G++ D + ++K L +I + +G+ YLH
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK-TLTEDEIATILQSTLKGLEYLHF 143
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
HRDIKA NILL+ + AK+ADFG++ + D A +TV+ GTP ++
Sbjct: 144 MR---KIHRDIKAGNILLNTEGHAKLADFGVA--GQLTDTM----AKRNTVI-GTPFWMA 193
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834
PE +D++SLG+ +E+ G P +
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD 227
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 51/207 (24%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
+G G + +V+ G + A+K ++ + EI L ++ H N+V+L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+ LV + +S G L D++ + E + + + YLH +
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVL----SAVKYLHENG---IV 128
Query: 748 HRDIKASNILLDHKF---TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 804
HRD+K N+L + DFGLS++ +ST GTPGY+ PE
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKM--------EQNGIMSTAC-GTPGYVAPEVL 179
Query: 805 LTHKLTDKSDVYSLGVVFLELLTGMQP 831
+ D +S+GV+ LL G P
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 54/266 (20%), Positives = 103/266 (38%), Gaps = 27/266 (10%)
Query: 89 LLNLNLSGN----LSPEI-GRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGNEL 142
+ +L+LS N +S R L L N I+ +I ++ ++ SLE L L+ N L
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYL 112
Query: 143 TGSLPEEL-GYLPKLDRIQIDQNYISGSLPKS--FANLNKTRHFHMNNNSISGQIPPE-L 198
+ +L L L + + N +L ++ F++L K + + N +I +
Sbjct: 113 S-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170
Query: 199 SRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPA-SYSNMSKLLKLS 257
+ L L + +D ++L Y P L + + L L + S + L
Sbjct: 171 AGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH--ILLLEIFVDVTSSVECLE 228
Query: 258 LRNCSLQ---------GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNK 308
LR+ L G L + + ++ L + + ++ S N+
Sbjct: 229 LRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQ 288
Query: 309 LTGTIPSN-FSGLPRLQRLFIANNSL 333
L ++P F L LQ++++ N
Sbjct: 289 LK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 56/280 (20%), Positives = 109/280 (38%), Gaps = 27/280 (9%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
SIP + ++++ L L+ N +T +L L + + N I+ SF++L
Sbjct: 45 SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSL 102
Query: 181 RHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPE--LSELPKLLILQLDNNN 237
H ++ N +S + L SL + L N L S L KL IL++ N +
Sbjct: 103 EHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMD 160
Query: 238 FEGTTIPASYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS 296
++ ++ L +L + LQ L I N+ +L L Q + +
Sbjct: 161 TFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVD 219
Query: 297 L--NITTIKLSNNKLTGT----IPS----NFSGLPRLQRLFIANNSLSGSIPSSIWQSRT 346
+ ++ ++L + L + + + + + I + SL + + Q
Sbjct: 220 VTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISG 278
Query: 347 LNATETFILDFQNNNLTNIS-GSFNIPPNVT-VRLRGNPF 384
L L+F N L ++ G F+ ++ + L NP+
Sbjct: 279 LL-----ELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 7e-08
Identities = 23/143 (16%), Positives = 46/143 (32%), Gaps = 15/143 (10%)
Query: 84 LRELQLLNLNLSGNLSPEI-GRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGNE 141
L EL++ +L + P+ + ++ L + + + S+E L L +
Sbjct: 176 LEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTD 233
Query: 142 LTG----SLPE----ELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQ 193
L L L ++I + + K ++ + N +
Sbjct: 234 LDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS- 291
Query: 194 IPPE-LSRLPSLVHMLLDNNNLT 215
+P RL SL + L N
Sbjct: 292 VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 35/114 (30%), Positives = 54/114 (47%), Gaps = 11/114 (9%)
Query: 274 PNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 333
G SS LN SIP G L+ + ++ LSNN++T S+ LQ L + +N +
Sbjct: 31 DRNGICKGSSGSLN-SIPSG-LTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI 88
Query: 334 SGSIPSSIWQS-RTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGNPF 384
+ +I + S +L LD N L+N+ S F ++T L GNP+
Sbjct: 89 N-TIEEDSFSSLGSLE-----HLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPY 136
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-26
Identities = 53/222 (23%), Positives = 89/222 (40%), Gaps = 33/222 (14%)
Query: 625 NFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLT----EIQFLSRL-HH 679
+F +G G G + + D VAVKR E + E+Q L H
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL-------PECFSFADREVQLLRESDEH 77
Query: 680 RNLVSLVGYCDEEGEQM--LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILY 737
N++ +C E+ Q + E + TL++ + K LG ++ ++ G+ +
Sbjct: 78 PNVIRY--FCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAH 133
Query: 738 LHTEADPPVFHRDIKASNILLDHK-----FTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 792
LH+ + HRD+K NIL+ A ++DFGL + G + V
Sbjct: 134 LHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA----VGRHSFSRRSGV 186
Query: 793 KGTPGYLDPEYF---LTHKLTDKSDVYSLGVVFLELLTGMQP 831
GT G++ PE T D++S G VF +++
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-26
Identities = 67/265 (25%), Positives = 110/265 (41%), Gaps = 25/265 (9%)
Query: 588 HMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGI-LP 646
H ++H+ R + ++ F + + + ++G G YG+V
Sbjct: 2 HHHHHHSSGRENLYFQGDLQA-TPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKV 60
Query: 647 DGTVVAVKRAQEGSLQGEKE--FLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 704
A+K ++ S+ L E+ L L H N++ L + +++ LV E
Sbjct: 61 THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG 120
Query: 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK--- 761
G L D++ + K A + + S G+ YLH + HRD+K N+LL+ K
Sbjct: 121 GELFDEIIHRMKFNEVDAAVIIKQVLS--GVTYLHKHN---IVHRDLKPENLLLESKEKD 175
Query: 762 FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVV 821
K+ DFGLS + GT Y+ PE L K +K DV+S+GV+
Sbjct: 176 ALIKIVDFGLSAV--------FENQKKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVI 226
Query: 822 FLELLTGMQPISHGKN---IVREVL 843
LL G P G+ I+R+V
Sbjct: 227 LFILLAGYPPF-GGQTDQEILRKVE 250
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 64/248 (25%), Positives = 106/248 (42%), Gaps = 31/248 (12%)
Query: 599 RHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQ 657
H +S G + + M + + +G+G YG V K G +VA+K+
Sbjct: 4 HHHHHSSGVDLGTENLYFQSM----EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL 59
Query: 658 EGSLQGEKEF-----LTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS 712
E + + + EI+ L +L H NLV+L+ C ++ LV+EF+ + T+ D L
Sbjct: 60 ESD---DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLE 115
Query: 713 AKSKEPLGFAMRL--SIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 770
P G ++ GI + H+ + HRDIK NIL+ K+ DFG
Sbjct: 116 LF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFG 169
Query: 771 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGM 829
+R P + V T Y PE + K+ DV+++G + E+ G
Sbjct: 170 FARTLAAP-----GEVYDDEVA--TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG- 221
Query: 830 QPISHGKN 837
+P+ G +
Sbjct: 222 EPLFPGDS 229
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 107 bits (271), Expect = 6e-26
Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 26/223 (11%)
Query: 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRL 677
+ +IG+G YG V+K +VA+KR + L + E L EI L L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR---LDDDDEGVPSSALREICLLKEL 58
Query: 678 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRD--QLSAKSKEPLGFAMRLSIALGSSRGI 735
H+N+V L + + LV+EF D + L + S +G+
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 736 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 795
+ H+ V HRD+K N+L++ K+A+FGL+R +P V + + VV T
Sbjct: 115 GFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-----VRCYSAEVV--T 164
Query: 796 PGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 837
Y P+ KL S D++S G +F EL +P+ G +
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-26
Identities = 54/287 (18%), Positives = 104/287 (36%), Gaps = 32/287 (11%)
Query: 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
+ + +L+ LT LD + I+ + I + L L+ N +T
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT 77
Query: 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPS 203
+L L L + D N ++ +L L K + + + N ++ ++ +S+ P
Sbjct: 78 -TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPL 128
Query: 204 LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263
L ++ N LT ++S +L L N + ++L L +
Sbjct: 129 LTYLNCARNTLT---EIDVSHNTQLTELDCHLNKK---ITKLDVTPQTQLTTLDCSFNKI 182
Query: 264 QGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRL 323
D+S+ L L+ +N + + + +T + S+NKLT I + L +L
Sbjct: 183 TE--LDVSQNKLLNRLNCDTNNIT-KLDLNQNI-QLTFLDCSSNKLT-EID--VTPLTQL 235
Query: 324 QRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFN 370
+ N L+ + S T L +L I + N
Sbjct: 236 TYFDCSVNPLT-ELDVSTLSKLT-------TLHCIQTDLLEIDLTHN 274
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-25
Identities = 54/304 (17%), Positives = 106/304 (34%), Gaps = 33/304 (10%)
Query: 88 QLLNLNLSGNL--SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGS 145
L LN + N ++ + LT LD NK + + L L + N++T
Sbjct: 128 LLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT-E 184
Query: 146 LPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLV 205
L + L+R+ D N I+ L + ++N ++ +I ++ L L
Sbjct: 185 LD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLT 236
Query: 206 HMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG 265
+ N LT L +S L KL L + I + + ++L+ C +
Sbjct: 237 YFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDL--LEIDLT--HNTQLIYFQAEGCR-KI 288
Query: 266 PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQR 325
D++ L LD + + + + + + L+N +LT + S +L+
Sbjct: 289 KELDVTHNTQLYLLDCQAAGIT-ELDLSQNP-KLVYLYLNNTELT-ELD--VSHNTKLKS 343
Query: 326 LFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 385
L N + S + + LN + ++T+ + +
Sbjct: 344 LSCVNAHIQ-DFSS-VGKIPALN-----NNFEAEGQTITMPKETLTNNSLTIAVSPDLLD 396
Query: 386 LNTN 389
N
Sbjct: 397 QFGN 400
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-25
Identities = 52/290 (17%), Positives = 110/290 (37%), Gaps = 25/290 (8%)
Query: 83 HLRELQLLNLNLSGNLS-PEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNE 141
H +L L+ +L+ ++ ++ + LT LD +NKI+ + + K L L + N
Sbjct: 146 HNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNN 202
Query: 142 LTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRL 201
+T L L +L + N ++ + L + +F + N ++ ++ +S L
Sbjct: 203 IT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTL 253
Query: 202 PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261
L + +L + L+ +L+ Q + ++ ++L L +
Sbjct: 254 SKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRK---IKELDVTHNTQLYLLDCQAA 307
Query: 262 SLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLP 321
+ DLS+ P L YL L++ +L + + + ++ N + S +P
Sbjct: 308 GIT--ELDLSQNPKLVYLYLNNTELT-ELDVSHNT-KLKSLSCVNAHIQ-DFSS-VGKIP 361
Query: 322 RLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNI 371
L F A ++ + A +LD N + G +
Sbjct: 362 ALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGV 411
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-24
Identities = 52/304 (17%), Positives = 102/304 (33%), Gaps = 51/304 (16%)
Query: 88 QLLNLNLSGNL--SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGS 145
L L + N + ++ + + LT L NK++ ++ + + L L + N+LT
Sbjct: 65 GLTKLICTSNNITTLDLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-K 120
Query: 146 LPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLV 205
L + P L + +N ++ + ++ + + N +++ L
Sbjct: 121 LD--VSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKIT--KLDVTPQTQLT 173
Query: 206 HMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG 265
+ N +T ++S+ L L D NN T + + +L L + L
Sbjct: 174 TLDCSFNKITEL---DVSQNKLLNRLNCDTNNI--TKLDLN--QNIQLTFLDCSSNKLT- 225
Query: 266 PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLT--------------- 310
D++ + L Y D S N L + LS +TT+ L
Sbjct: 226 -EIDVTPLTQLTYFDCSVNPLT-ELDVSTLS-KLTTLHCIQTDLLEIDLTHNTQLIYFQA 282
Query: 311 ----GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 366
+ + +L L ++ + S + L N LT +
Sbjct: 283 EGCRKIKELDVTHNTQLYLLDCQAAGIT-ELDLS-------QNPKLVYLYLNNTELTELD 334
Query: 367 GSFN 370
S N
Sbjct: 335 VSHN 338
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 52/297 (17%), Positives = 101/297 (34%), Gaps = 34/297 (11%)
Query: 88 QLLNLNLSGNL--SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGS 145
+L LN N ++ + LT L+ N ++ I + + L L + N+
Sbjct: 107 KLTYLNCDTNKLTKLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITK 163
Query: 146 LPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLV 205
L + +L + N I+ L + + + N+I+ +L++ L
Sbjct: 164 LD--VTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNITK---LDLNQNIQLT 215
Query: 206 HMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG 265
+ +N LT +++ L +L N T + S +SKL L L
Sbjct: 216 FLDCSSNKLTEI---DVTPLTQLTYFDCSVNPL--TELDVS--TLSKLTTLHCIQTDLLE 268
Query: 266 PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQR 325
DL+ L Y + + + + + +T + S P+L
Sbjct: 269 I--DLTHNTQLIYFQAEGCRKIKELDVTHNT-QLYLLDCQAAGIT-ELD--LSQNPKLVY 322
Query: 326 LFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGN 382
L++ N L+ + S + T+ L N ++ + S IP
Sbjct: 323 LYLNNTELT-ELDVS-------HNTKLKSLSCVNAHIQDFSSVGKIPALNNNFEAEG 371
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 28/169 (16%), Positives = 55/169 (32%), Gaps = 18/169 (10%)
Query: 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140
LH + LL ++L+ N L Y KI ++ + L LL
Sbjct: 258 TLHCIQTDLLEIDLTHNTQ-----LIYFQAEG--CRKIK---ELDVTHNTQLYLLDCQAA 307
Query: 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR 200
+T L L PKL + ++ ++ L ++ K + N I + +
Sbjct: 308 GIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQDF--SSVGK 359
Query: 201 LPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSN 249
+P+L + L+ + + D + G + +
Sbjct: 360 IPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGD 408
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-26
Identities = 49/302 (16%), Positives = 105/302 (34%), Gaps = 25/302 (8%)
Query: 71 LCFNTTMDDGYLHLRELQLLNLNLSG---------NLSPEIGRLS--YLTILDFMWNKIS 119
+ L L E++ + L+G ++ E+G++ + L +
Sbjct: 240 FNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLF 299
Query: 120 GSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS---FAN 176
+ ++ ++ + + +++ +L L+ + + +N + K+
Sbjct: 300 YDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGA 359
Query: 177 LNKTRHFHMNNNSIS--GQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 234
+ ++ N + + L L +L + + N +P K+ L L
Sbjct: 360 WPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLS 418
Query: 235 NNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGR 294
+ + L L + N +L L P L L +S N+L ++P
Sbjct: 419 STGI--RVVKTCI--PQTLEVLDVSNNNLDSFSLFL---PRLQELYISRNKLK-TLPDAS 470
Query: 295 LSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 354
L + +K+S N+L F L LQ++++ N S P + SR LN
Sbjct: 471 LFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKE 530
Query: 355 LD 356
Sbjct: 531 QG 532
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-25
Identities = 40/310 (12%), Positives = 101/310 (32%), Gaps = 19/310 (6%)
Query: 83 HLRELQLLNLNLSGNLSPE-IGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNE 141
+L+ L++ N+ + L+ L L+ + + + +I+ + L L+ +E
Sbjct: 124 NLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSE 183
Query: 142 LTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRL 201
L L + +++ ++ + S + L
Sbjct: 184 SAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNEL 243
Query: 202 PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261
L+ +L+ + + E + + + + + + ++ + +L +
Sbjct: 244 LKLLRYILELSEV------EFDDCTLNGLGDFNPSESDVVSELGKVETVT-IRRLHIPQF 296
Query: 262 SLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLTGTIPSN-- 316
L + S + + + + ++++ +P ++ + LS N + N
Sbjct: 297 YLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSA 355
Query: 317 -FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNV 375
P LQ L ++ N L S+ + TL + LD N + S P +
Sbjct: 356 CKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTS--LDISRNTFHPMPDSCQWPEKM 412
Query: 376 TV-RLRGNPF 384
L
Sbjct: 413 RFLNLSSTGI 422
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 6e-22
Identities = 54/340 (15%), Positives = 114/340 (33%), Gaps = 45/340 (13%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
L EL++ L+L S + + + L ++ + + + S+ L L L
Sbjct: 149 SLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNL 208
Query: 143 TGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSIS---------GQ 193
L ++ S +SF L K + + + + G
Sbjct: 209 ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGD 268
Query: 194 IPPELS---------RLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP 244
P S ++ + + L L S L K+ + ++N+ +P
Sbjct: 269 FNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV--FLVP 326
Query: 245 ASY-SNMSKLLKLSLRNCSLQ----GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-- 297
S+ ++ L L L + P+L L LS N L S+ L
Sbjct: 327 CSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLT 385
Query: 298 --NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS-RTLNATETFI 354
N+T++ +S N +P + +++ L +++ + + + I Q+ L+ + +
Sbjct: 386 LKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLEVLDVSNNNL 443
Query: 355 ------------LDFQNNNLTNISGSFNIPPNVTVRLRGN 382
L N L + + P + +++ N
Sbjct: 444 DSFSLFLPRLQELYISRNKLKTLPDASLFPVLLVMKISRN 483
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 5e-20
Identities = 38/300 (12%), Positives = 99/300 (33%), Gaps = 22/300 (7%)
Query: 105 LSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164
+ + LD +NKI+ ++ +L++L+L + + + L L+ + + N
Sbjct: 25 TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDN 84
Query: 165 YISGSLPKSFANLNKTRHFHMNNNSISG-QIPPELSRLPSLVHMLLDNNNLTGYLPPE-L 222
++S F L+ ++ ++ N + L +L + + N +
Sbjct: 85 HLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDF 144
Query: 223 SELPKLLILQLDNNNFEGTTIPASY-SNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLD 280
+ L L L++ + + ++ + L+L + + ++ YL+
Sbjct: 145 AGLTSLNELEIKALSL--RNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLE 202
Query: 281 LSSNQLNG-SIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN-------- 331
L L P + + +K + + +F+ L +L R + +
Sbjct: 203 LRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCT 262
Query: 332 -----SLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGNPF 384
+ S + + + L L S +++ V + +
Sbjct: 263 LNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV 322
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 9e-09
Identities = 27/113 (23%), Positives = 49/113 (43%), Gaps = 9/113 (7%)
Query: 274 PNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 333
G D S SIP G L+ + ++ LS NK+T + LQ L + ++ +
Sbjct: 5 DASGVCDGRSRSFT-SIPSG-LTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI 62
Query: 334 SGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GSFNIPPNVTV-RLRGNPF 384
+ + + +L LD +N+L+++S F ++ L GNP+
Sbjct: 63 NTIEGDAFYSLGSLE-----HLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPY 110
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-26
Identities = 51/207 (24%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
+G G +G V++ + G V K + EI +++LHH L++L +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR----GILYLHTEADPPV 746
++ E +L+ EF+S G L D+++A+ + M + + R G+ ++H + +
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAE-----DYKMSEAEVINYMRQACEGLKHMHEHS---I 170
Query: 747 FHRDIKASNILLDHKFTA--KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 804
H DIK NI+ + K + K+ DFGL+ + P + V T + PE
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATK--------LNPDEIVKVTTATAEFAAPEIV 222
Query: 805 LTHKLTDKSDVYSLGVVFLELLTGMQP 831
+ +D++++GV+ LL+G+ P
Sbjct: 223 DREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-26
Identities = 64/223 (28%), Positives = 104/223 (46%), Gaps = 25/223 (11%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLV 686
+G+G +G+V G AVK + Q ++ L E+Q L +L H N++ L
Sbjct: 33 VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 746
+ +++G LV E + G L D++ ++ + A R+ + S GI Y+H +
Sbjct: 93 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS--GITYMHKNK---I 147
Query: 747 FHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
HRD+K N+LL+ K ++ DFGLS + GT Y+ PE
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTH--------FEASKKMKDKIGTAYYIAPE- 198
Query: 804 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN---IVREVL 843
L +K DV+S GV+ LL+G P +G N I+++V
Sbjct: 199 VLHGTYDEKCDVWSTGVILYILLSGCPPF-NGANEYDILKKVE 240
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 29/213 (13%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKR---AQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
IG G +G VY + + VVA+K+ + + S + ++ + E++FL +L H N + G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
E LV E+ G+ D L K PL ++ G+ +G+ YLH+ +
Sbjct: 122 CYLREHTAWLVMEYCL-GSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHN---MI 176
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS---TVVKGTPGYLDPEYF 804
HRD+KA NILL K+ DFG + + ++ + V GTP ++ PE
Sbjct: 177 HRDVKAGNILLSEPGLVKLGDFGSA-------------SIMAPANSFV-GTPYWMAPEVI 222
Query: 805 LTHKLTD---KSDVYSLGVVFLELLTGMQPISH 834
L K DV+SLG+ +EL P+ +
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 255
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 57/249 (22%), Positives = 89/249 (35%), Gaps = 54/249 (21%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVK-----RAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 684
IGQG YG V I + A+K + ++ + + + TE++ + +LHH N+
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR----------- 733
L ++E LV E G L D+L+ + G +
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 734 ---------------------------GILYLHTEADPPVFHRDIKASNILLDHKFTA-- 764
+ YLH + + HRDIK N L +
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEI 209
Query: 765 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE--YFLTHKLTDKSDVYSLGVVF 822
K+ DFGLS+ + ++T GTP ++ PE K D +S GV+
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYG--MTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 823 LELLTGMQP 831
LL G P
Sbjct: 267 HLLLMGAVP 275
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 23/216 (10%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEF----LTEIQFLSRLHHRNLVSL 685
++G G Y VYKG+ G VA+K + L E+ + EI + L H N+V L
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVK---LDSEEGTPSTAIREISLMKELKHENIVRL 68
Query: 686 VGYCDEEGEQMLVYEFMSN---GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 742
E + LV+EFM N + + + L + +G+ + H
Sbjct: 69 YDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK 128
Query: 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
+ HRD+K N+L++ + K+ DFGL+R +P V S VV T Y P+
Sbjct: 129 ---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP-----VNTFSSEVV--TLWYRAPD 178
Query: 803 YFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 837
+ + S D++S G + E++TG +P+ G N
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITG-KPLFPGTN 213
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 68/222 (30%), Positives = 106/222 (47%), Gaps = 26/222 (11%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLH 678
+ ++G+G YG VYK G +VA+KR + L E E + EI L LH
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR---LDAEDEGIPSTAIREISLLKELH 77
Query: 679 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRD--QLSAKSKEPLGFAMRLSIALGSSRGIL 736
H N+VSL+ E LV+EFM D ++ ++K L + RG+
Sbjct: 78 HPNIVSLIDVIHSERCLTLVFEFMEK----DLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
+ H + HRD+K N+L++ K+ADFGL+R +P V ++ VV T
Sbjct: 134 HCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP-----VRSYTHEVV--TL 183
Query: 797 GYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 837
Y P+ + K S D++S+G +F E++TG +P+ G
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG-KPLFPGVT 224
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 24/237 (10%), Positives = 46/237 (19%), Gaps = 51/237 (21%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
+ G V+ + A+K E S + +RL +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 688 YC--------------------------DEEGEQMLVYEFMSNGTLRDQLSA-----KSK 716
+L+ S L S +
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFR 188
Query: 717 EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776
G + R L ++ + H N+ + + D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242
Query: 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL--TDKSDVYSLGVVFLELLTGMQP 831
Y E+ T + + LG+ + P
Sbjct: 243 -------KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 26/222 (11%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLH 678
++ +IG+G YG VYK G A+K+ + L+ E E + EI L L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR---LEKEDEGIPSTTIREISILKELK 58
Query: 679 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRD--QLSAKSKEPLGFAMRLSIALGSSRGIL 736
H N+V L + +LV+E + D +L + L S L GI
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQ----DLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
Y H V HRD+K N+L++ + K+ADFGL+R +P V + +V T
Sbjct: 115 YCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP-----VRKYTHEIV--TL 164
Query: 797 GYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 837
Y P+ + K + D++S+G +F E++ G P+ G +
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TPLFPGVS 205
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 31/231 (13%)
Query: 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-F----LTEIQFLSRL 677
+ + +IGQG +G+V+K G VA+K+ ++ EKE F L EI+ L L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLL 73
Query: 678 HHRNLVSLVGYCDEEGEQM--------LVYEFMSNGTLRD--QLSAKSKEPLGFAMRLSI 727
H N+V+L+ C + LV++F + D L + + +
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH----DLAGLLSNVLVKFTLSEIKRV 129
Query: 728 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 787
G+ Y+H + HRD+KA+N+L+ K+ADFGL+R + +
Sbjct: 130 MQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLA-KNSQPNRY 185
Query: 788 VSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
+ VV T Y PE L D++ G + E+ T PI G
Sbjct: 186 TNRVV--TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR-SPIMQGNT 233
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 63/223 (28%), Positives = 97/223 (43%), Gaps = 27/223 (12%)
Query: 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEF-----LTEIQFLSRL 677
+ +IG+G YG V+K G +VA+K+ E + L EI+ L +L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE---DDPVIKKIALREIRMLKQL 59
Query: 678 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGSSRGI 735
H NLV+L+ + LV+E+ + T+ +L G L SI + + +
Sbjct: 60 KHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRY---QRGVPEHLVKSITWQTLQAV 115
Query: 736 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 795
+ H HRD+K NIL+ K+ DFG +RL P + V T
Sbjct: 116 NFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP-----SDYYDDEVA--T 165
Query: 796 PGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 837
Y PE + DV+++G VF ELL+G P+ GK+
Sbjct: 166 RWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG-VPLWPGKS 207
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 62/214 (28%), Positives = 93/214 (43%), Gaps = 15/214 (7%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLVGYC 689
+G+G YG+V + VAVK E + EI L+H N+V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
E Q L E+ S G L D++ P A R L + G++YLH + HR
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG---ITHR 129
Query: 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 809
DIK N+LLD + K++DFGL+ + ++ + GT Y+ PE L +
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFR----YNNRERLLNKMC-GTLPYVAPE-LLKRRE 183
Query: 810 TD--KSDVYSLGVVFLELLTGMQPISHGKNIVRE 841
DV+S G+V +L G P + +E
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-24
Identities = 67/233 (28%), Positives = 98/233 (42%), Gaps = 35/233 (15%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVK-------------RAQEGSLQGEKEFLTEIQFLSR 676
++G G YG+V + A+K + + +E EI L
Sbjct: 43 KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 677 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 736
L H N++ L +++ LV EF G L +Q+ + K A + + S GI
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILS--GIC 160
Query: 737 YLHTEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 793
YLH + HRDIK NILL++K K+ DFGLS +
Sbjct: 161 YLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSF--------FSKDYKLRDRL 209
Query: 794 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN---IVREVL 843
GT Y+ PE L K +K DV+S GV+ LL G P G+N I+++V
Sbjct: 210 GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPF-GGQNDQDIIKKVE 260
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 23/220 (10%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT----EIQFLSRLHHRNLVSLV 686
+G+G YGKV + + AVK ++ L+ EIQ L RL H+N++ LV
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 687 GYCDEEGEQM--LVYEFMSNGT--LRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 742
E +Q +V E+ G + D + K + P+ A L G+ YLH++
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVCQAHGYFCQLID--GLEYLHSQG 129
Query: 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
+ H+DIK N+LL T K++ G++ + S G+P + PE
Sbjct: 130 ---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC--RTSQ---GSPAFQPPE 181
Query: 803 YFLTHKLTD--KSDVYSLGVVFLELLTGMQPISHGKNIVR 840
K D++S GV + TG+ P G NI +
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYK 220
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-24
Identities = 56/217 (25%), Positives = 102/217 (47%), Gaps = 29/217 (13%)
Query: 625 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 683
+ + +G G +G+V+K G +A K + ++ ++E EI +++L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS-----KEPLGFAMR--LSIALGSSRGIL 736
L + + + +LV E++ G L D++ +S + + F M+ GI
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF-MKQICE-------GIR 201
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTA--KVADFGLSRLAPVPDIEGIVPAHVSTVVKG 794
++H + H D+K NIL ++ K+ DFGL+R P V G
Sbjct: 202 HMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARR--------YKPREKLKVNFG 250
Query: 795 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
TP +L PE ++ +D++S+GV+ LL+G+ P
Sbjct: 251 TPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 56/339 (16%), Positives = 108/339 (31%), Gaps = 45/339 (13%)
Query: 83 HLRELQLLNL--NLSGNLSPEI-GRLSYLTILDFMWNKI-SGSIPKEI-GNIKSLELLLL 137
L L +L L N L L+ L +L + + + SLE+L+L
Sbjct: 77 GLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVL 136
Query: 138 NGNELTGSLPEEL-GYLPKLDRIQIDQNYISGSLPKSFANLNKTR----------HFHMN 186
N + P + + + + N + + N MN
Sbjct: 137 RDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMN 196
Query: 187 NNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQ-LDNNNFEGTTIPA 245
+ + + S+ + L N + + +Q L +N
Sbjct: 197 EYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF 256
Query: 246 SYSN-------------MSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIP 291
++N S + L + S +L L L+ N++N I
Sbjct: 257 GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KID 315
Query: 292 PG---RLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 347
L+ ++ + LS N L +I S F L +L+ L ++ N + ++ +
Sbjct: 316 DNAFWGLT-HLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFL---- 368
Query: 348 NATETFILDFQNNNLTNI-SGSFNIPPNVT-VRLRGNPF 384
L N L ++ G F+ ++ + L NP+
Sbjct: 369 GLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 9e-22
Identities = 46/241 (19%), Positives = 88/241 (36%), Gaps = 20/241 (8%)
Query: 154 PKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNN 212
++ + + N I+ SF+ L + + + I L SL+ + LD N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 213 NLTGYLPPE-LSELPKLLILQLDNNNFEGTTIPASY-SNMSKLLKLSLRNCSLQ--GPMP 268
L + L L +L L N +G + ++ ++ L L LR+ +++ P
Sbjct: 90 QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148
Query: 269 DLSRIPNLGYLDLSSNQLNGSIPPGRL----SLNITTIKLSNNKLT--------GTIPSN 316
+ LDL+ N++ SI L + T ++LS+ L N
Sbjct: 149 FFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGN 207
Query: 317 FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GSFNIPPNV 375
+ L ++ N S+ + + ++ IL N ++ +F P N
Sbjct: 208 PFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNF 267
Query: 376 T 376
T
Sbjct: 268 T 268
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 9e-21
Identities = 43/312 (13%), Positives = 93/312 (29%), Gaps = 43/312 (13%)
Query: 106 SYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQN 164
+++ +D N I+ ++ L+ L + + L L +++D N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 165 YISGSLPKSFANLNKTRHFHMNNNSI-SGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPE- 221
+F L + ++ + L SL ++L +NN+ + P
Sbjct: 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPAS 148
Query: 222 -LSELPKLLILQLDNNNFEGTTIPA-SYSNMSKLLKLSLRNCSLQ-----------GPMP 268
+ + +L L N +I N LR S+
Sbjct: 149 FFLNMRRFHVLDLTFNKV--KSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCG 206
Query: 269 DLSRIPNLGYLDLSSNQLNGSIPPGRLSL--------------NITTIKLSNNKLTGTIP 314
+ + ++ LDLS N S+ +
Sbjct: 207 NPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDN 266
Query: 315 SNFSGLPR--LQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNI 371
F GL ++ ++ + + ++ S++ + T+ L N + I +F
Sbjct: 267 FTFKGLEASGVKTCDLSKSKIF-ALLKSVFS----HFTDLEQLTLAQNEINKIDDNAFWG 321
Query: 372 PPNVTV-RLRGN 382
++ L N
Sbjct: 322 LTHLLKLNLSQN 333
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 35/201 (17%), Positives = 73/201 (36%), Gaps = 19/201 (9%)
Query: 198 LSRLPSL----VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKL 253
L ++P L ++ L N++ S L L L+++ ++ +S L
Sbjct: 22 LHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81
Query: 254 LKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGS-IPPG---RLSLNITTIKLSNNK 308
+ L L + + NL L L+ L+G+ + L+ ++ + L +N
Sbjct: 82 IILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLT-SLEMLVLRDNN 140
Query: 309 LTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 367
+ P++ F + R L + N + SI + +L + L +++
Sbjct: 141 IKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLN--FQGKHFTLLRLSSITLQDMN- 196
Query: 368 SFNIPPNVTVRLRGNPFCLNT 388
+ GNPF +
Sbjct: 197 ----EYWLGWEKCGNPFKNTS 213
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 19/92 (20%), Positives = 38/92 (41%), Gaps = 8/92 (8%)
Query: 280 DLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPS 339
+ L+ +P L ++ + LS N + ++FS L LQ L + + I +
Sbjct: 16 ICINRGLH-QVPE--LPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRN 72
Query: 340 SIWQSRTLNATETFILDFQNNNLTNI-SGSFN 370
+ ++ + IL N + +G+FN
Sbjct: 73 NTFR----GLSSLIILKLDYNQFLQLETGAFN 100
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 37/236 (15%), Positives = 72/236 (30%), Gaps = 32/236 (13%)
Query: 618 EMALATNNFNSSTQIGQGGYGKVYKGI------LPDGTVVAVKRAQEGSLQGEKEFLTEI 671
E L + +G+G + +VY+ + +K + + +
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118
Query: 672 QFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE-----PLGFAMRLS 726
+ L + + +LV E S GTL + ++ P G + +
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 727 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA-----------KVADFGLSRLA 775
+ + I +H + H DIK N +L + F + D G S
Sbjct: 179 MRM--LYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI-- 231
Query: 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
D++ + T T G+ E + D + + +L G
Sbjct: 232 ---DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 41/211 (19%), Positives = 89/211 (42%), Gaps = 32/211 (15%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK----RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLV 686
+G+G +G V++ + K + + + EI L+ HRN++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-----QVLVKKEISILNIARHRNILHLH 67
Query: 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL----YLHTEA 742
+ E ++++EF+S + ++++ F + + + +LH+
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTS-----AFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 743 DPPVFHRDIKASNILLDHKFTA--KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
+ H DI+ NI+ + ++ K+ +FG +R + P ++ P Y
Sbjct: 123 ---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ--------LKPGDNFRLLFTAPEYYA 171
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
PE ++ +D++SLG + LL+G+ P
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 29/210 (13%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
+G G +G V++ G A K ++ EIQ +S L H LV+L +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKS-----KEPLGFAMR--LSIALGSSRGILYLHTEAD 743
++ E +++YEFMS G L ++++ + E + + MR G+ ++H
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY-MRQVCK-------GLCHMHENN- 275
Query: 744 PPVFHRDIKASNILLDHKFTA--KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
H D+K NI+ K + K+ DFGL+ + P V GT + P
Sbjct: 276 --YVHLDLKPENIMFTTKRSNELKLIDFGLTAH--------LDPKQSVKVTTGTAEFAAP 325
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
E + +D++S+GV+ LL+G+ P
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 53/210 (25%), Positives = 83/210 (39%), Gaps = 23/210 (10%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVGY 688
++G G +G V+ G +K + Q E EI+ L L H N++ +
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLHTEADP 744
++ +V E G L +++ + L + + + Y H++
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN--ALAYFHSQH-- 144
Query: 745 PVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
V H+D+K NIL K+ DFGL+ L ST GT Y+ P
Sbjct: 145 -VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL--------FKSDEHSTNAAGTALYMAP 195
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
E +T K D++S GVV LLTG P
Sbjct: 196 E-VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-24
Identities = 64/222 (28%), Positives = 99/222 (44%), Gaps = 24/222 (10%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVG 687
+G+G +G+V K AVK + S + + L E++ L +L H N++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
++ +V E + G L D++ + + A R+ + S GI Y+H +
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS--GITYMHKHN---IV 143
Query: 748 HRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 804
HRD+K NILL+ K K+ DFGLS GT Y+ PE
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTC--------FQQNTKMKDRIGTAYYIAPE-V 194
Query: 805 LTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN---IVREVL 843
L +K DV+S GV+ LL+G P +GKN I++ V
Sbjct: 195 LRGTYDEKCDVWSAGVILYILLSGTPPF-YGKNEYDILKRVE 235
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 24/216 (11%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNLVS 684
+G+G + VYK +VA+K+ + G K+ L EI+ L L H N++
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRD--QLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 742
L+ + LV++FM D + + L + + L + +G+ YLH
Sbjct: 77 LLDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 132
Query: 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
+ HRD+K +N+LLD K+ADFGL++ P A+ VV T Y PE
Sbjct: 133 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-----NRAYTHQVV--TRWYRAPE 182
Query: 803 YFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 837
++ D++++G + ELL P G +
Sbjct: 183 LLFGARMYGVGVDMWAVGCILAELLLR-VPFLPGDS 217
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 52/205 (25%), Positives = 83/205 (40%), Gaps = 18/205 (8%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
IG+G +G+V + A K+ + ++ F EI+ + L H N++ L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
++ + LV E + G L +++ K A R+ + S + Y H V HR
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLS--AVAYCHKLN---VAHR 130
Query: 750 DIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 806
D+K N L K+ DFGL+ P + GTP Y+ P+ L
Sbjct: 131 DLKPENFLFLTDSPDSPLKLIDFGLAAR--------FKPGKMMRTKVGTPYYVSPQ-VLE 181
Query: 807 HKLTDKSDVYSLGVVFLELLTGMQP 831
+ D +S GV+ LL G P
Sbjct: 182 GLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 58/220 (26%), Positives = 84/220 (38%), Gaps = 34/220 (15%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVK---------RAQEGSLQGEKEFLTEIQFLSRL-HH 679
+G+G V + I P AVK + E + + L E+ L ++ H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 680 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILY 737
N++ L + LV++ M G L D L+ K E + ++ I
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL----EVICA 139
Query: 738 LHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG 797
LH + HRD+K NILLD K+ DFG S + P V GTP
Sbjct: 140 LHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ--------LDPGEKLREVCGTPS 188
Query: 798 YLDPE------YFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
YL PE + D++S GV+ LL G P
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 62/214 (28%), Positives = 93/214 (43%), Gaps = 15/214 (7%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLVGYC 689
+G+G YG+V + VAVK E + EI L+H N+V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
E Q L E+ S G L D++ P A R L + G++YLH + HR
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG---ITHR 129
Query: 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 809
DIK N+LLD + K++DFGL+ + ++ + GT Y+ PE L +
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFR----YNNRERLLNKMC-GTLPYVAPE-LLKRRE 183
Query: 810 TD--KSDVYSLGVVFLELLTGMQPISHGKNIVRE 841
DV+S G+V +L G P + +E
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-24
Identities = 54/236 (22%), Positives = 94/236 (39%), Gaps = 40/236 (16%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNL 682
N S +G G G V G VAVKR + L EI+ L+ H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPNV 71
Query: 683 VSLVGYCDEEGEQM--LVYEFMSNGTLRDQLSAKSKEPLGFAMR-----LSIALGSSRGI 735
+ YC E ++ + E N L+D + +K+ ++ +S+ + G+
Sbjct: 72 IRY--YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 736 LYLHTEADPPVFHRDIKASNILLDHK-------------FTAKVADFGLSRLAPVPDIEG 782
+LH+ + HRD+K NIL+ ++DFGL + + +
Sbjct: 129 AHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK--LDSGQS 183
Query: 783 IVPAHVSTVVKGTPGYLDPEYFL-------THKLTDKSDVYSLGVVFLELLTGMQP 831
+++ GT G+ PE +LT D++S+G VF +L+ +
Sbjct: 184 SFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 57/209 (27%), Positives = 89/209 (42%), Gaps = 24/209 (11%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE--FLTEIQFLSRLHHRNLVSLVG 687
+G+G +G+V K AVK + S + + L E++ L +L H N++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPP 745
++ +V E + G L D++ + + E + + GI Y+H
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVF----SGITYMHKHN--- 141
Query: 746 VFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
+ HRD+K NILL+ K K+ DFGLS GT Y+ PE
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTC--------FQQNTKMKDRIGTAYYIAPE 193
Query: 803 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
L +K DV+S GV+ LL+G P
Sbjct: 194 -VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 7e-24
Identities = 32/240 (13%), Positives = 63/240 (26%), Gaps = 49/240 (20%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRL---------- 677
+GQ + G V + K+ E+ L L
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 678 ------------HHRNLVSLVGYCDEEGEQMLVYEF-------MSNGTLRDQLSAKSK-- 716
++ +E + ++ F + T + L + S
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 717 EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776
+ L RL + L R + LH + H ++ +I+LD + + F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV--- 259
Query: 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK-----LTDKSDVYSLGVVFLELLTGMQP 831
+G P + +T D ++LG+ + P
Sbjct: 260 ---RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 36/218 (16%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVK----RAQEGSLQGE--KEFLTEIQFLSRLHHRNLV 683
++G G + V K G A K R S +G +E E+ L + H N++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS----KEPLGFAMR--LSIALGSSRGILY 737
+L + + + +L+ E +S G L D L+ K E F ++ L G+ Y
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-LKQILD-------GVHY 123
Query: 738 LHTEADPPVFHRDIKASNILLDHKFTA----KVADFGLSRLAPVPDIEGIVPAHVSTVVK 793
LH++ + H D+K NI+L K K+ DFG++ I + +
Sbjct: 124 LHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--------IEAGNEFKNIF 172
Query: 794 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
GTP ++ PE L ++D++S+GV+ LL+G P
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK----RAQEGSLQGE--KEFLTEIQFLSRLHHRNLVS 684
+G G + V K G A K R S +G +E E+ L ++ H N+++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS----KEPLGFAMR--LSIALGSSRGILYL 738
L + + +L+ E +S G L D L+ K +E F ++ L G+ YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-IKQILD-------GVNYL 131
Query: 739 HTEADPPVFHRDIKASNILLDHKFTA----KVADFGLSRLAPVPDIEGIVPAHVSTVVKG 794
HT+ + H D+K NI+L K K+ DFGL+ I + G
Sbjct: 132 HTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--------IEDGVEFKNIFG 180
Query: 795 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
TP ++ PE L ++D++S+GV+ LL+G P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 51/213 (23%), Positives = 80/213 (37%), Gaps = 25/213 (11%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK----RAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSL 685
IG+G + V + I G AVK S E E L H ++V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL----YLHTE 741
+ +G +V+EFM L ++ ++ ++ ++ R IL Y H
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY--MRQILEALRYCHDN 149
Query: 742 ADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
+ HRD+K +LL K K+ FG++ + V GTP +
Sbjct: 150 N---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV------AGGRV-GTPHF 199
Query: 799 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
+ PE DV+ GV+ LL+G P
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 57/250 (22%), Positives = 98/250 (39%), Gaps = 36/250 (14%)
Query: 597 RRRHSSKTSIKIDGVRSFTYGEMALATNNFN-SSTQIGQGGYGKVYKGI-LPDGTVVAVK 654
HSS + + + + N + +S ++G+G + V + I G A K
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENF---NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAK 60
Query: 655 --RAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL 711
+ + E L EI L +++L + E +L+ E+ + G +
Sbjct: 61 FLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC 120
Query: 712 SAKSKEPLG-----FAMR--LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 764
+ E + ++ L G+ YLH + H D+K NILL +
Sbjct: 121 LPELAEMVSENDVIRLIKQILE-------GVYYLHQNN---IVHLDLKPQNILLSSIYPL 170
Query: 765 ---KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVV 821
K+ DFG+SR I A + GTP YL PE +T +D++++G++
Sbjct: 171 GDIKIVDFGMSRK--------IGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGII 222
Query: 822 FLELLTGMQP 831
LLT P
Sbjct: 223 AYMLLTHTSP 232
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 53/209 (25%), Positives = 85/209 (40%), Gaps = 23/209 (11%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVG 687
++G+G + V + + G A K L ++ E + +L H N+V L
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPP 745
EE LV++ ++ G L + + A+ E I I Y H+
Sbjct: 73 SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----ESIAYCHSNG--- 125
Query: 746 VFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
+ HR++K N+LL K K+ADFGL+ + + GTPGYL PE
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIE--------VNDSEAWHGFAGTPGYLSPE 177
Query: 803 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
+ D+++ GV+ LL G P
Sbjct: 178 VLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 102 bits (254), Expect = 2e-23
Identities = 38/282 (13%), Positives = 72/282 (25%), Gaps = 74/282 (26%)
Query: 598 RRHSSKTSIKIDGVRSFTY--GEMALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVK 654
G R T G + +GQ + G V
Sbjct: 57 NTGQPFRVESELGERPRTLVRGTV------------LGQEDPYAYLEATDQETGESFEVH 104
Query: 655 ------RAQEGSLQGEKE----------------------FLTEIQFLSRLHHRNLVSLV 686
R +++ KE F+ + + ++ +
Sbjct: 105 VPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVR 164
Query: 687 GYCDEEGEQMLVYEFM----SNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHT 740
+ + + + T + L + S + L RL + L R + LH
Sbjct: 165 LDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 224
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
+ H ++ +I+LD + + F V V + G+
Sbjct: 225 YG---LVHTYLRPVDIVLDQRGGVFLTGFEHL-----------VRDGARVVSSVSRGFEP 270
Query: 801 PEYFLTHKL-----------TDKSDVYSLGVVFLELLTGMQP 831
PE T D ++LG+V + P
Sbjct: 271 PELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 26/222 (11%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEF----LTEIQFLSRLH 678
+ ++G+G Y VYKG +VA+K + L+ E+ + E+ L L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR---LEHEEGAPCTAIREVSLLKDLK 58
Query: 679 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRD--QLSAKSKEPLGFAMRLSIALGSSRGIL 736
H N+V+L E LV+E++ +D Q + RG+
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
Y H V HRD+K N+L++ + K+ADFGL+R +P + + VV T
Sbjct: 115 YCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP-----TKTYDNEVV--TL 164
Query: 797 GYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
Y P+ L + + + D++ +G +F E+ TG +P+ G
Sbjct: 165 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG-RPLFPGST 205
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK----RAQEGSLQGE--KEFLTEIQFLSRLHHRNLVS 684
+G G + V K G A K R S +G +E E+ L ++ H N+++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS----KEPLGFAMR--LSIALGSSRGILYL 738
L + + +L+ E +S G L D L+ K +E F ++ L G+ YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-IKQILD-------GVNYL 131
Query: 739 HTEADPPVFHRDIKASNILLDHKFTA----KVADFGLSRLAPVPDIEGIVPAHVSTVVKG 794
HT+ + H D+K NI+L K K+ DFGL+ I + G
Sbjct: 132 HTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--------IEDGVEFKNIFG 180
Query: 795 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
TP ++ PE L ++D++S+GV+ LL+G P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 36/217 (16%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK----RAQEGSLQGE--KEFLTEIQFLSRLHHRNLVS 684
+G G + V K G A K R + S +G ++ E+ L + H N+++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS----KEPLGFAMR--LSIALGSSRGILYL 738
L + + + +L+ E ++ G L D L+ K +E F ++ L+ G+ YL
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-LKQILN-------GVYYL 130
Query: 739 HTEADPPVFHRDIKASNILLDHKFTA----KVADFGLSRLAPVPDIEGIVPAHVSTVVKG 794
H+ + H D+K NI+L + K+ DFGL+ I + + G
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--------IDFGNEFKNIFG 179
Query: 795 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
TP ++ PE L ++D++S+GV+ LL+G P
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-23
Identities = 54/224 (24%), Positives = 86/224 (38%), Gaps = 33/224 (14%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVK--------RAQEGSLQGEKEFLTEIQFLSRLHHRN 681
+G G G+V VA++ TEI+ L +L+H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLH 739
++ + + D E + +V E M G L D++ + E + L + YLH
Sbjct: 202 IIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL----AVQYLH 256
Query: 740 TEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
+ HRD+K N+LL + K+ DFG S++ + + + GTP
Sbjct: 257 ENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--------LGETSLMRTLCGTP 305
Query: 797 GYLDPE---YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
YL PE T D +SLGV+ L+G P S +
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 7e-23
Identities = 65/233 (27%), Positives = 92/233 (39%), Gaps = 47/233 (20%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK----------------------RAQEGSLQGEKEFL 668
IG+G YG V D T A+K R G + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 669 T----EIQFLSRLHHRNLVSL--VGYCDEEGEQMLVYEFMSNGTLRDQLSAKS-KEPLGF 721
EI L +L H N+V L V E +V+E ++ G + + + K E
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQ-- 138
Query: 722 AMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781
A L GI YLH + + HRDIK SN+L+ K+ADFG+S D
Sbjct: 139 ARFYFQDLIK--GIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD-- 191
Query: 782 GIVPAHVSTVVKGTPGYLDPEYFL-THKLTD--KSDVYSLGVVFLELLTGMQP 831
A +S V GTP ++ PE T K+ DV+++GV + G P
Sbjct: 192 ----ALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 8e-23
Identities = 56/267 (20%), Positives = 91/267 (34%), Gaps = 34/267 (12%)
Query: 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
++ L L L + P L +L I L+ L L E+T
Sbjct: 65 IKSLSLKRLTVRAARIPSRILFGALRVL----------------GISGLQELTLENLEVT 108
Query: 144 GSLPEELG--YLPKLDRIQIDQNYISG---SLPKSFANLNKT-RHFHMNNNSISGQIPPE 197
G+ P L P L+ + + + L + L + + +
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168
Query: 198 LSRLPSLVHMLLDNNNLTGYLPPELS----ELPKLLILQLDNNNFE--GTTIPASYSNMS 251
+ P+L + L +N G + + P L +L L N E A +
Sbjct: 169 VRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV 228
Query: 252 KLLKLSLRNCSLQG--PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 309
+L L L + SL+ P L L+LS L +P G L ++ + LS N+L
Sbjct: 229 QLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG-LPAKLSVLDLSYNRL 286
Query: 310 TGTIPSNFSGLPRLQRLFIANNSLSGS 336
PS LP++ L + N S
Sbjct: 287 D-RNPS-PDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 1e-20
Identities = 56/279 (20%), Positives = 94/279 (33%), Gaps = 42/279 (15%)
Query: 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR 200
EL G L ++D + + + I +I R
Sbjct: 37 ELYGGGRSLEYLLKRVDTEADLGQFTD------IIKSLSLKRLTVRAARIPSRILFGALR 90
Query: 201 L---PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLS 257
+ L + L+N +TG PP L E + L+ N T A + + + LK
Sbjct: 91 VLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPG 150
Query: 258 LRNCSLQG------PMPDLSRIPNLGYLDLSSNQLNG------SIPPGRLSLNITTIKLS 305
L+ S+ + P L LDLS N G ++ P + + + L
Sbjct: 151 LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFP-TLQVLALR 209
Query: 306 NNKLT---GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS----RTLNATETFI---- 354
N + G + + +LQ L +++NSL + + +LN + T +
Sbjct: 210 NAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVP 269
Query: 355 ---------LDFQNNNLTNISGSFNIPPNVTVRLRGNPF 384
LD N L +P + L+GNPF
Sbjct: 270 KGLPAKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPF 308
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-23
Identities = 54/220 (24%), Positives = 88/220 (40%), Gaps = 35/220 (15%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVK--------RAQEGSLQGEKEFLTEIQFLSRLH-HR 680
IG+G V + + G AVK + E + + E L ++ H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYL 738
++++L+ + LV++ M G L D L+ K E ++ S+ + +L
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLL----EAVSFL 216
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV-STVVKGTPG 797
H + HRD+K NILLD +++DFG S + P + GTPG
Sbjct: 217 HANN---IVHRDLKPENILLDDNMQIRLSDFGFSCH--------LEPGEKLRELC-GTPG 264
Query: 798 YLDPE------YFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
YL PE + D+++ GV+ LL G P
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 8e-23
Identities = 65/233 (27%), Positives = 94/233 (40%), Gaps = 33/233 (14%)
Query: 622 ATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT--------EIQ 672
AT+ + +IG G YG VYK G VA+K + + E+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR---VPNGGGGGGGLPISTVREVA 63
Query: 673 FLSRLH---HRNLVSLV-----GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR 724
L RL H N+V L+ D E + LV+E + LR L L
Sbjct: 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETI 122
Query: 725 LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784
+ RG+ +LH + HRD+K NIL+ T K+ADFGL+R+
Sbjct: 123 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ------ 173
Query: 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
A VV T Y PE L D++S+G +F E+ +P+ G +
Sbjct: 174 MALTPVVV--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR-KPLFCGNS 223
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 54/215 (25%), Positives = 90/215 (41%), Gaps = 25/215 (11%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYC 689
+G+G + +V I L AVK ++ E++ L + HRN++ L+ +
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKS----KEPLGFAMRLSIALGSSRGILYLHTEADPP 745
+EE LV+E M G++ + + E A + + S + +LH +
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIHKRRHFNELE----ASVVVQDVAS--ALDFLH---NKG 131
Query: 746 VFHRDIKASNILLDHK---FTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
+ HRD+K NIL +H K+ DF L + D I + T G+ Y+ P
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEYMAP 190
Query: 802 EYFLTHKLTDKS-----DVYSLGVVFLELLTGMQP 831
E D++SLGV+ LL+G P
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 67/269 (24%), Positives = 109/269 (40%), Gaps = 46/269 (17%)
Query: 596 SRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQ----------IGQGGYGKVYKGIL 645
++ S+ S+K+ + + +AT IG G +G VY+ L
Sbjct: 16 PVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKL 75
Query: 646 -PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM------LV 698
G +VA+K+ LQ ++ E+Q + +L H N+V L + GE+ LV
Sbjct: 76 CDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131
Query: 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS------RGILYLHTEADPPVFHRDIK 752
+++ + + ++ L + R + Y+H+ + HRDIK
Sbjct: 132 LDYVP-----ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIK 183
Query: 753 ASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-T 810
N+LLD K+ DFG ++ V +VS + + Y PE T
Sbjct: 184 PQNLLLDPDTAVLKLCDFGSAK-QLVRG-----EPNVSYIC--SRYYRAPELIFGATDYT 235
Query: 811 DKSDVYSLGVVFLELLTGMQPISHGKNIV 839
DV+S G V ELL G QPI G + V
Sbjct: 236 SSIDVWSAGCVLAELLLG-QPIFPGDSGV 263
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 56/226 (24%), Positives = 97/226 (42%), Gaps = 29/226 (12%)
Query: 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRL 677
+ + T++G+G YG+VYK I VA+KR + L+ E+E + E+ L L
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR---LEHEEEGVPGTAIREVSLLKEL 90
Query: 678 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILY 737
HRN++ L L++E+ N L+ + + + S G+ +
Sbjct: 91 QHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMD--KNPDVSMRVIKSFLYQLINGVNF 147
Query: 738 LHTEADPPVFHRDIKASNILLDHKFTA-----KVADFGLSRLAPVPDIEGIVPAHVSTVV 792
H HRD+K N+LL + K+ DFGL+R +P + ++
Sbjct: 148 CH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP-----IRQFTHEII 199
Query: 793 KGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 837
T Y PE L + S D++S+ ++ E+L P+ G +
Sbjct: 200 --TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK-TPLFPGDS 242
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-22
Identities = 60/266 (22%), Positives = 107/266 (40%), Gaps = 44/266 (16%)
Query: 597 RRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQ---------IGQGGYGKVYKGILPD 647
++ +K++ + LA++ + IG G +G V++ L +
Sbjct: 4 TMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVE 63
Query: 648 GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL------VGYCDEEGEQMLVYEF 701
VA+K+ LQ ++ E+Q + + H N+V L G +E LV E+
Sbjct: 64 SDEVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119
Query: 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSS------RGILYLHTEADPPVFHRDIKASN 755
+ T+ +K + + L R + Y+H+ + HRDIK N
Sbjct: 120 VPE-TVYRASRHYAKLK----QTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQN 171
Query: 756 ILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKS 813
+LLD K+ DFG ++ + +VS + + Y PE T
Sbjct: 172 LLLDPPSGVLKLIDFGSAK-ILIAG-----EPNVSYIC--SRYYRAPELIFGATNYTTNI 223
Query: 814 DVYSLGVVFLELLTGMQPISHGKNIV 839
D++S G V EL+ G QP+ G++ +
Sbjct: 224 DIWSTGCVMAELMQG-QPLFPGESGI 248
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 56/228 (24%), Positives = 91/228 (39%), Gaps = 38/228 (16%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKR------AQEGSLQGEKEFLTEIQFLSRLH----HR 680
+G+GG+G V+ G L D VA+K L E+ L ++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGT-LRDQLSAKSK--EPLG---FAMRLSIALGSSRG 734
++ L+ + + + MLV E L D ++ K E F ++
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA-------A 151
Query: 735 ILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 793
I + H+ V HRDIK NIL+D + AK+ DFG L +
Sbjct: 152 IQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH--------DEPYTDFD- 199
Query: 794 GTPGYLDPEYFLTHKLT-DKSDVYSLGVVFLELLTGMQPISHGKNIVR 840
GT Y PE+ H+ + V+SLG++ +++ G P + I+
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILE 247
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 53/221 (23%), Positives = 90/221 (40%), Gaps = 26/221 (11%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKR------AQEGSLQGEKEFLTEIQFLSRLHHR--NL 682
+G GG+G VY GI + D VA+K + G L E+ L ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 683 VSLVGYCDEEGEQMLVYEFMSN-GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+ L+ + + +L+ E L D ++ + A + + + H
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE--AVRHCHNC 168
Query: 742 ADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
V HRDIK NIL+D ++ K+ DFG L + GT Y
Sbjct: 169 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK--------DTVYTDFD-GTRVYSP 216
Query: 801 PEYFLTHKLT-DKSDVYSLGVVFLELLTGMQPISHGKNIVR 840
PE+ H+ + V+SLG++ +++ G P H + I+R
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 257
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 3e-22
Identities = 62/223 (27%), Positives = 96/223 (43%), Gaps = 26/223 (11%)
Query: 631 QIGQGGYGKVYKGI---LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
++G+G YG VYK D A+K+ + + EI L L H N++SL
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQK 85
Query: 688 YCDEEGEQ--MLVYEFMSN------GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
++ L++++ + R + K L M S+ GI YLH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 740 TEADPPVFHRDIKASNILLDHKFTA----KVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 795
V HRD+K +NIL+ + K+AD G +RL P + VV T
Sbjct: 146 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL--KPLADLDPVVV--T 198
Query: 796 PGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 837
Y PE L + K+ D++++G +F ELLT +PI H +
Sbjct: 199 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQ 240
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-22
Identities = 65/229 (28%), Positives = 99/229 (43%), Gaps = 31/229 (13%)
Query: 624 NNFNSSTQIGQGGYGKVYKG--ILPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSR 676
+ +IG+G YGKV+K + G VA+KR + +Q +E + E+ L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR---VQTGEEGMPLSTIREVAVLRH 67
Query: 677 LH---HRNLVSL-----VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIA 728
L H N+V L V D E + LV+E + L L + + +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126
Query: 729 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 788
RG+ +LH+ V HRD+K NIL+ K+ADFGL+R+ A
Sbjct: 127 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ------MALT 177
Query: 789 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
S VV T Y PE L D++S+G +F E+ +P+ G +
Sbjct: 178 SVVV--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR-KPLFRGSS 223
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 3e-22
Identities = 53/209 (25%), Positives = 85/209 (40%), Gaps = 23/209 (11%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVG 687
++G+G + V + + G A K L ++ E + +L H N+V L
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPP 745
EE LV++ ++ G L + + A+ E I I Y H+
Sbjct: 96 SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----ESIAYCHSNG--- 148
Query: 746 VFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
+ HR++K N+LL K K+ADFGL+ + + GTPGYL PE
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIE--------VNDSEAWHGFAGTPGYLSPE 200
Query: 803 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
+ D+++ GV+ LL G P
Sbjct: 201 VLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 64/206 (31%), Positives = 92/206 (44%), Gaps = 20/206 (9%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
+G G +GKV G G VAVK R + SL + EIQ L H +++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+ +V E++S G L D + + A RL + S + Y H V
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS--AVDYCHRHM---VV 133
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
HRD+K N+LLD AK+ADFGLS + + T G+P Y PE ++
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNM-MSDG------EFLRTSC-GSPNYAAPE-VISG 184
Query: 808 KLTD--KSDVYSLGVVFLELLTGMQP 831
+L + D++S GV+ LL G P
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 62/206 (30%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
IG+G + KV + G VA+K + Q +K F E++ + L+H N+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVKLFE 81
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+ E L+ E+ S G + D L A + A + S + Y H + +
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS--AVQYCHQKR---IV 136
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
HRD+KA N+LLD K+ADFG S + G P Y PE F
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFSNE-FTVG------GKLDAFC-GAPPYAAPELFQ-G 187
Query: 808 KLTD--KSDVYSLGVVFLELLTGMQP 831
K D + DV+SLGV+ L++G P
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 5e-22
Identities = 54/217 (24%), Positives = 84/217 (38%), Gaps = 36/217 (16%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK-----RAQEGSLQGEKEFLT---EIQFLSRLHHRNL 682
+G G +G V+ + V VK + E + + EI LSR+ H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 683 VSLVGYCDEEGEQMLVYEFMSNGT-LRDQLSAKSK--EPLG---FAMRLSIALGSSRGIL 736
+ ++ + +G LV E +G L + + EPL F +S +
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS-------AVG 144
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
YL + + HRDIK NI++ FT K+ DFG + T GT
Sbjct: 145 YLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAY-LERG------KLFYTFC-GTI 193
Query: 797 GYLDPEYFLTHKLTD--KSDVYSLGVVFLELLTGMQP 831
Y PE L + +++SLGV L+ P
Sbjct: 194 EYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-22
Identities = 47/214 (21%), Positives = 94/214 (43%), Gaps = 29/214 (13%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSL--VG 687
+G+G Y +V++ I + + V VK + +K+ EI+ L L N+++L +
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPNIITLADIV 100
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR--LSIALGSSRGILYLHTEADPP 745
LV+E ++N + + + F M L + + Y H+
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL-------KALDYCHSMG--- 150
Query: 746 VFHRDIKASNILLDHKFTA-KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 804
+ HRD+K N+++DH+ ++ D+GL+ P V + + PE
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLAE--------FYHPGQEYNVRVASRYFKGPELL 202
Query: 805 LTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 837
+ +++ D S D++SLG + ++ +P HG +
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 236
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 7e-22
Identities = 54/218 (24%), Positives = 84/218 (38%), Gaps = 33/218 (15%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVK--------RAQEGSLQGEKEFLTEIQFLSRLHHRN 681
+G G G+V VA+K TEI+ L +L+H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLH 739
++ + + D E + +V E M G L D++ + E + L + YLH
Sbjct: 77 IIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL----AVQYLH 131
Query: 740 TEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
+ HRD+K N+LL + K+ DFG S++ + + + GTP
Sbjct: 132 ENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--------LGETSLMRTLCGTP 180
Query: 797 GYLDPE---YFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
YL PE T D +SLGV+ L+G P
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-21
Identities = 52/209 (24%), Positives = 82/209 (39%), Gaps = 22/209 (10%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVG 687
++G+G + V + + + G A L ++ E + L H N+V L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPP 745
EEG L+++ ++ G L + + A+ E I +L+ H
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL----EAVLHCHQMG--- 130
Query: 746 VFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
V HR++K N+LL K K+ADFGL+ GTPGYL PE
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ------QAWFGFA-GTPGYLSPE 183
Query: 803 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
D+++ GV+ LL G P
Sbjct: 184 VLRKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 44/173 (25%), Positives = 66/173 (38%), Gaps = 13/173 (7%)
Query: 180 TRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFE 239
T H++ N + L L + LD LT LP L L L +N
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK--LQVDGTLPVLGTLDLSHNQL- 89
Query: 240 GTTIPASYSNMSKLLKLSLRNCSLQGPMPDL-SRIPNLGYLDLSSNQLNGSIPPG---RL 295
++P + L L + L + L L L N+L ++PPG
Sbjct: 90 -QSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPT 147
Query: 296 SLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 347
+ + L+NN LT +P+ +GL L L + NSL +IP + S L
Sbjct: 148 P-KLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLL 197
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 54/203 (26%), Positives = 73/203 (35%), Gaps = 33/203 (16%)
Query: 108 LTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYIS 167
TIL N + + L L L+ ELT L + LP L + + N +
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDGT-LPVLGTLDLSHNQLQ 90
Query: 168 GSLPKSFANLNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPEL-SEL 225
SLP L ++ N ++ +P L L + L N L LPP L +
Sbjct: 91 -SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPT 147
Query: 226 PKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQ 285
PKL L L NNN T +PA L+ + NL L L N
Sbjct: 148 PKLEKLSLANNNL--TELPAGL----------------------LNGLENLDTLLLQENS 183
Query: 286 LNGSIPPGRL-SLNITTIKLSNN 307
L +IP G S + L N
Sbjct: 184 LY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 50/178 (28%), Positives = 75/178 (42%), Gaps = 16/178 (8%)
Query: 91 NLNLSGN----LSPEI-GRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGS 145
L+LS N S + LT L+ +++ + G + L L L+ N+L S
Sbjct: 35 ILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-S 91
Query: 146 LPEELGYLPKLDRIQIDQNYISGSLPKS-FANLNKTRHFHMNNNSISGQIPPEL-SRLPS 203
LP LP L + + N ++ SLP L + + ++ N + +PP L + P
Sbjct: 92 LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPK 149
Query: 204 LVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRN 260
L + L NNNLT LP L + L L L L N+ TIP + L L
Sbjct: 150 LEKLSLANNNLTE-LPAGLLNGLENLDTLLLQENSL--YTIPKGFFGSHLLPFAFLHG 204
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 8e-07
Identities = 24/110 (21%), Positives = 41/110 (37%), Gaps = 10/110 (9%)
Query: 274 PNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 333
+ ++ L ++PP L + T + LS N L + RL +L + L
Sbjct: 10 ASHLEVNCDKRNL-TALPPD-LPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
Query: 334 SGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTV-RLRGN 382
+ + TL T LD +N L ++ P +TV + N
Sbjct: 68 -----TKLQVDGTLPVLGT--LDLSHNQLQSLPLLGQTLPALTVLDVSFN 110
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 49/214 (22%), Positives = 79/214 (36%), Gaps = 36/214 (16%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVG-Y 688
+G G GKV + G A+K L + E+ + ++V ++ Y
Sbjct: 37 LGLGVNGKVLECFHRRTGQKCALK-----LLYDSPKARQEVDHHWQASGGPHIVCILDVY 91
Query: 689 CDEEGEQMLVY---EFMSNGTLRDQLSAKSKEPL-----GFAMRLSIALGSSRGILYLHT 740
+ + + E M G L ++ + + MR I I +LH+
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR-DIG----TAIQFLHS 146
Query: 741 EADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG 797
+ HRD+K N+L K K+ DFG ++ + T TP
Sbjct: 147 HN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE--------TTQNALQTPC-YTPY 194
Query: 798 YLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
Y+ PE K D++SLGV+ LL G P
Sbjct: 195 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 56/292 (19%), Positives = 112/292 (38%), Gaps = 22/292 (7%)
Query: 88 QLLNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
+ + + + L +T L ++ +I + + +L L L N++T
Sbjct: 20 NAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITD 77
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
L L K+ +++ N + + A L + + + I+ P L+ L +L
Sbjct: 78 --LAPLKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNL 131
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264
+ LD N +T L+ L L L + N + + +N+SKL L + +
Sbjct: 132 QVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQV--SDLTP-LANLSKLTTLKADDNKIS 186
Query: 265 GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQ 324
+ L+ +PNL + L +NQ++ P S N+ + L+N +T + L
Sbjct: 187 D-ISPLASLPNLIEVHLKNNQISDVSPLANTS-NLFIVTLTNQTITNQPVFYNNNLVVP- 243
Query: 325 RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVT 376
+ S + P++I S + + + N+S +FN
Sbjct: 244 -NVVKGPSGAPIAPATI--SDNGTYASPNLTWNLTSFINNVSYTFNQSVTFK 292
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 42/234 (17%), Positives = 90/234 (38%), Gaps = 20/234 (8%)
Query: 150 LGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLL 209
L +I ++ ++ + A+L+ ++ I + L +L+ + L
Sbjct: 15 DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLEL 70
Query: 210 DNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD 269
+N +T L L K+ L+L N + A + + + L L + + +
Sbjct: 71 KDNQITD--LAPLKNLTKITELELSGNPL--KNVSA-IAGLQSIKTLDLTSTQITD-VTP 124
Query: 270 LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 329
L+ + NL L L NQ+ +I P N+ + + N +++ + + L +L L
Sbjct: 125 LAGLSNLQVLYLDLNQIT-NISPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKAD 181
Query: 330 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNP 383
+N +S P + + + +NN ++++S N V L
Sbjct: 182 DNKISDISPLA-------SLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQT 228
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 5e-21
Identities = 64/206 (31%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
+G G +GKV G G VAVK R + SL + EIQ L H +++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+ +V E++S G L D + + + RL + S G+ Y H V
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS--GVDYCHRHM---VV 138
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
HRD+K N+LLD AK+ADFGLS + + T G+P Y PE ++
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNM-MSDG------EFLRTSC-GSPNYAAPE-VISG 189
Query: 808 KLTD--KSDVYSLGVVFLELLTGMQP 831
+L + D++S GV+ LL G P
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 5e-21
Identities = 51/221 (23%), Positives = 90/221 (40%), Gaps = 17/221 (7%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLP-KSFANLNK 179
IP + S + L L+ N L P+L + + + I ++ ++ +L+
Sbjct: 21 KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77
Query: 180 TRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNN 237
+ N I + S L SL ++ NL L L L L + +N
Sbjct: 78 LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNL 135
Query: 238 FEGTTIPASYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGY----LDLSSNQLNGSIPP 292
+ +P +SN++ L L L + +Q DL + + LDLS N +N I P
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQP 194
Query: 293 GRL-SLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANN 331
G + + + L N+L ++P F L LQ++++ N
Sbjct: 195 GAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 37/208 (17%), Positives = 69/208 (33%), Gaps = 32/208 (15%)
Query: 180 TRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNN 237
T++ ++ N + + P L + L + + L L L L N
Sbjct: 30 TKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87
Query: 238 FEGTTIPA-SYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRL 295
++ ++S +S L KL +L + + L L+++ N + S
Sbjct: 88 I--QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFK---- 140
Query: 296 SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 355
+P FS L L+ L +++N + SI + + L
Sbjct: 141 -----------------LPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSL 182
Query: 356 DFQNNNLTNI-SGSFNIPPNVTVRLRGN 382
D N + I G+F + L N
Sbjct: 183 DLSLNPMNFIQPGAFKEIRLKELALDTN 210
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 22/98 (22%), Positives = 38/98 (38%), Gaps = 10/98 (10%)
Query: 289 SIPPGRLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 347
IP L + + LS N L + S F P LQ L ++ + +I +QS L
Sbjct: 21 KIPDN-LPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQS--L 75
Query: 348 NATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGNP 383
+ T L N + ++ G+F+ ++
Sbjct: 76 SHLST--LILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 7e-21
Identities = 52/292 (17%), Positives = 96/292 (32%), Gaps = 25/292 (8%)
Query: 73 FNTTMDDGYLHLRELQLLNLNLSG-------NLSPEIGRLSYLTILDFMWNKISGSIPKE 125
F+ ++ L LQL N+ L+ E+ R L + + + +
Sbjct: 209 FSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVK 268
Query: 126 IGNI---KSLELLLLNGNELTGSLPEELG-----YLPKLDRIQIDQNYISGSLPKSFANL 177
+ + +E L + +T + E L L + S ++
Sbjct: 269 LFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVF 328
Query: 178 NKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNN 237
+ ++ + S + N T + S L +L L L N
Sbjct: 329 AEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNG 388
Query: 238 FEGTTIPASYSNMSKLLKLSLRNCSLQ----GPMPDLSRIP-NLGYLDLSSNQLNGSIPP 292
+ L + SL ++ L+LSSN L GS+
Sbjct: 389 L--KNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR 446
Query: 293 GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS 344
L + + L NN++ +IP + + L LQ L +A+N L S+P ++
Sbjct: 447 -CLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDR 495
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 4e-16
Identities = 61/322 (18%), Positives = 111/322 (34%), Gaps = 32/322 (9%)
Query: 88 QLLNLNLSGN------LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLL-LNGN 140
L +L+LS N + E G L+ LT L K + ++ +LL L
Sbjct: 122 SLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSY 181
Query: 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQ------- 193
+ G E L + + + S + ++N H ++N ++ +
Sbjct: 182 HIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT 240
Query: 194 IPPELSRLPSLVHMLLDNNNLTGYLPPELSEL---PKLLILQLDNNNFEGTTIPASYSNM 250
EL+R P+L+++ L + T +L + + L + N ++
Sbjct: 241 FLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYS 300
Query: 251 SKLLK----LSLRNCSLQGPMPDL-SRIPNLGYLDLSSNQLNG--SIPPGRLSLNITTIK 303
LK ++N L S + LS + + P S + T +
Sbjct: 301 ETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPS-SFTFLN 359
Query: 304 LSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 363
+ N T ++ S L RLQ L + N L + T N + LD N+L
Sbjct: 360 FTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVA--LMTKNMSSLETLDVSLNSLN 416
Query: 364 NI--SGSFNIPPNVTV-RLRGN 382
+ + ++ V L N
Sbjct: 417 SHAYDRTCAWAESILVLNLSSN 438
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 6e-15
Identities = 41/257 (15%), Positives = 85/257 (33%), Gaps = 34/257 (13%)
Query: 83 HLRELQLLNLNLSGNLSPEIGR-----LSYLTILDFMWNKISGSIPKEIGNIKSLELLLL 137
+ L + NL ++ + E L L I S + + +L
Sbjct: 277 PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKML 336
Query: 138 NGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE 197
+ ++ + QN + S+ + + L + + + N
Sbjct: 337 SISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNG-------- 388
Query: 198 LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLS 257
L + M + L L + N+ + + +L L+
Sbjct: 389 LKNFFKVALM--------------TKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLN 434
Query: 258 LRNCSLQ-GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPS 315
L + L L P + LDL +N++ SIP L + + +++N+L ++P
Sbjct: 435 LSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPD 490
Query: 316 N-FSGLPRLQRLFIANN 331
F L LQ +++ +N
Sbjct: 491 GVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 3e-13
Identities = 33/196 (16%), Positives = 77/196 (39%), Gaps = 14/196 (7%)
Query: 73 FNTTMDDGYLHLRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNI 129
F + + Y E+ + L + S T L+F N + S+ + +
Sbjct: 317 FLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTL 376
Query: 130 KSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYI----SGSLPKSFANLNKTRHFHM 185
K L+ L+L N L + + + ++ + S + ++ A ++
Sbjct: 377 KRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNL 435
Query: 186 NNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP- 244
++N ++G + L P + + L NN + +P +++ L L L + +N ++P
Sbjct: 436 SSNMLTGSVFRCLP--PKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQL--KSVPD 490
Query: 245 ASYSNMSKLLKLSLRN 260
+ ++ L + L +
Sbjct: 491 GVFDRLTSLQYIWLHD 506
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 3e-12
Identities = 57/340 (16%), Positives = 107/340 (31%), Gaps = 56/340 (16%)
Query: 91 NLNLSGN----LSP-EIGRLSYLTILDFMWNKISGSIPKEI------------------- 126
L+LS N L +I LS L +L N+I S+ +
Sbjct: 56 ALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQN 114
Query: 127 ---GNIKSLELLLLNGNELTGSLPE--ELGYLPKLDRIQIDQNYISGSLPKSFANLN-KT 180
+ SL L L+ N+ LP E G L KL + + A+L+
Sbjct: 115 ISCCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSC 173
Query: 181 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240
+ + I G L + V L+ + N + +S + L LQL N
Sbjct: 174 ILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMS-VNALGHLQLSNIKLND 232
Query: 241 TTIPASYS------NMSKLLKLSLRNCSLQGP----MPDLSRIPNLGYLDLSSNQLNGSI 290
+ LL ++L++ + + YL++ + + I
Sbjct: 233 ENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERI 292
Query: 291 PPGRLSLNITTIK------LSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS 344
+ + T +K + N + + +S + ++ + I S
Sbjct: 293 DREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTP-FIHMVCPPS 351
Query: 345 RTLNATETFILDFQNNNLTNI-SGSFNIPPNVT-VRLRGN 382
+ L+F N T+ + + + L+ N
Sbjct: 352 P----SSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRN 387
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 8e-09
Identities = 49/297 (16%), Positives = 98/297 (32%), Gaps = 46/297 (15%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS-FANLNK 179
+PK++ + L L+ N ++ ++ +L +L +++ N I SL F
Sbjct: 45 HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQD 101
Query: 180 TRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPP--ELSELPKLLILQLDNNN 237
+ +++N + I + SL H+ L N+ LP E L KL L L
Sbjct: 102 LEYLDVSHNRLQN-ISC--CPMASLRHLDLSFNDFDV-LPVCKEFGNLTKLTFLGLSAAK 157
Query: 238 FEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL 297
F + + L L + ++G + +IPN L L + + +S+
Sbjct: 158 FRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSV 217
Query: 298 N-ITTIKLSNNKLTGTIPSNFSGL----------------------------------PR 322
N + ++LSN KL
Sbjct: 218 NALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRP 277
Query: 323 LQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTVR 378
++ L I N +++ I + I +N +++ + ++
Sbjct: 278 VEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIK 334
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 22/89 (24%), Positives = 38/89 (42%), Gaps = 7/89 (7%)
Query: 278 YLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI 337
+D S+ L +P L + LS N ++ + S L L+ L +++N + S+
Sbjct: 35 MVDYSNRNLT-HVPKD-LPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SL 91
Query: 338 PSSIWQSRTLNATETFILDFQNNNLTNIS 366
++ E LD +N L NIS
Sbjct: 92 DFHVFLF--NQDLEY--LDVSHNRLQNIS 116
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 8e-21
Identities = 56/214 (26%), Positives = 87/214 (40%), Gaps = 36/214 (16%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSL 685
+G+G + K + AVK + E + Q EI L H N+V L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ------KEITALKLCEGHPNIVKL 71
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKS----KEPLGFAMRLSIALGSSRGILYLHTE 741
++ LV E ++ G L +++ K E A + L S + ++H
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETE----ASYIMRKLVS--AVSHMHDV 125
Query: 742 ADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
V HRD+K N+L + K+ DFG +RL P + + T T Y
Sbjct: 126 G---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN------QPLKTPC-FTLHY 175
Query: 799 LDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 831
PE L D+S D++SLGV+ +L+G P
Sbjct: 176 AAPE-LLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 9e-21
Identities = 56/211 (26%), Positives = 87/211 (41%), Gaps = 31/211 (14%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAV----KRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 685
++G+G VY+ A+ K + ++ TEI L RL H N++ L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR------TEIGVLLRLSHPNIIKL 113
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEAD 743
+ E LV E ++ G L D++ K E I + YLH
Sbjct: 114 KEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQIL----EAVAYLHENG- 168
Query: 744 PPVFHRDIKASNILLDHKF---TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
+ HRD+K N+L K+ADFGLS++ + + V GTPGY
Sbjct: 169 --IVHRDLKPENLLYATPAPDAPLKIADFGLSKI--------VEHQVLMKTVCGTPGYCA 218
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
PE + D++S+G++ LL G +P
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 9e-21
Identities = 54/212 (25%), Positives = 87/212 (41%), Gaps = 32/212 (15%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGY 688
IG G Y + I AVK + +E I+ L R H N+++L
Sbjct: 29 DIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----IEILLRYGQHPNIITLKDV 84
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLHTEADP 744
D+ +V E M G L D++ + F A + + + YLH +
Sbjct: 85 YDDGKYVYVVTELMKGGELLDKILRQKF----FSEREASAVLFTITK--TVEYLHAQG-- 136
Query: 745 PVFHRDIKASNILL----DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
V HRD+K SNIL + + ++ DFG ++ + + T T ++
Sbjct: 137 -VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN------GLLMTPC-YTANFVA 188
Query: 801 PEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 831
PE L + D + D++SLGV+ +LTG P
Sbjct: 189 PE-VLERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-20
Identities = 62/237 (26%), Positives = 97/237 (40%), Gaps = 40/237 (16%)
Query: 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEF----LTEIQFLSRL 677
+ F GQG +G V G G VA+K+ + + F L +Q L+ L
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ-----DPRFRNRELQIMQDLAVL 76
Query: 678 HHRNLVSLVGYCDEEGEQ-------MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 730
HH N+V L Y GE+ +V E++ D L + + L
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHRCCRNYYRRQVAPPPILI 131
Query: 731 SS------RGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGI 783
R I LH + V HRDIK N+L++ T K+ DFG ++ P
Sbjct: 132 KVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL-SPS---- 185
Query: 784 VPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIV 839
+V+ + + Y PE ++ T D++S+G +F E++ G +PI G N
Sbjct: 186 -EPNVAYIC--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPIFRGDNSA 238
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 2e-20
Identities = 44/197 (22%), Positives = 75/197 (38%), Gaps = 17/197 (8%)
Query: 660 SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA-KSKEP 718
S +I+ + +N V + + + + L+D ++ S E
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 719 LGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR----- 773
+ L I + + + +LH++ + HRD+K SNI KV DFGL
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 774 --LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELL----T 827
V H V GT Y+ PE + + K D++SLG++ ELL T
Sbjct: 218 EEEQTVLTPMPAYATHTGQV--GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST 275
Query: 828 GMQPISHGKNIVREVLP 844
M+ + ++ P
Sbjct: 276 QMERVRIITDVRNLKFP 292
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 17/83 (20%), Positives = 33/83 (39%), Gaps = 2/83 (2%)
Query: 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR-AQEGSLQGEKEFLTEIQFLSRLHHRN 681
+F +G+GG+G V++ D A+KR ++ + E++ L++L H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 682 LVSLVGYCDEEGEQMLVYEFMSN 704
+V E + E
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEI 88
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 7e-20
Identities = 52/229 (22%), Positives = 92/229 (40%), Gaps = 32/229 (13%)
Query: 623 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHH 679
+ + IG G G V VA+K+ + K E+ + ++H
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 680 RNLVSL--VGYCDEEGEQM----LVYEFMS---NGTLRDQLSAKSKEPLGFAMRLSIALG 730
+N++ L V + E+ +V E M ++ +L + L + M
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQML------ 137
Query: 731 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 790
GI +LH+ A + HRD+K SNI++ T K+ DFGL+R + + T
Sbjct: 138 --CGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLAR--------TAGTSFMMT 184
Query: 791 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 839
T Y PE L + D++S+G + E++ G + G + +
Sbjct: 185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVLFPGTDHI 232
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 8e-20
Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHH 679
+ F +G+GG+G+V+ + G + A K+ + L+ K + + E + L+++H
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 680 RNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLS------IALGSS 732
R +VSL Y E + LV M+ G +R + ++ GF + I G
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG-- 301
Query: 733 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 792
+ +LH + +RD+K N+LLD +++D GL+ E +
Sbjct: 302 --LEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAV-------ELKAGQTKTKGY 349
Query: 793 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
GTPG++ PE L + D ++LGV E++ P
Sbjct: 350 AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 57/205 (27%), Positives = 82/205 (40%), Gaps = 20/205 (9%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
IG G +G +VAVK + G+ E EI L H N+V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ-REIINHRSLRHPNIVRFKEVIL 86
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
++ E+ S G L +++ + A L S G+ Y H+ + HRD
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS--GVSYCHSMQ---ICHRD 141
Query: 751 IKASNILLDHKFTA--KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 808
+K N LLD K+ DFG S+ V + + V GTP Y+ PE L +
Sbjct: 142 LKLENTLLDGSPAPRLKICDFGYSKS-SVLH------SQPKSTV-GTPAYIAPE-VLLRQ 192
Query: 809 LTD--KSDVYSLGVVFLELLTGMQP 831
D +DV+S GV +L G P
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 56/206 (27%), Positives = 84/206 (40%), Gaps = 21/206 (10%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
+G+G +GKV VA+K R EI +L L H +++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+ ++V E+ + G L D + K + R + I Y H +
Sbjct: 77 VITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIIC--AIEYCHRHK---IV 130
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
HRD+K N+LLD K+ADFGLS + + T G+P Y PE +
Sbjct: 131 HRDLKPENLLLDDNLNVKIADFGLSNI-MTDG------NFLKTSC-GSPNYAAPE-VING 181
Query: 808 KLTD--KSDVYSLGVVFLELLTGMQP 831
KL + DV+S G+V +L G P
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-19
Identities = 51/214 (23%), Positives = 83/214 (38%), Gaps = 35/214 (16%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVG-Y 688
+G G GKV + A+K LQ + E++ R ++V +V Y
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDVY 124
Query: 689 CDEEGEQMLVY---EFMSNGTLRDQLSAKSKEPL-----GFAMRLSIALGSSRGILYLHT 740
+ + + E + G L ++ + + M+ SI I YLH+
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK-SIG----EAIQYLHS 179
Query: 741 EADPPVFHRDIKASNILLDHKF---TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG 797
+ HRD+K N+L K K+ DFG ++ + ++T TP
Sbjct: 180 IN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-------LTTPC-YTPY 228
Query: 798 YLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
Y+ PE K D++SLGV+ LL G P
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 4e-19
Identities = 56/325 (17%), Positives = 106/325 (32%), Gaps = 36/325 (11%)
Query: 88 QLLNLNLSGN------LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNE 141
L +L+LS N + E G +S L L + S I ++ ++LL+ G
Sbjct: 91 NLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGET 150
Query: 142 LTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFAN-----------LNKTRHFHMNNNSI 190
E+ L + + + + + N N S
Sbjct: 151 YG--EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSY 208
Query: 191 SGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPK---LLILQLDNNNFEG----TTI 243
I +L P L ++ L+N T + +L + + N +G
Sbjct: 209 FLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDF 268
Query: 244 PASYSNMSKLLKLSLRNCSLQGPMPDLSRI---PNLGYLDLSSNQLNGSIPPGRLSLNIT 300
S +++ L + + P + I N+ +S ++ + P ++S
Sbjct: 269 DYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKIS-PFL 327
Query: 301 TIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNN 360
+ SNN LT T+ N L L+ L + N L + T LD N
Sbjct: 328 HLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIA--EMTTQMKSLQQLDISQN 384
Query: 361 NLTNIS--GSFNIPPNVTV-RLRGN 382
+++ G + ++ + N
Sbjct: 385 SVSYDEKKGDCSWTKSLLSLNMSSN 409
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 1e-18
Identities = 36/254 (14%), Positives = 82/254 (32%), Gaps = 25/254 (9%)
Query: 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140
Y + ++L + L L+I + + ++ + +
Sbjct: 251 YFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVS 310
Query: 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR 200
+ + N ++ ++ ++ +L + + N L
Sbjct: 311 GTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQ--------LKE 362
Query: 201 LPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRN 260
L + M +++ L L + N+ S LL L++ +
Sbjct: 363 LSKIAEM--------------TTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSS 408
Query: 261 CSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSG 319
L + P + LDL SN++ SIP + L + + +++N+L F
Sbjct: 409 NILTDTIFR-CLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDR 466
Query: 320 LPRLQRLFIANNSL 333
L LQ++++ N
Sbjct: 467 LTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 4e-17
Identities = 42/220 (19%), Positives = 85/220 (38%), Gaps = 31/220 (14%)
Query: 73 FNTTMDDGYLHLRELQLLNLNLSGN---LSPEIGRLSYLTILDFMWNKISGSIPKEIGNI 129
F Y + + N +SG ++S LDF N ++ ++ + G++
Sbjct: 288 FGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHL 347
Query: 130 KSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNS 189
LE L+L N+L L + + + + + ++ NS
Sbjct: 348 TELETLILQMNQLK-ELSK---------------------IAEMTTQMKSLQQLDISQNS 385
Query: 190 ISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYS 248
+S S SL+ + + +N LT + L P++ +L L +N +IP
Sbjct: 386 VSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKI--KSIPKQVV 441
Query: 249 NMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLN 287
+ L +L++ + L+ P R+ +L + L +N +
Sbjct: 442 KLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 6e-16
Identities = 45/330 (13%), Positives = 99/330 (30%), Gaps = 38/330 (11%)
Query: 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
L++ +L++ + E + +++ ++S I + + L
Sbjct: 160 LQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELS-----NIKCVLEDNKCSYFLSILA 214
Query: 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR--- 200
L+ I+ N L +F ++N + GQ+
Sbjct: 215 KLQTNPKLSNLTLNNIETTWNSFIRIL--QLVWHTTVWYFSISNVKLQGQLDFRDFDYSG 272
Query: 201 --LPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSL 258
L +L + ++ + I + + S +S L L
Sbjct: 273 TSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCP-SKISPFLHLDF 331
Query: 259 RNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL----NITTIKLSNNKLTGTI 313
N L + + L L L NQL + ++ + +S N ++
Sbjct: 332 SNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDE 390
Query: 314 PSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTL----------------NATETFILD 356
S L L +++N L+ +I + + L+
Sbjct: 391 KKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIKSIPKQVVKLEALQELN 450
Query: 357 FQNNNLTNIS-GSFNIPPNVT-VRLRGNPF 384
+N L ++ G F+ ++ + L NP+
Sbjct: 451 VASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 4e-14
Identities = 56/343 (16%), Positives = 101/343 (29%), Gaps = 60/343 (17%)
Query: 91 NLNLSGN----LSPE-IGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGS 145
LN+S N L I LS L IL N+I + LE L L+ N+L
Sbjct: 25 ILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-K 83
Query: 146 LPEELGYLPKLDRIQIDQNYISGSLPKS--FANLNKTRHFHMNNNSISGQIPPELSRLPS 203
+ L + + N +LP F N+++ + ++ + ++ L
Sbjct: 84 IS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNI 140
Query: 204 LVHMLLDNNNLTGYLPPEL---SELPKLLILQLDNNNFEG-------------------- 240
+L+ PE L I+ N F
Sbjct: 141 SKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCV 200
Query: 241 ---------TTIPASYSNMSKLLKLSLRNCSLQGP----MPDLSRIPNLGYLDLSSNQLN 287
+I A KL L+L N + L + Y +S+ +L
Sbjct: 201 LEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQ 260
Query: 288 GSIPPGRLSLNITTIK------LSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSI 341
G + + T++K + ++ + + + +
Sbjct: 261 GQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR-MVHMLC 319
Query: 342 WQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGN 382
++ LDF NN LT+ + + L+ N
Sbjct: 320 PSK--ISPFLH--LDFSNNLLTDTVFENCGHLTELETLILQMN 358
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 5e-11
Identities = 44/274 (16%), Positives = 84/274 (30%), Gaps = 19/274 (6%)
Query: 137 LNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPP 196
+ N L +P++L K + I QNYIS +L+K R +++N I +
Sbjct: 7 RSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDI 62
Query: 197 E-LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLK 255
L ++ L +N L + L L L N F+ I + NMS+L
Sbjct: 63 SVFKFNQELEYLDLSHNKLVK-ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKF 119
Query: 256 LSLRNCSLQ-GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS----LNITTIKLSNNKLT 310
L L L+ + ++ + L + P L ++ + +N +
Sbjct: 120 LGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFH 179
Query: 311 GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF------ILDFQNNNLTN 364
+ + + L+ I + L ++ N+
Sbjct: 180 FILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIR 239
Query: 365 ISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHS 398
I + + F S +
Sbjct: 240 ILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGT 273
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 40/288 (13%), Positives = 89/288 (30%), Gaps = 22/288 (7%)
Query: 108 LTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYIS 167
TIL+ N IS +I ++ L +L+++ N + + +L+ + + N +
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82
Query: 168 GSLPKSFANLNKTRHFHMNNNSI-SGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELP 226
+ +H ++ N+ + I E + L + L +L ++ L
Sbjct: 83 -KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLN 139
Query: 227 KLLILQLDNNNFEGTTIPASYSN-----------MSKLLKLSLRNCSLQGPMPDLSRIPN 275
+L + + P + +K L +LS I
Sbjct: 140 ISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKC 199
Query: 276 LGYLDLS----SNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN 331
+ + S P +L + I+ + N + I+N
Sbjct: 200 VLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIR--ILQLVWHTTVWYFSISNV 257
Query: 332 SLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTVR 378
L G + + + I ++ S + I N+ ++
Sbjct: 258 KLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIK 305
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 6e-19
Identities = 56/227 (24%), Positives = 77/227 (33%), Gaps = 35/227 (15%)
Query: 632 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE-----------KEFLTEIQFLSRLHHR 680
I G YG V G+ +G VA+KR G K L EI+ L+ HH
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 681 NLVSLV-----GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 735
N++ L + LV E M T Q+ + + G+
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELM--RTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147
Query: 736 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST--VVK 793
LH A V HRD+ NILL + DF L+R T V
Sbjct: 148 HVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLAR--------EDTADANKTHYVT- 195
Query: 794 GTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIV 839
Y PE + K K D++S G V E+ + + G
Sbjct: 196 -HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-KALFRGSTFY 240
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 90.2 bits (223), Expect = 9e-19
Identities = 54/285 (18%), Positives = 95/285 (33%), Gaps = 27/285 (9%)
Query: 128 NIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNN 187
L +T L +D+I + + I S+ + L +N
Sbjct: 19 AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 74
Query: 188 NSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASY 247
N ++ I P L+ L +L + LD N + L +L KL L L++N + I
Sbjct: 75 NKLT-DIKP-LTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGI--SDING-L 127
Query: 248 SNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNN 307
++ +L L L N + + LSR+ L L L NQ++ I P + + LS N
Sbjct: 128 VHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKN 185
Query: 308 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 367
+ + +GL L L + + N + N G
Sbjct: 186 HI--SDLRALAGLKNLDVLELFSQEC------------LNKPINHQSNLVVPNTVKNTDG 231
Query: 368 SFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTL 412
S P ++ + + +F S + +
Sbjct: 232 SLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKA 276
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 87.5 bits (216), Expect = 6e-18
Identities = 63/291 (21%), Positives = 112/291 (38%), Gaps = 21/291 (7%)
Query: 88 QLLNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
+ + NL + L+ + + + I S+ + I + ++ L LNGN+LT
Sbjct: 22 ETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLT- 78
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
+ + L L L + +D+N I L S +L K + + +N IS I L LP L
Sbjct: 79 DI-KPLTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGIS-DING-LVHLPQL 133
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264
+ L NN +T LS L KL L L++N + I + ++KL L L +
Sbjct: 134 ESLYLGNNKITDITV--LSRLTKLDTLSLEDNQI--SDIV-PLAGLTKLQNLYLSKNHIS 188
Query: 265 GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQ 324
+ L+ + NL L+L S + + P S + + N + P S +
Sbjct: 189 -DLRALAGLKNLDVLELFSQECL-NKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYE 246
Query: 325 RLFIANNSLSGSIPSS---IWQSRTLNATETFILDFQNNNLTNISGSFNIP 372
+ + + + S A F + S+++
Sbjct: 247 KPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVD 297
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 77.5 bits (190), Expect = 8e-15
Identities = 56/295 (18%), Positives = 110/295 (37%), Gaps = 23/295 (7%)
Query: 88 QLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
+ + + + + I L +T L NK++ I K + N+K+L L L+ N++
Sbjct: 44 SIDQIIANNSDIKSVQG-IQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK 100
Query: 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPS 203
L L L KL + ++ N IS + +L + ++ NN I+ I LSRL
Sbjct: 101 -DL-SSLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKIT-DITV-LSRLTK 154
Query: 204 LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263
L + L++N ++ L+ L KL L L N+ + + A + + L L L +
Sbjct: 155 LDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHI--SDLRAL-AGLKNLDVLELFSQEC 209
Query: 264 QGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRL 323
++ NL + N + P +S + + +P + + +
Sbjct: 210 L--NKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGD---YEKPNVKWHLPEFTNEVSFI 264
Query: 324 QRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVR 378
+ + Q T ++ +D +G+ P +
Sbjct: 265 FYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTKVEAGTRITAPKPPTK 319
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 65.5 bits (159), Expect = 4e-11
Identities = 30/195 (15%), Positives = 71/195 (36%), Gaps = 26/195 (13%)
Query: 204 LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263
+ + + + P + + L + + + ++ + ++ N +
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAV---TQNELNSIDQIIANNSDI 55
Query: 264 QGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRL 323
+ + + +PN+ L L+ N+L I P N+ + L NK+ + S+ L +L
Sbjct: 56 KS-VQGIQYLPNVTKLFLNGNKLT-DIKPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKL 111
Query: 324 QRLFIANNSLSGSIP--SSIWQSRTLNATETFI--------------LDFQNNNLTNISG 367
+ L + +N +S I + Q +L I L ++N +++I
Sbjct: 112 KSLSLEHNGIS-DINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP 170
Query: 368 SFNIPPNVTVRLRGN 382
+ + L N
Sbjct: 171 LAGLTKLQNLYLSKN 185
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 1e-18
Identities = 57/264 (21%), Positives = 104/264 (39%), Gaps = 32/264 (12%)
Query: 588 HMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGI-LP 646
+ I++ + SK+ + + + IG G G V
Sbjct: 26 KQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAV 85
Query: 647 DGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSL--VGYCDEEGEQM----LV 698
VA+K+ + K E+ + ++H+N++SL V + E+ LV
Sbjct: 86 LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 145
Query: 699 YEFMS---NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 755
E M ++ +L + L + M GI +LH+ A + HRD+K SN
Sbjct: 146 MELMDANLCQVIQMELDHERMSYLLYQML--------CGIKHLHS-AG--IIHRDLKPSN 194
Query: 756 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDV 815
I++ T K+ DFGL+R A + + T T Y PE L + D+
Sbjct: 195 IVVKSDCTLKILDFGLARTAG--------TSFMMTPYVVTRYYRAPEVILGMGYKENVDI 246
Query: 816 YSLGVVFLELLTGMQPISHGKNIV 839
+S+G + E++ + + G++ +
Sbjct: 247 WSVGCIMGEMVRH-KILFPGRDYI 269
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 2e-18
Identities = 45/229 (19%), Positives = 86/229 (37%), Gaps = 20/229 (8%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS-FANLNK 179
IP ++ ++ L +L L++I+I QN + + F+NL K
Sbjct: 23 EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 180 TRHFHM-NNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNN 236
+ N++ I PE LP+L ++L+ N + +LP + ++L + +N
Sbjct: 81 LHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDN 138
Query: 237 NFEGTTIP--ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSS-NQLNGSIPPG 293
TI + + + L L +Q L L+LS N L +P
Sbjct: 139 I-NIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPND 196
Query: 294 RLS--LNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPS 339
+ +S ++ ++PS L +L+ N +P+
Sbjct: 197 VFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLPT 241
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 6e-18
Identities = 43/257 (16%), Positives = 78/257 (30%), Gaps = 37/257 (14%)
Query: 83 HLRELQLLNLNLSGNLSPEI-GRLSYLTILDFMWNKISGSIPKEI-GNIKSL-ELLLLNG 139
+ EL+ + L + L ++ N + I ++ N+ L E+ +
Sbjct: 31 NAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89
Query: 140 NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE-L 198
N L PE LP L + I I + + + +N I
Sbjct: 90 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSF 149
Query: 199 SRLPSLVHML-LDNNNLTGYLPPELSELPKLL-ILQLDNNNFEGTTIPASYSNMSKLLKL 256
L +L L+ N + + +L + DNNN +P
Sbjct: 150 VGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNL--EELPND---------- 196
Query: 257 SLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIK-LSNNKLTGTIPS 315
LD+S +++ S+P L N+ ++ S L +P+
Sbjct: 197 ------------VFHGASGPVILDISRTRIH-SLPSYGLE-NLKKLRARSTYNLK-KLPT 241
Query: 316 NFSGLPRLQRLFIANNS 332
L L + S
Sbjct: 242 -LEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 43/209 (20%), Positives = 80/209 (38%), Gaps = 21/209 (10%)
Query: 186 NNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFEGTTIP 244
+ ++ +IP +L + + + L + S L +++ N+ I
Sbjct: 17 QESKVT-EIPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVL-EVIE 71
Query: 245 AS-YSNMSKLLKLSLRNC-SLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRL--SLNI 299
A +SN+ KL ++ + +L P+ +PNL YL +S+ + +P SL
Sbjct: 72 ADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQK 130
Query: 300 TTIKLSNNKLTGTIPSN-FSGLP-RLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDF 357
+ + +N TI N F GL L++ N + I +S + E + D
Sbjct: 131 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNG--TQLDELNLSD- 186
Query: 358 QNNNLTNIS-GSF-NIPPNVTVRLRGNPF 384
NNNL + F V + +
Sbjct: 187 -NNNLEELPNDVFHGASGPVILDISRTRI 214
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 22/107 (20%), Positives = 42/107 (39%), Gaps = 9/107 (8%)
Query: 279 LDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSI 337
+++ IP L N ++ KL I FSG L+++ I+ N + I
Sbjct: 14 FLCQESKVT-EIPSD-LPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVI 70
Query: 338 PSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGN 382
+ ++ + L ++ + NNL I +F PN+ +
Sbjct: 71 EADVFSN--LPKLHEIRIE-KANNLLYINPEAFQNLPNLQYLLISNT 114
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 60/230 (26%), Positives = 98/230 (42%), Gaps = 35/230 (15%)
Query: 623 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHH 679
+ S T +G G YG V I G VA+K+ S K E+ L + H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 680 RNLVSL--VGYCDEEGEQM----LVYEFMS---NGTLRDQLSAKSKEPLGFAMRLSIALG 730
N++ L V LV FM + + S + + L + M
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQML------ 136
Query: 731 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 790
+G+ Y+H+ A V HRD+K N+ ++ K+ DFGL+R A ++ G V
Sbjct: 137 --KGLKYIHS-AG--VVHRDLKPGNLAVNEDCELKILDFGLARHAD-AEMTGYV------ 184
Query: 791 VVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIV 839
T Y PE L+ +++ D++S+G + E+LTG + + GK+ +
Sbjct: 185 ---VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTLFKGKDYL 230
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 6e-18
Identities = 61/223 (27%), Positives = 91/223 (40%), Gaps = 36/223 (16%)
Query: 624 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSR 676
++F IG+G +GKV + A+K + E E+Q +
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 677 LHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FAMRLSIALGS 731
L H LV+L Y ++ E M +V + + G LR L E F L +AL
Sbjct: 72 LEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALD- 129
Query: 732 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 791
YL + + HRD+K NILLD + DF ++ + + T
Sbjct: 130 -----YLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAM--------LPRETQITT 173
Query: 792 VKGTPGYLDPEYFLTHKLT--DKS-DVYSLGVVFLELLTGMQP 831
+ GT Y+ PE F + K + D +SLGV ELL G +P
Sbjct: 174 MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 7e-18
Identities = 23/207 (11%), Positives = 51/207 (24%), Gaps = 49/207 (23%)
Query: 631 QIGQGGYGKVYKGILPD---GTVVAVK--RAQEGSLQGEKE-FLTEIQFLSRLHHRNLVS 684
G + ++ + D VA+ Q + L+ LSR+ +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 685 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 744
++ ++V E++ G+L++ + + H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGAIRAMQSLAAAADAAHRA--- 148
Query: 745 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 804
V S + + +A + +P+
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPAT--MPDA----------------------NPQ-- 182
Query: 805 LTHKLTDKSDVYSLGVVFLELLTGMQP 831
D+ +G LL P
Sbjct: 183 --------DDIRGIGASLYALLVNRWP 201
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 7e-18
Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 29/219 (13%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHH 679
N F +G+GG+G+V + G + A K+ ++ ++ K L E Q L +++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 680 RNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLS------IALGSS 732
R +VSL Y E + + LV M+ G L+ + + GF + I G
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQA--GFPEARAVFYAAEICCG-- 298
Query: 733 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 792
+ LH E + +RD+K NILLD +++D GL+ + V
Sbjct: 299 --LEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAV-------HVPEGQTIKGRV 346
Query: 793 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
GT GY+ PE + T D ++LG + E++ G P
Sbjct: 347 -GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 7e-18
Identities = 59/238 (24%), Positives = 95/238 (39%), Gaps = 42/238 (17%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVK---------RAQEGSLQGEKEFLTEIQF 673
N+F+ IG+GG+G+VY D G + A+K + E E+ L+ +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV-- 246
Query: 674 LSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLS------ 726
S +V + Y +++ + + M+ G L LS F+
Sbjct: 247 -STGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGV----FSEADMRFYAAE 300
Query: 727 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 786
I LG + ++H V +RD+K +NILLD +++D GL+ V
Sbjct: 301 IILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-- 351
Query: 787 HVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVL 843
GT GY+ PE D S D +SLG + +LL G P K + +
Sbjct: 352 -------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 8e-18
Identities = 58/235 (24%), Positives = 91/235 (38%), Gaps = 51/235 (21%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQE-GSLQGEKEFLTEIQFLSRLHHRNLVSLV--- 686
+G+G YG V P G +VA+K+ + L EI+ L H N++++
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 687 --GYCDEEGEQMLVYEFM--------SNGTLRD--------QLSAKSKEPLGFAMRLSIA 728
+ E ++ E M S L D Q
Sbjct: 79 RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQT----------------- 121
Query: 729 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 788
L R + LH ++ V HRD+K SN+L++ KV DFGL+R+ + P
Sbjct: 122 L---RAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 789 STVVKG---TPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIV 839
+ + T Y PE LT ++ DV+S G + EL +PI G++
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPIFPGRDYR 229
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 1e-17
Identities = 57/277 (20%), Positives = 93/277 (33%), Gaps = 86/277 (31%)
Query: 631 QIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRL-HHRNL 682
+G+G +G+V + VAVK +EG+ E + ++E++ L + HH N+
Sbjct: 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88
Query: 683 VSLVGYC-DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR----------------- 724
V+L+G C G M++ EF G L L +K E + + +
Sbjct: 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVD 148
Query: 725 --------------LSIALGSSRGILYLHTEADPPVFHRDIKASNILL------------ 758
S + + + E P ++D L+
Sbjct: 149 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEF 208
Query: 759 ------------------DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
K K+ DFGL+R DI V+ L
Sbjct: 209 LASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIY-----KDPDYVRKGDARLP 258
Query: 801 -----PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 831
PE T +SDV+S GV+ E+ + G P
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-17
Identities = 68/257 (26%), Positives = 103/257 (40%), Gaps = 33/257 (12%)
Query: 588 HMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVY----KG 643
R S S + S + + N F +G+G +GKV K
Sbjct: 112 KQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKA 171
Query: 644 ILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVSLVGYCDEEGEQM-LVY 699
G A+K ++ + + E LTE + L H L +L Y + +++ V
Sbjct: 172 ---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVM 227
Query: 700 EFMSNGTLRDQLSAKSK--EPLG--FAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 755
E+ + G L LS + E + + AL YLH+E + V +RD+K N
Sbjct: 228 EYANGGELFFHLSRERVFSEDRARFYGAEIVSALD------YLHSEKN--VVYRDLKLEN 279
Query: 756 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-D 814
++LD K+ DFGL + EGI GTP YL PE L ++ D
Sbjct: 280 LMLDKDGHIKITDFGLCK-------EGIKDGATMKTFCGTPEYLAPE-VLEDNDYGRAVD 331
Query: 815 VYSLGVVFLELLTGMQP 831
+ LGVV E++ G P
Sbjct: 332 WWGLGVVMYEMMCGRLP 348
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-17
Identities = 27/164 (16%), Positives = 59/164 (35%), Gaps = 7/164 (4%)
Query: 125 EIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFH 184
+ SL + L +T L + Y + + I+ + + + L+
Sbjct: 39 TEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATNY--NPISGLSNLERLR 94
Query: 185 MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP 244
+ ++ P LS L SL + + ++ + +++ LPK+ + L N T
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG--AITDI 152
Query: 245 ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNG 288
+ +L L+++ + + P L L S + G
Sbjct: 153 MPLKTLPELKSLNIQFDGVHD-YRGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 34/162 (20%), Positives = 67/162 (41%), Gaps = 11/162 (6%)
Query: 175 ANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 234
+ + + +S + +++ SL ++ L N N+T L + + L ++
Sbjct: 20 STFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTD-LTG-IEYAHNIKDLTIN 74
Query: 235 NNNFEGTTIPASYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPG 293
N + S +S L +L + + +P+LS + +L LD+S + + SI
Sbjct: 75 NIHATNYN---PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
Query: 294 RLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 334
+L + +I LS N I LP L+ L I + +
Sbjct: 132 INTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-12
Identities = 27/168 (16%), Positives = 62/168 (36%), Gaps = 14/168 (8%)
Query: 201 LPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRN 260
+ ++ LL ++ +++ L + L N N T + L++ N
Sbjct: 22 FKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLT---GIEYAHNIKDLTINN 75
Query: 261 CSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSG 319
P +S + NL L + + P L ++T + +S++ +I + +
Sbjct: 76 IHATNYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
Query: 320 LPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 367
LP++ + ++ N I + L L+ Q + + + G
Sbjct: 135 LPKVNSIDLSYNGAITDI-MPLKTLPELK-----SLNIQFDGVHDYRG 176
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 8e-12
Identities = 30/146 (20%), Positives = 59/146 (40%), Gaps = 12/146 (8%)
Query: 223 SELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLS 282
S L L ++ T + + M+ L ++L N ++ + + N+ L ++
Sbjct: 20 STFKAYLNGLLGQSS----TANITEAQMNSLTYITLANINVTD-LTGIEYAHNIKDLTIN 74
Query: 283 SNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIW 342
+ P LS N+ +++ +T N SGL L L I++++ SI + I
Sbjct: 75 NIHATNYNPISGLS-NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 343 QSRTLNATETFILDFQNNN-LTNISG 367
+N +D N +T+I
Sbjct: 134 TLPKVN-----SIDLSYNGAITDIMP 154
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 21/110 (19%), Positives = 47/110 (42%), Gaps = 3/110 (2%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
+L L+++ +++ + P + L+ LT+LD + SI +I + + + L+ N
Sbjct: 89 NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
Query: 143 TGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG 192
+ L LP+L + I + + + K + + +I G
Sbjct: 149 ITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 1e-17
Identities = 54/231 (23%), Positives = 91/231 (39%), Gaps = 39/231 (16%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSLV-- 686
IG G YG V + + VVA+K+ L K L EI L+RL+H ++V ++
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120
Query: 687 ---GYCDEEGEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTE 741
++ E +V E + D ++ L ++ G+ Y+H+
Sbjct: 121 VIPKDVEKFDELYVVLEIA--DS--D-FKKLFRTPVYLTELHIKTLLYNLLVGVKYVHS- 174
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
A + HRD+K +N L++ + KV DFGL+R P+
Sbjct: 175 AG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232
Query: 802 EYFLTHKLTD--------------------KS-DVYSLGVVFLELLTGMQP 831
L +LT ++ DV+S+G +F ELL ++
Sbjct: 233 TKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 1e-17
Identities = 40/165 (24%), Positives = 72/165 (43%), Gaps = 16/165 (9%)
Query: 230 ILQLDNNNFEGTTIPASY--SNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQL 286
+L L +NN + + A + + ++ L L L + L + +PNL YLDLSSN L
Sbjct: 43 LLDLSHNNL--SRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHL 100
Query: 287 NGSIPPGRLS--LNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQ 343
+ ++ S + + L NN + + N F + +LQ+L+++ N +S P + +
Sbjct: 101 H-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIK 157
Query: 344 SRTLNATETFILDFQNNNLTNIS-GSFNIPPN---VTVRLRGNPF 384
+ +LD +N L + P + L NP
Sbjct: 158 DGN-KLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 3e-15
Identities = 43/162 (26%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 91 NLNLSGN----LSPEI--GRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGNELT 143
L+LS N L E RL+ L L N ++ I E + +L L L+ N L
Sbjct: 43 LLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH 101
Query: 144 GSLPEE-LGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE----L 198
+L E L L+ + + N+I +F ++ + + +++ N IS + P E
Sbjct: 102 -TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDG 159
Query: 199 SRLPSLVHMLLDNNNLTGYLPPELSELPKL--LILQLDNNNF 238
++LP L+ + L +N L +L +LP L L NN
Sbjct: 160 NKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 52/220 (23%), Positives = 89/220 (40%), Gaps = 30/220 (13%)
Query: 624 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSR 676
+F +G+G + V A+K ++ + E + E +SR
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSR 86
Query: 677 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLG--FAMRLSIALGSS 732
L H V L ++ + + NG L + E + + AL
Sbjct: 87 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE-- 144
Query: 733 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 792
YLH + + HRD+K NILL+ ++ DFG +++ + A+ + V
Sbjct: 145 ----YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV--LSPESKQARAN--SFV 193
Query: 793 KGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 831
GT Y+ PE LT K KS D+++LG + +L+ G+ P
Sbjct: 194 -GTAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 45/230 (19%), Positives = 100/230 (43%), Gaps = 15/230 (6%)
Query: 104 RLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQ 163
+ + ++ ++ + S++ ++ N +++ S+ + + YLP + ++ ++
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 77
Query: 164 NYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELS 223
N ++ + K ANL ++ N + + L L L + L++N ++ + L
Sbjct: 78 NKLT-DI-KPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DING-LV 131
Query: 224 ELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSS 283
LP+L L L NN T I S ++KL LSL + + + L+ + L L LS
Sbjct: 132 HLPQLESLYLGNNKI--TDITVL-SRLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSK 187
Query: 284 NQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 333
N ++ + N+ ++L + + ++ S L + + SL
Sbjct: 188 NHIS-DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 58/250 (23%), Positives = 104/250 (41%), Gaps = 18/250 (7%)
Query: 88 QLLNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
+ + NL + L+ + + + I S+ + I + ++ L LNGN+LT
Sbjct: 25 ETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLT- 81
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
+ + L L L + +D+N + L S +L K + + +N IS I L LP L
Sbjct: 82 DI-KPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DING-LVHLPQL 136
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264
+ L NN +T + LS L KL L L++N + I + ++KL L L +
Sbjct: 137 ESLYLGNNKITD-ITV-LSRLTKLDTLSLEDNQI--SDIV-PLAGLTKLQNLYLSKNHIS 191
Query: 265 GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQ 324
+ L+ + NL L+L S + + P S + + N + P S +
Sbjct: 192 D-LRALAGLKNLDVLELFSQECL-NKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYE 249
Query: 325 RLFIANNSLS 334
+ + +
Sbjct: 250 KPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 54/239 (22%), Positives = 99/239 (41%), Gaps = 24/239 (10%)
Query: 88 QLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
+ + + + + I L +T L NK++ I K + N+K+L L L+ N++
Sbjct: 47 SIDQIIANNSDIKSVQG-IQYLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKVK 103
Query: 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPS 203
L L L KL + ++ N IS + +L + ++ NN I+ I LSRL
Sbjct: 104 -DL-SSLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKIT-DITV-LSRLTK 157
Query: 204 LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263
L + L++N ++ + P L+ L KL L L N+ + + A + + L L L +
Sbjct: 158 LDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHI--SDLRAL-AGLKNLDVLELFSQEC 212
Query: 264 QGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNIT----TIKLSNNKLTGTIPSNFS 318
++ NL + N + P +S + +K + T + F
Sbjct: 213 L--NKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFY 269
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 39/218 (17%), Positives = 81/218 (37%), Gaps = 18/218 (8%)
Query: 175 ANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 234
+T ++ S++ + + L S+ ++ +N+++ + LP + L L+
Sbjct: 21 DAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLN 76
Query: 235 NNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGR 294
N T I +N+ L L L ++ + L + L L L N ++ I
Sbjct: 77 GNKL--TDIK-PLANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGIS-DINGLV 131
Query: 295 LSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 354
+ ++ L NNK+T + S L +L L + +N +S I L +
Sbjct: 132 HLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-----DIVPLAGLTKLQN-- 182
Query: 355 LDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQ 392
L N+++++ + + L Q
Sbjct: 183 LYLSKNHISDLRALAGLKNLDVLELFSQECLNKPINHQ 220
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 50/237 (21%), Positives = 92/237 (38%), Gaps = 27/237 (11%)
Query: 88 QLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
+ L L+GN + P + L L L NK+ + + ++K L+ L L N ++
Sbjct: 69 NVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS 125
Query: 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPS 203
+ L +LP+L+ + + N I+ + L K + +N IS I P L+ L
Sbjct: 126 -DI-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTK 179
Query: 204 LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASY-SNMSKLLKLSLRNCS 262
L ++ L N+++ L+ L L +L+L + P ++ SN+ +
Sbjct: 180 LQNLYLSKNHISDL--RALAGLKNLDVLELFSQEC--LNKPINHQSNLVVPNTVKN---- 231
Query: 263 LQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSG 319
G + I + G D + +P N + G + F G
Sbjct: 232 TDGSLVTPEIISDDG--DYEKPNVKWHLPE---FTNEVSFIFYQPVTIGKAKARFHG 283
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 16/98 (16%), Positives = 36/98 (36%), Gaps = 10/98 (10%)
Query: 270 LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 329
+L + ++ L+ +I I +N+ + ++ LP + +LF+
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVTQNELN-SIDQIIANNSDIK-SV-QGIQYLPNVTKLFLN 76
Query: 330 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 367
N L+ I + + L L N + ++S
Sbjct: 77 GNKLT-DI-KPLANLKNLG-----WLFLDENKVKDLSS 107
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 5e-17
Identities = 53/255 (20%), Positives = 96/255 (37%), Gaps = 68/255 (26%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY-- 688
+G G +G V + + G A+K+ LQ + E+ + L H N++ LV Y
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKV----LQDPRYKNRELDIMKVLDHVNIIKLVDYFY 70
Query: 689 ------------------------------------CDEEGEQMLVYEFMSNGTLRDQLS 712
+ ++ E++ D L
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-----DTLH 125
Query: 713 AKSKEPLGFAMRLSIALGSS------RGILYLHTEADPPVFHRDIKASNILLD-HKFTAK 765
K + + + L S R + ++H+ + HRDIK N+L++ T K
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLK 182
Query: 766 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLE 824
+ DFG ++ +P V+ + + Y PE L + T D++S+G VF E
Sbjct: 183 LCDFGSAKKL-IPS-----EPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234
Query: 825 LLTGMQPISHGKNIV 839
L+ G +P+ G+ +
Sbjct: 235 LILG-KPLFSGETSI 248
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 6e-17
Identities = 58/254 (22%), Positives = 84/254 (33%), Gaps = 64/254 (25%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSLV-- 686
IG+G YG VY VA+K+ L K L EI L+RL ++ L
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 687 ---GYCDEEGEQMLVYEFM---------SNGTLRD--------QLSAKSKEPLGFAMRLS 726
+ E +V E + L + L
Sbjct: 94 IIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNL--------------- 138
Query: 727 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 786
L G ++H + + HRD+K +N LL+ + KV DFGL+R IV
Sbjct: 139 --L---LGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 787 HVSTVVKGTPGYLD---------------PEYFLTHKLTDKS-DVYSLGVVFLELLTGMQ 830
G PE L + KS D++S G +F ELL +Q
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250
Query: 831 PISHGKNIVREVLP 844
+ + P
Sbjct: 251 SHINDPTNRFPLFP 264
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 9e-17
Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 36/222 (16%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSL--V 686
+G G YG V + G VA+K+ S K E++ L + H N++ L V
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 687 GYCDEEGEQM----LVYEFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSSRGILYL 738
DE + LV FM ++ + L + L + M +G+ Y+
Sbjct: 93 FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML--------KGLRYI 144
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
H A + HRD+K N+ ++ K+ DFGL+R VV T Y
Sbjct: 145 HA-AG--IIHRDLKPGNLAVNEDCELKILDFGLAR--------QADSEMTGYVV--TRWY 191
Query: 799 LDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIV 839
PE L ++ D++S+G + E++TG + + G + +
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITG-KTLFKGSDHL 232
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 44/207 (21%), Positives = 74/207 (35%), Gaps = 15/207 (7%)
Query: 131 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLP-KSFANLNKTRHFHM-NNN 188
S + L L L LP + RI + + L SF NL+K H + N
Sbjct: 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 189 SISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPE--LSELPKLLILQLDNNNFEGTTIPA 245
+++ I P+ L LP L + + N L P + IL++ +N + T+IP
Sbjct: 92 NLT-YIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYM-TSIPV 148
Query: 246 -SYSNMSKLLK-LSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG---RLSLNIT 300
++ + L L N L + L+ N+ I + +
Sbjct: 149 NAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPS 208
Query: 301 TIKLSNNKLTGTIPSN-FSGLPRLQRL 326
+ +S +T +PS L L
Sbjct: 209 LLDVSQTSVT-ALPSKGLEHLKELIAR 234
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 39/198 (19%), Positives = 73/198 (36%), Gaps = 18/198 (9%)
Query: 180 TRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNN 237
T+ + + IP S LP++ + + + L L K+ +++ N
Sbjct: 33 TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 238 FEGTTIPAS-YSNMSKLLKLSLRNCSLQGPMPDLSRI---PNLGYLDLSSNQLNGSIPPG 293
T I + L L + N L+ PDL+++ L+++ N SIP
Sbjct: 92 NL-TYIDPDALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIPVN 149
Query: 294 ---RLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNA 349
L T+KL NN T ++ F+G +L +++ N I +
Sbjct: 150 AFQGLCNETLTLKLYNNGFT-SVQGYAFNGT-KLDAVYLNKNKYLTVIDKDAFGGVYSGP 207
Query: 350 TETFILDFQNNNLTNISG 367
+ LD ++T +
Sbjct: 208 SL---LDVSQTSVTALPS 222
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-16
Identities = 39/214 (18%), Positives = 80/214 (37%), Gaps = 15/214 (7%)
Query: 153 LPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDN 211
P +++ + ++ +F+NL +++ + Q+ L + H+ + N
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 212 NNLTGYLPPE-LSELPKLLILQLDNNNFEGTTIPASY--SNMSKLLKLSLRNCSLQGPMP 268
Y+ P+ L ELP L L + N P + L + + +P
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGL--KMFPDLTKVYSTDIFFILEITDNPYMTSIP 147
Query: 269 D--LSRIPN-LGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSN-FSGLPR- 322
+ N L L +N S+ + + + L+ NK I + F G+
Sbjct: 148 VNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSG 206
Query: 323 LQRLFIANNSLSGSIPSSIWQS-RTLNATETFIL 355
L ++ S++ ++PS + + L A T+ L
Sbjct: 207 PSLLDVSQTSVT-ALPSKGLEHLKELIARNTWTL 239
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 35/152 (23%), Positives = 59/152 (38%), Gaps = 15/152 (9%)
Query: 241 TTIPASYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--L 297
IP S L L L+ P S +PN+ + +S + +
Sbjct: 24 QRIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLS 80
Query: 298 NITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILD 356
+T I++ N + I + LP L+ L I N L P ++ + FIL+
Sbjct: 81 KVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDL---TKVYSTDIFFILE 136
Query: 357 FQNNN-LTNIS-GSFNIPPN--VTVRLRGNPF 384
+N +T+I +F N +T++L N F
Sbjct: 137 ITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF 168
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 27/191 (14%), Positives = 68/191 (35%), Gaps = 18/191 (9%)
Query: 83 HLRELQLLNLNLSGNLSPEIGR-----LSYLTILDFMWNKISGSIPKEI-GNIKSLELLL 136
+L + + +++ L ++ LS +T ++ + I + + L+ L
Sbjct: 53 NLPNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111
Query: 137 LNGNELTGSLPEE--LGYLPKLDRIQIDQNYISGSLPK-SFANL-NKTRHFHMNNNSISG 192
+ L P+ + ++I N S+P +F L N+T + NN +
Sbjct: 112 IFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT- 169
Query: 193 QIPPELSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLL-ILQLDNNNFEGTTIPA-SYSN 249
+ L + L+ N + + + +L + + T +P+ +
Sbjct: 170 SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSV--TALPSKGLEH 227
Query: 250 MSKLLKLSLRN 260
+ +L+ +
Sbjct: 228 LKELIARNTWT 238
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 62/265 (23%), Positives = 111/265 (41%), Gaps = 43/265 (16%)
Query: 589 MKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGI-LPD 647
M ++H + + +++ + + + + +G G YG V
Sbjct: 1 MAHHHHHHSQERPTFYRQELNKTI-WE------VPERYQNLSPVGSGAYGSVCAAFDTKT 53
Query: 648 GTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSL--VGYCDEEGEQM----LVY 699
G VAVK+ S+ K E++ L + H N++ L V E+ LV
Sbjct: 54 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113
Query: 700 EFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 755
M N ++ Q L+ + L + + RG+ Y+H+ AD + HRD+K SN
Sbjct: 114 HLMGADLNNIVKCQKLTDDHVQFLIYQIL--------RGLKYIHS-AD--IIHRDLKPSN 162
Query: 756 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-D 814
+ ++ K+ DFGL+R ++ G V T Y PE L +++ D
Sbjct: 163 LAVNEDCELKILDFGLARHT-ADEMTGYV---------ATRWYRAPEIMLNWMHYNQTVD 212
Query: 815 VYSLGVVFLELLTGMQPISHGKNIV 839
++S+G + ELLTG + + G + +
Sbjct: 213 IWSVGCIMAELLTG-RTLFPGTDHI 236
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 16/170 (9%)
Query: 180 TRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNN 237
T+ + +N +S +P + RL L + L++N L LP + EL L L + +N
Sbjct: 39 TKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNK 96
Query: 238 FEGTTIPAS-YSNMSKLLKLSLRNCSLQGPMPDL-SRIPNLGYLDLSSNQLNGSIPPG-- 293
+P + + L +L L L+ P + + L YL L N+L S+P G
Sbjct: 97 L--QALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVF 153
Query: 294 -RLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSI 341
+L+ ++ ++L NN+L +P F L L+ L + NN L +P
Sbjct: 154 DKLT-SLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK-RVPEGA 200
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 51/184 (27%), Positives = 89/184 (48%), Gaps = 15/184 (8%)
Query: 156 LDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNL 214
++ + N +S K+F L K R ++N+N + +P + L +L + + +N L
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKL 97
Query: 215 TGYLPPEL-SELPKLLILQLDNNNFEGTTIPAS-YSNMSKLLKLSLRNCSLQGPMPD--L 270
LP + +L L L+LD N ++P + +++KL LSL LQ +P
Sbjct: 98 QA-LPIGVFDQLVNLAELRLDRNQL--KSLPPRVFDSLTKLTYLSLGYNELQS-LPKGVF 153
Query: 271 SRIPNLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLF 327
++ +L L L +NQL +P G +L+ + T+KL NN+L F L +L+ L
Sbjct: 154 DKLTSLKELRLYNNQLK-RVPEGAFDKLT-ELKTLKLDNNQLKRVPEGAFDSLEKLKMLQ 211
Query: 328 IANN 331
+ N
Sbjct: 212 LQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 32/138 (23%), Positives = 58/138 (42%), Gaps = 13/138 (9%)
Query: 83 HLRELQLLNLNLSGN----LSPEI-GRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLL 136
L+ L+ L ++ N L + +L L L N++ S+P + ++ L L
Sbjct: 83 ELKNLE--TLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLS 139
Query: 137 LNGNELTGSLPEEL-GYLPKLDRIQIDQNYISGSLPKS-FANLNKTRHFHMNNNSISGQI 194
L NEL SLP+ + L L +++ N + +P+ F L + + ++NN +
Sbjct: 140 LGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVP 197
Query: 195 PPELSRLPSLVHMLLDNN 212
L L + L N
Sbjct: 198 EGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 31/112 (27%), Positives = 53/112 (47%), Gaps = 9/112 (8%)
Query: 275 NLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 334
N +D SS +L +IP + + + L +NKL+ F L +L+ L++ +N L
Sbjct: 17 NKNSVDCSSKKLT-AIPSN-IPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ 74
Query: 335 GSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGNPF 384
++P+ I++ L ET L +N L + G F+ N+ RL N
Sbjct: 75 -TLPAGIFKE--LKNLET--LWVTDNKLQALPIGVFDQLVNLAELRLDRNQL 121
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 58/230 (25%), Positives = 99/230 (43%), Gaps = 39/230 (16%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL----- 685
+G GG G V+ + VA+K+ Q K L EI+ + RL H N+V +
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 686 ---------VGYCDEEGEQMLVYEFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSS 732
VG E +V E+M L L + + +
Sbjct: 79 PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLL-------- 130
Query: 733 RGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSR-LAPVPDIEGIVPAHVST 790
RG+ Y+H+ A+ V HRD+K +N+ ++ + K+ DFGL+R + P +G + +
Sbjct: 131 RGLKYIHS-AN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV- 186
Query: 791 VVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 839
T Y P L+ + T D+++ G +F E+LTG + + G + +
Sbjct: 187 ----TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KTLFAGAHEL 231
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-16
Identities = 65/221 (29%), Positives = 104/221 (47%), Gaps = 30/221 (13%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQE-GSLQGEKEFLTEIQFLSRLHHRNLVSLV--- 686
IG+G YG V + VA+K+ + L EI+ L R H N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 687 --GYCDEEGEQMLVYEFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSSRGILYLHT 740
++ + +V + M L+ Q LS + + L RG+ Y+H+
Sbjct: 95 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI-----L---RGLKYIHS 146
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA-PVPDIEGIVPAHVSTVVKGTPGYL 799
A+ V HRD+K SN+LL+ K+ DFGL+R+A P D G + +V+ T Y
Sbjct: 147 -AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-----TRWYR 198
Query: 800 DPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIV 839
PE L K KS D++S+G + E+L+ +PI GK+ +
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYL 238
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 43/198 (21%), Positives = 75/198 (37%), Gaps = 19/198 (9%)
Query: 186 NNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPA 245
I+ Q+ P L + V L ++T + EL + DN+N ++
Sbjct: 5 RPTPIN-QVFP-DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI--QSLA- 57
Query: 246 SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLS 305
+ L +L L + + + L + L L ++ N+L ++ ++ + L
Sbjct: 58 GMQFFTNLKELHLSHNQISD-LSPLKDLTKLEELSVNRNRLK-NLNGIPS-ACLSRLFLD 114
Query: 306 NNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 365
NN+L T + L L+ L I NN L SI + L +LD N +TN
Sbjct: 115 NNELRDT--DSLIHLKNLEILSIRNNKLK-SI-VMLGFLSKLE-----VLDLHGNEITNT 165
Query: 366 SGSFNIPPNVTVRLRGNP 383
G + + L G
Sbjct: 166 GGLTRLKKVNWIDLTGQK 183
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 9e-13
Identities = 40/246 (16%), Positives = 77/246 (31%), Gaps = 17/246 (6%)
Query: 89 LLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPE 148
+ + P L+ + ++ + + ++ + + + SL
Sbjct: 3 IQRPTPINQVFP-DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-A 57
Query: 149 ELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHML 208
+ + L + + N IS L +L K +N N + + L +
Sbjct: 58 GMQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLK-NLNG--IPSACLSRLF 112
Query: 209 LDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP 268
LDNN L L L L IL + NN +I +SKL L L +
Sbjct: 113 LDNNELRD--TDSLIHLKNLEILSIRNNKL--KSIV-MLGFLSKLEVLDLHGNEITN-TG 166
Query: 269 DLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 328
L+R+ + ++DL+ + + P T + + P S +
Sbjct: 167 GLTRLKKVNWIDLTGQKCV-NEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCV 225
Query: 329 ANNSLS 334
Sbjct: 226 LWELPV 231
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 44/236 (18%), Positives = 74/236 (31%), Gaps = 26/236 (11%)
Query: 88 QLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
+ N N + L+ + + L L N+IS + + ++ LE L +N N L
Sbjct: 42 GVQNFNGDNSNIQSLAG-MQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLK 98
Query: 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPS 203
L R+ +D N + S +L + NN + I L L
Sbjct: 99 NLNGIP---SACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLK-SIVM-LGFLSK 151
Query: 204 LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263
L + L N +T L+ L K+ + L L ++
Sbjct: 152 LEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQK-----CVNEPVKYQPELYITNTVKDP 204
Query: 264 QGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSG 319
G I N G + +P + + + K S G + F G
Sbjct: 205 DGRWISPYYISNGG--SYVDGCVLWELP---VYTDEVSYKFSEYINVGETEAIFDG 255
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 34/146 (23%), Positives = 51/146 (34%), Gaps = 16/146 (10%)
Query: 84 LRELQLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNG 139
+ L L L N + L L IL NK+ SI +G + LE+L L+G
Sbjct: 103 IPSACLSRLFLDNNELRDTDS-LIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHG 159
Query: 140 NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELS 199
NE+T + L L K++ I + K L T + P +S
Sbjct: 160 NEIT-NT-GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS--PYYIS 215
Query: 200 RLPSLVHMLLDNNNLTGYLPPELSEL 225
S + + LP E+
Sbjct: 216 NGGS-----YVDGCVLWELPVYTDEV 236
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 65/233 (27%), Positives = 100/233 (42%), Gaps = 37/233 (15%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLH-HRNLVSL-- 685
+G+G YG V+K I G VVAVK+ + + + EI L+ L H N+V+L
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 686 VGYCDEEGEQMLVYEFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
V D + + LV+++M + +R L K+ + + + + + I YLH+
Sbjct: 77 VLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQL-----I---KVIKYLHS- 127
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD- 800
+ HRD+K SNILL+ + KVADFGLSR
Sbjct: 128 GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 801 -------------PEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIV 839
PE L K D++SLG + E+L G +PI G + +
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPIFPGSSTM 237
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 5e-15
Identities = 66/261 (25%), Positives = 110/261 (42%), Gaps = 54/261 (20%)
Query: 613 SFTYGEMALATNNFNSSTQIGQGGYGKVY---KGILPD-GTVVAVK----------RAQE 658
S G + F +G+GGYGKV+ K + G + A+K
Sbjct: 6 SVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDT 65
Query: 659 GSLQGEKEFLTEIQ--FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKS 715
+ E+ L E++ F+ L Y + G ++ L+ E++S G L QL +
Sbjct: 66 AHTKAERNILEEVKHPFIVDLI---------YAFQTGGKLYLILEYLSGGELFMQLEREG 116
Query: 716 K--EPLG--FAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 771
E + +S+ALG +LH + + +RD+K NI+L+H+ K+ DFGL
Sbjct: 117 IFMEDTACFYLAEISMALG------HLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGL 167
Query: 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQ 830
+ E I V+ GT Y+ PE L +++ D +SLG + ++LTG
Sbjct: 168 CK-------ESIHDGTVTHTFCGTIEYMAPE-ILMRSGHNRAVDWWSLGALMYDMLTGAP 219
Query: 831 PISHG------KNIVREVLPY 845
P + I++ L
Sbjct: 220 PFTGENRKKTIDKILKCKLNL 240
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 8e-15
Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 50/229 (21%)
Query: 624 NNFNSSTQIGQGGYGKV----YKGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 670
N+F+ +G+G +GKV K G A+K + + E L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 671 IQ--FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FAM 723
+ FL+ L Y + +++ V E+ + G L LS + E +
Sbjct: 62 TRHPFLTALK---------YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA 112
Query: 724 RLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783
+ AL YLH+ V +RDIK N++LD K+ DFGL + EGI
Sbjct: 113 EIVSALE------YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK-------EGI 156
Query: 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 831
GTP YL PE L ++ D + LGVV E++ G P
Sbjct: 157 SDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 77.0 bits (189), Expect = 1e-14
Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 51/230 (22%)
Query: 624 NNFNSSTQIGQGGYGKV----YKGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 670
+FN +G+G +GKV KG + AVK EK L
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 397
Query: 671 IQ---FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLS--AKSKEPLG--FA 722
FL++LH C + +++ V E+++ G L + + KEP +A
Sbjct: 398 PGKPPFLTQLH---------SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYA 448
Query: 723 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782
++I L +L ++ + +RD+K N++LD + K+ADFG+ + E
Sbjct: 449 AEIAIGLF------FLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-------EN 492
Query: 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 831
I + GTP Y+ PE + ++ KS D ++ GV+ E+L G P
Sbjct: 493 IWDGVTTKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 58/230 (25%), Positives = 96/230 (41%), Gaps = 51/230 (22%)
Query: 624 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 670
+F+ IG+G Y KV K + A+K +Q EK +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 671 IQ---FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FA 722
FL LH C + ++ V E+++ G L + + K E ++
Sbjct: 66 ASNHPFLVGLH---------SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS 116
Query: 723 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782
+S+AL YLH + +RD+K N+LLD + K+ D+G+ + EG
Sbjct: 117 AEISLALN------YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-------EG 160
Query: 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 831
+ P ++ GTP Y+ PE L + S D ++LGV+ E++ G P
Sbjct: 161 LRPGDTTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 63/237 (26%), Positives = 104/237 (43%), Gaps = 30/237 (12%)
Query: 607 KIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVY---KGILPD-GTVVAVKRAQEGSLQ 662
+I G + F +GQG +GKV+ K D + A+K ++ +L+
Sbjct: 7 EIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK 66
Query: 663 --GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--E 717
E L ++H +V L Y + ++ L+ +F+ G L +LS + E
Sbjct: 67 VRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE 125
Query: 718 PLG--FAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775
+ L++AL +LH+ + +RD+K NILLD + K+ DFGLS+
Sbjct: 126 EDVKFYLAELALALD------HLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-- 174
Query: 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 831
E I + GT Y+ PE + + +S D +S GV+ E+LTG P
Sbjct: 175 -----ESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 61/230 (26%), Positives = 98/230 (42%), Gaps = 51/230 (22%)
Query: 624 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 670
+NF +G+G +GKV K G + AVK EK L+
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 671 IQ---FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FA 722
+ FL++L C + +++ V EF++ G L + + E +A
Sbjct: 80 ARNHPFLTQLF---------CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYA 130
Query: 723 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782
+ AL +LH + + +RD+K N+LLDH+ K+ADFG+ + EG
Sbjct: 131 AEIISALM------FLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK-------EG 174
Query: 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 831
I + GTP Y+ PE L L + D +++GV+ E+L G P
Sbjct: 175 ICNGVTTATFCGTPDYIAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 51/230 (22%)
Query: 624 NNFNSSTQIGQGGYGKV----YKGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 670
+FN +G+G +GKV KG + AVK EK L
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76
Query: 671 IQ---FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FA 722
FL++LH C + +++ V E+++ G L + + EP +A
Sbjct: 77 PGKPPFLTQLH---------SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYA 127
Query: 723 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782
++I L +L ++ + +RD+K N++LD + K+ADFG+ + E
Sbjct: 128 AEIAIGLF------FLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-------EN 171
Query: 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 831
I + GTP Y+ PE + ++ KS D ++ GV+ E+L G P
Sbjct: 172 IWDGVTTKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 57/235 (24%), Positives = 86/235 (36%), Gaps = 41/235 (17%)
Query: 618 EMALATNNFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKE---FLTE 670
E+ L ++F IG+G + +V K G V A+K + + E F E
Sbjct: 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREE 111
Query: 671 IQFLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK---EPLG--FAMR 724
L R + L + ++ + LV E+ G L LS + + +
Sbjct: 112 RDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE 170
Query: 725 LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784
+ +A+ +H HRDIK NILLD ++ADFG +
Sbjct: 171 IVMAID------SVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCL-------KLRA 214
Query: 785 PAHVST-VVKGTPGYLDPEYFLTHKLTDKSDVY-------SLGVVFLELLTGMQP 831
V + V GTP YL PE + Y +LGV E+ G P
Sbjct: 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 58/230 (25%), Positives = 95/230 (41%), Gaps = 51/230 (22%)
Query: 624 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 670
+F+ IG+G Y KV K + A++ +Q EK +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 671 IQ---FLSRLHHRNLVSLVGYCDE-EGEQMLVYEFMSNGTLRDQLSAKSK--EPLG--FA 722
FL LH C + E V E+++ G L + + K E ++
Sbjct: 109 ASNHPFLVGLH---------SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS 159
Query: 723 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782
+S+AL YLH + +RD+K N+LLD + K+ D+G+ + EG
Sbjct: 160 AEISLALN------YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-------EG 203
Query: 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 831
+ P ++ GTP Y+ PE L + S D ++LGV+ E++ G P
Sbjct: 204 LRPGDTTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 47/213 (22%), Positives = 75/213 (35%), Gaps = 54/213 (25%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVG-Y 688
+G G GKV + A+K LQ + E++ R ++V +V Y
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDVY 80
Query: 689 CDEEGEQMLVY---EFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLHTE 741
+ + + E + G L ++ + + F A + ++G I YLH+
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASEIMKSIGE--AIQYLHSI 136
Query: 742 ADPPVFHRDIKASNILLDHKF---TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
+ HRD+K N+L K K+ DFG A Y
Sbjct: 137 N---IAHRDVKPENLLYTSKRPNAILKLTDFG---FAKE-------------TTGE--KY 175
Query: 799 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
D D++SLGV+ LL G P
Sbjct: 176 -DKS----------CDMWSLGVIMYILLCGYPP 197
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 9e-14
Identities = 58/233 (24%), Positives = 89/233 (38%), Gaps = 39/233 (16%)
Query: 618 EMALATNNFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKE---FLTE 670
+M L +F IG+G +G+V K V A+K + + E F E
Sbjct: 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREE 124
Query: 671 IQFLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK---EPLG--FAMR 724
L + + +L Y ++ + LV ++ G L LS E + +
Sbjct: 125 RDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE 183
Query: 725 LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784
+ IA+ +H HRDIK NIL+D ++ADFG + +
Sbjct: 184 MVIAID------SVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCL-------KLME 227
Query: 785 PAHVSTVVK-GTPGYLDPEYFLTHKLTDKS-----DVYSLGVVFLELLTGMQP 831
V + V GTP Y+ PE + D +SLGV E+L G P
Sbjct: 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 1e-13
Identities = 54/230 (23%), Positives = 91/230 (39%), Gaps = 51/230 (22%)
Query: 624 NNFNSSTQIGQGGYGKV----YKGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 670
+F +G+G +GKV +K A+K EK L+
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73
Query: 671 IQ---FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FA 722
FL+ + + E + V E+++ G L + + K +A
Sbjct: 74 AWEHPFLTHMF---------CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYA 124
Query: 723 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782
+ + L +LH++ + +RD+K NILLD K+ADFG+ + E
Sbjct: 125 AEIILGLQ------FLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK-------EN 168
Query: 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 831
++ + GTP Y+ PE L + + S D +S GV+ E+L G P
Sbjct: 169 MLGDAKTNTFCGTPDYIAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 62/230 (26%), Positives = 101/230 (43%), Gaps = 51/230 (22%)
Query: 624 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 670
++F+ IG+G +GKV K + AVK + +E + E+ L +
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK 94
Query: 671 IQ---FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FA 722
FL LH + + +++ V ++++ G L L + EP +A
Sbjct: 95 NVKHPFLVGLH---------FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYA 145
Query: 723 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782
++ ALG YLH+ + +RD+K NILLD + + DFGL + E
Sbjct: 146 AEIASALG------YLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCK-------EN 189
Query: 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 831
I ++ GTP YL PE L + D++ D + LG V E+L G+ P
Sbjct: 190 IEHNSTTSTFCGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 72.9 bits (178), Expect = 2e-13
Identities = 43/286 (15%), Positives = 83/286 (29%), Gaps = 14/286 (4%)
Query: 52 SKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTIL 111
L P + W N L L +
Sbjct: 272 GTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKEC 331
Query: 112 DFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLP 171
+ ++ ++ + L L+ + T L EL +L ++ + + ++
Sbjct: 332 VLLKDRPE-CWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTII 389
Query: 172 KSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLIL 231
L+ + S + R L + + E + +L
Sbjct: 390 LLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDL---RSKFLLENSVLKMEYADVRVL 446
Query: 232 QLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIP 291
L + + T + + + L L + L+ P L+ + L L S N L ++
Sbjct: 447 HLAHKDL--TVLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVD 502
Query: 292 P-GRLSLNITTIKLSNNKLTGTIPS--NFSGLPRLQRLFIANNSLS 334
L + + L NN+L + PRL L + NSL
Sbjct: 503 GVANLP-RLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 69.8 bits (170), Expect = 2e-12
Identities = 49/325 (15%), Positives = 96/325 (29%), Gaps = 24/325 (7%)
Query: 72 CFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKS 131
L + LS S + S + L M ++ S+ + ++
Sbjct: 235 LLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRN 294
Query: 132 LELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYIS--------GSLPKSFANLNKTRHF 183
+ + SL ++L + + A +
Sbjct: 295 RPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRC 354
Query: 184 HMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTI 243
++ + + EL L + +N + + L LL + F
Sbjct: 355 ELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKA 413
Query: 244 PASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIK 303
M LR+ L ++ L L+ L + L +T +
Sbjct: 414 V---DPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCHLEQLLLVTHLD 469
Query: 304 LSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 363
LS+N+L +P + L L+ L ++N+L ++ + L L NN L
Sbjct: 470 LSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQ-----ELLLCNNRLQ 521
Query: 364 NISGSFNIPPN---VTVRLRGNPFC 385
+ + V + L+GN C
Sbjct: 522 QSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 53/220 (24%), Positives = 94/220 (42%), Gaps = 35/220 (15%)
Query: 624 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSR 676
+ F+ +G G +G+V K G A+K + + K+ L E + L
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 677 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLG--FAMRLSIALGSS 732
++ LV L + +V E+++ G + L + EP +A ++ +
Sbjct: 98 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE-- 155
Query: 733 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 792
YLH+ + +RD+K N+L+D + +V DFG ++ V T+
Sbjct: 156 ----YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---------RVKGRTWTLC 199
Query: 793 KGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 831
GTP L PE + K +K+ D ++LGV+ E+ G P
Sbjct: 200 -GTPEALAPE-IILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 5e-13
Identities = 30/159 (18%), Positives = 65/159 (40%), Gaps = 35/159 (22%)
Query: 231 LQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGS 289
L+L+NN F + + +L K++ N + + + L+SN+L +
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-N 95
Query: 290 IPPG---RLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSR 345
+ L ++ T+ L +N++T + ++ F GL ++ L + +N ++ ++
Sbjct: 96 VQHKMFKGLE-SLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAP------ 146
Query: 346 TLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPF 384
F + L ++S T+ L NPF
Sbjct: 147 -----GAF------DTLHSLS---------TLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 35/154 (22%), Positives = 63/154 (40%), Gaps = 18/154 (11%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGY--LPKLDRIQIDQNYISGSLPKSFANLN 178
IP+ I + L LN NE T L + LP+L +I N I+ +F +
Sbjct: 25 KIPEHIP--QYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGAS 81
Query: 179 KTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNN 236
+ +N + + ++ L SL ++L +N +T + + L + +L L +N
Sbjct: 82 GVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDN 139
Query: 237 NFEGTTIPA-SYSNMSKLLKLSLRN------CSL 263
TT+ ++ + L L+L C L
Sbjct: 140 QI--TTVAPGAFDTLHSLSTLNLLANPFNCNCYL 171
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 36/164 (21%), Positives = 61/164 (37%), Gaps = 21/164 (12%)
Query: 62 PCTSNWTGVLCFN---TTMDDG------YLHLRELQLLNLNLSGNLSPEIGRLSYLTILD 112
C T V C N + + L L + L +G +L L ++
Sbjct: 8 KCRCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFK----KLPQLRKIN 63
Query: 113 FMWNKISGSIPKEI-GNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQNYISGSL 170
F NKI+ I + + +LL N L ++ ++ L L + + N I+ +
Sbjct: 64 FSNNKIT-DIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CV 120
Query: 171 PK-SFANLNKTRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNN 212
SF L+ R + +N I+ + P L SL + L N
Sbjct: 121 GNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 8e-13
Identities = 36/160 (22%), Positives = 59/160 (36%), Gaps = 38/160 (23%)
Query: 231 LQLDNNNFEGTTIPASY-SNMSKLLKLSLRNCSLQGPMPDL-SRIPNLGYLDLSSNQLNG 288
++L+ N IP S KL ++ L N + PD + +L L L N++
Sbjct: 37 IRLEQNTI--KVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT- 93
Query: 289 SIPPG---RLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQS 344
+P L ++ + L+ NK+ + + F L L L + +N L +I
Sbjct: 94 ELPKSLFEGLF-SLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAK----- 145
Query: 345 RTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPF 384
TF + L I T+ L NPF
Sbjct: 146 ------GTF------SPLRAIQ---------TMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 5e-12
Identities = 37/157 (23%), Positives = 57/157 (36%), Gaps = 33/157 (21%)
Query: 180 TRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNN 237
+ N+I IPP S L + L NN ++ L P+ L L L L N
Sbjct: 34 ITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNK 91
Query: 238 FEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG---R 294
T +P S + +L L L++N++N +
Sbjct: 92 I--TELPKS----------------------LFEGLFSLQLLLLNANKIN-CLRVDAFQD 126
Query: 295 LSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN 331
L N+ + L +NKL FS L +Q + +A N
Sbjct: 127 LH-NLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 32/134 (23%), Positives = 53/134 (39%), Gaps = 6/134 (4%)
Query: 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQNYIS 167
T + N I P K L + L+ N+++ L + L L+ + + N I+
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 168 GSLPKS-FANLNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPELSEL 225
LPKS F L + +N N I+ + + L +L + L +N L S L
Sbjct: 94 -ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151
Query: 226 PKLLILQLDNNNFE 239
+ + L N F
Sbjct: 152 RAIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 37/156 (23%), Positives = 64/156 (41%), Gaps = 19/156 (12%)
Query: 72 CFNTTMDDGYLHLREL------QLLNLNLSGN----LSPEI-GRLSYLTILDFMWNKISG 120
C N +D L E+ + + L N + P L +D N+IS
Sbjct: 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS- 69
Query: 121 SIPKEI-GNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQNYISGSLPK-SFANL 177
+ + ++SL L+L GN++T LP+ L L L + ++ N I+ L +F +L
Sbjct: 70 ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDL 127
Query: 178 NKTRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNN 212
+ + +N + I S L ++ M L N
Sbjct: 128 HNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 24/84 (28%), Positives = 36/84 (42%), Gaps = 11/84 (13%)
Query: 289 SIPPGRLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSI-WQSRT 346
IP L IT I+L N + IP FS +L+R+ ++NN +S + R+
Sbjct: 25 EIPTN-LPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81
Query: 347 LNATETFILDFQNNNLTNI-SGSF 369
LN L N +T + F
Sbjct: 82 LN-----SLVLYGNKITELPKSLF 100
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 67/284 (23%), Positives = 107/284 (37%), Gaps = 66/284 (23%)
Query: 575 TISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQ 634
+ A+V L A KN + + T KI +R + ++ IG+
Sbjct: 28 GLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLR--------MKAEDYEVVKVIGR 79
Query: 635 GGYGKVY----KGILPDGTVVAVK---------RAQEGSLQGEKEFLTEIQ--FLSRLHH 679
G +G+V K V A+K R+ E++ + ++ +L +
Sbjct: 80 GAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 680 -----RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS-KEPLG--FAMRLSIALGS 731
R L Y +V E+M G L + +S E + + +AL
Sbjct: 137 AFQDDRYL-----Y--------MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALD- 182
Query: 732 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 791
+H+ HRD+K N+LLD K+ADFG + EG+V T
Sbjct: 183 -----AIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM---NKEGMVRCD--TA 229
Query: 792 VKGTPGYLDPEYFLTHKLT---DKS-DVYSLGVVFLELLTGMQP 831
V GTP Y+ PE + + D +S+GV E+L G P
Sbjct: 230 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 35/220 (15%)
Query: 624 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSR 676
+F +G G +G+V+ + +G A+K ++ + K+ E LS
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 677 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLG--FAMRLSIALGSS 732
+ H ++ + G + + ++ +++ G L L + P+ +A + +AL
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE-- 120
Query: 733 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 792
YLH++ + +RD+K NILLD K+ DFG ++ VP T+
Sbjct: 121 ----YLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK---------YVPDVTYTLC 164
Query: 793 KGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 831
GTP Y+ PE ++ K +KS D +S G++ E+L G P
Sbjct: 165 -GTPDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 63/233 (27%), Positives = 95/233 (40%), Gaps = 50/233 (21%)
Query: 624 NNFNSSTQIGQGGYGKVY---KGILPD-GTVVAVK----------RAQEGSLQGEKEFLT 669
NF +G G YGKV+ K D G + A+K + E++ L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 670 EIQ---FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--F 721
I+ FL LH Y + ++ L+ ++++ G L LS + + E +
Sbjct: 114 HIRQSPFLVTLH---------YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY 164
Query: 722 AMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781
+ +AL +LH + +RDIK NILLD + DFGLS+ E
Sbjct: 165 VGEIVLALE------HLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK-------E 208
Query: 782 GIVPAHVSTV-VKGTPGYLDPEYFLTHKL-TDKS-DVYSLGVVFLELLTGMQP 831
+ GT Y+ P+ DK+ D +SLGV+ ELLTG P
Sbjct: 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 67.2 bits (163), Expect = 2e-11
Identities = 96/623 (15%), Positives = 181/623 (29%), Gaps = 185/623 (29%)
Query: 7 AVLFLFLCLCWSSSKIVVAADDDS-------ITDPIEVSALRSIKKSLV-DDYSKLSN-- 56
L LF L ++V ++ + PI+ + S++ Y + +
Sbjct: 63 GTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKT---EQRQPSMMTRMYIEQRDRL 119
Query: 57 WNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPE----IGR--LSYLTI 110
+N +N + YL LR+ LL L + N+ + G+ ++
Sbjct: 120 YNDNQVFAK-------YNVSRLQPYLKLRQA-LLELRPAKNVLIDGVLGSGKTWVALDVC 171
Query: 111 LDFMWNKISGSIPKEI-----GNIKSLELLLLNGNEL--------------TGSLPEELG 151
L + K+ + +I N S E +L +L + ++ +
Sbjct: 172 LSY---KVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIH 228
Query: 152 YL-PKLDRIQIDQNY-----I-----SGSLPKSFAN----LNKTRHFHMNNNSISGQIPP 196
+ +L R+ + Y + + +F L TR ++ +
Sbjct: 229 SIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTR-----FKQVTDFLSA 283
Query: 197 ELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKL 256
+ SL H + P E+ LL+ LD + +P + L
Sbjct: 284 ATTTHISLDHHSM------TLTPDEVKS---LLLKYLDCRPQD---LPREVLTTNPRR-L 330
Query: 257 SLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSN 316
S+ S++ L+ N + ++ ++L T I+ S N L P+
Sbjct: 331 SIIAESIR---DGLATWDN--WKHVNCDKLT------------TIIESSLNVLE---PAE 370
Query: 317 FSGLPRLQRLFIANNSLSGSIPSS----IWQSRTLNATETFILDFQNNNLTNISGSFNIP 372
+ RL + S IP+ IW + + +L P
Sbjct: 371 YR--KMFDRLSVFPPSA--HIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQ-----P 421
Query: 373 PNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDR-STNSTLDCRAQSCPTDYEYSPTSPI 431
T+ + L E H + +D + T D P +Y
Sbjct: 422 KESTISIPSIYLELKVKLENEYALH---RSIVDHYNIPKTFDSDDLIPPYLDQY-----F 473
Query: 432 RCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRW--------- 482
+G+ LK+ LF ++ LD FR+
Sbjct: 474 YSH------IGHHLKNIEHP---ERMTLFRM---------VF-LD---FRFLEQKIRHDS 511
Query: 483 ----EKGP------RLKMYLKLF----PVYDNSSGN--SYVFNASEVGRIRSMFTGWNIP 526
G +LK Y P Y+ ++ E I S
Sbjct: 512 TAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEEN-LICS-------K 563
Query: 527 DSDIFGPYELINFTLQGPYRDVF 549
+D+ + L +F
Sbjct: 564 YTDL------LRIALMAEDEAIF 580
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 64.1 bits (155), Expect = 2e-10
Identities = 77/461 (16%), Positives = 138/461 (29%), Gaps = 126/461 (27%)
Query: 77 MDDGYLHLRELQLLNLN-LSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKS---- 131
MD E Q + LS + + D + +S I K
Sbjct: 7 MD---FETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSG 63
Query: 132 ----LELLLLNGNE-----LTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRH 182
LL E + L +L + I+ +Q S ++
Sbjct: 64 TLRLFWTLLSKQEEMVQKFVEEVLRINYKFL--MSPIKTEQRQPSMMTRMYIEQRDRL-- 119
Query: 183 FHMNNNSISGQIPP-ELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNF--- 238
N+N + +SR +L + L L+L
Sbjct: 120 --YNDNQV---FAKYNVSR------------------LQPYLKLRQAL-LELRPAKNVLI 155
Query: 239 EG------TTIPASYSNMSKLLK--------LSLRNCSLQGPMPDLSRIPNLGYLDLSSN 284
+G T + K+ L+L+NC P L + L + N
Sbjct: 156 DGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNC--NSPETVLEMLQKL-LYQIDPN 212
Query: 285 QLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA---NNSLSGSIPSSI 341
+ S + L I +I+ L+RL + N L + ++
Sbjct: 213 WTSRSDHSSNIKLRIHSIQ-----------------AELRRLLKSKPYENCLL--VLLNV 253
Query: 342 WQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAE-QFCGSHSDD 400
++ NA F + L +T R + L+ H
Sbjct: 254 QNAKAWNA---F--NLSCKIL------------LTTRFKQVTDFLSAATTTHISLDHHSM 296
Query: 401 DNEIDRSTN---STLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYK 457
D + LDCR Q P E T+P R ++ ++ GL+ + +K
Sbjct: 297 TLTPDEVKSLLLKYLDCRPQDLPR--EVLTTNPRRL-----SIIAESIR-DGLATWDNWK 348
Query: 458 NLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKL--FP 496
++ + +T+ ++ +L L+ +R KM+ +L FP
Sbjct: 349 HVNCDKLTTIIESSLNVLEPAEYR-------KMFDRLSVFP 382
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 6e-06
Identities = 34/184 (18%), Positives = 60/184 (32%), Gaps = 52/184 (28%)
Query: 633 GQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 692
G G GK T VA+ +Q + +F +I +L+ + C+
Sbjct: 157 GVLGSGK---------TWVALDVCLSYKVQCKMDF--KIFWLN----------LKNCNSP 195
Query: 693 GE-----QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
Q L+Y+ N T R S+ K +R+ R +L
Sbjct: 196 ETVLEMLQKLLYQIDPNWTSRSDHSSNIK------LRIHSIQAELRRLL----------K 239
Query: 748 HRDIKASNILLDHKFTAKVAD-FGL-------SRLAPVPD-IEGIVPAHVSTVVKGTPGY 798
+ + ++L + AK + F L +R V D + H+S + +
Sbjct: 240 SKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHIS-LDHHSMTL 298
Query: 799 LDPE 802
E
Sbjct: 299 TPDE 302
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 44/162 (27%), Positives = 72/162 (44%), Gaps = 18/162 (11%)
Query: 231 LQLDNNNFEGTTIPAS-YSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNG 288
L L + T+ + + ++KL L+L LQ + LG L L++NQL
Sbjct: 40 LDLQSTGL--ATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA- 96
Query: 289 SIPPG---RLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQS 344
S+P G L+ + + L N+L ++PS F L +L+ L + N L SIP+ +
Sbjct: 97 SLPLGVFDHLT-QLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDK 153
Query: 345 RTLNATETFILDFQNNNLTNIS-GSFNIPPNVT-VRLRGNPF 384
T L N L ++ G+F+ + + L GN F
Sbjct: 154 ----LTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 11/158 (6%)
Query: 180 TRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNNF 238
T + + ++ L L + LD N L L + +L +L L L NN
Sbjct: 37 TEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQL 95
Query: 239 EGTTIPAS-YSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPG--- 293
++P + ++++L KL L L+ P R+ L L L++NQL SIP G
Sbjct: 96 --ASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFD 152
Query: 294 RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN 331
+L+ N+ T+ LS N+L F L +LQ + + N
Sbjct: 153 KLT-NLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 41/154 (26%), Positives = 66/154 (42%), Gaps = 9/154 (5%)
Query: 90 LNLNLSGNLSPEI-GRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGNELTGSLP 147
L LS L+ LT L+ +N++ ++ + ++ L L L N+L SLP
Sbjct: 42 LQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-SLP 99
Query: 148 EEL-GYLPKLDRIQIDQNYISGSLPKS-FANLNKTRHFHMNNNSISGQIPPEL-SRLPSL 204
+ +L +LD++ + N + SLP F L K + +N N + IP +L +L
Sbjct: 100 LGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNL 157
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNF 238
+ L N L L KL + L N F
Sbjct: 158 QTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 34/157 (21%), Positives = 64/157 (40%), Gaps = 11/157 (7%)
Query: 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQNYIS 167
LD ++ + L L L+ N+L +L + L +L + + N ++
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 168 GSLPKS-FANLNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPEL-SE 224
SLP F +L + ++ N + +P + RL L + L+ N L +P +
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDK 153
Query: 225 LPKLLILQLDNNNFEGTTIPA-SYSNMSKLLKLSLRN 260
L L L L N ++P ++ + KL ++L
Sbjct: 154 LTNLQTLSLSTNQL--QSVPHGAFDRLGKLQTITLFG 188
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.0 bits (152), Expect = 1e-10
Identities = 38/217 (17%), Positives = 61/217 (28%), Gaps = 56/217 (25%)
Query: 609 DGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVK--------RAQEGS 660
G F++ L T +IG+G +G+V++ I D T VA+K
Sbjct: 8 KGPVPFSH---CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSH 63
Query: 661 LQGEKEFLTEIQFLSRLH---------HRNLVSLVGYCDEEGE----------------- 694
+ +E L EI L + L +G
Sbjct: 64 QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123
Query: 695 -------------QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+V EF G L + A SI + +
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEAS 180
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778
HRD+ N+LL K+ + + +P
Sbjct: 181 --LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIP 215
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 46/223 (20%), Positives = 85/223 (38%), Gaps = 44/223 (19%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLH---------- 678
+G G + V+ + + T VA+K R + + EI+ L R++
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 679 -HRNLVSLVG---YCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGS 731
+++ L+ + G + +V+E + L + K E G + I+
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALI--KKYEHRGIPLIYVKQISKQL 140
Query: 732 SRGILYLHTEADPPVFHRDIKASNILLDH------KFTAKVADFGLSRLAPVPDIEGIVP 785
G+ Y+H + H DIK N+L++ K+AD G +
Sbjct: 141 LLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW---------YD 189
Query: 786 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG 828
H + ++ T Y PE L +D++S + EL+TG
Sbjct: 190 EHYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 59.8 bits (144), Expect = 1e-09
Identities = 26/170 (15%), Positives = 46/170 (27%), Gaps = 23/170 (13%)
Query: 268 PDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGTIPSN-FSGLPRLQ 324
L NL L + + Q + L + + + + L + + F PRL
Sbjct: 25 HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLS 83
Query: 325 RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT-------------NISGSFNI 371
RL ++ N+L S+ Q +L L N L G
Sbjct: 84 RLNLSFNALE-SLSWKTVQGLSLQ-----ELVLSGNPLHCSCALRWLQRWEEEGLGGVPE 137
Query: 372 PPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPT 421
N + + +D + L C+ +
Sbjct: 138 QKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGL 187
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 1e-07
Identities = 18/105 (17%), Positives = 40/105 (38%), Gaps = 6/105 (5%)
Query: 185 MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFEGTTI 243
+ ++ L +L + ++N +L L L +L L + + +
Sbjct: 16 TRDGALD--SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL--RFV 71
Query: 244 PA-SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLN 287
++ +L +L+L +L+ + +L L LS N L+
Sbjct: 72 APDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 17/96 (17%), Positives = 39/96 (40%), Gaps = 2/96 (2%)
Query: 121 SIPKEIGNIKSL-ELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNK 179
+ ++L EL + N L +L L +L + I ++ + P +F +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 180 TRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT 215
+++ N++ + + + SL ++L N L
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.0 bits (116), Expect = 3e-06
Identities = 23/113 (20%), Positives = 39/113 (34%), Gaps = 11/113 (9%)
Query: 61 DPCTSNW-TGVLCFNTTMDD------GYLHLRELQLLNLNLSGNLSPE-IGRLSYLTILD 112
D C + +G+ C D G +L EL + N +L + L L L
Sbjct: 3 DACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLT 62
Query: 113 FMWNKISGSIPKEI-GNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164
+ + + + + L L L+ N L SL + L + + N
Sbjct: 63 IVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGN 113
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 3e-09
Identities = 49/320 (15%), Positives = 100/320 (31%), Gaps = 55/320 (17%)
Query: 83 HLRELQLLNLNLS----GNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNI-----KSLE 133
+ ++L + L+ ++S + L L+ N++ + ++
Sbjct: 29 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQ 88
Query: 134 LLLLNGNELT----GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNS 189
L L LT G L L LP L + + N + + +
Sbjct: 89 KLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQ------- 141
Query: 190 ISGQIPPELSRLPSLVHMLLDNNNLT----GYLPPELSELPKLLILQLDNNNFEGTTI-- 243
L + L+ +L+ L L P L + NN+ +
Sbjct: 142 ------------CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRV 189
Query: 244 --PASYSNMSKLLKLSLRNCSL-----QGPMPDLSRIPNLGYLDLSSNQLNGS----IPP 292
+ +L L L +C + + ++ +L L L SN+L + P
Sbjct: 190 LCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCP 249
Query: 293 GRLSLN--ITTIKLSNNKLT----GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRT 346
G L + + T+ + +T G + L+ L +A N L + ++
Sbjct: 250 GLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLL 309
Query: 347 LNATETFILDFQNNNLTNIS 366
+ L ++ + T
Sbjct: 310 EPGCQLESLWVKSCSFTAAC 329
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 5e-08
Identities = 48/290 (16%), Positives = 94/290 (32%), Gaps = 49/290 (16%)
Query: 108 LTILDFMWNKISGSIPKEIG-NIKSLELLLLNGNELT----GSLPEELGYLPKLDRIQID 162
+ LD ++S + E+ ++ +++ L+ LT + L P L + +
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 163 QNYISGSLPKSFANLNKTRHFH-----MNNNSISGQ----IPPELSRLPSLVHMLLDNNN 213
N + +T + N ++G + L LP+L + L +N
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124
Query: 214 LTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL-----QGPMP 268
L + L L LD +L KL L CSL +
Sbjct: 125 LGD------AGLQLLCEGLLDPQ--------------CRLEKLQLEYCSLSAASCEPLAS 164
Query: 269 DLSRIPNLGYLDLSSNQLNGS----IPPG--RLSLNITTIKLSNNKLT----GTIPSNFS 318
L P+ L +S+N +N + + G + +KL + +T + +
Sbjct: 165 VLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVA 224
Query: 319 GLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS 368
L+ L + +N L + + ++ L +T
Sbjct: 225 SKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCG 274
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 5e-04
Identities = 49/273 (17%), Positives = 85/273 (31%), Gaps = 48/273 (17%)
Query: 61 DPCTSNWTGVLCFNTTMDDGYLHLREL-----QLLNLNLSGN-LSPEIGRL--------- 105
DP L + + L + L +S N ++ R+
Sbjct: 139 DPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSP 198
Query: 106 SYLTILDFMWNKISGSIPKEIGNI----KSLELLLLNGNELTGS-----LPEELGYLPKL 156
L L ++ +++ I SL L L N+L P L +L
Sbjct: 199 CQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRL 258
Query: 157 DRIQIDQNYIS----GSLPKSFANLNKTRHFHMNNNSISGQIPPELSRL-----PSLVHM 207
+ I + I+ G L + + + N + + L L +
Sbjct: 259 RTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESL 318
Query: 208 LLDNNNLTG----YLPPELSELPKLLILQLDNNNFEGTTIP----ASYSNMSKLLKLSLR 259
+ + + T + L++ LL LQ+ NN E + S L L L
Sbjct: 319 WVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLA 378
Query: 260 NCSL--QGPMPDLSRI----PNLGYLDLSSNQL 286
+C + L+ +L LDLS+N L
Sbjct: 379 DCDVSDSS-CSSLAATLLANHSLRELDLSNNCL 410
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 8e-09
Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 21/218 (9%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
P + L +T + L +D+I + + I S+ L
Sbjct: 12 IFPDDAFA--ETIKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIK-SVQ-GIQYLPNV 65
Query: 181 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNNFE 239
R+ + N + L L +L +++L N L LP + +L L L L N
Sbjct: 66 RYLALGGNKL--HDISALKELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQL- 121
Query: 240 GTTIPAS-YSNMSKLLKLSLRNCSLQGPMPDL-SRIPNLGYLDLSSNQLNGSIPPG---R 294
++P + ++ L L+L + LQ + ++ NL LDLS NQL S+P G +
Sbjct: 122 -QSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDK 179
Query: 295 LSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANN 331
L+ + ++L N+L ++P F L LQ +++ +N
Sbjct: 180 LT-QLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 32/147 (21%), Positives = 64/147 (43%), Gaps = 20/147 (13%)
Query: 231 LQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSI 290
L + T + ++ + ++ N ++ + + +PN+ YL L N+L+ I
Sbjct: 24 ANLKKKSV--TDAVT-QNELNSIDQIIANNSDIKS-VQGIQYLPNVRYLALGGNKLH-DI 78
Query: 291 PP-GRLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLN 348
L+ N+T + L+ N+L ++P+ F L L+ L + N L S+P ++
Sbjct: 79 SALKELT-NLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDK---- 131
Query: 349 ATETFILDFQNNNLTNISGSFNIPPNV 375
T L+ +N L ++P V
Sbjct: 132 LTNLTYLNLAHNQLQ------SLPKGV 152
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-08
Identities = 35/161 (21%), Positives = 59/161 (36%), Gaps = 21/161 (13%)
Query: 125 EIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFH 184
E+G LEL +++ +EL LD + ++ + G +
Sbjct: 2 EMGRRIHLELRNRTPSDV-----KEL----VLDNSRSNEGKLEGLT----DEFEELEFLS 48
Query: 185 MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP 244
N ++ I L +L L + L +N ++G L + P L L L N + +
Sbjct: 49 TINVGLT-SIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTI 106
Query: 245 ASYSNMSKLLKLSLRNCSLQGPMPD-----LSRIPNLGYLD 280
+ L L L NC + + D +P L YLD
Sbjct: 107 EPLKKLENLKSLDLFNCEVTN-LNDYRENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 5e-06
Identities = 34/142 (23%), Positives = 56/142 (39%), Gaps = 11/142 (7%)
Query: 98 LSPEIGRLSYLTILDFMWNKISGSIPKEIGNI---KSLELLLLNGNELTGSLPEELGYLP 154
+ E+ + + + + + + K G + LE L LT S+ L L
Sbjct: 7 IHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLN 64
Query: 155 KLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSIS--GQIPPELSRLPSLVHMLLDNN 212
KL ++++ N +SG L H +++ N I I P L +L +L + L N
Sbjct: 65 KLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP-LKKLENLKSLDLFNC 123
Query: 213 ---NLTGYLPPELSELPKLLIL 231
NL Y LP+L L
Sbjct: 124 EVTNLNDYRENVFKLLPQLTYL 145
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 17/88 (19%), Positives = 32/88 (36%), Gaps = 3/88 (3%)
Query: 249 NMSKLLKLSLRNCSLQGP--MPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSN 306
S + +L L N L +L + L SI + ++LS+
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIANLPKLNKLKKLELSD 73
Query: 307 NKLTGTIPSNFSGLPRLQRLFIANNSLS 334
N+++G + P L L ++ N +
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 25/146 (17%), Positives = 54/146 (36%), Gaps = 22/146 (15%)
Query: 249 NMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSN 306
M + + L LRN + ++ L L +++ N G + + N
Sbjct: 2 EMGRRIHLELRNRTPS----------DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTIN 51
Query: 307 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 366
LT +I +N L +L++L +++N +SG + + L L+ N + ++S
Sbjct: 52 VGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLT-----HLNLSGNKIKDLS 104
Query: 367 GSFNIPPN---VTVRLRGNPFCLNTN 389
+ ++ L +
Sbjct: 105 TIEPLKKLENLKSLDLFNCEVTNLND 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 3e-08
Identities = 42/167 (25%), Positives = 60/167 (35%), Gaps = 21/167 (12%)
Query: 119 SGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLN 178
SGS ++ LEL + EL LD + + I G L F NL
Sbjct: 3 SGSSGMDMKRRIHLELRNRTPAAVR-----EL----VLDNCKSNDGKIEG-LTAEFVNL- 51
Query: 179 KTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNF 238
+ N + + L +LP L + L N + G L +LP L L L N
Sbjct: 52 --EFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKL 107
Query: 239 EGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-----LSRIPNLGYLD 280
+ + + L L L NC + + D +P L YLD
Sbjct: 108 KDISTLEPLKKLECLKSLDLFNCEVTN-LNDYRESVFKLLPQLTYLD 153
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 21/111 (18%), Positives = 40/111 (36%), Gaps = 11/111 (9%)
Query: 224 ELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSS 283
++ + + L+L N + L L + + NL +L L +
Sbjct: 9 DMKRRIHLELRNRTPAAV----------RELVLDNCKSNDGKIEGLTAEFVNLEFLSLIN 58
Query: 284 NQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 334
L S+ + ++LS N++ G + LP L L ++ N L
Sbjct: 59 VGLI-SVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 28/142 (19%), Positives = 53/142 (37%), Gaps = 22/142 (15%)
Query: 249 NMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSN 306
+M + + L LRN + + L L + + N G + N+ + L N
Sbjct: 9 DMKRRIHLELRNRTPA----------AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLIN 58
Query: 307 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 366
L ++ SN LP+L++L ++ N + G + + L L+ N L +IS
Sbjct: 59 VGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLT-----HLNLSGNKLKDIS 111
Query: 367 GSFNIPPN---VTVRLRGNPFC 385
+ ++ L
Sbjct: 112 TLEPLKKLECLKSLDLFNCEVT 133
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 34/115 (29%), Positives = 50/115 (43%), Gaps = 13/115 (11%)
Query: 230 ILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG-P--MPDLSRIPNLGYLDLSSNQL 286
IL L +N P + ++ L +L L + L P + D + L LDL +NQL
Sbjct: 44 ILYLHDNQIT-KLEPGVFDSLINLKELYLGSNQLGALPVGVFD--SLTQLTVLDLGTNQL 100
Query: 287 NGSIPPG---RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 338
+P RL ++ + + NKLT +P L L L + N L SIP
Sbjct: 101 T-VLPSAVFDRLV-HLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIP 151
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 35/146 (23%), Positives = 56/146 (38%), Gaps = 12/146 (8%)
Query: 189 SISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPAS-Y 247
S+ IP L L +N +T P L L L L +N +P +
Sbjct: 33 SVPAGIPTNAQIL------YLHDNQITKLEPGVFDSLINLKELYLGSNQL--GALPVGVF 84
Query: 248 SNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLS 305
++++L L L L P R+ +L L + N+L +P G L ++T + L
Sbjct: 85 DSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALD 143
Query: 306 NNKLTGTIPSNFSGLPRLQRLFIANN 331
N+L F L L ++ N
Sbjct: 144 QNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 37/133 (27%), Positives = 62/133 (46%), Gaps = 10/133 (7%)
Query: 180 TRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNNF 238
+ ++++N I+ P L +L + L +N L LP + L +L +L L N
Sbjct: 42 AQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQL 100
Query: 239 EGTTIPAS-YSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG---R 294
T +P++ + + L +L + L + R+ +L +L L NQL SIP G R
Sbjct: 101 --TVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQLK-SIPHGAFDR 157
Query: 295 LSLNITTIKLSNN 307
LS ++T L N
Sbjct: 158 LS-SLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 34/130 (26%), Positives = 55/130 (42%), Gaps = 5/130 (3%)
Query: 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQNYIS 167
IL N+I+ P ++ +L+ L L N+L +LP + L +L + + N ++
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 168 GSLPKS-FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELP 226
LP + F L + M N ++ +P + RL L H+ LD N L L
Sbjct: 102 -VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLS 159
Query: 227 KLLILQLDNN 236
L L N
Sbjct: 160 SLTHAYLFGN 169
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 49/233 (21%), Positives = 89/233 (38%), Gaps = 46/233 (19%)
Query: 631 QIGQGGYGKVYKGI---------LPDGTVVAVKR-AQEGSLQGEKEFLT------EIQFL 674
+ G +Y+ P ++K A++G L E+ F ++
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 675 SRLHHRNLV---SLVGYCDEEGE-QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 730
+L+ L+ + +G+ + + + LV + +L+ L K L L +A
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQVACR 167
Query: 731 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV--ADFGLS-RLAP----VPDIEGI 783
+ +LH H ++ A NI +D + ++V A +G + R P V +EG
Sbjct: 168 LLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGS 224
Query: 784 VPAHVSTVVKGTPGY--LDPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQP 831
H G + +D HK + +SD+ SLG L+ L G P
Sbjct: 225 RSPHE-----GDLEFISMD-----LHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 4e-08
Identities = 24/88 (27%), Positives = 43/88 (48%), Gaps = 8/88 (9%)
Query: 255 KLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSNNKLTG 311
+L L +LS +L +DLS+N+++ ++ ++ + T+ LS N+L
Sbjct: 35 ELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMT-QLLTLILSYNRLR- 91
Query: 312 TIPSN-FSGLPRLQRLFIANNSLSGSIP 338
IP F GL L+ L + N +S +P
Sbjct: 92 CIPPRTFDGLKSLRLLSLHGNDIS-VVP 118
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 5e-05
Identities = 32/121 (26%), Positives = 58/121 (47%), Gaps = 16/121 (13%)
Query: 271 SRIP-NLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGTIPSN-FSGLPRLQRL 326
IP ++ L L NQ ++ P LS ++T I LSNN+++ T+ + FS + +L L
Sbjct: 27 KGIPRDVTELYLDGNQF--TLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTL 83
Query: 327 FIANNSLSGSIPSSIWQSRT-LNATETFILDFQNNNLTNI-SGSFNIPPNVT-VRLRGNP 383
++ N L IP + L +L N+++ + G+FN ++ + + NP
Sbjct: 84 ILSYNRLR-CIPPRTFDGLKSLR-----LLSLHGNDISVVPEGAFNDLSALSHLAIGANP 137
Query: 384 F 384
Sbjct: 138 L 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 33/140 (23%), Positives = 57/140 (40%), Gaps = 25/140 (17%)
Query: 63 CTSNWTGVLCFN-----------TTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTIL 111
CT T V C N + + YL + L+ E+ +LT++
Sbjct: 8 CTCLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFTLV--------PKELSNYKHLTLI 59
Query: 112 DFMWNKISGSIPKEI-GNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQNYISGS 169
D N+IS ++ + N+ L L+L+ N L +P L L + + N IS
Sbjct: 60 DLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-V 116
Query: 170 LPK-SFANLNKTRHFHMNNN 188
+P+ +F +L+ H + N
Sbjct: 117 VPEGAFNDLSALSHLAIGAN 136
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 51/218 (23%), Positives = 90/218 (41%), Gaps = 29/218 (13%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK--RAQEG-SLQGEKEFLTEIQFLSRLHHR------N 681
IG+G +G+V K + VA+K + ++ Q E++ L ++
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMKYY 117
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+V L + LV+E +S L D L + + + A +L+L T
Sbjct: 118 IVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP 176
Query: 742 ADPPVFHRDIKASNILLDH--KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
+ + H D+K NILL + + K+ DFG S + + ++ + Y
Sbjct: 177 -ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC---------QLGQRIYQYIQ-SRFYR 225
Query: 800 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
PE L D++SLG + +E+ TG +P+ G N
Sbjct: 226 SPEVLLGMPYDLAIDMWSLGCILVEMHTG-EPLFSGAN 262
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 8e-08
Identities = 28/154 (18%), Positives = 59/154 (38%), Gaps = 7/154 (4%)
Query: 221 ELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLD 280
+ + ++L + A+ S + L+L +++ + LS + NL L
Sbjct: 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISSLSGMENLRILS 76
Query: 281 LSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSS 340
L N + ++ + + +S N++ ++ S L L+ L+++NN ++
Sbjct: 77 LGRNLIKKIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITN--WGE 132
Query: 341 IWQSRTLNATETFILDFQNNNLTNISGSFNIPPN 374
I + L+ E L N L N N
Sbjct: 133 IDKLAALDKLED--LLLAGNPLYNDYKENNATSE 164
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 5e-07
Identities = 26/127 (20%), Positives = 53/127 (41%), Gaps = 7/127 (5%)
Query: 111 LDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSL 170
L M I + + +K+ + L L+ N + + L + L + + +N I +
Sbjct: 30 LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KI 85
Query: 171 PKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLL 229
A + ++ N I+ + + +L +L + + NN +T + + L+ L KL
Sbjct: 86 ENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLE 143
Query: 230 ILQLDNN 236
L L N
Sbjct: 144 DLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 7e-07
Identities = 37/161 (22%), Positives = 58/161 (36%), Gaps = 30/161 (18%)
Query: 184 HMNNNSISGQIPPELSRLPSLVHMLLDNNNLT---GYLPPELSELPKLLILQLDNNNFEG 240
H I + LS L + H+ L NN+ LS + L IL L N
Sbjct: 31 HGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISS-----LSGMENLRILSLGRNLI-- 82
Query: 241 TTIPASYSNMSKLLKLSLRN---CSLQGPMPDLSRIPNLGYLDLSSNQLN--GSIPPGRL 295
I + L +L + SL G + ++ NL L +S+N++ G I
Sbjct: 83 KKIENLDAVADTLEELWISYNQIASLSG----IEKLVNLRVLYMSNNKITNWGEIDKLAA 138
Query: 296 SLNITTIKLSNNKLTGTIPSNFSG----------LPRLQRL 326
+ + L+ N L N + LP L++L
Sbjct: 139 LDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 36/166 (21%), Positives = 59/166 (35%), Gaps = 22/166 (13%)
Query: 82 LHLRELQLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLL 137
+ E + + L+ + + L L N I I + +++L +L L
Sbjct: 20 VVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSL 77
Query: 138 NGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSIS--GQIP 195
N + + L+ + I N I+ SL L R +M+NN I+ G+I
Sbjct: 78 GRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEID 134
Query: 196 PELSRLPSLVHMLLDNNNLTGYLPPE----------LSELPKLLIL 231
L+ L L +LL N L + LP L L
Sbjct: 135 K-LAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 56/220 (25%), Positives = 91/220 (41%), Gaps = 35/220 (15%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSL-QGEKEFLTEIQFLSRLHHR------N 681
IG+G +G+V K VA+K R ++ Q EI+ L L + N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDNTMN 160
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGSSRGILYLH 739
++ ++ + +E +S L + + K + GF++ L A + + LH
Sbjct: 161 VIHMLENFTFRNHICMTFELLSM-NLYELI--KKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 740 TEADPPVFHRDIKASNILLDH--KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG 797
+ H D+K NILL + KV DFG S V T ++ +
Sbjct: 218 ---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC---------YEHQRVYTYIQ-SRF 264
Query: 798 YLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
Y PE L + D++SLG + ELLTG P+ G++
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTG-YPLLPGED 303
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 51/213 (23%), Positives = 86/213 (40%), Gaps = 26/213 (12%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
+IG G +G +Y G + G VA+K E + E + + + + +C
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIK--LECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 73
Query: 690 DEEGE-QMLVYEFM--SNGTLRDQLSAKSKEPLGFAMR--LSIALGSSRGILYLHTEADP 744
EG+ ++V E + S L + S K F+++ L +A I Y+H++
Sbjct: 74 GAEGDYNVMVMELLGPSLEDLFNFCSRK------FSLKTVLLLADQMISRIEYIHSKN-- 125
Query: 745 PVFHRDIKASNILLDHKFTAK---VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
HRD+K N L+ + DFGL++ +P + + GT Y
Sbjct: 126 -FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 184
Query: 802 EYFLTHKLTDKS---DVYSLGVVFLELLTGMQP 831
TH ++S D+ SLG V + G P
Sbjct: 185 N---THLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 47/233 (20%), Positives = 81/233 (34%), Gaps = 46/233 (19%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVK--------RAQEGSLQGEKEFLTEIQ---FLSRLHH 679
IGQGG+G +Y + V + G L E +F + +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 680 RNLVSLVG-----YCDEEGEQMLVYEFM-------SNGTLRDQLSAKSKEPLGFAMR--L 725
+ +G + Y FM + + + + F+ + L
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKR------FSRKTVL 155
Query: 726 SIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV--ADFGLSRLAPVPDIEGI 783
++L + Y+H H DIKASN+LL++K +V D+GL+ +
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212
Query: 784 VPAHVSTVVKGTPGY--LDPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQP 831
A GT + +D H + + D+ LG ++ LTG P
Sbjct: 213 YAADPKRCHDGTIEFTSID-----AHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 51/209 (24%), Positives = 84/209 (40%), Gaps = 18/209 (8%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
+IG G +G++Y G + VA+K E + L E + L + V +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLLYESKIYRILQGGTGIPNVRWF 71
Query: 690 DEEGE-QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 748
EG+ +LV + + G + L L L +A + ++H+++ H
Sbjct: 72 GVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLH 126
Query: 749 RDIKASNILLDHKFTAK---VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
RDIK N L+ A + DFGL++ +P + + GT Y
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS---VN 183
Query: 806 THKLTDKS---DVYSLGVVFLELLTGMQP 831
TH ++S D+ SLG V + L G P
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 28/215 (13%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
+IG+G +G +++G L + VA+K E + E + L + V Y
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIK--FEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 690 DEEGE-QMLVYEFM--SNGTLRDQLSAKSKEPLGFAMR--LSIALGSSRGILYLHTEADP 744
+EG +LV + + S L D K F+++ A + +H ++
Sbjct: 75 GQEGLHNVLVIDLLGPSLEDLLDLCGRK------FSVKTVAMAAKQMLARVQSIHEKS-- 126
Query: 745 PVFHRDIKASNILLDHKFTAK-----VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
+ +RDIK N L+ + V DFG+ + P + +P + GT Y+
Sbjct: 127 -LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 185
Query: 800 DPEYFLTHKLTDKS---DVYSLGVVFLELLTGMQP 831
TH ++S D+ +LG VF+ L G P
Sbjct: 186 SIN---THLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 25/106 (23%), Positives = 47/106 (44%), Gaps = 6/106 (5%)
Query: 230 ILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDL-SRIPNLGYLDLSSNQLNG 288
L L++N + + + L+KL L+ L G P+ ++ L L N++
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK- 91
Query: 289 SIPPG---RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN 331
I L + T+ L +N+++ +P +F L L L +A+N
Sbjct: 92 EISNKMFLGLH-QLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 32/135 (23%), Positives = 57/135 (42%), Gaps = 20/135 (14%)
Query: 260 NCSLQGPMPDLSRIP-----NLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGT 312
+C+ +G L IP + L L+ N+L G ++ ++L N+LT
Sbjct: 14 DCTGRG----LKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-G 68
Query: 313 IPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GSFN 370
I N F G +Q L + N + I + ++ L+ +N ++ + GSF
Sbjct: 69 IEPNAFEGASHIQELQLGENKIK-EISNKMFLGLH-QLKT---LNLYDNQISCVMPGSFE 123
Query: 371 IPPNVT-VRLRGNPF 384
++T + L NPF
Sbjct: 124 HLNSLTSLNLASNPF 138
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 21/140 (15%), Positives = 45/140 (32%), Gaps = 13/140 (9%)
Query: 148 EELGYLPKLDRIQIDQNYIS--GSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLV 205
+ + + + I +L + ++N I ++ L L
Sbjct: 13 AQYTNAVRDRELDLRGYKIPVIENLGATLDQF---DAIDFSDNEIR-KLDG-FPLLRRLK 67
Query: 206 HMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG 265
+L++NN + LP L L L NN+ +++ L L + +
Sbjct: 68 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN 127
Query: 266 PMPD-----LSRIPNLGYLD 280
+ ++P + LD
Sbjct: 128 -KKHYRLYVIYKVPQVRVLD 146
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 21/90 (23%), Positives = 38/90 (42%), Gaps = 1/90 (1%)
Query: 245 ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKL 304
A Y+N + +L LR + + + +D S N++ + L + T+ +
Sbjct: 13 AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLV 71
Query: 305 SNNKLTGTIPSNFSGLPRLQRLFIANNSLS 334
+NN++ LP L L + NNSL
Sbjct: 72 NNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 30/163 (18%), Positives = 57/163 (34%), Gaps = 40/163 (24%)
Query: 79 DGYLHLRELQLLNLNLSGNLSPEI----GRLSYLTILDFMWNKISGSIPKEIGNI---KS 131
Y + + L+L G P I L +DF N+I +++ +
Sbjct: 13 AQYTNAVRDR--ELDLRGYKIPVIENLGATLDQFDAIDFSDNEI-----RKLDGFPLLRR 65
Query: 132 LELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSIS 191
L+ LL+N N + LP L + + N + +L+
Sbjct: 66 LKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-----ELGDLDP------------ 108
Query: 192 GQIPPELSRLPSLVHMLLDNN---NLTGYLPPELSELPKLLIL 231
L+ L SL ++ + N N Y + ++P++ +L
Sbjct: 109 ------LASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVL 145
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 53/229 (23%), Positives = 80/229 (34%), Gaps = 41/229 (17%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVA-----VKRAQEGSLQGEKEFLTEIQ---FLSRLHHRN 681
+IG GG+G +Y A V+ + G L E +F + + + R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 682 LVSLVG-----YCDEEGEQMLVYEFM-------SNGTLRDQLSAKSKEPLGFAMRLSIAL 729
+ +G + Y FM L+ ++L I +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID---LQKISGQNGTFKKSTVLQLGIRM 160
Query: 730 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV--ADFGLSRLAPVPDIEGIVPAH 787
+ Y+H H DIKA+N+LL +K +V AD+GLS +
Sbjct: 161 LDV--LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQEN 215
Query: 788 VSTVVKGTPGY--LDPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQP 831
GT + LD HK L+ +SDV LG L L G P
Sbjct: 216 PRKGHNGTIEFTSLD-----AHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 9e-06
Identities = 47/261 (18%), Positives = 80/261 (30%), Gaps = 80/261 (30%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRL-----HHRNLV 683
+G G + V+ + VA+K ++ E + + EI+ L + + N
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD---EIRLLKSVRNSDPNDPNRE 101
Query: 684 SLVGYCDE------EGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 736
+V D+ G + +V+E + + L + + + L I +G+
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLD 160
Query: 737 YLHTEADPPVFHRDIKASNILL-------------------------------------- 758
YLHT+ + H DIK NILL
Sbjct: 161 YLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 759 -----------DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
K K+AD G + E I Y E +
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ----------YRSLEVLIGS 268
Query: 808 KLTDKSDVYSLGVVFLELLTG 828
+D++S + EL TG
Sbjct: 269 GYNTPADIWSTACMAFELATG 289
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 47.6 bits (112), Expect = 1e-05
Identities = 31/175 (17%), Positives = 59/175 (33%), Gaps = 16/175 (9%)
Query: 192 GQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASY-SNM 250
+ P L +P L ++ + N L L I+ + I S N+
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNL 221
Query: 251 SKL-LKLSLRNCSLQGPMPDLS------RIPNLGYLDLSSNQLNGSIPPGRLSL----NI 299
KL L + + + G M R PNL +L + + + L +
Sbjct: 222 EKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQL 281
Query: 300 TTIKLSNNKLTGT----IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNAT 350
T+ +S LT + + + L+ + + N LS + + +S +
Sbjct: 282 ETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKID 336
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 44.2 bits (103), Expect = 1e-04
Identities = 23/161 (14%), Positives = 53/161 (32%), Gaps = 21/161 (13%)
Query: 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL--SRL 201
L L +P L+ ++I K NL + + + + + ++ S L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNL---KSLEIISGGLPDSVVEDILGSDL 218
Query: 202 PSLVHMLLD---NNNLTGYLPPELSEL------PKLLILQLDNNNF--EGTTIPASYSNM 250
P+L ++L + L P L L + + + +
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 251 SKLLKLSLRNCSLQGP-----MPDLSRIPNLGYLDLSSNQL 286
+L + + L + + +I +L ++++ N L
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 24/68 (35%), Positives = 37/68 (54%), Gaps = 8/68 (11%)
Query: 275 NLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIAN 330
L L LS NQ+ S+P G +L+ +T + L NKL ++P+ F L +L+ L +
Sbjct: 53 QLTKLSLSQNQIQ-SLPDGVFDKLT-KLTILYLHENKLQ-SLPNGVFDKLTQLKELALDT 109
Query: 331 NSLSGSIP 338
N L S+P
Sbjct: 110 NQLK-SVP 116
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 7e-05
Identities = 28/107 (26%), Positives = 51/107 (47%), Gaps = 9/107 (8%)
Query: 230 ILQLDNNNFEGTTIPAS-YSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLN 287
L+L++N ++P + +++L KLSL +Q P ++ L L L N+L
Sbjct: 32 RLELESNKL--QSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ 89
Query: 288 GSIPPG---RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN 331
S+P G +L+ + + L N+L F L LQ++++ N
Sbjct: 90 -SLPNGVFDKLT-QLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 8e-04
Identities = 30/104 (28%), Positives = 46/104 (44%), Gaps = 9/104 (8%)
Query: 209 LDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPAS-YSNMSKLLKLSLRNCSLQG-P 266
L++N L +L +L L L N ++P + ++KL L L LQ P
Sbjct: 35 LESNKLQSLPHGVFDKLTQLTKLSLSQNQI--QSLPDGVFDKLTKLTILYLHENKLQSLP 92
Query: 267 MPDLSRIPNLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSNN 307
++ L L L +NQL S+P G RL+ ++ I L N
Sbjct: 93 NGVFDKLTQLKELALDTNQLK-SVPDGIFDRLT-SLQKIWLHTN 134
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 37/149 (24%), Positives = 64/149 (42%), Gaps = 13/149 (8%)
Query: 241 TTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG---RLSL 297
T++P + L L N P + +L L L N+L S+P G +L+
Sbjct: 20 TSVPTGIPAQTTYLDLE-TNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLT- 76
Query: 298 NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDF 357
++T + LS N+L F L +L+ L + N L S+P ++ T+ L
Sbjct: 77 SLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFD----KLTQLKDLRL 131
Query: 358 QNNNLTNI-SGSFNIPPNVT-VRLRGNPF 384
N L ++ G F+ ++ + L NP+
Sbjct: 132 YQNQLKSVPDGVFDRLTSLQYIWLHDNPW 160
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 37/161 (22%), Positives = 65/161 (40%), Gaps = 22/161 (13%)
Query: 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL 682
NF +IG G +G++ G L VA+K E + E +F +L +
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDG 66
Query: 683 VSLVGYCDEEGE-QMLVYEFM--SNGTLRDQLSAKSKEPLGFAMR--LSIALGSSRGILY 737
+ V Y G+ +V E + S L D F+++ L IA+ + Y
Sbjct: 67 IPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRT------FSLKTVLMIAIQLISRMEY 120
Query: 738 LHTEADPPVFHRDIKASNILLDHKFTAK-----VADFGLSR 773
+H++ + +RD+K N L+ + DF L++
Sbjct: 121 VHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 7e-05
Identities = 45/340 (13%), Positives = 91/340 (26%), Gaps = 92/340 (27%)
Query: 89 LLNLNLSGN---------LSPEIGRLSYLTILDFMWNKISG----SIPKEIGNIKSLELL 135
+ +L + + + + + N I + + I + K LE+
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 136 LLNGNEL----------TGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANL---NKT-R 181
+ L + L PKL +++ N + + + +
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125
Query: 182 HFHMNNNSIS-------------GQIPPELSRLPSLVHMLLDNNNLTG----YLPPELSE 224
H +++NN + + + P L ++ N L
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185
Query: 225 LPKLLILQLDNNNF--EGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLS 282
L +++ N EG + LL L C L LDL
Sbjct: 186 HRLLHTVKMVQNGIRPEG---------IEHLLLEGLAYC------------QELKVLDLQ 224
Query: 283 SNQLNGSIPPGRLSL--------NITTIKLSNNKLTG----------TIPSNFSGLPRLQ 324
N G +L N+ + L++ L+ + N LQ
Sbjct: 225 DNTFT---HLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLEN----IGLQ 277
Query: 325 RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 364
L + N + ++ + L+ N +
Sbjct: 278 TLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 317
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 42/220 (19%), Positives = 75/220 (34%), Gaps = 34/220 (15%)
Query: 632 IGQGGYGKVYKGI--LPDGTVVAVK--RAQEG-SLQGEKEFLTEIQFLSRLHHR------ 680
+G+G +GKV + + + VA+K R EI L ++ +
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDKENKF 82
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGSSRGILYL 738
V + + + G + +E + + L K + + +A + +L
Sbjct: 83 LCVLMSDWFNFHGHMCIAFELLGK-NTFEFL--KENNFQPYPLPHVRHMAYQLCHALRFL 139
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI----------VPAHV 788
H + + H D+K NIL + + + S I H
Sbjct: 140 H---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH 196
Query: 789 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG 828
+T+V T Y PE L DV+S+G + E G
Sbjct: 197 TTIVA-TRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267 | Back alignment and structure |
|---|
Score = 41.1 bits (96), Expect = 7e-04
Identities = 30/140 (21%), Positives = 47/140 (33%), Gaps = 31/140 (22%)
Query: 156 LDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT 215
L ++ D + ++ ++ LN+ I +P L+ + L NN L
Sbjct: 134 LKGLRSDPDLVAQNI---DVVLNRRSCMAATLRIIE-------ENIPELLSLNLSNNRLY 183
Query: 216 G--YLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSK-----LLKLSLRNCSLQGPMP 268
+ + + P L IL L N + S + K L +L L SL
Sbjct: 184 RLDDMSSIVQKAPNLKILNLSGNELK------SERELDKIKGLKLEELWLDGNSLCDTFR 237
Query: 269 D--------LSRIPNLGYLD 280
D R P L LD
Sbjct: 238 DQSTYISAIRERFPKLLRLD 257
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 845 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.98 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.98 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.98 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.98 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.98 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.98 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.98 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.98 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.97 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.97 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.96 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.96 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.96 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.96 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.95 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.95 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.93 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.91 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.9 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.88 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.87 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.86 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.86 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.86 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.85 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.81 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.8 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.79 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.79 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.79 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.79 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.79 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.78 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.78 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.77 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.76 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.76 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.76 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.75 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.75 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.74 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.74 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.74 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.72 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.67 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.67 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.66 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.66 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.65 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.64 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.62 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.62 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.6 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.59 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.51 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.5 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.5 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.5 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.49 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.46 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.44 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.43 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.42 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.41 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.4 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.39 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.32 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.25 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.22 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.2 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.19 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.07 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.01 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.94 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.87 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.81 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.79 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.78 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.69 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.65 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.59 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.52 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.46 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.36 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.35 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.34 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 98.31 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.27 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.19 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.16 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.16 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.1 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.96 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.91 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.86 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.75 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.74 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.51 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.44 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.34 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.13 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.1 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.91 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.89 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.87 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.8 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.78 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.7 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.44 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.42 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.21 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.13 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.61 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 94.05 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.81 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.91 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 88.8 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 87.25 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 86.58 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 82.25 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=406.32 Aligned_cols=205 Identities=32% Similarity=0.514 Sum_probs=179.4
Q ss_pred cCCCCCccccccCceEEEEEEeC------CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
++|.+.+.||+|+||+||+|.+. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56777899999999999999863 478899999988777777899999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 003140 698 VYEFMSNGTLRDQLSAK-----------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV 766 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl 766 (845)
|||||++|+|.++|+.. ....++|..++.|+.|||+||+|||+++ ||||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 99999999999999763 2457999999999999999999999998 999999999999999999999
Q ss_pred EecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 767 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 767 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
+|||+|+.....+ .........||+.|||||++.+..|+.++|||||||++|||+| |+.||.+..
T Consensus 170 ~DFGla~~~~~~~-----~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~ 235 (299)
T 4asz_A 170 GDFGMSRDVYSTD-----YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 235 (299)
T ss_dssp CCCSCHHHHTGGG-----CEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred CCcccceecCCCC-----ceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999998654221 1122233568999999999999999999999999999999999 999997643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=406.47 Aligned_cols=205 Identities=32% Similarity=0.528 Sum_probs=174.0
Q ss_pred cCCCCCccccccCceEEEEEEeC------CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
++|...+.||+|+||+||+|.+. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45666789999999999999864 478999999988777777899999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 003140 698 VYEFMSNGTLRDQLSAKS-------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 764 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~ 764 (845)
|||||++|+|.++++... ..+++|..++.|+.|||+||+|||+++ ||||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 999999999999997642 246999999999999999999999988 9999999999999999999
Q ss_pred EEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 765 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 765 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
||+|||+|+.....+. ........||+.|||||++.+..|+.++|||||||++|||+| |+.||....
T Consensus 198 Ki~DFGla~~~~~~~~-----~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~ 265 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265 (329)
T ss_dssp EECCCC---------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC
T ss_pred EEcccccceeccCCCc-----ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC
Confidence 9999999987643321 222345679999999999999999999999999999999999 999997643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=404.04 Aligned_cols=203 Identities=26% Similarity=0.415 Sum_probs=176.5
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
++|.+.+.||+|+||+||+|+.. +|+.||||++.... ....++|.+|+++|++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999964 69999999987542 3345689999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
||++|+|.+++.......+++...+.|+.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-- 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-- 178 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH--
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC--
Confidence 999999999998776677899999999999999999999999 999999999999999999999999999875311
Q ss_pred CCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
........||+.|||||++.+..|+.++||||+||++|||+||+.||....
T Consensus 179 -----~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 229 (350)
T 4b9d_A 179 -----VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS 229 (350)
T ss_dssp -----HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred -----cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 122345679999999999999999999999999999999999999997543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=398.17 Aligned_cols=205 Identities=29% Similarity=0.484 Sum_probs=172.0
Q ss_pred HHHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 620 ALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 620 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
++..+++...+.||+|+||+||+|++++ .||||+++.. .....++|.+|++++++++|||||+++|++.+ +..+|
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 3455678888999999999999999753 6999998743 34456789999999999999999999999865 56899
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
|||||++|+|.++++... .+++|..++.|+.|||+||+|||+++ ||||||||+|||+++++.+||+|||+|+....
T Consensus 109 VmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 999999999999997643 46999999999999999999999988 99999999999999999999999999987643
Q ss_pred CCCCCccccceeecccCCCCccchhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.+ .........||+.|||||++.+ +.|+.++|||||||++|||+||+.||.+..
T Consensus 185 ~~-----~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~ 241 (307)
T 3omv_A 185 WS-----GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN 241 (307)
T ss_dssp --------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CC-----cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC
Confidence 22 1223345689999999999864 468999999999999999999999997654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=401.26 Aligned_cols=204 Identities=27% Similarity=0.437 Sum_probs=176.0
Q ss_pred CCCCCccccccCceEEEEEEeC------CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
++...+.||+|+||+||+|.+. +++.||||+++... ....++|.+|++++++++|||||+++|+|.+.+..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3455788999999999999862 46899999997543 3346789999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 003140 698 VYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 763 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~ 763 (845)
|||||++|+|.++|+... ...++|..++.|+.|||+||+|||+++ ||||||||+||||+++++
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 999999999999996532 246899999999999999999999998 999999999999999999
Q ss_pred EEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 764 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 764 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
+||+|||+|+.....+. ........||++|||||++.++.|+.++|||||||++|||+| |+.||.+..
T Consensus 184 ~Ki~DFGlar~~~~~~~-----~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~ 252 (308)
T 4gt4_A 184 VKISDLGLFREVYAADY-----YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 252 (308)
T ss_dssp EEECCSCCBCGGGGGGC-----BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred EEECCcccceeccCCCc-----eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence 99999999986543221 122344679999999999999999999999999999999999 899997643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=400.06 Aligned_cols=200 Identities=26% Similarity=0.425 Sum_probs=180.2
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcC
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 702 (845)
+.|+..+.||+|+||+||+|... +|+.||||++........+.+.+|+++|++++|||||++++++.+++..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56888899999999999999975 69999999987554455567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCC
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 782 (845)
++|+|.++++. ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 154 ~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~---- 223 (346)
T 4fih_A 154 EGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE---- 223 (346)
T ss_dssp TTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS----
T ss_pred CCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCC----
Confidence 99999999975 35899999999999999999999999 999999999999999999999999999876432
Q ss_pred ccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
........||+.|||||++.+..|+.++||||+||++|||++|+.||.+..
T Consensus 224 ---~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 274 (346)
T 4fih_A 224 ---VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 274 (346)
T ss_dssp ---SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ---CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 122345689999999999999999999999999999999999999997643
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=392.77 Aligned_cols=203 Identities=21% Similarity=0.361 Sum_probs=180.5
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46889999999999999999964 79999999986432 233567999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++|+|.+++++. ..+++.....++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.+....
T Consensus 112 Ey~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 999999999999765 35899999999999999999999999 9999999999999999999999999998764322
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.........||+.|||||++.+..|+.++||||+||++|||+||+.||...+
T Consensus 187 -----~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 238 (311)
T 4aw0_A 187 -----KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 238 (311)
T ss_dssp -----TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -----CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1122345689999999999999999999999999999999999999997543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=401.42 Aligned_cols=201 Identities=25% Similarity=0.418 Sum_probs=181.3
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
.+.|+..+.||+|+||.||+|... +|+.||||++........+.+.+|+++|++++|||||++++++.+.+..||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 356889999999999999999975 6999999999765555566789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
|++|+|.++++.. .+++..+..++.||++||+|||+++ ||||||||+|||++.++.+||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-- 301 (423)
T 4fie_A 230 LEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-- 301 (423)
T ss_dssp CTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--
T ss_pred CCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC--
Confidence 9999999999653 5899999999999999999999999 9999999999999999999999999998764321
Q ss_pred CccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......||+.|||||++.+..|+.++|||||||++|||++|+.||.+..
T Consensus 302 -----~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 351 (423)
T 4fie_A 302 -----PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 351 (423)
T ss_dssp -----CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred -----ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 22345689999999999999999999999999999999999999997643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=382.17 Aligned_cols=198 Identities=30% Similarity=0.510 Sum_probs=170.4
Q ss_pred CCCccccccCceEEEEEEeC-CCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEee----CCeEEEEE
Q 003140 627 NSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE----EGEQMLVY 699 (845)
Q Consensus 627 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~LV~ 699 (845)
...+.||+|+||+||+|.+. +++.||||++... .....++|.+|++++++++|||||++++++.+ ++..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45567999999999999975 6899999998643 33345679999999999999999999999865 34579999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcEEEEecCCcccCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~-~~~~~kl~DFGla~~~~~~ 778 (845)
|||++|+|.+++++. ..+++..+..++.||++||+|||+++ ++||||||||+|||++ +++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~- 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 184 (290)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-
Confidence 999999999999764 46899999999999999999999875 5699999999999998 479999999999986431
Q ss_pred CCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
.......||+.|||||++.+ .|+.++|||||||++|||+||+.||....+
T Consensus 185 --------~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~ 234 (290)
T 3fpq_A 185 --------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN 234 (290)
T ss_dssp --------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS
T ss_pred --------CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc
Confidence 12345689999999998865 699999999999999999999999976543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=388.13 Aligned_cols=201 Identities=23% Similarity=0.312 Sum_probs=172.0
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcC
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 702 (845)
+.|...++||+|+||+||+|+.. +|+.||||+++.... ..+|++++++++|||||++++++.+++..+||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 45777889999999999999975 699999999875322 246999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEEecCCcccCCCCCCC
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~-~~kl~DFGla~~~~~~~~~ 781 (845)
++|+|.++++.. ..+++..+..++.||++||+|||+++ ||||||||+|||++.++ ++||+|||+|+........
T Consensus 133 ~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 133 EGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp TTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999999999765 35899999999999999999999998 99999999999999987 6999999999876532211
Q ss_pred CccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
. .........||+.|||||++.+..|+.++|||||||++|||+||+.||....
T Consensus 208 ~--~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 260 (336)
T 4g3f_A 208 K--SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 260 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC
T ss_pred c--ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 0 0112234579999999999999999999999999999999999999997543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=374.33 Aligned_cols=198 Identities=25% Similarity=0.413 Sum_probs=163.5
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|++.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999964 79999999987543 223567999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+ +|+|.+++... ..+++.....++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG- 165 (275)
T ss_dssp ECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC-
Confidence 999 68999999764 46999999999999999999999999 999999999999999999999999999865321
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.......||+.|||||++.+..+ +.++||||+||++|||+||+.||.+.
T Consensus 166 -------~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~ 215 (275)
T 3hyh_A 166 -------NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 215 (275)
T ss_dssp ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -------CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC
Confidence 22345679999999999998776 57999999999999999999999754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=391.96 Aligned_cols=215 Identities=27% Similarity=0.456 Sum_probs=184.4
Q ss_pred cchHHHHHHhcCCCCCccccccCceEEEEEEeCC------CcEEEEEEccCCCh-hhHHHHHHHHHHHHhcCC-CceeeE
Q 003140 614 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHH-RNLVSL 685 (845)
Q Consensus 614 ~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~~~~~~~-~~~~~~~~Ei~~l~~l~H-~nIv~l 685 (845)
+..++|++..++|.+.+.||+|+||+||+|.+.. ++.||||+++.... ...++|.+|+++|++++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3446778888999999999999999999998642 46899999976543 345789999999999965 899999
Q ss_pred EEEEeeC-CeEEEEEEcCCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 003140 686 VGYCDEE-GEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750 (845)
Q Consensus 686 ~g~~~~~-~~~~LV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrD 750 (845)
+|+|.+. +..+||||||++|+|.++|+... ...++|..++.++.|||+||+|||+++ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999765 56899999999999999997532 345899999999999999999999998 99999
Q ss_pred CCCCCEEEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CC
Q 003140 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GM 829 (845)
Q Consensus 751 Lk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~ 829 (845)
|||+|||+++++.+||+|||+|+...... .........||+.|||||++.+..|+.++|||||||++|||+| |+
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~-----~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~ 285 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDP-----DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 285 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCT-----TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCC-----CceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCC
Confidence 99999999999999999999998764322 1122345678999999999999999999999999999999998 99
Q ss_pred CCCCCCC
Q 003140 830 QPISHGK 836 (845)
Q Consensus 830 ~Pf~~~~ 836 (845)
.||.+..
T Consensus 286 ~Pf~~~~ 292 (353)
T 4ase_A 286 SPYPGVK 292 (353)
T ss_dssp CSSTTCC
T ss_pred CCCCCCC
Confidence 9997643
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=385.67 Aligned_cols=201 Identities=27% Similarity=0.353 Sum_probs=170.9
Q ss_pred cCCCCCccccccCceEEEEEEeC----CCcEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
++|++.+.||+|+||+||+|+.. .++.||||+++.... ....++.+|+++|++++|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57899999999999999999852 478999999875322 223468899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
|||||++|+|.+++++.. .+++..+..++.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 999999999999997653 5899999999999999999999999 99999999999999999999999999986532
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
. ........||+.|||||++.+..|+.++||||+||++|||+||+.||.+.+
T Consensus 179 ~-------~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 230 (304)
T 3ubd_A 179 H-------EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230 (304)
T ss_dssp ---------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred C-------CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC
Confidence 2 122345679999999999999999999999999999999999999997543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=379.90 Aligned_cols=202 Identities=26% Similarity=0.372 Sum_probs=163.1
Q ss_pred CCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC----eEEEEEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----EQMLVYE 700 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~LV~E 700 (845)
+|.+.+.||+|+||+||+|++ +|+.||||+++.... ....+..|+..+.+++|||||+++|+|.+++ ..+||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 466778999999999999998 689999999865322 1223345666677889999999999997654 5799999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-----ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
||++|+|.++++.. .++|..+.+++.|+|+||+|||++ ++++||||||||+|||+++++++||+|||+|+..
T Consensus 82 y~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp CCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred CCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 99999999999764 589999999999999999999987 2456999999999999999999999999999875
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCC------CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH------KLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
...... .........||+.|||||++.+. .++.++|||||||++|||+||+.||..
T Consensus 159 ~~~~~~---~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~ 220 (303)
T 3hmm_A 159 DSATDT---IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp ETTTTE---ESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred cCCCCc---eeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence 432210 11122345799999999999764 367899999999999999999887753
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=370.19 Aligned_cols=206 Identities=27% Similarity=0.426 Sum_probs=163.0
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC--------
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG-------- 693 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-------- 693 (845)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+++.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45888999999999999999965 79999999987543 334567999999999999999999999986544
Q ss_pred ----eEEEEEEcCCCCCHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEe
Q 003140 694 ----EQMLVYEFMSNGTLRDQLSAKSK-EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 768 (845)
Q Consensus 694 ----~~~LV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~D 768 (845)
..++|||||++|+|.+++..... ...++..++.++.||++||+|||+++ ||||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999976533 34567778899999999999999999 99999999999999999999999
Q ss_pred cCCcccCCCCCCCCcc-----ccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 769 FGLSRLAPVPDIEGIV-----PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 769 FGla~~~~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
||+|+........... .....+...||+.|||||++.+..|+.++|||||||++|||++ ||...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~ 230 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ 230 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence 9999876533211100 0112244679999999999999999999999999999999996 88643
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=373.04 Aligned_cols=295 Identities=29% Similarity=0.495 Sum_probs=238.8
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCCCCCCCC-CCCcceEecCCCCCCCcceEeEEEecCCCCcc--cCCCCccCCCC
Q 003140 31 ITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCT-SNWTGVLCFNTTMDDGYLHLRELQLLNLNLSG--NLSPEIGRLSY 107 (845)
Q Consensus 31 ~~~~~~~~al~~~k~~~~~~~~~l~~W~~~~~c~-~~w~Gv~C~~~~~~~~~~~v~~L~L~~~~l~~--~~~~~l~~L~~ 107 (845)
.|++.|++||++||+++.++. .+++|..+++|| +.|.||+|...+ ...+|+.|+|+++++++ .+|+.|+.+++
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~~~~~C~~~w~gv~C~~~~---~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~ 77 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDT---QTYRVNNLDLSGLNLPKPYPIPSSLANLPY 77 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTTSCTTTTCSTTEEECCSS---SCCCEEEEEEECCCCSSCEECCGGGGGCTT
T ss_pred CCCHHHHHHHHHHHHhcCCcc-cccCCCCCCCCCcCCCcceEeCCCC---CCceEEEEECCCCCccCCcccChhHhCCCC
Confidence 588999999999999998765 688998765554 359999996532 12489999999999999 89999999999
Q ss_pred ccEEEecC-CCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEcc
Q 003140 108 LTILDFMW-NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMN 186 (845)
Q Consensus 108 L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 186 (845)
|++|+|++ |++.+.+|..|+++++|++|+|++|++++.+|..|..+++|++|+|++|.+++.+|..+..+++|++|+|+
T Consensus 78 L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 157 (313)
T 1ogq_A 78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157 (313)
T ss_dssp CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECC
T ss_pred CCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECc
Confidence 99999995 99999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccCCCC-CcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCC
Q 003140 187 NNSISGQIPPELSRLP-SLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG 265 (845)
Q Consensus 187 ~N~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~ 265 (845)
+|++++.+|..+..++ +|++|+|++|++++.+|..+..++ |++|+|++|++++ ..|..+..+++|+.|+|++|++++
T Consensus 158 ~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~ 235 (313)
T 1ogq_A 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEG-DASVLFGSDKNTQKIHLAKNSLAF 235 (313)
T ss_dssp SSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEE-CCGGGCCTTSCCSEEECCSSEECC
T ss_pred CCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccC-cCCHHHhcCCCCCEEECCCCceee
Confidence 9999988999998888 899999999999988888888887 9999999998887 577788888888888888888877
Q ss_pred CCCCCCCCCCccEEEcccccCCcCCCCCCCc-cccCEEEccCCcCCCCcccccCCCCCCCeEeccccc
Q 003140 266 PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNS 332 (845)
Q Consensus 266 ~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 332 (845)
.++.+..+++|++|++++|++++.+|..+.. .+|+.|+|++|++++.+|.. ..+++|+.|++++|+
T Consensus 236 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 236 DLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp BGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred ecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence 6666666666766666666666555544332 24555555555555554443 445555555555554
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=411.18 Aligned_cols=336 Identities=26% Similarity=0.393 Sum_probs=288.8
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCCCCCCCCCCCcceEecCCCCCCCcceEeEEEecCCCCccc---CC--------
Q 003140 31 ITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGN---LS-------- 99 (845)
Q Consensus 31 ~~~~~~~~al~~~k~~~~~~~~~l~~W~~~~~c~~~w~Gv~C~~~~~~~~~~~v~~L~L~~~~l~~~---~~-------- 99 (845)
.+.++|++||++||+++.|+. .+++|+.+++|| .|.||+|.. .+|+.|+|++++++|. ++
T Consensus 8 ~~~~~~~~all~~k~~~~~~~-~l~~W~~~~~~C-~w~gv~C~~-------~~v~~L~L~~~~l~g~~~~l~~~l~~L~~ 78 (768)
T 3rgz_A 8 QSLYREIHQLISFKDVLPDKN-LLPDWSSNKNPC-TFDGVTCRD-------DKVTSIDLSSKPLNVGFSAVSSSLLSLTG 78 (768)
T ss_dssp CCHHHHHHHHHHHHTTCSCTT-SSTTCCTTSCGG-GSTTEEEET-------TEEEEEECTTSCCCEEHHHHHHHTTTCTT
T ss_pred cCCHHHHHHHHHHHhhCCCcc-cccCCCCCCCCc-CCcceEECC-------CcEEEEECCCCCcCCccCccChhHhccCc
Confidence 335789999999999999877 889998766776 699999962 3899999999998886 33
Q ss_pred ---------------CCccCCCCccEEEecCCCCCCCCcc--cccccccchhhhccCCCCCCCCCCcc-CCCCccceeec
Q 003140 100 ---------------PEIGRLSYLTILDFMWNKISGSIPK--EIGNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQI 161 (845)
Q Consensus 100 ---------------~~l~~L~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L 161 (845)
..|+.+++|++|+|++|.++|.+|. .++++++|++|+|++|.+++.+|..+ .++++|++|+|
T Consensus 79 L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L 158 (768)
T 3rgz_A 79 LESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDL 158 (768)
T ss_dssp CCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEEC
T ss_pred ccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEEC
Confidence 5788889999999999999888887 88999999999999999988888776 78899999999
Q ss_pred ccccccCCCCcc---ccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcC
Q 003140 162 DQNYISGSLPKS---FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNF 238 (845)
Q Consensus 162 s~N~l~~~~p~~---~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 238 (845)
++|++++..|.. +.++++|++|++++|.+++..|. ..+++|++|+|++|++++.+|. ++.+++|++|+|++|++
T Consensus 159 s~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l 235 (768)
T 3rgz_A 159 SANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKL 235 (768)
T ss_dssp CSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCC
T ss_pred CCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcC
Confidence 999998888777 78889999999999999877654 7889999999999999988877 99999999999999999
Q ss_pred CCCCCccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCCcCCCCCCCc--cccCEEEccCCcCCCCcccc
Q 003140 239 EGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGTIPSN 316 (845)
Q Consensus 239 ~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~--~~L~~L~Ls~N~l~~~~p~~ 316 (845)
++ .+|..+.++++|++|+|++|++++..+.. .+++|++|++++|.+++.+|..... .+|+.|+|++|++++.+|..
T Consensus 236 ~~-~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~-~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~ 313 (768)
T 3rgz_A 236 SG-DFSRAISTCTELKLLNISSNQFVGPIPPL-PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPF 313 (768)
T ss_dssp CS-CHHHHTTTCSSCCEEECCSSCCEESCCCC-CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGG
T ss_pred CC-cccHHHhcCCCCCEEECCCCcccCccCcc-ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchH
Confidence 87 68889999999999999999999877766 8899999999999999999987654 58999999999999999999
Q ss_pred cCCCCCCCeEecccccCcccCChh-hhhhccCCCCcceEEEccCCCCC-CCCCCC-CCC-CCcEEEecCCccc
Q 003140 317 FSGLPRLQRLFIANNSLSGSIPSS-IWQSRTLNATETFILDFQNNNLT-NISGSF-NIP-PNVTVRLRGNPFC 385 (845)
Q Consensus 317 ~~~l~~L~~L~L~~N~l~~~ip~~-l~~l~~l~~~~l~~L~ls~N~l~-~i~~~~-~~~-~l~~l~l~~Np~~ 385 (845)
|+++++|++|+|++|+++|.+|.. +..+. +|+.|++++|+++ .+|..+ .++ .++.|++++|.+.
T Consensus 314 ~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~-----~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~ 381 (768)
T 3rgz_A 314 FGSCSLLESLALSSNNFSGELPMDTLLKMR-----GLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFS 381 (768)
T ss_dssp GGGCTTCCEEECCSSEEEEECCHHHHTTCT-----TCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEE
T ss_pred HhcCCCccEEECCCCcccCcCCHHHHhcCC-----CCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcC
Confidence 999999999999999999999976 66544 4558888888887 666665 344 7888888888765
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=371.19 Aligned_cols=204 Identities=26% Similarity=0.419 Sum_probs=173.7
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEee------CCe
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE------EGE 694 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~------~~~ 694 (845)
++|++.+.||+|+||+||+|... +|+.||||+++... ....+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999974 79999999987532 3345678999999999999999999998754 367
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003140 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (845)
Q Consensus 695 ~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~ 774 (845)
.|||||||+ |+|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeee
Confidence 899999995 7899999653 46999999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCCCCccccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
+...... .........||+.|||||++.+. .++.++||||+||++|||++|+.||.+.+
T Consensus 208 ~~~~~~~---~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~ 267 (398)
T 4b99_A 208 LCTSPAE---HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN 267 (398)
T ss_dssp C----------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred cccCccc---cccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC
Confidence 6432111 12234567899999999998875 56999999999999999999999997543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=367.67 Aligned_cols=207 Identities=24% Similarity=0.375 Sum_probs=174.3
Q ss_pred HhcCCCCCccccccCceEEEEEEeC----CCcEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeEE
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQM 696 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 696 (845)
..++|++.+.||+|+||+||+|+.+ .++.||||++.... ...++.+|+++|+.+ +|||||++++++.+.+..+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 4578999999999999999999853 46889999986543 345788999999998 6999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEEecCCcccC
Q 003140 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLSRLA 775 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~-~~~kl~DFGla~~~ 775 (845)
+||||+++|+|.++++ .+++..+..++.|+++||+|||+++ ||||||||+|||++.+ +.+||+|||+|+..
T Consensus 97 lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 9999999999999983 4889999999999999999999999 9999999999999877 79999999999865
Q ss_pred CCCCCCCc---------------------cccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCC
Q 003140 776 PVPDIEGI---------------------VPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPIS 833 (845)
Q Consensus 776 ~~~~~~~~---------------------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~ 833 (845)
........ ..........||+.|||||++.+. .|+.++||||+||++|||+||+.||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 43221100 001122345799999999999775 58999999999999999999999998
Q ss_pred CCCCc
Q 003140 834 HGKNI 838 (845)
Q Consensus 834 ~~~~~ 838 (845)
.+.+.
T Consensus 249 ~~~~~ 253 (361)
T 4f9c_A 249 KASDD 253 (361)
T ss_dssp CCSSH
T ss_pred CCCCH
Confidence 77654
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=402.45 Aligned_cols=336 Identities=21% Similarity=0.288 Sum_probs=273.2
Q ss_pred CCCCCCHHHHHHHHHHHHhccCCCCCCCCCCCC------CCCCCCC------------cceEecCCCCCCCcceEeEEEe
Q 003140 28 DDSITDPIEVSALRSIKKSLVDDYSKLSNWNRG------DPCTSNW------------TGVLCFNTTMDDGYLHLRELQL 89 (845)
Q Consensus 28 ~~~~~~~~~~~al~~~k~~~~~~~~~l~~W~~~------~~c~~~w------------~Gv~C~~~~~~~~~~~v~~L~L 89 (845)
..+.+...|++||++||+++.++ +|+.. ++|+|.| .||+|... .+|+.|+|
T Consensus 262 ~~~~~~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~------~~V~~L~L 330 (876)
T 4ecn_A 262 KETAEYIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNN------GRVTGLSL 330 (876)
T ss_dssp CCCCHHHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTT------SCEEEEEC
T ss_pred cccccchHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecCC------CCEEEEEC
Confidence 34455678999999999999775 66543 4654689 99999752 48999999
Q ss_pred cCCCCcccCCCCccCCCCccEEEe-cCCCCCCC-----------------------------------------------
Q 003140 90 LNLNLSGNLSPEIGRLSYLTILDF-MWNKISGS----------------------------------------------- 121 (845)
Q Consensus 90 ~~~~l~~~~~~~l~~L~~L~~L~L-~~N~l~~~----------------------------------------------- 121 (845)
++++|+|.+|++|++|++|++|+| ++|.++|.
T Consensus 331 s~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~ 410 (876)
T 4ecn_A 331 AGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR 410 (876)
T ss_dssp TTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHT
T ss_pred ccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhh
Confidence 999999999999999999999999 77765444
Q ss_pred -----------------------------CcccccccccchhhhccCCCCCC-----------------CCCCccC--CC
Q 003140 122 -----------------------------IPKEIGNIKSLELLLLNGNELTG-----------------SLPEELG--YL 153 (845)
Q Consensus 122 -----------------------------~p~~~~~l~~L~~L~Ls~N~l~~-----------------~~p~~~~--~l 153 (845)
+|..|+++++|++|+|++|+|++ .+|..++ ++
T Consensus 411 ~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L 490 (876)
T 4ecn_A 411 NPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNL 490 (876)
T ss_dssp CTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGC
T ss_pred CccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccC
Confidence 88899999999999999999998 3999988 99
Q ss_pred CccceeecccccccCCCCccccCccCCCEEEccCCC-CCC-CCccccCCCC-------CcceeeccccccccCCCc--cc
Q 003140 154 PKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNS-ISG-QIPPELSRLP-------SLVHMLLDNNNLTGYLPP--EL 222 (845)
Q Consensus 154 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~l~~l~-------~L~~L~L~~N~l~~~~p~--~l 222 (845)
++|++|+|++|++.+.+|..|.++++|+.|+|++|+ +++ .+|..++.++ +|++|+|++|+++ .+|. .+
T Consensus 491 ~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l 569 (876)
T 4ecn_A 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASL 569 (876)
T ss_dssp TTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHH
T ss_pred CCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhh
Confidence 999999999999999999999999999999999998 988 7887666555 9999999999999 8888 89
Q ss_pred CCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCCCCCCCCC-ccEEEcccccCCcCCCCCCCcc---c
Q 003140 223 SELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPN-LGYLDLSSNQLNGSIPPGRLSL---N 298 (845)
Q Consensus 223 ~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~-L~~L~Ls~N~l~~~ip~~~~~~---~ 298 (845)
+.+++|+.|+|++|+++ .+| .|+++++|+.|+|++|+++..+..+..+++ |+.|+|++|.++ .+|..+... +
T Consensus 570 ~~L~~L~~L~Ls~N~l~--~lp-~~~~L~~L~~L~Ls~N~l~~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~ 645 (876)
T 4ecn_A 570 QKMVKLGLLDCVHNKVR--HLE-AFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYV 645 (876)
T ss_dssp TTCTTCCEEECTTSCCC--BCC-CCCTTSEESEEECCSSCCSCCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSC
T ss_pred hcCCCCCEEECCCCCcc--cch-hhcCCCcceEEECcCCccccchHHHhhccccCCEEECcCCCCC-cCchhhhccccCC
Confidence 99999999999999998 567 899999999999999999966667888888 999999999998 777665443 4
Q ss_pred cCEEEccCCcCCCCccccc---C--CCCCCCeEecccccCcccCChhhh-hhccCCCCcceEEEccCCCCCCCCCCC-CC
Q 003140 299 ITTIKLSNNKLTGTIPSNF---S--GLPRLQRLFIANNSLSGSIPSSIW-QSRTLNATETFILDFQNNNLTNISGSF-NI 371 (845)
Q Consensus 299 L~~L~Ls~N~l~~~~p~~~---~--~l~~L~~L~L~~N~l~~~ip~~l~-~l~~l~~~~l~~L~ls~N~l~~i~~~~-~~ 371 (845)
|+.|+|++|++++.+|... . .+++|+.|+|++|+++ .+|..+. .+ ++|+.|+|++|+|+.+|... ..
T Consensus 646 L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l-----~~L~~L~Ls~N~L~~ip~~~~~~ 719 (876)
T 4ecn_A 646 MGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATG-----SPISTIILSNNLMTSIPENSLKP 719 (876)
T ss_dssp EEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTT-----CCCSEEECCSCCCSCCCTTSSSC
T ss_pred CCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccC-----CCCCEEECCCCcCCccChHHhcc
Confidence 8888888888887665432 2 3347778888888887 6676654 23 23446666666666666543 11
Q ss_pred --------CCCcEEEecCCccc
Q 003140 372 --------PPNVTVRLRGNPFC 385 (845)
Q Consensus 372 --------~~l~~l~l~~Np~~ 385 (845)
+.++.|+|++|.+.
T Consensus 720 ~~~~l~nl~~L~~L~Ls~N~L~ 741 (876)
T 4ecn_A 720 KDGNYKNTYLLTTIDLRFNKLT 741 (876)
T ss_dssp TTSCCTTGGGCCEEECCSSCCC
T ss_pred ccccccccCCccEEECCCCCCc
Confidence 15666666666654
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=396.63 Aligned_cols=338 Identities=22% Similarity=0.296 Sum_probs=288.9
Q ss_pred CCCCHHHHHHHHHHHHhccCCC-C-------CCCCCCCCCCCCCCC---cceEecCCCCCCCcceEeEEEecCCCCcccC
Q 003140 30 SITDPIEVSALRSIKKSLVDDY-S-------KLSNWNRGDPCTSNW---TGVLCFNTTMDDGYLHLRELQLLNLNLSGNL 98 (845)
Q Consensus 30 ~~~~~~~~~al~~~k~~~~~~~-~-------~l~~W~~~~~c~~~w---~Gv~C~~~~~~~~~~~v~~L~L~~~~l~~~~ 98 (845)
+..+..|+.||.++++++.++. . ...+|+...+|| .| .||+|... .+|+.|+|++++++|.+
T Consensus 25 ~~~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c-~w~~~~GV~C~~~------~~V~~L~L~~~~l~g~l 97 (636)
T 4eco_A 25 TAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELD-MWGAQPGVSLNSN------GRVTGLSLEGFGASGRV 97 (636)
T ss_dssp CCHHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGG-GTTCCTTEEECTT------CCEEEEECTTSCCEEEE
T ss_pred hhhHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcc-cccCCCCeEEcCC------CCEEEEEecCcccCCcC
Confidence 3445689999999999987542 1 234798776665 69 99999643 48999999999999999
Q ss_pred CCCccCCCCccEEEecCCC-------------------------------------------------------------
Q 003140 99 SPEIGRLSYLTILDFMWNK------------------------------------------------------------- 117 (845)
Q Consensus 99 ~~~l~~L~~L~~L~L~~N~------------------------------------------------------------- 117 (845)
|++|++|++|++|+|++|.
T Consensus 98 p~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~ 177 (636)
T 4eco_A 98 PDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK 177 (636)
T ss_dssp CGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCC
T ss_pred ChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCcccccccc
Confidence 9999999999999999884
Q ss_pred -----------------CCCCCcccccccccchhhhccCCCCCCC-----------------CCCccC--CCCccceeec
Q 003140 118 -----------------ISGSIPKEIGNIKSLELLLLNGNELTGS-----------------LPEELG--YLPKLDRIQI 161 (845)
Q Consensus 118 -----------------l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-----------------~p~~~~--~l~~L~~L~L 161 (845)
++| +|..|+++++|++|+|++|++++. +|..++ ++++|++|+|
T Consensus 178 ~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L 256 (636)
T 4eco_A 178 SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEV 256 (636)
T ss_dssp CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEE
T ss_pred ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEe
Confidence 445 888999999999999999999986 999999 9999999999
Q ss_pred ccccccCCCCccccCccCCCEEEccCCC-CCC-CCccccCCC------CCcceeeccccccccCCCc--ccCCCCCCcEE
Q 003140 162 DQNYISGSLPKSFANLNKTRHFHMNNNS-ISG-QIPPELSRL------PSLVHMLLDNNNLTGYLPP--ELSELPKLLIL 231 (845)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~l~~l------~~L~~L~L~~N~l~~~~p~--~l~~l~~L~~L 231 (845)
++|++.+.+|..+.++++|++|+|++|+ +++ .+|..++.+ ++|++|+|++|+++ .+|. .++.+++|++|
T Consensus 257 ~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L 335 (636)
T 4eco_A 257 YNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGML 335 (636)
T ss_dssp ECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEE
T ss_pred cCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEE
Confidence 9999999999999999999999999998 998 889888876 99999999999999 8888 89999999999
Q ss_pred EccCCcCCCCCCccccccCCCccEEEcccCCCCCCCCCCCCCCC-ccEEEcccccCCcCCCCCCCcc---ccCEEEccCC
Q 003140 232 QLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPN-LGYLDLSSNQLNGSIPPGRLSL---NITTIKLSNN 307 (845)
Q Consensus 232 ~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~-L~~L~Ls~N~l~~~ip~~~~~~---~L~~L~Ls~N 307 (845)
+|++|+++| .+| .+.++++|+.|+|++|+++..+..+..+++ |+.|++++|.++ .+|..+... +|+.|+|++|
T Consensus 336 ~L~~N~l~g-~ip-~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N 412 (636)
T 4eco_A 336 ECLYNQLEG-KLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYN 412 (636)
T ss_dssp ECCSCCCEE-ECC-CCEEEEEESEEECCSSEEEECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSS
T ss_pred eCcCCcCcc-chh-hhCCCCCCCEEECCCCccccccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCC
Confidence 999999997 577 899999999999999999977777888988 999999999999 788765443 6999999999
Q ss_pred cCCCCcccccC-------CCCCCCeEecccccCcccCChhhhh-hccCCCCcceEEEccCCCCCCCCCCC-C-CC-----
Q 003140 308 KLTGTIPSNFS-------GLPRLQRLFIANNSLSGSIPSSIWQ-SRTLNATETFILDFQNNNLTNISGSF-N-IP----- 372 (845)
Q Consensus 308 ~l~~~~p~~~~-------~l~~L~~L~L~~N~l~~~ip~~l~~-l~~l~~~~l~~L~ls~N~l~~i~~~~-~-~~----- 372 (845)
++++.+|..|. .+++|++|+|++|+++ .+|..+.. +. .|+.|+|++|+|+.+|... . ..
T Consensus 413 ~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~-----~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~ 486 (636)
T 4eco_A 413 EIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS-KFPKELFSTGS-----PLSSINLMGNMLTEIPKNSLKDENENFKN 486 (636)
T ss_dssp CTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCC-SCCTHHHHTTC-----CCSEEECCSSCCSBCCSSSSEETTEECTT
T ss_pred cCCCcchhhhcccccccccCCCCCEEECcCCccC-cCCHHHHccCC-----CCCEEECCCCCCCCcCHHHhccccccccc
Confidence 99999998888 8889999999999998 67766543 33 4557888888888777654 2 22
Q ss_pred --CCcEEEecCCccc
Q 003140 373 --PNVTVRLRGNPFC 385 (845)
Q Consensus 373 --~l~~l~l~~Np~~ 385 (845)
.++.|++++|.+.
T Consensus 487 l~~L~~L~Ls~N~l~ 501 (636)
T 4eco_A 487 TYLLTSIDLRFNKLT 501 (636)
T ss_dssp GGGCCEEECCSSCCC
T ss_pred cCCccEEECcCCcCC
Confidence 6777888877765
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=379.17 Aligned_cols=198 Identities=27% Similarity=0.387 Sum_probs=171.7
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh---hhHHHHH---HHHHHHHhcCCCceeeEEEEEeeCCeEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFL---TEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~~~---~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 696 (845)
++|++.+.||+|+||+||+|+.. +|+.||||+++.... .....+. .++++++.++|||||++++++.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 57889999999999999999975 699999999864221 1222333 3466777889999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCC
Q 003140 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~ 776 (845)
||||||+||+|.+++.+. ..+++..+..++.||+.||+|||+++ ||||||||+|||++.+|++||+|||+|+...
T Consensus 269 lVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 999999999999999765 35899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.. ......||+.|||||++.. ..|+.++||||+||++|||++|+.||.+.
T Consensus 344 ~~---------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~ 394 (689)
T 3v5w_A 344 KK---------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394 (689)
T ss_dssp SC---------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred CC---------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 22 1234689999999999975 57999999999999999999999999753
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=377.61 Aligned_cols=201 Identities=25% Similarity=0.408 Sum_probs=181.5
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcC
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 702 (845)
++|++.+.||+|+||.||+|... +|+.||+|++........+.+.+|+++|++++|||||++++++.+.+..+||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 68999999999999999999975 79999999998766666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC--CcEEEEecCCcccCCCCCC
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK--FTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~--~~~kl~DFGla~~~~~~~~ 780 (845)
++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.+..
T Consensus 237 ~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~--- 309 (573)
T 3uto_A 237 SGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--- 309 (573)
T ss_dssp CCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT---
T ss_pred CCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccC---
Confidence 999999999653 346899999999999999999999999 9999999999999854 8999999999987642
Q ss_pred CCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
........||+.|||||++.+..|+.++||||+||++|||++|+.||.+..
T Consensus 310 -----~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~ 360 (573)
T 3uto_A 310 -----KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 360 (573)
T ss_dssp -----TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred -----CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 223345679999999999999999999999999999999999999997544
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=364.01 Aligned_cols=331 Identities=17% Similarity=0.212 Sum_probs=279.1
Q ss_pred CCCCCCCcceEecCCCC---CCCcceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCC-cccccccccchhhh
Q 003140 61 DPCTSNWTGVLCFNTTM---DDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSI-PKEIGNIKSLELLL 136 (845)
Q Consensus 61 ~~c~~~w~Gv~C~~~~~---~~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~ 136 (845)
..|.|.+..|.|..... +....+++.|+|++|.+++..|..|+.+++|++|+|++|.+.+.+ +..|.++++|++|+
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~ 85 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEE
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEe
Confidence 34543344488865432 223468999999999999998999999999999999999998655 56799999999999
Q ss_pred ccCCCCCCCCCCccCCCCccceeecccccccCCCCcc--ccCccCCCEEEccCCCCCCCCccc-cCCCCCcceeeccccc
Q 003140 137 LNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS--FANLNKTRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNN 213 (845)
Q Consensus 137 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~L~~N~ 213 (845)
|++|++++..|..|+++++|++|+|++|++++.++.. +..+++|++|+|++|++++..|.. +..+++|++|++++|+
T Consensus 86 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~ 165 (455)
T 3v47_A 86 LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165 (455)
T ss_dssp CTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCC
T ss_pred CCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCc
Confidence 9999999888999999999999999999999866554 999999999999999999887876 8999999999999999
Q ss_pred cccCCCcccCCC----------------------------------CCCcEEEccCCcCCCCCCcccccc----------
Q 003140 214 LTGYLPPELSEL----------------------------------PKLLILQLDNNNFEGTTIPASYSN---------- 249 (845)
Q Consensus 214 l~~~~p~~l~~l----------------------------------~~L~~L~Ls~N~l~~~~~p~~~~~---------- 249 (845)
+++..+..+..+ ++|++|+|++|++++ ..|..+..
T Consensus 166 l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~-~~~~~~~~~~~~~~L~~L 244 (455)
T 3v47_A 166 VKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKE-SMAKRFFDAIAGTKIQSL 244 (455)
T ss_dssp BSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCH-HHHHHHHHHTTTCCEEEE
T ss_pred ccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccc-cchhhhhccccccceeeE
Confidence 998887766543 678888888888765 23333221
Q ss_pred -----------------------------CCCccEEEcccCCCCCCCCC-CCCCCCccEEEcccccCCcCCCCCCC-ccc
Q 003140 250 -----------------------------MSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRL-SLN 298 (845)
Q Consensus 250 -----------------------------l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~ip~~~~-~~~ 298 (845)
.++|+.|++++|++++.++. +..+++|+.|++++|.+++..|..+. ..+
T Consensus 245 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 324 (455)
T 3v47_A 245 ILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTH 324 (455)
T ss_dssp ECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred eeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCccc
Confidence 25789999999999887664 88999999999999999987776654 458
Q ss_pred cCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCCC--CCCCCcE
Q 003140 299 ITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVT 376 (845)
Q Consensus 299 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~--~~~~l~~ 376 (845)
|+.|+|++|++++..|..|.++++|++|+|++|++++..|..+..+. +|+.|+|++|+|++++... .++.++.
T Consensus 325 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-----~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 399 (455)
T 3v47_A 325 LLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLP-----NLKELALDTNQLKSVPDGIFDRLTSLQK 399 (455)
T ss_dssp CCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCT-----TCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred CCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccc-----cccEEECCCCccccCCHhHhccCCcccE
Confidence 99999999999999999999999999999999999988898887655 4569999999999999864 5899999
Q ss_pred EEecCCcccccCC-CccccCCC
Q 003140 377 VRLRGNPFCLNTN-AEQFCGSH 397 (845)
Q Consensus 377 l~l~~Np~~c~~~-~~~~~~~~ 397 (845)
|++++|||.|+|+ ..++..|.
T Consensus 400 L~l~~N~l~~~~~~~~~l~~~l 421 (455)
T 3v47_A 400 IWLHTNPWDCSCPRIDYLSRWL 421 (455)
T ss_dssp EECCSSCBCCCTTTTHHHHHHH
T ss_pred EEccCCCcccCCCcchHHHHHH
Confidence 9999999999998 44454554
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=357.49 Aligned_cols=329 Identities=22% Similarity=0.237 Sum_probs=290.9
Q ss_pred CCCC--CCcceEecCCCCC----CCcceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhh
Q 003140 62 PCTS--NWTGVLCFNTTMD----DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELL 135 (845)
Q Consensus 62 ~c~~--~w~Gv~C~~~~~~----~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 135 (845)
.|.| .|..|.|...... ....+++.|+|++|++++..+..|..+++|++|+|++|.+++..|..|.++++|++|
T Consensus 6 ~C~C~~~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 85 (477)
T 2id5_A 6 RCECSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTL 85 (477)
T ss_dssp TCEEETTTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCeECCCCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEE
Confidence 4544 4788999765432 234579999999999999889999999999999999999999889999999999999
Q ss_pred hccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccc
Q 003140 136 LLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT 215 (845)
Q Consensus 136 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 215 (845)
+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|+.|+|++|.+++..+..|..+++|++|+|++|+++
T Consensus 86 ~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 165 (477)
T 2id5_A 86 GLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT 165 (477)
T ss_dssp ECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCS
T ss_pred ECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCc
Confidence 99999999766677999999999999999999989999999999999999999999888899999999999999999999
Q ss_pred cCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCC-CCCCCCCCccEEEcccccCCcCCCC-C
Q 003140 216 GYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPM-PDLSRIPNLGYLDLSSNQLNGSIPP-G 293 (845)
Q Consensus 216 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~l~~l~~L~~L~Ls~N~l~~~ip~-~ 293 (845)
+..+..|..+++|+.|+|++|.+++ ..+..|..+++|+.|++++|.+.+.. +......+|+.|++++|.++ .+|. .
T Consensus 166 ~~~~~~l~~l~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~-~~~~~~ 243 (477)
T 2id5_A 166 SIPTEALSHLHGLIVLRLRHLNINA-IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLA 243 (477)
T ss_dssp SCCHHHHTTCTTCCEEEEESCCCCE-ECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCC-SCCHHH
T ss_pred ccChhHhcccCCCcEEeCCCCcCcE-eChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCccc-ccCHHH
Confidence 8777789999999999999999987 56778999999999999999876644 44556669999999999999 5553 2
Q ss_pred -CCccccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCCC--C
Q 003140 294 -RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--N 370 (845)
Q Consensus 294 -~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~--~ 370 (845)
....+|+.|+|++|.+++..+..|.++++|++|+|++|++++..|..+..+.. |+.|+|++|+|+.++... .
T Consensus 244 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~-----L~~L~L~~N~l~~~~~~~~~~ 318 (477)
T 2id5_A 244 VRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNY-----LRVLNVSGNQLTTLEESVFHS 318 (477)
T ss_dssp HTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTT-----CCEEECCSSCCSCCCGGGBSC
T ss_pred hcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCccc-----CCEEECCCCcCceeCHhHcCC
Confidence 23458999999999999998999999999999999999999988988876554 569999999999998864 5
Q ss_pred CCCCcEEEecCCcccccCCCccccCCC
Q 003140 371 IPPNVTVRLRGNPFCLNTNAEQFCGSH 397 (845)
Q Consensus 371 ~~~l~~l~l~~Np~~c~~~~~~~~~~~ 397 (845)
++.++.|++++|||.|+|...|+..+.
T Consensus 319 l~~L~~L~l~~N~l~c~c~~~~~~~~~ 345 (477)
T 2id5_A 319 VGNLETLILDSNPLACDCRLLWVFRRR 345 (477)
T ss_dssp GGGCCEEECCSSCEECSGGGHHHHTTT
T ss_pred CcccCEEEccCCCccCccchHhHHhhh
Confidence 889999999999999999998887654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=328.19 Aligned_cols=201 Identities=24% Similarity=0.424 Sum_probs=180.7
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
.++|...+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999996 47899999998765555667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+++|+|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 170 (297)
T 3fxz_A 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 170 (297)
T ss_dssp CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc--
Confidence 9999999999764 4889999999999999999999998 9999999999999999999999999998654321
Q ss_pred CccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 171 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 220 (297)
T 3fxz_A 171 -----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (297)
T ss_dssp -----CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred -----cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 12334579999999999999999999999999999999999999997654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=350.59 Aligned_cols=213 Identities=26% Similarity=0.316 Sum_probs=183.4
Q ss_pred cchHHHHHHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChh---hHHHHHHHHHHHHhcCCCceeeEEEEE
Q 003140 614 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYC 689 (845)
Q Consensus 614 ~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~---~~~~~~~Ei~~l~~l~H~nIv~l~g~~ 689 (845)
+.+.++....++|+..+.||+|+||+||+|... +++.||||+++..... ..+.+.+|.++++.++||||+++++++
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 345566677889999999999999999999976 5889999998642211 123488999999999999999999999
Q ss_pred eeCCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEec
Q 003140 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 769 (845)
Q Consensus 690 ~~~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DF 769 (845)
.+.+..++|||||++|+|.++++.. ...+++..++.++.|++.||+|||+.+ ||||||||+|||++.++.+||+||
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 9999999999999999999999763 346899999999999999999999998 999999999999999999999999
Q ss_pred CCcccCCCCCCCCccccceeecccCCCCccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 770 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 770 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
|+|+...... ........||+.|+|||++. ...++.++|||||||++|||++|+.||...+
T Consensus 220 Gla~~~~~~~------~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~ 285 (437)
T 4aw2_A 220 GSCLKLMEDG------TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 285 (437)
T ss_dssp TTCEECCTTS------CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred hhhhhcccCC------CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC
Confidence 9997654321 22234467999999999987 5678999999999999999999999997644
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=337.97 Aligned_cols=221 Identities=46% Similarity=0.831 Sum_probs=192.0
Q ss_pred ccCCccccchHHHHHHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChh-hHHHHHHHHHHHHhcCCCceeeE
Q 003140 607 KIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSL 685 (845)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l 685 (845)
.......+++.++....++|...+.||+|+||.||+|...+|+.||||++...... ....+.+|++++++++||||+++
T Consensus 13 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 92 (326)
T 3uim_A 13 HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 92 (326)
T ss_dssp --CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCC
T ss_pred ccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccce
Confidence 34456678999999999999999999999999999999888999999998764322 23478999999999999999999
Q ss_pred EEEEeeCCeEEEEEEcCCCCCHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 003140 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 763 (845)
Q Consensus 686 ~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~ 763 (845)
++++.+.+..++||||+++|+|.++++... ...+++..+..++.|+++||+|||+.+.++|+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~ 172 (326)
T 3uim_A 93 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 172 (326)
T ss_dssp CEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC
T ss_pred EEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC
Confidence 999999999999999999999999998753 345999999999999999999999993334999999999999999999
Q ss_pred EEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003140 764 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833 (845)
Q Consensus 764 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~ 833 (845)
+||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 173 ~kl~Dfg~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKD------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp EEECCCSSCEECCSSS------SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred EEeccCccccccCccc------ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 9999999998764322 223344569999999999998899999999999999999999999995
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=336.75 Aligned_cols=212 Identities=49% Similarity=0.834 Sum_probs=186.8
Q ss_pred hHHHHHHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeE
Q 003140 616 YGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (845)
Q Consensus 616 ~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 695 (845)
+.++...+++|+..+.||+|+||.||+|.+.+|+.||||++........+++.+|++++++++||||+++++++.+.+..
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 33445567899999999999999999999888999999998876666678899999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003140 696 MLVYEFMSNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~ 773 (845)
++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccc
Confidence 99999999999999997643 346899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.....+ .........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 188 ~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~ 244 (321)
T 2qkw_B 188 KGTELD-----QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS 244 (321)
T ss_dssp ECSSSS-----CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCS
T ss_pred cccccc-----ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCccccc
Confidence 653221 112233456899999999999999999999999999999999999999753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=331.60 Aligned_cols=201 Identities=29% Similarity=0.440 Sum_probs=177.9
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
.++|.+.+.||+|+||.||+|.. .+|+.||||++... .....+++.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35788999999999999999997 57999999998653 3344567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++|+|.+++... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG- 167 (328)
T ss_dssp CCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-
T ss_pred ECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC-
Confidence 999999999999765 35899999999999999999999998 999999999999999999999999999765321
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT-DKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......||+.|+|||++.+..+. .++||||+||++|||++|+.||....
T Consensus 168 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 218 (328)
T 3fe3_A 168 -------GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218 (328)
T ss_dssp -------CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -------CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence 123456799999999999888765 79999999999999999999997543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=373.17 Aligned_cols=302 Identities=32% Similarity=0.502 Sum_probs=271.4
Q ss_pred cceEeEEEecCCCCcccCCCCccCCC-CccEEEecCCCCCCCCcccccc--cccchhhhccCCCCCCCCCCccCCCCccc
Q 003140 81 YLHLRELQLLNLNLSGNLSPEIGRLS-YLTILDFMWNKISGSIPKEIGN--IKSLELLLLNGNELTGSLPEELGYLPKLD 157 (845)
Q Consensus 81 ~~~v~~L~L~~~~l~~~~~~~l~~L~-~L~~L~L~~N~l~~~~p~~~~~--l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 157 (845)
..+++.|++++|.+++.+|..+..++ +|++|+|++|++++.+|..+.. +++|++|+|++|++++.+|..+.++++|+
T Consensus 342 l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~ 421 (768)
T 3rgz_A 342 MRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELV 421 (768)
T ss_dssp CTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCC
T ss_pred CCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCC
Confidence 35789999999999999999999987 9999999999999988888877 88999999999999999999999999999
Q ss_pred eeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCc
Q 003140 158 RIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNN 237 (845)
Q Consensus 158 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 237 (845)
+|+|++|++++.+|..+.++++|+.|++++|++++.+|..+..+++|++|+|++|++++.+|..+..+++|++|+|++|+
T Consensus 422 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~ 501 (768)
T 3rgz_A 422 SLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNR 501 (768)
T ss_dssp EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC
T ss_pred EEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCccccccCCCccEEEcccCCCCCCCC-CCCCCCCccEEEcccccCCcCCCCCCCc--------------------
Q 003140 238 FEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLS-------------------- 296 (845)
Q Consensus 238 l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~ip~~~~~-------------------- 296 (845)
+++ .+|..++++++|+.|+|++|++++..| .+..+++|+.|++++|+++|.+|..++.
T Consensus 502 l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (768)
T 3rgz_A 502 LTG-EIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKN 580 (768)
T ss_dssp CCS-CCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEEC
T ss_pred cCC-cCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccc
Confidence 997 689999999999999999999998666 5889999999999999999888864321
Q ss_pred ---------------------------------------------------cccCEEEccCCcCCCCcccccCCCCCCCe
Q 003140 297 ---------------------------------------------------LNITTIKLSNNKLTGTIPSNFSGLPRLQR 325 (845)
Q Consensus 297 ---------------------------------------------------~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 325 (845)
.+|+.|||++|+++|.+|..++++++|+.
T Consensus 581 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~ 660 (768)
T 3rgz_A 581 DGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFI 660 (768)
T ss_dssp CSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCE
T ss_pred ccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCE
Confidence 25889999999999999999999999999
Q ss_pred EecccccCcccCChhhhhhccCCCCcceEEEccCCCCC-CCCCCC-CCCCCcEEEecCCcccccC
Q 003140 326 LFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT-NISGSF-NIPPNVTVRLRGNPFCLNT 388 (845)
Q Consensus 326 L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~-~i~~~~-~~~~l~~l~l~~Np~~c~~ 388 (845)
|+|++|+++|.+|..+..+..| +.|||++|+|+ .+|..+ .++.+..|++++|++...-
T Consensus 661 L~Ls~N~l~g~ip~~l~~L~~L-----~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~i 720 (768)
T 3rgz_A 661 LNLGHNDISGSIPDEVGDLRGL-----NILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPI 720 (768)
T ss_dssp EECCSSCCCSCCCGGGGGCTTC-----CEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEEC
T ss_pred EeCcCCccCCCCChHHhCCCCC-----CEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccC
Confidence 9999999999999999877655 59999999998 666666 5899999999999987543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=327.96 Aligned_cols=212 Identities=25% Similarity=0.361 Sum_probs=186.0
Q ss_pred cccchHHHHHHhcC----------CCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCC
Q 003140 612 RSFTYGEMALATNN----------FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHR 680 (845)
Q Consensus 612 ~~~~~~~~~~~~~~----------f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~ 680 (845)
..++++++..+++. |+..+.||+|+||.||+|... +|+.||||++........+.+.+|++++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34677777776654 666789999999999999976 7999999999876666677899999999999999
Q ss_pred ceeeEEEEEeeCCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC
Q 003140 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH 760 (845)
Q Consensus 681 nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~ 760 (845)
||+++++++...+..++||||+++|+|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL 176 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence 999999999999999999999999999999864 35899999999999999999999998 999999999999999
Q ss_pred CCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 761 KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 761 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~ 245 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDV-------PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS 245 (321)
T ss_dssp TCCEEECCCTTCEECCSSS-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CCcEEEeeeeeeeecccCc-------cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999998654321 11234579999999999999999999999999999999999999997543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=331.52 Aligned_cols=201 Identities=26% Similarity=0.346 Sum_probs=177.7
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|+..+.||+|+||+||+|... +|+.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57888999999999999999975 68999999986532 233567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 158 (337)
T 1o6l_A 85 EYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD- 158 (337)
T ss_dssp ECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC-
Confidence 999999999999764 35889999999999999999999998 999999999999999999999999999864321
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 159 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 209 (337)
T 1o6l_A 159 ------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp ------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ------CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC
Confidence 122345679999999999999999999999999999999999999997543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=344.29 Aligned_cols=209 Identities=22% Similarity=0.310 Sum_probs=180.3
Q ss_pred hHHHHHHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCceeeEEEEEee
Q 003140 616 YGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 691 (845)
Q Consensus 616 ~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~ 691 (845)
..++....++|...+.||+|+||+||+|... +++.||+|+++.... ...+.+.+|+++++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3455566788999999999999999999975 589999999864211 122358899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 003140 692 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 771 (845)
Q Consensus 692 ~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGl 771 (845)
.+..++||||+++|+|.++++.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 99999999999999999999653 4889999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCCCccccceeecccCCCCccchhhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK----LTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
|+...... ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+
T Consensus 215 a~~~~~~~------~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 277 (410)
T 3v8s_A 215 CMKMNKEG------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 277 (410)
T ss_dssp CEECCTTS------EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred eEeeccCC------cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC
Confidence 98754321 12234567999999999998655 7899999999999999999999997543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=323.89 Aligned_cols=209 Identities=24% Similarity=0.426 Sum_probs=180.2
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
.++|...+.||+|+||.||+|... +++.||+|++........+.|.+|++++++++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 356788899999999999999975 6899999998776777778899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+++|+|.++++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 89 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 89 IKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 9999999999764 346899999999999999999999999 999999999999999999999999999876432211
Q ss_pred Ccc-------ccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 782 GIV-------PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 782 ~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
... .........||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~ 225 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence 000 011112457999999999999999999999999999999999999998653
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=353.69 Aligned_cols=328 Identities=20% Similarity=0.231 Sum_probs=215.1
Q ss_pred ceEecCCCCC----CCcceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCC
Q 003140 69 GVLCFNTTMD----DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144 (845)
Q Consensus 69 Gv~C~~~~~~----~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 144 (845)
.+.|...... +...+++.|+|++|.+++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++
T Consensus 15 ~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~ 94 (606)
T 3vq2_A 15 TYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQS 94 (606)
T ss_dssp EEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCC
T ss_pred ceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccc
Confidence 4667543221 223567777888777777777777777777777777777777667777777777777777777776
Q ss_pred CCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCC-CCccccCCCCCcceeeccccccccCCCcc--
Q 003140 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG-QIPPELSRLPSLVHMLLDNNNLTGYLPPE-- 221 (845)
Q Consensus 145 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~-- 221 (845)
..|..|+++++|++|+|++|++++..+..+.++++|++|++++|.+++ .+|..++++++|++|+|++|++++..+..
T Consensus 95 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 174 (606)
T 3vq2_A 95 FSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQ 174 (606)
T ss_dssp CCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTH
T ss_pred cChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhh
Confidence 667777777777777777777776665667777777777777777664 45666666666666666666554332211
Q ss_pred --------------------------------------------------------------------------------
Q 003140 222 -------------------------------------------------------------------------------- 221 (845)
Q Consensus 222 -------------------------------------------------------------------------------- 221 (845)
T Consensus 175 ~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~ 254 (606)
T 3vq2_A 175 FLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254 (606)
T ss_dssp HHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGG
T ss_pred hhhccccccceeeccCCCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHH
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 003140 222 -------------------------------------------------------------------------------- 221 (845)
Q Consensus 222 -------------------------------------------------------------------------------- 221 (845)
T Consensus 255 ~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~~lp~~~l~~L~~L~ 334 (606)
T 3vq2_A 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLT 334 (606)
T ss_dssp GTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCSSCCCCCCSSCCEEE
T ss_pred hhhhhhccHhheeccccccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccCcccccCCCCccceee
Confidence
Q ss_pred -----------cCCCCCCcEEEccCCcCCCC------------------------CCccccccCCCccEEEcccCCCCCC
Q 003140 222 -----------LSELPKLLILQLDNNNFEGT------------------------TIPASYSNMSKLLKLSLRNCSLQGP 266 (845)
Q Consensus 222 -----------l~~l~~L~~L~Ls~N~l~~~------------------------~~p~~~~~l~~L~~L~Ls~N~l~~~ 266 (845)
+..+++|++|+|++|++++. .+|..+.++++|+.|++++|++++.
T Consensus 335 l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~ 414 (606)
T 3vq2_A 335 LTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRV 414 (606)
T ss_dssp EESCSSCEECCCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEEECCCCTTCTTCCEEECTTSEEEST
T ss_pred ccCCcCccchhhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccccchhhccCCCCCCeeECCCCccCCc
Confidence 01122333333333333221 1223344445555555555555444
Q ss_pred CC--C------------------------CCCCCCccEEEcccccCCcC-CCCCCC-ccccCEEEccCCcCCCCcccccC
Q 003140 267 MP--D------------------------LSRIPNLGYLDLSSNQLNGS-IPPGRL-SLNITTIKLSNNKLTGTIPSNFS 318 (845)
Q Consensus 267 ~~--~------------------------l~~l~~L~~L~Ls~N~l~~~-ip~~~~-~~~L~~L~Ls~N~l~~~~p~~~~ 318 (845)
++ . +..+++|+.|++++|.+++. +|..+. ..+|+.|+|++|++++..|..|.
T Consensus 415 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 494 (606)
T 3vq2_A 415 TEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFD 494 (606)
T ss_dssp TTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTT
T ss_pred cChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhc
Confidence 33 2 44555555555555555542 343332 23677777777777777777777
Q ss_pred CCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCCC-CCC-CCcEEEecCCcccccCCCccccCC
Q 003140 319 GLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIP-PNVTVRLRGNPFCLNTNAEQFCGS 396 (845)
Q Consensus 319 ~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~-~~~-~l~~l~l~~Np~~c~~~~~~~~~~ 396 (845)
++++|++|+|++|++++.+|..+..+. +|+.|++++|+|+.+|..+ .++ .+..+++++|||.|+|+..+|..|
T Consensus 495 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~-----~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~~~~~~ 569 (606)
T 3vq2_A 495 TLHRLQLLNMSHNNLLFLDSSHYNQLY-----SLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEHQKFLQW 569 (606)
T ss_dssp TCTTCCEEECCSSCCSCEEGGGTTTCT-----TCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSSTTHHHHTT
T ss_pred ccccCCEEECCCCcCCCcCHHHccCCC-----cCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCccHHHHHH
Confidence 777777777777777777777766544 4569999999999999886 476 599999999999999999999999
Q ss_pred CCCCC
Q 003140 397 HSDDD 401 (845)
Q Consensus 397 ~~~~~ 401 (845)
.....
T Consensus 570 l~~~~ 574 (606)
T 3vq2_A 570 VKEQK 574 (606)
T ss_dssp TTTSS
T ss_pred HHcCc
Confidence 85543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=342.68 Aligned_cols=213 Identities=28% Similarity=0.315 Sum_probs=183.1
Q ss_pred cchHHHHHHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCceeeEEEEE
Q 003140 614 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYC 689 (845)
Q Consensus 614 ~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~ 689 (845)
+.+.+.....++|+..+.||+|+||+||++... +|+.||||+++.... ...+.+.+|.+++.+++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 344556667789999999999999999999975 799999999865321 1223588999999999999999999999
Q ss_pred eeCCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEec
Q 003140 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 769 (845)
Q Consensus 690 ~~~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DF 769 (845)
.+.+..++||||+++|+|.+++++.. ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++++||+||
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 99999999999999999999997643 36899999999999999999999998 999999999999999999999999
Q ss_pred CCcccCCCCCCCCccccceeecccCCCCccchhhhc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 770 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-------THKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 770 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
|+++...... ........||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 207 Gla~~~~~~~------~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 274 (412)
T 2vd5_A 207 GSCLKLRADG------TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274 (412)
T ss_dssp TTCEECCTTS------CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred hhheeccCCC------ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC
Confidence 9998754321 11223467999999999987 4578999999999999999999999997644
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=334.02 Aligned_cols=205 Identities=28% Similarity=0.507 Sum_probs=177.4
Q ss_pred hcCCCCCccccccCceEEEEEEe--------CCCcEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeC
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGIL--------PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE 692 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~--------~~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~ 692 (845)
.++|.+.+.||+|+||.||+|.+ .++..||||+++... ....+++.+|+++++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 46788899999999999999985 245689999997643 33456899999999999 899999999999999
Q ss_pred CeEEEEEEcCCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 003140 693 GEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 758 (845)
Q Consensus 693 ~~~~LV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl 758 (845)
+..++||||+++|+|.++++... ...+++..++.++.||++||+|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 99999999999999999997643 245899999999999999999999998 9999999999999
Q ss_pred cCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 759 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 759 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
+.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~ 309 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCT-----TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCCCCEEEccccCCcccCcccc-----eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999986643221 111233457789999999999999999999999999999999 99999754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=334.07 Aligned_cols=204 Identities=26% Similarity=0.410 Sum_probs=174.1
Q ss_pred HHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeE
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQ 695 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 695 (845)
...++|.+.+.||+|+||+||+|... +|+.||||+++... ....+.+.+|.++++.+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 34578999999999999999999975 68999999987532 23346688999999998 799999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++||||+++|+|.++++.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 100 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999999765 35899999999999999999999998 999999999999999999999999999854
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 175 ~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 228 (353)
T 3txo_A 175 ICN-------GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228 (353)
T ss_dssp CC----------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccC-------CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC
Confidence 321 222345679999999999998899999999999999999999999997543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=336.18 Aligned_cols=204 Identities=19% Similarity=0.231 Sum_probs=176.1
Q ss_pred HHhcCCCCCccccccCceEEEEEE------eCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcC---CCceeeEEEEEee
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGI------LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH---HRNLVSLVGYCDE 691 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~------~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~ 691 (845)
...++|.+.+.||+|+||.||+|. ..+++.||||+++... ..++.+|++++++++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345778889999999999999994 4468999999997643 456778888888886 9999999999999
Q ss_pred CCeEEEEEEcCCCCCHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC--------
Q 003140 692 EGEQMLVYEFMSNGTLRDQLSAK---SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-------- 760 (845)
Q Consensus 692 ~~~~~LV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~-------- 760 (845)
.+..++||||+++|+|.++++.. ....+++..++.++.||++||+|||+.+ ||||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence 99999999999999999999752 3457999999999999999999999998 999999999999998
Q ss_pred ---CCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 761 ---KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 761 ---~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
++.+||+|||+|+...... .........||.+|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFP-----KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSC-----TTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred ccccCCEEEeeCchhhhhhccC-----CCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence 8999999999997543111 123345567999999999999999999999999999999999999999643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=322.15 Aligned_cols=203 Identities=28% Similarity=0.429 Sum_probs=174.0
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
.++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 367889999999999999999965 68999999885432 33356899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
|||+++|+|.+++.... ++++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999997653 5899999999999999999999998 999999999999999999999999999865422
Q ss_pred CCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
. ........||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 165 ~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 216 (294)
T 4eqm_A 165 S------LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET 216 (294)
T ss_dssp ----------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred c------ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 112234568999999999999999999999999999999999999997644
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=325.64 Aligned_cols=198 Identities=25% Similarity=0.427 Sum_probs=176.8
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|.+.+.||+|+||.||+|... +|+.||+|+++... ....+.+.+|..+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 57888999999999999999975 69999999987532 223567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 158 (318)
T ss_dssp CCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence 999999999999764 35899999999999999999999998 99999999999999999999999999986532
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 159 --------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 207 (318)
T 1fot_A 159 --------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 207 (318)
T ss_dssp --------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred --------ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 1234579999999999999999999999999999999999999997643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=328.98 Aligned_cols=201 Identities=27% Similarity=0.384 Sum_probs=177.9
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChh------hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~------~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 695 (845)
.++|.+.+.||+|+||.||+|... +|+.||||+++..... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467889999999999999999975 6899999998754322 356899999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC----cEEEEecCC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF----TAKVADFGL 771 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~----~~kl~DFGl 771 (845)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 91 ~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 9999999999999999653 46899999999999999999999998 99999999999998877 799999999
Q ss_pred cccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 166 a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~ 222 (361)
T 2yab_A 166 AHEIEDG--------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222 (361)
T ss_dssp CEECCTT--------CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred ceEcCCC--------CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 9876432 12234569999999999999999999999999999999999999997543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=327.18 Aligned_cols=212 Identities=36% Similarity=0.577 Sum_probs=173.2
Q ss_pred hHHHHHHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Q 003140 616 YGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 693 (845)
Q Consensus 616 ~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~ 693 (845)
..++....++|.+.+.||+|+||.||+|.. +|+.||||++.... ....+++.+|++++++++||||+++++++.+.+
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 334445567899999999999999999987 68899999987543 334568999999999999999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 003140 694 EQMLVYEFMSNGTLRDQLSAKSK-EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 772 (845)
Q Consensus 694 ~~~LV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla 772 (845)
..++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+.+ ++|+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 99999999999999999976432 34899999999999999999999875 45999999999999999999999999999
Q ss_pred ccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 187 ~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~ 243 (309)
T 3p86_A 187 RLKAST-------FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN 243 (309)
T ss_dssp ----------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred cccccc-------ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 754321 112334578999999999999999999999999999999999999997543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=334.33 Aligned_cols=200 Identities=25% Similarity=0.392 Sum_probs=175.6
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh---hhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~L 697 (845)
.++|.+.+.||+|+||+||+|+.. +++.||||+++.... ...+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467888999999999999999975 588999999875322 2234578899999887 89999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
||||+++|+|..++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 131 V~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 99999999999999764 35899999999999999999999999 99999999999999999999999999985322
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 206 ~-------~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 206 P-------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp T-------TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred C-------CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 1 2223456799999999999999999999999999999999999999963
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=328.41 Aligned_cols=205 Identities=25% Similarity=0.422 Sum_probs=178.0
Q ss_pred HHHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCe
Q 003140 620 ALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGE 694 (845)
Q Consensus 620 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 694 (845)
....++|...+.||+|+||.||+|... +|+.||||+++... ....+.+..|.++++.+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345578999999999999999999975 68999999987532 23345688899999887 89999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003140 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (845)
Q Consensus 695 ~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~ 774 (845)
.++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 99999999999999999764 35899999999999999999999998 99999999999999999999999999986
Q ss_pred CCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 168 ~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (345)
T 1xjd_A 168 NMLGD-------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222 (345)
T ss_dssp CCCTT-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccCC-------CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 43211 12345679999999999999999999999999999999999999997543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=323.03 Aligned_cols=201 Identities=21% Similarity=0.341 Sum_probs=178.2
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
.++|.+.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 367889999999999999999975 68999999987543 3456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC--CCcEEEEecCCcccCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH--KFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~--~~~~kl~DFGla~~~~~~~ 779 (845)
+++|+|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~- 157 (321)
T 1tki_A 83 ISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence 9999999999653 346899999999999999999999998 999999999999987 789999999999876422
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 158 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 207 (321)
T 1tki_A 158 -------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp -------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred -------CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC
Confidence 22344578999999999998889999999999999999999999997643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=332.36 Aligned_cols=211 Identities=21% Similarity=0.241 Sum_probs=180.4
Q ss_pred hcCCCCCcccccc--CceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 623 TNNFNSSTQIGQG--GYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 623 ~~~f~~~~~LG~G--~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
.++|.+.+.||+| +||.||+|... +|+.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4678889999999 99999999976 79999999987532 3345678899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
||||+++|+|.+++.......+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 999999999999998776667999999999999999999999998 99999999999999999999999999865432
Q ss_pred CCCCCccccceeecccCCCCccchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
................||..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 241 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence 11111111112233478999999999987 679999999999999999999999997543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=326.62 Aligned_cols=199 Identities=25% Similarity=0.387 Sum_probs=176.2
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV 698 (845)
++|...+.||+|+||.||+|... +++.||+|+++... ....+.+.+|.++++++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56888999999999999999975 68999999987532 23346688999999988 899999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 9999999999999764 35899999999999999999999998 999999999999999999999999999864321
Q ss_pred CCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 164 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 164 -------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp -------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred -------CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 1223456799999999999999999999999999999999999999964
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=344.60 Aligned_cols=204 Identities=28% Similarity=0.425 Sum_probs=181.6
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
..++|...+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3467888999999999999999975 79999999986532 2335678999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
||||+++|+|.+++.......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999999999999998766667999999999999999999999998 99999999999999999999999999987642
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 339 ~--------~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 339 G--------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp T--------CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred C--------ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 2 12334579999999999999899999999999999999999999998654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=330.77 Aligned_cols=200 Identities=27% Similarity=0.387 Sum_probs=176.2
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
.++|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367888999999999999999965 68999999986432 23356789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp ECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999999753 45899999999999999999999999 999999999999999999999999999875422
Q ss_pred CCCCccccceeecccCCCCccchhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 169 --------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~ 220 (384)
T 4fr4_A 169 --------TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220 (384)
T ss_dssp --------CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred --------CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCC
Confidence 22345679999999999864 45899999999999999999999999743
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=323.98 Aligned_cols=202 Identities=26% Similarity=0.399 Sum_probs=168.7
Q ss_pred hcCCCCCccccccCceEEEEEEe----CCCcEEEEEEccCCC----hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCe
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGS----LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 694 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~----~~g~~vAVK~~~~~~----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 694 (845)
.++|.+.+.||+|+||.||++.. .+|+.||+|+++... ......+.+|++++++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46788999999999999999986 478999999987643 2234568899999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003140 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (845)
Q Consensus 695 ~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~ 774 (845)
.++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 99999999999999999764 35889999999999999999999998 99999999999999999999999999975
Q ss_pred CCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 171 ~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 225 (327)
T 3a62_A 171 SIHD-------GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225 (327)
T ss_dssp ---------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccC-------CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence 4321 112334579999999999999999999999999999999999999997643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=324.83 Aligned_cols=206 Identities=30% Similarity=0.455 Sum_probs=175.5
Q ss_pred hcCCCCCccccccCceEEEEEEeC----CCcEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
.++|.+.+.||+|+||.||+|.+. .+..||||+++.. .....++|.+|++++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 356888899999999999999974 4556999999764 33445789999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
||||+++|+|.++++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 128 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 99999999999999654 346899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
... .........+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 204 ~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 259 (325)
T 3kul_A 204 DPD----AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT 259 (325)
T ss_dssp -------CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred Ccc----ceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC
Confidence 221 1122233456788999999998999999999999999999999 999996543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=324.02 Aligned_cols=206 Identities=21% Similarity=0.327 Sum_probs=177.8
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeEEEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..... .+++.+|+++++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 36788899999999999999996 5789999999875432 24688999999999 99999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc-----EEEEecCCcccC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT-----AKVADFGLSRLA 775 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~-----~kl~DFGla~~~ 775 (845)
|+ +|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++. +||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 86 LL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred eC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99 99999999764 457999999999999999999999998 999999999999998887 999999999876
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.........+........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~ 220 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGL 220 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccc
Confidence 443322111122234567999999999999999999999999999999999999999764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=326.29 Aligned_cols=201 Identities=26% Similarity=0.436 Sum_probs=177.1
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 467999999999999999999975 68999999987543 334567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CcEEEEecCCcccCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAP 776 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~---~~~kl~DFGla~~~~ 776 (845)
||+++|+|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.+ +.+||+|||+++...
T Consensus 108 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 108 DLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp CCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 999999999999653 46899999999999999999999998 9999999999999865 459999999998654
Q ss_pred CCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 183 ~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~ 234 (362)
T 2bdw_A 183 DSE--------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 234 (362)
T ss_dssp TCC--------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCc--------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 221 1234579999999999999999999999999999999999999997644
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=316.57 Aligned_cols=216 Identities=40% Similarity=0.716 Sum_probs=187.6
Q ss_pred ccccchHHHHHHhcCCCCC------ccccccCceEEEEEEeCCCcEEEEEEccCC----ChhhHHHHHHHHHHHHhcCCC
Q 003140 611 VRSFTYGEMALATNNFNSS------TQIGQGGYGKVYKGILPDGTVVAVKRAQEG----SLQGEKEFLTEIQFLSRLHHR 680 (845)
Q Consensus 611 ~~~~~~~~~~~~~~~f~~~------~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~----~~~~~~~~~~Ei~~l~~l~H~ 680 (845)
...|++.++..++++|... +.||+|+||.||+|.. +++.||||++... .....+.+.+|++++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4678999999999999887 8999999999999987 6889999998643 223457899999999999999
Q ss_pred ceeeEEEEEeeCCeEEEEEEcCCCCCHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 003140 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK-SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD 759 (845)
Q Consensus 681 nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~ 759 (845)
||+++++++.+.+..++||||+++|+|.+++... ....+++..++.++.|+++||+|||+.+ |+||||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence 9999999999999999999999999999999753 3456999999999999999999999998 99999999999999
Q ss_pred CCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 760 HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 760 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.++.+||+|||+++...... .........||+.|+|||.+.+ .++.++||||||+++|||++|+.||....
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFA-----QTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp TTCCEEECCCTTCEECCSCS-----SCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred CCCcEEEeeccccccccccc-----ccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 99999999999998654321 1122234568999999998865 58899999999999999999999997543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=319.67 Aligned_cols=202 Identities=30% Similarity=0.454 Sum_probs=173.6
Q ss_pred hcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
.++|.+.+.||+|+||.||+|...+|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 367889999999999999999998899999999875322 234678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
|++ |+|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 173 (311)
T 3niz_A 100 FME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV- 173 (311)
T ss_dssp CCS-EEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-
T ss_pred CCC-CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc-
Confidence 997 5888888654 345899999999999999999999998 9999999999999999999999999998754221
Q ss_pred CCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 174 ------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 224 (311)
T 3niz_A 174 ------RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT 224 (311)
T ss_dssp ------C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ------ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCC
Confidence 12334568999999999876 568999999999999999999999997543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=328.36 Aligned_cols=202 Identities=24% Similarity=0.401 Sum_probs=179.7
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
.++|.+.+.||+|+||.||+|... +|+.||+|++..........+.+|++++++++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 367899999999999999999975 6899999999876666667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC--CCcEEEEecCCcccCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH--KFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~--~~~~kl~DFGla~~~~~~~ 779 (845)
+++|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~- 204 (387)
T 1kob_A 130 LSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 204 (387)
T ss_dssp CCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred CCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC-
Confidence 9999999999653 346899999999999999999999998 999999999999974 478999999999876422
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 205 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 254 (387)
T 1kob_A 205 -------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 254 (387)
T ss_dssp -------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred -------cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC
Confidence 12234469999999999999999999999999999999999999997644
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=326.91 Aligned_cols=198 Identities=24% Similarity=0.359 Sum_probs=177.0
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57888999999999999999975 68999999986532 233567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999997653 5899999999999999999999999 999999999999999999999999999865321
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 195 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 242 (350)
T 1rdq_E 195 ---------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp ---------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ---------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC
Confidence 234568999999999999999999999999999999999999997543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=320.86 Aligned_cols=200 Identities=25% Similarity=0.408 Sum_probs=176.9
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChh------hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~------~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 695 (845)
.++|...+.||+|+||.||+|... +|+.||||+++..... ..+++.+|++++++++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356888999999999999999975 6899999998754321 357899999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC----cEEEEecCC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF----TAKVADFGL 771 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~----~~kl~DFGl 771 (845)
++||||+++|+|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 90 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 9999999999999999653 46899999999999999999999998 99999999999999887 899999999
Q ss_pred cccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 165 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 220 (326)
T 2y0a_A 165 AHKIDFGN--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220 (326)
T ss_dssp CEECCTTS--------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred CeECCCCC--------ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence 98764221 123456999999999999999999999999999999999999999654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=327.33 Aligned_cols=203 Identities=22% Similarity=0.346 Sum_probs=177.7
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeEE
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQM 696 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 696 (845)
..++|...+.||+|+||+||+|... +|+.||||+++... ....+.+..|.++++.+ +||+|+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 4468899999999999999999976 48899999987532 23356788999999988 8999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCC
Q 003140 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~ 776 (845)
+||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 98 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 9999999999999997643 5899999999999999999999998 9999999999999999999999999998543
Q ss_pred CCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 173 ~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 225 (353)
T 2i0e_A 173 WD-------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225 (353)
T ss_dssp CT-------TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cC-------CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC
Confidence 21 122345679999999999999999999999999999999999999997543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=326.40 Aligned_cols=203 Identities=23% Similarity=0.338 Sum_probs=176.5
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-----hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-----LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 696 (845)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 357888999999999999999975 68999999985321 123578999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc---EEEEecCC
Q 003140 697 LVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT---AKVADFGL 771 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~---~kl~DFGl 771 (845)
+||||+++|+|.+++... ....+++..+..++.||++||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999999888653 3456899999999999999999999998 999999999999987654 99999999
Q ss_pred cccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 180 a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 180 AIQLGESG-------LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp CEECCTTS-------CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred eeEecCCC-------eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 98764321 1223457999999999999999999999999999999999999999764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=325.07 Aligned_cols=204 Identities=27% Similarity=0.415 Sum_probs=174.9
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 67889999999999999999976 789999999865432 3346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+++|+|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 87 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 159 (323)
T 3tki_A 87 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN-- 159 (323)
T ss_dssp CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT--
T ss_pred CCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC--
Confidence 9999999998543 45899999999999999999999998 9999999999999999999999999998653221
Q ss_pred CccccceeecccCCCCccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
.........||+.|+|||++.+..+ +.++|||||||++|||++|+.||....+
T Consensus 160 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 213 (323)
T 3tki_A 160 ---RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (323)
T ss_dssp ---EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred ---cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence 1122334679999999999987765 7799999999999999999999976443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=316.79 Aligned_cols=204 Identities=32% Similarity=0.526 Sum_probs=179.0
Q ss_pred HhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
..++|...+.||+|+||.||+|...+++.||||++.... ...+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 346788899999999999999999889999999997643 3356899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+++|+|.++++.. ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 87 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 160 (269)
T 4hcu_A 87 MEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-- 160 (269)
T ss_dssp CTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH--
T ss_pred CCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc--
Confidence 9999999999654 346899999999999999999999999 9999999999999999999999999998653211
Q ss_pred CccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
........+|..|+|||.+.+..++.++||||+|+++|||++ |+.||....
T Consensus 161 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~ 212 (269)
T 4hcu_A 161 ----YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 212 (269)
T ss_dssp ----HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ----cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC
Confidence 112233456778999999999999999999999999999999 999997543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=325.83 Aligned_cols=203 Identities=28% Similarity=0.370 Sum_probs=172.1
Q ss_pred HHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC----eEE
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----EQM 696 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~ 696 (845)
...++|++.+.||+|+||.||+|... ++.||||++.... .....+.+|+.++++++||||+++++++.+.. ..+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 34578889999999999999999875 7999999986533 33445677999999999999999999997754 479
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCeEecCCCCCCEEEcCCCcEEE
Q 003140 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE----------ADPPVFHRDIKASNILLDHKFTAKV 766 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------~~~~iiHrDLk~~NILl~~~~~~kl 766 (845)
+||||+++|+|.++++.. .+++..++.++.|+++||+|||+. + |+||||||+|||++.++.+||
T Consensus 99 lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEE
T ss_pred EEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEE
Confidence 999999999999999763 489999999999999999999998 6 999999999999999999999
Q ss_pred EecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 767 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-----KLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 767 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
+|||+++....... ........||+.|+|||++.+. .++.++|||||||++|||+||+.||....
T Consensus 173 ~DFg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 173 ADFGLALKFEAGKS-----AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242 (322)
T ss_dssp CCCTTCEEECTTSC-----CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred ccCCcccccccccC-----ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence 99999986543221 1122335789999999999863 45668999999999999999999997543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=327.43 Aligned_cols=212 Identities=22% Similarity=0.300 Sum_probs=187.7
Q ss_pred CccccchHHHHHHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcC-----CCcee
Q 003140 610 GVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-----HRNLV 683 (845)
Q Consensus 610 ~~~~~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~-----H~nIv 683 (845)
....+++.+.....++|.+.+.||+|+||.||+|... +++.||||+++. .....+.+..|++++++++ ||||+
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 3456777777788899999999999999999999974 789999999875 3344567888999999996 99999
Q ss_pred eEEEEEeeCCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---
Q 003140 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH--- 760 (845)
Q Consensus 684 ~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~--- 760 (845)
++++++...+..++||||+ +++|.+++.......+++..+..++.||++||+|||+.+ |+||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYF 175 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTC
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccc
Confidence 9999999999999999999 999999998876667999999999999999999999998 999999999999975
Q ss_pred ----------------------CCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHH
Q 003140 761 ----------------------KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSL 818 (845)
Q Consensus 761 ----------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~ 818 (845)
++.+||+|||+|+..... .....||+.|+|||++.+..++.++|||||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 245 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----------HGSIINTRQYRAPEVILNLGWDVSSDMWSF 245 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCC----------CcCccCcccccCcHHHcCCCCCCccchHHH
Confidence 789999999999864321 234568999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCC
Q 003140 819 GVVFLELLTGMQPISHGK 836 (845)
Q Consensus 819 Gvvl~elltG~~Pf~~~~ 836 (845)
||++|||++|+.||...+
T Consensus 246 G~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 246 GCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp HHHHHHHHHSSCSCCCSS
T ss_pred HHHHHHHHHCCCCCCCCc
Confidence 999999999999997644
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=315.13 Aligned_cols=204 Identities=30% Similarity=0.465 Sum_probs=179.2
Q ss_pred HhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
..++|...+.||+|+||.||+|...++..||||+++... ...+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 456788899999999999999999888899999997643 3356799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 158 (268)
T 3sxs_A 85 ISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-- 158 (268)
T ss_dssp CTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC--
T ss_pred cCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh--
Confidence 9999999999764 235899999999999999999999998 9999999999999999999999999998764322
Q ss_pred CccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 159 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (268)
T 3sxs_A 159 ----YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT 210 (268)
T ss_dssp ----EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ----hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC
Confidence 112233456778999999998899999999999999999999 999997543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=329.47 Aligned_cols=206 Identities=29% Similarity=0.462 Sum_probs=166.3
Q ss_pred hcCCCCCccccccCceEEEEEEeC----CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
.++|.+.+.||+|+||.||+|... ++..||||+++... ....++|.+|++++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357889999999999999999864 57789999997643 3445689999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
||||+++|+|.++++.. ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 124 v~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 99999999999999754 346899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
... .........++..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 200 ~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~ 255 (373)
T 2qol_A 200 DPE----AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC
T ss_pred CCc----cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 211 0111122345778999999999999999999999999999998 999996543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=331.09 Aligned_cols=215 Identities=27% Similarity=0.469 Sum_probs=183.2
Q ss_pred cchHHHHHHhcCCCCCccccccCceEEEEEEe------CCCcEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeE
Q 003140 614 FTYGEMALATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSL 685 (845)
Q Consensus 614 ~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l 685 (845)
+...++....++|.+.+.||+|+||.||+|.+ .+++.||||+++... ....+.+.+|+++++++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 55667778889999999999999999999973 246899999997643 33456799999999999 79999999
Q ss_pred EEEEeeCCe-EEEEEEcCCCCCHHHHHhccCC------------------------------------------------
Q 003140 686 VGYCDEEGE-QMLVYEFMSNGTLRDQLSAKSK------------------------------------------------ 716 (845)
Q Consensus 686 ~g~~~~~~~-~~LV~E~~~~gsL~~~l~~~~~------------------------------------------------ 716 (845)
++++.+.+. .++||||+++|+|.++++....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987654 8999999999999999976432
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 717 ----------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 717 ----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
..+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~- 247 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP- 247 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT-
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc-
Confidence 12899999999999999999999998 9999999999999999999999999998654322
Q ss_pred CCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
.........||+.|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 248 ----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 300 (359)
T 3vhe_A 248 ----DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300 (359)
T ss_dssp ----TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ----cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc
Confidence 1222344568899999999999999999999999999999998 999997643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=320.31 Aligned_cols=200 Identities=28% Similarity=0.408 Sum_probs=174.4
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC--eEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG--EQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~LV~ 699 (845)
++|.+.+.||+|+||.||+|... +|+.||||+++... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 57888999999999999999976 58999999987533 334577889999999999999999999997765 789999
Q ss_pred EcCCCCCHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----cCCCcEEEEecCCccc
Q 003140 700 EFMSNGTLRDQLSAKS-KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL----DHKFTAKVADFGLSRL 774 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl----~~~~~~kl~DFGla~~ 774 (845)
||+++|+|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 9999999999997643 334899999999999999999999998 9999999999999 7888999999999987
Q ss_pred CCCCCCCCccccceeecccCCCCccchhhhc--------CCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFL--------THKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
..... ......||..|+|||++. +..++.++|||||||++|||++|+.||..
T Consensus 166 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 225 (319)
T 4euu_A 166 LEDDE--------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (319)
T ss_dssp CCTTC--------CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEEC
T ss_pred cCCCC--------ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 64321 123456899999999986 57889999999999999999999999964
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=330.46 Aligned_cols=332 Identities=18% Similarity=0.160 Sum_probs=257.5
Q ss_pred CCCCCCCCCCCCCCcceEecCCC-------CC-------CCcceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCC
Q 003140 54 LSNWNRGDPCTSNWTGVLCFNTT-------MD-------DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKIS 119 (845)
Q Consensus 54 l~~W~~~~~c~~~w~Gv~C~~~~-------~~-------~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~ 119 (845)
+++|.....|++.|.+..|.... .. -...+++.|++.++.++...+..+..+++|++|+|++|.++
T Consensus 3 ~~~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~ 82 (390)
T 3o6n_A 3 VKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE 82 (390)
T ss_dssp ----CCEECBCC------EEEESCEECSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCC
T ss_pred cCCCCCccceehhhhhhccceeeeeeecccccccccccccccCCceEEEecCCchhhCChhHhcccccCcEEECCCCccc
Confidence 57899888898766665552110 00 12357888999999988655556789999999999999999
Q ss_pred CCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccC
Q 003140 120 GSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELS 199 (845)
Q Consensus 120 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~ 199 (845)
+..+..|.++++|++|+|++|++++..|..|+++++|++|+|++|+++...+..|.++++|++|++++|++++..+..+.
T Consensus 83 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 162 (390)
T 3o6n_A 83 EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQ 162 (390)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTS
T ss_pred ccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhcc
Confidence 87778899999999999999999988888899999999999999999965556679999999999999999988888899
Q ss_pred CCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCcccc---------------ccCCCccEEEcccCCCC
Q 003140 200 RLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASY---------------SNMSKLLKLSLRNCSLQ 264 (845)
Q Consensus 200 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~---------------~~l~~L~~L~Ls~N~l~ 264 (845)
.+++|++|++++|++++.. +..+++|+.|++++|.+++...+..+ ...++|+.|++++|+++
T Consensus 163 ~l~~L~~L~l~~n~l~~~~---~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~n~l~ 239 (390)
T 3o6n_A 163 ATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLT 239 (390)
T ss_dssp SCTTCCEEECCSSCCSBCC---GGGCTTCSEEECCSSCCSEEECCSSCSEEECCSSCCCEEECCCCSSCCEEECCSSCCC
T ss_pred CCCCCCEEECCCCcCCccc---cccccccceeecccccccccCCCCcceEEECCCCeeeeccccccccccEEECCCCCCc
Confidence 9999999999999998653 34445555555555555432222111 12357888999999888
Q ss_pred CCCCCCCCCCCccEEEcccccCCcCCCCCCC-ccccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCChhhhh
Q 003140 265 GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRL-SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQ 343 (845)
Q Consensus 265 ~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~-~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~ 343 (845)
+. +.+..+++|+.|++++|.+++..|..+. ..+|+.|+|++|++++ +|..+..+++|++|+|++|+++ .+|..+..
T Consensus 240 ~~-~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~ 316 (390)
T 3o6n_A 240 DT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ 316 (390)
T ss_dssp CC-GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHH
T ss_pred cc-HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccc
Confidence 75 5688889999999999999987776654 4589999999999985 5677788999999999999998 67877776
Q ss_pred hccCCCCcceEEEccCCCCCCCCCCCCCCCCcEEEecCCcccccCCCccccCCC
Q 003140 344 SRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSH 397 (845)
Q Consensus 344 l~~l~~~~l~~L~ls~N~l~~i~~~~~~~~l~~l~l~~Np~~c~~~~~~~~~~~ 397 (845)
+.. |+.|++++|+|+.++ ...++.++.|++++|||.|+|....+..+.
T Consensus 317 l~~-----L~~L~L~~N~i~~~~-~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~ 364 (390)
T 3o6n_A 317 FDR-----LENLYLDHNSIVTLK-LSTHHTLKNLTLSHNDWDCNSLRALFRNVA 364 (390)
T ss_dssp HTT-----CSEEECCSSCCCCCC-CCTTCCCSEEECCSSCEEHHHHHHHTTTCC
T ss_pred cCc-----CCEEECCCCccceeC-chhhccCCEEEcCCCCccchhHHHHHHHHH
Confidence 654 559999999999986 235889999999999999999766655444
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=343.26 Aligned_cols=209 Identities=26% Similarity=0.433 Sum_probs=182.1
Q ss_pred hHHHHHHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeE
Q 003140 616 YGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (845)
Q Consensus 616 ~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 695 (845)
.+++++..++|...+.||+|+||.||+|.+.++..||||+++... ...++|.+|+++|++++||||+++++++. .+..
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 345566778899999999999999999999888999999998644 34678999999999999999999999987 5678
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++||||+++|+|.++++......+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 99999999999999998654456889999999999999999999998 999999999999999999999999999875
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
.... ........++..|+|||++....++.++|||||||++|||+| |+.||...
T Consensus 335 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~ 389 (454)
T 1qcf_A 335 EDNE------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 389 (454)
T ss_dssp CCHH------HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCCc------eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 4211 111223446788999999999999999999999999999999 99999754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=318.37 Aligned_cols=203 Identities=26% Similarity=0.464 Sum_probs=162.3
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
.++|...+.||+|+||.||+|... +|+.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467889999999999999999965 689999999875432 234678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCC
Q 003140 701 FMSNGTLRDQLSAK----SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (845)
Q Consensus 701 ~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~ 776 (845)
|++ |+|.+++... ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 6999998653 2245899999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 160 ~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 213 (317)
T 2pmi_A 160 IPV-------NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213 (317)
T ss_dssp SCC-------CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCc-------ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 221 11234568999999999976 468999999999999999999999997544
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=327.32 Aligned_cols=196 Identities=27% Similarity=0.407 Sum_probs=169.8
Q ss_pred CccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCCCCH
Q 003140 629 STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 707 (845)
Q Consensus 629 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL 707 (845)
.+.||+|+||.||+|... +|+.||+|+++.......+++.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 567999999999999964 6899999999877666778899999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE--cCCCcEEEEecCCcccCCCCCCCCccc
Q 003140 708 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL--DHKFTAKVADFGLSRLAPVPDIEGIVP 785 (845)
Q Consensus 708 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl--~~~~~~kl~DFGla~~~~~~~~~~~~~ 785 (845)
.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++......
T Consensus 174 ~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~------ 243 (373)
T 2x4f_A 174 FDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE------ 243 (373)
T ss_dssp HHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC------
T ss_pred HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc------
Confidence 9988653 345899999999999999999999998 9999999999999 567899999999998764321
Q ss_pred cceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 786 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 786 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 244 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 292 (373)
T 2x4f_A 244 --KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN 292 (373)
T ss_dssp --BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred --ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1233469999999999999999999999999999999999999997654
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=350.32 Aligned_cols=312 Identities=19% Similarity=0.245 Sum_probs=280.8
Q ss_pred eEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecc
Q 003140 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162 (845)
Q Consensus 83 ~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 162 (845)
.++.|++++|.+++..+..|+.+++|++|+|++|+++ .+|..+.++++|++|+|++|++++..|..+..+++|++|+++
T Consensus 255 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 333 (606)
T 3t6q_A 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIK 333 (606)
T ss_dssp EEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECC
T ss_pred ceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECC
Confidence 7999999999999888888999999999999999999 789899999999999999999998888899999999999999
Q ss_pred cccccCCCCc-cccCccCCCEEEccCCCCCCCC--ccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCC
Q 003140 163 QNYISGSLPK-SFANLNKTRHFHMNNNSISGQI--PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFE 239 (845)
Q Consensus 163 ~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~--p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 239 (845)
+|.+.+.+|. .+..+++|++|++++|.+++.. +..+..+++|++|++++|++++..|..|..+++|++|+|++|+++
T Consensus 334 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 413 (606)
T 3t6q_A 334 GNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLK 413 (606)
T ss_dssp SCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEE
T ss_pred CCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCC
Confidence 9999977765 4999999999999999998765 778999999999999999999999999999999999999999998
Q ss_pred CCCCccccccCCCccEEEcccCCCCCCCCC-CCCCCCccEEEcccccCCcC-CCC--CC-CccccCEEEccCCcCCCCcc
Q 003140 240 GTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGS-IPP--GR-LSLNITTIKLSNNKLTGTIP 314 (845)
Q Consensus 240 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~-ip~--~~-~~~~L~~L~Ls~N~l~~~~p 314 (845)
+...+..+.++++|+.|++++|.+++.++. +..+++|+.|++++|.+++. ++. .+ ...+|+.|+|++|++++..|
T Consensus 414 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 493 (606)
T 3t6q_A 414 VKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQ 493 (606)
T ss_dssp CCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECT
T ss_pred CcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccCh
Confidence 744445699999999999999999997764 88999999999999999863 222 22 23489999999999999999
Q ss_pred cccCCCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCCC--CCCCCcEEEecCCcccccCCCcc
Q 003140 315 SNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTNAEQ 392 (845)
Q Consensus 315 ~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~--~~~~l~~l~l~~Np~~c~~~~~~ 392 (845)
..|..+++|++|+|++|++++..|..+..+. .| .|++++|+++.++... .++.++.+++++|||.|+|+..+
T Consensus 494 ~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~-----~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~~~ 567 (606)
T 3t6q_A 494 HAFTSLKMMNHVDLSHNRLTSSSIEALSHLK-----GI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIY 567 (606)
T ss_dssp TTTTTCTTCCEEECCSSCCCGGGGGGGTTCC-----SC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGGHH
T ss_pred hhhccccCCCEEECCCCccCcCChhHhCccc-----cc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCcHH
Confidence 9999999999999999999999998887654 45 7999999999988764 58899999999999999999999
Q ss_pred ccCCCCCCC
Q 003140 393 FCGSHSDDD 401 (845)
Q Consensus 393 ~~~~~~~~~ 401 (845)
|..|.....
T Consensus 568 ~~~w~~~~~ 576 (606)
T 3t6q_A 568 FLEWYKENM 576 (606)
T ss_dssp HHHHHHHCG
T ss_pred HHHHHHhCc
Confidence 988875443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=336.66 Aligned_cols=201 Identities=32% Similarity=0.502 Sum_probs=176.5
Q ss_pred HHHHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-eEEE
Q 003140 619 MALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG-EQML 697 (845)
Q Consensus 619 ~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~L 697 (845)
+.+..++|...+.||+|+||.||+|.+. |+.||||+++... ..++|.+|+++|++++||||+++++++.+.+ ..++
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 3445677888999999999999999985 7899999998643 4568999999999999999999999987665 7999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
||||+++|+|.++++......+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 265 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 999999999999998876666899999999999999999999998 99999999999999999999999999985431
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
. .....++..|+|||.+.+..++.++|||||||++|||+| |+.||...
T Consensus 342 ~----------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~ 390 (450)
T 1k9a_A 342 T----------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 390 (450)
T ss_dssp ---------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTS
T ss_pred c----------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 122356889999999999999999999999999999998 99999753
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=338.97 Aligned_cols=204 Identities=24% Similarity=0.417 Sum_probs=179.9
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
.++|...+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367888899999999999999975 699999999865322 2346789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCC
Q 003140 699 YEFMSNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~ 776 (845)
|||+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999997643 456999999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 341 ~~~-------~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 341 AGQ-------TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp TTC-------CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred CCC-------cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 321 11234579999999999999999999999999999999999999997653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=344.16 Aligned_cols=210 Identities=31% Similarity=0.497 Sum_probs=183.7
Q ss_pred HHHHHHhcCCCCCccccccCceEEEEEEeCC-CcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeE
Q 003140 617 GEMALATNNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (845)
Q Consensus 617 ~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 695 (845)
++++...++|...+.||+|+||.||+|.+.. +..||||+++... ...++|.+|+++|++++||||++++++|.+.+..
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 291 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 291 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence 3445556778889999999999999999864 8899999997643 3467899999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++||||+++|+|.++++......+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceec
Confidence 99999999999999998766677999999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
.... ........++..|+|||++....++.++|||||||++|||+| |+.||...+
T Consensus 369 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~ 424 (495)
T 1opk_A 369 TGDT------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 424 (495)
T ss_dssp TTCC------EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cCCc------eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC
Confidence 4321 111223446788999999999999999999999999999999 999997543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=321.92 Aligned_cols=205 Identities=27% Similarity=0.407 Sum_probs=169.1
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC----e
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----E 694 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----~ 694 (845)
.++|.+.+.||+|+||.||+|.. .+++.||||+++.... ...+.+.+|++++++++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 36788999999999999999996 5789999999876432 33467899999999999999999999986654 3
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003140 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (845)
Q Consensus 695 ~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~ 774 (845)
.++||||+++|+|.++++... .+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 499999999999999997643 5899999999999999999999998 99999999999999999999999999986
Q ss_pred CCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
...... .........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 166 ~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 223 (311)
T 3ork_A 166 IADSGN----SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223 (311)
T ss_dssp --------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccc----ccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 543211 1112234568999999999999999999999999999999999999997544
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-35 Score=347.35 Aligned_cols=341 Identities=18% Similarity=0.238 Sum_probs=262.4
Q ss_pred ceEecCCC---CCC-CcceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCC
Q 003140 69 GVLCFNTT---MDD-GYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144 (845)
Q Consensus 69 Gv~C~~~~---~~~-~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 144 (845)
-|.|.... ++. -...++.|+|++|+|++..+.+|.++++|++|+|++|+|++..|.+|.++++|++|+|++|+|++
T Consensus 35 ~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~ 114 (635)
T 4g8a_A 35 TYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS 114 (635)
T ss_dssp EEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred EEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCC
Confidence 46786533 222 23579999999999998888899999999999999999998888889999999999999999997
Q ss_pred CCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCC-CCccccCCCCCcceeeccccccccCCCcccC
Q 003140 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG-QIPPELSRLPSLVHMLLDNNNLTGYLPPELS 223 (845)
Q Consensus 145 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~ 223 (845)
..+..|.++++|++|+|++|+|++..+..|+++++|++|+|++|.+++ ..|..++.+++|++|+|++|++++..+..|.
T Consensus 115 l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~ 194 (635)
T 4g8a_A 115 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 194 (635)
T ss_dssp ECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGH
T ss_pred CCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccccccccc
Confidence 777789999999999999999998878889999999999999999975 4678889999999999999987654322111
Q ss_pred --------------------------------------------------------------------------------
Q 003140 224 -------------------------------------------------------------------------------- 223 (845)
Q Consensus 224 -------------------------------------------------------------------------------- 223 (845)
T Consensus 195 ~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~ 274 (635)
T 4g8a_A 195 VLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 274 (635)
T ss_dssp HHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTT
T ss_pred chhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccc
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 003140 224 -------------------------------------------------------------------------------- 223 (845)
Q Consensus 224 -------------------------------------------------------------------------------- 223 (845)
T Consensus 275 ~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l 354 (635)
T 4g8a_A 275 LEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRL 354 (635)
T ss_dssp TGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEE
T ss_pred cccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhc
Confidence
Q ss_pred --------------CCCCCcEEEccCCcCCCC------------------------------------------------
Q 003140 224 --------------ELPKLLILQLDNNNFEGT------------------------------------------------ 241 (845)
Q Consensus 224 --------------~l~~L~~L~Ls~N~l~~~------------------------------------------------ 241 (845)
.+++|+.|+++.|.+...
T Consensus 355 ~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~ 434 (635)
T 4g8a_A 355 TFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQ 434 (635)
T ss_dssp EEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEES
T ss_pred ccccccCCCCcccccccccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhccccc
Confidence 122334444444433210
Q ss_pred -CCccccccCCCccEEEcccCCCCCCCCC-CCCCCCccEEEcccccCCc-CCCCCCCc-cccCEEEccCCcCCCCccccc
Q 003140 242 -TIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNG-SIPPGRLS-LNITTIKLSNNKLTGTIPSNF 317 (845)
Q Consensus 242 -~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~-~ip~~~~~-~~L~~L~Ls~N~l~~~~p~~~ 317 (845)
..+..+.++++|+.++++.|.+.+..+. +..+++|+.|++++|.+.. .+|..+.. .+|+.|+|++|+|++..|..|
T Consensus 435 ~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f 514 (635)
T 4g8a_A 435 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 514 (635)
T ss_dssp TTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTT
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHH
Confidence 0011233445555566666666665553 6677888888888887543 34544433 489999999999999999999
Q ss_pred CCCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCCC--CC-CCCcEEEecCCcccccCCCcccc
Q 003140 318 SGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NI-PPNVTVRLRGNPFCLNTNAEQFC 394 (845)
Q Consensus 318 ~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~--~~-~~l~~l~l~~Np~~c~~~~~~~~ 394 (845)
.++++|++|+|++|+|++..|..+..+.+ |++|||++|+|++++... .+ +.++.|+|++|||.|||++.+|.
T Consensus 515 ~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~-----L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~~~~ 589 (635)
T 4g8a_A 515 NSLSSLQVLNMSHNNFFSLDTFPYKCLNS-----LQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFL 589 (635)
T ss_dssp TTCTTCCEEECTTSCCCBCCCGGGTTCTT-----CCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGGHHHH
T ss_pred cCCCCCCEEECCCCcCCCCChhHHhCCCC-----CCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCcHHHH
Confidence 99999999999999999888888876554 569999999999987753 45 57999999999999999999999
Q ss_pred CCCCCCCcccccCCCCCCCcCC
Q 003140 395 GSHSDDDNEIDRSTNSTLDCRA 416 (845)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~ 416 (845)
.|.......+.. ...+.|..
T Consensus 590 ~wl~~~~~~~~~--~~~~~C~~ 609 (635)
T 4g8a_A 590 QWIKDQRQLLVE--VERMECAT 609 (635)
T ss_dssp HHHHHTTTTBSC--GGGCBBCS
T ss_pred HHHHhCCCccCC--CCCceeCC
Confidence 887544333222 23456655
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=327.74 Aligned_cols=200 Identities=27% Similarity=0.389 Sum_probs=167.4
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh---hhHHHHHHHHHH-HHhcCCCceeeEEEEEeeCCeEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQF-LSRLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~~-l~~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
++|...+.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|..+ ++.++||||+++++++.+.+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 56888999999999999999975 588999999875432 234556777776 5778999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.....
T Consensus 118 ~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 118 LDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 9999999999999764 35889999999999999999999999 999999999999999999999999999853221
Q ss_pred CCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 193 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 242 (373)
T 2r5t_A 193 -------NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 242 (373)
T ss_dssp -------CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred -------CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 12234567999999999999999999999999999999999999999754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=317.00 Aligned_cols=208 Identities=28% Similarity=0.462 Sum_probs=178.5
Q ss_pred HHHHHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 618 EMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 618 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
.+....++|...+.||+|+||.||+|.+.++..||||+++.... ..+++.+|++++++++||||+++++++.+.+..++
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 96 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence 44455678899999999999999999998889999999986433 35689999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
||||+++|+|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 97 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 97 ITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp EECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred EEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999999999763 235899999999999999999999998 99999999999999999999999999986542
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
.. ........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 173 ~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~ 226 (283)
T 3gen_A 173 DE------YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 226 (283)
T ss_dssp HH------HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cc------cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC
Confidence 21 111233456788999999998999999999999999999998 999997543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=331.32 Aligned_cols=203 Identities=25% Similarity=0.385 Sum_probs=176.6
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEE
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
..++|.+.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4567899999999999999999864 78999999987543 23456789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCcEEEEecCCcccC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD---HKFTAKVADFGLSRLA 775 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~---~~~~~kl~DFGla~~~ 775 (845)
|||+++|+|.+++... ..+++..+..++.||++||+|||+++ |+||||||+|||++ .++.+||+|||+++..
T Consensus 89 ~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp ECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 9999999999999764 45899999999999999999999998 99999999999998 4678999999999865
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 164 ~~~~-------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~ 217 (444)
T 3soa_A 164 EGEQ-------QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED 217 (444)
T ss_dssp CTTC-------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCCC-------ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc
Confidence 4321 12234679999999999999999999999999999999999999996543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=314.47 Aligned_cols=201 Identities=28% Similarity=0.434 Sum_probs=171.6
Q ss_pred cCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChh--hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
++|...+.||+|+||.||+|...+|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 468889999999999999999988999999998654322 246788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
++ ++|.+++... ...+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 153 (288)
T 1ob3_A 82 LD-QDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP--- 153 (288)
T ss_dssp CS-EEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc---
Confidence 97 5999988654 346899999999999999999999998 999999999999999999999999999765321
Q ss_pred CccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 154 ----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 205 (288)
T 1ob3_A 154 ----VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205 (288)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ----ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 112234468999999999876 458999999999999999999999997543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=313.04 Aligned_cols=202 Identities=27% Similarity=0.443 Sum_probs=173.6
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
++|+..+.||+|+||+||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 47888999999999999999975 68999999987533 2334678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
|+++ ++.+++... ...+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp CCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-
T ss_pred cCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc-
Confidence 9974 666666443 346899999999999999999999998 9999999999999999999999999998754221
Q ss_pred CCccccceeecccCCCCccchhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
.......||..|+|||++.+.. ++.++|||||||++|||++|..||..+.+
T Consensus 156 ------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~ 207 (292)
T 3o0g_A 156 ------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_dssp ------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS
T ss_pred ------ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC
Confidence 2233456899999999998765 89999999999999999999999865554
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=322.74 Aligned_cols=200 Identities=28% Similarity=0.431 Sum_probs=162.2
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
.++|.+.+.||+|+||.||+|... +++.||||+++... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 467889999999999999999976 58899999987543 345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEEecCCcccCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~---~~~~kl~DFGla~~~~~~ 778 (845)
+++|+|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 130 VTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp CCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 9999999999653 45899999999999999999999998 999999999999975 889999999999865321
Q ss_pred CCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 205 --------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 255 (349)
T 2w4o_A 205 --------VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG 255 (349)
T ss_dssp ----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC
T ss_pred --------cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 122345689999999999999999999999999999999999999975443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=325.05 Aligned_cols=210 Identities=30% Similarity=0.506 Sum_probs=179.6
Q ss_pred HHHHhcCCCCCccccccCceEEEEEEeC------CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEee
Q 003140 619 MALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 691 (845)
Q Consensus 619 ~~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~ 691 (845)
+....++|...+.||+|+||.||+|... +++.||||+++... ....++|.+|++++++++||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3445678999999999999999999974 34899999997643 3345789999999999999999999999999
Q ss_pred CCeEEEEEEcCCCCCHHHHHhccC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 003140 692 EGEQMLVYEFMSNGTLRDQLSAKS----------------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749 (845)
Q Consensus 692 ~~~~~LV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHr 749 (845)
.+..++||||+++|+|.++++... ...+++..++.++.||++||+|||+++ |+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 999999999999999999997642 256899999999999999999999998 9999
Q ss_pred CCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-C
Q 003140 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-G 828 (845)
Q Consensus 750 DLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G 828 (845)
||||+|||++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||+| |
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 273 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 273 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGC-----BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCcc-----ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcC
Confidence 9999999999999999999999976532210 112234567899999999999999999999999999999999 9
Q ss_pred CCCCCCCC
Q 003140 829 MQPISHGK 836 (845)
Q Consensus 829 ~~Pf~~~~ 836 (845)
+.||....
T Consensus 274 ~~p~~~~~ 281 (343)
T 1luf_A 274 LQPYYGMA 281 (343)
T ss_dssp CCTTTTSC
T ss_pred CCcCCCCC
Confidence 99997543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=337.14 Aligned_cols=202 Identities=26% Similarity=0.343 Sum_probs=168.1
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG---SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
.++|.+.+.||+|+||.||+|... +|+.||||+++.. .......+.+|++++++++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 357888999999999999999964 6899999998753 223345788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
|||+++|+|.+++... ..+++..+..++.|+++||+|||+ .+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 227 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp ECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 9999999999999764 358999999999999999999998 77 99999999999999999999999999985432
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 302 ~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 353 (446)
T 4ejn_A 302 D-------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353 (446)
T ss_dssp ------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred C-------CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 1 122345679999999999999999999999999999999999999997643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=317.88 Aligned_cols=198 Identities=27% Similarity=0.374 Sum_probs=168.6
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV 698 (845)
.++|+..+.||+|+||+||+|... +|+.||||++.... .....++..|+..+.++ +||||+++++++.+.+..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 467999999999999999999976 79999999976532 33344566677666665 899999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
|||+ +|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 136 ~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp EECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred Eecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 9999 789999887653 46999999999999999999999998 999999999999999999999999999865422
Q ss_pred CCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
.......||++|+|||++.+ .++.++|||||||++|||++|..|+..
T Consensus 211 --------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 211 --------GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp ------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred --------CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 12334568999999998875 789999999999999999999877754
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=339.54 Aligned_cols=304 Identities=21% Similarity=0.234 Sum_probs=243.0
Q ss_pred ceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeec
Q 003140 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (845)
Q Consensus 82 ~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (845)
.+++.|+|++|.+++..+..|+.+++|++|+|++|++++..|..|.++++|++|+|++|+++ .+|.. .+++|++|+|
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence 57888999999888877788888999999999999888887888888888999999988888 66666 7888888888
Q ss_pred ccccccCC-CCccccCccCCCEEEccCCCCCCC-------------------------CccccCCCC-------------
Q 003140 162 DQNYISGS-LPKSFANLNKTRHFHMNNNSISGQ-------------------------IPPELSRLP------------- 202 (845)
Q Consensus 162 s~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~-------------------------~p~~l~~l~------------- 202 (845)
++|++++. +|..|.++++|++|+|++|++++. .|..+..+.
T Consensus 129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~ 208 (562)
T 3a79_B 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSL 208 (562)
T ss_dssp CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTTTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSC
T ss_pred CCCCccccCchHhhcccCcccEEecCCCccccCchhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccc
Confidence 88888863 467888888888888888877532 222222211
Q ss_pred --------------------------------------------------------------------Ccceeecccccc
Q 003140 203 --------------------------------------------------------------------SLVHMLLDNNNL 214 (845)
Q Consensus 203 --------------------------------------------------------------------~L~~L~L~~N~l 214 (845)
+|++|++++|++
T Consensus 209 ~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l 288 (562)
T 3a79_B 209 FSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTI 288 (562)
T ss_dssp CCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEE
T ss_pred hhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEe
Confidence 566666677777
Q ss_pred ccCCCccc-----------------------------------------------------CCCCCCcEEEccCCcCCCC
Q 003140 215 TGYLPPEL-----------------------------------------------------SELPKLLILQLDNNNFEGT 241 (845)
Q Consensus 215 ~~~~p~~l-----------------------------------------------------~~l~~L~~L~Ls~N~l~~~ 241 (845)
+|.+|..+ ..+++|++|+|++|++++
T Consensus 289 ~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~~n~l~~- 367 (562)
T 3a79_B 289 TERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTD- 367 (562)
T ss_dssp CSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCT-
T ss_pred eccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECCCCcccc-
Confidence 76676654 567788888999988886
Q ss_pred CCccccccCCCccEEEcccCCCCCCCC---CCCCCCCccEEEcccccCCcCCCCCCC--ccccCEEEccCCcCCCCcccc
Q 003140 242 TIPASYSNMSKLLKLSLRNCSLQGPMP---DLSRIPNLGYLDLSSNQLNGSIPPGRL--SLNITTIKLSNNKLTGTIPSN 316 (845)
Q Consensus 242 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~---~l~~l~~L~~L~Ls~N~l~~~ip~~~~--~~~L~~L~Ls~N~l~~~~p~~ 316 (845)
..|..+.++++|+.|+|++|++++.++ .+..+++|+.|++++|++++.+|...+ ..+|+.|+|++|++++.+|..
T Consensus 368 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 447 (562)
T 3a79_B 368 SVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRC 447 (562)
T ss_dssp TTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSS
T ss_pred chhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhh
Confidence 578888888999999999999887542 478888999999999999876776533 348999999999998877765
Q ss_pred cCCCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCC-C-CCCCCcEEEecCCcccccCCCcccc
Q 003140 317 FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVRLRGNPFCLNTNAEQFC 394 (845)
Q Consensus 317 ~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~-~-~~~~l~~l~l~~Np~~c~~~~~~~~ 394 (845)
+. ++|++|+|++|+++ .+|..++.+ ++|+.|+|++|+|+++|.. + .++.++.+++++|||.|+|+..+|.
T Consensus 448 l~--~~L~~L~L~~N~l~-~ip~~~~~l-----~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~~ 519 (562)
T 3a79_B 448 LP--PKVKVLDLHNNRIM-SIPKDVTHL-----QALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGIRYL 519 (562)
T ss_dssp CC--TTCSEEECCSSCCC-CCCTTTTSS-----CCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHHHHHHH
T ss_pred hc--CcCCEEECCCCcCc-ccChhhcCC-----CCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcchHHHH
Confidence 54 68999999999998 788877644 4566999999999999987 5 5899999999999999999998885
Q ss_pred C-CC
Q 003140 395 G-SH 397 (845)
Q Consensus 395 ~-~~ 397 (845)
. |.
T Consensus 520 ~~~~ 523 (562)
T 3a79_B 520 SEWI 523 (562)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 4 53
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=321.40 Aligned_cols=198 Identities=26% Similarity=0.395 Sum_probs=173.5
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|.+.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+++++.++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5788899999999999999996 5789999999864321 22357899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+ +|+|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 89 E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~- 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG- 161 (336)
T ss_dssp CCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-
T ss_pred ECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC-
Confidence 999 78999988664 35899999999999999999999998 999999999999999999999999999865422
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...
T Consensus 162 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 211 (336)
T 3h4j_B 162 -------NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211 (336)
T ss_dssp -------BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred -------cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence 12234569999999999988776 78999999999999999999999653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=331.26 Aligned_cols=210 Identities=28% Similarity=0.463 Sum_probs=178.8
Q ss_pred HHHHHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeE
Q 003140 618 EMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (845)
Q Consensus 618 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 695 (845)
.+....++|...+.||+|+||.||+|.+. +++.||||+++... ....++|.+|++++++++||||+++++++.+.+..
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 187 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence 34455678888999999999999999986 78999999987643 23345789999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++||||+++|+|.++++... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 99999999999999997542 35889999999999999999999998 999999999999999999999999999864
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
.... .........++..|+|||.+.+..++.++|||||||++|||+| |+.||....
T Consensus 264 ~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~ 320 (377)
T 3cbl_A 264 ADGV-----YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320 (377)
T ss_dssp TTSE-----EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred CCCc-----eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 3211 0011112235678999999998899999999999999999998 999997543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=318.72 Aligned_cols=208 Identities=25% Similarity=0.402 Sum_probs=171.9
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-------
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG------- 693 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------- 693 (845)
.++|++.+.||+|+||.||+|... +|+.||||+++... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 357888999999999999999976 79999999987543 334578999999999999999999999986543
Q ss_pred --------------------------------------------------eEEEEEEcCCCCCHHHHHhccCC-CCCCHH
Q 003140 694 --------------------------------------------------EQMLVYEFMSNGTLRDQLSAKSK-EPLGFA 722 (845)
Q Consensus 694 --------------------------------------------------~~~LV~E~~~~gsL~~~l~~~~~-~~l~~~ 722 (845)
..++||||+++|+|.+++..... ....+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 37999999999999999977433 345777
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCcc-----ccceeecccCCCC
Q 003140 723 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV-----PAHVSTVVKGTPG 797 (845)
Q Consensus 723 ~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~-----~~~~~~~~~gt~~ 797 (845)
.++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++........... .........||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 88999999999999999998 999999999999999999999999999876543211000 0112234579999
Q ss_pred ccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003140 798 YLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833 (845)
Q Consensus 798 y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~ 833 (845)
|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 999999999999999999999999999999988764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=316.97 Aligned_cols=204 Identities=30% Similarity=0.468 Sum_probs=173.1
Q ss_pred hcCCCCCccccccCceEEEEEEe-----CCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CeE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQ 695 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~ 695 (845)
.++|++.+.||+|+||.||+|.+ .+++.||||++........+++.+|++++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46788899999999999999984 36899999999877766778899999999999999999999998553 568
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++||||+++|+|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 99999999999999997643 35899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
..... .........++..|+|||.+.+..++.++||||||+++|||+||..||..
T Consensus 165 ~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 165 PQDKE----FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp ---------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred cCCcc----eeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence 43211 11122334577889999999999999999999999999999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=315.08 Aligned_cols=204 Identities=30% Similarity=0.435 Sum_probs=172.4
Q ss_pred HHhcCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCC-----hhhHHHHHHHHHHHHhc---CCCceeeEEEEEee
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS-----LQGEKEFLTEIQFLSRL---HHRNLVSLVGYCDE 691 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~-----~~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~~ 691 (845)
...++|.+.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+++++++ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4467899999999999999999996 478999999986322 11234667777777766 49999999999977
Q ss_pred CC-----eEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 003140 692 EG-----EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV 766 (845)
Q Consensus 692 ~~-----~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl 766 (845)
.. ..++||||++ |+|.+++.......+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 55 5799999997 69999998876667999999999999999999999999 999999999999999999999
Q ss_pred EecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 767 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 767 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 162 ~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 223 (308)
T 3g33_A 162 ADFGLARIYSYQ--------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 223 (308)
T ss_dssp CSCSCTTTSTTC--------CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS
T ss_pred eeCccccccCCC--------cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999865422 12344578999999999999999999999999999999999999996544
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=319.68 Aligned_cols=210 Identities=30% Similarity=0.459 Sum_probs=180.2
Q ss_pred HHHHhcCCCCCccccccCceEEEEEEe------CCCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEee
Q 003140 619 MALATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 691 (845)
Q Consensus 619 ~~~~~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~ 691 (845)
+....++|.+.+.||+|+||.||+|.. .+++.||||+++... ....+++.+|++++++++||||+++++++.+
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 344567888999999999999999985 245889999997543 3445789999999999999999999999999
Q ss_pred CCeEEEEEEcCCCCCHHHHHhccCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 003140 692 EGEQMLVYEFMSNGTLRDQLSAKSK----------------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749 (845)
Q Consensus 692 ~~~~~LV~E~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHr 749 (845)
.+..++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+++ |+||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~ 174 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHR 174 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccc
Confidence 9999999999999999999976432 34899999999999999999999998 9999
Q ss_pred CCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-C
Q 003140 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-G 828 (845)
Q Consensus 750 DLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G 828 (845)
||||+|||++.++.+||+|||+++....... ........+|+.|+|||.+.+..++.++|||||||++|||++ |
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 249 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDS-----YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSC-----EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred ccchheEEEcCCCCEEEcccccccccccccc-----ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999999999999986643221 111233457788999999999899999999999999999999 9
Q ss_pred CCCCCCCC
Q 003140 829 MQPISHGK 836 (845)
Q Consensus 829 ~~Pf~~~~ 836 (845)
+.||....
T Consensus 250 ~~p~~~~~ 257 (314)
T 2ivs_A 250 GNPYPGIP 257 (314)
T ss_dssp CCSSTTCC
T ss_pred CCCCCCCC
Confidence 99997543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=326.66 Aligned_cols=197 Identities=24% Similarity=0.362 Sum_probs=163.1
Q ss_pred cCCCCC-ccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHh-cCCCceeeEEEEEee----CCeEE
Q 003140 624 NNFNSS-TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSR-LHHRNLVSLVGYCDE----EGEQM 696 (845)
Q Consensus 624 ~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~-l~H~nIv~l~g~~~~----~~~~~ 696 (845)
++|... +.||+|+||+||+|... +|+.||||+++.. ..+.+|++++.+ .+||||+++++++.. .+..+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 345554 68999999999999975 6899999998642 356788888755 489999999999865 56789
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEEecCCcc
Q 003140 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLSR 773 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~---~~~~kl~DFGla~ 773 (845)
+||||+++|+|.+++.......+++..+..++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 9999999999999998766667999999999999999999999998 999999999999997 7899999999998
Q ss_pred cCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 213 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 267 (400)
T 1nxk_A 213 ETTSH--------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_dssp ECC-------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred ccCCC--------CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 65321 12334578999999999999999999999999999999999999997543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=314.64 Aligned_cols=200 Identities=30% Similarity=0.449 Sum_probs=168.4
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChh--------------------------hHHHHHHHHHHHH
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--------------------------GEKEFLTEIQFLS 675 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~--------------------------~~~~~~~Ei~~l~ 675 (845)
.++|.+.+.||+|+||.||+|... +++.||||++...... ..+++.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 367888999999999999999964 6899999998654311 1246899999999
Q ss_pred hcCCCceeeEEEEEee--CCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 003140 676 RLHHRNLVSLVGYCDE--EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKA 753 (845)
Q Consensus 676 ~l~H~nIv~l~g~~~~--~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~ 753 (845)
+++||||+++++++.+ .+..++||||+++|+|.+++. ...+++..++.++.|+++||+|||+++ |+||||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp 165 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKP 165 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCH
Confidence 9999999999999986 568899999999999987653 346899999999999999999999998 99999999
Q ss_pred CCEEEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCC---CCchhhHHHHHHHHHHHHhCCC
Q 003140 754 SNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQ 830 (845)
Q Consensus 754 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwS~Gvvl~elltG~~ 830 (845)
+|||++.++.+||+|||+++...... .......||+.|+|||.+.+.. ++.++|||||||++|||++|+.
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 238 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSD-------ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSS-------CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred HHEEECCCCCEEEecCCCcccccccc-------ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 99999999999999999998654221 1233457999999999997655 4789999999999999999999
Q ss_pred CCCCC
Q 003140 831 PISHG 835 (845)
Q Consensus 831 Pf~~~ 835 (845)
||...
T Consensus 239 pf~~~ 243 (298)
T 2zv2_A 239 PFMDE 243 (298)
T ss_dssp SSCCS
T ss_pred CCCCc
Confidence 99754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=338.54 Aligned_cols=209 Identities=31% Similarity=0.473 Sum_probs=177.1
Q ss_pred hHHHHHHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeE
Q 003140 616 YGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (845)
Q Consensus 616 ~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 695 (845)
.+.+.+..++|...+.||+|+||.||+|.+.++..||||+++... ...++|.+|+++|++++||||+++++++.+ +..
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 253 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence 344556677888999999999999999999888889999998644 345689999999999999999999999876 678
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++||||+++|+|.++++......+++..++.++.|+++||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceec
Confidence 99999999999999997655556899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
.... ........++..|+|||.+....++.++|||||||++|||++ |+.||...
T Consensus 331 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~ 385 (452)
T 1fmk_A 331 EDNE------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385 (452)
T ss_dssp ------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred CCCc------eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC
Confidence 4221 111223456789999999999999999999999999999999 99999754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=324.60 Aligned_cols=207 Identities=29% Similarity=0.486 Sum_probs=178.9
Q ss_pred HHhcCCCCCccccccCceEEEEEEeC--------CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEEe
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCD 690 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~ 690 (845)
...++|.+.+.||+|+||.||+|... ++..||||+++... ....+++.+|+++++++ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 34567888999999999999999852 34689999987643 34457899999999999 9999999999999
Q ss_pred eCCeEEEEEEcCCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 003140 691 EEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 756 (845)
Q Consensus 691 ~~~~~~LV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NI 756 (845)
+.+..++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceE
Confidence 9999999999999999999997653 245899999999999999999999998 99999999999
Q ss_pred EEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 757 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 757 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
|++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDY-----YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCT-----TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EEcCCCcEEEcccCcccccccccc-----cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999987643221 112233457889999999999999999999999999999999 99999754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=325.80 Aligned_cols=208 Identities=20% Similarity=0.242 Sum_probs=170.9
Q ss_pred HhcCCCCCccccccCceEEEEEEeCC------CcEEEEEEccCCChhhH-----------HHHHHHHHHHHhcCCCceee
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSLQGE-----------KEFLTEIQFLSRLHHRNLVS 684 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~~~~~~~~~~-----------~~~~~Ei~~l~~l~H~nIv~ 684 (845)
..++|.+.+.||+|+||.||+|.+.+ ++.||||++........ ..+.+|+..++.++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34678999999999999999999754 47899999876542211 23455667788889999999
Q ss_pred EEEEEeeC----CeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-
Q 003140 685 LVGYCDEE----GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD- 759 (845)
Q Consensus 685 l~g~~~~~----~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~- 759 (845)
+++++... ...++||||+ +|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence 99998764 4589999999 99999999764 356999999999999999999999998 99999999999999
Q ss_pred -CCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 760 -HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 760 -~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
.++.+||+|||+++....................||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 889999999999987643221111111222345699999999999999999999999999999999999999975
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=343.06 Aligned_cols=166 Identities=22% Similarity=0.310 Sum_probs=130.2
Q ss_pred CCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCC---CCCCCCCCccEEEcccccCCcCCCCCCC--cc
Q 003140 223 SELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPM---PDLSRIPNLGYLDLSSNQLNGSIPPGRL--SL 297 (845)
Q Consensus 223 ~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~---~~l~~l~~L~~L~Ls~N~l~~~ip~~~~--~~ 297 (845)
..+++|++|++++|++++ ..|..+.++++|+.|+|++|++++.+ ..+..+++|++|++++|.+++.+|...+ ..
T Consensus 321 ~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~ 399 (520)
T 2z7x_B 321 SKISPFLHLDFSNNLLTD-TVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTK 399 (520)
T ss_dssp SSCCCCCEEECCSSCCCT-TTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCT
T ss_pred hhCCcccEEEeECCccCh-hhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCc
Confidence 556777788888888876 56777788888888888888887632 2367778888888888888865665422 34
Q ss_pred ccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCC-C-CCCCCc
Q 003140 298 NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNV 375 (845)
Q Consensus 298 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~-~-~~~~l~ 375 (845)
+|+.|+|++|++++.+|..+. ++|++|+|++|+++ .+|..+..+. .|+.|++++|+|+.+|.. + .++.++
T Consensus 400 ~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~-----~L~~L~L~~N~l~~l~~~~~~~l~~L~ 471 (520)
T 2z7x_B 400 SLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLE-----ALQELNVASNQLKSVPDGIFDRLTSLQ 471 (520)
T ss_dssp TCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCT-----TCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred cCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCC-----CCCEEECCCCcCCccCHHHhccCCccc
Confidence 788888888888877776654 68888888888888 7888776544 456999999999999987 5 589999
Q ss_pred EEEecCCcccccCCCccc-cCCC
Q 003140 376 TVRLRGNPFCLNTNAEQF-CGSH 397 (845)
Q Consensus 376 ~l~l~~Np~~c~~~~~~~-~~~~ 397 (845)
.+++++|||.|+|+..+| ..|.
T Consensus 472 ~L~l~~N~~~c~c~~~~~~~~~~ 494 (520)
T 2z7x_B 472 KIWLHTNPWDCSCPRIDYLSRWL 494 (520)
T ss_dssp EEECCSSCBCCCHHHHHHHHHHH
T ss_pred EEECcCCCCcccCCchHHHHHHH
Confidence 999999999999999998 6665
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=315.91 Aligned_cols=210 Identities=32% Similarity=0.495 Sum_probs=185.1
Q ss_pred HHHHHHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeE
Q 003140 617 GEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (845)
Q Consensus 617 ~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 695 (845)
+++....++|...+.||+|+||.||+|... ++..||||++.... ...+++.+|++++++++||||+++++++.+.+..
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 445566788999999999999999999976 48899999987643 3457899999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++||||+++|+|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 99999999999999998877778999999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
.... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 162 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~ 217 (288)
T 3kfa_A 162 TGDT------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217 (288)
T ss_dssp CSSS------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cCCc------cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 4322 122333456789999999999999999999999999999999 999997543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=328.34 Aligned_cols=206 Identities=29% Similarity=0.446 Sum_probs=175.7
Q ss_pred hcCCCCCccccccCceEEEEEEeC------CCcEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 695 (845)
.++|.+.+.||+|+||.||+|.+. +++.||||+++.. ......++.+|+.++++++||||+++++++.+.+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467888999999999999999843 4678999998754 344566899999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC---cEEEE
Q 003140 696 MLVYEFMSNGTLRDQLSAKS-----KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TAKVA 767 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~---~~kl~ 767 (845)
++||||+++|+|.++++... ...+++..++.++.||++||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997643 245899999999999999999999998 99999999999999554 59999
Q ss_pred ecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 768 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 768 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
|||+++...... .........||+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 227 DFG~a~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~ 291 (367)
T 3l9p_A 227 DFGMARDIYRAG-----YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291 (367)
T ss_dssp CCHHHHHHHHHS-----SCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCcccccccccc-----ccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999997542111 0112234567899999999999999999999999999999998 999997543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=313.88 Aligned_cols=208 Identities=30% Similarity=0.474 Sum_probs=179.7
Q ss_pred HHHHHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 618 EMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 618 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
++.+..++|...+.||+|+||.||+|...++..||||+++... ...+.+.+|++++++++||||+++++++.+ +..++
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 84 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence 4455667899999999999999999999888899999987643 345689999999999999999999999864 56889
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
||||+++|+|.+++.......+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 999999999999997654446899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
.. ........++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 162 ~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 215 (279)
T 1qpc_A 162 NE------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215 (279)
T ss_dssp SC------EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cc------cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC
Confidence 21 111223456789999999998899999999999999999999 999997543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=322.01 Aligned_cols=211 Identities=27% Similarity=0.471 Sum_probs=178.8
Q ss_pred HHHHHhcCCCCCccccccCceEEEEEEe------CCCcEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEE
Q 003140 618 EMALATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYC 689 (845)
Q Consensus 618 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~ 689 (845)
+++...++|...+.||+|+||.||+|.. .++..||||++.... ....+.+.+|+++++++ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 4556678899999999999999999996 246789999987543 23346799999999999 899999999999
Q ss_pred eeCCeEEEEEEcCCCCCHHHHHhccCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 003140 690 DEEGEQMLVYEFMSNGTLRDQLSAKSK---------------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFH 748 (845)
Q Consensus 690 ~~~~~~~LV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH 748 (845)
...+..++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+.+ |+|
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH 195 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVH 195 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 999999999999999999999976432 24799999999999999999999998 999
Q ss_pred cCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-
Q 003140 749 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT- 827 (845)
Q Consensus 749 rDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt- 827 (845)
|||||+|||++.++.+||+|||+++...... .........||+.|+|||.+.+..++.++|||||||++|||+|
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 270 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDS-----NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 270 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCT-----TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCc-----cceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcC
Confidence 9999999999999999999999998654221 1122334557889999999999999999999999999999998
Q ss_pred CCCCCCCCC
Q 003140 828 GMQPISHGK 836 (845)
Q Consensus 828 G~~Pf~~~~ 836 (845)
|+.||....
T Consensus 271 g~~p~~~~~ 279 (344)
T 1rjb_A 271 GVNPYPGIP 279 (344)
T ss_dssp SCCSSTTCC
T ss_pred CCCCcccCC
Confidence 999997644
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-35 Score=315.34 Aligned_cols=207 Identities=23% Similarity=0.366 Sum_probs=170.0
Q ss_pred cCCCCC-ccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeEEEEEE
Q 003140 624 NNFNSS-TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 624 ~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
+.|.+. +.||+|+||.||+|... +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 567664 78999999999999964 7899999999776555677899999999995 79999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc---EEEEecCCcccCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT---AKVADFGLSRLAPV 777 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~---~kl~DFGla~~~~~ 777 (845)
|+++|+|.+++... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++. +||+|||+++....
T Consensus 92 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 92 KMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp CCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred cCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 99999999999764 35889999999999999999999998 999999999999998775 99999999976542
Q ss_pred CCCCCccccceeecccCCCCccchhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
................||..|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 229 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR 229 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccc
Confidence 21111111112234569999999999875 56889999999999999999999999764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=307.64 Aligned_cols=200 Identities=25% Similarity=0.368 Sum_probs=177.0
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
.++|.+.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 467888999999999999999975 5789999998775556677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCcEEEEecCCcccCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl---~~~~~~kl~DFGla~~~~~~ 778 (845)
+++++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+||++ +.++.+||+|||+++.....
T Consensus 88 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 88 CTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 9999999998764 35899999999999999999999998 9999999999999 78899999999999865422
Q ss_pred CCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......||+.|+|||.+.+ .++.++||||||+++|||++|+.||....
T Consensus 163 --------~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 211 (277)
T 3f3z_A 163 --------KMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPT 211 (277)
T ss_dssp --------SCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred --------cchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCC
Confidence 12234568999999999865 48999999999999999999999997644
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=316.11 Aligned_cols=210 Identities=28% Similarity=0.452 Sum_probs=181.0
Q ss_pred HHHHhcCCCCCccccccCceEEEEEEe------CCCcEEEEEEccCCCh-hhHHHHHHHHHHHHhc-CCCceeeEEEEEe
Q 003140 619 MALATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCD 690 (845)
Q Consensus 619 ~~~~~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAVK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~ 690 (845)
+....++|...+.||+|+||.||+|.+ .+++.||||+++.... ...+.+.+|+++++++ +||||+++++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 344567889999999999999999985 3578999999876433 3457899999999999 9999999999999
Q ss_pred eCCeEEEEEEcCCCCCHHHHHhccCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 003140 691 EEGEQMLVYEFMSNGTLRDQLSAKSK----------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKAS 754 (845)
Q Consensus 691 ~~~~~~LV~E~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~ 754 (845)
+.+..++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+++ |+||||||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~ 174 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR 174 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccc
Confidence 99999999999999999999976542 25899999999999999999999998 999999999
Q ss_pred CEEEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 003140 755 NILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPIS 833 (845)
Q Consensus 755 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~ 833 (845)
||+++.++.+||+|||+++...... .........+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 249 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDS-----NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCT-----TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred eEEEcCCCCEEEccccccccccccc-----cceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999998764322 1112233457789999999999999999999999999999999 999997
Q ss_pred CCC
Q 003140 834 HGK 836 (845)
Q Consensus 834 ~~~ 836 (845)
...
T Consensus 250 ~~~ 252 (313)
T 1t46_A 250 GMP 252 (313)
T ss_dssp TCC
T ss_pred ccc
Confidence 644
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=344.54 Aligned_cols=333 Identities=18% Similarity=0.167 Sum_probs=263.2
Q ss_pred CCCCCCCCCCCCCC---CcceEecCC----CC-------CCCcceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCC
Q 003140 53 KLSNWNRGDPCTSN---WTGVLCFNT----TM-------DDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKI 118 (845)
Q Consensus 53 ~l~~W~~~~~c~~~---w~Gv~C~~~----~~-------~~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l 118 (845)
.+++|..+..|+.. |.++.|... +. .-...+++.|++.++.+....+..+..+++|++|+|++|.+
T Consensus 8 ~l~~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l 87 (597)
T 3oja_B 8 NVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI 87 (597)
T ss_dssp ---CCCSEECCCCC--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCC
T ss_pred cccCCCCCCcCcccCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCC
Confidence 46789888888764 555544311 00 00124678888999988876666688899999999999999
Q ss_pred CCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCcccc
Q 003140 119 SGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL 198 (845)
Q Consensus 119 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l 198 (845)
++..|..|+++++|++|+|++|.+++..|..|+++++|++|+|++|.|++..+..|.++++|++|+|++|.+++..|..+
T Consensus 88 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 167 (597)
T 3oja_B 88 EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTF 167 (597)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTT
T ss_pred CCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhh
Confidence 98888899999999999999999998888889999999999999999997666778999999999999999998888889
Q ss_pred CCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccc---------------cCCCccEEEcccCCC
Q 003140 199 SRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYS---------------NMSKLLKLSLRNCSL 263 (845)
Q Consensus 199 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~---------------~l~~L~~L~Ls~N~l 263 (845)
..+++|++|+|++|++++.. +..+++|+.|++++|.+++...|..+. ..++|+.|+|++|.+
T Consensus 168 ~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~~~~~L~~L~L~~n~l 244 (597)
T 3oja_B 168 QATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNL 244 (597)
T ss_dssp TTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEECSCCSCCCEEECCSSCC
T ss_pred hcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccccccCCchhheeeccCCcccccccccCCCCCEEECCCCCC
Confidence 99999999999999998653 344555666666555554322221111 125788888888888
Q ss_pred CCCCCCCCCCCCccEEEcccccCCcCCCCCCC-ccccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCChhhh
Q 003140 264 QGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRL-SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIW 342 (845)
Q Consensus 264 ~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~-~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~ 342 (845)
++. +.+..+++|+.|+|++|.+++.+|..+. ..+|+.|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+.
T Consensus 245 ~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~ 321 (597)
T 3oja_B 245 TDT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQP 321 (597)
T ss_dssp CCC-GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHH
T ss_pred CCC-hhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccc
Confidence 874 5688899999999999999988777654 4489999999999996 5777888999999999999999 7888887
Q ss_pred hhccCCCCcceEEEccCCCCCCCCCCCCCCCCcEEEecCCcccccCCCccccCCC
Q 003140 343 QSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSH 397 (845)
Q Consensus 343 ~l~~l~~~~l~~L~ls~N~l~~i~~~~~~~~l~~l~l~~Np~~c~~~~~~~~~~~ 397 (845)
.+.. |+.|+|++|+|+.++ ...++.+..|++++|||.|+|...++..+.
T Consensus 322 ~l~~-----L~~L~L~~N~l~~~~-~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~ 370 (597)
T 3oja_B 322 QFDR-----LENLYLDHNSIVTLK-LSTHHTLKNLTLSHNDWDCNSLRALFRNVA 370 (597)
T ss_dssp HHTT-----CSEEECCSSCCCCCC-CCTTCCCSEEECCSSCEEHHHHHHHTTTCC
T ss_pred cCCC-----CCEEECCCCCCCCcC-hhhcCCCCEEEeeCCCCCChhHHHHHHHHh
Confidence 7655 459999999999886 235889999999999999998666554443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=315.59 Aligned_cols=193 Identities=25% Similarity=0.368 Sum_probs=152.3
Q ss_pred CccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCeEEEEEEcCCCCC
Q 003140 629 STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEFMSNGT 706 (845)
Q Consensus 629 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~E~~~~gs 706 (845)
.+.||+|+||.||+|... +|+.||||++... ....+.+|+++++++. ||||+++++++.+.+..++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999975 6899999998642 3567889999999996 9999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC---cEEEEecCCcccCCCCCCCCc
Q 003140 707 LRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TAKVADFGLSRLAPVPDIEGI 783 (845)
Q Consensus 707 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~---~~kl~DFGla~~~~~~~~~~~ 783 (845)
|.+++... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++ .+||+|||+++.....
T Consensus 93 L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~----- 162 (325)
T 3kn6_A 93 LFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD----- 162 (325)
T ss_dssp HHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC-----
Confidence 99999764 46899999999999999999999998 99999999999998765 8999999999865422
Q ss_pred cccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 163 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 163 --NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp -----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred --CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 122334568999999999999999999999999999999999999997643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-35 Score=321.71 Aligned_cols=200 Identities=26% Similarity=0.387 Sum_probs=166.3
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
.++|.+.+.||+|+||.||++... +++.||||++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 467889999999999999999976 789999999876433 335788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc--EEEEecCCcccCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT--AKVADFGLSRLAPVPD 779 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~--~kl~DFGla~~~~~~~ 779 (845)
+++|+|.+++.... .+++..++.++.|+++||+|||+.+ |+||||||+|||++.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~-- 170 (361)
T 3uc3_A 98 ASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-- 170 (361)
T ss_dssp CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc--
Confidence 99999999997643 5899999999999999999999999 999999999999987765 99999999974321
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDK-SDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
........||+.|+|||++.+..++.+ +|||||||++|||++|+.||....
T Consensus 171 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (361)
T 3uc3_A 171 ------HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 222 (361)
T ss_dssp ----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC---
T ss_pred ------cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCc
Confidence 112234569999999999988887665 899999999999999999997643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=308.23 Aligned_cols=207 Identities=21% Similarity=0.323 Sum_probs=178.1
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeEEEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ..+.+.+|+++++++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46788999999999999999996 579999999986533 234678899999999 79999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc-----EEEEecCCcccC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT-----AKVADFGLSRLA 775 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~-----~kl~DFGla~~~ 775 (845)
|+ +++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++. +||+|||+++..
T Consensus 87 ~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 87 LL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99 99999999764 345899999999999999999999998 999999999999987776 999999999876
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
..................||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 222 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 222 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence 5433221111123345679999999999999999999999999999999999999998643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=320.15 Aligned_cols=211 Identities=27% Similarity=0.404 Sum_probs=164.2
Q ss_pred HHHHHhcCCCCCccccccCceEEEEEEeCC-C---cEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEee
Q 003140 618 EMALATNNFNSSTQIGQGGYGKVYKGILPD-G---TVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 691 (845)
Q Consensus 618 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~-g---~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~ 691 (845)
+.....++|.+.+.||+|+||.||+|.... + ..||||+++.. .....+++.+|++++++++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 334556789999999999999999999653 3 27999998754 33446789999999999999999999999987
Q ss_pred CCeE------EEEEEcCCCCCHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC
Q 003140 692 EGEQ------MLVYEFMSNGTLRDQLSAKS----KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK 761 (845)
Q Consensus 692 ~~~~------~LV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~ 761 (845)
.+.. ++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCC
Confidence 7655 99999999999999996532 235899999999999999999999998 9999999999999999
Q ss_pred CcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 762 FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 762 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
+.+||+|||+++....... ........+++.|+|||.+.+..++.++|||||||++|||++ |+.||...+
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 244 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDY-----YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE 244 (323)
T ss_dssp SCEEECCCCC----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCEEEeecccccccccccc-----ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC
Confidence 9999999999986543221 112233456789999999999999999999999999999999 999997544
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=321.58 Aligned_cols=208 Identities=31% Similarity=0.437 Sum_probs=165.6
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCC--eE
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEG--EQ 695 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~--~~ 695 (845)
..++|.+.+.||+|+||.||+|... +|+.||||++... .....+++.+|+.+++++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999964 7899999998643 3344567889999999997 999999999997544 68
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++|||||+ |+|.++++. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 87 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 99999997 799999975 35889999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCCC--------------ccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 776 PVPDIEG--------------IVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 776 ~~~~~~~--------------~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
....... ...........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 3211000 001122344679999999999976 678999999999999999999999997654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=321.18 Aligned_cols=213 Identities=27% Similarity=0.358 Sum_probs=174.7
Q ss_pred HHHHHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC-----ChhhHHHHHHHHHHHHhcCCCceeeEEEEEee
Q 003140 618 EMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG-----SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 691 (845)
Q Consensus 618 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~ 691 (845)
++....++|.+.+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 45566788999999999999999999974 6889999988643 23445789999999999999999999999999
Q ss_pred CCeEEEEEEcCCCCCHHHHHhcc--------------------------------------CCCCCCHHHHHHHHHHHHH
Q 003140 692 EGEQMLVYEFMSNGTLRDQLSAK--------------------------------------SKEPLGFAMRLSIALGSSR 733 (845)
Q Consensus 692 ~~~~~LV~E~~~~gsL~~~l~~~--------------------------------------~~~~l~~~~~~~i~~~ia~ 733 (845)
.+..++||||+++|+|.+++... ....+++..++.++.|+++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999998521 0112457778889999999
Q ss_pred HHHHHHhCCCCCeEecCCCCCCEEEcCCC--cEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcC--CCC
Q 003140 734 GILYLHTEADPPVFHRDIKASNILLDHKF--TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKL 809 (845)
Q Consensus 734 gL~yLH~~~~~~iiHrDLk~~NILl~~~~--~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~ 809 (845)
||+|||+.+ |+||||||+|||++.++ .+||+|||+++........ .........||+.|+|||++.+ ..+
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~ 253 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG---EYYGMTTKAGTPYFVAPEVLNTTNESY 253 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC-----------CCCGGGCCHHHHTCSSSCC
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCcc---ccccccccCCCccccCchhhccCCCCC
Confidence 999999998 99999999999998776 8999999999865322111 1112345579999999999875 678
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 810 TDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 810 ~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
+.++|||||||++|||++|+.||....
T Consensus 254 ~~~~DiwslG~il~el~~g~~pf~~~~ 280 (345)
T 3hko_A 254 GPKCDAWSAGVLLHLLLMGAVPFPGVN 280 (345)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 999999999999999999999997543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=317.94 Aligned_cols=203 Identities=29% Similarity=0.472 Sum_probs=167.4
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCc----EEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 696 (845)
.++|...+.||+|+||.||+|.+. +++ .||+|.+... .....++|.+|++++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 356888999999999999999964 444 3688887643 3345678999999999999999999999998754 78
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCC
Q 003140 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~ 776 (845)
+|+||+++|+|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 93 ~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 9999999999999997643 46899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
.... ........+|..|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 169 ~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 223 (327)
T 3poz_A 169 AEEK-----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223 (327)
T ss_dssp TTCC------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCcc-----cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCC
Confidence 3221 122233457889999999999999999999999999999999 99999754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=312.90 Aligned_cols=200 Identities=28% Similarity=0.389 Sum_probs=177.1
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChh------hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~------~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 695 (845)
.++|.+.+.||+|+||.||+|... +|+.||||+++..... ..+++.+|++++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467888999999999999999975 6899999998754321 357899999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC----cEEEEecCC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF----TAKVADFGL 771 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~----~~kl~DFGl 771 (845)
++||||+++|+|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 9999999999999999653 46899999999999999999999998 99999999999999887 799999999
Q ss_pred cccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 166 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 221 (321)
T 2a2a_A 166 AHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (321)
T ss_dssp CEECCTTC--------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred ceecCccc--------cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC
Confidence 98754321 123456899999999999999999999999999999999999999754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.06 Aligned_cols=201 Identities=34% Similarity=0.515 Sum_probs=166.0
Q ss_pred hcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCCh----hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL----QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~----~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
.++|...+.||+|+||.||+|.+. |+.||||+++.... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357888999999999999999974 89999999875332 2346789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC--------CCcEEEEecC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH--------KFTAKVADFG 770 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~--------~~~~kl~DFG 770 (845)
|||+++|+|.+++.. ..+++..++.++.|+++||+|||+++..+|+||||||+|||++. ++.+||+|||
T Consensus 85 ~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 999999999999853 46899999999999999999999988666999999999999986 6789999999
Q ss_pred CcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 771 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 771 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
+++..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 162 ~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 218 (271)
T 3dtc_A 162 LAREWHRT---------TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID 218 (271)
T ss_dssp C----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred cccccccc---------cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99765321 1223468999999999999999999999999999999999999997644
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=311.71 Aligned_cols=205 Identities=28% Similarity=0.432 Sum_probs=165.2
Q ss_pred HHhcCCCCCccccccCceEEEEEEeC----CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeE
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 695 (845)
...++|.+.+.||+|+||.||+|... .+..||+|+.+... ....+.+.+|++++++++||||+++++++. .+..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 34568888999999999999999864 25679999987543 334567999999999999999999999985 4578
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++||||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 8999999999999999754 346899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
.... ........+|+.|+|||.+....++.++|||||||++|||++ |+.||....
T Consensus 167 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~ 222 (281)
T 1mp8_A 167 EDST------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222 (281)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred Cccc------ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC
Confidence 4321 111233456789999999998999999999999999999997 999997543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=331.41 Aligned_cols=198 Identities=25% Similarity=0.347 Sum_probs=167.1
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC------C
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------G 693 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------~ 693 (845)
.++|.+.+.||+|+||.||+|... +|+.||||++... .....+++.+|+++++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467999999999999999999865 6899999998754 334467889999999999999999999999654 4
Q ss_pred eEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003140 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (845)
Q Consensus 694 ~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~ 773 (845)
..++||||+++ +|.+.+.. .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 67999999975 57676643 3889999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+
T Consensus 213 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 213 TAGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp ----C--------CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecCCC--------cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 65321 22345679999999999999999999999999999999999999997654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=319.73 Aligned_cols=204 Identities=24% Similarity=0.363 Sum_probs=177.0
Q ss_pred HhcCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCCh--------hhHHHHHHHHHHHHhcCCCceeeEEEEEeeC
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL--------QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 692 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~--------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~ 692 (845)
..++|...+.||+|+||.||+|.. .+++.||||+++.... ...+.+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 346899999999999999999996 4789999999875431 1234678899999999999999999999999
Q ss_pred CeEEEEEEcCCCC-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 003140 693 GEQMLVYEFMSNG-TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 771 (845)
Q Consensus 693 ~~~~LV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGl 771 (845)
+..++||||+.+| +|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeeccc
Confidence 9999999999777 999999654 35899999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCCCccccceeecccCCCCccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCc
Q 003140 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNI 838 (845)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltG~~Pf~~~~~~ 838 (845)
++...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....+.
T Consensus 177 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 236 (335)
T 3dls_A 177 AAYLERGK--------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET 236 (335)
T ss_dssp CEECCTTC--------CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG
T ss_pred ceECCCCC--------ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH
Confidence 98764321 1234568999999999988776 88999999999999999999999765443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=316.89 Aligned_cols=197 Identities=31% Similarity=0.511 Sum_probs=172.5
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
+.|...+.||+|+||.||+|.. .+|+.||||++.... ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4578889999999999999996 578999999987543 223467899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||++ |+|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 206 (348)
T ss_dssp ECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred ecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence 9997 7888888653 346899999999999999999999998 99999999999999999999999999976532
Q ss_pred CCCccccceeecccCCCCccchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 207 ---------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 257 (348)
T 1u5q_A 207 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 257 (348)
T ss_dssp ---------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ---------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 12346899999999984 5678999999999999999999999997543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=329.42 Aligned_cols=200 Identities=29% Similarity=0.432 Sum_probs=176.3
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|.+.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+++++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57888999999999999999975 799999999865322 23467899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++|+|.+++... ..+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~- 169 (476)
T 2y94_A 96 EYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG- 169 (476)
T ss_dssp ECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT-
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc-
Confidence 999999999999653 46899999999999999999999998 999999999999999999999999999875422
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......||+.|+|||++.+..+ +.++||||+||++|||++|+.||....
T Consensus 170 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 220 (476)
T 2y94_A 170 -------EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH 220 (476)
T ss_dssp -------CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -------ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC
Confidence 12234579999999999988765 789999999999999999999997543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=317.02 Aligned_cols=203 Identities=25% Similarity=0.347 Sum_probs=169.8
Q ss_pred hcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCC--CceeeEEEEEeeCCeEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHH--RNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~LV 698 (845)
.++|.+.+.||+|+||.||++...+++.||||++... .....+.+.+|++++++++| +||+++++++.+.+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4568889999999999999999988999999998643 33445789999999999976 9999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
|| +.+|+|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++ ++.+||+|||+++.....
T Consensus 88 ~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EC-CCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred Ee-CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 99 5689999999764 46899999999999999999999998 99999999999997 678999999999876432
Q ss_pred CCCCccccceeecccCCCCccchhhhcC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLT-----------HKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
. .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....+
T Consensus 161 ~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 225 (343)
T 3dbq_A 161 T-----TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 225 (343)
T ss_dssp --------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred c-----ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh
Confidence 1 1122335579999999999865 6789999999999999999999999976433
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=308.37 Aligned_cols=203 Identities=32% Similarity=0.523 Sum_probs=178.2
Q ss_pred HhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
..++|...+.||+|+||.||+|...+++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 3467888999999999999999998889999999986433 346899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-- 158 (267)
T 3t9t_A 85 MEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-- 158 (267)
T ss_dssp CTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH--
T ss_pred CCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc--
Confidence 9999999999764 346899999999999999999999998 9999999999999999999999999998653211
Q ss_pred CccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 159 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (267)
T 3t9t_A 159 ----YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 209 (267)
T ss_dssp ----HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ----ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC
Confidence 111223456788999999998999999999999999999999 89999754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=318.87 Aligned_cols=210 Identities=27% Similarity=0.448 Sum_probs=179.7
Q ss_pred HHHHHhcCCCCCccccccCceEEEEEEeCC------CcEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEE
Q 003140 618 EMALATNNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYC 689 (845)
Q Consensus 618 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~ 689 (845)
++....++|...+.||+|+||.||+|.... +..||||.+.... ....+.+.+|+++++++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 455667889999999999999999999642 2479999987643 33456799999999999 899999999999
Q ss_pred eeCCeEEEEEEcCCCCCHHHHHhccC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 003140 690 DEEGEQMLVYEFMSNGTLRDQLSAKS------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNIL 757 (845)
Q Consensus 690 ~~~~~~~LV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NIL 757 (845)
.+.+..++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence 99999999999999999999997532 346899999999999999999999998 999999999999
Q ss_pred EcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 758 LDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 758 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
++.++.+||+|||+++...... .........+|+.|+|||.+.+..++.++|||||||++|||+| |+.||...
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 270 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDS-----NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 270 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCT-----TSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ECCCCeEEECcccccccccccc-----ceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCccc
Confidence 9999999999999998653221 1112233456789999999999999999999999999999999 99999754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=306.53 Aligned_cols=200 Identities=21% Similarity=0.355 Sum_probs=173.5
Q ss_pred hcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CeEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQMLV 698 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~LV 698 (845)
.++|...+.||+|+||.||+|.+. ++.||||+++... ....++|.+|++++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 357888999999999999999984 8999999987543 34456899999999999999999999999877 788999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
|||+++|+|.++++......+++..++.++.|+++||+|||+.+ ++|+||||||+||+++.++.++|+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-- 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-- 164 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS--
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec--
Confidence 99999999999998766667999999999999999999999864 569999999999999999999999998875432
Q ss_pred CCCCccccceeecccCCCCccchhhhcCCCCCc---hhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD---KSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.....||+.|+|||.+.+..++. ++|||||||++|||++|+.||....
T Consensus 165 ----------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 215 (271)
T 3kmu_A 165 ----------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS 215 (271)
T ss_dssp ----------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC
T ss_pred ----------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 12245789999999998765444 8999999999999999999997543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=303.75 Aligned_cols=201 Identities=27% Similarity=0.439 Sum_probs=176.5
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
.++|.+.+.||+|+||.||+|... +|+.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 468899999999999999999975 6899999998653 3334567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc---EEEEecCCcccCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT---AKVADFGLSRLAP 776 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~---~kl~DFGla~~~~ 776 (845)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++....
T Consensus 85 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 999999999988764 35899999999999999999999998 999999999999986655 9999999997654
Q ss_pred CCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 160 ~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 211 (284)
T 3kk8_A 160 DSE--------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 211 (284)
T ss_dssp SSC--------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCc--------cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc
Confidence 221 1234568999999999999999999999999999999999999996543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=342.95 Aligned_cols=209 Identities=31% Similarity=0.473 Sum_probs=181.5
Q ss_pred hHHHHHHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeE
Q 003140 616 YGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (845)
Q Consensus 616 ~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 695 (845)
.+.+++..++|.+.+.||+|+||.||+|.+.++..||||+++... ...++|.+|+++|++++|+||+++++++.+ +..
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 344556677889999999999999999999888899999998644 345689999999999999999999999876 678
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++||||+++|+|.++++......+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 99999999999999997654556899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
.... ........++..|+|||++....++.++|||||||++|||++ |+.||...
T Consensus 414 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~ 468 (535)
T 2h8h_A 414 EDNE------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 468 (535)
T ss_dssp CCHH------HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC
T ss_pred CCCc------eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 4211 111223456788999999999999999999999999999999 99999754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=314.58 Aligned_cols=207 Identities=28% Similarity=0.505 Sum_probs=177.3
Q ss_pred HHhcCCCCCccccccCceEEEEEEeC--------CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEEe
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCD 690 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~ 690 (845)
...++|.+.+.||+|+||.||+|... ++..||||+++... ....+++.+|+++++++ +||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 44578889999999999999999863 46789999997643 34457799999999999 8999999999999
Q ss_pred eCCeEEEEEEcCCCCCHHHHHhccCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 003140 691 EEGEQMLVYEFMSNGTLRDQLSAKSK--------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 756 (845)
Q Consensus 691 ~~~~~~LV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NI 756 (845)
+.+..++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+.+ |+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceE
Confidence 99999999999999999999976432 34899999999999999999999998 99999999999
Q ss_pred EEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 757 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 757 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
|++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSS-----EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EEcCCCCEEEcccccccccccccc-----ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 999999999999999987643221 111233457789999999998899999999999999999999 99999754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=310.06 Aligned_cols=199 Identities=26% Similarity=0.413 Sum_probs=166.1
Q ss_pred hcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHh--cCCCceeeEEEEEeeC----CeEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSR--LHHRNLVSLVGYCDEE----GEQM 696 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~--l~H~nIv~l~g~~~~~----~~~~ 696 (845)
.++|.+.+.||+|+||.||+|.. +|+.||||++... ..+.+.+|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46788999999999999999998 6899999998653 34566777777776 7999999999987542 4589
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCCEEEcCCCcEEEEe
Q 003140 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH--------TEADPPVFHRDIKASNILLDHKFTAKVAD 768 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~iiHrDLk~~NILl~~~~~~kl~D 768 (845)
+||||+++|+|.++++. ..+++..++.++.|+++||+||| +.+ |+||||||+|||++.++.+||+|
T Consensus 83 lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECC
T ss_pred EehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEee
Confidence 99999999999999954 36899999999999999999999 666 99999999999999999999999
Q ss_pred cCCcccCCCCCCCCccccceeecccCCCCccchhhhcCC------CCCchhhHHHHHHHHHHHHhC----------CCCC
Q 003140 769 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH------KLTDKSDVYSLGVVFLELLTG----------MQPI 832 (845)
Q Consensus 769 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwS~Gvvl~elltG----------~~Pf 832 (845)
||+|+........ .........||+.|+|||++.+. .++.++|||||||++|||+|| +.||
T Consensus 157 fg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 157 LGLAVMHSQSTNQ---LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp CTTCEEEETTTTE---EECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred CCCeeeccccccc---ccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 9999765432210 01112334799999999999876 455799999999999999999 8888
Q ss_pred CC
Q 003140 833 SH 834 (845)
Q Consensus 833 ~~ 834 (845)
..
T Consensus 234 ~~ 235 (301)
T 3q4u_A 234 YD 235 (301)
T ss_dssp TT
T ss_pred cc
Confidence 54
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=309.81 Aligned_cols=201 Identities=28% Similarity=0.429 Sum_probs=171.0
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
++|...+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57888999999999999999975 589999998865432 235678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
|+++++|.++++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 156 (311)
T 4agu_A 83 YCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS- 156 (311)
T ss_dssp CCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred eCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-
Confidence 99999999988653 45899999999999999999999998 9999999999999999999999999998754221
Q ss_pred CCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......||..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 157 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 207 (311)
T 4agu_A 157 ------DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS 207 (311)
T ss_dssp ---------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ------cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 12234568999999999876 678999999999999999999999997654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-35 Score=316.89 Aligned_cols=203 Identities=28% Similarity=0.474 Sum_probs=170.0
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcE----EEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTV----VAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~----vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
++|...+.||+|+||.||+|.+. +++. ||+|.+.... ....+++.+|+.++++++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 56888899999999999999964 4443 8888875432 233456788999999999999999999986 467899
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
||||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 92 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 99999999999999764 346889999999999999999999998 99999999999999999999999999987653
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
... ........||..|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 168 ~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 222 (325)
T 3kex_A 168 DDK-----QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR 222 (325)
T ss_dssp CTT-----CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred ccc-----cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC
Confidence 321 122344567889999999999999999999999999999999 999997543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=305.29 Aligned_cols=200 Identities=30% Similarity=0.457 Sum_probs=173.5
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
.++|.+.+.||+|+||.||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467888999999999999999865 578999999864322 2346789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
|||+++|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 88 ~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 9999999999999765 35899999999999999999999998 999999999999999999999999998654321
Q ss_pred CCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
......||..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 163 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 211 (279)
T 3fdn_A 163 ---------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211 (279)
T ss_dssp --------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ---------cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc
Confidence 1234568999999999999999999999999999999999999997543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=342.26 Aligned_cols=204 Identities=22% Similarity=0.349 Sum_probs=178.2
Q ss_pred HHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeE
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQ 695 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 695 (845)
...++|.+.+.||+|+||.||+|... +++.||||+++... ....+.+..|.+++..+ +||+|+++++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 34568999999999999999999975 68899999987432 22345788899999988 799999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++||||+++|+|.++++... .+++..++.++.||+.||+|||+.+ ||||||||+|||++.++++||+|||+|+..
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 99999999999999997653 5899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 493 ~~~-------~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~ 546 (674)
T 3pfq_A 493 IWD-------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546 (674)
T ss_dssp CCT-------TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccC-------CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC
Confidence 322 122345679999999999999999999999999999999999999997643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=327.64 Aligned_cols=199 Identities=28% Similarity=0.421 Sum_probs=155.5
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----CeE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GEQ 695 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~ 695 (845)
++|.+.+.||+|+||.||+|... +|+.||||++... .....+++.+|++++++++||||+++++++... +..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 67899999999999999999965 7899999998653 334457899999999999999999999998443 578
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++||||+ +|+|.++++.. ..+++..+..++.||++||+|||+.+ ||||||||+|||++.++.+||+|||+|+..
T Consensus 133 ~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhc
Confidence 9999998 58999999653 46899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCCCcc--------------------ccceeecccCCCCccchhhh-cCCCCCchhhHHHHHHHHHHHHhC
Q 003140 776 PVPDIEGIV--------------------PAHVSTVVKGTPGYLDPEYF-LTHKLTDKSDVYSLGVVFLELLTG 828 (845)
Q Consensus 776 ~~~~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwS~Gvvl~elltG 828 (845)
......... .....+...||++|+|||++ ....++.++|||||||++|||++|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 432211000 01123456789999999986 466799999999999999999994
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=321.28 Aligned_cols=201 Identities=24% Similarity=0.339 Sum_probs=169.8
Q ss_pred cCCCCCccccccCceEEEEEEeCCCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcC--CCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLH--HRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~LV~ 699 (845)
.+|.+.+.||+|+||.||+|...+++.||||++... .....+.+.+|++++++++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458889999999999999999888999999998643 3344578999999999996 599999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
| +.+|+|.+++.... .+++..+..++.||++||+|||+.+ |+||||||+|||++ ++.+||+|||+++......
T Consensus 136 E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp E-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred e-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9 56899999997643 6889999999999999999999998 99999999999995 5899999999998764221
Q ss_pred CCCccccceeecccCCCCccchhhhcC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLT-----------HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 209 -----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 271 (390)
T 2zmd_A 209 -----TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271 (390)
T ss_dssp ----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred -----ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence 1112334579999999999865 468999999999999999999999997643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-35 Score=320.79 Aligned_cols=202 Identities=28% Similarity=0.350 Sum_probs=172.9
Q ss_pred hcCCCCCccccccCceEEEEEEe----CCCcEEEEEEccCCC----hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCC
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGS----LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEG 693 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~----~~g~~vAVK~~~~~~----~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 693 (845)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35788899999999999999997 378999999986532 12345677899999999 6999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003140 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (845)
Q Consensus 694 ~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~ 773 (845)
..++||||+++|+|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 999999999999999999764 35899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCCCCccccceeecccCCCCccchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 208 ~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 265 (355)
T 1vzo_A 208 EFVADE------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265 (355)
T ss_dssp ECCGGG------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred ecccCC------CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence 653211 222334579999999999985 45789999999999999999999999754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=313.80 Aligned_cols=214 Identities=24% Similarity=0.357 Sum_probs=182.8
Q ss_pred cccchHHHHHHhcCCCCC-ccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhc-CCCceeeEE
Q 003140 612 RSFTYGEMALATNNFNSS-TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRL-HHRNLVSLV 686 (845)
Q Consensus 612 ~~~~~~~~~~~~~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l-~H~nIv~l~ 686 (845)
....+.......++|.+. +.||+|+||.||+|... +|+.||||+++... ....+++.+|+++++++ +||||++++
T Consensus 16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~ 95 (327)
T 3lm5_A 16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95 (327)
T ss_dssp CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 445566666777788877 89999999999999975 68999999987532 33467899999999999 579999999
Q ss_pred EEEeeCCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCc
Q 003140 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFT 763 (845)
Q Consensus 687 g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~---~~~ 763 (845)
+++.+.+..++||||+++|+|.+++.......+++..++.++.|+++||+|||+.+ |+||||||+|||++. ++.
T Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp EEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCC
T ss_pred EEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCc
Confidence 99999999999999999999999997766678999999999999999999999998 999999999999987 789
Q ss_pred EEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 764 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 764 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 173 ~kL~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 237 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHA--------CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED 237 (327)
T ss_dssp EEECCGGGCEEC-----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEeeCccccccCCc--------cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999875422 11234568999999999999999999999999999999999999997644
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=305.71 Aligned_cols=201 Identities=28% Similarity=0.508 Sum_probs=156.6
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|.+.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 5688899999999999999996 4799999999864321 22467899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 91 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 91 EMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp ECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred ecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 999999999999754 346899999999999999999999998 9999999999999999999999999998654221
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 167 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 215 (278)
T 3cok_A 167 -------EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD 215 (278)
T ss_dssp --------------------------------CTHHHHHHHHHHHHHHSSCSSCCC
T ss_pred -------CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCh
Confidence 1123356899999999999889999999999999999999999999754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=309.86 Aligned_cols=198 Identities=24% Similarity=0.396 Sum_probs=172.6
Q ss_pred hcCCCCCccccccCceEEEEEEeCC-C-------cEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCe
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILPD-G-------TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 694 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g-------~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 694 (845)
.++|...+.||+|+||.||+|.... + ..||+|++........+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3578889999999999999998642 3 5799999977666667889999999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc--------EEE
Q 003140 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT--------AKV 766 (845)
Q Consensus 695 ~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~--------~kl 766 (845)
.++||||+++|+|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+|||++.++. +||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeee
Confidence 99999999999999999764 334899999999999999999999999 999999999999998887 999
Q ss_pred EecCCcccCCCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 767 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 767 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
+|||+++.... .....||..|+|||++.+ ..++.++|||||||++|||++|..|+...
T Consensus 163 ~Dfg~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~ 221 (289)
T 4fvq_A 163 SDPGISITVLP-----------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221 (289)
T ss_dssp CCCCSCTTTSC-----------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ccCcccccccC-----------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc
Confidence 99999875421 123457899999999987 77999999999999999999966655443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=317.20 Aligned_cols=214 Identities=28% Similarity=0.453 Sum_probs=182.3
Q ss_pred cchHHHHHHhcCCCCCccccccCceEEEEEEeC------CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEE
Q 003140 614 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLV 686 (845)
Q Consensus 614 ~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~ 686 (845)
+..+++....++|.+.+.||+|+||.||+|... +++.||||++.... .....++.+|++++++++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 444566677889999999999999999999864 37889999987543 33456799999999999999999999
Q ss_pred EEEeeCCeEEEEEEcCCCCCHHHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 003140 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKS--------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 758 (845)
Q Consensus 687 g~~~~~~~~~LV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl 758 (845)
+++.+.+..++||||+++|+|.++++... ...+++..++.++.|+++||+|||+++ |+||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEE
Confidence 99999999999999999999999997532 245789999999999999999999998 9999999999999
Q ss_pred cCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 759 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 759 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
+.++.+||+|||+++...... .........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 244 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETD-----YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGG-----CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred cCCCeEEECcCcccccccccc-----ccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence 999999999999997643211 0111223456889999999999999999999999999999999 89999754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=306.09 Aligned_cols=200 Identities=27% Similarity=0.399 Sum_probs=170.9
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
++|...+.||+|+||.||++... ++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 57888999999999999999975 68999999986533 33467899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCcEEEEecCCcccCC
Q 003140 702 MSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRLAP 776 (845)
Q Consensus 702 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl---~~~~~~kl~DFGla~~~~ 776 (845)
+++|+|.+++... ....+++..++.++.|+++||+|||+.+ |+||||||+||++ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999988653 3457999999999999999999999998 9999999999999 456789999999997654
Q ss_pred CCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.. .......||..|+|||.+. ..++.++|||||||++|||++|+.||...
T Consensus 179 ~~--------~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~ 228 (285)
T 3is5_A 179 SD--------EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGT 228 (285)
T ss_dssp ----------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred Cc--------ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCC
Confidence 22 1233456899999999875 57899999999999999999999999754
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=341.37 Aligned_cols=298 Identities=21% Similarity=0.351 Sum_probs=207.7
Q ss_pred CcceEeEEEecCCCCcccCCCCccCCCCccEEEecCCC-CCC-CCccccccc------ccchhhhccCCCCCCCCCC--c
Q 003140 80 GYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNK-ISG-SIPKEIGNI------KSLELLLLNGNELTGSLPE--E 149 (845)
Q Consensus 80 ~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~-l~~-~~p~~~~~l------~~L~~L~Ls~N~l~~~~p~--~ 149 (845)
...+++.|+|++|.+.+.+|..|+++++|++|+|++|+ ++| .+|..++++ ++|++|+|++|+++ .+|. .
T Consensus 247 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~ 325 (636)
T 4eco_A 247 NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETS 325 (636)
T ss_dssp GCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHH
T ss_pred ccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhh
Confidence 34578999999999999999999999999999999998 998 889888887 89999999999998 8888 8
Q ss_pred cCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCC-cceeeccccccccCCCcccCCCC--
Q 003140 150 LGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPS-LVHMLLDNNNLTGYLPPELSELP-- 226 (845)
Q Consensus 150 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~-L~~L~L~~N~l~~~~p~~l~~l~-- 226 (845)
++++++|++|+|++|+++|.+| .+.++++|+.|+|++|+++ .+|..+..+++ |++|++++|+++ .+|..+..++
T Consensus 326 l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~ 402 (636)
T 4eco_A 326 LQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVS 402 (636)
T ss_dssp HTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSS
T ss_pred hccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccC
Confidence 8999999999999999988888 7888888888888888877 67777777777 777777777777 6666666544
Q ss_pred CCcEEEccCCcCCCCCCccccc-------cCCCccEEEcccCCCCCCCCC-CCCCCCccEEEcccccCCcCCCCCCCc-c
Q 003140 227 KLLILQLDNNNFEGTTIPASYS-------NMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLS-L 297 (845)
Q Consensus 227 ~L~~L~Ls~N~l~~~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~ip~~~~~-~ 297 (845)
+|++|+|++|++++ ..|..+. .+++|+.|+|++|+++..++. +..+++|+.|+|++|+++ .+|...+. .
T Consensus 403 ~L~~L~Ls~N~l~~-~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~ 480 (636)
T 4eco_A 403 VMSAIDFSYNEIGS-VDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDE 480 (636)
T ss_dssp CEEEEECCSSCTTT-TTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEET
T ss_pred ccCEEECcCCcCCC-cchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccc
Confidence 67777777777766 4566665 566667777777766655443 334566666666666666 45544332 1
Q ss_pred --------ccCEEEccCCcCCCCcccccC--CCCCCCeEecccccCcccCChhhhhhccCC-------------------
Q 003140 298 --------NITTIKLSNNKLTGTIPSNFS--GLPRLQRLFIANNSLSGSIPSSIWQSRTLN------------------- 348 (845)
Q Consensus 298 --------~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~------------------- 348 (845)
+|+.|+|++|+|+ .+|..+. .+++|++|+|++|++++ +|..+..+..|+
T Consensus 481 ~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~ 558 (636)
T 4eco_A 481 NENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREW 558 (636)
T ss_dssp TEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCC
T ss_pred cccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccC
Confidence 5666666666666 4555554 56666666666666664 555554433222
Q ss_pred ------CCcceEEEccCCCCCCCCCCCCCCCCcEEEecCCcccc
Q 003140 349 ------ATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCL 386 (845)
Q Consensus 349 ------~~~l~~L~ls~N~l~~i~~~~~~~~l~~l~l~~Np~~c 386 (845)
.++|+.|+|++|+|+.+|..+. +.+..|++++||+.|
T Consensus 559 p~~l~~l~~L~~L~Ls~N~l~~ip~~~~-~~L~~L~Ls~N~l~~ 601 (636)
T 4eco_A 559 PEGITLCPSLTQLQIGSNDIRKVNEKIT-PNISVLDIKDNPNIS 601 (636)
T ss_dssp CTTGGGCSSCCEEECCSSCCCBCCSCCC-TTCCEEECCSCTTCE
T ss_pred hHHHhcCCCCCEEECCCCcCCccCHhHh-CcCCEEECcCCCCcc
Confidence 1223355555555555554433 455555555555543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-34 Score=302.52 Aligned_cols=201 Identities=26% Similarity=0.412 Sum_probs=174.6
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh------hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL------QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 695 (845)
.++|...+.||+|+||.||+|... +|+.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 356888999999999999999976 689999999875322 1357899999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC----cEEEEecCC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF----TAKVADFGL 771 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~----~~kl~DFGl 771 (845)
++||||+++++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 9999999999999999764 35899999999999999999999998 99999999999998877 899999999
Q ss_pred cccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 159 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 215 (283)
T 3bhy_A 159 AHKIEAGN--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET 215 (283)
T ss_dssp CEECC----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ceeccCCC--------cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc
Confidence 98654221 1234468999999999999999999999999999999999999997543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.78 Aligned_cols=200 Identities=24% Similarity=0.405 Sum_probs=176.7
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG---SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|...+.||+|+||.||++... +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 56888999999999999999976 5889999988643 2334567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 95 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 95 ELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp ECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 999999999998664 35899999999999999999999998 9999999999999999999999999998654221
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.......||..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 170 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 218 (294)
T 2rku_A 170 -------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 218 (294)
T ss_dssp -------CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred -------cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1123456899999999999989999999999999999999999999754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=324.60 Aligned_cols=200 Identities=28% Similarity=0.403 Sum_probs=173.3
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC--eEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG--EQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~LV~ 699 (845)
++|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 57888999999999999999976 58999999987543 234567889999999999999999999998765 789999
Q ss_pred EcCCCCCHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----cCCCcEEEEecCCccc
Q 003140 700 EFMSNGTLRDQLSAKS-KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL----DHKFTAKVADFGLSRL 774 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl----~~~~~~kl~DFGla~~ 774 (845)
||+++|+|.++++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999999999997643 334899999999999999999999998 9999999999999 7788899999999987
Q ss_pred CCCCCCCCccccceeecccCCCCccchhhhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--------HKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
.... .......||..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 166 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~ 225 (396)
T 4eut_A 166 LEDD--------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (396)
T ss_dssp CCCG--------GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred ccCC--------CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 5421 12234569999999999865 5678899999999999999999999964
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=312.87 Aligned_cols=215 Identities=27% Similarity=0.470 Sum_probs=182.4
Q ss_pred cchHHHHHHhcCCCCCccccccCceEEEEEEe------CCCcEEEEEEccCCCh-hhHHHHHHHHHHHHhc-CCCceeeE
Q 003140 614 FTYGEMALATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSL 685 (845)
Q Consensus 614 ~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAVK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l 685 (845)
+...++....++|.+.+.||+|+||.||+|.+ .+++.||||+++.... ...+.+.+|+++++++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 44556667778999999999999999999984 3568999999876433 3456799999999999 79999999
Q ss_pred EEEEeeCC-eEEEEEEcCCCCCHHHHHhccCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 003140 686 VGYCDEEG-EQMLVYEFMSNGTLRDQLSAKSK--------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750 (845)
Q Consensus 686 ~g~~~~~~-~~~LV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrD 750 (845)
++++...+ ..++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+.+ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99997755 58999999999999999976542 23889999999999999999999998 99999
Q ss_pred CCCCCEEEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CC
Q 003140 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GM 829 (845)
Q Consensus 751 Lk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~ 829 (845)
|||+||+++.++.+||+|||+++...... .........||+.|+|||++.+..++.++|||||||++|||+| |+
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~ 248 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDP-----DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 248 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCT-----TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CccceEEECCCCCEEECCCccccccccCc-----cceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999998654321 1122334567889999999999999999999999999999998 99
Q ss_pred CCCCCCC
Q 003140 830 QPISHGK 836 (845)
Q Consensus 830 ~Pf~~~~ 836 (845)
.||....
T Consensus 249 ~p~~~~~ 255 (316)
T 2xir_A 249 SPYPGVK 255 (316)
T ss_dssp CSSTTCC
T ss_pred CCCcccc
Confidence 9997543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-34 Score=310.35 Aligned_cols=200 Identities=24% Similarity=0.405 Sum_probs=176.9
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG---SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|...+.||+|+||.||++... +++.||+|++... .....+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 56888899999999999999975 5889999998643 2334567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++++|.+++... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 121 e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 121 ELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp CCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred ecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 999999999998764 35899999999999999999999998 9999999999999999999999999998654221
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 196 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 244 (335)
T 2owb_A 196 -------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 244 (335)
T ss_dssp -------CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred -------ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC
Confidence 1123456899999999999999999999999999999999999999754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=317.71 Aligned_cols=206 Identities=21% Similarity=0.235 Sum_probs=167.4
Q ss_pred hcCCCCCccccccCceEEEEEEeC----CCcEEEEEEccCCChhh-----------HHHHHHHHHHHHhcCCCceeeEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQG-----------EKEFLTEIQFLSRLHHRNLVSLVG 687 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~~~~~~~~~-----------~~~~~~Ei~~l~~l~H~nIv~l~g 687 (845)
.++|.+.+.||+|+||.||+|... ++..||||+........ .+.+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357888999999999999999975 57889999987543211 134678899999999999999999
Q ss_pred EEee----CCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-
Q 003140 688 YCDE----EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF- 762 (845)
Q Consensus 688 ~~~~----~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~- 762 (845)
++.. ....++||||+ +++|.+++.... .+++..++.++.||++||+|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSST
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCC
Confidence 9987 67899999999 999999997654 6899999999999999999999998 99999999999999887
Q ss_pred -cEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 763 -TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 763 -~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
.+||+|||+++....................||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999999999987643211111111122445799999999999999999999999999999999999999964
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=313.15 Aligned_cols=204 Identities=30% Similarity=0.431 Sum_probs=177.9
Q ss_pred hcCCCCCccccccCceEEEEEEe-----CCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEe--eCCeE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD--EEGEQ 695 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~--~~~~~ 695 (845)
.++|...+.||+|+||.||+|.+ .+++.||||++........+.+.+|++++++++||||+++++++. +.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36788899999999999999984 368899999998877667778999999999999999999999986 45678
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++||||+++|+|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 99999999999999997643 35899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
..... .........||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 178 ~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 232 (327)
T 3lxl_A 178 PLDKD----YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS 232 (327)
T ss_dssp CTTCS----EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred ccCCc----cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 43221 11222345688889999999998999999999999999999999999854
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-34 Score=322.10 Aligned_cols=205 Identities=29% Similarity=0.380 Sum_probs=168.2
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----Ce
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GE 694 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~ 694 (845)
.++|.+.+.||+|+||.||+|... +|+.||||++... .....+++.+|++++++++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 368999999999999999999965 6899999998753 334457899999999999999999999999766 57
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003140 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (845)
Q Consensus 695 ~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~ 774 (845)
.++||||++ |+|.++++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 899999996 6999999653 46899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCCCCcc---------------ccceeecccCCCCccchhhh-cCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003140 775 APVPDIEGIV---------------PAHVSTVVKGTPGYLDPEYF-LTHKLTDKSDVYSLGVVFLELLTGMQPIS 833 (845)
Q Consensus 775 ~~~~~~~~~~---------------~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwS~Gvvl~elltG~~Pf~ 833 (845)
.......... .....+...||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 6432211000 00123566899999999986 56679999999999999999998655543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=305.12 Aligned_cols=197 Identities=29% Similarity=0.470 Sum_probs=174.0
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEee---------
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--------- 691 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--------- 691 (845)
..++|...+.||+|+||.||+|... +|+.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3467888999999999999999976 79999999987643 356789999999999999999998854
Q ss_pred -------CCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 003140 692 -------EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 764 (845)
Q Consensus 692 -------~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~ 764 (845)
....++||||+++|+|.+++.......+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence 445799999999999999998765667999999999999999999999998 9999999999999999999
Q ss_pred EEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003140 765 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833 (845)
Q Consensus 765 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~ 833 (845)
||+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|..|+.
T Consensus 162 kl~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 162 KIGDFGLVTSLKNDG--------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp EECCCTTCEESSCCS--------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred EECcchhheeccccc--------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 999999998764321 1233468999999999999999999999999999999999999875
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=312.94 Aligned_cols=207 Identities=26% Similarity=0.417 Sum_probs=178.6
Q ss_pred HHHHHHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh--------hhHHHHHHHHHHHHhc-CCCceeeEE
Q 003140 617 GEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--------QGEKEFLTEIQFLSRL-HHRNLVSLV 686 (845)
Q Consensus 617 ~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--------~~~~~~~~Ei~~l~~l-~H~nIv~l~ 686 (845)
.......++|.+.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+++++++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 344555678999999999999999999985 799999999865431 1135678999999999 799999999
Q ss_pred EEEeeCCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 003140 687 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV 766 (845)
Q Consensus 687 g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl 766 (845)
+++...+..++||||+++|+|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999999754 35899999999999999999999998 999999999999999999999
Q ss_pred EecCCcccCCCCCCCCccccceeecccCCCCccchhhhcC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 767 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT------HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 767 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 242 ~DfG~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 309 (365)
T 2y7j_A 242 SDFGFSCHLEPGE--------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309 (365)
T ss_dssp CCCTTCEECCTTC--------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EecCcccccCCCc--------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence 9999998764221 1234578999999999863 358889999999999999999999997543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=313.55 Aligned_cols=201 Identities=26% Similarity=0.450 Sum_probs=167.1
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhh-HHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~-~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
++|...+.||+|+||.||+|... +++.||||++....... ...+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57888999999999999999975 78999999987543222 22456899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
++ |+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--- 153 (324)
T 3mtl_A 82 LD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP--- 153 (324)
T ss_dssp CS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC---
Confidence 97 6999998764 346899999999999999999999998 999999999999999999999999999865322
Q ss_pred CccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
........||..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 154 ----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 205 (324)
T 3mtl_A 154 ----TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST 205 (324)
T ss_dssp -------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ----ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 112234568999999999876 568999999999999999999999997643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=316.64 Aligned_cols=200 Identities=26% Similarity=0.433 Sum_probs=175.9
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
.++|...+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 357888999999999999999975 6899999998764 33445789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
|+++|+|.+++.... .+++..+..++.|+++||+|||+. + |+||||||+|||++.++.+||+|||+++...
T Consensus 112 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~--- 183 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--- 183 (360)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH---
T ss_pred CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccc---
Confidence 999999999997653 588999999999999999999985 7 9999999999999999999999999986542
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 184 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 184 ------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234 (360)
T ss_dssp ------HHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred ------cccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 112234578999999999999999999999999999999999999997544
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-34 Score=321.19 Aligned_cols=199 Identities=23% Similarity=0.308 Sum_probs=175.1
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhc------CCCceeeEEEEEeeCCeE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL------HHRNLVSLVGYCDEEGEQ 695 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l------~H~nIv~l~g~~~~~~~~ 695 (845)
..+|.+.+.||+|+||.||+|... +++.||||+++.. ....+++.+|+++++.+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 357889999999999999999865 5899999999763 33456788888888887 577999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc--EEEEecCCcc
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT--AKVADFGLSR 773 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~--~kl~DFGla~ 773 (845)
++||||++ |+|.+++.......+++..+..++.||++||+|||+.+ |+||||||+|||++.++. +||+|||+|+
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999996 79999998876667999999999999999999999998 999999999999999987 9999999997
Q ss_pred cCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 251 ~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 251 YEHQR----------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp ETTCC----------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecCCc----------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 64321 234568999999999999999999999999999999999999997654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=317.33 Aligned_cols=197 Identities=26% Similarity=0.426 Sum_probs=166.5
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC------
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG------ 693 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 693 (845)
.++|...+.||+|+||.||+|... +|+.||||++... .....+++.+|++++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 357888999999999999999974 7999999998653 2334567899999999999999999999997653
Q ss_pred eEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003140 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (845)
Q Consensus 694 ~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~ 773 (845)
..++||||+ +++|.++++. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 469999999 8999999975 35899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
..... .....+|..|+|||++.+ ..++.++||||+||++|||++|+.||.+.+
T Consensus 177 ~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 230 (367)
T 1cm8_A 177 QADSE----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 230 (367)
T ss_dssp ECCSS----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccc----------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 65321 234568999999999887 689999999999999999999999997654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-34 Score=303.19 Aligned_cols=200 Identities=35% Similarity=0.584 Sum_probs=170.5
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhh-------HHHHHHHHHHHHhcCCCceeeEEEEEeeCCe
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG-------EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 694 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~-------~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 694 (845)
.++|...+.||+|+||.||+|... +++.||||++....... .+++.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 367888999999999999999974 78999999986533221 167899999999999999999999997665
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc-----EEEEec
Q 003140 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT-----AKVADF 769 (845)
Q Consensus 695 ~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~-----~kl~DF 769 (845)
++||||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ ++|+||||||+|||++.++. +||+||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred -eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 6999999999999988654 346899999999999999999999875 45999999999999988776 999999
Q ss_pred CCcccCCCCCCCCccccceeecccCCCCccchhhh--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 770 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF--LTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 770 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
|+++.... ......||+.|+|||.+ ....++.++|||||||++|||++|+.||....
T Consensus 174 g~~~~~~~----------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 232 (287)
T 4f0f_A 174 GLSQQSVH----------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232 (287)
T ss_dssp TTCBCCSS----------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred Cccccccc----------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 99975321 23345789999999998 35567899999999999999999999997543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=307.46 Aligned_cols=199 Identities=25% Similarity=0.431 Sum_probs=173.8
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
.++|.+.+.||+|+||.||++... +|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 457888999999999999999975 7899999999865555566789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCcEEEEecCCcccCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl---~~~~~~kl~DFGla~~~~~~ 778 (845)
+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||+++.....
T Consensus 88 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 88 VSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred CCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 9999999998664 35889999999999999999999998 9999999999999 78899999999998754311
Q ss_pred CCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 163 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 210 (304)
T 2jam_A 163 ---------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE 210 (304)
T ss_dssp ---------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ---------ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 123346899999999999999999999999999999999999999754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=307.73 Aligned_cols=203 Identities=24% Similarity=0.333 Sum_probs=167.7
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
.++|.+.+.||+|+||.||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999975 689999999875432 2346789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
|||+++++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 113 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 9999999999999764 35899999999999999999999998 999999999999999999999999999765432
Q ss_pred CCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
. ........||..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 188 ~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 239 (309)
T 2h34_A 188 K------LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ 239 (309)
T ss_dssp ---------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH
T ss_pred c------cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch
Confidence 1 111234568999999999999999999999999999999999999997543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=308.51 Aligned_cols=197 Identities=30% Similarity=0.492 Sum_probs=164.4
Q ss_pred cCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCC
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 703 (845)
++|++.+.||+|+||.||+|... ++.||||++... ...+.|.+|++++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 56788899999999999999984 789999998753 345689999999999999999999998874 4789999999
Q ss_pred CCCHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc-EEEEecCCcccCCCCCCC
Q 003140 704 NGTLRDQLSAKSK-EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT-AKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 704 ~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~-~kl~DFGla~~~~~~~~~ 781 (845)
+|+|.++++.... ..+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||+++.....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999976533 34789999999999999999999943233999999999999998886 799999999754311
Q ss_pred CccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.....||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 160 -------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 160 -------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206 (307)
T ss_dssp ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred -------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence 22345899999999999999999999999999999999999999754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-34 Score=303.13 Aligned_cols=199 Identities=28% Similarity=0.448 Sum_probs=175.8
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56888999999999999999975 68899999986432 123467899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++|+|.+++.... .+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred EeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence 9999999999997653 5899999999999999999999998 999999999999999999999999998764321
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 168 --------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 216 (284)
T 2vgo_A 168 --------RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216 (284)
T ss_dssp --------CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred --------ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC
Confidence 1234568999999999999999999999999999999999999997543
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=336.07 Aligned_cols=312 Identities=20% Similarity=0.222 Sum_probs=219.1
Q ss_pred EeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccc---------------------------------cccc
Q 003140 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEI---------------------------------GNIK 130 (845)
Q Consensus 84 v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~---------------------------------~~l~ 130 (845)
++.|++++|.+++..+..|+.+++|++|+|++|++++..|..| ..++
T Consensus 250 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~ 329 (680)
T 1ziw_A 250 LTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLK 329 (680)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCT
T ss_pred CCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCC
Confidence 6677777777776666667777777777777776665555444 4445
Q ss_pred cchhhhccCCCCCCCCCCccCCCCccceeecccc----------------------------cccCCCCccccCccCCCE
Q 003140 131 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN----------------------------YISGSLPKSFANLNKTRH 182 (845)
Q Consensus 131 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N----------------------------~l~~~~p~~~~~l~~L~~ 182 (845)
+|++|+|++|++++..|..|.++++|++|+|++| ++++..|..|.++++|+.
T Consensus 330 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 409 (680)
T 1ziw_A 330 CLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEV 409 (680)
T ss_dssp TCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred CCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCE
Confidence 5555555666666555555555555555554433 333344455555556666
Q ss_pred EEccCCCCCCCCc-cccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCC-CCCccccccCCCccEEEccc
Q 003140 183 FHMNNNSISGQIP-PELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG-TTIPASYSNMSKLLKLSLRN 260 (845)
Q Consensus 183 L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-~~~p~~~~~l~~L~~L~Ls~ 260 (845)
|+|++|.+++.+| ..+..+++|++|++++|++++..+..|..+++|+.|++++|.+++ ...|..+.++++|+.|+|++
T Consensus 410 L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~ 489 (680)
T 1ziw_A 410 LDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489 (680)
T ss_dssp EECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCS
T ss_pred EeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCC
Confidence 6666666554443 455556666666666666665555566666666666666666642 14677888999999999999
Q ss_pred CCCCCCCCC-CCCCCCccEEEcccccCCcCCCC---------CCCccccCEEEccCCcCCCCcccccCCCCCCCeEeccc
Q 003140 261 CSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPP---------GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIAN 330 (845)
Q Consensus 261 N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~ip~---------~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 330 (845)
|++++.++. +..+++|+.|++++|++++..+. .....+|+.|+|++|+++...+..|.++++|+.|+|++
T Consensus 490 N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 569 (680)
T 1ziw_A 490 NNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGL 569 (680)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCC
Confidence 999987775 88899999999999999854221 12234899999999999966666799999999999999
Q ss_pred ccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCCC---CCCCCcEEEecCCcccccCCC-ccccCCCCCC
Q 003140 331 NSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF---NIPPNVTVRLRGNPFCLNTNA-EQFCGSHSDD 400 (845)
Q Consensus 331 N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~---~~~~l~~l~l~~Np~~c~~~~-~~~~~~~~~~ 400 (845)
|++++..+..+..+ ++|+.|+|++|+|+.++... .++.+..+++++|||.|+|+. .+|..|....
T Consensus 570 N~l~~l~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~~~~~~~~~~~~ 638 (680)
T 1ziw_A 570 NNLNTLPASVFNNQ-----VSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINET 638 (680)
T ss_dssp SCCCCCCTTTTTTC-----TTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCCCSSEECCSSCC
T ss_pred CCCCcCCHhHhCCC-----CCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCccHHHHHHHHHhc
Confidence 99995544445444 45669999999999988763 478999999999999999996 9999887443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=320.31 Aligned_cols=204 Identities=17% Similarity=0.235 Sum_probs=173.3
Q ss_pred cCCCCCccccccCceEEEEEEeCC---------CcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceee----------
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILPD---------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS---------- 684 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~~---------g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~---------- 684 (845)
++|.+.+.||+|+||.||+|.... ++.||||++... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 678889999999999999999763 789999998753 36889999999999999987
Q ss_pred -----EEEEEee-CCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 003140 685 -----LVGYCDE-EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 758 (845)
Q Consensus 685 -----l~g~~~~-~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl 758 (845)
+++++.. .+..++||||+ +|+|.+++.......+++..++.++.|+++||+|||+++ |+||||||+|||+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEE
Confidence 6777776 67889999999 999999998764567999999999999999999999998 9999999999999
Q ss_pred cCCC--cEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 759 DHKF--TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 759 ~~~~--~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
+.++ .+||+|||+++....................||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 99999999998764322111111112244579999999999999999999999999999999999999997653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-34 Score=307.04 Aligned_cols=202 Identities=29% Similarity=0.440 Sum_probs=172.2
Q ss_pred cCCCCCccccccCceEEEEEEe-----CCCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CeE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQ 695 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~ 695 (845)
.+|+..+.||+|+||.||+|.+ .+++.||||++.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4578889999999999999983 368999999987543 33457899999999999999999999999876 668
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++||||+++|+|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccccc
Confidence 99999999999999996543 45899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~ 833 (845)
..... .........||..|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus 177 ~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 177 ETDKE----YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp CTTCC----EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cCCCc----ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 43221 1122334568888999999999999999999999999999999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=302.38 Aligned_cols=204 Identities=30% Similarity=0.479 Sum_probs=173.7
Q ss_pred cCCCCCc-cccccCceEEEEEEeC---CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEE
Q 003140 624 NNFNSST-QIGQGGYGKVYKGILP---DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 624 ~~f~~~~-~LG~G~fG~Vy~~~~~---~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
++|.+.+ .||+|+||.||+|.+. ++..||||+++... ....+++.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4555555 8999999999999853 57889999998643 34467899999999999999999999999 55678999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
|||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 9999999999999653 346899999999999999999999998 999999999999999999999999999876432
Q ss_pred CCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
.. .........+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 164 ~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 218 (287)
T 1u59_A 164 DS----YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218 (287)
T ss_dssp SC----EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cc----eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 21 0111233456889999999998899999999999999999998 999997543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=302.79 Aligned_cols=205 Identities=27% Similarity=0.418 Sum_probs=176.9
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467888999999999999999975 78999999986432 3345788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
|+++|+|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~- 159 (276)
T 2yex_A 86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN- 159 (276)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT-
T ss_pred ecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc-
Confidence 99999999988543 45899999999999999999999998 9999999999999999999999999997653221
Q ss_pred CCccccceeecccCCCCccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
.........||..|+|||.+.+..+ +.++||||||+++|||++|+.||....+
T Consensus 160 ----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 213 (276)
T 2yex_A 160 ----RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (276)
T ss_dssp ----EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred ----chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence 1112234568999999999987665 7799999999999999999999976543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=314.06 Aligned_cols=197 Identities=26% Similarity=0.431 Sum_probs=170.6
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeEEEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
.++|...+.||+|+||.||+|... +|+.||||+++.... .+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 467889999999999999999975 689999999876432 245688888888 79999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC----CcEEEEecCCcccCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK----FTAKVADFGLSRLAP 776 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~----~~~kl~DFGla~~~~ 776 (845)
|+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+.++ +.+||+|||+++...
T Consensus 97 ~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 97 LMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp CCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 99999999999654 45899999999999999999999998 9999999999998543 359999999998654
Q ss_pred CCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 172 ~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 172 AEN-------GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp CTT-------CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred CCC-------CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence 221 1223457899999999998888999999999999999999999999754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=302.88 Aligned_cols=201 Identities=26% Similarity=0.385 Sum_probs=171.9
Q ss_pred CCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCC
Q 003140 625 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 703 (845)
+|.....||+|+||.||+|.. .+++.||||.+........+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 455567899999999999996 4689999999987666666789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEEecCCcccCCCCCCC
Q 003140 704 NGTLRDQLSAKS-KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 704 ~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~-~~~~kl~DFGla~~~~~~~~~ 781 (845)
+++|.+++.... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++. ++.+||+|||+++......
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-- 177 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-- 177 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC--
Confidence 999999997653 345778999999999999999999998 999999999999987 8999999999998654221
Q ss_pred CccccceeecccCCCCccchhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTH--KLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.......||..|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 178 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (295)
T 2clq_A 178 -----PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228 (295)
T ss_dssp --------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred -----CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence 112345689999999998764 3889999999999999999999999653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=312.22 Aligned_cols=202 Identities=25% Similarity=0.425 Sum_probs=166.1
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChh--hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEE
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
..++|.+.+.||+|+||.||+|... +++.||||+++..... ..+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 3467889999999999999999964 7899999998754332 245688999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-----CCCcEEEEecCCcc
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-----HKFTAKVADFGLSR 773 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~-----~~~~~kl~DFGla~ 773 (845)
|||++ |+|.+++.... .+++..++.++.|+++||+|||+++ |+||||||+|||++ .++.+||+|||+++
T Consensus 112 ~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 99997 69999997643 4899999999999999999999998 99999999999994 55569999999998
Q ss_pred cCCCCCCCCccccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
..... ........||..|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 186 ~~~~~-------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 242 (329)
T 3gbz_A 186 AFGIP-------IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS 242 (329)
T ss_dssp HHC------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCCc-------ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC
Confidence 65322 1123345679999999999874 58999999999999999999999997644
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-34 Score=304.51 Aligned_cols=205 Identities=29% Similarity=0.489 Sum_probs=163.8
Q ss_pred HHHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 620 ALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 620 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
++..++|.+.+.||+|+||.||+|... ..||||+++... ....+.|.+|++++++++||||+++++++ ..+..++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 344578999999999999999999864 359999987543 34457899999999999999999999965 4556899
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
||||+++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 97 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence 99999999999999654 346899999999999999999999998 99999999999999999999999999976532
Q ss_pred CCCCCccccceeecccCCCCccchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.. .........||+.|+|||.+. ...++.++||||||+++|||++|+.||....
T Consensus 173 ~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 229 (289)
T 3og7_A 173 WS-----GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cc-----ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc
Confidence 21 112233456899999999986 5678899999999999999999999997644
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-34 Score=302.09 Aligned_cols=203 Identities=28% Similarity=0.464 Sum_probs=171.6
Q ss_pred HhcCCCCCccccccCceEEEEEEeCC----CcEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEE
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 696 (845)
..++|...+.||+|+||.||+|.+.+ +..||||.+... .....+++.+|++++++++||||+++++++.+. ..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence 45678889999999999999998642 346999998764 334567899999999999999999999998754 568
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCC
Q 003140 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~ 776 (845)
+||||+++|+|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 89 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 9999999999999997643 45899999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
... ........+|..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 165 ~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~ 218 (281)
T 3cc6_A 165 DED------YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL 218 (281)
T ss_dssp --------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ccc------ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC
Confidence 322 111233457889999999998999999999999999999998 99999643
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-34 Score=316.44 Aligned_cols=201 Identities=24% Similarity=0.366 Sum_probs=167.7
Q ss_pred HHHhcCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC------
Q 003140 620 ALATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------ 692 (845)
Q Consensus 620 ~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------ 692 (845)
....++|...+.||+|+||.||+|.. .+|+.||||++..... ...+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999996 4799999999865422 234799999999999999999998443
Q ss_pred --------------------------------CeEEEEEEcCCCCCHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHH
Q 003140 693 --------------------------------GEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYL 738 (845)
Q Consensus 693 --------------------------------~~~~LV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yL 738 (845)
...++||||++ |+|.+.+.. .....+++..+..++.|+++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34889999998 688888764 3456799999999999999999999
Q ss_pred HhCCCCCeEecCCCCCCEEEc-CCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCC-CCCchhhHH
Q 003140 739 HTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVY 816 (845)
Q Consensus 739 H~~~~~~iiHrDLk~~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvw 816 (845)
|+.+ |+||||||+|||++ .++.+||+|||+|+...... ......||..|+|||.+.+. .++.++|||
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 226 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--------PSVAYICSRFYRAPELMLGATEYTPSIDLW 226 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--------CCCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--------CCcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence 9998 99999999999998 68999999999998654221 22345689999999998765 489999999
Q ss_pred HHHHHHHHHHhCCCCCCCCC
Q 003140 817 SLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 817 S~Gvvl~elltG~~Pf~~~~ 836 (845)
|+||++|||++|+.||....
T Consensus 227 slG~il~ell~g~~pf~~~~ 246 (383)
T 3eb0_A 227 SIGCVFGELILGKPLFSGET 246 (383)
T ss_dssp HHHHHHHHHHHSSCSSCCSS
T ss_pred hHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999997654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=306.74 Aligned_cols=195 Identities=22% Similarity=0.401 Sum_probs=171.7
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCceeeEEEEEee--CCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDE--EGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~--~~~~~LV~ 699 (845)
++|++.+.||+|+||.||+|.. .+++.||||+++... .+.+.+|++++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 6788899999999999999986 478999999987533 467899999999997 9999999999987 66789999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEEecCCcccCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVP 778 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~-~~kl~DFGla~~~~~~ 778 (845)
||+++++|.++++. +++..+..++.|+++||+|||+.+ |+||||||+|||++.++ .+||+|||+++.....
T Consensus 113 e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp ECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 99999999999853 788999999999999999999998 99999999999999776 8999999999865422
Q ss_pred CCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
. ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||..+.+
T Consensus 185 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~ 236 (330)
T 3nsz_A 185 Q--------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 236 (330)
T ss_dssp C--------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred C--------ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 1 1234568899999999877 6789999999999999999999999976554
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=302.58 Aligned_cols=200 Identities=30% Similarity=0.442 Sum_probs=177.3
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
.+.|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356888999999999999999864 68999999987543 3446789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
|+++++|.+++.. ..+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 101 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 173 (303)
T ss_dssp CCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc-
Confidence 9999999999964 46899999999999999999999998 9999999999999999999999999997654221
Q ss_pred CCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.......||..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 174 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 222 (303)
T 3a7i_A 174 ------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222 (303)
T ss_dssp ------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ------cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc
Confidence 1123456899999999999999999999999999999999999999754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=324.22 Aligned_cols=199 Identities=17% Similarity=0.192 Sum_probs=164.5
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCC---ChhhHHHHHHHH---HHHHhcCCCceeeEE-------EE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEG---SLQGEKEFLTEI---QFLSRLHHRNLVSLV-------GY 688 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~---~~~~~~~~~~Ei---~~l~~l~H~nIv~l~-------g~ 688 (845)
.++|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+ +++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999996 46999999998732 334457899999 555566899999998 66
Q ss_pred EeeCCe-----------------EEEEEEcCCCCCHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 003140 689 CDEEGE-----------------QMLVYEFMSNGTLRDQLSAKS-----KEPLGFAMRLSIALGSSRGILYLHTEADPPV 746 (845)
Q Consensus 689 ~~~~~~-----------------~~LV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 746 (845)
+.+.+. .++||||+ +|+|.+++.... ...+++..++.|+.||++||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 665532 78999999 689999997632 123446888899999999999999998 9
Q ss_pred EecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCC-----------CCCchhhH
Q 003140 747 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-----------KLTDKSDV 815 (845)
Q Consensus 747 iHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv 815 (845)
+||||||+|||++.++.+||+|||+|+... .......| +.|+|||++.+. .++.++||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~----------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv 296 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG----------ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA 296 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT----------CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC----------CcccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence 999999999999999999999999998532 12344567 999999999887 89999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCC
Q 003140 816 YSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 816 wS~Gvvl~elltG~~Pf~~~~ 836 (845)
|||||++|||++|+.||....
T Consensus 297 wSlG~il~elltg~~Pf~~~~ 317 (377)
T 3byv_A 297 WALGLVIYWIWCADLPITKDA 317 (377)
T ss_dssp HHHHHHHHHHHHSSCCC----
T ss_pred HHHHHHHHHHHHCCCCCcccc
Confidence 999999999999999996533
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=314.20 Aligned_cols=198 Identities=24% Similarity=0.354 Sum_probs=164.6
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC------
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG------ 693 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 693 (845)
.++|...+.||+|+||.||+|... +++.||||++... .....+.+.+|+++++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 367899999999999999999965 6899999998753 2344567899999999999999999999997654
Q ss_pred eEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003140 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (845)
Q Consensus 694 ~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~ 773 (845)
..++||||++ |+|.+++.. .+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 7899999997 578888853 4889999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 176 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 230 (371)
T 2xrw_A 176 TAGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230 (371)
T ss_dssp ----------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccc--------cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 65321 12334578999999999999999999999999999999999999997654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=335.36 Aligned_cols=197 Identities=30% Similarity=0.483 Sum_probs=166.1
Q ss_pred cccccCceEEEEEEeC---CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCCCC
Q 003140 631 QIGQGGYGKVYKGILP---DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGT 706 (845)
Q Consensus 631 ~LG~G~fG~Vy~~~~~---~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gs 706 (845)
.||+|+||.||+|.+. ++..||||+++... ....++|.+|+++|++++|||||++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999864 46789999998643 3456789999999999999999999999976 56899999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCcccc
Q 003140 707 LRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 786 (845)
Q Consensus 707 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 786 (845)
|.+++... ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++........ .
T Consensus 422 L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~----~ 493 (613)
T 2ozo_A 422 LHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY----Y 493 (613)
T ss_dssp HHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCce----e
Confidence 99999654 456899999999999999999999998 999999999999999999999999999876432210 1
Q ss_pred ceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 787 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 787 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
.......+++.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 544 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544 (613)
T ss_dssp --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 11223345689999999999999999999999999999998 999997644
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=309.44 Aligned_cols=201 Identities=28% Similarity=0.453 Sum_probs=170.9
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
++|...+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 57888999999999999999975 589999999865432 335668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
|+++++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 178 (331)
T 4aaa_A 105 FVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 178 (331)
T ss_dssp CCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred cCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc-
Confidence 99999998887543 35899999999999999999999998 9999999999999999999999999997654221
Q ss_pred CCccccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......||..|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 179 ------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (331)
T 4aaa_A 179 ------EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ------cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 223345689999999999875 78999999999999999999999997654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=310.93 Aligned_cols=205 Identities=27% Similarity=0.401 Sum_probs=172.7
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEee--------C
Q 003140 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--------E 692 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--------~ 692 (845)
++|.+.+.||+|+||.||+|.. .+|+.||||++..... .....+.+|++++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5788999999999999999997 4789999999865332 234578899999999999999999999876 4
Q ss_pred CeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 003140 693 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 772 (845)
Q Consensus 693 ~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla 772 (845)
+..++||||++ |+|.+.+.... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 97 GSIYLVFDFCE-HDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp CEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccC-CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 46899999997 58888775543 45899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
+........ .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 172 ~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 233 (351)
T 3mi9_A 172 RAFSLAKNS---QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 233 (351)
T ss_dssp EECCCCSSS---SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccc---cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 876432211 1222345678999999999876 458999999999999999999999997644
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-34 Score=314.76 Aligned_cols=209 Identities=24% Similarity=0.320 Sum_probs=172.5
Q ss_pred chHHHHHHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCCh-----------hhHHHHHHHHHHHHhcCCCcee
Q 003140 615 TYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL-----------QGEKEFLTEIQFLSRLHHRNLV 683 (845)
Q Consensus 615 ~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~-----------~~~~~~~~Ei~~l~~l~H~nIv 683 (845)
...++....++|.+.+.||+|+||.||+|...+|+.||||++..... ...+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 45677888899999999999999999999988899999998854221 1236899999999999999999
Q ss_pred eEEEEEee-----CCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 003140 684 SLVGYCDE-----EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 758 (845)
Q Consensus 684 ~l~g~~~~-----~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl 758 (845)
++++++.. ....++||||++ |+|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||+
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 99999844 336899999997 7898888753 346899999999999999999999998 9999999999999
Q ss_pred cCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 759 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 759 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
+.++.+||+|||+++..... .......||..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTAD--------ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp CTTCCEEECCTTC-----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCCCCEEEEecCcccccccc--------cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999754321 12334568899999999876 678999999999999999999999997654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=301.48 Aligned_cols=199 Identities=25% Similarity=0.416 Sum_probs=172.0
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC--ChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV 698 (845)
.++|.+.+.||+|+||.||+|... +++.||||+++.. ......++.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467889999999999999999976 7999999998753 234467889999999999 999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---------------
Q 003140 699 YEFMSNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK--------------- 761 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~--------------- 761 (845)
|||+++|+|.+++.... ...+++..++.++.|+++||+|||+++ |+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999997642 256899999999999999999999998 9999999999999844
Q ss_pred ----CcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 762 ----FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 762 ----~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
..+||+|||.++...... ...||..|+|||.+.+. .++.++|||||||++|||++|..|+...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 234 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred cCCceEEEEcccccccccCCcc-----------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence 489999999998754221 23489999999999765 6678999999999999999998877543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=322.66 Aligned_cols=202 Identities=26% Similarity=0.442 Sum_probs=164.7
Q ss_pred HHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh--------hhHHHHHHHHHHHHhcCCCceeeEEEEEee
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--------QGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 691 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~ 691 (845)
...++|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 45678999999999999999999965 689999999864321 11235889999999999999999999975
Q ss_pred CCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CcEEEEe
Q 003140 692 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK---FTAKVAD 768 (845)
Q Consensus 692 ~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~---~~~kl~D 768 (845)
.+..++||||+++|+|.+++... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.+ +.+||+|
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred cCceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEee
Confidence 45689999999999999988643 46899999999999999999999998 9999999999999754 4599999
Q ss_pred cCCcccCCCCCCCCccccceeecccCCCCccchhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 769 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 769 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
||+|+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 286 FG~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~ 348 (419)
T 3i6u_A 286 FGHSKILGET--------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 348 (419)
T ss_dssp SSTTTSCC-------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred cccceecCCC--------ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc
Confidence 9999875421 22334679999999999853 678889999999999999999999997543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=311.50 Aligned_cols=212 Identities=29% Similarity=0.448 Sum_probs=174.3
Q ss_pred cchHHHHHHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEee
Q 003140 614 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE 691 (845)
Q Consensus 614 ~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~ 691 (845)
+++.++....++|.+.+.||+|+||.||+|... +|+.||||++.... ...+++.+|+++++++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 344445556788999999999999999999974 78999999987543 3346889999999999 89999999999976
Q ss_pred ------CCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEE
Q 003140 692 ------EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAK 765 (845)
Q Consensus 692 ------~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~k 765 (845)
.+..++||||+++|+|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEE
Confidence 467899999999999999998765567899999999999999999999998 99999999999999999999
Q ss_pred EEecCCcccCCCCCCCCccccceeecccCCCCccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 766 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 766 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
|+|||++....... .......||..|+|||++. +..++.++|||||||++|||++|+.||....
T Consensus 170 l~Dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 238 (326)
T 2x7f_A 170 LVDFGVSAQLDRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238 (326)
T ss_dssp ECCCTTTC--------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred EeeCcCceecCcCc-------cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 99999987653211 1123456899999999987 5678999999999999999999999997543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=308.93 Aligned_cols=204 Identities=30% Similarity=0.477 Sum_probs=168.5
Q ss_pred cCCCCCccccccCceEEEEEEeCC-----CcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILPD-----GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~~-----g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
++|...+.||+|+||.||+|.... +..||||+++... .....++.+|++++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 466778899999999999998642 2469999987543 3345679999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
||||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 124 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 99999999999999764 346899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
... .........+|..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 200 ~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~ 254 (333)
T 1mqb_A 200 DPE----ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 254 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccc----cccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC
Confidence 211 0111223346788999999999999999999999999999999 99999654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=304.12 Aligned_cols=202 Identities=27% Similarity=0.426 Sum_probs=165.9
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEG---SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|.+.+.||+|+||.||+|.. .+|+.||||++... .....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 4688899999999999999996 47899999998753 2344567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 700 EFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 700 E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
||+++|+|.+++.. .....+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999965 24556899999999999999999999998 99999999999999999999999999976542
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.. .......|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 189 ~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 189 KT-------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp -----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred CC-------ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 21 1123346899999999999999999999999999999999999999754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=302.25 Aligned_cols=204 Identities=25% Similarity=0.393 Sum_probs=172.6
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC----hhhHHHHHHHHHHHHhcCCCceeeEEEEEe--eCCeE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS----LQGEKEFLTEIQFLSRLHHRNLVSLVGYCD--EEGEQ 695 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~--~~~~~ 695 (845)
.++|.+.+.||+|+||.||++... +++.||||+++... ....+.+.+|++++++++||||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999974 68999999987532 234578999999999999999999999984 45678
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++||||+++| |.+++.......+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999866 888887766678999999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK--LTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.... .........||..|+|||++.+.. ++.++||||||+++|||++|+.||...
T Consensus 160 ~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (305)
T 2wtk_C 160 HPFA-----ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD 216 (305)
T ss_dssp CTTC-----SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred Cccc-----cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 4221 112233456899999999987644 478999999999999999999999754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=309.09 Aligned_cols=212 Identities=29% Similarity=0.440 Sum_probs=168.2
Q ss_pred HHHHHHhcCCCCCccccccCceEEEEEEeC----CCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEe
Q 003140 617 GEMALATNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690 (845)
Q Consensus 617 ~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~ 690 (845)
+++....++|.+.+.||+|+||.||+|... .+..||||+++.. .....+.+.+|++++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 444556678899999999999999999854 3458999998754 3344567999999999999999999999997
Q ss_pred eCCe-----EEEEEEcCCCCCHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC
Q 003140 691 EEGE-----QMLVYEFMSNGTLRDQLSAK----SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK 761 (845)
Q Consensus 691 ~~~~-----~~LV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~ 761 (845)
+.+. .++||||+++|+|.+++... ....+++..++.++.|+++||.|||+.+ |+||||||+||+++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCC
Confidence 7553 49999999999999998542 3456999999999999999999999998 9999999999999999
Q ss_pred CcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 762 FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 762 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
+.+||+|||+++....... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 254 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDY-----YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ 254 (313)
T ss_dssp SCEEECSCSCC---------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CcEEEeecCcceecccccc-----cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 9999999999986543221 112234457889999999999999999999999999999999 889997544
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=301.25 Aligned_cols=208 Identities=22% Similarity=0.343 Sum_probs=171.0
Q ss_pred HhcCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEE-eeCCeEEEEE
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC-DEEGEQMLVY 699 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~-~~~~~~~LV~ 699 (845)
..++|...+.||+|+||.||+|.. .+++.||||+...... .+++.+|++++++++|++++..++++ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999996 5789999998654322 23588899999999888777666655 6777889999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCcEEEEecCCcccCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRLAP 776 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl---~~~~~~kl~DFGla~~~~ 776 (845)
||+ +|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 85 e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999 99999999753 345899999999999999999999998 9999999999999 788999999999998765
Q ss_pred CCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
........+........||..|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence 433221111122345679999999999999999999999999999999999999997643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=306.52 Aligned_cols=199 Identities=31% Similarity=0.479 Sum_probs=171.6
Q ss_pred CCCCccccccCceEEEEEEeC-----CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CeEEE
Q 003140 626 FNSSTQIGQGGYGKVYKGILP-----DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQML 697 (845)
Q Consensus 626 f~~~~~LG~G~fG~Vy~~~~~-----~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~L 697 (845)
|...+.||+|+||.||++.+. +++.||||+++... ....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 478899999999999988642 68899999997643 34467799999999999999999999999874 67899
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
||||+++|+|.+++... .+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 113 v~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 99999999999999654 3899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
... .........+|..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 187 ~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 239 (318)
T 3lxp_A 187 GHE----YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239 (318)
T ss_dssp TCS----EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred ccc----ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence 221 11223345678889999999998999999999999999999999999964
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=299.60 Aligned_cols=207 Identities=22% Similarity=0.345 Sum_probs=173.7
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEE-eeCCeEEEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC-DEEGEQMLVYE 700 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~-~~~~~~~LV~E 700 (845)
.++|...+.||+|+||.||+|.. .+|+.||||++..... .+++.+|++++++++|++++..++++ .+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46788999999999999999996 5799999999875432 24688999999999988776666655 66778899999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCcEEEEecCCcccCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl---~~~~~~kl~DFGla~~~~~ 777 (845)
|+ +++|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+|||+ +.++.+||+|||+++....
T Consensus 86 ~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99 99999999753 346899999999999999999999998 9999999999999 5889999999999987654
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......+........||..|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence 32211111122345679999999999999999999999999999999999999997643
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-34 Score=311.81 Aligned_cols=203 Identities=26% Similarity=0.411 Sum_probs=168.5
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhh-----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCeE
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG-----EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~-----~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 695 (845)
..++|...+.||+|+||.||+|... +|+.||||++....... .+.+.+|++++++++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3578999999999999999999975 68999999987532221 24688999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++||||+++ +|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 88 ~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp EEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred EEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 999999975 899988654 346888899999999999999999999 999999999999999999999999999875
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|..||....
T Consensus 163 ~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~ 217 (346)
T 1ua2_A 163 GSPN-------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS 217 (346)
T ss_dssp TSCC-------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCc-------ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence 4321 223345689999999998754 58999999999999999999999987544
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=298.83 Aligned_cols=200 Identities=30% Similarity=0.505 Sum_probs=170.8
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEee----CCeEEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE----EGEQML 697 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~L 697 (845)
.|...+.||+|+||.||+|... ++..||+|++... .....+.+.+|++++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4667788999999999999975 6889999998643 33445779999999999999999999999865 356899
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcEEEEecCCcccCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAP 776 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~-~~~~~kl~DFGla~~~~ 776 (845)
||||+++|+|.+++... ..+++..++.++.|+++||+|||+.+ ++|+||||||+|||++ +++.+||+|||+++...
T Consensus 107 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 99999999999999764 35889999999999999999999875 4599999999999998 78999999999997543
Q ss_pred CCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
.. ......||+.|+|||.+. +.++.++|||||||++|||++|+.||....+
T Consensus 184 ~~---------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 234 (290)
T 1t4h_A 184 AS---------FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN 234 (290)
T ss_dssp TT---------SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS
T ss_pred cc---------ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc
Confidence 21 223456899999999876 4689999999999999999999999976443
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=308.18 Aligned_cols=202 Identities=33% Similarity=0.525 Sum_probs=171.0
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcE--EEEEEccCC-ChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTV--VAVKRAQEG-SLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~--vAVK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV 698 (845)
++|...+.||+|+||.||+|... ++.. ||||.++.. .....+++.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67888999999999999999964 5664 499988753 233456789999999999 899999999999999999999
Q ss_pred EEcCCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 003140 699 YEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 764 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~ 764 (845)
|||+++|+|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999997643 346899999999999999999999998 9999999999999999999
Q ss_pred EEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 765 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 765 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
||+|||+++.... ........++..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 182 kL~Dfg~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 246 (327)
T 1fvr_A 182 KIADFGLSRGQEV--------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246 (327)
T ss_dssp EECCTTCEESSCE--------ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EEcccCcCccccc--------cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc
Confidence 9999999974321 111233456889999999998889999999999999999998 999997543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=326.42 Aligned_cols=324 Identities=20% Similarity=0.266 Sum_probs=211.0
Q ss_pred CCCcceEecCCC-----CC-CCcceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhcc
Q 003140 65 SNWTGVLCFNTT-----MD-DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLN 138 (845)
Q Consensus 65 ~~w~Gv~C~~~~-----~~-~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 138 (845)
|.|.|+ |.... .+ ....+++.|+|++|.+++..|..|+.+++|++|+|++|++++..|..|.++++|++|+|+
T Consensus 4 C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls 82 (549)
T 2z81_A 4 CDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLS 82 (549)
T ss_dssp ECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECT
T ss_pred CCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECC
Confidence 358887 74321 11 223578889999998888888888888888888888888888777888888888888888
Q ss_pred CCCCCCCCCCccCCCCccceeecccccccC-CCCccccCccCCCEEEccCCCCCCCCc-cccCCCCCcceeecccccccc
Q 003140 139 GNELTGSLPEELGYLPKLDRIQIDQNYISG-SLPKSFANLNKTRHFHMNNNSISGQIP-PELSRLPSLVHMLLDNNNLTG 216 (845)
Q Consensus 139 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~ 216 (845)
+|++++..|..|+++++|++|+|++|++++ ..|..+.++++|++|++++|.+.+.+| ..+..+++|++|++++|++++
T Consensus 83 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~ 162 (549)
T 2z81_A 83 DNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN 162 (549)
T ss_dssp TSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCE
T ss_pred CCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccc
Confidence 888887766678888888888888888876 356677777778888777777443443 456666666666666666555
Q ss_pred CCCcccCC------------------------CCCCcEEEccCCcCCCCC------------------------------
Q 003140 217 YLPPELSE------------------------LPKLLILQLDNNNFEGTT------------------------------ 242 (845)
Q Consensus 217 ~~p~~l~~------------------------l~~L~~L~Ls~N~l~~~~------------------------------ 242 (845)
..|..+.. +++|++|++++|++++..
T Consensus 163 ~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~ 242 (549)
T 2z81_A 163 YQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNE 242 (549)
T ss_dssp ECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHH
T ss_pred cChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHH
Confidence 44443332 233333333333333210
Q ss_pred --------------------------------------------------------------------------------
Q 003140 243 -------------------------------------------------------------------------------- 242 (845)
Q Consensus 243 -------------------------------------------------------------------------------- 242 (845)
T Consensus 243 l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l 322 (549)
T 2z81_A 243 LLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV 322 (549)
T ss_dssp HHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCC
T ss_pred HHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCcc
Confidence
Q ss_pred --Ccccc-ccCCCccEEEcccCCCC---------------------------CCCC---CCCCCCCccEEEcccccCCcC
Q 003140 243 --IPASY-SNMSKLLKLSLRNCSLQ---------------------------GPMP---DLSRIPNLGYLDLSSNQLNGS 289 (845)
Q Consensus 243 --~p~~~-~~l~~L~~L~Ls~N~l~---------------------------~~~~---~l~~l~~L~~L~Ls~N~l~~~ 289 (845)
+|..+ .++++|+.|+|++|+++ +.++ .+..+++|++|++++|+++ .
T Consensus 323 ~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ 401 (549)
T 2z81_A 323 FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-P 401 (549)
T ss_dssp CCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-C
T ss_pred ccCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-c
Confidence 01011 12333444444444433 2211 1445566777777777776 4
Q ss_pred CCCCCC-ccccCEEEccCCcCCCCccc-----------------ccCCCCCCCeEecccccCcccCChhhhhhccCCCCc
Q 003140 290 IPPGRL-SLNITTIKLSNNKLTGTIPS-----------------NFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATE 351 (845)
Q Consensus 290 ip~~~~-~~~L~~L~Ls~N~l~~~~p~-----------------~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~ 351 (845)
+|..+. ..+|+.|+|++|+++..... .+..+++|++|+|++|+|+ .+|.. .. .+.
T Consensus 402 lp~~~~~~~~L~~L~Ls~N~l~~l~~~~~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~l~-~ip~~-~~-----l~~ 474 (549)
T 2z81_A 402 MPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLPDA-SL-----FPV 474 (549)
T ss_dssp CCSCCCCCTTCCEEECTTSCCSCCCTTSCTTCSEEECCSSCCSCCCCCCTTCCEEECCSSCCS-SCCCG-GG-----CTT
T ss_pred CChhhcccccccEEECCCCCcccccchhcCCceEEECCCCChhhhcccCChhcEEECCCCccC-cCCCc-cc-----Ccc
Confidence 554332 22455555555554421110 1247889999999999998 67763 22 356
Q ss_pred ceEEEccCCCCCCCCCC-C-CCCCCcEEEecCCcccccCCC-ccccCCC
Q 003140 352 TFILDFQNNNLTNISGS-F-NIPPNVTVRLRGNPFCLNTNA-EQFCGSH 397 (845)
Q Consensus 352 l~~L~ls~N~l~~i~~~-~-~~~~l~~l~l~~Np~~c~~~~-~~~~~~~ 397 (845)
|+.|+|++|+|++++.. + .++.+..+++++|||.|+|+. .++..|.
T Consensus 475 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~l~~~l 523 (549)
T 2z81_A 475 LLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWL 523 (549)
T ss_dssp CCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHHHHHHHHHH
T ss_pred CCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCccHHHHHHHH
Confidence 77999999999998876 3 589999999999999999984 3443444
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=316.08 Aligned_cols=204 Identities=34% Similarity=0.535 Sum_probs=160.8
Q ss_pred CCCCCccccccCceEEEEEEeC--CC--cEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEee-CCeEEEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP--DG--TVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-EGEQMLV 698 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~--~g--~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~LV 698 (845)
.|...+.||+|+||.||+|.+. ++ ..||||.++... ....++|.+|++++++++||||+++++++.+ ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4566789999999999999863 22 468999987533 3456789999999999999999999999754 5678999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
|||+++|+|.++++.. ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 170 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccccc
Confidence 9999999999999754 345889999999999999999999998 999999999999999999999999999865432
Q ss_pred CCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
... .........+|+.|+|||.+.+..++.++|||||||++|||+| |..||...
T Consensus 246 ~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~ 300 (373)
T 3c1x_A 246 EFD---SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 300 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred ccc---cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC
Confidence 211 1112234457889999999999999999999999999999999 66677543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-34 Score=301.84 Aligned_cols=207 Identities=27% Similarity=0.435 Sum_probs=173.8
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEee--CCeEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQML 697 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~L 697 (845)
.++|.+.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+ .+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357888999999999999999975 68999999987543 3445679999999999999999999998754 578999
Q ss_pred EEEcCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003140 698 VYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEA--DPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDLk~~NILl~~~~~~kl~DFGla~ 773 (845)
||||+++|+|.+++... ....+++..++.++.|+++||+|||+.+ ..+|+||||||+||+++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999763 3456899999999999999999999876 2449999999999999999999999999998
Q ss_pred cCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
...... .......||..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 165 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 220 (279)
T 2w5a_A 165 ILNHDT-------SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220 (279)
T ss_dssp HC---C-------HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecccc-------ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC
Confidence 653211 11233568999999999999999999999999999999999999997643
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=312.46 Aligned_cols=206 Identities=29% Similarity=0.469 Sum_probs=164.1
Q ss_pred hcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHH--HHhcCCCceeeEEEEEee-----CCeE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQF--LSRLHHRNLVSLVGYCDE-----EGEQ 695 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~--l~~l~H~nIv~l~g~~~~-----~~~~ 695 (845)
.++|.+.+.||+|+||.||+|.. +++.||||++.... ...+..|.++ +..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46788899999999999999987 68999999986532 3344445444 555899999999986532 2356
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCeEecCCCCCCEEEcCCCcEEE
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE---------ADPPVFHRDIKASNILLDHKFTAKV 766 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------~~~~iiHrDLk~~NILl~~~~~~kl 766 (845)
++||||+++|+|.+++... ..++..++.++.|+++||+|||+. + |+||||||+|||++.++.+||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEE
T ss_pred EEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEE
Confidence 8999999999999999654 358999999999999999999998 6 999999999999999999999
Q ss_pred EecCCcccCCCCCCCCc-cccceeecccCCCCccchhhhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCc
Q 003140 767 ADFGLSRLAPVPDIEGI-VPAHVSTVVKGTPGYLDPEYFLT-------HKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 838 (845)
Q Consensus 767 ~DFGla~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~ 838 (845)
+|||+++.......... ..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..+...
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 99999987643221100 01122334579999999999976 45667899999999999999999988765543
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=310.77 Aligned_cols=233 Identities=27% Similarity=0.498 Sum_probs=216.5
Q ss_pred CCccEEEecCCCCCC--CCcccccccccchhhhccC-CCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCE
Q 003140 106 SYLTILDFMWNKISG--SIPKEIGNIKSLELLLLNG-NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRH 182 (845)
Q Consensus 106 ~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 182 (845)
.++++|+|++|++++ .+|..|.++++|++|+|++ |.+++.+|..|+++++|++|+|++|++++.+|..+.++++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 579999999999999 8999999999999999995 9999999999999999999999999999999999999999999
Q ss_pred EEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCC-CCcEEEccCCcCCCCCCccccccCCCccEEEcccC
Q 003140 183 FHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELP-KLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261 (845)
Q Consensus 183 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N 261 (845)
|+|++|.+++.+|..+..+++|++|+|++|++++.+|..+..++ +|++|+|++|++++ .+|..+..++ |+.|+|++|
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~-~~~~~~~~l~-L~~L~Ls~N 207 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTG-KIPPTFANLN-LAFVDLSRN 207 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEE-ECCGGGGGCC-CSEEECCSS
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeec-cCChHHhCCc-ccEEECcCC
Confidence 99999999999999999999999999999999999999999998 99999999999997 6899999987 999999999
Q ss_pred CCCCCCCC-CCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCChh
Q 003140 262 SLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSS 340 (845)
Q Consensus 262 ~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~ 340 (845)
++++..+. +..+++|+.|++++|.+++.+|......+|+.|+|++|+|++.+|..|..+++|++|+|++|+++|.+|..
T Consensus 208 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~ 287 (313)
T 1ogq_A 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287 (313)
T ss_dssp EEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred cccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence 99987664 88999999999999999987777555568999999999999888999999999999999999998888864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=306.38 Aligned_cols=203 Identities=29% Similarity=0.437 Sum_probs=173.5
Q ss_pred HhcCCCCCccccccCceEEEEEEe--CCCcEEEEEEccCCCh--hhHHHHHHHHHHHHhc---CCCceeeEEEEEe----
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGIL--PDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRL---HHRNLVSLVGYCD---- 690 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~--~~g~~vAVK~~~~~~~--~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~---- 690 (845)
..++|.+.+.||+|+||.||+|.. .+|+.||||+++.... .....+.+|+++++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 4688999998864321 1223566777777766 8999999999987
Q ss_pred -eCCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEec
Q 003140 691 -EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 769 (845)
Q Consensus 691 -~~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DF 769 (845)
.....++||||++ |+|.+++.......+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecC
Confidence 4567899999997 79999998876667999999999999999999999998 999999999999999999999999
Q ss_pred CCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 770 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 770 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
|+++.... ........||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 165 g~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (326)
T 1blx_A 165 GLARIYSF--------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 223 (326)
T ss_dssp CSCCCCCG--------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccC--------CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99976531 112334568999999999999999999999999999999999999997654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-34 Score=303.43 Aligned_cols=198 Identities=32% Similarity=0.515 Sum_probs=167.1
Q ss_pred HhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC-CeEEEEEE
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-GEQMLVYE 700 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-~~~~LV~E 700 (845)
..++|...+.||+|+||.||+|.. +|+.||||+++... ..+.+.+|++++++++||||+++++++.+. +..++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 346788899999999999999987 48999999987543 456799999999999999999999997554 47899999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
|+++|+|.+++.......+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 999999999997654445889999999999999999999998 999999999999999999999999998754321
Q ss_pred CCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 171 --------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 218 (278)
T 1byg_A 171 --------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 218 (278)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred --------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 122357889999999999999999999999999999998 99999754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-34 Score=315.18 Aligned_cols=197 Identities=26% Similarity=0.432 Sum_probs=156.1
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC------C
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------G 693 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------~ 693 (845)
.++|...+.||+|+||.||+|.. .+|+.||||++... .....+++.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 36899999999999999999996 46899999998753 334457889999999999999999999998654 5
Q ss_pred eEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003140 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (845)
Q Consensus 694 ~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~ 773 (845)
..++|+||+ +++|.++++. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 679999999 7899998864 46899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.... ......||..|+|||++.+ ..++.++||||+||++|||++|+.||.+.+
T Consensus 181 ~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 234 (367)
T 2fst_X 181 HTAD----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234 (367)
T ss_dssp --------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccc----------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 6431 1234578999999999877 678999999999999999999999997654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=308.94 Aligned_cols=204 Identities=28% Similarity=0.471 Sum_probs=167.0
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcE----EEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTV----VAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~----vAVK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 696 (845)
.++|...+.||+|+||.||+|.+. +++. ||+|.+... .....+++.+|++++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 367888999999999999999964 4443 577877543 3445678999999999999999999999998754 78
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCC
Q 003140 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~ 776 (845)
+|+||+++|+|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 9999999999999997643 46899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
... .........+|..|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 169 ~~~-----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 224 (327)
T 3lzb_A 169 AEE-----KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224 (327)
T ss_dssp ----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred Ccc-----ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 322 1122233456789999999999999999999999999999999 999997543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=324.15 Aligned_cols=200 Identities=28% Similarity=0.449 Sum_probs=170.1
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
.++|...+.||+|+||.||+|... ++..||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 356888999999999999999975 68999999987543 233567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CcEEEEecCCcccCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAP 776 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~---~~~kl~DFGla~~~~ 776 (845)
||+++|+|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.. +.+||+|||+++...
T Consensus 116 e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 116 ECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 999999999988664 35889999999999999999999998 9999999999999764 569999999998754
Q ss_pred CCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.. .......||+.|+|||++. ..++.++||||+||++|||++|+.||....
T Consensus 191 ~~--------~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 241 (494)
T 3lij_A 191 NQ--------KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT 241 (494)
T ss_dssp TT--------BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CC--------ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 22 1233457999999999886 569999999999999999999999997543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=322.73 Aligned_cols=200 Identities=30% Similarity=0.449 Sum_probs=172.4
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh-------------hhHHHHHHHHHHHHhcCCCceeeEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-------------QGEKEFLTEIQFLSRLHHRNLVSLVGY 688 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-------------~~~~~~~~Ei~~l~~l~H~nIv~l~g~ 688 (845)
.++|.+.+.||+|+||.||+|... +++.||||++..... ...+.+.+|++++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 468999999999999999999975 688999999875321 234678999999999999999999999
Q ss_pred EeeCCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC---cEE
Q 003140 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TAK 765 (845)
Q Consensus 689 ~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~---~~k 765 (845)
+.+.+..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEE
Confidence 99999999999999999999998664 35899999999999999999999998 99999999999998776 699
Q ss_pred EEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 766 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 766 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
|+|||+++..... .......||+.|+|||++. ..++.++||||+||++|||++|+.||....
T Consensus 190 l~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 251 (504)
T 3q5i_A 190 IVDFGLSSFFSKD--------YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251 (504)
T ss_dssp ECCCTTCEECCTT--------SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEECCCCEEcCCC--------CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999876422 1233456999999999986 568999999999999999999999997643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=305.91 Aligned_cols=199 Identities=24% Similarity=0.381 Sum_probs=175.4
Q ss_pred hcCCCCCccccccCceEEEEEEe--CCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCC------ceeeEEEEEeeCCe
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGIL--PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHR------NLVSLVGYCDEEGE 694 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~--~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~------nIv~l~g~~~~~~~ 694 (845)
.++|.+.+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|+++++.++|+ +++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46889999999999999999986 36899999998753 34456788999999998765 49999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC--------------
Q 003140 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-------------- 760 (845)
Q Consensus 695 ~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~-------------- 760 (845)
.++||||+ +++|.+++......++++..+..++.|+++||+|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 899999998876667999999999999999999999998 999999999999987
Q ss_pred -----CCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 761 -----KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 761 -----~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
++.+||+|||+++..... .....||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccCCCceEeeCcccccCccc----------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 668999999999864321 23456899999999999999999999999999999999999999765
Q ss_pred C
Q 003140 836 K 836 (845)
Q Consensus 836 ~ 836 (845)
+
T Consensus 238 ~ 238 (339)
T 1z57_A 238 D 238 (339)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-33 Score=298.67 Aligned_cols=201 Identities=29% Similarity=0.397 Sum_probs=175.1
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---------hhhHHHHHHHHHHHHhcC-CCceeeEEEEEee
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---------LQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDE 691 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---------~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~ 691 (845)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++++++. ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 468889999999999999999975 68999999986532 122456889999999995 9999999999999
Q ss_pred CCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 003140 692 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 771 (845)
Q Consensus 692 ~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGl 771 (845)
.+..++||||+++|+|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccc
Confidence 99999999999999999999764 35899999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCCCccccceeecccCCCCccchhhhc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL------THKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
++...... ......||..|+|||++. ...++.++||||||+++|||++|+.||....
T Consensus 171 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 233 (298)
T 1phk_A 171 SCQLDPGE--------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233 (298)
T ss_dssp CEECCTTC--------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhhcCCCc--------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc
Confidence 98654221 123456899999999985 4568899999999999999999999997543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=298.61 Aligned_cols=200 Identities=28% Similarity=0.416 Sum_probs=168.3
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 367888999999999999999976 79999999986532 22356789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
|||+++++|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 99999999999997653 5889999999999999999999998 999999999999999999999999999865422
Q ss_pred CCCCccccceeecccCCCCccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
. ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...
T Consensus 165 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 214 (276)
T 2h6d_A 165 E--------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214 (276)
T ss_dssp --------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred c--------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 1 1234468899999999987765 68999999999999999999999754
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=317.17 Aligned_cols=197 Identities=26% Similarity=0.382 Sum_probs=164.1
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC----C--eEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE----G--EQM 696 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~----~--~~~ 696 (845)
.+|...+.||+|+||.||+|.+. +|+.||||++..... .+.+|++++++++||||+++++++... + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 45778899999999999999975 689999999865322 234799999999999999999988542 2 367
Q ss_pred EEEEcCCCCCHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEEecCCcc
Q 003140 697 LVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLSR 773 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~-~~~kl~DFGla~ 773 (845)
+||||+++ ++.+.+.. .....+++..++.++.||++||+|||+.+ |+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999974 77776653 34567999999999999999999999998 9999999999999965 678999999998
Q ss_pred cCCCCCCCCccccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
...... ......||..|+|||++.+. .++.++|||||||++|||++|+.||.+..
T Consensus 206 ~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~ 261 (420)
T 1j1b_A 206 QLVRGE--------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 261 (420)
T ss_dssp ECCTTC--------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hcccCC--------CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 654221 12345689999999998764 79999999999999999999999997654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=315.09 Aligned_cols=199 Identities=22% Similarity=0.271 Sum_probs=172.1
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcC--------CCceeeEEEEEe---
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH--------HRNLVSLVGYCD--- 690 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~--------H~nIv~l~g~~~--- 690 (845)
.++|.+.+.||+|+||.||+|... +++.||||+++.. ....+.+.+|++++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 367999999999999999999864 6899999998753 344567899999999985 788999999987
Q ss_pred -eCCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCC------
Q 003140 691 -EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKF------ 762 (845)
Q Consensus 691 -~~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDLk~~NILl~~~~------ 762 (845)
.....++||||+ +|+|.+++.......+++..++.++.||++||+|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhh
Confidence 456789999999 67777777666556799999999999999999999998 7 99999999999999775
Q ss_pred -------------------------------------------cEEEEecCCcccCCCCCCCCccccceeecccCCCCcc
Q 003140 763 -------------------------------------------TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799 (845)
Q Consensus 763 -------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ 799 (845)
.+||+|||+++..... .....||..|+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----------~~~~~gt~~y~ 260 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----------FTEDIQTRQYR 260 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----------SCSCCSCGGGC
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----------CccCCCCCccc
Confidence 7999999999865321 23346899999
Q ss_pred chhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 800 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 800 aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
|||++.+..++.++|||||||++|||++|+.||....
T Consensus 261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 9999999999999999999999999999999997543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=325.40 Aligned_cols=200 Identities=28% Similarity=0.465 Sum_probs=175.9
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
.++|...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467888999999999999999975 78999999986432 33467899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCcEEEEecCCcccC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRLA 775 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl---~~~~~~kl~DFGla~~~ 775 (845)
|||+++|+|.+++... ..+++..+..++.|+++||+|||+++ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 105 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp ECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 9999999999998654 45899999999999999999999998 9999999999999 56789999999999865
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
... .......||+.|+|||++.+ .++.++||||+||++|||++|+.||....
T Consensus 180 ~~~--------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 231 (484)
T 3nyv_A 180 EAS--------KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN 231 (484)
T ss_dssp CCC--------CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccc--------cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC
Confidence 422 12234569999999999866 69999999999999999999999997643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=308.88 Aligned_cols=207 Identities=29% Similarity=0.458 Sum_probs=172.7
Q ss_pred HhcCCCCCccccccCceEEEEEEe------CCCcEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCe
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 694 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAVK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 694 (845)
..++|.+.+.||+|+||.||+|.+ .+++.||||++... ......++.+|+.++++++||||+++++++.+.+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 346888999999999999999984 25778999998754 34456789999999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhccCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEE
Q 003140 695 QMLVYEFMSNGTLRDQLSAKSK-----EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKV 766 (845)
Q Consensus 695 ~~LV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~---~~~~kl 766 (845)
.++||||+++|+|.+++..... ..+++..++.++.|+++||.|||+.+ |+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999986532 45899999999999999999999998 999999999999984 456999
Q ss_pred EecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 767 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 767 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
+|||+++...... .........||+.|+|||.+.+..++.++|||||||++|||+| |+.||....
T Consensus 185 ~Dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 250 (327)
T 2yfx_A 185 GDFGMARDIYRAS-----YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250 (327)
T ss_dssp CCCHHHHHHHC-----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred Ccccccccccccc-----ccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC
Confidence 9999987543221 1112234567899999999999999999999999999999998 999997543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=307.46 Aligned_cols=213 Identities=29% Similarity=0.402 Sum_probs=160.2
Q ss_pred HHHHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEE
Q 003140 619 MALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (845)
Q Consensus 619 ~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 696 (845)
+....++|.+.+.||+|+||.||+|... +++.||||++.... ....+++.+|++++++++||||+++++++...+..+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 3455678999999999999999999964 68999999886533 334567899999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhcc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 003140 697 LVYEFMSNGTLRDQLSAK------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 770 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFG 770 (845)
+||||+++|+|.+++... ....+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEecc
Confidence 999999999999998641 3456899999999999999999999998 9999999999999999999999999
Q ss_pred CcccCCCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 771 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 771 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
+++....... ...........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus 167 ~~~~~~~~~~--~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 231 (303)
T 2vwi_A 167 VSAFLATGGD--ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP 231 (303)
T ss_dssp HHHHCC-----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred chheeccCCC--ccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCc
Confidence 9976543210 011122334578999999999875 568999999999999999999999997643
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=305.21 Aligned_cols=210 Identities=26% Similarity=0.380 Sum_probs=173.9
Q ss_pred HHhcCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEee----CCeE
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE----EGEQ 695 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~ 695 (845)
+..++|...+.||+|+||.||++.. .+|+.||||++........+.+.+|++++++++||||+++++++.. ....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 3457899999999999999999997 5799999999877666667889999999999999999999999863 3478
Q ss_pred EEEEEcCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003140 696 MLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~ 773 (845)
++||||+++|+|.+++... ....+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 9999999999999999763 3467999999999999999999999998 9999999999999999999999999987
Q ss_pred cCCCCCCCCc--cccceeecccCCCCccchhhhcCCC---CCchhhHHHHHHHHHHHHhCCCCCC
Q 003140 774 LAPVPDIEGI--VPAHVSTVVKGTPGYLDPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQPIS 833 (845)
Q Consensus 774 ~~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwS~Gvvl~elltG~~Pf~ 833 (845)
.......... ..........||+.|+|||.+.... ++.++|||||||++|||++|+.||.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 247 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTH
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChh
Confidence 6431100000 0000112345799999999987554 6889999999999999999999995
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=304.41 Aligned_cols=200 Identities=28% Similarity=0.415 Sum_probs=163.0
Q ss_pred HHHHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhc--CCCceeeEEEEEeeC----
Q 003140 619 MALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL--HHRNLVSLVGYCDEE---- 692 (845)
Q Consensus 619 ~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l--~H~nIv~l~g~~~~~---- 692 (845)
.....++|.+.+.||+|+||.||+|... |+.||||++... ....+.+|.+++... +||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 3345578999999999999999999985 899999998643 234555666666554 899999999999887
Q ss_pred CeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCCEEEcCCCcEEEE
Q 003140 693 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA-----DPPVFHRDIKASNILLDHKFTAKVA 767 (845)
Q Consensus 693 ~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiHrDLk~~NILl~~~~~~kl~ 767 (845)
...++||||+++|+|.++++.. .+++..++.++.|+++||+|||+.+ .++|+||||||+|||++.++.+||+
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 7899999999999999999653 5899999999999999999999881 1229999999999999999999999
Q ss_pred ecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCch------hhHHHHHHHHHHHHhC
Q 003140 768 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDK------SDVYSLGVVFLELLTG 828 (845)
Q Consensus 768 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwS~Gvvl~elltG 828 (845)
|||+++........ .........||+.|+|||++.+...+.+ +|||||||++|||+||
T Consensus 185 Dfg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg 248 (337)
T 3mdy_A 185 DLGLAVKFISDTNE---VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248 (337)
T ss_dssp CCTTCEECC------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred eCCCceeecccccc---ccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence 99999765432211 0111234579999999999987766654 9999999999999999
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=301.80 Aligned_cols=205 Identities=29% Similarity=0.398 Sum_probs=171.3
Q ss_pred CCCCCccccccCceEEEEEEeC-C---CcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeE-EEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-D---GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ-MLV 698 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~---g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~-~LV 698 (845)
.|...+.||+|+||.||+|.+. + +..||+|++.... ....+.+.+|++++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 3455688999999999999853 2 3379999987543 34457899999999999999999999999776655 999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
|||+.+|+|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 9999999999999763 356899999999999999999999998 999999999999999999999999999865432
Q ss_pred CCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
... .........+|..|+|||.+.+..++.++|||||||++|||++|..|+....
T Consensus 178 ~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~ 232 (298)
T 3pls_A 178 EYY---SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI 232 (298)
T ss_dssp GGG---CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred ccc---ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC
Confidence 111 1122334567899999999999999999999999999999999777765443
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=303.27 Aligned_cols=202 Identities=27% Similarity=0.406 Sum_probs=167.1
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEe------------
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD------------ 690 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~------------ 690 (845)
++|...+.||+|+||.||+|... +|+.||||++........+++.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 67888999999999999999976 58999999998776667788999999999999999999999873
Q ss_pred --eCCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcEEEE
Q 003140 691 --EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVA 767 (845)
Q Consensus 691 --~~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~-~~~~~kl~ 767 (845)
+.+..++||||++ |+|.+++.. .++++..++.++.|+++||+|||+.+ |+||||||+|||++ +++.+||+
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEEC
T ss_pred ccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEc
Confidence 3467899999997 799999954 45889999999999999999999998 99999999999997 56799999
Q ss_pred ecCCcccCCCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 768 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 768 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
|||+++....... .........+|..|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus 164 Dfg~~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 229 (320)
T 2i6l_A 164 DFGLARIMDPHYS----HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229 (320)
T ss_dssp CCTTCBCC------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCccccccCCCcc----cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence 9999987542210 1112234467899999998865 678999999999999999999999997654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=302.40 Aligned_cols=203 Identities=29% Similarity=0.449 Sum_probs=172.6
Q ss_pred HHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
...++|.+.+.||+|+||.||+|... +|+.||||++.... ..+++.+|++++++++||||+++++++.+.+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34578999999999999999999975 58999999987543 3457899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++|+|.+++... ...+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 104 e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 104 EYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp ECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred ecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 999999999999643 346899999999999999999999998 9999999999999999999999999997653221
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......||..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 180 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 229 (314)
T 3com_A 180 -------AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH 229 (314)
T ss_dssp -------SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred -------cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 11234568999999999999999999999999999999999999997543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=300.79 Aligned_cols=202 Identities=25% Similarity=0.359 Sum_probs=160.3
Q ss_pred HhcCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCC-hhhHH-HHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEE
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS-LQGEK-EFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~-~~~~~-~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
..++|+..+.||+|+||.||+|.. .+|+.||||+++... ..... .+.++...++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 346788999999999999999997 478999999987542 22233 344555568888999999999999999999999
Q ss_pred EEcCCCCCHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 699 YEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
|||++ |+|.+++.. .....+++..++.++.|+++||+|||++ + |+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99997 699888765 2456799999999999999999999997 8 999999999999999999999999999865
Q ss_pred CCCCCCCccccceeecccCCCCccchhhh----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYF----LTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
... .......||+.|+|||++ .+..++.++|||||||++|||++|+.||...
T Consensus 161 ~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (290)
T 3fme_A 161 VDD--------VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 216 (290)
T ss_dssp -----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC
T ss_pred ccc--------ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc
Confidence 422 112334689999999996 5667899999999999999999999999753
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=303.10 Aligned_cols=205 Identities=29% Similarity=0.408 Sum_probs=170.9
Q ss_pred HhcCCCCCc-cccccCceEEEEEEe---CCCcEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeE
Q 003140 622 ATNNFNSST-QIGQGGYGKVYKGIL---PDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (845)
Q Consensus 622 ~~~~f~~~~-~LG~G~fG~Vy~~~~---~~g~~vAVK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 695 (845)
..++|.+.+ .||+|+||.||+|.+ .+++.||||+++.... ...+++.+|++++++++||||+++++++ +.+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 345677777 999999999999964 2478899999875432 2356899999999999999999999999 56778
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++||||+++|+|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 93 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 9999999999999999764 35899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
..... .........++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 168 ~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 225 (291)
T 1xbb_A 168 RADEN----YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225 (291)
T ss_dssp CTTCS----EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccCCC----cccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 43221 0111223446789999999998889999999999999999999 999997543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=302.49 Aligned_cols=204 Identities=34% Similarity=0.499 Sum_probs=168.4
Q ss_pred cCCCCCccccccCceEEEEEEeCC----CcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEe-eCCeEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCD-EEGEQML 697 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~-~~~~~~L 697 (845)
.+|...+.||+|+||.||+|...+ +..||||.+.... ....+++.+|++++++++||||+++++++. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 457778999999999999998642 2368999987543 344578999999999999999999999964 4567899
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
||||+++|+|.++++.. ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 105 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccc
Confidence 99999999999999753 346899999999999999999999998 99999999999999999999999999986643
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCC-CCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQ-PISH 834 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~-Pf~~ 834 (845)
.... .........+|+.|+|||.+.+..++.++||||||+++|||++|.. ||..
T Consensus 181 ~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 235 (298)
T 3f66_A 181 KEYY---SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 235 (298)
T ss_dssp GGGC---BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchh---ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 2211 1222344567889999999999999999999999999999999554 5543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-34 Score=313.34 Aligned_cols=202 Identities=23% Similarity=0.394 Sum_probs=177.2
Q ss_pred hcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhh-----------------HHHHHHHHHHHHhcCCCceeeE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG-----------------EKEFLTEIQFLSRLHHRNLVSL 685 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~-----------------~~~~~~Ei~~l~~l~H~nIv~l 685 (845)
.++|.+.+.||+|+||.||+|.. +|+.||||++....... .+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36788999999999999999999 89999999986432211 1789999999999999999999
Q ss_pred EEEEeeCCeEEEEEEcCCCCCHHHH------HhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEE
Q 003140 686 VGYCDEEGEQMLVYEFMSNGTLRDQ------LSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILL 758 (845)
Q Consensus 686 ~g~~~~~~~~~LV~E~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDLk~~NILl 758 (845)
++++.+.+..++||||+++|+|.++ +.......+++..++.++.|+++||+|||+ .+ |+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 9999999999999999999999998 655446789999999999999999999998 88 9999999999999
Q ss_pred cCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 759 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTD-KSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 759 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
+.++.+||+|||+++..... ......||..|+|||.+.+. .++. ++|||||||++|||++|+.||....
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCCcEEEeccccccccccc---------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999865321 23445689999999999877 6666 9999999999999999999997654
Q ss_pred C
Q 003140 837 N 837 (845)
Q Consensus 837 ~ 837 (845)
.
T Consensus 257 ~ 257 (348)
T 2pml_X 257 S 257 (348)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=327.69 Aligned_cols=147 Identities=17% Similarity=0.249 Sum_probs=115.3
Q ss_pred cccCCCccEEEcccCCCCCCCC--CCCCCCCccEEEcccccCCcCCCCCCC-ccccCEEEccCCcCC-CCcccccCCCCC
Q 003140 247 YSNMSKLLKLSLRNCSLQGPMP--DLSRIPNLGYLDLSSNQLNGSIPPGRL-SLNITTIKLSNNKLT-GTIPSNFSGLPR 322 (845)
Q Consensus 247 ~~~l~~L~~L~Ls~N~l~~~~~--~l~~l~~L~~L~Ls~N~l~~~ip~~~~-~~~L~~L~Ls~N~l~-~~~p~~~~~l~~ 322 (845)
+..+++|+.|++++|++++.++ .+..+++|++|++++|.+++..|..+. ..+|+.|+|++|.++ +.+|..+..+++
T Consensus 392 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~ 471 (570)
T 2z63_A 392 FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 471 (570)
T ss_dssp EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTT
T ss_pred ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccC
Confidence 4555666666666666666544 367778888888888888776666544 347888889888887 578888889999
Q ss_pred CCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCC-C-CCCCCcEEEecCCcccccCCCcccc-CCCC
Q 003140 323 LQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVRLRGNPFCLNTNAEQFC-GSHS 398 (845)
Q Consensus 323 L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~-~-~~~~l~~l~l~~Np~~c~~~~~~~~-~~~~ 398 (845)
|++|+|++|++++..|..+..+. +|+.|++++|+|++++.. + .++.++.+++++|||.|+|+..++- .|..
T Consensus 472 L~~L~l~~n~l~~~~~~~~~~l~-----~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~wl~ 545 (570)
T 2z63_A 472 LTFLDLSQCQLEQLSPTAFNSLS-----SLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLN 545 (570)
T ss_dssp CCEEECTTSCCCEECTTTTTTCT-----TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHHHHHHH
T ss_pred CCEEECCCCccccCChhhhhccc-----CCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchHHHHHHHH
Confidence 99999999999988888876554 456999999999998875 3 5899999999999999999988776 6653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=307.77 Aligned_cols=214 Identities=25% Similarity=0.424 Sum_probs=161.6
Q ss_pred HHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCceeeEEEEEe--------
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCD-------- 690 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~-------- 690 (845)
....+|.+.+.||+|+||.||+|... +++.||||++........+.+.+|+++++++. ||||+++++++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 34467888999999999999999964 78999999987766666778999999999996 999999999984
Q ss_pred eCCeEEEEEEcCCCCCHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEec
Q 003140 691 EEGEQMLVYEFMSNGTLRDQLSA-KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 769 (845)
Q Consensus 691 ~~~~~~LV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DF 769 (845)
.....++||||++ |+|.+++.. .....+++..++.++.|+++||+|||+.+ ++|+||||||+|||++.++.+||+||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecC
Confidence 3345899999995 899998865 33456999999999999999999999875 45999999999999999999999999
Q ss_pred CCcccCCCCCCCCccc-----cceeecccCCCCccchhhh---cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 770 GLSRLAPVPDIEGIVP-----AHVSTVVKGTPGYLDPEYF---LTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 770 Gla~~~~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
|+++............ ........||+.|+|||++ .+..++.++|||||||++|||++|+.||....
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 9998764322110000 0111244689999999998 56678999999999999999999999997543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=323.74 Aligned_cols=200 Identities=28% Similarity=0.432 Sum_probs=173.4
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
.++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 467899999999999999999975 78999999986422 234578999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCcEEEEecCCcccCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD---HKFTAKVADFGLSRLAP 776 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~---~~~~~kl~DFGla~~~~ 776 (845)
||+++|+|.+++... ..+++..+..++.|+++||.|||+.+ |+||||||+|||++ .++.+||+|||+++...
T Consensus 101 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 999999999988664 35899999999999999999999998 99999999999995 45689999999998654
Q ss_pred CCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.. .......||+.|+|||++.+ .++.++||||+||++|||++|+.||....
T Consensus 176 ~~--------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 226 (486)
T 3mwu_A 176 QN--------TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (486)
T ss_dssp CC------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CC--------CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 22 12334569999999999875 59999999999999999999999997543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=303.94 Aligned_cols=203 Identities=24% Similarity=0.403 Sum_probs=171.9
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
.++|++.+.||+|+||.||+|... +++.||+|++........+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 467889999999999999999976 5899999998876666678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+++|+|.+++.... ..+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 98 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---- 169 (302)
T 2j7t_A 98 CPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK---- 169 (302)
T ss_dssp CTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHH----
T ss_pred CCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccc----
Confidence 99999999987643 45899999999999999999999998 99999999999999999999999998753210
Q ss_pred CccccceeecccCCCCccchhhh-----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYF-----LTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.........||..|+|||++ ....++.++||||||+++|||++|+.||...+
T Consensus 170 ---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 226 (302)
T 2j7t_A 170 ---TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226 (302)
T ss_dssp ---HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ---cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 01112334689999999998 36778999999999999999999999997543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=314.14 Aligned_cols=198 Identities=25% Similarity=0.385 Sum_probs=164.0
Q ss_pred cCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCe------EEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE------QML 697 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~------~~L 697 (845)
.+|...+.||+|+||.||+|...++..||+|++..... ...+|+++++.++||||+++++++...+. .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 46888999999999999999987777799998765322 22369999999999999999999855433 789
Q ss_pred EEEcCCCCCHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcEEEEecCCcccC
Q 003140 698 VYEFMSNGTLRDQLSA-KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLA 775 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~-~~~~~kl~DFGla~~~ 775 (845)
||||++++.+....+. .....+++..+..++.|+++||+|||+.+ |+||||||+|||++ .++.+||+|||+|+..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999986544333321 23457899999999999999999999998 99999999999999 7999999999999875
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+..
T Consensus 193 ~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 246 (394)
T 4e7w_A 193 IAGE--------PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES 246 (394)
T ss_dssp CTTC--------CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCC--------CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 4221 12345689999999998764 58999999999999999999999997654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-34 Score=315.19 Aligned_cols=197 Identities=12% Similarity=0.037 Sum_probs=153.5
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh---hhHHHHHHHHHHHHhc--CCCceeeEE-------EEEe
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL--HHRNLVSLV-------GYCD 690 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~~l~~l--~H~nIv~l~-------g~~~ 690 (845)
.+|...+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+++++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45888999999999999999965 789999999986543 3345677885555444 699988755 4444
Q ss_pred eC-----------------CeEEEEEEcCCCCCHHHHHhccCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCCeE
Q 003140 691 EE-----------------GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR------LSIALGSSRGILYLHTEADPPVF 747 (845)
Q Consensus 691 ~~-----------------~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~ii 747 (845)
.. ...++||||++ |+|.+++..... .+.+..+ ..++.||++||+|||+++ |+
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---iv 216 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSKG---LV 216 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Cc
Confidence 33 33799999998 999999976422 2355555 788899999999999999 99
Q ss_pred ecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcC--CCCCchhhHHHHHHHHHHH
Q 003140 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLEL 825 (845)
Q Consensus 748 HrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~el 825 (845)
||||||+|||++.++.+||+|||+|+.... ......+|+.|+|||++.+ ..++.++|||||||++|||
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~el 286 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT----------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRV 286 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTC----------EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHH
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCC----------CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHH
Confidence 999999999999999999999999986531 1224457799999999987 6799999999999999999
Q ss_pred HhCCCCCCCC
Q 003140 826 LTGMQPISHG 835 (845)
Q Consensus 826 ltG~~Pf~~~ 835 (845)
++|+.||...
T Consensus 287 ltg~~Pf~~~ 296 (371)
T 3q60_A 287 WCLFLPFGLV 296 (371)
T ss_dssp HHSSCSTTBC
T ss_pred HhCCCCCCCc
Confidence 9999999765
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=304.88 Aligned_cols=201 Identities=28% Similarity=0.448 Sum_probs=168.9
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh--------hhHHHHHHHHHHHHhcCCCceeeEEEEEeeC
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--------QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 692 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~--------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~ 692 (845)
..++|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467899999999999999999975 689999999865321 1234588999999999999999999998765
Q ss_pred CeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc---EEEEec
Q 003140 693 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT---AKVADF 769 (845)
Q Consensus 693 ~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~---~kl~DF 769 (845)
+ .++||||+++|+|.+++... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++. +||+||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred c-eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 4 89999999999999998643 46899999999999999999999998 999999999999987654 999999
Q ss_pred CCcccCCCCCCCCccccceeecccCCCCccchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 770 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 770 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
|+++..... .......||..|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 162 g~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (322)
T 2ycf_A 162 GHSKILGET--------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223 (322)
T ss_dssp TTCEECCCC--------HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred ccceecccc--------cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 999865321 1123456899999999974 5678999999999999999999999997543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=316.09 Aligned_cols=203 Identities=29% Similarity=0.408 Sum_probs=155.9
Q ss_pred CCCC-CccccccCceEEEEEEeC---CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEee--CCeEEEE
Q 003140 625 NFNS-STQIGQGGYGKVYKGILP---DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQMLV 698 (845)
Q Consensus 625 ~f~~-~~~LG~G~fG~Vy~~~~~---~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~LV 698 (845)
.|.+ .++||+|+||.||+|... +++.||||++..... .+.+.+|++++++++||||+++++++.. ....++|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 3554 458999999999999965 578999999975432 3468899999999999999999999954 6789999
Q ss_pred EEcCCCCCHHHHHhcc-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----cCCCcEEEE
Q 003140 699 YEFMSNGTLRDQLSAK-------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL----DHKFTAKVA 767 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl----~~~~~~kl~ 767 (845)
|||++ |+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+
T Consensus 99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 99996 6888887532 2235899999999999999999999999 9999999999999 678899999
Q ss_pred ecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 768 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 768 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
|||+|+....... .........||+.|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 175 Dfg~a~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 175 DMGFARLFNSPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp CTTCCC--------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred ECCCceecCCCCc----ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 9999987642210 11223446789999999999874 589999999999999999999999976544
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-33 Score=335.87 Aligned_cols=290 Identities=19% Similarity=0.283 Sum_probs=222.7
Q ss_pred cceEeEEEecCCCCcc-----------------cCCCCcc--CCCCccEEEecCCCCCCCCcccccccccchhhhccCCC
Q 003140 81 YLHLRELQLLNLNLSG-----------------NLSPEIG--RLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNE 141 (845)
Q Consensus 81 ~~~v~~L~L~~~~l~~-----------------~~~~~l~--~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 141 (845)
..+++.|+|++|.|++ .+|+.++ ++++|++|+|++|++.+.+|..|+++++|++|+|++|+
T Consensus 447 L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 447 LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred CCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence 4578999999999998 4888888 99999999999999999999999999999999999998
Q ss_pred -CCC-CCCCccCCCC-------ccceeecccccccCCCCc--cccCccCCCEEEccCCCCCCCCccccCCCCCcceeecc
Q 003140 142 -LTG-SLPEELGYLP-------KLDRIQIDQNYISGSLPK--SFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLD 210 (845)
Q Consensus 142 -l~~-~~p~~~~~l~-------~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 210 (845)
++| .+|..++.++ +|++|+|++|+++ .+|. .+.++++|+.|+|++|+++ .+| .++.+++|+.|+|+
T Consensus 527 ~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls 603 (876)
T 4ecn_A 527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLD 603 (876)
T ss_dssp TSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECC
T ss_pred CcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECc
Confidence 887 7887666555 8999999999988 7887 8888889999999999888 777 88888888888888
Q ss_pred ccccccCCCcccCCCCC-CcEEEccCCcCCCCCCccccccCCC--ccEEEcccCCCCCCCCCC-----------------
Q 003140 211 NNNLTGYLPPELSELPK-LLILQLDNNNFEGTTIPASYSNMSK--LLKLSLRNCSLQGPMPDL----------------- 270 (845)
Q Consensus 211 ~N~l~~~~p~~l~~l~~-L~~L~Ls~N~l~~~~~p~~~~~l~~--L~~L~Ls~N~l~~~~~~l----------------- 270 (845)
+|+++ .+|..+..+++ |+.|+|++|+++ .+|..+..++. |+.|+|++|++++.++.+
T Consensus 604 ~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~--~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~L 680 (876)
T 4ecn_A 604 YNQIE-EIPEDFCAFTDQVEGLGFSHNKLK--YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTL 680 (876)
T ss_dssp SSCCS-CCCTTSCEECTTCCEEECCSSCCC--SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEEC
T ss_pred CCccc-cchHHHhhccccCCEEECcCCCCC--cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEc
Confidence 88888 78888888888 888888888887 46666655543 666666666666544321
Q ss_pred -------------CCCCCccEEEcccccCCcCCCCCCCcc---------ccCEEEccCCcCCCCcccccC--CCCCCCeE
Q 003140 271 -------------SRIPNLGYLDLSSNQLNGSIPPGRLSL---------NITTIKLSNNKLTGTIPSNFS--GLPRLQRL 326 (845)
Q Consensus 271 -------------~~l~~L~~L~Ls~N~l~~~ip~~~~~~---------~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L 326 (845)
..+++|+.|+|++|+|+ .+|...+.. +|+.|+|++|+|+ .+|..+. .+++|+.|
T Consensus 681 s~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L 758 (876)
T 4ecn_A 681 SYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNM 758 (876)
T ss_dssp CSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEE
T ss_pred cCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEE
Confidence 24567777777777777 566544321 6888888888888 6677776 78888888
Q ss_pred ecccccCcccCChhhhhhccCCCCcceEEEccC------CCCC-CCCCCC-CCCCCcEEEecCCcc
Q 003140 327 FIANNSLSGSIPSSIWQSRTLNATETFILDFQN------NNLT-NISGSF-NIPPNVTVRLRGNPF 384 (845)
Q Consensus 327 ~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~------N~l~-~i~~~~-~~~~l~~l~l~~Np~ 384 (845)
+|++|+|++ +|..+..+.. |+.|+|++ |++. .+|..+ .++.++.|+|++|++
T Consensus 759 ~Ls~N~L~~-lp~~l~~L~~-----L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L 818 (876)
T 4ecn_A 759 DVSYNCFSS-FPTQPLNSSQ-----LKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI 818 (876)
T ss_dssp ECCSSCCSS-CCCGGGGCTT-----CCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC
T ss_pred EeCCCCCCc-cchhhhcCCC-----CCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC
Confidence 888888886 6777765544 44677765 4443 445444 477777777777776
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=306.32 Aligned_cols=204 Identities=30% Similarity=0.482 Sum_probs=175.5
Q ss_pred hcCCCCCccccccCceEEEEEEe-----CCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC--eE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG--EQ 695 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~ 695 (845)
.++|.+.+.||+|+||.||+|.+ .+|+.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35678889999999999999984 368999999998766666788999999999999999999999986654 67
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++||||+++|+|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 99999999999999997643 45899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
..... .........++..|+|||.+.+..++.++|||||||++|||+||+.||..
T Consensus 196 ~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 196 PQDKE----YYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp CSSCS----EEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred ccccc----ccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 43221 01112334577889999999988899999999999999999999999863
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=332.91 Aligned_cols=197 Identities=29% Similarity=0.428 Sum_probs=165.2
Q ss_pred ccccccCceEEEEEEeC---CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCC
Q 003140 630 TQIGQGGYGKVYKGILP---DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~---~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 704 (845)
+.||+|+||.||+|.+. .++.||||+++... ....++|.+|++++++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 46889999987543 2346789999999999999999999999964 568899999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCcc
Q 003140 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (845)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 784 (845)
|+|.++++.. ..+++..++.++.||++||+|||+++ ||||||||+|||++.++.+||+|||+|+.......
T Consensus 454 g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~---- 524 (635)
T 4fl3_A 454 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN---- 524 (635)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc----
Confidence 9999999654 46899999999999999999999998 99999999999999999999999999987643221
Q ss_pred ccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
.........+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 525 ~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 577 (635)
T 4fl3_A 525 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 577 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 0112233456789999999999999999999999999999998 999997644
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-33 Score=308.84 Aligned_cols=203 Identities=26% Similarity=0.381 Sum_probs=172.7
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----CeE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GEQ 695 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~ 695 (845)
.++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457999999999999999999965 68899999987533 33457899999999999999999999999654 468
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++||||++ |+|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 106 ~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 99999997 6999998653 5899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
..... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 179 ~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 236 (364)
T 3qyz_A 179 DPDHD----HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236 (364)
T ss_dssp CGGGC----BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCCC----ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC
Confidence 42210 0111234579999999998754 558999999999999999999999997654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=314.78 Aligned_cols=208 Identities=23% Similarity=0.350 Sum_probs=175.1
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCC-CceeeEEEEEeeCCeEEEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH-RNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~LV~E 700 (845)
.++|.+.+.||+|+||.||+|.. .+++.||||++..... .+++.+|+++++.++| +++..+..++.+.+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 36899999999999999999996 5789999998765432 2358899999999976 566667777788889999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCcEEEEecCCcccCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl---~~~~~~kl~DFGla~~~~~ 777 (845)
|+ +++|.+++... ...+++..++.|+.||+.||+|||+++ ||||||||+|||+ +.++.+||+|||+++....
T Consensus 84 ~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99 99999999753 346999999999999999999999998 9999999999999 6889999999999987654
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
................||..|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 332211112223456799999999999999999999999999999999999999976443
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-33 Score=340.41 Aligned_cols=299 Identities=22% Similarity=0.221 Sum_probs=262.8
Q ss_pred ceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeec
Q 003140 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (845)
Q Consensus 82 ~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (845)
..++.|+|++|.+.+..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|..+++|++|+|
T Consensus 266 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 345 (844)
T 3j0a_A 266 SSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDL 345 (844)
T ss_dssp SCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEEC
T ss_pred CCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEEC
Confidence 47899999999999998999999999999999999999988999999999999999999999888999999999999999
Q ss_pred ccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCC
Q 003140 162 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT 241 (845)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 241 (845)
++|++++..+..|.++++|+.|+|++|.+++. ..+++|+.|++++|+++ .+|.. ..+++.|++++|++++.
T Consensus 346 ~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-----~~~~~L~~L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l 416 (844)
T 3j0a_A 346 QKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-----HFIPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSENRLENL 416 (844)
T ss_dssp CSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-----SSCCSCSEEEEESCCCC-CCCCC---CTTCCEEECCSCCCCSS
T ss_pred CCCCCCccChhhhcCCCCCCEEECCCCCCCcc-----cCCCCcchhccCCCCcc-ccccc---ccccceeecccCccccC
Confidence 99999988888999999999999999999842 33889999999999999 45543 46899999999999975
Q ss_pred CCccccccCCCccEEEcccCCCCCCCCC--CCCCCCccEEEcccccCCcCCC-----CCCC-ccccCEEEccCCcCCCCc
Q 003140 242 TIPASYSNMSKLLKLSLRNCSLQGPMPD--LSRIPNLGYLDLSSNQLNGSIP-----PGRL-SLNITTIKLSNNKLTGTI 313 (845)
Q Consensus 242 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~--l~~l~~L~~L~Ls~N~l~~~ip-----~~~~-~~~L~~L~Ls~N~l~~~~ 313 (845)
..+..+.++++|+.|+|++|++++..+. +..+++|+.|++++|.+++..+ ..+. ..+|+.|+|++|+|++..
T Consensus 417 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 496 (844)
T 3j0a_A 417 DILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLP 496 (844)
T ss_dssp TTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCC
T ss_pred chhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccC
Confidence 5555677999999999999999987654 6778999999999999984333 2232 348999999999999999
Q ss_pred ccccCCCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCCCCCCCCcEEEecCCcccccCCCccc
Q 003140 314 PSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQF 393 (845)
Q Consensus 314 p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~~~~~l~~l~l~~Np~~c~~~~~~~ 393 (845)
|..|.++++|+.|+|++|+|++..|..+. ++|+.|+|++|+|++++... ++.+..+++++|||.|+|+..+|
T Consensus 497 ~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~-------~~L~~L~Ls~N~l~~~~~~~-~~~L~~l~l~~Np~~C~c~~~~f 568 (844)
T 3j0a_A 497 PGVFSHLTALRGLSLNSNRLTVLSHNDLP-------ANLEILDISRNQLLAPNPDV-FVSLSVLDITHNKFICECELSTF 568 (844)
T ss_dssp TTSSSSCCSCSEEEEESCCCSSCCCCCCC-------SCCCEEEEEEECCCCCCSCC-CSSCCEEEEEEECCCCSSSCCSH
T ss_pred hhHccchhhhheeECCCCCCCccChhhhh-------ccccEEECCCCcCCCCChhH-hCCcCEEEecCCCcccccccHHH
Confidence 99999999999999999999976665542 56789999999999887754 56889999999999999999999
Q ss_pred cCCC
Q 003140 394 CGSH 397 (845)
Q Consensus 394 ~~~~ 397 (845)
..|.
T Consensus 569 ~~~~ 572 (844)
T 3j0a_A 569 INWL 572 (844)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8775
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-33 Score=305.28 Aligned_cols=207 Identities=26% Similarity=0.390 Sum_probs=172.0
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----CeE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GEQ 695 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~ 695 (845)
.++|.+.+.||+|+||.||+|... +|+.||||++.... .....++.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 367888999999999999999975 68999999987533 33456788999999999999999999998654 678
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++||||++ |+|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999997 799999865 35899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCCCccc---cceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 776 PVPDIEGIVP---AHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 776 ~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......... ........||..|+|||++.. ..++.++|||||||++|||++|+.||...+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 4322111000 011233578999999998764 778999999999999999999999997654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=307.99 Aligned_cols=203 Identities=24% Similarity=0.301 Sum_probs=174.0
Q ss_pred HHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcC-CC-----ceeeEEEEEeeCC
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HR-----NLVSLVGYCDEEG 693 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~-H~-----nIv~l~g~~~~~~ 693 (845)
...++|.+.+.||+|+||.||+|... +++.||||+++.. ....+++..|+++++.++ |+ +|+++++++...+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 34578999999999999999999965 6889999999753 334567888999988885 55 4999999999999
Q ss_pred eEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc--CCCcEEEEecCC
Q 003140 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD--HKFTAKVADFGL 771 (845)
Q Consensus 694 ~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~--~~~~~kl~DFGl 771 (845)
..++||||++ |+|.+++.......+++..+..++.|++.||.|||++ +.+|+||||||+|||++ .++.+||+|||+
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 9999999996 6999999877666799999999999999999999952 12399999999999995 478899999999
Q ss_pred cccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 208 a~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 208 SCQLGQR----------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CEETTCC----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceecccc----------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9875321 234568999999999999999999999999999999999999998654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-33 Score=305.76 Aligned_cols=207 Identities=26% Similarity=0.357 Sum_probs=161.9
Q ss_pred HHHHHHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCe-
Q 003140 617 GEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE- 694 (845)
Q Consensus 617 ~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~- 694 (845)
.......++|.+.+.||+|+||.||+|... +|+.||||++.... .....+.+|++.++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 345667789999999999999999999975 68999999886532 223466788888999999999999999866443
Q ss_pred ------EEEEEEcCCCCCHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEecCCCCCCEEEcC-CCc
Q 003140 695 ------QMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLH--TEADPPVFHRDIKASNILLDH-KFT 763 (845)
Q Consensus 695 ------~~LV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~iiHrDLk~~NILl~~-~~~ 763 (845)
.++||||+++ +|.+.+.. .....+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence 7899999975 56555443 34556899999999999999999999 877 999999999999997 899
Q ss_pred EEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 764 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 764 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
+||+|||+++...... ......||..|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 171 ~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 236 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE--------PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236 (360)
T ss_dssp EEECCCTTCBCCCTTS--------CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEeeCCCceecCCCC--------CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC
Confidence 9999999998764321 22345689999999998765 48999999999999999999999997654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-33 Score=308.23 Aligned_cols=196 Identities=27% Similarity=0.412 Sum_probs=168.0
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeE----
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ---- 695 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~---- 695 (845)
.++|...+.||+|+||.||+|... +|+.||||++.... ....+++.+|++++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 357888999999999999999965 68999999987542 33357889999999999999999999999877654
Q ss_pred --EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003140 696 --MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (845)
Q Consensus 696 --~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~ 773 (845)
++||||++ |+|.+++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999997 78988873 34899999999999999999999998 9999999999999999999999999997
Q ss_pred cCCCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus 193 ~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 246 (371)
T 4exu_A 193 HADA----------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 246 (371)
T ss_dssp -----------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccc----------CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 5432 1234568999999999987 789999999999999999999999997654
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=302.51 Aligned_cols=212 Identities=24% Similarity=0.343 Sum_probs=173.3
Q ss_pred ccchHHHHHHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcC--CCceeeEEEE
Q 003140 613 SFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLH--HRNLVSLVGY 688 (845)
Q Consensus 613 ~~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~--H~nIv~l~g~ 688 (845)
.+.++.+....++|.+.+.||+|+||.||++...+++.||||++... .....+.+.+|++++++++ |+||++++++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 34455555667789999999999999999999988999999998643 3344578999999999996 5999999999
Q ss_pred EeeCCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEe
Q 003140 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 768 (845)
Q Consensus 689 ~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~D 768 (845)
+.+.+..++||| +.+++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+|||+++ +.+||+|
T Consensus 97 ~~~~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 97 EITDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp EECSSEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECC
T ss_pred eecCCEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEee
Confidence 999999999999 5689999999764 36899999999999999999999998 999999999999965 8999999
Q ss_pred cCCcccCCCCCCCCccccceeecccCCCCccchhhhcC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 769 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-----------HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 769 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
||+++...... .........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus 170 fg~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (313)
T 3cek_A 170 FGIANQMQPDT-----TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243 (313)
T ss_dssp CSSSCC-------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccccccccCcc-----ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence 99998654221 1112234568999999999875 478899999999999999999999997643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=302.96 Aligned_cols=199 Identities=22% Similarity=0.370 Sum_probs=173.9
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CC-cEEEEEEccCCChhhHHHHHHHHHHHHhcCCCc------eeeEEEEEeeCCe
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DG-TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN------LVSLVGYCDEEGE 694 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g-~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~n------Iv~l~g~~~~~~~ 694 (845)
.++|.+.+.||+|+||.||+|... ++ +.||||+++.. ....+.+.+|++++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 468999999999999999999964 34 78999998753 344567889999999997765 9999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----------------
Q 003140 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---------------- 758 (845)
Q Consensus 695 ~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl---------------- 758 (845)
.++||||+ ++++.+++.......+++..++.++.||++||+|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 678888887766667999999999999999999999998 9999999999999
Q ss_pred ---cCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 759 ---DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 759 ---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
+.++.+||+|||+++..... .....||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH----------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccCCCcEEEeecCcccccccc----------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 67889999999999864321 23456899999999999999999999999999999999999999765
Q ss_pred C
Q 003140 836 K 836 (845)
Q Consensus 836 ~ 836 (845)
.
T Consensus 243 ~ 243 (355)
T 2eu9_A 243 E 243 (355)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-32 Score=323.13 Aligned_cols=318 Identities=19% Similarity=0.188 Sum_probs=263.1
Q ss_pred CCCCCC--CcceEecCCCCC----CCcceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchh
Q 003140 61 DPCTSN--WTGVLCFNTTMD----DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLEL 134 (845)
Q Consensus 61 ~~c~~~--w~Gv~C~~~~~~----~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 134 (845)
..|.|. +.-+.|...... .-..+++.|+|++|.+++..|..|+.+++|++|+|++|++++..|..|.++++|++
T Consensus 6 ~~C~~~~~~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 85 (606)
T 3t6q_A 6 QKCIEKEVNKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDT 85 (606)
T ss_dssp CCCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCE
T ss_pred CceecccCCceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCe
Confidence 345442 456888654322 23457999999999999998999999999999999999999988999999999999
Q ss_pred hhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeecccccc
Q 003140 135 LLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNL 214 (845)
Q Consensus 135 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l 214 (845)
|+|++|++++..|..|+++++|++|+|++|++++..+..+.++++|++|+|++|++++.....+..+++|++|++++|++
T Consensus 86 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 165 (606)
T 3t6q_A 86 LVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAI 165 (606)
T ss_dssp EECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCC
T ss_pred eeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcc
Confidence 99999999988999999999999999999999987788999999999999999999975545555699999999999999
Q ss_pred ccCCCcccCCCCCCc--EEEccCCcCCCCCCcccccc-------------------------------------------
Q 003140 215 TGYLPPELSELPKLL--ILQLDNNNFEGTTIPASYSN------------------------------------------- 249 (845)
Q Consensus 215 ~~~~p~~l~~l~~L~--~L~Ls~N~l~~~~~p~~~~~------------------------------------------- 249 (845)
++..+..++.+++|+ .|++++|++++ ..|..+..
T Consensus 166 ~~~~~~~~~~l~~L~~l~L~l~~n~l~~-~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~ 244 (606)
T 3t6q_A 166 HYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDIS 244 (606)
T ss_dssp CEECHHHHHTTTTCCSEEEECTTCCCCE-ECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCC
T ss_pred cccChhhhhhhcccceeEEecCCCccCc-cChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccC
Confidence 988888899999999 89999999986 34443322
Q ss_pred ------C--CCccEEEcccCCCCCCCCC-CCCCCCccEEEcccccCCcCCCCCCCc-cccCEEEccCCcCCCCcccccCC
Q 003140 250 ------M--SKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSG 319 (845)
Q Consensus 250 ------l--~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~ip~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~ 319 (845)
+ .+|+.|++++|.+++.++. +..+++|++|++++|.++ .+|..+.. .+|++|++++|++++..|..+..
T Consensus 245 ~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~ 323 (606)
T 3t6q_A 245 PAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASN 323 (606)
T ss_dssp GGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGG
T ss_pred hhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhc
Confidence 1 1678888888888887775 888899999999999998 67765543 48999999999999888888999
Q ss_pred CCCCCeEecccccCcccCChh-hhhhccCCCCcceEEEccCCCCCCCC---CCC-CCCCCcEEEecCCccc
Q 003140 320 LPRLQRLFIANNSLSGSIPSS-IWQSRTLNATETFILDFQNNNLTNIS---GSF-NIPPNVTVRLRGNPFC 385 (845)
Q Consensus 320 l~~L~~L~L~~N~l~~~ip~~-l~~l~~l~~~~l~~L~ls~N~l~~i~---~~~-~~~~l~~l~l~~Np~~ 385 (845)
+++|++|++++|++.+.+|.. +..+ ++|+.|++++|+++.++ ..+ .++.++.|++++|.+.
T Consensus 324 l~~L~~L~l~~n~~~~~~~~~~~~~l-----~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~ 389 (606)
T 3t6q_A 324 FPSLTHLSIKGNTKRLELGTGCLENL-----ENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL 389 (606)
T ss_dssp CTTCSEEECCSCSSCCBCCSSTTTTC-----TTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCE
T ss_pred cCcCCEEECCCCCcccccchhhhhcc-----CcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCC
Confidence 999999999999988877764 4443 44568888888887764 333 5788888888888754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=301.30 Aligned_cols=206 Identities=25% Similarity=0.396 Sum_probs=173.1
Q ss_pred HHHHHHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHh--cCCCceeeEEEEEeeCC-
Q 003140 617 GEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSR--LHHRNLVSLVGYCDEEG- 693 (845)
Q Consensus 617 ~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~--l~H~nIv~l~g~~~~~~- 693 (845)
.......++|.+.+.||+|+||.||+|.. +|+.||||++... ..+.+.+|.+++.. ++||||+++++++...+
T Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 35 LVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred eecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 33455667899999999999999999998 5899999998643 35678889999887 68999999999998776
Q ss_pred ---eEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCCEEEcCCC
Q 003140 694 ---EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH--------TEADPPVFHRDIKASNILLDHKF 762 (845)
Q Consensus 694 ---~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~iiHrDLk~~NILl~~~~ 762 (845)
..++||||+++|+|.+++... .+++..++.++.|+++||+||| +.+ |+||||||+|||++.++
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNG 184 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTS
T ss_pred ccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCC
Confidence 789999999999999999753 5899999999999999999999 666 99999999999999999
Q ss_pred cEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCC------CCchhhHHHHHHHHHHHHhC--------
Q 003140 763 TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK------LTDKSDVYSLGVVFLELLTG-------- 828 (845)
Q Consensus 763 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwS~Gvvl~elltG-------- 828 (845)
.+||+|||+++........ .........||+.|+|||++.+.. ++.++|||||||++|||+||
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDT---IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp CEEECCCTTCEEEETTTTE---EEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CEEEEECCCceeccccccc---cccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 9999999999765432100 011224457999999999997652 34789999999999999999
Q ss_pred --CCCCCCC
Q 003140 829 --MQPISHG 835 (845)
Q Consensus 829 --~~Pf~~~ 835 (845)
+.||...
T Consensus 262 ~~~~p~~~~ 270 (342)
T 1b6c_B 262 DYQLPYYDL 270 (342)
T ss_dssp CCCCTTTTT
T ss_pred ccccCcccc
Confidence 7888653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-33 Score=298.34 Aligned_cols=204 Identities=27% Similarity=0.415 Sum_probs=164.2
Q ss_pred hcCCCCCccccccCceEEEEEEeC--CCc--EEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP--DGT--VVAVKRAQEG---SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~--~g~--~vAVK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 695 (845)
.++|.+.+.||+|+||.||+|.+. +++ .||||+++.. .....+++.+|++++++++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357888999999999999999853 333 6899988754 2334578999999999999999999999998765 7
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++||||+++|+|.+++.... ..+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccc
Confidence 89999999999999997642 45889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
..... .........+|..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 172 ~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 228 (291)
T 1u46_A 172 PQNDD----HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 228 (291)
T ss_dssp CC-CC----EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccccc----chhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC
Confidence 43221 1112233457889999999998889999999999999999999 99999754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=299.52 Aligned_cols=202 Identities=28% Similarity=0.405 Sum_probs=153.5
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-hhhHHHHHHHHH-HHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQ-FLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
.++|...+.||+|+||.||+|... +|+.||||++.... ....+++..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 467888999999999999999975 78999999987643 333456666766 677789999999999999999999999
Q ss_pred EcCCCCCHHHHHhc---cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 700 EFMSNGTLRDQLSA---KSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 700 E~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
||++ |+|.+++.. .....+++..+..++.|+++||.|||+. + |+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 9997 588887753 2356789999999999999999999998 8 999999999999999999999999999765
Q ss_pred CCCCCCCccccceeecccCCCCccchhhh----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYF----LTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
... .......||..|+|||++ .+..++.++|||||||++|||++|+.||....
T Consensus 177 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (327)
T 3aln_A 177 VDS--------IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233 (327)
T ss_dssp -------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred ccc--------cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 321 112334689999999998 45678999999999999999999999997643
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-33 Score=307.09 Aligned_cols=199 Identities=21% Similarity=0.309 Sum_probs=170.7
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCChhhHHHHHHHHHHHHhcC-----------CCceeeEEEEEe
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-----------HRNLVSLVGYCD 690 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~-----------H~nIv~l~g~~~ 690 (845)
.++|.+.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|++++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 35788999999999999999996 47899999998753 334567889999999886 899999999987
Q ss_pred eCC----eEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEc------
Q 003140 691 EEG----EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLD------ 759 (845)
Q Consensus 691 ~~~----~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDLk~~NILl~------ 759 (845)
..+ ..++||||+ +++|.+++.......+++..+..++.||+.||+|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCc
Confidence 654 789999999 89999999876666799999999999999999999998 8 99999999999994
Q ss_pred CCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 760 HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 760 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH----------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TEEEEEECCCTTCEETTBC----------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred CcceEEEcccccccccCCC----------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 3448999999999865321 233468999999999999999999999999999999999999997543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=301.81 Aligned_cols=197 Identities=22% Similarity=0.351 Sum_probs=147.8
Q ss_pred hcCCCCC-ccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEee----CCeEE
Q 003140 623 TNNFNSS-TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE----EGEQM 696 (845)
Q Consensus 623 ~~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~ 696 (845)
.++|.+. +.||+|+||.||+|... +|+.||||++.... . ...+....++.++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-K---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-H---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 4678875 46999999999999976 68999999986532 1 12222334566799999999999876 44589
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEEecCCcc
Q 003140 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLSR 773 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~---~~~~kl~DFGla~ 773 (845)
+||||+++|+|.+++.......+++..++.++.|+++||+|||+++ |+||||||+|||++. ++.+||+|||+++
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 9999999999999998876678999999999999999999999998 999999999999976 4569999999998
Q ss_pred cCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 180 ~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (336)
T 3fhr_A 180 ETTQN---------ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN 232 (336)
T ss_dssp EC-------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ecccc---------ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 65321 123456899999999998888999999999999999999999999643
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=327.09 Aligned_cols=208 Identities=28% Similarity=0.429 Sum_probs=174.0
Q ss_pred HHHHHhcCCCCCccccccCceEEEEEEeC----CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC
Q 003140 618 EMALATNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 692 (845)
Q Consensus 618 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~ 692 (845)
+.....++|.+.+.||+|+||.||+|.+. .+..||||+++... ....+.|.+|+.++++++||||+++++++. .
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 34455678889999999999999999864 25689999987543 334578999999999999999999999985 4
Q ss_pred CeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 003140 693 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 772 (845)
Q Consensus 693 ~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla 772 (845)
+..++||||+++|+|.++++.. ...+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred CceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCC
Confidence 5689999999999999999754 346899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
+...... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 539 ~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 597 (656)
T 2j0j_A 539 RYMEDST------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 597 (656)
T ss_dssp CSCCC----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred eecCCCc------ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 8764322 112233456789999999999999999999999999999997 999997543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-32 Score=303.49 Aligned_cols=195 Identities=27% Similarity=0.411 Sum_probs=166.6
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCe------
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE------ 694 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~------ 694 (845)
++|...+.||+|+||.||+|... +|+.||||++.... ....+++.+|++++++++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 57888999999999999999975 68999999987532 2335678999999999999999999999977653
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003140 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (845)
Q Consensus 695 ~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~ 774 (845)
.++||||++ |+|.+++. ..+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred EEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccC
Confidence 499999997 68877763 24899999999999999999999998 99999999999999999999999999976
Q ss_pred CCCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
... ......||..|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus 176 ~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 176 ADA----------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp ------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred CCC----------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 431 1234568999999999877 678999999999999999999999997654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.8e-32 Score=291.88 Aligned_cols=200 Identities=29% Similarity=0.429 Sum_probs=173.2
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEE
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
..++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3468999999999999999999975 78999999986432 33467899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CcEEEEecCCcccC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLA 775 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~---~~~kl~DFGla~~~ 775 (845)
|||+++++|.+++.... .+++..++.++.|+++||+|||+.+ |+||||||+||+++.+ +.+||+|||+++..
T Consensus 100 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 99999999999886543 5899999999999999999999998 9999999999999754 47999999999865
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.... ......||..|+|||.+.+ .++.++||||||+++|||++|+.||...
T Consensus 175 ~~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (287)
T 2wei_A 175 QQNT--------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK 225 (287)
T ss_dssp CCCS--------SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCC--------ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCC
Confidence 4221 1223357899999998865 5899999999999999999999999754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.5e-33 Score=301.08 Aligned_cols=204 Identities=27% Similarity=0.410 Sum_probs=165.7
Q ss_pred HHHHhcCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCChh------hHHHHHHHHHHHHhc----CCCceeeEEE
Q 003140 619 MALATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ------GEKEFLTEIQFLSRL----HHRNLVSLVG 687 (845)
Q Consensus 619 ~~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~------~~~~~~~Ei~~l~~l----~H~nIv~l~g 687 (845)
.....++|.+.+.||+|+||.||+|.. .+++.||||++...... ....+.+|+++++++ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 344567899999999999999999986 47899999998754322 223466799999998 8999999999
Q ss_pred EEeeCCeEEEEEEc-CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcEE
Q 003140 688 YCDEEGEQMLVYEF-MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAK 765 (845)
Q Consensus 688 ~~~~~~~~~LV~E~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~-~~~~~k 765 (845)
++...+..++|||| +++++|.+++.... .+++..++.++.|+++||+|||+.+ |+||||||+||+++ .++.+|
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence 99999999999999 78999999997643 5899999999999999999999998 99999999999999 889999
Q ss_pred EEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 766 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT-DKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 766 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
|+|||+++...... .....||..|+|||++.+..+. .++|||||||++|||++|+.||....
T Consensus 181 l~dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 243 (312)
T 2iwi_A 181 LIDFGSGALLHDEP---------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ 243 (312)
T ss_dssp ECCCSSCEECCSSC---------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH
T ss_pred EEEcchhhhcccCc---------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH
Confidence 99999998764321 2345689999999998876664 58999999999999999999997543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.98 E-value=4.5e-32 Score=291.92 Aligned_cols=200 Identities=25% Similarity=0.390 Sum_probs=162.4
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEee----------
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE---------- 691 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~---------- 691 (845)
.++|+..+.||+|+||.||+|... +|+.||||++.. .....+.+.+|++++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 467888999999999999999964 789999999865 33445789999999999999999999998865
Q ss_pred ---CCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEe
Q 003140 692 ---EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 768 (845)
Q Consensus 692 ---~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~D 768 (845)
.+..++||||+++|+|.++++.. ...+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEee
Confidence 35679999999999999999764 345788999999999999999999998 99999999999999999999999
Q ss_pred cCCcccCCCCCCCCc-------cccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHh
Q 003140 769 FGLSRLAPVPDIEGI-------VPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLT 827 (845)
Q Consensus 769 FGla~~~~~~~~~~~-------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~ellt 827 (845)
||+++.......... ..........||..|+|||.+.+. .++.++|||||||++|||++
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 999986542110000 001222345689999999999764 78999999999999999998
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=6.8e-33 Score=301.58 Aligned_cols=203 Identities=26% Similarity=0.434 Sum_probs=173.4
Q ss_pred HHHhcCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCChh------hHHHHHHHHHHHHhcC--CCceeeEEEEEe
Q 003140 620 ALATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ------GEKEFLTEIQFLSRLH--HRNLVSLVGYCD 690 (845)
Q Consensus 620 ~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~------~~~~~~~Ei~~l~~l~--H~nIv~l~g~~~ 690 (845)
....++|.+.+.||+|+||.||+|.. .+++.||||++...... ..+.+.+|++++++++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 33457799999999999999999986 47899999998653221 2345778999999996 599999999999
Q ss_pred eCCeEEEEEEcCCC-CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcEEEEe
Q 003140 691 EEGEQMLVYEFMSN-GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVAD 768 (845)
Q Consensus 691 ~~~~~~LV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~-~~~~~kl~D 768 (845)
+.+..++||||+.+ ++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++ +++.+||+|
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEee
Confidence 99999999999976 8999999764 35889999999999999999999998 99999999999999 789999999
Q ss_pred cCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 769 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 769 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
||+++..... ......||..|+|||++.+..+ +.++|||||||++|||++|+.||...+
T Consensus 194 fg~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 253 (320)
T 3a99_A 194 FGSGALLKDT---------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 253 (320)
T ss_dssp CTTCEECCSS---------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH
T ss_pred Cccccccccc---------cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh
Confidence 9999876422 1233568999999999987665 688999999999999999999997543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-31 Score=307.92 Aligned_cols=292 Identities=20% Similarity=0.214 Sum_probs=262.2
Q ss_pred eEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccc
Q 003140 85 RELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164 (845)
Q Consensus 85 ~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 164 (845)
+.++..+++++ .+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 46888888888 4666554 68999999999999888899999999999999999999888999999999999999999
Q ss_pred cccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCc
Q 003140 165 YISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP 244 (845)
Q Consensus 165 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p 244 (845)
++++..+..|.++++|++|+|++|++++..+..+..+++|++|+|++|++++..+..|..+++|++|+|++|++++ ..+
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~ 169 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTS-IPT 169 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSS-CCH
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcc-cCh
Confidence 9997777789999999999999999998889999999999999999999999989999999999999999999986 456
Q ss_pred cccccCCCccEEEcccCCCCCCCC-CCCCCCCccEEEcccccCCcCCCCCCC-ccccCEEEccCCcCCCCcccccCCCCC
Q 003140 245 ASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRL-SLNITTIKLSNNKLTGTIPSNFSGLPR 322 (845)
Q Consensus 245 ~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~ip~~~~-~~~L~~L~Ls~N~l~~~~p~~~~~l~~ 322 (845)
..+.++++|+.|+|++|++++..+ .+..+++|+.|++++|.+.+.+|.... ..+|+.|+|++|+++...+..|..+++
T Consensus 170 ~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~ 249 (477)
T 2id5_A 170 EALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVY 249 (477)
T ss_dssp HHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTT
T ss_pred hHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccc
Confidence 679999999999999999999776 589999999999999998888877654 348999999999999776688999999
Q ss_pred CCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCC-C-CCCCCcEEEecCCccc
Q 003140 323 LQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVRLRGNPFC 385 (845)
Q Consensus 323 L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~-~-~~~~l~~l~l~~Np~~ 385 (845)
|++|+|++|++++..+..+..+. +|+.|+|++|+|+.++.. + .++.++.|++++|.+.
T Consensus 250 L~~L~Ls~n~l~~~~~~~~~~l~-----~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 309 (477)
T 2id5_A 250 LRFLNLSYNPISTIEGSMLHELL-----RLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT 309 (477)
T ss_dssp CCEEECCSSCCCEECTTSCTTCT-----TCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCS
T ss_pred cCeeECCCCcCCccChhhccccc-----cCCEEECCCCccceECHHHhcCcccCCEEECCCCcCc
Confidence 99999999999987777776554 466999999999988654 4 5899999999999875
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-32 Score=299.86 Aligned_cols=284 Identities=21% Similarity=0.232 Sum_probs=155.9
Q ss_pred CCHHHHHHHHHHHHhcc-CCCCCCCCCC----CCCCCCCCCcceEecCCCC---CCCcceEeEEEecCCCCcccCCCCcc
Q 003140 32 TDPIEVSALRSIKKSLV-DDYSKLSNWN----RGDPCTSNWTGVLCFNTTM---DDGYLHLRELQLLNLNLSGNLSPEIG 103 (845)
Q Consensus 32 ~~~~~~~al~~~k~~~~-~~~~~l~~W~----~~~~c~~~w~Gv~C~~~~~---~~~~~~v~~L~L~~~~l~~~~~~~l~ 103 (845)
...+|++||++||+++. ++...+.+|. ....|| .|.|+.|..... .....+++.|+|++++++ .+|+.++
T Consensus 24 ~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~-~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~ 101 (328)
T 4fcg_A 24 ALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE-TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAF 101 (328)
T ss_dssp CCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSC-CSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGG
T ss_pred cCchHHHHHHHHHHhccCCchhhhhhhccccccccccc-ccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhh
Confidence 34568999999999984 5545567883 333333 599999942100 001124566666666665 5555566
Q ss_pred CCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEE
Q 003140 104 RLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHF 183 (845)
Q Consensus 104 ~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 183 (845)
.+++|++|+|++|.++ .+|..|+++++|++|+|++|+++ .+|..++.+++|++|+|++|++.+.+|..+...
T Consensus 102 ~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~------ 173 (328)
T 4fcg_A 102 RLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST------ 173 (328)
T ss_dssp GGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEE------
T ss_pred hCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhc------
Confidence 6666666666666666 55555666666666666666665 555556666666666666655555555444320
Q ss_pred EccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCC
Q 003140 184 HMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263 (845)
Q Consensus 184 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l 263 (845)
..+..+..+++|++|+|++|+++ .+|..+..+++|++|+|++|++++ +|..+.++++|+.|+|++|++
T Consensus 174 ---------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~--l~~~l~~l~~L~~L~Ls~n~~ 241 (328)
T 4fcg_A 174 ---------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA--LGPAIHHLPKLEELDLRGCTA 241 (328)
T ss_dssp ---------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC--CCGGGGGCTTCCEEECTTCTT
T ss_pred ---------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc--CchhhccCCCCCEEECcCCcc
Confidence 01112334555555555555555 455555555555555555555553 344455555555555555555
Q ss_pred CCCCC-CCCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCChhhh
Q 003140 264 QGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIW 342 (845)
Q Consensus 264 ~~~~~-~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~ 342 (845)
.+..+ .+..+++|+.|++++|.+. +.+|..+.++++|++|+|++|++.+.+|..+.
T Consensus 242 ~~~~p~~~~~l~~L~~L~L~~n~~~-----------------------~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~ 298 (328)
T 4fcg_A 242 LRNYPPIFGGRAPLKRLILKDCSNL-----------------------LTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIA 298 (328)
T ss_dssp CCBCCCCTTCCCCCCEEECTTCTTC-----------------------CBCCTTGGGCTTCCEEECTTCTTCCCCCGGGG
T ss_pred hhhhHHHhcCCCCCCEEECCCCCch-----------------------hhcchhhhcCCCCCEEeCCCCCchhhccHHHh
Confidence 44333 2445555555555554444 44444455555555555555555555555555
Q ss_pred hhccCCCCcceEEEccCCCCCCC
Q 003140 343 QSRTLNATETFILDFQNNNLTNI 365 (845)
Q Consensus 343 ~l~~l~~~~l~~L~ls~N~l~~i 365 (845)
.+..+ +.+++..|.+..+
T Consensus 299 ~L~~L-----~~l~l~~~~~~~l 316 (328)
T 4fcg_A 299 QLPAN-----CIILVPPHLQAQL 316 (328)
T ss_dssp GSCTT-----CEEECCGGGSCC-
T ss_pred hccCc-----eEEeCCHHHHHHH
Confidence 44332 3555555554443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-33 Score=302.30 Aligned_cols=212 Identities=24% Similarity=0.363 Sum_probs=172.2
Q ss_pred hHHHHHHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Q 003140 616 YGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 693 (845)
Q Consensus 616 ~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~ 693 (845)
..++.+..++|.+.+.||+|+||.||+|...+ .||+|+++... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 34555667889999999999999999999754 49999987532 223356788999999999999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003140 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (845)
Q Consensus 694 ~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~ 773 (845)
..++||||+++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++ ++.+||+|||+++
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred ceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 999999999999999999654 346899999999999999999999998 99999999999998 6799999999987
Q ss_pred cCCCCCCCCccccceeecccCCCCccchhhhcC---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT---------HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
........ ..........||..|+|||.+.. ..++.++|||||||++|||++|+.||....
T Consensus 178 ~~~~~~~~--~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 247 (319)
T 2y4i_B 178 ISGVLQAG--RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247 (319)
T ss_dssp ------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC
T ss_pred cccccccc--ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 65321111 01122334568999999999864 457899999999999999999999997543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-32 Score=308.67 Aligned_cols=201 Identities=25% Similarity=0.318 Sum_probs=157.5
Q ss_pred CCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeEEEEEEcCC
Q 003140 625 NFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMS 703 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~ 703 (845)
.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+.+..++||||++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 34456889999999998766668999999998653 345678999999987 89999999999999999999999995
Q ss_pred CCCHHHHHhccCCCC-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-------------CcEE
Q 003140 704 NGTLRDQLSAKSKEP-----LGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-------------FTAK 765 (845)
Q Consensus 704 ~gsL~~~l~~~~~~~-----l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~-------------~~~k 765 (845)
|+|.+++....... ..+..++.++.||+.||+|||+.+ |+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 79999997643221 133345789999999999999998 9999999999999754 4899
Q ss_pred EEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 766 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-------HKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 766 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
|+|||+++........ .........||++|+|||++.+ ..++.++|||||||++|||+| |+.||...
T Consensus 169 L~DFG~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSS---FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp ECCCTTCEECCC-----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred EcccccceecCCCCcc---ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 9999999876432210 0111234579999999999975 678999999999999999999 99999654
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-32 Score=310.85 Aligned_cols=282 Identities=18% Similarity=0.200 Sum_probs=239.0
Q ss_pred CcceEeEEEecCCCCcccC-CCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCc--cCCCCcc
Q 003140 80 GYLHLRELQLLNLNLSGNL-SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEE--LGYLPKL 156 (845)
Q Consensus 80 ~~~~v~~L~L~~~~l~~~~-~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L 156 (845)
...+++.|+|++|.+.+.+ +..|..+++|++|+|++|++++..|..|+++++|++|+|++|++++.+|.. |..+++|
T Consensus 52 ~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L 131 (455)
T 3v47_A 52 RLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSL 131 (455)
T ss_dssp SCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTC
T ss_pred cCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccC
Confidence 3457899999999998766 457899999999999999999888989999999999999999998755554 8899999
Q ss_pred ceeecccccccCCCCcc-ccCccCCCEEEccCCCCCCCCccccCCC----------------------------------
Q 003140 157 DRIQIDQNYISGSLPKS-FANLNKTRHFHMNNNSISGQIPPELSRL---------------------------------- 201 (845)
Q Consensus 157 ~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l---------------------------------- 201 (845)
++|+|++|++++..|.. +.++++|++|++++|++++..+..+..+
T Consensus 132 ~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~ 211 (455)
T 3v47_A 132 EMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKN 211 (455)
T ss_dssp CEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTT
T ss_pred CEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhcccccccccccc
Confidence 99999999999887776 8899999999999999998877766544
Q ss_pred CCcceeeccccccccCCCcccC---------------------------------------CCCCCcEEEccCCcCCCCC
Q 003140 202 PSLVHMLLDNNNLTGYLPPELS---------------------------------------ELPKLLILQLDNNNFEGTT 242 (845)
Q Consensus 202 ~~L~~L~L~~N~l~~~~p~~l~---------------------------------------~l~~L~~L~Ls~N~l~~~~ 242 (845)
++|++|++++|++++..|..+. ..++|++|++++|++++ .
T Consensus 212 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~-~ 290 (455)
T 3v47_A 212 TSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFA-L 290 (455)
T ss_dssp CEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCE-E
T ss_pred ceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccc-c
Confidence 6799999999988765443321 12589999999999987 6
Q ss_pred CccccccCCCccEEEcccCCCCCCCC-CCCCCCCccEEEcccccCCcCCCCCCC-ccccCEEEccCCcCCCCcccccCCC
Q 003140 243 IPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRL-SLNITTIKLSNNKLTGTIPSNFSGL 320 (845)
Q Consensus 243 ~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~ip~~~~-~~~L~~L~Ls~N~l~~~~p~~~~~l 320 (845)
.|..+.++++|+.|+|++|++++.++ .+..+++|+.|+|++|.+++..|..+. ..+|+.|+|++|++++..|..|.++
T Consensus 291 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 370 (455)
T 3v47_A 291 LKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGL 370 (455)
T ss_dssp CTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred chhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhcccc
Confidence 88899999999999999999999766 589999999999999999877666644 4589999999999999999999999
Q ss_pred CCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCC
Q 003140 321 PRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 367 (845)
Q Consensus 321 ~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~ 367 (845)
++|++|+|++|++++..+..+..+ ++|+.|++++|+++.-.+
T Consensus 371 ~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 371 PNLKELALDTNQLKSVPDGIFDRL-----TSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp TTCCEEECCSSCCSCCCTTTTTTC-----TTCCEEECCSSCBCCCTT
T ss_pred ccccEEECCCCccccCCHhHhccC-----CcccEEEccCCCcccCCC
Confidence 999999999999997555555544 456699999999986433
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-31 Score=325.82 Aligned_cols=299 Identities=19% Similarity=0.210 Sum_probs=207.3
Q ss_pred CcceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCC-cccccccccchhhhccCCCCCCCCCCccCCCCccce
Q 003140 80 GYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSI-PKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDR 158 (845)
Q Consensus 80 ~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 158 (845)
...+++.|+|++|.+++..+..|..+++|++|+|++|.+.+.+ |..|.++++|++|+|++|++++..|..|.++++|++
T Consensus 22 lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 101 (844)
T 3j0a_A 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFE 101 (844)
T ss_dssp SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCC
T ss_pred CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCE
Confidence 3457899999999999988899999999999999999766666 778999999999999999999888999999999999
Q ss_pred eecccccccCCCCcc--ccCccCCCEEEccCCCCCCCCc-cccCCCCCcceeeccccccccCCCcccCCC--CCCcEEEc
Q 003140 159 IQIDQNYISGSLPKS--FANLNKTRHFHMNNNSISGQIP-PELSRLPSLVHMLLDNNNLTGYLPPELSEL--PKLLILQL 233 (845)
Q Consensus 159 L~Ls~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l--~~L~~L~L 233 (845)
|+|++|.+++.+|.. +.++++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++..+..+..+ ++|+.|+|
T Consensus 102 L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L 181 (844)
T 3j0a_A 102 LRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSL 181 (844)
T ss_dssp EECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEE
T ss_pred eeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEEC
Confidence 999999999866665 8899999999999999987655 578999999999999999988877777665 66777777
Q ss_pred cCCcCCCCCCccccccCCC------ccEEEcccCCCCCCCCC-------------------------------------C
Q 003140 234 DNNNFEGTTIPASYSNMSK------LLKLSLRNCSLQGPMPD-------------------------------------L 270 (845)
Q Consensus 234 s~N~l~~~~~p~~~~~l~~------L~~L~Ls~N~l~~~~~~-------------------------------------l 270 (845)
+.|.+.+ ..|..+..+++ |+.|++++|.+++..+. +
T Consensus 182 ~~n~l~~-~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f 260 (844)
T 3j0a_A 182 AANSLYS-RVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTF 260 (844)
T ss_dssp CCSBSCC-CCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTT
T ss_pred CCCcccc-ccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhh
Confidence 7776665 34444444443 66666666655432221 0
Q ss_pred CC--CCCccEEEcccccCCcCCCCCCCc-cccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCChhhhhhccC
Q 003140 271 SR--IPNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 347 (845)
Q Consensus 271 ~~--l~~L~~L~Ls~N~l~~~ip~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l 347 (845)
.. .++|+.|++++|.+++..|..+.. .+|+.|+|++|++++..|..|.++++|++|+|++|++++..|..+..+.
T Consensus 261 ~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-- 338 (844)
T 3j0a_A 261 AGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLP-- 338 (844)
T ss_dssp TTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCT--
T ss_pred hccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCC--
Confidence 01 145556666666655444443322 2556666666666555555555566666666666665555555544333
Q ss_pred CCCcceEEEccCCCCCCCCCC-C-CCCCCcEEEecCCcc
Q 003140 348 NATETFILDFQNNNLTNISGS-F-NIPPNVTVRLRGNPF 384 (845)
Q Consensus 348 ~~~~l~~L~ls~N~l~~i~~~-~-~~~~l~~l~l~~Np~ 384 (845)
+|+.|++++|+|+.++.. + .++.++.|++++|.+
T Consensus 339 ---~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l 374 (844)
T 3j0a_A 339 ---KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL 374 (844)
T ss_dssp ---TCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCS
T ss_pred ---CCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCC
Confidence 233555555555555443 2 355555555555554
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-31 Score=317.83 Aligned_cols=185 Identities=23% Similarity=0.288 Sum_probs=154.1
Q ss_pred CCCCCcceEecCCCCC----CCcceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhcc
Q 003140 63 CTSNWTGVLCFNTTMD----DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLN 138 (845)
Q Consensus 63 c~~~w~Gv~C~~~~~~----~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 138 (845)
|.+.++-+.|...... +...+++.|+|++|++++..+..|+.+++|++|+|++|.+++..|..|+++++|++|+|+
T Consensus 2 C~~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 81 (680)
T 1ziw_A 2 CTVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQ 81 (680)
T ss_dssp --CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECC
T ss_pred ceeECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECC
Confidence 5555666888653322 233689999999999998877889999999999999999999889999999999999999
Q ss_pred CCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCC
Q 003140 139 GNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYL 218 (845)
Q Consensus 139 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 218 (845)
+|++++..+..|+++++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..+..+++|++|++++|++++..
T Consensus 82 ~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 161 (680)
T 1ziw_A 82 HNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALK 161 (680)
T ss_dssp SSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBC
T ss_pred CCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccC
Confidence 99999665567999999999999999999888889999999999999999999888888999999999999999998776
Q ss_pred CcccC--CCCCCcEEEccCCcCCCCCCccccc
Q 003140 219 PPELS--ELPKLLILQLDNNNFEGTTIPASYS 248 (845)
Q Consensus 219 p~~l~--~l~~L~~L~Ls~N~l~~~~~p~~~~ 248 (845)
+..+. .+++|++|++++|++++ ..|..+.
T Consensus 162 ~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~ 192 (680)
T 1ziw_A 162 SEELDIFANSSLKKLELSSNQIKE-FSPGCFH 192 (680)
T ss_dssp HHHHGGGTTCEESEEECTTCCCCC-BCTTGGG
T ss_pred HHHhhccccccccEEECCCCcccc-cChhhhh
Confidence 66544 45788888888888875 3444443
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-32 Score=319.21 Aligned_cols=201 Identities=28% Similarity=0.432 Sum_probs=173.6
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEee------CCeE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE------EGEQ 695 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~------~~~~ 695 (845)
++|.+.+.||+|+||.||+|... +|+.||||++... .....+.+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 68999999999999999999974 6899999998754 34446789999999999999999999999765 6678
Q ss_pred EEEEEcCCCCCHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc---EEEEecCC
Q 003140 696 MLVYEFMSNGTLRDQLSAKS-KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT---AKVADFGL 771 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~---~kl~DFGl 771 (845)
++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999997643 346889999999999999999999998 999999999999997664 99999999
Q ss_pred cccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
++...... ......||..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 171 a~~~~~~~--------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~ 226 (676)
T 3qa8_A 171 AKELDQGE--------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226 (676)
T ss_dssp CCBTTSCC--------CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccccc--------ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcc
Confidence 98764321 223457899999999999999999999999999999999999999754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.4e-32 Score=292.31 Aligned_cols=201 Identities=25% Similarity=0.389 Sum_probs=153.2
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh-hhHHH-HHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKE-FLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-~~~~~-~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
.++|...+.||+|+||.||+|... +|+.||||++..... ....+ +.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467888999999999999999975 789999999875432 22333 445556788889999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
||+ ++.+..+... ....+++..+..++.|+++||+|||++ + |+||||||+||+++.++.+||+|||+++.....
T Consensus 104 e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999 5566555543 245689999999999999999999985 7 999999999999999999999999999765322
Q ss_pred CCCCccccceeecccCCCCccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 179 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (318)
T 2dyl_A 179 --------KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK 233 (318)
T ss_dssp ----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred --------ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC
Confidence 1123446899999999984 5578899999999999999999999997643
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-32 Score=323.91 Aligned_cols=191 Identities=23% Similarity=0.382 Sum_probs=165.6
Q ss_pred cCCCCCccccccCceEEEEEEeC--CCcEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCe-----E
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP--DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE-----Q 695 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vAVK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~-----~ 695 (845)
++|.+.+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|++++++++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 67889999999999999999975 6899999998653 33445678999999999999999999999987665 7
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++||||+++++|.+++.. .+++..++.++.||++||.|||+++ ||||||||+|||++.+ .+||+|||+++..
T Consensus 160 ~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred EEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhc
Confidence 999999999999988743 6899999999999999999999998 9999999999999986 8999999999865
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
... ....||++|+|||++.+. ++.++|||||||++|||++|..||..
T Consensus 232 ~~~-----------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 232 NSF-----------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp TCC-----------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred ccC-----------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcc
Confidence 321 345689999999998765 48999999999999999999998864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-32 Score=304.72 Aligned_cols=202 Identities=25% Similarity=0.363 Sum_probs=160.0
Q ss_pred HhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeEEEEEE
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
...+|...+.||+|+||+||.....+|+.||||++...... .+.+|+++++++ +|||||++++++.+.+..++|||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 34568888999999999976555568899999998754332 356899999999 79999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-----CCcEEEEecCCcccC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-----KFTAKVADFGLSRLA 775 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~-----~~~~kl~DFGla~~~ 775 (845)
|++ |+|.+++..... ...+..++.++.||++||+|||+.+ |+||||||+|||++. ...+||+|||+|+..
T Consensus 99 ~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 996 799999976542 3444456789999999999999998 999999999999953 236889999999876
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhc---CCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
..... .........||++|+|||++. ...++.++|||||||++|||++ |+.||...
T Consensus 174 ~~~~~----~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~ 233 (432)
T 3p23_A 174 AVGRH----SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233 (432)
T ss_dssp ----------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred cCCCc----ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence 43210 012234467999999999997 4567889999999999999999 99999543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=308.60 Aligned_cols=290 Identities=19% Similarity=0.214 Sum_probs=205.2
Q ss_pred ceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeec
Q 003140 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (845)
Q Consensus 82 ~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (845)
.+++.|+|++|.+++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|+++ .+|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 58999999999999888889999999999999999999888999999999999999999999 67776 8999999999
Q ss_pred ccccccC-CCCccccCccCCCEEEccCCCCCCCCccccCCCCCc--ceeecccccc--ccCCCcccCCCC----------
Q 003140 162 DQNYISG-SLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL--VHMLLDNNNL--TGYLPPELSELP---------- 226 (845)
Q Consensus 162 s~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L--~~L~L~~N~l--~~~~p~~l~~l~---------- 226 (845)
++|++++ .+|..|+++++|++|++++|.+++ ..+..+++| ++|++++|++ .+..|..+..+.
T Consensus 98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~ 174 (520)
T 2z7x_B 98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPT 174 (520)
T ss_dssp CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCS
T ss_pred cCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEecc
Confidence 9999997 478999999999999999999874 345555555 6666666666 444444444422
Q ss_pred -------------------------------------------------------------------------CCcEEEc
Q 003140 227 -------------------------------------------------------------------------KLLILQL 233 (845)
Q Consensus 227 -------------------------------------------------------------------------~L~~L~L 233 (845)
+|++|++
T Consensus 175 n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l 254 (520)
T 2z7x_B 175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSI 254 (520)
T ss_dssp SSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEE
T ss_pred CcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEe
Confidence 4555555
Q ss_pred cCCcCCCCCCcccc-----------------------------------------------------ccCCCccEEEccc
Q 003140 234 DNNNFEGTTIPASY-----------------------------------------------------SNMSKLLKLSLRN 260 (845)
Q Consensus 234 s~N~l~~~~~p~~~-----------------------------------------------------~~l~~L~~L~Ls~ 260 (845)
++|+++| .+|..+ ..+++|++|++++
T Consensus 255 ~~n~l~~-~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~ 333 (520)
T 2z7x_B 255 SNVKLQG-QLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSN 333 (520)
T ss_dssp EEEEEES-CCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCS
T ss_pred ecccccC-ccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEeEC
Confidence 5555554 344443 3455555566666
Q ss_pred CCCCCCCC-CCCCCCCccEEEcccccCCc--CCCCCC-CccccCEEEccCCcCCCCccc-ccCCCCCCCeEecccccCcc
Q 003140 261 CSLQGPMP-DLSRIPNLGYLDLSSNQLNG--SIPPGR-LSLNITTIKLSNNKLTGTIPS-NFSGLPRLQRLFIANNSLSG 335 (845)
Q Consensus 261 N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~--~ip~~~-~~~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~ 335 (845)
|++++..+ .+..+++|+.|++++|++++ .+|..+ ...+|+.|+|++|++++.+|. .+..+++|++|++++|++++
T Consensus 334 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~ 413 (520)
T 2z7x_B 334 NLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTD 413 (520)
T ss_dssp SCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCG
T ss_pred CccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCc
Confidence 65555322 35555566666666666553 222221 223566666666666653443 25555666666666666655
Q ss_pred cCChhhhhhccCCCCcceEEEccCCCCCCCCCCC-CCCCCcEEEecCCccc
Q 003140 336 SIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFC 385 (845)
Q Consensus 336 ~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~-~~~~l~~l~l~~Np~~ 385 (845)
.+|..+. +.|+.|++++|+|+.+|..+ .++.++.|++++|++.
T Consensus 414 ~~~~~l~-------~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~L~~N~l~ 457 (520)
T 2z7x_B 414 TIFRCLP-------PRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLK 457 (520)
T ss_dssp GGGGSCC-------TTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCC
T ss_pred chhhhhc-------ccCCEEECCCCcccccchhhhcCCCCCEEECCCCcCC
Confidence 5554431 46778888888888888765 6888888888888765
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-33 Score=304.28 Aligned_cols=192 Identities=23% Similarity=0.281 Sum_probs=161.7
Q ss_pred hcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCC--------hhhHHHHHHHHHHHHhcC---------CCceeeE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS--------LQGEKEFLTEIQFLSRLH---------HRNLVSL 685 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~--------~~~~~~~~~Ei~~l~~l~---------H~nIv~l 685 (845)
.++|.+.+.||+|+||.||+|+. +|+.||||++.... ....+.+.+|++++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46788899999999999999998 78999999987542 223477899999998885 8888888
Q ss_pred EEEEe------------------------------eCCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHH
Q 003140 686 VGYCD------------------------------EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 735 (845)
Q Consensus 686 ~g~~~------------------------------~~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL 735 (845)
.+.+. +.+..++||||+++|++.+.+.+ ..+++..++.++.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 87643 26789999999999976666533 4589999999999999999
Q ss_pred HHHH-hCCCCCeEecCCCCCCEEEcCCC--------------------cEEEEecCCcccCCCCCCCCccccceeecccC
Q 003140 736 LYLH-TEADPPVFHRDIKASNILLDHKF--------------------TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 794 (845)
Q Consensus 736 ~yLH-~~~~~~iiHrDLk~~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~g 794 (845)
+||| +.+ |+||||||+|||++.++ .+||+|||+|+.... ....|
T Consensus 175 ~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------------~~~~g 239 (336)
T 2vuw_A 175 AVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------------GIVVF 239 (336)
T ss_dssp HHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------------TEEEC
T ss_pred HHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------------CcEEE
Confidence 9999 888 99999999999999887 999999999986531 12369
Q ss_pred CCCccchhhhcCCCCCchhhHHHHHHH-HHHHHhCCCCCCC
Q 003140 795 TPGYLDPEYFLTHKLTDKSDVYSLGVV-FLELLTGMQPISH 834 (845)
Q Consensus 795 t~~y~aPE~~~~~~~~~~~DvwS~Gvv-l~elltG~~Pf~~ 834 (845)
|+.|+|||++.+.. +.++||||+|++ .+++++|..||..
T Consensus 240 t~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 240 CDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp CCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred eecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 99999999998766 899999998777 8888999999853
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-30 Score=282.47 Aligned_cols=290 Identities=21% Similarity=0.312 Sum_probs=203.1
Q ss_pred eEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecc
Q 003140 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162 (845)
Q Consensus 83 ~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 162 (845)
+++.+++++++++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|..+++|++|+|+
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 3445555555655 3454443 577788888888876666677788888888888888877667778888888888888
Q ss_pred cccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeecccccccc--CCCcccCCCCCCcEEEccCCcCCC
Q 003140 163 QNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTG--YLPPELSELPKLLILQLDNNNFEG 240 (845)
Q Consensus 163 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~--~~p~~l~~l~~L~~L~Ls~N~l~~ 240 (845)
+|+++ .+|..+. ++|++|++++|++++..+..+..+++|++|++++|+++. ..+..+..+++|++|++++|+++.
T Consensus 109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~ 185 (330)
T 1xku_A 109 KNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 185 (330)
T ss_dssp SSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred CCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc
Confidence 88877 4554443 678888888888876666677778888888888887753 566677778888888888888763
Q ss_pred CCCccccccCCCccEEEcccCCCCCCCC-CCCCCCCccEEEcccccCCcCCCCCCC-ccccCEEEccCCcCCCCcccccC
Q 003140 241 TTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRL-SLNITTIKLSNNKLTGTIPSNFS 318 (845)
Q Consensus 241 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~ip~~~~-~~~L~~L~Ls~N~l~~~~p~~~~ 318 (845)
+|..+. ++|++|++++|++++..+ .+..+++|+.|++++|.+++..+..+. ..+|+.|+|++|+++ .+|..+.
T Consensus 186 --l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~ 260 (330)
T 1xku_A 186 --IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLA 260 (330)
T ss_dssp --CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTT
T ss_pred --CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhc
Confidence 454443 678888888888877654 477778888888888888765554433 347888888888887 6777788
Q ss_pred CCCCCCeEecccccCcccCChhhhhhcc-CCCCcceEEEccCCCCCC--CCC-CC-CCCCCcEEEecCCc
Q 003140 319 GLPRLQRLFIANNSLSGSIPSSIWQSRT-LNATETFILDFQNNNLTN--ISG-SF-NIPPNVTVRLRGNP 383 (845)
Q Consensus 319 ~l~~L~~L~L~~N~l~~~ip~~l~~l~~-l~~~~l~~L~ls~N~l~~--i~~-~~-~~~~l~~l~l~~Np 383 (845)
.+++|++|+|++|++++..+..|..... .....+..|++++|.+.. ++. .+ .++.+..+++++|.
T Consensus 261 ~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 261 DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp TCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred cCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 8888888888888888655555543321 123567788888888864 332 23 37778888888873
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-30 Score=283.21 Aligned_cols=289 Identities=22% Similarity=0.316 Sum_probs=209.9
Q ss_pred eEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecc
Q 003140 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162 (845)
Q Consensus 83 ~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 162 (845)
+++.+++++++++ .+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|+
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 4455666666666 4565553 578888888888887667778888888888888888887777788888888888888
Q ss_pred cccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccc--cCCCcccCCCCCCcEEEccCCcCCC
Q 003140 163 QNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT--GYLPPELSELPKLLILQLDNNNFEG 240 (845)
Q Consensus 163 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~--~~~p~~l~~l~~L~~L~Ls~N~l~~ 240 (845)
+|+++ .+|..+. ++|++|++++|++++..+..+..+++|++|++++|+++ +..+..+..+ +|++|++++|++++
T Consensus 111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~ 186 (332)
T 2ft3_A 111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG 186 (332)
T ss_dssp SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS
T ss_pred CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc
Confidence 88887 4555444 77888888888888666666788888888888888885 3666777777 88888888888874
Q ss_pred CCCccccccCCCccEEEcccCCCCCCCC-CCCCCCCccEEEcccccCCcCCCCCCC-ccccCEEEccCCcCCCCcccccC
Q 003140 241 TTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRL-SLNITTIKLSNNKLTGTIPSNFS 318 (845)
Q Consensus 241 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~ip~~~~-~~~L~~L~Ls~N~l~~~~p~~~~ 318 (845)
+|..+. ++|++|++++|++++.++ .+..+++|+.|++++|.+++..+..+. ..+|+.|+|++|+++ .+|..+.
T Consensus 187 --l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~ 261 (332)
T 2ft3_A 187 --IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLP 261 (332)
T ss_dssp --CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGG
T ss_pred --cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhh
Confidence 455443 678888888888887765 477888888888888888865554433 347888888888888 6777788
Q ss_pred CCCCCCeEecccccCcccCChhhhhhc-cCCCCcceEEEccCCCCC--CCCCC-C-CCCCCcEEEecCCc
Q 003140 319 GLPRLQRLFIANNSLSGSIPSSIWQSR-TLNATETFILDFQNNNLT--NISGS-F-NIPPNVTVRLRGNP 383 (845)
Q Consensus 319 ~l~~L~~L~L~~N~l~~~ip~~l~~l~-~l~~~~l~~L~ls~N~l~--~i~~~-~-~~~~l~~l~l~~Np 383 (845)
.+++|++|++++|++++..+..+.... ......++.|++++|.+. .++.. + .++.+..+++++|.
T Consensus 262 ~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 262 DLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp GCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred cCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 888888888888888866555554432 112455778888888887 44433 3 47788888888774
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-30 Score=303.27 Aligned_cols=147 Identities=17% Similarity=0.212 Sum_probs=125.1
Q ss_pred eEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccc
Q 003140 85 RELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164 (845)
Q Consensus 85 ~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 164 (845)
+.++++++++++ +|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 789999999996 777665 89999999999999888899999999999999999999888999999999999999999
Q ss_pred cccCCCCccccCccCCCEEEccCCCCCC-CCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcC
Q 003140 165 YISGSLPKSFANLNKTRHFHMNNNSISG-QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNF 238 (845)
Q Consensus 165 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 238 (845)
+|+ .+|.. .+++|++|+|++|++++ .+|..++++++|++|+|++|++++.....+..+ +|++|+|++|++
T Consensus 111 ~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L-~L~~L~L~~n~l 181 (562)
T 3a79_B 111 RLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHL-HLSCILLDLVSY 181 (562)
T ss_dssp CCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTTTGGGTTS-CEEEEEEEESSC
T ss_pred cCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccCchhhhhhc-eeeEEEeecccc
Confidence 999 56666 89999999999999996 456899999999999999999875322222222 226666666655
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.2e-30 Score=278.91 Aligned_cols=288 Identities=23% Similarity=0.299 Sum_probs=233.4
Q ss_pred CCCCCCCcceEecCCCCC----CCcceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhh
Q 003140 61 DPCTSNWTGVLCFNTTMD----DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLL 136 (845)
Q Consensus 61 ~~c~~~w~Gv~C~~~~~~----~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 136 (845)
..|.|.|+.+.|...... .....++.|+|++|++++..+..|+.+++|++|+|++|++++..|..|.++++|++|+
T Consensus 27 ~~c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (330)
T 1xku_A 27 FRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY 106 (330)
T ss_dssp TTCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred CCCcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEE
Confidence 346667999999654322 1235788999999999987777899999999999999999988888999999999999
Q ss_pred ccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCC--CCccccCCCCCcceeecccccc
Q 003140 137 LNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG--QIPPELSRLPSLVHMLLDNNNL 214 (845)
Q Consensus 137 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~l~~l~~L~~L~L~~N~l 214 (845)
|++|+++ .+|..+. ++|++|++++|++++..+..+.++++|+.|++++|.+.. ..+..+..+++|++|++++|++
T Consensus 107 Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l 183 (330)
T 1xku_A 107 LSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 183 (330)
T ss_dssp CCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCC
T ss_pred CCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcc
Confidence 9999998 6676665 789999999999998878889999999999999999863 6677888999999999999999
Q ss_pred ccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCC-CCCCCCCccEEEcccccCCcCCCCC
Q 003140 215 TGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPG 293 (845)
Q Consensus 215 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~ip~~ 293 (845)
+. +|..+. ++|++|+|++|++++ ..+..+.++++|+.|+|++|++++.++ .+..+++|+.|++++|+++ .+|..
T Consensus 184 ~~-l~~~~~--~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~ 258 (330)
T 1xku_A 184 TT-IPQGLP--PSLTELHLDGNKITK-VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGG 258 (330)
T ss_dssp CS-CCSSCC--TTCSEEECTTSCCCE-ECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTT
T ss_pred cc-CCcccc--ccCCEEECCCCcCCc-cCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChh
Confidence 84 555554 789999999999986 567889999999999999999998776 5888899999999999998 67765
Q ss_pred CC-ccccCEEEccCCcCCCCcccccCCC------CCCCeEecccccCcc--cCChhhhhhccCCCCcceEEEccCCC
Q 003140 294 RL-SLNITTIKLSNNKLTGTIPSNFSGL------PRLQRLFIANNSLSG--SIPSSIWQSRTLNATETFILDFQNNN 361 (845)
Q Consensus 294 ~~-~~~L~~L~Ls~N~l~~~~p~~~~~l------~~L~~L~L~~N~l~~--~ip~~l~~l~~l~~~~l~~L~ls~N~ 361 (845)
+. ..+|+.|+|++|+|++..+..|... +.|+.|++++|.+.. ..|..+..+ ..++.++|++|+
T Consensus 259 l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~-----~~l~~l~L~~N~ 330 (330)
T 1xku_A 259 LADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV-----YVRAAVQLGNYK 330 (330)
T ss_dssp TTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTC-----CCGGGEEC----
T ss_pred hccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccc-----cceeEEEecccC
Confidence 44 4589999999999998877777643 778899999999863 344555443 345688999885
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=295.11 Aligned_cols=279 Identities=15% Similarity=0.178 Sum_probs=195.0
Q ss_pred cCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCC
Q 003140 90 LNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGS 169 (845)
Q Consensus 90 ~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 169 (845)
++++++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++.
T Consensus 39 ~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 115 (353)
T 2z80_A 39 SSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNL 115 (353)
T ss_dssp CSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSC
T ss_pred CCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcC
Confidence 445565 4565554 4788888888888876666788888888888888888877777888888888888888888865
Q ss_pred CCccccCccCCCEEEccCCCCCCCCc-cccCCCCCcceeecccc-ccccCCCcccCCCCCCcEEEccCCcCCCCCCcccc
Q 003140 170 LPKSFANLNKTRHFHMNNNSISGQIP-PELSRLPSLVHMLLDNN-NLTGYLPPELSELPKLLILQLDNNNFEGTTIPASY 247 (845)
Q Consensus 170 ~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~ 247 (845)
.+..+.++++|++|+|++|+++...+ ..+..+++|++|++++| .++...+..|..+++|++|++++|++++ ..|..+
T Consensus 116 ~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~l 194 (353)
T 2z80_A 116 SSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQS-YEPKSL 194 (353)
T ss_dssp CHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCE-ECTTTT
T ss_pred CHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCc-cCHHHH
Confidence 55568888888888888888884333 36778888888888888 4666666777888888888888888876 467777
Q ss_pred ccCCCccEEEcccCCCCCCCCC-CCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccCCCCCCCeE
Q 003140 248 SNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRL 326 (845)
Q Consensus 248 ~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 326 (845)
.++++|++|++++|+++..+.. +..+++|+.|++++|.+++..+..... ......++.+
T Consensus 195 ~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~--------------------~~~~~~l~~l 254 (353)
T 2z80_A 195 KSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST--------------------GETNSLIKKF 254 (353)
T ss_dssp TTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC--------------------------CCCCCCEE
T ss_pred hccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccccccccc--------------------ccccchhhcc
Confidence 7788888888888877654433 334677777777777777543322110 1123344455
Q ss_pred ecccccCcc----cCChhhhhhccCCCCcceEEEccCCCCCCCCCCC--CCCCCcEEEecCCcccccCC-CccccCCC
Q 003140 327 FIANNSLSG----SIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTN-AEQFCGSH 397 (845)
Q Consensus 327 ~L~~N~l~~----~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~--~~~~l~~l~l~~Np~~c~~~-~~~~~~~~ 397 (845)
+|++|.+++ .+|..+..+. +|+.|++++|+|+.+|... .++.++.|++++|||.|+|+ +.++..|.
T Consensus 255 ~L~~~~l~~~~l~~l~~~l~~l~-----~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~~l~~l~~~~ 327 (353)
T 2z80_A 255 TFRNVKITDESLFQVMKLLNQIS-----GLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWL 327 (353)
T ss_dssp EEESCBCCHHHHHHHHHHHHTCT-----TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHHHHHHHHHH
T ss_pred ccccccccCcchhhhHHHHhccc-----CCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCCCcHHHHHHH
Confidence 555555543 2444444333 3446777777777666653 47888999999999999996 55555554
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-30 Score=281.12 Aligned_cols=287 Identities=23% Similarity=0.312 Sum_probs=227.2
Q ss_pred CCCCCCCcceEecCCCCC----CCcceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhh
Q 003140 61 DPCTSNWTGVLCFNTTMD----DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLL 136 (845)
Q Consensus 61 ~~c~~~w~Gv~C~~~~~~----~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 136 (845)
..|.|.|+.+.|...... ....+++.|++++|++++..+..|..+++|++|+|++|++++..|..|.++++|++|+
T Consensus 29 ~~c~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 108 (332)
T 2ft3_A 29 FGCHCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLY 108 (332)
T ss_dssp SSCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEE
T ss_pred CCCcccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEE
Confidence 345567888888654322 1235788899999999887778899999999999999999888888899999999999
Q ss_pred ccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCC--CCCccccCCCCCcceeecccccc
Q 003140 137 LNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSIS--GQIPPELSRLPSLVHMLLDNNNL 214 (845)
Q Consensus 137 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~l~~l~~L~~L~L~~N~l 214 (845)
|++|+++ .+|..+. ++|++|+|++|++++..+..|.++++|+.|++++|.++ +..+..+..+ +|++|++++|++
T Consensus 109 L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l 184 (332)
T 2ft3_A 109 ISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKL 184 (332)
T ss_dssp CCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBC
T ss_pred CCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCC
Confidence 9999988 6676665 78999999999998777777889999999999999985 3667778777 899999999998
Q ss_pred ccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCC-CCCCCCCccEEEcccccCCcCCCCC
Q 003140 215 TGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPG 293 (845)
Q Consensus 215 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~ip~~ 293 (845)
++ +|..+. ++|++|+|++|++++ ..+..+.++++|+.|+|++|++++.++ .+..+++|+.|++++|+++ .+|..
T Consensus 185 ~~-l~~~~~--~~L~~L~l~~n~i~~-~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~ 259 (332)
T 2ft3_A 185 TG-IPKDLP--ETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAG 259 (332)
T ss_dssp SS-CCSSSC--SSCSCCBCCSSCCCC-CCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTT
T ss_pred Cc-cCcccc--CCCCEEECCCCcCCc-cCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChh
Confidence 85 565554 689999999999986 466788889999999999999988776 4888889999999999998 67765
Q ss_pred CC-ccccCEEEccCCcCCCCcccccCCC------CCCCeEecccccCc--ccCChhhhhhccCCCCcceEEEccCCC
Q 003140 294 RL-SLNITTIKLSNNKLTGTIPSNFSGL------PRLQRLFIANNSLS--GSIPSSIWQSRTLNATETFILDFQNNN 361 (845)
Q Consensus 294 ~~-~~~L~~L~Ls~N~l~~~~p~~~~~l------~~L~~L~L~~N~l~--~~ip~~l~~l~~l~~~~l~~L~ls~N~ 361 (845)
+. ..+|+.|+|++|+|++..+..|..+ ++|+.|++++|.+. +..|..+..+.. |+.+++++|+
T Consensus 260 l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~-----L~~l~l~~n~ 331 (332)
T 2ft3_A 260 LPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTD-----RLAIQFGNYK 331 (332)
T ss_dssp GGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCC-----STTEEC----
T ss_pred hhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccch-----hhhhhccccc
Confidence 43 3479999999999988877777654 67889999999887 555666655444 4578888874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=278.37 Aligned_cols=173 Identities=12% Similarity=0.096 Sum_probs=151.9
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|.+.+.||+|+||.||+|... +|+.||||++..... ...+++.+|++++++++||||+++++++.+.+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57888999999999999999975 589999999976432 33478999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++++|.++++.. ........++.|+++||+|||+++ |+||||||+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc---------
Confidence 999999999999542 345578889999999999999999 9999999999999999999998543
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
|++ .++.++|||||||++|||+||+.||.....
T Consensus 175 ------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~ 207 (286)
T 3uqc_A 175 ------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGV 207 (286)
T ss_dssp ------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSB
T ss_pred ------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 333 368899999999999999999999986543
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-30 Score=294.27 Aligned_cols=258 Identities=18% Similarity=0.264 Sum_probs=189.0
Q ss_pred ccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccC
Q 003140 108 LTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNN 187 (845)
Q Consensus 108 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 187 (845)
...++.+++.++ .+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 56 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 456888888888 5776654 5788888888888877788888888888888888888877778888888888888888
Q ss_pred CCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCC
Q 003140 188 NSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPM 267 (845)
Q Consensus 188 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 267 (845)
|+|++..+..|..+++|++|+|++|+++...+..|..+++|++|+|++|+..+...+..|.++++|+.|+|++|++++.
T Consensus 133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~- 211 (452)
T 3zyi_A 133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM- 211 (452)
T ss_dssp SCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-
T ss_pred CcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-
Confidence 8888666666777888888888888887666667777777777777774433322333466666666666666666543
Q ss_pred CCCCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCChhhhhhccC
Q 003140 268 PDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 347 (845)
Q Consensus 268 ~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l 347 (845)
+.+..++ +|+.|+|++|+|++..|..|.++++|+.|+|++|++++..|..|..+.
T Consensus 212 ~~~~~l~-----------------------~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-- 266 (452)
T 3zyi_A 212 PNLTPLV-----------------------GLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLA-- 266 (452)
T ss_dssp CCCTTCT-----------------------TCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCT--
T ss_pred ccccccc-----------------------cccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCC--
Confidence 2344444 455555555555656667777777777777777777777676665543
Q ss_pred CCCcceEEEccCCCCCCCCCCC--CCCCCcEEEecCCcccccCCCccccCCC
Q 003140 348 NATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTNAEQFCGSH 397 (845)
Q Consensus 348 ~~~~l~~L~ls~N~l~~i~~~~--~~~~l~~l~l~~Np~~c~~~~~~~~~~~ 397 (845)
+|+.|+|++|+|+.++... .++.++.|+|++|||.|||++.++..|.
T Consensus 267 ---~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~~~l~~~l 315 (452)
T 3zyi_A 267 ---SLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDILWLAWWL 315 (452)
T ss_dssp ---TCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTTHHHHHHH
T ss_pred ---CCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCCchHHHHHH
Confidence 3457888888887777653 4888999999999999999999887665
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-30 Score=292.01 Aligned_cols=259 Identities=20% Similarity=0.268 Sum_probs=193.8
Q ss_pred ccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccC
Q 003140 108 LTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNN 187 (845)
Q Consensus 108 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 187 (845)
.+.++.++++++ .+|..+. ++|+.|+|++|++++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 121 (440)
T 3zyj_A 45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121 (440)
T ss_dssp SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence 457888999998 7787665 6899999999999988888899999999999999999987788899999999999999
Q ss_pred CCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCC
Q 003140 188 NSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPM 267 (845)
Q Consensus 188 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 267 (845)
|+|+...+..|..+++|++|+|++|+++...+..|..+++|++|+|++|+..+...+..|.++++|+.|+|++|+++..+
T Consensus 122 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~ 201 (440)
T 3zyj_A 122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIP 201 (440)
T ss_dssp SCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCC
T ss_pred CcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcccc
Confidence 99986666678888899999999998887777778888888888888854433233446777777777777777776442
Q ss_pred CCCCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCChhhhhhccC
Q 003140 268 PDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 347 (845)
Q Consensus 268 ~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l 347 (845)
.+..+++|+.|+|++|.++ +..|..|.++++|+.|+|++|++++..|..|..+.
T Consensus 202 -~~~~l~~L~~L~Ls~N~l~-----------------------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-- 255 (440)
T 3zyj_A 202 -NLTPLIKLDELDLSGNHLS-----------------------AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQ-- 255 (440)
T ss_dssp -CCTTCSSCCEEECTTSCCC-----------------------EECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCT--
T ss_pred -ccCCCcccCEEECCCCccC-----------------------ccChhhhccCccCCEEECCCCceeEEChhhhcCCC--
Confidence 3555555555555555554 44555566666666666666666655555554433
Q ss_pred CCCcceEEEccCCCCCCCCCCC--CCCCCcEEEecCCcccccCCCccccCCCC
Q 003140 348 NATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTNAEQFCGSHS 398 (845)
Q Consensus 348 ~~~~l~~L~ls~N~l~~i~~~~--~~~~l~~l~l~~Np~~c~~~~~~~~~~~~ 398 (845)
+|+.|+|++|+|+.++... .++.+..|+|++|||.|||++.+|..|..
T Consensus 256 ---~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~l~~l~~~~~ 305 (440)
T 3zyj_A 256 ---SLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDILWLSWWIK 305 (440)
T ss_dssp ---TCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSSTTHHHHHHHH
T ss_pred ---CCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCCchHHHHHHH
Confidence 3346666666666666543 47888999999999999999999877653
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-31 Score=296.53 Aligned_cols=197 Identities=17% Similarity=0.175 Sum_probs=154.4
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCCh---hhHHHHHHHHHHHHhcCC-Cce----------e-----
Q 003140 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHH-RNL----------V----- 683 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~---~~~~~~~~Ei~~l~~l~H-~nI----------v----- 683 (845)
.+|...+.||+|+||.||+|.+ .+|+.||||++..... ...+.|.+|+.+++.++| +|. +
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 4466678999999999999995 4799999999874322 225679999999999987 221 1
Q ss_pred ------eEEEEEee-----CCeEEEEEEcCCCCCHHHHHh-----ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 003140 684 ------SLVGYCDE-----EGEQMLVYEFMSNGTLRDQLS-----AKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747 (845)
Q Consensus 684 ------~l~g~~~~-----~~~~~LV~E~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ii 747 (845)
.++.++.. ....+++|+++ +++|.++++ ......+++..++.++.|+++||+|||+++ |+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 11111111 22457777765 699999885 233456888999999999999999999998 99
Q ss_pred ecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhh----------cCCCCCchhhHHH
Q 003140 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF----------LTHKLTDKSDVYS 817 (845)
Q Consensus 748 HrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwS 817 (845)
||||||+|||++.++.+||+|||+++... .......| +.|+|||++ ....++.++||||
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~----------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwS 302 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDG----------ASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWT 302 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETT----------EEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecC----------CccccCCC-CceeCchhhhccccccccccCcCCCchhhHHH
Confidence 99999999999999999999999987642 11344567 999999999 5556889999999
Q ss_pred HHHHHHHHHhCCCCCCCC
Q 003140 818 LGVVFLELLTGMQPISHG 835 (845)
Q Consensus 818 ~Gvvl~elltG~~Pf~~~ 835 (845)
|||++|||++|+.||...
T Consensus 303 lGvil~elltg~~Pf~~~ 320 (413)
T 3dzo_A 303 LGLAIYWIWCADLPNTDD 320 (413)
T ss_dssp HHHHHHHHHHSSCCCCTT
T ss_pred HHHHHHHHHHCCCCCCCc
Confidence 999999999999999754
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-29 Score=278.83 Aligned_cols=281 Identities=21% Similarity=0.300 Sum_probs=217.9
Q ss_pred ceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeec
Q 003140 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (845)
Q Consensus 82 ~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (845)
.+++.|++++|.+++..+ +..+++|++|+|++|.+++ +| .+.++++|++|+|++|++++. +. +..+++|++|++
T Consensus 66 ~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~l 139 (347)
T 4fmz_A 66 TNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLRELYLNEDNISDI-SP-LANLTKMYSLNL 139 (347)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECTTSCCCCC-GG-GTTCTTCCEEEC
T ss_pred CCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC-ch-HHcCCCcCCEEECcCCcccCc-hh-hccCCceeEEEC
Confidence 468888888888875433 8888888888888888874 44 588888888888888888843 33 778888888888
Q ss_pred ccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCC
Q 003140 162 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT 241 (845)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 241 (845)
++|.....++ .+..+++|++|++++|.+.+..+ +..+++|++|++++|++++..+ +..+++|+.|++++|.+++.
T Consensus 140 ~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~ 214 (347)
T 4fmz_A 140 GANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDI 214 (347)
T ss_dssp TTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred CCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCC
Confidence 8886554444 37888888888888888875433 7788888888888888885432 77888888888888888752
Q ss_pred CCccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccCCCC
Q 003140 242 TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLP 321 (845)
Q Consensus 242 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~ 321 (845)
+. +..+++|+.|++++|++++.++ +..+++|+.|++++|.+++ ++......+|+.|++++|++++. ..+..++
T Consensus 215 --~~-~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~-~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~ 287 (347)
T 4fmz_A 215 --TP-VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISD-INAVKDLTKLKMLNVGSNQISDI--SVLNNLS 287 (347)
T ss_dssp --GG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-CGGGTTCTTCCEEECCSSCCCCC--GGGGGCT
T ss_pred --ch-hhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCccCC-ChhHhcCCCcCEEEccCCccCCC--hhhcCCC
Confidence 22 7888889999999998887766 8888899999999998884 45444556899999999988865 4588889
Q ss_pred CCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCCCCCCCCcEEEecCCccc
Q 003140 322 RLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 385 (845)
Q Consensus 322 ~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~~~~~l~~l~l~~Np~~ 385 (845)
+|++|++++|++++..|..+..+.. |+.|++++|+++.++....++.+..+++++|++.
T Consensus 288 ~L~~L~L~~n~l~~~~~~~l~~l~~-----L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 288 QLNSLFLNNNQLGNEDMEVIGGLTN-----LTTLFLSQNHITDIRPLASLSKMDSADFANQVIK 346 (347)
T ss_dssp TCSEEECCSSCCCGGGHHHHHTCTT-----CSEEECCSSSCCCCGGGGGCTTCSEESSSCC---
T ss_pred CCCEEECcCCcCCCcChhHhhcccc-----CCEEEccCCccccccChhhhhccceeehhhhccc
Confidence 9999999999998888877776544 5589999999988877446888899999988863
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-30 Score=277.16 Aligned_cols=175 Identities=23% Similarity=0.374 Sum_probs=152.7
Q ss_pred cCCCCC-ccccccCceEEEEEEe-CCCcEEEEEEccCCChhhHHHHHHHHHHH-HhcCCCceeeEEEEEee----CCeEE
Q 003140 624 NNFNSS-TQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFL-SRLHHRNLVSLVGYCDE----EGEQM 696 (845)
Q Consensus 624 ~~f~~~-~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l-~~l~H~nIv~l~g~~~~----~~~~~ 696 (845)
++|.+. +.||+|+||.||+|.. .+++.||||+++.. ..+.+|++++ +..+||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 456665 7799999999999997 47899999998642 3577888888 55599999999999876 67789
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEEecCCcc
Q 003140 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLSR 773 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~---~~~~kl~DFGla~ 773 (845)
+||||+++|+|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 9999999999999998876678999999999999999999999998 999999999999998 7899999999986
Q ss_pred cCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
... +..++.++|||||||++|||++|+.||...
T Consensus 169 ~~~-----------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~ 201 (299)
T 3m2w_A 169 ETT-----------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSN 201 (299)
T ss_dssp ECT-----------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred ccc-----------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 432 134678999999999999999999999654
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-29 Score=300.13 Aligned_cols=153 Identities=20% Similarity=0.229 Sum_probs=141.9
Q ss_pred eEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccc
Q 003140 85 RELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164 (845)
Q Consensus 85 ~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 164 (845)
..+++++++++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n 90 (606)
T 3vq2_A 14 ITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90 (606)
T ss_dssp TEEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred CceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCC
Confidence 46899999998 5666655 89999999999999888889999999999999999999888999999999999999999
Q ss_pred cccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeecccccccc-CCCcccCCCCCCcEEEccCCcCCC
Q 003140 165 YISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTG-YLPPELSELPKLLILQLDNNNFEG 240 (845)
Q Consensus 165 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~ 240 (845)
++++..|..|.++++|++|+|++|.+++..+..++++++|++|+|++|++++ .+|..|+++++|++|+|++|++++
T Consensus 91 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~ 167 (606)
T 3vq2_A 91 PIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT 167 (606)
T ss_dssp CCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCE
T ss_pred cccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCccee
Confidence 9998889999999999999999999998877899999999999999999986 579999999999999999998875
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-30 Score=279.83 Aligned_cols=255 Identities=17% Similarity=0.254 Sum_probs=148.0
Q ss_pred CCCCCCCcceEecCCCCCCCcceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCC
Q 003140 61 DPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140 (845)
Q Consensus 61 ~~c~~~w~Gv~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 140 (845)
+.|.|.|.+|.|..... + .+|..+. ++|++|+|++|+++...+..|.++++|++|+|++|
T Consensus 3 ~~C~C~~~~l~c~~~~l-----------------~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n 62 (306)
T 2z66_A 3 SRCSCSGTEIRCNSKGL-----------------T-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSN 62 (306)
T ss_dssp TTCEEETTEEECCSSCC-----------------S-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSS
T ss_pred CCCeeCCCEEEcCCCCc-----------------c-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCC
Confidence 46877899999965432 2 2232222 45556666666655333333555666666666666
Q ss_pred CCCC--CCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCc-cccCCCCCcceeeccccccccC
Q 003140 141 ELTG--SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIP-PELSRLPSLVHMLLDNNNLTGY 217 (845)
Q Consensus 141 ~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~ 217 (845)
+++. ..|..+..+++|++|+|++|.++ .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|++++.
T Consensus 63 ~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~ 141 (306)
T 2z66_A 63 GLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 141 (306)
T ss_dssp CCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEEC
T ss_pred ccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCcc
Confidence 5551 12444445566666666666655 344455566666666666666654433 3555666666666666666655
Q ss_pred CCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCC-CCCCCCCccEEEcccccCCcCCCCCCC-
Q 003140 218 LPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRL- 295 (845)
Q Consensus 218 ~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~ip~~~~- 295 (845)
.+..+..+++|++|+|++|.+++...|..+..+++|+.|+|++|++++.++ .+..+++|+.|++++|.+++..+..+.
T Consensus 142 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 221 (306)
T 2z66_A 142 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 221 (306)
T ss_dssp STTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTT
T ss_pred chhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccC
Confidence 555566666666666666666542345556666666666666666666543 355666666666666666643332222
Q ss_pred ccccCEEEccCCcCCCCcccccCCCC-CCCeEecccccCccc
Q 003140 296 SLNITTIKLSNNKLTGTIPSNFSGLP-RLQRLFIANNSLSGS 336 (845)
Q Consensus 296 ~~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~ 336 (845)
..+|+.|+|++|++++..|..+..++ +|++|+|++|++++.
T Consensus 222 l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~ 263 (306)
T 2z66_A 222 LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 263 (306)
T ss_dssp CTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred cccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecc
Confidence 23666666666666666666666664 677777777777654
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-29 Score=280.91 Aligned_cols=272 Identities=20% Similarity=0.205 Sum_probs=192.2
Q ss_pred ccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCC
Q 003140 102 IGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTR 181 (845)
Q Consensus 102 l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 181 (845)
-..+++|+.|++++|.++...+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..|..|.++++|+
T Consensus 41 ~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 120 (390)
T 3o6n_A 41 DITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLT 120 (390)
T ss_dssp SGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred ccccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCC
Confidence 34578999999999999965555579999999999999999988788999999999999999999988899999999999
Q ss_pred EEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccC
Q 003140 182 HFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261 (845)
Q Consensus 182 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N 261 (845)
+|+|++|+++...+..+..+++|++|++++|++++..+..+..+++|++|+|++|++++. .+..+++|+.|++++|
T Consensus 121 ~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~----~~~~l~~L~~L~l~~n 196 (390)
T 3o6n_A 121 VLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV----DLSLIPSLFHANVSYN 196 (390)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC----CGGGCTTCSEEECCSS
T ss_pred EEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc----ccccccccceeecccc
Confidence 999999999955555679999999999999999988888899999999999999999863 3566777777777777
Q ss_pred CCCCCCCC--C---------------CCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccCCCCCCC
Q 003140 262 SLQGPMPD--L---------------SRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQ 324 (845)
Q Consensus 262 ~l~~~~~~--l---------------~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 324 (845)
.+++.... + ...++|+.|++++|.+++. +......+|+.|+|++|.+++..|..|..+++|+
T Consensus 197 ~l~~~~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 275 (390)
T 3o6n_A 197 LLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLE 275 (390)
T ss_dssp CCSEEECCSSCSEEECCSSCCCEEECCCCSSCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCC
T ss_pred cccccCCCCcceEEECCCCeeeeccccccccccEEECCCCCCccc-HHHcCCCCccEEECCCCcCCCcChhHccccccCC
Confidence 76652110 0 1123455555555555422 2222223455555555555555555555555555
Q ss_pred eEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCCC-CCCCCcEEEecCCcc
Q 003140 325 RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPF 384 (845)
Q Consensus 325 ~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~-~~~~l~~l~l~~Np~ 384 (845)
+|+|++|++++ +|..+. ..++|+.|+|++|+|+.+|..+ .++.++.|++++|++
T Consensus 276 ~L~L~~n~l~~-~~~~~~-----~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~L~~N~i 330 (390)
T 3o6n_A 276 RLYISNNRLVA-LNLYGQ-----PIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSI 330 (390)
T ss_dssp EEECCSSCCCE-EECSSS-----CCTTCCEEECCSSCCCCCGGGHHHHTTCSEEECCSSCC
T ss_pred EEECCCCcCcc-cCcccC-----CCCCCCEEECCCCcceecCccccccCcCCEEECCCCcc
Confidence 55555555543 222221 1233445555555555555443 345555555555554
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-28 Score=279.57 Aligned_cols=278 Identities=18% Similarity=0.156 Sum_probs=173.5
Q ss_pred ceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeec
Q 003140 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (845)
Q Consensus 82 ~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (845)
.+++.|+|++|.+++. + ++.+++|++|+|++|++++. | ++++++|++|+|++|++++ +| ++.+++|++|++
T Consensus 64 ~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l 134 (457)
T 3bz5_A 64 TGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNC 134 (457)
T ss_dssp TTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEEC
Confidence 3455666666665553 2 55566666666666666542 2 5556666666666666654 33 555666666666
Q ss_pred ccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCC
Q 003140 162 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT 241 (845)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 241 (845)
++|++++. + +.++++|++|++++|+..+.+ .+..+++|++|++++|++++ +| +..+++|+.|++++|++++.
T Consensus 135 ~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~ 206 (457)
T 3bz5_A 135 ARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL 206 (457)
T ss_dssp TTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC
T ss_pred CCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee
Confidence 66666542 2 555666666666666444444 35566666666666666665 33 66666677777777776652
Q ss_pred CCccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCCcCCCCCCCcc--------ccCEEEccCCcCCCCc
Q 003140 242 TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL--------NITTIKLSNNKLTGTI 313 (845)
Q Consensus 242 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~--------~L~~L~Ls~N~l~~~~ 313 (845)
.++.+++|+.|++++|++++.+ +..+++|+.|++++|++++..+..+... +|+.|++++|.+.+.+
T Consensus 207 ----~l~~l~~L~~L~Ls~N~l~~ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~ 280 (457)
T 3bz5_A 207 ----DLNQNIQLTFLDCSSNKLTEID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYF 280 (457)
T ss_dssp ----CCTTCTTCSEEECCSSCCSCCC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEE
T ss_pred ----ccccCCCCCEEECcCCcccccC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCcc
Confidence 3666677777777777777643 6666777777777777765433222111 3455555555555555
Q ss_pred ccccCCCCCCCeEecccccCcccCChhhhhhccCC---CCcceEEEccCCCCCCCCCCCCCCCCcEEEecCCccc
Q 003140 314 PSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLN---ATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 385 (845)
Q Consensus 314 p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~---~~~l~~L~ls~N~l~~i~~~~~~~~l~~l~l~~Np~~ 385 (845)
| ++.+++|+.|++++|++.+.+|.....+..+. .++|+.|++++|+|++++ -..++.++.|++++|.+.
T Consensus 281 ~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l~-l~~l~~L~~L~l~~N~l~ 352 (457)
T 3bz5_A 281 Q--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTELD-VSHNTKLKSLSCVNAHIQ 352 (457)
T ss_dssp E--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCCC-CTTCTTCSEEECCSSCCC
T ss_pred c--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCcccccc-cccCCcCcEEECCCCCCC
Confidence 5 45677888888888888777776544444442 456889999999999874 235888999999999875
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-29 Score=295.40 Aligned_cols=271 Identities=20% Similarity=0.216 Sum_probs=202.0
Q ss_pred CCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEE
Q 003140 104 RLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHF 183 (845)
Q Consensus 104 ~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 183 (845)
.+++++.|++++|.++...+..|.++++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|.++++|++|
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 47889999999999997666678999999999999999998888899999999999999999999889999999999999
Q ss_pred EccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCC
Q 003140 184 HMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263 (845)
Q Consensus 184 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l 263 (845)
+|++|.|++..+..|+.+++|++|+|++|.+++..|..|..+++|++|+|++|.+++. .+..+++|+.|++++|.+
T Consensus 129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~l~~L~~L~l~~n~l 204 (597)
T 3oja_B 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV----DLSLIPSLFHANVSYNLL 204 (597)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC----CGGGCTTCSEEECCSSCC
T ss_pred EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc----ChhhhhhhhhhhcccCcc
Confidence 9999999966666789999999999999999999998999999999999999999863 255667777777777776
Q ss_pred CCCCCC--C---------------CCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccCCCCCCCeE
Q 003140 264 QGPMPD--L---------------SRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRL 326 (845)
Q Consensus 264 ~~~~~~--l---------------~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 326 (845)
++.... + ...++|+.|+|++|.+++. +......+|+.|+|++|.+++.+|..|..+++|+.|
T Consensus 205 ~~l~~~~~L~~L~ls~n~l~~~~~~~~~~L~~L~L~~n~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 283 (597)
T 3oja_B 205 STLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERL 283 (597)
T ss_dssp SEEECCTTCSEEECCSSCCCEEECSCCSCCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEE
T ss_pred ccccCCchhheeeccCCcccccccccCCCCCEEECCCCCCCCC-hhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEE
Confidence 652110 0 0113555556666655532 222223356666666666666666666666666666
Q ss_pred ecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCCC-CCCCCcEEEecCCccc
Q 003140 327 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFC 385 (845)
Q Consensus 327 ~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~-~~~~l~~l~l~~Np~~ 385 (845)
+|++|++++ +|..+.. .+.|+.|+|++|+|+.+|..+ .++.+..|+|++|++.
T Consensus 284 ~Ls~N~l~~-l~~~~~~-----l~~L~~L~Ls~N~l~~i~~~~~~l~~L~~L~L~~N~l~ 337 (597)
T 3oja_B 284 YISNNRLVA-LNLYGQP-----IPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIV 337 (597)
T ss_dssp ECTTSCCCE-EECSSSC-----CTTCCEEECCSSCCCCCGGGHHHHTTCSEEECCSSCCC
T ss_pred ECCCCCCCC-CCccccc-----CCCCcEEECCCCCCCccCcccccCCCCCEEECCCCCCC
Confidence 666666654 3333322 234556666666666666554 3566666666666653
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.1e-30 Score=298.51 Aligned_cols=171 Identities=14% Similarity=0.208 Sum_probs=147.4
Q ss_pred EEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccc
Q 003140 87 LQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYI 166 (845)
Q Consensus 87 L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 166 (845)
.++++++++ .+|+.+. ++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|++
T Consensus 10 c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 86 (549)
T 2z81_A 10 CDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86 (549)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred EECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCcc
Confidence 678888888 5676664 7999999999999988899999999999999999999988889999999999999999999
Q ss_pred cCCCCccccCccCCCEEEccCCCCCC-CCccccCCCCCcceeeccccccccCCC-cccCCCCCCcEEEccCCcCCCCCCc
Q 003140 167 SGSLPKSFANLNKTRHFHMNNNSISG-QIPPELSRLPSLVHMLLDNNNLTGYLP-PELSELPKLLILQLDNNNFEGTTIP 244 (845)
Q Consensus 167 ~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~~p 244 (845)
++..|..|+++++|++|+|++|++++ ..|..++.+++|++|++++|++.+.+| ..|..+++|++|++++|++++ ..|
T Consensus 87 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~ 165 (549)
T 2z81_A 87 SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN-YQS 165 (549)
T ss_dssp CSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCE-ECT
T ss_pred CccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccc-cCh
Confidence 98888889999999999999999986 457889999999999999999554554 689999999999999999987 567
Q ss_pred cccccCCCccEEEcccC
Q 003140 245 ASYSNMSKLLKLSLRNC 261 (845)
Q Consensus 245 ~~~~~l~~L~~L~Ls~N 261 (845)
..+.++++|++|+++.|
T Consensus 166 ~~l~~l~~L~~L~l~~n 182 (549)
T 2z81_A 166 QSLKSIRDIHHLTLHLS 182 (549)
T ss_dssp TTTTTCSEEEEEEEECS
T ss_pred hhhhccccCceEecccC
Confidence 76665444443333333
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=281.82 Aligned_cols=278 Identities=25% Similarity=0.340 Sum_probs=154.6
Q ss_pred cceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceee
Q 003140 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (845)
Q Consensus 81 ~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (845)
..+++.|+|++|.+++..+ +..+++|++|+|++|.+++..+ +.++++|++|+|++|++++. +. +..+++|++|+
T Consensus 67 l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~L~~L~ 140 (466)
T 1o6v_A 67 LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDI-DP-LKNLTNLNRLE 140 (466)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-GG-GTTCTTCSEEE
T ss_pred hcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCC-hH-HcCCCCCCEEE
Confidence 3578999999999887644 8999999999999999986544 89999999999999999854 33 88999999999
Q ss_pred cccccccCCCCccccCccCCCEEE---------------------ccCCCCCCCCccccCCCCCcceeeccccccccCCC
Q 003140 161 IDQNYISGSLPKSFANLNKTRHFH---------------------MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLP 219 (845)
Q Consensus 161 Ls~N~l~~~~p~~~~~l~~L~~L~---------------------L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 219 (845)
|++|.+++. + .+..+++|+.|+ +++|.+++. ..+..+++|++|++++|++++..|
T Consensus 141 l~~n~l~~~-~-~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~ 216 (466)
T 1o6v_A 141 LSSNTISDI-S-ALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP 216 (466)
T ss_dssp EEEEEECCC-G-GGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred CCCCccCCC-h-hhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc
Confidence 999998853 2 244454444444 444444422 124444444444444444443322
Q ss_pred cccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCCcCCCCCCCcccc
Q 003140 220 PELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNI 299 (845)
Q Consensus 220 ~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L 299 (845)
++.+++|++|++++|++++. ..+..+++|+.|++++|++++.++ +..+++|+.|++++|.+++..+ .....+|
T Consensus 217 --~~~l~~L~~L~l~~n~l~~~---~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L 289 (466)
T 1o6v_A 217 --LGILTNLDELSLNGNQLKDI---GTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNISP-LAGLTAL 289 (466)
T ss_dssp --GGGCTTCCEEECCSSCCCCC---GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCCGG-GTTCTTC
T ss_pred --ccccCCCCEEECCCCCcccc---hhhhcCCCCCEEECCCCccccchh-hhcCCCCCEEECCCCccCcccc-ccCCCcc
Confidence 33444444444444444321 234444445555555554444333 4444445555555554443222 2222344
Q ss_pred CEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCCCCCCCCcEEEe
Q 003140 300 TTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRL 379 (845)
Q Consensus 300 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~~~~~l~~l~l 379 (845)
+.|+|++|++++..+ +..+++|+.|+|++|++++..| +.. .++|+.|++++|++++++.-..++.++.|++
T Consensus 290 ~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~-----l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l 360 (466)
T 1o6v_A 290 TNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSS-----LTKLQRLFFYNNKVSDVSSLANLTNINWLSA 360 (466)
T ss_dssp SEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGG-----CTTCCEEECCSSCCCCCGGGTTCTTCCEEEC
T ss_pred CeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hcc-----CccCCEeECCCCccCCchhhccCCCCCEEeC
Confidence 555555555444332 4444555555555555544333 221 1233345555555444432223444445555
Q ss_pred cCCcc
Q 003140 380 RGNPF 384 (845)
Q Consensus 380 ~~Np~ 384 (845)
++|++
T Consensus 361 ~~n~l 365 (466)
T 1o6v_A 361 GHNQI 365 (466)
T ss_dssp CSSCC
T ss_pred CCCcc
Confidence 44443
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=270.98 Aligned_cols=258 Identities=19% Similarity=0.211 Sum_probs=180.3
Q ss_pred cEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCC--CCccccCccCCCEEEcc
Q 003140 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGS--LPKSFANLNKTRHFHMN 186 (845)
Q Consensus 109 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~L~ 186 (845)
+.++++++.++ .+|..+. ++|++|+|++|+++...+..|.++++|++|+|++|+++.. .+..+..+++|++|+|+
T Consensus 10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls 86 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86 (306)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence 46788888887 5676553 5888899999998854445578888999999998888733 36667778888888888
Q ss_pred CCCCCCCCccccCCCCCcceeeccccccccCCC-cccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCC
Q 003140 187 NNSISGQIPPELSRLPSLVHMLLDNNNLTGYLP-PELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG 265 (845)
Q Consensus 187 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~ 265 (845)
+|.++ .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+++ ..+..+.++++|++|+|++|.+++
T Consensus 87 ~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~ 164 (306)
T 2z66_A 87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQE 164 (306)
T ss_dssp SCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEE-CSTTTTTTCTTCCEEECTTCEEGG
T ss_pred CCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCc-cchhhcccCcCCCEEECCCCcccc
Confidence 88887 466677788888888888888876554 467777788888888887775 456667777777777777777765
Q ss_pred --CCCCCCCCCCccEEEcccccCCcCCCCCCCc-cccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCChhhh
Q 003140 266 --PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIW 342 (845)
Q Consensus 266 --~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~ 342 (845)
.+..+..+++|+.|++++|.+++..|..+.. .+|+.|+|++|++++..+..+..+++|++|+|++|++++..|..+.
T Consensus 165 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 244 (306)
T 2z66_A 165 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQ 244 (306)
T ss_dssp GEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCC
T ss_pred ccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHH
Confidence 3344666667777777766666544443322 3555555555555555554555555555555555555544443322
Q ss_pred hhccCCCCcceEEEccCCCCCCCCCCCCC-CCCcEEEecCCcccccCCCccccCCCC
Q 003140 343 QSRTLNATETFILDFQNNNLTNISGSFNI-PPNVTVRLRGNPFCLNTNAEQFCGSHS 398 (845)
Q Consensus 343 ~l~~l~~~~l~~L~ls~N~l~~i~~~~~~-~~l~~l~l~~Np~~c~~~~~~~~~~~~ 398 (845)
.+ +.++.|++++|||.|+|...+|-.|..
T Consensus 245 ---------------------------~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~ 274 (306)
T 2z66_A 245 ---------------------------HFPSSLAFLNLTQNDFACTCEHQSFLQWIK 274 (306)
T ss_dssp ---------------------------CCCTTCCEEECTTCCEECSGGGHHHHHHHH
T ss_pred ---------------------------hhhccCCEEEccCCCeecccChHHHHHHHH
Confidence 24 378899999999999999988887763
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-28 Score=279.67 Aligned_cols=281 Identities=27% Similarity=0.364 Sum_probs=239.2
Q ss_pred cceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCC-------------
Q 003140 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLP------------- 147 (845)
Q Consensus 81 ~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p------------- 147 (845)
..+++.|++++|.+++..+ ++.+++|++|+|++|.+++. +. +.++++|++|+|++|++++. +
T Consensus 89 l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~l 163 (466)
T 1o6v_A 89 LTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDI-DP-LKNLTNLNRLELSSNTISDI-SALSGLTSLQQLSF 163 (466)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-GG-GTTCTTCSEEEEEEEEECCC-GGGTTCTTCSEEEE
T ss_pred cccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCC-hH-HcCCCCCCEEECCCCccCCC-hhhccCCcccEeec
Confidence 4678999999999987654 89999999999999999864 43 88899999999999988742 2
Q ss_pred -------CccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCc
Q 003140 148 -------EELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPP 220 (845)
Q Consensus 148 -------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~ 220 (845)
..+.++++|++|++++|.+++. ..+..+++|++|++++|.+++..| ++.+++|++|++++|++++. .
T Consensus 164 ~~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~ 237 (466)
T 1o6v_A 164 GNQVTDLKPLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--G 237 (466)
T ss_dssp EESCCCCGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--G
T ss_pred CCcccCchhhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--h
Confidence 1266788899999999999854 358899999999999999997655 78899999999999999964 4
Q ss_pred ccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCCcCCCCCCCccccC
Q 003140 221 ELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNIT 300 (845)
Q Consensus 221 ~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~ 300 (845)
.+..+++|+.|++++|.+++. .+ +..+++|+.|++++|++++.++ +..+++|+.|++++|++++..+ .....+|+
T Consensus 238 ~l~~l~~L~~L~l~~n~l~~~-~~--~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~ 312 (466)
T 1o6v_A 238 TLASLTNLTDLDLANNQISNL-AP--LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLEDISP-ISNLKNLT 312 (466)
T ss_dssp GGGGCTTCSEEECCSSCCCCC-GG--GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCGG-GGGCTTCS
T ss_pred hhhcCCCCCEEECCCCccccc-hh--hhcCCCCCEEECCCCccCcccc-ccCCCccCeEEcCCCcccCchh-hcCCCCCC
Confidence 688999999999999999863 32 8999999999999999998776 8899999999999999996544 44455899
Q ss_pred EEEccCCcCCCCcccccCCCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCCCCCCCCcEEEec
Q 003140 301 TIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLR 380 (845)
Q Consensus 301 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~~~~~l~~l~l~ 380 (845)
.|+|++|++++..| +..+++|++|++++|++++. ..+.. .++|+.|++++|+++++++...++.+..|+++
T Consensus 313 ~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~-----l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~ 383 (466)
T 1o6v_A 313 YLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLAN-----LTNINWLSAGHNQISDLTPLANLTRITQLGLN 383 (466)
T ss_dssp EEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTT-----CTTCCEEECCSSCCCBCGGGTTCTTCCEEECC
T ss_pred EEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhcc-----CCCCCEEeCCCCccCccchhhcCCCCCEEecc
Confidence 99999999998876 78999999999999999965 34444 35667999999999988875579999999999
Q ss_pred CCcccc
Q 003140 381 GNPFCL 386 (845)
Q Consensus 381 ~Np~~c 386 (845)
+|+|..
T Consensus 384 ~n~~~~ 389 (466)
T 1o6v_A 384 DQAWTN 389 (466)
T ss_dssp CEEEEC
T ss_pred CCcccC
Confidence 999875
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-30 Score=281.28 Aligned_cols=244 Identities=23% Similarity=0.262 Sum_probs=151.9
Q ss_pred eEeEEEecCCCCcccCCCCccCCCCccEEEecCCCC-CCCCccccc-------ccccchhhhccCCCCCCCCCCcc--CC
Q 003140 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKI-SGSIPKEIG-------NIKSLELLLLNGNELTGSLPEEL--GY 152 (845)
Q Consensus 83 ~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l-~~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~p~~~--~~ 152 (845)
+++.|++++|.+ .+|..+... |++|+|++|++ .+.+|..+. ++++|++|+|++|++++.+|..+ ..
T Consensus 44 ~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~ 119 (312)
T 1wwl_A 44 SLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEAT 119 (312)
T ss_dssp ECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCC
T ss_pred CceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhc
Confidence 455666666666 555555443 66667777766 345555554 56677777777777766666665 66
Q ss_pred CCccceeecccccccCCCCccccCc-----cCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccC--CCccc--C
Q 003140 153 LPKLDRIQIDQNYISGSLPKSFANL-----NKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGY--LPPEL--S 223 (845)
Q Consensus 153 l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~--~p~~l--~ 223 (845)
+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..|..++.+++|++|+|++|++.+. .+..+ .
T Consensus 120 l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 198 (312)
T 1wwl_A 120 GPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198 (312)
T ss_dssp SCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTT
T ss_pred CCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhc
Confidence 67777777777777655 6666655 6677777777777666666666777777777777766543 22233 5
Q ss_pred CCCCCcEEEccCCcCCCC-CCc-cccccCCCccEEEcccCCCCCCCC--CCCCCCCccEEEcccccCCcCCCCCCCcccc
Q 003140 224 ELPKLLILQLDNNNFEGT-TIP-ASYSNMSKLLKLSLRNCSLQGPMP--DLSRIPNLGYLDLSSNQLNGSIPPGRLSLNI 299 (845)
Q Consensus 224 ~l~~L~~L~Ls~N~l~~~-~~p-~~~~~l~~L~~L~Ls~N~l~~~~~--~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L 299 (845)
.+++|++|+|++|++++. .++ ..+.++++|+.|+|++|++++.++ .+..+++|+.|+|++|.|+ .+|.... .+|
T Consensus 199 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~-~~L 276 (312)
T 1wwl_A 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP-AKL 276 (312)
T ss_dssp SCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC-SEE
T ss_pred cCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc-CCc
Confidence 666777777777766531 011 233456667777777777666542 3455666677777777666 5555544 566
Q ss_pred CEEEccCCcCCCCcccccCCCCCCCeEecccccCcc
Q 003140 300 TTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSG 335 (845)
Q Consensus 300 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 335 (845)
+.|+|++|+|++. |. +..+++|++|+|++|++++
T Consensus 277 ~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 277 SVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp EEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred eEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 6666666666655 44 6666666666666666653
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.1e-28 Score=264.46 Aligned_cols=281 Identities=20% Similarity=0.292 Sum_probs=240.2
Q ss_pred ceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeec
Q 003140 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (845)
Q Consensus 82 ~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (845)
.+++.|++.++.+... + .+..+++|++|+|++|++++ ++. +.++++|++|+|++|.+++ +| .+..+++|++|+|
T Consensus 44 ~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~~L~l 117 (347)
T 4fmz_A 44 ESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLRELYL 117 (347)
T ss_dssp TTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEEC
T ss_pred ccccEEEEeCCccccc-h-hhhhcCCccEEEccCCcccc-chh-hhcCCcCCEEEccCCcccC-ch-HHcCCCcCCEEEC
Confidence 4689999999999853 3 59999999999999999995 444 9999999999999999995 44 6999999999999
Q ss_pred ccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCC
Q 003140 162 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT 241 (845)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 241 (845)
++|.+++..+ +..+++|+.|++++|.....++ .+..+++|++|++++|.+++..+ +..+++|++|++++|++++
T Consensus 118 ~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~- 191 (347)
T 4fmz_A 118 NEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED- 191 (347)
T ss_dssp TTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCC-
T ss_pred cCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcccc-
Confidence 9999996544 8999999999999997765544 48999999999999999986543 8899999999999999985
Q ss_pred CCccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccCCCC
Q 003140 242 TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLP 321 (845)
Q Consensus 242 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~ 321 (845)
++. +..+++|+.|++++|.+++..+ +..+++|+.|++++|.+++. +......+|+.|++++|.+++. ..+..++
T Consensus 192 -~~~-~~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~ 265 (347)
T 4fmz_A 192 -ISP-LASLTSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKITDL-SPLANLSQLTWLEIGTNQISDI--NAVKDLT 265 (347)
T ss_dssp -CGG-GGGCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCCC--GGGTTCT
T ss_pred -ccc-ccCCCccceeecccCCCCCCch-hhcCCcCCEEEccCCccCCC-cchhcCCCCCEEECCCCccCCC--hhHhcCC
Confidence 333 8899999999999999998766 88899999999999999954 4444556999999999999975 5789999
Q ss_pred CCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCC-C-CCCCCcEEEecCCccccc
Q 003140 322 RLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVRLRGNPFCLN 387 (845)
Q Consensus 322 ~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~-~-~~~~l~~l~l~~Np~~c~ 387 (845)
+|++|++++|++++. | .+..+ ++|+.|++++|+++.++.. + .++.++.|++++|++...
T Consensus 266 ~L~~L~l~~n~l~~~-~-~~~~l-----~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 326 (347)
T 4fmz_A 266 KLKMLNVGSNQISDI-S-VLNNL-----SQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI 326 (347)
T ss_dssp TCCEEECCSSCCCCC-G-GGGGC-----TTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCC
T ss_pred CcCEEEccCCccCCC-h-hhcCC-----CCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccc
Confidence 999999999999964 3 34443 4567999999999977654 3 689999999999998754
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.1e-29 Score=265.64 Aligned_cols=254 Identities=17% Similarity=0.193 Sum_probs=158.0
Q ss_pred eEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccc
Q 003140 85 RELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164 (845)
Q Consensus 85 ~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 164 (845)
+.+++++++++. +|..+ .++|++|+|++|++++..+..|.++++|++|+|++|.+++..|..|..+++|++|+|++|
T Consensus 14 ~~~~c~~~~l~~-ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQA-VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCSS-CCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCccc-CCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 345555555552 34332 356677777777776655566666677777777777766665666667777777777777
Q ss_pred c-ccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCC
Q 003140 165 Y-ISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTI 243 (845)
Q Consensus 165 ~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~ 243 (845)
. ++...|..+..+++|++|++++|++++..|..+..+++|++|++++|++++..+..|..+++|++|+|++|++++ ..
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~ 169 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS-VP 169 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCE-EC
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccc-cC
Confidence 5 655556666667777777777777766666666667777777777777765555556666777777777776664 23
Q ss_pred ccccccCCCccEEEcccCCCCCCCC-CCCCCCCccEEEcccccCCcCCCCCC-CccccCEEEccCCcCCCCcccccCCCC
Q 003140 244 PASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGR-LSLNITTIKLSNNKLTGTIPSNFSGLP 321 (845)
Q Consensus 244 p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~ip~~~-~~~~L~~L~Ls~N~l~~~~p~~~~~l~ 321 (845)
+..+.++++|+.|+|++|++++..+ .+..+++|+.|++++|.+++..+..+ ...+|+.|+|++|.+....+.. .-+.
T Consensus 170 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~ 248 (285)
T 1ozn_A 170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWA 248 (285)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHH
T ss_pred HHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHH
Confidence 3456666777777777777766543 46666777777777777764333322 2336777777777666433221 1112
Q ss_pred CCCeEecccccCcccCChhhhh
Q 003140 322 RLQRLFIANNSLSGSIPSSIWQ 343 (845)
Q Consensus 322 ~L~~L~L~~N~l~~~ip~~l~~ 343 (845)
.|+.+..+.|.+....|..+..
T Consensus 249 ~l~~~~~~~~~~~c~~p~~l~g 270 (285)
T 1ozn_A 249 WLQKFRGSSSEVPCSLPQRLAG 270 (285)
T ss_dssp HHHHCCSEECCCBEEESGGGTT
T ss_pred HHHhcccccCccccCCchHhCC
Confidence 3445556677777777776543
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-28 Score=265.30 Aligned_cols=233 Identities=21% Similarity=0.330 Sum_probs=176.4
Q ss_pred CCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEE
Q 003140 105 LSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFH 184 (845)
Q Consensus 105 L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 184 (845)
.++++.|+|++|+++ .+|..+.++++|++|+|++|.++ .+|..++.+++|++|+|++|+++ .+|..+.++++|++|+
T Consensus 80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~ 156 (328)
T 4fcg_A 80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156 (328)
T ss_dssp STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence 477888888888888 77777888888888888888888 78888888888888888888887 6677777777777777
Q ss_pred ccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCC
Q 003140 185 MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264 (845)
Q Consensus 185 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~ 264 (845)
|++|++.+.+|..+... ..+..|..+++|++|+|++|+++ .+|..+.++++|++|+|++|+++
T Consensus 157 L~~n~~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~--~lp~~l~~l~~L~~L~L~~N~l~ 219 (328)
T 4fcg_A 157 IRACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR--SLPASIANLQNLKSLKIRNSPLS 219 (328)
T ss_dssp EEEETTCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC--CCCGGGGGCTTCCEEEEESSCCC
T ss_pred CCCCCCccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC--cchHhhcCCCCCCEEEccCCCCC
Confidence 77777776666554421 11233556777888888888776 46777777777777777777777
Q ss_pred CCCCCCCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCChhhhhh
Q 003140 265 GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS 344 (845)
Q Consensus 265 ~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l 344 (845)
+.++.+..+++|+.|+++ +|++.+.+|..|.++++|++|+|++|++.+.+|..+..+
T Consensus 220 ~l~~~l~~l~~L~~L~Ls-----------------------~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l 276 (328)
T 4fcg_A 220 ALGPAIHHLPKLEELDLR-----------------------GCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRL 276 (328)
T ss_dssp CCCGGGGGCTTCCEEECT-----------------------TCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGC
T ss_pred cCchhhccCCCCCEEECc-----------------------CCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcC
Confidence 665555555555555555 455555667788899999999999999999999998776
Q ss_pred ccCCCCcceEEEccCCCC-CCCCCCC-CCCCCcEEEecCCccc
Q 003140 345 RTLNATETFILDFQNNNL-TNISGSF-NIPPNVTVRLRGNPFC 385 (845)
Q Consensus 345 ~~l~~~~l~~L~ls~N~l-~~i~~~~-~~~~l~~l~l~~Np~~ 385 (845)
.. |+.|+|++|++ ..+|..+ .++.+..+++..|.+.
T Consensus 277 ~~-----L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 277 TQ-----LEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp TT-----CCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred CC-----CCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 55 55999999876 5677776 6999999999877653
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.2e-28 Score=284.37 Aligned_cols=139 Identities=18% Similarity=0.208 Sum_probs=116.9
Q ss_pred cCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCC-CCCCCCCccEEEcccccCC-cCCCCCCC-ccc
Q 003140 222 LSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLN-GSIPPGRL-SLN 298 (845)
Q Consensus 222 l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~-~~ip~~~~-~~~ 298 (845)
+..+++|++|++++|.+++......+.++++|+.|++++|.+++..+ .+..+++|+.|++++|.++ +.+|..+. ..+
T Consensus 392 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~ 471 (570)
T 2z63_A 392 FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 471 (570)
T ss_dssp EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTT
T ss_pred ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccC
Confidence 55667777777777777753233578999999999999999998766 4889999999999999998 56776654 348
Q ss_pred cCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCC
Q 003140 299 ITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 365 (845)
Q Consensus 299 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i 365 (845)
|+.|+|++|++++..|..|..+++|++|+|++|++++..|..+..+. +|+.|++++|.++.-
T Consensus 472 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-----~L~~L~l~~N~~~~~ 533 (570)
T 2z63_A 472 LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLT-----SLQKIWLHTNPWDCS 533 (570)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCT-----TCCEEECCSSCBCCC
T ss_pred CCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhccc-----CCcEEEecCCcccCC
Confidence 99999999999999999999999999999999999988777776554 456999999999854
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=272.16 Aligned_cols=243 Identities=21% Similarity=0.254 Sum_probs=194.7
Q ss_pred EEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccc
Q 003140 87 LQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYI 166 (845)
Q Consensus 87 L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 166 (845)
++..+.+|+ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|+|
T Consensus 48 v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 124 (440)
T 3zyj_A 48 VICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124 (440)
T ss_dssp EECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCC
T ss_pred EEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcC
Confidence 333444555 4555554 6788888888888877778888888888888888888877778888888888888888888
Q ss_pred cCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeecccc-ccccCCCcccCCCCCCcEEEccCCcCCCCCCcc
Q 003140 167 SGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNN-NLTGYLPPELSELPKLLILQLDNNNFEGTTIPA 245 (845)
Q Consensus 167 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~ 245 (845)
++..+..|.++++|++|+|++|+++...+..|..+++|++|+|++| .+....+..|..+++|++|+|++|+++. +|
T Consensus 125 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~--~~- 201 (440)
T 3zyj_A 125 TTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE--IP- 201 (440)
T ss_dssp SSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS--CC-
T ss_pred CeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc--cc-
Confidence 8766777888888888888888888666678888888888888884 4444444568888899999999998874 44
Q ss_pred ccccCCCccEEEcccCCCCCCCC-CCCCCCCccEEEcccccCCcCCCCCCCc-cccCEEEccCCcCCCCcccccCCCCCC
Q 003140 246 SYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRL 323 (845)
Q Consensus 246 ~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~ip~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L 323 (845)
.+..+++|+.|+|++|++++..+ .+..+++|+.|+|++|++++..+..+.. .+|+.|+|++|+|++..+..|..+++|
T Consensus 202 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 281 (440)
T 3zyj_A 202 NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHL 281 (440)
T ss_dssp CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTC
T ss_pred ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCC
Confidence 47888899999999999988755 5888899999999999998766655443 488999999999988888888999999
Q ss_pred CeEecccccCcc
Q 003140 324 QRLFIANNSLSG 335 (845)
Q Consensus 324 ~~L~L~~N~l~~ 335 (845)
+.|+|++|.+..
T Consensus 282 ~~L~L~~Np~~C 293 (440)
T 3zyj_A 282 ERIHLHHNPWNC 293 (440)
T ss_dssp CEEECCSSCEEC
T ss_pred CEEEcCCCCccC
Confidence 999999999863
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-27 Score=282.22 Aligned_cols=176 Identities=18% Similarity=0.207 Sum_probs=141.6
Q ss_pred CCCCCCCCCCCCCCCCcceEecCCCCCCCcceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCccccccccc
Q 003140 52 SKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKS 131 (845)
Q Consensus 52 ~~l~~W~~~~~c~~~w~Gv~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~ 131 (845)
..+++|+..-|.+ |....|... -...+.++.+|+ .+|..+. +++++|||++|+|++..|.+|.++++
T Consensus 11 ~~~~~~~~~~p~~--~~~c~~~~~--------~~~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~ 77 (635)
T 4g8a_A 11 DKLAAANSSIPES--WEPCVEVVP--------NITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPE 77 (635)
T ss_dssp ----------------CCSEEEET--------TTEEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred chhhcccCCCCCC--CCCccccCC--------CCEEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCC
Confidence 3466776655543 666555432 134578888888 5676654 57999999999999877889999999
Q ss_pred chhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccc
Q 003140 132 LELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDN 211 (845)
Q Consensus 132 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 211 (845)
|++|+|++|+|++..|..|.+|++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|+++++|++|+|++
T Consensus 78 L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~ 157 (635)
T 4g8a_A 78 LQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAH 157 (635)
T ss_dssp CCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCS
T ss_pred CCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeecccc
Confidence 99999999999987788999999999999999999987788999999999999999999987777899999999999999
Q ss_pred ccccc-CCCcccCCCCCCcEEEccCCcCCC
Q 003140 212 NNLTG-YLPPELSELPKLLILQLDNNNFEG 240 (845)
Q Consensus 212 N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~ 240 (845)
|++++ .+|..+..+++|++|+|++|++++
T Consensus 158 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~ 187 (635)
T 4g8a_A 158 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 187 (635)
T ss_dssp SCCCCCCCCGGGGGCTTCCEEECCSSCCCE
T ss_pred CccccCCCchhhccchhhhhhcccCccccc
Confidence 99986 467888999999999999998865
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.95 E-value=8.3e-28 Score=273.69 Aligned_cols=268 Identities=25% Similarity=0.337 Sum_probs=206.5
Q ss_pred ceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccc-------------hhhhccCCCCCCCCCC
Q 003140 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSL-------------ELLLLNGNELTGSLPE 148 (845)
Q Consensus 82 ~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L-------------~~L~Ls~N~l~~~~p~ 148 (845)
.+++.|+++++++ |.+|++|++|++|++|+|++|+++|.+|..++++++| ++|++++|.+++ +|.
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~ 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPE 88 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCS
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCC
Confidence 4789999999999 8999999999999999999999999999999999876 899999999995 555
Q ss_pred ccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCC
Q 003140 149 ELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKL 228 (845)
Q Consensus 149 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 228 (845)
. .++|++|+|++|++++ +|.. +++|++|++++|++++ ++.. .++|++|++++|++++ +| .++.+++|
T Consensus 89 ~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L 155 (454)
T 1jl5_A 89 L---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFL 155 (454)
T ss_dssp C---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTC
T ss_pred C---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCC
Confidence 2 3789999999999997 6654 4889999999999985 3322 2699999999999996 67 69999999
Q ss_pred cEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCc
Q 003140 229 LILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNK 308 (845)
Q Consensus 229 ~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~ 308 (845)
++|++++|++++ +|..+ .+|++|++++|++++.+ .+..+++|+.|++++|++++ +|... .+|+.|++++|+
T Consensus 156 ~~L~l~~N~l~~--lp~~~---~~L~~L~L~~n~l~~l~-~~~~l~~L~~L~l~~N~l~~-l~~~~--~~L~~L~l~~n~ 226 (454)
T 1jl5_A 156 KIIDVDNNSLKK--LPDLP---PSLEFIAAGNNQLEELP-ELQNLPFLTAIYADNNSLKK-LPDLP--LSLESIVAGNNI 226 (454)
T ss_dssp CEEECCSSCCSC--CCCCC---TTCCEEECCSSCCSSCC-CCTTCTTCCEEECCSSCCSS-CCCCC--TTCCEEECCSSC
T ss_pred CEEECCCCcCcc--cCCCc---ccccEEECcCCcCCcCc-cccCCCCCCEEECCCCcCCc-CCCCc--CcccEEECcCCc
Confidence 999999999985 55543 58999999999999854 79999999999999999995 55533 489999999999
Q ss_pred CCCCcccccCCCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCCCCCCCCcEEEecCCcccc
Q 003140 309 LTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCL 386 (845)
Q Consensus 309 l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~~~~~l~~l~l~~Np~~c 386 (845)
++ .+| .++.+++|++|++++|++++ +|.. ..+|+.|++++|+++++|.. .+.++.+++++|.+..
T Consensus 227 l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~--------~~~L~~L~l~~N~l~~l~~~--~~~L~~L~ls~N~l~~ 291 (454)
T 1jl5_A 227 LE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL--------PPSLEALNVRDNYLTDLPEL--PQSLTFLDVSENIFSG 291 (454)
T ss_dssp CS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC--------CTTCCEEECCSSCCSCCCCC--CTTCCEEECCSSCCSE
T ss_pred CC-ccc-ccCCCCCCCEEECCCCcCCc-cccc--------ccccCEEECCCCcccccCcc--cCcCCEEECcCCccCc
Confidence 99 667 49999999999999999985 5543 24677899999999888764 3778888888887654
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=6e-28 Score=283.37 Aligned_cols=285 Identities=26% Similarity=0.329 Sum_probs=231.2
Q ss_pred CCCCCCCCCCCCCCcceEecCCCCCC-CcceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccc
Q 003140 54 LSNWNRGDPCTSNWTGVLCFNTTMDD-GYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSL 132 (845)
Q Consensus 54 l~~W~~~~~c~~~w~Gv~C~~~~~~~-~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L 132 (845)
++.|....+|| .|.|..|....... ....++.|++++++|+ .+|..+. ++|++|+|++|+|+ .+|. .+++|
T Consensus 12 w~~W~~~~~~~-~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L 83 (622)
T 3g06_A 12 WSAWRRAAPAE-ESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPEL 83 (622)
T ss_dssp HHHHHHTCCGG-GHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTC
T ss_pred HHHHHhcCCcc-hhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCC
Confidence 45687666665 68764321100000 0124889999999999 7787776 89999999999999 5675 57899
Q ss_pred hhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeecccc
Q 003140 133 ELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNN 212 (845)
Q Consensus 133 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 212 (845)
++|+|++|+|+ .+|. .+++|++|+|++|+|++ +|. .+++|+.|++++|+|++ +|.. +++|++|+|++|
T Consensus 84 ~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N 151 (622)
T 3g06_A 84 RTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDN 151 (622)
T ss_dssp CEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSS
T ss_pred CEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCC
Confidence 99999999999 5676 77999999999999995 444 67899999999999995 5653 489999999999
Q ss_pred ccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCCcCCCC
Q 003140 213 NLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP 292 (845)
Q Consensus 213 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~ 292 (845)
++++ +|. .+++|+.|++++|++++ +| ..+++|+.|+|++|++++.+.. +++|+.|++++|.++ .+|.
T Consensus 152 ~l~~-l~~---~~~~L~~L~L~~N~l~~--l~---~~~~~L~~L~Ls~N~l~~l~~~---~~~L~~L~L~~N~l~-~l~~ 218 (622)
T 3g06_A 152 QLAS-LPA---LPSELCKLWAYNNQLTS--LP---MLPSGLQELSVSDNQLASLPTL---PSELYKLWAYNNRLT-SLPA 218 (622)
T ss_dssp CCSC-CCC---CCTTCCEEECCSSCCSC--CC---CCCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCS-SCCC
T ss_pred cCCC-cCC---ccCCCCEEECCCCCCCC--Cc---ccCCCCcEEECCCCCCCCCCCc---cchhhEEECcCCccc-ccCC
Confidence 9995 443 35789999999999985 55 5578999999999999986653 479999999999999 5665
Q ss_pred CCCccccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCCC-CC
Q 003140 293 GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NI 371 (845)
Q Consensus 293 ~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~-~~ 371 (845)
. ..+|+.|+|++|+|++ +| ..+++|+.|+|++|+|+ .+|. ..++|+.|+|++|+|+.+|..+ .+
T Consensus 219 ~--~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~--------~~~~L~~L~Ls~N~L~~lp~~l~~l 283 (622)
T 3g06_A 219 L--PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM--------LPSGLLSLSVYRNQLTRLPESLIHL 283 (622)
T ss_dssp C--CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC--------CCTTCCEEECCSSCCCSCCGGGGGS
T ss_pred C--CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc--------ccccCcEEeCCCCCCCcCCHHHhhc
Confidence 3 3589999999999996 55 56789999999999999 5665 2356789999999999999876 59
Q ss_pred CCCcEEEecCCcccc
Q 003140 372 PPNVTVRLRGNPFCL 386 (845)
Q Consensus 372 ~~l~~l~l~~Np~~c 386 (845)
+.+..|+|++|++..
T Consensus 284 ~~L~~L~L~~N~l~~ 298 (622)
T 3g06_A 284 SSETTVNLEGNPLSE 298 (622)
T ss_dssp CTTCEEECCSCCCCH
T ss_pred cccCEEEecCCCCCC
Confidence 999999999999874
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-27 Score=269.67 Aligned_cols=246 Identities=20% Similarity=0.240 Sum_probs=217.7
Q ss_pred eEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccc
Q 003140 85 RELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164 (845)
Q Consensus 85 ~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 164 (845)
..++..+.+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus 57 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n 133 (452)
T 3zyi_A 57 SKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133 (452)
T ss_dssp CEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred cEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence 46788888888 4666554 68999999999999988999999999999999999999888899999999999999999
Q ss_pred cccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccc-cccccCCCcccCCCCCCcEEEccCCcCCCCCC
Q 003140 165 YISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDN-NNLTGYLPPELSELPKLLILQLDNNNFEGTTI 243 (845)
Q Consensus 165 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~ 243 (845)
+|++..+..|.++++|++|+|++|+++...+..|..+++|++|+|++ |.+....+..|..+++|++|+|++|++++ +
T Consensus 134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~--~ 211 (452)
T 3zyi_A 134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD--M 211 (452)
T ss_dssp CCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS--C
T ss_pred cCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc--c
Confidence 99988888899999999999999999977777899999999999999 45554445579999999999999999985 3
Q ss_pred ccccccCCCccEEEcccCCCCCCCC-CCCCCCCccEEEcccccCCcCCCCCCCc-cccCEEEccCCcCCCCcccccCCCC
Q 003140 244 PASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLP 321 (845)
Q Consensus 244 p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~ip~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~ 321 (845)
| .+..+++|+.|+|++|++++..+ .+..+++|+.|+|++|++++..+..+.. .+|+.|+|++|+|++..+..|..++
T Consensus 212 ~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 290 (452)
T 3zyi_A 212 P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLR 290 (452)
T ss_dssp C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCT
T ss_pred c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcccc
Confidence 3 58899999999999999999766 4899999999999999999777765543 4899999999999988888889999
Q ss_pred CCCeEecccccCccc
Q 003140 322 RLQRLFIANNSLSGS 336 (845)
Q Consensus 322 ~L~~L~L~~N~l~~~ 336 (845)
+|+.|+|++|.+...
T Consensus 291 ~L~~L~L~~Np~~Cd 305 (452)
T 3zyi_A 291 YLVELHLHHNPWNCD 305 (452)
T ss_dssp TCCEEECCSSCEECS
T ss_pred CCCEEEccCCCcCCC
Confidence 999999999988743
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-26 Score=260.94 Aligned_cols=264 Identities=27% Similarity=0.316 Sum_probs=136.9
Q ss_pred ceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeec
Q 003140 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (845)
Q Consensus 82 ~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (845)
.+++.|++++|.+++ +|.. +++|++|+|++|++++ +|.. .++|++|+|++|++++ +| .|+++++|++|++
T Consensus 91 ~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l 160 (454)
T 1jl5_A 91 PHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDV 160 (454)
T ss_dssp TTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEEC
Confidence 356666776666665 4432 2556666666666553 2211 1456666666666663 45 3666666666666
Q ss_pred ccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCC
Q 003140 162 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT 241 (845)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 241 (845)
++|++++ +|..+ .+|++|++++|++++ +| .++.+++|++|++++|++++ +|... ++|++|++++|+++
T Consensus 161 ~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-- 228 (454)
T 1jl5_A 161 DNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-- 228 (454)
T ss_dssp CSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS--
T ss_pred CCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC--
Confidence 6666653 34322 356666666666654 34 35556666666666666553 23221 35556666666554
Q ss_pred CCccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCC--cccc---
Q 003140 242 TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGT--IPSN--- 316 (845)
Q Consensus 242 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~--~p~~--- 316 (845)
.+| .+..+++|++|++++|++++.+.. +++|+.|++++|++++ +|... .+|+.|++++|++++. +|..
T Consensus 229 ~lp-~~~~l~~L~~L~l~~N~l~~l~~~---~~~L~~L~l~~N~l~~-l~~~~--~~L~~L~ls~N~l~~l~~~~~~L~~ 301 (454)
T 1jl5_A 229 ELP-ELQNLPFLTTIYADNNLLKTLPDL---PPSLEALNVRDNYLTD-LPELP--QSLTFLDVSENIFSGLSELPPNLYY 301 (454)
T ss_dssp SCC-CCTTCTTCCEEECCSSCCSSCCSC---CTTCCEEECCSSCCSC-CCCCC--TTCCEEECCSSCCSEESCCCTTCCE
T ss_pred ccc-ccCCCCCCCEEECCCCcCCccccc---ccccCEEECCCCcccc-cCccc--CcCCEEECcCCccCcccCcCCcCCE
Confidence 234 255555666666666655553321 2455555555555553 33321 3455555555555441 1100
Q ss_pred ----------cCCC-CCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCCCCCCCCcEEEecCCccc
Q 003140 317 ----------FSGL-PRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 385 (845)
Q Consensus 317 ----------~~~l-~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~~~~~l~~l~l~~Np~~ 385 (845)
+..+ ++|++|++++|++++ +|.. .+.|+.|++++|+++.+|. .++.++.|++++|++.
T Consensus 302 L~l~~N~l~~i~~~~~~L~~L~Ls~N~l~~-lp~~--------~~~L~~L~L~~N~l~~lp~--~l~~L~~L~L~~N~l~ 370 (454)
T 1jl5_A 302 LNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPAL--------PPRLERLIASFNHLAEVPE--LPQNLKQLHVEYNPLR 370 (454)
T ss_dssp EECCSSCCSEECCCCTTCCEEECCSSCCSC-CCCC--------CTTCCEEECCSSCCSCCCC--CCTTCCEEECCSSCCS
T ss_pred EECcCCcCCcccCCcCcCCEEECCCCcccc-cccc--------CCcCCEEECCCCccccccc--hhhhccEEECCCCCCC
Confidence 1112 355555555555553 4432 1344566666666666555 3455666666666554
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.4e-27 Score=266.08 Aligned_cols=274 Identities=21% Similarity=0.177 Sum_probs=228.9
Q ss_pred ceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeec
Q 003140 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (845)
Q Consensus 82 ~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (845)
.+++.|+++++.+++. | .++.+++|++|+|++|++++. | ++++++|++|+|++|++++. | ++.+++|++|+|
T Consensus 42 ~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L 113 (457)
T 3bz5_A 42 ATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNC 113 (457)
T ss_dssp TTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEEC
T ss_pred CCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEEC
Confidence 4789999999999975 4 799999999999999999974 4 89999999999999999964 4 899999999999
Q ss_pred ccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCC
Q 003140 162 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT 241 (845)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 241 (845)
++|++++ +| +..+++|++|++++|++++. + ++.+++|++|++++|+..+.+ .+..+++|++|++++|++++
T Consensus 114 ~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~- 184 (457)
T 3bz5_A 114 DTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE- 184 (457)
T ss_dssp CSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-
T ss_pred CCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-
Confidence 9999997 44 89999999999999999974 3 889999999999999766666 58899999999999999986
Q ss_pred CCccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccCCCC
Q 003140 242 TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLP 321 (845)
Q Consensus 242 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~ 321 (845)
+| +..+++|+.|++++|++++. .+..+++|+.|++++|++++ +| .....+|+.|++++|++++..+..+..+.
T Consensus 185 -l~--l~~l~~L~~L~l~~N~l~~~--~l~~l~~L~~L~Ls~N~l~~-ip-~~~l~~L~~L~l~~N~l~~~~~~~l~~L~ 257 (457)
T 3bz5_A 185 -LD--VSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNKLTE-ID-VTPLTQLTYFDCSVNPLTELDVSTLSKLT 257 (457)
T ss_dssp -CC--CTTCTTCCEEECCSSCCSCC--CCTTCTTCSEEECCSSCCSC-CC-CTTCTTCSEEECCSSCCSCCCCTTCTTCC
T ss_pred -ec--cccCCCCCEEECcCCcCCee--ccccCCCCCEEECcCCcccc-cC-ccccCCCCEEEeeCCcCCCcCHHHCCCCC
Confidence 34 88999999999999999987 48899999999999999996 66 44456899999999999988766666655
Q ss_pred -------CCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCC-CCCCCC--------C-CCCCCcEEEecCCcc
Q 003140 322 -------RLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNL-TNISGS--------F-NIPPNVTVRLRGNPF 384 (845)
Q Consensus 322 -------~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l-~~i~~~--------~-~~~~l~~l~l~~Np~ 384 (845)
+|+.|++++|++.|.+|. . ..++|+.|++++|.+ ..+|.. + ..+.++.|++++|.+
T Consensus 258 ~L~l~~n~L~~L~l~~n~~~~~~~~--~-----~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l 330 (457)
T 3bz5_A 258 TLHCIQTDLLEIDLTHNTQLIYFQA--E-----GCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTEL 330 (457)
T ss_dssp EEECTTCCCSCCCCTTCTTCCEEEC--T-----TCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCC
T ss_pred EEeccCCCCCEEECCCCccCCcccc--c-----ccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCcc
Confidence 567777777877777763 2 235667888998864 223321 2 367788888888887
Q ss_pred cc
Q 003140 385 CL 386 (845)
Q Consensus 385 ~c 386 (845)
..
T Consensus 331 ~~ 332 (457)
T 3bz5_A 331 TE 332 (457)
T ss_dssp SC
T ss_pred cc
Confidence 54
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.3e-29 Score=288.82 Aligned_cols=185 Identities=18% Similarity=0.115 Sum_probs=129.8
Q ss_pred cccccCceEEEEEE-eCCCcEEEEEEccCCC----------hhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeEEEE
Q 003140 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGS----------LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 631 ~LG~G~fG~Vy~~~-~~~g~~vAVK~~~~~~----------~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV 698 (845)
..+.|++|.+..++ .--|+.+|||.+.... ....++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35667777666554 3358899999986431 12346799999999999 799999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
|||++||+|.++|...+ +++.. +|+.||+.||+|+|+++ ||||||||+|||+++++.+||+|||+|+.....
T Consensus 321 MEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999997643 45543 48899999999999999 999999999999999999999999999876432
Q ss_pred CCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~P 831 (845)
........||++|||||++.+ .+..++|+||+|++++++.++..|
T Consensus 393 -------~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 -------CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred -------CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 122345679999999999865 567789999999998877665443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.9e-27 Score=250.85 Aligned_cols=235 Identities=17% Similarity=0.267 Sum_probs=154.0
Q ss_pred cEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCC
Q 003140 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN 188 (845)
Q Consensus 109 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 188 (845)
++++.+++.++ .+|..+ .++|++|+|++|++++..+..|..+++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 67788888887 556544 357888888888887666667777778888888887777666777777777777777777
Q ss_pred C-CCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCC
Q 003140 189 S-ISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPM 267 (845)
Q Consensus 189 ~-l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 267 (845)
. +....|..+..+++|++|++++|++++..+..+..+++|++|+|++|++++ ..+..|.++++|+.|+|++|++++.+
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~ 169 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSVP 169 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccc-cCHhHhccCCCccEEECCCCcccccC
Confidence 6 665556666667777777777777666556666666666666666666654 23334555555555555555555443
Q ss_pred CC-CCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCChhhhhhcc
Q 003140 268 PD-LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRT 346 (845)
Q Consensus 268 ~~-l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~ 346 (845)
+. +..+++ |+.|+|++|++++..|..|..+++|+.|+|++|++++..+..+..
T Consensus 170 ~~~~~~l~~-----------------------L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~--- 223 (285)
T 1ozn_A 170 ERAFRGLHS-----------------------LDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAP--- 223 (285)
T ss_dssp TTTTTTCTT-----------------------CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTT---
T ss_pred HHHhcCccc-----------------------cCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHccc---
Confidence 32 334444 444444444444455666667777777777777777544443432
Q ss_pred CCCCcceEEEccCCCCCCCCCCCCCCCCcEEEecCCcccccCCCccccCCC
Q 003140 347 LNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSH 397 (845)
Q Consensus 347 l~~~~l~~L~ls~N~l~~i~~~~~~~~l~~l~l~~Np~~c~~~~~~~~~~~ 397 (845)
++.++.|++++|||.|+|...++..|.
T Consensus 224 ------------------------l~~L~~L~l~~N~~~c~~~~~~~~~~l 250 (285)
T 1ozn_A 224 ------------------------LRALQYLRLNDNPWVCDCRARPLWAWL 250 (285)
T ss_dssp ------------------------CTTCCEEECCSSCEECSGGGHHHHHHH
T ss_pred ------------------------CcccCEEeccCCCccCCCCcHHHHHHH
Confidence 456678888899999999887776554
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.8e-28 Score=266.40 Aligned_cols=273 Identities=18% Similarity=0.172 Sum_probs=217.5
Q ss_pred CCCCCcceEecCC--C---CC-CCcceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhh
Q 003140 63 CTSNWTGVLCFNT--T---MD-DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLL 136 (845)
Q Consensus 63 c~~~w~Gv~C~~~--~---~~-~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 136 (845)
|.|.|.|+ |... . .+ ....+++.|++++|++++..+..|..+++|++|+|++|++++..|..|.++++|++|+
T Consensus 28 ~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (353)
T 2z80_A 28 LSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLD 106 (353)
T ss_dssp CEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEE
Confidence 44468887 5422 1 11 2235899999999999987777999999999999999999988888999999999999
Q ss_pred ccCCCCCCCCCCccCCCCccceeecccccccCCCC-ccccCccCCCEEEccCCC-CCCCCccccCCCCCcceeecccccc
Q 003140 137 LNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLP-KSFANLNKTRHFHMNNNS-ISGQIPPELSRLPSLVHMLLDNNNL 214 (845)
Q Consensus 137 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~L~~N~l 214 (845)
|++|++++..+..|.++++|++|+|++|++++..+ ..+.++++|++|++++|+ +....+..+..+++|++|++++|++
T Consensus 107 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l 186 (353)
T 2z80_A 107 LSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL 186 (353)
T ss_dssp CCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred CCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCc
Confidence 99999996555559999999999999999995544 489999999999999994 7766678899999999999999999
Q ss_pred ccCCCcccCCCCCCcEEEccCCcCCCCCCcc-ccccCCCccEEEcccCCCCCCCCC----CCCCCCccEEEcccccCCcC
Q 003140 215 TGYLPPELSELPKLLILQLDNNNFEGTTIPA-SYSNMSKLLKLSLRNCSLQGPMPD----LSRIPNLGYLDLSSNQLNGS 289 (845)
Q Consensus 215 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~~~----l~~l~~L~~L~Ls~N~l~~~ 289 (845)
++..|..+..+++|++|++++|+++. +|. .+..+++|+.|++++|++++.... ......++.+++++|.+++.
T Consensus 187 ~~~~~~~l~~l~~L~~L~l~~n~l~~--~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~ 264 (353)
T 2z80_A 187 QSYEPKSLKSIQNVSHLILHMKQHIL--LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDE 264 (353)
T ss_dssp CEECTTTTTTCSEEEEEEEECSCSTT--HHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHH
T ss_pred CccCHHHHhccccCCeecCCCCcccc--chhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCc
Confidence 99999999999999999999999974 444 456689999999999999986543 33456778888888877642
Q ss_pred ----CCCCC-CccccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCC
Q 003140 290 ----IPPGR-LSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 338 (845)
Q Consensus 290 ----ip~~~-~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip 338 (845)
+|..+ ...+|+.|+|++|+|+...+..|..+++|++|+|++|++++..|
T Consensus 265 ~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 265 SLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp HHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred chhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 33322 22367777777777774333335777777777777777776554
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.3e-29 Score=268.28 Aligned_cols=226 Identities=19% Similarity=0.251 Sum_probs=148.3
Q ss_pred ccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCC-CCCCCCccC-------CCCccceeecccccccCCCCcc
Q 003140 102 IGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL-TGSLPEELG-------YLPKLDRIQIDQNYISGSLPKS 173 (845)
Q Consensus 102 l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l-~~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~p~~ 173 (845)
++..++|+.|++++|.+ .+|..+... |+.|+|++|++ .+.+|..+. ++++|++|+|++|++++.+|..
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 45566778888888888 677766654 88888888887 345666555 6788888888888888777776
Q ss_pred c--cCccCCCEEEccCCCCCCCCccccCCC-----CCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCC-CCcc
Q 003140 174 F--ANLNKTRHFHMNNNSISGQIPPELSRL-----PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT-TIPA 245 (845)
Q Consensus 174 ~--~~l~~L~~L~L~~N~l~~~~p~~l~~l-----~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-~~p~ 245 (845)
+ ..+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..|..|+.+++|++|+|++|++.+. ..+.
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 193 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence 5 7788888888888888766 6666666 7788888888888777777777788888888888876541 1233
Q ss_pred cc--ccCCCccEEEcccCCCCCCCC---C-CCCCCCccEEEcccccCCcCCCCCCC--ccccCEEEccCCcCCCCccccc
Q 003140 246 SY--SNMSKLLKLSLRNCSLQGPMP---D-LSRIPNLGYLDLSSNQLNGSIPPGRL--SLNITTIKLSNNKLTGTIPSNF 317 (845)
Q Consensus 246 ~~--~~l~~L~~L~Ls~N~l~~~~~---~-l~~l~~L~~L~Ls~N~l~~~ip~~~~--~~~L~~L~Ls~N~l~~~~p~~~ 317 (845)
.+ .++++|++|+|++|++++.+. . +..+++|+.|++++|++++.+|.... ..+|+.|+|++|+|+ .+|..+
T Consensus 194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~ 272 (312)
T 1wwl_A 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL 272 (312)
T ss_dssp HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSC
T ss_pred HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhc
Confidence 33 667777777777777764221 1 34556666666666666655432211 234555555555555 344433
Q ss_pred CCCCCCCeEecccccCcc
Q 003140 318 SGLPRLQRLFIANNSLSG 335 (845)
Q Consensus 318 ~~l~~L~~L~L~~N~l~~ 335 (845)
. ++|++|+|++|+|++
T Consensus 273 ~--~~L~~L~Ls~N~l~~ 288 (312)
T 1wwl_A 273 P--AKLSVLDLSYNRLDR 288 (312)
T ss_dssp C--SEEEEEECCSSCCCS
T ss_pred c--CCceEEECCCCCCCC
Confidence 3 445555555555543
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.7e-28 Score=279.25 Aligned_cols=230 Identities=24% Similarity=0.214 Sum_probs=190.0
Q ss_pred ccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCC
Q 003140 102 IGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTR 181 (845)
Q Consensus 102 l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 181 (845)
...+++|++|+|++|.+++..|..|.++++|++|+|++|.+++..| +..+++|++|+|++|.|++..+ .++|+
T Consensus 30 ~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~ 102 (487)
T 3oja_A 30 RQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIE 102 (487)
T ss_dssp STTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCC
T ss_pred cccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcC
Confidence 3344589999999999998888899999999999999999987665 8999999999999999985432 38999
Q ss_pred EEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccc-cCCCccEEEccc
Q 003140 182 HFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYS-NMSKLLKLSLRN 260 (845)
Q Consensus 182 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~-~l~~L~~L~Ls~ 260 (845)
.|++++|.|++..+. .+++|+.|+|++|++++..|..++.+++|++|+|++|.+++ ..|..+. .+++|+.|+|++
T Consensus 103 ~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~l~~~l~~L~~L~Ls~ 178 (487)
T 3oja_A 103 TLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT-VNFAELAASSDTLEHLNLQY 178 (487)
T ss_dssp EEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCE-EEGGGGGGGTTTCCEEECTT
T ss_pred EEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCC-cChHHHhhhCCcccEEecCC
Confidence 999999999866543 45789999999999998888889999999999999999987 4666665 789999999999
Q ss_pred CCCCCCCCCCCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccCCCCCCCeEecccccCc-ccCCh
Q 003140 261 CSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS-GSIPS 339 (845)
Q Consensus 261 N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~ip~ 339 (845)
|.+++.++ +..+++|+.|+|++|.|++..|......+|+.|+|++|.|++ +|..+..+++|+.|++++|.+. +.+|.
T Consensus 179 N~l~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~ 256 (487)
T 3oja_A 179 NFIYDVKG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRD 256 (487)
T ss_dssp SCCCEEEC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHH
T ss_pred Cccccccc-cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHH
Confidence 99988744 446889999999999998765554444589999999999985 6777888899999999999887 56666
Q ss_pred hhhhh
Q 003140 340 SIWQS 344 (845)
Q Consensus 340 ~l~~l 344 (845)
.+..+
T Consensus 257 ~~~~l 261 (487)
T 3oja_A 257 FFSKN 261 (487)
T ss_dssp HHTTC
T ss_pred HHHhC
Confidence 55443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=8e-28 Score=261.12 Aligned_cols=258 Identities=22% Similarity=0.204 Sum_probs=209.1
Q ss_pred eEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecc
Q 003140 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162 (845)
Q Consensus 83 ~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 162 (845)
++..++++++++...+...+..+++|++|+|++|++++..|..|.++++|++|+|++|++++..+ +..+++|++|+|+
T Consensus 11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls 88 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN 88 (317)
T ss_dssp EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence 45666777777776555566778899999999999998888899999999999999999986554 8999999999999
Q ss_pred cccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCC
Q 003140 163 QNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTT 242 (845)
Q Consensus 163 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 242 (845)
+|++++.. ..++|++|++++|++++..+. .+++|++|++++|++++..+..+..+++|++|+|++|++++ .
T Consensus 89 ~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~ 159 (317)
T 3o53_A 89 NNYVQELL-----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT-V 159 (317)
T ss_dssp SSEEEEEE-----ECTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCE-E
T ss_pred CCcccccc-----CCCCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCc-c
Confidence 99998433 348999999999999865443 36789999999999998878888899999999999999986 3
Q ss_pred Ccccc-ccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccCCCC
Q 003140 243 IPASY-SNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLP 321 (845)
Q Consensus 243 ~p~~~-~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~ 321 (845)
.+..+ ..+++|++|+|++|++++.+ ....+++|+.|++++|++++..+......+|+.|+|++|+|+ .+|..+..++
T Consensus 160 ~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~ 237 (317)
T 3o53_A 160 NFAELAASSDTLEHLNLQYNFIYDVK-GQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQ 237 (317)
T ss_dssp EGGGGGGGTTTCCEEECTTSCCCEEE-CCCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC-EECTTCCCCT
T ss_pred cHHHHhhccCcCCEEECCCCcCcccc-cccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCccc-chhhHhhcCC
Confidence 45555 57899999999999998874 344588999999999999965454334458999999999998 5688889999
Q ss_pred CCCeEecccccCc-ccCChhhhhhccCCCCcceEEEcc
Q 003140 322 RLQRLFIANNSLS-GSIPSSIWQSRTLNATETFILDFQ 358 (845)
Q Consensus 322 ~L~~L~L~~N~l~-~~ip~~l~~l~~l~~~~l~~L~ls 358 (845)
+|+.|+|++|+++ +.+|..+..+.. |+.|+++
T Consensus 238 ~L~~L~l~~N~~~~~~~~~~~~~~~~-----L~~l~l~ 270 (317)
T 3o53_A 238 NLEHFDLRGNGFHCGTLRDFFSKNQR-----VQTVAKQ 270 (317)
T ss_dssp TCCEEECTTCCCBHHHHHHHHHTCHH-----HHHHHHH
T ss_pred CCCEEEccCCCccCcCHHHHHhcccc-----ceEEECC
Confidence 9999999999998 666776665443 3355555
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.4e-26 Score=240.48 Aligned_cols=228 Identities=20% Similarity=0.252 Sum_probs=147.0
Q ss_pred EEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccc
Q 003140 87 LQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYI 166 (845)
Q Consensus 87 L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 166 (845)
++..+.++. .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++
T Consensus 12 ~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 88 (276)
T 2z62_A 12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88 (276)
T ss_dssp EECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCcc
Confidence 455555555 3454443 4677777777777766666777777777777777777765566677777777777777777
Q ss_pred cCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccC-CCcccCCCCCCcEEEccCCcCCCCCCcc
Q 003140 167 SGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGY-LPPELSELPKLLILQLDNNNFEGTTIPA 245 (845)
Q Consensus 167 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~~p~ 245 (845)
++..+..|.++++|++|++++|++++..+..+..+++|++|++++|++++. +|..+..+++|++|+|++|++++ ..+.
T Consensus 89 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~-~~~~ 167 (276)
T 2z62_A 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS-IYCT 167 (276)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCE-ECGG
T ss_pred CccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCc-CCHH
Confidence 766666666667777777766666655554566666666666666666542 35555555555555555555554 2333
Q ss_pred ccccCCCccEEEcccCCCCCCCCCCCCCCCcc-EEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccCCCCCCC
Q 003140 246 SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLG-YLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQ 324 (845)
Q Consensus 246 ~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~-~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 324 (845)
.+..+++|+ .|. .|++++|.+++..+..+...+|+.|+|++|++++..+..|..+++|+
T Consensus 168 ~~~~l~~L~--------------------~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 227 (276)
T 2z62_A 168 DLRVLHQMP--------------------LLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQ 227 (276)
T ss_dssp GGHHHHTCT--------------------TCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCC
T ss_pred Hhhhhhhcc--------------------ccceeeecCCCcccccCccccCCCcccEEECCCCceeecCHhHhccccccc
Confidence 444443333 222 56666666664444444444677777777777766667788899999
Q ss_pred eEecccccCcccCC
Q 003140 325 RLFIANNSLSGSIP 338 (845)
Q Consensus 325 ~L~L~~N~l~~~ip 338 (845)
.|+|++|++++..|
T Consensus 228 ~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 228 KIWLHTNPWDCSCP 241 (276)
T ss_dssp EEECCSSCBCCCTT
T ss_pred EEEccCCcccccCC
Confidence 99999999997665
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-25 Score=235.39 Aligned_cols=213 Identities=21% Similarity=0.272 Sum_probs=173.6
Q ss_pred CCcceEecCCCCCCCcceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCC
Q 003140 66 NWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGS 145 (845)
Q Consensus 66 ~w~Gv~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 145 (845)
.|.|+.|.... ..+.+++++++++. +|..+. ++|++|+|++|++++..+..|.++++|++|+|++|+++..
T Consensus 6 ~~~~~~C~c~~------~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i 76 (270)
T 2o6q_A 6 KKDGGVCSCNN------NKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTL 76 (270)
T ss_dssp GGGTCSBEEET------TTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCC
T ss_pred CCCCCCCEeCC------CCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCee
Confidence 59999985431 35679999999984 666554 6799999999999977777899999999999999999866
Q ss_pred CCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCC
Q 003140 146 LPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSEL 225 (845)
Q Consensus 146 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l 225 (845)
.+..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+
T Consensus 77 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 156 (270)
T 2o6q_A 77 PAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKL 156 (270)
T ss_dssp CTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred ChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCC
Confidence 66667889999999999999987777788888999999999999987777778888889999999888887666668888
Q ss_pred CCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCCC-CCCCCCccEEEcccccCCc
Q 003140 226 PKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNG 288 (845)
Q Consensus 226 ~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~ 288 (845)
++|++|+|++|++++ ..+..|.++++|+.|+|++|++++.++. +..+++|+.|+|++|.+..
T Consensus 157 ~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 219 (270)
T 2o6q_A 157 TSLKELRLYNNQLKR-VPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC 219 (270)
T ss_dssp TTCCEEECCSSCCSC-CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred cccceeEecCCcCcE-eChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence 888888888888876 4555678888888888888888877664 6777788888888887764
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-25 Score=238.42 Aligned_cols=218 Identities=22% Similarity=0.253 Sum_probs=131.2
Q ss_pred cCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCc
Q 003140 150 LGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLL 229 (845)
Q Consensus 150 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 229 (845)
+.++++|+++++++|.++ .+|..+. ++|+.|+|++|.+++..+..+..+++|++|+|++|++++..+ ...+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcCC
Confidence 455666777777777776 4444433 466666666666665555666666666666666666664322 24556666
Q ss_pred EEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCCC-CCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCc
Q 003140 230 ILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNK 308 (845)
Q Consensus 230 ~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~ 308 (845)
+|+|++|+++ .+|..+..+++|+.|+|++|++++.++. |..+++|+.|+|++|+++
T Consensus 81 ~L~Ls~N~l~--~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~--------------------- 137 (290)
T 1p9a_G 81 TLDLSHNQLQ--SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK--------------------- 137 (290)
T ss_dssp EEECCSSCCS--SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCC---------------------
T ss_pred EEECCCCcCC--cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCC---------------------
Confidence 6666666665 3455555555666666666655555442 555555555555555554
Q ss_pred CCCCcccccCCCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCCC-CCCCCcEEEecCCccccc
Q 003140 309 LTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFCLN 387 (845)
Q Consensus 309 l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~-~~~~l~~l~l~~Np~~c~ 387 (845)
+..+..|..+++|+.|+|++|+|++..+..+..+ ++|+.|+|++|+|+.+|..+ ..+.+..++|++|||.|+
T Consensus 138 --~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l-----~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 138 --TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGL-----ENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp --CCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTC-----TTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred --ccChhhcccccCCCEEECCCCcCCccCHHHhcCc-----CCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCc
Confidence 4444445556666666666666653222223322 23446666666666666654 466788999999999999
Q ss_pred CCCccccCCCCCCCc
Q 003140 388 TNAEQFCGSHSDDDN 402 (845)
Q Consensus 388 ~~~~~~~~~~~~~~~ 402 (845)
|++.+|..|...+..
T Consensus 211 c~~~~l~~wl~~~~~ 225 (290)
T 1p9a_G 211 CEILYFRRWLQDNAE 225 (290)
T ss_dssp GGGHHHHHHHHHTGG
T ss_pred CccHHHHHHHHhCcc
Confidence 999888877654433
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-27 Score=258.09 Aligned_cols=244 Identities=20% Similarity=0.213 Sum_probs=213.3
Q ss_pred ceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeec
Q 003140 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (845)
Q Consensus 82 ~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (845)
.+++.|+|++|.+++..+..|..+++|++|+|++|++++..+ +..+++|++|+|++|++++. + ..++|++|++
T Consensus 34 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l-~----~~~~L~~L~l 106 (317)
T 3o53_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQEL-L----VGPSIETLHA 106 (317)
T ss_dssp GGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEE-E----ECTTCCEEEC
T ss_pred CCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccccc-c----CCCCcCEEEC
Confidence 479999999999999888899999999999999999997554 99999999999999999843 3 3489999999
Q ss_pred ccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccC-CCCCCcEEEccCCcCCC
Q 003140 162 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELS-ELPKLLILQLDNNNFEG 240 (845)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~ 240 (845)
++|++++..+.. +++|+.|++++|++++..+..+..+++|++|+|++|++++..+..+. .+++|++|+|++|++++
T Consensus 107 ~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~ 183 (317)
T 3o53_A 107 ANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD 183 (317)
T ss_dssp CSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE
T ss_pred CCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcc
Confidence 999999765544 57899999999999988788999999999999999999988777774 78999999999999985
Q ss_pred CCCccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCCcCCCCCC-CccccCEEEccCCcCC-CCcccccC
Q 003140 241 TTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGR-LSLNITTIKLSNNKLT-GTIPSNFS 318 (845)
Q Consensus 241 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~-~~~~L~~L~Ls~N~l~-~~~p~~~~ 318 (845)
. + ....+++|++|+|++|++++.++.+..+++|+.|++++|+++ .+|..+ ...+|+.|+|++|.++ +.+|..+.
T Consensus 184 ~--~-~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~ 259 (317)
T 3o53_A 184 V--K-GQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259 (317)
T ss_dssp E--E-CCCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHH
T ss_pred c--c-cccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHh
Confidence 3 3 344589999999999999998888999999999999999999 456554 3459999999999999 88899999
Q ss_pred CCCCCCeEecc-cccCcccCCh
Q 003140 319 GLPRLQRLFIA-NNSLSGSIPS 339 (845)
Q Consensus 319 ~l~~L~~L~L~-~N~l~~~ip~ 339 (845)
.+++|+.|+++ .+.++|..|.
T Consensus 260 ~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 260 KNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp TCHHHHHHHHHHHHHHHSSSSC
T ss_pred ccccceEEECCCchhccCCchh
Confidence 99999999999 4456665554
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=8e-27 Score=268.13 Aligned_cols=235 Identities=21% Similarity=0.213 Sum_probs=209.7
Q ss_pred cceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceee
Q 003140 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (845)
Q Consensus 81 ~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (845)
..+++.|+|++|.+++..|..|+.+++|++|+|++|.+++..| |..+++|++|+|++|.|++.. ..++|++|+
T Consensus 33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L~ 105 (487)
T 3oja_A 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLH 105 (487)
T ss_dssp GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----ECTTCCEEE
T ss_pred CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----CCCCcCEEE
Confidence 3479999999999999888899999999999999999997665 999999999999999998533 338999999
Q ss_pred cccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccC-CCCCCcEEEccCCcCC
Q 003140 161 IDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELS-ELPKLLILQLDNNNFE 239 (845)
Q Consensus 161 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~ 239 (845)
|++|.|++..+. .+++|+.|+|++|.+++..|..++.+++|++|+|++|.+++..|..+. .+++|++|+|++|.++
T Consensus 106 L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~ 182 (487)
T 3oja_A 106 AANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182 (487)
T ss_dssp CCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC
T ss_pred CcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccc
Confidence 999999976664 357899999999999998899999999999999999999998888886 7999999999999998
Q ss_pred CCCCccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCCcCCCCCC-CccccCEEEccCCcCC-CCccccc
Q 003140 240 GTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGR-LSLNITTIKLSNNKLT-GTIPSNF 317 (845)
Q Consensus 240 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~-~~~~L~~L~Ls~N~l~-~~~p~~~ 317 (845)
+. ..+..+++|+.|+|++|++++.++.+..+++|+.|+|++|.|++ +|..+ ...+|+.|+|++|.+. +.+|..+
T Consensus 183 ~~---~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~ 258 (487)
T 3oja_A 183 DV---KGQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFF 258 (487)
T ss_dssp EE---ECCCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHH
T ss_pred cc---cccccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHH
Confidence 63 33456999999999999999998889999999999999999996 55544 3458999999999998 7888999
Q ss_pred CCCCCCCeEecc
Q 003140 318 SGLPRLQRLFIA 329 (845)
Q Consensus 318 ~~l~~L~~L~L~ 329 (845)
..++.|+.|+++
T Consensus 259 ~~l~~L~~l~~~ 270 (487)
T 3oja_A 259 SKNQRVQTVAKQ 270 (487)
T ss_dssp TTCHHHHHHHHH
T ss_pred HhCCCCcEEecc
Confidence 999999988886
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-25 Score=235.32 Aligned_cols=229 Identities=20% Similarity=0.235 Sum_probs=191.2
Q ss_pred CCCCCCCc--ceEecCCCC---CC-CcceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchh
Q 003140 61 DPCTSNWT--GVLCFNTTM---DD-GYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLEL 134 (845)
Q Consensus 61 ~~c~~~w~--Gv~C~~~~~---~~-~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 134 (845)
|+|.+.+. .+.|.+... +. ....++.|++++|++++..+..|..+++|++|+|++|++++..+..|.++++|++
T Consensus 1 ~~C~~~~~~~~~~c~~~~l~~ip~~l~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 80 (276)
T 2z62_A 1 EPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLST 80 (276)
T ss_dssp CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCE
T ss_pred CCceeccCCceEEecCCCccccCCCCCCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCE
Confidence 45644444 477865432 12 2356999999999999888889999999999999999999877888999999999
Q ss_pred hhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCC-CccccCCCCCcceeeccccc
Q 003140 135 LLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQ-IPPELSRLPSLVHMLLDNNN 213 (845)
Q Consensus 135 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~L~~N~ 213 (845)
|+|++|++++..+..|.++++|++|++++|++++..+..+.++++|++|++++|++++. +|..+..+++|++|+|++|+
T Consensus 81 L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~ 160 (276)
T 2z62_A 81 LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK 160 (276)
T ss_dssp EECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSC
T ss_pred EECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCC
Confidence 99999999988889999999999999999999988787899999999999999999864 69999999999999999999
Q ss_pred cccCCCcccCCCCCCc----EEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCCC-CCCCCCccEEEcccccCCc
Q 003140 214 LTGYLPPELSELPKLL----ILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNG 288 (845)
Q Consensus 214 l~~~~p~~l~~l~~L~----~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~ 288 (845)
+++..+..+..+++|+ .|++++|++++ ++.......+|+.|+|++|++++.++. +..+++|+.|++++|++++
T Consensus 161 l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~--~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c 238 (276)
T 2z62_A 161 IQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF--IQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 238 (276)
T ss_dssp CCEECGGGGHHHHTCTTCCEEEECCSSCCCE--ECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCC
T ss_pred CCcCCHHHhhhhhhccccceeeecCCCcccc--cCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccc
Confidence 9988777777777776 88999999975 333333445788888888888887765 5778888888888888775
Q ss_pred CCC
Q 003140 289 SIP 291 (845)
Q Consensus 289 ~ip 291 (845)
..+
T Consensus 239 ~c~ 241 (276)
T 2z62_A 239 SCP 241 (276)
T ss_dssp CTT
T ss_pred cCC
Confidence 443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-26 Score=267.45 Aligned_cols=191 Identities=14% Similarity=0.184 Sum_probs=146.8
Q ss_pred CCCccccccCceEEEEEEeCCCcEEEEEEccCCChh--------hHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEE
Q 003140 627 NSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 627 ~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~--------~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
...+.||+|+||.||+|.. .++.+++|+....... ..+++.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 5788899876432211 134689999999999999999666666677778999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
|||+++|+|.++++. +..++.|+++||+|||+++ |+||||||+|||++. .+||+|||+|+.....
T Consensus 418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 999999999999965 4579999999999999998 999999999999999 9999999999876432
Q ss_pred CCCCccccceeecccCCCCccchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPIS 833 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltG~~Pf~ 833 (845)
...............||+.|||||++.. ..|+.++|+||..+-..+-+.++.+|.
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 1000000001235679999999999986 668888999999999999998887774
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.8e-24 Score=233.94 Aligned_cols=224 Identities=18% Similarity=0.200 Sum_probs=181.1
Q ss_pred CCccEEEecCCCCCCCCcc---cccccccchhhhccCCCCCCCCCCcc--CCCCccceeecccccccCCCC----ccccC
Q 003140 106 SYLTILDFMWNKISGSIPK---EIGNIKSLELLLLNGNELTGSLPEEL--GYLPKLDRIQIDQNYISGSLP----KSFAN 176 (845)
Q Consensus 106 ~~L~~L~L~~N~l~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p----~~~~~ 176 (845)
..++.|.+.++.++...-. .+..+++|++|+|++|++++..|..+ ..+++|++|+|++|.+++..+ ..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 3578899988887631111 12345679999999999999999988 899999999999999997655 44568
Q ss_pred ccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccC--C--CcccCCCCCCcEEEccCCcCCCCCCcc----ccc
Q 003140 177 LNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGY--L--PPELSELPKLLILQLDNNNFEGTTIPA----SYS 248 (845)
Q Consensus 177 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~--~--p~~l~~l~~L~~L~Ls~N~l~~~~~p~----~~~ 248 (845)
+++|++|+|++|++++..+..++.+++|++|+|++|++.+. + +..+..+++|++|+|++|+++. ++. .+.
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~--l~~~~~~l~~ 221 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET--PTGVCAALAA 221 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC--HHHHHHHHHH
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc--hHHHHHHHHh
Confidence 99999999999999988889999999999999999998752 2 2234788999999999999973 333 357
Q ss_pred cCCCccEEEcccCCCCCCC-CCCCCC---CCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccCCCCCCC
Q 003140 249 NMSKLLKLSLRNCSLQGPM-PDLSRI---PNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQ 324 (845)
Q Consensus 249 ~l~~L~~L~Ls~N~l~~~~-~~l~~l---~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 324 (845)
++++|++|+|++|++++.. +.+..+ ++|++|+|++|+|+ .+|.... .+|+.|+|++|+|++. |. +..+++|+
T Consensus 222 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~-~~L~~L~Ls~N~l~~~-~~-~~~l~~L~ 297 (310)
T 4glp_A 222 AGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP-AKLRVLDLSSNRLNRA-PQ-PDELPEVD 297 (310)
T ss_dssp HTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC-SCCSCEECCSCCCCSC-CC-TTSCCCCS
T ss_pred cCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc-CCCCEEECCCCcCCCC-ch-hhhCCCcc
Confidence 8899999999999999974 445554 79999999999999 7777665 6899999999999865 33 67788888
Q ss_pred eEecccccCcc
Q 003140 325 RLFIANNSLSG 335 (845)
Q Consensus 325 ~L~L~~N~l~~ 335 (845)
.|+|++|+++.
T Consensus 298 ~L~L~~N~l~~ 308 (310)
T 4glp_A 298 NLTLDGNPFLV 308 (310)
T ss_dssp CEECSSTTTSC
T ss_pred EEECcCCCCCC
Confidence 88888888873
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.91 E-value=3.9e-28 Score=277.72 Aligned_cols=304 Identities=17% Similarity=0.161 Sum_probs=211.2
Q ss_pred eEeEEEecCCCCcccCCCCc-cCCC----CccEEEecCCCCCC----CCcccccccccchhhhccCCCCCCCCCCcc---
Q 003140 83 HLRELQLLNLNLSGNLSPEI-GRLS----YLTILDFMWNKISG----SIPKEIGNIKSLELLLLNGNELTGSLPEEL--- 150 (845)
Q Consensus 83 ~v~~L~L~~~~l~~~~~~~l-~~L~----~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~--- 150 (845)
+++.|+|++|.+++..+..+ ..++ +|++|+|++|+++. .++..+.++++|++|+|++|.+++..+..+
T Consensus 57 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~ 136 (461)
T 1z7x_W 57 ALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEG 136 (461)
T ss_dssp TCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHH
T ss_pred CcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHH
Confidence 57788888887765433332 2244 58888888888774 457777788888888888888764333322
Q ss_pred --CCCCccceeecccccccCC----CCccccCccCCCEEEccCCCCCCCCccccC-----CCCCcceeeccccccccC--
Q 003140 151 --GYLPKLDRIQIDQNYISGS----LPKSFANLNKTRHFHMNNNSISGQIPPELS-----RLPSLVHMLLDNNNLTGY-- 217 (845)
Q Consensus 151 --~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~-----~l~~L~~L~L~~N~l~~~-- 217 (845)
...++|++|+|++|++++. ++..+..+++|++|++++|.++...+..+. ..++|++|+|++|++++.
T Consensus 137 l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~ 216 (461)
T 1z7x_W 137 LLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNC 216 (461)
T ss_dssp HTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHH
T ss_pred HhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHH
Confidence 2245788888888887753 355566678888888888887644333332 256888888888888753
Q ss_pred --CCcccCCCCCCcEEEccCCcCCCCCC----ccccccCCCccEEEcccCCCCCC-----CCCCCCCCCccEEEcccccC
Q 003140 218 --LPPELSELPKLLILQLDNNNFEGTTI----PASYSNMSKLLKLSLRNCSLQGP-----MPDLSRIPNLGYLDLSSNQL 286 (845)
Q Consensus 218 --~p~~l~~l~~L~~L~Ls~N~l~~~~~----p~~~~~l~~L~~L~Ls~N~l~~~-----~~~l~~l~~L~~L~Ls~N~l 286 (845)
++..+..+++|++|+|++|++++... +..+..+++|++|++++|+++.. +..+..+++|+.|++++|.+
T Consensus 217 ~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i 296 (461)
T 1z7x_W 217 RDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNEL 296 (461)
T ss_dssp HHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCC
T ss_pred HHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCC
Confidence 45666777888888888888764211 22233578888888888888763 33356678888899988888
Q ss_pred CcCCCCCCC------ccccCEEEccCCcCCCC----cccccCCCCCCCeEecccccCcccCChhhhhhccCCCCcceEEE
Q 003140 287 NGSIPPGRL------SLNITTIKLSNNKLTGT----IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILD 356 (845)
Q Consensus 287 ~~~ip~~~~------~~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ 356 (845)
++..+.... ..+|+.|+|++|.+++. ++..+..+++|++|+|++|++++..+..+.....-..+.|+.|+
T Consensus 297 ~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~ 376 (461)
T 1z7x_W 297 GDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLW 376 (461)
T ss_dssp HHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEE
T ss_pred chHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEE
Confidence 644332211 13789999999988865 56677778999999999999887766666543222245778999
Q ss_pred ccCCCCC-----CCCCCC-CCCCCcEEEecCCcccc
Q 003140 357 FQNNNLT-----NISGSF-NIPPNVTVRLRGNPFCL 386 (845)
Q Consensus 357 ls~N~l~-----~i~~~~-~~~~l~~l~l~~Np~~c 386 (845)
+++|+++ .++..+ .++.++.|++++|++..
T Consensus 377 L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~ 412 (461)
T 1z7x_W 377 LADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 412 (461)
T ss_dssp CTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred CCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCH
Confidence 9999988 455554 47889999999998754
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.8e-24 Score=229.30 Aligned_cols=211 Identities=19% Similarity=0.232 Sum_probs=118.6
Q ss_pred ccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCC
Q 003140 102 IGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTR 181 (845)
Q Consensus 102 l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 181 (845)
+..+++|+.|++++|.++. ++ .+..+++|++|+|++|++++ + ..+..+++|++|+|++|.+++..+..|.++++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-~~-~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 112 (272)
T 3rfs_A 37 QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLK 112 (272)
T ss_dssp HHHHTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred cccccceeeeeeCCCCccc-cc-ccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCC
Confidence 3445556666666666552 22 35556666666666666553 2 2455556666666666666555555555555666
Q ss_pred EEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccC
Q 003140 182 HFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261 (845)
Q Consensus 182 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N 261 (845)
+|+|++|++++..+..+..+++|++|+|++|++++..+..+..+++|++|+|++|++++ ..+..+.++++|+.|+|++|
T Consensus 113 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~L~~N 191 (272)
T 3rfs_A 113 ELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQN 191 (272)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSS
T ss_pred EEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCc-cCHHHhcCCccCCEEECCCC
Confidence 66666665554444455555555555555555554444445555555555555555554 23334455555555555555
Q ss_pred CCCCCCCC-CCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCChh
Q 003140 262 SLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSS 340 (845)
Q Consensus 262 ~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~ 340 (845)
++++.++. +..+++|+.|++++|.+ .+ .+++|++|+++.|+++|.+|.+
T Consensus 192 ~l~~~~~~~~~~l~~L~~L~l~~N~~-----------------------~~-------~~~~l~~l~~~~n~~~g~ip~~ 241 (272)
T 3rfs_A 192 QLKSVPDGVFDRLTSLQYIWLHDNPW-----------------------DC-------TCPGIRYLSEWINKHSGVVRNS 241 (272)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCB-----------------------CC-------CTTTTHHHHHHHHHTGGGBBCT
T ss_pred cCCccCHHHHhCCcCCCEEEccCCCc-----------------------cc-------cCcHHHHHHHHHHhCCCcccCc
Confidence 55554443 44445555555444444 42 2446777788888888888877
Q ss_pred hhhhccC
Q 003140 341 IWQSRTL 347 (845)
Q Consensus 341 l~~l~~l 347 (845)
++.+...
T Consensus 242 ~~~~~~~ 248 (272)
T 3rfs_A 242 AGSVAPD 248 (272)
T ss_dssp TSCBCGG
T ss_pred ccccCCC
Confidence 7665543
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.8e-23 Score=241.82 Aligned_cols=240 Identities=25% Similarity=0.320 Sum_probs=199.4
Q ss_pred ceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeec
Q 003140 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (845)
Q Consensus 82 ~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (845)
.+++.|+|++|+|+ .+|. .+++|++|+|++|+|+ .+|. .+++|++|+|++|++++ +|. .+++|+.|+|
T Consensus 61 ~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L 128 (622)
T 3g06_A 61 AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWI 128 (622)
T ss_dssp TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEEC
T ss_pred CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEEC
Confidence 57999999999999 4555 5799999999999999 5675 67899999999999994 555 6789999999
Q ss_pred ccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCC
Q 003140 162 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT 241 (845)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 241 (845)
++|+|++ +|.. +++|++|+|++|++++ +|. .+++|+.|++++|++++ +| ..+++|+.|+|++|++++
T Consensus 129 ~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~- 195 (622)
T 3g06_A 129 FGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS- 195 (622)
T ss_dssp CSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-
T ss_pred CCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-
Confidence 9999995 5554 4899999999999995 454 35789999999999995 55 457899999999999985
Q ss_pred CCccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccCCCC
Q 003140 242 TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLP 321 (845)
Q Consensus 242 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~ 321 (845)
+|.. +++|+.|++++|.++..+.. +++|+.|++++|.|++ +|. ...+|+.|+|++|+|+. +|. .++
T Consensus 196 -l~~~---~~~L~~L~L~~N~l~~l~~~---~~~L~~L~Ls~N~L~~-lp~--~l~~L~~L~Ls~N~L~~-lp~---~~~ 261 (622)
T 3g06_A 196 -LPTL---PSELYKLWAYNNRLTSLPAL---PSGLKELIVSGNRLTS-LPV--LPSELKELMVSGNRLTS-LPM---LPS 261 (622)
T ss_dssp -CCCC---CTTCCEEECCSSCCSSCCCC---CTTCCEEECCSSCCSC-CCC--CCTTCCEEECCSSCCSC-CCC---CCT
T ss_pred -CCCc---cchhhEEECcCCcccccCCC---CCCCCEEEccCCccCc-CCC--CCCcCcEEECCCCCCCc-CCc---ccc
Confidence 4443 47899999999999976643 4789999999999995 662 33589999999999994 555 678
Q ss_pred CCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCC
Q 003140 322 RLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 366 (845)
Q Consensus 322 ~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~ 366 (845)
+|+.|+|++|+|+ .+|..+..+.+ |+.|+|++|.|++..
T Consensus 262 ~L~~L~Ls~N~L~-~lp~~l~~l~~-----L~~L~L~~N~l~~~~ 300 (622)
T 3g06_A 262 GLLSLSVYRNQLT-RLPESLIHLSS-----ETTVNLEGNPLSERT 300 (622)
T ss_dssp TCCEEECCSSCCC-SCCGGGGGSCT-----TCEEECCSCCCCHHH
T ss_pred cCcEEeCCCCCCC-cCCHHHhhccc-----cCEEEecCCCCCCcC
Confidence 9999999999999 88988876654 559999999998643
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-24 Score=228.84 Aligned_cols=222 Identities=21% Similarity=0.239 Sum_probs=165.4
Q ss_pred cccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceee
Q 003140 129 IKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHML 208 (845)
Q Consensus 129 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 208 (845)
+.++..+++..+.+... ..+..+++|+.|++++|.++. + ..+..+++|++|+|++|.+++. ..+..+++|++|+
T Consensus 18 ~~~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~ 91 (272)
T 3rfs_A 18 FAETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLI 91 (272)
T ss_dssp HHHHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEE
T ss_pred HHHHHHHHhcCcccccc--cccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEE
Confidence 45666777777766643 235567777777777777763 2 2467777777888887777752 3677778888888
Q ss_pred ccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCCC-CCCCCCccEEEcccccCC
Q 003140 209 LDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLN 287 (845)
Q Consensus 209 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~ 287 (845)
|++|++++..+..|..+++|++|+|++|++++ ..+..|.++++|++|+|++|++++.++. +..+++|+.|++++|+++
T Consensus 92 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 170 (272)
T 3rfs_A 92 LTGNQLQSLPNGVFDKLTNLKELVLVENQLQS-LPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ 170 (272)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCCccCccChhHhcCCcCCCEEECCCCcCCc-cCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcC
Confidence 88888887666667778888888888888875 4555677888888888888888877665 677888888888888888
Q ss_pred cCCCCCCC-ccccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCC-CC
Q 003140 288 GSIPPGRL-SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT-NI 365 (845)
Q Consensus 288 ~~ip~~~~-~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~-~i 365 (845)
+..+..+. ..+|+.|+|++|++++..+..|..+++|++|+|++|.+.+..| .++.|+++.|+++ .+
T Consensus 171 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~------------~l~~l~~~~n~~~g~i 238 (272)
T 3rfs_A 171 SLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP------------GIRYLSEWINKHSGVV 238 (272)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT------------TTHHHHHHHHHTGGGB
T ss_pred ccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc------------HHHHHHHHHHhCCCcc
Confidence 55554433 3588889999999998888889999999999999999997655 2456788889887 45
Q ss_pred CCCC
Q 003140 366 SGSF 369 (845)
Q Consensus 366 ~~~~ 369 (845)
|..+
T Consensus 239 p~~~ 242 (272)
T 3rfs_A 239 RNSA 242 (272)
T ss_dssp BCTT
T ss_pred cCcc
Confidence 5544
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.7e-23 Score=223.71 Aligned_cols=203 Identities=24% Similarity=0.270 Sum_probs=112.0
Q ss_pred ccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCC
Q 003140 102 IGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTR 181 (845)
Q Consensus 102 l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 181 (845)
++.+++|+++++++|+++ .+|..+. ++|++|+|++|++++..|..|..+++|++|+|++|.|++..+. ..+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 455566666666666666 4444443 4566666666666655555566666666666666666533221 4555566
Q ss_pred EEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccC
Q 003140 182 HFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261 (845)
Q Consensus 182 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N 261 (845)
+|+|++|+|+ .+|..+..+++|++|+|++|++++..+..|..+++|++|+|++|++++ ..+..|..+++|+.|+|++|
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N 158 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLANN 158 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECTTS
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCc-cChhhcccccCCCEEECCCC
Confidence 6666666555 445555555555555555555554444455555555555555555553 23334455555555555555
Q ss_pred CCCCCCCC-CCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcc
Q 003140 262 SLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSG 335 (845)
Q Consensus 262 ~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 335 (845)
+++..++. +..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|.+..
T Consensus 159 ~l~~l~~~~~~~l~~L~~L~L~~N~l~------------------------~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 159 NLTELPAGLLNGLENLDTLLLQENSLY------------------------TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCCC------------------------CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred cCCccCHHHhcCcCCCCEEECCCCcCC------------------------ccChhhcccccCCeEEeCCCCccC
Confidence 55544443 344444554444444444 445555556677777777777653
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.90 E-value=4.1e-27 Score=269.24 Aligned_cols=303 Identities=17% Similarity=0.171 Sum_probs=225.4
Q ss_pred ceEeEEEecCCCCcccCCCC-ccCCCCccEEEecCCCCCC----CCcccccccccchhhhccCCCCCCCCCCcc-CCCC-
Q 003140 82 LHLRELQLLNLNLSGNLSPE-IGRLSYLTILDFMWNKISG----SIPKEIGNIKSLELLLLNGNELTGSLPEEL-GYLP- 154 (845)
Q Consensus 82 ~~v~~L~L~~~~l~~~~~~~-l~~L~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~- 154 (845)
.+++.|+|++++++...... +..+++|++|+|++|++++ .++..+..+++|++|+|++|++++..+..+ ..++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 47889999999887654333 7788899999999999875 356677888999999999999875434333 2344
Q ss_pred ---ccceeecccccccC----CCCccccCccCCCEEEccCCCCCCCCcccc-----CCCCCcceeeccccccccCC----
Q 003140 155 ---KLDRIQIDQNYISG----SLPKSFANLNKTRHFHMNNNSISGQIPPEL-----SRLPSLVHMLLDNNNLTGYL---- 218 (845)
Q Consensus 155 ---~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l-----~~l~~L~~L~L~~N~l~~~~---- 218 (845)
+|++|+|++|+++. .++..+..+++|++|+|++|.++...+..+ ...++|++|+|++|++++..
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 162 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence 69999999999884 458888999999999999999875433332 23567999999999988643
Q ss_pred CcccCCCCCCcEEEccCCcCCCCCCccccc-----cCCCccEEEcccCCCCCC-----CCCCCCCCCccEEEcccccCCc
Q 003140 219 PPELSELPKLLILQLDNNNFEGTTIPASYS-----NMSKLLKLSLRNCSLQGP-----MPDLSRIPNLGYLDLSSNQLNG 288 (845)
Q Consensus 219 p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~-----~l~~L~~L~Ls~N~l~~~-----~~~l~~l~~L~~L~Ls~N~l~~ 288 (845)
+..+..+++|++|+|++|.+++ ..+..+. .+++|++|+|++|.++.. +..+..+++|+.|++++|.+++
T Consensus 163 ~~~l~~~~~L~~L~L~~n~i~~-~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~ 241 (461)
T 1z7x_W 163 ASVLRAKPDFKELTVSNNDINE-AGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD 241 (461)
T ss_dssp HHHHHHCTTCCEEECCSSBCHH-HHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHH
T ss_pred HHHHhhCCCCCEEECcCCCcch-HHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCCh
Confidence 5556677899999999999864 2333332 356899999999998874 2236677899999999998875
Q ss_pred CCC----CC-C-CccccCEEEccCCcCCCC----cccccCCCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEcc
Q 003140 289 SIP----PG-R-LSLNITTIKLSNNKLTGT----IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQ 358 (845)
Q Consensus 289 ~ip----~~-~-~~~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls 358 (845)
... .. . ...+|+.|+|++|+++.. ++..+..+++|++|+|++|++++..+..+.....-..+.|+.|+++
T Consensus 242 ~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~ 321 (461)
T 1z7x_W 242 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVK 321 (461)
T ss_dssp HHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred HHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcC
Confidence 321 11 1 245899999999999865 6777778899999999999998776666665543344578899999
Q ss_pred CCCCCCCC-----CCC-CCCCCcEEEecCCccc
Q 003140 359 NNNLTNIS-----GSF-NIPPNVTVRLRGNPFC 385 (845)
Q Consensus 359 ~N~l~~i~-----~~~-~~~~l~~l~l~~Np~~ 385 (845)
+|.++... ..+ ..+.++.|++++|.+.
T Consensus 322 ~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~ 354 (461)
T 1z7x_W 322 SCSFTAACCSHFSSVLAQNRFLLELQISNNRLE 354 (461)
T ss_dssp TSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCH
T ss_pred CCCCchHHHHHHHHHHhhCCCccEEEccCCccc
Confidence 99987642 222 3688899999988764
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.90 E-value=9.1e-23 Score=215.90 Aligned_cols=204 Identities=22% Similarity=0.319 Sum_probs=125.5
Q ss_pred CccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEcc
Q 003140 107 YLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMN 186 (845)
Q Consensus 107 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 186 (845)
.++.+++++++++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|+++...+..|.++++|++|+|+
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 4567777777777 4565443 467777777777775555567777777777777777765555555666666666666
Q ss_pred CCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCC
Q 003140 187 NNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGP 266 (845)
Q Consensus 187 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 266 (845)
+|++++..+..+..+++|++|+|++|++++..+..|..+++|++|+|++|++++ ..+..|..+++|+.|+|++|++++.
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~ 172 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQLKRV 172 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCc-cCHhHccCCcccceeEecCCcCcEe
Confidence 666665555555666666666666666665555555556666666666666553 2333345555555555555555544
Q ss_pred CCC-CCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccC
Q 003140 267 MPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI 337 (845)
Q Consensus 267 ~~~-l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~i 337 (845)
++. +..++ +|+.|+|++|+|++..+..|..+++|+.|+|++|.+...-
T Consensus 173 ~~~~~~~l~-----------------------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 221 (270)
T 2o6q_A 173 PEGAFDKLT-----------------------ELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTC 221 (270)
T ss_dssp CTTTTTTCT-----------------------TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSS
T ss_pred ChhHhccCC-----------------------CcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCC
Confidence 432 34444 4555555555555455556777888888888888887543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-23 Score=218.09 Aligned_cols=191 Identities=20% Similarity=0.264 Sum_probs=118.5
Q ss_pred CCCCCCcceEecCCCCCCCcceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCC
Q 003140 62 PCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNE 141 (845)
Q Consensus 62 ~c~~~w~Gv~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 141 (845)
.|+ .|.|++|.. ..+.+++++++++ .+|..+. ++|+.|+|++|++++..+..|.++++|++|+|++|+
T Consensus 3 ~Cp-~~~gC~C~~--------~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 70 (251)
T 3m19_A 3 TCE-TVTGCTCNE--------GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQ 70 (251)
T ss_dssp -CH-HHHSSEEEG--------GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred cCC-CCCceEcCC--------CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCc
Confidence 354 589999943 2456778877777 4555554 567777777777777666667777777777777777
Q ss_pred CCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcc
Q 003140 142 LTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE 221 (845)
Q Consensus 142 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~ 221 (845)
+++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..+..+++|++|+|++|++++..+..
T Consensus 71 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 150 (251)
T 3m19_A 71 LQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGA 150 (251)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT
T ss_pred CCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHH
Confidence 77666666677777777777777776555556666666666666666666444444555555555555555555444434
Q ss_pred cCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCC-CCCCCCCccEEEcccccCCcC
Q 003140 222 LSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGS 289 (845)
Q Consensus 222 l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~ 289 (845)
|..+++|++|+|++|++ ++.++ .+..+++|+.|+|++|.+++.
T Consensus 151 ~~~l~~L~~L~L~~N~l-------------------------~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 151 FDKLTNLQTLSLSTNQL-------------------------QSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTTCTTCCEEECCSSCC-------------------------SCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred cCcCcCCCEEECCCCcC-------------------------CccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 44455555555555544 44444 245555566666666666543
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.8e-23 Score=215.66 Aligned_cols=195 Identities=16% Similarity=0.187 Sum_probs=143.2
Q ss_pred CccEEEecCCCCCCCCcccccccccchhhhccCCC-CCCCCCCccCCCCccceeeccc-ccccCCCCccccCccCCCEEE
Q 003140 107 YLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNE-LTGSLPEELGYLPKLDRIQIDQ-NYISGSLPKSFANLNKTRHFH 184 (845)
Q Consensus 107 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~ 184 (845)
+|++|+|++|++++..+..|.++++|++|+|++|+ +++..+..|.++++|++|+|++ |++++..+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 67788888888876666677778888888888886 7755555777788888888887 778766667777888888888
Q ss_pred ccCCCCCCCCccccCCCCCcc---eeecccc-ccccCCCcccCCCCCCc-EEEccCCcCCCCCCccccccCCCccEEEcc
Q 003140 185 MNNNSISGQIPPELSRLPSLV---HMLLDNN-NLTGYLPPELSELPKLL-ILQLDNNNFEGTTIPASYSNMSKLLKLSLR 259 (845)
Q Consensus 185 L~~N~l~~~~p~~l~~l~~L~---~L~L~~N-~l~~~~p~~l~~l~~L~-~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls 259 (845)
+++|++++ +|. +..+++|+ +|++++| ++++..+..|..+++|+ +|++++|+++. +|......++|+.|+|+
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~--i~~~~~~~~~L~~L~L~ 187 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS--VQGYAFNGTKLDAVYLN 187 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCE--ECTTTTTTCEEEEEECT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcc--cCHhhcCCCCCCEEEcC
Confidence 88888775 555 77777777 8888888 77766666678888888 88888888863 44433233778888888
Q ss_pred cCC-CCCCCCC-CCCC-CCccEEEcccccCCcCCCCCCCccccCEEEccCC
Q 003140 260 NCS-LQGPMPD-LSRI-PNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNN 307 (845)
Q Consensus 260 ~N~-l~~~~~~-l~~l-~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N 307 (845)
+|+ +++.++. +..+ ++|+.|++++|+++ .+|.. ...+|+.|+++++
T Consensus 188 ~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~-~l~~~-~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK-GLEHLKELIARNT 236 (239)
T ss_dssp TCTTCCEECTTTTTTCSBCCSEEECTTCCCC-CCCCT-TCTTCSEEECTTC
T ss_pred CCCCcccCCHHHhhccccCCcEEECCCCccc-cCChh-HhccCceeeccCc
Confidence 884 7776554 6777 78888888888887 45544 3347888888776
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=6e-23 Score=221.93 Aligned_cols=225 Identities=20% Similarity=0.196 Sum_probs=186.0
Q ss_pred ceEeEEEecCCCCcccCCC---CccCCCCccEEEecCCCCCCCCcccc--cccccchhhhccCCCCCCCCC----CccCC
Q 003140 82 LHLRELQLLNLNLSGNLSP---EIGRLSYLTILDFMWNKISGSIPKEI--GNIKSLELLLLNGNELTGSLP----EELGY 152 (845)
Q Consensus 82 ~~v~~L~L~~~~l~~~~~~---~l~~L~~L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p----~~~~~ 152 (845)
.+++.+.+.++.++...-. .+..+++|++|+|++|++++.+|..+ .++++|++|+|++|++++..+ ..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 3578888988887653111 12345679999999999999999888 999999999999999997666 34567
Q ss_pred CCccceeecccccccCCCCccccCccCCCEEEccCCCCCCC--C--ccccCCCCCcceeeccccccccCCCc----ccCC
Q 003140 153 LPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQ--I--PPELSRLPSLVHMLLDNNNLTGYLPP----ELSE 224 (845)
Q Consensus 153 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~--p~~l~~l~~L~~L~L~~N~l~~~~p~----~l~~ 224 (845)
+++|++|+|++|++++..+..+.++++|++|+|++|++.+. + +..+..+++|++|+|++|+++. ++. .+..
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~ 222 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAA 222 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHH
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhc
Confidence 99999999999999988889999999999999999998742 2 2334789999999999999973 233 2577
Q ss_pred CCCCcEEEccCCcCCCCCCccccccC---CCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCCcCCCCCCCccccCE
Q 003140 225 LPKLLILQLDNNNFEGTTIPASYSNM---SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITT 301 (845)
Q Consensus 225 l~~L~~L~Ls~N~l~~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~ 301 (845)
+++|++|+|++|++++ ..|..+..+ ++|++|+|++|+++..+..+. ++|+.|+|++|+|++. |......+|+.
T Consensus 223 l~~L~~L~Ls~N~l~~-~~p~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~--~~L~~L~Ls~N~l~~~-~~~~~l~~L~~ 298 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRA-TVNPSAPRCMWSSALNSLNLSFAGLEQVPKGLP--AKLRVLDLSSNRLNRA-PQPDELPEVDN 298 (310)
T ss_dssp TCCCSSEECTTSCCCC-CCCSCCSSCCCCTTCCCEECCSSCCCSCCSCCC--SCCSCEECCSCCCCSC-CCTTSCCCCSC
T ss_pred CCCCCEEECCCCCCCc-cchhhHHhccCcCcCCEEECCCCCCCchhhhhc--CCCCEEECCCCcCCCC-chhhhCCCccE
Confidence 8999999999999997 567777776 699999999999997766664 7999999999999953 44444568999
Q ss_pred EEccCCcCCC
Q 003140 302 IKLSNNKLTG 311 (845)
Q Consensus 302 L~Ls~N~l~~ 311 (845)
|+|++|.|+.
T Consensus 299 L~L~~N~l~~ 308 (310)
T 4glp_A 299 LTLDGNPFLV 308 (310)
T ss_dssp EECSSTTTSC
T ss_pred EECcCCCCCC
Confidence 9999999974
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.88 E-value=6.8e-25 Score=242.68 Aligned_cols=253 Identities=18% Similarity=0.161 Sum_probs=147.8
Q ss_pred EEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCc----ccccccc-cchhhhccCCCCCCCCCCccCCC-----Ccc
Q 003140 87 LQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIP----KEIGNIK-SLELLLLNGNELTGSLPEELGYL-----PKL 156 (845)
Q Consensus 87 L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~L 156 (845)
.++++++++|.+|..+...++|++|+|++|.+++..+ ..|.+++ +|++|+|++|++++..+..+..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 4567777777777666666668888888887776555 5666676 77777777777776666666654 777
Q ss_pred ceeecccccccCCCCccccC----c-cCCCEEEccCCCCCCCCcccc----CC-CCCcceeeccccccccCCCc----cc
Q 003140 157 DRIQIDQNYISGSLPKSFAN----L-NKTRHFHMNNNSISGQIPPEL----SR-LPSLVHMLLDNNNLTGYLPP----EL 222 (845)
Q Consensus 157 ~~L~Ls~N~l~~~~p~~~~~----l-~~L~~L~L~~N~l~~~~p~~l----~~-l~~L~~L~L~~N~l~~~~p~----~l 222 (845)
++|+|++|++++..+..+.. + ++|++|+|++|++++..+..+ .. .++|++|+|++|++++.... .+
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l 162 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQIL 162 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHH
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHH
Confidence 77777777777665554433 3 677777777777765554433 22 24677777777777643322 23
Q ss_pred CCCC-CCcEEEccCCcCCCCCCcccc----ccC-CCccEEEcccCCCCCCCC-----CCCC-CCCccEEEcccccCCcCC
Q 003140 223 SELP-KLLILQLDNNNFEGTTIPASY----SNM-SKLLKLSLRNCSLQGPMP-----DLSR-IPNLGYLDLSSNQLNGSI 290 (845)
Q Consensus 223 ~~l~-~L~~L~Ls~N~l~~~~~p~~~----~~l-~~L~~L~Ls~N~l~~~~~-----~l~~-l~~L~~L~Ls~N~l~~~i 290 (845)
..++ +|++|+|++|++++ ..+..+ ..+ ++|+.|+|++|.+++... .+.. .++|+.|+|++|.+++..
T Consensus 163 ~~~~~~L~~L~Ls~n~l~~-~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 163 AAIPANVNSLNLRGNNLAS-KNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HTSCTTCCEEECTTSCGGG-SCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred hcCCccccEeeecCCCCch-hhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 3343 67777777777664 233322 333 466666666666665221 1222 236666666666665332
Q ss_pred CCC-----CCccccCEEEccCCcCCCCc-------ccccCCCCCCCeEecccccCcccCChh
Q 003140 291 PPG-----RLSLNITTIKLSNNKLTGTI-------PSNFSGLPRLQRLFIANNSLSGSIPSS 340 (845)
Q Consensus 291 p~~-----~~~~~L~~L~Ls~N~l~~~~-------p~~~~~l~~L~~L~L~~N~l~~~ip~~ 340 (845)
+.. ....+|+.|+|++|.+.+.. +..+..+++|++|++++|++.+..+..
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~~ 303 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIP 303 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGCHH
T ss_pred HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcchHH
Confidence 211 11224555555555533222 224445555555555555555444433
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.3e-22 Score=210.30 Aligned_cols=178 Identities=21% Similarity=0.258 Sum_probs=132.9
Q ss_pred cchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeecc
Q 003140 131 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLD 210 (845)
Q Consensus 131 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 210 (845)
..++++++++.++ .+|..+. ++|+.|+|++|++++..+..|.++++|++|+|++|+|++..+..+..+++|++|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 4455666666666 4555444 466667777777666666666777777777777777776666667777777777777
Q ss_pred ccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCC-CCCCCCCccEEEcccccCCcC
Q 003140 211 NNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGS 289 (845)
Q Consensus 211 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~ 289 (845)
+|++++..+..|..+++|++|+|++|++++ ..+..|.++++|+.|+|++|++++.++ .+..+++|+.|+|++|++++.
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 170 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV 170 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCCC-cChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence 777776666677778888888888888875 345567888888889999998888777 488999999999999999966
Q ss_pred CCCCCC-ccccCEEEccCCcCCCC
Q 003140 290 IPPGRL-SLNITTIKLSNNKLTGT 312 (845)
Q Consensus 290 ip~~~~-~~~L~~L~Ls~N~l~~~ 312 (845)
.+..+. ..+|+.|+|++|.+++.
T Consensus 171 ~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 171 PHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CHHHHhCCCCCCEEEeeCCceeCC
Confidence 654443 35899999999999876
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.7e-22 Score=209.74 Aligned_cols=196 Identities=16% Similarity=0.141 Sum_probs=121.4
Q ss_pred eEeEEEecCCCCcccCCCCccCCCCccEEEecCCC-CCCCCcccccccccchhhhccC-CCCCCCCCCccCCCCccceee
Q 003140 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNK-ISGSIPKEIGNIKSLELLLLNG-NELTGSLPEELGYLPKLDRIQ 160 (845)
Q Consensus 83 ~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~ 160 (845)
.++.|++++|++++..+..|..+++|++|+|++|+ +++..+..|.++++|++|+|++ |++++..+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 56666666666666555566666666666666665 6654455666666666666666 666655555666666666666
Q ss_pred cccccccCCCCccccCccCCC---EEEccCC-CCCCCCccccCCCCCcc-eeeccccccccCCCcccCCCCCCcEEEccC
Q 003140 161 IDQNYISGSLPKSFANLNKTR---HFHMNNN-SISGQIPPELSRLPSLV-HMLLDNNNLTGYLPPELSELPKLLILQLDN 235 (845)
Q Consensus 161 Ls~N~l~~~~p~~~~~l~~L~---~L~L~~N-~l~~~~p~~l~~l~~L~-~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 235 (845)
|++|++++ +|. +..+++|+ +|++++| ++++..+..|..+++|+ +|++++|+++ .+|......++|+.|+|++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~ 188 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNK 188 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCC
Confidence 66666664 444 66666666 6666666 66655555566666666 6666666666 3333322225666666666
Q ss_pred Cc-CCCCCCccccccC-CCccEEEcccCCCCCCCCCCCCCCCccEEEcccc
Q 003140 236 NN-FEGTTIPASYSNM-SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSN 284 (845)
Q Consensus 236 N~-l~~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N 284 (845)
|+ +++ ..+..|.++ ++|+.|++++|++++.++. .+++|+.|+++++
T Consensus 189 n~~l~~-i~~~~~~~l~~~L~~L~l~~N~l~~l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 189 NKYLTV-IDKDAFGGVYSGPSLLDVSQTSVTALPSK--GLEHLKELIARNT 236 (239)
T ss_dssp CTTCCE-ECTTTTTTCSBCCSEEECTTCCCCCCCCT--TCTTCSEEECTTC
T ss_pred CCCccc-CCHHHhhccccCCcEEECCCCccccCChh--HhccCceeeccCc
Confidence 63 653 334556666 6666666666666655543 4556666666654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.88 E-value=2e-22 Score=233.70 Aligned_cols=224 Identities=28% Similarity=0.350 Sum_probs=137.4
Q ss_pred cchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeecc
Q 003140 131 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLD 210 (845)
Q Consensus 131 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 210 (845)
+|+.|+|++|+|++ +|..+. ++|++|+|++|+|+ .+| ..+++|+.|+|++|+|++ +|. +.. +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 55555555555553 444332 45555555555555 344 334566666666666664 444 443 66666666
Q ss_pred ccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCCcCC
Q 003140 211 NNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSI 290 (845)
Q Consensus 211 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~i 290 (845)
+|+|++ +|. .+++|+.|+|++|++++ +|. .+++|+.|+|++|+|++.+. +. ++|+.|+|++|+|+ .+
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~--lp~---~l~~L~~L~Ls~N~L~~lp~-l~--~~L~~L~Ls~N~L~-~l 195 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM--LPE---LPTSLEVLSVRNNQLTFLPE-LP--ESLEALDVSTNLLE-SL 195 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC--CCC---CCTTCCEEECCSSCCSCCCC-CC--TTCCEEECCSSCCS-SC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc--CCC---cCCCcCEEECCCCCCCCcch-hh--CCCCEEECcCCCCC-ch
Confidence 666665 444 45667777777777764 343 45677777777777777555 44 77888888888887 66
Q ss_pred CCCCCcccc-------CEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCChhhhhhccCCCC--cceEEEccCCC
Q 003140 291 PPGRLSLNI-------TTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNAT--ETFILDFQNNN 361 (845)
Q Consensus 291 p~~~~~~~L-------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~--~l~~L~ls~N~ 361 (845)
|. +.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|..+..+.....- ....+++++|+
T Consensus 196 p~-~~~-~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~~~~~~~~~~~~l~~~~ 272 (571)
T 3cvr_A 196 PA-VPV-RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQ 272 (571)
T ss_dssp CC-CC---------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHHSCC---CEEECCC----
T ss_pred hh-HHH-hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhcCccccCCeeEEeecccc
Confidence 66 333 66 99999999999 578888889999999999999999999999887653210 11123444444
Q ss_pred CCCCCCCCCCCCCcEEEecCCcccccCCCccccCCC
Q 003140 362 LTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSH 397 (845)
Q Consensus 362 l~~i~~~~~~~~l~~l~l~~Np~~c~~~~~~~~~~~ 397 (845)
+.. ..|| .|+|...|+-...
T Consensus 273 ~~~---------------~~~p-~~~~~~~Wl~~~~ 292 (571)
T 3cvr_A 273 QNT---------------LHRP-LADAVTAWFPENK 292 (571)
T ss_dssp ---------------------C-CSHHHHTTCC---
T ss_pred ccc---------------cccc-chhhHHHHhhhhc
Confidence 432 2345 6888888774433
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=5.8e-22 Score=218.00 Aligned_cols=247 Identities=19% Similarity=0.224 Sum_probs=190.3
Q ss_pred CCCCCcceEecCCCCCCCcceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCC
Q 003140 63 CTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142 (845)
Q Consensus 63 c~~~w~Gv~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 142 (845)
|.|.|..|.|.+ ++|+ .+|..+ .+++++|+|++|+|+...+..|.++++|++|+|++|++
T Consensus 7 C~C~~~~v~C~~-----------------~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i 66 (350)
T 4ay9_X 7 CHCSNRVFLCQE-----------------SKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66 (350)
T ss_dssp SEEETTEEEEES-----------------TTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTT
T ss_pred cEeeCCEEEecC-----------------CCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCC
Confidence 655666677743 4555 456655 36789999999999965556789999999999999998
Q ss_pred CCCCC-CccCCCCccce-eecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccc-cccccCCC
Q 003140 143 TGSLP-EELGYLPKLDR-IQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDN-NNLTGYLP 219 (845)
Q Consensus 143 ~~~~p-~~~~~l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~p 219 (845)
.+.+| ..|.++++|++ +.++.|+|+...|..|.++++|++|++++|+++...+..+....++..|++.+ |++....+
T Consensus 67 ~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~ 146 (350)
T 4ay9_X 67 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIER 146 (350)
T ss_dssp CCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECT
T ss_pred CCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccc
Confidence 76665 46788888775 66777999988888999999999999999999877666777778888888865 56776656
Q ss_pred cccCCCC-CCcEEEccCCcCCCCCCccccccCCCccEEEccc-CCCCCCCCC-CCCCCCccEEEcccccCCcCCCCCCCc
Q 003140 220 PELSELP-KLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRN-CSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLS 296 (845)
Q Consensus 220 ~~l~~l~-~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~ip~~~~~ 296 (845)
..|..+. .++.|+|++|+|+. ++.......+|+.|++++ |.++..+++ |..+++|+.|||++|+|+ .+|...+
T Consensus 147 ~~f~~~~~~l~~L~L~~N~i~~--i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~-~lp~~~~- 222 (350)
T 4ay9_X 147 NSFVGLSFESVILWLNKNGIQE--IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGL- 222 (350)
T ss_dssp TSSTTSBSSCEEEECCSSCCCE--ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCC-CCCSSSC-
T ss_pred cchhhcchhhhhhccccccccC--CChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcC-ccChhhh-
Confidence 6677764 68899999999974 555555667899999975 677777664 788999999999999998 6665432
Q ss_pred cccCEEEccCCcCCCCcccccCCCCCCCeEecccccCc
Q 003140 297 LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 334 (845)
Q Consensus 297 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 334 (845)
.+|+.|.+.++.--..+| .+.++++|+.++++++.-.
T Consensus 223 ~~L~~L~~l~~~~l~~lP-~l~~l~~L~~l~l~~~~~c 259 (350)
T 4ay9_X 223 ENLKKLRARSTYNLKKLP-TLEKLVALMEASLTYPSHC 259 (350)
T ss_dssp TTCCEEECTTCTTCCCCC-CTTTCCSCCEEECSCHHHH
T ss_pred ccchHhhhccCCCcCcCC-CchhCcChhhCcCCCCccc
Confidence 378888877765444666 4788999999999876543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=4.5e-22 Score=214.73 Aligned_cols=195 Identities=22% Similarity=0.388 Sum_probs=121.0
Q ss_pred ccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcc
Q 003140 126 IGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLV 205 (845)
Q Consensus 126 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 205 (845)
+.++++|++|++++|.++ .+| .+..+++|++|+|++|++++..+ +..+++|++|+|++|++++. + .+..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~ 110 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV-S-AIAGLQSIK 110 (308)
T ss_dssp HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCC
T ss_pred HHHcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc-h-hhcCCCCCC
Confidence 344555555556655555 233 35555666666666666653333 55666666666666666532 2 456666666
Q ss_pred eeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEccccc
Q 003140 206 HMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQ 285 (845)
Q Consensus 206 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~ 285 (845)
+|+|++|++++. + .+..+++|++|+|++|++++ ++. +..+++|+.|+|++|++++.++ +..+++|+.|++++|.
T Consensus 111 ~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~--~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~ 184 (308)
T 1h6u_A 111 TLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITN--ISP-LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNK 184 (308)
T ss_dssp EEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCC--CGG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSC
T ss_pred EEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCc--Ccc-ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCc
Confidence 666666666643 2 26666677777777776664 222 6666777777777777766544 6667777777777777
Q ss_pred CCcCCCCCCCccccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcc
Q 003140 286 LNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSG 335 (845)
Q Consensus 286 l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 335 (845)
+++ ++......+|+.|+|++|++++..+ +..+++|+.|+|++|++++
T Consensus 185 l~~-~~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 185 ISD-ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CCC-CGGGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred cCc-ChhhcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 763 3333333467777777777775543 7788888888888888873
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=6.8e-23 Score=217.84 Aligned_cols=165 Identities=13% Similarity=0.066 Sum_probs=128.6
Q ss_pred HHHHHHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCCh------------------hhHHHHHHHHHHHHhcC
Q 003140 617 GEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL------------------QGEKEFLTEIQFLSRLH 678 (845)
Q Consensus 617 ~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~------------------~~~~~~~~Ei~~l~~l~ 678 (845)
..+......|...+.||+|+||.||+|...+|+.||||.++.... .....+.+|++++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 344445566777899999999999999997799999999864321 13457899999999999
Q ss_pred CCceeeEEEEEeeCCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 003140 679 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 758 (845)
Q Consensus 679 H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl 758 (845)
| +++.+++.. +..++||||+++|+|.+ +.. .....++.|+++||+|||+.+ |+||||||+|||+
T Consensus 163 ~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl 226 (282)
T 1zar_A 163 G---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV 226 (282)
T ss_dssp T---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred C---CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEE
Confidence 4 555554433 45699999999999988 421 123469999999999999999 9999999999999
Q ss_pred cCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcC----------CCCCchhhHHHH
Q 003140 759 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT----------HKLTDKSDVYSL 818 (845)
Q Consensus 759 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~DvwS~ 818 (845)
+ ++.+||+|||+|+.. ..|+|||++.+ .+++..+|+|.+
T Consensus 227 ~-~~~vkl~DFG~a~~~--------------------~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVEV--------------------GEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp E-TTEEEECCCTTCEET--------------------TSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred E-CCcEEEEECCCCeEC--------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 9 999999999998642 35789998754 345555666653
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.87 E-value=4.2e-24 Score=236.33 Aligned_cols=255 Identities=15% Similarity=0.156 Sum_probs=196.4
Q ss_pred EEEecCCCCCCCCcccccccccchhhhccCCCCCCCCC----CccCCCC-ccceeecccccccCCCCccccCc-----cC
Q 003140 110 ILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLP----EELGYLP-KLDRIQIDQNYISGSLPKSFANL-----NK 179 (845)
Q Consensus 110 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~ 179 (845)
.++|++|+++|.+|..+...++|++|+|++|.+++..+ ..+..++ +|++|+|++|++++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46899999999999877777789999999999997666 7788888 89999999999998888877776 99
Q ss_pred CCEEEccCCCCCCCCccccC----CC-CCcceeeccccccccCCCccc----CC-CCCCcEEEccCCcCCCC---CCccc
Q 003140 180 TRHFHMNNNSISGQIPPELS----RL-PSLVHMLLDNNNLTGYLPPEL----SE-LPKLLILQLDNNNFEGT---TIPAS 246 (845)
Q Consensus 180 L~~L~L~~N~l~~~~p~~l~----~l-~~L~~L~L~~N~l~~~~p~~l----~~-l~~L~~L~Ls~N~l~~~---~~p~~ 246 (845)
|++|+|++|++++..+..+. .+ ++|++|+|++|++++..+..+ .. .++|++|+|++|++++. .++..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 99999999999977766544 34 899999999999997665543 34 36999999999999752 12334
Q ss_pred cccCC-CccEEEcccCCCCCCCCC-----CCCC-CCccEEEcccccCCcC----CCCCCC--ccccCEEEccCCcCCCCc
Q 003140 247 YSNMS-KLLKLSLRNCSLQGPMPD-----LSRI-PNLGYLDLSSNQLNGS----IPPGRL--SLNITTIKLSNNKLTGTI 313 (845)
Q Consensus 247 ~~~l~-~L~~L~Ls~N~l~~~~~~-----l~~l-~~L~~L~Ls~N~l~~~----ip~~~~--~~~L~~L~Ls~N~l~~~~ 313 (845)
+..++ +|++|+|++|++++..+. +..+ ++|+.|+|++|.+++. ++..+. ..+|+.|+|++|.|++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 45555 999999999999876652 4455 5999999999999853 222222 237999999999998765
Q ss_pred c----cccCCCCCCCeEecccccCcccCChhhhhhcc--CCCCcceEEEccCCCCCC
Q 003140 314 P----SNFSGLPRLQRLFIANNSLSGSIPSSIWQSRT--LNATETFILDFQNNNLTN 364 (845)
Q Consensus 314 p----~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~--l~~~~l~~L~ls~N~l~~ 364 (845)
+ ..+..+++|+.|+|++|.+.+..+..+..+.. -....|+.||+++|+|..
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~ 298 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP 298 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCG
T ss_pred HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCC
Confidence 4 44567889999999999977555554443321 134557778888887764
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.86 E-value=7.7e-25 Score=239.48 Aligned_cols=265 Identities=15% Similarity=0.194 Sum_probs=166.4
Q ss_pred CCCCCCcceEecCCCCCCCcceEeEEEecCCCCcccCCCCccCC--CCccEEEecCCCCCCCCcccccccccchhhhccC
Q 003140 62 PCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRL--SYLTILDFMWNKISGSIPKEIGNIKSLELLLLNG 139 (845)
Q Consensus 62 ~c~~~w~Gv~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~l~~L--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 139 (845)
.|. .|.++.|... .++.|+++++.+. +..+..+ ++++.|++++|.+++..+. +.++++|++|+|++
T Consensus 35 vc~-~W~~~~~~~~-------~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~ 102 (336)
T 2ast_B 35 VCK-RWYRLASDES-------LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSN 102 (336)
T ss_dssp SCH-HHHHHHTCST-------TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTT
T ss_pred HHH-HHHHHhcCch-------hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccC
Confidence 343 6999887432 3567888877766 3455666 7788888888887766554 55677788888887
Q ss_pred CCCCCC-CCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCC-CCCCC-CccccCCCCCcceeecccc-ccc
Q 003140 140 NELTGS-LPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN-SISGQ-IPPELSRLPSLVHMLLDNN-NLT 215 (845)
Q Consensus 140 N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~l~~l~~L~~L~L~~N-~l~ 215 (845)
|.+++. +|..+..+++|++|+|++|.+++..+..++.+++|++|+|++| .+++. ++..+..+++|++|++++| .++
T Consensus 103 ~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~ 182 (336)
T 2ast_B 103 SVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFT 182 (336)
T ss_dssp CEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCC
T ss_pred CCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcC
Confidence 777654 6666777777777777777777667777777777777777777 56542 4555666777777777777 766
Q ss_pred cC-CCcccCCCC-CCcEEEccCC--cCCCCCCccccccCCCccEEEcccCC-CCC-CCCCCCCCCCccEEEcccccCCcC
Q 003140 216 GY-LPPELSELP-KLLILQLDNN--NFEGTTIPASYSNMSKLLKLSLRNCS-LQG-PMPDLSRIPNLGYLDLSSNQLNGS 289 (845)
Q Consensus 216 ~~-~p~~l~~l~-~L~~L~Ls~N--~l~~~~~p~~~~~l~~L~~L~Ls~N~-l~~-~~~~l~~l~~L~~L~Ls~N~l~~~ 289 (845)
+. ++..+..++ +|++|+|++| .+++..++..+.++++|+.|++++|. +++ .++.+..+++|+.|++++|.
T Consensus 183 ~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~---- 258 (336)
T 2ast_B 183 EKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY---- 258 (336)
T ss_dssp HHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT----
T ss_pred hHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC----
Confidence 43 455566677 7777777777 34422455566667777777777776 443 23345555666666666654
Q ss_pred CCCCCCccccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCC
Q 003140 290 IPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS 368 (845)
Q Consensus 290 ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~ 368 (845)
.+.......+.++++|++|++++| ++.. .+..+. ..+..|++++|+++++.+.
T Consensus 259 ------------------~~~~~~~~~l~~~~~L~~L~l~~~-i~~~---~~~~l~----~~l~~L~l~~n~l~~~~~~ 311 (336)
T 2ast_B 259 ------------------DIIPETLLELGEIPTLKTLQVFGI-VPDG---TLQLLK----EALPHLQINCSHFTTIARP 311 (336)
T ss_dssp ------------------TCCGGGGGGGGGCTTCCEEECTTS-SCTT---CHHHHH----HHSTTSEESCCCSCCTTCS
T ss_pred ------------------CCCHHHHHHHhcCCCCCEEeccCc-cCHH---HHHHHH----hhCcceEEecccCccccCC
Confidence 111111124556677777777766 3321 222221 1123455677777655443
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.86 E-value=1.8e-24 Score=241.40 Aligned_cols=241 Identities=19% Similarity=0.251 Sum_probs=144.8
Q ss_pred CCCCccCCCCccEEEecCCCCCCCCc----ccccccccchhhhccCC---CCCCCCCCcc-------CCCCccceeeccc
Q 003140 98 LSPEIGRLSYLTILDFMWNKISGSIP----KEIGNIKSLELLLLNGN---ELTGSLPEEL-------GYLPKLDRIQIDQ 163 (845)
Q Consensus 98 ~~~~l~~L~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~Ls~N---~l~~~~p~~~-------~~l~~L~~L~Ls~ 163 (845)
++..+..+++|++|+|++|++++..+ ..|.++++|++|+|++| ++++.+|..+ ..+++|++|+|++
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~ 103 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 103 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence 45566677778888888887776433 33567777888877775 3444555544 5677777777777
Q ss_pred ccccC----CCCccccCccCCCEEEccCCCCCCCCccccC----CC---------CCcceeeccccccc-cCCC---ccc
Q 003140 164 NYISG----SLPKSFANLNKTRHFHMNNNSISGQIPPELS----RL---------PSLVHMLLDNNNLT-GYLP---PEL 222 (845)
Q Consensus 164 N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~----~l---------~~L~~L~L~~N~l~-~~~p---~~l 222 (845)
|.+++ .+|..+..+++|++|+|++|.++...+..+. .+ ++|++|+|++|+++ +.++ ..+
T Consensus 104 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l 183 (386)
T 2ca6_A 104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183 (386)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred CcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHH
Confidence 77775 3566677777777777777777533332222 22 66777777777665 2333 245
Q ss_pred CCCCCCcEEEccCCcCCCC----CCccccccCCCccEEEcccCCCC----C-CCCCCCCCCCccEEEcccccCCcC----
Q 003140 223 SELPKLLILQLDNNNFEGT----TIPASYSNMSKLLKLSLRNCSLQ----G-PMPDLSRIPNLGYLDLSSNQLNGS---- 289 (845)
Q Consensus 223 ~~l~~L~~L~Ls~N~l~~~----~~p~~~~~l~~L~~L~Ls~N~l~----~-~~~~l~~l~~L~~L~Ls~N~l~~~---- 289 (845)
..+++|++|+|++|+++.. ..+..+..+++|+.|+|++|.++ . .+..+..+++|+.|+|++|.+++.
T Consensus 184 ~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~ 263 (386)
T 2ca6_A 184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 263 (386)
T ss_dssp HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHH
T ss_pred HhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHH
Confidence 5566677777777666521 12225566666666666666664 2 222355666666666666666543
Q ss_pred CCCCC---CccccCEEEccCCcCCC----Cccccc-CCCCCCCeEecccccCcccCC
Q 003140 290 IPPGR---LSLNITTIKLSNNKLTG----TIPSNF-SGLPRLQRLFIANNSLSGSIP 338 (845)
Q Consensus 290 ip~~~---~~~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~L~~N~l~~~ip 338 (845)
++... ...+|+.|+|++|.+++ .+|..+ .++++|++|+|++|++++..|
T Consensus 264 l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 264 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp HHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred HHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 22221 13356666666666665 355555 446666666666666665553
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=7.6e-22 Score=200.17 Aligned_cols=186 Identities=19% Similarity=0.247 Sum_probs=128.6
Q ss_pred CCCCCCCcceEecCCCCCCCcceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCC
Q 003140 61 DPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140 (845)
Q Consensus 61 ~~c~~~w~Gv~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 140 (845)
+.|.|.|++|.|.... ++ .+|..+ .++|++|+|++|++++..+..|.++++|++|+|++|
T Consensus 3 ~~C~C~~~~v~c~~~~-----------------l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 62 (208)
T 2o6s_A 3 SRCSCSGTTVECYSQG-----------------RT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGN 62 (208)
T ss_dssp TTCEEETTEEECCSSC-----------------CS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSS
T ss_pred CCCEECCCEEEecCCC-----------------cc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCC
Confidence 4677789999996532 22 233322 346777777777777655556677777777777777
Q ss_pred CCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCc
Q 003140 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPP 220 (845)
Q Consensus 141 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~ 220 (845)
++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..+..+++|++|+|++|++++..+.
T Consensus 63 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 142 (208)
T 2o6s_A 63 KLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDG 142 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred ccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHH
Confidence 77755555667777777777777777766666677777777777777777766566677777777777777777766555
Q ss_pred ccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCCC-CCCCC
Q 003140 221 ELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIP 274 (845)
Q Consensus 221 ~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~ 274 (845)
.+..+++|++|+|++|.+.+ .+++|+.|+++.|+++|..|. ++.++
T Consensus 143 ~~~~l~~L~~L~l~~N~~~~--------~~~~l~~L~~~~n~~~g~ip~~~~~l~ 189 (208)
T 2o6s_A 143 VFDRLTSLQYIWLHDNPWDC--------TCPGIRYLSEWINKHSGVVRNSAGSVA 189 (208)
T ss_dssp TTTTCTTCCEEECCSCCBCC--------CTTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred HhccCCCccEEEecCCCeec--------CCCCHHHHHHHHHhCCceeeccCcccc
Confidence 67777777777777777654 245677777777777775553 44443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.2e-21 Score=215.62 Aligned_cols=242 Identities=17% Similarity=0.165 Sum_probs=135.5
Q ss_pred cEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCC-ccccCccCCCE-EEcc
Q 003140 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLP-KSFANLNKTRH-FHMN 186 (845)
Q Consensus 109 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~-L~L~ 186 (845)
++++.++++++ .+|..+. ++|++|+|++|+|+...+..|.++++|++|+|++|++.+.+| ..|.++++|+. +.++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 45666666666 4555442 456666666666663333445666666666666666544333 23455555443 3344
Q ss_pred CCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEccc-CCCCC
Q 003140 187 NNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRN-CSLQG 265 (845)
Q Consensus 187 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~-N~l~~ 265 (845)
.|+|+...|..|..+++|++|++++|+++...+.. +....++..|++.+ |++..
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~-------------------------~~~~~~l~~l~l~~~~~i~~ 143 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVH-------------------------KIHSLQKVLLDIQDNINIHT 143 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCT-------------------------TCCBSSCEEEEEESCTTCCE
T ss_pred CCcccccCchhhhhccccccccccccccccCCchh-------------------------hcccchhhhhhhcccccccc
Confidence 45554444444444455555555555444333333 33444455555533 34444
Q ss_pred CCC-CCCCC-CCccEEEcccccCCcCCCCCCCccccCEEEccC-CcCCCCcccccCCCCCCCeEecccccCcccCCh-hh
Q 003140 266 PMP-DLSRI-PNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSN-NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPS-SI 341 (845)
Q Consensus 266 ~~~-~l~~l-~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~-~l 341 (845)
.++ .+..+ ..++.|++++|+|+...+..+...+|+.|++++ |.++...+..|.++++|++|+|++|+|+ .+|. .+
T Consensus 144 l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~-~lp~~~~ 222 (350)
T 4ay9_X 144 IERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGL 222 (350)
T ss_dssp ECTTSSTTSBSSCEEEECCSSCCCEECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCC-CCCSSSC
T ss_pred ccccchhhcchhhhhhccccccccCCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcC-ccChhhh
Confidence 333 23333 246667777777763333333444677777764 5555444566788888888888888888 4554 33
Q ss_pred hhhccCCCCcceEEEcc-CCCCCCCCCCCCCCCCcEEEecCCcccccC
Q 003140 342 WQSRTLNATETFILDFQ-NNNLTNISGSFNIPPNVTVRLRGNPFCLNT 388 (845)
Q Consensus 342 ~~l~~l~~~~l~~L~ls-~N~l~~i~~~~~~~~l~~l~l~~Np~~c~~ 388 (845)
.. |+.|.+. .++++.+|....++.+..+++. ||+.|+|
T Consensus 223 ~~--------L~~L~~l~~~~l~~lP~l~~l~~L~~l~l~-~~~~c~~ 261 (350)
T 4ay9_X 223 EN--------LKKLRARSTYNLKKLPTLEKLVALMEASLT-YPSHCCA 261 (350)
T ss_dssp TT--------CCEEECTTCTTCCCCCCTTTCCSCCEEECS-CHHHHHH
T ss_pred cc--------chHhhhccCCCcCcCCCchhCcChhhCcCC-CCccccc
Confidence 32 3344433 3567888865578899999985 7777765
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.86 E-value=5e-24 Score=237.86 Aligned_cols=241 Identities=18% Similarity=0.270 Sum_probs=180.2
Q ss_pred CCcccccccccchhhhccCCCCCCCC----CCccCCCCccceeecccc---cccCCCCccc-------cCccCCCEEEcc
Q 003140 121 SIPKEIGNIKSLELLLLNGNELTGSL----PEELGYLPKLDRIQIDQN---YISGSLPKSF-------ANLNKTRHFHMN 186 (845)
Q Consensus 121 ~~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N---~l~~~~p~~~-------~~l~~L~~L~L~ 186 (845)
.++..+..+++|++|+|++|++++.. +..+..+++|++|+|++| ++++.+|..+ ..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 56778888999999999999998653 344778999999999995 4555666655 788999999999
Q ss_pred CCCCCC----CCccccCCCCCcceeeccccccccCCCcccC----CC---------CCCcEEEccCCcCCCCCCc---cc
Q 003140 187 NNSISG----QIPPELSRLPSLVHMLLDNNNLTGYLPPELS----EL---------PKLLILQLDNNNFEGTTIP---AS 246 (845)
Q Consensus 187 ~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~----~l---------~~L~~L~Ls~N~l~~~~~p---~~ 246 (845)
+|.++. .+|..+..+++|++|+|++|++++..+..+. .+ ++|++|+|++|+++...++ ..
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 182 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 182 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHH
Confidence 999986 3677888899999999999998754333333 33 8999999999999743455 46
Q ss_pred cccCCCccEEEcccCCCC--C---CCC-CCCCCCCccEEEcccccCC----cCCCCCCC-ccccCEEEccCCcCCCC---
Q 003140 247 YSNMSKLLKLSLRNCSLQ--G---PMP-DLSRIPNLGYLDLSSNQLN----GSIPPGRL-SLNITTIKLSNNKLTGT--- 312 (845)
Q Consensus 247 ~~~l~~L~~L~Ls~N~l~--~---~~~-~l~~l~~L~~L~Ls~N~l~----~~ip~~~~-~~~L~~L~Ls~N~l~~~--- 312 (845)
+..+++|+.|+|++|+++ + ..+ .+..+++|+.|+|++|.++ +.+|..+. ..+|+.|+|++|.|++.
T Consensus 183 l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~ 262 (386)
T 2ca6_A 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 262 (386)
T ss_dssp HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHH
T ss_pred HHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHH
Confidence 778889999999999887 2 233 6778888999999999885 34554332 34788888888888765
Q ss_pred -ccccc--CCCCCCCeEecccccCcc----cCChhh-hhhccCCCCcceEEEccCCCCCCCC
Q 003140 313 -IPSNF--SGLPRLQRLFIANNSLSG----SIPSSI-WQSRTLNATETFILDFQNNNLTNIS 366 (845)
Q Consensus 313 -~p~~~--~~l~~L~~L~L~~N~l~~----~ip~~l-~~l~~l~~~~l~~L~ls~N~l~~i~ 366 (845)
++..+ +.+++|++|+|++|++++ .+|..+ .++ +.|+.|++++|+++...
T Consensus 263 ~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l-----~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 263 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM-----PDLLFLELNGNRFSEED 319 (386)
T ss_dssp HHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHC-----TTCCEEECTTSBSCTTS
T ss_pred HHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcC-----CCceEEEccCCcCCcch
Confidence 55666 337888888888888886 366665 223 34457777777777544
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=2.9e-21 Score=208.46 Aligned_cols=190 Identities=21% Similarity=0.363 Sum_probs=117.8
Q ss_pred ceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeec
Q 003140 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (845)
Q Consensus 82 ~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (845)
.+++.|++.++.++. ++ .+..+++|++|+|++|++++. +. +.++++|++|+|++|++++ ++ .+..+++|++|+|
T Consensus 41 ~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~-~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l 114 (308)
T 1h6u_A 41 DGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDL-AP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDL 114 (308)
T ss_dssp HTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEEC
T ss_pred CCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCC-hh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEEC
Confidence 356667777776664 23 566677777777777777643 32 6667777777777777664 22 5666677777777
Q ss_pred ccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCC
Q 003140 162 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT 241 (845)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 241 (845)
++|++++. +. +..+++|++|++++|++++..+ +..+++|++|+|++|++++..+ +..+++|+.|+|++|++++
T Consensus 115 ~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~- 187 (308)
T 1h6u_A 115 TSTQITDV-TP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISD- 187 (308)
T ss_dssp TTSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-
T ss_pred CCCCCCCc-hh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCc-
Confidence 77776643 22 6666677777777776664322 6666666666666666664322 6666666666666666654
Q ss_pred CCccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCC
Q 003140 242 TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLN 287 (845)
Q Consensus 242 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~ 287 (845)
++. +..+++|++|+|++|++++.++ +..+++|+.|++++|+++
T Consensus 188 -~~~-l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~l~~N~i~ 230 (308)
T 1h6u_A 188 -ISP-LASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLTNQTIT 230 (308)
T ss_dssp -CGG-GGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEEEEEEE
T ss_pred -Chh-hcCCCCCCEEEccCCccCcccc-ccCCCCCCEEEccCCeee
Confidence 222 5666666666666666665543 555666666666666655
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.6e-21 Score=226.19 Aligned_cols=202 Identities=27% Similarity=0.364 Sum_probs=146.8
Q ss_pred CCC-CCCCCCC---CCcce-EecCCCCCCCcceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccc
Q 003140 56 NWN-RGDPCTS---NWTGV-LCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIK 130 (845)
Q Consensus 56 ~W~-~~~~c~~---~w~Gv-~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~ 130 (845)
+|. ..++|.. .|.|+ .|... +++.|+|++|+|++ +|..+. ++|++|+|++|+|+ .+| ..++
T Consensus 35 ~W~~~~~~~~~~~~~~~~l~~C~~~-------~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~ 100 (571)
T 3cvr_A 35 KWEKQALPGENRNEAVSLLKECLIN-------QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPA 100 (571)
T ss_dssp HHHTTCCTTCCHHHHHHHHHHHHHT-------TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCT
T ss_pred HHhccCCccccccchhhhccccccC-------CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccC
Confidence 453 2345632 48998 78542 68899999999987 777663 78999999999998 677 4578
Q ss_pred cchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeecc
Q 003140 131 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLD 210 (845)
Q Consensus 131 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 210 (845)
+|++|+|++|+|++ +|. +.. +|++|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|++|+|+
T Consensus 101 ~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls 168 (571)
T 3cvr_A 101 SLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVR 168 (571)
T ss_dssp TCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECC
T ss_pred CCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECC
Confidence 89999999999986 777 665 89999999999886 555 67888888888888885 555 56788888888
Q ss_pred ccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCc-------cEEEcccCCCCCCCCCCCCCCCccEEEccc
Q 003140 211 NNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKL-------LKLSLRNCSLQGPMPDLSRIPNLGYLDLSS 283 (845)
Q Consensus 211 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L-------~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~ 283 (845)
+|+|++ +|. |. ++|+.|+|++|+|+ .+|. +.. +| +.|+|++|+|+..+..+..+++|+.|+|++
T Consensus 169 ~N~L~~-lp~-l~--~~L~~L~Ls~N~L~--~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~L~~ 239 (571)
T 3cvr_A 169 NNQLTF-LPE-LP--ESLEALDVSTNLLE--SLPA-VPV--RNHHSEETEIFFRCRENRITHIPENILSLDPTCTIILED 239 (571)
T ss_dssp SSCCSC-CCC-CC--TTCCEEECCSSCCS--SCCC-CC----------CCEEEECCSSCCCCCCGGGGGSCTTEEEECCS
T ss_pred CCCCCC-cch-hh--CCCCEEECcCCCCC--chhh-HHH--hhhcccccceEEecCCCcceecCHHHhcCCCCCEEEeeC
Confidence 888886 565 55 78888888888887 3555 443 55 666666666666555555566666666666
Q ss_pred ccCCcCCCC
Q 003140 284 NQLNGSIPP 292 (845)
Q Consensus 284 N~l~~~ip~ 292 (845)
|.|++.+|.
T Consensus 240 N~l~~~~p~ 248 (571)
T 3cvr_A 240 NPLSSRIRE 248 (571)
T ss_dssp SSCCHHHHH
T ss_pred CcCCCcCHH
Confidence 666655444
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.85 E-value=5.7e-23 Score=224.61 Aligned_cols=247 Identities=16% Similarity=0.204 Sum_probs=164.6
Q ss_pred CccEEEecCCCCCCCCccccccc--ccchhhhccCCCCCCCCCCccCCCCccceeecccccccCC-CCccccCccCCCEE
Q 003140 107 YLTILDFMWNKISGSIPKEIGNI--KSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGS-LPKSFANLNKTRHF 183 (845)
Q Consensus 107 ~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L 183 (845)
.++.|++++|.+. +..+..+ ++|+.|++++|.+++..+. +..+++|++|+|++|.+++. ++..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 4788999988877 5667777 7888888888888866555 55788888888888888755 67777778888888
Q ss_pred EccCCCCCCCCccccCCCCCcceeecccc-ccccC-CCcccCCCCCCcEEEccCC-cCCCCCCccccccCC-CccEEEcc
Q 003140 184 HMNNNSISGQIPPELSRLPSLVHMLLDNN-NLTGY-LPPELSELPKLLILQLDNN-NFEGTTIPASYSNMS-KLLKLSLR 259 (845)
Q Consensus 184 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~-~p~~l~~l~~L~~L~Ls~N-~l~~~~~p~~~~~l~-~L~~L~Ls 259 (845)
+|++|.+++..+..++.+++|++|+|++| .+++. ++..+..+++|++|+|++| .+++..++..+..++ +|++|+|+
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~ 203 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 203 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence 88888777666667777777777777777 56542 4444566666777777766 665422455555666 66666666
Q ss_pred cCCCCCCCCCCCCCCCccEEEcccccCC-cCCCCCC-CccccCEEEccCCc-CCCCcccccCCCCCCCeEecccccCccc
Q 003140 260 NCSLQGPMPDLSRIPNLGYLDLSSNQLN-GSIPPGR-LSLNITTIKLSNNK-LTGTIPSNFSGLPRLQRLFIANNSLSGS 336 (845)
Q Consensus 260 ~N~l~~~~~~l~~l~~L~~L~Ls~N~l~-~~ip~~~-~~~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 336 (845)
+|.+ .++ +.+|... ...+|+.|+|++|. +++..+..+..+++|++|+|++|. +.
T Consensus 204 ~~~~---------------------~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~--~~ 260 (336)
T 2ast_B 204 GYRK---------------------NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY--DI 260 (336)
T ss_dssp SCGG---------------------GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT--TC
T ss_pred CCcc---------------------cCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC--CC
Confidence 5521 122 1122111 12256666666666 566677788999999999999996 34
Q ss_pred CChhhhhhccCCCCcceEEEccCCCCCCCCCCC--CC-CCCcEEEecCCcccc
Q 003140 337 IPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NI-PPNVTVRLRGNPFCL 386 (845)
Q Consensus 337 ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~--~~-~~l~~l~l~~Np~~c 386 (845)
.+..+..+.. .++|+.|++++| ++... .+ ..+..|++++|.+..
T Consensus 261 ~~~~~~~l~~--~~~L~~L~l~~~----i~~~~~~~l~~~l~~L~l~~n~l~~ 307 (336)
T 2ast_B 261 IPETLLELGE--IPTLKTLQVFGI----VPDGTLQLLKEALPHLQINCSHFTT 307 (336)
T ss_dssp CGGGGGGGGG--CTTCCEEECTTS----SCTTCHHHHHHHSTTSEESCCCSCC
T ss_pred CHHHHHHHhc--CCCCCEEeccCc----cCHHHHHHHHhhCcceEEecccCcc
Confidence 4554333332 456789999999 44432 12 235566688887754
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.4e-20 Score=190.75 Aligned_cols=179 Identities=18% Similarity=0.246 Sum_probs=88.1
Q ss_pred cEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCC
Q 003140 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN 188 (845)
Q Consensus 109 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 188 (845)
+.++++++.++ .+|..+ .++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|
T Consensus 10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 35566666655 344333 235566666666665444444555555555555555555444444455555555555555
Q ss_pred CCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCC
Q 003140 189 SISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP 268 (845)
Q Consensus 189 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 268 (845)
++++..+..+..+++|++|+|++|++++..+..| .++++|+.|+|++|++++.++
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-------------------------~~l~~L~~L~l~~N~l~~~~~ 141 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVF-------------------------DKLTQLKDLRLYQNQLKSVPD 141 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT-------------------------TTCTTCCEEECCSSCCSCCCT
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHh-------------------------ccCCcCCEEECCCCccceeCH
Confidence 5554333344444445555544444443333334 444444444444444444443
Q ss_pred C-CCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccCCCC
Q 003140 269 D-LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLP 321 (845)
Q Consensus 269 ~-l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~ 321 (845)
. +..+++|+.|++++|.+.+..| +|+.|+++.|+++|.+|..++.++
T Consensus 142 ~~~~~l~~L~~L~l~~N~~~~~~~------~l~~L~~~~n~~~g~ip~~~~~l~ 189 (208)
T 2o6s_A 142 GVFDRLTSLQYIWLHDNPWDCTCP------GIRYLSEWINKHSGVVRNSAGSVA 189 (208)
T ss_dssp TTTTTCTTCCEEECCSCCBCCCTT------TTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred HHhccCCCccEEEecCCCeecCCC------CHHHHHHHHHhCCceeeccCcccc
Confidence 3 4445555555555554443222 334444444444455555444443
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.7e-19 Score=185.80 Aligned_cols=154 Identities=22% Similarity=0.278 Sum_probs=124.6
Q ss_pred CCcceEecCCCCCCCcceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCC
Q 003140 66 NWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGS 145 (845)
Q Consensus 66 ~w~Gv~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 145 (845)
.|.+|.|... +++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|+..
T Consensus 20 s~~~v~c~~~-----------------~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i 79 (229)
T 3e6j_A 20 SGTTVDCRSK-----------------RHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGAL 79 (229)
T ss_dssp ETTEEECTTS-----------------CCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred eCCEeEccCC-----------------CcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCc
Confidence 5999999543 232 4555443 7899999999999988888899999999999999999866
Q ss_pred CCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCC
Q 003140 146 LPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSEL 225 (845)
Q Consensus 146 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l 225 (845)
.+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|..+
T Consensus 80 ~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 158 (229)
T 3e6j_A 80 PVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRL 158 (229)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTC
T ss_pred ChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCC
Confidence 6667788999999999999998777777888888888888888888 677788888888888888888886666667778
Q ss_pred CCCcEEEccCCcCCC
Q 003140 226 PKLLILQLDNNNFEG 240 (845)
Q Consensus 226 ~~L~~L~Ls~N~l~~ 240 (845)
++|+.|+|++|.+.+
T Consensus 159 ~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 159 SSLTHAYLFGNPWDC 173 (229)
T ss_dssp TTCCEEECTTSCBCT
T ss_pred CCCCEEEeeCCCccC
Confidence 888888888887765
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.2e-19 Score=185.52 Aligned_cols=150 Identities=19% Similarity=0.210 Sum_probs=113.7
Q ss_pred EecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeeccccccc
Q 003140 88 QLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYIS 167 (845)
Q Consensus 88 ~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 167 (845)
++++++++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|+|+
T Consensus 17 ~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~ 93 (220)
T 2v9t_B 17 DCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT 93 (220)
T ss_dssp ECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCC
T ss_pred EcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCC
Confidence 33444555 3555544 67888888888888776777888888888888888888777888888888888888888888
Q ss_pred CCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCC
Q 003140 168 GSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240 (845)
Q Consensus 168 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 240 (845)
+..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|++|+|++|.+..
T Consensus 94 ~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 94 ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 6666667778888888888888887777777777778888887777776666667777777777777777754
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.1e-19 Score=200.75 Aligned_cols=185 Identities=21% Similarity=0.233 Sum_probs=91.0
Q ss_pred ceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccC-CCCCcceeeccccccccCCCcccCCCCCCcEEEccC
Q 003140 157 DRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELS-RLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDN 235 (845)
Q Consensus 157 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 235 (845)
+.+++++|+|+ .+|..+. +.++.|+|++|+|++..+..+. .+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 45566666555 3443332 2345555555555544444444 455555555555555544444455555555555555
Q ss_pred CcCCCCCCccccccCCCccEEEcccCCCCCCCC-CCCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcc
Q 003140 236 NNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIP 314 (845)
Q Consensus 236 N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p 314 (845)
|++++ ..+..|.++++|+.|+|++|++++..+ .|..+++|+.|+|++|+|+ +..+
T Consensus 98 N~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-----------------------~l~~ 153 (361)
T 2xot_A 98 NHLHT-LDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-----------------------RFPV 153 (361)
T ss_dssp SCCCE-ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-----------------------SCCG
T ss_pred CcCCc-CCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC-----------------------eeCH
Confidence 55543 223334444444444444444444322 2333444444444433333 2222
Q ss_pred ccc---CCCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCCCCCCCCcEEEecCCcccccCCCc
Q 003140 315 SNF---SGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAE 391 (845)
Q Consensus 315 ~~~---~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~~~~~l~~l~l~~Np~~c~~~~~ 391 (845)
..| ..+++|+.|+|++|+|++..+..+..+..+ .+..|+|.+|||.|||.+.
T Consensus 154 ~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~-------------------------~l~~l~l~~N~~~C~C~l~ 208 (361)
T 2xot_A 154 ELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAW-------------------------VKNGLYLHNNPLECDCKLY 208 (361)
T ss_dssp GGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHH-------------------------HHTTEECCSSCEECCHHHH
T ss_pred HHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHh-------------------------hcceEEecCCCccCCcCcH
Confidence 222 345666666666666663333333332211 0256889999999999987
Q ss_pred cc
Q 003140 392 QF 393 (845)
Q Consensus 392 ~~ 393 (845)
++
T Consensus 209 ~~ 210 (361)
T 2xot_A 209 QL 210 (361)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.79 E-value=8e-20 Score=214.15 Aligned_cols=35 Identities=20% Similarity=0.324 Sum_probs=15.5
Q ss_pred ccCEEEccCCcCCCCcccccCCCCCCCeEecccccCc
Q 003140 298 NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 334 (845)
Q Consensus 298 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 334 (845)
+|+.|+|++|+|++. ..+..+++|+.|+|++|+++
T Consensus 176 ~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~ 210 (605)
T 1m9s_A 176 KLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECL 210 (605)
T ss_dssp TCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEE
T ss_pred CCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCc
Confidence 344444444444332 23444555555555555544
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=2.6e-19 Score=183.11 Aligned_cols=152 Identities=18% Similarity=0.201 Sum_probs=119.2
Q ss_pred EEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCc-ccccccccchhhhccCCCCCCCCCCccCCCCccceeecccc
Q 003140 86 ELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIP-KEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164 (845)
Q Consensus 86 ~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 164 (845)
.++++++.++. +|..+. ..+++|+|++|+|++..| ..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 46666777764 566554 356889999999887654 45788888888888888888777778888888888888888
Q ss_pred cccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCC
Q 003140 165 YISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240 (845)
Q Consensus 165 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 240 (845)
+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|++++..|..|..+++|++|+|++|.+.+
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 167 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC 167 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence 8887777778888888888888888887777778888888888888888887777777777788888888877765
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.6e-19 Score=193.13 Aligned_cols=171 Identities=25% Similarity=0.359 Sum_probs=82.0
Q ss_pred CCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEE
Q 003140 152 YLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLIL 231 (845)
Q Consensus 152 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 231 (845)
.+++|+.|++++|.++.. + .+..+++|+.|+|++|++++..+ +..+++|++|+|++|++++. ..+..+++|++|
T Consensus 44 ~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L 117 (291)
T 1h6t_A 44 ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL--SSLKDLKKLKSL 117 (291)
T ss_dssp HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCG--GGGTTCTTCCEE
T ss_pred hcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCC--hhhccCCCCCEE
Confidence 344444444444444422 1 23444444444444444443222 44444444444444444431 224444444455
Q ss_pred EccCCcCCCCCCccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCC
Q 003140 232 QLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTG 311 (845)
Q Consensus 232 ~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~ 311 (845)
+|++|++++ + ..+..+++|+.|++++|++++. +.+..+++|+.|++++|.+++..+ .....+|+.|+|++|.|++
T Consensus 118 ~L~~n~i~~--~-~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N~i~~ 192 (291)
T 1h6t_A 118 SLEHNGISD--I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISD 192 (291)
T ss_dssp ECTTSCCCC--C-GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCB
T ss_pred ECCCCcCCC--C-hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh-hcCCCccCEEECCCCcCCC
Confidence 554444443 1 2344445555555555554443 334445555555555555543322 2223355555555555554
Q ss_pred CcccccCCCCCCCeEecccccCcc
Q 003140 312 TIPSNFSGLPRLQRLFIANNSLSG 335 (845)
Q Consensus 312 ~~p~~~~~l~~L~~L~L~~N~l~~ 335 (845)
. + .+..+++|+.|++++|+++.
T Consensus 193 l-~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 193 L-R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp C-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred C-h-hhccCCCCCEEECcCCcccC
Confidence 3 2 36777788888888887774
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.5e-20 Score=225.90 Aligned_cols=231 Identities=18% Similarity=0.216 Sum_probs=116.5
Q ss_pred HHHHHHHHHHHHhccCC-CCCCCCCCCC-CCCCCCCcceEecCCCCCCCcceEeEEEecCCCCcccCCCCccCCCCc---
Q 003140 34 PIEVSALRSIKKSLVDD-YSKLSNWNRG-DPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYL--- 108 (845)
Q Consensus 34 ~~~~~al~~~k~~~~~~-~~~l~~W~~~-~~c~~~w~Gv~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L--- 108 (845)
..++++|.++..+.... ...-..|... .++ ..|.++.++.. +++.|+|.++++... +..+.....|
T Consensus 131 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~-------~~~~l~L~~n~~~~~-~~~~l~~l~Ls~~ 201 (727)
T 4b8c_D 131 DCTKQALMEMADTLTDSKTAKKQQPTGDSTPS-GTATNSAVSTP-------LTPKIELFANGKDEA-NQALLQHKKLSQY 201 (727)
T ss_dssp -CCCHHHHHHHHHHHHHHTTC-----------------------------------------------------------
T ss_pred ccchhhhhhhhhhcccccCcccCCCcCCCCcc-ccCCCceecCC-------ccceEEeeCCCCCcc-hhhHhhcCccCcc
Confidence 45688899998777432 2233467443 333 35888888653 688999998888863 3333222222
Q ss_pred --cEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEcc
Q 003140 109 --TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMN 186 (845)
Q Consensus 109 --~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 186 (845)
..++++.|.+. ..|..|..+++|+.|+|++|.+. .+|..+..+++|++|+|++|.|+ .+|..|.+|++|++|+|+
T Consensus 202 ~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls 278 (727)
T 4b8c_D 202 SIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLS 278 (727)
T ss_dssp ---------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECT
T ss_pred cccCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCc
Confidence 22233334444 45677788888888888888887 67777778888888888888888 777778888888888888
Q ss_pred CCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCC-ccEEEcccCCCCC
Q 003140 187 NNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSK-LLKLSLRNCSLQG 265 (845)
Q Consensus 187 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~-L~~L~Ls~N~l~~ 265 (845)
+|+|+ .+|..|+.+++|++|+|++|.|+ .+|..|+.+++|++|+|++|+|++ .+|..+..+.. +..|+|++|.+++
T Consensus 279 ~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~~~~~~~~l~l~~N~l~~ 355 (727)
T 4b8c_D 279 HNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEK-QFLKILTEKSVTGLIFYLRDNRPEI 355 (727)
T ss_dssp TSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCS-HHHHHHHHHHHHHHHHHHHHCCCCC
T ss_pred CCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCC-CChHHHhhcchhhhHHhhccCcccC
Confidence 88888 66888888888888888888887 667778888888888888888876 56666654422 2235666776666
Q ss_pred CCCCCCCCCCccEEEcccc
Q 003140 266 PMPDLSRIPNLGYLDLSSN 284 (845)
Q Consensus 266 ~~~~l~~l~~L~~L~Ls~N 284 (845)
.+|. .|+.|+++.|
T Consensus 356 ~~p~-----~l~~l~l~~n 369 (727)
T 4b8c_D 356 PLPH-----ERRFIEINTD 369 (727)
T ss_dssp CCCC-----C---------
T ss_pred cCcc-----ccceeEeecc
Confidence 5442 4455555555
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.79 E-value=3.3e-19 Score=190.54 Aligned_cols=189 Identities=21% Similarity=0.369 Sum_probs=120.0
Q ss_pred ccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccC
Q 003140 108 LTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNN 187 (845)
Q Consensus 108 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 187 (845)
+..+.+..+.+++.. .+..+++|++|++++|.++. ++ .+..+++|++|+|++|++++..+ +.++++|++|+|++
T Consensus 26 ~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~ 99 (291)
T 1h6t_A 26 TIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDE 99 (291)
T ss_dssp HHHHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred HHHHHhcCCCccccc--chhhcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCC
Confidence 344455555555432 24556667777777777663 33 36667777777777777765443 66777777777777
Q ss_pred CCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCC
Q 003140 188 NSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPM 267 (845)
Q Consensus 188 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 267 (845)
|++++ + ..+..+++|++|+|++|++++. ..+..+++|++|+|++|++++. ..+..+++|+.|+|++|++++.+
T Consensus 100 n~l~~-~-~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~---~~l~~l~~L~~L~L~~N~l~~~~ 172 (291)
T 1h6t_A 100 NKVKD-L-SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI---TVLSRLTKLDTLSLEDNQISDIV 172 (291)
T ss_dssp SCCCC-G-GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC---GGGGGCTTCSEEECCSSCCCCCG
T ss_pred CcCCC-C-hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc---hhhccCCCCCEEEccCCccccch
Confidence 77764 2 2366677777777777777653 4566667777777777777642 45666777777777777776655
Q ss_pred CCCCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCC
Q 003140 268 PDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTG 311 (845)
Q Consensus 268 ~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~ 311 (845)
+ +..+++|+.|++++|.+++ ++......+|+.|++++|+++.
T Consensus 173 ~-l~~l~~L~~L~L~~N~i~~-l~~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 173 P-LAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp G-GTTCTTCCEEECCSSCCCB-CGGGTTCTTCSEEEEEEEEEEC
T ss_pred h-hcCCCccCEEECCCCcCCC-ChhhccCCCCCEEECcCCcccC
Confidence 5 6666777777777777763 4443334467777777776664
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=4.1e-19 Score=208.11 Aligned_cols=200 Identities=21% Similarity=0.346 Sum_probs=144.4
Q ss_pred CCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEE
Q 003140 105 LSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFH 184 (845)
Q Consensus 105 L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 184 (845)
+..+..+.|..+.+.+.++ +..|++|+.|+|++|.+. .+| .+..+++|+.|+|++|+|++..+ +..+++|+.|+
T Consensus 20 l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~ 93 (605)
T 1m9s_A 20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLF 93 (605)
T ss_dssp HHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEE
T ss_pred HHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEE
Confidence 3345556677777765443 567788888888888887 344 47788888888888888886554 77888888888
Q ss_pred ccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCC
Q 003140 185 MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264 (845)
Q Consensus 185 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~ 264 (845)
|++|.|++ +| .+..+++|+.|+|++|++++. ..+..+++|+.|+|++|++++. ..+..+++|+.|+|++|+++
T Consensus 94 Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l---~~l~~l~~L~~L~Ls~N~l~ 166 (605)
T 1m9s_A 94 LDENKIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI---TVLSRLTKLDTLSLEDNQIS 166 (605)
T ss_dssp CCSSCCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC---GGGGSCTTCSEEECCSSCCC
T ss_pred CcCCCCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc---hhhcccCCCCEEECcCCcCC
Confidence 88888874 33 677788888888888888753 4577788888888888888752 56777888888888888887
Q ss_pred CCCCCCCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccCC
Q 003140 265 GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSG 319 (845)
Q Consensus 265 ~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~ 319 (845)
+.++ +..+++|+.|+|++|.|++ +|......+|+.|+|++|++++.....+..
T Consensus 167 ~~~~-l~~l~~L~~L~Ls~N~i~~-l~~l~~l~~L~~L~L~~N~l~~~p~~~~~~ 219 (605)
T 1m9s_A 167 DIVP-LAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFSQECLNKPINHQSN 219 (605)
T ss_dssp CCGG-GTTCTTCCEEECCSSCCCB-CGGGTTCTTCSEEECCSEEEECCCCCCCSS
T ss_pred Cchh-hccCCCCCEEECcCCCCCC-ChHHccCCCCCEEEccCCcCcCCccccccc
Confidence 7666 7777888888888888874 454444557888888888877654433333
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.78 E-value=3.7e-19 Score=196.39 Aligned_cols=152 Identities=22% Similarity=0.296 Sum_probs=100.2
Q ss_pred EEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCccccc-ccccchhhhccCCCCCCCCCCccCCCCccceeecccc
Q 003140 86 ELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIG-NIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164 (845)
Q Consensus 86 ~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 164 (845)
.+++++++|+. +|..+. +.++.|+|++|+|++..+..|. ++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 22 ~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 46666677764 555443 3477788888888766666666 7777777777777777666667777777777777777
Q ss_pred cccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCccc---CCCCCCcEEEccCCcCCC
Q 003140 165 YISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPEL---SELPKLLILQLDNNNFEG 240 (845)
Q Consensus 165 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l---~~l~~L~~L~Ls~N~l~~ 240 (845)
+|++..+..|.++++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..+..| ..+++|+.|+|++|+|++
T Consensus 99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 7776666667777777777777777766556666666666666666666664333333 345555555555555553
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.78 E-value=8.9e-19 Score=179.12 Aligned_cols=150 Identities=21% Similarity=0.318 Sum_probs=87.9
Q ss_pred cEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCC
Q 003140 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN 188 (845)
Q Consensus 109 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 188 (845)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 45777777777 5565544 46777777777777555556667777777777777776666666666666666666666
Q ss_pred CCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCC
Q 003140 189 SISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCS 262 (845)
Q Consensus 189 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~ 262 (845)
+|+...+..|..+++|++|+|++|++++..|..|..+++|++|+|++|++++ ..+..|..+++|+.|+|++|.
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~ 163 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQT-IAKGTFSPLRAIQTMHLAQNP 163 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC-CCTTTTTTCTTCCEEECCSSC
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCE-ECHHHHhCCCCCCEEEeCCCC
Confidence 6664444445555666666666665555555555555555555555555543 222333334334333333333
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=1e-18 Score=178.73 Aligned_cols=151 Identities=23% Similarity=0.295 Sum_probs=91.6
Q ss_pred cEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCC-CccCCCCccceeecccccccCCCCccccCccCCCEEEccC
Q 003140 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLP-EELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNN 187 (845)
Q Consensus 109 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 187 (845)
+++++++|.++ .+|..+. ..+++|+|++|+|++..| ..|..+++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 46777777777 4665553 245677777777775543 3466677777777777777665566666666666666666
Q ss_pred CCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCC
Q 003140 188 NSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263 (845)
Q Consensus 188 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l 263 (845)
|+|++..+..|..+++|++|+|++|++++..|..|..+++|++|+|++|++++ ..|..|..+++|+.|+|++|.+
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l 165 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITT-VAPGAFDTLHSLSTLNLLANPF 165 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCC-BCTTTTTTCTTCCEEECCSCCE
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCE-ECHHHhcCCCCCCEEEecCcCC
Confidence 66665555556666666666666666665555555555555555555555554 2344444444444444444443
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=7.2e-19 Score=184.42 Aligned_cols=137 Identities=19% Similarity=0.105 Sum_probs=107.5
Q ss_pred CCCCccccccCceEEEEEEe-CCCcE--EEEEEccCCChh------------------------hHHHHHHHHHHHHhcC
Q 003140 626 FNSSTQIGQGGYGKVYKGIL-PDGTV--VAVKRAQEGSLQ------------------------GEKEFLTEIQFLSRLH 678 (845)
Q Consensus 626 f~~~~~LG~G~fG~Vy~~~~-~~g~~--vAVK~~~~~~~~------------------------~~~~~~~Ei~~l~~l~ 678 (845)
|.+.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|++++++++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999998 68999 999987543111 1236889999999998
Q ss_pred CCce--eeEEEEEeeCCeEEEEEEcCCC-C----CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecC
Q 003140 679 HRNL--VSLVGYCDEEGEQMLVYEFMSN-G----TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH-TEADPPVFHRD 750 (845)
Q Consensus 679 H~nI--v~l~g~~~~~~~~~LV~E~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~iiHrD 750 (845)
|+++ +.++++ +..+|||||+.+ | +|.++... .++.....++.|+++||.||| +.+ |+|||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrD 196 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE---LVHAD 196 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC---EECSS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC---EEeCC
Confidence 8754 444443 356899999942 4 78776543 123456789999999999999 888 99999
Q ss_pred CCCCCEEEcCCCcEEEEecCCcccCC
Q 003140 751 IKASNILLDHKFTAKVADFGLSRLAP 776 (845)
Q Consensus 751 Lk~~NILl~~~~~~kl~DFGla~~~~ 776 (845)
|||+|||+++ .++|+|||+|....
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEETT
T ss_pred CCHHHEEEcC--cEEEEECcccccCC
Confidence 9999999998 99999999997653
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=4.2e-19 Score=186.81 Aligned_cols=171 Identities=20% Similarity=0.337 Sum_probs=115.8
Q ss_pred CCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEE
Q 003140 104 RLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHF 183 (845)
Q Consensus 104 ~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 183 (845)
.+.++..++|++|.+++ ++ .+..+++|++|++++|+++ .+| .+..+++|++|+|++|+|++..+ +.++++|+.|
T Consensus 17 ~l~~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 34556666677777663 33 4666777777777777776 444 56677777777777777775444 6777777777
Q ss_pred EccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCC
Q 003140 184 HMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263 (845)
Q Consensus 184 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l 263 (845)
+|++|++++ +|... . ++|++|+|++|++++. +.+..+++|+.|+|++|++++ ++ .+..+++|+.|+|++|++
T Consensus 91 ~L~~N~l~~-l~~~~-~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~--~~-~l~~l~~L~~L~L~~N~i 162 (263)
T 1xeu_A 91 SVNRNRLKN-LNGIP-S-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKS--IV-MLGFLSKLEVLDLHGNEI 162 (263)
T ss_dssp ECCSSCCSC-CTTCC-C-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCB--CG-GGGGCTTCCEEECTTSCC
T ss_pred ECCCCccCC-cCccc-c-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCC--Ch-HHccCCCCCEEECCCCcC
Confidence 777777764 33322 2 6777777777777753 357777777777777777765 22 577777777777777777
Q ss_pred CCCCCCCCCCCCccEEEcccccCCcC
Q 003140 264 QGPMPDLSRIPNLGYLDLSSNQLNGS 289 (845)
Q Consensus 264 ~~~~~~l~~l~~L~~L~Ls~N~l~~~ 289 (845)
++. ..+..+++|+.|++++|.+++.
T Consensus 163 ~~~-~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 163 TNT-GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp CBC-TTSTTCCCCCEEEEEEEEEECC
T ss_pred cch-HHhccCCCCCEEeCCCCcccCC
Confidence 776 5577777777777777777643
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.76 E-value=6.5e-18 Score=173.84 Aligned_cols=133 Identities=19% Similarity=0.226 Sum_probs=74.4
Q ss_pred CccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEc
Q 003140 154 PKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQL 233 (845)
Q Consensus 154 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 233 (845)
++|++|+|++|+|++..|..|.++++|+.|+|++|+|+...+..|..+++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L 119 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFM 119 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEec
Confidence 34444444444444444444444444444444444444333334455555555555555555444444555666666666
Q ss_pred cCCcCCCCCCccccccCCCccEEEcccCCCCCCCCC-CCCCCCccEEEcccccCCc
Q 003140 234 DNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNG 288 (845)
Q Consensus 234 s~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~ 288 (845)
++|+++ .+|..+..+++|+.|+|++|++++.++. +..+++|+.|+|++|.+.+
T Consensus 120 s~N~l~--~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 120 CCNKLT--ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp CSSCCC--SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred cCCccc--ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 666665 3566666666777777777777665543 6666777777777777664
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.76 E-value=7.3e-21 Score=224.49 Aligned_cols=295 Identities=15% Similarity=0.098 Sum_probs=160.2
Q ss_pred EeEEEecCCC-Ccc-cCCCCccCCCCccEEEecCCCCCCC----CcccccccccchhhhccCCCCCC----CCCCccCCC
Q 003140 84 LRELQLLNLN-LSG-NLSPEIGRLSYLTILDFMWNKISGS----IPKEIGNIKSLELLLLNGNELTG----SLPEELGYL 153 (845)
Q Consensus 84 v~~L~L~~~~-l~~-~~~~~l~~L~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l 153 (845)
++.|+|.+|. ++. .++..+..+++|++|+|++|.+++. ++..+.++++|++|+|++|.+++ .++..+.++
T Consensus 140 L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~ 219 (592)
T 3ogk_B 140 LETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNC 219 (592)
T ss_dssp CCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHC
T ss_pred CcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhC
Confidence 7777777765 211 1222234667777777777776654 33344566777777777777762 223334566
Q ss_pred CccceeecccccccCCCCccccCccCCCEEEccCCCC--------------------------CCCCccccCCCCCccee
Q 003140 154 PKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSI--------------------------SGQIPPELSRLPSLVHM 207 (845)
Q Consensus 154 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l--------------------------~~~~p~~l~~l~~L~~L 207 (845)
++|++|+|++|.+.+ ++..+.++++|+.|+++.+.. .+.+|..+..+++|++|
T Consensus 220 ~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~l~~~~~~~~~L~~L 298 (592)
T 3ogk_B 220 RSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKL 298 (592)
T ss_dssp TTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTTTGGGGGGGGGGCCEE
T ss_pred CCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchhHHHHHHhhcCCCcEE
Confidence 777777777776663 445555555555555543211 12345555566677777
Q ss_pred eccccccccCCC-cccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEccc-----------CCCCCCC-CC-CCCC
Q 003140 208 LLDNNNLTGYLP-PELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRN-----------CSLQGPM-PD-LSRI 273 (845)
Q Consensus 208 ~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~-----------N~l~~~~-~~-l~~l 273 (845)
+|++|.+++... ..+..+++|++|+|+ |.+.+..++..+..+++|++|+|++ |.+++.. .. ...+
T Consensus 299 ~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~ 377 (592)
T 3ogk_B 299 DLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGC 377 (592)
T ss_dssp EETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHC
T ss_pred ecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhC
Confidence 777776553322 224566667777666 4443323344445566677777762 4444311 11 2335
Q ss_pred CCccEEEcccccCCcCCCCCCC--ccccCEEEcc----CCcCCCC-----cccccCCCCCCCeEecccc--cCcccCChh
Q 003140 274 PNLGYLDLSSNQLNGSIPPGRL--SLNITTIKLS----NNKLTGT-----IPSNFSGLPRLQRLFIANN--SLSGSIPSS 340 (845)
Q Consensus 274 ~~L~~L~Ls~N~l~~~ip~~~~--~~~L~~L~Ls----~N~l~~~-----~p~~~~~l~~L~~L~L~~N--~l~~~ip~~ 340 (845)
++|++|+++.|.+++..+.... ..+|+.|+|+ .|.+++. ++..+.++++|++|+|++| .+++..+..
T Consensus 378 ~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~ 457 (592)
T 3ogk_B 378 QELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSY 457 (592)
T ss_dssp TTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHH
T ss_pred ccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHH
Confidence 6677777766666644333221 2356666664 5566643 3333555666666666532 255444444
Q ss_pred hhhhccCCCCcceEEEccCCCCCC--CCCCC-CCCCCcEEEecCCcc
Q 003140 341 IWQSRTLNATETFILDFQNNNLTN--ISGSF-NIPPNVTVRLRGNPF 384 (845)
Q Consensus 341 l~~l~~l~~~~l~~L~ls~N~l~~--i~~~~-~~~~l~~l~l~~Np~ 384 (845)
+.. ..++|+.|++++|+++. ++..+ .++.++.|++++|++
T Consensus 458 ~~~----~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l 500 (592)
T 3ogk_B 458 IGQ----YSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCF 500 (592)
T ss_dssp HHH----SCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCC
T ss_pred HHH----hCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCC
Confidence 332 12345566666666653 22211 356666666666664
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.3e-20 Score=222.41 Aligned_cols=298 Identities=12% Similarity=0.082 Sum_probs=199.8
Q ss_pred ceEeEEEecCCCCccc----CCCCccCCCCccEEEecCCCCCC----CCcccccccccchhhhccCCCCCC---------
Q 003140 82 LHLRELQLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISG----SIPKEIGNIKSLELLLLNGNELTG--------- 144 (845)
Q Consensus 82 ~~v~~L~L~~~~l~~~----~~~~l~~L~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~--------- 144 (845)
.+++.|+|++|.+++. ++..+..+++|++|+|++|.+++ .++..+.++++|++|+|++|.+.+
T Consensus 164 ~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~~~~~~~~ 243 (592)
T 3ogk_B 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAA 243 (592)
T ss_dssp TTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGHHHHHHCT
T ss_pred CCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHHHHHhhhh
Confidence 3567777777766544 22334556677777777776652 233344556667777777766553
Q ss_pred -----------------CCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCc-cccCCCCCcce
Q 003140 145 -----------------SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIP-PELSRLPSLVH 206 (845)
Q Consensus 145 -----------------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~ 206 (845)
..+..+..+++|+.|+++++. .+.+|..+..+++|++|+|++|.+++... ..+..+++|++
T Consensus 244 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~-~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~ 322 (592)
T 3ogk_B 244 NLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMG-PNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEV 322 (592)
T ss_dssp TCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCC-TTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCE
T ss_pred HHHhhcccccccccchHHHHHHhhccccccccCccccc-hhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCE
Confidence 222344455555555555543 23677788889999999999999764433 34688999999
Q ss_pred eeccccccccCCCcccCCCCCCcEEEcc-----------CCcCCCCCCccccccCCCccEEEcccCCCCCCCC-CCCC-C
Q 003140 207 MLLDNNNLTGYLPPELSELPKLLILQLD-----------NNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSR-I 273 (845)
Q Consensus 207 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls-----------~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~-l 273 (845)
|+++++...+.++..+..+++|++|+|+ .|.+++..++.....+++|++|+++.|++++... .+.. +
T Consensus 323 L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~ 402 (592)
T 3ogk_B 323 LETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYL 402 (592)
T ss_dssp EEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHC
T ss_pred EeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhC
Confidence 9999443333334444668899999999 4667643344445678999999999999976433 2433 7
Q ss_pred CCccEEEcc----cccCCcCCCC-----C-CCccccCEEEccCC--cCCCCcccccCC-CCCCCeEecccccCcccC-Ch
Q 003140 274 PNLGYLDLS----SNQLNGSIPP-----G-RLSLNITTIKLSNN--KLTGTIPSNFSG-LPRLQRLFIANNSLSGSI-PS 339 (845)
Q Consensus 274 ~~L~~L~Ls----~N~l~~~ip~-----~-~~~~~L~~L~Ls~N--~l~~~~p~~~~~-l~~L~~L~L~~N~l~~~i-p~ 339 (845)
++|+.|+++ .|.+++...+ . ....+|+.|+|++| .+++..+..+.. +++|++|+|++|++++.. +.
T Consensus 403 ~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~ 482 (592)
T 3ogk_B 403 KNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLME 482 (592)
T ss_dssp CSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHH
T ss_pred CCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHH
Confidence 899999996 7778753211 1 11348999999854 477666666554 889999999999988633 22
Q ss_pred hhhhhccCCCCcceEEEccCCCCCC--CCCCC-CCCCCcEEEecCCccc
Q 003140 340 SIWQSRTLNATETFILDFQNNNLTN--ISGSF-NIPPNVTVRLRGNPFC 385 (845)
Q Consensus 340 ~l~~l~~l~~~~l~~L~ls~N~l~~--i~~~~-~~~~l~~l~l~~Np~~ 385 (845)
.+.. .++|+.|++++|.++. ++... .++.++.|++++|++.
T Consensus 483 ~~~~-----~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it 526 (592)
T 3ogk_B 483 FSRG-----CPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRAS 526 (592)
T ss_dssp HHTC-----CTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCC
T ss_pred HHhc-----CcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCC
Confidence 2222 3567799999999863 22222 4889999999999864
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=5.9e-21 Score=222.44 Aligned_cols=203 Identities=16% Similarity=0.134 Sum_probs=109.3
Q ss_pred cCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCE
Q 003140 103 GRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRH 182 (845)
Q Consensus 103 ~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 182 (845)
..+++|+.|+|++|+++ .+|..++++++|+.|++++|.....+| ..+..+.+.+.+|..+.++++|+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~-----------~ll~~~~~~~~~~~~l~~l~~L~~ 413 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTII-----------LLMRALDPLLYEKETLQYFSTLKA 413 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHH-----------HHHHHHCTGGGHHHHHHHHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHH-----------HHHHhcccccCCHHHHHHHHhccc
Confidence 45677777777777776 667777777777777776554100000 000011123344444555555555
Q ss_pred EE-ccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccC
Q 003140 183 FH-MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261 (845)
Q Consensus 183 L~-L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N 261 (845)
|+ ++.|.+ .+|..+.+++|.++...+ ..|+.|+|++|++++ +|. ++++++|+.|+|++|
T Consensus 414 L~~l~~n~~-----------~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~--lp~-~~~l~~L~~L~Ls~N 473 (567)
T 1dce_A 414 VDPMRAAYL-----------DDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV--LCH-LEQLLLVTHLDLSHN 473 (567)
T ss_dssp HCGGGHHHH-----------HHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS--CCC-GGGGTTCCEEECCSS
T ss_pred Ccchhhccc-----------chhhhhhhhcccccccCc------cCceEEEecCCCCCC--CcC-ccccccCcEeecCcc
Confidence 54 333322 234444444454442211 125555555555553 333 555555555555555
Q ss_pred CCCCCCCCCCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCc-ccccCCCCCCCeEecccccCcccCC
Q 003140 262 SLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTI-PSNFSGLPRLQRLFIANNSLSGSIP 338 (845)
Q Consensus 262 ~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~ip 338 (845)
+|+..+..+..+++|+.|+|++|.|++ +|......+|+.|+|++|+|++.. |..|+.+++|+.|+|++|+|++..|
T Consensus 474 ~l~~lp~~~~~l~~L~~L~Ls~N~l~~-lp~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 474 RLRALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp CCCCCCGGGGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred cccccchhhhcCCCCCEEECCCCCCCC-CcccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 555444445555555555555555553 442223335666666666666665 7777777777777777777775544
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=2.5e-18 Score=172.53 Aligned_cols=131 Identities=17% Similarity=0.264 Sum_probs=59.4
Q ss_pred cCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCE
Q 003140 103 GRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRH 182 (845)
Q Consensus 103 ~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 182 (845)
+.+++|++|+|++|.++ .+| .+..+++|++|+|++|.++ .+..+..+++|++|+|++|++++..+..+..+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 34445555555555555 333 3555555555555555443 1224444555555555555554444444444444444
Q ss_pred EEccCCCCCCCCccccCCCCCcceeeccccc-cccCCCcccCCCCCCcEEEccCCcCC
Q 003140 183 FHMNNNSISGQIPPELSRLPSLVHMLLDNNN-LTGYLPPELSELPKLLILQLDNNNFE 239 (845)
Q Consensus 183 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~Ls~N~l~ 239 (845)
|+|++|++++..+..+..+++|++|++++|+ ++ .++ .+..+++|++|++++|+++
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~ 172 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVH 172 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCC
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCc
Confidence 4444444444334444444444444444444 22 222 3333444444444444443
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=3.4e-18 Score=171.57 Aligned_cols=154 Identities=17% Similarity=0.273 Sum_probs=105.4
Q ss_pred ccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcc
Q 003140 126 IGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLV 205 (845)
Q Consensus 126 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 205 (845)
...+++|++|+|++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|++++..+..++.+++|+
T Consensus 40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 356677777777777777 555 5777777777777777654 233667777777777777777766666777777777
Q ss_pred eeeccccccccCCCcccCCCCCCcEEEccCCc-CCCCCCccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccc
Q 003140 206 HMLLDNNNLTGYLPPELSELPKLLILQLDNNN-FEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSN 284 (845)
Q Consensus 206 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N 284 (845)
+|+|++|++++..+..+..+++|++|+|++|+ ++. ++ .+..+++|+.|++++|++++.. .+..+++|+.|++++|
T Consensus 116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~--~~-~l~~l~~L~~L~l~~n~i~~~~-~l~~l~~L~~L~l~~N 191 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD--IM-PLKTLPELKSLNIQFDGVHDYR-GIEDFPKLNQLYAFSQ 191 (197)
T ss_dssp EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCC--CG-GGGGCSSCCEEECTTBCCCCCT-TGGGCSSCCEEEECBC
T ss_pred EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccc--cH-hhcCCCCCCEEECCCCCCcChH-HhccCCCCCEEEeeCc
Confidence 77777777776666677777777777777776 542 33 5677777777777777776644 5666667777777777
Q ss_pred cCC
Q 003140 285 QLN 287 (845)
Q Consensus 285 ~l~ 287 (845)
++.
T Consensus 192 ~i~ 194 (197)
T 4ezg_A 192 TIG 194 (197)
T ss_dssp ---
T ss_pred ccC
Confidence 664
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=1.4e-20 Score=219.40 Aligned_cols=199 Identities=21% Similarity=0.241 Sum_probs=151.1
Q ss_pred CCccceeecccccccCCCCccccCccCCCEEEccCCC-------------CCCCCccccCCCCCcceee-ccccccccCC
Q 003140 153 LPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNS-------------ISGQIPPELSRLPSLVHML-LDNNNLTGYL 218 (845)
Q Consensus 153 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-------------l~~~~p~~l~~l~~L~~L~-L~~N~l~~~~ 218 (845)
+++|+.|+|++|+|+ .+|..++++++|+.|++++|. +.+.+|..++.+++|+.|+ ++.|.+.
T Consensus 348 ~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~--- 423 (567)
T 1dce_A 348 DEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD--- 423 (567)
T ss_dssp TTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH---
T ss_pred CccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc---
Confidence 444444444444444 344444444444444443332 4556778888889999998 7777654
Q ss_pred CcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCCcCCCCCCCc-c
Q 003140 219 PPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS-L 297 (845)
Q Consensus 219 p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~-~ 297 (845)
+|..+.+++|.++. ++. ..|+.|+|++|+|++.+. +..+++|+.|+|++|.|+ .+|..+.. .
T Consensus 424 --------~L~~l~l~~n~i~~--l~~-----~~L~~L~Ls~n~l~~lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~ 486 (567)
T 1dce_A 424 --------DLRSKFLLENSVLK--MEY-----ADVRVLHLAHKDLTVLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALR 486 (567)
T ss_dssp --------HHHHHHHHHHHHHH--HHH-----TTCSEEECTTSCCSSCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCT
T ss_pred --------hhhhhhhhcccccc--cCc-----cCceEEEecCCCCCCCcC-ccccccCcEeecCccccc-ccchhhhcCC
Confidence 56677788888864 222 358999999999999765 999999999999999999 78876544 4
Q ss_pred ccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccC-ChhhhhhccCCCCcceEEEccCCCCCCCCCCC-----CC
Q 003140 298 NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI-PSSIWQSRTLNATETFILDFQNNNLTNISGSF-----NI 371 (845)
Q Consensus 298 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~i-p~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~-----~~ 371 (845)
+|+.|+|++|+|++ +| .++++++|+.|+|++|+|++.+ |..+..+..| +.|+|++|+|+++|+.. .+
T Consensus 487 ~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L-----~~L~L~~N~l~~~~~~~~~l~~~l 559 (567)
T 1dce_A 487 CLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL-----VLLNLQGNSLCQEEGIQERLAEML 559 (567)
T ss_dssp TCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTC-----CEEECTTSGGGGSSSCTTHHHHHC
T ss_pred CCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCC-----CEEEecCCcCCCCccHHHHHHHHC
Confidence 89999999999997 56 8999999999999999999887 9998876654 59999999999988754 27
Q ss_pred CCCcEEEe
Q 003140 372 PPNVTVRL 379 (845)
Q Consensus 372 ~~l~~l~l 379 (845)
|.+..|++
T Consensus 560 p~L~~L~l 567 (567)
T 1dce_A 560 PSVSSILT 567 (567)
T ss_dssp TTCSEEEC
T ss_pred cccCccCC
Confidence 88888753
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=6.5e-18 Score=177.67 Aligned_cols=171 Identities=22% Similarity=0.305 Sum_probs=122.0
Q ss_pred ccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCccee
Q 003140 128 NIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHM 207 (845)
Q Consensus 128 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 207 (845)
++.+++.+++++|.+++ ++ .+..+++|++|++++|.++. ++ .+..+++|+.|+|++|++++..+ +..+++|++|
T Consensus 17 ~l~~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 57788899999999884 44 57788899999999998884 44 67888888888888888885443 7788888888
Q ss_pred eccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCC
Q 003140 208 LLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLN 287 (845)
Q Consensus 208 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~ 287 (845)
+|++|++++. |. +.. ++|++|+|++|++++ + ..+.++++|+.|+|++|++++.+ .+..+++|+.|++++|+++
T Consensus 91 ~L~~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~--~-~~l~~l~~L~~L~Ls~N~i~~~~-~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 91 SVNRNRLKNL-NG-IPS-ACLSRLFLDNNELRD--T-DSLIHLKNLEILSIRNNKLKSIV-MLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp ECCSSCCSCC-TT-CCC-SSCCEEECCSSCCSB--S-GGGTTCTTCCEEECTTSCCCBCG-GGGGCTTCCEEECTTSCCC
T ss_pred ECCCCccCCc-Cc-ccc-CcccEEEccCCccCC--C-hhhcCcccccEEECCCCcCCCCh-HHccCCCCCEEECCCCcCc
Confidence 8888888753 32 222 677777777777764 2 34666777777777777766542 4555555555555555554
Q ss_pred cCCCCCCCccccCEEEccCCcCCCCcccccCCCCCCCeEecccccCccc
Q 003140 288 GSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGS 336 (845)
Q Consensus 288 ~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 336 (845)
+. ..+..+++|+.|++++|++++.
T Consensus 164 -----------------------~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 164 -----------------------NT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp -----------------------BC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred -----------------------ch--HHhccCCCCCEEeCCCCcccCC
Confidence 33 4566778888888888888754
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.72 E-value=1e-18 Score=209.78 Aligned_cols=195 Identities=17% Similarity=0.174 Sum_probs=96.5
Q ss_pred CCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEc
Q 003140 106 SYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHM 185 (845)
Q Consensus 106 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 185 (845)
+.++.|+|.+|.+.. ++.. .|+.++|+.|.|.+ ++++.|.+. ..+..+..+++|+.|+|
T Consensus 173 ~~~~~l~L~~n~~~~-~~~~-----~l~~l~Ls~~~i~~--------------~~~~~n~~~-~~~~~~~~l~~L~~L~L 231 (727)
T 4b8c_D 173 PLTPKIELFANGKDE-ANQA-----LLQHKKLSQYSIDE--------------DDDIENRMV-MPKDSKYDDQLWHALDL 231 (727)
T ss_dssp ----------------------------------------------------------------------CCCCCCEEEC
T ss_pred CccceEEeeCCCCCc-chhh-----HhhcCccCcccccC--------------cccccccee-cChhhhccCCCCcEEEC
Confidence 457788888888774 3322 34555566655542 234445554 55666677777777777
Q ss_pred cCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCC
Q 003140 186 NNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG 265 (845)
Q Consensus 186 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~ 265 (845)
++|.+. .+|..+..+++|++|+|++|+|+ .+|..|+.+++|++|+|++|+|+ .+|..|+++++|++|+|++|.|+.
T Consensus 232 s~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~--~lp~~~~~l~~L~~L~L~~N~l~~ 307 (727)
T 4b8c_D 232 SNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT--SLPAELGSCFQLKYFYFFDNMVTT 307 (727)
T ss_dssp TTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS--SCCSSGGGGTTCSEEECCSSCCCC
T ss_pred CCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC--ccChhhcCCCCCCEEECCCCCCCc
Confidence 777776 56666667777777777777777 66777777777777777777776 457777777777777777777776
Q ss_pred CCCCCCCCCCccEEEcccccCCcCCCCCCCcc--ccCEEEccCCcCCCCcccccCCCCCCCeEecccc
Q 003140 266 PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN 331 (845)
Q Consensus 266 ~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 331 (845)
.+..|..+++|+.|+|++|.|++.+|..+... .+..|+|++|.+++.+|.. |+.|++++|
T Consensus 308 lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n 369 (727)
T 4b8c_D 308 LPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTD 369 (727)
T ss_dssp CCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------------
T ss_pred cChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecc
Confidence 66667777777777777777777666654332 2234567777777766653 344555555
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.67 E-value=3.1e-19 Score=210.63 Aligned_cols=296 Identities=16% Similarity=0.150 Sum_probs=159.7
Q ss_pred ceEeEEEecCCCCcccCCCCcc-CCCCccEEEecCC-CCCCC-CcccccccccchhhhccCCCCCCCCCCccC----CCC
Q 003140 82 LHLRELQLLNLNLSGNLSPEIG-RLSYLTILDFMWN-KISGS-IPKEIGNIKSLELLLLNGNELTGSLPEELG----YLP 154 (845)
Q Consensus 82 ~~v~~L~L~~~~l~~~~~~~l~-~L~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----~l~ 154 (845)
.+++.|+|+++.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+. .++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 3688899998888876666665 6888999999888 55432 444455788899999998887765544443 566
Q ss_pred ccceeeccccc--ccC-CCCccccCccCCCEEEccCC-CCCCCCccccCCC-----------------------------
Q 003140 155 KLDRIQIDQNY--ISG-SLPKSFANLNKTRHFHMNNN-SISGQIPPELSRL----------------------------- 201 (845)
Q Consensus 155 ~L~~L~Ls~N~--l~~-~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~l~~l----------------------------- 201 (845)
+|++|+|++|. ++. .++..+.++++|+.|+|++| .+.+ ++..+..+
T Consensus 185 ~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~ 263 (594)
T 2p1m_B 185 SLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSG 263 (594)
T ss_dssp CCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHT
T ss_pred cCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHHHHhc
Confidence 88888888886 221 11222344578888888877 2221 33333333
Q ss_pred -------------------------CCcceeeccccccccCCC-cccCCCCCCcEEEccCCcCCCCCCccccccCCCccE
Q 003140 202 -------------------------PSLVHMLLDNNNLTGYLP-PELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLK 255 (845)
Q Consensus 202 -------------------------~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~ 255 (845)
++|++|+|++|.+++... ..+..+++|++|++++| +....++.....+++|++
T Consensus 264 ~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~ 342 (594)
T 2p1m_B 264 CKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRE 342 (594)
T ss_dssp CTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCE
T ss_pred CCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCE
Confidence 445555555554432211 11334445555555544 221111222223455555
Q ss_pred EEccc---------CCCCCCCC-CC-CCCCCccEEEcccccCCcCCCCCCC--ccccCEEEcc--C----CcCCCC----
Q 003140 256 LSLRN---------CSLQGPMP-DL-SRIPNLGYLDLSSNQLNGSIPPGRL--SLNITTIKLS--N----NKLTGT---- 312 (845)
Q Consensus 256 L~Ls~---------N~l~~~~~-~l-~~l~~L~~L~Ls~N~l~~~ip~~~~--~~~L~~L~Ls--~----N~l~~~---- 312 (845)
|++++ +.+++... .+ ..+++|+.|+++.|.+++....... ..+|+.|+|+ + |.++..
T Consensus 343 L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~ 422 (594)
T 2p1m_B 343 LRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDI 422 (594)
T ss_dssp EEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHH
T ss_pred EEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhh
Confidence 55522 22221100 01 1245666666666666543222211 2366677776 3 444421
Q ss_pred -cccccCCCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCC-C--CCCCCcEEEecCCcc
Q 003140 313 -IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F--NIPPNVTVRLRGNPF 384 (845)
Q Consensus 313 -~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~-~--~~~~l~~l~l~~Np~ 384 (845)
++..+..+++|+.|+|++ .+++..+..+.. ..++|+.|+|++|.++..... + .++.++.|++++|++
T Consensus 423 ~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~----~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~ 493 (594)
T 2p1m_B 423 GFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGT----YAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF 493 (594)
T ss_dssp HHHHHHHHCTTCCEEECCS-SCCHHHHHHHHH----HCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSC
T ss_pred HHHHHHhhCCCccEEeecC-cccHHHHHHHHH----hchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCC
Confidence 122245566666666655 555444444433 123466788888777532111 1 367778888887775
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.67 E-value=1.4e-16 Score=159.05 Aligned_cols=129 Identities=22% Similarity=0.244 Sum_probs=63.1
Q ss_pred eEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcc-cccccccchhhhccCCCCCCCCCCccCCCCccceeeccc
Q 003140 85 RELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPK-EIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQ 163 (845)
Q Consensus 85 ~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 163 (845)
+.|++++++|+ .+|..+.. +|++|+|++|+|++..+. .|.++++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 34566666653 34443332 555555555555543332 244555555555555555544444444444444444444
Q ss_pred ccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCC
Q 003140 164 NYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240 (845)
Q Consensus 164 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 240 (845)
|+|++..+ ..|..+++|++|+|++|++++..|..|..+++|++|+|++|.+++
T Consensus 88 N~l~~~~~------------------------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 140 (192)
T 1w8a_A 88 NKIKEISN------------------------KMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp CCCCEECS------------------------SSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred CcCCccCH------------------------HHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence 44444333 334444444444444444444444445555555555555555543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.66 E-value=1.2e-16 Score=159.62 Aligned_cols=105 Identities=15% Similarity=0.264 Sum_probs=54.4
Q ss_pred hhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCc-cccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccc
Q 003140 133 ELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPK-SFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDN 211 (845)
Q Consensus 133 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 211 (845)
++|++++|+++ .+|..+.. +|++|+|++|+|++..+. .|..+++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 45666666665 55554432 556666666665544433 255555555555555555544455555555555555555
Q ss_pred cccccCCCcccCCCCCCcEEEccCCcCCC
Q 003140 212 NNLTGYLPPELSELPKLLILQLDNNNFEG 240 (845)
Q Consensus 212 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 240 (845)
|+|++..+..|..+++|++|+|++|++++
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 116 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISC 116 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCE
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCe
Confidence 55554444444444444444444444443
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.66 E-value=2.5e-16 Score=154.93 Aligned_cols=136 Identities=20% Similarity=0.260 Sum_probs=84.4
Q ss_pred CCCCCCCcceEecCCCCCCCcceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCC
Q 003140 61 DPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140 (845)
Q Consensus 61 ~~c~~~w~Gv~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 140 (845)
+.|.|.|+++.|... +++ .+|..+ .++|++|+|++|++++..+..|.++++|++|+|++|
T Consensus 3 ~~C~C~~~~l~~~~~-----------------~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 62 (177)
T 2o6r_A 3 SRCSCSGTEIRCNSK-----------------GLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQN 62 (177)
T ss_dssp TTCEEETTEEECCSS-----------------CCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSS
T ss_pred CCCEeCCCEEEecCC-----------------CCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCC
Confidence 457667888888542 333 233332 257777788777777655556677777777777777
Q ss_pred CCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeecccccccc
Q 003140 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTG 216 (845)
Q Consensus 141 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 216 (845)
++++..+..|..+++|++|+|++|+|++..+..+..+++|++|+|++|++++..+..+..+++|++|+|++|.+++
T Consensus 63 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 63 QIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred cceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 7775555556667777777777777665555556666666666666666664444344555555555555555553
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.7e-16 Score=154.67 Aligned_cols=133 Identities=23% Similarity=0.241 Sum_probs=91.2
Q ss_pred CCCccEEEecCCCCC-CCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEE
Q 003140 105 LSYLTILDFMWNKIS-GSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHF 183 (845)
Q Consensus 105 L~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 183 (845)
.++|++|+|++|+++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+.++++|++|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 366777777777776 66777777777777777777777754 667777777777777777776666666667777777
Q ss_pred EccCCCCCCCC-ccccCCCCCcceeeccccccccCCC---cccCCCCCCcEEEccCCcCC
Q 003140 184 HMNNNSISGQI-PPELSRLPSLVHMLLDNNNLTGYLP---PELSELPKLLILQLDNNNFE 239 (845)
Q Consensus 184 ~L~~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~~p---~~l~~l~~L~~L~Ls~N~l~ 239 (845)
+|++|++++.. +..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+.
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 77777776432 2566666666777776666664433 35666666666666666654
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.65 E-value=2.8e-16 Score=153.20 Aligned_cols=132 Identities=21% Similarity=0.307 Sum_probs=64.8
Q ss_pred Cccceeeccccccc-CCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEE
Q 003140 154 PKLDRIQIDQNYIS-GSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQ 232 (845)
Q Consensus 154 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 232 (845)
++|++|+|++|.++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 34444444444444 33444444444444444444444432 3444445555555555555544444444455555555
Q ss_pred ccCCcCCCCCCccccccCCCccEEEcccCCCCCCCC----CCCCCCCccEEEcccccCC
Q 003140 233 LDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP----DLSRIPNLGYLDLSSNQLN 287 (845)
Q Consensus 233 Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~----~l~~l~~L~~L~Ls~N~l~ 287 (845)
|++|++++...+..+..+++|+.|++++|++++.++ .+..+++|++|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 555555432122445555555555555555555544 3555555666666655555
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.64 E-value=1.6e-18 Score=204.36 Aligned_cols=295 Identities=12% Similarity=0.103 Sum_probs=191.5
Q ss_pred ceEeEEEecCC-CCccc-CCCCccCCCCccEEEecCCCCCCCCccccc----ccccchhhhccCCCCCCCCC-Cc----c
Q 003140 82 LHLRELQLLNL-NLSGN-LSPEIGRLSYLTILDFMWNKISGSIPKEIG----NIKSLELLLLNGNELTGSLP-EE----L 150 (845)
Q Consensus 82 ~~v~~L~L~~~-~l~~~-~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~----~l~~L~~L~Ls~N~l~~~~p-~~----~ 150 (845)
.+++.|+|.+| .++.. ++..+..+++|++|+|++|.+++..+..+. .+++|++|+|++|. . .+. .. +
T Consensus 130 ~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~-~~~~~~l~~l~ 207 (594)
T 2p1m_B 130 KNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-S-EVSFSALERLV 207 (594)
T ss_dssp TTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-S-CCCHHHHHHHH
T ss_pred CCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-C-cCCHHHHHHHH
Confidence 46777888777 44432 333344677788888877777655444333 45577777777775 1 111 11 2
Q ss_pred CCCCccceeeccccc--------------------------------------------------ccC----CCCccccC
Q 003140 151 GYLPKLDRIQIDQNY--------------------------------------------------ISG----SLPKSFAN 176 (845)
Q Consensus 151 ~~l~~L~~L~Ls~N~--------------------------------------------------l~~----~~p~~~~~ 176 (845)
..+++|++|+|++|. +.. .++..+..
T Consensus 208 ~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~~ 287 (594)
T 2p1m_B 208 TRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSV 287 (594)
T ss_dssp HHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGGGGGGHHH
T ss_pred HhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchhhHHHHHHh
Confidence 334666666666551 111 12223336
Q ss_pred ccCCCEEEccCCCCCCCC-ccccCCCCCcceeeccccccccC-CCcccCCCCCCcEEEcc---------CCcCCCCCCcc
Q 003140 177 LNKTRHFHMNNNSISGQI-PPELSRLPSLVHMLLDNNNLTGY-LPPELSELPKLLILQLD---------NNNFEGTTIPA 245 (845)
Q Consensus 177 l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~Ls---------~N~l~~~~~p~ 245 (845)
+++|+.|+|++|.+++.. ...+..+++|++|++++| ++.. ++.....+++|++|+|+ .+.+++..+..
T Consensus 288 ~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~ 366 (594)
T 2p1m_B 288 CSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVS 366 (594)
T ss_dssp HTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHH
T ss_pred hCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHH
Confidence 789999999999976432 233568899999999998 4422 22223357899999994 35555422222
Q ss_pred ccccCCCccEEEcccCCCCCCCC-CC-CCCCCccEEEcc--c----ccCCcCCCC------CCCccccCEEEccCCcCCC
Q 003140 246 SYSNMSKLLKLSLRNCSLQGPMP-DL-SRIPNLGYLDLS--S----NQLNGSIPP------GRLSLNITTIKLSNNKLTG 311 (845)
Q Consensus 246 ~~~~l~~L~~L~Ls~N~l~~~~~-~l-~~l~~L~~L~Ls--~----N~l~~~ip~------~~~~~~L~~L~Ls~N~l~~ 311 (845)
...++++|+.|+++.|.+++... .+ ..+++|+.|+++ + |.+++...+ .....+|+.|+|++ .+++
T Consensus 367 l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~ 445 (594)
T 2p1m_B 367 VSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTD 445 (594)
T ss_dssp HHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCH
T ss_pred HHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccH
Confidence 23458999999999999876433 23 257899999999 4 556522111 11124899999987 7777
Q ss_pred CcccccCC-CCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCC--CC-CCCCCcEEEecCCcc
Q 003140 312 TIPSNFSG-LPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG--SF-NIPPNVTVRLRGNPF 384 (845)
Q Consensus 312 ~~p~~~~~-l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~--~~-~~~~l~~l~l~~Np~ 384 (845)
..+..+.. +++|++|+|++|.+++..+..+.. ..++|+.|+|++|.++.... .. .++.++.|++++|+.
T Consensus 446 ~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~----~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 446 KVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLS----GCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp HHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHH----HCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred HHHHHHHHhchhccEeeccCCCCcHHHHHHHHh----cCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 66666666 899999999999998766655522 13457799999999954222 12 378999999999986
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.2e-15 Score=152.47 Aligned_cols=125 Identities=24% Similarity=0.315 Sum_probs=66.1
Q ss_pred EEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeeccccc
Q 003140 86 ELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNY 165 (845)
Q Consensus 86 ~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 165 (845)
.+++++++|+ .+|..+. ++|++|+|++|+|+ .+|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 4666666666 3444332 45666666666665 455556666666666666666665555555555555555555555
Q ss_pred ccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeecccccc
Q 003140 166 ISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNL 214 (845)
Q Consensus 166 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l 214 (845)
|++..+..|.++++|+.|+|++|+|+...+..|..+++|+.|+|++|.+
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~ 138 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPL 138 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCE
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCe
Confidence 5544444455555555555555554433333334444444444444433
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.7e-15 Score=151.17 Aligned_cols=128 Identities=24% Similarity=0.340 Sum_probs=116.7
Q ss_pred cEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCC
Q 003140 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN 188 (845)
Q Consensus 109 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 188 (845)
+.+++++|+++ .+|..+. ++|++|+|++|+|+ .+|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 57999999998 6776664 58999999999998 78899999999999999999999888889999999999999999
Q ss_pred CCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCC
Q 003140 189 SISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240 (845)
Q Consensus 189 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 240 (845)
+|++..+..|..+++|++|+|++|+|+...+..|..+++|+.|+|++|.+..
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 9998888899999999999999999997777779999999999999999975
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.62 E-value=2.1e-16 Score=150.73 Aligned_cols=109 Identities=23% Similarity=0.256 Sum_probs=54.2
Q ss_pred CCccEEEecCCCCC-CCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEE
Q 003140 106 SYLTILDFMWNKIS-GSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFH 184 (845)
Q Consensus 106 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 184 (845)
++|++|++++|.++ +.+|..+..+++|++|+|++|++++. ..+..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 44555555555555 44555555555555555555555533 4455555555555555555544444444455555555
Q ss_pred ccCCCCCCC-CccccCCCCCcceeecccccccc
Q 003140 185 MNNNSISGQ-IPPELSRLPSLVHMLLDNNNLTG 216 (845)
Q Consensus 185 L~~N~l~~~-~p~~l~~l~~L~~L~L~~N~l~~ 216 (845)
+++|++++. .+..+..+++|++|++++|++++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~ 127 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTN 127 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGG
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccc
Confidence 555555431 12344444444444444444443
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=8.3e-16 Score=167.53 Aligned_cols=139 Identities=17% Similarity=0.192 Sum_probs=102.3
Q ss_pred cCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCCh-----h---------hH--------HHHHHHHHHHHhcCCCc
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL-----Q---------GE--------KEFLTEIQFLSRLHHRN 681 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~-----~---------~~--------~~~~~Ei~~l~~l~H~n 681 (845)
.-|.+.+.||+|+||.||+|...+|+.||||+++.... . .. ....+|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34888999999999999999999999999998753210 0 00 11245677777775544
Q ss_pred ee--eEEEEEeeCCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 003140 682 LV--SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD 759 (845)
Q Consensus 682 Iv--~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~ 759 (845)
+. ..+++ . ..+|||||+++++|.++... .....++.|++.+|.|||+.+ ||||||||.|||++
T Consensus 175 v~vp~p~~~--~--~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~ 239 (397)
T 4gyi_A 175 FPVPEPIAQ--S--RHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIR 239 (397)
T ss_dssp CSCCCEEEE--E--TTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred CCCCeeeec--c--CceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEe
Confidence 32 23322 1 23799999999888654321 123467899999999999998 99999999999998
Q ss_pred CCC----------cEEEEecCCcccCCC
Q 003140 760 HKF----------TAKVADFGLSRLAPV 777 (845)
Q Consensus 760 ~~~----------~~kl~DFGla~~~~~ 777 (845)
+++ .+.|+||+-+.....
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEETTS
T ss_pred CCCCcccccccccceEEEEeCCcccCCC
Confidence 876 389999998765443
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.60 E-value=4.4e-15 Score=146.03 Aligned_cols=130 Identities=22% Similarity=0.247 Sum_probs=94.2
Q ss_pred ccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccC
Q 003140 108 LTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNN 187 (845)
Q Consensus 108 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 187 (845)
.+.+++++|+++ .+|..+. ++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 466788888877 4554443 5788888888888766666677788888888888888766666677777777888877
Q ss_pred CCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCC
Q 003140 188 NSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240 (845)
Q Consensus 188 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 240 (845)
|+|++..+..+..+++|++|+|++|++++..+..+..+++|++|+|++|.+++
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 77776666666777777777777777775555556667777777777777765
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.59 E-value=6.1e-16 Score=147.54 Aligned_cols=127 Identities=19% Similarity=0.259 Sum_probs=76.9
Q ss_pred ccchhhhccCCCCC-CCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceee
Q 003140 130 KSLELLLLNGNELT-GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHML 208 (845)
Q Consensus 130 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 208 (845)
++|+.|++++|.++ +.+|..+..+++|++|+|++|.+++. ..+.++++|++|+|++|.+++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 56677777777766 56666666677777777777766644 5566666666666666666655555555566666666
Q ss_pred ccccccccC-CCcccCCCCCCcEEEccCCcCCCCCCc---cccccCCCccEEEcc
Q 003140 209 LDNNNLTGY-LPPELSELPKLLILQLDNNNFEGTTIP---ASYSNMSKLLKLSLR 259 (845)
Q Consensus 209 L~~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~~p---~~~~~l~~L~~L~Ls 259 (845)
+++|++++. .+..+..+++|++|++++|++++ ..+ ..+..+++|+.|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTN-LNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGG-STTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccc-hHHHHHHHHHHCCCcccccCC
Confidence 666666542 22455556666666666666654 122 245555555555544
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.51 E-value=7.5e-15 Score=144.25 Aligned_cols=134 Identities=18% Similarity=0.223 Sum_probs=87.9
Q ss_pred CCccCCCCccEEEecCCCCCCCCcccccccc-cchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCcc
Q 003140 100 PEIGRLSYLTILDFMWNKISGSIPKEIGNIK-SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLN 178 (845)
Q Consensus 100 ~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 178 (845)
+.+..+.+|++|+|++|+++. +|. +..+. +|++|+|++|++++. ..+..+++|++|+|++|+|++..+..+..++
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 88 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALP 88 (176)
T ss_dssp CEEECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred HhcCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCC
Confidence 345667777888888887773 443 44444 777777777777753 5677777777777777777755444557777
Q ss_pred CCCEEEccCCCCCCCCcc--ccCCCCCcceeeccccccccCCCcc----cCCCCCCcEEEccCCcCC
Q 003140 179 KTRHFHMNNNSISGQIPP--ELSRLPSLVHMLLDNNNLTGYLPPE----LSELPKLLILQLDNNNFE 239 (845)
Q Consensus 179 ~L~~L~L~~N~l~~~~p~--~l~~l~~L~~L~L~~N~l~~~~p~~----l~~l~~L~~L~Ls~N~l~ 239 (845)
+|++|+|++|+|+ .+|. .+..+++|+.|++++|.++. +|.. +..+++|+.|++++|.+.
T Consensus 89 ~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 89 DLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp TCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHH
Confidence 7777777777775 4454 56666667777777666663 3332 555666666666666553
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.50 E-value=1.1e-14 Score=158.20 Aligned_cols=213 Identities=15% Similarity=0.180 Sum_probs=105.5
Q ss_pred CCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeecccccc----ccCCCcccCCCCCC
Q 003140 153 LPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNL----TGYLPPELSELPKL 228 (845)
Q Consensus 153 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l----~~~~p~~l~~l~~L 228 (845)
+++|+.|+|.+ .++.+.+.+|.++++|+.|++++|.+....+.+|..+.++..+.+..+.. .......|.++..|
T Consensus 100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L 178 (329)
T 3sb4_A 100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL 178 (329)
T ss_dssp CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence 66666666666 55544555566666666666666666544455555555555555544221 11112233333344
Q ss_pred c-EEEccCCcCCCCCCcccc----ccCCCccEEEcccCCCCCCCCCC-CCCCCccEEEcccccCCcCCCCCCCc--cccC
Q 003140 229 L-ILQLDNNNFEGTTIPASY----SNMSKLLKLSLRNCSLQGPMPDL-SRIPNLGYLDLSSNQLNGSIPPGRLS--LNIT 300 (845)
Q Consensus 229 ~-~L~Ls~N~l~~~~~p~~~----~~l~~L~~L~Ls~N~l~~~~~~l-~~l~~L~~L~Ls~N~l~~~ip~~~~~--~~L~ 300 (845)
+ .+.+....- ++..+ ....++..+.+.++-.......+ ..+++|+.|+|++|+++ .+|...+. .+|+
T Consensus 179 ~~~i~~~~~~~----l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~-~I~~~aF~~~~~L~ 253 (329)
T 3sb4_A 179 ETTIQVGAMGK----LEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNAT-TIPDFTFAQKKYLL 253 (329)
T ss_dssp EEEEEECTTCC----HHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCC-EECTTTTTTCTTCC
T ss_pred ceeEEecCCCc----HHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcc-eecHhhhhCCCCCC
Confidence 3 222221110 01100 01223333333322110000000 12456666666666666 44443322 2666
Q ss_pred EEEccCCcCCCCcccccCCCCCCC-eEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCC-C-CCCCCcEE
Q 003140 301 TIKLSNNKLTGTIPSNFSGLPRLQ-RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTV 377 (845)
Q Consensus 301 ~L~Ls~N~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~-~-~~~~l~~l 377 (845)
.|+|.+| ++...+..|.++++|+ .|++.+ .++...+..|..+ .+|+.+++++|+++.|+.. | ..+.++.+
T Consensus 254 ~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c-----~~L~~l~l~~n~i~~I~~~aF~~~~~L~~l 326 (329)
T 3sb4_A 254 KIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGC-----DNLRYVLATGDKITTLGDELFGNGVPSKLI 326 (329)
T ss_dssp EEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTC-----TTEEEEEECSSCCCEECTTTTCTTCCCCEE
T ss_pred EEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCC-----ccCCEEEeCCCccCccchhhhcCCcchhhh
Confidence 6666666 5555566677777777 777766 5554444455443 3345777777777777664 2 35666666
Q ss_pred E
Q 003140 378 R 378 (845)
Q Consensus 378 ~ 378 (845)
+
T Consensus 327 y 327 (329)
T 3sb4_A 327 Y 327 (329)
T ss_dssp E
T ss_pred c
Confidence 5
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.50 E-value=6.2e-17 Score=162.50 Aligned_cols=130 Identities=20% Similarity=0.296 Sum_probs=63.3
Q ss_pred CCccEEEecCCCCCCCCcc------cccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccC
Q 003140 106 SYLTILDFMWNKISGSIPK------EIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNK 179 (845)
Q Consensus 106 ~~L~~L~L~~N~l~~~~p~------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 179 (845)
..++.++|+.+.++|.+|. .|.++++|++|+|++|++++ +| .+..+++|++|+|++|+++ .+|..+..+++
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~ 94 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADT 94 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence 3444444444444444443 45555555555555555553 34 4555555555555555555 34444444455
Q ss_pred CCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCC-cccCCCCCCcEEEccCCcCCC
Q 003140 180 TRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLP-PELSELPKLLILQLDNNNFEG 240 (845)
Q Consensus 180 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~ 240 (845)
|++|+|++|++++ +| .+..+++|++|+|++|++++..+ ..+..+++|++|++++|.+++
T Consensus 95 L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~ 154 (198)
T 1ds9_A 95 LEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp CSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHH
T ss_pred CCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccc
Confidence 5555555555543 22 34445555555555555543211 234555555555555555543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.50 E-value=6.2e-17 Score=162.53 Aligned_cols=155 Identities=22% Similarity=0.304 Sum_probs=116.9
Q ss_pred ccccccchhhhccCCCCCCCCCC------ccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccC
Q 003140 126 IGNIKSLELLLLNGNELTGSLPE------ELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELS 199 (845)
Q Consensus 126 ~~~l~~L~~L~Ls~N~l~~~~p~------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~ 199 (845)
+.....++.++++.+.++|.+|. .+..+++|++|+|++|++++ +| .+.++++|++|++++|.++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 55667888999999999888887 78888889999999888886 56 7888888888888888888 6677777
Q ss_pred CCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCCC----------
Q 003140 200 RLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD---------- 269 (845)
Q Consensus 200 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~---------- 269 (845)
.+++|++|+|++|++++ +| .+..+++|++|+|++|++++......+..+++|++|++++|.+++..+.
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~ 168 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIE 168 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHH
T ss_pred cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHH
Confidence 77888888888888885 33 5777778888888888886421123677777788888877777665443
Q ss_pred -CCCCCCccEEEcccccCC
Q 003140 270 -LSRIPNLGYLDLSSNQLN 287 (845)
Q Consensus 270 -l~~l~~L~~L~Ls~N~l~ 287 (845)
+..+++|+.|| +|.++
T Consensus 169 ~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 169 VVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHHHCSSCSEEC--CGGGT
T ss_pred HHHhCCCcEEEC--CcccC
Confidence 55666777665 45544
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.49 E-value=1.5e-14 Score=142.01 Aligned_cols=132 Identities=23% Similarity=0.265 Sum_probs=72.8
Q ss_pred cccccccchhhhccCCCCCCCCCCccCCCC-ccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCC
Q 003140 125 EIGNIKSLELLLLNGNELTGSLPEELGYLP-KLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPS 203 (845)
Q Consensus 125 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 203 (845)
.+.++.+|++|+|++|+++ .+|. +..+. +|++|+|++|.|++. ..+..+++|++|+|++|+|++..+..+..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 3556667777777777776 3443 33333 677777777766643 45566666666666666666433333455566
Q ss_pred cceeeccccccccCCCc--ccCCCCCCcEEEccCCcCCCCCCccc----cccCCCccEEEcccCCC
Q 003140 204 LVHMLLDNNNLTGYLPP--ELSELPKLLILQLDNNNFEGTTIPAS----YSNMSKLLKLSLRNCSL 263 (845)
Q Consensus 204 L~~L~L~~N~l~~~~p~--~l~~l~~L~~L~Ls~N~l~~~~~p~~----~~~l~~L~~L~Ls~N~l 263 (845)
|++|+|++|+++ .+|. .+..+++|+.|++++|.++. +|.. +..+++|+.|++++|.+
T Consensus 90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~--~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN--KKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG--STTHHHHHHHHCTTCSEETTEECCH
T ss_pred CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC--cHhHHHHHHHHCCccceeCCCcCCH
Confidence 666666666554 2333 45555555555555555542 3332 44455555555544443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.46 E-value=4.9e-14 Score=153.22 Aligned_cols=238 Identities=13% Similarity=0.101 Sum_probs=142.0
Q ss_pred CCCccEEEecCCCCC--------------------CCCcccccc--------cccchhhhccCCCCCCCCCCccCCCCcc
Q 003140 105 LSYLTILDFMWNKIS--------------------GSIPKEIGN--------IKSLELLLLNGNELTGSLPEELGYLPKL 156 (845)
Q Consensus 105 L~~L~~L~L~~N~l~--------------------~~~p~~~~~--------l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 156 (845)
+++|++|||++|++. ...+..|.+ +++|+.|+|.+ .++..-+..|.++++|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L 126 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNL 126 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTC
T ss_pred hccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCccc
Confidence 566666666666665 122356777 99999999999 8886667789999999
Q ss_pred ceeecccccccCCCCccccCccCCCEEEccCCCC----CCCCccccCCCCCcc-eeeccccc-cccCCCcccCCCCCCcE
Q 003140 157 DRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSI----SGQIPPELSRLPSLV-HMLLDNNN-LTGYLPPELSELPKLLI 230 (845)
Q Consensus 157 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l----~~~~p~~l~~l~~L~-~L~L~~N~-l~~~~p~~l~~l~~L~~ 230 (845)
+.|+|++|.++...+..|.++.++..+.+..+.. .......|..+..|+ .+.+.... +...+...-....++..
T Consensus 127 ~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~ 206 (329)
T 3sb4_A 127 KICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINF 206 (329)
T ss_dssp CEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSE
T ss_pred ceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccCccccce
Confidence 9999999999877888999988888877766322 222234455556666 34443221 00000001112334555
Q ss_pred EEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCCC-CCCCCCccEEEcccccCCcCCCCCCCc--cccC-EEEccC
Q 003140 231 LQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLS--LNIT-TIKLSN 306 (845)
Q Consensus 231 L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~ip~~~~~--~~L~-~L~Ls~ 306 (845)
+.+.++-... ........+++|+.|+|++|+++..++. |..+++|+.|+|.+| ++ .++...+. .+|+ .|+|.+
T Consensus 207 l~~~~~l~~~-~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~ 283 (329)
T 3sb4_A 207 LTIEGKLDNA-DFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA 283 (329)
T ss_dssp EEEEECCCHH-HHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT
T ss_pred EEEeeeecHH-HHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc
Confidence 5554432210 1111112356666666666666665553 666666666666666 44 34443322 2566 666666
Q ss_pred CcCCCCcccccCCCCCCCeEecccccCcccCChhhhhhccC
Q 003140 307 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 347 (845)
Q Consensus 307 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l 347 (845)
.++...+..|.++++|+.|++++|+++..-+..|..+.+|
T Consensus 284 -~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L 323 (329)
T 3sb4_A 284 -SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPS 323 (329)
T ss_dssp -TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCC
T ss_pred -cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcch
Confidence 5665556677777777777777777764444555554443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.44 E-value=1.2e-12 Score=145.86 Aligned_cols=254 Identities=9% Similarity=0.130 Sum_probs=191.5
Q ss_pred CCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCc
Q 003140 93 NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPK 172 (845)
Q Consensus 93 ~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 172 (845)
+++..-..+|.+. +|+.+.|..| ++..-..+|.+. +|+.+.|.. .++..-+..|.++++|+.++|++|+++.....
T Consensus 123 ~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~ 198 (401)
T 4fdw_A 123 SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPAS 198 (401)
T ss_dssp TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTT
T ss_pred ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechh
Confidence 4444445577764 7999999876 765666778774 799999986 66656667899999999999999999855555
Q ss_pred cccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCC
Q 003140 173 SFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSK 252 (845)
Q Consensus 173 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~ 252 (845)
.|. ..+|+.+.|.++ ++..-..+|.++++|+.+++.+| ++..-..+|.. .+|+.+.|. |.++. .....|.++++
T Consensus 199 aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~-I~~~aF~~c~~ 272 (401)
T 4fdw_A 199 TFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTN-IASRAFYYCPE 272 (401)
T ss_dssp TTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCE-ECTTTTTTCTT
T ss_pred hEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccE-EChhHhhCCCC
Confidence 666 689999999854 66566778999999999999875 56555667777 789999994 55653 45678999999
Q ss_pred ccEEEcccCCCC-----CCCC-CCCCCCCccEEEcccccCCcCCCCCCC-c-cccCEEEccCCcCCCCcccccCCCCCCC
Q 003140 253 LLKLSLRNCSLQ-----GPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRL-S-LNITTIKLSNNKLTGTIPSNFSGLPRLQ 324 (845)
Q Consensus 253 L~~L~Ls~N~l~-----~~~~-~l~~l~~L~~L~Ls~N~l~~~ip~~~~-~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 324 (845)
|+.+++.+|.+. .... .|..+++|+.++|.+ .++ .++...+ . .+|+.|+|..| ++.....+|.++ +|+
T Consensus 273 L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~-~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~ 348 (401)
T 4fdw_A 273 LAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIR-ILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIK 348 (401)
T ss_dssp CCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCC-EECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCC
T ss_pred CCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceE-EEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCC
Confidence 999999998876 2222 488999999999994 476 5555443 3 58999999655 776778889999 999
Q ss_pred eEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCC
Q 003140 325 RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 364 (845)
Q Consensus 325 ~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~ 364 (845)
.|++.+|.+....+..|..+. ..+..|.+..|.+..
T Consensus 349 ~l~l~~n~~~~l~~~~F~~~~----~~l~~l~vp~~~~~~ 384 (401)
T 4fdw_A 349 EVKVEGTTPPQVFEKVWYGFP----DDITVIRVPAESVEK 384 (401)
T ss_dssp EEEECCSSCCBCCCSSCCCSC----TTCCEEEECGGGHHH
T ss_pred EEEEcCCCCcccccccccCCC----CCccEEEeCHHHHHH
Confidence 999999988755455554432 245678888877654
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.43 E-value=2.6e-13 Score=132.33 Aligned_cols=104 Identities=20% Similarity=0.251 Sum_probs=55.4
Q ss_pred eEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccc
Q 003140 85 RELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164 (845)
Q Consensus 85 ~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 164 (845)
+.|++++++|+. +|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 12 ~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 455666666553 444332 55555555555555555555555555555555555555444444555555555555555
Q ss_pred cccCCCCccccCccCCCEEEccCCCCC
Q 003140 165 YISGSLPKSFANLNKTRHFHMNNNSIS 191 (845)
Q Consensus 165 ~l~~~~p~~~~~l~~L~~L~L~~N~l~ 191 (845)
+|++..+..|.++++|+.|+|++|.++
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 555444444555555555555555544
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.42 E-value=4.3e-13 Score=130.78 Aligned_cols=86 Identities=20% Similarity=0.295 Sum_probs=38.6
Q ss_pred CccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEc
Q 003140 154 PKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQL 233 (845)
Q Consensus 154 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 233 (845)
++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 109 (170)
T 3g39_A 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL 109 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence 33444444444444433444444444444444444444333333444444444444444444433334444444555555
Q ss_pred cCCcCC
Q 003140 234 DNNNFE 239 (845)
Q Consensus 234 s~N~l~ 239 (845)
++|.++
T Consensus 110 ~~N~~~ 115 (170)
T 3g39_A 110 LNNPWD 115 (170)
T ss_dssp CSSCBC
T ss_pred CCCCCC
Confidence 555444
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.41 E-value=5e-13 Score=130.85 Aligned_cols=104 Identities=21% Similarity=0.269 Sum_probs=64.7
Q ss_pred eEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccc
Q 003140 85 RELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164 (845)
Q Consensus 85 ~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 164 (845)
+.++++++.|+ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45677777664 4555443 66667777777776666666666666666666666666544444566666666666666
Q ss_pred cccCCCCccccCccCCCEEEccCCCCC
Q 003140 165 YISGSLPKSFANLNKTRHFHMNNNSIS 191 (845)
Q Consensus 165 ~l~~~~p~~~~~l~~L~~L~L~~N~l~ 191 (845)
+|++..+..|..+++|+.|+|++|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 666444444666666666666666655
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.40 E-value=2.7e-12 Score=142.91 Aligned_cols=263 Identities=11% Similarity=0.102 Sum_probs=203.9
Q ss_pred cCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCE
Q 003140 103 GRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRH 182 (845)
Q Consensus 103 ~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 182 (845)
.....++.+.+.+ .++.+-..+|.+. +|+.++|..| ++..-...|.+ .+|+.+.|.. .++...+.+|.++++|+.
T Consensus 110 ~~~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~ 184 (401)
T 4fdw_A 110 EILKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKK 184 (401)
T ss_dssp EECSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCE
T ss_pred EecCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCe
Confidence 3447788888864 5665666778875 7999999877 66555667777 5799999986 777677789999999999
Q ss_pred EEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCC
Q 003140 183 FHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCS 262 (845)
Q Consensus 183 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~ 262 (845)
++|.+|+++......|. ..+|+.+.|.++ ++..-..+|.++++|+.+++..| ++. .-..+|.+ .+|+.+.| .++
T Consensus 185 l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~-I~~~aF~~-~~L~~i~l-p~~ 258 (401)
T 4fdw_A 185 ADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VST-IGQEAFRE-SGITTVKL-PNG 258 (401)
T ss_dssp EECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCE-ECTTTTTT-CCCSEEEE-ETT
T ss_pred eecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccC-cccccccc-CCccEEEe-CCC
Confidence 99999999955555666 689999999855 77677788999999999999876 543 34566777 89999999 566
Q ss_pred CCCCCC-CCCCCCCccEEEcccccCC----cCCCCCCCc--cccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcc
Q 003140 263 LQGPMP-DLSRIPNLGYLDLSSNQLN----GSIPPGRLS--LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSG 335 (845)
Q Consensus 263 l~~~~~-~l~~l~~L~~L~Ls~N~l~----~~ip~~~~~--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 335 (845)
++.... .|..+++|+.+++.+|.+. ..++...+. .+|+.++|. |.++......|.++++|+.|.|.+| ++.
T Consensus 259 i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~ 336 (401)
T 4fdw_A 259 VTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQ 336 (401)
T ss_dssp CCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCE
T ss_pred ccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccE
Confidence 766554 5999999999999998875 124444333 389999999 5588778889999999999999665 664
Q ss_pred cCChhhhhhccCCCCcceEEEccCCCCCCCCCCC--CCC-CCcEEEecCCcc
Q 003140 336 SIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIP-PNVTVRLRGNPF 384 (845)
Q Consensus 336 ~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~--~~~-~l~~l~l~~Np~ 384 (845)
.-+..|..+ +|+.+++++|.+..++... .++ .+..|++..|..
T Consensus 337 I~~~aF~~~------~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~ 382 (401)
T 4fdw_A 337 INFSAFNNT------GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV 382 (401)
T ss_dssp ECTTSSSSS------CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred EcHHhCCCC------CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence 444555443 5669999999999888763 454 667899887764
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.39 E-value=9.1e-13 Score=129.00 Aligned_cols=80 Identities=21% Similarity=0.360 Sum_probs=38.0
Q ss_pred cEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCC
Q 003140 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN 188 (845)
Q Consensus 109 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 188 (845)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45555555554 4444332 44555555555555444444555555555555555444333333344444444444444
Q ss_pred CCC
Q 003140 189 SIS 191 (845)
Q Consensus 189 ~l~ 191 (845)
+|+
T Consensus 92 ~l~ 94 (174)
T 2r9u_A 92 HLK 94 (174)
T ss_dssp CCC
T ss_pred ccc
Confidence 444
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.32 E-value=1.7e-12 Score=142.11 Aligned_cols=111 Identities=17% Similarity=0.262 Sum_probs=92.7
Q ss_pred CC-CCCCcceEecCCCCCCCcceEeEEEecCC-CCcccCCCCccCCCCccEEEecC-CCCCCCCcccccccccchhhhcc
Q 003140 62 PC-TSNWTGVLCFNTTMDDGYLHLRELQLLNL-NLSGNLSPEIGRLSYLTILDFMW-NKISGSIPKEIGNIKSLELLLLN 138 (845)
Q Consensus 62 ~c-~~~w~Gv~C~~~~~~~~~~~v~~L~L~~~-~l~~~~~~~l~~L~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls 138 (845)
.| .|.|..|.|. ++ +|++ +|. |..+++|++|+|++ |.|++..+..|.+|++|++|+|+
T Consensus 4 ~c~~C~~~~v~~~-----------------~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~ 64 (347)
T 2ifg_A 4 ACCPHGSSGLRCT-----------------RDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64 (347)
T ss_dssp SSCCSSSSCEECC-----------------SSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECC
T ss_pred cCccccCCEEEcC-----------------CCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECC
Confidence 46 5567777774 33 5664 777 99999999999996 99998888889999999999999
Q ss_pred CCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCC
Q 003140 139 GNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG 192 (845)
Q Consensus 139 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 192 (845)
+|+|++..|..|.+|++|++|+|++|+|++..+..|..++ |+.|+|.+|.|..
T Consensus 65 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 65 KSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp SSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred CCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 9999988888999999999999999999976666676666 9999999998874
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=1.8e-11 Score=128.13 Aligned_cols=145 Identities=14% Similarity=0.081 Sum_probs=113.6
Q ss_pred HhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCeEEEEEE
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~E 700 (845)
..+.|.....++.|+.+.||+.... ++.+++|+..........++.+|+++++.+. |..+.++++++.+.+..++|||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 3456777888898999999999764 6889999986522222346889999999984 6778899999999899999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE--------------------------------------- 741 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------------- 741 (845)
|++|.+|.+.+.. ......++.++++++..||+.
T Consensus 91 ~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 91 EADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred ecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 9999999876321 112346788999999999981
Q ss_pred -----------------CCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003140 742 -----------------ADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (845)
Q Consensus 742 -----------------~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~ 774 (845)
..+.++|+|+++.||+++++..+.|+||+.+..
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 114489999999999998776678999998753
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.22 E-value=8.1e-12 Score=136.63 Aligned_cols=102 Identities=17% Similarity=0.216 Sum_probs=51.8
Q ss_pred EEecCC-CCCCCCcccccccccchhhhccC-CCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCC
Q 003140 111 LDFMWN-KISGSIPKEIGNIKSLELLLLNG-NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN 188 (845)
Q Consensus 111 L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 188 (845)
++++++ +|+ .+|. |..+++|++|+|++ |+|++..+..|.+|++|++|+|++|+|++..|..|.+|++|+.|+|++|
T Consensus 13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 455555 555 3454 55555555555553 5555444455555555555555555555555555555555555555555
Q ss_pred CCCCCCccccCCCCCcceeeccccccc
Q 003140 189 SISGQIPPELSRLPSLVHMLLDNNNLT 215 (845)
Q Consensus 189 ~l~~~~p~~l~~l~~L~~L~L~~N~l~ 215 (845)
+|++..+..+..++ |+.|+|.+|.+.
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 55533333333333 444444444443
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.20 E-value=1e-13 Score=152.88 Aligned_cols=47 Identities=17% Similarity=0.185 Sum_probs=28.4
Q ss_pred ccCEEEccCCcCCCC----cccccCCCCCCCeEecccccCcccCChhhhhh
Q 003140 298 NITTIKLSNNKLTGT----IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS 344 (845)
Q Consensus 298 ~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l 344 (845)
+|+.|+|++|.|+.. ++..+...++|++|+|++|.|+......+..+
T Consensus 212 ~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~ 262 (372)
T 3un9_A 212 QLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDL 262 (372)
T ss_dssp CCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHC
T ss_pred CcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHH
Confidence 455555555555432 33445556778888888888876555555543
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.19 E-value=1.9e-13 Score=150.69 Aligned_cols=65 Identities=17% Similarity=0.178 Sum_probs=33.0
Q ss_pred CCCCCCcEEEccCCcCCCC---CCccccccCCCccEEEcccCCCCCCCC-----CCCCCCCccEEEcccccCC
Q 003140 223 SELPKLLILQLDNNNFEGT---TIPASYSNMSKLLKLSLRNCSLQGPMP-----DLSRIPNLGYLDLSSNQLN 287 (845)
Q Consensus 223 ~~l~~L~~L~Ls~N~l~~~---~~p~~~~~l~~L~~L~Ls~N~l~~~~~-----~l~~l~~L~~L~Ls~N~l~ 287 (845)
..+++|++|+|++|.+++. .++..+...++|+.|+|++|.++.... .+...++|++|+|++|.|+
T Consensus 180 ~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~ 252 (372)
T 3un9_A 180 AGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELS 252 (372)
T ss_dssp HTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCC
T ss_pred hcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCC
Confidence 3444555555555554321 113334455556666666666543211 1334456777777777665
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.07 E-value=1.8e-10 Score=120.15 Aligned_cols=129 Identities=21% Similarity=0.152 Sum_probs=98.3
Q ss_pred cccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCc--eeeEEEEEeeCCeEEEEEEcCCCCCHHHH
Q 003140 633 GQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN--LVSLVGYCDEEGEQMLVYEFMSNGTLRDQ 710 (845)
Q Consensus 633 G~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~g~~~~~~~~~LV~E~~~~gsL~~~ 710 (845)
+.|..+.||++...+|+.+++|..... ....+.+|+++++.+.+.+ +.+++++....+..++||||++|.++.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 456669999998877888999997654 2245788999999985444 456889888888899999999998884
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------------
Q 003140 711 LSAKSKEPLGFAMRLSIALGSSRGILYLHTEA------------------------------------------------ 742 (845)
Q Consensus 711 l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------------ 742 (845)
... .+ ...++.++++.+..||+..
T Consensus 104 ~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (264)
T 1nd4_A 104 SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 175 (264)
T ss_dssp TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence 211 11 2356777888888888642
Q ss_pred -------CCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003140 743 -------DPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (845)
Q Consensus 743 -------~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~ 774 (845)
.+.++|||++|.||++++++.+.|+|||.+..
T Consensus 176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12289999999999998877778999998754
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.01 E-value=9.7e-09 Score=114.18 Aligned_cols=279 Identities=13% Similarity=0.012 Sum_probs=147.2
Q ss_pred eEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecc
Q 003140 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162 (845)
Q Consensus 83 ~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 162 (845)
.++++.+.. +++..-..+|.++++|+.++|..+ ++..-...|.++++|+.+.+..+- ...-...|.+...++.....
T Consensus 72 ~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l-~~i~~~aF~~~~~~~~~~~~ 148 (394)
T 4fs7_A 72 KVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLML-KSIGVEAFKGCDFKEITIPE 148 (394)
T ss_dssp TEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTC-CEECTTTTTTCCCSEEECCT
T ss_pred CceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCce-eeecceeeecccccccccCc
Confidence 466666643 355444556777777777777543 443344556666666666554331 11112222222111111111
Q ss_pred cccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCC----------------
Q 003140 163 QNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELP---------------- 226 (845)
Q Consensus 163 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~---------------- 226 (845)
. +......+|.++++|+.+.+.++... .....|..+++|+.+.+..| ++......|.++.
T Consensus 149 ~--~~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~i~~ 224 (394)
T 4fs7_A 149 G--VTVIGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYYLGD 224 (394)
T ss_dssp T--CCEECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCEECT
T ss_pred c--ccccchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceEeeh
Confidence 1 11112234455555555555433221 22334444555555555443 2222223344444
Q ss_pred ------CCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCCcCCCCCC--Cccc
Q 003140 227 ------KLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGR--LSLN 298 (845)
Q Consensus 227 ------~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~--~~~~ 298 (845)
+|+.+.+..+. +. .....|.++.+|+.+.+..+..+-....+.....|+.+.+..+.+ +... ...+
T Consensus 225 ~~~~~~~l~~i~ip~~~-~~-i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~i----~~~~F~~~~~ 298 (394)
T 4fs7_A 225 FALSKTGVKNIIIPDSF-TE-LGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGSVIV----PEKTFYGCSS 298 (394)
T ss_dssp TTTTTCCCCEEEECTTC-CE-ECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECSSEE----CTTTTTTCTT
T ss_pred hhcccCCCceEEECCCc-ee-cccccccccccceeEEcCCCcceeeccccccccccceeccCceee----cccccccccc
Confidence 45555443322 11 223345666677777776665443344566667777776665543 2322 2347
Q ss_pred cCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCC-C-CCCCCcE
Q 003140 299 ITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVT 376 (845)
Q Consensus 299 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~-~-~~~~l~~ 376 (845)
|+.+.+.++ ++.....+|.++.+|+.++|.++ ++..-...|..+. +|+.+++..| ++.|... + ..+.|++
T Consensus 299 L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~-----~L~~i~lp~~-l~~I~~~aF~~C~~L~~ 370 (394)
T 4fs7_A 299 LTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCT-----SLSNINFPLS-LRKIGANAFQGCINLKK 370 (394)
T ss_dssp CCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCT-----TCCEECCCTT-CCEECTTTBTTCTTCCE
T ss_pred ccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCC-----CCCEEEECcc-ccEehHHHhhCCCCCCE
Confidence 888888765 66566778889999999999754 6533344555443 4557888776 8887765 3 4678888
Q ss_pred EEecCC
Q 003140 377 VRLRGN 382 (845)
Q Consensus 377 l~l~~N 382 (845)
+++..|
T Consensus 371 i~lp~~ 376 (394)
T 4fs7_A 371 VELPKR 376 (394)
T ss_dssp EEEEGG
T ss_pred EEECCC
Confidence 887544
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.94 E-value=1.5e-09 Score=119.24 Aligned_cols=141 Identities=23% Similarity=0.326 Sum_probs=106.0
Q ss_pred CccccccCceEEEEEEeCCCcEEEEEEcc--CCC-hhhHHHHHHHHHHHHhcC--CCceeeEEEEEeeC---CeEEEEEE
Q 003140 629 STQIGQGGYGKVYKGILPDGTVVAVKRAQ--EGS-LQGEKEFLTEIQFLSRLH--HRNLVSLVGYCDEE---GEQMLVYE 700 (845)
Q Consensus 629 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~--~~~-~~~~~~~~~Ei~~l~~l~--H~nIv~l~g~~~~~---~~~~LV~E 700 (845)
.+.++.|.++.||+....+ ..+++|+.. ... ......+.+|+++++.+. +..++++++++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 4678999999999988754 577888765 322 123457888999999996 45678999998776 45899999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA-------------------------------------- 742 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------- 742 (845)
|++|..+.+. ....++...+..++.++++.|..||+..
T Consensus 122 ~v~G~~l~~~----~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 122 FVSGRVLWDQ----SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp CCCCBCCCCT----TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred ecCCeecCCC----ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 9998776431 1223678888899999999999999731
Q ss_pred -----------------CCCeEecCCCCCCEEEcCCCc--EEEEecCCccc
Q 003140 743 -----------------DPPVFHRDIKASNILLDHKFT--AKVADFGLSRL 774 (845)
Q Consensus 743 -----------------~~~iiHrDLk~~NILl~~~~~--~kl~DFGla~~ 774 (845)
.+.++|||+++.|||++.++. +.|+||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245899999999999997753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.87 E-value=2e-09 Score=115.15 Aligned_cols=193 Identities=17% Similarity=0.161 Sum_probs=122.9
Q ss_pred CccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCc--eeeEEEEEeeCC---eEEEEEEcC
Q 003140 629 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRN--LVSLVGYCDEEG---EQMLVYEFM 702 (845)
Q Consensus 629 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~-H~n--Iv~l~g~~~~~~---~~~LV~E~~ 702 (845)
.+.++.|....||+.. ..+++|+.... .....+.+|.++++.+. +.. +.+.+......+ ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999863 45888885432 34567899999999883 333 445555544333 348899999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE----------------------------------------- 741 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------- 741 (845)
+|.++..... ..++...+..++.++++.+..||+.
T Consensus 99 ~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 9988865332 1356777778888888888888861
Q ss_pred --------------CCCCeEecCCCCCCEEEcC--CCcEEEEecCCcccCCCC-CCCCcccc------ceeecccCCCCc
Q 003140 742 --------------ADPPVFHRDIKASNILLDH--KFTAKVADFGLSRLAPVP-DIEGIVPA------HVSTVVKGTPGY 798 (845)
Q Consensus 742 --------------~~~~iiHrDLk~~NILl~~--~~~~kl~DFGla~~~~~~-~~~~~~~~------~~~~~~~gt~~y 798 (845)
..+.++|+|+++.||++++ +..+.|+||+.+..-... |....... ..........+.
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 1245899999999999998 556889999988653210 00000000 000000000111
Q ss_pred cc-hhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003140 799 LD-PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833 (845)
Q Consensus 799 ~a-PE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~ 833 (845)
.. |+..... ....+.|++|.++|++.+|..+|.
T Consensus 255 ~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 255 KDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp SCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHHH
Confidence 12 2221111 223689999999999999998873
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.81 E-value=6.1e-08 Score=107.68 Aligned_cols=179 Identities=9% Similarity=-0.055 Sum_probs=122.6
Q ss_pred cccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccc
Q 003140 95 SGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSF 174 (845)
Q Consensus 95 ~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 174 (845)
+..-..+|.++++|+.+.|.. .++.+-..+|.++++|+.++|.++ ++..-...|.++++|+.+.+..+ +......+|
T Consensus 60 tsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF 136 (394)
T 4fs7_A 60 VSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAF 136 (394)
T ss_dssp EEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTT
T ss_pred eEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceee
Confidence 333456899999999999974 577566778999999999999865 55455677899999999888765 443556677
Q ss_pred cCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCcc
Q 003140 175 ANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLL 254 (845)
Q Consensus 175 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~ 254 (845)
.++..++......... ....+|..+++|+.+.+.++. .......|..+.+|+.+.+..| ++. .....|.++..|+
T Consensus 137 ~~~~~~~~~~~~~~~~--i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~-I~~~~F~~~~~L~ 211 (394)
T 4fs7_A 137 KGCDFKEITIPEGVTV--IGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKI-IRDYCFAECILLE 211 (394)
T ss_dssp TTCCCSEEECCTTCCE--ECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCE-ECTTTTTTCTTCC
T ss_pred ecccccccccCccccc--cchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceE-eCchhhccccccc
Confidence 7776544444333322 334678899999999998764 3355667899999999999877 432 3445677778888
Q ss_pred EEEcccCCCCCCCCCCCCCCCccEEEcc
Q 003140 255 KLSLRNCSLQGPMPDLSRIPNLGYLDLS 282 (845)
Q Consensus 255 ~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls 282 (845)
.+.+..+...- ........+|+.+.+.
T Consensus 212 ~i~~~~~~~~i-~~~~~~~~~l~~i~ip 238 (394)
T 4fs7_A 212 NMEFPNSLYYL-GDFALSKTGVKNIIIP 238 (394)
T ss_dssp BCCCCTTCCEE-CTTTTTTCCCCEEEEC
T ss_pred eeecCCCceEe-ehhhcccCCCceEEEC
Confidence 77766554321 1112223455555544
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.79 E-value=1.1e-09 Score=119.72 Aligned_cols=141 Identities=18% Similarity=0.243 Sum_probs=73.2
Q ss_pred ccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccc--cCCCccEEEccc--CCCCCC------
Q 003140 197 ELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYS--NMSKLLKLSLRN--CSLQGP------ 266 (845)
Q Consensus 197 ~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~--~l~~L~~L~Ls~--N~l~~~------ 266 (845)
.+..+|+|+.|+|++|.-. .++. +. +++|+.|+|..+.+.. .....+. .+++|+.|+|+. |...+.
T Consensus 167 ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~-~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l 242 (362)
T 2ra8_A 167 VLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPD-SVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVF 242 (362)
T ss_dssp HHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCH-HHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGT
T ss_pred HHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCCh-HHHHHHHHccCCCCcEEEEeccccccccchhHHHH
Confidence 3444556666666555211 1222 22 5566666666666543 1222222 566666666642 111111
Q ss_pred CCCC--CCCCCccEEEcccccCCcCCCCC----CCccccCEEEccCCcCCCC----cccccCCCCCCCeEecccccCccc
Q 003140 267 MPDL--SRIPNLGYLDLSSNQLNGSIPPG----RLSLNITTIKLSNNKLTGT----IPSNFSGLPRLQRLFIANNSLSGS 336 (845)
Q Consensus 267 ~~~l--~~l~~L~~L~Ls~N~l~~~ip~~----~~~~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~ 336 (845)
.+.+ ..+++|+.|+|++|.+.+..+.. ....+|++|+|+.|.|++. ++..+..+++|+.|+|++|.++..
T Consensus 243 ~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~ 322 (362)
T 2ra8_A 243 RPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322 (362)
T ss_dssp GGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHH
T ss_pred HHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHH
Confidence 0112 24677778888777776432211 1234677777777777653 233334567788888887777644
Q ss_pred CChhh
Q 003140 337 IPSSI 341 (845)
Q Consensus 337 ip~~l 341 (845)
.-..+
T Consensus 323 ~~~~l 327 (362)
T 2ra8_A 323 MKKEL 327 (362)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 33333
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.78 E-value=1.1e-09 Score=119.64 Aligned_cols=182 Identities=12% Similarity=0.220 Sum_probs=90.6
Q ss_pred ceEeEEEecCCCCcc-c-------CCCCccCCCCccEEEecCCCCC---------CCCcccccccccchhhhccCCC-CC
Q 003140 82 LHLRELQLLNLNLSG-N-------LSPEIGRLSYLTILDFMWNKIS---------GSIPKEIGNIKSLELLLLNGNE-LT 143 (845)
Q Consensus 82 ~~v~~L~L~~~~l~~-~-------~~~~l~~L~~L~~L~L~~N~l~---------~~~p~~~~~l~~L~~L~Ls~N~-l~ 143 (845)
.+|+.|.+......| . +..++..+++|+.|.+..+... +.+...+..+++|+.|+|++|. +.
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~ 186 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS 186 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce
Confidence 357777777655442 1 1334566778888887654321 1222333445555555555542 11
Q ss_pred CCCCCccCCCCccceeecccccccCCCCcccc--CccCCCEEEccC--CCCCCCCccccCCCCCcceeeccccccccCCC
Q 003140 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFA--NLNKTRHFHMNN--NSISGQIPPELSRLPSLVHMLLDNNNLTGYLP 219 (845)
Q Consensus 144 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~L~~--N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 219 (845)
++. + .+++|+.|+|..+.++......+. .+++|+.|+|+. |...+.. .+. .+.
T Consensus 187 --l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~------------------~~~-~l~ 243 (362)
T 2ra8_A 187 --IGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDG------------------DMN-VFR 243 (362)
T ss_dssp --CCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCS------------------CGG-GTG
T ss_pred --ecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccch------------------hHH-HHH
Confidence 122 2 245555555555444322222221 344454444431 1111000 000 000
Q ss_pred ccc--CCCCCCcEEEccCCcCCCCCCcccc---ccCCCccEEEcccCCCCCC-----CCCCCCCCCccEEEcccccCC
Q 003140 220 PEL--SELPKLLILQLDNNNFEGTTIPASY---SNMSKLLKLSLRNCSLQGP-----MPDLSRIPNLGYLDLSSNQLN 287 (845)
Q Consensus 220 ~~l--~~l~~L~~L~Ls~N~l~~~~~p~~~---~~l~~L~~L~Ls~N~l~~~-----~~~l~~l~~L~~L~Ls~N~l~ 287 (845)
..+ ..+++|++|+|.+|.+.+ ..+..+ ..+++|+.|+|+.|.+++. ...+..+++|+.|+|++|.|+
T Consensus 244 ~~l~~~~~p~Lr~L~L~~~~i~~-~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 244 PLFSKDRFPNLKWLGIVDAEEQN-VVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp GGSCTTTCTTCCEEEEESCTTHH-HHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred HHHhcCCCCCcCEEeCCCCCCch-HHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 112 235677777777777653 122222 2467788888888777652 122345678888888888776
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.69 E-value=4.2e-07 Score=100.84 Aligned_cols=282 Identities=13% Similarity=0.139 Sum_probs=147.8
Q ss_pred EeEEEecCCCCcccCCCCccCCCCccEEEecCCC---CCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceee
Q 003140 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNK---ISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (845)
Q Consensus 84 v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~---l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (845)
++.+.+.. +++..-..+|.++++|+.+.+..|. ++..-..+|.++.+|+.+.+..+ ++..-...|..+.+|+.+.
T Consensus 66 L~sI~iP~-svt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~ 143 (394)
T 4gt6_A 66 LTSVQIPD-TVTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVT 143 (394)
T ss_dssp CCEEEECT-TCCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEE
T ss_pred CEEEEECC-CeeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhccccccc
Confidence 45555543 2444444567777777777776653 44344556777777777776654 3324445567777777777
Q ss_pred cccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCC
Q 003140 161 IDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240 (845)
Q Consensus 161 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 240 (845)
+..+ ++......|.++.+|+.+.+.++ +...-..+|.. ..|+.+.+..+-.. .....|..+.+|.......+....
T Consensus 144 lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~~~~~~~ 219 (394)
T 4gt6_A 144 IPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFALSTITSDSESYPA 219 (394)
T ss_dssp CCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTCCEEEECCSSSCB
T ss_pred ccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhccccceeccccccccc
Confidence 7643 33244556777777777777654 33222334433 45666666544322 334456666666666554443321
Q ss_pred CCCcccc--------------ccCCCccEEEcccCCCCCCCC-CCCCCCCccEEEcccccCCcCCCCCCC--ccccCEEE
Q 003140 241 TTIPASY--------------SNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRL--SLNITTIK 303 (845)
Q Consensus 241 ~~~p~~~--------------~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~ip~~~~--~~~L~~L~ 303 (845)
....+ .....+..+.+. +.++.... .|..+.+|+.+.+.++..+ +....+ ..+|+.+.
T Consensus 220 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~--I~~~aF~~c~~L~~i~ 294 (394)
T 4gt6_A 220 --IDNVLYEKSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS--IGTGAFMNCPALQDIE 294 (394)
T ss_dssp --SSSCEEEECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE--ECTTTTTTCTTCCEEE
T ss_pred --ccceeecccccccccccccccccccceEEcC-CcceEcccceeeecccccEEecccccce--ecCccccccccccccc
Confidence 11100 011112222221 11111111 3556667777776655432 333222 23677777
Q ss_pred ccCCcCCCCcccccCCCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCC-C-CCCCCcEEEecC
Q 003140 304 LSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVRLRG 381 (845)
Q Consensus 304 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~-~-~~~~l~~l~l~~ 381 (845)
+. +.++......|.++.+|+.++|..+ ++..-...|..+. +|+.+.|..+ ++.|... | ....|+.+++.+
T Consensus 295 l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~-----~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~ 366 (394)
T 4gt6_A 295 FS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCE-----QLERIAIPSS-VTKIPESAFSNCTALNNIEYSG 366 (394)
T ss_dssp CC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCT-----TCCEEEECTT-CCBCCGGGGTTCTTCCEEEESS
T ss_pred CC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCC-----CCCEEEECcc-cCEEhHhHhhCCCCCCEEEECC
Confidence 65 4455455566777777777777654 4422233444333 3446666533 6666554 3 356777777777
Q ss_pred Ccc
Q 003140 382 NPF 384 (845)
Q Consensus 382 Np~ 384 (845)
|..
T Consensus 367 ~~~ 369 (394)
T 4gt6_A 367 SRS 369 (394)
T ss_dssp CHH
T ss_pred cee
Confidence 653
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.65 E-value=1.5e-10 Score=120.18 Aligned_cols=78 Identities=27% Similarity=0.374 Sum_probs=36.7
Q ss_pred ccCCCEEEccCCCCCC--CCccccCCCCCcceeeccccccccCCCcccCCCC--CCcEEEccCCcCCCCCCc-------c
Q 003140 177 LNKTRHFHMNNNSISG--QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELP--KLLILQLDNNNFEGTTIP-------A 245 (845)
Q Consensus 177 l~~L~~L~L~~N~l~~--~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~--~L~~L~Ls~N~l~~~~~p-------~ 245 (845)
+++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+.+ ..| .
T Consensus 169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~-~~~~~~~y~~~ 245 (267)
T 3rw6_A 169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCD-TFRDQSTYISA 245 (267)
T ss_dssp CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGG-GCSSHHHHHHH
T ss_pred CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCcc-ccCcchhHHHH
Confidence 4444444444444443 2223334445555555555555433 1222222 56666666666654 222 2
Q ss_pred ccccCCCccEEE
Q 003140 246 SYSNMSKLLKLS 257 (845)
Q Consensus 246 ~~~~l~~L~~L~ 257 (845)
.+..+++|+.||
T Consensus 246 il~~~P~L~~LD 257 (267)
T 3rw6_A 246 IRERFPKLLRLD 257 (267)
T ss_dssp HHHHCTTCCEES
T ss_pred HHHHCcccCeEC
Confidence 355666666665
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.59 E-value=2.5e-06 Score=94.57 Aligned_cols=267 Identities=11% Similarity=0.100 Sum_probs=180.5
Q ss_pred CCCccCCC-CccEEEecCCCCCCCCcccccccccchhhhccCCC---CCCCCCCccCCCCccceeecccccccCCCCccc
Q 003140 99 SPEIGRLS-YLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNE---LTGSLPEELGYLPKLDRIQIDQNYISGSLPKSF 174 (845)
Q Consensus 99 ~~~l~~L~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~---l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 174 (845)
..+|.+.. .|+.+.|-. .++.+-..+|.++++|+.+.+..|. ++..-...|.++.+|+.+.+..+ ++......|
T Consensus 56 ~~aF~~~~~~L~sI~iP~-svt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF 133 (394)
T 4gt6_A 56 DRVFCNYKYVLTSVQIPD-TVTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAF 133 (394)
T ss_dssp TTTTTTCCSCCCEEEECT-TCCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTT
T ss_pred HhhccCCCCcCEEEEECC-CeeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhh
Confidence 45677764 599999975 4776667889999999999998774 55444567888999999988765 454556788
Q ss_pred cCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCcc
Q 003140 175 ANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLL 254 (845)
Q Consensus 175 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~ 254 (845)
.++.+|+.+.+..+. .......|....+|+.+.+.++ ++..-..+|.. .+|+.+.+..+-.. .....|.++.+|.
T Consensus 134 ~~c~~L~~i~lp~~~-~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~--i~~~af~~c~~l~ 208 (394)
T 4gt6_A 134 HHCEELDTVTIPEGV-TSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR--IGTNAFSECFALS 208 (394)
T ss_dssp TTCTTCCEEECCTTC-CEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE--ECTTTTTTCTTCC
T ss_pred hhhccccccccccee-eeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc--cccchhhhccccc
Confidence 999999999997553 3345667888899999999765 44344445544 67999998766543 3456788888888
Q ss_pred EEEcccCCCCCCCCC--------------CCCCCCccEEEcccccCCcCCCCCCC--ccccCEEEccCCcCCCCcccccC
Q 003140 255 KLSLRNCSLQGPMPD--------------LSRIPNLGYLDLSSNQLNGSIPPGRL--SLNITTIKLSNNKLTGTIPSNFS 318 (845)
Q Consensus 255 ~L~Ls~N~l~~~~~~--------------l~~l~~L~~L~Ls~N~l~~~ip~~~~--~~~L~~L~Ls~N~l~~~~p~~~~ 318 (845)
......+........ +.....+..+.+..+ ++ .+....+ ..+|+.+.+.++..+ .....|.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~-v~-~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~ 285 (394)
T 4gt6_A 209 TITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPNG-VA-RIETHAFDSCAYLASVKMPDSVVS-IGTGAFM 285 (394)
T ss_dssp EEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCTT-EE-EECTTTTTTCSSCCEEECCTTCCE-ECTTTTT
T ss_pred eecccccccccccceeecccccccccccccccccccceEEcCCc-ce-EcccceeeecccccEEecccccce-ecCcccc
Confidence 887776655432221 111223333433222 22 1222222 247999999876543 5667899
Q ss_pred CCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCC-C-CCCCCcEEEecCC
Q 003140 319 GLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVRLRGN 382 (845)
Q Consensus 319 ~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~-~-~~~~l~~l~l~~N 382 (845)
+++.|+.+.+. +.++..-...|..+ .+|+.++|..| ++.|... | ....|+++.+..+
T Consensus 286 ~c~~L~~i~l~-~~i~~I~~~aF~~c-----~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s 344 (394)
T 4gt6_A 286 NCPALQDIEFS-SRITELPESVFAGC-----ISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS 344 (394)
T ss_dssp TCTTCCEEECC-TTCCEECTTTTTTC-----TTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT
T ss_pred cccccccccCC-CcccccCceeecCC-----CCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc
Confidence 99999999996 45653333345444 44568999754 8888765 4 4688999998654
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.36 E-value=2.1e-08 Score=104.05 Aligned_cols=105 Identities=18% Similarity=0.260 Sum_probs=62.0
Q ss_pred ccccccchh--hhccCCCCC---CCCCCccCCCCccceeecccccccC--CCCccccCccCCCEEEccCCCCCCCCcccc
Q 003140 126 IGNIKSLEL--LLLNGNELT---GSLPEELGYLPKLDRIQIDQNYISG--SLPKSFANLNKTRHFHMNNNSISGQIPPEL 198 (845)
Q Consensus 126 ~~~l~~L~~--L~Ls~N~l~---~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l 198 (845)
|...+.|+. ++++.|+.. +.++....++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l 214 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL 214 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence 444555655 566666433 1111122456677777777777776 3445666777777777777777643 223
Q ss_pred CCCC--CcceeeccccccccCCCc-------ccCCCCCCcEEE
Q 003140 199 SRLP--SLVHMLLDNNNLTGYLPP-------ELSELPKLLILQ 232 (845)
Q Consensus 199 ~~l~--~L~~L~L~~N~l~~~~p~-------~l~~l~~L~~L~ 232 (845)
..+. +|++|+|++|.+.+.+|. .+..+++|+.||
T Consensus 215 ~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 215 DKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 3333 777777777777765542 245566776665
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=2.4e-06 Score=89.25 Aligned_cols=135 Identities=16% Similarity=0.147 Sum_probs=97.4
Q ss_pred cccccCce-EEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCeEEEEEEcCCCCCH
Q 003140 631 QIGQGGYG-KVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEFMSNGTL 707 (845)
Q Consensus 631 ~LG~G~fG-~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~E~~~~gsL 707 (845)
.+..|..| .||+.... ++..+.+|+.... ...++.+|.+.|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34555555 68987765 4677888986542 3457888999998884 44577899999999999999999999888
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 003140 708 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA--------------------------------------------- 742 (845)
Q Consensus 708 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------------- 742 (845)
.+..... ......++.++++.|.-||+..
T Consensus 108 ~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 108 FQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 7755321 1123345556666666666421
Q ss_pred ----------CCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003140 743 ----------DPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (845)
Q Consensus 743 ----------~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~ 774 (845)
.+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12378999999999999887778999998754
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=3.2e-06 Score=90.20 Aligned_cols=136 Identities=21% Similarity=0.204 Sum_probs=93.2
Q ss_pred CccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCC---ceeeEEEEEe-eCCeEEEEEEcCCC
Q 003140 629 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHR---NLVSLVGYCD-EEGEQMLVYEFMSN 704 (845)
Q Consensus 629 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~---nIv~l~g~~~-~~~~~~LV~E~~~~ 704 (845)
.+.++.|....||+. |..+++|+.. .......+.+|.++|+.+.+. .+.+.+.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888999999987 5667888743 233456789999999999642 3567777764 45567899999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 003140 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE------------------------------------------- 741 (845)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------- 741 (845)
..+.+.... .++...+..++.++++.|..||+.
T Consensus 98 ~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 887653211 123334444444444444444432
Q ss_pred --------------CCCCeEecCCCCCCEEEcC---CCc-EEEEecCCccc
Q 003140 742 --------------ADPPVFHRDIKASNILLDH---KFT-AKVADFGLSRL 774 (845)
Q Consensus 742 --------------~~~~iiHrDLk~~NILl~~---~~~-~kl~DFGla~~ 774 (845)
..+.++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2345799999999999987 455 58999998764
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=3e-07 Score=84.56 Aligned_cols=69 Identities=20% Similarity=0.280 Sum_probs=50.9
Q ss_pred eEecccccCc-ccCChhhhhhccCCCCcceEEEccCCCCCCCCCCC--CCCCCcEEEecCCcccccCCCccccCCCCCC
Q 003140 325 RLFIANNSLS-GSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTNAEQFCGSHSDD 400 (845)
Q Consensus 325 ~L~L~~N~l~-~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~--~~~~l~~l~l~~Np~~c~~~~~~~~~~~~~~ 400 (845)
.++.+++.|+ ..+|..+ ..+++.|+|++|+|+.++... .++.++.|+|.+|||.|||.+.+|..|....
T Consensus 12 ~v~Cs~~~L~~~~vP~~l-------p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l~~l~~wl~~~ 83 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAF-------PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRLVPLRAWLAGR 83 (130)
T ss_dssp EEECCSSCCCTTTSCSCC-------CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGGHHHHHHHHTS
T ss_pred EEEeCCCCCccccCCCCC-------CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCccHHHHHHHHhC
Confidence 4556666654 3455433 124567888888888888764 4888999999999999999999999887543
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.27 E-value=3.2e-08 Score=97.44 Aligned_cols=69 Identities=14% Similarity=0.139 Sum_probs=36.0
Q ss_pred CCCccCCCCccEEEecCC-CCCCC----CcccccccccchhhhccCCCCCCC----CCCccCCCCccceeeccccccc
Q 003140 99 SPEIGRLSYLTILDFMWN-KISGS----IPKEIGNIKSLELLLLNGNELTGS----LPEELGYLPKLDRIQIDQNYIS 167 (845)
Q Consensus 99 ~~~l~~L~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 167 (845)
...+...+.|++|+|++| .+... +...+...++|++|+|++|.|+.. +...+...++|++|+|++|.|+
T Consensus 29 ~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 29 KRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 344566777777777777 76532 223344445566666666665521 1122223344555555555544
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.19 E-value=1.1e-07 Score=93.59 Aligned_cols=14 Identities=36% Similarity=0.223 Sum_probs=6.4
Q ss_pred cccccchhhhccCC
Q 003140 127 GNIKSLELLLLNGN 140 (845)
Q Consensus 127 ~~l~~L~~L~Ls~N 140 (845)
...++|++|+|++|
T Consensus 33 ~~~~~L~~L~L~~n 46 (185)
T 1io0_A 33 NNDPDLEEVNLNNI 46 (185)
T ss_dssp TTCTTCCEEECTTC
T ss_pred hcCCCCCEEEecCC
Confidence 33444444444444
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.16 E-value=6.4e-05 Score=82.57 Aligned_cols=239 Identities=10% Similarity=0.035 Sum_probs=110.6
Q ss_pred eEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecc
Q 003140 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162 (845)
Q Consensus 83 ~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 162 (845)
+++++.+.. +++..-..+|.++.+|+.++|.. .++.+-..+|.++ +|+.+.+..+ ++..-...|.. .+|+.+.+.
T Consensus 47 ~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~-~v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~~i~lp 121 (379)
T 4h09_A 47 RISEVRVNS-GITSIGEANFNSCYNMTKVTVAS-TVTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLDDFEFP 121 (379)
T ss_dssp GCSEEEECT-TEEEECTTTTTTCTTCCEEEECT-TCCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCSEEECC
T ss_pred CCEEEEeCC-CccChHHHHhhCCCCCCEEEeCC-cceEechhhhcCC-CCceEECCce-eeEeccceecc-CCcccccCC
Confidence 455555543 45544456778888888888864 3554445566665 5666665543 34222333433 467777776
Q ss_pred cccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeecccccccc------------CCCcccCCCCCCcE
Q 003140 163 QNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTG------------YLPPELSELPKLLI 230 (845)
Q Consensus 163 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~------------~~p~~l~~l~~L~~ 230 (845)
.+- +......|.+. +|+.+.+..+ ++......+.....++.+.+..+.... .....+.....+..
T Consensus 122 ~~~-~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (379)
T 4h09_A 122 GAT-TEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTE 198 (379)
T ss_dssp TTC-CEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSE
T ss_pred Ccc-ccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccccccccccc
Confidence 542 21223334433 4555544332 222333445555555555544332210 11112233333444
Q ss_pred EEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCCcCCCCCCC--ccccCEEEccCCc
Q 003140 231 LQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRL--SLNITTIKLSNNK 308 (845)
Q Consensus 231 L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~--~~~L~~L~Ls~N~ 308 (845)
+.+..+... .....+....+|+.+.+..+--.-....+....+|+.+.+..+ ++ .+....+ ..+|+.+.+..+
T Consensus 199 ~~~~~~~~~--i~~~~f~~~~~l~~i~~~~~~~~i~~~~f~~~~~L~~i~lp~~-v~-~I~~~aF~~~~~l~~i~l~~~- 273 (379)
T 4h09_A 199 FTIPSTVKT--VTAYGFSYGKNLKKITITSGVTTLGDGAFYGMKALDEIAIPKN-VT-SIGSFLLQNCTALKTLNFYAK- 273 (379)
T ss_dssp EECCTTCCE--ECTTTTTTCSSCSEEECCTTCCEECTTTTTTCSSCCEEEECTT-CC-EECTTTTTTCTTCCEEEECCC-
T ss_pred cccccceeE--EeecccccccccceeeeccceeEEccccccCCccceEEEcCCC-cc-EeCccccceeehhcccccccc-
Confidence 443332221 2223344445555555543321111123445555555555444 32 2222222 124555555433
Q ss_pred CCCCcccccCCCCCCCeEecccccCc
Q 003140 309 LTGTIPSNFSGLPRLQRLFIANNSLS 334 (845)
Q Consensus 309 l~~~~p~~~~~l~~L~~L~L~~N~l~ 334 (845)
+.......|.++.+|+.+.+.++.++
T Consensus 274 i~~i~~~aF~~c~~L~~i~l~~~~i~ 299 (379)
T 4h09_A 274 VKTVPYLLCSGCSNLTKVVMDNSAIE 299 (379)
T ss_dssp CSEECTTTTTTCTTCCEEEECCTTCC
T ss_pred ceeccccccccccccccccccccccc
Confidence 33333445555666666666555555
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=2.9e-06 Score=92.68 Aligned_cols=79 Identities=4% Similarity=-0.010 Sum_probs=55.4
Q ss_pred Cccc-cccCceEEEEEEeC-------CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcC-C--CceeeEEEEEeeC--
Q 003140 629 STQI-GQGGYGKVYKGILP-------DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLH-H--RNLVSLVGYCDEE-- 692 (845)
Q Consensus 629 ~~~L-G~G~fG~Vy~~~~~-------~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~-H--~nIv~l~g~~~~~-- 692 (845)
.+.| +.|....+|+.... +++.+++|+..... ......+.+|+++++.+. + -.+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88989999988764 26778888865422 111245778888888884 3 3567888887665
Q ss_pred -CeEEEEEEcCCCCCH
Q 003140 693 -GEQMLVYEFMSNGTL 707 (845)
Q Consensus 693 -~~~~LV~E~~~~gsL 707 (845)
+..++||||++|..+
T Consensus 105 ~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TSSCEEEEECCCCBCC
T ss_pred cCCceEEEEecCCCCh
Confidence 356899999988654
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.96 E-value=0.00043 Score=75.87 Aligned_cols=251 Identities=10% Similarity=0.043 Sum_probs=151.9
Q ss_pred ceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeec
Q 003140 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (845)
Q Consensus 82 ~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (845)
..++.++|.. +++..-..+|.+. +|+.+.+..+ ++..-...|.. .+|+.+.+..+-.. .-...|.+ .+|+.+.+
T Consensus 69 ~~L~~I~lp~-~v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~~i~lp~~~~~-i~~~~F~~-~~l~~~~~ 142 (379)
T 4h09_A 69 YNMTKVTVAS-TVTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLDDFEFPGATTE-IGNYIFYN-SSVKRIVI 142 (379)
T ss_dssp TTCCEEEECT-TCCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCSEEECCTTCCE-ECTTTTTT-CCCCEEEE
T ss_pred CCCCEEEeCC-cceEechhhhcCC-CCceEECCce-eeEeccceecc-CCcccccCCCcccc-cccccccc-ceeeeeec
Confidence 4688888864 4665555677776 6888887643 55344455655 47888888765322 33334444 35666666
Q ss_pred ccccccCCCCccccCccCCCEEEccCCCCCC------------CCccccCCCCCcceeeccccccccCCCcccCCCCCCc
Q 003140 162 DQNYISGSLPKSFANLNKTRHFHMNNNSISG------------QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLL 229 (845)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~------------~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 229 (845)
..+ ++......|.++.+++.+.+..+.... .....+.....+..+.+..+.- ......+....+|+
T Consensus 143 ~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~i~~~~f~~~~~l~ 220 (379)
T 4h09_A 143 PKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVK-TVTAYGFSYGKNLK 220 (379)
T ss_dssp CTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCC-EECTTTTTTCSSCS
T ss_pred cce-eeccccchhcccccccccccccccceeecccceecccccceecccccccccccccccccee-EEeecccccccccc
Confidence 543 343556677888888888776654321 1112233344455554443322 23345566677788
Q ss_pred EEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCC-CCCCCCCccEEEcccccCCcCCCCCCCc--cccCEEEccC
Q 003140 230 ILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSN 306 (845)
Q Consensus 230 ~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~ip~~~~~--~~L~~L~Ls~ 306 (845)
.+.+..+- +. .....|.++..|+.+.+..+ ++.... .+..+.+|+.+.+..+ ++ .++...+. .+|+.+.+.+
T Consensus 221 ~i~~~~~~-~~-i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~ 295 (379)
T 4h09_A 221 KITITSGV-TT-LGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVMDN 295 (379)
T ss_dssp EEECCTTC-CE-ECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEEECC
T ss_pred eeeeccce-eE-EccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ce-eccccccccccccccccccc
Confidence 88876553 21 33456777788888888665 444333 4677778888887654 44 34443332 4788888888
Q ss_pred CcCCCCcccccCCCCCCCeEecccccCcccCChhhhhhcc
Q 003140 307 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRT 346 (845)
Q Consensus 307 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~ 346 (845)
+.++......|.++.+|+.+.|..+ ++..-..+|..+.+
T Consensus 296 ~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~ 334 (379)
T 4h09_A 296 SAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKA 334 (379)
T ss_dssp TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTT
T ss_pred cccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCC
Confidence 8887677778888888888888654 55333344544433
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=2.7e-05 Score=86.32 Aligned_cols=75 Identities=16% Similarity=0.061 Sum_probs=49.8
Q ss_pred CccccccCceEEEEEEeC-CCcEEEEEEccCCCh-------hhHHHHHHHHHHHHhcCC--C-ceeeEEEEEeeCCeEEE
Q 003140 629 STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-------QGEKEFLTEIQFLSRLHH--R-NLVSLVGYCDEEGEQML 697 (845)
Q Consensus 629 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-------~~~~~~~~Ei~~l~~l~H--~-nIv~l~g~~~~~~~~~L 697 (845)
.+.||.|.++.||++... +++.++||....... ....++..|.++++.+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457999999999999764 468899997653221 123456788888888732 3 34456654 3445689
Q ss_pred EEEcCCCC
Q 003140 698 VYEFMSNG 705 (845)
Q Consensus 698 V~E~~~~g 705 (845)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.86 E-value=3.9e-05 Score=82.83 Aligned_cols=140 Identities=19% Similarity=0.199 Sum_probs=80.1
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcC--CCceeeEEE------EEeeCCeEEEEEEc
Q 003140 630 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH--HRNLVSLVG------YCDEEGEQMLVYEF 701 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~--H~nIv~l~g------~~~~~~~~~LV~E~ 701 (845)
+.|+.|..+.||+....+| .+++|+.... ..++..|.++++.+. .-.+.+++. +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999987655 4889988752 223344555555442 112333332 12346778999999
Q ss_pred CCCCCHH-----------H---HHhcc-C----C-------CCCCHHHHH------------------------------
Q 003140 702 MSNGTLR-----------D---QLSAK-S----K-------EPLGFAMRL------------------------------ 725 (845)
Q Consensus 702 ~~~gsL~-----------~---~l~~~-~----~-------~~l~~~~~~------------------------------ 725 (845)
++|..+. . .+|.. . . ..-.|....
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986431 1 11211 0 0 011232210
Q ss_pred -HHHHHHHHHHHHHHh----------CCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003140 726 -SIALGSSRGILYLHT----------EADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (845)
Q Consensus 726 -~i~~~ia~gL~yLH~----------~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~ 774 (845)
.+...+.+++++|++ ...+.++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 011123345667763 1234599999999999998888999999998754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.75 E-value=6.7e-05 Score=79.08 Aligned_cols=78 Identities=19% Similarity=0.244 Sum_probs=57.8
Q ss_pred CCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcC-C--CceeeEEEEEeeCCeEEEEEEc
Q 003140 625 NFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-H--RNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~-H--~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
.....+.+|.|..+.||+....||+.|.||+...........|..|.+.|+.+. . --+.+.+++. ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 344567899999999999999999999999876544444456888999998884 2 2345555542 23689999
Q ss_pred CCCCC
Q 003140 702 MSNGT 706 (845)
Q Consensus 702 ~~~gs 706 (845)
++++.
T Consensus 92 l~~~~ 96 (288)
T 3f7w_A 92 VDERP 96 (288)
T ss_dssp CCCCC
T ss_pred ecccC
Confidence 98764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00011 Score=78.25 Aligned_cols=137 Identities=16% Similarity=0.147 Sum_probs=92.7
Q ss_pred CccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcC---CCceeeEEEEEeeCCeEEEEEEcCCCC
Q 003140 629 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH---HRNLVSLVGYCDEEGEQMLVYEFMSNG 705 (845)
Q Consensus 629 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~LV~E~~~~g 705 (845)
.+.|+.|....+|+... ++..+++|+.... ....|..|.+.|+.+. ...+++.++++...+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 46789999999999886 4677888986542 3557889999988883 367888999988888999999999987
Q ss_pred CHH--------H---HHhccCC-C-------------------CCCHHHHH-----HHHH--------------HHH-HH
Q 003140 706 TLR--------D---QLSAKSK-E-------------------PLGFAMRL-----SIAL--------------GSS-RG 734 (845)
Q Consensus 706 sL~--------~---~l~~~~~-~-------------------~l~~~~~~-----~i~~--------------~ia-~g 734 (845)
.+. . -+|.... . .-+|.... .-.. .+. +.
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 541 1 1232211 0 12454321 1111 111 11
Q ss_pred HHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 003140 735 ILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFG 770 (845)
Q Consensus 735 L~yLH~-~~~~~iiHrDLk~~NILl~~~~~~kl~DFG 770 (845)
...|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223432 2356799999999999999887 8999984
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.51 E-value=1.4e-05 Score=76.92 Aligned_cols=34 Identities=6% Similarity=0.066 Sum_probs=18.7
Q ss_pred eEeEEEecCCCCcccCCCCccCCCCccEEEecCC
Q 003140 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWN 116 (845)
Q Consensus 83 ~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N 116 (845)
.++.||++++.++..--..+..+++|++|+|++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C 95 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC 95 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence 4566666666555433334455555666666555
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00042 Score=77.22 Aligned_cols=73 Identities=10% Similarity=0.122 Sum_probs=45.7
Q ss_pred CccccccCceEEEEEEeCCCcEEEEEEccCC----Ch-----hhHHHHHHHHHHHH-hcCCCceeeEEEEEeeCCeEEEE
Q 003140 629 STQIGQGGYGKVYKGILPDGTVVAVKRAQEG----SL-----QGEKEFLTEIQFLS-RLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 629 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~----~~-----~~~~~~~~Ei~~l~-~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
.+.+|.|....||++.. +++.++||...+. .. .....+..|+..+. ...+..+.+++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 46789999999999965 5678999943221 11 12223444443322 22334566777765 4667899
Q ss_pred EEcC-CC
Q 003140 699 YEFM-SN 704 (845)
Q Consensus 699 ~E~~-~~ 704 (845)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.34 E-value=3.6e-05 Score=74.02 Aligned_cols=82 Identities=18% Similarity=0.145 Sum_probs=33.8
Q ss_pred ccceeecccccccCCCCccccCccCCCEEEccCCC-CCCCCccccCCC----CCcceeeccccc-cccCCCcccCCCCCC
Q 003140 155 KLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNS-ISGQIPPELSRL----PSLVHMLLDNNN-LTGYLPPELSELPKL 228 (845)
Q Consensus 155 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~l~~l----~~L~~L~L~~N~-l~~~~p~~l~~l~~L 228 (845)
+|+.|||+++.|+..--..+.++++|+.|+|++|. ++..--..++.+ ++|++|+|++|. ++..--..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 34444444444443322334444555555555543 331111122222 245555555542 442222234444555
Q ss_pred cEEEccCC
Q 003140 229 LILQLDNN 236 (845)
Q Consensus 229 ~~L~Ls~N 236 (845)
++|+|+++
T Consensus 142 ~~L~L~~c 149 (176)
T 3e4g_A 142 KYLFLSDL 149 (176)
T ss_dssp CEEEEESC
T ss_pred CEEECCCC
Confidence 55555544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0021 Score=69.03 Aligned_cols=140 Identities=15% Similarity=0.119 Sum_probs=74.0
Q ss_pred ccccccCceE-EEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcC-C-CceeeEEEEEeeCCeEEEEEEcCCCCC
Q 003140 630 TQIGQGGYGK-VYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-H-RNLVSLVGYCDEEGEQMLVYEFMSNGT 706 (845)
Q Consensus 630 ~~LG~G~fG~-Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~-H-~nIv~l~g~~~~~~~~~LV~E~~~~gs 706 (845)
+.|+.|+... +|+....+|..+++|....... .++..|+++++.+. + -.+.+++.+..+.+ ++|||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4566565544 6677654467777776544221 23445666666663 2 23556777654443 68999998767
Q ss_pred HHHHHhcc---------------------CC---CCCCHHHHH-------H-------------HHHHHHHHHHHHH---
Q 003140 707 LRDQLSAK---------------------SK---EPLGFAMRL-------S-------------IALGSSRGILYLH--- 739 (845)
Q Consensus 707 L~~~l~~~---------------------~~---~~l~~~~~~-------~-------------i~~~ia~gL~yLH--- 739 (845)
+.+++... .. ..++..... . ....+.+.++.+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 65544211 00 011111100 0 0011112223331
Q ss_pred hCCCCCeEecCCCCCCEEEcCC----CcEEEEecCCccc
Q 003140 740 TEADPPVFHRDIKASNILLDHK----FTAKVADFGLSRL 774 (845)
Q Consensus 740 ~~~~~~iiHrDLk~~NILl~~~----~~~kl~DFGla~~ 774 (845)
....+.++|||+.+.|||++.+ +.+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1223458999999999999875 6899999998865
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0021 Score=68.45 Aligned_cols=158 Identities=13% Similarity=0.116 Sum_probs=86.7
Q ss_pred cchHHHHHHhcCCCC-----CccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCc--eeeEE
Q 003140 614 FTYGEMALATNNFNS-----STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN--LVSLV 686 (845)
Q Consensus 614 ~~~~~~~~~~~~f~~-----~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~ 686 (845)
++.+++......|.. .+.|+.|....+|+....+| .+++|...... ...++..|+++++.+.... +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 334444444445544 34567788899999987666 57788876521 1234556777777663212 23333
Q ss_pred EE------EeeCCeEEEEEEcCCCCCHH-----H---------HHhccC----CC---C---CCHHHHHH----------
Q 003140 687 GY------CDEEGEQMLVYEFMSNGTLR-----D---------QLSAKS----KE---P---LGFAMRLS---------- 726 (845)
Q Consensus 687 g~------~~~~~~~~LV~E~~~~gsL~-----~---------~l~~~~----~~---~---l~~~~~~~---------- 726 (845)
.. ....+..+++|+|++|..+. . -+|... .. . ..|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 12346678999999875431 1 112110 00 0 11322111
Q ss_pred --HHHHHHHHHHHHHhC----CCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003140 727 --IALGSSRGILYLHTE----ADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (845)
Q Consensus 727 --i~~~ia~gL~yLH~~----~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~ 774 (845)
+...+.+.++++++. ....++|+|+++.|||++.+..+.|+||+.+..
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011234455666532 234589999999999999876678999998753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0018 Score=70.65 Aligned_cols=141 Identities=18% Similarity=0.179 Sum_probs=82.7
Q ss_pred CccccccCceEEEEEEeC--------CCcEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCeEEEEE
Q 003140 629 STQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 629 ~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~ 699 (845)
.+.+..|-...+|+.... +++.+.+|+.... ........+|.++++.+. +.-..++++++.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 345777888889998864 2478999986432 233456678999998884 3334577777654 2999
Q ss_pred EcCCCCCHH--------------HH---HhccC---CCCCC--HHHHHHHHHHHH-------------------HHHHHH
Q 003140 700 EFMSNGTLR--------------DQ---LSAKS---KEPLG--FAMRLSIALGSS-------------------RGILYL 738 (845)
Q Consensus 700 E~~~~gsL~--------------~~---l~~~~---~~~l~--~~~~~~i~~~ia-------------------~gL~yL 738 (845)
||++|..|. +. +|... ..... |.+..++..++. +.++.|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 999875432 11 12211 11222 334443433321 123333
Q ss_pred ----HhC-CCCCeEecCCCCCCEEEcCC----CcEEEEecCCccc
Q 003140 739 ----HTE-ADPPVFHRDIKASNILLDHK----FTAKVADFGLSRL 774 (845)
Q Consensus 739 ----H~~-~~~~iiHrDLk~~NILl~~~----~~~kl~DFGla~~ 774 (845)
... ....++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 222 23357899999999999876 7899999998853
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0015 Score=72.94 Aligned_cols=70 Identities=14% Similarity=0.130 Sum_probs=49.2
Q ss_pred CccccccCceEEEEEEeCC--------CcEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCeEEEEE
Q 003140 629 STQIGQGGYGKVYKGILPD--------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 629 ~~~LG~G~fG~Vy~~~~~~--------g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~ 699 (845)
.+.|+.|-...||+....+ +..+.+|+..... ....+.+|..+++.+. +.-..++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3568888889999998753 5789999885421 1245668999888884 3333577776543 2899
Q ss_pred EcCCC
Q 003140 700 EFMSN 704 (845)
Q Consensus 700 E~~~~ 704 (845)
||+++
T Consensus 152 e~l~G 156 (429)
T 1nw1_A 152 EYIPS 156 (429)
T ss_dssp CCCCE
T ss_pred EEeCC
Confidence 99986
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0054 Score=65.48 Aligned_cols=141 Identities=17% Similarity=0.173 Sum_probs=81.8
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCC--ceeeEEEE-----EeeCCeEEEEEEcC
Q 003140 630 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHR--NLVSLVGY-----CDEEGEQMLVYEFM 702 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~--nIv~l~g~-----~~~~~~~~LV~E~~ 702 (845)
..++ |....||+....+|+.+++|...... ....++..|.++++.+... .+++++.. ....+..++||||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3466 78889999887778789999986432 2345667788888777421 23444432 22355678999999
Q ss_pred CCCCHH-----H------H---Hhcc----C---CCCCCHHHH----HHH---------------HHHHHHHHHHHHhC-
Q 003140 703 SNGTLR-----D------Q---LSAK----S---KEPLGFAMR----LSI---------------ALGSSRGILYLHTE- 741 (845)
Q Consensus 703 ~~gsL~-----~------~---l~~~----~---~~~l~~~~~----~~i---------------~~~ia~gL~yLH~~- 741 (845)
+|..+. . . +|.. . ....++... ..+ ...+.+.++.+.+.
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 874321 1 1 1210 0 011222211 000 00111223333221
Q ss_pred ---CCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003140 742 ---ADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (845)
Q Consensus 742 ---~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~ 774 (845)
....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234478999999999999 4 899999988754
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.80 E-value=9.5e-05 Score=72.42 Aligned_cols=67 Identities=19% Similarity=0.237 Sum_probs=34.9
Q ss_pred CccCCCCccEEEecCC-CCCC----CCcccccccccchhhhccCCCCCCC----CCCccCCCCccceeeccccccc
Q 003140 101 EIGRLSYLTILDFMWN-KISG----SIPKEIGNIKSLELLLLNGNELTGS----LPEELGYLPKLDRIQIDQNYIS 167 (845)
Q Consensus 101 ~l~~L~~L~~L~L~~N-~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 167 (845)
.+.+-+.|++|+|++| +|.. .+-..+..-+.|+.|+|++|+|... +-..+..-+.|++|+|++|.|+
T Consensus 36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 3445567777777774 6642 1233444455666666666666522 1112223344555555555554
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0021 Score=67.87 Aligned_cols=137 Identities=12% Similarity=0.075 Sum_probs=74.6
Q ss_pred CccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCce-eeEEEEEeeCCeEEEEEEcC-CCCC
Q 003140 629 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL-VSLVGYCDEEGEQMLVYEFM-SNGT 706 (845)
Q Consensus 629 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~LV~E~~-~~gs 706 (845)
.+.|+.|....+|+. ..+++|+....... ..+..+|.++++.+....+ .++++++ .+.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 677999999999998 55788887643211 1123457777777642222 4666553 33346899999 5543
Q ss_pred HHH---------------H---HhccCC---CCCCHHHHH-HHHH--------------HHHHHH----HHHHh-CCCCC
Q 003140 707 LRD---------------Q---LSAKSK---EPLGFAMRL-SIAL--------------GSSRGI----LYLHT-EADPP 745 (845)
Q Consensus 707 L~~---------------~---l~~~~~---~~l~~~~~~-~i~~--------------~ia~gL----~yLH~-~~~~~ 745 (845)
+.. . +|.... ...+...++ .+.. .+.+.+ +.+.. ...+.
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 321 0 111111 001111111 1100 011111 12211 22344
Q ss_pred eEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003140 746 VFHRDIKASNILLDHKFTAKVADFGLSRL 774 (845)
Q Consensus 746 iiHrDLk~~NILl~~~~~~kl~DFGla~~ 774 (845)
++|+|+.+.||+ ..++.+.++||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 789999999999 6667789999998764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.70 E-value=0.00052 Score=67.16 Aligned_cols=35 Identities=26% Similarity=0.219 Sum_probs=15.1
Q ss_pred CCCcceeeccccccccC----CCcccCCCCCCcEEEccC
Q 003140 201 LPSLVHMLLDNNNLTGY----LPPELSELPKLLILQLDN 235 (845)
Q Consensus 201 l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~ 235 (845)
-+.|++|+|+.|+|... +.+.+..-+.|++|+|++
T Consensus 97 N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n 135 (197)
T 1pgv_A 97 SPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADN 135 (197)
T ss_dssp CSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCC
T ss_pred CCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCC
Confidence 34445555555544421 112333334455555543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.44 E-value=0.0085 Score=67.11 Aligned_cols=73 Identities=12% Similarity=-0.024 Sum_probs=47.3
Q ss_pred CccccccCceEEEEEEeCC-CcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCce-eeEEEEEeeCCeEEEEEEcCCCCC
Q 003140 629 STQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL-VSLVGYCDEEGEQMLVYEFMSNGT 706 (845)
Q Consensus 629 ~~~LG~G~fG~Vy~~~~~~-g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~LV~E~~~~gs 706 (845)
.+.|+.|-...+|+....+ +..+++|+....... .-+-.+|..+++.+...++ .++++++. + .+||||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4568889899999998765 578889987542211 1112578888888864444 57777763 2 25999998743
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.42 E-value=0.0042 Score=56.60 Aligned_cols=56 Identities=25% Similarity=0.447 Sum_probs=40.9
Q ss_pred EEEcccccCC-cCCCCCCCccccCEEEccCCcCCCCcccccCCCCCCCeEecccccCc
Q 003140 278 YLDLSSNQLN-GSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 334 (845)
Q Consensus 278 ~L~Ls~N~l~-~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 334 (845)
.++.+++.|+ ..+|.. ...+|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~-lp~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTA-FPVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSC-CCTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCC-CCcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5666666664 244433 2336788888888888777778888999999999999886
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.21 E-value=0.018 Score=61.91 Aligned_cols=32 Identities=25% Similarity=0.366 Sum_probs=27.9
Q ss_pred CCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003140 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (845)
Q Consensus 743 ~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~ 774 (845)
...++|+|+.+.||++++++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 34589999999999999888899999988754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.13 E-value=0.007 Score=65.90 Aligned_cols=72 Identities=14% Similarity=0.117 Sum_probs=43.2
Q ss_pred ccccccCceEEEEEEeCC---------CcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCc-eeeEEEEEeeCCeEEEEE
Q 003140 630 TQIGQGGYGKVYKGILPD---------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN-LVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~~---------g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~LV~ 699 (845)
+.++.|..-.+|+....+ +..+++|+....... ..+...|.++++.+...+ ..++++.. .+ ++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEE
Confidence 457788888999988654 268888887653221 112356788887774223 44666554 22 6899
Q ss_pred EcCCCCC
Q 003140 700 EFMSNGT 706 (845)
Q Consensus 700 E~~~~gs 706 (845)
||++|..
T Consensus 114 e~i~G~~ 120 (369)
T 3c5i_A 114 EWLYGDP 120 (369)
T ss_dssp ECCCSEE
T ss_pred EEecCCc
Confidence 9998743
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=94.05 E-value=0.026 Score=38.68 Aligned_cols=30 Identities=20% Similarity=0.491 Sum_probs=21.8
Q ss_pred CCCCCccceeehhHHHHHHHHHHHHHHHHH
Q 003140 554 NSGISKAALAGIILGAIAGAVTISAIVSLL 583 (845)
Q Consensus 554 ~~~~~~~~~~~ii~~~~~~~~~~~~~~~~~ 583 (845)
+++.+..+++||++|+++++.++.+++.++
T Consensus 5 ~~~ls~GaIAGiVvG~v~gv~li~~l~~~~ 34 (38)
T 2k1k_A 5 SRGLTGGEIVAVIFGLLLGAALLLGILVFR 34 (38)
T ss_dssp STTCCHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCceeeeehHHHHHHHHHHHHHHHH
Confidence 445677889999999888877766655444
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.81 E-value=0.18 Score=55.52 Aligned_cols=73 Identities=10% Similarity=0.007 Sum_probs=47.1
Q ss_pred CccccccCceEEEEEEeCC--------CcEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCeEEEEE
Q 003140 629 STQIGQGGYGKVYKGILPD--------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 629 ~~~LG~G~fG~Vy~~~~~~--------g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~ 699 (845)
.+.+..|-...+|+....+ +..+++|+...... ..-+-.+|.++++.+. +.-..++++.+. + ++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADFP--E--GRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--CEEE
Confidence 3457778888999988753 57889998654321 1112356778877774 333456665432 2 6899
Q ss_pred EcCCCCC
Q 003140 700 EFMSNGT 706 (845)
Q Consensus 700 E~~~~gs 706 (845)
||++|..
T Consensus 150 efI~G~~ 156 (424)
T 3mes_A 150 EFIDGEP 156 (424)
T ss_dssp ECCCSEE
T ss_pred EEeCCcc
Confidence 9999855
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.91 E-value=0.69 Score=50.59 Aligned_cols=29 Identities=34% Similarity=0.458 Sum_probs=24.6
Q ss_pred eEecCCCCCCEEE------cCCCcEEEEecCCccc
Q 003140 746 VFHRDIKASNILL------DHKFTAKVADFGLSRL 774 (845)
Q Consensus 746 iiHrDLk~~NILl------~~~~~~kl~DFGla~~ 774 (845)
++|+|+.+.|||+ +++..++++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5699999999999 4567899999998854
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.80 E-value=0.54 Score=33.22 Aligned_cols=8 Identities=25% Similarity=0.484 Sum_probs=3.1
Q ss_pred ceeehhHH
Q 003140 561 ALAGIILG 568 (845)
Q Consensus 561 ~~~~ii~~ 568 (845)
+|++-++|
T Consensus 12 ~IA~gVVg 19 (44)
T 2ks1_B 12 SIATGMVG 19 (44)
T ss_dssp SSTHHHHH
T ss_pred eEEeehhH
Confidence 34333333
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.25 E-value=0.48 Score=33.39 Aligned_cols=8 Identities=50% Similarity=0.825 Sum_probs=3.3
Q ss_pred hhHHHHHH
Q 003140 565 IILGAIAG 572 (845)
Q Consensus 565 ii~~~~~~ 572 (845)
|+.|++.+
T Consensus 12 IA~gVVgG 19 (44)
T 2l2t_A 12 IAAGVIGG 19 (44)
T ss_dssp HHHHHHHH
T ss_pred EEEeehHH
Confidence 44444443
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=86.58 E-value=2.4 Score=41.58 Aligned_cols=100 Identities=15% Similarity=0.171 Sum_probs=64.7
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCc
Q 003140 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (845)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 783 (845)
.-||.+.|+.. +.++++.++|.++.|.++.|.-+-...++ ..+=+.|..|++..+|.|...+ +.+.
T Consensus 32 ~vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 32 ALSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred cccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc----------
Confidence 34789988764 46899999999999999887665211111 1233446889999999998764 2110
Q ss_pred cccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh
Q 003140 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 827 (845)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt 827 (845)
.....+.+||... ...+.+.=|||+|+++|.-+-
T Consensus 98 ---------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ---------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ------------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ---------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 0113467888653 355788999999999999874
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=82.25 E-value=1.3 Score=31.10 Aligned_cols=26 Identities=23% Similarity=0.465 Sum_probs=11.6
Q ss_pred ceeehhHHHHHHHHHHHHHHHHHHHhh
Q 003140 561 ALAGIILGAIAGAVTISAIVSLLIVRA 587 (845)
Q Consensus 561 ~~~~ii~~~~~~~~~~~~~~~~~~~~~ 587 (845)
.++++++| +..++++++.+.++++|+
T Consensus 13 ~Ia~~vVG-vll~vi~~l~~~~~~RRR 38 (44)
T 2jwa_A 13 SIISAVVG-ILLVVVLGVVFGILIKRR 38 (44)
T ss_dssp HHHHHHHH-HHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHH-HHHHHHHHHHHHhheehh
Confidence 45666666 333333333333444333
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 845 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-59 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-58 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-57 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-55 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-53 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-53 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-52 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-52 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-52 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-52 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-51 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-51 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-51 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-51 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-50 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-50 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-49 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-49 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-49 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-49 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-48 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-47 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-46 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-46 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-46 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-45 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-45 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-42 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-42 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-42 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-41 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-41 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-38 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-35 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-34 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-29 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-26 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-22 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-17 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 8e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 4e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 2e-59
Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 13/210 (6%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
+IG G +G VYKG V + + Q + F E+ L + H N++ +GY
Sbjct: 15 RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 691 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 750
+ +V ++ +L L + + IA +++G+ YLH + HRD
Sbjct: 75 -APQLAIVTQWCEGSSLYHHLH-IIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 129
Query: 751 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK-- 808
+K++NI L T K+ DFGL+ + +H + G+ ++ PE
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWS-----GSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 809 -LTDKSDVYSLGVVFLELLTGMQPISHGKN 837
+ +SDVY+ G+V EL+TG P S+ N
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINN 214
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 2e-58
Identities = 55/221 (24%), Positives = 97/221 (43%), Gaps = 15/221 (6%)
Query: 619 MALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG-EKEFLTEIQFLSR 676
M L ++F +++G G G V+K P G V+A K + + E+Q L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 677 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 736
+ +V G +GE + E M G+L L K + + +++ +G+
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLT 118
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
YL + + HRD+K SNIL++ + K+ DFG+S + ++ GT
Sbjct: 119 YLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSG---------QLIDSMANSFVGTR 167
Query: 797 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
Y+ PE + +SD++S+G+ +E+ G PI
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 6e-57
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 11/214 (5%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 683
++G G +G+V+ G T VAVK ++GS FL E + +L H+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
L + ++ E+M NG+L D L S L L +A + G+ ++ +
Sbjct: 72 RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
HRD++A+NIL+ + K+ADFGL+RL + K + PE
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE------YTAREGAKFPIKWTAPEA 181
Query: 804 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
T KSDV+S G++ E++T + G
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 3e-55
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 11/214 (5%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 683
+ +IG G +G V+ G + VA+K +EG+ E++F+ E + + +L H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
L G C E+ LV+EFM +G L D + L + L G + +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSD-YLRTQRGLFAAETLLGMCLDVCEG---MAYLEE 119
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
V HRD+ A N L+ KV+DFG++R ST K + PE
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY------TSSTGTKFPVKWASPEV 173
Query: 804 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
F + + KSDV+S GV+ E+ + + ++
Sbjct: 174 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 207
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 3e-53
Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 11/214 (5%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 683
+ ++G G +G V G VA+K +EGS E EF+ E + + L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
L G C ++ ++ E+M+NG L + L + L + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE---S 118
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
HRD+ A N L++ + KV+DFGLSR + S K + PE
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE------YTSSVGSKFPVRWSPPEV 172
Query: 804 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
+ K + KSD+++ GV+ E+ + +
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 206
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 4e-53
Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 11/214 (5%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 683
+ ++GQG +G+V+ G T VA+K + G+ + FL E Q + +L H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
L E +V E+MS G+L D L ++ + L + +A + G+ Y+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---R 131
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
HRD++A+NIL+ KVADFGL+RL + K + PE
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE------YTARQGAKFPIKWTAPEA 185
Query: 804 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
L + T KSDV+S G++ EL T + G
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 219
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 6e-53
Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 17/216 (7%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 683
IG+G +G V G G VAVK + + + FL E +++L H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 684 SLVGYC-DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 742
L+G +E+G +V E+M+ G+L D L ++ + LG L +L + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 120
Query: 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
HRD+ A N+L+ AKV+DFGL++ A K + PE
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS----------STQDTGKLPVKWTAPE 170
Query: 803 YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 838
K + KSDV+S G++ E+ + + +
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 206
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 182 bits (462), Expect = 2e-52
Identities = 68/228 (29%), Positives = 104/228 (45%), Gaps = 11/228 (4%)
Query: 612 RSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTE 670
S Y + + + ++G G YG+VY+G+ VAVK +E +++ E EFL E
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKE 63
Query: 671 IQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 730
+ + H NLV L+G C E ++ EFM+ G L D L +++ + + L +A
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123
Query: 731 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 790
S + YL HRD+ A N L+ KVADFGLSRL
Sbjct: 124 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------TYTAHA 174
Query: 791 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 838
K + PE +K + KSDV++ GV+ E+ T G ++
Sbjct: 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 222
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 182 bits (463), Expect = 2e-52
Identities = 63/241 (26%), Positives = 102/241 (42%), Gaps = 20/241 (8%)
Query: 611 VRSFTYGEMALATNNFNSSTQ---------IGQGGYGKVYKGILP----DGTVVAVKRAQ 657
+ FT+ + A F IG G +G+V G L VA+K +
Sbjct: 4 IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63
Query: 658 EG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK 716
G + + ++FL+E + + H N++ L G + M++ EFM NG+L D ++
Sbjct: 64 SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQND 122
Query: 717 EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776
+ + G + G+ YL D HRD+ A NIL++ KV+DFGLSR
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF-- 177
Query: 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836
+ D + K + PE K T SDV+S G+V E+++ +
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237
Query: 837 N 837
Sbjct: 238 T 238
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 6e-52
Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 14/225 (6%)
Query: 618 EMALATNNFN-SSTQIGQGGYGKVYKGIL---PDGTVVAVKRAQEGSLQGE-KEFLTEIQ 672
++ L +N + ++G G +G V +G+ VA+K ++G+ + + +E + E Q
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 673 FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS 732
+ +L + +V L+G C + MLV E G L L K +E + + + S
Sbjct: 62 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVS 119
Query: 733 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 792
G+ YL + HRD+ A N+LL ++ AK++DFGLS+ D +
Sbjct: 120 MGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY----TARSAG 172
Query: 793 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
K + PE K + +SDV+S GV E L+ Q
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 217
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 9e-52
Identities = 73/246 (29%), Positives = 113/246 (45%), Gaps = 13/246 (5%)
Query: 600 HSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKR 655
H +++ + V++ + + ++ + + IG+G +G VY G L D AVK
Sbjct: 3 HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 62
Query: 656 AQEGSLQGE-KEFLTEIQFLSRLHHRNLVSLVGYC-DEEGEQMLVYEFMSNGTLRDQLSA 713
+ GE +FLTE + H N++SL+G C EG ++V +M +G LR+
Sbjct: 63 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIR 121
Query: 714 KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773
+ L ++G + A HRD+ A N +LD KFT KVADFGL+R
Sbjct: 122 NETHNPTVKDLIGFGLQVAKG---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178
Query: 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833
+ + + H T K ++ E T K T KSDV+S GV+ EL+T P
Sbjct: 179 DMYDKEFDSV---HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 235
Query: 834 HGKNIV 839
N
Sbjct: 236 PDVNTF 241
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 3e-51
Identities = 57/216 (26%), Positives = 92/216 (42%), Gaps = 16/216 (7%)
Query: 625 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRN 681
++ IG G YG+ K DG ++ K GS+ ++ ++E+ L L H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 682 LVSLVGYCDEEGEQML--VYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILY 737
+V + L V E+ G L ++ K ++ L L + + +
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 738 LH--TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 795
H ++ V HRD+K +N+ LD K K+ DFGL+R+ + GT
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-------SFAKAFVGT 177
Query: 796 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
P Y+ PE +KSD++SLG + EL M P
Sbjct: 178 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 213
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 179 bits (454), Expect = 4e-51
Identities = 63/249 (25%), Positives = 101/249 (40%), Gaps = 37/249 (14%)
Query: 618 EMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKR-AQEGSLQGEKEFLTE 670
+ NN IG+G +G+V++ P T+VAVK +E S + +F E
Sbjct: 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE 66
Query: 671 IQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL------------------- 711
++ + N+V L+G C L++E+M+ G L + L
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 712 ---SAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 768
S+ PL A +L IA + G+ YL + HRD+ N L+ K+AD
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIAD 183
Query: 769 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG 828
FGLSR D ++ PE ++ T +SDV++ GVV E+ +
Sbjct: 184 FGLSRNIYSADYY-----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238
Query: 829 MQPISHGKN 837
+G
Sbjct: 239 GLQPYYGMA 247
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 5e-51
Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 21/216 (9%)
Query: 631 QIGQGGYGKVYKGILPD-GTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVG 687
+IG+G + VYKG+ + VA Q+ L + F E + L L H N+V
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 688 YCDEEGEQ----MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
+ + +LV E M++GTL+ L K + + + S +G+ +LH
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLH-TRT 132
Query: 744 PPVFHRDIKASNILLDHK-FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
PP+ HRD+K NI + + K+ D GL+ L A + V GTP ++ PE
Sbjct: 133 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---------KRASFAKAVIGTPEFMAPE 183
Query: 803 YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 838
K + DVY+ G+ LE+ T P S +N
Sbjct: 184 M-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNA 218
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 8e-51
Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 17/207 (8%)
Query: 631 QIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
++G G +GKVYK + + A K S + ++++ EI L+ H N+V L+
Sbjct: 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
E ++ EF + G + + + + PL + + + + YLH D + HR
Sbjct: 79 YYENNLWILIEFCAGGAVDAVML-ELERPLTESQIQVVCKQTLDALNYLH---DNKIIHR 134
Query: 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 809
D+KA NIL K+ADFG+S GTP ++ PE +
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTI-------QRRDSFIGTPYWMAPEVVMCETS 187
Query: 810 TD-----KSDVYSLGVVFLELLTGMQP 831
D K+DV+SLG+ +E+ P
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPP 214
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 178 bits (452), Expect = 1e-50
Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 23/220 (10%)
Query: 626 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHRN 681
F+ +IG G +G VY + + VVA+K+ Q ++ + E++FL +L H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+ G E LV E+ K+PL ++ G+ +G+ YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLH-- 132
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
+ HRD+KA NILL K+ DFG + + + GTP ++ P
Sbjct: 133 -SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI-----------MAPANSFVGTPYWMAP 180
Query: 802 EYFLTH---KLTDKSDVYSLGVVFLELLTGMQPISHGKNI 838
E L + K DV+SLG+ +EL P+ + +
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 9e-50
Identities = 59/212 (27%), Positives = 89/212 (41%), Gaps = 18/212 (8%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHH 679
+F +G+G +G VY ++A+K +AQ E + E++ S L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 680 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
N++ L GY + L+ E+ GT+ +L + + + + Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCH 123
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
V HRDIK N+LL K+ADFG S P+ T + GT YL
Sbjct: 124 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH---------APSSRRTTLCGTLDYL 171
Query: 800 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
PE +K D++SLGV+ E L G P
Sbjct: 172 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 203
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 2e-49
Identities = 49/202 (24%), Positives = 91/202 (45%), Gaps = 14/202 (6%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
+IGQG G VY + + G VA+++ ++ + EI + + N+V+ +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
E +V E+++ G+L D ++ + ++ + + +LH+ V HR
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDE---GQIAAVCRECLQALEFLHSN---QVIHR 140
Query: 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 809
DIK+ NILL + K+ DFG + + GTP ++ PE
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQ-------SKRSTMVGTPYWMAPEVVTRKAY 193
Query: 810 TDKSDVYSLGVVFLELLTGMQP 831
K D++SLG++ +E++ G P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 2e-49
Identities = 58/212 (27%), Positives = 88/212 (41%), Gaps = 15/212 (7%)
Query: 631 QIGQGGYGKVYKGILPD---GTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSL 685
++G G +G V KG VAVK + + E L E + +L + +V +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
+G C+ E MLV E G L L + + + + S G+ YL +
Sbjct: 74 IGICEAE-SWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE---ESN 127
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
HRD+ A N+LL + AK++DFGLS+ T K + PE
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALR----ADENYYKAQTHGKWPVKWYAPECIN 183
Query: 806 THKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
+K + KSDV+S GV+ E + Q G
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 215
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 2e-49
Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 23/216 (10%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690
IG+G +G+V++G G VAVK + EI L H N++ + +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 691 EEGEQ----MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA---- 742
++ LV ++ +G+L D L+ + + + +AL ++ G+ +LH E
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 743 -DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
P + HRD+K+ NIL+ T +AD GL+ D GT Y+ P
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH---DSATDTIDIAPNHRVGTKRYMAP 181
Query: 802 EYFLTH------KLTDKSDVYSLGVVFLELLTGMQP 831
E + ++D+Y++G+VF E+
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 217
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 5e-49
Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 13/223 (5%)
Query: 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR-AQEGSLQGEKEFLTEIQFLSRLHHRN 681
+++ +G+G YG+V + VAVK + ++ + EI L+H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+V G+ E Q L E+ S G L D++ + + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH-- 120
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
+ HRDIK N+LLD + K++DFGL+ + + E + + GT Y+ P
Sbjct: 121 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-----RLLNKMCGTLPYVAP 174
Query: 802 EYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVL 843
E + + DV+S G+V +L G P + +E
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 217
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 8e-49
Identities = 58/223 (26%), Positives = 100/223 (44%), Gaps = 14/223 (6%)
Query: 621 LATNNFNSSTQIGQGGYGKVYKGILPDGT-----VVAVKRAQEGSLQGEK-EFLTEIQFL 674
+ + IG G +G+VYKG+L + VA+K + G + ++ +FL E +
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 63
Query: 675 SRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 734
+ H N++ L G + M++ E+M NG L + + + G + G
Sbjct: 64 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK-FLREKDGEFSVLQLVGMLRGIAAG 122
Query: 735 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 794
+ YL + HRD+ A NIL++ KV+DFGLSR+ + + ++ K
Sbjct: 123 MKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE----DDPEATYTTSGGKI 175
Query: 795 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
+ PE K T SDV+S G+V E++T + +
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS 218
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 5e-48
Identities = 61/249 (24%), Positives = 100/249 (40%), Gaps = 37/249 (14%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSLQGEKE-FLTEIQFLSR 676
N +G G +GKV VAVK +E + E+E ++E++ +++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 677 L-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK------------------- 716
L H N+V+L+G C G L++E+ G L + L +K +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 717 --EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774
L F L A ++G+ +L HRD+ A N+L+ H K+ DFGL+R
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLAR- 212
Query: 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834
DI V + ++ PE T KSDV+S G++ E+ +
Sbjct: 213 ----DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268
Query: 835 GKNIVREVL 843
G +
Sbjct: 269 GIPVDANFY 277
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 4e-47
Identities = 62/236 (26%), Positives = 98/236 (41%), Gaps = 30/236 (12%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPDG---TVVAVKR-AQEGSLQGEKEFLTEIQFLSRL-H 678
N+ IG+G +G+V K + A+KR + S ++F E++ L +L H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 679 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLGFAMR 724
H N+++L+G C+ G L E+ +G L D L + + L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 725 LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784
L A +RG+ YL HRD+ A NIL+ + AK+ADFGLSR
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQE-------- 178
Query: 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 840
T+ + ++ E T SDV+S GV+ E+++ G
Sbjct: 179 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 234
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 2e-46
Identities = 55/217 (25%), Positives = 82/217 (37%), Gaps = 16/217 (7%)
Query: 631 QIGQGGYGKVYKGILP----DGTVVAVKR---AQEGSLQGEKEFLTEIQFLSRLHHRNLV 683
++G G +G V +G VAVK + +F+ E+ + L HRNL+
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
L G +V E G+L D K + A+ + G+ YL
Sbjct: 75 RLYGVV-LTPPMKMVTELAPLGSLLD-RLRKHQGHFLLGTLSRYAVQVAEGMGYLE---S 129
Query: 744 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
HRD+ A N+LL + K+ DFGL R P + + K + PE
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP----QNDDHYVMQEHRKVPFAWCAPES 185
Query: 804 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 840
T + SD + GV E+ T Q G N +
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ 222
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 2e-46
Identities = 56/212 (26%), Positives = 85/212 (40%), Gaps = 16/212 (7%)
Query: 631 QIGQGGYGKVYKGILPD----GTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSL 685
IG+G +G V++GI VA+K + + +E FL E + + H ++V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
+G E ++ E + G LR K L A + A S + YL
Sbjct: 74 IGVI-TENPVWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTALAYLE---SKR 128
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
HRDI A N+L+ K+ DFGLSR + ++ K ++ PE
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY------YKASKGKLPIKWMAPESIN 182
Query: 806 THKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
+ T SDV+ GV E+L G
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 214
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 4e-46
Identities = 59/237 (24%), Positives = 96/237 (40%), Gaps = 32/237 (13%)
Query: 631 QIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRL-HHRNL 682
+G G +GKV + VAVK + + E+E ++E++ LS L +H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 683 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK----------------SKEPLGFAMRLS 726
V+L+G C G +++ E+ G L + L K + L LS
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 727 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 786
+ ++G+ +L HRD+ A NILL H K+ DFGL+R
Sbjct: 150 FSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS-----NY 201
Query: 787 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVL 843
V + ++ PE T +SDV+S G+ EL + G + +
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 165 bits (419), Expect = 1e-45
Identities = 51/211 (24%), Positives = 95/211 (45%), Gaps = 15/211 (7%)
Query: 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL 682
++++ ++G G +G V++ G A K ++ EIQ +S L H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 683 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 742
V+L +++ E +++YEFMS G L ++++ + + +G+ ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVA-DEHNKMSEDEAVEYMRQVCKGLCHMH--- 141
Query: 743 DPPVFHRDIKASNILLDHKF--TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
+ H D+K NI+ K K+ DFGL+ + P V GT +
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH--------LDPKQSVKVTTGTAEFAA 193
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
PE + +D++S+GV+ LL+G+ P
Sbjct: 194 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 224
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 3e-45
Identities = 42/211 (19%), Positives = 76/211 (36%), Gaps = 14/211 (6%)
Query: 625 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHR 680
+F +G+G + V L A+K ++ + E E +SRL H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 740
V L ++ + + NG L + + + + L
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI-----VSALEY 123
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
+ HRD+K NILL+ ++ DFG +++ + GT Y+
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-----KQARANSFVGTAQYVS 178
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
PE SD+++LG + +L+ G+ P
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 4e-45
Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 16/218 (7%)
Query: 626 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRA-----QEGSLQGEKEFLTEIQFLSRLHH 679
F +G G +G VYKG+ +P+G V + A + S + KE L E ++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 680 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
++ L+G C L+ + M G L D + K+ +G L+ + ++G+ YL
Sbjct: 71 PHVCRLLGIC-LTSTVQLITQLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
D + HRD+ A N+L+ K+ DFGL++L + E + + K ++
Sbjct: 129 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE-----YHAEGGKVPIKWM 180
Query: 800 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
E L T +SDV+S GV EL+T G
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 218
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 162 bits (412), Expect = 9e-45
Identities = 50/211 (23%), Positives = 101/211 (47%), Gaps = 15/211 (7%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
++G G +G V++ + G V K + EI +++LHH L++L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
+++ E +L+ EF+S G L D+++A+ + A ++ + G+ ++H + + H
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMH---EHSIVHL 151
Query: 750 DIKASNILLDHKF--TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
DIK NI+ + K + K+ DFGL+ + P + V T + PE
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATK--------LNPDEIVKVTTATAEFAAPEIVDRE 203
Query: 808 KLTDKSDVYSLGVVFLELLTGMQPISHGKNI 838
+ +D++++GV+ LL+G+ P + ++
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 234
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 1e-42
Identities = 60/236 (25%), Positives = 98/236 (41%), Gaps = 31/236 (13%)
Query: 631 QIGQGGYGKVYKGI------LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSR-LHHRNL 682
+G+G +G+V + VAVK +EG+ E + ++E++ L HH N+
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 683 VSLVGYCDEEGEQ-MLVYEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSI 727
V+L+G C + G M++ EF G L L +K K+ L +
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 728 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 787
+ ++G+ +L + HRD+ A NILL K K+ DFGL+R
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-----DYV 191
Query: 788 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVL 843
+ ++ PE T +SDV+S GV+ E+ + G I E
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 2e-42
Identities = 56/229 (24%), Positives = 95/229 (41%), Gaps = 23/229 (10%)
Query: 624 NNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKR-AQEGSLQGEKEFLTEIQFLSR 676
S ++GQG +G VY+G+ T VA+K + S++ EFL E +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 677 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------SAKSKEPLGFAMRLSIA 728
+ ++V L+G + +++ E M+ G L+ L + P + + +A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 729 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 788
+ G+ YL+ HRD+ A N ++ FT K+ DFG++R D
Sbjct: 140 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-----RK 191
Query: 789 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
++ PE T SDV+S GVV E+ T + G +
Sbjct: 192 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 240
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (390), Expect = 3e-42
Identities = 50/211 (23%), Positives = 84/211 (39%), Gaps = 12/211 (5%)
Query: 623 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHR 680
+ ++ +G G + +V +VA+K + +L+G E EI L ++ H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 740
N+V+L + G L+ + +S G L D++ K + + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLHD 125
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
+ LD ++DFGLS++ P V + GTPGY+
Sbjct: 126 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--------EDPGSVLSTACGTPGYVA 177
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
PE + D +S+GV+ LL G P
Sbjct: 178 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 208
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 154 bits (390), Expect = 3e-42
Identities = 49/215 (22%), Positives = 86/215 (40%), Gaps = 19/215 (8%)
Query: 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHH 679
+F +G G +G+V+ +G A+K + L+ + E LS + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 680 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
++ + G + + ++ +++ G L L + P A + + L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-----CLALE 118
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
+ +RD+K NILLD K+ DFG ++ P V+ + GTP Y+
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----------DVTYTLCGTPDYI 168
Query: 800 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834
PE T D +S G++ E+L G P
Sbjct: 169 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 203
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 5e-42
Identities = 45/210 (21%), Positives = 87/210 (41%), Gaps = 16/210 (7%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
+G+G +G V++ + K + + EI L+ HRN++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 690 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749
+ E ++++EF+S + ++++ S L +S + +LH + H
Sbjct: 71 ESMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFLH---SHNIGHF 126
Query: 750 DIKASNILLDHK--FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
DI+ NI+ + T K+ +FG +R D ++ P Y PE
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--------FRLLFTAPEYYAPEVHQHD 178
Query: 808 KLTDKSDVYSLGVVFLELLTGMQPISHGKN 837
++ +D++SLG + LL+G+ P N
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETN 208
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 151 bits (382), Expect = 1e-41
Identities = 62/231 (26%), Positives = 86/231 (37%), Gaps = 30/231 (12%)
Query: 625 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR---------AQEGSLQGEKEFLTEIQFL 674
N+ +G+G V + I P AVK + E + + L E+ L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 675 SRLH-HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR 733
++ H N++ L + LV++ M G L D L K L I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLE 121
Query: 734 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 793
I LH + HRD+K NILLD K+ DFG S + P V
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ--------LDPGEKLREVC 170
Query: 794 GTPGYLDPEYFLT------HKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 838
GTP YL PE + D++S GV+ LL G P H K +
Sbjct: 171 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 221
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 150 bits (380), Expect = 2e-41
Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 17/217 (7%)
Query: 623 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLH 678
++ + +G GG +V+ L VAVK + + F E Q + L+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 679 HRNLVSLVGYCDEEGEQ----MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 734
H +V++ + E +V E++ TLRD + ++ P+ + + + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQA 123
Query: 735 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 794
+ + H + HRD+K +NI++ KV DFG++R + + V G
Sbjct: 124 LNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIA----DSGNSVTQTAAVIG 176
Query: 795 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
T YL PE + +SDVYSLG V E+LTG P
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 213
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 152 bits (385), Expect = 5e-41
Identities = 54/216 (25%), Positives = 89/216 (41%), Gaps = 22/216 (10%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSL---QGEKEFLTE---IQFLSR 676
N+F+ IG+GG+G+VY D G + A+K + + QGE L E + +S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 677 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 736
+V + + + + M+ G L LS + + G+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI--ILGLE 121
Query: 737 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 796
++H + V +RD+K +NILLD +++D GL+ GT
Sbjct: 122 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACD---------FSKKKPHASVGTH 169
Query: 797 GYLDPEYFLTHKLTD-KSDVYSLGVVFLELLTGMQP 831
GY+ PE D +D +SLG + +LL G P
Sbjct: 170 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 205
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-40
Identities = 60/239 (25%), Positives = 104/239 (43%), Gaps = 32/239 (13%)
Query: 624 NNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKR-AQEGSLQGEKEFLTEIQFL 674
+ +G+G +G+V T VAVK + + + + ++E++ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 675 SRL-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPL 719
+ H+N+++L+G C ++G ++ E+ S G LR+ L S +E L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 720 GFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779
+S A +RG+ YL HRD+ A N+L+ K+ADFGL+R D
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----D 184
Query: 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 838
I I +T + ++ PE T +SDV+S GV+ E+ T G +
Sbjct: 185 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 144 bits (364), Expect = 5e-39
Identities = 45/205 (21%), Positives = 80/205 (39%), Gaps = 14/205 (6%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
+IG+G +G +++G L + VA+K E + E + L + V Y
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKF--EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 690 DEEGEQ-MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 748
+EG +LV + + G + L A + +H + + +
Sbjct: 70 GQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVY 124
Query: 749 RDIKASNILLD-----HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 803
RDIK N L+ + V DFG+ + P + +P + GT Y+
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 804 FLTHKLTDKSDVYSLGVVFLELLTG 828
L + + + D+ +LG VF+ L G
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRG 209
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 1e-38
Identities = 55/226 (24%), Positives = 93/226 (41%), Gaps = 24/226 (10%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKR------AQEGSLQGEKEFLTEIQFLSRLH--HRN 681
+G GG+G VY GI + D VA+K + G L E+ L ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
++ L+ + + +L+ E + L + S + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCH-- 127
Query: 742 ADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
+ V HRDIK NIL+D ++ K+ DFG L + V T GT Y
Sbjct: 128 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL---------LKDTVYTDFDGTRVYSP 177
Query: 801 PEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVLPY 845
PE+ H+ +S V+SLG++ +++ G P H + I+R + +
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF 223
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 1e-38
Identities = 53/213 (24%), Positives = 88/213 (41%), Gaps = 17/213 (7%)
Query: 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE---FLTEIQFLSR-LH 678
+F +G+G +GKV+ A+K ++ + + + + E + LS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 679 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 738
H L + + V E+++ G L + + K L A + + IL L
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI-----ILGL 116
Query: 739 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
+ +RD+K NILLD K+ADFG+ + E ++ + GTP Y
Sbjct: 117 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK-------ENMLGDAKTNTFCGTPDY 169
Query: 799 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
+ PE L K D +S GV+ E+L G P
Sbjct: 170 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 202
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (360), Expect = 2e-38
Identities = 42/203 (20%), Positives = 72/203 (35%), Gaps = 12/203 (5%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 689
+IG G +G +Y G + G VA+K + + E + + + + +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 690 DEEGEQ-MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 748
EG+ ++V E + L +A I Y+H H
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFN--FCSRKFSLKTVLLLADQMISRIEYIH---SKNFIH 126
Query: 749 RDIKASNIL---LDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
RD+K N L + DFGL++ +P + + GT Y L
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 806 THKLTDKSDVYSLGVVFLELLTG 828
+ + + D+ SLG V + G
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLG 209
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 2e-38
Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 13/210 (6%)
Query: 625 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRN 681
NF +IG+G YG VYK G VVA+K R + + EI L L+H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 682 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+V L+ E + LV+EF+ L+ + A + + + S +G+ + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
V HRD+K N+L++ + K+ADFGL+R VP + V
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV------RTYTHEVVTLWYRAPE 172
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
+ D++SLG +F E++T
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 4e-38
Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 24/229 (10%)
Query: 622 ATNNFNSSTQIGQGGYGKVYKG--ILPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRL 677
A + +IG+G YGKV+K + G VA+K R Q G + E+ L L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 678 ---HHRNLVSLVGYC-----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIAL 729
H N+V L C D E + LV+E + L + + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT-TYLDKVPEPGVPTETIKDMMF 123
Query: 730 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 789
RG+ +LH+ V HRD+K NIL+ K+ADFGL+R+
Sbjct: 124 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS--------FQMAL 172
Query: 790 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 838
T V T Y PE L D++S+G +F E+ ++
Sbjct: 173 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV 221
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-37
Identities = 47/207 (22%), Positives = 79/207 (38%), Gaps = 19/207 (9%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKR-----AQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 685
+G+G + VYK +VA+K+ E + L EI+ L L H N++ L
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 686 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
+ + LV++FM + + L
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT-----LQGLEYLHQHW 120
Query: 746 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 805
+ HRD+K +N+LLD K+ADFGL++ P+ T T Y PE
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-------RAYTHQVVTRWYRAPELLF 173
Query: 806 THKLTD-KSDVYSLGVVFLELLTGMQP 831
++ D++++G + ELL +
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPF 200
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 3e-37
Identities = 47/212 (22%), Positives = 88/212 (41%), Gaps = 24/212 (11%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE------KEFLTEIQFLSRLHHRNLV 683
++G G + V K G A K ++ + ++ E+ L + H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 684 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 743
+L + + + +L+ E ++ G L D L+ K A + + ++
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI-----LNGVYYLHS 131
Query: 744 PPVFHRDIKASNILLDH----KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
+ H D+K NI+L K K+ DFGL+ I + + GTP ++
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--------IDFGNEFKNIFGTPEFV 183
Query: 800 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
PE L ++D++S+GV+ LL+G P
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASP 215
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 6e-37
Identities = 53/212 (25%), Positives = 80/212 (37%), Gaps = 16/212 (7%)
Query: 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE---FLTEIQFLSRLHH 679
N+F+ +G+G +GKV G A+K ++ + + E +TE + L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 680 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
L +L V E+ + G L LS + A + + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI-----VSALE 119
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
V +RDIK N++LD K+ DFGL + GTP YL
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-------ATMKTFCGTPEYL 172
Query: 800 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
PE + D + LGVV E++ G P
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 8e-37
Identities = 53/213 (24%), Positives = 85/213 (39%), Gaps = 11/213 (5%)
Query: 623 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHHR 680
+ + + IG+G YG V + VA+K+ Q + L EI+ L R H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTL-RDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
N++ + + + ++ + D + L RG+ Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
V HRD+K SN+LL+ K+ DFGL+R+A T T Y
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD----PDHDHTGFLTEYVATRWYR 179
Query: 800 DPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 831
PE L K KS D++S+G + E+L+
Sbjct: 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 137 bits (346), Expect = 1e-36
Identities = 53/203 (26%), Positives = 84/203 (41%), Gaps = 13/203 (6%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 688
+IG+G YG VYK G A+K R ++ + EI L L H N+V L
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 748
+ +LV+E + + + L S L GI Y H D V H
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLH 123
Query: 749 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 808
RD+K N+L++ + K+ADFGL+R +P + + + K
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPV------RKYTHEIVTLWYRAPDVLMGSKK 177
Query: 809 LTDKSDVYSLGVVFLELLTGMQP 831
+ D++S+G +F E++ G
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPL 200
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 7e-36
Identities = 54/220 (24%), Positives = 90/220 (40%), Gaps = 20/220 (9%)
Query: 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHR 680
+ + +IGQG +G+V+K G VA+K+ + + L EI+ L L H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 681 NLVSLVGYCDE--------EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS 732
N+V+L+ C +G LV++F + + K L R+ L
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 733 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 792
+ L+ + HRD+KA+N+L+ K+ADFGL+R + + T
Sbjct: 127 --LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS---QPNRYTNR 181
Query: 793 KGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQP 831
T Y PE L + D++ G + E+ T
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 9e-36
Identities = 52/212 (24%), Positives = 81/212 (38%), Gaps = 14/212 (6%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
+IG+G YG V+K +VA+K R + L EI L L H+N+V L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 688 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747
+ + LV+EF + S L + L V
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL-----LKGLGFCHSRNVL 123
Query: 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 807
HRD+K N+L++ K+A+FGL+R +P S V F
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPV------RCYSAEVVTLWYRPPDVLFGAK 177
Query: 808 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 839
+ D++S G +F EL +P+ G ++
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-35
Identities = 49/209 (23%), Positives = 77/209 (36%), Gaps = 25/209 (11%)
Query: 632 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYC 689
+G G GKV + A+K LQ + E++ R ++V +V
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKM-----LQDCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 690 D----EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 745
+ ++V E + G L ++ + + I I YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SIN 131
Query: 746 VFHRDIKASNILLDHKF---TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
+ HRD+K N+L K K+ DFG ++ + T TP Y+ PE
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--------TTSHNSLTTPCYTPYYVAPE 183
Query: 803 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
K D++SLGV+ LL G P
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPP 212
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 3e-35
Identities = 55/216 (25%), Positives = 89/216 (41%), Gaps = 23/216 (10%)
Query: 625 NFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 683
++ + IG G +G VY+ L D G +VA+K+ LQ ++ E+Q + +L H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 76
Query: 684 SLVGYCDEEGEQM------LVYEFMSNGTLRDQLS-AKSKEPLGFAMRLSIALGSSRGIL 736
L + GE+ LV +++ R +++K+ L R +
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 737 YLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 795
Y+H + HRDIK N+LLD K+ DFG ++ + + +
Sbjct: 137 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-------PNVSYICSR 186
Query: 796 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
F T DV+S G V ELL G
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 131 bits (331), Expect = 4e-34
Identities = 47/212 (22%), Positives = 82/212 (38%), Gaps = 19/212 (8%)
Query: 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE---FLTEIQFLSRLHH 679
+ F+ +G G +G+V G A+K + + K+ L E + L ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 680 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
LV L + +V E+++ G + L + A YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 740 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 799
+ +RD+K N+L+D + +V DFG ++ + + GTP L
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------RVKGRTWTLCGTPEAL 205
Query: 800 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
PE L+ D ++LGV+ E+ G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 127 bits (319), Expect = 7e-33
Identities = 83/334 (24%), Positives = 134/334 (40%), Gaps = 34/334 (10%)
Query: 31 ITDPIEVSALRSIKKSLVDDYSKLSNWNRG-DPCTSNWTGVLCFNTTMDDGYLHLRELQL 89
+ +P + AL IKK L + + LS+W D C W GVLC T + L L
Sbjct: 2 LCNPQDKQALLQIKKDLGNP-TTLSSWLPTTDCCNRTWLGVLCDTDT---QTYRVNNLDL 57
Query: 90 LNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNE-LTGSLPE 148
LNL IP + N+ L L + G L G +P
Sbjct: 58 SGLNLPKPYP----------------------IPSSLANLPYLNFLYIGGINNLVGPIPP 95
Query: 149 ELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHML 208
+ L +L + I +SG++P + + + N++SG +PP +S LP+LV +
Sbjct: 96 AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155
Query: 209 LDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP 268
D N ++G +P KL + N IP +++N++ RN
Sbjct: 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASV 215
Query: 269 DLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 328
N + L+ N L + LS N+ + L NN++ GT+P + L L L +
Sbjct: 216 LFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNV 275
Query: 329 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNL 362
+ N+L G IP + + + + NN
Sbjct: 276 SFNNLCGEIP-QGGNLQRFD-----VSAYANNKC 303
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 122 bits (306), Expect = 5e-31
Identities = 44/220 (20%), Positives = 94/220 (42%), Gaps = 25/220 (11%)
Query: 624 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRN 681
+++ ++G+G Y +V++ I + + V VK + +K+ EI+ L L N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 682 LVSLVGYCDEEGEQM--LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 739
+++L + + LV+E ++N + + L + + Y H
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCH 146
Query: 740 TEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 798
+ HRD+K N+++DH+ ++ D+GL+ P V + +
Sbjct: 147 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF--------YHPGQEYNVRVASRYF 195
Query: 799 LDPEYFLTHKLTD-KSDVYSLGVVFLELLTGMQPISHGKN 837
PE + +++ D D++SLG + ++ +P HG +
Sbjct: 196 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 6e-31
Identities = 48/210 (22%), Positives = 81/210 (38%), Gaps = 25/210 (11%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
+G G YG V + G VA+K S K E++ L + H N++ L+
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 688 YCDEEG------EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+ + LV FM GT +L E LG + +G+ Y+H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFM--GTDLGKL--MKHEKLGEDRIQFLVYQMLKGLRYIH-- 138
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
+ HRD+K N+ ++ K+ DFGL+R + ++ V
Sbjct: 139 -AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---------QADSEMTGYVVTRWYRAPE 188
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
+ T D++S+G + E++TG
Sbjct: 189 VILNWMRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 2e-29
Identities = 49/210 (23%), Positives = 79/210 (37%), Gaps = 25/210 (11%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
IG G G V VA+K + K E+ + ++H+N++SL+
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 688 YC------DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 741
+E + LV E M + E + GI +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE-----RMSYLLYQMLCGIKHLH-- 136
Query: 742 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 801
+ HRD+K SNI++ T K+ DFGL+R A + + T T Y P
Sbjct: 137 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--------TSFMMTPYVVTRYYRAP 187
Query: 802 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
E L + D++S+G + E++
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 6e-29
Identities = 56/219 (25%), Positives = 87/219 (39%), Gaps = 22/219 (10%)
Query: 624 NNFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSL----QGEKEFLTEIQFLS 675
NF +G G YGKV+ G + A+K ++ ++ + + TE Q L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 676 RL-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 734
+ LV+L E + L+ ++++ G L LS + + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI----- 138
Query: 735 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 794
+L L + +RDIK NILLD + DFGLS+ + E G
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC------G 192
Query: 795 TPGYLDPEYFLTHK--LTDKSDVYSLGVVFLELLTGMQP 831
T Y+ P+ D +SLGV+ ELLTG P
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 1e-26
Identities = 50/210 (23%), Positives = 78/210 (37%), Gaps = 25/210 (11%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 687
+G G YG V G VAVK S+ K E++ L + H N++ L+
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 688 YCDE-----EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 742
E + + + D + + L + RG+ Y+H
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGA---DLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 138
Query: 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 802
+ HRD+K SN+ ++ K+ DFGL+R T T Y PE
Sbjct: 139 SADIIHRDLKPSNLAVNEDCELKILDFGLAR----------HTDDEMTGYVATRWYRAPE 188
Query: 803 YFLTHKLTD-KSDVYSLGVVFLELLTGMQP 831
L + D++S+G + ELLTG
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 97.8 bits (242), Expect = 2e-22
Identities = 37/217 (17%), Positives = 71/217 (32%), Gaps = 24/217 (11%)
Query: 631 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG-- 687
++G G + V+ + + T VA+K G + EI+ L R++ +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKI-VRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 688 ------------YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 735
+ G +++ + L + + I+ G+
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 736 LYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 794
Y+H + H DIK N+L++ + ++ L T
Sbjct: 139 DYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLG-----NACWYDEHYTNSIQ 191
Query: 795 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 831
T Y PE L +D++S + EL+TG
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.1 bits (215), Expect = 3e-20
Identities = 31/204 (15%), Positives = 59/204 (28%), Gaps = 29/204 (14%)
Query: 631 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSL----------QGEKEFLTEIQFLSRLHHR 680
+G+G V+ VK + G G+ F +R R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 681 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 740
L L G + VY + N L + + AK + + + +
Sbjct: 67 ALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY- 120
Query: 741 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 800
+ H D+ N+L+ + + DF S I+ V ++
Sbjct: 121 --HRGIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWREILERDVRNIIT------- 170
Query: 801 PEYFLTHKLTDKSDVYSLGVVFLE 824
+ + + D+ S L+
Sbjct: 171 ---YFSRTYRTEKDINSAIDRILQ 191
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 87.8 bits (216), Expect = 2e-19
Identities = 61/321 (19%), Positives = 109/321 (33%), Gaps = 57/321 (17%)
Query: 62 PCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGS 121
C + V C + L+ + +L + +LD NKI+
Sbjct: 7 RCQCHLRVVQCSD----------LGLEKVPKDLPPDT----------ALLDLQNNKITEI 46
Query: 122 IPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTR 181
+ N+K+L L+L N+++ P L KL+R+ + +N + LP+ +
Sbjct: 47 KDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQEL 105
Query: 182 HFHMN------------------------NNSISGQIPPELSRLPSLVHMLLDNNNLTGY 217
H N SG + L ++ + + N+T
Sbjct: 106 RVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-T 164
Query: 218 LPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSR-IPNL 276
+P L P L L LD N AS ++ L KL L S+ P+L
Sbjct: 165 IPQGL--PPSLTELHLDGNKITK-VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL 221
Query: 277 GYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSG------LPRLQRLFIAN 330
L L++N+L I + L NN ++ ++F + + +
Sbjct: 222 RELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFS 281
Query: 331 NSLS-GSIPSSIWQSRTLNAT 350
N + I S ++ + A
Sbjct: 282 NPVQYWEIQPSTFRCVYVRAA 302
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 85.1 bits (209), Expect = 2e-18
Identities = 54/279 (19%), Positives = 100/279 (35%), Gaps = 32/279 (11%)
Query: 131 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSI 190
L ++ + L +P++L P + + N I+ F NL + NN I
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 191 SGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNM 250
S P + L L + L N L LP ++ + + L + + ++ + M
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKE-LPEKMPKTLQELRVHENEITKVRKSVFNGLNQM 126
Query: 251 SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLT 310
+ + S + L Y+ ++ + +IP G ++T + L NK+T
Sbjct: 127 IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPP-SLTELHLDGNKIT 184
Query: 311 GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF----------------- 353
++ GL L +L ++ NS+S S+ + L
Sbjct: 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYI 244
Query: 354 -ILDFQNNNLTNISGSFNIPPNV--------TVRLRGNP 383
++ NNN++ I + PP V L NP
Sbjct: 245 QVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNP 283
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 88.5 bits (218), Expect = 3e-19
Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 15/205 (7%)
Query: 103 GRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162
+L+ L L N+IS P I + +L+ L LNGN+L L L L + +
Sbjct: 194 AKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 163 QNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPEL 222
N IS P + L K + N IS P L+ L +L ++ L+ N L P
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPIS- 304
Query: 223 SELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLS 282
L L L L NN + S+++KL +L N + L+ + N+ +L
Sbjct: 305 -NLKNLTYLTLYFNNISD---ISPVSSLTKLQRLFFANNKVSDV-SSLANLTNINWLSAG 359
Query: 283 SNQLNGSIPPGRLSLNITTIKLSNN 307
NQ++ P L+ IT + L++
Sbjct: 360 HNQISDLTPLANLT-RITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 83.1 bits (204), Expect = 2e-17
Identities = 42/186 (22%), Positives = 65/186 (34%), Gaps = 31/186 (16%)
Query: 174 FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQL 233
A L NN IS P + +L + L+ N L L+ L L L L
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDL 248
Query: 234 DNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLS---------------------R 272
NN A S ++KL +L L + P
Sbjct: 249 ANNQISN---LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISN 305
Query: 273 IPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNS 332
+ NL YL L N ++ P L+ + + +NNK++ S+ + L + L +N
Sbjct: 306 LKNLTYLTLYFNNISDISPVSSLT-KLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQ 362
Query: 333 LSGSIP 338
+S P
Sbjct: 363 ISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 78.5 bits (192), Expect = 5e-16
Identities = 69/360 (19%), Positives = 131/360 (36%), Gaps = 81/360 (22%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
+ LQ L + ++ + L+ LT ++F N+++ P + N+ L +L+N N++
Sbjct: 45 QVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 100
Query: 143 TGSLP---------------------------------------EELGYLPKLDRIQIDQ 163
P ++ L L +Q
Sbjct: 101 ADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLS 160
Query: 164 NYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELS 223
+ K ANL +++N +S ++L +L ++ NN ++ P +
Sbjct: 161 FGNQVTDLKPLANLTTLERLDISSNKVSDISVL--AKLTNLESLIATNNQISDITPLGIL 218
Query: 224 ELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSS 283
L L L+ N + + ++++ L L L N + P LS + L L L +
Sbjct: 219 --TNLDELSLNGNQLKD---IGTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGA 272
Query: 284 NQLNGSIPPGRLSLN---------------------ITTIKLSNNKLTGTIPSNFSGLPR 322
NQ++ P L+ +T + L N ++ P S L +
Sbjct: 273 NQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTK 330
Query: 323 LQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGN 382
LQRLF ANN +S SS+ +N L +N +++++ N+ + L
Sbjct: 331 LQRLFFANNKVSD--VSSLANLTNIN-----WLSAGHNQISDLTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 53.5 bits (127), Expect = 5e-08
Identities = 27/138 (19%), Positives = 54/138 (39%), Gaps = 9/138 (6%)
Query: 30 SITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQL 89
I++ +S L + L +++SN + T+ L N D + + L
Sbjct: 252 QISNLAPLSGLTKLT-ELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK-NL 309
Query: 90 LNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSL 146
L L N + L+ L L F NK+S + N+ ++ L N+++
Sbjct: 310 TYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLT 367
Query: 147 PEELGYLPKLDRIQIDQN 164
P L L ++ ++ ++
Sbjct: 368 P--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 2e-04
Identities = 14/74 (18%), Positives = 31/74 (41%), Gaps = 4/74 (5%)
Query: 223 SELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLS 282
+ L + + L N T S +++ ++ L ++ + + + NL ++ S
Sbjct: 19 TALAEKMKTVLGKTNVTDTV---SQTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFS 74
Query: 283 SNQLNGSIPPGRLS 296
+NQL P L+
Sbjct: 75 NNQLTDITPLKNLT 88
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 7e-04
Identities = 38/246 (15%), Positives = 80/246 (32%), Gaps = 27/246 (10%)
Query: 153 LPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNN 212
L + + + + ++ ++ ++ +L++ + I + L +L + NN
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNN 76
Query: 213 NLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSR 272
LT L L KL+ + ++NN T A+ +N++ L + + + +
Sbjct: 77 QLTD--ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 273 IPNLGYL--------------DLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFS 318
+ N L+ T +L + + S +
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194
Query: 319 GLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVR 378
L L+ L NN +S P I + L N L +I ++ +
Sbjct: 195 KLTNLESLIATNNQISDITPLGILTNLD-------ELSLNGNQLKDIGTLASLTNLTDLD 247
Query: 379 LRGNPF 384
L N
Sbjct: 248 LANNQI 253
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.8 bits (200), Expect = 1e-17
Identities = 48/254 (18%), Positives = 88/254 (34%), Gaps = 4/254 (1%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
+ + L +S + LTIL N ++ + LE L L+ N
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92
Query: 143 TGSL-PEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRL 201
S+ P L +L + +D+ + P F L ++ ++ +N++ L
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDL 152
Query: 202 PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261
+L H+ L N ++ L L L L N A + N
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212
Query: 262 SLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLP 321
P L+ + L YL L+ N L + + S++++ ++P +G
Sbjct: 213 LSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLAGRD 272
Query: 322 RLQRLFIANNSLSG 335
+ +A N L G
Sbjct: 273 LKR---LAANDLQG 283
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.8 bits (138), Expect = 1e-09
Identities = 41/204 (20%), Positives = 59/204 (28%), Gaps = 7/204 (3%)
Query: 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
E+ NL+ L P++ + TIL N + + L L L+ ELT
Sbjct: 12 HLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68
Query: 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPS 203
+ LP L + + N + T N S +P R
Sbjct: 69 KLQVDG--TLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS--LPLGALRGLG 124
Query: 204 LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263
+ L N LPP L L NN + + L L L+ SL
Sbjct: 125 ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184
Query: 264 QGPMPDLSRIPNLGYLDLSSNQLN 287
L + L N
Sbjct: 185 YTIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.0 bits (128), Expect = 2e-08
Identities = 39/210 (18%), Positives = 72/210 (34%), Gaps = 8/210 (3%)
Query: 101 EIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160
E+ +++ ++ ++ ++P ++ K +L L+ N L L +L ++
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 161 IDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPP 220
+D+ ++ + T N +P LP+L + + N LT
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQ---SLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 221 ELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLD 280
L L +L L L N + N + P L+ + NL L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 281 LSSNQLNGSIPPGRLSL-NITTIKLSNNKL 309
L N L +IP G + L N
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.6 bits (114), Expect = 1e-06
Identities = 14/67 (20%), Positives = 29/67 (43%), Gaps = 2/67 (2%)
Query: 266 PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQR 325
P+ ++S++ + ++ L ++PP L + T + LS N L + RL +
Sbjct: 2 PICEVSKVASHLEVNCDKRNLT-ALPPD-LPKDTTILHLSENLLYTFSLATLMPYTRLTQ 59
Query: 326 LFIANNS 332
L +
Sbjct: 60 LNLDRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.2 bits (113), Expect = 2e-06
Identities = 41/213 (19%), Positives = 73/213 (34%), Gaps = 11/213 (5%)
Query: 173 SFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQ 232
+ + + + +++ +PP+L + L N L + L +L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 233 LDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP 292
LD + + + L + SL L + L L +
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLP--LGA 119
Query: 293 GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATET 352
R + + L N+L P + P+L++L +ANN+L+ + L+
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD---- 175
Query: 353 FILDFQNNNLTNI-SGSFNIPPNVTVRLRGNPF 384
L Q N+L I G F L GNP+
Sbjct: 176 -TLLLQENSLYTIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 51.3 bits (122), Expect = 2e-08
Identities = 23/107 (21%), Positives = 40/107 (37%), Gaps = 5/107 (4%)
Query: 230 ILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGS 289
+L L + + T+ + + L L + L+ P L+ + L L S N +
Sbjct: 2 VLHLAHKDL---TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNA-LEN 57
Query: 290 IPPGRLSLNITTIKLSNNKLTGT-IPSNFSGLPRLQRLFIANNSLSG 335
+ + + L NN+L + PRL L + NSL
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.4 bits (112), Expect = 4e-07
Identities = 23/121 (19%), Positives = 43/121 (35%), Gaps = 7/121 (5%)
Query: 110 ILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGS 169
+L ++ + + + + L L+ N L P L L L+ + + +
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVL--QASDNALE 56
Query: 170 LPKSFANLNKTRHFHMNNNSI-SGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKL 228
ANL + + + NN + L P LV + L N+L L ++
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
Query: 229 L 229
L
Sbjct: 116 L 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.7 bits (92), Expect = 2e-04
Identities = 23/125 (18%), Positives = 44/125 (35%), Gaps = 29/125 (23%)
Query: 181 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKL------------ 228
R H+ + ++ + L +L + H+ L +N L PP L+ L L
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALEN 57
Query: 229 ----------LILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG----PMPDLSRIP 274
L L NN + + + +L+ L+L+ SL +P
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 275 NLGYL 279
++ +
Sbjct: 118 SVSSI 122
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 53.1 bits (126), Expect = 2e-08
Identities = 33/226 (14%), Positives = 69/226 (30%), Gaps = 17/226 (7%)
Query: 105 LSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164
L+ + + ++ ++ + ++ + L G +T E + YL L +++ N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 165 YISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSE 224
I+ P N I S + + L
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 225 LPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSN 284
L L + + G T S + + L+ + L L N
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIG----------NAQVSDLTPLANLSKLTTLKADDN 183
Query: 285 QLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIAN 330
+++ P L N+ + L NN+++ P + L + + N
Sbjct: 184 KISDISPLASLP-NLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 3e-04
Identities = 32/201 (15%), Positives = 66/201 (32%), Gaps = 21/201 (10%)
Query: 153 LPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNN 212
L +I ++ ++ ++ + A+L+ ++ + L +L+ + L +N
Sbjct: 18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 213 NLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYS----------NMSKLLKLSLRNCS 262
+T P + L L + L
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 263 LQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-----NITTIKLSNNKLTGTIPSNF 317
L + ++ I L L G+ L+ +TT+K +NK++ P
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 318 SGLPRLQRLFIANNSLSGSIP 338
+ LP L + + NN +S P
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP 212
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 5e-07
Identities = 19/93 (20%), Positives = 33/93 (35%), Gaps = 6/93 (6%)
Query: 275 NLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLTG----TIPSNFSGLPRLQRLFI 328
++ LD+ +L+ + L L ++L + LT I S P L L +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 329 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNN 361
+N L + Q + + L QN
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 6e-05
Identities = 12/72 (16%), Positives = 31/72 (43%), Gaps = 2/72 (2%)
Query: 296 SLNITTIKLSNNKLTGT-IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 354
SL+I ++ + +L+ L + Q + + + L+ + I + +N
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE- 59
Query: 355 LDFQNNNLTNIS 366
L+ ++N L ++
Sbjct: 60 LNLRSNELGDVG 71
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 1e-04
Identities = 19/102 (18%), Positives = 34/102 (33%), Gaps = 9/102 (8%)
Query: 63 CTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGN----LSPEIGRLSYLTILDFMWNKI 118
GV + LR L L + ++S + L+ + L LD N +
Sbjct: 350 NRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 409
Query: 119 SGSIPKEIG-----NIKSLELLLLNGNELTGSLPEELGYLPK 155
+ ++ LE L+L + + + L L K
Sbjct: 410 GDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 1e-04
Identities = 21/90 (23%), Positives = 32/90 (35%), Gaps = 9/90 (10%)
Query: 181 RHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTG----YLPPELSELPKLLILQLDN 235
+ + +S EL L + LD+ LT + L P L L L +
Sbjct: 5 QSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRS 64
Query: 236 NNFEGTTIP----ASYSNMSKLLKLSLRNC 261
N + + K+ KLSL+NC
Sbjct: 65 NELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 13/91 (14%), Positives = 31/91 (34%), Gaps = 5/91 (5%)
Query: 108 LTILDFMWNKISGSIPKEI-GNIKSLELLLLNGNELTG----SLPEELGYLPKLDRIQID 162
+ LD ++S + E+ ++ +++ L+ LT + L P L + +
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 163 QNYISGSLPKSFANLNKTRHFHMNNNSISGQ 193
N + +T + S+
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 4e-04
Identities = 8/73 (10%), Positives = 25/73 (34%), Gaps = 4/73 (5%)
Query: 298 NITTIKLSNNKLTGT----IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 353
+ + L++ ++ + + + L+ L ++NN L + + +S
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 354 ILDFQNNNLTNIS 366
L + +
Sbjct: 430 QLVLYDIYWSEEM 442
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 4e-04
Identities = 13/97 (13%), Positives = 26/97 (26%), Gaps = 15/97 (15%)
Query: 128 NIKSLELLLLNGNELTG----SLPEELGYLPKLDRIQIDQNYISGSLPKSFA-----NLN 178
L +L L +++ SL L L + + N + +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 179 KTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT 215
+ + S ++ L L D +L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL------EKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 4e-04
Identities = 16/91 (17%), Positives = 25/91 (27%), Gaps = 11/91 (12%)
Query: 228 LLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-----LSRIPNLGYLDLS 282
+ L + + + + L +C L L P L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 283 SNQLNGSIPPG------RLSLNITTIKLSNN 307
SN+L S I + L N
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 20/102 (19%), Positives = 31/102 (30%), Gaps = 17/102 (16%)
Query: 244 PASYSNMSKLLKLSLRNCSLQGPMPD-----LSRIPNLGYLDLSSNQLNGSIPPG----- 293
S L L L +C + L +L LDLS+N L +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 294 -RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 334
+ + + L + + + RLQ L SL
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMED------RLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 15/112 (13%), Positives = 32/112 (28%), Gaps = 5/112 (4%)
Query: 82 LHLRELQLLNLNLSGNLSPEI-GRLSYLTILDFMWNKISGSIPKEIG----NIKSLELLL 136
L ++ L + LS E+ L ++ ++ + K+I +L L
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 137 LNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN 188
L NEL + + +I + + +
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPT 113
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.002
Identities = 10/90 (11%), Positives = 32/90 (35%), Gaps = 5/90 (5%)
Query: 156 LDRIQIDQNYISGS-LPKSFANLNKTRHFHMNNNSISGQ----IPPELSRLPSLVHMLLD 210
+ + I +S + + L + + +++ ++ I L P+L + L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 211 NNNLTGYLPPELSELPKLLILQLDNNNFEG 240
+N L + + + ++ + +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (117), Expect = 6e-07
Identities = 18/98 (18%), Positives = 35/98 (35%), Gaps = 4/98 (4%)
Query: 231 LQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSI 290
L L N S ++ + P+ + + ++DLS++ + S
Sbjct: 5 LDLTGKNLHPDVTGRLLSQ--GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVST 62
Query: 291 PPGRLSL--NITTIKLSNNKLTGTIPSNFSGLPRLQRL 326
G LS + + L +L+ I + + L RL
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL 100
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.2 bits (95), Expect = 3e-04
Identities = 20/95 (21%), Positives = 38/95 (40%), Gaps = 3/95 (3%)
Query: 187 NNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPAS 246
++ + L ++ + + L S ++ + L N+ E +T+
Sbjct: 9 GKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEVSTLHGI 66
Query: 247 YSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLD 280
S SKL LSL L P+ + L++ NL L+
Sbjct: 67 LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.7 bits (114), Expect = 2e-06
Identities = 23/102 (22%), Positives = 39/102 (38%), Gaps = 12/102 (11%)
Query: 182 HFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT 241
N+ S +I PSL + + NN L LP + P+L L N+
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHL--A 317
Query: 242 TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSS 283
+P L +L + L+ PD+ ++ L ++S
Sbjct: 318 EVPEL---PQNLKQLHVEYNPLRE-FPDI--PESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.5 bits (111), Expect = 4e-06
Identities = 21/92 (22%), Positives = 36/92 (39%), Gaps = 9/92 (9%)
Query: 113 FMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPK 172
+ N S I SLE L ++ N+L LP L +L N+++ +P+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPE 321
Query: 173 SFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
NL + H+ N + + P + L
Sbjct: 322 LPQNL---KQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.1 bits (110), Expect = 6e-06
Identities = 21/84 (25%), Positives = 33/84 (39%), Gaps = 9/84 (10%)
Query: 260 NCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSG 319
N S P+L L++S+N+L +P L + S N L +P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL--ERLIASFNHLA-EVPEL--- 322
Query: 320 LPRLQRLFIANNSLSG--SIPSSI 341
L++L + N L IP S+
Sbjct: 323 PQNLKQLHVEYNPLREFPDIPESV 346
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.1 bits (97), Expect = 2e-04
Identities = 58/353 (16%), Positives = 101/353 (28%), Gaps = 30/353 (8%)
Query: 45 KSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGR 104
KS + Y+ S W R P + + + D EL+L NL LS +L
Sbjct: 1 KSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPPH 59
Query: 105 LSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164
L L N ++ +P+ ++KSL + N L+ P ++++
Sbjct: 60 L---ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPE 115
Query: 165 YISGSLPKSFANLNKTRHFHMNNNSISGQIP-PELSRLPSLVHMLLDNNNLTGYLPPELS 223
+ S K N + + I L L
Sbjct: 116 LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLK 175
Query: 224 ELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSS 283
+LP L + L + +L +PDL + +
Sbjct: 176 KLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNY 235
Query: 284 NQLNGSIPPGRL-----------SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNS 332
+P + N + I S P L+ L ++NN
Sbjct: 236 LTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNK 295
Query: 333 LSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTV-RLRGNPF 384
L +P+ + L N+L + +P N+ + NP
Sbjct: 296 LI-ELPALPPRLERL--------IASFNHLAEVP---ELPQNLKQLHVEYNPL 336
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.4 bits (104), Expect = 8e-06
Identities = 25/139 (17%), Positives = 48/139 (34%), Gaps = 13/139 (9%)
Query: 87 LQLLNLNLSGN-LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG- 144
L+L G P++ + +L+ + ++ ++ NI L L L+ N L
Sbjct: 22 GSQQALDLKGLRSDPDLVAQNIDVVLNRR-SSMAATLRIIEENIPELLSLNLSNNRLYRL 80
Query: 145 -SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE------ 197
+ + P L + + N + K ++ NS+S +
Sbjct: 81 DDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISA 140
Query: 198 -LSRLPSLVHMLLDNNNLT 215
R P L+ LD + L
Sbjct: 141 IRERFPKLLR--LDGHELP 157
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.5 bits (99), Expect = 4e-05
Identities = 25/125 (20%), Positives = 44/125 (35%), Gaps = 6/125 (4%)
Query: 218 LPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLG 277
L +S+ LD + + L+ R+ IP L
Sbjct: 12 LKLIMSKRYDGSQQALDLKGL---RSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELL 68
Query: 278 YLDLSSNQLNGSIPPGRLS---LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 334
L+LS+N+L + N+ + LS N+L + +L+ L++ NSLS
Sbjct: 69 SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128
Query: 335 GSIPS 339
+
Sbjct: 129 DTFRD 133
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.3 bits (88), Expect = 0.001
Identities = 25/162 (15%), Positives = 51/162 (31%), Gaps = 22/162 (13%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
+ + L+ L +L + + + +L N+ +
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPEL 67
Query: 181 RHFHMNNNSISGQ--IPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNF 238
+++NN + + + + P+L + L N L + + KL L LD N+
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 239 EGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLD 280
T + +S + + R P L LD
Sbjct: 128 S-DTFRDQSTYISAIRE----------------RFPKLLRLD 152
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 32/202 (15%), Positives = 78/202 (38%), Gaps = 15/202 (7%)
Query: 105 LSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164
+ + ++ ++ + + S++ ++ N +++ + YLP + ++ ++ N
Sbjct: 23 FAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78
Query: 165 YISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSE 224
++ K ANL ++ N + + L + +L +++
Sbjct: 79 KLTD--IKPLANLKNLGWLFLDENKVKDLSSLK-------DLKKLKSLSLEHNGISDING 129
Query: 225 LPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSN 284
L L L+ T S ++KL LSL + + + L+ + L L LS N
Sbjct: 130 LVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSKN 188
Query: 285 QLNGSIPPGRLSLNITTIKLSN 306
++ L N+ ++L +
Sbjct: 189 HISDLRALAGLK-NLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 3e-05
Identities = 42/207 (20%), Positives = 87/207 (42%), Gaps = 21/207 (10%)
Query: 139 GNELTGSLPEELGY------LPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG 192
G+E ++P + + + + + ++ ++ ++ LN NN+ I
Sbjct: 4 GSETI-TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS 60
Query: 193 QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSK 252
+ LP++ + L+ N LT L+ L L L LD N + + +
Sbjct: 61 VQG--IQYLPNVTKLFLNGNKLTDI--KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKS 116
Query: 253 LLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGT 312
L + G L +P L L L +N++ RL+ + T+ L +N+++
Sbjct: 117 LSLEHNGISDING----LVHLPQLESLYLGNNKITDITVLSRLT-KLDTLSLEDNQISDI 171
Query: 313 IPSNFSGLPRLQRLFIANNSLSGSIPS 339
+P +GL +LQ L+++ N +S + +
Sbjct: 172 VP--LAGLTKLQNLYLSKNHIS-DLRA 195
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (100), Expect = 3e-05
Identities = 25/145 (17%), Positives = 50/145 (34%), Gaps = 10/145 (6%)
Query: 94 LSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEEL 150
L+ L + + LD KI I + + + + NE+ +
Sbjct: 3 LTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK--LDGF 59
Query: 151 GYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG-QIPPELSRLPSLVHMLL 209
L +L + ++ N I L + NNS+ L+ L SL ++ +
Sbjct: 60 PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCI 119
Query: 210 DNNN---LTGYLPPELSELPKLLIL 231
N Y + ++P++ +L
Sbjct: 120 LRNPVTNKKHYRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (84), Expect = 0.003
Identities = 21/90 (23%), Positives = 37/90 (41%), Gaps = 1/90 (1%)
Query: 245 ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKL 304
A Y+N + +L LR + + + +D S N++ L + T+ +
Sbjct: 12 AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFPLLR-RLKTLLV 70
Query: 305 SNNKLTGTIPSNFSGLPRLQRLFIANNSLS 334
+NN++ LP L L + NNSL
Sbjct: 71 NNNRICRIGEGLDQALPDLTELILTNNSLV 100
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.9 bits (99), Expect = 1e-04
Identities = 32/311 (10%), Positives = 82/311 (26%), Gaps = 29/311 (9%)
Query: 82 LHLRELQLLNLNLSG--NLSPEIGRLSYLTILDFMWNKISG----SIPKEIGNIKSLELL 135
+ + L+L + ++ + + + N I + + I + K LE+
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 136 LLNGN---ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG 192
+ + +PE L L + + + S + ++ ++
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124
Query: 193 QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSK 252
+ + L + + + P L + N E ++
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184
Query: 253 LLKLSLRNCSLQGPMPDLSRIPNLGYL--------------DLSSNQLNGSIPPGRLSLN 298
L G P+ L L + + + N
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244
Query: 299 ITTIKLSNNKLTGTIPS------NFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATET 352
+ + L++ L+ + + LQ L + N + ++ +
Sbjct: 245 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 304
Query: 353 FILDFQNNNLT 363
L+ N +
Sbjct: 305 LFLELNGNRFS 315
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.002
Identities = 14/90 (15%), Positives = 27/90 (30%), Gaps = 13/90 (14%)
Query: 182 HFHMNNNSISGQIPPELSR------LPSLVHMLLDNNNLTGYLPPELSE-----LPKLLI 230
+N+ +S + + L + L N + L +P LL
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306
Query: 231 LQLDNNNFEGTTIPASYSNMSKLLKLSLRN 260
L+L+ N F + ++ R
Sbjct: 307 LELNGNRFSE--EDDVVDEIREVFSTRGRG 334
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.8 bits (96), Expect = 2e-04
Identities = 30/224 (13%), Positives = 62/224 (27%), Gaps = 10/224 (4%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLP---KLDRIQIDQNYISGSLPKSFANL 177
IP ++ ++ L +L K++ Q D + + S
Sbjct: 22 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79
Query: 178 NKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNN 237
NN + + ++ + ++ L K+L+ DN N
Sbjct: 80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139
Query: 238 FEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL 297
+ + + L L +Q L L+LS N +P
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199
Query: 298 --NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPS 339
+ +S ++ L +L+ N +P+
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (94), Expect = 3e-04
Identities = 35/257 (13%), Positives = 82/257 (31%), Gaps = 26/257 (10%)
Query: 63 CTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSI 122
C + LC ++ + +L N L F+ K+
Sbjct: 6 CHCSNRVFLCQE----------SKVTEIPSDLPRNA----------IELRFVLTKLRVIQ 45
Query: 123 PKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSL--PKSFANLNKT 180
LE + ++ N++ + ++ + + P++F NL
Sbjct: 46 KGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNL 105
Query: 181 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240
++ ++N I V + + +N + + L N
Sbjct: 106 QYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI 165
Query: 241 TTIPASYSNMSKLLKLSLRNCSLQGPMPD--LSRIPNLGYLDLSSNQLNGSIPPGRLSLN 298
I N ++L +L+L + + +P+ LD+S +++ S+P L N
Sbjct: 166 QEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLE-N 223
Query: 299 ITTIKLSNNKLTGTIPS 315
+ ++ + +P+
Sbjct: 224 LKKLRARSTYNLKKLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.002
Identities = 13/65 (20%), Positives = 26/65 (40%), Gaps = 2/65 (3%)
Query: 279 LDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 338
+++ IP L N ++ KL FSG L+++ I+ N + I
Sbjct: 13 FLCQESKVT-EIPSD-LPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIE 70
Query: 339 SSIWQ 343
+ ++
Sbjct: 71 ADVFS 75
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 2e-04
Identities = 21/147 (14%), Positives = 36/147 (24%), Gaps = 3/147 (2%)
Query: 196 PELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLK 255
P+ + + L L L ++N + +L
Sbjct: 2 PDACCPHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 256 LSLRNCSLQGP-MPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLT-GTI 313
L++ L+ P L L+LS N L L++ + LS N L
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCA 120
Query: 314 PSNFSGLPRLQRLFIANNSLSGSIPSS 340
+ L
Sbjct: 121 LRWLQRWEEEGLGGVPEQKLQCHGQGP 147
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 25/193 (12%), Positives = 59/193 (30%), Gaps = 16/193 (8%)
Query: 105 LSYLTILDFMWNKISGSIP-KEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQ 163
L+ ++ ++ ++ + +L+ L + G + YL L +I
Sbjct: 17 LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSN 71
Query: 164 NYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELS 223
N ++ P + N + + + + + L+
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131
Query: 224 ELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSS 283
L D + G T + + + P L+ + L LD+SS
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFS---------SNQVTDLKP-LANLTTLERLDISS 181
Query: 284 NQLNGSIPPGRLS 296
N+++ +L+
Sbjct: 182 NKVSDISVLAKLT 194
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 845 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.93 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.93 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.92 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.91 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.78 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.76 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.73 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.72 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.71 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.7 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.69 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.55 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.51 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.48 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.48 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.47 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.47 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.45 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.44 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.43 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.41 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.35 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.29 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.26 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.22 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.43 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.37 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.36 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.95 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.4 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.37 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.32 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.61 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.22 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.21 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.9 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.38 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=376.83 Aligned_cols=200 Identities=25% Similarity=0.426 Sum_probs=180.3
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcC
Q 003140 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 702 (845)
++|...+.||+|+||+||+|.. .+|+.||||+++.......+.+.+|++++++++|||||++++++.+.+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 5799999999999999999996 479999999987655555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCC
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 782 (845)
++|+|.+++.+. .+++..+..++.||+.||+|||+++ ||||||||+|||++.++++||+|||+|+......
T Consensus 100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--- 170 (293)
T d1yhwa1 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 170 (293)
T ss_dssp TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT---
T ss_pred CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc---
Confidence 999999988653 5899999999999999999999998 9999999999999999999999999998764321
Q ss_pred ccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......||+.|+|||++.+..++.++||||+||++|||+||+.||.+..
T Consensus 171 ----~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 220 (293)
T d1yhwa1 171 ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (293)
T ss_dssp ----CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ----ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC
Confidence 22345579999999999999999999999999999999999999997544
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-44 Score=383.61 Aligned_cols=213 Identities=31% Similarity=0.470 Sum_probs=187.9
Q ss_pred chHHHHHHhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Q 003140 615 TYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 693 (845)
Q Consensus 615 ~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~ 693 (845)
.+++|++..++|...+.||+|+||+||+|.+. +|+.||||+++... ...++|.+|+++|++++|||||+++|+|.+.+
T Consensus 8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (287)
T d1opja_ 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 86 (287)
T ss_dssp TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence 44566667788999999999999999999975 58999999987643 34668999999999999999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003140 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (845)
Q Consensus 694 ~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~ 773 (845)
..++||||+++|+|.+++.......+++..++.++.|||+||+|||+++ |+||||||+|||+++++.+||+|||+|+
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEcccccee
Confidence 9999999999999999998877778999999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
...... ........||+.|+|||++.+..++.++|||||||++|||++|..||..+.+
T Consensus 164 ~~~~~~------~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~ 221 (287)
T d1opja_ 164 LMTGDT------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 221 (287)
T ss_dssp TCCSSS------SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ecCCCC------ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch
Confidence 764321 2223345688999999999999999999999999999999998888765544
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-44 Score=378.36 Aligned_cols=206 Identities=28% Similarity=0.482 Sum_probs=172.3
Q ss_pred HHHHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEE
Q 003140 619 MALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (845)
Q Consensus 619 ~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 696 (845)
|++..++|.+.+.||+|+||+||+|+++ ..||||+++.. .....++|.+|++++++++|||||+++|++.+ +..+
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~ 79 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLA 79 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEE
Confidence 3445678999999999999999999874 35999998643 34456789999999999999999999999765 5679
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCC
Q 003140 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~ 776 (845)
+||||+++|+|.++++... ..+++..++.++.|||+||+|||+++ ||||||||+|||++.++.+||+|||+|+...
T Consensus 80 lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 9999999999999997543 46999999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCCCccccceeecccCCCCccchhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
... .........||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+..
T Consensus 156 ~~~-----~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~ 213 (276)
T d1uwha_ 156 RWS-----GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213 (276)
T ss_dssp ---------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccC-----CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC
Confidence 322 1223345679999999999864 458999999999999999999999997654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=377.55 Aligned_cols=204 Identities=27% Similarity=0.420 Sum_probs=176.2
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
++|++.+.||+|+||+||+|... +|+.||||++.... ....+++.+|++++++++|||||++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57888999999999999999975 79999999986543 23346799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+++|+|.++++. ...+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.....+
T Consensus 85 ~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~-- 157 (271)
T d1nvra_ 85 CSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN-- 157 (271)
T ss_dssp CTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT--
T ss_pred cCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC--
Confidence 999999999964 346899999999999999999999998 9999999999999999999999999998764222
Q ss_pred CccccceeecccCCCCccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
.........||+.|||||++.+..+ +.++||||+||++|||+||+.||....+
T Consensus 158 ---~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~ 211 (271)
T d1nvra_ 158 ---RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 211 (271)
T ss_dssp ---EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST
T ss_pred ---ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCCh
Confidence 1222345679999999999988776 5789999999999999999999976544
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=379.62 Aligned_cols=208 Identities=29% Similarity=0.455 Sum_probs=180.7
Q ss_pred HHHHHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 618 EMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 618 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
++++..++|++.+.||+|+||+||+|.+++++.||||+++... ...++|.+|++++++++|||||+++|++.+ +..++
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence 4445567888899999999999999999888999999997643 345689999999999999999999998865 56789
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
||||+++|+|.+++.......+++..++.|+.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccC
Confidence 999999999999887765567999999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.. ........||+.|+|||++.+..++.++|||||||++|||+||..|+....
T Consensus 162 ~~------~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~ 214 (272)
T d1qpca_ 162 NE------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (272)
T ss_dssp SC------EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred Cc------cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence 22 122344578999999999999999999999999999999999766665443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=370.61 Aligned_cols=198 Identities=30% Similarity=0.463 Sum_probs=177.4
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|++.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888999999999999999975 68999999986432 233567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++|+|.+++.... .+++..+..++.||++||+|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred eecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 9999999999997643 5899999999999999999999998 999999999999999999999999999865421
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
......||+.|||||++.+..++.++|||||||++|||++|+.||...
T Consensus 160 --------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 207 (263)
T d2j4za1 160 --------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 207 (263)
T ss_dssp --------CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred --------cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC
Confidence 233467999999999999999999999999999999999999999754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=372.53 Aligned_cols=205 Identities=27% Similarity=0.439 Sum_probs=166.7
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEee--CCeEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQMLV 698 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~LV 698 (845)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57889999999999999999964 78999999987543 3335678999999999999999999999865 4568999
Q ss_pred EEcCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003140 699 YEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEA--DPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~ 774 (845)
|||+++|+|.+++.+. ....+++..++.++.|+++||+|||+++ ..+||||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999653 3467999999999999999999999864 23599999999999999999999999999987
Q ss_pred CCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.... ........||+.|||||++.+..++.++|||||||++|||+||+.||...
T Consensus 164 ~~~~-------~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~ 217 (269)
T d2java1 164 LNHD-------TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 217 (269)
T ss_dssp C------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccC-------CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC
Confidence 6422 12234567999999999999999999999999999999999999999754
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-44 Score=386.16 Aligned_cols=202 Identities=25% Similarity=0.425 Sum_probs=178.8
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 622 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 622 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
..++|++.+.||+|+||+||+|... +|+.||||+++... ....+++.+|+++|++++|||||+++++|.+++..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3578999999999999999999964 78999999987543 334568999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
||+++|+|.+++.+.. .+++..+..++.|+++||+|||++ + |+||||||+|||+++++.+||+|||+|+...
T Consensus 84 Ey~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~-- 156 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-- 156 (322)
T ss_dssp ECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH--
T ss_pred EcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccC--
Confidence 9999999999997653 589999999999999999999974 7 9999999999999999999999999998642
Q ss_pred CCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
........||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+.
T Consensus 157 -------~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 157 -------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp -------HHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred -------CCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 1223456899999999999999999999999999999999999999976543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=369.82 Aligned_cols=200 Identities=32% Similarity=0.503 Sum_probs=167.6
Q ss_pred cCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCC
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 703 (845)
++|+..+.||+|+||+||+|.+.+++.||||+++... ...++|.+|++++++++|||||+++|+|.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5678889999999999999999889999999997643 445789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCc
Q 003140 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (845)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 783 (845)
+|+|.+++... ...+++..++.++.|||+||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 84 ~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~---- 155 (263)
T d1sm2a_ 84 HGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---- 155 (263)
T ss_dssp TCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC----
Confidence 99999998754 356899999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
........||+.|+|||++.+..++.++|||||||++|||+||..|+..
T Consensus 156 --~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~ 204 (263)
T d1sm2a_ 156 --YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 204 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred --ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCC
Confidence 1222345689999999999999999999999999999999996555543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=373.94 Aligned_cols=202 Identities=26% Similarity=0.412 Sum_probs=178.6
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcC
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 702 (845)
+.|++.+.||+|+||+||+|... +|+.||||+++.......+.|.+|+++|++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56888999999999999999975 68999999998766666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCC
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 782 (845)
++|+|.+++.+. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 92 ~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~----- 162 (288)
T d2jfla1 92 AGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR----- 162 (288)
T ss_dssp TTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH-----
T ss_pred CCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC-----
Confidence 999999998654 346999999999999999999999999 99999999999999999999999999975421
Q ss_pred ccccceeecccCCCCccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 783 IVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.........||+.|+|||++. ...|+.++|||||||++|||+||+.||....
T Consensus 163 --~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~ 219 (288)
T d2jfla1 163 --TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN 219 (288)
T ss_dssp --HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred --CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC
Confidence 112233567999999999984 4568999999999999999999999997643
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-43 Score=372.33 Aligned_cols=203 Identities=21% Similarity=0.361 Sum_probs=176.6
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|++.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56889999999999999999974 79999999986432 223467999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++|+|.+++... ..+++..++.++.|++.||+|||+++ ||||||||+|||+++++.+||+|||+|+......
T Consensus 88 Ey~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCC
Confidence 999999999998765 35899999999999999999999999 9999999999999999999999999998764322
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.........||+.|+|||++.+..++.++||||+||++|||+||+.||...+
T Consensus 163 -----~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 214 (288)
T d1uu3a_ 163 -----KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 214 (288)
T ss_dssp ------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -----cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC
Confidence 1222345679999999999999999999999999999999999999997643
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-42 Score=371.10 Aligned_cols=207 Identities=29% Similarity=0.467 Sum_probs=164.8
Q ss_pred cCCCCCccccccCceEEEEEEeC-CC---cEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DG---TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g---~~vAVK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
++|++.+.||+|+||+||+|.+. ++ ..||||++... .....++|.+|+++|++++|||||+++|++.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 34556689999999999999974 23 36899998754 344467899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
||||++|+|.+++... ...++|..++.++.|||+||+|||+++ |+||||||+|||++.++++||+|||+|+.....
T Consensus 106 ~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCC
Confidence 9999999999988754 346899999999999999999999998 999999999999999999999999999876532
Q ss_pred CCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
.... .........||+.|||||.+.+..++.++|||||||++|||+| |+.||.+..
T Consensus 182 ~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~ 238 (299)
T d1jpaa_ 182 TSDP--TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCcc--eeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC
Confidence 2110 1111223467899999999999999999999999999999998 899997543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-42 Score=359.61 Aligned_cols=201 Identities=29% Similarity=0.463 Sum_probs=179.6
Q ss_pred cCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCC
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 703 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 703 (845)
++|+..+.||+|+||+||+|++++++.||||+++... ...++|++|++++++++||||++++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 6788999999999999999999889999999998643 345689999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCc
Q 003140 704 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 783 (845)
Q Consensus 704 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 783 (845)
+|+|.+++.... ..+++..+++++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+|+......
T Consensus 83 ~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~---- 154 (258)
T d1k2pa_ 83 NGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---- 154 (258)
T ss_dssp TEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS----
T ss_pred CCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC----
Confidence 999999976543 45889999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 784 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
........||+.|+|||.+.+..++.++|||||||++|||+| |+.||...
T Consensus 155 --~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~ 205 (258)
T d1k2pa_ 155 --YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 205 (258)
T ss_dssp --CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred --ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC
Confidence 122334568999999999999999999999999999999998 89999754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-42 Score=360.94 Aligned_cols=197 Identities=30% Similarity=0.506 Sum_probs=169.0
Q ss_pred CCCccccccCceEEEEEEeC-CCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEee----CCeEEEEE
Q 003140 627 NSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE----EGEQMLVY 699 (845)
Q Consensus 627 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~LV~ 699 (845)
...+.||+|+||+||+|... +++.||+|++... .....++|.+|+++|++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 44567999999999999975 6889999998653 33345679999999999999999999999865 34579999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcEEEEecCCcccCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~-~~~~~kl~DFGla~~~~~~ 778 (845)
||+++|+|.+++++. ..+++..++.++.||++||+|||+++ ++|+||||||+|||++ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~- 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 167 (270)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred eCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC-
Confidence 999999999999764 35899999999999999999999875 5699999999999996 578999999999986432
Q ss_pred CCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......||+.|||||++.+ .++.++|||||||++|||++|+.||....
T Consensus 168 --------~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~ 216 (270)
T d1t4ha_ 168 --------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 216 (270)
T ss_dssp --------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred --------CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc
Confidence 12345679999999998865 69999999999999999999999997544
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.5e-42 Score=373.16 Aligned_cols=200 Identities=25% Similarity=0.403 Sum_probs=180.5
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcC
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 702 (845)
++|++.+.||+|+||.||+|... +|+.||||++........+.+.+|++++++++|||||++++++.+++..++|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999974 79999999998766666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC--CCcEEEEecCCcccCCCCCC
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH--KFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~--~~~~kl~DFGla~~~~~~~~ 780 (845)
++|+|.+++... ...+++..+..++.||+.||+|||+++ ||||||||+|||++. ++.+||+|||+|+.....
T Consensus 106 ~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-- 179 (350)
T d1koaa2 106 SGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 179 (350)
T ss_dssp CSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT--
T ss_pred CCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc--
Confidence 999999999653 346999999999999999999999999 999999999999964 578999999999876422
Q ss_pred CCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.......||+.|||||++.+..++.++||||+||++|||++|+.||.+.
T Consensus 180 ------~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 228 (350)
T d1koaa2 180 ------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE 228 (350)
T ss_dssp ------SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ------cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC
Confidence 2234567999999999999999999999999999999999999999754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-42 Score=363.44 Aligned_cols=204 Identities=30% Similarity=0.471 Sum_probs=174.0
Q ss_pred cCCCCCcc-ccccCceEEEEEEeC---CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEE
Q 003140 624 NNFNSSTQ-IGQGGYGKVYKGILP---DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 624 ~~f~~~~~-LG~G~fG~Vy~~~~~---~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
++|...+. ||+|+||+||+|.+. ++..||||+++... ....++|.+|+++|++++|||||+++|++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45556664 999999999999864 45689999987543 3446789999999999999999999999865 568999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
|||+++|+|.+++... ...+++..+..++.|||+||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 87 mE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccc
Confidence 9999999999998553 346999999999999999999999998 999999999999999999999999999876533
Q ss_pred CCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
+. .........||+.|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 163 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~ 217 (285)
T d1u59a_ 163 DS----YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 217 (285)
T ss_dssp SC----EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cc----ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC
Confidence 21 1122334568999999999999999999999999999999998 999997644
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-43 Score=368.59 Aligned_cols=208 Identities=31% Similarity=0.453 Sum_probs=175.9
Q ss_pred HHHHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEE
Q 003140 619 MALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 619 ~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
+++..++|++.+.||+|+||.||+|.+++++.||||+++.. ....++|.+|+.++++++|||||+++|++.+ +..++|
T Consensus 12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv 89 (285)
T d1fmka3 12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 89 (285)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEE
Confidence 33445789999999999999999999988889999998754 3446789999999999999999999999854 567899
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
|||+++|+|..++.......++|..++.++.||++||+|||+++ |+||||||+|||++.++++||+|||+|+.....
T Consensus 90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 99999999999998766667999999999999999999999998 999999999999999999999999999876422
Q ss_pred CCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
. ........||+.|+|||++.++.++.++|||||||++|||+||..|+.....
T Consensus 167 ~------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~ 219 (285)
T d1fmka3 167 E------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 219 (285)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred C------ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC
Confidence 1 1223445789999999999999999999999999999999998777765443
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-41 Score=371.18 Aligned_cols=201 Identities=24% Similarity=0.408 Sum_probs=181.0
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcC
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 702 (845)
++|++.+.||+|+||+||+|... +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..++|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999964 79999999998766666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc--CCCcEEEEecCCcccCCCCCC
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD--HKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~--~~~~~kl~DFGla~~~~~~~~ 780 (845)
++|+|.+++... ..++++..++.|+.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+|+.....
T Consensus 109 ~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-- 182 (352)
T d1koba_ 109 SGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 182 (352)
T ss_dssp CCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred CCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC--
Confidence 999999987543 346999999999999999999999999 99999999999998 6789999999999876422
Q ss_pred CCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......||+.|+|||++.+..++.++||||+||++|||+||+.||.+..
T Consensus 183 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 232 (352)
T d1koba_ 183 ------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 232 (352)
T ss_dssp ------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred ------CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 23445679999999999999999999999999999999999999997644
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-42 Score=368.04 Aligned_cols=201 Identities=26% Similarity=0.423 Sum_probs=162.7
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
.+.|++.+.||+|+||+||+|... +|+.||||++..... ...+.+.+|+++|++++|||||++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467899999999999999999975 689999999875432 234578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCcEEEEecCCcccCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD---HKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~---~~~~~kl~DFGla~~~~~ 777 (845)
|+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+|+....
T Consensus 88 ~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 88 LVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred ccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 99999999999653 46999999999999999999999998 99999999999994 578999999999986532
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
. .......||+.|||||++.+..|+.++||||+||++|||++|+.||.+..
T Consensus 163 ~--------~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 213 (307)
T d1a06a_ 163 G--------SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN 213 (307)
T ss_dssp ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred C--------CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC
Confidence 1 22344679999999999999999999999999999999999999997543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-42 Score=369.44 Aligned_cols=201 Identities=26% Similarity=0.346 Sum_probs=179.3
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++||||+++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5788999999999999999996 479999999987432 234567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
|||++|+|.+++.... .+++...+.++.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|+......
T Consensus 85 ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 85 EYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp ECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 9999999999997653 5889999999999999999999999 9999999999999999999999999998654221
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+
T Consensus 160 -------~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~ 209 (337)
T d1o6la_ 160 -------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp -------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -------cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC
Confidence 22345679999999999999999999999999999999999999997654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.3e-42 Score=365.89 Aligned_cols=197 Identities=29% Similarity=0.468 Sum_probs=173.4
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh---hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
+.|+..+.||+|+||+||+|... +|+.||||+++.... ...+++.+|+++|++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45888999999999999999964 789999999875432 23467999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
|||++|+|..++... .++++..++.++.||++||+|||+++ ||||||||+|||+++++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp ECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 999999998776543 46899999999999999999999999 99999999999999999999999999986431
Q ss_pred CCCccccceeecccCCCCccchhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+..
T Consensus 168 ---------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~ 218 (309)
T d1u5ra_ 168 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (309)
T ss_dssp ---------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ---------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC
Confidence 223569999999999864 468999999999999999999999997543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-41 Score=366.05 Aligned_cols=198 Identities=24% Similarity=0.416 Sum_probs=176.9
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46888999999999999999974 69999999986432 233567999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+++|+|..++.... .+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 9999999999987643 5788888999999999999999998 999999999999999999999999999875421
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.....||+.|||||++.+..|+.++||||+||++|||+||+.||.+..
T Consensus 158 ---------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 205 (316)
T d1fota_ 158 ---------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 205 (316)
T ss_dssp ---------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ---------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC
Confidence 234679999999999999999999999999999999999999997643
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-42 Score=369.86 Aligned_cols=210 Identities=28% Similarity=0.474 Sum_probs=176.8
Q ss_pred HHHHhcCCCCCccccccCceEEEEEEeCC------CcEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEEe
Q 003140 619 MALATNNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCD 690 (845)
Q Consensus 619 ~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~ 690 (845)
+++..++|++.+.||+|+||+||+|++.. ...||||++.... ....+.|.+|+++++++ +|||||++++++.
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 34556789999999999999999998642 2369999986543 33346799999999998 8999999999999
Q ss_pred eCCeEEEEEEcCCCCCHHHHHhccCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 003140 691 EEGEQMLVYEFMSNGTLRDQLSAKSK---------------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 749 (845)
Q Consensus 691 ~~~~~~LV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHr 749 (845)
+.+..++||||+++|+|.++++.... ..+++..++.++.||++||+|||+++ ||||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHR 188 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR 188 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 99999999999999999999976432 35899999999999999999999998 9999
Q ss_pred CCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-C
Q 003140 750 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-G 828 (845)
Q Consensus 750 DLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G 828 (845)
||||+|||++.++.+||+|||+|+...... .........||+.|||||++.+..++.++|||||||++|||+| |
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~-----~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g 263 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDS-----NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 263 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCT-----TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred cCchhccccccCCeEEEeeccccccccCCC-----ceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCC
Confidence 999999999999999999999998654322 1122334568999999999999999999999999999999998 8
Q ss_pred CCCCCCCC
Q 003140 829 MQPISHGK 836 (845)
Q Consensus 829 ~~Pf~~~~ 836 (845)
+.||.+..
T Consensus 264 ~~Pf~~~~ 271 (325)
T d1rjba_ 264 VNPYPGIP 271 (325)
T ss_dssp CCSSTTCC
T ss_pred CCCCCCCC
Confidence 99997543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-41 Score=359.56 Aligned_cols=200 Identities=25% Similarity=0.396 Sum_probs=177.7
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh------hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL------QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 695 (845)
.++|++.+.||+|+||+||+|... +|+.||||+++.... ...+.|.+|+++|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 367999999999999999999974 799999999864321 2357899999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC----cEEEEecCC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF----TAKVADFGL 771 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~----~~kl~DFGl 771 (845)
++|||||++|+|.+++.... .+++..++.++.|+++||+|||+++ |+||||||+|||++.++ .+|++|||+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhh
Confidence 99999999999999997653 6899999999999999999999999 99999999999998776 599999999
Q ss_pred cccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 772 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 772 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
|+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus 164 a~~~~~~--------~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 219 (293)
T d1jksa_ 164 AHKIDFG--------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 219 (293)
T ss_dssp CEECTTS--------CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hhhcCCC--------ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC
Confidence 9876422 2234457899999999999999999999999999999999999999754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=358.40 Aligned_cols=197 Identities=29% Similarity=0.428 Sum_probs=166.4
Q ss_pred ccccccCceEEEEEEeC---CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcCCC
Q 003140 630 TQIGQGGYGKVYKGILP---DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 704 (845)
Q Consensus 630 ~~LG~G~fG~Vy~~~~~---~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 704 (845)
+.||+|+||+||+|.++ .++.||||+++... ....++|.+|+++|++++|||||+++|+|.+ +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999864 35689999986532 2335689999999999999999999999865 467899999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCcc
Q 003140 705 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 784 (845)
Q Consensus 705 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 784 (845)
|+|.++++.. ..+++..++.++.||++||+|||+++ ||||||||+|||++.++.+||+|||+|+.......
T Consensus 92 g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~---- 162 (277)
T d1xbba_ 92 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN---- 162 (277)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS----
T ss_pred CcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccc----
Confidence 9999999764 45899999999999999999999998 99999999999999999999999999987643221
Q ss_pred ccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 785 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
.........||+.|+|||.+.+..++.++|||||||++|||+| |+.||....
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~ 215 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 215 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC
Confidence 1122334578999999999999999999999999999999998 899997543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-41 Score=358.91 Aligned_cols=204 Identities=29% Similarity=0.449 Sum_probs=168.1
Q ss_pred cCCCCCccccccCceEEEEEEeCCC-----cEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILPDG-----TVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~~g-----~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
+.|+..++||+|+||+||+|.+++. ..||||+++... ....++|.+|++++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4677889999999999999997532 479999987543 3345679999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
||||+++|++.+++... ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 87 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccC
Confidence 99999999999988654 356999999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
... .........||+.|+|||++.+..++.++|||||||++|||++|..|+...
T Consensus 163 ~~~----~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~ 216 (283)
T d1mqba_ 163 DPE----ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 216 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CCc----cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcccc
Confidence 211 122233456899999999999999999999999999999999977776543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.5e-41 Score=365.46 Aligned_cols=198 Identities=24% Similarity=0.359 Sum_probs=177.7
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~ 699 (845)
++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57889999999999999999975 79999999986422 233567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~ 779 (845)
||+.+|+|.+++.... .+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 9999999999997653 5899999999999999999999999 999999999999999999999999999876421
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.....||+.|||||++.+..++.++|||||||++|||+||+.||.+.+
T Consensus 195 ---------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 242 (350)
T d1rdqe_ 195 ---------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp ---------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ---------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC
Confidence 234579999999999999999999999999999999999999997543
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=3.6e-41 Score=363.20 Aligned_cols=295 Identities=29% Similarity=0.483 Sum_probs=228.3
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCCCCCCCC-CCCcceEecCCCCCCCcceEeEEEecCCCCcc--cCCCCccCCCC
Q 003140 31 ITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCT-SNWTGVLCFNTTMDDGYLHLRELQLLNLNLSG--NLSPEIGRLSY 107 (845)
Q Consensus 31 ~~~~~~~~al~~~k~~~~~~~~~l~~W~~~~~c~-~~w~Gv~C~~~~~~~~~~~v~~L~L~~~~l~~--~~~~~l~~L~~ 107 (845)
-|+|+|++||++||+++.++. .+++|..+++|| +.|.||+|... ....||+.|+|++++++| .+|++|++|++
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~-~l~sW~~~~d~C~~~w~gv~C~~~---~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~ 77 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTD---TQTYRVNNLDLSGLNLPKPYPIPSSLANLPY 77 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTTSCTTTTCSTTEEECCS---SSCCCEEEEEEECCCCSSCEECCGGGGGCTT
T ss_pred CCCHHHHHHHHHHHHHCCCCC-cCCCCCCCCCCCCCcCCCeEEeCC---CCcEEEEEEECCCCCCCCCCCCChHHhcCcc
Confidence 489999999999999998764 689998666665 36999999753 234589999999999998 58899999999
Q ss_pred ccEEEecC-CCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEcc
Q 003140 108 LTILDFMW-NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMN 186 (845)
Q Consensus 108 L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 186 (845)
|++|+|++ |+++|.+|.+|+++++|++|+|++|++.+..+..+..+.+|+.+++++|.+.+.+|..+.++++|+.++++
T Consensus 78 L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~ 157 (313)
T d1ogqa_ 78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157 (313)
T ss_dssp CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECC
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecc
Confidence 99999986 88999999999999999999999999998888889999999999999999998899999999999999999
Q ss_pred CCCCCCCCccccCCCCCc-ceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCC
Q 003140 187 NNSISGQIPPELSRLPSL-VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG 265 (845)
Q Consensus 187 ~N~l~~~~p~~l~~l~~L-~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~ 265 (845)
+|.+.+.+|..+..+..+ +.+++++|++++..|..+..+..+ .++++.|.+.+ .+|..+..+++|+.+++++|.+++
T Consensus 158 ~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~-~~~~~~~~~~~l~~l~~~~~~l~~ 235 (313)
T d1ogqa_ 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEG-DASVLFGSDKNTQKIHLAKNSLAF 235 (313)
T ss_dssp SSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEE-CCGGGCCTTSCCSEEECCSSEECC
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc-ccccccccccc-cccccccccccccccccccccccc
Confidence 999988888888887776 788888888888888887776544 68888888876 577777777777777777777777
Q ss_pred CCCCCCCCCCccEEEcccccCCcCCCCCCCc-cccCEEEccCCcCCCCcccccCCCCCCCeEeccccc
Q 003140 266 PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNS 332 (845)
Q Consensus 266 ~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 332 (845)
.++.+..+++|+.|+|++|+++|.+|..+.. .+|+.|+|++|+|+|.+|. ++++++|+.+++++|+
T Consensus 236 ~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 236 DLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302 (313)
T ss_dssp BGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred cccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence 6666666666666666666666555543322 2444444444444444442 3344444444444443
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-40 Score=356.24 Aligned_cols=201 Identities=25% Similarity=0.420 Sum_probs=175.6
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC---hhhHHHHHHHHHHHH-hcCCCceeeEEEEEeeCCeEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLS-RLHHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~-~l~H~nIv~l~g~~~~~~~~~LV 698 (845)
++|.+.+.||+|+||+||+|+.. +|+.||||+++... ....+.+..|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57889999999999999999975 69999999986432 223456777777765 68999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCC
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~ 778 (845)
|||+++|+|.++++... .+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 82 mEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999999997653 5788999999999999999999999 999999999999999999999999999865422
Q ss_pred CCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
........||+.|+|||++.+..++.++||||+||++|||+||+.||.+..
T Consensus 157 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~ 207 (320)
T d1xjda_ 157 -------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 207 (320)
T ss_dssp -------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -------cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC
Confidence 122344679999999999999999999999999999999999999997543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.2e-40 Score=361.35 Aligned_cols=199 Identities=28% Similarity=0.402 Sum_probs=171.4
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh---hhHHHHHHH---HHHHHhcCCCceeeEEEEEeeCCeEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTE---IQFLSRLHHRNLVSLVGYCDEEGEQM 696 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~---~~~~~~~~E---i~~l~~l~H~nIv~l~g~~~~~~~~~ 696 (845)
++|++.+.||+|+||.||+|+.. +|+.||||++..... .....+.+| +++++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57889999999999999999975 699999999864221 223334444 66777788999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCC
Q 003140 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~ 776 (845)
+||||+++|+|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+...
T Consensus 84 ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 999999999999999765 35789999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.. ......||+.|+|||++.. ..|+.++|||||||++|||+||+.||....
T Consensus 159 ~~---------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 210 (364)
T d1omwa3 159 KK---------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 210 (364)
T ss_dssp SS---------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred CC---------cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCC
Confidence 22 1234579999999999975 568999999999999999999999997543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.2e-40 Score=348.94 Aligned_cols=205 Identities=27% Similarity=0.390 Sum_probs=170.0
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCC---hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC----e
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----E 694 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----~ 694 (845)
.++|++.+.||+|+||+||+|.. .+|+.||||+++... ....++|.+|++++++++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 36799999999999999999996 479999999987543 233567999999999999999999999987654 3
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003140 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (845)
Q Consensus 695 ~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~ 774 (845)
.++||||+++|+|.+++... .++++..++.++.||++||+|||+++ ||||||||+|||++.++..+|+|||.++.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhh
Confidence 78999999999999998665 35899999999999999999999998 99999999999999999999999999876
Q ss_pred CCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
...... .........||+.|+|||++.+..++.++||||+||++|||+||+.||....
T Consensus 161 ~~~~~~----~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 218 (277)
T d1o6ya_ 161 IADSGN----SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 218 (277)
T ss_dssp CC--------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hccccc----cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC
Confidence 543221 1223345679999999999999999999999999999999999999997543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.9e-41 Score=357.85 Aligned_cols=211 Identities=29% Similarity=0.459 Sum_probs=179.2
Q ss_pred HHHHHHhcCCCCCccccccCceEEEEEEeC------CCcEEEEEEccCCCh-hhHHHHHHHHHHHHhcCCCceeeEEEEE
Q 003140 617 GEMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYC 689 (845)
Q Consensus 617 ~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~ 689 (845)
.+++...++|++.+.||+|+||+||+|++. +++.||||+++.... ...++|.+|++++++++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 445566788999999999999999999863 467899999976443 3457899999999999999999999999
Q ss_pred eeCCeEEEEEEcCCCCCHHHHHhccC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 003140 690 DEEGEQMLVYEFMSNGTLRDQLSAKS----------------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVF 747 (845)
Q Consensus 690 ~~~~~~~LV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ii 747 (845)
.+.+..++||||+++|+|.++++... ...+++..++.|+.|++.||+|||+++ ||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eE
Confidence 99999999999999999999996432 235889999999999999999999998 99
Q ss_pred ecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh
Q 003140 748 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 827 (845)
Q Consensus 748 HrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt 827 (845)
||||||+|||++.++.+||+|||+|+...... .........||+.|+|||.+.+..++.++|||||||++|||++
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~ 237 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSAD-----YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGG-----CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCc-----cccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHc
Confidence 99999999999999999999999998653221 1222345678899999999999999999999999999999999
Q ss_pred CCC-CCCCC
Q 003140 828 GMQ-PISHG 835 (845)
Q Consensus 828 G~~-Pf~~~ 835 (845)
|.. ||...
T Consensus 238 ~~~~p~~~~ 246 (301)
T d1lufa_ 238 YGLQPYYGM 246 (301)
T ss_dssp TTCCTTTTS
T ss_pred cCCCCCCCC
Confidence 965 56543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.5e-40 Score=345.82 Aligned_cols=200 Identities=30% Similarity=0.404 Sum_probs=175.5
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCChh---------hHHHHHHHHHHHHhcC-CCceeeEEEEEeeC
Q 003140 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ---------GEKEFLTEIQFLSRLH-HRNLVSLVGYCDEE 692 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~---------~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~ 692 (845)
++|++.+.||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|++++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6789999999999999999996 47999999998653211 1246889999999996 99999999999999
Q ss_pred CeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 003140 693 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 772 (845)
Q Consensus 693 ~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla 772 (845)
+..+||||||++|+|.++++... .+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchhe
Confidence 99999999999999999997643 6899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCCCccccceeecccCCCCccchhhhcC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT------HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
+..... .......||..|+|||.+.+ ..++.++||||+||++|||++|+.||.+..
T Consensus 158 ~~~~~~--------~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~ 219 (277)
T d1phka_ 158 CQLDPG--------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 219 (277)
T ss_dssp EECCTT--------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eEccCC--------CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC
Confidence 876422 12344679999999999853 357889999999999999999999997654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-40 Score=353.35 Aligned_cols=201 Identities=21% Similarity=0.349 Sum_probs=177.9
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
.++|.+.+.||+|+||+||+|... +|+.||||+++... .....+.+|+++|++++|||||++++++.+++..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 367899999999999999999975 68999999997644 3345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC--CcEEEEecCCcccCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK--FTAKVADFGLSRLAPVPD 779 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~--~~~kl~DFGla~~~~~~~ 779 (845)
|++|+|.+++... ...+++..++.++.||++||+|||+++ |+||||||+|||++.+ ..+||+|||+++....
T Consensus 83 ~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~-- 156 (321)
T d1tkia_ 83 ISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-- 156 (321)
T ss_dssp CCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred CCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc--
Confidence 9999999999654 346899999999999999999999998 9999999999999854 5899999999987542
Q ss_pred CCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 780 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
........+|+.|+|||...+..++.++||||+||++|||++|+.||....
T Consensus 157 ------~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~ 207 (321)
T d1tkia_ 157 ------GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp ------TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ------CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC
Confidence 222345678999999999999999999999999999999999999997644
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-41 Score=351.22 Aligned_cols=197 Identities=32% Similarity=0.514 Sum_probs=165.6
Q ss_pred hcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEee-CCeEEEEEEc
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-EGEQMLVYEF 701 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~LV~E~ 701 (845)
-++|+..+.||+|+||.||+|.+ .|+.||||+++... ..++|.+|++++++++||||++++|+|.+ .+..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 45677889999999999999998 57899999997542 34689999999999999999999999865 4568999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+++|+|.++++......++|..++.++.||++||+|||+.+ |+||||||+|||++.++.+|++|||+++.....
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence 99999999997765556899999999999999999999998 999999999999999999999999999864321
Q ss_pred CccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
.....+|..|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 157 -------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~ 204 (262)
T d1byga_ 157 -------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 204 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred -------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC
Confidence 223457899999999999999999999999999999998 67777643
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=351.74 Aligned_cols=205 Identities=28% Similarity=0.434 Sum_probs=165.5
Q ss_pred HHhcCCCCCccccccCceEEEEEEeCC----CcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeE
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 695 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 695 (845)
+..++|++.+.||+|+||.||+|.+.. +..||||+++... ....+.|.+|++++++++|||||+++|++. ++..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 345788899999999999999998642 4579999987543 334567999999999999999999999996 4678
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccC
Q 003140 696 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 775 (845)
Q Consensus 696 ~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~ 775 (845)
++||||+++|+|.+++... ...+++..++.++.||++||+|||+++ ||||||||+||++++++.+||+|||+|+..
T Consensus 83 ~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheec
Confidence 9999999999999987654 346899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 836 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 836 (845)
.... ........||+.|+|||.+.+..++.++|||||||++|||+| |+.||....
T Consensus 159 ~~~~------~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~ 214 (273)
T d1mp8a_ 159 EDST------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 214 (273)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cCCc------ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC
Confidence 4322 222344568999999999999999999999999999999998 888987543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-40 Score=354.00 Aligned_cols=202 Identities=29% Similarity=0.481 Sum_probs=168.4
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCc----EEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~L 697 (845)
++|+..+.||+|+||+||+|.+. +|+ .||||+++.. ..+..++|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 45888999999999999999864 444 5899988653 344567899999999999999999999999865 5678
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
++||+.+|+|.+++... ...+++..++.++.|||+||+|||+++ ||||||||+|||++.++.+||+|||+|+....
T Consensus 88 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 89999999999988764 456899999999999999999999998 99999999999999999999999999987653
Q ss_pred CCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
... ........||+.|+|||++.++.++.++|||||||++|||+| |+.||...
T Consensus 164 ~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~ 217 (317)
T d1xkka_ 164 EEK-----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 217 (317)
T ss_dssp TCC-------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred ccc-----cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC
Confidence 321 122334568999999999999999999999999999999999 78888653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-40 Score=354.10 Aligned_cols=211 Identities=27% Similarity=0.444 Sum_probs=168.5
Q ss_pred HHHHHHhcCCCCCccccccCceEEEEEEeC------CCcEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEE
Q 003140 617 GEMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGY 688 (845)
Q Consensus 617 ~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~ 688 (845)
.++++..++|++.+.||+|+||.||+|.+. +++.||||+++... ....+++.+|.+++.++ +|+||+.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 455566688999999999999999999853 35689999987543 34456788999888887 68999999999
Q ss_pred EeeC-CeEEEEEEcCCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 003140 689 CDEE-GEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKA 753 (845)
Q Consensus 689 ~~~~-~~~~LV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~ 753 (845)
+.+. +..++|||||++|+|.++++... ...+++..++.++.||++||+|||+++ ||||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCc
Confidence 8665 46899999999999999997532 245899999999999999999999998 99999999
Q ss_pred CCEEEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCC-CCC
Q 003140 754 SNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGM-QPI 832 (845)
Q Consensus 754 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~-~Pf 832 (845)
+|||+++++++||+|||+|+...... .........||+.|+|||++.+..++.++|||||||++|||+||. .||
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~-----~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~ 237 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDP-----DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 237 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCT-----TSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cceeECCCCcEEEccCcchhhccccc-----cccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCC
Confidence 99999999999999999998754322 112233457999999999999999999999999999999999975 466
Q ss_pred CCC
Q 003140 833 SHG 835 (845)
Q Consensus 833 ~~~ 835 (845)
...
T Consensus 238 ~~~ 240 (299)
T d1ywna1 238 PGV 240 (299)
T ss_dssp TTC
T ss_pred CCC
Confidence 543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-40 Score=357.45 Aligned_cols=196 Identities=24% Similarity=0.368 Sum_probs=170.8
Q ss_pred cCCCCCc-cccccCceEEEEEEe-CCCcEEEEEEccCCChhhHHHHHHHHHHHHhc-CCCceeeEEEEEee----CCeEE
Q 003140 624 NNFNSST-QIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE----EGEQM 696 (845)
Q Consensus 624 ~~f~~~~-~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~----~~~~~ 696 (845)
++|.+.+ .||+|+||+||+|.. .+|+.||||+++.. +.+.+|++++.++ +|||||++++++.+ ....+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 5787764 699999999999996 57999999998642 4677899987665 89999999999865 45689
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEEecCCcc
Q 003140 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLSR 773 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~---~~~~kl~DFGla~ 773 (845)
+|||||++|+|.+++.......+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccceee
Confidence 9999999999999998766678999999999999999999999999 999999999999985 5679999999998
Q ss_pred cCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
...... ......||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.
T Consensus 163 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~ 216 (335)
T d2ozaa1 163 ETTSHN--------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 216 (335)
T ss_dssp ECCCCC--------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEET
T ss_pred eccCCC--------ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCC
Confidence 764322 234457999999999999999999999999999999999999999643
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-39 Score=345.50 Aligned_cols=201 Identities=34% Similarity=0.512 Sum_probs=171.1
Q ss_pred CccccccCceEEEEEEeCC----CcEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEee-CCeEEEEEEcC
Q 003140 629 STQIGQGGYGKVYKGILPD----GTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-EGEQMLVYEFM 702 (845)
Q Consensus 629 ~~~LG~G~fG~Vy~~~~~~----g~~vAVK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~LV~E~~ 702 (845)
.++||+|+||+||+|.+.+ ...||||+++.. .....++|.+|+++|++++|||||+++|++.+ ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4679999999999999753 236899998753 44456789999999999999999999999876 46889999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCC
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 782 (845)
++|+|.++++.. ....++..++.++.|+|+||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~- 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD- 186 (311)
T ss_dssp TTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC-
T ss_pred ecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc-
Confidence 999999998754 345788999999999999999999998 999999999999999999999999999876543221
Q ss_pred ccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 783 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.........||..|+|||.+.+..++.++||||||+++|||+||+.||....
T Consensus 187 --~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~ 238 (311)
T d1r0pa_ 187 --SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238 (311)
T ss_dssp --CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--
T ss_pred --cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC
Confidence 1222334578999999999999999999999999999999999989987544
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-39 Score=346.70 Aligned_cols=201 Identities=31% Similarity=0.483 Sum_probs=172.8
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
++|++.+.||+|+||+||+|.. .+|+.||||+++.... ...+++.+|++++++++|||||++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5789999999999999999996 4799999999865332 234689999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
|+. |++.+++.......+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~-- 155 (298)
T d1gz8a_ 82 FLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-- 155 (298)
T ss_dssp CCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC--
T ss_pred ecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC--
Confidence 996 55666665555667999999999999999999999999 999999999999999999999999999865432
Q ss_pred CCccccceeecccCCCCccchhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
........||+.|+|||.+.... ++.++||||+||++|||++|+.||...
T Consensus 156 -----~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~ 206 (298)
T d1gz8a_ 156 -----VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206 (298)
T ss_dssp -----SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred -----cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC
Confidence 12234457999999999887655 588999999999999999999999754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-40 Score=344.19 Aligned_cols=203 Identities=28% Similarity=0.419 Sum_probs=163.9
Q ss_pred cCCCCCccccccCceEEEEEEeC--CC--cEEEEEEccCC---ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP--DG--TVVAVKRAQEG---SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 696 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~--~g--~~vAVK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 696 (845)
++|++.+.||+|+||.||+|++. ++ ..||||+++.. .....++|.+|++++++++|||||+++|++.+. ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence 56888999999999999999853 22 47899988653 233457899999999999999999999999764 668
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCC
Q 003140 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 776 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~ 776 (845)
+||||+++|++.+++.... ..+++..++.++.|||+||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcc
Confidence 9999999999999887643 35999999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 777 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 777 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
.... .........|+..|+|||.+.+..++.++|||||||++|||+| |+.||.+.
T Consensus 163 ~~~~----~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~ 218 (273)
T d1u46a_ 163 QNDD----HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 218 (273)
T ss_dssp C-CC----EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cCCC----cceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc
Confidence 3321 1222334567889999999999999999999999999999998 89999654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-39 Score=348.51 Aligned_cols=199 Identities=33% Similarity=0.510 Sum_probs=168.8
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCc--EEEEEEccCC-ChhhHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCeEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGT--VVAVKRAQEG-SLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLV 698 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~--~vAVK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~LV 698 (845)
++|++.+.||+|+||+||+|.+. +|. .||||+++.. .....++|.+|+++|+++ +|||||+++|+|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 67888899999999999999975 444 5788887643 333456899999999999 799999999999999999999
Q ss_pred EEcCCCCCHHHHHhcc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 003140 699 YEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 764 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~ 764 (845)
|||+++|+|.++++.. ....+++..++.++.|||+||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999754 2457999999999999999999999998 9999999999999999999
Q ss_pred EEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCC-CC
Q 003140 765 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP-IS 833 (845)
Q Consensus 765 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~P-f~ 833 (845)
||+|||+|+.... ........||..|+|||.+....++.++|||||||++|||++|..| |.
T Consensus 167 kl~DfG~a~~~~~--------~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~ 228 (309)
T d1fvra_ 167 KIADFGLSRGQEV--------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 228 (309)
T ss_dssp EECCTTCEESSCE--------ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred EEccccccccccc--------cccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCC
Confidence 9999999986431 1122344689999999999999999999999999999999997765 54
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-39 Score=346.90 Aligned_cols=196 Identities=27% Similarity=0.387 Sum_probs=165.0
Q ss_pred CccccccCceEEEEEEeC-CCcEEEEEEccCCChhh-----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEcC
Q 003140 629 STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG-----EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 702 (845)
Q Consensus 629 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~-----~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 702 (845)
.++||+|+||+||+|... +|+.||||+++...... .+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999975 69999999986543221 246889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCCC
Q 003140 703 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 782 (845)
Q Consensus 703 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 782 (845)
+++++..+.. ....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 83 ~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--- 154 (299)
T d1ua2a_ 83 ETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--- 154 (299)
T ss_dssp SEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC---
T ss_pred cchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc---
Confidence 9887766653 3346888899999999999999999999 9999999999999999999999999998654321
Q ss_pred ccccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 783 IVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.......||+.|+|||++... .++.++||||+||++|||+||+.||....
T Consensus 155 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 205 (299)
T d1ua2a_ 155 ----RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS 205 (299)
T ss_dssp ----CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ----ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC
Confidence 122345789999999998754 67999999999999999999999996543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-39 Score=348.72 Aligned_cols=211 Identities=28% Similarity=0.439 Sum_probs=180.4
Q ss_pred HHHHHhcCCCCCccccccCceEEEEEEe------CCCcEEEEEEccCCC-hhhHHHHHHHHHHHHhc-CCCceeeEEEEE
Q 003140 618 EMALATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYC 689 (845)
Q Consensus 618 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~ 689 (845)
.++...++|+..+.||+|+||.||+|++ .+++.||||+++... .....+|.+|+.+++++ +|||||+++|+|
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 3445567888999999999999999985 346789999997643 34456799999999999 699999999999
Q ss_pred eeCCeEEEEEEcCCCCCHHHHHhccC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 003140 690 DEEGEQMLVYEFMSNGTLRDQLSAKS----------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKA 753 (845)
Q Consensus 690 ~~~~~~~LV~E~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~ 753 (845)
.+.+..++|||||++|+|.++++... ...+++..+..++.||++||+|||+++ ||||||||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp 173 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAA 173 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccc
Confidence 99999999999999999999997642 236899999999999999999999998 99999999
Q ss_pred CCEEEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003140 754 SNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 833 (845)
Q Consensus 754 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~ 833 (845)
+|||++.++.+|++|||+++...... .........||+.|+|||.+.+..++.++|||||||++|||+|+..|+.
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~ 248 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDS-----NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCT-----TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred ccccccccCcccccccchheeccCCC-----cceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCC
Confidence 99999999999999999998765322 1233345678999999999999999999999999999999999655554
Q ss_pred CCC
Q 003140 834 HGK 836 (845)
Q Consensus 834 ~~~ 836 (845)
...
T Consensus 249 ~~~ 251 (311)
T d1t46a_ 249 PGM 251 (311)
T ss_dssp TTC
T ss_pred CCC
Confidence 443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-39 Score=345.42 Aligned_cols=200 Identities=27% Similarity=0.419 Sum_probs=162.3
Q ss_pred CCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHH--HHHHHHHhcCCCceeeEEEEEeeCC----eEEEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFL--TEIQFLSRLHHRNLVSLVGYCDEEG----EQMLV 698 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~--~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~LV 698 (845)
+|...+.||+|+||.||+|++ +|+.||||+++... .+++. .|+..+++++|||||+++|++.+.+ ..++|
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 455678899999999999997 68999999986532 33444 4555566789999999999997654 57999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003140 699 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-----ADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (845)
Q Consensus 699 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~ 773 (845)
||||++|+|.+++++. .++|..++.++.|+|.||+|||+. .+++||||||||+||||+.++.+||+|||+++
T Consensus 80 ~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 9999999999999764 589999999999999999999974 13459999999999999999999999999998
Q ss_pred cCCCCCCCCccccceeecccCCCCccchhhhcCCC------CCchhhHHHHHHHHHHHHhCCCCCCC
Q 003140 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK------LTDKSDVYSLGVVFLELLTGMQPISH 834 (845)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwS~Gvvl~elltG~~Pf~~ 834 (845)
....... ..........||++|+|||++.+.. ++.++|||||||++|||+||..||..
T Consensus 157 ~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 157 RHDSATD---TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp EEETTTT---EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred cccCCCc---ceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 7643221 1112234567999999999987643 57799999999999999999988854
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-39 Score=345.58 Aligned_cols=208 Identities=29% Similarity=0.481 Sum_probs=173.5
Q ss_pred HHhcCCCCCccccccCceEEEEEEeC--------CCcEEEEEEccCCCh-hhHHHHHHHHHHHHhc-CCCceeeEEEEEe
Q 003140 621 LATNNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCD 690 (845)
Q Consensus 621 ~~~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~ 690 (845)
+..++|.+.+.||+|+||.||+|+.. ++..||||+++.... ....++.+|+..+.++ +|||||+++++|.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 44578888999999999999999853 235799999976543 4457899999999888 8999999999999
Q ss_pred eCCeEEEEEEcCCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 003140 691 EEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 756 (845)
Q Consensus 691 ~~~~~~LV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NI 756 (845)
+++..++||||+++|+|.++++... ...+++..++.++.||++||+|||+.+ ||||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccce
Confidence 9999999999999999999997543 246899999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003140 757 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 835 (845)
Q Consensus 757 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 835 (845)
|++.++.+||+|||+++...... .........||+.|+|||.+.++.|+.++|||||||++|||++ |+.||...
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~ 241 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHID-----YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCC-----TTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred eecCCCCeEeccchhhccccccc-----cccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC
Confidence 99999999999999998664322 1222345678999999999999999999999999999999998 68888644
Q ss_pred C
Q 003140 836 K 836 (845)
Q Consensus 836 ~ 836 (845)
.
T Consensus 242 ~ 242 (299)
T d1fgka_ 242 P 242 (299)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-39 Score=347.48 Aligned_cols=209 Identities=29% Similarity=0.462 Sum_probs=178.5
Q ss_pred HHHHHhcCCCCCccccccCceEEEEEEeC------CCcEEEEEEccCC-ChhhHHHHHHHHHHHHhcCCCceeeEEEEEe
Q 003140 618 EMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 690 (845)
Q Consensus 618 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~ 690 (845)
+|++..++|...+.||+|+||+||+|.+. +++.||||+++.. .......|.+|++++++++|||||+++|++.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 45556688899999999999999999863 3578999999754 3344567999999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCCHHHHHhcc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC
Q 003140 691 EEGEQMLVYEFMSNGTLRDQLSAK--------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF 762 (845)
Q Consensus 691 ~~~~~~LV~E~~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~ 762 (845)
..+..++||||+++|+|.+++... ....+++..+.+++.|+|+||.|||+++ |+||||||+|||++.++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCc
Confidence 999999999999999999998653 2245789999999999999999999998 99999999999999999
Q ss_pred cEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCC-CCCCC
Q 003140 763 TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGM-QPISH 834 (845)
Q Consensus 763 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~-~Pf~~ 834 (845)
++||+|||+|+...... .........||+.|+|||.+.+..++.++|||||||++|||+||. .||..
T Consensus 171 ~~Kl~DFGla~~~~~~~-----~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~ 238 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETD-----YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 238 (308)
T ss_dssp CEEECCTTCCCGGGGGG-----CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred eEEEeecccceeccCCc-----ceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC
Confidence 99999999998654221 112223346899999999999999999999999999999999985 55643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=343.41 Aligned_cols=200 Identities=26% Similarity=0.436 Sum_probs=171.1
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCCh------hhHHHHHHHHHHHHhcC--CCceeeEEEEEeeCCe
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL------QGEKEFLTEIQFLSRLH--HRNLVSLVGYCDEEGE 694 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~------~~~~~~~~Ei~~l~~l~--H~nIv~l~g~~~~~~~ 694 (845)
++|++.+.||+|+||+||+|... +|+.||||+++.... ...+++.+|++++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57899999999999999999964 799999999864321 12245778999999996 8999999999999999
Q ss_pred EEEEEEcCCC-CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEEecCCc
Q 003140 695 QMLVYEFMSN-GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLS 772 (845)
Q Consensus 695 ~~LV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~-~~~kl~DFGla 772 (845)
.++||||+.+ +++.+++... ..+++..++.++.||++||+|||+++ |+||||||+|||++.+ +.+||+|||+|
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccc
Confidence 9999999976 6888888654 35899999999999999999999998 9999999999999854 79999999999
Q ss_pred ccCCCCCCCCccccceeecccCCCCccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
+..... ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||.+.++
T Consensus 159 ~~~~~~---------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~ 215 (273)
T d1xwsa_ 159 ALLKDT---------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 215 (273)
T ss_dssp EECCSS---------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH
T ss_pred eecccc---------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH
Confidence 865321 2345679999999999987665 5779999999999999999999976543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1e-38 Score=339.05 Aligned_cols=200 Identities=28% Similarity=0.400 Sum_probs=171.6
Q ss_pred cCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCCh--hhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEEc
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E~ 701 (845)
++|+..+.||+|+||+||+|+.++|+.||||+++.... ...+++.+|+.+|++++|||||++++++.+.+..++||||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 57889999999999999999999999999999875432 2257899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 781 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 781 (845)
+.++.+..+.+. ...+++..+..++.||++||+|||+++ ||||||||+|||++.++.+|++|||.|.....+.
T Consensus 82 ~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-- 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-- 154 (286)
T ss_dssp CSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc--
Confidence 987777666543 356999999999999999999999998 9999999999999999999999999998754322
Q ss_pred CccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 782 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus 155 -----~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~ 204 (286)
T d1ob3a_ 155 -----RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (286)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred -----cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence 22334468899999999875 45689999999999999999999999654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-38 Score=336.03 Aligned_cols=202 Identities=28% Similarity=0.406 Sum_probs=168.0
Q ss_pred hcCCCCCccccccCceEEEEEEeC-C-CcEEEEEEccCCCh--hhHHHHHHHHHHHHhc---CCCceeeEEEEEee----
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-D-GTVVAVKRAQEGSL--QGEKEFLTEIQFLSRL---HHRNLVSLVGYCDE---- 691 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~-g~~vAVK~~~~~~~--~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~~---- 691 (845)
.++|++.+.||+|+||+||+|... + ++.||||+++.... .....+.+|+++++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999963 4 67899999864221 2233566777777665 79999999999853
Q ss_pred -CCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 003140 692 -EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 770 (845)
Q Consensus 692 -~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFG 770 (845)
....+++|||+++|++.... ......+++...+.++.|+++||+|||+++ ||||||||+|||+++++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchh
Confidence 34679999999877665444 344567899999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 771 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 771 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
+++.... ........||+.|+|||++.+..|+.++||||+||++|||++|+.||.+..
T Consensus 162 ~~~~~~~--------~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~ 219 (305)
T d1blxa_ 162 LARIYSF--------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 219 (305)
T ss_dssp SCCCCCG--------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hhhhhcc--------cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC
Confidence 9876432 223455679999999999999999999999999999999999999997653
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.6e-37 Score=330.59 Aligned_cols=208 Identities=21% Similarity=0.319 Sum_probs=176.6
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCC-CceeeEEEEEeeCCeEEEEEE
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH-RNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~LV~E 700 (845)
.++|.+.+.||+|+||+||+|+.. +|+.||||++.... ...++.+|++.++.++| +|++.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 367999999999999999999965 68999999876532 22357788999999965 899999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-----CCcEEEEecCCcccC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-----KFTAKVADFGLSRLA 775 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~-----~~~~kl~DFGla~~~ 775 (845)
|+ +|+|.++++.. ...+++..+..++.|++.||+|||+++ ||||||||+|||++. ++.+||+|||+|+..
T Consensus 82 ~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 82 LL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 99 69999988654 346899999999999999999999999 999999999999974 578999999999876
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
.........+........||+.|||||++.+..++.++|||||||++|||+||+.||.+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~ 218 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 218 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccc
Confidence 54332222223334556899999999999999999999999999999999999999975443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-37 Score=331.89 Aligned_cols=205 Identities=25% Similarity=0.375 Sum_probs=168.1
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEee--------C
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--------E 692 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--------~ 692 (845)
++|++.+.||+|+||+||+|... +|+.||||++... .....+++.+|+++|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 68889999999999999999974 7999999997543 22335678999999999999999999998854 3
Q ss_pred CeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 003140 693 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 772 (845)
Q Consensus 693 ~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla 772 (845)
+..++||||++++.+..+.. ....++....+.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeeccee
Confidence 46799999998777665443 3456888999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCCCccccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 773 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
+........ .........||+.|+|||.+.+. .++.++||||+||++|||++|+.||....
T Consensus 165 ~~~~~~~~~---~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~ 226 (318)
T d3blha1 165 RAFSLAKNS---QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 226 (318)
T ss_dssp EECCC--------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred eeccccccc---ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC
Confidence 876533211 11222345799999999998765 68999999999999999999999997543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-37 Score=334.97 Aligned_cols=197 Identities=26% Similarity=0.377 Sum_probs=164.0
Q ss_pred CCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeC------CeEEE
Q 003140 625 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------GEQML 697 (845)
Q Consensus 625 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~~L 697 (845)
+|+..++||+|+||+||+|++. +|+.||||+++.... .+.+|+++|++++||||+++++++... .+.+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5777889999999999999975 699999999875432 234799999999999999999998543 34789
Q ss_pred EEEcCCCCCHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEEecCCcccC
Q 003140 698 VYEFMSNGTLRDQLSA-KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLA 775 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~-~~kl~DFGla~~~ 775 (845)
||||+++|.+..+.+. .....+++..++.++.||++||+|||+++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999986644444332 34567999999999999999999999998 99999999999999775 8999999999876
Q ss_pred CCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 776 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.... ......||..|+|||.+.+ ..++.++||||+||++|||++|+.||....
T Consensus 174 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~ 227 (350)
T d1q5ka_ 174 VRGE--------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 227 (350)
T ss_dssp CTTS--------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred cCCc--------ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC
Confidence 4322 2234579999999998865 578999999999999999999999997554
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-36 Score=324.37 Aligned_cols=206 Identities=22% Similarity=0.313 Sum_probs=169.9
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCcee-eEEEEEeeCCeEEEEEEc
Q 003140 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV-SLVGYCDEEGEQMLVYEF 701 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~LV~E~ 701 (845)
++|++.+.||+|+||.||+|.+ .+|+.||||++..... .+++..|++++++++|+|++ .+.++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5789999999999999999996 4689999998775432 24578999999999876655 555566788889999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCcEEEEecCCcccCCCC
Q 003140 702 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD---HKFTAKVADFGLSRLAPVP 778 (845)
Q Consensus 702 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~---~~~~~kl~DFGla~~~~~~ 778 (845)
+ +|++.+.+... ...+++..+..++.|+++||+|||+++ ||||||||+|||++ .+..+||+|||+|+.....
T Consensus 85 ~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 85 L-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp C-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred c-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9 56777766443 356899999999999999999999999 99999999999985 4567999999999987543
Q ss_pred CCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
...............||+.|+|||.+.+..++.++|||||||++|||+||+.||....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~ 217 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 217 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccc
Confidence 3222222333456689999999999999999999999999999999999999997543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-37 Score=334.79 Aligned_cols=203 Identities=25% Similarity=0.372 Sum_probs=167.5
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCC-hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC----eEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----EQML 697 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~L 697 (845)
++|.+.+.||+|+||+||+|.. .+|+.||||++.... ....+++++|+++|++++||||+++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 5788999999999999999986 479999999987543 334568999999999999999999999996543 2344
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCC
Q 003140 698 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 777 (845)
Q Consensus 698 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~ 777 (845)
+++|+.+|+|.+++... .+++..++.++.|+++||+|||+++ ||||||||+|||++.++.+||+|||+|+....
T Consensus 88 l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 55667799999999653 5899999999999999999999998 99999999999999999999999999986542
Q ss_pred CCCCCccccceeecccCCCCccchhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 778 PDIEGIVPAHVSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 778 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
... .........||+.|+|||.+. ...++.++||||+||++|||++|+.||....
T Consensus 162 ~~~----~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~ 217 (345)
T d1pmea_ 162 DHD----HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217 (345)
T ss_dssp GGC----BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCc----cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence 211 111234457899999999985 4567899999999999999999999997654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-37 Score=331.63 Aligned_cols=202 Identities=27% Similarity=0.343 Sum_probs=172.5
Q ss_pred cCCCCCccccccCceEEEEEEe----CCCcEEEEEEccCCC----hhhHHHHHHHHHHHHhcCC-CceeeEEEEEeeCCe
Q 003140 624 NNFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGS----LQGEKEFLTEIQFLSRLHH-RNLVSLVGYCDEEGE 694 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~----~~g~~vAVK~~~~~~----~~~~~~~~~Ei~~l~~l~H-~nIv~l~g~~~~~~~ 694 (845)
++|++.+.||+|+||+||+|.. .+|+.||||+++... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6699999999999999999985 248899999986432 1234578899999999966 899999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003140 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (845)
Q Consensus 695 ~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~ 774 (845)
.++||||+.+|+|.++++... .+.......++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhh
Confidence 999999999999999997654 4677888899999999999999998 99999999999999999999999999986
Q ss_pred CCCCCCCCccccceeecccCCCCccchhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH--KLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
..... ........|++.|+|||.+... .++.++||||+||++|||+||+.||.+..
T Consensus 179 ~~~~~------~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~ 236 (322)
T d1vzoa_ 179 FVADE------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 236 (322)
T ss_dssp CCGGG------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred hcccc------cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 54221 2223456799999999998754 47889999999999999999999997643
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-36 Score=321.76 Aligned_cols=203 Identities=27% Similarity=0.423 Sum_probs=176.5
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCCeEEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 700 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~LV~E 700 (845)
++|++.+.||+|+||+||+|++. +|+.||||+++... ....+++.+|++++++++||||+++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57899999999999999999974 78999999986432 2346789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccCCCCCC
Q 003140 701 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 780 (845)
Q Consensus 701 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~ 780 (845)
++.++++..+++.. ..+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||.|+......
T Consensus 82 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~- 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp CCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-
T ss_pred eccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC-
Confidence 99999998887543 46789999999999999999999998 9999999999999999999999999998764322
Q ss_pred CCccccceeecccCCCCccchhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCc
Q 003140 781 EGIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGKNI 838 (845)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~ 838 (845)
.......++..|+|||.+.... ++.++||||+||++|||++|+.||..+.+.
T Consensus 156 ------~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 208 (292)
T d1unla_ 156 ------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208 (292)
T ss_dssp ------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH
T ss_pred ------ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH
Confidence 1223345778999999987654 689999999999999999999998766653
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-37 Score=333.38 Aligned_cols=198 Identities=26% Similarity=0.424 Sum_probs=165.8
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCC--ChhhHHHHHHHHHHHHhcCCCceeeEEEEEeeCC------
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG------ 693 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 693 (845)
.++|++.+.||+|+||+||+|... +|+.||||+++.. .....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 367899999999999999999964 6999999998753 2333567899999999999999999999997654
Q ss_pred eEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003140 694 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (845)
Q Consensus 694 ~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~ 773 (845)
..++||||+ +++|..+.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+|+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccccccee
Confidence 569999999 6788887754 35999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCCCccccceeecccCCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 774 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
.... ..+...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+.++
T Consensus 170 ~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~ 224 (346)
T d1cm8a_ 170 QADS----------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 224 (346)
T ss_dssp ECCS----------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccCC----------ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh
Confidence 6532 1244579999999999876 4578999999999999999999999976543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.3e-36 Score=326.21 Aligned_cols=195 Identities=22% Similarity=0.398 Sum_probs=169.0
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCceeeEEEEEee--CCeEEEEE
Q 003140 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDE--EGEQMLVY 699 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~--~~~~~LV~ 699 (845)
++|++.+.||+|+||+||+|+. .+|+.||||+++... .+++.+|+++|++++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999997 479999999987533 467899999999995 9999999999874 35689999
Q ss_pred EcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEEecCCcccCCCC
Q 003140 700 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVP 778 (845)
Q Consensus 700 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~-~~kl~DFGla~~~~~~ 778 (845)
||+++|+|.++. +.+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+.....
T Consensus 112 e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCC
Confidence 999999997654 35899999999999999999999999 99999999999998655 6999999999876422
Q ss_pred CCCCccccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 003140 779 DIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKN 837 (845)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 837 (845)
.......+|..|+|||.+.+. .++.++||||+||++|||++|+.||....+
T Consensus 184 --------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~ 235 (328)
T d3bqca1 184 --------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235 (328)
T ss_dssp --------CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred --------CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch
Confidence 123445689999999998765 579999999999999999999999987654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-35 Score=323.63 Aligned_cols=197 Identities=25% Similarity=0.334 Sum_probs=160.5
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEee------CCe
Q 003140 624 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE------EGE 694 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~------~~~ 694 (845)
++|++.+.||+|+||+||+|.+. +|+.||||++.... ....+++.+|++++++++|||||++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999975 69999999987542 3345678999999999999999999999953 367
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003140 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (845)
Q Consensus 695 ~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~ 774 (845)
.++||||+.++ +.+.+. ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+|++|||+++.
T Consensus 97 ~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhc
Confidence 89999999755 444443 35889999999999999999999999 99999999999999999999999999876
Q ss_pred CCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
... ........+|+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 169 ~~~--------~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~ 222 (355)
T d2b1pa1 169 AGT--------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_dssp --------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccc--------ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC
Confidence 432 222345578999999999999999999999999999999999999997554
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-35 Score=323.93 Aligned_cols=198 Identities=25% Similarity=0.409 Sum_probs=166.7
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCC--hhhHHHHHHHHHHHHhcCCCceeeEEEEEee-----CCe
Q 003140 623 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-----EGE 694 (845)
Q Consensus 623 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-----~~~ 694 (845)
.++|++.+.||+|+||+||+|.. .+|+.||||+++... ....+++.+|++++++++|||||++++++.. ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46799999999999999999996 479999999987543 3345678999999999999999999999853 334
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003140 695 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (845)
Q Consensus 695 ~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~ 774 (845)
.++++||+.+|+|.++++. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+|..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcc
Confidence 5677788889999999954 35999999999999999999999999 99999999999999999999999999875
Q ss_pred CCCCCCCCccccceeecccCCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003140 775 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGK 836 (845)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 836 (845)
.. .......||..|+|||...+. .++.++||||+||++|||++|+.||.+.+
T Consensus 171 ~~----------~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~ 223 (348)
T d2gfsa1 171 TD----------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223 (348)
T ss_dssp CT----------GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cC----------cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC
Confidence 43 123345688999999987665 56889999999999999999999997654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=8.7e-31 Score=287.45 Aligned_cols=198 Identities=21% Similarity=0.259 Sum_probs=160.7
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCcEEEEEEccCCChhhHHHHHHHHHHHHhcC-----------CCceeeEEEEEee
Q 003140 624 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-----------HRNLVSLVGYCDE 691 (845)
Q Consensus 624 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~-----------H~nIv~l~g~~~~ 691 (845)
++|.+.+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|++++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3588999999999999999997 479999999997643 33457888999888875 5789999988754
Q ss_pred --CCeEEEEEEcCCCC-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCC-----
Q 003140 692 --EGEQMLVYEFMSNG-TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKF----- 762 (845)
Q Consensus 692 --~~~~~LV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDLk~~NILl~~~~----- 762 (845)
....++||+++..+ +............+++..+..++.||++||+|||+ .+ |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 45667777766544 34444444556678999999999999999999998 66 99999999999998665
Q ss_pred -cEEEEecCCcccCCCCCCCCccccceeecccCCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003140 763 -TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 835 (845)
Q Consensus 763 -~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 835 (845)
.++++|||.|+.... ......||+.|+|||++....++.++||||+||+++||++|+.||...
T Consensus 169 ~~~kl~dfg~s~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE----------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp EEEEECCCTTCEETTB----------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ceeeEeeccccccccc----------ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 499999999875432 123456999999999999999999999999999999999999999743
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=3.1e-31 Score=284.95 Aligned_cols=248 Identities=26% Similarity=0.467 Sum_probs=221.8
Q ss_pred CCccEEEecCCCCCC--CCcccccccccchhhhccC-CCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCE
Q 003140 106 SYLTILDFMWNKISG--SIPKEIGNIKSLELLLLNG-NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRH 182 (845)
Q Consensus 106 ~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 182 (845)
.+++.|+|++|+++| .+|.+|++|++|++|+|++ |+++|.+|..|++|++|++|+|++|++.+..+..+..+.+|+.
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence 479999999999998 5889999999999999997 8999999999999999999999999999999999999999999
Q ss_pred EEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCC-cEEEccCCcCCCCCCccccccCCCccEEEcccC
Q 003140 183 FHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKL-LILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261 (845)
Q Consensus 183 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L-~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N 261 (845)
+++++|.+.+.+|..+..++.|+.+++++|.+++.+|..+..+.++ +.+++++|++++ ..|..+.++..+ .+++++|
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~-~~~~~~~~l~~~-~l~l~~~ 207 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTG-KIPPTFANLNLA-FVDLSRN 207 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEE-ECCGGGGGCCCS-EEECCSS
T ss_pred cccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccc-cccccccccccc-ccccccc
Confidence 9999999999999999999999999999999999999999988876 899999999998 578888877655 7999999
Q ss_pred CCCCCCCC-CCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCChh
Q 003140 262 SLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSS 340 (845)
Q Consensus 262 ~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~ 340 (845)
.+.+..+. +..+++|+.+++++|.+++.+|......+|+.|+|++|+|+|.+|..|+++++|++|+|++|+|+|.+|.
T Consensus 208 ~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~- 286 (313)
T d1ogqa_ 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ- 286 (313)
T ss_dssp EEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-
T ss_pred cccccccccccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-
Confidence 99987775 7788999999999999998887766667999999999999999999999999999999999999999985
Q ss_pred hhhhccCCCCcceEEEccCCC
Q 003140 341 IWQSRTLNATETFILDFQNNN 361 (845)
Q Consensus 341 l~~l~~l~~~~l~~L~ls~N~ 361 (845)
+..+.. |+.+++++|+
T Consensus 287 ~~~L~~-----L~~l~l~~N~ 302 (313)
T d1ogqa_ 287 GGNLQR-----FDVSAYANNK 302 (313)
T ss_dssp STTGGG-----SCGGGTCSSS
T ss_pred cccCCC-----CCHHHhCCCc
Confidence 333333 3355555554
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.3e-25 Score=234.83 Aligned_cols=210 Identities=22% Similarity=0.239 Sum_probs=126.4
Q ss_pred CCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcc
Q 003140 180 TRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLR 259 (845)
Q Consensus 180 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls 259 (845)
+.+++.+++.|+ .+|..+. ++|++|+|++|+|++..+..|..+++|++|+|++|+|+. ++ .++.+++|+.|+|+
T Consensus 12 ~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~--l~-~~~~l~~L~~L~Ls 85 (266)
T d1p9ag_ 12 HLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK--LQ-VDGTLPVLGTLDLS 85 (266)
T ss_dssp CCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE--EE-CCSCCTTCCEEECC
T ss_pred CeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc--cc-cccccccccccccc
Confidence 333444444444 2343332 345555555555554444445555555555555555542 22 23455556666666
Q ss_pred cCCCCCCCCCCCCCCCccEEEcccccCCcCCCCCCC-ccccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCC
Q 003140 260 NCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRL-SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 338 (845)
Q Consensus 260 ~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~-~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip 338 (845)
+|+++..++.+..+++|+.|++++|.+.+..+..+. ..+++.|++++|.++...+..+..+++|+.|++++|+|++..+
T Consensus 86 ~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~ 165 (266)
T d1p9ag_ 86 HNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPA 165 (266)
T ss_dssp SSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCT
T ss_pred cccccccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCc
Confidence 666655555555566666666666666533333222 2256666666666666666666677777777777777776555
Q ss_pred hhhhhhccCCCCcceEEEccCCCCCCCCCCC-CCCCCcEEEecCCcccccCCCccccCCCCCC
Q 003140 339 SSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFCLNTNAEQFCGSHSDD 400 (845)
Q Consensus 339 ~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~-~~~~l~~l~l~~Np~~c~~~~~~~~~~~~~~ 400 (845)
..|..+. +|+.|+|++|+|+.+|..+ .++.++.|+|+||||.|||++.+|..|...+
T Consensus 166 ~~~~~l~-----~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~CdC~~~~l~~wl~~~ 223 (266)
T d1p9ag_ 166 GLLNGLE-----NLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEILYFRRWLQDN 223 (266)
T ss_dssp TTTTTCT-----TCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGGGHHHHHHHHHT
T ss_pred ccccccc-----ccceeecccCCCcccChhHCCCCCCCEEEecCCCCCCCcchHHHHHHHHhc
Confidence 5554433 3447777777777777654 5788899999999999999999988776433
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.93 E-value=4.4e-25 Score=243.05 Aligned_cols=276 Identities=28% Similarity=0.372 Sum_probs=208.3
Q ss_pred eEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecc
Q 003140 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162 (845)
Q Consensus 83 ~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 162 (845)
++++|++++++++.. +.++.|++|++|+|++|+|++ +| .|+++++|++|+|++|++++. + .++.+++|+.|+++
T Consensus 45 ~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~-l~-~l~~L~~L~~L~L~~n~i~~i-~-~l~~l~~L~~L~~~ 118 (384)
T d2omza2 45 QVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQIADI-T-PLANLTNLTGLTLF 118 (384)
T ss_dssp TCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECC
T ss_pred CCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCC-Cc-cccCCcccccccccccccccc-c-cccccccccccccc
Confidence 588999999988853 468889999999999999985 44 389999999999999999854 3 38889999999998
Q ss_pred cccccCCCC---------------------------------------------------------------ccccCccC
Q 003140 163 QNYISGSLP---------------------------------------------------------------KSFANLNK 179 (845)
Q Consensus 163 ~N~l~~~~p---------------------------------------------------------------~~~~~l~~ 179 (845)
+|.+++..+ ..+..+++
T Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 198 (384)
T d2omza2 119 NNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTN 198 (384)
T ss_dssp SSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccccccccccccccc
Confidence 887764211 23455677
Q ss_pred CCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcc
Q 003140 180 TRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLR 259 (845)
Q Consensus 180 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls 259 (845)
++.+++++|.+++..| +...++|++|++++|+++.. ..+..+++|+.|++++|.+++. ..+..+++|+.|+++
T Consensus 199 ~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~---~~~~~~~~L~~L~l~ 271 (384)
T d2omza2 199 LESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNL---APLSGLTKLTELKLG 271 (384)
T ss_dssp CSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCC---GGGTTCTTCSEEECC
T ss_pred cceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCC---CcccccccCCEeecc
Confidence 7888888888875543 45567888888888887742 3577778888888888888752 237777888888888
Q ss_pred cCCCCCCCCCCCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCCh
Q 003140 260 NCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPS 339 (845)
Q Consensus 260 ~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~ 339 (845)
+|++++.. .+..++.++.++++.|.+++ ++......+++.|++++|++++..+ +..+++|++|++++|+|++ +|
T Consensus 272 ~~~l~~~~-~~~~~~~l~~l~~~~n~l~~-~~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~-l~- 345 (384)
T d2omza2 272 ANQISNIS-PLAGLTALTNLELNENQLED-ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VS- 345 (384)
T ss_dssp SSCCCCCG-GGTTCTTCSEEECCSSCCSC-CGGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-CG-
T ss_pred CcccCCCC-cccccccccccccccccccc-ccccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCC-Ch-
Confidence 88887654 36677788888888888874 4444444578889999998887643 7888899999999998874 33
Q ss_pred hhhhhccCCCCcceEEEccCCCCCCCCCCCCCCCCcEEEecCC
Q 003140 340 SIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGN 382 (845)
Q Consensus 340 ~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~~~~~l~~l~l~~N 382 (845)
.+..+ ++|++|++++|+|+++++-..++.++.|+|++|
T Consensus 346 ~l~~l-----~~L~~L~l~~N~l~~l~~l~~l~~L~~L~L~~N 383 (384)
T d2omza2 346 SLANL-----TNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383 (384)
T ss_dssp GGGGC-----TTCCEEECCSSCCCBCGGGTTCTTCSEEECCCE
T ss_pred hHcCC-----CCCCEEECCCCcCCCChhhccCCCCCEeeCCCC
Confidence 45543 456689999999988876446888888888877
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.92 E-value=1.5e-24 Score=231.40 Aligned_cols=267 Identities=22% Similarity=0.334 Sum_probs=156.1
Q ss_pred eEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecc
Q 003140 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162 (845)
Q Consensus 83 ~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 162 (845)
+.+.++.++.+|+ .+|..+. ++|++|+|++|+|+...+.+|.++++|++|++++|.+....|..|.++++|++|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 3456777777777 4565553 567778888877775444567777777777777777776666677777777777777
Q ss_pred cccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCC
Q 003140 163 QNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTT 242 (845)
Q Consensus 163 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 242 (845)
+|+++ .+|..+ ...|+.|++.+|.+.+..+..+.....+..++...|..... ..
T Consensus 88 ~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~-----------------------~~ 141 (305)
T d1xkua_ 88 KNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS-----------------------GI 141 (305)
T ss_dssp SSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGG-----------------------GB
T ss_pred CCccC-cCccch--hhhhhhhhccccchhhhhhhhhhcccccccccccccccccc-----------------------CC
Confidence 77776 333322 23556666666666544444444445555555554432211 01
Q ss_pred CccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCCcCCCCCCCc-cccCEEEccCCcCCCCcccccCCCC
Q 003140 243 IPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLP 321 (845)
Q Consensus 243 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~ 321 (845)
.+..+..+++|+.+++++|+++..+..+ .++|+.|++++|.+++..+..+.. ..++.|++++|.+++..+..+.+++
T Consensus 142 ~~~~~~~l~~L~~l~l~~n~l~~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~ 219 (305)
T d1xkua_ 142 ENGAFQGMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP 219 (305)
T ss_dssp CTTGGGGCTTCCEEECCSSCCCSCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGST
T ss_pred CccccccccccCccccccCCccccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccc
Confidence 2233444445555555555544433222 345555555555555444433322 2455666666666655566666666
Q ss_pred CCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCCC--------CCCCCcEEEecCCcccc
Q 003140 322 RLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--------NIPPNVTVRLRGNPFCL 386 (845)
Q Consensus 322 ~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~--------~~~~l~~l~l~~Np~~c 386 (845)
+|++|+|++|+|+ .+|.++..++ +|++|+|++|+|+.++... ..+.+..++|+||||.+
T Consensus 220 ~L~~L~L~~N~L~-~lp~~l~~l~-----~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~ 286 (305)
T d1xkua_ 220 HLRELHLNNNKLV-KVPGGLADHK-----YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 286 (305)
T ss_dssp TCCEEECCSSCCS-SCCTTTTTCS-----SCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred cceeeeccccccc-cccccccccc-----CCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCcc
Confidence 6666666666666 4565554433 3346666666666665421 25677888889998754
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.92 E-value=2.4e-24 Score=229.77 Aligned_cols=266 Identities=24% Similarity=0.330 Sum_probs=206.8
Q ss_pred CCCCCCCcceEecCCCCC----CCcceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhh
Q 003140 61 DPCTSNWTGVLCFNTTMD----DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLL 136 (845)
Q Consensus 61 ~~c~~~w~Gv~C~~~~~~----~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 136 (845)
-.|.|.|++|.|.+.... .-...++.|+|++|+|+...+..|.++++|++|++++|.+....|..|.++++|++|+
T Consensus 6 ~~c~c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~ 85 (305)
T d1xkua_ 6 FRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY 85 (305)
T ss_dssp TTCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred CCCEecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEec
Confidence 458788999999764322 1246799999999999976667899999999999999999988888999999999999
Q ss_pred ccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCC--CCCccccCCCCCcceeecccccc
Q 003140 137 LNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSIS--GQIPPELSRLPSLVHMLLDNNNL 214 (845)
Q Consensus 137 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~l~~l~~L~~L~L~~N~l 214 (845)
|++|+++ .+|..+ ...|+.|++++|.+.+..+..+.....+..++...|... ...+..+..+++|+.+++++|++
T Consensus 86 l~~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l 162 (305)
T d1xkua_ 86 LSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 162 (305)
T ss_dssp CCSSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCC
T ss_pred ccCCccC-cCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCc
Confidence 9999999 566544 368999999999999877778888899999999988654 34456788889999999999998
Q ss_pred ccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCCC-CCCCCCccEEEcccccCCcCCCCC
Q 003140 215 TGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPG 293 (845)
Q Consensus 215 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~ip~~ 293 (845)
+. +|..+ +++|+.|++++|.+++ ..+..|.+++.++.|++++|.+++.++. +..+++|++|+|++|+|+ .+|..
T Consensus 163 ~~-l~~~~--~~~L~~L~l~~n~~~~-~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~ 237 (305)
T d1xkua_ 163 TT-IPQGL--PPSLTELHLDGNKITK-VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGG 237 (305)
T ss_dssp CS-CCSSC--CTTCSEEECTTSCCCE-ECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTT
T ss_pred cc-cCccc--CCccCEEECCCCcCCC-CChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccc
Confidence 84 45443 5789999999999886 5777888888999999999988886654 677788888888888887 45544
Q ss_pred CC-ccccCEEEccCCcCCCCccccc------CCCCCCCeEecccccCc
Q 003140 294 RL-SLNITTIKLSNNKLTGTIPSNF------SGLPRLQRLFIANNSLS 334 (845)
Q Consensus 294 ~~-~~~L~~L~Ls~N~l~~~~p~~~------~~l~~L~~L~L~~N~l~ 334 (845)
+. ..+|+.|+|++|+|+......| ..+.+|+.|+|++|+++
T Consensus 238 l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 238 LADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp TTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred cccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 33 2366666666666664433222 23455666666666654
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.7e-25 Score=236.24 Aligned_cols=250 Identities=17% Similarity=0.194 Sum_probs=151.5
Q ss_pred EecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecc-cccc
Q 003140 88 QLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID-QNYI 166 (845)
Q Consensus 88 ~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls-~N~l 166 (845)
+.++++++ .+|..+. +.+++|+|++|+|+...+..|.++++|++|++++|++....+..+..+..++.++.. .|.+
T Consensus 17 ~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~ 93 (284)
T d1ozna_ 17 SCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93 (284)
T ss_dssp ECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTC
T ss_pred EcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccccc
Confidence 44455555 4444443 456667777776665444556666667777777766666666666666666666543 4455
Q ss_pred cCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccc
Q 003140 167 SGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPAS 246 (845)
Q Consensus 167 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~ 246 (845)
+...+..|.++++|++|++++|.+....+..+...++|+.+++++|++++..+..|..+++|+.|+|++|++++ ..+..
T Consensus 94 ~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~-l~~~~ 172 (284)
T d1ozna_ 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS-VPERA 172 (284)
T ss_dssp CCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCE-ECTTT
T ss_pred ccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccc-cchhh
Confidence 55556666666677777777766665555566666667777777777665555566666667777777776664 34556
Q ss_pred cccCCCccEEEcccCCCCCCCC-CCCCCCCccEEEcccccCCcCCCCCCC-ccccCEEEccCCcCCCCcccccCCCCCCC
Q 003140 247 YSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRL-SLNITTIKLSNNKLTGTIPSNFSGLPRLQ 324 (845)
Q Consensus 247 ~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~ip~~~~-~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 324 (845)
|.++++|+.+++++|++++..+ .|..+++|++|++++|.+.+..+..+. ..+|+.|+|++|.+...-+. ..-...++
T Consensus 173 f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~-~~l~~~l~ 251 (284)
T d1ozna_ 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQ 251 (284)
T ss_dssp TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHHHHH
T ss_pred hccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc-hHHHHHHH
Confidence 6666677777777776666544 366666677777777776654444332 23567777777766543221 00112344
Q ss_pred eEecccccCcccCChhhh
Q 003140 325 RLFIANNSLSGSIPSSIW 342 (845)
Q Consensus 325 ~L~L~~N~l~~~ip~~l~ 342 (845)
.+....+++....|..+.
T Consensus 252 ~~~~~~~~~~C~~p~~l~ 269 (284)
T d1ozna_ 252 KFRGSSSEVPCSLPQRLA 269 (284)
T ss_dssp HCCSEECCCBEEESGGGT
T ss_pred hCcCCCCceEeCCchHHc
Confidence 555566666666666654
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.5e-24 Score=228.95 Aligned_cols=234 Identities=18% Similarity=0.250 Sum_probs=135.7
Q ss_pred EEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEcc-CC
Q 003140 110 ILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMN-NN 188 (845)
Q Consensus 110 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~-~N 188 (845)
.++.++++++ .+|..+. +++++|+|++|+|+...+..|.++++|++|++++|++....+..+.++..++.+... .|
T Consensus 15 ~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp EEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred EEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 4566666666 5665543 456777777777764444556667777777777777666556666666666665543 34
Q ss_pred CCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCC
Q 003140 189 SISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP 268 (845)
Q Consensus 189 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 268 (845)
.++...+..+.++++|++|++++|.+....+..+..+++|+.+++++|++++ ..+..|.
T Consensus 92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~-i~~~~f~-------------------- 150 (284)
T d1ozna_ 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA-LPDDTFR-------------------- 150 (284)
T ss_dssp TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTT--------------------
T ss_pred ccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccc-cChhHhc--------------------
Confidence 4444444455555555555555555554444444444445555555544443 2223333
Q ss_pred CCCCCCCccEEEcccccCCcCCCCCCC-ccccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCChhhhhhccC
Q 003140 269 DLSRIPNLGYLDLSSNQLNGSIPPGRL-SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 347 (845)
Q Consensus 269 ~l~~l~~L~~L~Ls~N~l~~~ip~~~~-~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l 347 (845)
.+++|+.|++++|++++..+..+. ..+|+.|++++|++++..|..|.++++|++|++++|++.+..|..|..
T Consensus 151 ---~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~---- 223 (284)
T d1ozna_ 151 ---DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAP---- 223 (284)
T ss_dssp ---TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTT----
T ss_pred ---cccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccccccccccccccccccc----
Confidence 344444444444444422222221 124455555555555555666777777777777777777555555533
Q ss_pred CCCcceEEEccCCCCCCCCCCCCCCCCcEEEecCCcccccCCCccccCCC
Q 003140 348 NATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSH 397 (845)
Q Consensus 348 ~~~~l~~L~ls~N~l~~i~~~~~~~~l~~l~l~~Np~~c~~~~~~~~~~~ 397 (845)
++.++.|++++|||.|||++.++-.|.
T Consensus 224 -----------------------~~~L~~L~l~~N~l~C~C~~~~l~~~l 250 (284)
T d1ozna_ 224 -----------------------LRALQYLRLNDNPWVCDCRARPLWAWL 250 (284)
T ss_dssp -----------------------CTTCCEEECCSSCEECSGGGHHHHHHH
T ss_pred -----------------------ccccCEEEecCCCCCCCccchHHHHHH
Confidence 456678899999999999988877666
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.90 E-value=6.4e-23 Score=225.51 Aligned_cols=274 Identities=27% Similarity=0.327 Sum_probs=219.6
Q ss_pred EecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeeccccccc
Q 003140 88 QLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYIS 167 (845)
Q Consensus 88 ~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 167 (845)
.+...++++.+. ...+.+|++|++++|+|+. + +.+..+++|++|+|++|+|++. | .++++++|++|+|++|+++
T Consensus 28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i~ 101 (384)
T d2omza2 28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIA 101 (384)
T ss_dssp HTTCSSTTSEEC--HHHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC
T ss_pred HhCCCCCCCccC--HHHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCC-c-cccCCcccccccccccccc
Confidence 445556665543 3567889999999999984 4 4689999999999999999954 4 3999999999999999998
Q ss_pred CCCCccccCccCCCEEEccCCCCCCCC-----------------------------------------------------
Q 003140 168 GSLPKSFANLNKTRHFHMNNNSISGQI----------------------------------------------------- 194 (845)
Q Consensus 168 ~~~p~~~~~l~~L~~L~L~~N~l~~~~----------------------------------------------------- 194 (845)
+..+ ++++++|+.|++++|.+++..
T Consensus 102 ~i~~--l~~l~~L~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (384)
T d2omza2 102 DITP--LANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLER 179 (384)
T ss_dssp CCGG--GTTCTTCCEEECCSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCE
T ss_pred cccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccc
Confidence 6543 889999999999998876321
Q ss_pred ----------ccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCC
Q 003140 195 ----------PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264 (845)
Q Consensus 195 ----------p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~ 264 (845)
...+..+++++.+++++|.+++..| +..+++|++|++++|++++ + ..+..+++|+.|++++|+++
T Consensus 180 ~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~--~-~~l~~l~~L~~L~l~~n~l~ 254 (384)
T d2omza2 180 LDISSNKVSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--I-GTLASLTNLTDLDLANNQIS 254 (384)
T ss_dssp EECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC--C-GGGGGCTTCSEEECCSSCCC
T ss_pred ccccccccccccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC--c-chhhcccccchhccccCccC
Confidence 1234456778889999999886644 4567889999999999874 2 46888999999999999998
Q ss_pred CCCCCCCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCChhhhhh
Q 003140 265 GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS 344 (845)
Q Consensus 265 ~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l 344 (845)
+.++ +..+++|+.|++++|.+++ ++.......++.+++++|++++. ..+..+++++.|++++|++++..| +..+
T Consensus 255 ~~~~-~~~~~~L~~L~l~~~~l~~-~~~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~~--l~~l 328 (384)
T d2omza2 255 NLAP-LSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDISP--VSSL 328 (384)
T ss_dssp CCGG-GTTCTTCSEEECCSSCCCC-CGGGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCGG--GGGC
T ss_pred CCCc-ccccccCCEeeccCcccCC-CCccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCcc--cccC
Confidence 7654 7888999999999999984 44455556889999999999863 458889999999999999996533 4443
Q ss_pred ccCCCCcceEEEccCCCCCCCCCCCCCCCCcEEEecCCccc
Q 003140 345 RTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 385 (845)
Q Consensus 345 ~~l~~~~l~~L~ls~N~l~~i~~~~~~~~l~~l~l~~Np~~ 385 (845)
++|+.|++++|+|+.++.-..++.+++|++++|++.
T Consensus 329 -----~~L~~L~L~~n~l~~l~~l~~l~~L~~L~l~~N~l~ 364 (384)
T d2omza2 329 -----TKLQRLFFANNKVSDVSSLANLTNINWLSAGHNQIS 364 (384)
T ss_dssp -----TTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCC
T ss_pred -----CCCCEEECCCCCCCCChhHcCCCCCCEEECCCCcCC
Confidence 456799999999999885446999999999999875
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=1.3e-22 Score=211.76 Aligned_cols=196 Identities=26% Similarity=0.226 Sum_probs=139.1
Q ss_pred eEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccc
Q 003140 85 RELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164 (845)
Q Consensus 85 ~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 164 (845)
.+++.++++|+ .+|+.+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+ .+| .++.+++|++|+|++|
T Consensus 13 ~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N 87 (266)
T d1p9ag_ 13 LEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHN 87 (266)
T ss_dssp CEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSS
T ss_pred eEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-cccccccccccccccc
Confidence 44577777777 4676664 57888888888888665667888888888888888887 444 3567788888888888
Q ss_pred cccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCc
Q 003140 165 YISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP 244 (845)
Q Consensus 165 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p 244 (845)
+++ ..+..+.++++|+.|++++|.+....+..+..+.++++|++++|.++...+..+..+++|+.|++++|++++ ..+
T Consensus 88 ~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~-~~~ 165 (266)
T d1p9ag_ 88 QLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE-LPA 165 (266)
T ss_dssp CCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC-CCT
T ss_pred ccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccc-cCc
Confidence 877 446667777777777777777776666667777777777777777776656666667777777777777765 345
Q ss_pred cccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCC
Q 003140 245 ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLN 287 (845)
Q Consensus 245 ~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~ 287 (845)
..|..+++|++|+|++|+|+..++++..+++|+.|+|++|.+.
T Consensus 166 ~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 166 GLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBC
T ss_pred cccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCC
Confidence 5566667777777777776655555666666666666666654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=7.8e-23 Score=202.11 Aligned_cols=163 Identities=14% Similarity=0.138 Sum_probs=120.3
Q ss_pred CCCccccccCceEEEEEEeCCCcEEEEEEccCCCh------------------hhHHHHHHHHHHHHhcCCCceeeEEEE
Q 003140 627 NSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL------------------QGEKEFLTEIQFLSRLHHRNLVSLVGY 688 (845)
Q Consensus 627 ~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~------------------~~~~~~~~Ei~~l~~l~H~nIv~l~g~ 688 (845)
.+.+.||+|+||.||+|...+|+.||||+++.... .....+..|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 34678999999999999998999999998653211 011345678899999999999998866
Q ss_pred EeeCCeEEEEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEe
Q 003140 689 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 768 (845)
Q Consensus 689 ~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLk~~NILl~~~~~~kl~D 768 (845)
.. .++||||++++.+.+ ++......++.|++++++|||+++ |+||||||+|||++++ .++|+|
T Consensus 83 ~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECC
T ss_pred cC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEE
Confidence 32 369999998765432 233445678999999999999999 9999999999999965 589999
Q ss_pred cCCcccCCCCCCCCccccceeecccCCCCccch------hhhcCCCCCchhhHHHHHHHH
Q 003140 769 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP------EYFLTHKLTDKSDVYSLGVVF 822 (845)
Q Consensus 769 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DvwS~Gvvl 822 (845)
||+|+....+.. ..|... |.+ ...|+.++|+||..--+
T Consensus 146 FG~a~~~~~~~~---------------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGW---------------REILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTH---------------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCc---------------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 999976543221 011111 111 35678889999986544
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.78 E-value=3.7e-19 Score=180.49 Aligned_cols=204 Identities=20% Similarity=0.334 Sum_probs=112.1
Q ss_pred cEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCC
Q 003140 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN 188 (845)
Q Consensus 109 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 188 (845)
..++++.+++++.+ .+..+++|+.|++.+|+++ .+ ..+..+++|++|+|++|++++..| +..+++|+++++++|
T Consensus 22 ~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n 95 (227)
T d1h6ua2 22 IKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGN 95 (227)
T ss_dssp HHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSC
T ss_pred HHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-cc-hhHhcCCCCcEeecCCceeecccc--ccccccccccccccc
Confidence 33445555555432 3445556666666666665 23 235566666666666666654332 556666666666666
Q ss_pred CCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCC
Q 003140 189 SISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP 268 (845)
Q Consensus 189 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 268 (845)
.++ .++ .+..+++|+++++++|...+. ..+...+.+..+.++.+.+.. ...+.++++|+.|++++|.++...
T Consensus 96 ~~~-~i~-~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~---~~~~~~~~~L~~L~l~~n~~~~~~- 167 (227)
T d1h6ua2 96 PLK-NVS-AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITN---ISPLAGLTNLQYLSIGNAQVSDLT- 167 (227)
T ss_dssp CCS-CCG-GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCC---CGGGGGCTTCCEEECCSSCCCCCG-
T ss_pred ccc-ccc-ccccccccccccccccccccc--chhccccchhhhhchhhhhch---hhhhccccccccccccccccccch-
Confidence 655 222 355566666666666655532 234555666666666666542 223555666666666666665432
Q ss_pred CCCCCCCccEEEcccccCCcCCCCCCCccccCEEEccCCcCCCCcccccCCCCCCCeEecc
Q 003140 269 DLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 329 (845)
Q Consensus 269 ~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 329 (845)
.+..+++|+.|+|++|++++ ++......+|++|+|++|+|+... .+.++++|++|+|+
T Consensus 168 ~l~~l~~L~~L~Ls~n~l~~-l~~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 168 PLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLT 225 (227)
T ss_dssp GGTTCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEE
T ss_pred hhcccccceecccCCCccCC-ChhhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEee
Confidence 25556666666666666652 333222335566666666555432 25566666666665
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.76 E-value=6.1e-17 Score=174.54 Aligned_cols=264 Identities=27% Similarity=0.308 Sum_probs=170.8
Q ss_pred eEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecc
Q 003140 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162 (845)
Q Consensus 83 ~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 162 (845)
++++|+|++++|+ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.. .+.|++|+|+
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence 4778999999998 46753 468999999999999 778654 47888889999988 45432 1469999999
Q ss_pred cccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCC-
Q 003140 163 QNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT- 241 (845)
Q Consensus 163 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~- 241 (845)
+|.++ .+|. ++.+++|+.|++++|.+... +.. ...+..+.+..+.... ...+..++.++.|++++|.+...
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~-~~~---~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~~n~~~~~~ 178 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKKL-PDL---PPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSLKKLP 178 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSS--CCCCTTCTTCCEEECCSSCCSSCC
T ss_pred ccccc-cccc-hhhhccceeecccccccccc-ccc---cccccchhhccccccc--cccccccccceecccccccccccc
Confidence 99998 4554 67899999999999988733 222 2344555555444432 23455556666666666554421
Q ss_pred ----------------CCccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCCcCCCCCCC----------
Q 003140 242 ----------------TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRL---------- 295 (845)
Q Consensus 242 ----------------~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ip~~~~---------- 295 (845)
.....+..++.|+.+++++|.....+. ...++..+.+++|.+... +....
T Consensus 179 ~~~~~~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~---~~~~l~~~~~~~~~~~~~-~~~~~~l~~~~~~~~ 254 (353)
T d1jl5a_ 179 DLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPD---LPPSLEALNVRDNYLTDL-PELPQSLTFLDVSEN 254 (353)
T ss_dssp CCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCS---CCTTCCEEECCSSCCSCC-CCCCTTCCEEECCSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccc-ccccccccccccccc
Confidence 011224556677777777776654432 223455556666655422 11100
Q ss_pred --------ccccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCC
Q 003140 296 --------SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 367 (845)
Q Consensus 296 --------~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~ 367 (845)
.......++..|.+. .....+++|++|+|++|+|+ .+|..+ ++|+.|+|++|+|+++|.
T Consensus 255 ~~~~l~~l~~~~~~~~~~~~~~~----~~~~~~~~L~~L~Ls~N~l~-~lp~~~--------~~L~~L~L~~N~L~~l~~ 321 (353)
T d1jl5a_ 255 IFSGLSELPPNLYYLNASSNEIR----SLCDLPPSLEELNVSNNKLI-ELPALP--------PRLERLIASFNHLAEVPE 321 (353)
T ss_dssp CCSEESCCCTTCCEEECCSSCCS----EECCCCTTCCEEECCSSCCS-CCCCCC--------TTCCEEECCSSCCSCCCC
T ss_pred cccccccccchhcccccccCccc----cccccCCCCCEEECCCCccC-cccccc--------CCCCEEECCCCcCCcccc
Confidence 002233333333333 22234678999999999988 677542 456789999999998876
Q ss_pred CCCCCCCcEEEecCCccc
Q 003140 368 SFNIPPNVTVRLRGNPFC 385 (845)
Q Consensus 368 ~~~~~~l~~l~l~~Np~~ 385 (845)
. ++++++|++++|++.
T Consensus 322 ~--~~~L~~L~L~~N~L~ 337 (353)
T d1jl5a_ 322 L--PQNLKQLHVEYNPLR 337 (353)
T ss_dssp C--CTTCCEEECCSSCCS
T ss_pred c--cCCCCEEECcCCcCC
Confidence 4 457889999999864
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=1.1e-17 Score=169.54 Aligned_cols=193 Identities=19% Similarity=0.302 Sum_probs=122.2
Q ss_pred cccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcce
Q 003140 127 GNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVH 206 (845)
Q Consensus 127 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 206 (845)
..+.++..++++.+++++.+ .+..+.+|++|++.+|.|+. + ..+..+++|++|++++|++++..| +..+++|++
T Consensus 16 ~~l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~ 89 (227)
T d1h6ua2 16 PALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITE 89 (227)
T ss_dssp HHHHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCE
T ss_pred HHHHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc--ccccccccc
Confidence 34566677888888888643 45678888899999888884 3 357888888888888888875433 777888888
Q ss_pred eeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccC
Q 003140 207 MLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQL 286 (845)
Q Consensus 207 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l 286 (845)
+++++|.++. + ..+..+++|+.|+++++...+ ...+...+.+..+.++.+.+.... .+...++|+.|++++|.+
T Consensus 90 l~~~~n~~~~-i-~~l~~l~~L~~l~l~~~~~~~---~~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~L~~L~l~~n~~ 163 (227)
T d1h6ua2 90 LELSGNPLKN-V-SAIAGLQSIKTLDLTSTQITD---VTPLAGLSNLQVLYLDLNQITNIS-PLAGLTNLQYLSIGNAQV 163 (227)
T ss_dssp EECCSCCCSC-C-GGGTTCTTCCEEECTTSCCCC---CGGGTTCTTCCEEECCSSCCCCCG-GGGGCTTCCEEECCSSCC
T ss_pred cccccccccc-c-ccccccccccccccccccccc---cchhccccchhhhhchhhhhchhh-hhcccccccccccccccc
Confidence 8888887773 2 357777788888887777654 234555666777777766665432 244555666666666665
Q ss_pred CcCCCCCCCccccCEEEccCCcCCCCcccccCCCCCCCeEecccccCc
Q 003140 287 NGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 334 (845)
Q Consensus 287 ~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 334 (845)
++. +......+|+.|+|++|++++. + .++++++|++|+|++|+++
T Consensus 164 ~~~-~~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt 208 (227)
T d1h6ua2 164 SDL-TPLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQIS 208 (227)
T ss_dssp CCC-GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCC
T ss_pred ccc-hhhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCC
Confidence 522 2222223455555555554432 1 2444444555555554444
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=1.2e-17 Score=170.82 Aligned_cols=199 Identities=17% Similarity=0.172 Sum_probs=105.3
Q ss_pred cEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCC-CccccCccCCCEEEccC
Q 003140 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSL-PKSFANLNKTRHFHMNN 187 (845)
Q Consensus 109 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~ 187 (845)
+.++.++++++ .+|..+. +++++|+|++|+|+...+..|.++++|++|+|++|.+...+ +..|.+++++++|.+..
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 46777777777 5665543 46677777777776444445667777777777777665443 33456666666666543
Q ss_pred -CCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCC
Q 003140 188 -NSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGP 266 (845)
Q Consensus 188 -N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 266 (845)
|++....+..|..+++|++|++++|++....+ ...+..+..|..+...++.+...
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~------------------------~~~~~~l~~l~~~~~~n~~l~~i 143 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPD------------------------VHKIHSLQKVLLDIQDNINIHTI 143 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCC------------------------CTTTCBSSCEEEEEESCTTCCEE
T ss_pred cccccccccccccccccccccccchhhhccccc------------------------ccccccccccccccccccccccc
Confidence 45554445555556666666666665553211 11222333333333344444332
Q ss_pred CC-CCCCC-CCccEEEcccccCCcCCCCCCCccccCEE-EccCCcCCCCcccccCCCCCCCeEecccccCc
Q 003140 267 MP-DLSRI-PNLGYLDLSSNQLNGSIPPGRLSLNITTI-KLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 334 (845)
Q Consensus 267 ~~-~l~~l-~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L-~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 334 (845)
.+ .+..+ ..++.|++++|+++...+..+...++..+ ++++|+|+...+..|.++++|++|+|++|+|+
T Consensus 144 ~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~ 214 (242)
T d1xwdc1 144 ERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 214 (242)
T ss_dssp CTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCC
T ss_pred cccccccccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCC
Confidence 22 12222 24555555555555322222222333333 34555565444455666777777777777766
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.72 E-value=2.4e-18 Score=169.60 Aligned_cols=128 Identities=23% Similarity=0.280 Sum_probs=82.8
Q ss_pred eEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCC-cccccccccchhhhccCCCCCCCCCCccCCCCccceeeccc
Q 003140 85 RELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSI-PKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQ 163 (845)
Q Consensus 85 ~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 163 (845)
+.+++++++|+ .+|..+. +++++|+|++|+|++.+ +..|.++++|++|+|++|++.+..+..|..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 35777777777 4565553 56777777777776533 44566677777777777777766666666677777777777
Q ss_pred ccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccc
Q 003140 164 NYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT 215 (845)
Q Consensus 164 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 215 (845)
|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|.+.
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccc
Confidence 7766555666666666666666666666555555555555555555555554
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=8.8e-18 Score=171.83 Aligned_cols=207 Identities=20% Similarity=0.268 Sum_probs=151.6
Q ss_pred ecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCC-CCccCCCCccceeeccc-ccc
Q 003140 89 LLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSL-PEELGYLPKLDRIQIDQ-NYI 166 (845)
Q Consensus 89 L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~-N~l 166 (845)
.++.+++ .+|+.+. +++++|+|++|+|+...+..|.++++|++|+|++|.+...+ +..|..++++++|.+.. |++
T Consensus 15 c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l 91 (242)
T d1xwdc1 15 CQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNL 91 (242)
T ss_dssp EESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTC
T ss_pred EeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccc
Confidence 3344555 5665553 57889999999998655567888999999999999887654 44678889999988764 678
Q ss_pred cCCCCccccCccCCCEEEccCCCCCCCCc-cccCCCCCcceeeccccccccCCCcccCCCC-CCcEEEccCCcCCCCCCc
Q 003140 167 SGSLPKSFANLNKTRHFHMNNNSISGQIP-PELSRLPSLVHMLLDNNNLTGYLPPELSELP-KLLILQLDNNNFEGTTIP 244 (845)
Q Consensus 167 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~~p 244 (845)
....+..|.++++|+.|++++|.+....+ ..+..++.+..+..+++++....+..|..++ .++.|++++|+++. ++
T Consensus 92 ~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~--i~ 169 (242)
T d1xwdc1 92 LYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE--IH 169 (242)
T ss_dssp CEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE--EC
T ss_pred cccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc--cc
Confidence 77778888999999999999998874432 2345566777777788888866666777664 78889999999974 44
Q ss_pred cccccCCCccEE-EcccCCCCCCCCC-CCCCCCccEEEcccccCCcCCCCCCCccccCEE
Q 003140 245 ASYSNMSKLLKL-SLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTI 302 (845)
Q Consensus 245 ~~~~~l~~L~~L-~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~L~~L 302 (845)
....+..+++.+ ++++|+++..++. |..+++|++|+|++|+|+ .+|...+ .+|..|
T Consensus 170 ~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~-~~l~~L 227 (242)
T d1xwdc1 170 NCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGL-ENLKKL 227 (242)
T ss_dssp TTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCC-CCCSSSC-TTCCEE
T ss_pred cccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCC-ccCHHHH-cCCccc
Confidence 444455665555 5678888887664 788999999999999998 5665432 234444
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=2.5e-17 Score=164.59 Aligned_cols=186 Identities=24% Similarity=0.324 Sum_probs=112.4
Q ss_pred ccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeec
Q 003140 130 KSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLL 209 (845)
Q Consensus 130 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 209 (845)
.++...+++.+.+++.++. ..+.+|++|++++|.+++.. .+..+++|++|+|++|+|++. + .++.+++|++|++
T Consensus 24 ~~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l 97 (210)
T d1h6ta2 24 AETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFL 97 (210)
T ss_dssp HHHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEEC
T ss_pred HHHHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCc-c-ccccCcccccccc
Confidence 3444556666666654432 24566777777777766432 356667777777777777643 2 2566677777777
Q ss_pred cccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCCcC
Q 003140 210 DNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGS 289 (845)
Q Consensus 210 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ 289 (845)
++|++++ ++ .+..+++|+.|++++|.+.. ...+..+++|+.+++++|.+++.. .+..+++|+.+++++|++++
T Consensus 98 ~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~---~~~l~~l~~l~~l~~~~n~l~~~~-~~~~l~~L~~l~l~~n~l~~- 170 (210)
T d1h6ta2 98 DENKVKD-LS-SLKDLKKLKSLSLEHNGISD---INGLVHLPQLESLYLGNNKITDIT-VLSRLTKLDTLSLEDNQISD- 170 (210)
T ss_dssp CSSCCCC-GG-GGTTCTTCCEEECTTSCCCC---CGGGGGCTTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCC-
T ss_pred ccccccc-cc-cccccccccccccccccccc---cccccccccccccccccccccccc-cccccccccccccccccccc-
Confidence 7777764 22 46667777777777776642 234666677777777777765432 34556666666666666663
Q ss_pred CCCCCCccccCEEEccCCcCCCCcccccCCCCCCCeEeccc
Q 003140 290 IPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIAN 330 (845)
Q Consensus 290 ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 330 (845)
++......+|+.|+|++|+|+. ++ .+.++++|++|+|++
T Consensus 171 i~~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 171 IVPLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp CGGGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred cccccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 3332233456666666666653 33 466777777777653
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.70 E-value=8.4e-18 Score=165.58 Aligned_cols=172 Identities=16% Similarity=0.227 Sum_probs=89.6
Q ss_pred chhhhccCCCCCCCCCCccCCCCccceeecccccccCCC-CccccCccCCCEEEccCCCCCCCCccccCCCCCcceeecc
Q 003140 132 LELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSL-PKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLD 210 (845)
Q Consensus 132 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 210 (845)
.+++++++|+++ .+|..+. +++++|+|++|+|++.+ +..|.++++|+.|+|++|++....+..+..+++|++|+|+
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 345666667666 5565543 45666666666665433 3445555555555555555555555555555555555555
Q ss_pred ccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCCC-CCCCCCccEEEcccccCCcC
Q 003140 211 NNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGS 289 (845)
Q Consensus 211 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~ 289 (845)
+|+|+...+..|.++++|++|+|++|+| ++.++. |..+++|++|+|++|.+...
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l-------------------------~~i~~~~f~~l~~L~~l~L~~N~~~~~ 141 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQI-------------------------SCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCC-------------------------CEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred cccccccCHHHHhCCCcccccccCCccc-------------------------cccCHHHhcCCcccccccccccccccc
Confidence 5555544444455555555555555555 444332 44555555555555555533
Q ss_pred CCCCCCccccCEEEccCCcCCCCcccccCCCCCCCeEecccccCc
Q 003140 290 IPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 334 (845)
Q Consensus 290 ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 334 (845)
.+..+....++.+.+..|.++...|..+ ..++.++|+.|.++
T Consensus 142 ~~~~~~~~~l~~~~l~~~~~~c~~p~~l---~~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 142 CHLAWFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEFK 183 (192)
T ss_dssp GGGHHHHHHHHHHCCSGGGCBBCSSTTT---TTSBGGGSCTTTCC
T ss_pred cchHHHhhhhhhhcccCCCeEeCCChhh---cCCEeeecCHhhCc
Confidence 3222222234444455555555445433 33445555555554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=2.5e-17 Score=164.52 Aligned_cols=178 Identities=28% Similarity=0.405 Sum_probs=102.5
Q ss_pred ecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccC
Q 003140 89 LLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISG 168 (845)
Q Consensus 89 L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 168 (845)
+....+++.++. ..|.+|++|++++|.+++ ++ .+..+++|++|+|++|++++. + .++.+++|++|++++|+|++
T Consensus 31 l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~ 104 (210)
T d1h6ta2 31 LKKKSVTDAVTQ--NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKD 104 (210)
T ss_dssp TTCSCTTSEECH--HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC
T ss_pred hCcCccCCccCH--HHhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCc-c-ccccCccccccccccccccc
Confidence 444444443321 235566666777666663 22 356666677777777666642 2 25566666666666666663
Q ss_pred CCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccc
Q 003140 169 SLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYS 248 (845)
Q Consensus 169 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~ 248 (845)
++ .+.++++|+.|++++|.+.. + ..+..++.|+.+++++|.+++. ..+..+++|+++++++|++++ ++ .+.
T Consensus 105 -l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~--i~-~l~ 175 (210)
T d1h6ta2 105 -LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD--IV-PLA 175 (210)
T ss_dssp -GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC--CG-GGT
T ss_pred -cc-cccccccccccccccccccc-c-cccccccccccccccccccccc--ccccccccccccccccccccc--cc-ccc
Confidence 33 35666666666666666652 2 2455666666666666666532 345556666666666666653 22 255
Q ss_pred cCCCccEEEcccCCCCCCCCCCCCCCCccEEEcc
Q 003140 249 NMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLS 282 (845)
Q Consensus 249 ~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls 282 (845)
++++|+.|+|++|+++.. +.+..+++|++|+|+
T Consensus 176 ~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 176 GLTKLQNLYLSKNHISDL-RALAGLKNLDVLELF 208 (210)
T ss_dssp TCTTCCEEECCSSCCCBC-GGGTTCTTCSEEEEE
T ss_pred CCCCCCEEECCCCCCCCC-hhhcCCCCCCEEEcc
Confidence 666666666666666543 345566666666654
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=5.2e-17 Score=160.78 Aligned_cols=147 Identities=25% Similarity=0.361 Sum_probs=83.8
Q ss_pred cccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceee
Q 003140 129 IKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHML 208 (845)
Q Consensus 129 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 208 (845)
+.++..+.++.+.+++.++ ...+.+|++|++++|.++.. +.+..+++|++|++++|++++..+ +.++++|++|+
T Consensus 17 l~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~ 90 (199)
T d2omxa2 17 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDIL 90 (199)
T ss_dssp HHHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred HHHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccc
Confidence 4445556666666664432 23456666677776666632 235566666666666666664322 56666666666
Q ss_pred ccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCC
Q 003140 209 LDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLN 287 (845)
Q Consensus 209 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~ 287 (845)
+++|.+... + .+..+++|+.|++++|.+.. ...+..+++|+.|++++|++... +.+..+++|+.|++++|+++
T Consensus 91 l~~n~~~~~-~-~l~~l~~L~~L~l~~~~~~~---~~~~~~l~~L~~L~l~~n~l~~~-~~l~~~~~L~~L~l~~n~l~ 163 (199)
T d2omxa2 91 MNNNQIADI-T-PLANLTNLTGLTLFNNQITD---IDPLKNLTNLNRLELSSNTISDI-SALSGLTSLQQLNFSSNQVT 163 (199)
T ss_dssp CCSSCCCCC-G-GGTTCTTCSEEECCSSCCCC---CGGGTTCTTCSEEECCSSCCCCC-GGGTTCTTCSEEECCSSCCC
T ss_pred ccccccccc-c-cccccccccccccccccccc---ccccchhhhhHHhhhhhhhhccc-cccccccccccccccccccc
Confidence 666666532 2 35666666666666666643 12355566666666666665532 23555555555555555555
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=7.8e-17 Score=159.49 Aligned_cols=147 Identities=28% Similarity=0.428 Sum_probs=66.2
Q ss_pred cccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceee
Q 003140 129 IKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHML 208 (845)
Q Consensus 129 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 208 (845)
+.+|++|++++|.++ .+ +.+..+++|++|+|++|++++..| +.++++|++|++++|.+.. ++ .+.+++.|+.|+
T Consensus 39 l~~l~~L~l~~~~i~-~l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~ 112 (199)
T d2omxa2 39 LDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLT 112 (199)
T ss_dssp HTTCCEEECTTSCCC-CC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEE
T ss_pred hcCCCEEECCCCCCC-Cc-cccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-cccccccccccc
Confidence 334444444444444 12 123444444444444444443221 4444444444444444432 22 244445555555
Q ss_pred ccccccccCCCcccCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCCCCCCCCCccEEEcccccCC
Q 003140 209 LDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLN 287 (845)
Q Consensus 209 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~ 287 (845)
+++|.+... ..+..+++|+.|++++|++.. + ..+..+++|+.|++++|++++.. .+..+++|+.|++++|+++
T Consensus 113 l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~--~-~~l~~~~~L~~L~l~~n~l~~l~-~l~~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 113 LFNNQITDI--DPLKNLTNLNRLELSSNTISD--I-SALSGLTSLQQLNFSSNQVTDLK-PLANLTTLERLDISSNKVS 185 (199)
T ss_dssp CCSSCCCCC--GGGTTCTTCSEEECCSSCCCC--C-GGGTTCTTCSEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCC
T ss_pred ccccccccc--cccchhhhhHHhhhhhhhhcc--c-ccccccccccccccccccccCCc-cccCCCCCCEEECCCCCCC
Confidence 555444422 234445555555555555532 1 23445555555555555555432 2444455555555555444
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.69 E-value=2.1e-15 Score=162.34 Aligned_cols=261 Identities=28% Similarity=0.330 Sum_probs=172.3
Q ss_pred CcceEeEEEecCCCCcccCCCCccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCcccee
Q 003140 80 GYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRI 159 (845)
Q Consensus 80 ~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 159 (845)
...+++.|+|++|+|+ .+|..+ .+|++|++++|+++ .++. +. +.|++|+|++|.+. .+|. ++.+++|+.|
T Consensus 56 ~~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~-lp--~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L 125 (353)
T d1jl5a_ 56 LPPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD-LP--PLLEYLGVSNNQLE-KLPE-LQNSSFLKII 125 (353)
T ss_dssp CCTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS-CC--TTCCEEECCSSCCS-SCCC-CTTCTTCCEE
T ss_pred CCCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh-hc--cccccccccccccc-cccc-hhhhccceee
Confidence 3457899999999999 567554 57899999999988 4442 21 46999999999998 6664 6889999999
Q ss_pred ecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccC------------------CCcc
Q 003140 160 QIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGY------------------LPPE 221 (845)
Q Consensus 160 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~------------------~p~~ 221 (845)
++++|.++... .. ...+..+.+..+... ....+..++.++.|++++|.+... ....
T Consensus 126 ~l~~~~~~~~~-~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~~l~~~~~~~~~~~~ 199 (353)
T d1jl5a_ 126 DVDNNSLKKLP-DL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPE 199 (353)
T ss_dssp ECCSSCCSCCC-CC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSSCCC
T ss_pred ccccccccccc-cc---cccccchhhcccccc--ccccccccccceeccccccccccccccccccccccccccccccccc
Confidence 99999887332 22 234444544444433 122344455555555555543321 1123
Q ss_pred cCCCCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCCCCCCC-----------------CCccEEEcccc
Q 003140 222 LSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRI-----------------PNLGYLDLSSN 284 (845)
Q Consensus 222 l~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l-----------------~~L~~L~Ls~N 284 (845)
+..++.|+.+++++|.... .+. ...++..+.+.+|.+.........+ ......++..|
T Consensus 200 ~~~l~~L~~l~l~~n~~~~--~~~---~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~~ 274 (353)
T d1jl5a_ 200 LQNLPFLTTIYADNNLLKT--LPD---LPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSN 274 (353)
T ss_dssp CTTCTTCCEEECCSSCCSS--CCS---CCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSEESCCCTTCCEEECCSS
T ss_pred ccccccccccccccccccc--ccc---ccccccccccccccccccccccccccccccccccccccccccchhcccccccC
Confidence 5667889999999988763 332 3456778888888776543321111 12233444444
Q ss_pred cCCcCCCCCCCccccCEEEccCCcCCCCcccccCCCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCC
Q 003140 285 QLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 364 (845)
Q Consensus 285 ~l~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~ 364 (845)
.+.+. +. ...+|++|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|.. ..+|+.|++++|+|+.
T Consensus 275 ~~~~~-~~--~~~~L~~L~Ls~N~l~-~lp~---~~~~L~~L~L~~N~L~-~l~~~--------~~~L~~L~L~~N~L~~ 338 (353)
T d1jl5a_ 275 EIRSL-CD--LPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA-EVPEL--------PQNLKQLHVEYNPLRE 338 (353)
T ss_dssp CCSEE-CC--CCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCS-CCCCC--------CTTCCEEECCSSCCSS
T ss_pred ccccc-cc--cCCCCCEEECCCCccC-cccc---ccCCCCEEECCCCcCC-ccccc--------cCCCCEEECcCCcCCC
Confidence 44321 11 1248999999999999 5564 4688999999999998 67753 2357799999999999
Q ss_pred CCCCCCCCCCcEEEe
Q 003140 365 ISGSFNIPPNVTVRL 379 (845)
Q Consensus 365 i~~~~~~~~l~~l~l 379 (845)
+|.. .+.+..|++
T Consensus 339 lp~~--~~~L~~L~~ 351 (353)
T d1jl5a_ 339 FPDI--PESVEDLRM 351 (353)
T ss_dssp CCCC--CTTCCEEEC
T ss_pred CCcc--ccccCeeEC
Confidence 9863 234566654
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=1.3e-17 Score=186.48 Aligned_cols=164 Identities=18% Similarity=0.082 Sum_probs=110.8
Q ss_pred cCCCCCCcEEEccCCcCCCCC---CccccccCCCccEEEcccCCCCCCCCC------CCCCCCccEEEcccccCCcCCCC
Q 003140 222 LSELPKLLILQLDNNNFEGTT---IPASYSNMSKLLKLSLRNCSLQGPMPD------LSRIPNLGYLDLSSNQLNGSIPP 292 (845)
Q Consensus 222 l~~l~~L~~L~Ls~N~l~~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~~~------l~~l~~L~~L~Ls~N~l~~~ip~ 292 (845)
......++.|++++|.+.... ....+...+.++.+++++|.++..... ......|+.+++++|.++.....
T Consensus 251 ~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~ 330 (460)
T d1z7xw1 251 LHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCS 330 (460)
T ss_dssp TSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhh
Confidence 344678999999999986421 233456788999999999998642111 22446899999999998743222
Q ss_pred CC-----CccccCEEEccCCcCCCC----cccccC-CCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCC
Q 003140 293 GR-----LSLNITTIKLSNNKLTGT----IPSNFS-GLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNL 362 (845)
Q Consensus 293 ~~-----~~~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l 362 (845)
.. ...+|++|+|++|+|+.. +++.+. ..+.|++|+|++|+|+..-...+...-. ..+.|++|||++|+|
T Consensus 331 ~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~-~~~~L~~L~Ls~N~i 409 (460)
T d1z7xw1 331 HFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLL-ANHSLRELDLSNNCL 409 (460)
T ss_dssp HHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHH-HCCCCCEEECCSSSC
T ss_pred hcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHh-cCCCCCEEECCCCcC
Confidence 11 123799999999999753 344443 4678999999999998543333322111 134677999999999
Q ss_pred CC-----CCCCC--CCCCCcEEEecCCcccc
Q 003140 363 TN-----ISGSF--NIPPNVTVRLRGNPFCL 386 (845)
Q Consensus 363 ~~-----i~~~~--~~~~l~~l~l~~Np~~c 386 (845)
+. +...+ ....+..+.+.+|.|..
T Consensus 410 ~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~ 440 (460)
T d1z7xw1 410 GDAGILQLVESVRQPGCLLEQLVLYDIYWSE 440 (460)
T ss_dssp CHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred CHHHHHHHHHHHHhCCCccCEEECCCCCCCH
Confidence 74 11111 23468899999998864
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=3.2e-17 Score=183.32 Aligned_cols=304 Identities=17% Similarity=0.182 Sum_probs=202.4
Q ss_pred ceEeEEEecCCCCccc-CCCCccCCCCccEEEecCCCCCC----CCcccccccccchhhhccCCCCCCC----CCCccC-
Q 003140 82 LHLRELQLLNLNLSGN-LSPEIGRLSYLTILDFMWNKISG----SIPKEIGNIKSLELLLLNGNELTGS----LPEELG- 151 (845)
Q Consensus 82 ~~v~~L~L~~~~l~~~-~~~~l~~L~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~- 151 (845)
.+++.||++++++++. +..-+..++++++|+|++|+++. .+...+..+++|++|||++|+|+.. +...+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 3789999999999974 23456778999999999999873 3455678899999999999998621 222232
Q ss_pred CCCccceeecccccccCC----CCccccCccCCCEEEccCCCCCCCCcc-------------------------------
Q 003140 152 YLPKLDRIQIDQNYISGS----LPKSFANLNKTRHFHMNNNSISGQIPP------------------------------- 196 (845)
Q Consensus 152 ~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~------------------------------- 196 (845)
...+|++|+|++|+++.. ++..+..+++|++|+|++|.++.....
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 161 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccc
Confidence 235799999999999854 456788899999999999987521000
Q ss_pred --ccCCCCCcceeeccccccccC---------------------------------CCcccCCCCCCcEEEccCCcCCCC
Q 003140 197 --ELSRLPSLVHMLLDNNNLTGY---------------------------------LPPELSELPKLLILQLDNNNFEGT 241 (845)
Q Consensus 197 --~l~~l~~L~~L~L~~N~l~~~---------------------------------~p~~l~~l~~L~~L~Ls~N~l~~~ 241 (845)
.+.....++.++++++..... ....+...+.++.+++++|++...
T Consensus 162 ~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~ 241 (460)
T d1z7xw1 162 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 241 (460)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhcccccc
Confidence 011123455555555443210 000122345677777777765321
Q ss_pred ----CCccccccCCCccEEEcccCCCCCCCC-----CCCCCCCccEEEcccccCCcCCCCC------CCccccCEEEccC
Q 003140 242 ----TIPASYSNMSKLLKLSLRNCSLQGPMP-----DLSRIPNLGYLDLSSNQLNGSIPPG------RLSLNITTIKLSN 306 (845)
Q Consensus 242 ----~~p~~~~~l~~L~~L~Ls~N~l~~~~~-----~l~~l~~L~~L~Ls~N~l~~~ip~~------~~~~~L~~L~Ls~ 306 (845)
...........|+.|++++|.+..... .+...+.++.+++++|.++...... .....|+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~ 321 (460)
T d1z7xw1 242 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKS 321 (460)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred ccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccc
Confidence 112233445678888888888764322 1455678889999999886321111 1223799999999
Q ss_pred CcCCCCcccc----cCCCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCC-----CCCC-CCCCCcE
Q 003140 307 NKLTGTIPSN----FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-----SGSF-NIPPNVT 376 (845)
Q Consensus 307 N~l~~~~p~~----~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i-----~~~~-~~~~l~~ 376 (845)
|.++...... +...++|++|+|++|+++......+...-.-....|++|+|++|+|+.. ...+ ..+.+++
T Consensus 322 ~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~ 401 (460)
T d1z7xw1 322 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRE 401 (460)
T ss_dssp SCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCE
T ss_pred cchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCE
Confidence 9988654333 3456789999999999986444444332222345688999999999752 2222 3688999
Q ss_pred EEecCCccc
Q 003140 377 VRLRGNPFC 385 (845)
Q Consensus 377 l~l~~Np~~ 385 (845)
|+|++|++.
T Consensus 402 L~Ls~N~i~ 410 (460)
T d1z7xw1 402 LDLSNNCLG 410 (460)
T ss_dssp EECCSSSCC
T ss_pred EECCCCcCC
Confidence 999999875
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=9.3e-15 Score=138.87 Aligned_cols=111 Identities=20% Similarity=0.191 Sum_probs=65.7
Q ss_pred CccCCCCccEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCC
Q 003140 101 EIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180 (845)
Q Consensus 101 ~l~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 180 (845)
.+.+...|++|+|++|+|+ .++..+..+++|++|+|++|+|+ .++ .|..+++|++|+|++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 3455566677777777776 34545556666777777777766 332 36666666666666666664444445556666
Q ss_pred CEEEccCCCCCCCCc--cccCCCCCcceeeccccccc
Q 003140 181 RHFHMNNNSISGQIP--PELSRLPSLVHMLLDNNNLT 215 (845)
Q Consensus 181 ~~L~L~~N~l~~~~p--~~l~~l~~L~~L~L~~N~l~ 215 (845)
+.|++++|+|+. ++ ..+..+++|++|++++|.++
T Consensus 90 ~~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 90 TELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp CEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG
T ss_pred ccceeccccccc-cccccccccccccchhhcCCCccc
Confidence 666666666652 22 23445555555555555554
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.48 E-value=2.9e-14 Score=128.84 Aligned_cols=102 Identities=24% Similarity=0.341 Sum_probs=53.1
Q ss_pred cEEEecCCCCCCCCcccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCC
Q 003140 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN 188 (845)
Q Consensus 109 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 188 (845)
|.|+|++|+++ .++ .+.++++|++|+|++|+|+ .+|..++.+++|++|++++|+|++ +| .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 34566666665 333 3555666666666666665 445555555666666666665553 22 2555555555555555
Q ss_pred CCCCCC-ccccCCCCCcceeeccccccc
Q 003140 189 SISGQI-PPELSRLPSLVHMLLDNNNLT 215 (845)
Q Consensus 189 ~l~~~~-p~~l~~l~~L~~L~L~~N~l~ 215 (845)
+|+... ...+..+++|++|++++|+++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 554221 123444445555555555444
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=9.8e-15 Score=138.73 Aligned_cols=112 Identities=25% Similarity=0.261 Sum_probs=68.2
Q ss_pred cccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCc
Q 003140 125 EIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204 (845)
Q Consensus 125 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 204 (845)
.+.+..+|++|+|++|+|+ .++..+..+++|+.|+|++|+|+. + +.+..+++|++|++++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-c-CCcccCcchhhhhcccccccCCCcccccccccc
Confidence 3556667777777777777 456656667777777777777763 3 246666666666666666664433444556666
Q ss_pred ceeeccccccccCCC-cccCCCCCCcEEEccCCcCC
Q 003140 205 VHMLLDNNNLTGYLP-PELSELPKLLILQLDNNNFE 239 (845)
Q Consensus 205 ~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~ 239 (845)
++|++++|+++.... ..+..+++|++|++++|.++
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred ccceeccccccccccccccccccccchhhcCCCccc
Confidence 666666666653211 23455555556666555554
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.47 E-value=6.4e-14 Score=126.52 Aligned_cols=101 Identities=27% Similarity=0.435 Sum_probs=50.0
Q ss_pred hhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeecccc
Q 003140 133 ELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNN 212 (845)
Q Consensus 133 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 212 (845)
|+|+|++|+++ .++ .+..+++|++|+|++|+|+ .+|..+..+++|+.|++++|+|+. +| .+..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 34566666665 333 2555555555555555555 344455555555555555555552 22 2444555555555555
Q ss_pred ccccCC-CcccCCCCCCcEEEccCCcC
Q 003140 213 NLTGYL-PPELSELPKLLILQLDNNNF 238 (845)
Q Consensus 213 ~l~~~~-p~~l~~l~~L~~L~Ls~N~l 238 (845)
+++... ...+..+++|++|++++|++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i 102 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSL 102 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcC
Confidence 544221 12344444444444444444
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=1.4e-13 Score=129.75 Aligned_cols=111 Identities=19% Similarity=0.223 Sum_probs=79.6
Q ss_pred ccCEEEccCC-cCCCCcccccCCCCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCCCCCCC-CCCCCc
Q 003140 298 NITTIKLSNN-KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNV 375 (845)
Q Consensus 298 ~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~i~~~~-~~~~l~ 375 (845)
+|+.|++++| .|+...+..|.++++|+.|+|++|+|+...|..|..+.+ |+.|+|++|+|++++... ....+.
T Consensus 32 ~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~-----L~~L~Ls~N~l~~l~~~~~~~~~l~ 106 (156)
T d2ifga3 32 NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR-----LSRLNLSFNALESLSWKTVQGLSLQ 106 (156)
T ss_dssp CCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSC-----CCEEECCSSCCSCCCSTTTCSCCCC
T ss_pred ccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccc-----ccceeccCCCCcccChhhhcccccc
Confidence 5555555444 355555667888888888888888888666666765544 458888888888888764 456789
Q ss_pred EEEecCCcccccCCCccccCCCCCCCcccccCCCCCCCcCC
Q 003140 376 TVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRA 416 (845)
Q Consensus 376 ~l~l~~Np~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (845)
.|+|++|||.|+|.+.++..|.......+. ...+.|.+
T Consensus 107 ~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~---~~~~~C~~ 144 (156)
T d2ifga3 107 ELVLSGNPLHCSCALRWLQRWEEEGLGGVP---EQKLQCHG 144 (156)
T ss_dssp EEECCSSCCCCCGGGHHHHHHHHTTCSSCG---GGCCCCSS
T ss_pred ccccCCCcccCCchHHHHHHHHHhccCccC---cCCcEECc
Confidence 999999999999999999887744333322 24456665
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.44 E-value=2.7e-15 Score=161.61 Aligned_cols=92 Identities=16% Similarity=0.159 Sum_probs=48.0
Q ss_pred CCCccCCCCccEEEecCCCCCCC----CcccccccccchhhhccCCCCCCCC----------CCccCCCCccceeecccc
Q 003140 99 SPEIGRLSYLTILDFMWNKISGS----IPKEIGNIKSLELLLLNGNELTGSL----------PEELGYLPKLDRIQIDQN 164 (845)
Q Consensus 99 ~~~l~~L~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----------p~~~~~l~~L~~L~Ls~N 164 (845)
...+.....|++|+|++|.+... +-..+...++|+.|+++++.+.... ...+...++|+.|+|++|
T Consensus 24 ~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n 103 (344)
T d2ca6a1 24 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDN 103 (344)
T ss_dssp SHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSC
T ss_pred HHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccc
Confidence 34556677777788877776532 2233455667777777766543111 111233455555555555
Q ss_pred cccCC----CCccccCccCCCEEEccCCCC
Q 003140 165 YISGS----LPKSFANLNKTRHFHMNNNSI 190 (845)
Q Consensus 165 ~l~~~----~p~~~~~l~~L~~L~L~~N~l 190 (845)
.++.. +...+...++|+.|++++|.+
T Consensus 104 ~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l 133 (344)
T d2ca6a1 104 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGL 133 (344)
T ss_dssp CCCTTTHHHHHHHHHHCTTCCEEECCSSCC
T ss_pred ccccccccchhhhhcccccchheecccccc
Confidence 55432 222233445555555555544
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=7.2e-15 Score=153.63 Aligned_cols=219 Identities=18% Similarity=0.225 Sum_probs=121.7
Q ss_pred cEEEecCCCCCCCCcccccccc--cchhhhccCCCCCCCCCCccCCCCccceeecccccccCC-CCccccCccCCCEEEc
Q 003140 109 TILDFMWNKISGSIPKEIGNIK--SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGS-LPKSFANLNKTRHFHM 185 (845)
Q Consensus 109 ~~L~L~~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L 185 (845)
++|||+++.+. |..++.+. .+..+.++.+.+... ........+|++|||+++.++.. +...+.++++|++|+|
T Consensus 3 ~~lDLs~~~l~---~~~l~~l~~~~~~~lrl~~~~~~~~-~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L 78 (284)
T d2astb2 3 QTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQP-LAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSL 78 (284)
T ss_dssp SEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSC-CCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEEC
T ss_pred CEEECCCCCCC---chHHHHHHhccceEeeccccccccc-hhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccc
Confidence 35666666654 33333221 233344444444422 22233445677777777766533 3445666777777777
Q ss_pred cCCCCCCCCccccCCCCCcceeecccc-ccccC-CCcccCCCCCCcEEEccCC-cCCCCCCcccccc-CCCccEEEcccC
Q 003140 186 NNNSISGQIPPELSRLPSLVHMLLDNN-NLTGY-LPPELSELPKLLILQLDNN-NFEGTTIPASYSN-MSKLLKLSLRNC 261 (845)
Q Consensus 186 ~~N~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~-~p~~l~~l~~L~~L~Ls~N-~l~~~~~p~~~~~-l~~L~~L~Ls~N 261 (845)
++|.++...+..++.+++|++|+++++ .++.. +...+..+++|++|+|+++ .++...+...+.. .++|+.|+++++
T Consensus 79 ~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~ 158 (284)
T d2astb2 79 EGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY 158 (284)
T ss_dssp TTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSC
T ss_pred cccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccc
Confidence 777776555666667777777777774 44421 1111234667777777764 3432122222333 356777777654
Q ss_pred C--CCCC-CCC-CCCCCCccEEEcccc-cCCcCCCCCC-CccccCEEEccCC-cCCCCcccccCCCCCCCeEecccc
Q 003140 262 S--LQGP-MPD-LSRIPNLGYLDLSSN-QLNGSIPPGR-LSLNITTIKLSNN-KLTGTIPSNFSGLPRLQRLFIANN 331 (845)
Q Consensus 262 ~--l~~~-~~~-l~~l~~L~~L~Ls~N-~l~~~ip~~~-~~~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N 331 (845)
. ++.. ... ...+++|+.|++++| .+++...... ...+|++|+|++| .++......++++++|+.|+++++
T Consensus 159 ~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 159 RKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp GGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred ccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 2 2221 111 234567777777765 3443332222 2236777777774 566666667778888888888877
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.41 E-value=1.3e-15 Score=164.12 Aligned_cols=241 Identities=17% Similarity=0.198 Sum_probs=103.5
Q ss_pred ccccccccchhhhccCCCCCCC----CCCccCCCCccceeecccccccCC----------CCccccCccCCCEEEccCCC
Q 003140 124 KEIGNIKSLELLLLNGNELTGS----LPEELGYLPKLDRIQIDQNYISGS----------LPKSFANLNKTRHFHMNNNS 189 (845)
Q Consensus 124 ~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----------~p~~~~~l~~L~~L~L~~N~ 189 (845)
..+.+..+|++|+|++|.++.. +-..+...++|+.|+++++.+... +...+...++|+.|+|++|.
T Consensus 25 ~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~ 104 (344)
T d2ca6a1 25 AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA 104 (344)
T ss_dssp HHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCC
T ss_pred HHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccc
Confidence 3344445555555555554321 122234445555555554433211 11223334555555555555
Q ss_pred CCCCC----ccccCCCCCcceeeccccccccCCCc-------------ccCCCCCCcEEEccCCcCCCC---CCcccccc
Q 003140 190 ISGQI----PPELSRLPSLVHMLLDNNNLTGYLPP-------------ELSELPKLLILQLDNNNFEGT---TIPASYSN 249 (845)
Q Consensus 190 l~~~~----p~~l~~l~~L~~L~L~~N~l~~~~p~-------------~l~~l~~L~~L~Ls~N~l~~~---~~p~~~~~ 249 (845)
++..- ...+...++|+.|++++|.+...... .....+.|+.|++++|+++.. .+...+..
T Consensus 105 i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~ 184 (344)
T d2ca6a1 105 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184 (344)
T ss_dssp CCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHH
T ss_pred cccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhh
Confidence 54321 12223345555555555544311000 011234455555555555321 11222334
Q ss_pred CCCccEEEcccCCCCCC------CCCCCCCCCccEEEcccccCCcCC----CC-CCCccccCEEEccCCcCCCCcccc--
Q 003140 250 MSKLLKLSLRNCSLQGP------MPDLSRIPNLGYLDLSSNQLNGSI----PP-GRLSLNITTIKLSNNKLTGTIPSN-- 316 (845)
Q Consensus 250 l~~L~~L~Ls~N~l~~~------~~~l~~l~~L~~L~Ls~N~l~~~i----p~-~~~~~~L~~L~Ls~N~l~~~~p~~-- 316 (845)
.+.|+.|+|++|+++.. ...+...++|+.|+|++|.++... .. .....+|++|+|++|.|++.....
T Consensus 185 ~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~ 264 (344)
T d2ca6a1 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVV 264 (344)
T ss_dssp CTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHH
T ss_pred hhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHH
Confidence 45555555555555431 112444555555555555553210 00 011224555556555555432222
Q ss_pred --cCC--CCCCCeEecccccCcccCChhhhhhccCCCCcceEEEccCCCCCC
Q 003140 317 --FSG--LPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 364 (845)
Q Consensus 317 --~~~--l~~L~~L~L~~N~l~~~ip~~l~~l~~l~~~~l~~L~ls~N~l~~ 364 (845)
+.. .+.|++|+|++|+|+......+.....-+.+.|+.|+|++|++..
T Consensus 265 ~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 265 DAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 221 244666666666655433333332211123345566666666643
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.35 E-value=9.6e-15 Score=152.66 Aligned_cols=58 Identities=19% Similarity=0.210 Sum_probs=27.9
Q ss_pred CCccEEEecCCCCCCC-CcccccccccchhhhccCCCCCCCCCCccCCCCccceeeccc
Q 003140 106 SYLTILDFMWNKISGS-IPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQ 163 (845)
Q Consensus 106 ~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 163 (845)
.+|++|||++|.+++. +...+.++++|++|+|++|.+++..+..++.+++|++|+|++
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~ 104 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 104 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence 3455555555544421 222344455555555555555444444444555555555554
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.29 E-value=1.9e-14 Score=141.54 Aligned_cols=110 Identities=21% Similarity=0.327 Sum_probs=44.1
Q ss_pred ccccccccchhhhccCCCCCCCCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCC
Q 003140 124 KEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPS 203 (845)
Q Consensus 124 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 203 (845)
.++..+++|++|+|++|+|+ .++ .+..+++|++|+|++|.|+ .+|..+..+++|+.|++++|+++. + +.+..+++
T Consensus 42 ~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~~ 116 (198)
T d1m9la_ 42 ATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKLVN 116 (198)
T ss_dssp HHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHHHH
T ss_pred hHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-cccccccc
Confidence 33444444444444444444 222 2444444444444444443 223323333344444444444432 1 12333444
Q ss_pred cceeeccccccccCCC-cccCCCCCCcEEEccCCcC
Q 003140 204 LVHMLLDNNNLTGYLP-PELSELPKLLILQLDNNNF 238 (845)
Q Consensus 204 L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l 238 (845)
|++|++++|+++.... ..+..+++|+.|+|++|++
T Consensus 117 L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l 152 (198)
T d1m9la_ 117 LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPL 152 (198)
T ss_dssp SSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHH
T ss_pred ccccccccchhccccccccccCCCccceeecCCCcc
Confidence 4444444444442111 2244444444444444444
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.26 E-value=1.5e-14 Score=142.38 Aligned_cols=131 Identities=21% Similarity=0.306 Sum_probs=95.3
Q ss_pred CCCCccCCCCccceeecccccccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccccccccCCCcccCC
Q 003140 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSE 224 (845)
Q Consensus 145 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~ 224 (845)
.+|..+..+++|++|+|++|+|+. ++ .+.++++|+.|+|++|+|+ .+|.....+++|++|++++|+++.. ..+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHH
T ss_pred hhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--ccccc
Confidence 445667888899999999999884 43 5888888999999999887 5565555567788888888888843 34677
Q ss_pred CCCCcEEEccCCcCCCCCCccccccCCCccEEEcccCCCCCCCCC-----------CCCCCCccEEE
Q 003140 225 LPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-----------LSRIPNLGYLD 280 (845)
Q Consensus 225 l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-----------l~~l~~L~~L~ 280 (845)
+++|+.|+|++|+++.......+..+++|+.|+|++|++....+. +..+++|+.||
T Consensus 114 l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred cccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 788888888888887421224577788888888888877654332 23466676665
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.22 E-value=8.3e-12 Score=117.26 Aligned_cols=105 Identities=16% Similarity=0.126 Sum_probs=55.7
Q ss_pred hhhhccCCCCCCCCCCccCCCCccceeecccc-cccCCCCccccCccCCCEEEccCCCCCCCCccccCCCCCcceeeccc
Q 003140 133 ELLLLNGNELTGSLPEELGYLPKLDRIQIDQN-YISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDN 211 (845)
Q Consensus 133 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 211 (845)
+.++++++.+. ..|..+..+++|++|+|++| .|+...+..|.++++|+.|+|++|+|+...+.+|..+++|++|+|++
T Consensus 11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 34445555544 34445555555555555443 35544445555556666666666665544455555666666666666
Q ss_pred cccccCCCcccCCCCCCcEEEccCCcCC
Q 003140 212 NNLTGYLPPELSELPKLLILQLDNNNFE 239 (845)
Q Consensus 212 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 239 (845)
|+|+. +|.......+|+.|+|++|.+.
T Consensus 90 N~l~~-l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 90 NALES-LSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp SCCSC-CCSTTTCSCCCCEEECCSSCCC
T ss_pred CCCcc-cChhhhccccccccccCCCccc
Confidence 66653 3332222335666666666654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.43 E-value=4.3e-07 Score=92.00 Aligned_cols=149 Identities=14% Similarity=0.102 Sum_probs=101.7
Q ss_pred HHHHHhcCCCCCccccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCeEE
Q 003140 618 EMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQM 696 (845)
Q Consensus 618 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~ 696 (845)
++...-..|...+..+.++.+.||+... +++.+.+|+...........+.+|..++..+. +--+.+++.+..+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 3444445666666555555678998875 45667788776543333445778888888774 444678888888889999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 003140 697 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA---------------------------------- 742 (845)
Q Consensus 697 LV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------- 742 (845)
+||+++++.++.+..... . ....++.++++.+..||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEECCSSEEHHHHTTTC----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEEeccccccccccccc----c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 999999998886544211 1 12234555566666666421
Q ss_pred ----------------------CCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003140 743 ----------------------DPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (845)
Q Consensus 743 ----------------------~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~ 774 (845)
.+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12378999999999999877778999998753
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.37 E-value=7.6e-09 Score=97.27 Aligned_cols=8 Identities=50% Similarity=0.841 Sum_probs=3.6
Q ss_pred cCCCccEE
Q 003140 249 NMSKLLKL 256 (845)
Q Consensus 249 ~l~~L~~L 256 (845)
.+++|+.|
T Consensus 144 ~~P~L~~L 151 (162)
T d1koha1 144 RFPKLLRL 151 (162)
T ss_dssp TSTTCCEE
T ss_pred HCCCCCEE
Confidence 34444444
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.36 E-value=1.7e-08 Score=94.72 Aligned_cols=10 Identities=50% Similarity=0.693 Sum_probs=5.3
Q ss_pred CCCCCccEEE
Q 003140 271 SRIPNLGYLD 280 (845)
Q Consensus 271 ~~l~~L~~L~ 280 (845)
..+|+|+.||
T Consensus 143 ~~~P~L~~LD 152 (162)
T d1koha1 143 ERFPKLLRLD 152 (162)
T ss_dssp TTSTTCCEET
T ss_pred HHCCCCCEEC
Confidence 4455565554
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.95 E-value=7.1e-06 Score=82.25 Aligned_cols=141 Identities=21% Similarity=0.209 Sum_probs=85.5
Q ss_pred cccccCc-eEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcC--CCceeeEEEEEeeCCeEEEEEEcCCCCCH
Q 003140 631 QIGQGGY-GKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH--HRNLVSLVGYCDEEGEQMLVYEFMSNGTL 707 (845)
Q Consensus 631 ~LG~G~f-G~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~LV~E~~~~gsL 707 (845)
.+..|.. +.||+...+++..+.+|....... .++..|.+.++.+. .-.+.+++++..+.+..++||||+++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3445543 679999888888889998665432 24667888777763 33466788888888899999999987554
Q ss_pred HH--------------HH---hccC--CCCC--CHHHHHHHH--------------------HHHHHHHHHHHhC----C
Q 003140 708 RD--------------QL---SAKS--KEPL--GFAMRLSIA--------------------LGSSRGILYLHTE----A 742 (845)
Q Consensus 708 ~~--------------~l---~~~~--~~~l--~~~~~~~i~--------------------~~ia~gL~yLH~~----~ 742 (845)
.+ .+ |... ..++ .+.....-. ......+..+... .
T Consensus 94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred ccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence 22 11 1100 0000 010000000 0011122333222 1
Q ss_pred CCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003140 743 DPPVFHRDIKASNILLDHKFTAKVADFGLSRL 774 (845)
Q Consensus 743 ~~~iiHrDLk~~NILl~~~~~~kl~DFGla~~ 774 (845)
.+.++|+|+.|.|||++++..+-|+||+.+..
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 22379999999999999887788999998753
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.40 E-value=2.4e-05 Score=72.97 Aligned_cols=65 Identities=22% Similarity=0.220 Sum_probs=28.2
Q ss_pred ccCccCCCEEEccCCCCCC----CCccccCCCCCcceeeccccccccC----CCcccCCCCCCcEEEccCCcC
Q 003140 174 FANLNKTRHFHMNNNSISG----QIPPELSRLPSLVHMLLDNNNLTGY----LPPELSELPKLLILQLDNNNF 238 (845)
Q Consensus 174 ~~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l 238 (845)
+...++|++|+|++|.+.. .+...+...+.|++|+|++|.++.. +...+...++|++|+|++|++
T Consensus 40 L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~ 112 (167)
T d1pgva_ 40 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQ 112 (167)
T ss_dssp HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSS
T ss_pred HhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcC
Confidence 3344445555555555431 1112223344555555555554421 112334444555555555543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.37 E-value=1.1e-05 Score=75.34 Aligned_cols=63 Identities=19% Similarity=0.274 Sum_probs=28.2
Q ss_pred CCCccEEEecCC-CCCCC----CcccccccccchhhhccCCCCCCC----CCCccCCCCccceeeccccccc
Q 003140 105 LSYLTILDFMWN-KISGS----IPKEIGNIKSLELLLLNGNELTGS----LPEELGYLPKLDRIQIDQNYIS 167 (845)
Q Consensus 105 L~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 167 (845)
.++|++|+|+++ .++.. +-..+...++|++|+|++|.++.. +...+...+.|++|+|++|.|+
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 85 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence 456666666653 34321 122334445555555555555411 1112223344555555555544
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.32 E-value=0.00024 Score=75.68 Aligned_cols=76 Identities=17% Similarity=0.089 Sum_probs=48.6
Q ss_pred CccccccCceEEEEEEeCC-CcEEEEEEccCC-------ChhhHHHHHHHHHHHHhc-CC--CceeeEEEEEeeCCeEEE
Q 003140 629 STQIGQGGYGKVYKGILPD-GTVVAVKRAQEG-------SLQGEKEFLTEIQFLSRL-HH--RNLVSLVGYCDEEGEQML 697 (845)
Q Consensus 629 ~~~LG~G~fG~Vy~~~~~~-g~~vAVK~~~~~-------~~~~~~~~~~Ei~~l~~l-~H--~nIv~l~g~~~~~~~~~L 697 (845)
.+.||.|....||+....+ ++.|+||...+. ......+...|.+.++.+ .+ ..+++++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3568999999999998754 678999964321 111223455688887766 23 345566655 4455679
Q ss_pred EEEcCCCCC
Q 003140 698 VYEFMSNGT 706 (845)
Q Consensus 698 V~E~~~~gs 706 (845)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.61 E-value=0.0027 Score=65.41 Aligned_cols=66 Identities=20% Similarity=0.185 Sum_probs=46.2
Q ss_pred eEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCce--eeEE-----EEEeeCCeEEEEEEcCCC
Q 003140 638 GKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL--VSLV-----GYCDEEGEQMLVYEFMSN 704 (845)
Q Consensus 638 G~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nI--v~l~-----g~~~~~~~~~LV~E~~~~ 704 (845)
-.||++..++|+.+++|+..+. ....+++..|.+.+..+....+ +..+ ......+..+.++++++|
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 4799999999999999998763 3345678888888887742222 1111 123456778899999976
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.22 E-value=0.00019 Score=66.49 Aligned_cols=15 Identities=7% Similarity=0.118 Sum_probs=6.5
Q ss_pred CccCCCEEEccCCCC
Q 003140 176 NLNKTRHFHMNNNSI 190 (845)
Q Consensus 176 ~l~~L~~L~L~~N~l 190 (845)
..++|+.|+|++|.+
T Consensus 44 ~n~~L~~L~Ls~n~l 58 (166)
T d1io0a_ 44 TNTYVKKFSIVGTRS 58 (166)
T ss_dssp TCCSCCEEECTTSCC
T ss_pred cCCccCeeeccCCcc
Confidence 334444444444444
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.21 E-value=0.0001 Score=68.41 Aligned_cols=16 Identities=19% Similarity=0.169 Sum_probs=8.8
Q ss_pred cCCCCCCcEEEccCCc
Q 003140 222 LSELPKLLILQLDNNN 237 (845)
Q Consensus 222 l~~l~~L~~L~Ls~N~ 237 (845)
+...++|+.|+++.+.
T Consensus 128 L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 128 LEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHHCSSCCEEECCCSS
T ss_pred HHhCCCcCEEeCcCCC
Confidence 3445566666665543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.90 E-value=0.0063 Score=64.31 Aligned_cols=72 Identities=14% Similarity=0.122 Sum_probs=48.7
Q ss_pred CccccccCceEEEEEEeCCC--------cEEEEEEccCCChhhHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCeEEEEE
Q 003140 629 STQIGQGGYGKVYKGILPDG--------TVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVY 699 (845)
Q Consensus 629 ~~~LG~G~fG~Vy~~~~~~g--------~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~LV~ 699 (845)
.+.|+.|-.=.+|+....++ +.|.+++.... ....+..+|.++++.+. +.-..++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 35688888889999886543 45667665432 22335567888888884 4444578887753 5899
Q ss_pred EcCCCCC
Q 003140 700 EFMSNGT 706 (845)
Q Consensus 700 E~~~~gs 706 (845)
||+++..
T Consensus 121 efi~g~~ 127 (395)
T d1nw1a_ 121 EYIPSRP 127 (395)
T ss_dssp CCCCEEE
T ss_pred EEecccc
Confidence 9998643
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.38 E-value=0.076 Score=53.50 Aligned_cols=157 Identities=11% Similarity=0.084 Sum_probs=81.4
Q ss_pred cchHHHHHHhcCCCCCcc-----ccccCceEEEEEEeCCCcEEEEEEccCCChhhHHHHHHHHHHHHhcCCCce--eeEE
Q 003140 614 FTYGEMALATNNFNSSTQ-----IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL--VSLV 686 (845)
Q Consensus 614 ~~~~~~~~~~~~f~~~~~-----LG~G~fG~Vy~~~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~~l~~l~H~nI--v~l~ 686 (845)
.+.++++....+|...+. |..|---+.|+....+|+ +++|++.... ..++...|++++..+...++ ...+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 345667777777876543 345666778998877665 7888875432 22344556666666632221 1111
Q ss_pred E------EEeeCCeEEEEEEcCCCCCHH--------------HHHhcc----C---CCCCCH------------------
Q 003140 687 G------YCDEEGEQMLVYEFMSNGTLR--------------DQLSAK----S---KEPLGF------------------ 721 (845)
Q Consensus 687 g------~~~~~~~~~LV~E~~~~gsL~--------------~~l~~~----~---~~~l~~------------------ 721 (845)
. +....+....++.++.+.... ..++.. . ......
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1 123345667777777653221 011100 0 000000
Q ss_pred HHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003140 722 AMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSR 773 (845)
Q Consensus 722 ~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDLk~~NILl~~~~~~kl~DFGla~ 773 (845)
......+..+...+.-.+. .....+||+|+.++||+++.+...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0011112222222222221 123349999999999999998878899999875
|